0001564590-22-011706.txt : 20220324 0001564590-22-011706.hdr.sgml : 20220324 20220324172932 ACCESSION NUMBER: 0001564590-22-011706 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220324 DATE AS OF CHANGE: 20220324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 22767600 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 10-K 1 etnb-10k_20211231.htm 10-K etnb-10k_20211231.htm
false FY 0001785173 --12-31 P3Y 2019-06-30 P4Y P3Y P1Y 0 0 0 P5Y6M P4Y 0.869 0.864 0.007 0.002 P6Y1M6D P6Y1M6D 0.919 0.976 0.013 0.015 P8Y7M6D P8Y1M6D P7Y3M18D 0001785173 2021-01-01 2021-12-31 iso4217:USD 0001785173 2021-06-30 xbrli:shares 0001785173 2022-03-01 0001785173 2021-12-31 0001785173 2020-12-31 iso4217:USD xbrli:shares 0001785173 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember 2019-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001785173 us-gaap:RetainedEarningsMember 2019-12-31 0001785173 2019-12-31 0001785173 us-gaap:CommonStockMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001785173 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember 2020-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001785173 us-gaap:RetainedEarningsMember 2020-12-31 0001785173 us-gaap:CommonStockMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001785173 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001785173 us-gaap:CommonStockMember 2021-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001785173 us-gaap:RetainedEarningsMember 2021-12-31 0001785173 etnb:ConvertiblePreferredSharesMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 etnb:ConvertiblePreferredSharesMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001785173 etnb:UnderwrittenPublicOfferingMember us-gaap:CommonStockMember 2020-07-01 2020-07-31 0001785173 etnb:UnderwrittenPublicOfferingMember us-gaap:CommonStockMember 2020-07-31 0001785173 etnb:UnderwrittenPublicOfferingMember us-gaap:CommonStockMember 2020-09-01 2020-09-30 0001785173 etnb:UnderwrittenPublicOfferingMember us-gaap:CommonStockMember 2020-09-30 0001785173 etnb:ATMFacilityMember srt:MaximumMember 2021-03-01 2021-03-31 xbrli:pure 0001785173 etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember 2021-03-31 0001785173 etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember 2021-10-01 2021-12-31 etnb:Segment 0001785173 srt:MinimumMember 2021-01-01 2021-12-31 0001785173 srt:MaximumMember 2021-01-01 2021-12-31 0001785173 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AgencySecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashEquivalentsMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ShortTermInvestmentsMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AgencySecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryBillSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member etnb:AgencyDiscountSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashEquivalentsMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ShortTermInvestmentsMember 2020-12-31 0001785173 2018-05-01 2018-05-31 0001785173 2018-05-31 0001785173 etnb:SanFranciscoOfficeMember 2019-12-01 2019-12-31 0001785173 etnb:SanFranciscoOfficeMember 2020-01-01 2020-12-31 0001785173 etnb:SanFranciscoOfficeMember 2021-12-31 0001785173 etnb:RestrictedCashAndOtherAssetsMember 2021-12-31 0001785173 etnb:RestrictedCashAndOtherAssetsMember 2020-12-31 0001785173 etnb:TevaAgreementMember 2018-04-01 2018-04-30 0001785173 etnb:TevaAgreementMember etnb:TevasGlycoPEGylatedFGF21ProgramMember 2018-04-01 2018-04-30 0001785173 etnb:TevaAgreementMember etnb:TevasDevelopmentProgramMember 2018-04-01 2018-04-30 0001785173 etnb:TevaAgreementMember 2021-01-01 2021-12-31 0001785173 etnb:TevaAgreementMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001785173 etnb:TevaAgreementMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001785173 etnb:LoanAndSecurityAgreementMember etnb:TermALoanFacilityMember 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember etnb:TermBLoanFacilityMember 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember 2020-04-01 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:OtherAssetsMember 2020-04-30 0001785173 2020-04-01 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember etnb:TermALoanFacilityMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember 2021-05-01 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember srt:MaximumMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember etnb:TermBLoanFacilityMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember etnb:TermALoanFacilityMember 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember etnb:TermALoanFacilityMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember srt:MinimumMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:PrimeRateMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:MeasurementInputExpectedDividendPaymentMember 2021-05-01 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-05-01 2021-05-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2021-01-01 2021-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember srt:MaximumMember 2021-01-01 2021-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2021-12-31 0001785173 us-gaap:EmployeeStockMember 2019-10-01 2019-10-31 0001785173 srt:MaximumMember us-gaap:EmployeeStockMember 2019-10-01 2019-10-31 0001785173 us-gaap:EmployeeStockMember 2021-12-31 0001785173 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001785173 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001785173 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001785173 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001785173 srt:MinimumMember 2020-01-01 2020-12-31 0001785173 srt:MaximumMember 2020-01-01 2020-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2020-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2020-01-01 2020-12-31 0001785173 etnb:TwoThousandAndTwentyEquityIncentivePlanMember 2021-01-01 2021-12-31 0001785173 etnb:TwoThousandAndTwentyEquityIncentivePlanMember 2020-01-01 2020-12-31 0001785173 etnb:ServiceBasedRSUsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-02-01 2021-02-28 0001785173 etnb:ServiceBasedRSUsMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-01-01 2021-12-31 0001785173 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001785173 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001785173 etnb:PerformanceRSUsMember srt:ExecutiveOfficerMember 2021-02-01 2021-02-28 0001785173 etnb:PerformanceRSUsMember srt:ExecutiveOfficerMember 2021-01-01 2021-12-31 0001785173 etnb:EightyNineBioLtdMember 2021-01-01 2021-12-31 0001785173 etnb:EightyNineBioLtdMember 2020-01-01 2020-12-31 0001785173 etnb:EightyNineBioManagementIncorporationMember 2021-01-01 2021-12-31 0001785173 etnb:EightyNineBioManagementIncorporationMember 2020-01-01 2020-12-31 0001785173 etnb:UABEightyNineBioLithuaniaMember 2021-01-01 2021-12-31 0001785173 etnb:UABEightyNineBioLithuaniaMember 2020-01-01 2020-12-31 0001785173 country:US 2021-12-31 0001785173 country:US 2020-12-31 0001785173 country:IL 2021-12-31 0001785173 country:IL 2020-12-31 0001785173 country:IL 2020-01-01 2020-12-31 0001785173 country:US 2021-01-01 2021-12-31 0001785173 country:US 2020-01-01 2020-12-31 0001785173 country:LT 2021-01-01 2021-12-31 0001785173 country:LT 2020-01-01 2020-12-31 0001785173 country:IL 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001785173 etnb:UnvestedRestrictedStockUnitsMember 2021-01-01 2021-12-31 0001785173 us-gaap:WarrantMember 2021-01-01 2021-12-31

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO                     

Commission File Number 001-39122

 

89bio, Inc.

(Exact name of Registrant as specified in its Charter)

 

 

Delaware

 

36-4946844

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

142 Sansome Street, Second Floor

San Francisco, California 94104

 

94104

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (415) 432-9270

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange on which registered

Common stock, par value $0.001 per share

 

ETNB

 

Nasdaq Global Market

 

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes ☐ No ☒

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

☐

  

Accelerated filer

 

☐

 

 

 

 

 

 

 

Non-accelerated filer

 

☒

  

Smaller reporting company

 

☒

 

 

 

 

 

 

 

Emerging growth company

 

☒

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The Nasdaq Global Market on June 30, 2021, the last business day of the Registrant’s most recently completed second fiscal quarter, was approximately $165.5 million. Shares of common stock held by each officer and director and by each person who is known to own 10% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates of the Registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

 

The number of shares of Registrant’s common stock outstanding as of March 1, 2022 was 20,351,384.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement relating to its 2022 Annual Meeting of Stockholders, to be held on or about June 1, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.

Auditor Firm Id:

185

Auditor Name:

KPMG LLP

Auditor Location:

San Francisco, California, USA

 

 

 

Table of Contents

 

 

 

Page

PART I

 

 

Item 1.

Business

5

Item 1A.

Risk Factors

33

Item 1B.

Unresolved Staff Comments

54

Item 2.

Properties

54

Item 3.

Legal Proceedings

54

Item 4.

Mine Safety Disclosures

54

 

 

 

PART II

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

55

Item 6.

[Reserved]

55

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

56

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

64

Item 8.

Financial Statements and Supplementary Data

65

Item 9.

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

86

Item 9A.

Controls and Procedures

86

Item 9B.

Other Information

87

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

87

 

 

 

PART III

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

88

Item 11.

Executive Compensation

88

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

88

Item 13.

Certain Relationships and Related Transactions, and Director Independence

88

Item 14.

Principal Accounting Fees and Services

88

 

 

 

PART IV

 

 

Item 15.

Exhibits, Financial Statement Schedules

89

Item 16.

Form 10-K Summary

92

 

 

 

SIGNATURES

93

 

 

2

 

 

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains “forward-looking statements” within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. All statements, other than statements of historical facts included in this Annual Report on Form 10-K, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, financing needs, plans or intentions relating to acquisitions, business trends and other information referred to in “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “design,” “estimate,” “predict,” “potential,” “plan,” “anticipate,” “target,” “forecast,” or the negative of these terms, and similar expressions intended to identify forward-looking statements. Forward-looking statements are not historical facts and reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from the forward-looking statements contained in this Annual Report on Form 10-K. Such risks, uncertainties and other important factors include, among others, the risks, uncertainties and factors set forth in “Risk Factors,” and the following risks, uncertainties and factors:

 

•

our plans to develop and commercialize pegozafermin (previously BIO89-100) or any future product candidates;

 

•

our ongoing and planned clinical trials;

 

•

the timing of and our ability to obtain regulatory approvals for pegozafermin or any future product candidates;

 

•

the effect of the ongoing COVID-19 pandemic on our business;

 

•

our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;

 

•

our ability to identify additional products or product candidates with significant commercial potential that are consistent with our commercial objectives;

 

•

the rate and degree of market acceptance and clinical utility of pegozafermin or any future product candidates, if approved;

 

•

our commercialization, marketing and manufacturing capabilities and strategy;

 

•

substantial competition in our industry and with respect to the product candidates that we are developing;

 

•

our intellectual property position;

 

•

loss of key members of management;

 

•

failure to successfully execute our growth strategy, including any delays in our planned future growth; and

 

•

our failure to maintain effective internal controls.

There may be other factors that may cause our actual results to differ materially from the forward-looking statements, including factors disclosed in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You should evaluate all forward-looking statements made in this Annual Report on Form 10-K in the context of these risks and uncertainties.

3

 

We caution you that the risks, uncertainties and other factors referred to above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. All forward-looking statements in this Annual Report on Form 10-K apply only as of the date made and are expressly qualified in their entirety by the cautionary statements included in this Annual Report on Form 10-K. We undertake no obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

 

4

 

 

PART I

In this Annual Report on Form 10-K, unless context otherwise requires or where otherwise indicated, the terms “89bio” “we,” “us,” “our,” “our company,” “the company,” and “our business” refer to 89bio, Inc. and its consolidated subsidiaries.

Item 1. Business.

Overview

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Our lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (“FGF21”), is currently being developed for the treatment of nonalcoholic steatohepatitis (“NASH”) and for the treatment of severe hypertriglyceridemia (“SHTG”). NASH is a severe form of nonalcoholic fatty liver disease (“NAFLD”), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, hepatocellular carcinoma (“HCC”) and death. There are currently no approved products for the treatment of NASH. In January 2022, we announced positive topline results from an expansion cohort (cohort 7) of the Phase 1b/2a trial of pegozafermin in NASH after announcing positive topline data from cohorts 1 through 6 in September 2020. We also initiated a Phase 2b trial (ENLIVEN) evaluating pegozafermin in fibrosis stage 2 or 3 NASH patients in June 2021. Patients will receive weekly doses or a every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. We are making good progress in ENLIVEN and expect to report topline data from this trial in the first half of 2023. Based on learnings from our recent cohort, developments in the field, and feedback from our steering committee, we are working on steps to optimize the ENLIVEN trial. In 2021, we completed a pharmacokinetic study of pegozafermin in NASH patients with compensated cirrhosis (fibrosis stage F4) demonstrating that pegozafermin 30 mg has similar single-dose pharmacokinetics and pharmacodynamics in F4 as it does in non-cirrhotic NASH. We are currently evaluating the potential opportunity for pegozafermin in these fibrosis stage F4 patients. SHTG is a condition identified by severely elevated levels of triglycerides (≥500 mg/dL), which is associated with an increased risk of NASH, cardiovascular events and acute pancreatitis. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and expect to report topline data in the second quarter of 2022. We closed enrollment in this trial in February 2022 with 85 patients enrolled.

FGF21 is a metabolic hormone that regulates energy expenditure and glucose and lipid metabolism. FGF21 analogs represent a promising class of drugs to treat NASH, because they not only address the liver manifestations, but also have an effect on the multiple co-morbidities that worsen NASH. FGF21 is a clinically validated mechanism that has been shown in humans to reduce steatosis, improve the histological features of NASH and address cardio-metabolic dysregulation. It is thought to exert effects on liver fibrosis by improving metabolic regulation, which reduces ongoing liver injury thus giving the liver time to heal. FGF21 also generates an on-target effect to increase adiponectin, a hormone released from adipose tissue that, among other functions, can suppress development and progression of hepatic fibrosis. However, FGF21 in its native form suffers from a short half-life and a tendency to aggregate in solution, both of which impact its suitability as a viable drug. To address these challenges, we have specifically engineered pegozafermin to extend the half-life of the molecule while maintaining potency and thereby the clinical benefits of FGF21.

Pegozafermin may be a differentiated FGF21 therapy based on its robust and durable biological effects, a favorable tolerability profile and its potential for every two-week dosing. Given its ability to address the key liver pathologies in NASH, as well as the underlying metabolic dysregulation in NASH patients, pegozafermin has the potential to become a backbone of treatment in NASH. Pegozafermin is the only FGF21 analog being developed for the treatment of SHTG and its broad metabolic effects could potentially differentiate it from competitors in this market. Pegozafermin has a long half-life which allows convenient weekly or every-two-week dosing and is currently the only FGF21 analog being tested for every-two-week dosing. The convenient dosing regimen may support adoption and compliance amongst patients living with these chronic and generally asymptomatic diseases. Pegozafermin is self-administered by patents subcutaneously in a liquid formulation.

In September 2020 and January 2022, we presented positive topline results from cohorts 1 through 6 and cohort 7 respectively in our Phase 1b/2a trial in NASH patients which has informed the advancement of our clinical

5

 

strategy in NASH. The 13-week multicenter, randomized, double-blind, placebo-controlled, multiple ascending dose-ranging portion of the trial enrolled a total of 81 patients in cohorts 1 through 6 with biopsy-confirmed NASH and phenotypic NASH (“PNASH”). All dose groups demonstrated statistically significant reductions in liver fat at week 13, with relative reduction of up to 60% versus baseline, and up to 70% versus placebo, as measured by magnetic resonance imaging—proton density fat factor (“MRI-PDFF”). A majority of patients achieved a greater than or equal to 30% (up to 88%) or a greater than or equal to 50% (up to 71%) reduction in liver fat from baseline. ALT, a liver enzyme, was significantly reduced (up to 44%) in these patients and key lipid markers like triglycerides, LDL, and non-HDL were also significantly improved. Cohort 7 in the Phase 1b/2a trial was a single-arm cohort that enrolled 20 patients with biopsy-confirmed fibrosis stage F2 and F3 NASH who were treated once weekly for 20 weeks with 27 mg of pegozafermin. Cohort 7 data was consistent with previous findings and validate pegozafermin’s effect on histology. Meaningful changes were observed on key histology endpoints with a greater than or equal to 2-point improvement in NAS and no worsening of fibrosis, NASH resolution without worsening of fibrosis, and improvement in at least one stage of fibrosis without worsening NAS. Clinically meaningful and significant changes were observed across key non-invasive tests (NITs) associated with fibrosis, risk of fibrosis, or NASH resolution suggesting pegozafermin is improving total liver health. In addition to significant improvement in liver health, treatment with pegozafermin also had significant positive effects on glycemic control, lipids, adiponectin, and body weight. In 83 patients treated with pegozafermin across the full Phase 1b/2a study in cohorts 1 through 7, pegozafermin was generally well tolerated with a favorable safety profile. There were no drug-related serious adverse events and only one treatment-related discontinuation. Pooled pegozafermin treatment related adverse events in greater than or equal to 10% of patients were increased appetite (13% vs 0% placebo), diarrhea (13% vs 11% placebo), and nausea (12% vs 11% placebo). Most of the GI adverse events were mild and of short duration. A few mild injection site reactions were reported and there were no tremors and no hypersensitivity adverse events observed. Pegozafermin had no adverse effects on blood pressure or heart rate.

Given the potential of FGF21 to meaningfully reduce triglycerides and provide other metabolic benefits, and the established regulatory path for approval, we are developing pegozafermin for the treatment of SHTG. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and have closed enrollment with 85 patients either on stable background treatment with statins and/or prescription fish oil and/or fibrates or not on any background therapy. In this randomized, double-blind, placebo-controlled study, patients receive pegozafermin administered weekly (9 mg, 18 mg or 27 mg) or every two weeks (36 mg) or placebo over an eight-week treatment period. The primary endpoint is the percentage change in fasting triglyceride levels from baseline. Key secondary endpoints include other lipid and metabolic markers and a sub-study evaluating change in liver fat measured by MRI-PDFF. Screening in the fibrate cohort was stopped with the main study and will be analyzed as part of main ENTRIGUE trial. Topline data from ENTRIGUE is expected in the second quarter of 2022.

Impact of COVID-19 Pandemic

The ongoing COVID-19 pandemic has disrupted and may continue to disrupt our business and delay our development timeline. The extent to which the COVID-19 pandemic may impact our future operating results and financial condition is uncertain. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and our Phase 2b trial in NASH patients in the middle of 2021. The COVID-19 pandemic has impacted execution and enrollment of these trials. We do not yet know the full extent of potential delays that may affect our clinical trials, which could prevent or delay us from obtaining approval for pegozafermin. Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing trials may be impacted. For more information regarding risks related to the ongoing COVID-19 pandemic, please see the risk factor entitled “The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business,” in Part I. Item 1A of this Annual Report on Form 10-K. To the extent the ongoing COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks set forth under “Risk Factors” in this Annual Report on Form 10-K.

6

 

Strategy

Our goal is to become a leading biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The key components of our strategy are to:

 

•

Rapidly advance pegozafermin through clinical development for the treatment of NASH. We believe pegozafermin may be a differentiated FGF21 therapy based on its robust and durable biological effects, a favorable tolerability profile and its potential for every two-week dosing. We reported positive topline results in September 2020 and January 2022 from our Phase 1b/2a trial in NASH patients and have initiated a Phase 2b trial (ENLIVEN) in NASH patients with F2 and F3 fibrosis that is expected to report topline data in the first half of 2023. We are also evaluating the potential opportunity for pegozafermin in NASH patients with compensated cirrhosis.

 

•

Pursue SHTG as a second indication with pegozafermin given its unique profile and its potential for a quicker path to market. Pegozafermin’s mechanism of action supports its potential to become a differentiated treatment for SHTG patients with other metabolic co-morbidities. We expect to report topline data from the Phase 2 ENTRIGUE trial in the second quarter of 2022. We believe that a combination of smaller clinical trials and shorter development timelines could mean that SHTG potentially represents a quicker path to market for pegozafermin.

 

•

Scale-up and optimize the manufacturing of pegozafermin. We currently use an external contract manufacturing organization (“CMO”) to manufacture pegozafermin for our ongoing and planned clinical trials. While these trials are ongoing, we plan to work with our CMO to optimize and scale-up the manufacturing process for pegozafermin to support the increased production that will be needed for later-stage clinical trials and commercialization, if pegozafermin is approved.

 

•

Establish a commercial infrastructure in key geographies. We have worldwide rights to pegozafermin and intend to develop the sales infrastructure required for commercialization in the United States. We also plan to evaluate options, including strategic collaborations, for commercializing pegozafermin, if approved, in other key markets, such as Europe and China.

 

•

Build a diversified multi-asset pipeline of novel therapies. We intend to employ a value-driven strategy to identify, acquire, develop and commercialize product candidates for liver and cardio-metabolic diseases. We intend to focus on product candidates that we believe have attractive profiles and address a clear unmet medical need and can advance quickly and efficiently into late-stage development.

Our Focus on Liver and Cardio-Metabolic Disease

We are focused on developing and commercializing therapeutic interventions that have a clinically meaningful impact on patients with liver and cardio-metabolic diseases. These diseases, including NASH and SHTG, represent leading global causes of morbidity and mortality. Despite a wave of public health campaigns to promote better diet and exercise habits and a range of treatment options available for many of these diseases, there is a significant unmet medical need for more effective therapies to improve patient outcomes and reduce the burden on global healthcare systems.

We are currently developing our lead product candidate, pegozafermin, a specifically engineered glycoPEGylated analog of FGF21, for the treatment of NASH and SHTG. We believe pegozafermin is an ideal candidate for the treatment of NASH based on its ability to address the key liver pathologies in NASH, its ability to address the underlying metabolic dysregulation in NASH patients, its favorable tolerability profile, and its potential for a longer dosing interval. Multiple epidemiological studies have linked NAFLD to increased cardiovascular disease, concluding that the majority of deaths among NAFLD patients are attributable to cardiovascular disease. As a result, we believe it is important that new therapeutics options for NASH address the underlying cardiovascular and metabolic dysregulations in these patients.

Given the potential of pegozafermin to meaningfully reduce triglycerides, we are also developing pegozafermin for the treatment of SHTG. Pegozafermin may have a competitive differentiation from approved therapies and other molecules in development based on its impact on improving liver fat and other metabolic

7

 

markers in addition to triglyceride reduction. There is regulatory precedence for the approval of therapies for the treatment of SHTG in the United States based on the percent reduction in triglycerides from baseline as the primary endpoint for full approval. Based on the regulatory path followed by other companies that have successfully developed SHTG therapies, we believe that a combination of smaller clinical trials and shorter development timelines could mean that SHTG potentially represents a quicker path to market for pegozafermin.

Disease Overview - NASH

NASH, a severe form of NAFLD, is characterized histologically by the additional presence of inflammation and hepatocellular injury such as visible ballooning and has a significantly worse prognosis, with the potential to progress to liver fibrosis, cirrhosis or HCC.

NASH represents a large and rapidly growing problem in the United States and worldwide. Diagnoses have been on the rise and are expected to increase dramatically in the next decade. The prevalence of NAFLD, which affects approximately 25% of the global population, and NASH, which develops in approximately 20% to 25% of NAFLD patients, is driven primarily by the worldwide obesity epidemic. As a result, the prevalence of NASH has increased significantly in recent decades, paralleling similar trends in the prevalence of obesity, insulin resistance and Type 2 diabetes. The prevalence of these conditions is expected to increase further in view of the unhealthy nutrition habits, such as consumption of a diet high in fructose, sucrose and saturated fats, and sedentary behavior that characterize modern lifestyle.

The critical pathophysiologic mechanisms underlying the development and progression of NASH include reduced ability to handle lipids, increased insulin resistance, injury to hepatocytes and liver fibrosis in response to hepatocyte injury. NASH patients have an excessive accumulation of fat in the liver resulting primarily from a caloric intake above and beyond energy needs. A healthy liver contains less than 5% fat, but a liver in someone with NASH can contain more than 20% fat. This abnormal liver fat contributes to the progression to NASH, a liver necro-inflammatory state, that can lead to scarring, also known as fibrosis, and, for some, can progress to cirrhosis and liver failure—cirrhosis develops in approximately 20% to 45% of patients. In some cases, cirrhosis progresses to decompensated cirrhosis, which results in permanent liver damage that can lead to liver failure. In addition, it is estimated that 8% of patients with advanced fibrosis will develop HCC. NASH is a complex, multifaceted disease that doesn’t just affect the liver. Patients with NASH frequently have other significant metabolic co-morbidities such as obesity, hyperglycemia, dyslipidemia and systemic hypertension (a constellation of which is commonly referred to as metabolic syndrome) and these further contribute to the risk of cardiovascular disease.

Disease Overview - SHTG

We are also developing pegozafermin for the treatment of SHTG. Hypertriglyceridemia (“HTG”) is characterized by elevated fasting plasma triglyceride levels >200 mg/dL and SHTG is typically defined as triglyceride levels of ≥500 mg/dL. SHTG is associated with an increased risk of NAFLD, NASH and cardiovascular diseases, as well as acute pancreatitis, accounting for up to 10% of all acute pancreatitis episodes. A third-party study utilizing an omega-3 fatty acid (“omega-3 FA”) demonstrated the linkage between a reduction in triglycerides and favorable cardiovascular clinical outcomes. Additionally, SHTG increases the risk of developing NAFLD, NASH and cardiovascular disease.

It is estimated that there are 4 million patients in the United States with triglyceride levels of ≥500 mg/dL. Of these patients, it is estimated that up to 100% of patients have clinically meaningful hepatic fat (MRI-PDFF ≥5%; baseline data from the sub-study in ENTRIGUE; n=14), up to 70% have Type 2 diabetes, and up to 65% have high LDL. This patient population is expected to increase due to the triple epidemic of obesity, metabolic syndrome and Type 2 diabetes. In addition, the addressable market has the potential to expand as a result of increasing awareness of the importance of treating elevated triglyceride levels, similar to the focus today of physicians on managing LDL levels, as well as due to third party commercial efforts expected to promote triglyceride reduction.

The treatment regimen for SHTG includes dietary restrictions and lipid-lowering drug treatment such as fibrates, omega-3 fish oils and niacin. Some statins are indicated in HTG but do not have an indication for use in SHTG. Despite multiple agents approved for the treatment of SHTG, these agents have limitations that may not make them ideal for all patients. For example, fibrates have demonstrated reductions in triglycerides of up to

8

 

approximately 55% at 12 weeks of treatment. However, they have also shown increases in LDL-C (up to 45%), a detrimental effect in this patient population, risk of drug-drug interactions and increases in transaminases, as well as tolerability issues including myopathy. Omega 3 fish oils have shown more modest benefits in reduction of triglycerides from baseline of approximately 25% to 45%. Some fish oils have also showed major increases in LDL-C (up to 45%). Fish oils also have a significant pill burden given the high daily doses required. In addition, these agents fail to meaningfully address the related co-morbidities of SHTG, including liver fat reduction and glycemic control, which, when left untreated, may further exacerbate the condition. In third-party studies, up to 50% of treated SHTG patients were unable to reduce their triglyceride levels to < 500 mg/dL despite using approved drugs and are considered refractory patients. These refractory patients have substantial unmet medical need and represent a significant market opportunity for pegozafermin as an add-on therapy along with the opportunity for pegozafermin to be used in patients not on any background therapy. Given the continuing unmet need in SHTG and limitations of current treatments, there are several agents in development for the treatment of SHTG, including a fibrate, and novel drugs targeting aspects of HTG and SHTG, including ANGPTL3 and APOC3 inhibitors.

Etiology of NASH

Understanding of the pathophysiologic mechanisms that lead to NASH has evolved in recent years. Excessive caloric overload, metabolic dysregulation, cardio-metabolic co-morbidities and genetic risk factors increase the likelihood of developing NASH, with a multitude of potential mechanistic contributors to pathophysiology. In NASH, the liver’s capacity to handle the primary metabolic energy substrates, carbohydrates and fatty acids, is overwhelmed. This occurs when there is an excess of free fatty acids deposited in the liver or their disposal from the liver is impaired. The accumulation of surplus free fatty acids leads to the formation of toxic lipid species. These toxic lipids then induce endoplasmic reticulum stress, oxidative stress and an inflammatory response, which can result in hepatocellular injury and death. This may lead to fibrosis and genomic instability, which may worsen over time to cirrhosis and HCC, respectively.

The critical pathophysiologic mechanisms underlying development and progression of NASH include (1) reduced ability to handle lipids, (2) increased insulin resistance, (3) injury to hepatocytes and (4) development and progression of liver fibrosis in response to hepatocyte injury.

 

Reduced Ability to Handle Lipids

Excess consumption of calories, poor diet and a sedentary lifestyle, each often associated with obesity, can burden the body with a surplus of carbohydrates and lipids. This burden can be progressively more difficult for the liver to handle thereby resulting in steatosis in the liver. The problem is compounded further as insulin resistance develops.

Free fatty acids (“FFA”) accumulate in the liver primarily from three sources, namely, through (1) the transfer from peripheral adipose tissues where triglycerides are mobilized, (2) de-novo lipogenesis (“DNL”), and (3) direct dietary intake. The FFA that lead to NASH are believed to arise primarily from the peripheral tissue pool and secondarily through DNL. The increase in the influx of FFA to the liver from the peripheral tissues is driven by excessive caloric intake greater than the body’s demand and increased insulin resistance resulting in deposition of fat to the liver for processing. DNL is a distinct process in the liver by which hepatocytes convert excess carbohydrates, especially fructose, to fatty acids.

The three main fates of fatty acids in the liver are (1) mitochondrial beta-oxidation (to release ATP, or energy), (2) re-esterification to form triglyceride, which can then be exported into the blood as very low density lipoproteins, or (3) stored in lipid droplets, resulting in liver steatosis and ultimately NASH. Adiponectin, a hormone derived from adipose tissue, appears to have a pivotal role in improving fatty acid oxidation and decreasing fatty acid synthesis, components of lipid handling.

An increase in cholesterol accumulation in the liver can also contribute to NASH, though its role is not as clearly defined as in the case of triglycerides. The dysregulation of the cholesterol pathway can result in an increase in the cholesterol levels in the liver. The increased cholesterol can accumulate in the liver cell membranes and

9

 

activate Kupffer cells (activated stellate macrophages), thereby triggering inflammatory pathways and resulting in the progression of NASH.

Increased Insulin Resistance

Insulin resistance, which typically develops in obese individuals, is considered to be a fundamental underlying mechanism in the majority of NASH patients. Fatty acids are primarily delivered to the liver from blood following lipolysis of triglycerides in adipose tissue, a process that is regulated by the actions of insulin on adipocytes. Insulin resistance in adipose tissue manifests as dysregulated lipolysis resulting in excessive delivery of FFA to the liver. The liver tries to cope with the large influx of FFA; however, the build-up of metabolic intermediates interferes with signaling, resulting in hepatic insulin resistance and the inability of the liver to process this excess FFA influx. The state of hepatic insulin resistance further exacerbates the problem by triggering DNL and the build-up of excess fat in the liver.

Injury to Hepatocytes

When the disposal of fatty acids through beta-oxidation or the formation of triglycerides is chronically overwhelmed, fatty acids can form lipotoxic species that lead to stress on the endoplasmic reticulum, oxidative stress and inflammation, all of which are pivotal processes in the development of NASH. Liver inflammation may be an important link between the initial metabolic stress and subsequent hepatocyte death and stimulation of fibrogenesis in NASH by promotion of the expression of pro-inflammatory cytokines and of apoptosis (cell death). These processes are core to the steatohepatitis that gives NASH its name. For example, hepatocyte apoptosis results in the ballooning of cells, a classic pathological feature of NASH. While hepatocytes are the primary and major target of toxic lipids, other cells such as Kupffer cells and hepatic stellate cells are also affected by lipotoxicity and contribute to the development of NASH pathology.

Additional factors, including dysregulation of cytokines and adipokines, energy depletion, anti-oxidant deficiencies, products of the gut microbiome and iron load may modulate hepatocyte vulnerability to the development of lipotoxic stress, injury and inflammation.

Development and Progression of Liver Fibrosis in Response to Hepatocyte Injury

Signaling from stressed or injured hepatocytes and Kupffer cells leads to activation of quiescent hepatic stellate cells. Upon activation, hepatic stellate cells release collagen and other factors. When the production of collagen and matrix proteins is faster than their degradation, accumulation of these proteins in the extracellular matrix can lead to progressive fibrosis. As the lipotoxicity and inflammation continue to damage the liver, the hepatic stellate cells continue to be activated resulting in greater collagen deposition that ultimately leads to fibrosis and cirrhosis.

Diagnosis

Most people with NASH are asymptomatic and their disease is often discovered incidentally following a liver imaging procedure, such as an ultrasound, prescribed for other reasons or as part of an investigation for elevated liver enzymes. Once suspected clinically, a liver biopsy is required to definitively diagnose NASH, which necessitates the joint presence of steatosis, ballooning and lobular inflammation. Once pathologically confirmed, the severity of NAFLD and NASH is determined using the histologically validated NAS, which grades disease activity on a scale of 0 to 8. The NAS is the sum of the individual scores for steatosis (0 to 3), lobular inflammation (0 to 3), and hepatocellular ballooning (0 to 2) but does not include a score for fibrosis. Fibrosis staging (F0-F4) relies on the Kleiner classification (F0 = no fibrosis; F1 = perisinusoidal or periportal fibrosis (not both); F2 = both perisinusoidal and periportal fibrosis; F3 = bridging fibrosis; F4 = cirrhosis).

Histological diagnosis remains the gold standard for assessment of NASH and fibrosis. However, given that liver biopsy is associated with risks of pain, bleeding and other morbidity, as well as significant cost, the procedure is not practical for general patient screening. Additionally, histology diagnosis is confounded by evaluation of a small sliver of a large heterogenous organ that may not represent the full organ, and significant variability in reading

10

 

of slides including inter- and intra-reader variability. Several non-invasive tools such as clinical risk scores, serum markers and imaging techniques are increasingly used to assess NASH patients. Non-invasive tests (“NITs”) such as the Fibroscan-AST (“FAST”) score, Fibrosis-4 index, the Enhanced Liver Fibrosis score and vibration-controlled transient elastography, (“VCTE”), have been validated and are increasingly used. These NITs have an excellent negative predictive value and an acceptable positive predictive value for detection of advanced (≥ F3) fibrosis and are increasingly used in clinical settings. Additionally, evidence is emerging that shows a correlation between reduction in steatosis as measured by MRI-PDFF and reduction in ALT ≥17 U/L and histologic improvement on liver biopsy. In draft guidance, the FDA encouraged sponsors to identify biochemical or noninvasive imaging biomarkers that, once characterized and agreed by the FDA, could replace liver biopsies for patient selection and efficacy assessment in clinical trials.

We expect that the validation and subsequent adoption of these NITs will result in an increase in the diagnosis and treatment rates for NASH in the future.

FGF21 Overview

Fibroblast growth factors (“FGFs”), including FGF21 and FGF19, are a large family of cell-signaling proteins involved in the regulation of many processes within the body. FGF21 is an endogenous metabolic hormone that regulates energy homeostasis, glucose-lipid-protein metabolism and insulin sensitivity, and modulates the pathways that mitigate against intracellular stress. FGF21 is secreted primarily by the liver but is also secreted by the white adipose tissue (“WAT”), skeletal muscle and the pancreas. FGF21 exerts its biological benefits through the activation of three fibroblast growth factor receptors (“FGFRs”), FGFR1c, FGFR2c and FGFR3c, and requires co-activation of the transmembrane protein cofactor beta Klotho (“ß-Klotho”). FGF21 is not believed to activate FGFR4, which has been associated with adverse effects. FGF21 can act directly or indirectly on target organs by mediating downstream regulators, such as adiponectin, and upstream regulators that induce FGF21, such as nutritional stress or transcription factors.

Biological Effects of FGF21:

Reducing Liver Steatosis by Improving Lipid Handling and Insulin Sensitivity

FGF21 has been clinically shown to reduce liver steatosis. FGF21 reduces liver steatosis by (1) increasing fatty acid oxidation in the liver, (2) reducing the deposition of free fatty acids from peripheral tissue to the liver and (3) reducing DNL in the liver. FGF21 exerts its systemic effects by reducing the serum levels of lipids (e.g., triglycerides, LDL cholesterol) and increasing insulin sensitivity. Increasing insulin sensitivity reduces lipolysis and can also reduce serum levels of lipids. In particular, FGF21 has been demonstrated to reduce liver fat in patients with NASH in multiple clinical trials.

Improving Liver Inflammation and Fibrosis

FGF21 is also believed to reduce liver fibrosis, the pathological change mostly clearly linked to liver-related morbidity in NASH patients via two potential pathways. One pathway is through the metabolic benefits of FGF21 described above. Long-term improvements in metabolic regulation reduce the ongoing liver injury that drives fibrosis and thus allows the liver time to heal. The other pathway is a direct anti-fibrotic effect mediated via adiponectin, an adipokine that is upregulated by FGF21. Increased adiponectin downregulates the hepatic stellate cells that are activated upon hepatic injury and responsible for collagen deposition and subsequent fibrosis. FGF21 demonstrated an improvement in liver fibrosis in patients in NASH in a clinical trial.

11

 

FGF21 Signaling

As noted above, FGF21 exerts its biological benefits through the co-activation of FGFRs and ß-Klotho. FGFRs are expressed widely throughout the body whereas ß-Klotho is primarily expressed in metabolic tissues such as adipose tissue, liver, and pancreas, thereby providing organ specificity to FGF21. The binding of FGF21 is a two-step process. The C-terminus of FGF21 initially binds to ß-Klotho enabling the N-terminus to form an expanded complex with one of the FGFRs. Once the co-receptor complex has formed with ß-Klotho and one of the FGFRs, a series of intracellular signaling cascades is initiated. These signaling cascades enable FGF21 to exert its biological functions.

FGF21 activates three specific FGFRs (FGFR1c, FGFR2c and FGFR3c), which based on nonclinical studies and clinical trials, appear to be responsible for mediating the desired therapeutic actions of FGF21 in NASH. FGF21 is not believed to activate FGFR4. Activation of FGFR4 results in an increase in LDL cholesterol and has been implicated in the etiology or progression of HCC.

Pegozafermin

Overview

We are developing pegozafermin, a specifically engineered glycoPEGylated analog of FGF21, for the treatment of NASH and SHTG. Pegozafermin has been specifically engineered to retain the activity of native FGF21 while extending its half-life. Specifically, it has been engineered to: (1) protect against proteolysis and reduce renal clearance, (2) have an extended half-life, (3) minimize susceptibility to aggregate in solution and (4) optimize its potency, enabling the potential use of lower dosage/doses. Additionally, we believe that pegozafermin may enhance binding affinity for ß-Klotho, by altering the conformation of the C-terminus which could have a positive impact on efficacy.

Primary Structure and Protein Engineering of Pegozafermin

Pegozafermin has been optimally constructed with two mutations via substitutions with natural amino acids at site-specific positions (173 and 176) toward the C-terminus end of the hormone. The mutations were incorporated into the FGF21 sequence after existing proline to create a consensus sequence for glycosylation. Subsequently, the glycosyl linker and a single 20 kDa glycoPEG moiety were enzymatically introduced at the O-linked glycosylation consensus site (position 173) via the proprietary glycoPEGylation technology. Our glycoPEG moiety is an activated form of the PEG molecule with the use of Sialic Acid, CMP-SA-PEG. The proximity of the mutations ensures consistent and efficient attachment of the glycoPEG moiety.

Pegozafermin has two modified natural amino acid residues:

 

•

S173T: Serine modified to Threonine at position 173; and

 

•

R176A: Arginine modified to Alanine at position 176.

In addition, a Methionine residue was introduced at the N-terminus which acts as the translation initiation signal. Figure 1 below shows the structure of pegozafermin.

12

 

Figure 1: Structure of Pegozafermin

 

 

The increase in the size of the molecule from 19.4 kDa to 40 kDa together with the site-specific mutations adjacent to the primary cleavage site of FGF21 (by the FAP enzyme between positions 171 and 172 on the native amino acid chain, which would be represented by positions 172 and 173 in our molecule starting with Methionine in position 1) are designed to prolong the half-life of the molecule. Additionally, we believe that the use of glycoPEGylation technology produces a comparatively stronger and more flexible structure, which aids in the development of a stable formulation. PEGylation technology has been used successfully in many pharmaceutical products including products that have been marketed for more than 10 years.

Pegozafermin uses a proprietary glycoPEGylation technology that has been previously validated by a third party, as this technology is incorporated in another pharmaceutical product (Lonquex® by Teva) that has received regulatory approval and is currently commercialized in the European Union.

Figure 2: Summary of Pegozafermin Attributes and Benefits

 

Features

Description

Potential Benefit

Use of PEG (via glycoPEGylation)

▪      Increases protein size and hydrodynamic volume that reduces renal filtration

▪      Prevents degradation by endocytosis and proteolytic enzymes

▪      Prolongs half-life

▪      Protects antigenic sites present on the protein surface (i.e. antigenic epitopes)

▪      Reduces immunogenicity

▪      Steric repulsion between the PEGylated surfaces increases water solubility and reduces aggregates

▪      Results in more stable formulation

Site-Specific Mutations

▪      Mutation at position 173 is immediately adjacent to the primary cleavage (FAP enzyme) site of FGF21

▪      Prolongs half-life

GlycoPEGylation Technology

▪      Allows site specific linkage (glycoPEG moiety to position 173)

▪      Proximity of the glycoPEG moiety to the

C-terminus induces conformational changes to the molecule

▪      Retains potency against receptor to improve efficacy

▪      Provides a strong and flexible glycosyl bond that helps the glycoPEG moiety remain intact, further reducing degradation

▪      Further enhances half-life

 

13

 

 

Therapeutic Potential of Pegozafermin Supported by Preclinical Animal Models of NASH, Diabetes and Obesity

Pegozafermin has been evaluated in three animal models of direct relevance to NASH. These included: (1) Stelic Animal Model, (“STAM”), (2) Diet-induced NASH (“DIN”) model and (3) spontaneous diabetic obese cynomolgus monkey model. Additional studies done in diabetes mouse model and diet induced obesity mouse model showed benefits in key markers of relevance in NASH.

A wide range of doses were tested in these studies as well as weekly and once every two-week dosing regimen was tested in a cynomolgus monkey study. The key outcomes of these studies are summarized in Figure 3 below.

Figure 3: Summary of NASH Pharmacology Studies

 

Preclinical pharmacology study with

pegozafermin

Improved

Insulin

Sensitivity

Improved Triglycerides and Cholesterol

Reduced

Hepatocyte

Injury

Reduced Liver Steatosis, Inflammation &

Fibrosis

Body

Weight

Reduction

DIN mouse model I (10 weeks)

✓

✓

✓

✓

✓

DIN mouse model II (19 weeks)

✓

✓

✓

✓

✓

Diabetic obese cynomolgus monkey study 1 (8 weeks; weekly dosing)

✓

✓

✓

Not evaluated

✓

Diabetic obese cynomolgus monkey study 2 (4 weeks; QW or Q2W dosing)

✓

✓

✓

Not evaluated

✓

 

✓

Statistically significant benefit observed.

Pegozafermin Clinical Development in NASH

Phase 1a Clinical Trial of Single-Dose of Pegozafermin in Healthy Volunteers

 

We conducted a Phase 1a clinical trial to evaluate the safety, tolerability and PK of pegozafermin in 58 healthy volunteers. In this randomized, double-blind, placebo-controlled, Phase 1a, first-in-human, SAD clinical trial the PK profile of pegozafermin was generally dose-proportional or slightly more than dose-proportional with a half-life of approximately 55 to 100 hours. At single doses of 9.1 mg and higher, significant improvements were observed in key lipid parameters measured at Day 8 and Day 15 after dosing on Day 1. The mean changes versus baseline include significant reductions in triglycerides (up to 51%) and LDL-C (up to 37%) and increase in HDL-C (up to 36%) despite the baseline values being in the normal range. Pegozafermin demonstrated rapid (starting from Day 2), sustained and durable improvements on lipid parameters for two weeks or more after single-dose administration. Pegozafermin was well tolerated across the dose range and there were no deaths, serious adverse events or discontinuations due to adverse events. The most commonly observed treatment-related adverse events, occurring in at least two subjects in the pooled pegozafermin group, were injection site reactions and headache, all of which were reported as mild. No clinically meaningful trends were observed in gastrointestinal events, laboratories or vital signs including blood pressure or heart rate changes.

Phase 1b/2a Proof of Concept Clinical Trial in NASH Patients

In September 2020 and January 2022, we presented positive topline results from cohorts 1 to 6 and cohort 7 respectively in our Phase 1b/2a trial in NASH patients which has informed the advancement of our clinical strategy in NASH. The phase 1b/2a trial for cohorts 1 to 6 was multicenter, randomized, double-blind, placebo-controlled, multiple ascending dose-ranging and enrolled a total of 81 patients to receive weekly (3mg/9mg/18mg/27mg) or every two-week (18mg/36mg) dosing of pegozafermin or placebo for up to 12 weeks. Key endpoints assessed were safety, tolerability, and PK of pegozafermin as well as change in liver fat measured by MRI-PDFF and other metabolic markers. The trial design is shown in Figure 4 below.

14

 

Figure 4: Phase 1b/2a Trial Design

 

 

As shown in Figure 5 below, all dose groups in cohorts 1 to 6 demonstrated significant reductions in liver fat at week 13, with relative reductions up to 60% versus baseline and up to 70% versus placebo, as measured by MRI-PDFF. 43% of the patients at the highest dose achieved normal liver fat content of < 5%. A significant proportion of patients responded to therapy with up to 88% and 71% of patients achieving a ≥30% or a ≥50% reduction in liver fat versus baseline, respectively.

Figure 5: Relative Reduction in Liver Fat vs. Placebo at Week 13

 

 

 

As shown in Figure 6 below for cohorts 1 to 6, treatment with pegozafermin also resulted in significant improvements in liver transaminases, with up to a 44% reduction in ALT and a 35 U/L decrease in ALT in patients with elevated baseline levels. Treatment with pegozafermin resulted in significant reductions in triglycerides (up to 28%; p <0.05), non-HDL (up to 16%; p<0.01) and LDL-C (up to 16%; p<0.05). Triglycerides were reduced to a greater extent in patients with elevated triglycerides at baseline (TG ≥200 mg/dL), and 53% of the pegozafermin patients in this group normalized triglyceride levels versus 0% in the placebo group. Pegozafermin also demonstrated significant increases in the insulin-sensitizing hormone adiponectin (up to 61%; p<0.001). Improvements were also noted across the spectrum of metabolic marker data vs. placebo for the 27mg QW dose group including HOMA-IR, glucose, HbA1c, and body weight (p<0.05).

15

 

Figure 6: Clinically Meaningful ALT Reduction; Greater Reduction in Patients with High ALT

 

 

Additional analyses presented at the Endocrine Society’s annual meeting in March 2021 demonstrated that pegozafermin treatment resulted in significant reductions in liver volume of up to 15% and liver fat volume of up to 65% in treated patients at 13 weeks compared to baseline, as measured by MRI-PDFF. A post-hoc analysis presented at The Liver Meeting of AASLD in November 2021 assessed the effect of pegozafermin on spleen volume (SV) in NASH patients without advanced fibrosis. SV was evaluated by MRI in all eligible patients on pegozafermin 27mg every week dose (n=8), pegozafermin 36mg every two-week dose (n=8) and 16 patients on placebo. At baseline, it was observed that SV was correlated with liver volume, vibration-controlled transient elastography (VCTE) score and body mass index (BMI), and negatively correlated with platelet count. Findings at study Day 50 and Day 92 demonstrated that treatment with pegozafermin led to a progressive and significant decrease in SV compared to placebo (on Day 50, treated patients saw an average 7.4% decrease in SV and by Day 92 patients saw an average 11.8% decrease in SV).

 

Paired-biopsy, Open-label Histology Cohort (Cohort 7)

Cohort 7 in the Phase 1b/2a trial was a single-arm cohort that enrolled 20 patients with biopsy-confirmed fibrosis stage F2 and F3 NASH who were treated once weekly for 20 weeks with 27 mg of pegozafermin. 19 of 20 patents received an end of treatment biopsy and one patient withdrew consent. A greater than or equal to 2-point improvement in NAS (with 1-point from either ballooning or inflammation) and no worsening of fibrosis was the nominal primary endpoint. Key secondary endpoints included response rates on NASH resolution without worsening of fibrosis, improvement in at least one stage of fibrosis without worsening NAS and safety/tolerability. Patients had a mean BMI of 37 and type 2 diabetes was prevalent in most patients. 65% had fibrosis stage F3 NASH and 35% had fibrosis stage F2 NASH, a higher proportion of F3 patients than is typical for most proof-of-concept NASH studies. The baseline values for VCTE, ProC3, and transaminases were consistent with a more advanced population.

74% of patients achieved a greater than or equal to 2-point improvement in NAS with at least a 1-point improvement in ballooning or inflammation. Substantial reductions were observed across all 3 NAS components (≥1 point change) – ballooning (79%), inflammation (47%), and steatosis (74%). All patients had improvement or no change in ballooning and inflammation. The histology results demonstrate proof-of-concept for the translation of pegozafermin’s effects on liver fat, ALT, and other relevant non-invasive measures into histological improvement.

 

16

 

 

Figure 7: Histology Results

≥2-point improvement in NAS without worsening of fibrosis1 (primary endpoint)

63%

≥2-point improvement in NAS1

74%

NASH resolution without worsening of fibrosis

32%; 95% CI: 13%-57%

One-stage improvement of fibrosis without worsening of NASH

26%; 95% CI: 9%-51%

NASH resolution or fibrosis improvement

47%

NAS = NAFLD Activity Score

1A 2-point improvement in NAS score required a 1-point improvement in either ballooning or inflammation

Data from a new analysis of the same histology slides by a panel of an additional three expert liver pathologists resulted in a wide range of response rates, with rates of NASH resolution without worsening of fibrosis up to 47% and rates of ≥ 1-stage improvement in fibrosis without worsening of NASH up to 42% as shown in Figure 8 below.

 

Figure 8: New Analysis of Cohort 7 Histology Slides By a Panel of Three Experts

To assess pegozafermin’s effect on the whole liver, a number of NITs including imaging, serum biomarkers, and risk stratification scores were built into the study. Clinically meaningful and significant changes were observed across these key NITs associated with fibrosis, risk of fibrosis, or NASH resolution. The consistency of data across all these endpoints and the magnitude of changes observed in these NITs suggest that pegozafermin is improving total liver health.

 

 

 

 

 

 

 

 

17

 

 

Figure 9: Non-Invasive Tests (NITs) [marker of]

 

Mean change from baseline at Week 20

Responder rates by clinically relevant thresholds

MRI-PDFF [liver fat content]1

-64%***

100%/78% [≥ 30%/≥ 50%]

ALT (Alanine aminotransferase) [liver damage]2

-46%***

         71%3 [≥ 17 U/L]

FAST Score [risk for advanced fibrosis]4

-76%***

          88% [≤ 0.35]

VCTE [liver stiffness]5

-31%***

          72% [> 20% decrease]

Pro-C3 [collagen deposition]6

-20%***

         63% [> 15% decrease]

*** p<0.001

1 Changes from baseline ≥ 30% and ≥ 50% have been correlated with NASH improvement

2 ALT changes ≥ 17 U/L have been correlated with histological improvement

3 In patients with elevated ALT as defined by ≥30 U/L in women and ≥40 U/L in men (n=14)

4 FAST score is a composite of imaging and blood markers and measured on 0-1 scale, a score ≤ 0.35 predicts Fibrosis Stage F0/F1 and NAS <4

5 VCTE is a Fibroscan assessment, >20% reduction has been correlated with fibrosis improvement

6 Pro-C3 is a blood-based measurement, >15% reduction has been correlated with fibrosis improvement

 

In addition to significant improvement in liver health, treatment with pegozafermin also had significant positive effects on glycemic control, lipids, adiponectin, and body weight.

 

Figure 10: Cardio-Metabolic Endpoints

 

Mean change from baseline at Week 20

HbA1c absolute change1

                               -0.9%**

Triglycerides2

-32%***

LDL-C

                               -13%*

HDL-C

                               +23%***

Adiponectin

                               +87%***

Body Weight

                                -4%***

*p<0.05; **p<0.01; ***p<0.001

1 In patients with HbA1c ≥ 6.5% at baseline (n=10); patients were all on concomitant diabetes medications

2 In patients with elevated triglycerides at baseline (n=11); reduction was -26% across total population

In 83 patients treated with pegozafermin across the full Phase 1b/2a study in cohorts 1 to 7, pegozafermin continues to be generally well tolerated with a favorable safety profile. There have been no drug-related serious adverse events and only one treatment-related discontinuation. Pooled pegozafermin treatment related adverse events in greater than or equal to 10% of patients were increased appetite (13% vs 0% placebo), diarrhea (13% vs 11% placebo), and nausea (12% vs 11% placebo). Most of the GI adverse events were mild and of short duration. A few mild injection site reactions were reported and there were no tremors and no hypersensitivity adverse events observed. Pegozafermin had no adverse effects on blood pressure or heart rate.

 

Phase 2b (ENLIVEN) Trial in Fibrosis Stage 2 or 3 NASH Patients

 

The ENLIVEN trial is planned to enroll NASH patients with fibrosis stage 2 or 3 and NAS ≥4. These patients will receive either 15 mg or 30 mg weekly doses or 44 mg every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. We expect to report topline data in the first half of 2023. Based on learnings from our recent cohort, developments in the field, and feedback from our steering committee, we are working on steps to optimize the ENLIVEN trial.

Pegozafermin Clinical Development in SHTG

Pegozafermin has demonstrated significant reduction in triglyceride levels across all our preclinical and clinical studies. In our Phase 1b/2a trial, treatment with pegozafermin in cohorts 1 to 6 (mean baseline TG=174 mg/dL) and cohort 7 (mean baseline TG=170 mg/dL) resulted in significant reductions in triglycerides (up to 28% and 26% respectively) Triglycerides were reduced to a greater extent in patients with elevated levels at baseline across cohorts 1 to 6 (TG ≥ 200mg/mL) and cohort 7 (TG ≥ 150mg/mL) of 37% and 32%, respectively. While

18

 

currently approved SHTG therapies decrease triglyceride levels, they generally do not have broader metabolic benefits such as reduction in liver fat content, reduction in transaminases, and improvement in glycemic control. We presented data at the National Lipid Association meeting in 2021 that demonstrated a mean liver fat content of 20% at baseline in the first 14 patients in the MRI-PDFF sub-study of the ENTRIGUE trial.

We initiated the ENTRIGUE trial in SHTG patients in the third quarter of 2020 and have closed enrollment with 85 patients either on background lipid treatment with statins and/or prescription fish oil and/or fibrates or not on any background therapy. In this randomized, double-blind, placebo-controlled study, patients receive pegozafermin administered weekly (9 mg, 18 mg or 27 mg) or every two weeks (36 mg) or placebo over an eight-week treatment period. The primary endpoint is the percentage change in fasting triglyceride levels from baseline. Key secondary endpoints include other lipids and metabolic markers and a sub-study evaluating change in liver fat measured by MRI-PDFF. Screening in the fibrate cohort was stopped with the main study and will be analyzed as part of main ENTRIGUE trial. Topline data from ENTRIGUE is expected in the second quarter of 2022.

There is regulatory precedence for the approval of therapies for the treatment of SHTG in the United States based on the reduction in triglycerides from baseline as the primary endpoint for full approval. The FDA surrogate endpoint table for drug approval lists a reduction in triglycerides from baseline as the endpoint for full approval of a therapy in SHTG. A clinical outcome study was not required for certain third-party approvals in SHTG or as a post-marketing commitment. The SHTG Phase 3 trial for some of these products consisted of a single study of 75 to 100 patients per treatment group with a 12-week duration. Based on the regulatory path followed by other companies that have successfully developed SHTG therapies, we believe that a combination of smaller clinical trials and shorter development timelines could mean that SHTG potentially represents a quicker path to market for pegozafermin. The Phase 3 trial could potentially evaluate pegozafermin as an add-on therapy in refractory patients or patients not on background therapy with a primary endpoint of percentage change in fasting triglyceride levels from baseline at 12-24 weeks. The key secondary endpoints could include an assessment of liver fat reduction, glycemic control, weight, and other lipids. The safety database could potentially include trials in other hypertriglyceridemia patient populations.

Figure 11: Pegozafermin Could Potentially Address Metabolic Conditions Associated With SHTG

 

 

19

 

 

Agreements with Teva

Agreements Relating to FGF21 Program

In April 2018, we entered into an Asset Transfer and License Agreement (the “FGF21 Agreement”) with Teva Pharmaceutical Industries Ltd (“Teva”), under which we acquired certain patents, intellectual property and other assets relating to Teva’s glycoPEGylated FGF21 program. Under this agreement, Teva also granted a perpetual, non-exclusive (but exclusive as to pegozafermin), non-transferable, worldwide license to patents and know-how related to glycoPEGylation technology for use in the research, development, manufacture and commercialization of the compound pegozafermin and products containing pegozafermin. In addition, we entered into a Sublicense Agreement with ratiopharm (the “ratiopharm Sublicense”), under which we were granted a perpetual, exclusive, worldwide sublicense to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin.

Under the FGF21 Agreement, we are obligated to use commercially reasonable efforts to develop and commercialize pegozafermin in each of the United States and five major European countries. We have the right to sublicense all rights licensed to us by Teva under the FGF21 Agreement.

Pursuant to the FGF21 Agreement and the FASN Agreement (as defined and described below), we paid Teva a nonrefundable upfront payment of $6.0 million. In addition, under the FGF21 Agreement, we are required to make certain payments to Teva totaling $2.5 million for the achievement of certain clinical development milestones, and additional payments totaling up to $65.0 million upon achievement of certain commercial milestones. We are also obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales of products containing pegozafermin. Our royalty obligations will terminate, on a product-by-product and country-by-country basis, at the later of: (1) the date of expiration of the last to expire valid claim in the assigned patents that covers pegozafermin in such country, (2) the expiration of data or regulatory exclusivity for pegozafermin in such country and (3) 10 years from the first commercial sale of pegozafermin in such country. We are not required to make any payments to ratiopharm pursuant to the ratiopharm Sublicense.

The term of the FGF21 Agreement will continue, on a product-by-product and country-by-country basis, until the royalty term with respect to pegozafermin in such country expires. The ratiopharm Sublicense will continue until terminated in accordance with its terms. We may terminate the FGF21 Agreement and the ratiopharm Sublicense for any reason. Either party may terminate the FGF21 Agreement for cause for the other party’s uncured material breach. ratiopharm may terminate the ratiopharm Sublicense for certain material breaches by us. Either party may terminate the FGF21 Agreement or the ratiopharm Sublicense in the event of bankruptcy of the other party. Teva may terminate the FGF21 Agreement if we challenge the validity of any patent licensed to us under the FGF21 Agreement. Termination of the FGF21 Agreement or the ratiopharm Sublicense will impact our rights under the intellectual property licensed to us by Teva and ratiopharm, respectively, but will not affect our rights under the assets assigned to us.

In April 2018, we also entered into a Reagent Supply and Technology Transfer Agreement, under which Teva will supply us with certain reagents required for the glycoPEGylation process that are necessary for our development and commercialization of pegozafermin, and transfer to us certain know-how required for the production of such reagents. The term of this agreement was extended by mutual agreement until December 31, 2022.

FASN Agreements

In April 2018, we entered into an Asset Transfer and License Agreement with Teva under which we acquired from Teva patents, intellectual property and other assets relating to Teva’s development program of small molecule inhibitors of FASN (the “FASN Agreement”). Under the FASN Agreement we are obligated to use commercially reasonable efforts to develop and commercialize FASN in the United States and five major European countries. We have the right to sublicense all rights licensed to us by Teva under the FASN Agreement.

Pursuant to the FASN Agreement and the FGF21 Agreement (as described above), we paid Teva a nonrefundable upfront payment of $6.0 million. In addition, under the FASN Agreement, we are required to make certain payments to Teva totaling $2.5 million for the achievement of certain clinical development milestones, and

20

 

additional payments totaling up to $65.0 million upon achievement of certain commercial milestones. We are also obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales of products arising from the FASN program. Our royalty obligations will terminate, on a product-by-product and country-by-country basis, at the later of: (1) the date of expiration of the last to expire valid claim in the assigned patents that covers FASN in such country, (2) the expiration of data or regulatory exclusivity for such product arising from the FASN program in such country and (3) 10 years from the first commercial sale of a product arising from the FASN program in such country.

The term of the FASN Agreement will continue, on a product-by-product and country-by-country basis, until the royalty term with respect to the product arising from the FASN program in such country expires. We may terminate the FASN Agreement for any reason. Either party may terminate the agreement for cause for the other party’s uncured material breach, or in the event of bankruptcy of the other party.

Government Regulation and Product Approval

The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of biologics, such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates.

The process required by the FDA before biologic product candidates may be marketed in the United States is expensive and time-consuming. Generally, this process involves completing pre-clinical laboratory studies before the FDA will allow human clinical trials to commence. We are then required to complete human clinical trials to demonstrate that a product candidate is safe and effective. Following the completion of these clinical trials, we are required to prepare and submit a biologics license (“BLA”) application, which presents the FDA with detailed clinical and safety data, as well as manufacturing data. As part of the review of a BLA, the FDA may inspect manufacturing facilities to assure that the facilities, methods and controls are adequate to preserve the biological product’s continued safety, purity and potency, and may also inspect selected clinical investigation sites to assess compliance with current Good Clinical Practices (“cGCP”). This process takes many years from inception through filing of a BLA application and the likelihood of success is highly uncertain.

Preclinical and Clinical Development

Prior to beginning the first clinical trial with a product candidate, we must submit an investigational new drug (“IND”) application to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is the general investigational plan and the protocol(s) for clinical studies. Submission of an IND may or may not result in FDA authorization to begin a clinical trial.

Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with cGCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Furthermore, an independent review board (“IRB”) for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives.

For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap.

 

•

Phase 1—The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance,

21

 

 

absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.

 

•

Phase 2—The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning larger and more expensive Phase 3 clinical trials.

 

•

Phase 3—The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval.

Concurrent with clinical trials, companies must finalize a process for manufacturing the product in commercial quantities in accordance with current good manufacturing practices (“cGMP”) requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency.

BLA Submission and Review

Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. The submission of a BLA requires payment of a substantial application user fee to FDA, unless a waiver or exemption applies.

Once a BLA has been submitted, the FDA’s goal is to review standard applications within ten months after it accepts the application for filing, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process may be extended by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product’s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with cGCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.

After the FDA evaluates a BLA and conducts necessary inspections, the FDA may either issue an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter will describe deficiencies that the FDA has identified in the BLA. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.

If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy (“REMS”) to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted

22

 

distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require, or companies may voluntarily pursue, one or more Phase 4 post-market studies and surveillance to further assess and monitor the product’s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these post-marketing studies.

Expedited Programs for Serious Conditions

The FDA maintains several programs intended to facilitate and expedite development and review of new drugs and biologics to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval. These programs can significantly reduce the time it takes for the FDA to review a BLA, but they do not guarantee that a product will receive FDA approval. Even if a product qualifies initially, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review will not be shortened.

Post-Approval Requirements

Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon companies and third-party manufacturers. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.

The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program, among other potential consequences.

The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties.

23

 

Biosimilars and Reference Product Exclusivity

The Patient Protection and Affordable Care Act, as amended (collectively, the “Affordable Care Act”) includes a provision called the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”), which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product.

Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity and potency, can be shown through analytical studies, animal studies, and a clinical study or studies.

Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant’s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product. At this juncture, it is unclear whether products deemed “interchangeable” by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.

The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12-year reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty.

Other U.S. Healthcare Laws and Compliance Requirements

Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business. Such laws include, without limitation: the federal Anti-Kickback Statute (“AKS”), the federal False Claims Act, HIPAA and similar foreign, federal and state fraud, abuse and transparency laws.

The federal AKS prohibits, among other things, any person or entity from knowingly and willfully offering, paying, soliciting or receiving any remuneration, to induce or in return for either the referral of an individual, or the purchase or recommendation of an item or service for which payment may be made under any federal healthcare program. The term remuneration has been interpreted broadly to include anything of value. The AKS has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand, and prescribers and purchasers on the other. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the AKS. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.

The federal false claims laws, including the False Claims Act (“FCA”), which imposes significant penalties and can be enforced by private citizens through civil qui tam actions, and civil monetary penalty laws prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of federal government funds, including federal healthcare programs, such as Medicare and Medicaid. Pharmaceutical and other healthcare companies have been prosecuted under these laws for engaging in a variety of different types of conduct that caused the submission of false claims to federal healthcare programs. Under the AKS, for example, a claim resulting from a violation of the AKS is deemed to be a false or fraudulent claim for purposes of the FCA. The FCA imposes mandatory treble damages and per-violation civil penalties up to approximately $23,000.

24

 

HIPAA created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program, including private third-party payors, and making false statements relating to healthcare matters. A person or entity does not need to have actual knowledge of the healthcare fraud statute implemented under HIPAA or specific intent to violate the statute in order to have committed a violation.

Also, many states have similar, and typically more prohibitive, fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.

The U.S. federal Physician Payments Sunshine Act requires certain manufacturers of drugs and biologics covered by Medicare, Medicaid or the Children’s Health Insurance Program, with specific exceptions, to annually report to CMS information related to payments or other transfers of value made to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, such reporting obligations will be expanded to include payments and other transfers of value provided in 2021 to certain other healthcare professionals.

Ensuring business arrangements with third parties comply with applicable healthcare laws and regulations is a difficult and costly endeavor. If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other current or future governmental regulations that apply to us, we may be subject to significant penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private “qui tam” actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.

Data Privacy and Security

Numerous state, federal and foreign laws, govern the collection, dissemination, use, access to, confidentiality and security of personal information, including health-related information. In the United States, numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws and regulations, govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. Entities that are found to be in violation of HIPAA or other laws may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. Further, entities that knowingly obtain, use, or disclose certain individually identifiable health information in an improper fashion may be subject to criminal penalties.

Coverage, Pricing and Reimbursement

Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we may obtain regulatory approval. In the United States and in foreign markets, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such products. In the United States, third-party payors include federal and state healthcare programs, private managed care providers, private health insurers and other organizations. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid in the United States, and commercial payors are critical to new product acceptance.

25

 

Decisions regarding whether to cover any of our product candidates, if approved, the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. Further, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.

For products administered under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the treatment or procedure in which the product is used may not be available, which may impact physician utilization. In addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics.

In addition, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. Third-party payors are increasingly challenging the prices charged for medical products and services, examining the medical necessity and reviewing the cost effectiveness of pharmaceutical or biological products, medical devices and medical services, in addition to questioning safety and efficacy. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product that receives approval. Decreases in third-party reimbursement for any product or a decision by a third-party not to cover a product could reduce physician usage and patient demand for the product.

Healthcare Reform

In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.

For example, the Affordable Care Act has substantially changed healthcare financing and delivery by both governmental and private insurers. The Affordable Care Act and its implementing regulations, among other things, revised the methodology for calculating rebates for covered outpatient drugs and certain biologics owed by manufacturers to the state and federal government under the Medicaid Drug Rebate Program, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and expanded programs designed to test innovative payment models, service delivery models, or value-based arrangements, and fund comparative effectiveness research.

There remain legal and political challenges to certain aspects of the Affordable Care Act. In December 2018, a United States District Court judge in Texas ruled that the Affordable Care Act is unconstitutional in its entirety because the “individual mandate” was repealed by Congress in 2017. The decision was appealed to the United States Supreme Court, which overturned it on the basis that the plaintiffs lacked standing. The Supreme Court’s decision did not address the constitutionality of the Affordable Care Act, and left open the opportunity for additional challenges to the Affordable Care Act. It is unclear how such litigation and other efforts to repeal, replace or otherwise modify the Affordable Care Act will impact reimbursement of pharmaceutical and biological products.

26

 

We anticipate that the Affordable Care Act, if substantially maintained in its current form, will continue to result in additional downward pressure on coverage and the price that we receive for any approved product, and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.

In addition, further legislation or regulation could be passed that could harm our business, financial condition and results of operations. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted.

There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. In October 2020, the FDA issued guidance describing procedures for manufacturers to facilitate the importation of FDA-approved biologics manufactured abroad and originally intended for sale in a foreign country into the United States. Previously, the Trump administration released a “Blueprint,” or plan, to lower drug prices and reduce out of pocket costs of drugs that contained proposals to increase drug manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products, and reduce the out of pocket costs of drug products paid by consumers.

Although the Biden administration has stayed the effective dates of some last-minute drug price regulations issued by the Trump administration, Congress and the Biden administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs.

Additional Regulation

In addition to the foregoing, local, state and federal laws, including in the United States and Israel, regarding such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous or biohazardous substances, we could be liable for damages, environmental remediation, and/or governmental fines. We believe that we are in material compliance with applicable environmental laws and occupational health and safety laws that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations. We may incur significant costs to comply with such laws and regulations now or in the future.

Competition

The biopharmaceutical industry is intensely competitive and subject to rapid innovation and significant technological advancements. We believe the key competitive factors that will affect the development and commercial success of pegozafermin and any future product candidates are efficacy, safety and tolerability profile, reliability, convenience of dosing, price, the level of generic competition and reimbursement. Our competitors include multinational pharmaceutical companies, specialized biotechnology companies, universities and other research institutions. A number of biotechnology and pharmaceutical companies are pursuing the development or marketing of pharmaceuticals that target the same diseases that we are targeting. Smaller or earlier-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Given the high incidence of NASH, it is likely that the number of companies seeking to develop products and therapies for the treatment of liver and cardio-metabolic diseases, such as NASH, will increase.

27

 

If pegozafermin is approved for the treatment of NASH, future competition could also arise from select products currently in development, including: Firsocostat/GS-0976, an ACC inhibitor, and Cilofexor/GS-9674, an FXR agonist, from Gilead Sciences, Inc.; Clesacostat/PF-05221304, an ACC inhibitor, and PF-06835919, a KHK inhibitor, from Pfizer Inc.; Ocaliva, an FXR agonist from Intercept Pharmaceuticals, Inc.; Resmetirom, a beta-thyroid hormone receptor agonist from Madrigal Pharmaceuticals, Inc.; VK2809, a beta-thyroid hormone receptor agonist from Viking Therapeutics, Inc.; Aldafermin, an FGF19 analog from NGM Biopharmaceuticals, Inc.; MK-3655, an FGFR1c/KLB agonist antibody from Merck & Co., Inc.; Efruxifermin, a FGF21 fusion protein from Akero Therapeutics, Inc.; Belapectin, a Galectin-3 inhibitor from Galectin Therapeutics Inc.; Aramchol, a synthetic conjugate of cholic acid and arachidic acid from Galmed Pharmaceuticals Ltd.; Semaglutide, a GLP-1 receptor agonist from Novo Nordisk A/S; Pemvidutide/ALT-801, a dual GLP-1/glucagon agonist from Altimmune; Tirzepatide, a dual GIP/GLP-1 receptor agonist from Eli Lilly and Company; and Lanifibranor, a PPAR alpha/delta/gamma agonist from Inventiva; NNC0194-0499, an FGF21 analog from Novo Nordisk; BOS-580, an FGF21 analog from Boston Pharmaceuticals; and BFKB8488A, an FGFR1/KLB agonist antibody from Genentech.

If pegozafermin is approved for the treatment of SHTG, we would face competition from currently approved and marketed products, including statins, fibrates, Vascepa (Pure EPA), and Lovaza (EPA and DHA), as well as generic products. Further competition could arise from products currently in development, including: Olezarsen/AKCEA-APOCIII-LRx, an APOC3 inhibitor from Ionis; Evinacumab, an Anti-ANGPTL3 from Regeneron Pharmaceuticals, Inc.; Pemafibrate, a PPAR alpha agonist from Kowa Research Institute, Inc.; and ARO-APOC3, an ApoC-III inhibitor from Arrowhead Pharmaceuticals, Inc.

Many of our competitors have substantially greater financial, technical, human and other resources than we do and may be better equipped to develop, manufacture and market technologically superior products. In addition, many of these competitors have significantly longer operating histories and greater experience than we have in undertaking nonclinical studies and human clinical trials of new pharmaceutical products and in obtaining regulatory approvals of human therapeutic products. Many of our competitors have established distribution channels for the commercialization of their products, whereas we have no such channel or capabilities. In addition, many competitors have greater name recognition and more extensive collaborative relationships. As a result, our competitors may obtain regulatory approval of their products more rapidly than we do or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidate or any future product candidates. Our competitors may also develop and succeed in obtaining approval for drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than we are in manufacturing and marketing their products. If we are unable to compete effectively against these companies, then we may not be able to commercialize our product candidate or any future product candidates or achieve a competitive position in the market. This would adversely affect our ability to generate revenue. Our competitors also compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and enrolling patients for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.

Manufacturing and Supply

We do not own or operate manufacturing facilities for the production of pegozafermin, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely, and expect to continue to rely, on third parties for the manufacturing of our product candidates for preclinical and clinical testing, as well as for commercial manufacturing if pegozafermin or any future product candidate receives marketing approval.

Pegozafermin drug substance is manufactured by fermentation of a recombinant strain of the bacterium E. coli. Product accumulates as insoluble particles (inclusion bodies) within the cells and is recovered by cell disruption, followed by solubilization of the inclusion bodies, protein refolding and purification with two chromatographic separation columns. Purified material is glycoPEGylated in a 2-step enzymatic reaction where a 20kDa linear glycoPEG moiety is attached to the protein through GalNAc and Sialic Acid linkers.

GlycoPEGylated protein is purified with two chromatographic columns to yield product with target quality attributes. Purified glycoPEGylated protein is concentrated and then formulated to a target concentration with formulation buffer as drug product.

28

 

Northway Biotechpharma (“BTPH”) is our sole source supplier for pegozafermin. Any reduction or halt in supply of drug product from BTPH could limit our ability to develop pegozafermin until a replacement contract manufacturer is found and qualified.

We are working with BTPH and a second vendor on process optimization to support large-scale production for future trials and commercialization. We have successfully developed a new refrigerated liquid formulation. This formulation is approved by the FDA and is currently in use in our trials. We are currently developing an additional liquid formulation at various concentrations. In parallel, we have entered into a contract with a vendor for Pre-Filled Syringe (“PFS”) development and commercial fill.

BTPH Agreement

In May 2018, we entered into a master services agreement with BTPH, under which BTPH agreed to provide us certain services, including development, manufacturing, and storing of pegozafermin, under statements of work for such services to be agreed by the parties from time to time. The master services agreement will continue for the duration of time that BTPH is providing services to us, unless earlier terminated by either party upon its terms. We may terminate the agreement at any time after a specified notice period and subject to the payment of certain agreed upon fees where such termination results in cancellation of manufacturing scheduled within a certain period. In addition, either party may terminate the agreement for cause for the other party’s uncured material breach, in the event of bankruptcy of the other party, in the event of the commission of fraud by the other party or in the event of a force majeure.

Sales and Marketing

We currently have no marketing, sales or distribution capabilities. In order to commercialize any products that are approved for commercial sale, we must either develop a sales and marketing infrastructure or collaborate with third parties that have sales and marketing experience.

We may elect to establish our own sales force to market and sell a product for which we obtain regulatory approval if we expect that the geographic market for a product we develop on our own is limited or that the prescriptions for the product will be written principally by a relatively small number of physicians. If we decide to market and sell any products ourselves, we do not expect to establish direct sales capability until shortly before the products are approved for commercial sale.

We plan to seek third-party support from established pharmaceutical and biotechnology companies for those products that would benefit from the promotional support of a large sales and marketing force. In these cases, we might seek to promote our products in collaboration with marketing partners or rely on relationships with one or more companies with large established sales forces and distribution systems.

Intellectual Property

Our success depends in part upon our ability to protect our core technology and intellectual property. To protect our intellectual property rights, we rely on patents, trademarks, copyrights and trade secret laws, confidentiality procedures, and employee disclosure and invention assignment agreements. Our intellectual property is critical to our business and we strive to protect it through a variety of approaches, including by obtaining and maintaining patent protection in the United States and internationally for our product candidates, novel biological discoveries, new targets and applications, and other inventions that are important to our business. For our product candidates, we generally intend to pursue patent protection covering compositions of matter, methods of making and methods of use. As we continue the development of our product candidates, we plan to identify additional means of obtaining patent protection that would potentially enhance commercial success, including pursuit of claims directed to new therapeutic indications.

29

 

FGF21 Patents

Our FGF21 patent portfolio includes four families:

The first family is entitled “Remodeling and GlycoPEGylation of Fibroblast Growth Factor (FGF)”. This patent family provides granted patent protection in 39 countries around the globe, including the United States (U.S. Patent Number 9,200,049, expiry date: June 25, 2028; and U.S. Patent No. 10,874,714, expiry date: October 10, 2028), Canada, Europe (broadly), and Japan (latter three expire October 31, 2025) for FGF21 conjugates comprising a variety of modifying groups that can be attached at several different amino acid positions. GlycoPEGylated FGF21 is specifically claimed. The granted claims broadly protect our lead drug candidate pegozafermin and pharmaceutical compositions thereof, as well as methods for making and using pegozafermin to treat FGF21 deficiency in a patient in need thereof. One U.S. application is pending in this family.

The second family is entitled “Mutant FGF-21 Peptide Conjugate and Uses Thereof” and is specifically directed to pegozafermin. The PCT Patent Application for this family was filed on September 4, 2018 (PCT/IB2018/00112). A U.S. Prioritized Examination Continuation Patent Application (Application Serial No. 16/225,640) was filed on December 19, 2018 as a continuation of PCT/IB2018/0112 and from which U.S. Patent Number 10,407,479 was issued on September 10, 2019. The term of the U.S. Patent Number 10,407,479 is September 4, 2038. The issued claims are directed to pegozafermin and a defined genus specifically encompassing pegozafermin and compositions thereof (including site-specific mutations at positions 173 and 176), as well as methods for making and using pegozafermin for a variety of therapeutic indications. Such indications include methods for treating NASH or metabolic syndrome. Subjects where there is a need to reduce blood glucose or to reduce HbA1C include those afflicted with diabetes Type 2, NASH and metabolic syndrome. The claims encompass different therapeutic regimens for administering pegozafermin (e.g., once a week or once every two weeks), which regimens are based on pegozafermin’s surprisingly long half-life in vivo. One U.S. application is pending in this family. National phase entry of this PCT Application has been initiated in Australia (granted), Korea (granted), Europe, China (allowed), Hong Kong, Japan (granted), Canada and Israel to pursue global protection of specific mutant FGF21 peptide conjugates, and particularly pegozafermin, in these jurisdictions. Australian patent No. 2018322943 was granted on September 17, 2020 (expiry date: September 4, 2038). Korean patent No. 10-2229037 was granted on March 11, 2021 (expiry date: September 4, 2038). Japan patent No. 6852939 was granted on March 15, 2021 (expiry date: September 4, 2038).

The third family is entitled “Methods Of Treatment Using Mutant FGF-21 Peptide Conjugates”. A U.S. patent application was filed on May 28, 2020 (US Serial Number 16/885,353). This patent application is not published.

The fourth family is entitled “Methods for promoting weight loss”. A PCT application was filed January 29, 2021 (PCT/IB2021/000044) with claims directed towards method to reduce total body weight, body fat content and/or BMI. National phase entry of this application is due by July 31, 2022.

We will continue to file patent applications to cover various formulations of FGF21. We have filed a provisional application on March 11, 2021 on stable liquid formulation of FGF21. A PCT patent application claiming the benefit and priority to the provisional application will be filed by the March 11, 2022 deadline.

FASN Patents

Our FASN patent portfolio currently consists of three patent families, including patents and/or patent applications in the United States, the European Patent Convention, Canada, Mexico, Israel, China and Japan.

The first patent family, directed to TEV-48317, which we acquired from Teva under the FASN Agreement, and other 1,4-substituted piperidine-based FASN inhibitors, is currently protected by three granted U.S. patents that cover these compounds, pharmaceutical compositions comprising these compounds, and/or methods of treating FASN-mediated disorders using these compounds. The non-extended term for these patents would expire on June 17, 2036. A pending U.S. application has also been filed. The first patent family also includes twelve foreign patents and two foreign patent applications. The second patent family is directed to other 1,4-substituted piperidine-based FASN inhibitors, pharmaceutical compositions, and methods of treating FASN-mediated disorders. The second patent family includes one granted U.S. patent, one U.S. patent application, nine foreign patents, and two foreign patent applications. The third patent family is directed to spiropiperidine FASN inhibitors, pharmaceutical

30

 

compositions containing these compounds, and methods of treating FASN-mediated disorders using these compounds. The third patent family includes one granted U.S. patent, one U.S. patent application and five foreign patent applications.

Employees

As of December 31, 2021, we had 41 full-time employees, of which 28 employees are engaged in research and development activities. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.

Corporate Information

We were incorporated in January 2018 in Israel under the name 89Bio Ltd. 89bio, Inc., the registrant whose name appears on the cover page of this Annual Report on Form 10-K, was incorporated in June 2019 for the purpose of an internal reorganization transaction. In September 2019, all of the equity holders of 89Bio Ltd. exchanged 100% of the equity of 89Bio Ltd. for 100% of the equity of 89bio, Inc. Following this exchange, 89Bio Ltd. became a wholly owned subsidiary of 89bio, Inc.

Our principal executive offices are located at 142 Sansome Street, San Francisco, California 94104 and our telephone number is (415) 432-9270. Our website is www.89bio.com. Information contained on or accessible through our website is not a part of this Annual Report on Form 10-K, and the inclusion of our website address in this Annual Report on Form 10-K is an inactive textual reference only.

We file electronically with the SEC our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We make available on our website at www.89bio.com, under “Investors,” free of charge, copies of these reports as soon as reasonably practicable after filing or furnishing these reports with the SEC.

Implications of Being an Emerging Growth Company and a Smaller Reporting Company

We are an “emerging growth company”, as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including relief from the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, less extensive disclosure obligations regarding executive compensation in our registration statements, periodic reports and proxy statements, exemptions from the requirements to hold a nonbinding advisory vote on executive compensation, and exemptions from stockholder approval of any golden parachute payments not previously approved. We may also elect to take advantage of other reduced reporting requirements in future filings. As a result, our stockholders may not have access to certain information that they may deem important and the information that we provide to our stockholders may be different than, and not comparable to, information presented by other public reporting companies. We could remain an emerging growth company until the earlier of (1) the last day of the year following the fifth anniversary of the completion of our initial public offering (“IPO”), (2) the last day of the year in which we have total annual gross revenue of at least $1.07 billion, (3) the last day of the year in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year or (4) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

31

 

In addition, the JOBS Act also provides that an emerging growth company may take advantage of the extended transition period provided in the Securities Act for complying with new or revised accounting standards. An emerging growth company may therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a result, will not be subject to the same implementation timing for new or revised accounting standards as are required of other public companies that are not emerging growth companies, which may make comparison of our consolidated financial information to those of other public companies more difficult.

We are also a smaller reporting company, as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i) our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.

 

32

 

 

Item 1A. Risk Factors.

An investment in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below before deciding whether to make an investment decision with respect to shares of our common stock. You should also refer to the other information contained in this Annual Report on Form 10-K, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our audited consolidated financial statements and related notes. Our business, financial condition, results of operations and prospects could be materially and adversely affected by any of these risks or uncertainties. In any such case, the trading price of our common stock could decline, and you could lose all or part of your investment. We caution you that the risks, uncertainties and other factors referred to below and elsewhere in this Annual Report on Form 10-K may not contain all of the risks, uncertainties and other factors that may affect our future results and operations. Moreover, new risks will emerge from time to time. It is not possible for our management to predict all risks.

Risk Factor Summary

Investing in our common stock involves significant risks. You should carefully consider the risks described below before making a decision to invest in our common stock. If we are unable to successfully address these risks and challenges, our business, financial condition, results of operations, or prospects could be materially adversely affected. In such case, the trading price of our common stock would likely decline, and you may lose all or part of your investment. Below is a summary of some of the risks we face.

 

•

We are a clinical-stage biopharmaceutical company with a limited operating history and no products approved for commercial sale. We have incurred net losses since our inception, we expect to incur significant and increasing operating losses and we may never be profitable. Our stock is a highly speculative investment.

 

•

We will require substantial additional capital to finance our operations, which may not be available to us on acceptable terms, or at all. As a result, we may not complete the development and commercialization of pegozafermin or develop new product candidates.

 

•

The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business.

 

•

Our business depends on the success of pegozafermin, our only product candidate under clinical development, which has not completed a pivotal trial. If we are unable to obtain regulatory approval for and successfully commercialize pegozafermin or other future product candidates, or we experience significant delays in doing so, our business will be materially harmed.

 

•

Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and the results of prior preclinical or clinical trials are not necessarily predictive of our future results.

 

•

If we experience delays in clinical testing, our commercial prospects will be adversely affected, our costs may increase and our business may be harmed.

 

•

If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.

 

•

We have relied on, and expect to continue to rely on, third-party manufacturers and vendors to produce and release pegozafermin or any future product candidates. Any failure by a third-party to produce and release acceptable product candidates for us pursuant to our specifications and regulatory standards may delay or impair our ability to initiate or complete our clinical trials, obtain and maintain regulatory approvals or commercialize approved products.

 

•

Pegozafermin and any future product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval or limit the commercial profile of an approved label.

33

 

 

•

We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products. This makes it difficult to predict the timing and costs of the clinical development of pegozafermin for the treatment of NASH.

 

•

Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates, which could adversely affect our stock price, our ability to attract additional capital and our development program.

 

•

Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.

 

•

The manufacture of biologic products is complex and we are subject to many manufacturing risks, any of which could substantially increase our costs and limit supply of our products.

 

•

We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than us.

 

•

Unstable market and economic conditions may have serious adverse consequences on our business and financial condition.

 

•

Our Loan and Security Agreement with Silicon Valley Bank contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay any outstanding indebtedness sooner than planned and possibly at a time when we do not have sufficient capital to meet this obligation.

 

•

Pegozafermin has not received regulatory approval. If we are unable to obtain regulatory approvals to market pegozafermin or any future product candidates, our business will be adversely affected.

 

•

Our success depends upon our ability to obtain and maintain intellectual property protection for our products and technologies.

 

•

We rely on a license from Teva and a sublicense from ratiopharm to patents and know-how related to glycoPEGylation technology that are used in the development, manufacture and commercialization of pegozafermin. Any termination or loss of significant rights, including the right to glycoPEGylation technology, or breach, under these agreements or any future license agreement related to our product candidates, would materially and adversely affect our ability to continue the development and commercialization of the related product candidates.

Risks Related to Our Business and Industry

We are a clinical-stage biopharmaceutical company with a limited operating history and no products approved for commercial sale. We have incurred net losses since our inception, we expect to incur significant and increasing operating losses and we may never be profitable. Our stock is a highly speculative investment.

We are a clinical-stage biopharmaceutical company with a limited operating history that may make it difficult to evaluate the success of our business to date and to assess our future viability. We commenced operations in 2018, and to date, our operations have been focused on organizing and staffing our company, raising capital, acquiring our initial product candidate, pegozafermin and licensing certain related technology, conducting research and development activities, including preclinical studies and clinical trials, and providing general and administrative support for these operations. Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect and/or an acceptable safety profile, gain regulatory approval and become commercially viable. We have no products approved for commercial sale, we have not generated any revenue from product sales to date and we continue to incur significant research and development and other expenses related to our ongoing operations. We have limited experience as a company conducting clinical trials and no experience as a company commercializing any products.

Pegozafermin is in development and, to date, we have not generated any revenue from the licensing or commercialization of pegozafermin. We will not be able to generate product revenue unless and until pegozafermin

34

 

or any future product candidate, alone or with future partners, successfully completes clinical trials, receives regulatory approval and is successfully commercialized. As pegozafermin is in development, we do not expect to receive revenue from it for a number of years, if ever. Although we may seek to obtain revenue from collaboration or licensing agreements with third parties, we currently have no such agreements that could provide us with material, ongoing future revenue and we may never enter into any such agreements.

We are not profitable and have incurred net losses since our inception. Consequently, predictions about our future success or viability may not be as accurate as they would be if we had a longer operating history or a history of successfully developing and commercializing pharmaceutical products. We have spent, and expect to continue to spend, significant resources to fund research and development of, and seek regulatory approvals for, pegozafermin and any future product candidates. We expect to incur substantial and increasing operating losses over the next several years as our research, development clinical trial and manufacturing activities increase. In addition, because of the numerous risks and uncertainties associated with pharmaceutical product development, including that our product candidates may not advance through development or achieve the endpoints of applicable clinical trials, we are unable to predict the timing or amount of increased expenses, or if or when we will achieve or maintain profitability. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. The net losses we incur may fluctuate significantly from quarter-to-quarter such that a period-to-period comparison of our results of operations may not be a good indication of our future performance. Even if we eventually generate product revenue, we may never be profitable and, if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.

We will require substantial additional capital to finance our operations, which may not be available to us on acceptable terms, or at all. As a result, we may not complete the development and commercialization of pegozafermin or develop new product candidates.

As a clinical-stage biopharmaceutical company, our operations have consumed significant amounts of cash since our inception. We expect our research and development expenses to increase in connection with our ongoing activities, particularly as we conduct clinical trials of and seek regulatory approvals for pegozafermin. We believe that our existing cash and cash equivalents and short-term available-for-sale securities, together with the proceeds available from our line of credit pursuant to our Loan and Security Agreement (as amended, the “2021 Loan Agreement”) with Silicon Valley Bank (“SVB”) will fund our projected operating requirements for a period of at least one year from the date of this Annual Report on Form 10-K is filed with the SEC.

We will require additional capital to discover, develop, obtain regulatory approval for and commercialize pegozafermin and any future product candidates. We do not have any committed external source of funds other than the unused portion of the line of credit available to us pursuant to the 2021 Loan Agreement and as a result of any sales that we may make pursuant to the sales agreement for our “at-the-market” offering facility. We expect to finance future cash needs through public or private equity or debt offerings or product collaborations. Additional capital may not be available in sufficient amounts or on reasonable terms, if at all. If we do not raise additional capital, we may not be able to expand our operations or otherwise capitalize on our business opportunities, our business and financial condition will be negatively impacted and we may need to: significantly delay, scale back or discontinue research and discovery efforts and the development or commercialization of any product candidates or cease operations altogether; seek strategic alliances for research and development programs when we otherwise would not, or at an earlier stage than we would otherwise desire or on terms less favorable than might otherwise be available; or relinquish, or license on unfavorable terms, our rights to technologies or any product candidates that we otherwise would seek to develop or commercialize ourselves.

In addition, if pegozafermin receives approval and is commercialized, we will be required to make milestone and royalty payments to Teva, from whom we acquired certain patents and intellectual property relating to pegozafermin, and from whom we licensed patents and know-how related to glycoPEGylation technology that is used in the manufacture of pegozafermin. For additional information regarding this license agreement, please see Note 5 of our accompanying audited consolidated financial statements.

35

 

The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business.

Our business and its operations, including but not limited to our research and development activities, could be adversely affected by health epidemics in regions where we have business operations, and such health epidemics could cause significant disruption in the operations of third parties upon whom we rely. In response to public health directives and orders related to COVID-19 and based on guidance from public health officials, we have implemented and may continue to implement work-from-home policies for our employees on an office-by-office basis. The effects of executive and similar government orders, shelter-in-place orders and our work-from-home policies may negatively impact our growth, including our ability to recruit and onboard new employees, and productivity, disrupt our business and delay our preclinical and clinical programs and timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. These and similar, and perhaps more severe, disruptions in our operations could negatively impact our business, operating results and financial condition.

Our clinical trials have been and may continue to be affected by the COVID-19 pandemic. For example, while we initiated the Phase 2 trial (ENTRIGUE) of pegozafermin for the treatment of SHTG, our successful completion of these trials will depend on the external environment with respect to COVID-19 remaining conducive to executing the trial safely and effectively. The COVID-19 pandemic has impacted execution and enrollment of our trials. We expect to report topline data from this study in the second quarter of 2022. Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing trials may be impacted. 

In addition, quarantines, shelter-in-place, executive and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, have impacted and may continue to impact personnel at third-party manufacturing facilities in the United States, Europe and other countries, or the availability or cost of materials we use or require to conduct our business, including product development, which would disrupt our supply chain. In particular, BTPH, our sole source supplier for pegozafermin, has missed certain project deadlines for our manufacturing scale-up due to quarantine orders and has forecasted other delays due to COVID-19-related impacts on their suppliers. Furthermore, we have experienced and may continue to experience delays due to widespread supply chain issues relating to the COVID-19 pandemic, as well as historically the designation of certain supplies for vaccine production, which may limit our ability to obtain sufficient materials for our drug products. However, we have not experienced and do not expect to experience any delays to the overall timeline for the delivery of clinical supplies.

If COVID-19 continues to spread in the United States and elsewhere, we may experience additional disruptions that could severely impact our business, preclinical studies and clinical trials, including: delays in receiving authorization from local regulatory authorities to initiate our planned clinical trials; delays or difficulties in enrolling patients in our clinical trials; delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff; delays in clinical sites receiving the supplies and materials needed to conduct our clinical trials; changes in local regulations as part of a response to the COVID-19 pandemic which may require us to change the ways in which our clinical trials are conducted and result in unexpected costs, or discontinuing our clinical trials altogether; a diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; interruption of key clinical trial activities, such as clinical trial site monitoring and data entry and verification, due to limitations on travel imposed or recommended by federal or state governments, employers and others, or interruption of clinical trial subject visits and study procedures, the occurrence of which could affect the completeness and integrity of clinical trial data and, as a result, determine the outcomes of the trial; the risk that participants enrolled in our clinical trials will acquire COVID-19 while the clinical trial is ongoing, which could impact the results of the clinical trial, including by increasing the number of observed adverse events; the risk that participants enrolled in our clinical trials will not be able to travel to our clinical trial sites as a result of quarantines or other restrictions resulting from COVID-19 or comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services; interruptions or delays in preclinical studies due to restricted or limited operations at our research and development laboratory facilities; limitations in employee resources that would otherwise be focused on the conduct of our clinical trials; the refusal of the FDA to accept data from clinical trials in affected geographies; and interruption or delays to our clinical activities.

36

 

The COVID-19 pandemic continues to evolve rapidly. The ultimate impact of the COVID-19 pandemic or a similar public health emergency is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, healthcare systems, or the global economy as a whole. However, any one or a combination of these events could have an adverse effect on the operation of and results from our clinical trials and on our other business operations, including preventing or delaying approval for pegozafermin.

Our business depends on the success of pegozafermin, our only product candidate under clinical development, which has not completed a pivotal trial. If we are unable to obtain regulatory approval for and successfully commercialize pegozafermin or other future product candidates, or we experience significant delays in doing so, our business will be materially harmed.

To date, the primary focus of our product development has been pegozafermin for the treatment of patients with NASH. Currently, pegozafermin is our only product candidate under clinical development. This may make an investment in our company riskier than similar companies that have multiple product candidates in active development and that therefore may be able to better sustain a failure of a lead candidate. Successful continued development and ultimate regulatory approval of pegozafermin for the treatment of NASH or other indications, including SHTG, is critical to the future success of our business. We have invested, and will continue to invest, a significant portion of our time and financial resources in the clinical development of pegozafermin. If we cannot successfully develop, obtain regulatory approval for and commercialize pegozafermin, we may not be able to continue our operations. The future regulatory and commercial success of pegozafermin is subject to a number of risks, including that if approved for NASH or SHTG, pegozafermin will likely compete with products that may reach approval for the treatment of NASH prior to pegozafermin, products that are currently approved for the treatment of SHTG and the off-label use of currently marketed products for NASH and SHTG.

Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and the results of prior preclinical or clinical trials are not necessarily predictive of our future results.

Pegozafermin and any future product candidates will be subject to rigorous and extensive clinical trials and extensive regulatory approval processes implemented by the FDA and comparable foreign regulatory authorities before obtaining marketing approval from these regulatory authorities. The drug development and approval process is lengthy and expensive, and approval is never certain. Investigational new drugs, such as pegozafermin, may not prove to be safe and effective in clinical trials. We have no direct experience as a company in conducting pivotal trials required to obtain regulatory approval. We may be unable to conduct clinical trials at preferred sites, enlist clinical investigators, enroll sufficient numbers of participants or begin or successfully complete clinical trials in a timely fashion, if at all. In addition, the design of a clinical trial can determine whether its results will support approval of a product, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. We may be unable to design and execute a clinical trial to support regulatory approval. Even if a current clinical trial is successful, it may be insufficient to demonstrate that pegozafermin is safe or effective for registration purposes.

There is a high failure rate for drugs and biologic products proceeding through clinical trials. Failure can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of pegozafermin or any future product candidate may not be predictive of the results of later-stage clinical studies or trials and the results of studies or trials in one set of patients or line of treatment may not be predictive of those obtained in another. In fact, many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials even after achieving promising results in preclinical studies and earlier stage clinical trials. In addition, data obtained from preclinical and clinical activities is subject to varying interpretations, which may delay, limit or prevent regulatory approval. It is impossible to predict when or if pegozafermin or any future product candidate will prove effective or safe in humans or will receive regulatory approval. Owing in part to the complexity of biological pathways, pegozafermin or any future product candidate may not demonstrate in patients the biochemical and pharmacological properties we anticipate based on laboratory studies or earlier stage clinical trials, and they may interact with human biological systems or other drugs in unforeseen, ineffective or harmful ways. The number of patients exposed to product candidates and the average exposure time in the clinical development programs may be inadequate to detect rare adverse events or findings that may only be detected once a product candidate is administered to more patients and for greater periods of time. To date, our Phase 1a and Phase 1b/2a clinical trials have involved small patient populations and, because of the small

37

 

sample size in such trials, the results of these clinical trials may be subject to substantial variability, including the inherent variability associated with biopsies in NASH patients, and may not be indicative of either future interim results or final results in future trials of patients with liver or cardio-metabolic diseases. If we are unable to successfully demonstrate the safety and efficacy of pegozafermin or other future product candidates and receive the necessary regulatory approvals, our business will be materially harmed.

If we experience delays in clinical testing, our commercial prospects will be adversely affected, our costs may increase and our business may be harmed.

We cannot guarantee that we will be able to initiate and complete clinical trials and successfully accomplish all required regulatory activities or other activities necessary to gain approval and commercialize pegozafermin or any future product candidates. We currently have two active investigational new drug (“IND”) applications with the FDA in the United States for pegozafermin. In the future, we may file an additional IND with another division for any future indications or future product candidates. If any such future IND is not approved by the FDA, our clinical development timeline may be negatively impacted and any future clinical programs may be delayed or terminated. As a result, we may be unable to obtain regulatory approvals or successfully commercialize our products. We do not know whether any other clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Our product development costs will increase if we experience delays in clinical testing. Significant clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize pegozafermin and any future product candidates or allow our competitors to bring products to market before we do, which would impair our ability to successfully commercialize pegozafermin or any future product candidates and may harm our business, results of operations and prospects. Our or our future collaborators’ inability to timely complete clinical development could result in additional costs to us as well as impair our ability to generate product revenue, continue development, commercialize pegozafermin and any future product candidates, reach sales milestone payments and receive royalties on product sales. In addition, if we make changes to a product candidate including, for example, a new formulation, we may need to conduct additional nonclinical studies or clinical trials to bridge or demonstrate the comparability of our modified product candidate to earlier versions, which could delay our clinical development plan or marketing approval for our current product candidate and any future product candidates.

If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.

The timely completion of clinical trials largely depends on patient enrollment. We may encounter delays in enrolling, or be unable to enroll, a sufficient number of patients to complete any of our future clinical trials, and even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. Furthermore, there are inherent difficulties in diagnosing NASH, which can currently only be definitively diagnosed through a liver biopsy, and identifying SHTG patients. Specifically, identifying patients most likely to meet NASH enrollment criteria on biopsy is an on-going challenge, with existing clinical indicators lacking both sensitivity and specificity. As a result, NASH trials often suffer from high levels of screen failure following central review of the baseline liver biopsy, which can lead to lower enrollment. As a result of such difficulties and the significant competition for recruiting NASH and SHTG patients in clinical trials, we or our future collaborators may be unable to enroll the patients we need to complete clinical trials on a timely basis, or at all. In addition, our competitors, some of whom have significantly greater resources than we do, are conducting clinical trials for the same indications and seek to enroll patients in their studies that may otherwise be eligible for our clinical studies or trials. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which could further reduce the number of patients who are available for our clinical trials in these sites. Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays or may require us to abandon one or more clinical trials altogether. Even if we are able to enroll a sufficient number of patients in our clinical studies or trials, delays in patient enrollment may result in increased costs or may affect the timing or outcome of our clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of pegozafermin and any future product candidates.

38

 

We have relied on, and expect to continue to rely on, third-party manufacturers and vendors to produce and release pegozafermin or any future product candidates. Any failure by a third-party to produce and release acceptable product candidates for us pursuant to our specifications and regulatory standards may delay or impair our ability to initiate or complete our clinical trials, obtain and maintain regulatory approvals or commercialize approved products.

We do not own or operate manufacturing facilities for the production of clinical or commercial quantities of our product candidates, and we lack the resources and the capabilities to do so. As a result, we currently rely, and expect to rely for the foreseeable future, on third-party manufacturers to supply us with pegozafermin and any future product candidates. We currently have a sole source relationship with BTPH pursuant to which they supply us with pegozafermin. If there should be any disruption in our supply arrangement with BTPH, including any adverse events affecting BTPH, it could have a negative effect on the clinical development of pegozafermin and other operations while we work to identify and qualify an alternate supply source. In addition, we will require large quantities of pegozafermin for large clinical trials and to commercialize pegozafermin. Our current manufacturer may not be able to scale production to the larger quantities. We have identified a manufacturing partner for commercial-scale manufacturing, however, we cannot guarantee that such partner will be able to scale up and produce the quantities we would require to commercialize pegozafermin.

We do not have a long-term supply agreement with any third-party manufacturer. Reliance on third-party manufacturers entails risks to which we would not be subject if we manufacture product candidates or products ourselves. For example, if we do not maintain our key manufacturing relationships, we may fail to find replacement manufacturers or develop our own manufacturing capabilities in a timely manner or at all, which could delay or impair our ability to obtain regulatory approval for our products and substantially increase our costs or deplete profit margins, if any. If we do find replacement manufacturers, we may not be able to enter into agreements with them on terms and conditions favorable to us, and there could be a substantial delay before new facilities could be qualified and registered with the FDA and other comparable foreign regulatory authorities.

We have begun producing certain of the reagents required for the glycoPEGylation at BTPH using the know-how transferred to us from Teva Pharmaceutical Industries Ltd (“Teva”) under our Reagent Supply and Technology Transfer Agreement. We have not completed the manufacturing process for all these reagents and cannot guarantee that we will be able to produce them successfully, or scale up our production for the quantities needed for commercialization.

Teva continues to supply us with certain reagents and will continue to do so until December 31, 2022. We expect the manufacturing of such reagents will be transferred to a new supplier prior to the end of 2022. Any complications arising under our agreement with Teva or any difficulties securing a new supplier could considerably delay the manufacture of pegozafermin. Any significant delay in the acquisition or decrease in the availability of these raw materials from Teva or any new supplier could considerably delay the manufacture of pegozafermin, which could adversely impact the timing of any planned trials or the regulatory approvals of pegozafermin.

We rely on third-party vendors for our assay development and testing. If such third-party vendors are unable to successfully produce or test such assays, it may substantially increase our cost or could adversely impact the timing of any planned trials or the regulatory approvals of pegozafermin.

The FDA and other comparable foreign regulatory authorities require manufacturers to register manufacturing facilities. The FDA and other comparable foreign regulatory authorities also inspect these facilities to confirm compliance with cGMP. We have little to no control regarding the occurrence of third-party manufacturer incidents. Any failure to comply with cGMP requirements or other FDA or comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop pegozafermin or any future product candidates and market our products following approval. Our sole source supplier, BTPH, has not yet manufactured a commercial product, and as a result, has not been subject to inspection by the FDA and other comparable foreign regulatory authorities.

Our current and anticipated future dependence upon others for the manufacture of our product candidates may adversely affect our future profit margins and our ability to develop our product candidates and commercialize any products that receive regulatory approval on a timely basis. If we are required to change manufacturers for any

39

 

reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. For example, in the event that we need to switch our third-party manufacturer of pegozafermin from BTPH, which is our sole manufacturing source for pegozafermin, we anticipate that the complexity of the glycoPEGylation manufacturing process may materially impact the amount of time it may take to secure a replacement manufacturer. The delays associated with the verification of a new manufacturer, if we are able to identify an alternative source, could negatively affect our ability to develop product candidates in a timely manner or within budget.

Pegozafermin and any future product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval or limit the commercial profile of an approved label.

Undesirable side effects caused by pegozafermin or any future product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign regulatory authorities. Additional clinical studies may be required to evaluate the safety profile of pegozafermin or any future product candidates. As with other drugs, we have seen evidence of adverse effects in animal and human studies and it is possible that other adverse effects will become apparent in ongoing or future animal or human safety studies. It may be difficult to discern whether certain events or symptoms observed during our clinical trials or by patients using our approved products are related to pegozafermin or any future product candidates or approved products or some other factor. As a result, we and our development programs may be negatively affected even if such events or symptoms are ultimately determined to be unlikely related to pegozafermin or any future product candidates or approved products. Further, we expect that pegozafermin will require multiple administrations via subcutaneous injection in the course of a clinical trial. This chronic administration increases the risk that rare adverse events or chance findings are discovered in the commercial setting, where pegozafermin would be administered to more patients or for greater periods of time, that were not uncovered by our clinical drug development programs.

We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products. This makes it difficult to predict the timing and costs of the clinical development of pegozafermin for the treatment of NASH.

We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products. Although there are guidelines issued by the FDA for the development of drugs for the treatment of NASH, the development of a novel product candidates such as pegozafermin may be more expensive and take longer than for other, better known or extensively studied product candidates. As other companies are in later stages of clinical trials for their potential NASH therapies, we expect that the path for regulatory approval for NASH therapies may continue to evolve in the near term as these other companies refine their regulatory approval strategies and interact with regulatory authorities. Such evolution may impact our future clinical trial designs, including trial size and endpoints, in ways that we cannot predict today. In particular, regulatory authority expectations about liver biopsy data may evolve especially as more information is published about the inherent variability in liver biopsy data. Certain of our competitors have experienced regulatory setbacks for NASH therapies following communications from the FDA. We currently do not know the impact, if any, that these setbacks could have on the path for regulatory approval for NASH therapies generally or for pegozafermin. Furthermore, the histology endpoints from our Phase 2b ENLIVEN trial may not be accepted as primary endpoints for a pivotal Phase 3 trial or for FDA approval.

Our anticipated development costs would likely increase if development of pegozafermin or any future product candidate is delayed because we are required by the FDA to perform studies or trials in addition to, or different from, those that we currently anticipate.

We are also developing pegozafermin for the treatment of SHTG. Clinical trials for the treatment of SHTG may be relatively costly and time consuming. The requirements for approval by the FDA and comparable foreign regulatory authorities may change over time and this may require changes to ongoing or future clinical trial designs that could impact timelines and cost.

40

 

Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates, which could adversely affect our stock price, our ability to attract additional capital and our development program.

Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates like ours. For example, Novo Nordisk and Akero Therapeutics, Inc. are also developing FGF21 product candidates for the treatment of NASH. We have no control over their clinical trials or development program, and lack of efficacy, adverse events or undesirable side effects experienced by subjects in their clinical trials could adversely affect our stock price, our ability to attract additional capital and our clinical development plans for pegozafermin or even the viability or prospects of pegozafermin as a product candidate, including by creating a negative perception of FGF therapeutics by healthcare providers or patients.

Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.

From time to time, we may publicly disclose preliminary or topline data from our clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. From time to time, we may also disclose interim data from our clinical trials. In addition, we may report interim analyses of only certain endpoints rather than all endpoints. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.

The manufacture of biologic products is complex and we are subject to many manufacturing risks, any of which could substantially increase our costs and limit supply of our products.

To date, pegozafermin has been manufactured by a single third-party manufacturer, BTPH, solely for preclinical studies and clinical trials. The process of manufacturing pegozafermin, and in particular, the glycoPEGylation process, is complex, highly regulated, subject to several risks and requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of biologic products often encounter difficulties in production, including difficulties with production costs and yields, quality control, including stability of the product, quality assurance testing, operator error and shortages of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. We cannot assure you that any stability or other issues relating to the manufacture of pegozafermin will not occur in the future. We have limited process development capabilities and have access only to external manufacturing capabilities. We do not have and we do not currently plan to acquire or develop the facilities or capabilities to manufacture bulk drug substance or filled drug product for use in human clinical trials or commercialization.

We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than us.

The biopharmaceutical industry is intensely competitive and subject to rapid innovation and significant technological advancements. Our competitors include multinational pharmaceutical companies, specialized biotechnology companies, universities and other research institutions. A number of biotechnology and pharmaceutical companies are pursuing the development or marketing of pharmaceuticals that target the same diseases that we are targeting. Certain of these companies have recently published positive data regarding their clinical trials, which may further increase the competition we face. Smaller or earlier-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Given the high incidence of NASH and SHTG, it is likely that the number of companies seeking to

41

 

develop products and therapies for the treatment of liver and cardio-metabolic diseases, such as NASH and SHTG, will increase.

There are numerous currently approved therapies for treating diseases other than NASH and some of these currently approved therapies may exert effects that could be similar to pegozafermin in NASH. Many of these approved drugs are well-established therapies or products and are widely accepted by physicians, patients and third-party payors. Some of these drugs are branded and subject to patent protection, and others are available on a generic basis. This may make it difficult for us to differentiate our products from currently approved therapies, which may adversely impact our business strategy. We expect that if pegozafermin or any future product candidates are approved, they will be priced at a significant premium over competitive generic products, including branded generic products. Insurers and other third-party payors may also encourage the use of generic products or specific branded products prior to utilization of pegozafermin. In addition, many companies are developing new therapeutics, and we cannot predict what the standard of care will be as pegozafermin or any future product candidates progress through clinical development. In addition, to the extent pegozafermin or any future product candidates are approved for liver or cardio-metabolic indications, such as SHTG, the commercial success of our products will also depend on our ability to demonstrate benefits over the then-prevailing standard of care, including diet, exercise and lifestyle modifications.

Further, if pegozafermin or any future product candidates are approved for the treatment of SHTG, we will compete with currently approved therapies and therapies further along in development. Our competitors both in the United States and abroad include large, well-established pharmaceutical and generic companies with significantly greater name recognition. Our competitors may be able to charge lower prices than we can, which may adversely affect our market acceptance. Many of these competitors have greater resources than we do, including financial, product development, marketing, personnel and other resources.

If our competitors market products that are more effective, safer or cheaper than our products or that reach the market sooner than our products, we may not achieve commercial success. Many of our competitors have substantially greater financial, technical, human and other resources than we do and may be better equipped to develop, manufacture and market technologically superior products. As a result, our competitors may obtain regulatory approval of their products more rapidly than we do or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidate or any future product candidates. Our competitors may also develop and succeed in obtaining approval for drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than we are in manufacturing and marketing their products.

Unstable market and economic conditions may have serious adverse consequences on our business and financial condition.

Global credit and financial markets have experienced extreme disruptions at various points over the last few decades. If another such disruption in credit and financial markets and deterioration of confidence in economic conditions occurs, it may make any necessary debt or equity financing more difficult to complete, more costly, and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and share price and could require us to delay or abandon development or commercialization plans. In addition, there is a risk that one or more of our service providers, manufacturers or other partners would not survive or be able to meet their commitments to us under such circumstances, which could directly affect our ability to attain our operating goals on schedule and on budget.

The 2021 Loan Agreement contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay any outstanding indebtedness sooner than planned and possibly at a time when we do not have sufficient capital to meet this obligation.

Pursuant to the 2021 Loan Agreement, we have pledged substantially all of our assets, other than our intellectual property rights, and have agreed that we may not sell or assign rights to our patents and other intellectual property without the prior consent of SVB. Additionally, the 2021 Loan Agreement contains certain affirmative and negative covenants that could prevent us from taking certain actions without the consent of our lenders. These covenants may limit our flexibility in operating our business and our ability to take actions that might be

42

 

advantageous to us and our stockholders. The 2021 Loan Agreement also includes customary events of default, including, among other things, a change of control. Upon the occurrence and continuation of an event of default, all amounts due under the 2021 Loan Agreement become (in the case of a bankruptcy event) or may become (in the case of all other events of default and at the option of SVB), immediately due and payable. If an event of default under the 2021 Loan Agreement should occur, we could be required to immediately repay any outstanding indebtedness. If we are unable to repay such debt, the lenders would be able to foreclose on the secured collateral, including our cash accounts, and take other remedies permitted under the 2021 Loan Agreement. Even if we are able to repay any indebtedness on an event of default, the repayment of these sums may significantly reduce our working capital and impair our ability to operate as planned.

We may encounter difficulties in managing our growth, which could adversely affect our operations.

We are in the early stages of building the full team that we anticipate we will need to complete the development pegozafermin and other future product candidates. As we advance our preclinical and clinical development programs for product candidates, seek regulatory approval in the United States and elsewhere and increase the number of ongoing product development programs, we anticipate that we will need to increase our product development, scientific and administrative headcount. We will also need to establish commercial capabilities in order to commercialize any product candidates that may be approved. Such an evolution may impact our strategic focus and our deployment and allocation of resources. Our ability to manage our operations and growth effectively depends upon the continual improvement of our procedures, reporting systems and operational, financial and management controls. We may not be able to implement administrative and operational improvements in an efficient or timely manner and may discover deficiencies in existing systems and controls. In addition, in order to continue to meet our obligations as a public company and to support our anticipated long-term growth, we will need to increase our general and administrative capabilities. Our management, personnel and systems may experience difficulty in adjusting to our growth and strategic focus.

We must attract and retain highly skilled employees in order to succeed. If we are not able to retain our current senior management team and our scientific advisors or continue to attract and retain qualified scientific, technical and business personnel, our business will suffer.

We may not be able to attract or retain qualified personnel and consultants due to the intense competition for such individuals in the biotechnology and pharmaceutical industries. If we are not able to attract and retain necessary personnel and consultants to accomplish our business objectives, it may significantly impede the achievement of our development and commercial objectives and our ability to implement our business strategy. In addition, we are highly dependent on the development, regulatory, manufacturing, commercialization and financial expertise of the members of our executive team, as well as other key employees and consultants. If we lose one or more of our executive officers or other key employees or consultants, our ability to implement our business strategy successfully could be seriously harmed.

We are developing a new drug product formulation for pegozafermin and we may be unsuccessful. Any changes in methods of product candidate manufacturing or formulation may result in the need to perform new clinical trials or obtain new drug product, which would require additional costs and cause delay.

 

Our current drug product comes in two formulations, frozen and liquid, with the latter being used in all new studies, beginning with our ENLIVEN study. We are developing a new drug product formulation of pegozafermin for late-stage clinical trials and commercialization. We have commenced development of a pre-filled syringe for the new drug product formulation and we also plan to begin development of a pen-type autoinjector. There is no assurance that we will be successful in developing a new drug product formulation, a pre-filled syringe or an autoinjector on a timely basis or at all, any of which could impede our development and commercialization strategy for pegozafermin. The FDA or other comparable foreign regulatory authorities could require nonclinical studies or clinical trials to support introduction of any new formulation, pre-filled syringe and autoinjector, which could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical

43

 

trials, increase our clinical trial costs, delay approval of pegozafermin and jeopardize our ability to commence product sales and generate revenue from pegozafermin, if approved.

We rely on third parties for certain aspects of our product candidate development process and we may not be able to obtain and maintain the third-party relationships that are necessary to develop, commercialize and manufacture some or all of our product candidates.

We expect to depend on collaborators, partners, licensees, clinical investigators, contract research organizations, manufacturers and other third parties to support our discovery efforts, to formulate product candidates, to conduct clinical trials for some or all of our product candidates, to manufacture clinical and commercial scale quantities of our drug substance and drug product and to market, sell and distribute any products we successfully develop. Any of these third parties may terminate their engagements with us at any time. If we need to enter into alternative arrangements, it would delay our product development activities and such alternative arrangements may not be available on terms acceptable to us. We also expect to rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development, marketing approval and/or commercialization of pegozafermin or any future product candidates, producing additional losses and depriving us of potential revenue.

Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.

Our operations, and those of our contract research organizations, CMO, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, acts of war, medical pandemics or epidemics, such as the novel coronavirus, and other natural or man-made disasters or business interruptions. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.

If we fail to develop and commercialize additional product candidates, we may be unable to grow our business.

Although the development and commercialization of pegozafermin is currently our primary focus, as part of our longer-term growth strategy, we plan to evaluate the development and commercialization of other therapies related to NASH and other liver and cardio-metabolic diseases. The success of this strategy depends primarily upon our ability to identify and validate new therapeutic candidates, and to identify, develop and commercialize new drugs and biologics. Our research efforts may initially show promise in discovering potential new drugs and biologics yet fail to yield product candidates for clinical development for a number of reasons.

We may use our limited financial and human resources to pursue a particular research program or product candidate that is ultimately unsuccessful or less successful than other programs or product candidates that we may have forgone or delayed.

Because we have limited personnel and financial resources, we may forego or delay the development of certain programs or product candidates that later prove to have greater commercial potential than the programs or product candidates that we do pursue. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for product candidates may not yield any commercially viable products. Similarly, our decisions to delay or terminate drug development programs may also be incorrect and could cause us to miss valuable opportunities.

We may seek to establish commercial collaborations for our product candidates, and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans.

Our drug development programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. We may decide to collaborate with other pharmaceutical and

44

 

biotechnology companies for the development and potential commercialization of our product candidates. Collaborations are complex and time-consuming to negotiate and document. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities or increase our expenditures and undertake development or commercialization activities at our own expense.

We may not be successful in our efforts to identify, in-license or acquire, discover, develop or commercialize additional product candidates.

We may seek to identify, in-license or acquire, discover, develop and commercialize additional product candidates. We cannot assure you that our effort to in-license or acquire additional product candidates will be successful. Even if we are successful in in-licensing or acquiring additional product candidates, their requisite development activities may require substantial resources, and we cannot assure you that these development activities will result in regulatory approvals.

Our international operations may expose us to business, regulatory, political, operational, financial, pricing and reimbursement risks associated with doing business outside of the United States.

Our use of our international facilities subjects us to U.S. and foreign governmental trade, import and export, and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Doing business internationally potentially involves a number of risks, any of which could harm our ongoing international clinical operations and supply chain, as well as any future international expansion and operations and, consequently, our business, financial condition, prospects and results of operations.

Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.

We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercialize any resulting products. Product liability claims may be brought against us by subjects enrolled in our clinical trials, patients, or others using our products. Our clinical trial liability insurance coverage may not adequately cover all liabilities that we may incur.

Our employees, contractors, vendors, principal investigators, consultants and future partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements and insider trading.

We are exposed to the risk of fraud or other misconduct by our employees, contractors, vendors, principal investigators, consultants or future partners. Misconduct by these parties could include failures to comply with FDA regulations, to provide accurate information to the FDA, to comply with federal and state healthcare fraud and abuse laws and regulations, to report financial information or data timely, completely or accurately, or to disclose unauthorized activities to us. Most states also have statutes or regulations similar to these federal laws, which may apply to items such as pharmaceutical products and services reimbursed by private insurers. We and/or our future partners may be subject to administrative, civil and criminal sanctions for violations of any of these laws.

We depend on our information technology systems and those of our third-party collaborators, service providers, contractors or consultants. Our internal computer systems, or those of our third-party collaborators, service providers, contractors or consultants, may fail or suffer security breaches, disruptions, or incidents, which could result in a material disruption of our development programs or loss of data or compromise the privacy, security, integrity or confidentiality of sensitive information related to our business and have a material adverse effect on our reputation, business, financial condition or results of operations.

In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information. Our internal

45

 

technology systems and infrastructure, and those of our current or future third-party collaborators, service providers, contractors and consultants are vulnerable to damage from computer viruses, unauthorized access or use resulting from malware, natural disasters, terrorism, war and telecommunication and electrical failures, denial-of-service attacks, cyber-attacks or cyber-intrusions over the Internet, hacking, phishing and other social engineering attacks, persons inside our organizations (including employees or contractors), loss or theft, or persons with access to systems inside our organization. From time to time, we are subject to periodic phishing attempts. In the third quarter of 2021, we discovered a business email compromise caused by phishing. The phishing attack did not result in the misappropriation of any funds. Even though we are implementing remedial measures promptly following this incident and do not believe that it had a material adverse effect on our business, we cannot guarantee that our implemented remedial measures will prevent additional related, as well as unrelated, incidents. If a material system failure, accident or security breach were to occur and cause interruptions in our operations or the operations of third-party collaborators, service providers, contractors and consultants, it could result in a material disruption of our development programs and significant reputational, financial, legal, regulatory, business or operational harm.

To the extent that any real or perceived security breach affects our systems (or those of our third-party collaborators, service providers, contractors or consultants), or results in the loss of or accidental, unlawful or unauthorized access to, use of, release of, or other processing of personally identifiable information or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could incur liabilities and the further development of our product candidates could be delayed. Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with our privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, processing of, or transfer of sensitive information, including personally identifiable information, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including those that assert that we have breached our privacy, confidentiality, data security or similar obligations, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations.

Risks Related to Regulatory Approvals

Pegozafermin has not received regulatory approval. If we are unable to obtain regulatory approvals to market pegozafermin or any future product candidates, our business will be adversely affected.

We do not expect pegozafermin or any future product candidate to be commercially available for several years, if at all. Pegozafermin is and any future product candidate will be subject to strict regulation by regulatory authorities in the United States and in other countries. We cannot market any product candidate until we have completed all necessary preclinical studies and clinical trials and have obtained the necessary regulatory approvals. We do not know whether regulatory agencies will grant approval for pegozafermin or any future product candidate. Even if we complete preclinical studies and clinical trials successfully, we may not be able to obtain regulatory approvals or we may not receive approvals to make claims about our products that we believe to be necessary to effectively market our products. Data obtained from preclinical studies and clinical trials is subject to varying interpretations that could delay, limit or prevent regulatory approval, and failure to comply with regulatory requirements or inadequate manufacturing processes are examples of other problems that could prevent approval. The regulatory authorities in the United States and the EU have not approved any products for the treatment of NASH, and while there are guidelines issued by the FDA for the development of drugs for the treatment of NASH and an FDA surrogate endpoint table for drug approval that includes SHTG, it is unclear whether the requirements for approval will change in the future. Any such changes may require us to conduct new trials that could delay our timeframe and increase the costs of our programs related to pegozafermin or any future product candidate for the treatment of NASH or SHTG. While the FDA has approved reduction in triglycerides levels as a surrogate endpoint for the full approval of drugs for the treatment of SHTG, it is unclear whether this endpoint will apply to any product candidates that we develop. If such endpoint is not deemed to apply to our product candidates, it would delay our development timeline and increase the costs of our programs for the treatment of SHTG. We have not had any discussions with the FDA regarding a surrogate endpoint or accelerated approval regulations. However, we currently expect that our SHTG program would be subject to smaller clinical trials and that we may expect a relatively quicker overall development timeline for this indication. These expectations are based on a published

46

 

FDA surrogate endpoint table for drug approval that includes SHTG, as well as the development path followed by other companies that developed an SHTG therapy.

Even if we are able to obtain regulatory approvals for pegozafermin or any future product candidate, if they exhibit harmful side effects after approval, our regulatory approvals could be revoked or otherwise negatively impacted, and we could be subject to costly and damaging product liability claims.

Even if we receive regulatory approval for pegozafermin or any future product candidates, we will have tested them in only a small number of patients during our clinical trials. If our applications for marketing are approved and more patients begin to use our product, new risks and side effects associated with our products may be discovered. As a result, regulatory authorities may revoke their approvals. We have not had any discussions with the FDA regarding a surrogate endpoint or accelerated approval regulations. However, based on recent guidelines issued by the FDA for the development of drugs for the treatment of NASH, if pegozafermin is approved by the FDA based on a surrogate endpoint pursuant to section 506(c) of the Federal Food, Drug, and Cosmetic Act and the accelerated approval regulations (21 C.F.R. part 314, subpart H; 21 C.F.R. part 601, subpart E), consistent with FDA guidance, we will be required to conduct additional clinical trials establishing clinical benefit on the ultimate outcome of NASH. If pegozafermin is approved by the FDA for the treatment of SHTG based on an endpoint of the reduction of triglycerides, the FDA may still require a cardiovascular outcomes study as part of a post-marketing authorization commitment. Such a study would be time consuming and costly and we cannot guarantee that we will see positive results, which could result in the revocation of the approval. Additionally, we may be required to conduct additional clinical trials, make changes in labeling of our product, reformulate our product or make changes and obtain new approvals for our and our suppliers’ manufacturing facilities for pegozafermin and any future product candidates. We might have to withdraw or recall our products from the marketplace. We may also experience a significant drop in the potential sales of our product if and when regulatory approvals for such product are revoked. As a result, we may experience harm to our reputation in the marketplace or become subject to lawsuits, including class actions. Any of these results could decrease or prevent any sales of our approved product or substantially increase the costs and expenses of commercializing and marketing our product.

The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming and inherently unpredictable. Our inability to obtain regulatory approval for pegozafermin or any future product candidates would substantially harm our business.

Currently, we do not have any product candidates that have received regulatory approval. The time required to obtain approval from the FDA and comparable foreign regulatory authorities is unpredictable but typically takes many years following the commencement of preclinical studies and clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate’s development and may vary among jurisdictions. It is possible that none of pegozafermin or any future product candidates will ever obtain regulatory approval. Pegozafermin or any future product candidate could fail to receive regulatory approval from the FDA or comparable foreign regulatory authorities for many reasons, including those referenced in Part I, Item 1. “Business—Government Regulation and Product Approval” in this Annual Report on Form 10-K. If we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, may grant approval contingent on the performance of costly post-marketing clinical trials or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of the product candidate.

Even if pegozafermin or any future product candidate receives regulatory approval, it may still face future development and regulatory difficulties.

Even if we obtained regulatory approval for a product candidate, it would be subject to ongoing requirements by the FDA and comparable foreign regulatory authorities governing the manufacture, quality control, further development, labeling, packaging, storage, distribution, safety surveillance, import, export, advertising, promotion, recordkeeping and reporting of safety and other post-market information. In addition, manufacturers of drug products and their facilities are subject to continual review and periodic inspections by the FDA and other regulatory authorities for compliance with cGMP, regulations and standards. If we or a regulatory agency discover previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with

47

 

the facility where the product is manufactured, a regulatory agency may impose restrictions on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing. If we, our product candidates or the manufacturing facilities for our product candidates fail to comply with applicable regulatory requirements, or undesirable side effects caused by such products are identified, a regulatory agency may: issue safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings about such product; mandate modifications to promotional materials or require us to provide corrective information to healthcare practitioners; require that we conduct post-marketing studies; require us to enter into a consent decree, which can include imposition of various fines, reimbursements for inspection costs, required due dates for specific actions and penalties for noncompliance; seek an injunction or impose civil or criminal penalties or monetary fines; suspend marketing of, withdraw regulatory approval of or recall such product; suspend any ongoing clinical studies; refuse to approve pending applications or supplements to applications filed by us; suspend or impose restrictions on operations, including costly new manufacturing requirements; or seize or detain products, refuse to permit the import or export of products or require us to initiate a product recall. The occurrence of any event or penalty described above may inhibit our ability to commercialize our products and generate product revenue.

Risks Relating to Intellectual Property

Our success depends upon our ability to obtain and maintain intellectual property protection for our products and technologies.

Our success will depend in significant part on our current or future licensors’, licensees’ or collaborators’ ability to establish and maintain adequate protection of our owned and licensed intellectual property covering the product candidates we plan to develop, and the ability to develop these product candidates and commercialize the products resulting therefrom, without infringing the intellectual property rights of others. In addition to taking other steps to protect our intellectual property, we hold issued patents, we have applied for patents, and we intend to continue to apply for, patents with claims covering our technologies, processes and product candidates when and where we deem it appropriate to do so. We have filed numerous patent applications both in the United States and in certain foreign jurisdictions to obtain patent rights to inventions we have discovered, with claims directed to compositions of matter, methods of use and other technologies relating to our programs. There can be no assurance that any of these patent applications will issue as patents or, for those applications that do mature into patents, that the claims of the patents will exclude others from making, using or selling our product candidates or products that compete with or are similar to our product candidates. In countries where we have not sought and do not seek patent protection, third parties may be able to manufacture and sell our product candidates without our permission, and we may not be able to stop them from doing so.

With respect to patent rights, we do not know whether any of the pending patent applications for any of our product candidates will result in the issuance of patents that effectively protect our technologies, processes and product candidates, or if any of our issued patents or our current or future licensors’, licensees’ or collaborators’ issued patents will effectively prevent others from commercializing competitive technologies, processes and products. We cannot be certain that we or our current or future licensors, licensees or collaborators were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we or our current or future licensors, licensees or collaborators were the first to file for patent protection of such inventions.

Any changes we make to our pegozafermin or any future product candidates to cause them to have what we view as more advantageous properties may not be covered by our existing patents and patent applications, and we may be required to file new applications and/or seek other forms of protection for any such altered product candidates. The patent landscape surrounding the technology underlying our product candidates is crowded, and there can be no assurance that we would be able to secure patent protection that would adequately cover an alternative to pegozafermin or any future product candidates.

We and our current or future licensors, licensees or collaborators may not be able to prepare, file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our current or future licensors, licensees or collaborators will fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection for them. Moreover, in some circumstances, we may not have the right to control the preparation, filing

48

 

and prosecution of patent applications, or to maintain or enforce the patents, covering technology that we license from or license to third parties and may be reliant on our current or future licensors, licensees or collaborators to perform these activities, which means that these patent applications may not be prosecuted, and these patents enforced, in a manner consistent with the best interests of our business. If our current or future licensors, licensees or collaborators fail to establish, maintain, protect or enforce such patents and other intellectual property rights, such rights may be reduced or eliminated. If our current or future licensors, licensees or collaborators are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised.

Similar to the patent rights of other biotechnology companies, the scope, validity and enforceability of our owned and licensed patent rights generally are highly uncertain and involve complex legal and factual questions. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. In recent years, these areas have been the subject of much litigation in the industry. As a result, the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors’, licensees’ or collaborators’ patent rights are highly uncertain. Our and our current or future licensors’, licensees’ or collaborators’ pending and future patent applications may not result in patents being issued that protect our technology or product candidates, or products resulting therefrom, in whole or in part, or that effectively prevent others from commercializing competitive technologies and products. The patent examination process may require us or our current or future licensors, licensees or collaborators to narrow the scope of the claims of pending and future patent applications, which would limit the scope of patent protection that is obtained, if any. Our and our current or future licensors’, licensees’ or collaborators’ patent applications cannot be enforced against third parties practicing the technology that is currently claimed in such applications unless and until a patent issues from such applications, and then only to the extent the claims that issue are broad enough to cover the technology being practiced by those third parties.

Furthermore, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after the resulting products are commercialized. As a result, our owned and in-licensed patents may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. We expect to seek extensions of patent terms for our issued patents, where available. The applicable authorities, including the FDA in the United States, and any comparable foreign regulatory authorities, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. In addition, we may not be granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to the expiration of relevant patents or otherwise failing to satisfy applicable requirements.

We may not be able to protect our intellectual property rights throughout the world.

The legal protection afforded to inventors and owners of intellectual property in countries outside of the United States may not be as protective or effective as that in the United States and we may, therefore, be unable to acquire and enforce intellectual property rights outside the United States to the same extent as in the United States. Whether filed in the United States or abroad, our patent applications may be challenged or may fail to result in issued patents. Filing, prosecuting, enforcing and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States are less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and certain state laws in the United States.

Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with pegozafermin or any future product candidates and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

49

 

We rely on a license from Teva and a sublicense from ratiopharm to patents and know-how related to glycoPEGylation technology that are used in the development, manufacture and commercialization of pegozafermin. Any termination or loss of significant rights, including the right to glycoPEGylation technology, or breach, under these agreements or any future license agreement related to our product candidates, would materially and adversely affect our ability to continue the development and commercialization of the related product candidates.

In April 2018, we entered into an Asset Transfer and License Agreement (the “FGF21 Agreement”) with Teva under which we acquired certain patents, intellectual property and other assets relating to Teva’s glycoPEGylated FGF21 program, including pegozafermin. Under this agreement, we were granted a perpetual, non-exclusive (but exclusive as to pegozafermin), non-transferable, worldwide license to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin. The FGF21 Agreement also contains numerous covenants with which we must comply, including the utilization of commercially reasonable efforts to develop and ultimately commercialize pegozafermin, as well as certain reporting covenants and the obligation to make royalty payments, if and when pegozafermin is approved for commercialization. Our failure to satisfy any of these covenants could result in the termination of the FGF21 Agreement. In addition, we entered into a Sublicense Agreement with ratiopharm (the “ratiopharm Sublicense”), under which we were granted a perpetual, exclusive, worldwide sublicense to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin. Termination of the FGF21 Agreement or the ratiopharm Sublicense will impact our rights under the intellectual property licensed to us by Teva and ratiopharm, respectively, including our license to glycoPEGylation technology, but will not affect our rights under the assets assigned to us.

Beyond this agreement, our commercial success will also depend upon our ability, and the ability of our licensors, to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. A third party may hold intellectual property rights, including patent rights, that are important or necessary to the development of our product candidates. As a result, we may enter into additional license agreements in the future. If we fail to comply with the obligations under these agreements, including payment and diligence obligations, our licensors may have the right to terminate these agreements, in which event we may not be able to develop, manufacture, market or sell any product that is covered by these agreements or to engage in any other activities necessary to our business that require the freedom to operate afforded by the agreements, or we may face other penalties under the agreements.

We may be unable to obtain intellectual property rights or technology necessary to develop and commercialize pegozafermin and any future product candidates.

The patent landscape around our programs is complex, and we are aware of several third-party patents and patent applications containing subject matter that might be relevant to pegozafermin. Depending on what claims ultimately issue from these patent applications, and how courts construe the issued patent claims, as well as depending on the ultimate formulation and method of use of pegozafermin or any future product candidates, we may need to obtain a license to practice the technology claimed in such patents. There can be no assurance that such licenses will be available on commercially reasonable terms, or at all.

We may become involved in lawsuits or other proceedings to protect or enforce our intellectual property, which could be expensive, time-consuming and unsuccessful and have a material adverse effect on the success of our business.

Third parties may infringe our patents or misappropriate or otherwise violate our intellectual property rights. In the future, we may initiate legal proceedings to enforce or defend our intellectual property rights, to protect our trade secrets or to determine the validity or scope of intellectual property rights we own or control. Also, third parties may initiate legal proceedings against us to challenge the validity or scope of intellectual property rights we own, control or to which we have rights. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated, narrowed, held unenforceable or interpreted in such a manner that would not preclude third parties from entering the market with competing products.

50

 

Third-party pre-issuance submission of prior art to the USPTO, or opposition, derivation, revocation, reexamination, inter partes review or interference proceedings, or other pre-issuance or post-grant proceedings or other patent office proceedings or litigation in the United States or other jurisdictions provoked by third parties or brought by us, may be necessary to determine the inventorship, priority, patentability or validity of inventions with respect to our patents or patent applications. An unfavorable outcome could leave our technology or product candidates without patent protection, allow third parties to commercialize our technology or product candidates and compete directly with us, without payment to us, or could require us to obtain license rights from the prevailing party in order to be able to manufacture or commercialize our product candidates without infringing third-party patent rights. Our business could be harmed if the prevailing party in such a case does not offer us a license on commercially reasonable terms, or at all. Even if we obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. Even if we successfully defend such litigation or proceeding, we may incur substantial costs and our defense may distract our management and other employees.

Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, many foreign jurisdictions have rules of discovery that are different than those in the United States and that may make defending or enforcing our patents extremely difficult. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our common stock.

Third parties may initiate legal proceedings against us alleging that we infringe their intellectual property rights or we may initiate legal proceedings against third parties to challenge the validity or scope of intellectual property rights controlled by third parties.

Third parties may initiate legal proceedings against us alleging that we infringe their intellectual property rights or we may initiate legal proceedings against third parties to challenge the validity or scope of intellectual property rights controlled by third parties, including in oppositions, interferences, revocations, reexaminations, inter partes review or derivation proceedings before the USPTO or its counterparts in other jurisdictions. These proceedings can be expensive and time-consuming and many of our adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can. We could be found liable for monetary damages, including treble damages and attorneys’ fees, if we are found to have willfully infringed a patent of a third party. A finding of infringement could prevent us from commercializing our pegozafermin or any future product candidates or force us to cease some of our business operations, which could materially harm our business.

Although we have reviewed certain third-party patents and patent filings that we believe may be relevant to our therapeutic candidates or products, we have not conducted a freedom-to-operate search or analysis for any of our therapeutic candidates or products, and we may not be aware of patents or pending or future patent applications that, if issued, would block us from commercializing our product candidates. Thus, we cannot guarantee that our product candidates, or our commercialization thereof, do not and will not infringe any third party’s intellectual property.

Risks Related to Ownership of Our Common Stock

The price of our common stock may be volatile, and you may lose all or part of your investment.

The market price of our common stock could fluctuate significantly, and you may not be able to resell your shares at or above the price you paid for your shares. Those fluctuations could be based on various factors in addition to those otherwise described in this prospectus, including those described in these “Risk Factors.” Any of these factors may result in large and sudden changes in the volume and trading price of our common stock. In the past, following periods of volatility in the market price of a company’s securities, stockholders have often instituted securities class action litigation against that company.

51

 

Sales of our common stock, or the perception that such sales may occur, could depress the price of our common stock.

Sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur, could depress the market price of our common stock. Certain holders of shares of our common stock have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. In addition, we have filed a registration statement registering under the Securities Act the shares of our common stock reserved for issuance under our 2019 Equity Incentive Plan, including shares issuable upon exercise of outstanding options. These shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. Further, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt or equity securities.

Raising additional capital may cause dilution to existing stockholders, restrict our operations or require us to relinquish rights to our technologies.

Existing stockholders could suffer dilution or be negatively affected by fixed payment obligations we may incur if we raise additional funds through the issuance of additional equity securities, including under the ATM Facility, or debt or pursuant to the 2021 Loan Agreement. Furthermore, these securities may have rights senior to those of our common stock and could contain covenants or protective rights that would restrict our operations and potentially impair our competitiveness, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business.

General Risk Factors

Our directors, executive officers and current holders of 5% or more of our capital stock have substantial control over our company, which could limit your ability to influence the outcome of matters subject to stockholder approval, including a change of control.

As of December 31, 2021, our executive officers, directors and other holders of 5% or more of our common stock beneficially owned a majority of our outstanding common stock. As a result, our executive officers, directors and other holders of 5% or more of our common stock, if they act, will be able to influence or control matters requiring approval by our stockholders, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. In addition, our current directors, executive officers and other holders of 5% or more of our common stock, acting together, would have the ability to control the management and affairs of our company. They may also have interests that differ from yours and may vote in a way with which you disagree and that may be adverse to your interests. This concentration of ownership may have the effect of delaying, preventing or deterring a change of control of our company, could deprive our stockholders of an opportunity to receive a premium for their shares of our common stock as part of a sale of our company.

We previously identified material weaknesses in our internal control over financial reporting, which have been remediated. If we identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, we may not be able to produce timely and accurate financial statements, and we or our independent registered public accounting firm may conclude that our internal control over financial reporting is not effective, which could adversely affect our investors’ confidence and our stock price.

As an emerging growth company under the JOBS Act, our management is required to report upon the effectiveness of our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act. Our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until the date we are no longer an emerging growth company and reach accelerated filer status. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our consolidated financial statements or identify other areas for further attention or improvement. As previously disclosed, in connection with our financial statement close process

52

 

for 2018, we identified material weaknesses in the design and operating effectiveness of our internal control over financial reporting. While we have remediated such material weaknesses, we cannot assure you that we have identified all material weaknesses or that there will not be additional material weaknesses or deficiencies that we will identify in the future.

Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could prevent a third party from acquiring us (even if an acquisition would benefit our stockholders), may limit the ability of our stockholders to replace our management and limit the price that investors might be willing to pay for shares of our common stock.

Our amended and restated certificate of incorporation and our amended and restated bylaws could have the effect of making it more difficult for a third party to acquire, or of discouraging a third party from attempting to acquire, control of us. These provisions could delay or prevent a change in control of the company and could limit the price that investors might be willing to pay in the future for shares of our common stock. In addition, as a Delaware corporation, we are subject to the anti-takeover provisions of Section 203 of the Delaware General Corporation Law, which prohibits a Delaware corporation from engaging in a business combination specified in the statute with an interested stockholder (as defined in the statute) for a period of three years after the date of the transaction in which the person first becomes an interested stockholder, unless the business combination is approved in advance by a majority of the independent directors or by the holders of at least two-thirds of the outstanding disinterested shares. The application of Section 203 of the Delaware General Corporation Law could also have the effect of delaying or preventing a change of control of us.

Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.

Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for certain actions or proceedings under Delaware statutory or common law. Our amended and restated certificate of incorporation provides further that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. These choice of forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees. If a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable, we may incur additional costs associated with resolving such action in other jurisdictions.

53

 

Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties.

We lease office space, which consists of approximately 1,600 square feet located at 6 Hamada Street, Herzliya, 4673340, Israel. This lease expires on April 30, 2022. We also lease office space at 142 Sansome Street, San Francisco, California 94104, which consists of approximately 3,600 square feet. This lease expires on January 14, 2023. We believe that our current spaces are adequate for our needs. We also believe we will be able to obtain additional space, as needed, on commercially reasonable terms.

We are currently not a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors, and there can be no assurances that favorable outcomes will be obtained.

Item 4. Mine Safety Disclosures.

Not applicable.

54

 

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock is traded on The Nasdaq Global Market under the symbol “ETNB.”

As of March 1, 2022, there were approximately 7 stockholders of record of our common stock.

Dividend Policy

We have never declared or paid cash dividends on our capital stock and have no present intention to pay cash dividends on our common stock for the foreseeable future. Any determination to pay dividends to holders of our common stock will be at the discretion of our board of directors and will depend on many factors, including our financial condition, results of operations, liquidity, earnings, projected capital and other cash requirements, legal requirements, restrictions in the agreements governing any indebtedness we may enter into, business prospects and other factors that our board of directors deems relevant.

Item 6. [Reserved].

 

55

 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes and other financial information included elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis includes forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those described in or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled “Risk Factors” included elsewhere in this Annual Report on Form 10-K.

Overview

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Our lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (“FGF21”), is currently being developed for the treatment of nonalcoholic steatohepatitis (“NASH”) and for the treatment of severe hypertriglyceridemia (“SHTG”). NASH is a severe form of nonalcoholic fatty liver disease (“NAFLD”), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, hepatocellular carcinoma (“HCC”) and death. There are currently no approved products for the treatment of NASH. In January 2022, we announced positive topline results from an expansion cohort (cohort 7) of the Phase 1b/2a trial of pegozafermin in NASH after announcing positive topline data from cohorts 1 through 6 in September 2020. We also initiated a Phase 2b trial (ENLIVEN) evaluating pegozafermin in fibrosis stage 2 or 3 NASH patients in June 2021. Patients will receive weekly doses or a every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. We are making good progress in ENLIVEN and expect to report topline data from this trial in the first half of 2023. Based on learnings from our recent cohort, developments in the field, and feedback from our steering committee, we are working on steps to optimize the ENLIVEN trial. In 2021, we completed a pharmacokinetic study of pegozafermin in NASH patients with compensated cirrhosis (fibrosis stage F4) demonstrating that pegozafermin 30 mg has similar single-dose pharmacokinetics and pharmacodynamics in F4 as it does in non-cirrhotic NASH. We are currently evaluating the potential opportunity for pegozafermin in these fibrosis stage F4 patients. SHTG is a condition identified by severely elevated levels of triglycerides (≥500 mg/dL), which is associated with an increased risk of NASH, cardiovascular events and acute pancreatitis. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and expect to report topline data in the second quarter of 2022. We closed enrollment in this trial in February 2022 with 85 patients enrolled.

We commenced operations in 2018 and have devoted substantially all of our resources to raising capital, acquiring our initial product candidate, identifying and developing pegozafermin, licensing certain related technology, conducting research and development activities (including preclinical studies and clinical trials) and providing general and administrative support for these operations.

As of December 31, 2021, our cash and cash equivalents and short-term available-for-sale securities totaled $150.7 million. Based on our current operating plan, we believe that our cash and cash equivalents and short-term available-for-sale securities together with the proceeds available under our term loan facility will be sufficient to meet our anticipated cash requirements for a period of at least one year from the date this Annual Report on Form 10-K is filed with the Securities and Exchange Commission (“SEC”).

We have incurred net losses since our inception. Our net losses for the years ended December 31, 2021 and 2020 were $90.1 million and $49.5 million, respectively. As of December 31, 2021, we had an accumulated deficit of $213.2 million. We expect to continue to incur significant expenses and increasing operating losses as we advance pegozafermin and any future product candidates through clinical trials, seek regulatory approval for pegozafermin and any future product candidates, expand our clinical, regulatory, quality, manufacturing and commercialization capabilities, protect our intellectual property, prepare for and, if approved, proceed to commercialization of pegozafermin and any future product candidates, expand our general and administrative support functions, including hiring additional personnel, and incur additional costs associated with operating as a public company. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities.

56

 

Impact of COVID-19 Pandemic

The ongoing COVID-19 pandemic has disrupted and may continue to disrupt our business and delay our development timeline. The extent to which the COVID-19 pandemic may impact our future operating results and financial condition is uncertain. We initiated our Phase 2 trial (ENTRIGUE) in SHTG patients in the third quarter of 2020 and our Phase 2b trial in NASH patients in the middle of the 2021. The COVID-19 pandemic has impacted execution and enrollment of our trials. We do not yet know the full extent of potential delays that may affect our clinical trials, which could prevent or delay us from obtaining approval for pegozafermin. Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing trials may be impacted. For more information regarding risks related to the ongoing COVID-19 pandemic, please see the risk factor entitled “The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business,” in Part I. Item 1A of this Annual Report on Form 10-K. To the extent the ongoing COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks set forth under “Risk Factors” in this Annual Report on Form 10-K.

Components of Results of Operations

Research and Development Expenses

Research and development expenses consist primarily of costs incurred for the development of our lead product candidate, pegozafermin. Our research and development expenses consist primarily of external costs related to preclinical and clinical development, including costs related to acquiring patents and intellectual property, expenses incurred under license agreements and agreements with contract research organizations and consultants, costs related to acquiring and manufacturing clinical trial materials, including under agreements with contract manufacturing organizations and other vendors, costs related to the preparation of regulatory submissions and expenses related to laboratory supplies and services, as well as personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts.

We expense all research and development expenses in the periods in which they are incurred. We accrue for costs incurred as the services are being provided by monitoring the status of specific activities and the invoices received from our external service providers. We adjust our accrued expenses as actual costs become known.

Payments associated with licensing agreements to acquire licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate commercial use are expensed as incurred. Where contingent milestone payments are due to third parties under research and development arrangements or license agreements, the milestone payment obligations are expensed when the milestone results are probable and estimable, which is generally upon achievement of milestones.

We expect our research and development expenses to increase for the foreseeable future as we continue the development of pegozafermin and continue to invest in research and development activities. The process of conducting the necessary clinical research to obtain regulatory approval is costly and time consuming, and the successful development of pegozafermin and any future product candidates is highly uncertain. To the extent that pegozafermin continues to advance into larger and later stage clinical trials, our expenses will increase substantially and may become more variable. The actual probability of success for pegozafermin or any future product candidate may be affected by a variety of factors, including the safety and efficacy of our product candidates, investment in our clinical programs, manufacturing capability and competition with other products. As a result, we are unable to determine the timing of initiation, duration and completion costs of our research and development efforts or when and to what extent we will generate revenue from the commercialization and sale of pegozafermin or any future product candidate.

General and Administrative Expenses

General and administrative expenses consist primarily of personnel costs, expenses for outside professional services, including legal, human resource, audit and accounting services, consulting costs and allocated facilities costs. Personnel and related costs consist of salaries, benefits and stock-based compensation for personnel in executive, finance and other administrative functions. Facilities costs consist of rent and maintenance of facilities.

57

 

We expect our general and administrative expenses to increase for the foreseeable future as we increase the size of our administrative function to support the growth of our business and support our continued research and development activities.

Other Expenses, Net

Other expenses, net primarily consists of amortization of deferred debt issuance costs and amortization of premium on available-for-sale securities offset by interest income on available-for-sale securities.

Results of Operations

Years Ended December 31, 2021 and 2020

The following table summarizes our results of operations for the periods presented (in thousands):

 

 

 

Year Ended December 31,

 

 

 

 

 

 

 

2021

 

 

2020

 

 

Change

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

70,330

 

 

$

36,199

 

 

$

34,131

 

General and administrative

 

 

19,413

 

 

 

13,156

 

 

 

6,257

 

Total operating expenses

 

 

89,743

 

 

 

49,355

 

 

 

40,388

 

Loss from operations

 

 

(89,743

)

 

 

(49,355

)

 

 

(40,388

)

Other expenses, net

 

 

(526

)

 

 

(203

)

 

 

(323

)

Income tax benefit

 

 

147

 

 

 

59

 

 

 

88

 

Net loss

 

$

(90,122

)

 

$

(49,499

)

 

$

(40,623

)

 

Research and Development Expenses

The following table summarizes the period-over-period changes in research and development expenses for the periods presented (in thousands):

 

 

 

Year Ended

December 31,

 

 

 

 

 

 

 

2021

 

 

2020

 

 

Change

 

Clinical development

 

$

29,500

 

 

$

13,613

 

 

$

15,887

 

Contract manufacturing

 

 

27,584

 

 

 

12,995

 

 

 

14,589

 

Personnel-related expenses

 

 

11,725

 

 

 

6,841

 

 

 

4,884

 

Preclinical costs

 

 

66

 

 

 

1,684

 

 

 

(1,618

)

Other expenses

 

 

1,455

 

 

 

1,066

 

 

 

389

 

Total research and development expenses

 

$

70,330

 

 

$

36,199

 

 

$

34,131

 

 

Research and development expenses increased by $34.1 million, or 94%, to $70.3 million in 2021 compared to $36.2 million in 2020. The change was primarily due to an increase of $15.9 million in clinical development costs related to our ongoing clinical trials and an increase of $14.6 million in contract manufacturing costs, mainly as a result of the manufacture of supplies and the scaling up of manufacturing for our ongoing clinical trials. The increase of $4.9 million in personnel-related costs, including stock-based compensation, was due to higher headcount and the increase of $0.4 million in other expenses was primarily due to higher allocated facilities and overhead costs. The increases were partially offset by a decrease of $1.6 million in preclinical costs; the timing of such costs is dependent upon the status and stage of our clinical trials.

General and Administrative Expenses

General and administrative expenses increased by $6.3 million, or 48%, to $19.4 million in 2021 compared to $13.2 million in 2020. The change was due to an increase of $4.1 million in personnel-related costs, including stock-based compensation, driven by higher headcount, an increase of $1.1 million in professional services primarily due

58

 

to legal and consulting services, an increase of $0.7 million in insurance related costs and an increase of $0.4 million in other costs primarily due to higher allocated facilities and overhead costs.

Other Expenses, Net

Other expenses, net increased by $0.3 million to $0.5 million in 2021 compared to $0.2 million in 2020, primarily due to higher amortization of debt issuance costs in 2021.

Liquidity and Capital Resources

To date, we have incurred significant net losses and negative cash flows from operations. As of December 31, 2021, we had available cash and cash equivalents and short-term available-for-sale securities of $150.7 million and an accumulated deficit of $213.2 million.

In July 2020, we completed an underwritten public offering of 3,047,040 shares of our common stock, at a public offering price of $27.50 per share. Upon completion of the offering, we received proceeds of $78.2 million, net of underwriting discounts and commissions and offering expenses. In September 2020, we completed an underwritten public offering of 3,025,000 shares of our common stock, at a public offering price of $28.00 per share. Upon completion of the offering, we received proceeds of $79.5 million, net of underwriting discounts and commissions and offering expenses.

In March 2021, we entered into a sales agreement (the “Sales Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (the “Sales Agents”) pursuant to which we may offer and sell up to $75.0 million of shares of our common stock, from time to time, in “at-the-market” offerings (the “ATM Facility”). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. During the fourth quarter of 2021, we received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of our common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.

In May 2021, we amended our secured term loan facility (“2021 Loan Agreement”) to increase the aggregate committed principal amount up to $25.0 million. As of December 31, 2021, we had drawn $20.0 million under our term loan facility and $5.0 million remains available to be drawn on the achievement of certain milestones and is available to be drawn on or before September 30, 2022.

Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures related to our lead product candidate, pegozafermin. We plan to increase our research and development expenses for the foreseeable future as we continue the clinical development of our current and future product candidates. At this time, due to the inherently unpredictable nature of clinical development, we cannot reasonably estimate the costs we will incur and the timelines that will be required to complete development, obtain marketing approval, and commercialize our current product candidate or any future product candidates. For the same reasons, we are also unable to predict when, if ever, we will generate revenue from product sales or our current or any future license agreements which we may enter into or whether, or when, if ever, we may achieve profitability. Clinical and preclinical development timelines, the probability of success, and development costs can differ materially from expectations. In addition, we cannot forecast the timing and amounts of milestone, royalty and other revenue from licensing activities, which future product candidates may be subject to future collaborations, when such arrangements will be secured, if at all, and to what degree such arrangements would affect our development plans and capital requirements.

Based on our research and development plans, we expect that our existing cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with the proceeds available from our term loan facility and our ATM Facility, will be sufficient to fund our operations for a period of at least one year from the date this Annual Report on Form 10-K is filed with the SEC. However, our operating plans and other demands on our cash resources may change as a result of many factors, and we may seek additional funds sooner than planned. There can be no assurance that we will be successful in acquiring additional funding at levels sufficient to fund our operations or on terms favorable to us.

59

 

Our future funding requirements will depend on many factors, including the following:

 

•

the progress, timing, scope, results and costs of our clinical trials of pegozafermin and preclinical studies or clinical trials of other potential product candidates we may choose to pursue in the future, including the ability to enroll patients in a timely manner for our clinical trials;

 

•

the costs and timing of obtaining clinical and commercial supplies and validating the commercial manufacturing process for pegozafermin and any other product candidates we may identify and develop;

 

•

the cost, timing and outcomes of regulatory approvals;

 

•

the timing and amount of any milestone, royalty or other payments we are required to make pursuant to current or any future collaboration or license agreements;

 

•

costs of acquiring or in-licensing other product candidates and technologies;

 

•

the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements;

 

•

the costs associated with attracting, hiring and retaining additional qualified personnel as our business grows;

 

•

our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal controls over financial reporting; and

 

•

the cost of preparing, filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights.

We expect to continue to generate substantial operating losses for the foreseeable future as we expand our research and development activities. We will continue to fund our operations primarily through utilization of our current financial resources and through additional raises of capital to advance our current product candidate through clinical development, to develop, acquire or in-license other potential product candidates and to fund operations for the foreseeable future. However, there is no assurance that such funding will be available to us or that it will be obtained on terms favorable to us or will provide us with sufficient funds to meet our objectives. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies.

To the extent that we raise additional capital through partnerships or licensing arrangements with third parties, we may have to relinquish valuable rights to our product candidates, future revenue streams or research programs or to grant licenses on terms that may not be favorable to us. If we raise additional capital through public or private equity offerings, the ownership interest of our then-existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders’ rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to obtain adequate financing when needed, we may have to delay, reduce the scope of or suspend one or more of our clinical trials or preclinical studies, research and development programs or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.

60

 

Cash Flows

The following table summarizes our cash flows for the periods presented (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Net cash used in (provided by)

 

 

 

 

 

 

 

 

Operating activities

 

$

(76,781

)

 

$

(46,244

)

Investing activities

 

 

7,159

 

 

 

(106,832

)

Financing activities

 

 

23,871

 

 

 

157,924

 

Net change in cash and cash equivalents, and

   restricted cash

 

$

(45,751

)

 

$

4,848

 

Operating Activities

During the year ended December 31, 2021, net cash used in operating activities was $76.8 million, which consisted of a net loss of $90.1 million, partially offset by non-cash charges of $10.1 million and a net change of $3.3 million in our net operating assets and liabilities. The non-cash charges were primarily comprised of $8.7 million in stock-based compensation, $0.9 million in amortization of premium on available-for-sale securities and $0.6 million in amortization of debt issuance costs. The change in our operating assets and liabilities was due to a $8.9 million increase in accounts payable and accrued expenses due to the timing of our accounts payable as well as continued expansion of our operations, offset in part by a $5.7 million increase in prepaid and other current assets due to timing of payments.

During the year ended December 31, 2020, net cash used in operating activities was $46.2 million, which consisted of a net loss of $49.5 million and a net change of $1.0 million in our net operating assets and liabilities, partially offset by non-cash charges of $4.3 million. The change in our operating assets and liabilities was primarily due to a $3.6 million increase in prepaid and other current assets due to the timing of payments as well as increased scale of operations and the initiation of clinical trials in the second half of 2020, offset in part by a $2.6 million increase in accounts payable and accrued expenses as we grew our operations. The non-cash charges were primarily comprised of $3.8 million in stock-based compensation, $0.3 million in amortization of premium on available-for-sale securities and $0.2 million in amortization of debt issuance costs.

Investing Activities

During the year ended December 31, 2021, net cash provided by investing activities was $7.2 million, which consisted primarily of $148.4 million in proceeds from sales and maturities of available-for-sale securities, offset in part by $141.2 million in purchases of available-for-sale securities.

During the year ended December 31, 2020, net cash used in investing activities was $106.8 million, which consisted of $118.9 million in purchases of available-for-sale securities and $0.1 million in purchases of property and equipment, offset in part by $12.2 million in proceeds from maturities of available-for-sale securities.

 

Financing Activities

During the year ended December 31, 2021, net cash provided by financing activities was $23.9 million, which consisted of $20.0 million in proceeds from our term loan facility, $3.3 million in net proceeds from the sale and issuance of common stock pursuant to our ATM Facility and $0.6 million in proceeds from the issuance of common stock upon exercise of stock options and employee stock purchase plan (“ESPP”) purchases.

During the year ended December 31, 2020, net cash provided by financing activities was $157.9 million, which consisted of $157.7 million in net proceeds from the sale and issuance of common stock from our public offerings and $0.4 million in proceeds from the issuance of common stock upon exercise of stock options and ESPP purchases, offset in part by a $0.2 million payment of debt issuance costs.

61

 

Debt Obligations

Our 2021 Loan Agreement provides for a total term loan facility of $25.0 million. As of December 31, 2021, we had drawn $20.0 million under the term loan facility and are required to make interest-only payments until October 1, 2022 followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through September 1, 2024, the maturity date of the term loan. The interest-only period may be extended to April 1, 2023, if on or before September 20, 2022, we receive net cash proceeds of at least $75.0 million from the sale of our equity securities. Our term loan bears interest at the greater of (i) 4.25% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) 1.00% (or 4.25% initially and as of December 31, 2021). In addition, a final payment fee of 5% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If we elect to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.

Other Contractual Obligations and Commitments

Our cash requirements greater than twelve months related to other contractual obligations and commitments include:

In April 2018, we entered into two agreements with Teva Pharmaceutical Industries Ltd (the “Teva Agreements”) under which we acquired certain patents and intellectual property relating to two programs. Pursuant to the Teva Agreements, we could be obligated to pay Teva up to $67.5 million under each program, for a total of $135.0 million, upon the achievement of certain clinical development and commercial milestones. In addition, we are obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. As of December 31, 2021, the timing and likelihood of achieving the milestones and generating product sales are uncertain.

We lease office space for our corporate headquarters in San Francisco under a lease that expires in January 2023. We also lease office space in Israel under a lease that expires in April 2022. As of December 31, 2021, undiscounted future minimum lease payments of $0.2 million remain on both leases.

 

In addition, we enter into agreements in the normal course of business with contract research organizations, contract manufacturing organizations and other vendors for research and development services. Such agreements generally provide for termination upon written notice but obligate us to reimburse vendors for any time or costs incurred through the date of termination.

Critical Accounting Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

62

 

While our significant accounting policies are described in the notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K, we believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results.

Accrued Research and Development Expenses

We record accrued expenses for estimated preclinical and clinical trial and research expenses related to the services performed but not yet invoiced pursuant to contracts with research institutions, contract research organizations and clinical manufacturing organizations that conduct and manage preclinical studies, and clinical trials, and research services on our behalf. Payments for these services are based on the terms of individual agreements and payment timing may differ significantly from the period in which the services were performed. Our estimates are based on factors such as the work completed, including the level of patient enrollment. We monitor patient enrollment levels and related activity to the extent reasonably possible and make judgments and estimates in determining the accrued balance in each reporting period. Our estimates of accrued expenses are based on the facts and circumstances known at the time. If we underestimate or overestimate the level of services performed or the costs of these services, our actual expenses could differ from our estimates. As actual costs become known, we adjust our accrued expenses. To date, we have not experienced significant changes in our estimates of preclinical studies and clinical trial accruals.

Stock-Based Compensation

We measure compensation related to all equity awards granted to employees, directors, and non-employee service providers, including stock options and restricted stock units based on the estimated fair value. We recognize forfeitures as they occur.

We estimate the fair value of stock option awards on the date of grant, and the resulting stock-based compensation, using the Black-Scholes option-pricing model. The grant date fair value of stock option awards, which have graded vesting, is recognized as an expense using the straight-line method over the requisite service period of each award, which is generally the vesting period of the respective awards.

We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards that requires the use of subjective assumptions to determine the fair value of equity awards. These assumptions include:

 

•

Expected volatility— Since we have limited trading history for our common stock, expected volatility is estimated based on weighting our volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. We chose comparable companies based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group.

 

•

Expected term—The expected term of options granted to employees and directors is determined using the “simplified” method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.

 

•

Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.

 

•

Expected dividend—We have never paid dividends and have no foreseeable plans to pay dividends on our shares of common stock. Therefore, we use an expected dividend of zero.

We will continue to use judgment in evaluating the expected volatility and expected term utilized for our stock-based compensation calculations on a prospective basis.

63

 

The fair value of restricted stock units is based on the fair value of our common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, we evaluate the probability of achieving the performance condition at each reporting date and recognize expense for such performance awards over the requisite service period using the accelerated attribution method. We recognize forfeitures as they occur.

Recent Accounting Pronouncements

See Note 2 to our consolidated financial statements appearing under Part II, Item 8 for more information about recent accounting pronouncements, the timing of their adoption, and our assessment, to the extent we have made one yet, of their potential impact on our financial condition of results of operations.

JOBS Act Accounting Election

We are an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies.

We have elected to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our consolidated financial statements and our interim consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company, as defined by Rule 12b-2 under the Securities and Exchange Act of 1934 and in Item 10(f)(1) of Regulation S-K, and are not required to provide the information under this item.

 

 

 

64

 

 

Item 8. Financial Statements and Supplementary Data.

89BIO, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

65

 

 

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors
89bio, Inc.:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of 89bio, Inc. and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows for each of the years in the two‑year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two‑year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

                                                                                /s/ KPMG LLP

We have served as the Company’s auditor since 2020.

San Francisco, California

March 24, 2022

66

 

 

89bio, Inc.

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

 

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

52,432

 

 

$

98,183

 

Restricted cash

 

 

25

 

 

 

25

 

Short-term available-for-sale securities

 

 

98,288

 

 

 

106,446

 

Prepaid and other current assets

 

 

11,237

 

 

 

5,548

 

Total current assets

 

 

161,982

 

 

 

210,202

 

Property and equipment, net

 

 

150

 

 

 

166

 

Other assets

 

 

290

 

 

 

706

 

Total assets

 

$

162,422

 

 

$

211,074

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

6,843

 

 

$

2,065

 

Accrued expenses

 

 

10,194

 

 

 

6,048

 

Term loan, current

 

 

2,500

 

 

 

—

 

Total current liabilities

 

 

19,537

 

 

 

8,113

 

Term loan, non-current, net

 

 

16,898

 

 

 

—

 

Other non-current liability

 

 

30

 

 

 

—

 

Total liabilities

 

 

36,465

 

 

 

8,113

 

Commitments and contingencies (Note 5)

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 10,000,000 shares authorized

   as of December 31, 2021 and 2020, respectively, no shares

   issued and outstanding as of December 31, 2021 and 2020, respectively

 

 

—

 

 

 

—

 

Common stock, $0.001 par value, 100,000,000 shares authorized

   as of December 31, 2021 and 2020, respectively; 20,317,204 and

   19,931,660 shares issued and outstanding as of December 31, 2021

   and 2020, respectively

 

 

20

 

 

 

20

 

Additional paid-in capital

 

 

339,218

 

 

 

326,046

 

Accumulated other comprehensive loss

 

 

(64

)

 

 

(10

)

Accumulated deficit

 

 

(213,217

)

 

 

(123,095

)

Total stockholders’ equity

 

 

125,957

 

 

 

202,961

 

Total liabilities and stockholders’ equity

 

$

162,422

 

 

$

211,074

 

 

The accompanying notes are an integral part of these consolidated financial statements.

67

 

89bio, Inc.

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

$

70,330

 

 

$

36,199

 

General and administrative

 

 

19,413

 

 

 

13,156

 

Total operating expenses

 

 

89,743

 

 

 

49,355

 

Loss from operations

 

 

(89,743

)

 

 

(49,355

)

Other expenses, net

 

 

(526

)

 

 

(203

)

Net loss before income tax

 

 

(90,269

)

 

 

(49,558

)

Income tax benefit

 

 

147

 

 

 

59

 

Net loss

 

$

(90,122

)

 

$

(49,499

)

Other comprehensive (loss) income:

 

 

 

 

 

 

 

 

Unrealized (loss) gain on available-for-sale securities

 

 

(71

)

 

 

8

 

Foreign currency translation adjustments

 

 

17

 

 

 

(18

)

Total other comprehensive loss

 

$

(54

)

 

$

(10

)

Comprehensive loss

 

$

(90,176

)

 

$

(49,509

)

Net loss per share, basic and diluted

 

$

(4.48

)

 

$

(3.08

)

Weighted-average shares used to compute net loss per share,

   basic and diluted

 

 

20,098,340

 

 

 

16,087,785

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

68

 

 

89bio, Inc.

Consolidated Statements of Stockholders’ Equity

(In thousands, except share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Other

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders’

 

 

 

Shares

 

 

Amounts

 

 

Capital

 

 

Loss

 

 

Deficit

 

 

Equity

 

Balance as of December 31, 2019

 

 

13,788,982

 

 

$

14

 

 

$

163,526

 

 

$

-

 

 

$

(73,596

)

 

$

89,944

 

Issuance of common stock upon public offerings,

   net of issuance costs of $1,208

 

 

6,072,040

 

 

 

6

 

 

 

157,674

 

 

 

—

 

 

 

—

 

 

 

157,680

 

Issuance of common stock upon exercise of stock options

 

 

63,366

 

 

 

—

 

 

 

271

 

 

 

—

 

 

 

—

 

 

 

271

 

Issuance of common stock upon ESPP purchase

 

 

7,272

 

 

 

—

 

 

 

134

 

 

 

—

 

 

 

—

 

 

 

134

 

Issuance of common stock warrant in connection with term loan facility

 

 

—

 

 

 

—

 

 

 

634

 

 

 

—

 

 

 

—

 

 

 

634

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

3,807

 

 

 

—

 

 

 

—

 

 

 

3,807

 

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(49,499

)

 

 

(49,499

)

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(10

)

 

 

—

 

 

 

(10

)

Balance as of December 31, 2020

 

 

19,931,660

 

 

$

20

 

 

$

326,046

 

 

$

(10

)

 

$

(123,095

)

 

$

202,961

 

Issuance of common stock upon at-the-market public

   offerings, net of issuance costs of $165

 

 

186,546

 

 

 

—

 

 

 

3,289

 

 

 

—

 

 

 

—

 

 

 

3,289

 

Issuance of common stock upon exercise of stock options

 

 

188,286

 

 

 

—

 

 

 

487

 

 

 

—

 

 

 

—

 

 

 

487

 

Issuance of common stock upon ESPP purchase

 

 

10,712

 

 

 

—

 

 

 

144

 

 

 

—

 

 

 

—

 

 

 

144

 

Issuance of common stock warrant in connection with term loan facility

 

 

—

 

 

 

—

 

 

 

574

 

 

 

—

 

 

 

—

 

 

 

574

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

8,678

 

 

 

—

 

 

 

—

 

 

 

8,678

 

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(90,122

)

 

 

(90,122

)

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(54

)

 

 

—

 

 

 

(54

)

Balance as of December 31, 2021

 

 

20,317,204

 

 

$

20

 

 

$

339,218

 

 

$

(64

)

 

$

(213,217

)

 

$

125,957

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

69

 

 

89bio, Inc.

Consolidated Statements of Cash Flows

(In thousands)

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(90,122

)

 

$

(49,499

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

8,678

 

 

 

3,807

 

Amortization of premium on available-for-sale securities

 

 

865

 

 

 

268

 

Amortization of debt issuance costs and accretion of final payment fee

 

 

617

 

 

 

230

 

Depreciation

 

 

79

 

 

 

60

 

Deferred tax assets

 

 

(150

)

 

 

(69

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid and other current assets

 

 

(5,672

)

 

 

(3,600

)

Accounts payable

 

 

4,778

 

 

 

1,131

 

Accrued expenses

 

 

4,146

 

 

 

1,428

 

Net cash used in operating activities

 

 

(76,781

)

 

 

(46,244

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Proceeds from sales and maturities of available-for-sale securities

 

 

148,422

 

 

 

12,189

 

Purchases of available-for-sale securities

 

 

(141,200

)

 

 

(118,895

)

Purchases of property and equipment

 

 

(63

)

 

 

(126

)

Net cash provided by (used in) investing activities

 

 

7,159

 

 

 

(106,832

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from term loan facility, net of issuance costs

 

 

19,951

 

 

 

—

 

Proceeds from issuance of common stock upon public offerings,

   net of issuance costs

 

 

3,289

 

 

 

157,680

 

Proceeds from issuance of common stock upon stock option exercises

 

 

487

 

 

 

271

 

Proceeds from issuance of common stock upon ESPP purchases

 

 

144

 

 

 

134

 

Payment of debt issuance costs

 

 

—

 

 

 

(161

)

Net cash provided by financing activities

 

 

23,871

 

 

 

157,924

 

Net change in cash and cash equivalents, and restricted cash

 

 

(45,751

)

 

 

4,848

 

Cash and cash equivalents, and restricted cash at beginning of period

 

 

98,208

 

 

 

93,360

 

Cash and cash equivalents, and restricted cash at end of period

 

$

52,457

 

 

$

98,208

 

Components of cash and cash equivalents, and restricted cash:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

52,432

 

 

$

98,183

 

Restricted cash

 

 

25

 

 

 

25

 

Total cash and cash equivalents, and restricted cash

 

$

52,457

 

 

$

98,208

 

Supplemental disclosures of cash information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

16

 

 

$

—

 

Cash paid for income taxes

 

$

—

 

 

$

142

 

Supplemental disclosures of noncash information:

 

 

 

 

 

 

 

 

Issuance of common stock warrant in connection with term loan facility

 

$

574

 

 

$

634

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

70

 

 

89bio, Inc.

Notes to Consolidated Financial Statements

1. Organization and Basis of Presentation

Description of Business

89bio, Inc. (“89bio” or the “Company”) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia.

89bio, Inc. was formed as a Delaware corporation in June 2019 to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018.

Public Offerings

In July 2020, the Company completed an underwritten public offering of 3,047,040 shares of its common stock at the public offering price of $27.50 per share. The Company raised a total of $78.2 million in net proceeds after deducting underwriting discounts and commissions of $5.0 million and offering costs of $0.6 million.

In September 2020, the Company completed an underwritten public offering of 3,025,000 shares of its common stock, at a public offering price of $28.00 per share. The Company raised a total of $79.5 million in net proceeds after deducting underwriting discounts and commissions of $4.6 million and offering costs of $0.6 million.

 

In March 2021, the Company entered into a sales agreement (the “Sales Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (the “Sales Agents”) pursuant to which it may offer and sell up to $75.0 million of shares of the Company’s common stock, from time to time, in “at-the-market” offerings (the “ATM Facility”). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. During the fourth quarter of 2021, the Company received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of its common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.

Liquidity

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of $150.7 million as of December 31, 2021.

The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with proceeds available from the Company’s term loan (see Note 6) and its ATM Facility, will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission (“SEC”).

2. Summary of Significant Accounting Policies

Basis of Presentation

The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”).

71

89bio, Inc.

Notes to Consolidated Financial Statements

 

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Foreign Currencies

Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company’s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.

Fair Value Measurements

Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company’s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company’s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:

Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

Level 2—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.

72

89bio, Inc.

Notes to Consolidated Financial Statements

 

Other Risks and Uncertainties

The Company’s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company’s early stages of clinical drug development; the Company’s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company’s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company’s ability to enroll patients in its ongoing and future clinical trials; the Company’s ability to successfully manufacture and supply its product candidates for clinical trials; the Company’s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company’s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company’s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.

The Company’s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.

The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company’s business and delay its preclinical and clinical programs and timelines. The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for pegozafermin. The extent to which the COVID-19 pandemic may impact the Company’s future operating results and financial condition is uncertain.

Segment Reporting

The Company has one operating segment. The Company’s chief operating decision maker, its Chief Executive Officer, manages the Company’s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.

Restricted Cash

Restricted cash consists of a money market account that serves as collateral for the Company’s operating lease agreement for its facility in Israel.

Investments

Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management’s intent to use the investments to fund current operations or to make them available for current operations.

73

89bio, Inc.

Notes to Consolidated Financial Statements

 

Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method. The Company has not experienced material realized gains or losses or other-than-temporary losses in the periods presented. Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.

Property and Equipment, Net

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from three to seven years. Leasehold improvements are amortized on a straight-line basis over the shorter of the assets’ estimated useful life or the remaining term of the lease. Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. Maintenance and repair costs are expensed as incurred.

Impairment of Long-Lived Assets

The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.

Accrued Research and Development Expenses

The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company’s research and development expenses.

The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company’s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company’s accrued expenses could materially affect the Company’s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.

Leases

The Company leases its office facilities under non-cancelable operating lease agreements and recognizes related rent expense on a straight-line basis over the term of the lease.

74

89bio, Inc.

Notes to Consolidated Financial Statements

 

Research and Development Expenses

Research and development expenses consist primarily of costs incurred for the development of the Company’s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies, and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.

Stock-Based Compensation

The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.

The Company estimates the fair value of stock option awards on the date of grant using a Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.

The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:

 

•

Expected volatility—Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company’s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group.

 

•

Expected term—The expected term of options granted to employees and directors is determined using the “simplified” method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.

 

•

Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.

 

•

Expected dividend—The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.

The fair value of restricted stock units is based on the fair value of the Company’s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.

Income Taxes

Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to

75

89bio, Inc.

Notes to Consolidated Financial Statements

 

taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.

Basic and Diluted Net Loss per Share

Basic loss per share is computed by dividing the net loss by the weighted-average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss by the weighted-average number of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive.

Comprehensive Loss

The Company’s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.

Recent Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2016-02—Leases (“ASU 2016-02”), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company’s consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.

 

76

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

3. Fair Value Measurements

The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):

 

 

 

 

 

As of December 31, 2021

 

 

 

Valuation

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

 

 

 

 

 

Hierarchy

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Money market funds

 

Level 1

 

$

21,477

 

 

$

—

 

 

$

—

 

 

$

21,477

 

Commercial paper

 

Level 2

 

 

59,647

 

 

 

—

 

 

 

(10

)

 

 

59,637

 

U.S. government bonds

 

Level 2

 

 

21,662

 

 

 

—

 

 

 

(42

)

 

 

21,620

 

Corporate debt securities

 

Level 2

 

 

8,776

 

 

 

1

 

 

 

(1

)

 

 

8,776

 

Agency bonds

 

Level 2

 

 

7,747

 

 

 

1

 

 

 

(7

)

 

 

7,741

 

Municipal bonds

 

Level 2

 

 

4,251

 

 

 

—

 

 

 

(4

)

 

 

4,247

 

Non-U.S. debt securities

 

Level 2

 

 

2,506

 

 

 

—

 

 

 

(1

)

 

 

2,505

 

Total cash equivalents and available-for-sale securities

 

 

 

$

126,066

 

 

$

2

 

 

$

(65

)

 

$

126,003

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

27,715

 

Short-term available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

98,288

 

Total cash equivalents and available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

126,003

 

 

The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):

 

 

 

As of December 31, 2021

 

Within one year

 

$

120,726

 

After one year through two years

 

 

5,277

 

Total cash equivalents and available-for-sale securities

 

$

126,003

 

 

The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):

 

 

 

 

 

As of December 31, 2020

 

 

 

Valuation

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

 

 

 

 

 

Hierarchy

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Money market funds

 

Level 1

 

$

46,134

 

 

$

—

 

 

$

—

 

 

$

46,134

 

Commercial paper

 

Level 2

 

 

76,605

 

 

 

—

 

 

 

(2

)

 

 

76,603

 

Agency bonds

 

Level 2

 

 

29,654

 

 

 

15

 

 

 

—

 

 

 

29,669

 

Corporate debt securities

 

Level 2

 

 

11,890

 

 

 

—

 

 

 

(6

)

 

 

11,884

 

U.S. government bonds

 

Level 2

 

 

7,093

 

 

 

—

 

 

 

—

 

 

 

7,093

 

Municipal bonds

 

Level 2

 

 

5,592

 

 

 

2

 

 

 

(1

)

 

 

5,593

 

U.S. treasury bills

 

Level 2

 

 

4,680

 

 

 

—

 

 

 

—

 

 

 

4,680

 

Agency discount securities

 

Level 2

 

 

200

 

 

 

—

 

 

 

—

 

 

 

200

 

Total cash equivalents and available-for-sale securities

 

 

 

$

181,848

 

 

$

17

 

 

$

(9

)

 

$

181,856

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

75,410

 

Short-term available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

106,446

 

Total cash equivalents and available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

181,856

 

 

77

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):

 

 

 

As of December 31, 2020

 

Within one year

 

$

160,304

 

After one year through two years

 

 

21,552

 

Total cash equivalents and available-for-sale securities

 

$

181,856

 

 

4. Consolidated Balance Sheet Components

Prepaid and Other Current Assets

Prepaid and other current assets consist of the following as of the periods presented (in thousands):

 

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Prepaid research and development

 

$

7,895

 

 

$

2,534

 

Prepaid taxes

 

 

836

 

 

 

481

 

Prepaid other

 

 

2,506

 

 

 

2,533

 

Total prepaid and other current assets

 

$

11,237

 

 

$

5,548

 

 

Accrued Expenses

Accrued expenses consist of the following as of the periods presented (in thousands):

 

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Accrued research and development expenses

 

$

6,195

 

 

$

2,884

 

Accrued employee and related expenses

 

 

3,168

 

 

 

2,552

 

Accrued professional and legal fees

 

 

495

 

 

 

453

 

Accrued other

 

 

336

 

 

 

159

 

Total accrued expenses

 

$

10,194

 

 

$

6,048

 

 

 

5. Commitments and Contingencies

Leases

In May 2018, the Company entered into an operating lease agreement for its facility in Israel. The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months. Under the lease agreement, monthly lease payments are approximately $4,200.

In December 2019, the Company entered into an operating lease for its headquarters in San Francisco, with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year. Under the lease agreement, monthly lease payments are approximately $18,000.

Future minimum lease payments under the Company’s non-cancellable operating lease obligations as of December 31, 2021, are as follows (in thousands):

 

2022

 

$

212

 

2023

 

 

7

 

Total future minimum annual payments

 

$

219

 

 

78

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

Rent expense was $290,000 and $273,000 for the years ended December 31, 2021 and 2020, respectively. The Company has security deposit balances of $95,000, a portion of which is included in restricted cash and a portion in other assets in the consolidated balance sheets as of December 31, 2021 and 2020.

Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd

In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the “Teva Agreements”) with Teva Pharmaceutical Industries Ltd (“Teva”) under which it acquired certain patents and intellectual property relating to two programs: (1) Teva’s glycoPEGylated FGF21 program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2) Teva’s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $6.0 million and the Company could be obligated to pay Teva up to $67.5 million under each program, for a total of $135.0 million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds.

The Teva Agreements can be terminated (i) by the Company without cause upon 120 days’ written notice to Teva, (ii) by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within 60 days after receiving notice thereof, or (iii) by either party, if a bankruptcy petition is filed against the other party and is not dismissed within 60 days. In addition, Teva can also terminate the agreement related to the Company’s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva.

During the years ended December 31, 2021 and 2020, none of the development and commercial milestones were met and accordingly, there were no milestone payments related to the Teva Agreements.

6. Term Loan

Loan and Security Agreement

In April 2020, the Company entered into a Loan and Security Agreement, (the “Loan Agreement”) with the lenders referred to therein (the “Lenders”), and Silicon Valley Bank (“SVB”), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the “Term A Loan Facility”) of up to $10.0 million and (ii) a secured term B loan facility (the “Term B Loan Facility”) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company’s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.

In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase 25,000 shares of the Company’s common stock with a warrant exercise price of $22.06 per share that is immediately exercisable and expires on June 30, 2025, as amended. The fair value of the warrant at issuance date was determined by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 0.75%, no dividends, expected volatility of 92.3% and expected term of 10.0 years. Upon issuance, the fair value allocated to the warrant of $0.6 million met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. Additionally, the Company incurred $0.2 million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs classified within other assets in the consolidated balance sheets.

In May 2021, the parties further amended the Loan Agreement (as amended, the “2021 Loan Agreement”). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022.

79

89bio, Inc.

Notes to Consolidated Financial Statements

 

Concurrent with the closing and as a condition of the 2021 Loan Agreement, the Company drew $1.5 million and in December 2021, drew the remaining $18.5 million under the Term Loan A Facility. The 2021 Loan Agreement provides for interest-only payments until October 1, 2022, followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through September 1, 2024, the maturity date of the term loan. The interest only period may be extended to April 1, 2023, if on or before September 20, 2022, the Company receives net cash proceeds of at least $75.0 million from the sale of its equity securities. The term loan bears interest at the greater of (i) 4.25% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) 1.00% (or for both amounts drawn 4.25% initially and as of December 31, 2021). In addition, a final payment fee of 5% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.

In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase 33,923 shares of the Company’s common stock with a warrant exercise price of $19.12 per share that is immediately exercisable and expires on May 28, 2031. The Company determined the fair value of the warrant at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 1.6%, no dividends, expected volatility of 98.6% and expected term of 10.0 years. Upon issuance, the fair value of the warrant of $0.6 million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term Loan B Facility, if funded, the Company will issue additional warrant to purchase 11,305 shares of the Company’s common stock with the exercise price at the Company’s stock price at the time of issuance.

The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $0.4 million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount. The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method. Interest expense is recorded within other expenses, net in the consolidated statements of operations and comprehensive loss.

 The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):

 

 

 

 

 

 

2022

 

$

2,500

 

2023

 

$

10,000

 

2024

 

$

7,500

 

Total principal repayments

 

$

20,000

 

Less: unamortized debt discount

 

 

(602

)

Total term loan, net

 

 

19,398

 

Less: term loan, current

 

 

(2,500

)

Term loan, non-current, net

 

$

16,898

 

 

 

80

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

7. Stock-Based Compensation

Equity Incentive Plans

The Company’s board of directors approved the 2019 Equity Incentive Plan (the “2019 Plan”), which became effective in September 2019. The Company initially reserved 2,844,193 shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to ten years, commencing on January 1, 2020, in an amount equal to 4% of the total number of shares of the Company’s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company’s board of directors. As of December 31, 2021, there were 1,428,304 shares of common stock available for issuance as future option grants under the 2019 Plan.

The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant.

Employee Stock Purchase Plan

In October 2019, the Company adopted the 2019 Employee Stock Purchase Plan (“ESPP”), which became effective in November 2019. The Company initially reserved 225,188 shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to ten years, in an amount equal to 1% of the total number of shares of the Company’s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company’s board of directors. Purchases will be accomplished through the participation of discrete offering periods and each offering is expected to be 6 months long. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to 85% of the lesser of the fair market value of the Company’s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period. The first six month offering period under the ESPP commenced on January 1, 2020.

As of December 31, 2021, there were 544,410 shares of common stock available for issuance under the ESPP.

The Company recorded stock-based compensation for the periods presented as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

2,966

 

 

$

1,250

 

General and administrative

 

 

5,712

 

 

 

2,557

 

Total stock-based compensation

 

$

8,678

 

 

$

3,807

 

 

The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Expected term (years)

 

5.5-6.1

 

 

4.0-6.1

 

Expected volatility

 

86.9-91.9%

 

 

86.4-97.6%

 

Risk-free interest rate

 

0.7-1.3%

 

 

0.2-1.5%

 

Expected dividend

 

 

—

 

 

 

—

 

 

81

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

The following table summarizes stock option activity for the year ended December 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

 

Value

 

 

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Balance outstanding as of December 31, 2020

 

 

1,898,395

 

 

$

12.79

 

 

 

8.6

 

 

$

25,918

 

Granted

 

 

830,013

 

 

 

22.22

 

 

 

 

 

 

 

 

 

Exercised

 

 

(188,286

)

 

 

2.59

 

 

 

 

 

 

 

 

 

Cancelled and forfeited

 

 

(133,454

)

 

 

19.55

 

 

 

 

 

 

 

 

 

Balance outstanding as of December 31, 2021

 

 

2,406,668

 

 

$

16.46

 

 

 

8.1

 

 

$

9,970

 

Exercisable as of December 31, 2021

 

 

922,104

 

 

$

10.76

 

 

 

7.3

 

 

$

6,800

 

 

The estimated grant date fair value of stock options that vested during the year ended December 31, 2021, was $7.0 million. The weighted-average grant date fair value of stock options that were granted during the years ended December 31, 2021 and 2020 was $16.18 and $21.88 per share, respectively. As of December 31, 2021, there was $17.9 million of unrecognized stock-based compensation cost related to stock options granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of 2.3 years.

Restricted Stock Units (“RSUs”)

In February 2021, the Company granted 56,545 service-based RSUs to its employees with a total grant date fair value of $1.3 million. The RSUs vest annually over a three-year period. During the year ended December 31, 2021, the Company recognized $0.3 million in expense related to the service-based RSUs. As of December 31, 2021, 11,651 RSUs were cancelled and 44,894 remain outstanding.

In February 2021, the Company granted 61,500 performance-based RSUs to certain executives, one-third of which vest on each one-year anniversary of the grant date subject to achievement of a development milestone and continued service to the Company. The performance-based RSUs have a total grant date fair value of $1.4 million. During the year ended December 31, 2021, the Company recognized $0.8 million in expense, using the accelerated attribution method, related to the performance-based RSUs. As of December 31, 2021, all of the performance-based RSUs remain outstanding. Subsequently, one-third of the performance-based RSUs vested in February 2022, upon achievement of the development milestone and satisfaction of the continued service condition.

 

8. Income Taxes

 

Tax Rates Applicable to the Income of the Company and its Subsidiaries

The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

89bio, Inc.

 

 

21

%

 

 

21

%

89Bio Ltd.

 

 

23

%

 

 

23

%

89bio Management, Inc.

 

 

21

%

 

 

21

%

UAB 89bio Lithuania

 

 

15

%

 

 

15

%

 

82

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

The income tax benefit is comprised of (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Current:

 

 

 

 

 

 

 

 

Federal

 

$

—

 

 

$

(11

)

State

 

 

(2

)

 

 

1

 

Foreign

 

 

(1

)

 

 

—

 

Total

 

 

(3

)

 

 

(10

)

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

150

 

 

 

69

 

Total

 

 

150

 

 

 

69

 

Income tax benefit

 

$

147

 

 

$

59

 

 

Deferred Income Taxes

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets for the periods presented are as follows (in thousands):

 

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

U.S. net operating loss carryforwards

 

$

29,094

 

 

$

11,342

 

Research and development expenses

 

 

6,529

 

 

 

5,392

 

Israel net operating loss carryforwards

 

 

4,262

 

 

 

3,978

 

Stock-based compensation

 

 

1,969

 

 

 

610

 

Accrued expenses

 

 

220

 

 

 

635

 

Other

 

 

191

 

 

 

48

 

Total deferred tax assets

 

 

42,265

 

 

 

22,005

 

Less: valuation allowance

 

 

(42,046

)

 

 

(21,936

)

Net deferred tax assets

 

$

219

 

 

$

69

 

 

As of December 31, 2021 and 2020, the Company recorded a valuation allowance of $42.0 million and $21.9 million, respectively, in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by $20.1 million in 2021, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction. The valuation allowance increased by $11.9 million in 2020, which primarily relates to significant taxable losses. The change in valuation allowance during 2020 also includes a partial release of the valuation allowance against deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction, which decreased the valuation allowance by $69,000 in 2020.

Available Carryforward Tax Losses and Credits

As of December 31, 2021, the Company had an accumulated tax loss carryforward of approximately $138.5 million and $18.5 million for U.S. and Israeli tax purposes, respectively. As of December 31, 2020, the Company had an accumulated tax loss carryforward of approximately $54.1 million and $17.3 million for U.S. and Israeli tax purposes, respectively. Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. Carryforward tax losses in Israel have no expiration date.

83

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

As of December 31, 2021 and 2020, the Company had federal research and development credit carryforwards of approximately $2.1 million and $0.6 million, respectively, which expire beginning in 2040. As of December 31, 2021 and December 31, 2020, the Company has state research and development credit carryforwards of approximately $1.1 million and $0.7 million, respectively, which will carry forward indefinitely.

Loss from Operations, Before Income Tax

The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

United States

 

$

(91,141

)

 

$

(58,760

)

Lithuania

 

 

10

 

 

 

(73

)

Israel

 

 

862

 

 

 

9,275

 

Net loss before income tax

 

$

(90,269

)

 

$

(49,558

)

Reconciliation of Income Tax Benefit

The reconciliation of income tax benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Income tax benefit computed at statutory rates

 

$

18,757

 

 

$

8,285

 

Change in valuation allowance

 

 

(20,111

)

 

 

(11,914

)

Foreign rate differential

 

 

(19

)

 

 

1,671

 

Change in Israel effective tax rate due to the 2019

   reorganization

 

 

(2

)

 

 

647

 

Research and development credits, net of

   uncertain tax position

 

 

1,331

 

 

 

815

 

Other

 

 

191

 

 

 

555

 

Income tax benefit

 

$

147

 

 

$

59

 

 

Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.

Unrecognized Tax Benefits

During the years ended December 31, 2021 and 2020, the amount of gross unrecognized tax benefits increased by $0.5 million and $0.3 million, respectively. If the total amount of unrecognized tax benefits was recognized, it would not have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.

The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2021 and 2020, such interest and penalties were not material.

The Company is subject to taxation in the United States, California, and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli taxing authorities for 2018 and 2019. As of December 31, 2021 all tax years remain open to examination.

84

89bio, Inc.

Notes to Consolidated Financial Statements

 

 

9. Net Loss Per Share

The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect:

 

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Stock options to purchase common stock

 

 

2,406,668

 

 

 

1,898,395

 

Unvested restricted stock units

 

 

106,394

 

 

 

—

 

Warrants to purchase common stock

 

 

58,923

 

 

 

—

 

Total

 

 

2,571,985

 

 

 

1,898,395

 

 

 

 

 

85

 

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As of December 31, 2021, our management, with the participation and supervision of our principal executive officer and our principal financial officer, evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2021 to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended December 31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States.

As of December 31, 2021, our management assessed the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework. Based on this assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2021.

86

 

Attestation Report of Registered Public Accounting Firm

As an emerging growth company, we are not required to provide and this Annual Report on Form 10-K does not include an attestation report on our internal control over financial reporting issued by the Company’s independent registered public accounting firm. Our auditors will not be required to formally opine on the effectiveness of our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 until we are no longer an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, and are no longer a non-accelerated filer.

Item 9B. Other Information.

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

87

 

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

The information required by this Item 10 is incorporated herein by reference to information in our proxy statement for our 2022 Annual Meeting of Stockholders (the “2022 Proxy Statement”), which we expect to be filed with the SEC within 120 days of the end of our fiscal year ended December 31, 2021, including under the heading “Directors, Executive Officers and Corporate Governance.”

We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is available on our website located at www.89bio.com, under “Corporate Governance.” We intend to disclose on our website any amendments to, or waivers from, the code of business conduct and ethics that are required to be disclosed pursuant to the disclosure requirements of Item 5.05 of Form 8-K within four business days following the date of the amendment or waiver.

Item 11. Executive Compensation.

The information required by this Item 11 is incorporated herein by reference to information in our 2022 Proxy Statement, including under headings “Executive Compensation” and “Directors, Executive Officers and Corporate Governance.”

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this Item 12 is incorporated herein by reference to information in our 2022 Proxy Statement, including under headings “Security Ownership of Certain Beneficial Owners and Management” and “Executive Compensation-Securities Authorized for Issuance Under Equity Compensation Plans.”

The information required by this Item 13 is incorporated herein by reference to information in our 2022 Proxy Statement, including under headings “Directors, Executive Officers and Corporate Governance” and “Certain Relationships and Related Party Transactions.”

Item 14. Principal Accountant Fees and Services.

The information required by this Item 14 is incorporated herein by reference to information in our 2022 Proxy Statement, including under the heading “Ratification of Selection of Independent Registered Public Accounting Firm.”

 

88

 

 

PART IV

Item 15. Exhibits, Financial Statement Schedules.

 

(a)

The following documents are filed as a part of this report:

 

(1)

Financial Statements

See Index to Consolidated Financial Statements at Part II Item 8 “Financial Statements and Supplementary Data.”

 

(2)

Financial Statement Schedules

The financial statement schedules are omitted as they are either not applicable or the information required is presented in the financial statements and notes thereto under Part II Item 8 “Financial Statements and Supplementary Data.”

 

(3)

Exhibits:

89

 

 

Exhibit Index

 

Exhibit

Number

 

Description

 

 

 

    1.1

 

Sales Agreement, by and among the Company, SVB Leerink LLC and Cantor Fitzgerald & Co, dated March 25, 2021 (filed with the SEC as Exhibit 1.2 to the Company’s Form S-3 filed on March 25, 2021)

 

 

 

    2.1

 

Contribution and Exchange Agreement, dated as of September 17, 2019, by and among 89Bio Ltd., the Company and its shareholders (filed with the SEC as Exhibit 2.1 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

    3.1

 

Second Amended and Restated Certificate of Incorporation of the Company (filed with the SEC as Exhibit 3.1 to the Company’s Form 8-K filed on November 15, 2019)

 

 

 

    3.2

 

Second Amended and Restated Bylaws of the Company (filed with the SEC as Exhibit 3.2 to the Company’s Form 8-K filed on November 15, 2019)

 

 

 

    4.1

 

Specimen common stock certificate of the Company (filed with the SEC as Exhibit 4.1 to the Company’s Form S-1/A filed on October 28, 2019)

 

 

 

    4.2

 

Investors’ Rights Agreement, dated as of September 17, 2019, by and among the Company and certain of its shareholders (filed with the SEC as Exhibit 4.2 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

    4.3*

 

Description of Securities

 

 

 

    4.4

 

Form of Warrant to Purchase Common Stock for Silicon Valley Bank (filed with SEC as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 13, 2020)

 

 

 

    4.5

 

Form of Warrant to Purchase Common Stock for Silicon Valley Bank (filed with the SEC as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on June 4, 2021)

 

 

 

  10.1+

 

Form of Indemnification Agreement for directors and executive officers (filed with the SEC as Exhibit 10.1 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  10.2+

 

Amended and Restated 2019 Equity Incentive Plan and form of agreements thereunder (filed with the SEC as Exhibit 10.2 to the Company’s Form S-1/A filed on October 28, 2019)

 

 

 

  10.3+

 

2019 Employee Stock Purchase Plan (filed with the SEC as Exhibit 10.3 to the Company’s Form S-1/A filed on October 28, 2019)

 

 

 

  10.4+

 

Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Rohan Palekar (filed with the SEC as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 4, 2020)

 

 

 

  10.5+

 

Amended and Restated Executive Employment Agreement, dated July 28, 2020, by and between 89Bio Ltd. and Ram Waisbourd (filed with the SEC as Exhibit 10.5 to the Company’s S-1 filed on September 14, 2020)

 

 

 

  10.6+

 

Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Hank Mansbach (filed with the SEC as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on May 4, 2020)

 

 

 

  10.7+

 

Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Quoc Le-Nguyen (filed with the SEC as Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on May 4, 2020)

 

 

 

  10.8+

 

Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Ryan Martins (filed with the SEC as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 4, 2020)

 

 

 

90

 

Exhibit

Number

 

Description

  10.9+

 

Director Offer Letter, dated July 1, 2018, by and between 89Bio Ltd. and Michael Hayden (filed with the SEC as Exhibit 10.9 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  10.10+

 

Non-Employee Director Compensation Policy (filed with the SEC as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2020)

 

 

 

  10.11†

 

Asset Transfer and License Agreement—FGF21 by and among 89Bio Ltd., ratiopharm GmbH, Teva Branded Pharmaceutical Products R&D, Inc. and Teva Pharmaceutical Industries Ltd, dated as of April 16, 2018 (filed with the SEC as Exhibit 10.11 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  10.12+

 

Reagent Supply and Technology Transfer Agreement by and between 89Bio Ltd. and Teva Biotech GmbH, dated as of April 16, 2018, as amended (filed with the SEC as Exhibit 10.12 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  10.13+

 

Sublicense Agreement by and between 89Bio Ltd. and ratiopharm GmbH, dated as of April 16, 2018 (filed with the SEC as Exhibit 10.13 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  10.14+

 

Master Services Agreement by and between 89Bio Ltd. and Biotechpharma UAB, dated as of May 7, 2018, as amended (filed with the SEC as Exhibit 10.14 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  10.15

 

Office Lease by and between 89bio, Inc. and King Family Irrevocable Trust, dated as of December 5, 2019 (filed with the SEC as Exhibit 10.15 to the Company’s Annual Report on Form 10-K filed on March 18, 2020)

 

 

 

  10.16

 

Loan and Security Agreement, dated as of April 7, 2020, among Silicon Valley Bank, the Lenders party thereto, 89bio, Inc., 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 13, 2020)

 

 

 

  10.17

 

First Amendment to Loan and Security Agreement, dated as of March 31, 2021, among Silicon Valley Bank, the Lenders party thereto, 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on May 15, 2021)

 

 

 

  10.18

 

Second Amendment to Loan and Security Agreement, dated as of April 30, 2021, among Silicon Valley Bank, the Lenders party thereto, 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on May 15, 2021)

 

 

 

  10.19

 

Third Amendment to Loan and Security Agreement, dated as of May 28, 2021, among Silicon Valley Bank, the Lenders party thereto, 89bio, Inc., 89bio Management, Inc. and 89Bio Ltd. (filed with the SEC as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 4, 2021)

 

 

 

  10.20

 

First Amendment to Office Lease, dated as of July 27, 2021, by and between King Family Irrevocable Trust and the Company (filed with the SEC as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2021)

 

 

 

  16.1

 

Letter from Deloitte & Touche LLP, dated April 21, 2020 (filed with the SEC as Exhibit 16.1 to the Company’s Current Report on Form 8-K filed on April 23, 2020)

 

 

 

  21.1+

 

List of subsidiaries (filed with the SEC as Exhibit 21.1 to the Company’s Form S-1 filed on October 11, 2019)

 

 

 

  23.1*

 

Consent of Independent Registered Public Accounting Firm

 

 

 

  31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934

 

 

 

  31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934

 

 

 

91

 

Exhibit

Number

 

Description

  32.1#

 

Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350

 

 

 

101.INS

 

Inline XBRL Instance Document

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104 

 

Cover Page Interactive Data File

 

*

Filed herewith.

+

Indicates management contract or compensatory plan.

†

Portions of the exhibit have been omitted for confidentiality purposes.

#

Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Exchange Act, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 16. Form 10-K Summary.

None.

92

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

89bio, Inc.

 

 

 

 

Date: March 24, 2022

 

By:

/s/ Rohan Palekar

 

 

 

Rohan Palekar

 

 

 

Chief Executive Officer and Director

(principal executive officer)

Date: March 24, 2022

 

By:

/s/ Ryan Martins

 

 

 

Ryan Martins

 

 

 

Chief Financial Officer

(principal financial and accounting officer)

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Rohan Palekar, Ram Waisbourd and Ryan Martins, and each of them, the true and lawful attorneys-in-fact and agents of the undersigned, with full power of substitution and resubstitution, for and in the name, place and stead of the undersigned, to sign in any and all capacities (including, without limitation, the capacities listed below), this Annual Report on Form 10-K, any and all amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and anything necessary to be done to enable the registrant to comply with the provisions of the Securities Exchange Act and all the requirements of the Securities and Exchange Commission, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute, or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

 

 

Name

 

Title

 

Date

 

 

 

 

 

/s/ Rohan Palekar

 

Chief Executive Officer and Director

 

March 24, 2022

Rohan Palekar

 

(principal executive officer)

 

 

 

 

 

 

 

/s/ Ryan Martins

 

Chief Financial Officer

 

March 24, 2022

Ryan Martins

 

(principal financial and accounting officer)

 

 

 

 

 

 

 

/s/ Steven Altschuler

 

Director

 

March 24, 2022

Steven Altschuler, M.D.

 

 

 

 

 

 

 

 

 

/s/ Derek DiRocco

 

Director

 

March 24, 2022

Derek DiRocco, Ph.D.

 

 

 

 

 

 

 

 

 

/s/ Gregory Grunberg

 

Director

 

March 24, 2022

Gregory Grunberg, M.D.

 

 

 

 

 

 

 

 

 

/s/ Michael Hayden

 

Director

 

March 24, 2022

Michael Hayden, M.B., Ch.B., Ph.D.

 

 

 

 

 

 

 

 

 

/s/ Kathy LaPorte

 

Director

 

March 24, 2022

Kathy LaPorte

 

 

 

 

 

 

 

 

 

/s/ Lota Zoth

 

Director

 

March 24, 2022

Lota Zoth, C.P.A.

 

 

 

 

 

93

 

 

/s/ Edward Morrow Atkinson III

 

Director

 

March 24, 2022

Edward Morrow Atkinson III

 

 

 

 

 

94

 EX-4.3 2 etnb-ex43_8.htm EX-4.3 etnb-ex43_8.htm

 

Exhibit 4.3

 

DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

The following description of our capital stock is intended as a summary only and therefore is not a complete description of our capital stock. This description is based upon, and is qualified by reference to, our second amended and restated certificate of incorporation (the “Amended Certificate”), our second amended and restated bylaws (the “Amended Bylaws”) and applicable provisions of Delaware corporate law. You should read our Amended Certificate and Amended Bylaws, which are filed as exhibits to our Annual Report on Form 10-K, to which this exhibit is also appended.

Our authorized capital stock consists of 100,000,000 shares of common stock and 10,000,000 shares of preferred stock.

Common Stock

Our Amended Certificate authorizes the issuance of up to 100,000,000 shares of our common stock. All outstanding shares of our common stock are validly issued, fully paid and nonassessable.

The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. A majority vote of the shares present in person or represented by proxy and entitled to vote on the subject matter is required for the holders of our common stock to take action on all matters (except for election of directors (as discussed below)), except as otherwise required by law, our Amended Certificate or our Amended Bylaws. Our Amended Certificate does not provide for cumulative voting in the election of directors. The holders of our common stock will receive ratably any dividends declared by our board of directors out of funds legally available therefor. In the event of our liquidation, dissolution or winding-up, the holders of our common stock will be entitled to share ratably in all assets remaining after payment of or provision for any liabilities.

Preferred Stock

Under the terms of our Amended Certificate, our board of directors has the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the dividend, voting and other rights, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.

Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock.

 

Registration Rights

Certain holders of shares of our common stock are entitled to rights with respect to the registration of these securities under the Securities Act of 1933, as amended (the “Securities Act”). These rights are provided under the terms of our investors’ rights agreement, effective as of September 17, 2019 (the “IRA”). The IRA includes demand registration rights, short-form registration rights and piggyback registration rights. All fees, costs and expenses of underwritten registrations under this agreement will be borne by us and all selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares being registered.

Demand Registration Rights

 

 

Certain holders of shares of our common stock are entitled to demand registration rights. Under the terms of the IRA, we will be required, upon the written request of at least 50% of the holders of the registrable securities, including either OrbiMed Israel Partners II, L.P. or OrbiMed Private Investments VI, LP, provided that the anticipated aggregate offering price is at least $10 million, to file a registration statement on Form S-1 and use commercially reasonable efforts to effect the registration of these shares for public resale. The right to have such shares registered on Form S-1 is further subject to other specified conditions and limitations.

Piggyback Registration Rights

Pursuant to the IRA, if we register any of our common stock either for our own account or for the account of other security holders, the holders of registrable shares party to the IRA are entitled to include their shares in the registration, subject to certain marketing and other limitations. We may terminate or withdraw any registration initiated before the effective date of such registration in our sole discretion.

Form S-3 Registration Rights

Pursuant to the IRA, if we are eligible to file a registration statement on Form S-3, upon the written request of at least 10% of the holders of registrable securities to sell registrable securities at an aggregate price of at least $5 million, we will be required to use commercially reasonable efforts to effect a registration of such shares. The right to have such shares registered on Form S-3 is further subject to other specified conditions and limitations.

Anti-Takeover Effects of Our Amended Certificate, Amended Bylaws and Delaware Law

Our Amended Certificate and our Amended Bylaws include a number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue non-negotiated takeover attempts.

 

•

Issuance of undesignated preferred stock: Under our Amended Certificate, our board of directors has the authority, without further action by the stockholders, to issue up to 10,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock enables our board of directors to make it more difficult to attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.

 

•

Classified board: Our Amended Certificate establishes a classified board of directors consisting of three classes of directors, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. This provision may have the effect of delaying a change in control of our board of directors.

 

•

Election and removal of directors and board vacancies: Our Amended Bylaws provide that directors will be elected by a plurality vote. Our Amended Certificate and Amended Bylaws also provide that our board of directors has the right to increase or decrease the size of the board and to fill vacancies on the board. Directors may be removed only for cause by the affirmative vote of the holders of at least 662⁄3% of the votes that all our stockholders would be entitled to cast in an annual election of directors. Only our board of directors is authorized to fill vacant directorships. In addition the number of directors constituting our board of directors may be set only by resolution adopted by a majority vote of the directors then in office. These provisions prevent stockholders from increasing the size of our board of directors and gaining control of our board of directors by filling the resulting vacancies with its own nominees.

2

 

 

•

Requirements for advance notification of stockholder nominations and proposals: Our Amended Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors that specify certain requirements as to the timing, form and content of a stockholder’s notice. Business that may be conducted at an annual meeting of stockholders will be limited to those matters properly brought before the meeting. These provisions may make it more difficult for our stockholders to bring matters before our annual meeting of stockholders or to nominate directors at annual meetings of stockholders.

 

•

No written consent of stockholders: Our Amended Certificate provides that all stockholder actions be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our Amended Bylaws or removal of directors by our stockholders without holding a meeting of stockholders.

 

•

No stockholder ability to call special meetings: Our Amended Certificate and Amended Bylaws provide that only a majority of the members of our board of directors then in office may be able to call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders.

 

•

Amendments to certificate of incorporation and bylaws: Any amendment to our Amended Certificate will be required to be approved by a majority of our board of directors as well as, if required by law or the Amended Certificate, a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of provisions to board classification, stockholder action, certificate amendments, and liability of directors must be approved by not less than 662⁄3% of the outstanding shares entitled to vote on the amendment, voting together as a single class. Any amendment to our Amended Bylaws must be approved by either a majority of our board of directors or not less than 662⁄3% of the outstanding shares entitled to vote on the amendment, voting together as a single class.

These provisions are designed to enhance the likelihood of continued stability in the composition of our board of directors and its policies, to discourage certain types of transactions that may involve an actual or threatened acquisition of us and to reduce our vulnerability to an unsolicited acquisition proposal. We also designed these provisions to discourage certain tactics that may be used in proxy fights. However, these provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they may also reduce fluctuations in the market price of our shares that could result from actual or rumored takeover attempts.

 

Section 203 of the Delaware General Corporation Law

We are subject to the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner.

Choice of Forum

Our Amended Certificate requires that the Court of Chancery of the State of Delaware be the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a breach of fiduciary duty owed by any director, officer or other employee to us or our stockholders; (3) any action asserting a claim against us or any director or officer or other employee arising pursuant to the Delaware General Corporation Law, our Amended Certificate or Amended Bylaws; or (4) any action asserting a claim against us or any director or officer or other employee that is governed by the internal affairs doctrine. This provision would not apply to claims brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts have exclusive jurisdiction. Our Amended Certificate provides further that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, subject to and contingent upon a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of discouraging lawsuits against us or our directors or officers.

3

 

Transfer Agent and Registrar

American Stock Transfer and Trust Company, LLC serves as the transfer agent and registrar for our common stock.

Listing

Our common stock is listed on The Nasdaq Global Market under the symbol “ETNB.”

4

 EX-23.1 3 etnb-ex231_7.htm EX-23.1 etnb-ex231_7.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (No. 333-254684) on Form S-3 and (No. 333-254683) on Form S-8 of our report dated March 24, 2022, with respect to the consolidated financial statements of 89bio, Inc.

/s/ KPMG LLP

San Francisco, California
March 24, 2022

 

 

 

 EX-31.1 4 etnb-ex311_9.htm EX-31.1 etnb-ex311_9.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rohan Palekar, certify that:

1.

I have reviewed this Annual Report on Form 10-K of 89bio, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: March 24, 2022

 

By:

/s/ Rohan Palekar

 

 

 

Rohan Palekar

 

 

 

Chief Executive Officer

(principal executive officer)

 

 EX-31.2 5 etnb-ex312_6.htm EX-31.2 etnb-ex312_6.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ryan Martins, certify that:

1.

I have reviewed this Annual Report on Form 10-K of 89bio, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: March 24, 2022

 

By:

/s/ Ryan Martins

 

 

 

Ryan Martins

 

 

 

Chief Financial Officer

(principal financial and accounting officer)

 

 EX-32.1 6 etnb-ex321_10.htm EX-32.1 etnb-ex321_10.htm

 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of 89bio, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 24, 2022

By:

/s/ Rohan Palekar

 

 

Rohan Palekar

 

 

Chief Executive Officer

(principal executive officer)

 

Date: March 24, 2022

By:

/s/ Ryan Martins

 

 

Ryan Martins

 

 

Chief Financial Officer

(principal financial and accounting officer)

 

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Note: A signed original of this written statement required by § 906 has been provided to 89bio, Inc. and will be retained by 89bio, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 GRAPHIC 7 gb2k1ptlkg5v000007.jpg GRAPHIC begin 644 gb2k1ptlkg5v000007.jpg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end GRAPHIC 8 gb2k1ptlkg5v000006.jpg GRAPHIC begin 644 gb2k1ptlkg5v000006.jpg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

&?$Z:#KW[1WA[QEX:T_48-5\8VND_#_ %WP M#K<7Q;TK2I/#_AK7-<^('@[XEZ'^R1XEU3PKI.K^#?'_ (QO-.[Z$Z^$QV*C M5G1JX;#)XW$OZKADJJG3INC22E2;I2K3G1HRI0E%4VZCCK%R?)55+$87#NG& MK"M6<<-17MZ[=/EG)5)^[47M%2C&I4522?.HP4M))&;^T5\0/VK];_:H_P"" M;O\ P2*;]HSXB_!R_P#$W[+'P^\7_M5_'SX1^-;S6_B)\4M<\+Z#XSU?7[?P MK\1O$'A_P_\ %OPCK,NI_LH>-K/3_BE#XQM[CQB/C7=7GQ-^'/B?3O"]UX2\ M5V?V4?\ @I7\7OA7_P $S_B;XG^+7C30?VGOVA/AA^TCXM_87_9<\5?"O2?& M'QVTW]I'XLVWPV\+Z]\&;[4O$NC:EH&L?%KPWJVHZKK&IM\2&O?!7BWXH?"_ MP_HTD;^)_CEXIMIO'/Z??\%#/V!_V3_VX/AC#+^U+?:UX,TWX1Z'XLUK1OB_ MHGCFR\'2_"OPW?WOA#Q1\1]9O5\86VO_ DNM(U'1_AQI=GKVK_$GP3XE@\, M^'H]7U#P[=^&-4F?7(/X^_'NLCX:_"6__P""C'[._P *9O@K^SWIG[3UM\"_ M^"?'P?\ B!81^--:^%?Q)L/#UO\ &/XC_M7W*?$/PSXT^'?Q?\5:S9_ 77?A M(UYXCO\ XS:YX*\<^([?PMX3^,'AZ+]@7X!VMV8..&QU"E2E2491JTE/]U3I MPJ8FI7KRC&->#=5_6(3ITYTU3M1H4*E2*DZ=*$WB'7PM63G*% M&%*BI2=&25/]S*$Y1GSWJ5:T(.RG4E'^PK]@_P" OQT\-_LEW?A/]NWQ5JOQ MM^,GQSU?X@^-?CKX3^)'B/0_BGX)T&P^)>[2G^#&B:5%H%CX*TWP%9>"+;3K M?Q7\-?#EMKGPOTOQQKGQ"TOP%J6J_#FY\/ ? O\ P0B\?>,/"VD?ME?L&^(] M7C\<:'^PE^T!K_@?P3\38M/TKPNGB+2_%7Q#^+^A>)=&C\$:=8W=SHL<'Q#^ M%OC+XC?VAKGCSQUJ\\WQ7F\)K>V>C^!M(DU*_P#\$_=6_:#_ &F?LT^$OVA+?Q5\0_'?B/XD_&/P+\3K:W^"'@KQ=X?UZ[\ M2:WK.L?"O2_&&H^*=>\?:1\$]4\0?$&VT'X:ZM\&/%^D>+(_$/C+XBZGXVX# M_@G6/^%D?\%DO^"H?Q<^#Z'X>_ ;P0M[\'/B1\+6;_A%&\6_M!Q>.]%\-W7Q M:/@7PH=0\$^(%U#QE\#_ -I/Q+%X]\0:E:>.IE^+QU672DU;X@_$&VTCGG3E M[+-%4E3G&>'PN84ITH.%)2EB*-.GR0<8RIOV6)JTE!Q6UM4E(UC->TP+@JD9 M1K5\).,Y*4VE1G.;E-2:G[]"G-RN[]D[H_HKHHHKPSU HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _DO_P"" M\7_)WGPY_P"S;_"'_JSOC!7XGU^V'_!>+_D[SX<_]FW^$/\ U9WQ@K\3Z_N3 MPZ_Y(CAO_L6T_P#TNH?\_P!])W_D_OBE_P!E/7_]1<*%%%%?:'X0%%%% !11 M10 4444 %%%% !1110!_I 4445_G.?\ 3P%%%% !1110 4444 %%%% 'XZ?\ M%Q?^3+],_P"RU^!O_3#XTK^0JOZ]?^"XO_)E^F?]EK\#?^F'QI7\A5?UYX*? M\D4O^QMC_P#TG#G^*WT\?^3[S_[([AW_ -.9B%%%%?KA_& 4444 %%%% !11 M10 4444 %%%% ']GG_!'+_DPCX7_ /8R?$W_ -3_ %^OU$K\N_\ @CE_R81\ M+_\ L9/B;_ZG^OU^HE?P?QM_R6'%'_8^S7_U,K'_ $/^ W_)DO"7_LW7!_\ MZH<"%%%%?+GZR%%%% !1110 4444 %%%% '%Z'_R.'CC_N6?_37+7:5Q>A_\ MCAXX_P"Y9_\ 37+7:54MU_AA_P"D1)CL_P#%/_TN04445)04444 8OB3_D7= M?_[ NJ?^D,]'AO\ Y%W0/^P+I?\ Z0P4>)/^1=U__L"ZI_Z0ST>&_P#D7= _ M[ NE_P#I#!5?8_[>_0G[?_;OZFU1114E!1110 4444 %%%% !1110 4444 ? MCU_P5+_Y+#_P2R_[2!_"K_T=%7["U^/7_!4O_DL/_!++_M('\*O_ $=%7["U MWXG_ '++O\&*_P#4F1R4/]YQO^.A_P"F(!1117 =84444 %%%% !117\M_\ MP4-^)_\ P5W_ &@OVQ?VB_V7/V)D^*%K\$_A=I'PST>_U+X11^%_A%"GB&/P M3\(OC%K<>I_M.^*M3\*:CHOQ0GO/BKX:AN/AYX-^+'A2]UOX41::\GP_U/1) M_'VO^(.O!X1XRK*FJV'P\84W5G5Q-3V=.,%.$'K9WDW-6C;775)7.?$XA8:F MI^RK5G*:A&G0ASS)M$\&?$'PW8?M(_!/XV^(=4^-NM:EX'T#^TXM=@^'%U\3/%\S M^'-=O/"OB:^\8_#GQ3\-OB)X1\$?$?6;;X;^(/%>L^/?AE#9V-]_0+_P6=_X M*K?$']A^\^'WP0_9_A\&CXP?$/P7XE\;^,O%WC#1]5MR2.2EFN&J4*U M>2J4OJ\E"K3J1_>*;=HQ23U^BOXZ= _8P_P""^_BGP'H7 M[6>E?M(?&*'Q]XBU[2OBUIO[-^O_ +2GQ!\%>/(;W6/&UOJEGI^N_!+QH_A[ M]FKPKH4-ET*'XEV>KZWX L? KP M^$/B'X4LW^&7A!?$OQ)TKX[WM[J_P1GM/&7AGQ+\/_!>M>!/%G@3PO/:1^-9 M>42EB*&&P^-P>*G6E4C-T9S<:'L8\\YU+PO[/EORSBGSN+C%7M>O[04:-6M6 MPV)H1IJ#2J0BI5/:2Y81@E-^_P UE*,FN5--NU[?U@T5_([_ ,$X_CW_ ,%" M/V;O^"H6E_\ !.7]H_\ :#/QOT2?4?&(^*-KXG\<>-_CO;Z?K.J_LT:?\=O" M>N?#7XP?%32/#'Q=TZ;3K#1_!^BW?A?54_X5O:IXA^(TEGX%NO$^J:7\0+/V MK_@I#^UY^U#^V#^UEI'_ 3>_P""=]SXQ\,^*_A9XRM]=^*WQX^'_P 7/$G@ M6TBU[3_#DNE^)-+\0>,OA3XB?_A&/@G\)3XUDTKXL0^++;5_%VN_&W2;#P'X M9^']OXR\%^%+/XJ+^QZWUF%'VU%T986.->+3G["&$E?]]/GC"BXSJ*I&N\-]7:BZLL0K?NX\LG%Z-2YE+E4;M[6/Z>**Y'X?\ MA+_A / 7@CP'_P )-XN\:_\ "$^$?#?A'_A,OB!K1\2>/?%O_"-Z-9:-_P ) M-XW\1&VLSK_B[7OL7]J^)-:-I:_VIK-W>WWV:#S_ "EZZO)=DVD[I-V=K771 MVZ7['H*]E=6?5;V\KA1112 **** "BBB@ HHHH **** "BBB@#\&?^"^/_)" M?@=_V5K4?_4.U6OY9:_J:_X+X_\ )"?@=_V5K4?_ %#M5K^66O['\'?^2$R_ M_L+S+_U,JG^'OTW?^4A>)O\ L3\+?^J+!A1117ZB?R2%%%% !1110 4444 % M%%% !1110!_95_P1D_Y,2\$?]CM\2/\ U*+JOU6K\J?^",G_ "8EX(_[';XD M?^I1=5^JU?PCQS_R67$__8\S+_U*J'_0UX ?\F0\)O\ LW_"W_JHPH4445\J M?KP4444 %%%% !1110 4444 %%%% 'P3_P %#/V%=(_X*!_"CX;_ @\0_$7 M4/AKX>\'_'+P=\5_$.I:/X9M/$>NZ_X?T'PYXT\*Z[X2\/W&H:MI^G^$]>UK M2?&MX=(\9ZAIOC"PT"]M89KWP3XEM99K$_RS_P#!7C_@GY^Q+^P3X&^"_A?X M/?%;XG^(/VC/$=[OUGP+X[\3^&/$=WK/PB2^^)FHZC\7O%5CX6^'/ANS\+ZU M_P )1?>"?A7X/$-_X2\.^+?#7@S5KC0O!GB;QAX6^*WC+M)T^SUB?P]XF\%^+_#WQ \':I=Z+?26L6N MZ);>+O"FB-XCT&'4]"U#7/#W]IZ5I7B;POJEY9^(=,_CF_X*#?\ !$+XM_L1 M_!2'XXZ/\9/#_P"T!\.M)U.'2/BU(OAW:^(=1TC0?!GB'3='O?B M7X__ .$TT+6/$NIIX8UW^Q]'L3& M-7#TJF9U<.EB&J6!C2E[+$2J12C[2M%N*YZCY>6I"3T7+)-JWA9Q0;IUJD,% M3JN5).IBG./M*,:;N^2G+5V@KWA*.[YDTG?]L/\ @E9\-?BK\9/^"'OC;X/6 MDGPG@7XK^"_VQ?AO^S_+:WGB?3K&+2_'>I_$7PS>2_&J_P#[)U\V.O)\?-5^ M*+ZE>>"="UJSMOAL/"$_]DZCXN37K.;XQ_:1_P""!W[/?[-'[&7Q>^,_BS]J MGQW/\6OA9X%\2>*[?Q-K.F?#_P $_!;Q5K=GKDMQX.\"P?#_ %+^T_%^G>(O M'EG-HGPI\/2Q_&W59]0^)6O:;XATOP[J<5Y9_#2?[X_X(,_MS>,OVI_@=\2/ M@U\3(-)E\;_LOWG@+3M$U7PE\//!/PU\&-\%OB#I_B6S^%GA:Q\-^ 9-'\+V M.L> KWX:^.?"RZ?X8^'?@/POIGPZLOAA:6T?B+Q./&&M2?F+_P %;/V[?$O_ M 4&^,OP^_8/_8:O/&?Q,\'1>++W2O%$?@+4=*_X1/\ :/\ B3;S:?J&B0Z9 M<"VMI-1^%/P:30M=\22>.-:\6Z?\*=;U"74?BAJ>FGPG\*OA]\5;O3#?VI'. M,9AZ=18.E'&RQF.E!Q]C3I*3J7E4E%.4)4W:$'RJ;ES3BDI.$5_J+R[#59P^ ML5'AHX?"QE?VLYM*%HP4FE)32EVWQ*\%^%=6U76/&EU/QEJ6BZS=GP5\1+KPI9Z%%\YQ^$?V?#^P=/\ $#^U M/#)_:Z3]NE? 7]@GXFZF/&:?LHG]F:+Q,-:7X+CQ7_8K>%#\;BVG?\+3/@8: MG_;)?P@/%WV5/[%K^X;_ ()Q_P#!-;P/^Q5^S'XJ^#OQ 7P=\7_&OQP^UW_[ M0^H7WA+0K_P=XDL]5\.+X:/P?L(M6T?%WP>\,:/<:W96%C\0!?GQ#K7B_ MXB>*AH'@_3?'"Y/MWC?XFZ-XLT:[_:)\??"+P1JUGI?C M/QOX>MOBMKUMXN^(GB;P7\+_ !/<^&_A=X_NTT3MI9SA\1F6(IT(8CFK8W#U M:$L-&-\7]7H^R=.MSSI\E*I;VG-)-1A=S2:.>IEU:E@J4JLZ-J>%K4ZJK2E: MA[:HJBG2Y8SYIP7N!H+?P]9Z[X0\2?LR^$O$FD? C3M0UG3[.2\\.>(?">O>' MOB+\7?'>F^(_"'P[\*?#S2?^$0\9>*]?\*:Y\:?#W@K^E#]A']BGX=_L%_ + M3?@CX U?6O%-W>ZY=^.?B+XWUV6>&Z\#=#7 M2_#FA:'X>\)Z--+#IFAZ-82ZWJGBGQA=^)?&7B/^1#6/ _QA_P""8O[.GPZ_ M:L\.?''A;PQ\2M5^*%Y\0OB'%\&OB;JOA[1=.\"?$;6_C0GA MSL/V0OVH/^"CO[*_[67[#7@7XA?M.:]\6_!'[<>D_L@?&"X\'_$KXG_$C]HC M3W^ W[1_BWQ#X(\.VM[J7Q@LM/\ %?PJ^*6AV%_XD\0WUE\*/$8\,W7BO1/ M[>+M=^)_AC29_"S\F+P,\1AO88*MAX8>-7%5FG*:GF.*H1Y\3.FXPE#V&'BW M2PZE**DU)N]XS-\/BHTJ_M<5"JZSA0IJRCRX.A5:C1C-.2E[6M)*I6<8R<;I M:6<3^XJBBBOD#Z$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGPE_P @ MJZ_[&;QK_P"IEKU=-7,^$O\ D%77_8S>-?\ U,M>I]'ZK\F2_CC_ (9?G @\ M%?\ ('O/^QM\??\ J=^(ZZVN2\%?\@>\_P"QM\??^IWXCKK:'N_5_F$/@C_A MC^2"BBBD4%%%% !1110 4444 %%%% !1110!^/?_ #G;_P"\9_\ [\)7SY_P M3&_9.\=? '5_^"BW_!-'XN_!SQQXH_9$U#7+S5_ WQOU2Q\0Z%H_Q3\#_&OP M!9>!=8\#ZS\4C/\ #&Y\:^.+OX/:=X#L?$.H? 7P /#_ ,-_B/X=^,.F^(_' MF@7.H?".RUOZ#_YSM_\ >,__ -^$K]A*];%8B=*G2I1MRU\OP+>Z<)T9.=.I M!IJTX^_!7NN6I+2]FO/H48U*E6H[\U+%XFVUI1J4X1G"2:=XNT9:6=XK6UT_ MQ?\ A1_P0-_X)S_##Q[XI\=W_@'QK\5QK/C/2O&/A;P;\4_&DFI^!OANFC:] MJ>NVGA'0]&\)Z9X.NO'W@F<7NFZ+J^A?'O4_C$=?T#P[ING:[=ZD=3\6S>)O MT6_:8_9/^ /[8?@C0_AQ^T7X$D^(7@OPWXRL?'^CZ(GB[QSX.6W\6:=H/B/P MS9ZE-?> O$OA?4[^&+1?%FOV;:5J-[=Z/,U\EW/I\E[9:?FL)RT6A^17[*W_!$3]@W]E/Q'X6\=Z1X2\:? ^!?'$GC[P1X^^ M-/BFUU>]\+ZNFF6ECI$5GX+\ Z'\.OA-JB^%]1MYO%OA+6/$OP[UWQ9X;\:7 M4/B?2O$=OJ>@>$9?#OVA\9OV0OA/\>/CO^R_^T#\01K&H>*/V3=5^)&N?#GP MV;?PC?\ @G5]7^)&D^&[&34_%^F^(?">N:Q/J/@K5_"'AGQKX U#POKWA2^\ M/^-M#TK79[C4FT^SMX/J6L[5]7TG0-,O];UW5-.T71M*M9K[4]7U>]MM-TS3 MK*W0R7%Y?W]Y+#:V=K!&"\UQ<2QQ1("SNJ@FB6)Q=:K&K6<72A)SG.IR MU(NFZ<-6[24Y1Y8[\S25V2Z>%P]&=X4:.'I_OJC:A3I05*U1U:DG:*4.13E. M;T4;MV1\0_MU_P#!.?\ 9N_X*&^$/#OAGX]67C*SU;P3%K,'@'QUX$\3?V/X MD\%Q>*-9\$ZMXN2PT77]/\4?#77SXG@\ Z'HEY)XZ\ >+9M(TN349O"(O$OB34=9\4>)M6-G::;HMG?^(=9U.ZTOPSHGA[PKI/\ P5H__"#?V)_PFW]J>*M"T_\ X0__ (2;R_\ MA&_^$I^UW\/_ C_ /PD'G1?V)_:WV3^UO-C^P?:-ZY-4^)7PYT/_A*?[:\? M^"M'_P"$&_L3_A-O[4\5:%I__"'_ /"3>7_PC?\ PE/VN_A_X1__ (2#SHO[ M$_M;[)_:WFQ_8/M&]*H.%EJ\ M33<=:\>?EEF&3TJE6K/'9;3JP52-:I+$X:$XJA]=]LJDG-.*H_V7F'M>9KD_ ML[&<]OJ=;V?BG[3G[&'[,G[9.D>$=%_:1^%.F?$BV\!:Q?:WX/O&UOQ7X2U_ M0+O5;);#6;2Q\4>!=>\,>)1H.N0PZ?-KWA>75I?#6N:CH?AG5M6TF\U7PMX= MO-+^7?V)O^"0_P"R!^PKXFD^(7P[T[QQ\2/BM%)K\.A_%+XR:YH6O>)_"6B^ M)-,T?2]3T+PII'@SPMX!^'^CAX-,OU3Q7'X*D^(GV#Q7XN\-S>,YO"&MR>'H M?T-U3XE?#G0_^$I_MKQ_X*T?_A!O[$_X3;^U/%6A:?\ \(?_ ,)-Y?\ PC?_ M E/VN_A_P"$?_X2#SHO[$_M;[)_:WFQ_8/M&],;[0SXI\:>+_/\1WNB:!X= MN=1_M/QWXC\3ZQ%YNC^&-#L_LD.H1V"&R^TI:K=W5Y/<>I:I\2OASH?_ E/ M]M>/_!6C_P#"#?V)_P )M_:GBK0M/_X0_P#X2;R_^$;_ .$I^UW\/_"/_P#" M0>=%_8G]K?9/[6\V/[!]HWKDU3XE?#G0_P#A*?[:\?\ @K1_^$&_L3_A-O[4 M\5:%I_\ PA__ DWE_\ "-_\)3]KOX?^$?\ ^$@\Z+^Q/[6^R?VMYL?V#[1O M7,[>)PL/8\CQKQ-[S7L^1Y9F+KWMRO+\:ZEOJE?V?@'[47[#'[*_[:#^!) M/VE_A7'\3'^&B>*4\$&3QC\0?"?]B+XT/AMO$P \"^+/# U#^TSX1\/$G51? M&T_L\?8#:BZO?M/E'P2_X)4_L#_LY_%7PI\;?@U\!(_!WQ0\$-K;^%_%/_"R M_C%XADTMO$7AG6?!VL_\2GQ3\0M7_PC?\ MPE/VN_A_X1__ (2#SHO[$_M;[)_:WFQ_8/M&]=%_8G]K M?9/[6\V/[!]HWKFX2S14E0IO'JA-(]E.-;V6BIQ]R2J_6J&EFI_6:6_ MMH; ME^IU_9_E1\+OBO\3])\(?$G4[O MP]\:O$?CCQ99^,?$EGXXC^(%IX\UOPMH=WJ2Z[;6]E\$=<^$=QIVF^+-:M]/ MO;66Q\*7'AK]&/V=_P!FGX&?LH?#F+X4?L^?#S2_AQX%76]7\2W.F6-[K6M: MAJ_B+798FU'7/$7B?Q/J>M^*O$^K/;6VGZ/::AXBUK4[K3/#>C>'_"VF2V?A MOP]H>E:?W^J?$KXN35/B5\.=#_X2 MG^VO'_@K1_\ A!O[$_X3;^U/%6A:?_PA_P#PDWE_\(W_ ,)3]KOX?^$?_P"$ M@\Z+^Q/[6^R?VMYL?V#[1O7)-YG7ITZ4_KM:DN3V=.2KSA[RHJERQ::=UBVG]8PM.4?8O&NO[27.G'V;RO,76Y MK-5U3XS>)OBK?^#_'6EZ)XE^& M%SX"N=&TU+;]+]4^)7PYT/\ X2G^VO'_ (*T?_A!O[$_X3;^U/%6A:?_ ,(? M_P )-Y?_ C?_"4_:[^'_A'_ /A(/.B_L3^UOLG]K>;']@^T;UR:I\2OASH? M_"4_VUX_\%:/_P (-_8G_";?VIXJT+3_ /A#_P#A)O+_ .$;_P"$I^UW\/\ MPC__ D'G1?V)_:WV3^UO-C^P?:-ZY4?[2;J2@L;?%6]JX1K?O\ VGLN7FY5 M[_/];HJ._,L322NJ\5(GCLE@DJF,RR*POM+>TQ.%7U?ZO]=]K\4_W?L?[+S! MU+V]F\NQCG9X.LZ?:U^.WQR_X(6_L"?';XMV?QEUCPU\2_!_B6^^)OBOXJ_$ M[3O!_P 2-3N="^-/B#QMXKM?&'B2P\<)X^M/'6M>%]!O=2_MRWALO@GK?PEN MM.T[Q5K-OIM_:26?A>?P[^JFJ?$KXU/5]\,-IJ^)-$L=4LKO5_#S:Q:&_TA=2\TEM M5L ;W31?PVYOK0&YMO-A^>HI/'86]6C]:PZ<$Y5(*K3BX-49)RDK)QMB,/*+ M;M^^HR7\2FWK+$Y7BIQPTL1@<15]I*G&@ZU"I4]M"6,A*$:?,Y>TC/+LPA*" M7,G@<;"2_P!FKJ'D7[.O[,WP+_9,^'$?PF_9Z^'FF?#CP(NNZSXGN=,LK[6] MO31R:EKOB/Q3XIU37/%?BC5FMK;3]&L[_ ,1:WJEUI?AG1O#WA32I M++PUX=T+2=/Y+]EW]BS]E[]B_0/$?AO]F;X1:)\+].\7WFE7OB:>UU/Q+XFU MW6_[ L9-.\/Z??\ BGQIK?B3Q/-H/AZWN=1?P_X;.KCP_H=]KGB34]*TRSU+ MQ-X@N]2^HZ*P=:J_:)U:C5:2E5O.3]K*+;C*I=^_)-MIRNTVVM6SL5.FN2U. M"]FG&G:*7(FDFH:>ZFDDU&R:270^#/ MB(WA*35M;\!77AZR\7:=/X+\<>&OB!HUQHUUXK\->,/#\,W]N>%=-2X;4/#F MI V3W*VRVUXUO>VVU\5_V:?@;\:_@;=_LU?$+X>Z9>? N[TWP7HO_"N/#5]K M?P]T2PT7X=ZYX>\1>"M$T27X>:IX5U+P_HOA[4_"OA_[#I&A7^G:<=.TZ/19 M[:;19KG3YO=**(U:L5!1J3BJ=1U:?+)QY*KY%[2+33C/]W#WEJN56>@.$).3 M<(MS@J/O2T>CN[GYB?LR?\$^?V3?^"6GPI^)7Q)^!_PH^)?Q M0^('AOX7^,+_ ,3^*X+"P^(W[1OQ4\/>'+C7/B'_ ,*[\!>&M L/!?@NW\0^ M);N#2M TSPE\.?"W@&V^(VL>'?AZ/&SZ_P"(-!TO7K?Y]_X(9_L\?%GX<_ C MXQ_M%_M)>%M<\/\ [2?[77QJ\3^/OB!<>,/#7C#X<^/[_0/#>JZU::>_C[X2 M:_X9\$Z!\/->U;XI:]\:_'^DVWA'PI:Z?K/@;X@>#[_^T9-/71O#WA?]O:*W M>,K2IXB$Y.I+$RHNK5G*4JCA1YG"G=OX.9QDUKK3II643-8>G&=*4(J$:,:B MITX)1@I5>7FG9+XK*23_ +\V[MW"BBBN0W"BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^2__ (+Q?\G>?#G_ M +-O\(?^K.^,%?B?7[8?\%XO^3O/AS_V;?X0_P#5G?&"OQ/K^Y/#K_DB.&_^ MQ;3_ /2ZA_S_ 'TG?^3^^*7_ &4]?_U%PH4445]H?A 4444 %%%% !1110 4 M444 %%%% '^D!1117^?\$./^Y9_]-&_P#D7= _[ NE_P#I#!1XD_Y%W7_^P+JG_I#/1X;_ .1=T#_L"Z7_ .D, M%5]C_M[]"?M_]N_J;5%%%24%%%% !1110 4444 %%%% !1110!^/7_!4O_DL M/_!++_M('\*O_1T5?L+7X]?\%2_^2P_\$LO^T@?PJ_\ 1T5?L+7?B?\ 1_'OXV>"/VUN]"L]6UM].MV.E^%/#3>)]:\.:%>>,?&6L/I M_A/P7H^HZ[I46N^+-9T;14O8)]0B<>N5_ 1_P6#_ &]/C-^U5^TG\4?@YJ\\ M/A3X-_LV_&'XG?#+P)\-](U*XO='U;Q7\-?%?B7X$/#J7&J:AXZ\9>/O4RC+9YIBU14E"G3C[6O+[2IJ M234%UG)M15](WT<>:#]:O/A5XG\?+\1?V@KBUCAN?#OP\^">DV]Q:> ?@ MMJOC#PQ/\(KJXU'Q3X7\*:%\!O"WB?PZEA\3M3MX-<^,9\.ZS_PA?CV_L=3_ M (*X^*?&EW_P6'^*R1>&Y?CG=>"/&_[-6F?#WX+^,]!UOXK^%/$]H/@]\&?% M\/PO>#?B!XR\0:_P#VU\./#4-NWBW5?&_B8VUNVN>)KRZN/I'] MES_@NE\*/V//@YX>^"/P1_X)]0:+X6T5I-0U75=0_:B2\\6>._%E[;VL&M^. M_'FMP?LUV0UWQ;KHLK2.ZNH[.RTO2=+L=)\+^%M(\/\ @[P_X=\.Z3Y!_P % M,].\":S8^!OCOH_ M@31KWP=X"_L&TA\0Z'HGB'1/ACX$^&'CW_A%O&\WBS1_&NOR_$B3PGK?B_PU MX4\3Z/X0^PIO$PS:E#$8:.$PSP&(P.64:E6E)2<%2=INE4FXSJ0BDTFGRJ,( MN4DY/YZ2H2R^I*C7=>NL51Q..J0A4BX\[GK%5(1YHPDVT[6YKRDHII+UCXZ_ MMI_\%^/V*O\ A7GC3]IS6]2T#PCK'BR&UTQ_$'PZ_9/\8>!/&M_X?:SUJ^\" M^+O$'P.T.[OO"R^*M)BO4ATY?%'@#QGK^AVGBN_\!:I#<^%=8U;0/LK]M_\ M9>\5_P#!;S]D7]F?]MG]F;P5X1\$_$2S\%?&?PWXT^%?C]]'TSQU\0])T'7] M;\/#P-X9^,.GQ_V7J\7A?XG^ _&EA\(M,^($7@CPGK6D_&'5?'/B/7/@WJ4? MB#PUK'YB?\%'_P#@K5XC_P""D?PY^!'P'\)_L_2?#^XC^(=GXMUG0+'Q'JGQ M5\8^*/C%=WWC3X:_#'P)\+GT7PYX4N=?T_5?"/C"&[N[.?P5+XL\4_$3Q;:> M#/#>DZ?8> X?$7Q6_HS^#GB33/\ @D)_P28^'#_M!ZQHS^/_ (=^ _%FJ6'@ M#6=3L?#5[XM^.WQ4UWQU\8-%_9ST;4_"EQ\4[?4]9TC7_$5YX"U+QUX6M_%> MBKX>\)^(_C%>:7IG@G2]8CT?S<7[7"4LMQ$,%A<'G,L55IQPV&I04:N'E&=/ M]Y1C*:ESN48)RDVU)N,DV[=F']GB*F-HRQ-?$Y:J$)RK5ZDFX5HRA-/X?!W[>?Q4TSQ%X/\ !G@^ MT\GZ/XG^ M&_C?Q%\8=-U'XLRSWV@_ CQ3X6^+_P!*_ C]J3X0?\$*=-\7_#_QU\!M'^,_ M[>^L2^#)OC)?S>*8?A5X _9_^$GCCP?I'C#PU^SUIGQGO]+^):>-/&^FR1^! M?B!\0W^&'PTTOX5^(]2^(&D^$Y/BOX[U/X#:%)/]C?\ !(#]G+QK^W1^T?\ M$_\ X*P?M9Z/X)\1W&H>-KK3/A7X;D^'NNZ'H][\5O ]CX'T32OBOX,AO);? MPSJ/@SX'^'/#UK\)?AWJ=Y<_%37+CXB:#KVL^(/$V@_%?X+VWB/Q+\*_'#Q] M)/CQ\>KOXQ?%OPMX:^)OQ(^,EI>V6@1IXU\2?#C]H#X'_$C MP]X#\/\ P]C^(_CG2-#\2>!_@SJWQ MO@KI^LV_C.Q\/0Z9\'=>T?0M-T;4? M#P\!Z5NYQQ,ZV6SC&O5PV!]KB*&%_VK\D4FTHPII1W:9_3Y_P3 MN_X*3?"'_@HGX+\7:IX%\,>+_ 'Q!^%L'@.+XJ^ /%-O%J%CHU]X[T.^O=.U M+P7XXTQ1H_C;P;=Z]X=\;^'-'U*]L_"/C>4^$)]8\4_#CP;IVO\ A9M:_16O MY>/^#9+X2?$GP=\+?VD/B7XF\)ZOIGP_^(\OP6\-_#[QIJ*06UCX\U3X6CXM MZ?X^ET"WDE34[[2_#NI>)=(TNY\0+8KX?N]?DUKP_INI7FN>%?%>GZ+_ %#U M\MFN'HX3'XC#X=MTJNM+!1117GG8%%%% !1110 4444 %%%% !111 M0!^#/_!?'_DA/P._[*UJ/_J':K7\LM?U-?\ !?'_ )(3\#O^RM:C_P"H=JM? MRRU_8_@[_P D)E__ &%YE_ZF53_#WZ;O_*0O$W_8GX6_]46#"BBBOU$_DD** M** "BBB@ HHHH **** "BBB@#^RK_@C)_P F)>"/^QV^)'_J475?JM7Y4_\ M!&3_ ),2\$?]CM\2/_4HNJ_5:OX1XY_Y++B?_L>9E_ZE5#_H:\ /^3(>$W_9 MO^%O_51A0HHHKY4_7@HHHH **** "BBB@ HHKYTF_;!_9)MII;>X_:D_9TM[ MBWEDAG@F^-OPTBFAFB39,J+S?-LLRI8AS6'>98_" MX%5W2Y/:*B\55I>U=/VE/GY.;DYX^,NA>$=-UW6_"GQ(^&NE^(?%&AZ[I MT/@>'PW/X?AT2VL_$_A[QKKLMWXJT=="31/%?\\,G_!+7_@MY^T1J'A[X<_' M5?C#/X*GU>[\11:Y^TY^VAHOQ7^&'@KQ%H_AWQ#'I>MWN@:'\9/CAXML=5U* MWO;[PEI.J^"_AUKU_:OXI,&IOI?AVXUS4K'^Q/\ X;(_9#_Z.I_9O_\ #X_# M'_YJ*/\ ALC]D/\ Z.I_9O\ _#X_#'_YJ*];"/B'!TH4J63XB?L^;V-2KE-> M=:CSR/BQHDGQ@^*GB>+Q#XL^, M.N7'CWX4>'/&BZS\5/!5UXQL-9TGP_K/Q;U7PWI.J?L^>$[7X.ZQX;T!KOPS MX]AL[N3Q'I6GVOC;Q2Z_D5\._P#@@=_P4R^$&OW'BKX1_M0?!;X4^*+O2+KP M_=^)/AG\@7U[INI7FB7>L>$_A#I&HW.D76HZ/I-_<:;/<264U[ MI>GW4D+3V=N\?]2W_#9'[(?_ $=3^S?_ .'Q^&/_ ,U%'_#9'[(?_1U/[-__ M (?'X8__ #448>?$V'5=++,95^M576KNMEE>HZDY**UO22Y=%RPMRQ^RE<57 MB/@&LZ+?%O#'-.\0:3!K%WI6LZOX:\0?/7PF_X)P?M M??MN_P#!1/7/VQ/^"DOP(\*?"SX.:$ND7NC_ +/'BOXD>'_CEI'BC2M%T'4M M%^&_PAT)/!/Q)\1Z+I_@CP7K2+\4/B]/XBMM#\$?%#QUJFO6-G\%]1\/_&#X M@)X$_?G_ (;(_9#_ .CJ?V;_ /P^/PQ_^:BC_ALC]D/_ *.I_9O_ /#X_#'_ M .:BH<.('4KUHY/B:=6O06'=2EEF)IRITV[R]DH0483J)J$ZG+*?+91<=W:X MGX%4*5-\8\/3ITJOME"IQ'E4U.=ER\_-BFY1B[2C!-1YG=IZ'Q[_ ,%:?^"? M?B+_ (* _ CP;X4^&NJ?#/PO\8/AK\1;'Q9X4\3_ !&T:]^SW?A35M,OO#_C MSP'%XWT+2=>\4^"=+UT7/ASQM??V7X?\1Z?XGU_X9^$=!UK2+-)K+Q?X3_'' M]@W_ ()3?M[?$7]I;X _%O\ ;Y@UKX2^!_V*?!_P-\,_!'3#K?[/>N^+/%/A MGX&>(M1\0_"'X2Z1)\$M3\3Z19^"O VJ)<7OCWQE\1C=_$/Q'I.L67AC0M2U MF]UB_P#&GPU_I0_X;(_9#_Z.I_9O_P##X_#'_P":BC_ALC]D/_HZG]F__P / MC\,?_FHJ:$.(L/AGA:>5XWD_>JG.66XB56BJZ4:JHS=+W/:*REHWKHTV.KQ1 MP)6K*O/B[AOF_=\T8\196J=3V3YJ?M(+%^]R-IK5+:]T?2%%?-__ V1^R'_ M -'4_LW_ /A\?AC_ /-11_PV1^R'_P!'4_LW_P#A\?AC_P#-17G?V/F__0JS M+_PAQ/\ \J\U]YV_Z[\&?]%=PQ_X?\J_^:_-?>?2%%>&>&?VG_V:?&NO:;X6 M\&_M#_ SQ;XGUF(+O4+Z=88I9C%:V M\L@BBDD*[$8CW.N2OAL3A9*&*P]?#3E'GC"O1J492BVTI*-2,6XW35TK735] M&>OEV;97F]*=?*\_P"QM\??^IWX MCKK:Y+P5_P @>\_[&WQ]_P"IWXCKK:'N_5_F$/@C_AC^2"BBBD4%%%% !111 M0 4444 %%%% !1110!^/?_.=O_O&?_[\)7["5^/?_.=O_O&?_P"_"5^PE=^/ MWP?_ & 8;\I')A-\5_V%U?R@%%%%#_ "I_^$KU+PIY']O: M-X:\B;^W=8L+'2_*D^U;#ZU7DOQYUO\ X1KX+_%#Q'_PF^F_#+_A'_!/B#6_ M^%D:KX:_X3.U^'W]E6$U_P#\)O%X/\J?_A*]2\*>1_;VC>&O(F_MW6+"QTOR MI/M6P]> 7-CL%'EY^;%X:/+R>TYKUH+E]G]7Q?/S;3YG4]K[;ZM[+DP5>7M/K']I9-[#DMS>V_M?*O96Y_[2P/+ M]:I?@S_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_% M;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ M$IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I\7]_G_ .XG/[3_ ,*_:^U^M_\ M4;[?Z[_S-/[4_P",X/X7_3GV/_[^V[_Q\?\+R_P""D'QR M^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#P MRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_ MR*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"S_B]G_%;_\ #*O_ M G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG MQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z[_S-/[4_XS@_A?\ 3GV/_[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R* MW_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_L MU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_- M[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S M_A5G_%[/^+V?\5O_ ,,J_P#"[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\ M"OVOM?K?_4;[?Z[_ ,S3^U/^,X/X7_3GV/\ W+>P^K?^&;ZI]4_L;_J0_P!G M_P!@_P#-)?ZI?\<_G_(K?]4L_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ? M'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L M_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_: M&D_\2FT^R?*?%_?Y_P#N)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C.#^%_TY M]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\ MB]G_ !6__#*O_"$O(_X0O[)=>#?&7_"HO%1_PA?V2Z\&^,O^ M%1>*Y?\ A(_VA=)_X6#%XGU?_A<_[7/C[,OV_P#:0_:%^R?\)=XE^'7VEO\ MA4W@C2/A]H'V6R^W^4WS?%WO?/S7Q-[_6?:>U]K._UO MVOUZ?]H?7^+_ -1\&/W?B1P]&WLK1S>AR6]ARVR/,J'U?V?+E?+;^ROJ_P!3 M^I4.7^QOJ?\ J[1_U9_U<\%/T6HHHK\7/[K"BBB@ HHHH **** "BBB@ HHH MH ***_+#_@H)_P %9O@3_P $_=?TGX<^+/!OQ$^)7Q>\5?#;6_B%X6\)^$[/ M2]*\+6D*7>IZ)X*C\>^.M?O[;^P-)\:^*-$UW2A?^"_#7Q+U[PU8>'M7UG6_ M"4:7/A2R\4[4,/7Q56-'#TIU:LKVA!7=DKMOHDENVTEW,ZM:G0@ZE:<:<%:\ MI.RNW9+NVWLEJ?J?17\POP@_X.8?AGKWC>TTKX]_LO>)OA!\/+N*UMYOB#X! M^)X^-E_H&I7>NZ+8OJ/B/P++\,?AAJK>"M%T"ZU[Q)K^J>#M0\:>.1_8EKHW MA?X:>+-1UE!8_P!&'QB^,7PR_9_^&7C'XR?&3QCI/@'X:^ =).L^*?%.LFX: MWLK=KB"QL;.SL;&"\U;7-?US5KRPT'POX7T&PU/Q+XL\2ZGI/AKPUI.K:_JN MG:==;8K 8S!3A3Q.'G2G5_AK2?M-4K0<'*,FG))Q3;3:NM49T,7A\3&4Z%6- M2,/C>L>72_O*2BTK)V;5G9]F>E45_,C\;/\ @Y6^&?A/QYJ&@_ ;]F77_C-X M%TU+JT7X@>-OBD/@Q-KNK66MZS8F\\-^$(/AC\4-2D\&ZIHUKHFO:'K/BB]\ M)>+I?[8N]+U[X?>'+O2-^H_H9\$O^"O?P"^*G[#/Q8_;G\3>"?B7\//"'P(\ M0Z=\//B?X,_L_2_&6N7GQ5OO#/PJU2#PK\,+W1=1MX?%>@:YXI^,'A3P1X4\ M:>-[+X66LE[)<^(?'FE?#KPK:7^K66M;*>)].LM M!\2_$[X,Z=X/\.W7A/2$\%3ZKXQ\767@+QQ\7?%&EW>DCPQX(\._$J>_@U1/ MW2_;&_:K^'O[&?[/OCWXZ_$#4-$#Z!I.HVG@#PCK&N3Z!6+BY)R4FHRC>\6TI)%T\7AJL*E2G6A*%)7J2N MUR+EYE*7,DU%QU4K6:V;/J"BOAW_ ()Z?M>>*?VY/V<[']HC7_@Q#\%-(\1^ M,_%V@>!](@^)FG?%"/Q7X:\'7D/AO4_%W]J6/ACP?=:%(GC[3_&W@V7PWK.A M6VIQ2^#WUI)+C2MK2G0J3HU$HU*:#E%M/1V;L MTUNC:G4C5A"I!MPG%2BW&4;QDKIVDE)76JNEH%%%%9EA1110 4444 %%%% ! M1110 4444 ?R7_\ !>+_ ).\^'/_ &;?X0_]6=\8*_$^OVP_X+Q?\G>?#G_L MV_PA_P"K.^,%?B?7]R>'7_)$<-_]BVG_ .EU#_G^^D[_ ,G]\4O^RGK_ /J+ MA0HHHK[0_" HHHH **** "BBB@ HHHH **** /\ 2 HHHK_.<_Z> HHHH ** M** "BBB@ HHHH _'3_@N+_R9?IG_ &6OP-_Z8?&E?R%5_7K_ ,%Q?^3+],_[ M+7X&_P#3#XTK^0JOZ\\%/^2*7_8VQ_\ Z3AS_%;Z>/\ R?>?_9'<._\ IS,0 MHHHK]-/#GB#P=XQ\/Z)XL\(^+-$U7PUX MI\+>)=*L==\.>)?#FNV$^EZYX?\ $&AZI!=:9K.B:SIEU=:=JNE:C:W-AJ-A M'_[3&@KK_\ PAVAZ-_;"Z(-:U@:0NH_:1IO]K:G]B$/V^Z\ MW:^*7P8^#WQRT&P\*_&OX4?#7XP^&-*UJ#Q)IGASXI>!?"_Q!T'3O$5KI^IZ M3;:_8:/XMTK5]/L]:M]*UK6-,@U6WMX[Z'3]6U.RCG6VO[J.7TJBJYY\W/S2 MYM^:[YM-%KOIZBY5;EY5R]K*WW;&-X<\.>'O!_A[0?"/A'0=&\+>%/"VC:7X M<\,>&/#FEV6B>'O#GA[1+-%T'0=%TR"UTW2-&TC3;6VT_2]+T^VM['3[& MW@M+2"*"*.->+^*WP4^#7QX\/67A'XX_"3X9?&7PIIFM6_B33O#'Q6\!>%?B M)X>T_P 16EAJ6EVFOV6B^+]*UC3;76K73-9U?3K?58+:.^AL-5U*SCG6WOKJ M.7TVBDI-/F3:=[W3=[][[W"RM:RMM:VGW&)X:\->'/!?ASP_X.\'>']$\)^$ M?">B:5X:\+>%O#6E6.A>'/#7AS0K"#2]#\/^']#TN"UTS1M$T;3+6UT[2M*T MZUMK#3K"V@M+2"&WACC7;HHI#"BBB@ HHHH **** "BBB@ HHHH **** /P9 M_P""^/\ R0GX'?\ 96M1_P#4.U6OY9:_J:_X+X_\D)^!W_96M1_]0[5:_EEK M^Q_!W_DA,O\ ^PO,O_4RJ?X>_3=_Y2%XF_[$_"W_ *HL&%%%%?J)_)(4444 M%%%% !1110 4444 %%%% ']E7_!&3_DQ+P1_V.WQ(_\ 4HNJ_5:ORI_X(R?\ MF)>"/^QV^)'_ *E%U7ZK5_"/'/\ R67$_P#V/,R_]2JA_P!#7@!_R9#PF_[- M_P +?^JC"A1117RI^O!1110 4444 %%%% !7^=)XS_Y'#Q9_V,NN_P#ITNJ_ MT6Z_SI/&?_(X>+/^QEUW_P!.EU7]$> /\7BG_KWDW_I6:'^9G[1S_<_"+_L) MXY_]-<)G-4445_2!_ET%%%% !1110 4444 %%%% !1110!]U?\$S?^3[?V;O M^QVO/_47U^O[EJ_AI_X)F_\ )]O[-W_8[7G_ *B^OU_7_)J^,O\ LX&(_P#6\_P"QM\??^IWXCKK:Y+P5_P @>\_[&WQ]_P"IWXCK MK:'N_5_F$/@C_AC^2"BBBD4%%%% !1110 4444 %%%% !1110!^/?_.=O_O& M?_[\)7["5^/?_.=O_O&?_P"_"5^PE=^/WP?_ & 8;\I')A-\5_V%U?R@%%%% M#_ "I_^$KU+PIY']O:-X:\B;^W=8L+'2_*D^U;#ZU7DOQY MUO\ X1KX+_%#Q'_PF^F_#+_A'_!/B#6_^%D:KX:_X3.U^'W]E6$U_P#\)O%X M/\J?_A*]2\*>1_;VC>&O(F_MW6+"QTORI/M6P]> 7-CL%'EY^;%X:/+R>TYK MUH+E]G]7Q?/S;3YG4]K[;ZM[+DP M5>7M/K']I9-[#DMS>V_M?*O96Y_[2P/+]:I?@S_R*W_5+/\ A5G_ !>S_B]G M_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_ MX*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9 M_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q* M;3[)\I\7]_G_ .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^ MR?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+ M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J M_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1 M_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z M[_S-/[4_XS@_A?\ 3GV/_[^V[_P ?'_"\O^"D'QR^T?\ M&-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\ M)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_ MU2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S M7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A M6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\ "OVOM?K?_4;[?Z[_ ,S3^U/^,X/X M7_3GV/\ W+>P^K?^&;ZI]4_L;_J0_P!G_P!@_P#-)?ZI?\<_G_(K?]4L_P"% M6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A M6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ M ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6? M\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^ M%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\ M?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?%_?Y_P#N)S^T_P#" MOVOM?K?_ %&^W^N_\S3^U/\ C.#^%_TY]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ M -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\ B]G_ !6__#*O_"$O(_X M0O[)=>#?&7_"HO%1_PA?V2Z\&^,O^%1>*Y?\ A(_VA=)_X6#%XGU?_A<_ M[7/C[,OV_P#:0_:%^R?\)=XE^'7VEO\ A4W@C2/A]H'V6R^W^4WS?%WO?/S7Q-[_6?:>U]K._UOVOUZ?]H?7^+_ -1\&/W?B1P]&WLK M1S>AR6]ARVR/,J'U?V?+E?+;^ROJ_P!3^I4.7^QOJ?\ J[1_U9_U<\%/T6HH MHK\7/[K"BBB@ HHHH **** "BBB@ HHHH *^+_BU_P $_?V5OCY^T)HW[2?Q MS^&ME\7O&OACX=Z#\-?"GACQ^Z:[\+="T;1]0^*.H7NH7'PXD@C\.>,]6\1- M\5+Z/4/^%D6WC31]%N/"G@O7/ ^C^$?$^F:EKFL_:%?A?_P5L_X*Z:!^QQI& MJ_ 7X"ZGI'B7]K#7-+@&IWGEV.M:%^SUHVM:?#?:?XC\66-PESI^I_$O5])O M;75_A_\ #S4X+BTM--O--^(?Q!L9/"-UX0\*_%/LP-'%XC$1H8)S5:JG!N$I M0M3=N=SG'6--+X^Z]VS;47SXJKAZ-&57$J+IP:DE**E>:^%0B]YM_#VWNDFU M_.-_P5W\,_L\W'_!0#Q-\*/V,?A3IFAKX>L/ OPM\5^#/@YH6F77A;Q;\?E> M2RU/2/A7X(^'^HZU86FIV5KJ7@[X8^(O!OA_PYX6U9OC)X5\//V8?^">/_!.']A#5VC_M:7X>^$M,^)GB;P+XSUNS\&:O M-?B+I7CW0;KQ(FB_V'JOPQ\+:K-X4 MFUN>QNO#'EO_ 1P_9B_8)^%T7@O]K#]K;]J+]D6#XC6)TKQ'\"/@1K_ ,?? M@W##\)39F*[\/_$GXCZ#<^+E1/BM:LEMJ/@/P/?6X'P@>(_#NJ:!?ZG\7M"^$7 MC7X8_P!AM::I+=^(]+\9>$OAEX[U_3/$/A^UU/P]%8:"CW^J6DFM>'X]5^O] MM3EFF29?[]6C@'*#Q-6,DJ^)C1=O9REO&%2G'DLVFW9.48QE+YWV,K'0O&WQT^+_@/X8^"M.L_&/BW6--_MW3/A_:S>/_CAI_B1 M]&^ VG^(9OA);BVTGPWX*U_Q5X=\;_%#PKH41^)FJZUKWT]^WCIG[.7[2?\ MP1J\1_%W_@GEIFD?![X2^$OBEX-^-OQC^"_P.^%ND>";K7[W1M,L? OQ"\ _ M'OP+\++O2](T/4/A7IOB+P3\9O&7B37+/QKX7M_#'P3\&^-],O;_ ,!KX.^) M.E>)Z!!_P2-U_P#X(LZ[XMD\$?L]>'OCIX=^!,W@S4+S6H_"FI?M3Z?^UOJK M^.T\ 3WNM>%-;\4?&O2],^*WQ=^'OB;Q_P##[0M3UBQ\-7?[/6G:FNO^&/#G MP3\->,/#/ASJ/^#8SP_J]O'^VUXKF\/ZS;Z!K,G[.'AW3?%4^D7T/A[6=9\, M)\=]3USP]IFO26ZZ;J6M>&;'Q?X=U/7M'M+N>_T2P\7>&[W4;:UM_$.ERWG+ MB(4(1Q6;4H8NGB,?BI;_M _LR?L%?LI?#W MPKXNG^(_[- _;5N_&VI>(9_!6@?#O6M+^.'Q;L?C;I?B+2?%U_XR,.@>$?AQ M\/\ PQKNJ?%GQG\3K3X>^$? &D:?JWB74M9D\&:/JWB.P_6?Q/\ $+4/^"V7 M_!0*[O?'&J^!O /[ 7[$-OXW^(&K^,-=T[Q?HGAJ3]GC3_%^@2>*]8\:_$R\ MT_X>ZQX&\;_M/:+X#L=9ATSQ;XC^&UG\(?ACX-\4:UH5AXH\6_"#QMJ?Q&]1 M_P""G'Q4^%GQ(_:KTS]AG_@FYX$^"OA7]H+]H#QKXN^%7[9OQN^$GP6T+1O& MWBO5/'/BG0]6\6?"GQ?\/-4\%:1JFE>)_B-^VHVG^']?6SA\*V>D M^+_%,G_")_''P#7P[_P68^"\W[#OPL_9&_8I\':/XPU?P#\,?AO\2_V@O$'Q MKO[,^&?"/[1'[0OQ$U_4=!\27.J>#M#T:U\,WGC/X&^%O">E:!X/U/5O%?C_ M .(7@CX,_&#POX U'719F3Q)X^[:52-?ZG&%-X/%8A8ZK@_:3]O5PM'$N5?% MXUIQI^_/D=+!02B^5SJRFXOW>:=.5'ZRY3^LT*+PM/$O+!136O]KOP'^)7[/?Q*^'U@W[,?C_ .#7C[X5^!6M/ASIC? ? MQ5X(\5?#[P<_AK0]':Q\"6!^'U_?^'/#S>'_ WJ'A]K3PQ;_9#I6AWNCF&Q M@L+FRW^RU_%Q^QM^S_HG[&/_ <#:'^S5\+_ !Q\3=4\$>"8_$_A=M:\8Z_H M\?BGQ[X9\8_L6I\:M0\/>.G\!^'O GA?Q+X>L/B!?:9K.F:)+X5@TV#4O W@ MW7+FTN_$GARSUT?VCU\AF&$CA*E#V=65:EB<-2Q=*SGR5G)*-2'--*:<' M>TI)IIWU/H<)B)8B%3FIJG.A7GAZD8RYX?#G_LV_P (?^K.^,%?B?7[ M8?\ !>+_ ).\^'/_ &;?X0_]6=\8*_$^O[D\.O\ DB.&_P#L6T__ $NH?\_W MTG?^3^^*7_93U_\ U%PH4445]H?A 4444 %%%% !1110 4444 %%%% '^D!1 M117^A_\ (X>./^Y9_P#37+7:5Q>A_P#(X>./^Y9_]-&_^1=T# M_L"Z7_Z0P4>)/^1=U_\ [ NJ?^D,]'AO_D7= _[ NE_^D,%5]C_M[]"?M_\ M;OZFU1114E!1110 4444 %%%% !1110 4444 ?CU_P %2_\ DL/_ 2R_P"T M@?PJ_P#1T5?>_P 1OVMOV?/A3\9_A;^SKXR\?F/XY?&94N/A]\+O#/A3QOX_ M\7ZAI4FH3::OB;7=+\ ^&_$TG@?P8)K'7;A_&_CH^&_",>D^$/'NN2:TNB_# M[QM?Z!\$?\%2_P#DL/\ P2R_[2!_"K_T=%7RM^SH@_:X_P""]'[47QU;S/B/ M\*/V)?AI*K1@DYUL5AJ2NFTH_5U4J2LFG=4J<[/92Y>;2Z/W0 M^*O[0?P$^!3: GQN^-_PA^#C^*UU9O"R?%7XE>#/AZWB1= _LTZZV@+XNUK2 M#K"Z*-9TC^UCIPN1IO\ :NF_;/)^W6OF^B^'?$?A_P 8>']"\6^$M=T;Q1X5 M\4:-IGB+PSXF\.ZG9:WX?\1>'];LH-3T;7="UG3)[G3=7T;5]-N;;4-,U/3[ MFXLK^RN(+NTGE@ECD;^1K]DSX9_L.?'G_@HG_P %:;O]O7Q#\.O$6K^'?C=\ M5[7X3W?QL^.>K^#=2F\':-=_M7>&?C5_8=M??$#PX?$&C_ [X(^!O!LFFZX\ M&I-^SIX7\%>%_%?@K4/A\_A'0]9TS["_X("^+M2T_P 6?\%!OV^--!\5^'M)TS3]2TSXI:1X M#\'^-+F+PTEE\/+S7+O5_&G@[0-*N/&WB*]UJ,1EL*-&M*-6I*MA:6%K5U*D MHT90Q7LTO834Y2DZE'EY;2JCC95*M).$%3KSKTZ34VZD94.:_ MM8N*24U";7*VX^ZG?F;7Z]K_ ,%#/V V 9?VX_V/F5@&5E_:8^"Q# C(((\: MX((Y!'!%>ZZW\:?@YX:^%]M\;_$?Q9^&?A_X+WNC>&_$=G\7M;\=^%M*^%]W MX>\92Z7;^$->MO']_JL'A2?1O%<^N:+#X;U2+5GL==EUC2X]+GNGU"T6;^,_ M]BM/^"!K?LO?#:Z_;.N+^3]I-(_&;_$J+3+_ /;>E8(GC_Q6O@WR=/\ @K<- MX$.? \*_+X:MB78YU0-KCZB3]%_%'AO5+'7?#OB3P[KMC!JFB:_H&MZ7 M/=:9K&BZQIEU;:CI6JZ=$_'W@7QZ/$I\"^-?"7C M0>#/%NM> ?&!\)^(]'\1CPIX[\-FW7Q%X*\2_P!CWEY_87BW06N[5=:\.:I] MEUC2S(?%GACX4:;\.?#NL>)O$R:79^(-2X\7@?JD:CG.3 ME[9PH1Y+.=*+DIU:FK]G::]E&-WS5(UDG:D[].'Q7UAPY8I+V:G5?-=1G)1< M:<-%S^Z^>4K*T)4VU>I9?H/7@NA_M4_LP>)_B9+\%O#7[1_P%\0_&.#6O$?A MN?X3:'\8/A[JWQ,A\1>#X=5N/%N@R^ [#Q%<>*8]:\+6^A:W/XCTM]*%]HD. MCZK+J<%JFGW;0_D%_P %W_B_\:?^$4_9:_8E^".L0>#M>_;L^)^K?#+7/&=] MXEGT#0[K0[;4_A[X#M?AAXM.F>$_$7B6W\"_$'Q3\9?#FH^.=:\*W5OJJ^%/ M!.K>"[WP_P"-/#?CW7M!?T'7_P#@WT_X)N:U\.8_!5GX*^*OASQ5_8WAO2+O MXQ:3\8_&=_X]U";1)]*DUC6KKPMXLNO$WP)CU/QQ!I]Y8^*(;'X-6>B6MKK^ MK/X-T?PE>1:'=Z,4\+AH8>C7Q=>M3^M.I[&-"C"JXPI2]G*K5YZU*T?:*45" M-Y-0D[J\;DJ]:5:I2P]*G/V*A[656K*G>4XJ:IP4:=37D:DY2LES)6>MOUJU M7XT_!S0OB=X:^"6M_%GX9Z-\9O&>DSZ]X/\ A'JOCOPMI_Q.\5Z%;6WB&\N= M:\-> KO58?%6NZ3;VGA+Q7=3ZCI>DW5G%;>&?$,\DRQ:+J36WIE?SN?M*?\ M*QQ_P3\_[-<\5?\ J"?MW5^CW@7]N'7/%7_!1SXR_L!:W\$[GP?:_#;X'Z=\ M=?!_Q?U+QK>/+\5/"UY)\)-)N;WP_P##V[\ Z5''X3YG[MDV73Q*E*K&:Y>3$O#0MS2YG[.%1-V7NWYGOHK+6[/T%KPCX7_M3?LQ M_&[7KCPK\%_VC/@1\7O$]IHMSXENO#GPO^+WP^\?Z];>'+.^T[3+O7[C1_"G MB'5M0AT6UU+5])T^YU62W6Q@OM4TZTEG6>]MHY?QF_X.5=9UO3/V _ UCHVK MZK8KX@_:;\$:=J6B6.IWUEIOC.'2_A9\:/%^D>'O$FGVMQ#:^(=(LO%GACPY MXPL]*U:*\L;7Q/X4\.^(X+>/6-!TJ]M/SE_X*C>"?V$_V/?AY^R;^TA_P3#^ M,O@3P!\?_"7CC4].\%W/P.^/&B_%BZ\2?"O69?CQ?ZO\5O$FFZ[XB^(VL^/= M*\+?%GP7XH^"\WBS6;^]\%ZIHFN>)?V??B'!XK\.>&_ W@SP3TX3+88BEAW* MK4C5QE6M1PZA24Z4)T8Q?^T3'P_8^*/BKX[\+?#SP[>Z])Y_@M-^P=>: M'^Q_%X \/:)XF^(X'BOP;H_A70;CP'IGA[3-6\/0>-K/XIZS^V-=?#/Q%^U% M:Q^#O!?Q(BT/QE?ZGH6AZ%\+=6+]M4ITHIRE%23Q]JM6FZ:?(YQIQC M.]252,Z<(PG%I*'MG4YJ3NU[.$ZDFHIV_KE\"^/O OQ0\*Z5XZ^&GC7PE\1/ M!&NB\;1/&/@7Q'H_BWPKK(T[4+O2=0.E>(= O-0TC4!8ZK87VF7AM+R86NH6 M5W93[+FVFC34\1^(_#W@_P /:]XN\7:[HWA;PIX6T;5/$?B?Q/XCU2RT3P]X M<\/:)8SZGK6O:]K6ISVNFZ1HVD:;:W.H:IJFH7-O8Z?8V\]W=SQ0122+X-^Q M_P"%O@)X&_9G^#G@?]F'QCX0^(GP0\%>$HO"'@WQ_P""=<\#>)])\;7'AB^O M=#\7>+-2\1_#6ST[P3KWC;Q#XVL/$FK?$G6=#TZP34OB)=^*+R^L;34YKVWC MPOV\RH_8:_;.,A4(/V4/VB2Y? 0(/A!XP+%BW 4#.XGC&<\5YL:<9XA4HN:A M.LJ<7-)3493Y4Y13MSI/WDG:]U<['.4:+J247*-+GDHM\KDH5O9VVU M,Q_^"AW[ ,:/))^W)^Q[''&K.[O^TQ\%E1$4%F=V;QL%554$LQ( ))Q7V%7 M\=/[/'A__@W"\2_"3X$:%\:=0AA^.'B3P!\+-"^+5UJOC/\ ;G\,>'++XLZY MX=T+3_'-QX@\3Z7KFD?"OP;X?@\87.JRZMXE35M#^''AW38[G5?[5TSPQ9&\ M@_H3_;Z_85O_ -OGP_\ #GX5>*/V@OB!\)O@!I.K^(-=^,GPX^&VA>&SXB^, MFIPV6FW'PID;QMXECUG2_#=E\,/&%A)XO_L'6_ GC_PUXIU&33KVYT72?%/A M3P;XL\/=V+P5##5Z=*4L9AX-U%.KB\)[.\8;2H1A.3K*;32NX1NXOS6$=&B\1^+/A#IGCOPM?_%#PQX>GB\/W$.O>(? %KJLOBO1=&F@\6^%9HM4 MU+2;:QDB\3>'Y$G*:SIS7/\ -I_P0J?XQ2?\$G/V]'_9\+M^T _Q=^/C_! I M_P (IYA^,3?L=_ $_#4I_P )UCP/O/C4Z*5_X3'_ (I3./\ A(?^)1]LK\G/ MV2OB%^QYX4T?_@E!B?LXW M?Q&TT^*]4^)GQ$UJSL'?PCX<_9?\$:3JTNF_#+Q#/\$_ 7P<'[4GB'XZ6&@Z MKXMU74-RH_N.1R7-:=2/:TLO[0: MIX2HZ<4\32C5:<^6UYT8.%*\7[2I^^YE%\MXP?>Z_O-\6>/O O@(^&1XY\:^ M$O!A\:^+='\ ^#1XL\1Z/X=/BWQWXA%TV@>"O#/]L7EG_;WBW7%L;UM'\.:5 M]JUC4Q9W1LK.<6\NSSKQ3^TA\(/!7QR^&/[.'BCQ!K>D_%WXS:1XBUOX8:)+ M\/\ XBS^'?%]GX0TC7->\5PZ=\1[3PG'[S4M=\/WWB^TU[2K2 M_P##,M]IL \9>$?[;_";X,>,?A?^WI^WE\/_ -O7]HOXQ?#3X7? CX7?$SQK M\ /^";'P(\?^(I]"?]J'QAX6U^VT:X_:!\-^&?CKIOAVUUS6;SQ=X]\%W&EV M_P &?!]GX]T[XP>%_A7\/O%6O6/B/]G*%_BKW'_!Q#X8\0:!\ _V:/VG_AIH M.NK\9OV^(].^$.C>(?#^K^*1XK\2>'KZ#5OA\^ES_&3 MX6_ FRL-8\?>'=3L8_$O]@^$[*:./QKJ>CZ_SPP$'B\/@ZDYJM6C*$[)*-+% M34E1I7:?/R5/9QQ"5G&3G3BU*%S66*E]7K8F$8NG3DI1NVW4H1<74J65N7FA MSRHWO>*A-IJ7*?T)T5B>&O$OASQIX<\/^,?!VOZ)XL\(^+-$TKQ+X6\4^&M5 ML==\.>)?#FNV$&J:'X@\/ZYI<]UIFLZ)K.F75KJ.E:KIUU"/\ ML=OB1_ZE%U7ZK5^5/_!&3_DQ+P1_V.WQ(_\ 4HNJ_5:OX1XY_P"2RXG_ .QY MF7_J54/^AKP _P"3(>$W_9O^%O\ U484****^5/UX**** "BBB@ HHHH *_S MI/&?_(X>+/\ L9==_P#3I=5_HMU_G2>,_P#D?^HOK]?W+5_#3_P3-_Y/M_9N_P"Q MVO/_ %%]?K^Y:OY7\=_^2ERC_L1P_P#4_''^OG[/+_DU?&7_ &<#$?\ K.?WX%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !7,^$O^05=?\ 8S>-?_4RUZNF MKF?"7_(*NO\ L9O&O_J9:]3Z/U7Y,E_''_#+\X$'@K_D#WG_ &-OC[_U._$= M=;7)>"O^0/>?]C;X^_\ 4[\1UUM#W?J_S"'P1_PQ_)!1112*"BBB@ HHHH * M*** "BBB@ HHHH _'O\ YSM_]XS_ /WX2OV$K\>_^<[?_>,__P!^$K]A*[\? MO@_^P##?E(Y,)OBO^PNK^4 HHHK@.L*\E^/.M_\ "-?!?XH>(_\ A-]-^&7_ M C_ ()\0:W_ ,+(U7PU_P )G:_#[^RK":__ .$WB\'^5/\ \)7J7A3R/[>T M;PUY$W]NZQ86.E^5)]JV'UJO)?CSK?\ PC7P7^*'B/\ X3?3?AE_PC_@GQ!K M?_"R-5\-?\)G:_#[^RK":_\ ^$WB\'^5/_PE>I>%/(_M[1O#7D3?V[K%A8Z7 MY4GVK8>O +FQV"CR\_-B\-'EY/:U]M]6]ER8*O+VGUC^TLF]AR6YO;?VOE7LK<_]I8' ME^M4OP9_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4 M@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W M_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ MB4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE M7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^7^ M@?B_O\__ '$Y_:?^%?M?:_6_^HWV_P!=_P"9I_:G_&S_BM M_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I M]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^. M7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K? M_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/ M^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_X MQK_9K_XF/_"L_P"T-)_XE-I]D^4^+^_S_P#<3G]I_P"%?M?:_6_^HWV_UW_F M:?VI_P 9P?PO^G/L?^Y;V'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y M%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C& MO]FO_B8_\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X M_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%; M_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O] MFO\ XF/_ K/^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_Y MO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4^+^_S_ /<3 MG]I_X5^U]K];_P"HWV_UW_F:?VI_QG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ M4A_L_P#L'_FDO]4O^.?S_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^ M/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9 M_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T M-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7 ME_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[ M/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M# M2?\ B4VGV3Y3XO[_ #_]Q.?VG_A7[7VOUO\ ZC?;_7?^9I_:G_&<'\+_ *<^ MQ_[EO8?5O_#-]4^J?V-_U(?[/_L'_FDO]4O^.?S_ )%;_JEG_"K/^+V?\7L_ MXK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-) M_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%( M/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_ M^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3 MY3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?: M/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3XO[_/_P!Q.?VG_A7[7VOUO_J-]O\ M7?\ F:?VI_QG!_"_Z<^Q_P"Y;V'U;_PS?5/JG]C?]2'^S_[!_P":2_U2_P". M?S_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?: M/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ (95 M_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9 M/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQ MK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_ MYO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3XO[_/_ M -Q.?VG_ (5^U]K];_ZC?;_7?^9I_:G_ !G!_"_Z<^Q_[EO8?5O_ S?5/JG M]C?]2'^S_P"P?^:2_P!4O^.?S_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F M]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E_2K_ ()^ MI_8UG\5/"7D?\(7]DNO!OC+_ (5%XKE_X2/]H72?^%@Q>)]7_P"%S_M<^/LR M_;_VD/VA?LG_ EWB7X=?:6_X5-X(TCX?:!]ELOM_E-^:O\ R*W_ %2S_A5G M_%[/^+V?\5O_ ,,J_P#"#?&7_"HO%94/J_L^7*^6W]E?5_J?U*AR_V-]3 M_P!7:/\ JS_JYX*?HM1117XN?W6%%%% !1110 4444 %%%% !1110 5^./[3 M_P#P1#_93_:R^/OQ'_:+^(_Q#_:&T?QK\3KGPM$? 7 MA3X>::FC66M_"7Q%K$$<^C>#].O;[[?KNI/)JUSJ$UN]K926NGVG['45OA\5 MB,)4=7#59T:CBX.<'9N+:;CK?1N*?R1E6H4L1#V=:G&I!24N66W,DTGZV;^\ M_GX_XAO/V'?^BJ?M6_\ A-O'/CV/Q_P"#_%6D>$M'T71O%OA?5OB% MXBTO0[F/PK)I>I^#[N\\$^.=)\8^%?$'B[2?$?Z.45O6S/'XCV?ML76J>RJ* MK2;E9PJ1^&<6DFI+H[Z&5+ X2CS^SP]./M(.G.RNI0>\9)W33MJC^7;0/^#9 M?P+;_$J?4_%/[7GC#6/@XVM^)IK;P/X?^$.A^&OBC#X:NX-53P=ID_Q:U'QU MXL\(W'B#0;B;1)O$WB%/@A:Z9XLCT_58-+\*>"SK%I-H?[D?!K]CGP5^RS^R MKK7[-?[)VL/\'=9G\'>*[;0_C-JWAS0?B#XQ?XQ>(?#!T:V^/7Q$TF]@T/0? MB5XPL]7MM$UF[T*^@T7PG)H^@:-\/?#^E^%?A]HWA[P[HOV#11B*X+[PW>^/OB#=^+O'7C7QUHEGXB\6_$7Q=XFUC5)X MM,T;3_#NG^&)KGQYJ?C_ -=_X*(?\$W?A%_P42\$>%-'\=^)?%O@'Q_\,8?' M,WPK\?\ AB:'4+/1=0\<:)966H:?XR\$:FRZ1XU\&W>N>'_!7B#6=+L[SPEX MTF'A*#1_#'Q%\'6&O>)O[7_1*BH>.Q;Q*QCKS6)BURU8VBX\L>1**BE!14/= MY%%1Y;IJS92PN'5!X;V4?8.]Z;NT[RYFVVW)RYO>YFW*^M[GXP?\$TO^",7P MC_X)^>(-:^)7B+QCI7Q[^,[2WFG> /'!^&D7PVT+X5^$]1TM;'6;3P;X+D\: M?$/[+XU\2R7>M67B/X@-XB%_+X1O8O!WA_2_#>GZCX]N/'W[/T45GB,37Q51 MU<14E5J-*/-*VD8JT8Q22C&*Z1BDKW=KMET:-+#P5.C!4X)MV5]6]VV[N4GU M MO^"I?_)8?^"67_:0/X5?^CHJ^6_^")1XRA^*MQ-^ MU==_$ -_8!\+7>N>,=$^*=M\-V\* :Y_:Y6V_;*?2_\ A+#XCTHN/AL-1_X1 MA1XR%EX6^I/^"I?_ "6'_@EE_P!I _A5_P"CHJ[GXP_L(?$:^_X*1_L[?MU? ML\^,/!/PTAM?#GB+P-^V!I>L_P!N0GXN>"['1ETSP6MGX-\":3X9_P"%B^-- M5TZ\;PYJ?BCXK?%'^Q/A^?AI^S_XMT7P1XY7X6MX(U_W(5:<,!2I59\8?M(Z;J7Q$_:-^'2>*?AOX MYT+P!H'[6/@CQ%XK\7_!N[USPU/X.GU3P9)\-_A#KOCB'4M'D\":1X\\8^*[ M*QGTW3?#.DW_ ,0+7P-X?T2XTFK_ ,$8_A^O[(G[*?[-?%&C?LY? _P_P#%'XGZ'K/ACXA>.?%&CZWX[L_$ MFD_$'5?!O@;5/B/I_@.Z\3Z5\/=(^)C:S:_P!!VJ?!/X,ZW\4O M#GQRUKX1_#'5_C9X/T2;PUX2^,.J> ?"NH?%+PMX#;3QEK7B7QO\3O@5 MJEAX?^$OBOX-^+!JGA;XA^*=%@_X1&\U[Q#XAT)?@W;ZO\'?&EUI/C35?$7A MWXD:];Z3>>"YM<^&VJ^+-K>\_LY>$?A3^Q1_P11\!V'[>GPRT/Q9\- MO"/@O4/B1\2OA!XA^%]QX]:^U'XP_'K4_BK\,_ 'B+X7_$3PUI<,'Q+L_&/Q M"\"Z%KFG^,M,TCP_X#^*%K=ZAK7B?2O#WAR?QE;?K?I?P5^#>A_%'Q)\<-%^ M$GPRT?XU>,=%@\-^+OB_I?@+PMI_Q1\5>'K6'0;>VT'Q)\0+32H?%FN:+;V_ MA7PQ!!I>IZM=6,,/AS08HX%31]/6WV_B#\.?A]\6O"&L?#WXJ>!/!OQ,\ ^( MELD\0>!_B#X7T3QGX0UU--U&SUC3DUCPUXCL=2T74UL-6T^PU2R6]LIQ:ZC8 MV=[ ([FVAE29XO#^QIX:C0KPPZQ4,56Y\1"I5E*,/9\E*4:%*--*#DE)QE*4 MG&4K*"B5'#UO:3KU*M*=7V$J%/DHRA32.[K2_$OQXM9OB] MXV^)C_M0>,=$U77?!^MW.MZA_3G7%_#SX;?#OX1>#M&^'?PG\ ^"_AA\/_#H MOE\/^!?AYX6T/P5X.T)=4U.]UK4QHWAGPU8Z9HFF#4=9U+4=6OA96, N]3O[ MV_N/,NKJ>6366:RGAJU"5)IU/:1@H5'&A"E-890@Z+A)S>'CA8QH2]I&W/)R MNU[V<< HUJ=55+J'(Y4JJY'S#X2_ M&2'PK^RS^V]\&-(C\7ZO^PC\4=5^)GB+P?>>&IM>T2S\/76J?#WQW#\4?%W] MF^+/#WB2;P)\//$_P;\.Z?XZTCPQ:W&HKX3\;:OXWU+Q#X*\+^ /$.OQ]D__ M 7Z_8K\1?"*3Q/\+-,^+/C?X_Z\6T/X9?LGWWP_\2:7\2?'7CW5O%)\(>!O M"[>,?"NE_$'X66=OXMO;C2O$"77AOQ?XV\2VWA341%IG@O7_ (CQQ?#6Z_<: MO,=+^"?P9T3XI>(_CEHOPC^&.D?&SQAHD/AKQ;\8=+\ ^%=/^*7BGPY;Q>'X M(/#_ (C^(-II,7BW6]$@@\)^%88=*U/5[JPCB\->'XT@5-&TX6V,,70EAZ-# M%8>I5^K.HZ$Z5=4;PJS525*LG1JN4.=SDI0=.HN9Q4M4XZ2P]:-:I5H5H4_; MJ'M8U*3J^]"/(JE-JI3Y9N?"&O\ BOPE)/#LU]:7$FB:_K&F-;:C&? MB/:_%GX'> ],^(7BSQ1J>E^%8?AKJ.CZKH_PGUNVL_#NJVGC*]\676JK:?&+ MPTDT.I^"](LDGT_7E2_DCM],EU;[/HK.KBJ=:-%3HO\ <8-8:FXU;)5(U9U% M6:Y'>*524/97UTE[3H73H3I2J.-5?O<2Z\DZ=_==.$'33YM'>"ESV\N3J?%_ M[>OQ4_8W^&O[/NJZ-^W7J&F6OP%^,6LV_P );ZPU7PMX^\51:[XBU+1=>\8Z M586,7PUT36_%OA_7M.M/!.J^*/#7C#2O['U+PKX@\/:9K.@:_I'BBUT*XK^3 MSX[_ +/_ /P3D_;-^-7P _91_P""3/PB^(,GC+Q3KT'BSXS_ +2"Z]^T)J/A M?X5?!^*>]\(>+3J7PI_:'\:Z)_PD,'A9-'/&GASQ!X.\8^']$\6>$?%FB:KX:\4^%O$NE6. MN^'/$OAS7;"?2]<\/^(-#U2"ZTS6=$UG3+JZT[5=*U&UN;#4;"YGM+N":WFD MC;'^'OPX^'GPD\(:1\/?A3X#\&?#+P#X?^W_ -@^!_A[X7T/P7X0T3^U=4O= M;U3^R/#7ANQTW1=-_M+6M2U'5[_['90_;-4O[V_N/,N[J>63;!9A]1@W3^L^ MVO)I+%K*#U2E549-1OHG&6>)PGUF24_8>SLDVZ'-B$N:\H MPK.=H1FKIM4VTF[:NZ^+?^"E/QJ^&?P#_9[TSX@>+OA-H/QK^+<'Q*\.:9^Q MQX#UOX/S_&B:Z_;*O=$\4R? [5M#\/6AL]2T75M!O+;6]6G\1Z!XA\*^,ET& MUUOP]X UBZ\>^(O#/AW7?YA?VM?V)O%_[+'PX_8B^)G[:,;2:'^UE^VM?_%O M_@J!J=EXETC4]-B\<:GXQN_%/P[\.>&-,^$ND>'/%VA>)M+_ &?_ ![^V;K' MC*;]G;3-0L[KXC>*O'5A8>-O%&BZ-^SHFC_VF^,OAS\/OB*/"R_$'P)X-\=+ MX'\9:#\1O!0\9>%]$\3CP?\ $+PL]Q)X8\=^%AK=C?#P_P",O#DEW=/H/B?2 M?LFMZ0]S<-I]];M-(6U_$OAKPYXT\.>(/!WC'P_HGBSPCXLT35?#7BGPMXET MJQUWPYXE\.:[83Z7KGA_Q!H>J076F:SHFLZ9=76G:KI6HVMS8:C87,]I=P36 M\TD;3@\?]45-0IMWJ2E7DI\LYPY>6G"G+E?LO9R;K)VE>M&E-K]U%#Q&%>(< MW*:7N*-)_VF?VDO#%Y\?OB#X)\0R?!.+X@Z/>R?!C5_%;RV/CN]^'O@R/P? M;Z=X<^!?A_?+KGQEEFUP>)O$DV;"TC?1C%>QR6.K_LGX;\.>'O!WA[0?"/A' M0=%\*^$_"NBZ7X;\,>&/#>EV.A^'O#GA[0[-%T'0=%TR"UTW1]%T?3;6V MT_2]+T^VM['3[&W@M+2"&WACC7:I5\PJ5ISBW56%J2H>UH.K>554:=&FY3J\ MFM6HJ$93J]RO8=+"1IPB_<=>$:JA5]G90=6=2=HT^;2G!U&HPY_@7+S M=3^77_@J]_P4S_8._:\_8^U[]G_X"^)M;^/7QV\>?$SX2Z7\(?#FC_ KXG1: M]H7C-/'&E3OK'AN7X@>!O#%W+KOB3PTGB'X4Z-:?#G_A(?'FOZE\2+?PO9:# M<^'M;\2WNG_J[!^TG^SK_P $O?V9/V-O@=^US\5-(\ ^)M(^ ?@CX7Z3-X4\ M%_%;Q_X;\0:Q\"?A_P##KPAXZGT"Z\'_ ^U34+30[+4-7T9M(F\3Z5X$O$/Q*\0K?:UJ:Z]X_UK0-*T_4O&.M+J7B/Q#J"ZIXBN=1OA?:]K5V M)_M&J7TD_IM.IB\-*E0PT*&(6%I5:M>498FFZ\ZE6G3@^6K]5]G3A'V<;15& M7-[SDTVN10H5U4JUY5:3KU(4Z46J$E2C"G.4O>A[?GG*7/+7VL5'2R:3YOY4 M/^#!?A?XM_9,\5>-I-*_: ^+O[2OCGQY\// 7_"*>-;V/Q!X4TK] MG#X227^J_P#"7:=XC#4/I']OK MP=<_MK_M::K_ ,$^OV8OAIX>\/Z-XE\1_!+Q_P#\%:?C]IOPO\.>#?$%QX#\ M&/X'\9_L_P#@QOC9K7AK7YO%_P 0](\(6UYKWPZTK_A#/%\K>(T^'6A:1XOT M?X<^$?VE=)\/?T/5QNB_#GX?>&_%_C;XA>'? G@W0/'WQ+7PTGQ&\<:+X7T3 M2O%_C]/!>G7&C^#D\;>);&Q@UKQ4OA/2;N[TOPTNNWM^-"TZZN++2Q:VTTD3 M75Q].>-K8ZG0G"I44IPA.M&K&&)E--5=*-&\::]ZG3:;5:,)RG**<":>$G'# M4L+.K&<(Y^!UMJ?BL MQ^(OAKHNA67[-'@C]D72_B3XZ^*NNVO[06K_ .;XC>&-'\2:A\8?&/CW2]= M_8+_ (*P?%CXN?#G_@A_^RAH/CBSUB;Q?\9-%_9.^'?[0%Q\7;3Q9-\4=)O= M$^"6I_&OQ-?:Q)KVIV&NV'Q./Q0^$6A:?XPN?'-MK%\UO?>+K+5-.A\1W=KK M&E?T;:Y\-OAWXF\8^!OB)XD\ ^"_$'Q ^& \3K\-?'6N>%M#U;QC\/%\;:9! MHOC,>!O$U_8W&M^$AXMT:UMM)\3C0+[3QKVF6\%AJOVNUACB7\S/VP?V%_C1 M^U7^WU^PO\:+_6_A?HG[,7[(M[>_$2Z;3?$'BK2OVAM2^*MQXFT[QL^DVFF7 M?@+Q7\.-:^&&H^(/A%\ ['48)=>\'^*H]!N_BTMOJ+:E-X,NM.ZZ>:4ZM; R MK1E"."E'$R_3=_Y2%XF_[$_"W_JBP844 M45^HG\DA1110 4444 %%%% !1110 4444 ?V5?\ !&3_ ),2\$?]CM\2/_4H MNJ_5:ORI_P"",G_)B7@C_L=OB1_ZE%U7ZK5_"/'/_)9<3_\ 8\S+_P!2JA_T M-> '_)D/";_LW_"W_JHPH4445\J?KP4444 %%%% !1110 5_G2>,_P#D*?^O>3?\ I6:' M^9G[1S_<_"+_ +">.?\ TUPF7_)J^,O^S@8C_UG.'PHHHK\//[\"BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ KF?"7_ ""KK_L9O&O_ *F6O5TU\_[&WQ]_P"IWXCKK:Y+P5_R M![S_ +&WQ]_ZG?B.NMH>[]7^80^"/^&/Y(****104444 %%%% !1110 4444 M %%%% 'X]_\ .=O_ +QG_P#OPE?L)7X]_P#.=O\ [QG_ /OPE?L)7?C]\'_V M 8;\I')A-\5_V%U?R@%%%%1_;VC>&O(F_MW6+"Q MTORI/M6P^M5Y+\>=;_X1KX+_ !0\1_\ ";Z;\,O^$?\ !/B#6_\ A9&J^&O^ M$SM?A]_95A-?_P#";Q>#_*G_ .$KU+PIY']O:-X:\B;^W=8L+'2_*D^U;#UX M!7GYL7AH\O)[3FO6@N7V?U?%\_-MR?5,5S7Y?J]:_LY>/Q%4]EP_GM M7VGL?9Y/F=3VOMOJWLN3!5Y>T^L?VEDWL.2W-[;^U\J]E;G_ +2P/+]:I?@S M_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q\?\ "\O^"D'QR^T?\8U_ MLU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ M #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGR_T#\7] M_G_[B<_M/_"OVOM?K?\ U&^W^N_\S3^U/^,X_P V_P"%_P!.?8_]RWL/JW_A MF^J?5/[&_P"I#_9_]@_\TE_JE_QS^?\ (K?]4L_X59_Q>S_B]G_%;_\ #*O_ M G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG M_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC M7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"< M?\WN_MN_\?'_ O+_@I!\P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4 ML_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_ M\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S> M[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+ M/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ M$Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[; MO_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3 M_P *_:^U^M_]1OM_KO\ S-/[4_XS@_A?].?8_P#S_B]G_%;_\ #*O_ G'_-[O[;O_ M !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_ MQ>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6 M?]H:3_Q*;3[)\I\7]_G_ .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7 M_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_: M&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P + MR_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V? M\5O_ ,,J_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_ MX*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M M_P#4;[?Z[_S-/[4_XS@_A?\ 3GV/_[^V[_P ?'_"\O^"D M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ M%;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^ MR?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+ M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J M_P#"%G?X[WQF'GS\U\3>_UGVGM?:SO];]K]>G_:'U_B_] M1\&/W?B1P]&WLK1S>AR6]ARVR/,J'U?V?+E?+;^ROJ_U/ZE0Y?[&^I_ZNT?] M6?\ 5SP4_1:BBBOQ<_NL**** "BBB@ HHHH **** /Y4OC%_P6;_ &O/ GQ= M^*?@?1--^#KZ-X-^(_CCPII#7W@S7)[UM,\/>)M4TBP:\GC\8P1S71M+.(W$ MJ00I)*7=8HU(0>/\ \3(>._\ T=7C+_PZU/\ +^OFS]C/^'XW[:'_ $"_ M@G_X0VO_ /S;4?\ #\;]M#_H%_!/_P (;7__ )MJ_'.BC_B'_!7_ $3.4_\ MA+'_ ##_ (F0\=_^CJ\9?^'6I_E_7S9^QG_#\;]M#_H%_!/_ ,(;7_\ YMJ/ M^'XW[:'_ $"_@G_X0VO_ /S;5^.=%'_$/^"O^B9RG_PEC_F'_$R'CO\ ]'5X MR_\ #K4_R_KYL_8S_A^-^VA_T"_@G_X0VO\ _P VU'_#\;]M#_H%_!/_ ,(; M7_\ YMJ_'.BC_B'_ 5_T3.4_P#A+'_,/^)D/'?_ *.KQE_X=:G^7]?-G[&? M\/QOVT/^@7\$_P#PAM?_ /FVH_X?C?MH?] OX)_^$-K_ /\ -M7XYT4?\0_X M*_Z)G*?_ EC_F'_ !,AX[_]'5XR_P##K4_R_KYL_8S_ (?C?MH?] OX)_\ MA#:__P#-M7VK_P $^O\ @J-^TK^T[^U#X,^#WQ(L?AE!X3U_1_&5_?2>&O"V MK:7JXGT'PMJFL6(@O+OQ-J<$:&[LXA.K6DADAWHK1L0X_F>K]1?^"./_ "?M M\,?^Q:^)G_J Z]7S_%G!'"6#X7XAQ>%X?RRAB<-DN95\/6IX=1J4JU+"59TZ MD)=)0G%2B^C1^D>#?CYXSYWXL^&F39OXD\5YAE>:\=<+9?F.!Q.95*F'QF"Q M>=8*AB<-7IM6G2KT9SIU(OXHRDNK/[.Z***_C<_W#"BBB@ HHHH **** "BB MB@#^2_\ X+Q?\G>?#G_LV_PA_P"K.^,%?B?7[8?\%XO^3O/AS_V;?X0_]6=\ M8*_$^O[D\.O^2(X;_P"Q;3_]+J'_ #_?2=_Y/[XI?]E/7_\ 47"A1117VA^$ M!1110 4444 %%%% !1110 4444 ?Z0%%%%?YSG_3P%%%% !1110 4444 %%% M% 'XZ?\ !<7_ ),OTS_LM?@;_P!,/C2OY"J_KU_X+B_\F7Z9_P!EK\#?^F'Q MI7\A5?UYX*?\D4O^QMC_ /TG#G^*WT\?^3[S_P"R.X=_].9B%%%%?KA_& 44 M44 %%%% !1110 4444 %%%% ']GG_!'+_DPCX7_]C)\3?_4_U^OU$K\N_P#@ MCE_R81\+_P#L9/B;_P"I_K]?J)7\'\;?\EAQ1_V/LU_]3*Q_T/\ @-_R9+PE M_P"S=<'_ /JAP(4445\N?K(4444 %%%% !1110 4444 <7H?_(X>./\ N6?_ M $URUVE<7H?_ ".'CC_N6?\ TURUVE5+=?X8?^D1)CL_\4__ $N04445)044 M44 8OB3_ )%W7_\ L"ZI_P"D,]'AO_D7= _[ NE_^D,%'B3_ )%W7_\ L"ZI M_P"D,]'AO_D7= _[ NE_^D,%5]C_ +>_0G[?_;OZFU1114E!1110 4444 %% M%% !1110 4444 ?CU_P5+_Y+#_P2R_[2!_"K_P!'15^PM?CU_P %2_\ DL/_ M 2R_P"T@?PJ_P#1T5?L+7?B?]RR[_!BO_4F1R4/]YQO^.A_Z8@%%%%M_MQ_& MBV_X3?[?:^"?A+_9NF^&O&>O?\+1T/4-2_X9&^ EYY7]E^/OVIO^$)-<^-G_ !77_%;^$/V5?^$XU.Z_XS=_:S_X^/\ A>7[?GQR^T?\8G_L MU_\ $Q_X5GIFH:!_Q*;3[)\O-_\ (K?]4L_X59_Q>S_B]G_%;_\ #*O_ G' M_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGR_N-'( M,FE2HR66X23E"BTU24^9N.&<'&WUOGYG]5Y+?7?:^THS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T M?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK M_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\ MMQX?R7W>7+,(_@Y;4E._^[^SY;?6^>_^R\EOKOM?:4+?VG]>I_Z[85/$CCS] MY[7BK.8_QO:^TQ4J/+_R,OK'M.99-[#DMF_MN;^POJGU;,N?_53^P,3_ ,0$ M^QM;_;C^-%M_PF_V^U\$_"7^S=-\->,]>_X6CH>H:E_PR-\!+SRO[+\??M3? M\(YK=E_PDO[47Q\W)_PI#]D+X;_V)X@T;^TM/_X3#5M2\N?>:W^W'\:+;_A- M_M]KX)^$O]FZ;X:\9Z]_PM'0]0U+_AD;X"7GE?V7X^_:F_X1S6[+_A)?VHOC MYN3_ (4A^R%\-_[$\0:-_:6G_P#"8:MJ7ES[_CG_ )%;_JEG_"K/^+V?\7L_ MXK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-) M_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%( M/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4CP_DON\N681_!RVI*=_P#=_9\M MOK?/?_9>2WUWVOM*%O[3^O4_]=BIXD<>?O/:\59S'^-[7VF*E1Y?^1E]8]IS M+)O87/O-;_;C^-%M_PF_P!OM?!/PE_LW3?#7C/7O^%H MZ'J&I?\ #(WP$O/*_LOQ]^U-_P (YK=E_P )+^U%\?-R?\*0_9"^&_\ 8GB# M1O[2T_\ X3#5M2\N??\ '/\ R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU M_P#$Q_X5G_:&D_\ $IM/LGRD>'\E]WERS"/X.6U)3O\ [O[/EM];Y[_[+R6^ MN^U]I0M_:?UZG_KL5/$CCS]Y[7BK.8_QO:^TQ4J/+_R,OK'M.99-[#DMF_MN M;^POJGU;,N?_ %4_L#$_\0$^QM;_ &X_C1;?\)O]OM?!/PE_LW3?#7C/7O\ MA:.AZAJ7_#(WP$O/*_LOQ]^U-_PCFMV7_"2_M1?'SO?\+1T/4-2_P"& M1O@)>>5_9?C[]J;_ (1S6[+_ (27]J+X^;D_X4A^R%\-_P"Q/$&C?VEI_P#P MF&K:EY<^_P".?^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^ M%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_XO9_Q M>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[ M0TG_ (E-I]D^4CP_DON\N681_!RVI*=_]W]GRV^M\]_]EY+?7?:^TH6_M/Z] M3_UV*GB1QY^\]KQ5G,?XWM?:8J5'E_Y&7UCVG,LF]AR6S?VW-_87U3ZMF7/_ M *J?V!B?^("?8VM_MQ_&BV_X3?[?:^"?A+_9NF^&O&>O?\+1T/4-2_X9&^ E MYY7]E^/OVIO^$,]>_X6CH>H:E_PR-\!+SRO[+\??M3 M?\(YK=E_PDO[47Q\W)_PI#]D+X;_ -B>(-&_M+3_ /A,-6U+RY]_QS_R*W_5 M+/\ A5G_ !>S_B]G_%;_ /#*O_"PY+9O[;F_L+ZI]6S+G_ -5/[ Q/_$!/L;6_VX_C M1;?\)O\ ;[7P3\)?[-TWPUXSU[_A:.AZAJ7_ R-\!+SRO[+\??M3?\ ".:W M9?\ "2_M1?'S-_ MBQ;^";_P1I>@RZQJG@G5M3\%^)A#I.N_LW_!37)8K?PSXA_:<\40WTFC1_M- M_M&ZA+9VWPB_9H\%6%AJ7@72]6CUGQS?:Q%IURDGYU?\BM_U2S_A5G_%[/\ MB]G_ !6__#*O_")?,O_@M_PLUV ML/\ AJ;]N7QAYI_X6-_P4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3EQ MN19-3P.*J0R["1=/"U9PFH1T<:-*5.2G[=I[81QE]9J*?M*#5?&_7H5.-/8R M#Q!XYQ7$&38;$<2YS5AB,YP5#$495JEYQJXW%T\52G1671E%M/.(5J?]DX65 M#ZOF,99?D+R'$X;P(_=RBBBOQ4_NT**** "BBB@ HHHH **** /P9_X+X_\ M)"?@=_V5K4?_ %#M5K^66OZFO^"^/_)"?@=_V5K4?_4.U6OY9:_L?P=_Y(3+ M_P#L+S+_ -3*I_A[]-W_ )2%XF_[$_"W_JBP84445^HG\DA1110 4444 %%% M% !1110 4444 ?V5?\$9/^3$O!'_ &.WQ(_]2BZK]5J_*G_@C)_R8EX(_P"Q MV^)'_J475?JM7\(\<_\ )9<3_P#8\S+_ -2JA_T-> '_ "9#PF_[-_PM_P"J MC"A1117RI^O!1110 4444 %%%% !7^=)XS_Y'#Q9_P!C+KO_ *=+JO\ 1;K_ M #I/&?\ R.'BS_L9==_].EU7]$> /\7BG_KWDW_I6:'^9G[1S_<_"+_L)XY_ M]-<)G-4445_2!_ET%%%% !1110 4444 %%%% !1110!]U?\ !,W_ )/M_9N_ M[':\_P#47U^O[EJ_AI_X)F_\GV_LW?\ 8[7G_J+Z_7]RU?ROX[_\E+E'_8CA M_P"I^./]?/V>7_)J^,O^S@8C_P!9SA\****_#S^_ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *YGPE_R"KK_L9O&O\ ZF6O5TU\_[&WQ]_ZG?B.NMKDO!7_('O/^QM\??^IWXCKK:'N_5_ MF$/@C_AC^2"BBBD4%%%% !1110 4444 %%%% !1110!^/?\ SG;_ .\9_P#[ M\)7["5^/?_.=O_O&?_[\)7["5WX_?!_]@&&_*1R83?%?]A=7\H!1117 =85Y M+\>=;_X1KX+_ !0\1_\ ";Z;\,O^$?\ !/B#6_\ A9&J^&O^$SM?A]_95A-? M_P#";Q>#_*G_ .$KU+PIY']O:-X:\B;^W=8L+'2_*D^U;#ZU7DOQYUO_ (1K MX+_%#Q'_ ,)OIOPR_P"$?\$^(-;_ .%D:KX:_P"$SM?A]_95A-?_ /";Q>#_ M "I_^$KU+PIY']O:-X:\B;^W=8L+'2_*D^U;#UX!7GYL7AH\O)[3FO M6@N7V?U?%\_-MR?5,5S7Y?J]:_LY>/Q%4]EP_GM7VGL?9Y/F=3VOMOJWLN3! M5Y>T^L?VEDWL.2W-[;^U\J]E;G_M+ \OUJE^#/\ R*W_ %2S_A5G_%[/^+V? M\5O_ ,,J_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_ MX*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9 M_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q* M;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_% M;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ M$IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ M /#*O_"S_B]G_%;_ M /#*O_"S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC M7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"< M?\WN_MN_\?'_ O+_@I!\S_B]G_%;_\ #*O_ G'_-[O M[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_ MX59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3 M'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ? M'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L M_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_: M&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P + MR_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P *_:^U M^M_]1OM_KO\ S-/[4_XS@_A?].?8_P#"-(^'V@?9;+[?Y3?-\7>] MP_CG\5WA9W^.]\9AY\_-?$WO]9]I[7VL[_6_:_7I_P!H?7^+_P!1\&/W?B1P M]&WLK1S>AR6]ARVR/,J'U?V?+E?+;^ROJ_U/ZE0Y?[&^I_ZNT?\ 5G_5SP4_ M1:BBBOQ<_NL**** "BBB@ HHHH **** /\^O]I;_ ).-^/\ _P!EL^*O_J=: M]7B=>V?M+?\ )QOQ_P#^RV?%7_U.M>KQ.O\ 0O+?^1=@/^P+"_\ IBF?\TG% M'_)3<1?]CW-__5AB HHHKM/""BBB@ HHHH **** "BBB@ K]1?\ @CC_ ,G[ M?#'_ +%KXF?^H#KU?EU7ZB_\$$O_9QN#?\ U?X _L[HHHK^#C_H@"BBB@ HHHH **** M "BBB@#^2_\ X+Q?\G>?#G_LV_PA_P"K.^,%?B?7[8?\%XO^3O/AS_V;?X0_ M]6=\8*_$^O[D\.O^2(X;_P"Q;3_]+J'_ #_?2=_Y/[XI?]E/7_\ 47"A1117 MVA^$!1110 4444 %%%% !1110 4444 ?Z0%%%%?YSG_3P%%%% !1110 4444 M %%%% 'XZ?\ !<7_ ),OTS_LM?@;_P!,/C2OY"J_KU_X+B_\F7Z9_P!EK\#? M^F'QI7\A5?UYX*?\D4O^QMC_ /TG#G^*WT\?^3[S_P"R.X=_].9B%%%%?KA_ M& 4444 %%%% !1110 4444 %%%% ']GG_!'+_DPCX7_]C)\3?_4_U^OU$K\N M_P#@CE_R81\+_P#L9/B;_P"I_K]?J)7\'\;?\EAQ1_V/LU_]3*Q_T/\ @-_R M9+PE_P"S=<'_ /JAP(4445\N?K(4444 %%%% !1110 4444 <7H?_(X>./\ MN6?_ $URUVE<7H?_ ".'CC_N6?\ TURUVE5+=?X8?^D1)CL_\4__ $N04445 M)04444 8OB3_ )%W7_\ L"ZI_P"D,]'AO_D7= _[ NE_^D,%'B3_ )%W7_\ ML"ZI_P"D,]'AO_D7= _[ NE_^D,%5]C_ +>_0G[?_;OZFU1114E!1110 444 M4 %%%% !1110 4444 ?CU_P5+_Y+#_P2R_[2!_"K_P!'15^PM?CU_P %2_\ MDL/_ 2R_P"T@?PJ_P#1T5?L+7?B?]RR[_!BO_4F1R4/]YQO^.A_Z8@%%%%< M!UA1110!_/'XR_XI;Q?XJ_Y%OX6?\*L\2:Y\;/\ BNO^*W\(?LJ_\)QJ=U_Q MF[^UG_Q\?\+R_;\^.7VC_C$_]FO_ (F/_"L],U#0/^)3:?9/EYO_ )%;_JEG M_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ MXF/_ K/^T-)_P")3:?9/EZ3QE_Q2WB_Q5_R+?PL_P"%6>)-<^-G_%=?\5OX M0_95_P"$XU.Z_P",W?VL_P#CX_X7E^WY\[^V[_Q\?\+R_P"" MD'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?+_ $11]ZC2^WSTZ?\ T\Y_:17G MC/:^U^M]\=[?Z[_S-/[4_P",X_S-QO[K&8O_ )<^QQ5?_J&]A]6JS_[$OU3Z MI_8W;(/[/_L'_FDO]4O^.?S_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO M=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^16_Z MI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P") MC_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X M^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ JS M_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8_P#" ML_[0TG_B4VGV3Y=/B_O\_P#W$Y_:?^%?M?:_6_\ J-]O]=_YFG]J?\9QR_PO M^G/L?^Y;V'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y%;_JEG_"K/\ MB]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ M +0TG_B4VGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C M_A>7_!2#XY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V? M\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/ M^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y M?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4^+^_S_ /<3G]I_X5^U]K]; M_P"HWV_UW_F:?VI_QG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ 4A_L_P#L'_FD MO]4O^.?S_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE M7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_ MY%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C M&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ MA./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3 MXO[_ #_]Q.?VG_A7[7VOUO\ ZC?;_7?^9I_:G_&<'\+_ *<^Q_[EO8?5O_#- M]4^J?V-_U(?[/_L'_FDO]4O^.?S_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$ MX_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^ M16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K M_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_ M;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ M JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8 M_P#"L_[0TG_B4VGV3Y3XO[_/_P!Q.?VG_A7[7VOUO_J-]O\ 7?\ F:?VI_QG M!_"_Z<^Q_P"Y;V'U;_PS?5/JG]C?]2'^S_[!_P":2_U2_P".?S_D5O\ JEG_ M JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8 M_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;= M_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^16_ZI9_P MJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK M/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ MA>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3XO[_/_ -Q.?VG_ (5^ MU]K];_ZC?;_7?^9I_:G_ !G!_"_Z<^Q_[EO8?5O_ S?5/JG]C?]2'^S_P"P M?^:2_P!4O^.?S_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"% MY?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E]D_9[T39\;?AEX<_X0C7 M(?\ A#/%NF_%'_A6_P 3/$OF7_P6_P"%FNUA_P -3?MR^,/-/_"QO^"@O[3O M]H?V#\$?@AY]U_PI;PWX@_M3^S[#^RMZ>-_\BM_U2S_A5G_%[/\ B]G_ !6_ M_#*O_")?,O_@M_PLUVL/\ AJ;] MN7QAYI_X6-_P4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3DS"7^P8Z7- MOA,3+FY]^>C-\WM/K&O/];OS_6JGM?KM_K&._M/VG&WN<,P_XR3A^E[/X<\R MFG[+V/P^QQ^'C[/ZO_9JY/8?V/R^Q_LC#?5/["Y/[-R#_53ZKX"?NY1117\_ M'^D 4444 %%%% !1110 4444 ?@S_P %\?\ DA/P._[*UJ/_ *AVJU_++7]3 M7_!?'_DA/P._[*UJ/_J':K7\LM?V/X._\D)E_P#V%YE_ZF53_#WZ;O\ RD+Q M-_V)^%O_ %18,****_43^20HHHH **** "BBB@ HHHH **** /[*O^",G_)B M7@C_ +';XD?^I1=5^JU?E3_P1D_Y,2\$?]CM\2/_ %*+JOU6K^$>.?\ DLN) M_P#L>9E_ZE5#_H:\ /\ DR'A-_V;_A;_ -5&%"BBBOE3]>"BBB@ HHHH *** M* "O\Z3QG_R.'BS_ +&77?\ TZ75?Z+=?YTGC/\ Y'#Q9_V,NN_^G2ZK^B/ M'^+Q3_U[R;_TK-#_ #,_:.?[GX1?]A/'/_IKA,YJBBBOZ0/\N@HHHH **** M"BBB@ HHHH **** /NK_ ()F_P#)]O[-W_8[7G_J+Z_7]RU?PT_\$S?^3[?V M;O\ L=KS_P!1?7Z_N6K^5_'?_DIKIJYGPE_R"KK_ +&;QK_ZF6O4^C]5^3)?QQ_PR_.!!X*_Y ]Y_P!C;X^_ M]3OQ'76UR7@K_D#WG_8V^/O_ %._$==;0]WZO\PA\$?\,?R04444B@HHHH * M*_+M?^"T7_!,E_&I\!+^U/H/]LCQF? G]K-\/OC O@ ZR-OB\_#4^'R/%@\6'PLRZP?O[XN?%SX;_ ?X:^,?C!\7?%NF>! MOAQX!T>;7?%/B?51=2P6-FDD5M;V]I8:?;WFK:WK>KZA<6>C>'/#>A6&I>(O M$_B#4-,\/>'=+U37-3T_3[G:>'Q%-PC4H5J[ M?5KN9QK49J;A5IS5/XW&<9*%KWYVF^6UGO;9GHU%?#?[.O\ P4H_8=_:M\5R M^!/@9^T'X8\3>. ;==/\'>(=%\9_#+Q3XE>?2?$&O31^"?#_ ,4_#7@O5O'D MVD:'X6UW6?$L/@NTUZ7PKI=DFH>)4TFTO;"6ZT/C?_P46_8D_9Q^)'A[X0_& M;]HOP%X/^(WB#7++P[)X81M9\27/@W4=2@\*WVG2?%F\\):3KVE_!72+_2?& MOASQ!9>(?B_?>!_#]UX8N[OQ3!JNJJCS.DZ515%& MU^9PY>;EMK>UK:B5>BX>T56DZ;?+SJI%PYKVMS7Y;WTM>]]#[4HKSKXM?%KX M;_ GX<>+OBY\7?%^D> _ASX%TIM8\3^*-:DE6TL+8SP65G;6]M:Q7.HZOK.L M:G=66B>'?#NC6>H:_P")O$&HZ9X>\/Z9J>MZG86%SK_#_P =^%/BEX#\$_$W MP'JRZ_X'^(OA'PWX[\&:ZEGJ&GIK7A3Q=HUEX@\.ZLMAJUI8:I9+J.D:A9WB MVFI6-GJ%L)A#>6EO<))"F7+/EY^67)S2_'G6_^$:^ M"_Q0\1_\)OIOPR_X1_P3X@UO_A9&J^&O^$SM?A]_95A-?_\ ";Q>#_*G_P"$ MKU+PIY']O:-X:\B;^W=8L+'2_*D^U;#ZU7DOQYUO_A&O@O\ %#Q'_P )OIOP MR_X1_P $^(-;_P"%D:KX:_X3.U^'W]E6$U__ ,)O%X/\J?\ X2O4O"GD?V]H MWAKR)O[=UBPL=+\J3[5L/7@%S8[!1Y>?FQ>&CR\GM.:]:"Y?9_5\7S\VW)]4 MQ7-?E^KUK^SEX_$53V7#^>U?:>Q]GD^9U/:^V^K>RY,%7E[3ZQ_:63>PY+ M[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+ M/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ M$Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[; MO_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G M_%[/^+V?\5O_ ,,J_P#"P^K?^&;ZI]4_L;_ *D/]G_V#_S27^J7_'/Y_P BM_U2 MS_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A M6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ M ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRGQ?W^?_N)S^T_\ M*_:^U^M_]1OM_KO_ #-/[4_XS@_A?].?8_\ S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5 MG_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_ MPO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S M_B]G_%;_ /#*O_"S M_B]G_%;_ /#*O_"S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ M /#*O_"S_B]G_%;_\ #*O_ M G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG M_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC M7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"< M?\WN_MN_\?'_ O+_@I!\P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4 ML_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_ M\3'_ (5G_:&D_P#$IM/LGR_I5_P3]3^QK/XJ>$O(_P"$+^R77@WQE_PJ+Q7+ M_P )'^T+I/\ PL&+Q/J__"Y_VN?'V9?M_P"TA^T+]D_X2[Q+\.OM+?\ "IO! M&D?#[0/LME]O\IOS5_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_ MX7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y?TJ_X)^I_8UG\5/"7D?\ M(7]DNO!OC+_A47BN7_A(_P!H72?^%@Q>)]7_ .%S_M<^/LR_;_VD/VA?LG_" M7>)?AU]I;_A4W@C2/A]H'V6R^W^4WS?%WO?/S7Q-[_6 M?:>U]K._UOVOUZ?]H?7^+_U'P8_=^)'#T;>RM'-Z');V'+;(\RH?5_9\N5\M MO[*^K_4_J5#E_L;ZG_J[1_U9_P!7/!3]%J***_%S^ZPHHHH **** "BBB@ H MHHH _P ^O]I;_DXWX_\ _9;/BK_ZG6O5XG7MG[2W_)QOQ_\ ^RV?%7_U.M>K MQ.O]"\M_Y%V _P"P+"_^F*9_S2<4?\E-Q%_V/KYCC7_DC^*/^Q!FW_J#7/UCP'_Y/9X2_]G&X-_\ 5_@#^SNB MBBOX./\ H@"BBB@ HHHH **** "BBB@#^2__ (+Q?\G>?#G_ +-O\(?^K.^, M%?B?7[8?\%XO^3O/AS_V;?X0_P#5G?&"OQ/K^Y/#K_DB.&_^Q;3_ /2ZA_S_ M 'TG?^3^^*7_ &4]?_U%PH4445]H?A 4444 %%%% !1110 4444 %%%% '^D M!1117^?\$./^Y9_]-&_P#D7= _ M[ NE_P#I#!1XD_Y%W7_^P+JG_I#/1X;_ .1=T#_L"Z7_ .D,%5]C_M[]"?M_ M]N_J;5%%%24%%%% !17CWQ6_:'^ 'P(F\.6_QP^.7P>^#5QXP76'\)0?%;XF M>"OAY-XI7P\=*&OMXF#^T+3SNO\ ?$ M7X??%CPEI7C_ .%GCKP;\2_ FNMJ*Z'XU\ >)]$\9>$M9;2-4OM#U9=*\2>' M;[4=&U%M+UO3-2T?41:7DQLM4T^^T^Y\J[M)X8ZY9**FXR46[*7*^5M;I2M9 MM=KBYE=QNN9:N-U=+NUN=E17@_Q/_:G_ &8O@EXAM_"7QG_:-^ _PB\5W>AV MWB>T\,_$_P"+WP^\ ^(;GPW>7VHZ79^(;?1?%?B'2=2FT.ZU/1]7TZVU:.V: MPGOM+U&TBN&N+&YCB]?\1^(_#W@_P]KWB[Q=KNC>%O"GA;1M4\1^)_$_B/5+ M+1/#WASP]HEC/J>M:]KVM:G/:Z;I&C:1IMK._!GQ,\!Z\VHIH?C;X?>*-$\9^$=9;1]5OM"U==*\2>'+[4M&U%M+ MUS3-2T;419WLQL=5T^^TZY$5W:7$,^ MT[[3:HTH7++WO=?N_%H_=U4?>[>\TM>K2W8G?1-Z=$WLCK: M***0S\>O^"I?_)8?^"67_:0/X5?^CHJ_86OQZ_X*E_\ )8?^"67_ &D#^%7_ M *.BK]A:[\3_ +EEW^#%?^I,CDH?[SC?\=#_ -,0"BBBN ZPHHHH _GC\9?\ M4MXO\5?\BW\+/^%6>)-<^-G_ !77_%;^$/V5?^$XU.Z_XS=_:S_X^/\ A>7[ M?GQR^T?\8G_LU_\ $Q_X5GIFH:!_Q*;3[)\O-_\ (K?]4L_X59_Q>S_B]G_% M;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ M$IM/LGR])XR_XI;Q?XJ_Y%OX6?\ "K/$FN?&S_BNO^*W\(?LJ_\ "<:G=?\ M&;O[6?\ Q\?\+R_;\^.7VC_C$_\ 9K_XF/\ PK/3-0T#_B4VGV3Y>;_Y%;_J MEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO M_B8_\*S_ +0TG_B4VGV3Y?Z(H^]1I?;YZ=/_ *><_M(KSQGM?:_6^^.]O]=_ MYFG]J?\ &P^K59_]B7ZI]4_L;MD']G_V#_S2 M7^J7_'/Y_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q\?\ "\O^"D'Q MR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P## M*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/L MGRZ?%_?Y_P#N)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C..7^%_TY]C_ -RW ML/JW_AF^J?5/[&_ZD/\ 9_\ 8/\ S27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G M_%;_ /#*O_"S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[ M1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#* MO_"S_B]G_%;_\ #*O_ G' M_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K? M]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7 M_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X5 M9_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ M (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[ M_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6 M?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X M5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q M_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P * M_:^U^M_]1OM_KO\ S-/[4_XS@_A?].?8_P#B;/C;\,O#G_" M$:Y#_P (9XMTWXH_\*W^)GB7S+_X+?\ "S7:P_X:F_;E\8>:?^%C?\%!?VG? M[0_L'X(_!#S[K_A2WAOQ!_:G]GV']E;T\;_Y%;_JEG_"K/\ B]G_ !>S_BM_ M^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3 MY?9/V>]$V?&WX9>'/^$(UR'_ (0SQ;IOQ1_X5O\ $SQ+YE_\%O\ A9KM8?\ M#4W[?=?\*6\-^(/[4_L^P_LK>G)F$O\ M8,=+FWPF)ES<^_/1F^;VGUC7G^MWY_K53VOUV_UC'?VG[3C;W.&8?\9)P_2] MG\.>933]E['X?8X_#Q]G]7_LU '_ "9#PF_[-_PM_P"JC"A1117RI^O!1110 444 M4 %%%% !7^=)XS_Y'#Q9_P!C+KO_ *=+JO\ 1;K_ #I/&?\ R.'BS_L9==_] M.EU7]$> /\7BG_KWDW_I6:'^9G[1S_<_"+_L)XY_]-<)G-4445_2!_ET%%%% M !1110 4444 %%%% !1110!]U?\ !,W_ )/M_9N_[':\_P#47U^O[EJ_AI_X M)F_\GV_LW?\ 8[7G_J+Z_7]RU?ROX[_\E+E'_8CA_P"I^./]?/V>7_)J^,O^ MS@8C_P!9SA\****_#S^_ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGPE_R"KK_L9O M&O\ ZF6O5TU\_[& MWQ]_ZG?B.NMKDO!7_('O/^QM\??^IWXCKK:'N_5_F$/@C_AC^2"BBBD4%<7\ M2?AYX/\ B[\.O'WPG^(>D'7_ !\3_!?BGX>>.=!74=5T=M;\'^-=#OO#?B; M2!JVA7VF:YI9U+1=3O;,:CHVI:=JMD9OM.G7UI=Q0W$?:5Q_Q#\8?\*]\ >. M?'W_ B_C#QO_P (/X/\3>,/^$+^'FB'Q-X_\7_\(UHM[K7_ B_@;PX+FR/ MB#QAK_V+^R?#.B"\M/[5UJ[LK#[3!Y_FHU>ZMO=6Z:WTUZ:]1.UG?:SOZ=3^ M=[_@LS^S]_P3O_9,_8#\0>'/!GP8_9N^$7QO\5Q?#7PC\$-=LOAMX5F^-WB+ M2_AS\0/ASK/Q%OE^(LFBZE\2]1M].^&FG:G:^/OB+XM\2RQWUWXCTO2/%?B> M\\3^/=$LM?\ !_\ @H_\*=*+&^U'P!XDCTZY\1^%=%\6_$3PIX:\<^%]9DU30;/Q M5XEF\%>)K*#7;J[O.'_9_P!>\!M(U*YUKX>6]OJ'B2\^%PUSQ!\+VU.XTSP%:6GP\T'1- M&\4VVO\ Q[UAO%?QN\>Q^)_ GV+_ ,%,]$_:&_::\,?\$Z?V^?@?^RI\;]7T M_P#9<^.>N?$3QO\ LP_$/POJO@/]IQI](^-?PCN_!LLWPZT+2_B#J$7AG7-6 M^"MX=6U;0E\4Z_H/A3QQX-\>_P#"%ZOX3A\9W_A'ZNDJN&J8+#5:G.^;&U9X MJI5BX+'8G SIT:5*HYNT:4XPO6;2G6DY1:C&,I>#)TZT<16IPY5;#0C0A3:D M\+0Q4)U:E2"BKRG&4K4U?EI))KF!_A"GQDU*PDT;XU>%;O7O''@_0XQI+6@;XCWFLVALCHD^E^(OB+]I?2?%GP-_:+_X*K? SX_\ [+?Q MN_:J^.?[??BMX/V+?%_A#0?'>JI<> O!WC2^_:)FM?!7Q&O+"R^*?C#0OV?? M!FL?LY7WB[X1?!GPS\0/A[=>*/V>=&^#?CRYT3X<:#I'B>#[)\8?M->,?^"X M?Q^_9%\&_LU? /QC/^PY\$/C5H_Q6_:7\5?'_P ->!;CX7>-];\$ZUX8GU_X M?:O/X?M_B;X=O=7TWX3^)-1T3PU\.;+Q[J>H_$ZY^.L]S\0OASX9^'_P^/Q( M@_3_ /X*E_';XWZ/HGP8_8M_94;5O#_[4G[=.K>-O!_PT^)T'C#0? FB_"SP M9\*;3PSXP^-7BB\\0WMIK7B>WUE_AYJE[9Z9)X#T!O&NAZ')XM\:^!==LOB; MX2\ >'/&&-.K5P_U##58PGB'2K>V52NX/#T88NGC*4JU2'-*$:;P\ZU2&LG0 MGI:3ARZ3ITZWUNO!RC252FJ;C3YE6J2P[PTU3A*RDYJK&E"6D54CUBI7_"G5 M_CM^SE^U3X%_8^^ '[4_Q8T_X:?\$[OV'?V>O@E!\5M4\/6FEZQK'[1W[9GP MT\#^"?A)XS^$?P,\:_#GQ-XL^)'Q3^'7P^\,?%*&Q\6?$3]E_P )ZSIFA^$= M;\5^,+_QE;>#/BM^S1\;]*_KN^$/Q=^&WQZ^&G@WXP_"#Q=IGCKX;^/]'BUS MPKXGTH744%]9O++;7-M>6&H6]EJ^AZYH^HVUYHOB3PSKVGZ9XC\+>(=.U3P[ MXCTK2]=TO4-/MOY3?VFOV7_"O_!)G]I3_@GI^T#XJ^&7B/XP_L5?LZ?!VXF^ M,$_PW^'U]K=B_P"UGIZ^)/#FL?M(>-M ^(_B(_"3X9>,_BM\3/B/^S7>?##6 M/$GQDD\4V\7P-\.> O!]VFF_ KX3Z:WZK?\ !##X.^._A!^RS\83XS_9Z\7? MLNZ5\2OVK_B?\2/AE\&?'>IZ]J_BGPA\,;KP;\+_ ;X>T;4K_QG;Z=\0]1C M\/7_ (+UKPGIOB'XB:%X?\5>-M*\/67CW^S9="\4Z'JNI\^80H5,)2Q%*+$OV<*]63Y_/\ _LY?'K_AHK_@L_?>.O\ A2_Q]^!7V+_@GKJ'AK_A M#OVC?AU_PK'QW=_8/CII&H?\)!8^'O[8UO[1X9O?[6^PZ?JOVQ/M.HZ9J]MY M"?8M\G] %?CW_P YV_\ O&?_ ._"5^PE=V9.,IX5PA[.#P.&<8:=H5Y+\>=;_ .$:^"_Q0\1_\)OI MOPR_X1_P3X@UO_A9&J^&O^$SM?A]_95A-?\ _";Q>#_*G_X2O4O"GD?V]HWA MKR)O[=UBPL=+\J3[5L/K5>2_'G6_^$:^"_Q0\1_\)OIOPR_X1_P3X@UO_A9& MJ^&O^$SM?A]_95A-?_\ ";Q>#_*G_P"$KU+PIY']O:-X:\B;^W=8L+'2_*D^ MU;#UX!7GYL7AH\O)[3FO6@N7V?U?%\_-MR?5,5S7Y?J]:_LY>/Q%4] MEP_GM7VGL?9Y/F=3VOMOJWLN3!5Y>T^L?VEDWL.2W-[;^U\J]E;G_M+ \OUJ ME^#/_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[ M1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#* MO_"P^ MK?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\ B]G_ !6_ M_#*O_"[^V[_Q\?\ "\O^"D'QR^T? M\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ MPG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ M "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ M&-?[-?\ Q,?^%9_VAI/_ !*;3[)\I\7]_G_[B<_M/_"OVOM?K?\ U&^W^N_\ MS3^U/^,X/X7_ $Y]C_W+>P^K?^&;ZI]4_L;_ *D/]G_V#_S27^J7_'/Y_P B MM_U2S_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\ M3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[ M^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRGQ?W^?_N)S M^T_\*_:^U^M_]1OM_KO_ #-/[4_XS@_A?].?8_\ S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$ MQ_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O M_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ M !>S_B]G_%;_ /#*O_"S_B]G_%;_ /#*O_"S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ M (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G M_%;_ /#*O_"S_B]G_%;_\ M#*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/ MLGR_I5_P3]3^QK/XJ>$O(_X0O[)=>#?&7_"HO%1_PA?V2Z\&^,O\ A47B MN7_A(_VA=)_X6#%XGU?_ (7/^USX^S+]O_:0_:%^R?\ "7>)?AU]I;_A4W@C M2/A]H'V6R^W^4WS?%WO?/S7Q-[_ %GVGM?:SO\ 6_:_ M7I_VA]?XO_4?!C]WXDV?M+?\G&_'_\ [+9\5?\ U.M>KQ.O]"\M_P"1 M=@/^P+"_^F*9_P TG%'_ "4W$7_8]S?_ -6&("BBBNT\(**** "BBB@ HHHH M **** "OU%_X(X_\G[?#'_L6OB9_Z@.O5^75?J+_ ,$KYCC7_DC^*/^Q!FW_J#7/UCP'_Y/9X2_P#9QN#?_5_@#^SNBBBOX./^ MB **** "BBB@ HHHH **** /Y+_^"\7_ "=Y\.?^S;_"'_JSOC!7XGU^V'_! M>+_D[SX<_P#9M_A#_P!6=\8*_$^O[D\.O^2(X;_[%M/_ -+J'_/]])W_ )/[ MXI?]E/7_ /47"A1117VA^$!1110 4444 %%%% !1110 4444 ?Z0%%%%?YSG M_3P%%%% !1110 4444 %%%% 'XZ?\%Q?^3+],_[+7X&_],/C2OY"J_KU_P"" MXO\ R9?IG_9:_ W_ *8?&E?R%5_7G@I_R12_[&V/_P#2<.?XK?3Q_P"3[S_[ M([AW_P!.9B%%%%?KA_& 4444 %%%% !1110 4444 %%%% ']GG_!'+_DPCX7 M_P#8R?$W_P!3_7Z_42OR[_X(Y?\ )A'PO_[&3XF_^I_K]?J)7\'\;?\ )8<4 M?]C[-?\ U,K'_0_X#?\ )DO"7_LW7!__ *H<"%%%%?+GZR%%%% !1110 444 M4 %%%% '%Z'_ ,CAXX_[EG_TURUVE<7H?_(X>./^Y9_]-_0G[?\ MV[^IM4445)04444 ?F;\;/\ @DI^QY^TS\D:%X9\1_&3Q_P"%_!7P@T+P)H#Z,/#OPFL/A=J_@#6]'\/>*]1GO?&GBK1/ M$WB'Q;ILGCG5M?\ $7A^W\/S>(_$$6I_ /\ P0>T>S\._%C_ (*@^'_AC+J] MS^S#H?[2UEI/P#O-)U_Q!XM^$%[I6F>*_C5IR77@'Q;?:GK6A>*?$,_PMM/@ MM+XM\0V.LZMXCUCPP_PRU'Q+J5[8W/ABXD\O_P""V7[>>E^(OBGX8_X)R^$? MC\W[/W@75YUMOVX_BO+4/&/BO2_$G M@S5;K5?B%X2\*>&[/2/'LGB3X:_#?Q!\6/#?@+4_CQHD/Z*_\$Q/CO\ \$R[ M3PU:_LA_L#^/9O$FH>$?"NK?%'Q9'JGPY^*GASQ;XVEM]0\)>%?%?Q2\?>,? M&WPY\%Z/XE\7ZIJ>M^$M,GAM)K==,T9-%\->#?#FA> /".D:%X?]]QQM+**C MK1Q56GBH4/8P<*L\/A%/@E_P4-\<76F?"SP?X0MIKCQX?%6H0W/Q4\5Z-#IOZJ?\$J? MVZO@K_P2Y^#'[57[-/[:VE?$_P"%/[0GA'XY:]\4)/AA%X"OO%%_XMO-3^#7 MPX\.VG@;P?KOARYU'PC#KEY-\-+;4-'\3>-O$7@_X4>)] ^('@+Q5X4^)6N^ M%=2UG6?#_P!O_P#!)CPCI.F?L?\ [;W[+_BG\>$=6\!:G?\ I5Z];#5,=5JPJU,+]8PJRV',XPE%J<8/!.TH MKEPTFU*C&2C/V7.KI''2ITZT,+3A*$,1["L\;*R& MO$^BZ+\2OC;XPU7QK;_%R#X1_"3X;^&X)(_#?@73O%/PSUFQ\!:;H7@SXDW7 MPAF_98^#OQ-UOP/\3/B#X K]KO\ @DU^SM\'/V8OAW\7_AUI'[2'PV_:=_:M MO_B+)XO_ &S_ !GX6\<>%?'GC7PQ\4-4EUC2(OA_XPU>":Z^*9TSP[X@\/\ MC^6RO/C+='Q=XH^)6H_&/QP=+\)7/BG5?!'AC\/_ (M_L\_'_P#:7_9M_;/_ M ."FUU\+;7X3^'/!WP"TSX/_ /!//X66.D?#[X56_@;_ ()X:9K?B;P_\;M9 M\8_"V9=1\-'17_8Z\=?%2Q\%_;_'NOG5;[QK\5O%7P9\#Z=I-M^R?KFF1_\ M!-?7_P!FK5/V]?\ @F%I?[&D7Q;3Q?X9_8Y\8Z'^WJ^@>'_%NC_"NZ\6W'PQ M\?\ BOQ!=^*]3UG3;#Q?XPN$_: \3:;9^*/$OB6ZUOX#6 M%;'0]&Y\51C7P^*<)SA.$8_6W95DZN#P<)0I8BNG#E^#DYE#]_CZE6ZY:5(U MH5)4JM!2C&<9-K#IWI/DQ&):E4HTGS7^/FY7*]+"0A9\U2H?V4U\_P#[2O[1 MGA+]ESX:GXH>-/"WQ'\8:*-?TKP]_8_PM\)/XT\4_:]72[>"Z&BI?:>QTZ 6 M<@O+K[1^X,D(*-YG'T!17S--PC.+J0=2"DG*"ER.4>J4[2Y6^]G;LSVY*3BU M%J,FM)./,D^C<;J_I=>I_,S^U'^WM\,/VN/VB?\ @FQX3\"?#;X^^";[PK^W M+\)/$-[>_%WX8R^!=)O+2;5[+35M=*OI-8U(7NHK-<)*]H(XRMLLDV\[=I_I MFK\>O^"I?_)8?^"67_:0/X5?^CHJ_86O1QTJ4L+ESHTI48>SQ%H2J.JTUB)7 M?/RPW>MN73;4X\*IQKXQ5)JI/GHWDH:5OO"BBBO+.X**** /YX_& M7_%+>+_%7_(M_"S_ (59XDUSXV?\5U_Q6_A#]E7_ (3C4[K_ (S=_:S_ ./C M_A>7[?GQR^T?\8G_ +-?_$Q_X5GIFH:!_P 2FT^R?+S?_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\O2>,O\ BEO%_BK_ )%OX6?\*L\2:Y\;/^*Z_P"*W\(?LJ_\)QJ= MU_QF[^UG_P ?'_"\OV_/CE]H_P",3_V:_P#B8_\ "L],U#0/^)3:?9/EYO\ MY%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C M&O\ 9K_XF/\ PK/^T-)_XE-I]D^7^B*/O4:7V^>G3_Z><_M(KSQGM?:_6^^. M]O\ 7?\ F:?VI_QG'^9N-_=8S%_\N?8XJO\ ]0WL/JU6?_8E^J?5/[&[9!_9 M_P#8/_-)?ZI?\<_G_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_ MPO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S M_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\? M\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_ /#*O_"S_ (O9_P 5 MO_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[) M\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8 MU_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG M'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5 M+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?^&;ZI]4_L;_J M0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[ M^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGR^R?L]Z)L^- MOPR\.?\ "$:Y#_PAGBW3?BC_ ,*W^)GB7S+_ ."W_"S7:P_X:F_;E\8>:?\ MA8W_ 4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO\ Y%;_ *I9_P * ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ MPK/^T-)_XE-I]D^7V3]GO1-GQM^&7AS_ (0C7(?^$,\6Z;\4?^%;_$SQ+YE_ M\%O^%FNUA_PU-^W+XP\T_P#"QO\ @H+^T[_:']@_!'X(>?=?\*6\-^(/[4_L M^P_LK>G)F$O]@QTN;?"8F7-S[\]&;YO:?6->?ZW?G^M5/:_7;_6,=_:?M.-O M933]E['X?8X_#Q]G]7_ +-7)[#^Q^7V/]D8;ZI_87)_ M9N0?ZJ?5? 3]W****_GX_P!( HHHH **** "BBB@ HHHH _!G_@OC_R0GX'? M]E:U'_U#M5K^66OZFO\ @OC_ ,D)^!W_ &5K4?\ U#M5K^66O['\'?\ DA,O M_P"PO,O_ %,JG^'OTW?^4A>)O^Q/PM_ZHL&%%%%?J)_)(4444 %%%% !1110 M 4444 %%%% ']E7_ 1D_P"3$O!'_8[?$C_U*+JOU6K\J?\ @C)_R8EX(_[' M;XD?^I1=5^JU?PCQS_R67$__ &/,R_\ 4JH?]#7@!_R9#PF_[-_PM_ZJ,*%% M%%?*GZ\%%%% !1110 4444 %?YTGC/\ Y'#Q9_V,NN_^G2ZK_1;K_.D\9_\ M(X>+/^QEUW_TZ75?T1X _P 7BG_KWDW_ *5FA_F9^T<_W/PB_P"PGCG_ --< M)G-4445_2!_ET%%%% !1110 4444 %%%% !1110!]U?\$S?^3[?V;O\ L=KS M_P!1?7Z_N6K^&G_@F;_R?;^S=_V.UY_ZB^OU_-?\ U,M>I]'ZK\F2_CC_ M (9?G @\%?\ ('O/^QM\??\ J=^(ZZVN2\%?\@>\_P"QM\??^IWXCKK:'N_5 M_F$/@C_AC^2"BBBD4%%%% !1110 4444 %%%% !1110!^/?_ #G;_P"\9_\ M[\)7["5^/?\ SG;_ .\9_P#[\)7["5WX_?!_]@&&_*1R83?%?]A=7\H!1117 M =85Y+\>=;_X1KX+_%#Q'_PF^F_#+_A'_!/B#6_^%D:KX:_X3.U^'W]E6$U_ M_P )O%X/\J?_ (2O4O"GD?V]HWAKR)O[=UBPL=+\J3[5L/K5>2_'G6_^$:^" M_P 4/$?_ F^F_#+_A'_ 3X@UO_ (61JOAK_A,[7X??V5837_\ PF\7@_RI M_P#A*]2\*>1_;VC>&O(F_MW6+"QTORI/M6P]> 7-CL%'EY^;%X:/+R>TYKUH M+E]G]7Q?/S;3YG4]K[;ZM[+DP5> M7M/K']I9-[#DMS>V_M?*O96Y_P"TL#R_6J7X,_\ (K?]4L_X59_Q>S_B]G_% M;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ M$IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ M /#*O_"[^V[_P ?'_"\O^"D M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ M%;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^ MR?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+ M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J M_P#"[^V[_Q\?\ "\O^"D'QR^T?\8U_ MLU_\3'_A6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\ "OVOM?K?_4;[?Z[_ ,S3 M^U/^,X/X7_3GV/\ W+>P^K?^&;ZI]4_L;_J0_P!G_P!@_P#-)?ZI?\<_G_(K M?]4L_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^"D'QR^T?\8U_ MLU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ M #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W M_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[ M-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S M>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?%_?Y_P#N M)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C.#^%_TY]C_W+>P^K?\ AF^J?5/[ M&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\ B]G_ !6__#*O_"[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A M6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ M ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6? M\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^ M%9_VAI/_ !*;3[)\I\7]_G_[B<_M/_"OVOM?K?\ U&^W^N_\S3^U/^,X/X7_ M $Y]C_W+>P^K?^&;ZI]4_L;_ *D/]G_V#_S27^J7_'/Y_P BM_U2S_A5G_%[ M/^+V?\5O_P ,J_\ "[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_ M\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O M^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRGQ?W^?_N)S^T_\*_:^U^M_ M]1OM_KO_ #-/[4_XS@_A?].?8_\ #?&7_"HO%S_ (K?_AE7 M_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E_2K_@ MGZG]C6?Q4\)>1_PA?V2Z\&^,O^%1>*Y?^$C_ &A=)_X6#%XGU?\ X7/^USX^ MS+]O_:0_:%^R?\)=XE^'7VEO^%3>"-(^'V@?9;+[?Y3?-\7>]P_CG\5WA9W^ M.]\9AY\_-?$WO]9]I[7VL[_6_:_7I_VA]?XO_4?!C]WXDV?M+?\G&_' M_P#[+9\5?_4ZUZO$Z_T+RW_D78#_ + L+_Z8IG_-)Q1_R4W$7_8]S?\ ]6&( M"BBBNT\(**** "BBB@ HHHH **** "OU%_X(X_\ )^WPQ_[%KXF?^H#KU?EU M7ZB_\$>"G_)%+_L; M8_\ ])PY_BM]/'_D^\_^R.X=_P#3F8A1117ZX?Q@%%%% !1110 4444 %%%% M !1110!_9Y_P1R_Y,(^%_P#V,GQ-_P#4_P!?K]1*_+O_ ((Y?\F$?"__ +&3 MXF_^I_K]?J)7\'\;?\EAQ1_V/LU_]3*Q_P!#_@-_R9+PE_[-UP?_ .J' A11 M17RY^LA1110 4444 %%%% !1110!Q>A_\CAXX_[EG_TURUVE<7H?_(X>./\ MN6?_ $URUVE5+=?X8?\ I$28[/\ Q3_]+D%%%%24%%%% &+XD_Y%W7_^P+JG M_I#/1X;_ .1=T#_L"Z7_ .D,%'B3_D7=?_[ NJ?^D,]'AO\ Y%W0/^P+I?\ MZ0P57V/^WOT)^W_V[^IM4445)04444 %%%% 'F/CKX)_!GXH^(O 'B_XF?"/ MX8_$3Q9\)]:;Q)\+/%'CKP#X5\7>(OAIXA:_T356U[P!K?B#2=0U+P;K3:IX M:\.:DVJ>';G3;XW_ (?T2\,_VC2K"2#MO$/A[0/%V@:YX4\5Z'H_B?PMXGT? M4_#WB7PUXATRRUK0/$.@:U93Z;K.AZYHVI07.G:MH^K:=F7]M<65_9 M7$]K=02P2R1ML44^9Z:OW?AU>FM].VNNG45EKHM=]-^FO?0Q?#?AOP[X,\.Z M!X/\'Z!HOA3PEX4T72O#?A?POX;TJQT+P[X;\.Z%8P:7HF@:!HFEP6NF:/HN MCZ9:VVG:5I6G6UM8Z?8VT%I:00V\,<:XO@OX;?#OX;CQ6/AWX!\%^ AX\\:Z M]\2?' \%^%M#\+#QG\1?%36S>)_'WBL:'8V/_"1>-?$C65FVO>*=7^V:YK#6 MEL=0OK@P1;.THHN]=7KOY]=>^H_EML%%%%(#\>O^"I?_ "6'_@EE_P!I _A5 M_P"CHJ_86OQZ_P""I?\ R6'_ ()9?]I _A5_Z.BK]A:[\3_N67?X,5_ZDR.2 MA_O.-_QT/_3$ HHHK@.L**** /YX_&7_ !2WB_Q5_P BW\+/^%6>)-<^-G_% M=?\ %;^$/V5?^$XU.Z_XS=_:S_X^/^%Y?M^?'+[1_P 8G_LU_P#$Q_X5GIFH M:!_Q*;3[)\O-_P#(K?\ 5+/^%6?\7L_XO9_Q6_\ PRK_ ,)Q_P WN_MN_P#' MQ_PO+_@I!\,O^*6\7^*O^1;^ M%G_"K/$FN?&S_BNO^*W\(?LJ_P#"<:G=?\9N_M9_\?'_ O+]OSXY?:/^,3_ M -FO_B8_\*STS4- _P")3:?9/EYO_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./ M^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E_HBC[U&E] MOGIT_P#IYS^TBO/&>U]K];[X[V_UW_F:?VI_QG'^9N-_=8S%_P#+GV.*K_\ M4-[#ZM5G_P!B7ZI]4_L;MD']G_V#_P TE_JE_P <_G_(K?\ 5+/^%6?\7L_X MO9_Q6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\[^V[_Q\?\ "\O^ M"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?+I\7]_G_[B<_M/_"OVOM?K?\ MU&^W^N_\S3^U/^,XY?X7_3GV/_[^V[_Q\?\+R_P""D'QR M^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#P MRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_ MR*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"S_B]G_%;_\ #*O_ M G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG MQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z[_S-/[4_XS@_A?\ 3GV/_[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R* MW_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_L MU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_- M[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S M_A5G_%[/^+V?\5O_ ,,J_P#"[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\ M"OVOM?K?_4;[?Z[_ ,S3^U/^,X/X7_3GV/\ W+>P^K?^&;ZI]4_L;_J0_P!G M_P!@_P#-)?ZI?\<_G_(K?]4L_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ? M'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L M_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_: M&D_\2FT^R?*?%_?Y_P#N)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C.#^%_TY M]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\ MB]G_ !6__#*O_")?,O_@M_PLUV ML/\ AJ;]N7QAYI_X6-_P4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO M_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V M:_\ B8_\*S_M#2?^)3:?9/E]D_9[T39\;?AEX<_X0C7(?^$,\6Z;\4?^%;_$ MSQ+YE_\ !;_A9KM8?\-3?MR^,/-/_"QO^"@O[3O]H?V#\$?@AY]U_P *6\-^ M(/[4_L^P_LK>G)F$O]@QTN;?"8F7-S[\]&;YO:?6->?ZW?G^M5/:_7;_ %C' M?VG[3C;W.&8?\9)P_2]G\.>933]E['X?8X_#Q]G]7_LU_3=_Y2%XF_[$_"W_ *HL&%%%%?J)_)(4444 %%%% !11 M10 4444 %%%% ']E7_!&3_DQ+P1_V.WQ(_\ 4HNJ_5:ORI_X(R?\F)>"/^QV M^)'_ *E%U7ZK5_"/'/\ R67$_P#V/,R_]2JA_P!#7@!_R9#PF_[-_P +?^JC M"A1117RI^O!1110 4444 %%%% !7^=)XS_Y'#Q9_V,NN_P#ITNJ_T6Z_SI/& M?_(X>+/^QEUW_P!.EU7]$> /\7BG_KWDW_I6:'^9G[1S_<_"+_L)XY_]-<)G M-4445_2!_ET%%%% !1110 4444 %%%% !1110!]U?\$S?^3[?V;O^QVO/_47 MU^O[EJ_AI_X)F_\ )]O[-W_8[7G_ *B^OU_7_)J^,O\ LX&(_P#6\_P"QM\??^IWXCKK:Y+P5_P @>\_[&WQ]_P"IWXCKK:'N_5_F M$/@C_AC^2"BBBD4%%%% !1110 4444 %%%% !1110!^/?_.=O_O&?_[\)7[" M5^/?_.=O_O&?_P"_"5^PE=^/WP?_ & 8;\I')A-\5_V%U?R@%%%%#_ "I_^$KU+PIY']O:-X:\B;^W=8L+'2_*D^U;#ZU7DOQYUO\ X1KX M+_%#Q'_PF^F_#+_A'_!/B#6_^%D:KX:_X3.U^'W]E6$U_P#\)O%X/\J?_A*] M2\*>1_;VC>&O(F_MW6+"QTORI/M6P]> 7-CL%'EY^;%X:/+R>TYKUH+E]G]7 MQ?/S;3YG4]K[;ZM[+DP5>7M/K'] MI9-[#DMS>V_M?*O96Y_[2P/+]:I?@S_R*W_5+/\ A5G_ !>S_B]G_%;_ /#* MO_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1 M_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PR MK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I\7 M]_G_ .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_ MU2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S M7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU M_P#$Q_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z[_S-/[4_ MXS@_A?\ 3GV/_[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ MQ,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V M[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59 M_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9 M_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_ M\2FT^R?*?%_?Y_\ N)S^T_\ "OVOM?K?_4;[?Z[_ ,S3^U/^,X/X7_3GV/\ MW+>P^K?^&;ZI]4_L;_J0_P!G_P!@_P#-)?ZI?\<_G_(K?]4L_P"%6?\ %[/^ M+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_ M\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O M^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_ MQ6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ M !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P"" MD'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?%_?Y_P#N)S^T_P#"OVOM?K?_ M %&^W^N_\S3^U/\ C.#^%_TY]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_ MJE_QS^?\BM_U2S_A5G_%[/\ B]G_ !6__#*O_"$O(_X0O[)=>#? M&7_"HO%1_PA?V2Z\&^,O^%1>*Y?\ A(_VA=)_X6#%XGU?_A<_[7/C[,OV M_P#:0_:%^R?\)=XE^'7VEO\ A4W@C2/A]H'V6R^W^4WS?%WO?/S7Q-[_6?:>U]K._UOVOUZ?]H?7^+_ -1\&/W?B1P]&WLK1S>AR6]A MRVR/,J'U?V?+E?+;^ROJ_P!3^I4.7^QOJ?\ J[1_U9_U<\%/T6HHHK\7/[K" MBBB@ HHHH **** "BBB@#_/K_:6_Y.-^/_\ V6SXJ_\ J=:]7B=>V?M+?\G& M_'__ ++9\5?_ %.M>KQ.O]"\M_Y%V _[ L+_ .F*9_S2<4?\E-Q%_P!CW-__ M %88@****[3P@HHHH **** "BBB@ HHHH *_47_@CC_R?M\,?^Q:^)G_ *@. MO5^75?J+_P $KYCC7_ )(_BC_L09M_Z@US]8\! M_P#D]GA+_P!G&X-_]7^ /[.Z***_@X_Z( HHHH **** "BBB@ HHHH _DO\ M^"\7_)WGPY_[-O\ "'_JSOC!7XGU^V'_ 7B_P"3O/AS_P!FW^$/_5G?&"OQ M/K^Y/#K_ )(CAO\ [%M/_P!+J'_/]])W_D_OBE_V4]?_ -1<*%%%%?:'X0%% M%% !1110 4444 %%%% !1110!_I 4445_G.?]/ 4444 %%%% !1110 4444 M?CI_P7%_Y,OTS_LM?@;_ -,/C2OY"J_KU_X+B_\ )E^F?]EK\#?^F'QI7\A5 M?UYX*?\ )%+_ +&V/_\ 2<.?XK?3Q_Y/O/\ [([AW_TYF(4445^N'\8!1110 M 4444 %%%% !1110 4444 ?V>?\ !'+_ ),(^%__ &,GQ-_]3_7Z_42OR[_X M(Y?\F$?"_P#[&3XF_P#J?Z_7ZB5_!_&W_)8<4?\ 8^S7_P!3*Q_T/^ W_)DO M"7_LW7!__JAP(4445\N?K(4444 %%%% !1110 4444 <7H?_ ".'CC_N6?\ MTURUVE<7H?\ R.'CC_N6?_37+7:54MU_AA_Z1$F.S_Q3_P#2Y!1114E!1110 M!B^)/^1=U_\ [ NJ?^D,]'AO_D7= _[ NE_^D,%'B3_D7=?_ .P+JG_I#/1X M;_Y%W0/^P+I?_I#!5?8_[>_0G[?_ &[^IM4445)04444 %%%% !1110 4444 M %%%% 'X]?\ !4O_ )+#_P $LO\ M('\*O\ T=%7["U^/7_!4O\ Y+#_ ,$L MO^T@?PJ_]'15^PM=^)_W++O\&*_]29')0_WG&_XZ'_IB 4445P'6%%%% '\\ M?C+_ (I;Q?XJ_P"1;^%G_"K/$FN?&S_BNO\ BM_"'[*O_"<:G=?\9N_M9_\ M'Q_PO+]OSXY?:/\ C$_]FO\ XF/_ K/3-0T#_B4VGV3Y>;_ .16_P"J6?\ M"K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ M ,*S_M#2?^)3:?9/EZ3QE_Q2WB_Q5_R+?PL_X59XDUSXV?\ %=?\5OX0_95_ MX3C4[K_C-W]K/_CX_P"%Y?M^?'+[1_QB?^S7_P 3'_A6>F:AH'_$IM/LGR\W M_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "W^N_\S3^U/^,X_P S<;^ZQF+_ .7/L<57_P"H;V'U:K/_ +$OU3ZI_8W; M(/[/_L'_ )I+_5+_ (Y_/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O= M_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\ M*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B M8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW M_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L_P"+ MV?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ MM#2?^)3:?9/ET^+^_P __<3G]I_X5^U]K];_ .HWV_UW_F:?VI_QG'+_ O^ MG/L?^Y;V'U;_ ,,WU3ZI_8W_ %(?[/\ [!_YI+_5+_CG\_Y%;_JEG_"K/^+V M?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG M_B4VGV3Y3_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ M!2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\7L_X MK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3 M:?9/E/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/ MCE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4^+^_P __<3G]I_X5^U]K];_ M .HWV_UW_F:?VI_QG!_"_P"G/L?^Y;V'U;_PS?5/JG]C?]2'^S_[!_YI+_5+ M_CG\_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^. M7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K? M_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/ M^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_X MQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A M./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4^+^_ MS_\ <3G]I_X5^U]K];_ZC?;_ %W_ )FG]J?\9P?PO^G/L?\ N6]A]6_\,WU3 MZI_8W_4A_L_^P?\ FDO]4O\ CG\_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A M./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"1 M6_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK M_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./ M^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_ MPJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF M/_"L_P"T-)_XE-I]D^4^+^_S_P#<3G]I_P"%?M?:_6_^HWV_UW_F:?VI_P 9 MP?PO^G/L?^Y;V'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y%;_JEG_" MK/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_ M\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW M?^/C_A>7_!2#XY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/ M^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ M K/^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^ M/^%Y?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4^+^_S_ /<3G]I_X5^U M]K];_P"HWV_UW_F:?VI_QG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ 4A_L_P#L M'_FDO]4O^.?S_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_! M2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E]D_9[T39\;?AEX<_X0C7(?^$, M\6Z;\4?^%;_$SQ+YE_\ !;_A9KM8?\-3?MR^,/-/_"QO^"@O[3O]H?V#\$?@ MAY]U_P *6\-^(/[4_L^P_LK>GC?_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P ) MQ_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\OLG[ M/>B;/C;\,O#G_"$:Y#_PAGBW3?BC_P *W^)GB7S+_P""W_"S7:P_X:F_;E\8 M>:?^%C?\%!?VG?[0_L'X(_!#S[K_ (4MX;\0?VI_9]A_96].3,)?[!CIT^L:\_UN_/\ 6JGM?KM_K&._M/VG&WN<,P_XR3A^E[/X<\RF MG[+V/P^QQ^'C[/ZO_9JY/8?V/R^Q_LC#?5/["Y/[-R#_ %4^J^ G[N4445_/ MQ_I %%%% !1110 4444 %%%% 'X,_P#!?'_DA/P._P"RM:C_ .H=JM?RRU_4 MU_P7Q_Y(3\#O^RM:C_ZAVJU_++7]C^#O_)"9?_V%YE_ZF53_ ]^F[_RD+Q- M_P!B?A;_ -46#"BBBOU$_DD**** "BBB@ HHHH **** "BBB@#^RK_@C)_R8 MEX(_[';XD?\ J475?JM7Y4_\$9/^3$O!'_8[?$C_ -2BZK]5J_A'CG_DLN)_ M^QYF7_J54/\ H:\ /^3(>$W_ &;_ (6_]5&%"BBBOE3]>"BBB@ HHHH **** M "O\Z3QG_P CAXL_[&77?_3I=5_HMU_G2>,_^1P\6?\ 8RZ[_P"G2ZK^B/ ' M^+Q3_P!>\F_]*S0_S,_:.?[GX1?]A/'/_IKA,YJBBBOZ0/\ +H**** "BBB@ M HHHH **** "BBB@#[J_X)F_\GV_LW?]CM>?^HOK]?W+5_#3_P $S?\ D^W] MF[_L=KS_ -1?7Z_N6K^5_'?_ )*7*/\ L1P_]3\?WX%%%% !1110 4444 %%%% !1110 5\'_ +2G_!3C]A3]D;Q2 MG@;X\_M">'O#?C=3<+JG@WPKX:\??%GQ9X5:'2/#WB"!/'?AOX0>$_'FL_#Z M36-!\5:%K7AJ/QQ9>'W\5Z3>2:CX975K2QU":U[+]OGPA^TCX]_8^^.WA']D M?Q)<>%?V@M;\)VT'@35-/U^S\)ZY+K]!:^$?&WC#P!;^ M*?"7@?Q;)J7AAO#'B_6]%UV'QQX"FT^/QKH/\%7_ 4'_8^^+G[%_P 6],\" M?'?XB:!\3/BS\3/AO=?'+QOXB\-ZCXH\0V)UGQI\3_BOH$C7?C3QG9Z/XG\< MZ[KL'@RW\:>)O$FL>'=!O/\ A(_%.K:*\6N+HR>+O$?N9-E>'S*;C7Q?LI>^ MH4*<;UI\D%-S;<7"%-)V3=W*2<4E:[\S,L=6P<%*E0]HO=YZLW:G#FERJ*2: MG.;WLK**LVWL?Z2=? /QP_X*F?\ !/[]G;78_"_Q0_:=\"1>)5UGQ9X_L]*\4>'_'FF_!KP[X^O/A[KFF:G>C3AI'CF'P]J%]?6 M.MVNG6UY/X>UU-.^_J_E>\(_\&XOP<\&? 3Q+XH_:3_:NU_PI\2=%\&ZQXIU M3Q?X+@\&^&_V>OA'%I_@2RO=1?Q)K3Q%K>K^-F\6_ 8> M)_ L-C!<>'/AQ?VE_J\O'@*67U'-YAB*]&*=-4X8>ESSJ.?-S2YFI1A&G:-T MXN4N?W5HSHQ53&0Y%A*-*HVIN5FFE'EUW1_0A^S9^U] M^S5^U]X7N_%O[./Q?\+?$W3]+6"37])L3J6A>-_"4=]J_B31-(E\;_#?Q78: M#\0O T/B*]\(>))/"LWB_P ,:)%XLTO2I]=\-OJNB/!J,OD/[27_ 4U_87_ M &2?%&8O'-GX>D\6:3>R:CX975K.QU&:T_D*_X(/ZK\1M* M_P""EWPAB\"6NL2^'_$7@GXQ>&OC+:#->>)QX9\(OJLUOXHGT/6?G;PEX>\"_$'X_\ M_!1G5/VZM,^'7PU^,NF_L^_MT?%C0/!L?Q3O/AQX8T[_ (*$6?C_ $'5-#\# M> ;K0OB48/B5JT/C;6OB18^&/AI<^*/B5I'C:UL[B:YL/&0T^/41[-7(*%#& MXJE4Q%:>'P]"A72I1@\3+ZQ5]C]SW&G*4E'6+@^532BFU:7-JU'7_ $/? /Q#\ ?%;PIIGCSX7>.? M!_Q)\#:U)J<.C>,_ /B;1?&'A35I=%U:^T#68M,\1>'KW4=(OY-)UW2]3T74 MTM;R5K#5M.OM.NA%>6EQ#'\\#]NK]EAOVIW_ &*?^%FSK^TPDP@_X5P_@#XF MQPO(?AHOQ@Q#XYD\&+\.IU'P[;^WC)#XNDC659-#9QXABETE/Y3OV&O^"A'A MG]@C_@E/\9;?PU_;7_#0WQY_:;^.?A[X+2:)I6GRV/A3Q%H?[/\ ^S7IVM_% MWQ1JWB/0/$'@W[)\+XO%'@O5--\(ZUI>MZA\0-=N] \.QZ%_PAX\;^+O!7[( M?\$7/^">6M?L^>#-0_:]_: 3XF']K?\ :&T3Q$GB;2?B5J=^NN^!? OB;QG! MXIF@\4V4VNZOJ7B+XE_%/4- \-?$KQWX@^(KIXY\-3W&F^![OP[X,\5:=\3) MO&G%B)K1:I]'ZK\F2_CC_AE^<"#P5_R![S_ +&WQ]_ZG?B.NMKDO!7_ "![ MS_L;?'W_ *G?B.NMH>[]7^80^"/^&/Y(****104444 %%%% !1110 4444 % M%%% 'X]_\YV_^\9__OPE?L)7X]_\YV_^\9__ +\)7["5WX_?!_\ 8!AORD2_'G6_\ A&O@O\4/$?\ PF^F_#+_ (1_P3X@UO\ MX61JOAK_ (3.U^'W]E6$U_\ \)O%X/\ *G_X2O4O"GD?V]HWAKR)O[=UBPL= M+\J3[5L/K5>2_'G6_P#A&O@O\4/$?_";Z;\,O^$?\$^(-;_X61JOAK_A,[7X M??V5837_ /PF\7@_RI_^$KU+PIY']O:-X:\B;^W=8L+'2_*D^U;#UX!7GYL7AH\O)[3FO6@N7V?U?%\_-MR?5,5S7Y?J]:_LY>/Q%4]EP_GM7VGL?9 MY/F=3VOMOJWLN3!5Y>T^L?VEDWL.2W-[;^U\J]E;G_M+ \OUJE^#/_(K?]4L M_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\ M3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[ M^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/ M^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ MQ,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V M[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?+_ $#\7]_G_P"X MG/[3_P *_:^U^M_]1OM_KO\ S-/[4_XSC_-O^%_TY]C_ -RWL/JW_AF^J?5/ M[&_ZD/\ 9_\ 8/\ S27^J7_'/Y_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"< M?\WN_MN_\?'_ O+_@I!\S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3 M'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\? M\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_" MP^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B]G_%; M_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$ MIM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ M%;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^ MR?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+ M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P *_:^U^M_]1OM_ MKO\ S-/[4_XS@_A?].?8_P#S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1 M_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PR MK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I\7 M]_G_ .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?+^E7_! M/U/[&L_BIX2\C_A"_LEUX-\9?\*B\5R_\)'^T+I/_"P8O$^K_P#"Y_VN?'V9 M?M_[2'[0OV3_ (2[Q+\.OM+?\*F\$:1\/M ^RV7V_P IOS5_Y%;_ *I9_P * ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ MPK/^T-)_XE-I]D^7]*O^"?J?V-9_%3PEY'_"%_9+KP;XR_X5%XKE_P"$C_:% MTG_A8,7B?5_^%S_M<^/LR_;_ -I#]H7[)_PEWB7X=?:6_P"%3>"-(^'V@?9; M+[?Y3?-\7>]P_CG\5WA9W^.]\9AY\_-?$WO]9]I[7VL[_6_:_7I_VA]?XO\ MU'P8_=^)'#T;>RM'-Z');V'+;(\RH?5_9\N5\MO[*^K_ %/ZE0Y?[&^I_P"K MM'_5G_5SP4_1:BBBOQ<_NL**** "BBB@ HHHH **** /\^O]I;_DXWX__P#9 M;/BK_P"IUKU>)U[9^TM_R<;\?_\ LMGQ5_\ 4ZUZO$Z_T+RW_D78#_L"PO\ MZ8IG_-)Q1_R4W$7_ &/$O_ &<;@W_U?X _L[HHHK^#C_H@"BBB M@ HHHH **** "BBB@#^2_P#X+Q?\G>?#G_LV_P (?^K.^,%?B?7[8?\ !>+_ M ).\^'/_ &;?X0_]6=\8*_$^O[D\.O\ DB.&_P#L6T__ $NH?\_WTG?^3^^* M7_93U_\ U%PH4445]H?A 4444 %%%% !1110 4444 %%%% '^D!1117^A_\ (X>./^Y9_P#37+7:5Q>A_P#(X>./^Y9_]-&_^1=T#_L"Z7_Z0 MP4>)/^1=U_\ [ NJ?^D,]'AO_D7= _[ NE_^D,%5]C_M[]"?M_\ ;OZFU111 M4E!1110 4444 %%%% !1110 4444 ?CU_P %2_\ DL/_ 2R_P"T@?PJ_P#1 MT5?L+7X]?\%2_P#DL/\ P2R_[2!_"K_T=%7["UWXG_<; M_CH?^F(!1117 =84444 ?SQ^,O\ BEO%_BK_ )%OX6?\*L\2:Y\;/^*Z_P"* MW\(?LJ_\)QJ=U_QF[^UG_P ?'_"\OV_/CE]H_P",3_V:_P#B8_\ "L],U#0/ M^)3:?9/EYO\ Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7 ME_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^7I/&7_%+>+_%7_(M_"S_A M5GB37/C9_P 5U_Q6_A#]E7_A.-3NO^,W?VL_^/C_ (7E^WY\ M[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\O]$4?>HT MOM\].G_T\Y_:17GC/:^U^M]\=[?Z[_S-/[4_XSC_ #-QO[K&8O\ Y<^QQ5?_ M *AO8?5JL_\ L2_5/JG]C=L@_L_^P?\ FDO]4O\ CG\_Y%;_ *I9_P *L_XO M9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^ MT-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X M7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_ MQ>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^ M)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P % M(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^73XO[_ #_]Q.?VG_A7[7VOUO\ MZC?;_7?^9I_:G_&<S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE M7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_ MY%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C M&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ MA./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3 MXO[_ #_]Q.?VG_A7[7VOUO\ ZC?;_7?^9I_:G_&<'\+_ *<^Q_[EO8?5O_#- M]4^J?V-_U(?[/_L'_FDO]4O^.?S_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$ MX_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^ M16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K M_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_ M;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ M JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8 M_P#"L_[0TG_B4VGV3Y3XO[_/_P!Q.?VG_A7[7VOUO_J-]O\ 7?\ F:?VI_QG M!_"_Z<^Q_P"Y;V'U;_PS?5/JG]C?]2'^S_[!_P":2_U2_P".?S_D5O\ JEG_ M JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8 M_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;= M_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^16_ZI9_P MJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK M/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ MA>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3XO[_/_ -Q.?VG_ (5^ MU]K];_ZC?;_7?^9I_:G_ !G!_"_Z<^Q_[EO8?5O_ S?5/JG]C?]2'^S_P"P M?^:2_P!4O^.?S_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"% MY?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\ M7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2 M?^)3:?9/E/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y? M\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L M_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4V MGV3Y3XO[_/\ ]Q.?VG_A7[7VOUO_ *C?;_7?^9I_:G_&<'\+_IS['_N6]A]6 M_P##-]4^J?V-_P!2'^S_ .P?^:2_U2_XY_/^16_ZI9_PJS_B]G_%[/\ BM_^ M&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^7V3 M]GO1-GQM^&7AS_A"--_\ (K?]4L_X M59_Q>S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$ MQ_X5G_:&D_\ $IM/LGR^R?L]Z)L^-OPR\.?\(1KD/_"&>+=-^*/_ K?XF>) M?,O_ (+?\+-=K#_AJ;]N7QAYI_X6-_P4%_:=_M#^P?@C\$//NO\ A2WAOQ!_ M:G]GV']E;TY,PE_L&.ES;X3$RYN??GHS?-[3ZQKS_6[\_P!:J>U^NW^L8[^T M_:<;>YPS#_C).'Z7L_ASS*:?LO8_#[''X>/L_J_]FKD]A_8_+['^R,-]4_L+ MD_LW(/\ 53ZKX"?NY1117\_'^D 4444 %%%% !1110 4444 ?@S_ ,%\?^2$ M_ [_ +*UJ/\ ZAVJU_++7]37_!?'_DA/P._[*UJ/_J':K7\LM?V/X._\D)E_ M_87F7_J95/\ #WZ;O_*0O$W_ &)^%O\ U18,****_43^20HHHH **** "BBB M@ HHHH **** /[*O^",G_)B7@C_L=OB1_P"I1=5^JU?E3_P1D_Y,2\$?]CM\ M2/\ U*+JOU6K^$>.?^2RXG_['F9?^I50_P"AKP _Y,AX3?\ 9O\ A;_U484* M***^5/UX**** "BBB@ HHHH *_SI/&?_ ".'BS_L9==_].EU7^BW7^=)XS_Y M'#Q9_P!C+KO_ *=+JOZ(\ ?XO%/_ %[R;_TK-#_,S]HY_N?A%_V$\<_^FN$S MFJ***_I _P N@HHHH **** "BBB@ HHHH **** /NK_@F;_R?;^S=_V.UY_Z MB^OU_KZMX>M/#NCW/C+P[_PL*2U\0Z!X8\7^(/# MVN:A\-E\7Z1X:U_P]HH\0:)XCU#2M4T/6O"^JVEIXGT?^7CXA?\ ! G_ (*7 M_%[68?$GQ<_:@^#/Q9\1VVD0>'[7Q%\4?CK^T5\1-?M= M;K4+^VT.TUOQC\ M)-:U.UT:VO\ 5M5OK?2[>ZCL8+W4]1NXH%N+ZZDE^CX=EAL/B?KF)QE"@H1J MTE2J2?-9 M7VMJM=[?V5U_+-_P7 _X*1Q^+U;_ ()\_LI>(O&/B/X@>(/&=EX0^/>K?"Z1 M=0776OOMWAL?LKZ)#I.DZKXE\6^)_%/B?4])@^).F>";_29+:?28/@GJTGC" M;Q=\4_ GAOZW_9._82_X*?\ P@^$'[:7@GXS?MG:=\2?$_QM^ /B'P/\"-8U M#XW?M+?$'Q%\,_C%<>&/'&D^%/'FC_%#QI_9>I_!_1='U#Q):W7B$^!O 7C' MQ9XDOK?PSXAT_6O"]Q\-[?1O'7Y2>"O^#>__ (**?#7Q+H_C3X;_ +0G[/OP M[\9>'3>'P_XN\!_%SX\>#?%&AG4-+O=#U#^R/$'AOX,Z9J^FB^T74M1TB\6S MO(1=:9?WEA.)+6YFB=Y7ALMP^+K5,5C\+5^J^SEA5[ZH5JTH:K&[4F](Z6N[Q_9 M3_@CI_P3$U+]A7P'XD^)OQAFTG4?VC_C)HN@V6O:-96?AW4[/X*^#-/FN=53 MX;Z)XRM+6ZU36-?\0:G* M-0L](%G9Q>&?C7X<\5_#>U^)?C'Q)8+IGABV\*'XV\+_9Z_X)R?\ !:'X3_'CX-?$;Q?^W[IGC3P)X2^)W@C5/B3X/\1? MM*?M(?$G3_%7PN'B+3[?XH>'(?!GQ&^&>H^#M6UK6_A_/XDTWPU-JJ6$NC^( M[G2ME^+M7USX>QC7?A/ M\)/"C>!K/57UV_\ &E]??%3PS\._BUJ6J^"%*6 ME!V>'A&7*YS<80C1IQYV_=E9N+8XQBL![)9;-NG)4Z.'KPA4YJDDK5IR5U&/ M-*3J3?+LU=*[WXC^/O@UXI^,^EZOI'P__9^^$^I^$FAN/&/Q;^!\OQ=U^YU?]I7Q5_;G MPQ\*?%O]H7QYXL\1^*9+_3?$G[16B^&?&U_;#_X*E-X!?_@HE_PVGX_71$_: M&'[*@T<^/M2^P/\ %4_L[)XY_ME?V5/^$"_X9-/@T?#ECOZC!>ZEX:^)4V@:UJ=K>>+_ !GX7^(DUE\5I/$.K>([?QAK M_P 0[$^,;_Q?%XONY?$B_P H?AS_ ((P_P#!4^?5=&_8M\5)X1T3]DB^^..E M?'/Q1\6O#WB;X1>*OA9HOQ&D^$MMX-UKXE:%INI'P;^U3XCUK3_!2S_"W3/! M-_X7\+>"]9\80P7UU%H/ANZF^*EIZ&$S+ XMUIXGZK25.O2C"EC(JJEED8R] MI3I<\:KEB:D_?K2B_:59OFN^5'+7P>*P\:<:"KU'.E4E.>&DZ=\:Y1Y)SY7! M*C"-XTXM-+;0[/QC\5?@7\)/B1XL MM/#%I?V'AJU\3>./ 'A_Q/KUMX>L=4U37-3LM#@U35+J+2;34=:UB_MK!;>& M\U34+A)+N;W2O._A#\--$^"_PF^%_P '?#-]K.J>&_A-\._!/PT\/ZEXCGL; MOQ#J.B>!/#6F>%M)OM=NM,T[2--N=9N[#2K>XU2XT_2=,L9KV2>2TTZR@:.V MB]$KX^HXNI-TTU!SDX)[J%WRI^:5CZ&',H14]9\L>9K^:RYOQN%%%%04%%%% M !1110 4444 %%%% !1110 5S/A+_D%77_8S>-?_ %,M>KIJYGPE_P @JZ_[ M&;QK_P"IEKU/H_5?DR7\"O^0/ M>?\ 8V^/O_4[\1UUM#W?J_S"'P1_PQ_)!1112*"BBB@ HHHH **** "BBB@ MHHHH _'O_G.W_P!XS_\ WX2OV$K\>_\ G.W_ -XS_P#WX2OV$KOQ^^#_ .P# M#?E(Y,)OBO\ L+J_E ****X#K"O)?CSK?_"-?!?XH>(_^$WTWX9?\(_X)\0: MW_PLC5?#7_"9VOP^_LJPFO\ _A-XO!_E3_\ "5ZEX4\C^WM&\->1-_;NL6%C MI?E2?:MA]:KR7X\ZW_PC7P7^*'B/_A-]-^&7_"/^"?$&M_\ "R-5\-?\)G:_ M#[^RK":__P"$WB\'^5/_ ,)7J7A3R/[>T;PUY$W]NZQ86.E^5)]JV'KP"YL= M@H\O/S8O#1Y>3VG->M!7ZU2_!G_D5O M^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ MB8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW? M^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P * ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ MPK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ MCX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y?Z!^+^_S_ /<3 MG]I_X5^U]K];_P"HWV_UW_F:?VI_QG'^;?\ "_Z<^Q_[EO8?5O\ PS?5/JG] MC?\ 4A_L_P#L'_FDO]4O^.?S_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W? MVW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ M (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L M_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_C MX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B] MG_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P * MS_M#2?\ B4VGV3Y3XO[_ #_]Q.?VG_A7[7VOUO\ ZC?;_7?^9I_:G_&<'\+_ M *<^Q_[EO8?5O_#-]4^J?V-_U(?[/_L'_FDO]4O^.?S_ )%;_JEG_"K/^+V? M\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/ M^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y M?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S M_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4 MVGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2# MXY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3XO[_/_P!Q.?VG_A7[7VOUO_J- M]O\ 7?\ F:?VI_QG!_"_Z<^Q_P"Y;V'U;_PS?5/JG]C?]2'^S_[!_P":2_U2 M_P".?S_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2# MXY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ M (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P") M3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE] MH_XQK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5? M^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3XO M[_/_ -Q.?VG_ (5^U]K];_ZC?;_7?^9I_:G_ !G!_"_Z<^Q_[EO8?5O_ S? M5/JG]C?]2'^S_P"P?^:2_P!4O^.?S_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X M3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E/^16 M_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_XQK_ M &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C M_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4_Y% M;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ M (F/_"L_[0TG_B4VGV3Y3XO[_/\ ]Q.?VG_A7[7VOUO_ *C?;_7?^9I_:G_& M<'\+_IS['_N6]A]6_P##-]4^J?V-_P!2'^S_ .P?^:2_U2_XY_/^16_ZI9_P MJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK M/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ MA>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ JS_B]G M_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8_P#"L_[0 MTG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A> M7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/B_O\ /_W$Y_:?^%?M M?:_6_P#J-]O]=_YFG]J?\9P?PO\ IS['_N6]A]6_\,WU3ZI_8W_4A_L_^P?^ M:2_U2_XY_/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y? M\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^7]*O^"?J?V-9_%3PEY'_ M A?V2Z\&^,O^%1>*Y?^$C_:%TG_ (6#%XGU?_A<_P"USX^S+]O_ &D/VA?L MG_"7>)?AU]I;_A4W@C2/A]H'V6R^W^4WYJ_\BM_U2S_A5G_%[/\ B]G_ !6_ M_#*O_"$O(_X0O[)=>#?&7_"HO%94/J_L^7*^6W]E?5_J?U*AR_V-]3_U=H_ZL_ZN>"GZ+4445^+G M]UA1110 4444 %%%% !1110!_GU_M+?\G&_'_P#[+9\5?_4ZUZO$Z]L_:6_Y M.-^/_P#V6SXJ_P#J=:]7B=?Z%Y;_ ,B[ ?\ 8%A?_3%,_P":3BC_ )*;B+_L M>YO_ .K#$!1117:>$%%%% !1110 4444 %%%% !7ZB_\$ _ M_)[/"7_LXW!O_J_P!_9W1117\''_ $0!1110 4444 %%%% !1110!_)?_P % MXO\ D[SX<_\ 9M_A#_U9WQ@K\3Z_;#_@O%_R=Y\.?^S;_"'_ *L[XP5^)]?W M)X=?\D1PW_V+:?\ Z74/^?[Z3O\ R?WQ2_[*>O\ ^HN%"BBBOM#\("BBB@ H MHHH **** "BBB@ HHHH _P!("BBBO\YS_IX"BBB@ HHHH **** "BBB@#\=/ M^"XO_)E^F?\ 9:_ W_IA\:5_(57]>O\ P7%_Y,OTS_LM?@;_ -,/C2OY"J_K MSP4_Y(I?]C;'_P#I.'/\5OIX_P#)]Y_]D=P[_P"G,Q"BBBOUP_C **** "BB MB@ HHHH **** "BBB@#^SS_@CE_R81\+_P#L9/B;_P"I_K]?J)7Y=_\ !'+_ M ),(^%__ &,GQ-_]3_7Z_42OX/XV_P"2PXH_['V:_P#J96/^A_P&_P"3)>$O M_9NN#_\ U0X$****^7/UD**** "BBB@ HHHH **** .+T/\ Y'#QQ_W+/_IK MEKM*XO0_^1P\CPW_ ,B[H'_8%TO_ -(8*/$G_(NZ_P#]@75/_2&> MCPW_ ,B[H'_8%TO_ -(8*K['_;WZ$_;_ .W?U-JBBBI*"BBB@ HHHH **** M"BBB@ HHHH _'K_@J7_R6'_@EE_VD#^%7_HZ*OV%K\>O^"I?_)8?^"67_:0/ MX5?^CHJ_86N_$_[EEW^#%?\ J3(Y*'^\XW_'0_\ 3$ HHHK@.L**** /YX_& M7_%+>+_%7_(M_"S_ (59XDUSXV?\5U_Q6_A#]E7_ (3C4[K_ (S=_:S_ ./C M_A>7[?GQR^T?\8G_ +-?_$Q_X5GIFH:!_P 2FT^R?+S?_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\O2>,O\ BEO%_BK_ )%OX6?\*L\2:Y\;/^*Z_P"*W\(?LJ_\)QJ= MU_QF[^UG_P ?'_"\OV_/CE]H_P",3_V:_P#B8_\ "L],U#0/^)3:?9/EYO\ MY%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C M&O\ 9K_XF/\ PK/^T-)_XE-I]D^7^B*/O4:7V^>G3_Z><_M(KSQGM?:_6^^. M]O\ 7?\ F:?VI_QG'^9N-_=8S%_\N?8XJO\ ]0WL/JU6?_8E^J?5/[&[9!_9 M_P#8/_-)?ZI?\<_G_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_ MPO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S M_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\? M\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_ /#*O_"S_ (O9_P 5 MO_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[) M\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8 MU_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG M'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5 M+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?^&;ZI]4_L;_J M0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[ M^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGR^R?L]Z)L^- MOPR\.?\ "$:Y#_PAGBW3?BC_ ,*W^)GB7S+_ ."W_"S7:P_X:F_;E\8>:?\ MA8W_ 4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO\ Y%;_ *I9_P * ML_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ MPK/^T-)_XE-I]D^7V3]GO1-GQM^&7AS_ (0C7(?^$,\6Z;\4?^%;_$SQ+YE_ M\%O^%FNUA_PU-^W+XP\T_P#"QO\ @H+^T[_:']@_!'X(>?=?\*6\-^(/[4_L M^P_LK>G)F$O]@QTN;?"8F7-S[\]&;YO:?6->?ZW?G^M5/:_7;_6,=_:?M.-O M933]E['X?8X_#Q]G]7_ +-7)[#^Q^7V/]D8;ZI_87)_ M9N0?ZJ?5? 3]W****_GX_P!( HHHH **** "BBB@ HHHH _!G_@OC_R0GX'? M]E:U'_U#M5K^66OZFO\ @OC_ ,D)^!W_ &5K4?\ U#M5K^66O['\'?\ DA,O M_P"PO,O_ %,JG^'OTW?^4A>)O^Q/PM_ZHL&%%%%?J)_)(4444 %%%% !1110 M 4444 %%%% ']E7_ 1D_P"3$O!'_8[?$C_U*+JOU6K\J?\ @C)_R8EX(_[' M;XD?^I1=5^JU?PCQS_R67$__ &/,R_\ 4JH?]#7@!_R9#PF_[-_PM_ZJ,*%% M%%?*GZ\%%%% !1110 4444 %?YTGC/\ Y'#Q9_V,NN_^G2ZK_1;K_.D\9_\ M(X>+/^QEUW_TZ75?T1X _P 7BG_KWDW_ *5FA_F9^T<_W/PB_P"PGCG_ --< M)G-4445_2!_ET%%%% !1110 4444 %%%% !1110!]U?\$S?^3[?V;O\ L=KS M_P!1?7Z_N6K^&G_@F;_R?;^S=_V.UY_ZB^OU__""U\*_#[PUXY7XE6OCFXOG\0:GJFG'3#X3E\)QVZV@TY6$PNQ MXBF,QFP4-M%L^^]>IDN38_B#,L/E.64HUL=BE6=&G.K3HQE["A4Q%2]2K*-. M-J5*.N..'/#CA?,N,>+,75P.092\%''8JAA,3CJM-YAC\+ MEF%Y<+A*=7$5.?%XRA3?)3ER1DZDK0C)K]3J*_EW_P"'^WQ>_P"B ?#?_P * M;Q/_ /&Z/^'^WQ>_Z(!\-_\ PIO$_P#\;K[O_B#W'G_0LPW_ (<\!_\ +S^> M_P#B=KZ/'_15YI_XBO$7_P [C^HBBOY=_P#A_M\7O^B ?#?_ ,*;Q/\ _&Z/ M^'^WQ>_Z(!\-_P#PIO$__P ;H_X@]QY_T+,-_P"'/ ?_ "\/^)VOH\?]%7FG M_B*\1?\ SN/ZB**_EW_X?[?%[_H@'PW_ /"F\3__ !NC_A_M\7O^B ?#?_PI MO$__ ,;H_P"(/<>?]"S#?^'/ ?\ R\/^)VOH\?\ 15YI_P"(KQ%_\[C^HBBO MY=_^'^WQ>_Z(!\-__"F\3_\ QNC_ (?[?%[_ *(!\-__ IO$_\ \;H_X@]Q MY_T+,-_X<\!_\O#_ (G:^CQ_T5>:?^(KQ%_\[C^HBBOY=_\ A_M\7O\ H@'P MW_\ "F\3_P#QNC_A_M\7O^B ?#?_ ,*;Q/\ _&Z/^(/<>?\ 0LPW_ASP'_R\ M/^)VOH\?]%7FG_B*\1?_ #N/ZB**_EW_ .'^WQ>_Z(!\-_\ PIO$_P#\;H_X M?[?%[_H@'PW_ /"F\3__ !NC_B#W'G_0LPW_ (<\!_\ +P_XG:^CQ_T5>:?^ M(KQ%_P#.X_J(HK^7?_A_M\7O^B ?#?\ \*;Q/_\ &Z_>;]B_X_:Q^U#^S3\- MOCIKWA_3?"^K>./^$Q^UZ%I%S=7FG6/_ C/C[Q3X/@^SW-X!2 M^8/DGN)8T_=JM>#Q#P%Q-PM@J689S@Z.'PM;%0P=.=/&8;$-UZE*O7C%PHU9 MS2=/#U7S->XOAO@;.\;F6;8+*:^=XBAB,ES;+80 MR[#8S 8"M55?'86A1G..)S+"05*,W4DJDIJ+C";7U%1117QQ^WA1110 4444 M %%%% !1110 5S/A+_D%77_8S>-?_4RUZNFKF?"7_(*NO^QF\:_^IEKU/H_5 M?DR7\"O^0/>?]C;X^_]3OQ'76UR7@K_ ) ]Y_V-OC[_ -3OQ'76 MT/=^K_,(?!'_ Q_)!1112*"BBB@ HHHH **** "BBB@ HHHH _'O_G.W_WC M/_\ ?A*_82OQ[_YSM_\ >,__ -^$K]A*[\?O@_\ L PWY2.3";XK_L+J_E * M***X#K"O)?CSK?\ PC7P7^*'B/\ X3?3?AE_PC_@GQ!K?_"R-5\-?\)G:_#[ M^RK":_\ ^$WB\'^5/_PE>I>%/(_M[1O#7D3?V[K%A8Z7Y4GVK8?6J\E^/.M_ M\(U\%_BAXC_X3?3?AE_PC_@GQ!K?_"R-5\-?\)G:_#[^RK":_P#^$WB\'^5/ M_P )7J7A3R/[>T;PUY$W]NZQ86.E^5)]JV'KP"YL=@H\O/S8O#1Y>3VG->M! MS_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7 MVC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"& M5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VG MV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^ M,:_V:_\ B8_\*S_M#2?^)3:?9/E_H'XO[_/_ -Q.?VG_ (5^U]K];_ZC?;_7 M?^9I_:G_ !G'^;?\+_IS['_N6]A]6_\ #-]4^J?V-_U(?[/_ +!_YI+_ %2_ MXY_/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE M]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#A ME7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4 M_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ M (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7 M_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/B_O\ M_P#W$Y_:?^%?M?:_6_\ J-]O]=_YFG]J?\9P?PO^G/L?^Y;V'U;_ ,,WU3ZI M_8W_ %(?[/\ [!_YI+_5+_CG\_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F] MW]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L M_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_P MK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_ MX^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_X MO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ M"L_[0TG_ (E-I]D^4^+^_P __<3G]I_X5^U]K];_ .HWV_UW_F:?VI_QG!_" M_P"G/L?^Y;V'U;_PS?5/JG]C?]2'^S_[!_YI+_5+_CG\_P"16_ZI9_PJS_B] MG_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P * MS_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A M>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7 ML_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_X ME-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4 M@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4^+^_S_\ <3G]I_X5^U]K];_Z MC?;_ %W_ )FG]J?\9P?PO^G/L?\ N6]A]6_\,WU3ZI_8W_4A_L_^P?\ FDO] M4O\ CG\_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4 M@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W M_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ MB4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE M7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4^ M+^_S_P#<3G]I_P"%?M?:_6_^HWV_UW_F:?VI_P 9P?PO^G/L?^Y;V'U;_P , MWU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5? M^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D M5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,: M_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$ MX_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^ M16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K M_P")C_PK/^T-)_XE-I]D^4^+^_S_ /<3G]I_X5^U]K];_P"HWV_UW_F:?VI_ MQG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ 4A_L_P#L'_FDO]4O^.?S_D5O^J6? M\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\ M*S_M#2?^)3:?9/E_2K_@GZG]C6?Q4\)>1_PA?V2Z\&^,O^%1>*Y?^$C_ &A= M)_X6#%XGU?\ X7/^USX^S+]O_:0_:%^R?\)=XE^'7VEO^%3>"-(^'V@?9;+[ M?Y3?FK_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"C;V5HYO0Y+>PY;9'F5#ZO[/EROEM_97U M?ZG]2HK\NJ_47_ ((X_P#)^WPQ M_P"Q:^)G_J Z]7S'&O\ R1_%'_8@S;_U!KGZQX#_ /)[/"7_ +.-P;_ZO\ ? MV=T445_!Q_T0!1110 4444 %%%% !1110!_)?_P7B_Y.\^'/_9M_A#_U9WQ@ MK\3Z_;#_ (+Q?\G>?#G_ +-O\(?^K.^,%?B?7]R>'7_)$<-_]BVG_P"EU#_G M^^D[_P G]\4O^RGK_P#J+A0HHHK[0_" HHHH **** "BBB@ HHHH **** /] M("BBBO\ .<_Z> HHHH **** "BBB@ HHHH _'3_@N+_R9?IG_9:_ W_IA\:5 M_(57]>O_ 7%_P"3+],_[+7X&_\ 3#XTK^0JOZ\\%/\ DBE_V-L?_P"DX<_Q M6^GC_P GWG_V1W#O_IS,0HHHK]$O_9NN#__ %0X$****^7/UD**** " MBBB@ HHHH **** .+T/_ )'#QQ_W+/\ Z:Y:[2N+T/\ Y'#QQ_W+/_IKEKM* MJ6Z_PP_](B3'9_XI_P#I<@HHHJ2@HHHH Q?$G_(NZ_\ ]@75/_2&>CPW_P B M[H'_ &!=+_\ 2&"CQ)_R+NO_ /8%U3_TAGH\-_\ (NZ!_P!@72__ $A@JOL? M]O?H3]O_ +=_4VJ***DH**** "BBB@ HHHH **** "BBB@#\>O\ @J7_ ,EA M_P""67_:0/X5?^CHJ_86OQZ_X*E_\EA_X)9?]I _A5_Z.BK]A:[\3_N67?X, M5_ZDR.2A_O.-_P =#_TQ ****X#K"BBB@#^>/QE_Q2WB_P 5?\BW\+/^%6>) M-<^-G_%=?\5OX0_95_X3C4[K_C-W]K/_ (^/^%Y?M^?'+[1_QB?^S7_Q,?\ MA6>F:AH'_$IM/LGR\W_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E_H MBC[U&E]OGIT_^GG/[2*\\9[7VOUOOCO;_7?^9I_:G_&P^K59_P#8E^J?5/[&[9!_9_\ 8/\ S27^J7_'/Y_R*W_5+/\ A5G_ M !>S_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_ MX*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9 M_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q* M;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K? M^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B]G_%;_P## M*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/L MGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^ MT?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\ M,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*? M\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_Q MC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P *_:^U^M_]1OM_KO\ MS-/[4_XS@_A?].?8_P#S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8 MU_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG M'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I\7]_G_ M .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ M (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q, M?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$ MQ_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z[_S-/[4_XS@_ MA?\ 3GV/_[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^ M%9_VAI/_ !*;3[)\OLG[/>B;/C;\,O#G_"$:Y#_PAGBW3?BC_P *W^)GB7S+ M_P""W_"S7:P_X:F_;E\8>:?^%C?\%!?VG?[0_L'X(_!#S[K_ (4MX;\0?VI_ M9]A_96]/&_\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y? M\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^7V3]GO1-GQM^&7AS_A"- M933]E['X?8X_#Q]G]7 M_LU)O\ L3\+?^J+!A1117ZB M?R2%%%% !1110 4444 %%%% !1110!_95_P1D_Y,2\$?]CM\2/\ U*+JOU6K M\J?^",G_ "8EX(_[';XD?^I1=5^JU?PCQS_R67$__8\S+_U*J'_0UX ?\F0\ M)O\ LW_"W_JHPH4445\J?KP4444 %%%% !1110 5_G2>,_\ D*?\ KWDW_I6:'^9G[1S_ M '/PB_[">.?_ $UPF7_ ":OC+_LX&(_]9SA\****_#S^_ HHHH **** M "BBB@ K^:W_ (.!?^0Q^RM_V#?C+_Z5?#"OZ4J_FM_X.!?^0Q^RM_V#?C+_ M .E7PPK](\)/^3@9%_AS3_U3X\_ESZ9W_*.'B!_U]X1_];;AT_G1HHHK^T#_ M J"BBB@ HHHH **** "BBB@ HHHH *_M@_X)'?\H]?V??\ NJ__ *N[XDU_ M$_7]L'_!([_E'K^S[_W5?_U=WQ)K\6\=?^21R[_LH\)_ZK,W/[M_9[?\GGXF M_P"S89U_ZU?!1^D%%%%?R@?[%A1110 4444 %%%% !1110 5S/A+_D%77_8S M>-?_ %,M>KIJYGPE_P @JZ_[&;QK_P"IEKU/H_5?DR7\"O^0/>?\ 8V^/O_4[\1UUM#W?J_S"'P1_PQ_)!111 M2*"BBB@ HHHH **** "BBB@ HHHH _'O_G.W_P!XS_\ WX2OV$K\>_\ G.W_ M -XS_P#WX2OV$KOQ^^#_ .P##?E(Y,)OBO\ L+J_E ****X#K"O)?CSK?_"- M?!?XH>(_^$WTWX9?\(_X)\0:W_PLC5?#7_"9VOP^_LJPFO\ _A-XO!_E3_\ M"5ZEX4\C^WM&\->1-_;NL6%CI?E2?:MA]:KR7X\ZW_PC7P7^*'B/_A-]-^&7 M_"/^"?$&M_\ "R-5\-?\)G:_#[^RK":__P"$WB\'^5/_ ,)7J7A3R/[>T;PU MY$W]NZQ86.E^5)]JV'KP"YL=@H\O/S8O#1Y>3VG->M!7ZU2_!G_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^ M/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9 M_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T M-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7 ME_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[ M/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M# M2?\ B4VGV3Y?Z!^+^_S_ /<3G]I_X5^U]K];_P"HWV_UW_F:?VI_QG'^;?\ M"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ 4A_L_P#L'_FDO]4O^.?S_D5O^J6?\*L_ MXO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E M_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q> MS_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_ MXE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P M4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3XO[_ #_]Q.?VG_A7[7VO MUO\ ZC?;_7?^9I_:G_&<'\+_ *<^Q_[EO8?5O_#-]4^J?V-_U(?[/_L'_FDO M]4O^.?S_ )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2 M#XY?:/\ C&O]FO\ XF/_ K/^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ MBM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D M^4_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7V MC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5 M?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3X MO[_/_P!Q.?VG_A7[7VOUO_J-]O\ 7?\ F:?VI_QG!_"_Z<^Q_P"Y;V'U;_PS M?5/JG]C?]2'^S_[!_P":2_U2_P".?S_D5O\ JEG_ JS_B]G_%[/^*W_ .&5 M?^$X_P";W?VW?^/C_A>7_!2#XY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ M )%;_JEG_"K/^+V?\7L_XK?_ (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ MC&O]FO\ XF/_ K/^T-)_P")3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^ M$X_YO=_;=_X^/^%Y?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_J MEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO M_B8_\*S_ +0TG_B4VGV3Y3XO[_/_ -Q.?VG_ (5^U]K];_ZC?;_7?^9I_:G_ M !G!_"_Z<^Q_[EO8?5O_ S?5/JG]C?]2'^S_P"P?^:2_P!4O^.?S_D5O^J6 M?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^ M)C_PK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O= M_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\ M*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B M8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW M_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3XO[_/\ ]Q.?VG_A M7[7VOUO_ *C?;_7?^9I_:G_&<'\+_IS['_N6]A]6_P##-]4^J?V-_P!2'^S_ M .P?^:2_U2_XY_/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y M?\%(/CE]H_XQK_9K_P")C_PK/^T-)_XE-I]D^4_Y%;_JEG_"K/\ B]G_ !>S M_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4 MVGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2# MXY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ M (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P") M3:?9/E/B_O\ /_W$Y_:?^%?M?:_6_P#J-]O]=_YFG]J?\9P?PO\ IS['_N6] MA]6_\,WU3ZI_8W_4A_L_^P?^:2_U2_XY_/\ D5O^J6?\*L_XO9_Q>S_BM_\ MAE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E- MI]D^7]*O^"?J?V-9_%3PEY'_ A?V2Z\&^,O^%1>*Y?^$C_:%TG_ (6#%XGU M?_A<_P"USX^S+]O_ &D/VA?LG_"7>)?AU]I;_A4W@C2/A]H'V6R^W^4WYJ_\ MBM_U2S_A5G_%[/\ B]G_ !6__#*O_"$O(_X0O[)=>#?&7_"HO%< MO_"1_M"Z3_PL&+Q/J_\ PN?]KGQ]F7[?^TA^T+]D_P"$N\2_#K[2W_"IO!&D M?#[0/LME]O\ *;YOB[WN'\<_BN\+._QWOC,//GYKXF]_K/M/:^UG?ZW[7Z]/ M^T/K_%_ZCX,?N_$CAZ-O96CF]#DM[#EMD>94/J_L^7*^6W]E?5_J?U*AR_V- M]3_U=H_ZL_ZN>"GZ+4445^+G]UA1110 4444 %%%% !1110!_GU_M+?\G&_' M_P#[+9\5?_4ZUZO$Z]L_:6_Y.-^/_P#V6SXJ_P#J=:]7B=?Z%Y;_ ,B[ ?\ M8%A?_3%,_P":3BC_ )*;B+_L>YO_ .K#$!1117:>$%%%% !1110 4444 %%% M% !7ZB_\$ __)[/"7_LXW!O_J_P!_9W1117\''_ $0!1110 M 4444 %%%% !1110!_)?_P %XO\ D[SX<_\ 9M_A#_U9WQ@K\3Z_;#_@O%_R M=Y\.?^S;_"'_ *L[XP5^)]?W)X=?\D1PW_V+:?\ Z74/^?[Z3O\ R?WQ2_[* M>O\ ^HN%"BBBOM#\("BBB@ HHHH **** "BBB@ HHHH _P!("BBBO\YS_IX" MBBB@ HHHH **** "BBB@#\=/^"XO_)E^F?\ 9:_ W_IA\:5_(57]>O\ P7%_ MY,OTS_LM?@;_ -,/C2OY"J_KSP4_Y(I?]C;'_P#I.'/\5OIX_P#)]Y_]D=P[ M_P"G,Q"BBBOUP_C **** "BBB@ HHHH **** "BBB@#^SS_@CE_R81\+_P#L M9/B;_P"I_K]?J)7Y=_\ !'+_ ),(^%__ &,GQ-_]3_7Z_42OX/XV_P"2PXH_ M['V:_P#J96/^A_P&_P"3)>$O_9NN#_\ U0X$****^7/UD**** "BBB@ HHHH M **** .+T/\ Y'#QQ_W+/_IKEKM*XO0_^1P\CPW_ ,B[H'_8%TO_ M -(8*/$G_(NZ_P#]@75/_2&>CPW_ ,B[H'_8%TO_ -(8*K['_;WZ$_;_ .W? MU-JBBBI*"BBB@ HHHH **** "BBB@ HHHH _'K_@J7_R6'_@EE_VD#^%7_HZ M*OV%K\>O^"I?_)8?^"67_:0/X5?^CHJ_86N_$_[EEW^#%?\ J3(Y*'^\XW_' M0_\ 3$ HHHK@.L**** /YX_&7_%+>+_%7_(M_"S_ (59XDUSXV?\5U_Q6_A# M]E7_ (3C4[K_ (S=_:S_ ./C_A>7[?GQR^T?\8G_ +-?_$Q_X5GIFH:!_P 2 MFT^R?+S?_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\O2>,O\ BEO%_BK_ )%OX6?\*L\2 M:Y\;/^*Z_P"*W\(?LJ_\)QJ=U_QF[^UG_P ?'_"\OV_/CE]H_P",3_V:_P#B M8_\ "L],U#0/^)3:?9/EYO\ Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ MF]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^7^B*/O4:7 MV^>G3_Z><_M(KSQGM?:_6^^.]O\ 7?\ F:?VI_QG'^9N-_=8S%_\N?8XJO\ M]0WL/JU6?_8E^J?5/[&[9!_9_P#8/_-)?ZI?\<_G_(K?]4L_X59_Q>S_ (O9 M_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q* M;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_% M;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ M$IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ M /#*O_"S_B]G_%;_ M /#*O_"S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC M7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"< M?\WN_MN_\?'_ O+_@I!\S_B]G_%;_\ #*O_ G'_-[O M[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_ MX59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3 M'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGR^R?L]Z)L^-OPR\.?\ "$:Y#_PAGBW3?BC_ ,*W^)GB7S+_ M ."W_"S7:P_X:F_;E\8>:?\ A8W_ 4%_:=_M#^P?@C\$//NO^%+>&_$']J? MV?8?V5O3QO\ Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7 ME_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^7V3]GO1-GQM^&7AS_ (0C M7(?^$,\6Z;\4?^%;_$SQ+YE_\%O^%FNUA_PU-^W+XP\T_P#"QO\ @H+^T[_: M']@_!'X(>?=?\*6\-^(/[4_L^P_LK>G)F$O]@QTN;?"8F7-S[\]&;YO:?6-> M?ZW?G^M5/:_7;_6,=_:?M.-O933]E['X?8X_#Q]G]7_ M +-7)[#^Q^7V/]D8;ZI_87)_9N0?ZJ?5? 3]W****_GX_P!( HHHH **** " MBBB@ HHHH _!G_@OC_R0GX'?]E:U'_U#M5K^66OZFO\ @OC_ ,D)^!W_ &5K M4?\ U#M5K^66O['\'?\ DA,O_P"PO,O_ %,JG^'OTW?^4A>)O^Q/PM_ZHL&% M%%%?J)_)(4444 %%%% !1110 4444 %%%% ']E7_ 1D_P"3$O!'_8[?$C_U M*+JOU6K\J?\ @C)_R8EX(_[';XD?^I1=5^JU?PCQS_R67$__ &/,R_\ 4JH? M]#7@!_R9#PF_[-_PM_ZJ,*%%%%?*GZ\%%%% !1110 4444 %?YTGC/\ Y'#Q M9_V,NN_^G2ZK_1;K_.D\9_\ (X>+/^QEUW_TZ75?T1X _P 7BG_KWDW_ *5F MA_F9^T<_W/PB_P"PGCG_ --<)G-4445_2!_ET%%%% !1110 4444 %%%% !1 M110!]U?\$S?^3[?V;O\ L=KS_P!1?7Z_N6K^&G_@F;_R?;^S=_V.UY_ZB^OU M_O[/O_ '5?_P!7=\2:_%O'7_DDW_ ">?B;_LV&=?^M7P4?I!1117\H'^Q84444 %%%% !1110 4444 % M,_P#]^$K]A*[\?O@_^P##?E(Y,)OBO^PNK^4 HHHK@.L* M\E^/.M_\(U\%_BAXC_X3?3?AE_PC_@GQ!K?_ LC5?#7_"9VOP^_LJPFO_\ MA-XO!_E3_P#"5ZEX4\C^WM&\->1-_;NL6%CI?E2?:MA]:KR7X\ZW_P (U\%_ MBAXC_P"$WTWX9?\ "/\ @GQ!K?\ PLC5?#7_ F=K\/O[*L)K_\ X3>+P?Y4 M_P#PE>I>%/(_M[1O#7D3?V[K%A8Z7Y4GVK8>O +FQV"CR\_-B\-'EY/:U]M]6]ER8*O M+VGUC^TLF]AR6YO;?VOE7LK<_P#:6!Y?K5+\&?\ D5O^J6?\*L_XO9_Q>S_B MM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ M (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^ M.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L_P"+V?\ %[/^*W_X M95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E M/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_ MXQK_ &:_^)C_ ,*S_M#2?^)3:?9/E_H'XO[_ #_]Q.?VG_A7[7VOUO\ ZC?; M_7?^9I_:G_&S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H M_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X9 M5_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5 MO^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_ MV:_^)C_PK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ M )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/B_O\__ M '$Y_:?^%?M?:_6_^HWV_P!=_P"9I_:G_&<'\+_IS['_ +EO8?5O_#-]4^J? MV-_U(?[/_L'_ )I+_5+_ (Y_/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ M )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^ MJ6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V: M_P#B8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F] MW]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L M_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_P MK/\ M#2?^)3:?9/E/B_O\_\ W$Y_:?\ A7[7VOUO_J-]O]=_YFG]J?\ &<'\ M+_IS['_N6]A]6_\ #-]4^J?V-_U(?[/_ +!_YI+_ %2_XY_/^16_ZI9_PJS_ M (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L M_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_C MX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B] MG_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P * MS_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A M>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/B_O\_P#W$Y_:?^%?M?:_ M6_\ J-]O]=_YFG]J?\9P?PO^G/L?^Y;V'U;_ ,,WU3ZI_8W_ %(?[/\ [!_Y MI+_5+_CG\_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^ M.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L_P"+V?\ %[/^*W_X M95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E M/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_ MXQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ M (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^ M4^+^_P __<3G]I_X5^U]K];_ .HWV_UW_F:?VI_QG!_"_P"G/L?^Y;V'U;_P MS?5/JG]C?]2'^S_[!_YI+_5+_CG\_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ MA./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3 M_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V M:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W M?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9 M_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_X MF/\ PK/^T-)_XE-I]D^4^+^_S_\ <3G]I_X5^U]K];_ZC?;_ %W_ )FG]J?\ M9P?PO^G/L?\ N6]A]6_\,WU3ZI_8W_4A_L_^P?\ FDO]4O\ CG\_Y%;_ *I9 M_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_X MF/\ PK/^T-)_XE-I]D^7]*O^"?J?V-9_%3PEY'_"%_9+KP;XR_X5%XKE_P"$ MC_:%TG_A8,7B?5_^%S_M<^/LR_;_ -I#]H7[)_PEWB7X=?:6_P"%3>"-(^'V M@?9;+[?Y3?FK_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "X?QS^*[PL[_ !WOC,//GYKX MF]_K/M/:^UG?ZW[7Z]/^T/K_ !?^H^#'[OQ(X>C;V5HYO0Y+>PY;9'F5#ZO[ M/EROEM_97U?ZG]2H"GZ+4445^+G]UA1110 4444 M%%%% !1110!_GU_M+?\ )QOQ_P#^RV?%7_U.M>KQ.O;/VEO^3C?C_P#]EL^* MO_J=:]7B=?Z%Y;_R+L!_V!87_P!,4S_FDXH_Y*;B+_L>YO\ ^K#$!1117:>$ M%%%% !1110 4444 %%%% !7ZB_\ !''_ )/V^&/_ &+7Q,_]0'7J_+JOU%_X M(X_\G[?#'_L6OB9_Z@.O5\QQK_R1_%'_ &(,V_\ 4&N?K'@/_P GL\)?^SC< M&_\ J_P!_9W1117\''_1 %%%% !1110 4444 %%%% '\E_\ P7B_Y.\^'/\ MV;?X0_\ 5G?&"OQ/K]L/^"\7_)WGPY_[-O\ "'_JSOC!7XGU_ HHHH **** "BBB@ HHHH _'3_@N+_P F7Z9_ MV6OP-_Z8?&E?R%5_7K_P7%_Y,OTS_LM?@;_TP^-*_D*K^O/!3_DBE_V-L?\ M^DX<_P 5OIX_\GWG_P!D=P[_ .G,Q"BBBOUP_C **** "BBB@ HHHH **** M"BBB@#^SS_@CE_R81\+_ /L9/B;_ .I_K]?J)7Y=_P#!'+_DPCX7_P#8R?$W M_P!3_7Z_42OX/XV_Y+#BC_L?9K_ZF5C_ *'_ &_Y,EX2_\ 9NN#_P#U0X$* M***^7/UD**** "BBB@ HHHH **** .+T/_D/QE_Q2WB_Q M5_R+?PL_X59XDUSXV?\ %=?\5OX0_95_X3C4[K_C-W]K/_CX_P"%Y?M^?'+[ M1_QB?^S7_P 3'_A6>F:AH'_$IM/LGR\W_P BM_U2S_A5G_%[/^+V?\5O_P , MJ_\ "U]K];[X[V_UW_F:?VI M_P 9Q_F;C?W6,Q?_ "Y]CBJ__4-[#ZM5G_V)?JGU3^QNV0?V?_8/_-)?ZI?\ M<_G_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^ MT?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\ M,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*? M\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_Q MC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#" MP^K?^ M&;ZI]4_L;_J0_P!G_P!@_P#-)?ZI?\<_G_(K?]4L_P"%6?\ %[/^+V?\5O\ M\,J_\)Q_S>[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?* M?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T M?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK M_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\ MI_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\ M8U_LU_\ $Q_X5G_:&D_\2FT^R?*?%_?Y_P#N)S^T_P#"OVOM?K?_ %&^W^N_ M\S3^U/\ C.#^%_TY]C_W+>P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\ MBM_U2S_A5G_%[/\ B]G_ !6__#*O_"[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4 ML_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_ M\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S> M[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I\7]_G_[ MB<_M/_"OVOM?K?\ U&^W^N_\S3^U/^,X/X7_ $Y]C_W+>P^K?^&;ZI]4_L;_ M *D/]G_V#_S27^J7_'/Y_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGRGQ?W^?_N)S^T_\*_:^U^M_]1OM_KO_ #-/[4_XS@_A?].? M8_\ S_B]G_%;_\ #*O_ G'_-[O[;O_ !\? M\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_ /#*O_")?,O_@M_P +-=K#_AJ;]N7QAYI_X6-_P4%_:=_M#^P? M@C\$//NO^%+>&_$']J?V?8?V5O3QO_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X M3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E]D_9 M[T39\;?AEX<_X0C7(?\ A#/%NF_%'_A6_P 3/$OF7_P6_P"%FNUA_P -3?MR M^,/-/_"QO^"@O[3O]H?V#\$?@AY]U_PI;PWX@_M3^S[#^RMZ?ZW?G^M5/:_7;_6,=_:?M.-OP_L?E]C_9&&^J?V%R?V;D'^JGU7P$_=RBBBOY^ M/]( HHHH **** "BBB@ HHHH _!G_@OC_P D)^!W_96M1_\ 4.U6OY9:_J:_ MX+X_\D)^!W_96M1_]0[5:_EEK^Q_!W_DA,O_ .PO,O\ U,JG^'OTW?\ E(7B M;_L3\+?^J+!A1117ZB?R2%%%% !1110 4444 %%%% !1110!_95_P1D_Y,2\ M$?\ 8[?$C_U*+JOU6K\J?^",G_)B7@C_ +';XD?^I1=5^JU?PCQS_P EEQ/_ M -CS,O\ U*J'_0UX ?\ )D/";_LW_"W_ *J,*%%%%?*GZ\%%%% !1110 444 M4 %?YTGC/_D+/^QEUW_TZ75?T M1X _Q>*?^O>3?^E9H?YF?M'/]S\(O^PGCG_TUPF?^HOK]?W+5_*_CO_R4N4?]B.'_ *GXX_U\_9Y?\FKXR_[.!B/_ M %G.'PHHHK\//[\"BBB@ HHHH **** "OYK?^#@7_D,?LK?]@WXR_P#I5\,* M_I2K^:W_ (.!?^0Q^RM_V#?C+_Z5?#"OTCPD_P"3@9%_AS3_ -4^//Y<^F=_ MRCAX@?\ 7WA'_P!;;AT_G1HHHK^T#_"H**** "BBB@ HHHH **** "BBB@ K M^V#_ ()'?\H]?V??^ZK_ /J[OB37\3]?VP?\$CO^4>O[/O\ W5?_ -7=\2:_ M%O'7_DDW_)Y^)O^S89U_ZU?!1^D%%%%?R@?[%A1110 M 4444 %%%% !1110 5S/A+_D%77_ &,WC7_U,M>KIJYGPE_R"KK_ +&;QK_Z MF6O4^C]5^3)?QQ_PR_.!!X*_Y ]Y_P!C;X^_]3OQ'76UR7@K_D#WG_8V^/O_ M %._$==;0]WZO\PA\$?\,?R04444B@HHHH **** "BBB@ HHHH **** /Q[_ M .<[?_>,_P#]^$K]A*_'O_G.W_WC/_\ ?A*_82N_'[X/_L PWY2.3";XK_L+ MJ_E ****X#K"O)?CSK?_ C7P7^*'B/_ (3?3?AE_P (_P""?$&M_P#"R-5\ M-?\ "9VOP^_LJPFO_P#A-XO!_E3_ /"5ZEX4\C^WM&\->1-_;NL6%CI?E2?: MMA]:KR7X\ZW_ ,(U\%_BAXC_ .$WTWX9?\(_X)\0:W_PLC5?#7_"9VOP^_LJ MPFO_ /A-XO!_E3_\)7J7A3R/[>T;PUY$W]NZQ86.E^5)]JV'KP"YL=@H\O/S M8O#1Y>3VG->M!S_BM_\ AE7_ (3C_F]W]MW_ M (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4_Y%;_JEG_"K M/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_ M[0TG_B4VGV3Y3_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"% MY?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E_H'XO[_/_P!Q.?VG_A7[ M7VOUO_J-]O\ 7?\ F:?VI_QG'^;?\+_IS['_ +EO8?5O_#-]4^J?V-_U(?[/ M_L'_ )I+_5+_ (Y_/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_ MX^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_X MO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ M"L_[0TG_ (E-I]D^4_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_ MX7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L_P"+V?\ M%[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2? M^)3:?9/E/B_O\_\ W$Y_:?\ A7[7VOUO_J-]O]=_YFG]J?\ &<'\+_IS['_N M6]A]6_\ #-]4^J?V-_U(?[/_ +!_YI+_ %2_XY_/^16_ZI9_PJS_ (O9_P 7 ML_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_X ME-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4 M@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W M_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ MB4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/B_O\_P#W$Y_:?^%?M?:_6_\ J-]O M]=_YFG]J?\9P?PO^G/L?^Y;V'U;_ ,,WU3ZI_8W_ %(?[/\ [!_YI+_5+_CG M\_Y%;_JEG_"K/^+V?\7L_P"*W_X95_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O M]FO_ (F/_"L_[0TG_B4VGV3Y3_D5O^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F M]W]MW_CX_P"%Y?\ !2#XY?:/^,:_V:_^)C_PK/\ M#2?^)3:?9/E/^16_P"J M6?\ "K/^+V?\7L_XK?\ X95_X3C_ )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_ M^)C_ ,*S_M#2?^)3:?9/E/\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W M]MW_ (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^4^+^_P _ M_<3G]I_X5^U]K];_ .HWV_UW_F:?VI_QG!_"_P"G/L?^Y;V'U;_PS?5/JG]C M?]2'^S_[!_YI+_5+_CG\_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?V MW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6? M\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\ M*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ M (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO M9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^ MT-)_XE-I]D^4^+^_S_\ <3G]I_X5^U]K];_ZC?;_ %W_ )FG]J?\9P?PO^G/ ML?\ N6]A]6_\,WU3ZI_8W_4A_L_^P?\ FDO]4O\ CG\_Y%;_ *I9_P *L_XO M9_Q>S_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^ MT-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X M7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_ MQ>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^ M)3:?9/E/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P % M(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4^+^_S_P#<3G]I_P"%?M?:_6_^ MHWV_UW_F:?VI_P 9P?PO^G/L?^Y;V'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\ M5+_CG\_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@ M^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y?TJ_P""?J?V-9_%3PEY'_"%_9+K MP;XR_P"%1>*Y?^$C_:%TG_A8,7B?5_\ A<_[7/C[,OV_]I#]H7[)_P )=XE^ M'7VEO^%3>"-(^'V@?9;+[?Y3?FK_ ,BM_P!4L_X59_Q>S_B]G_%;_P##*O\ MPG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGR_I M5_P3]3^QK/XJ>$O(_P"$+^R77@WQE_PJ+Q7+_P )'^T+I/\ PL&+Q/J__"Y_ MVN?'V9?M_P"TA^T+]D_X2[Q+\.OM+?\ "IO!&D?#[0/LME]O\IOF^+O>X?QS M^*[PL[_'>^,P\^?FOB;W^L^T]K[6=_K?M?KT_P"T/K_%_P"H^#'[OQ(X>C;V M5HYO0Y+>PY;9'F5#ZO[/EROEM_97U?ZG]2H"GZ+4 M445^+G]UA1110 4444 %%%% !1110!_GU_M+?\G&_'__ ++9\5?_ %.M>KQ. MO;/VEO\ DXWX_P#_ &6SXJ_^IUKU>)U_H7EO_(NP'_8%A?\ TQ3/^:3BC_DI MN(O^Q[F__JPQ 4445VGA!1110 4444 %%%% !1110 5^HO\ P1Q_Y/V^&/\ MV+7Q,_\ 4!UZORZK]1?^"./_ "?M\,?^Q:^)G_J Z]7S'&O_ "1_%'_8@S;_ M -0:Y^L> _\ R>SPE_[.-P;_ .K_ !_9W1117\''_1 %%%% !1110 4444 M%%%% '\E_P#P7B_Y.\^'/_9M_A#_ -6=\8*_$^OVP_X+Q?\ )WGPY_[-O\(? M^K.^,%?B?7]R>'7_ "1'#?\ V+:?_I=0_P"?[Z3O_)_?%+_LIZ__ *BX4*** M*^T/P@**** "BBB@ HHHH **** "BBB@#_2 HHHK_.<_Z> HHHH **** "BB MB@ HHHH _'3_ (+B_P#)E^F?]EK\#?\ IA\:5_(57]>O_!<7_DR_3/\ LM?@ M;_TP^-*_D*K^O/!3_DBE_P!C;'_^DX<_Q6^GC_R?>?\ V1W#O_IS,0HHHK]< M/XP"BBB@ HHHH **** "BBB@ HHHH _L\_X(Y?\ )A'PO_[&3XF_^I_K]?J) M7Y=_\$$O\ V;K@_P#]4.!"BBBOES]9"BBB@ HHHH **** "BBB@#B]#_Y'#QQ_ MW+/_ *:Y:[2N+T/_ )'#QQ_W+/\ Z:Y:[2JENO\ ##_TB),=G_BG_P"ER"BB MBI*"BBB@#%\2?\B[K_\ V!=4_P#2&>CPW_R+N@?]@72__2&"CQ)_R+NO_P#8 M%U3_ -(9Z/#?_(NZ!_V!=+_](8*K['_;WZ$_;_[=_4VJ***DH**** "BBB@ MHHHH **** "BBB@#\>O^"I?_ "6'_@EE_P!I _A5_P"CHJ_86OQZ_P""I?\ MR6'_ ()9?]I _A5_Z.BK]A:[\3_N67?X,5_ZDR.2A_O.-_QT/_3$ HHHK@.L M**** /YX_&7_ !2WB_Q5_P BW\+/^%6>)-<^-G_%=?\ %;^$/V5?^$XU.Z_X MS=_:S_X^/^%Y?M^?'+[1_P 8G_LU_P#$Q_X5GIFH:!_Q*;3[)\O-_P#(K?\ M5+/^%6?\7L_XO9_Q6_\ PRK_ ,)Q_P WN_MN_P#'Q_PO+_@I!\,O^*6\7^*O^1;^%G_"K/$FN?&S_BNO^*W\ M(?LJ_P#"<:G=?\9N_M9_\?'_ O+]OSXY?:/^,3_ -FO_B8_\*STS4- _P") M3:?9/EYO_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY M?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E_HBC[U&E]OGIT_P#IYS^TBO/&>U]K M];[X[V_UW_F:?VI_QG'^9N-_=8S%_P#+GV.*K_\ 4-[#ZM5G_P!B7ZI]4_L; MMD']G_V#_P TE_JE_P <_G_(K?\ 5+/^%6?\7L_XO9_Q6_\ PRK_ ,)Q_P W MN_MN_P#'Q_PO+_@I!\[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A M6?\ :&D_\2FT^R?+I\7]_G_[B<_M/_"OVOM?K?\ U&^W^N_\S3^U/^,XY?X7 M_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_: M&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P + MR_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V? M\5O_ ,,J_P#"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_ MX*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M M_P#4;[?Z[_S-/[4_XS@_A?\ 3GV/_[^V[_P ?'_"\O^"D M'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ M%;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^ MR?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+ M[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J M_P#"[^V[_Q\?\ "\O^"D'QR^T?\8U_ MLU_\3'_A6?\ :&D_\2FT^R?*?%_?Y_\ N)S^T_\ "OVOM?K?_4;[?Z[_ ,S3 M^U/^,X/X7_3GV/\ W+>P^K?^&;ZI]4_L;_J0_P!G_P!@_P#-)?ZI?\<_G_(K M?]4L_P"%6?\ %[/^+V?\5O\ \,J_\)Q_S>[^V[_Q\?\ "\O^"D'QR^T?\8U_ MLU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ M #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W M_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[ M-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S M>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*?%_?Y_P#N M)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C.#^%_TY]C_W+>P^K?\ AF^J?5/[ M&_ZD/]G_ -@_\TE_JE_QS^?\BM_U2S_A5G_%[/\ B]G_ !6__#*O_")?,O_@M_PLUVL/\ AJ;]N7QAYI_X6-_P M4%_:=_M#^P?@C\$//NO^%+>&_$']J?V?8?V5O3QO_D5O^J6?\*L_XO9_Q>S_ M (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:? M9/E]D_9[T39\;?AEX<_X0C7(?^$,\6Z;\4?^%;_$SQ+YE_\ !;_A9KM8?\-3 M?MR^,/-/_"QO^"@O[3O]H?V#\$?@AY]U_P *6\-^(/[4_L^P_LK>G)F$O]@Q MTN;?"8F7-S[\]&;YO:?6->?ZW?G^M5/:_7;_ %C'?VG[3C;W.&8?\9)P_2]G M\.>933]E['X?8X_#Q]G]7_LU_3=_ MY2%XF_[$_"W_ *HL&%%%%?J)_)(4444 %%%% !1110 4444 %%%% ']E7_!& M3_DQ+P1_V.WQ(_\ 4HNJ_5:ORI_X(R?\F)>"/^QV^)'_ *E%U7ZK5_"/'/\ MR67$_P#V/,R_]2JA_P!#7@!_R9#PF_[-_P +?^JC"A1117RI^O!1110 4444 M %%%% !7^=)XS_Y'#Q9_V,NN_P#ITNJ_T6Z_SI/&?_(X>+/^QEUW_P!.EU7] M$> /\7BG_KWDW_I6:'^9G[1S_<_"+_L)XY_]-<)G-4445_2!_ET%%%% !111 M0 4444 %%%% !1110!]U?\$S?^3[?V;O^QVO/_47U^O[EJ_AI_X)F_\ )]O[ M-W_8[7G_ *B^OU_7_)J^,O\ LX&( M_P#6('_7WA'_ -;;AT_G1HHHK^T#_"H**** "BBB@ HHHH **** "BBB@ K^ MV#_@D=_RCU_9]_[JO_ZN[XDU_$_7]L'_ 2._P"4>O[/O_=5_P#U=WQ)K\6\ M=?\ DD-?_4RUZNFKF?"7_(*NO^QF\:_^ MIEKU/H_5?DR7\"O^0/>?]C;X^_]3OQ'76UR7@K_ ) ]Y_V-OC[_ M -3OQ'76T/=^K_,(?!'_ Q_)!1112*"BBB@ HHHH **** "BBB@ HHHH _' MO_G.W_WC/_\ ?A*_82OQ[_YSM_\ >,__ -^$K]A*[\?O@_\ L PWY2.3";XK M_L+J_E ****X#K"O)?CSK?\ PC7P7^*'B/\ X3?3?AE_PC_@GQ!K?_"R-5\- M?\)G:_#[^RK":_\ ^$WB\'^5/_PE>I>%/(_M[1O#7D3?V[K%A8Z7Y4GVK8?6 MJ\E^/.M_\(U\%_BAXC_X3?3?AE_PC_@GQ!K?_"R-5\-?\)G:_#[^RK":_P#^ M$WB\'^5/_P )7J7A3R/[>T;PUY$W]NZQ86.E^5)]JV'KP"YL=@H\O/S8O#1Y M>3VG->M!S_BM_P#AE7_A./\ F]W]MW_CX_X7 ME_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B]G_%[ M/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P *S_M# M2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_! M2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E_H'XO[_/_ -Q.?VG_ (5^U]K] M;_ZC?;_7?^9I_:G_ !G'^;?\+_IS['_N6]A]6_\ #-]4^J?V-_U(?[/_ +!_ MYI+_ %2_XY_/^16_ZI9_PJS_ (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E M_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q> MS_BM_P#AE7_A./\ F]W]MW_CX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_ MXE-I]D^4_P"16_ZI9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P M4@^.7VC_ (QK_9K_ .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ M (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:? M9/E/B_O\_P#W$Y_:?^%?M?:_6_\ J-]O]=_YFG]J?\9P?PO^G/L?^Y;V'U;_ M ,,WU3ZI_8W_ %(?[/\ [!_YI+_5+_CG\_Y%;_JEG_"K/^+V?\7L_P"*W_X9 M5_X3C_F]W]MW_CX_X7E_P4@^.7VC_C&O]FO_ (F/_"L_[0TG_B4VGV3Y3_D5 MO^J6?\*L_P"+V?\ %[/^*W_X95_X3C_F]W]MW_CX_P"%Y?\ !2#XY?:/^,:_ MV:_^)C_PK/\ M#2?^)3:?9/E/^16_P"J6?\ "K/^+V?\7L_XK?\ X95_X3C_ M )O=_;=_X^/^%Y?\%(/CE]H_XQK_ &:_^)C_ ,*S_M#2?^)3:?9/E/\ D5O^ MJ6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ (^/^%Y?\%(/CE]H_P",:_V: M_P#B8_\ "L_[0TG_ (E-I]D^4^+^_P __<3G]I_X5^U]K];_ .HWV_UW_F:? MVI_QG!_"_P"G/L?^Y;V'U;_PS?5/JG]C?]2'^S_[!_YI+_5+_CG\_P"16_ZI M9_PJS_B]G_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ M .)C_P *S_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W? MVW?^/C_A>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ M (O9_P 7L_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L M_P"T-)_XE-I]D^4_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_C MX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4^+^_S_\ <3G]I_X5 M^U]K];_ZC?;_ %W_ )FG]J?\9P?PO^G/L?\ N6]A]6_\,WU3ZI_8W_4A_L_^ MP?\ FDO]4O\ CG\_Y%;_ *I9_P *L_XO9_Q>S_BM_P#AE7_A./\ F]W]MW_C MX_X7E_P4@^.7VC_C&O\ 9K_XF/\ PK/^T-)_XE-I]D^4_P"16_ZI9_PJS_B] MG_%[/^*W_P"&5?\ A./^;W?VW?\ CX_X7E_P4@^.7VC_ (QK_9K_ .)C_P * MS_M#2?\ B4VGV3Y3_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A M>7_!2#XY?:/^,:_V:_\ B8_\*S_M#2?^)3:?9/E/^16_ZI9_PJS_ (O9_P 7 ML_XK?_AE7_A./^;W?VW?^/C_ (7E_P %(/CE]H_XQK_9K_XF/_"L_P"T-)_X ME-I]D^4^+^_S_P#<3G]I_P"%?M?:_6_^HWV_UW_F:?VI_P 9P?PO^G/L?^Y; MV'U;_P ,WU3ZI_8W_4A_L_\ L'_FDO\ 5+_CG\_Y%;_JEG_"K/\ B]G_ !>S M_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ +0TG_B4 MVGV3Y3_D5O\ JEG_ JS_B]G_%[/^*W_ .&5?^$X_P";W?VW?^/C_A>7_!2# MXY?:/^,:_P!FO_B8_P#"L_[0TG_B4VGV3Y3_ )%;_JEG_"K/^+V?\7L_XK?_ M (95_P"$X_YO=_;=_P"/C_A>7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P") M3:?9/E/^16_ZI9_PJS_B]G_%[/\ BM_^&5?^$X_YO=_;=_X^/^%Y?\%(/CE] MH_XQK_9K_P")C_PK/^T-)_XE-I]D^4^+^_S_ /<3G]I_X5^U]K];_P"HWV_U MW_F:?VI_QG!_"_Z<^Q_[EO8?5O\ PS?5/JG]C?\ 4A_L_P#L'_FDO]4O^.?S M_D5O^J6?\*L_XO9_Q>S_ (K?_AE7_A./^;W?VW?^/C_A>7_!2#XY?:/^,:_V M:_\ B8_\*S_M#2?^)3:?9/E_2K_@GZG]C6?Q4\)>1_PA?V2Z\&^,O^%1>*Y? M^$C_ &A=)_X6#%XGU?\ X7/^USX^S+]O_:0_:%^R?\)=XE^'7VEO^%3>"-(^ M'V@?9;+[?Y3?FK_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"C;V5HYO0Y+>PY;9'F5#ZO[/E MROEM_97U?ZG]2HK\NJ_47_ ((X M_P#)^WPQ_P"Q:^)G_J Z]7S'&O\ R1_%'_8@S;_U!KGZQX#_ /)[/"7_ +.- MP;_ZO\ ?V=T445_!Q_T0!1110 4444 %%%% !1110!_)?_P7B_Y.\^'/_9M_ MA#_U9WQ@K\3Z_;#_ (+Q?\G>?#G_ +-O\(?^K.^,%?B?7]R>'7_)$<-_]BVG M_P"EU#_G^^D[_P G]\4O^RGK_P#J+A0HHHK[0_" HHHH **** "BBB@ HHHH M **** /]("BBBO\ .<_Z> HHHH **** "BBB@ HHHH _'3_@N+_R9?IG_9:_ M W_IA\:5_(57]>O_ 7%_P"3+],_[+7X&_\ 3#XTK^0JOZ\\%/\ DBE_V-L? M_P"DX<_Q6^GC_P GWG_V1W#O_IS,0HHHK]$O_9NN#__ %0X$****^7/ MUD**** "BBB@ HHHH **** .+T/_ )'#QQ_W+/\ Z:Y:[2N+T/\ Y'#QQ_W+ M/_IKEKM*J6Z_PP_](B3'9_XI_P#I<@HHHJ2@HHHH Q?$G_(NZ_\ ]@75/_2& M>CPW_P B[H'_ &!=+_\ 2&"CQ)_R+NO_ /8%U3_TAGH\-_\ (NZ!_P!@72__ M $A@JOL?]O?H3]O_ +=_4VJ***DH**** "BBB@ HHHH **** "BBB@#\>O\ M@J7_ ,EA_P""67_:0/X5?^CHJ_86OQZ_X*E_\EA_X)9?]I _A5_Z.BK]A:[\ M3_N67?X,5_ZDR.2A_O.-_P =#_TQ ****X#K"BBB@#^>/QE_Q2WB_P 5?\BW M\+/^%6>)-<^-G_%=?\5OX0_95_X3C4[K_C-W]K/_ (^/^%Y?M^?'+[1_QB?^ MS7_Q,?\ A6>F:AH'_$IM/LGR\W_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"< M?\WN_MN_\?'_ O+_@I!\7_!2#XY?:/\ C&O]FO\ XF/_ K/^T-)_P") M3:?9/E_HBC[U&E]OGIT_^GG/[2*\\9[7VOUOOCO;_7?^9I_:G_&P^K59_P#8E^J?5/[&[9!_9_\ 8/\ S27^J7_'/Y_R*W_5 M+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ M !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_ MQ>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6 M?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^?\BM_P!4L_X59_Q>S_B] MG_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G_:&D M_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S>[^V[_P ?'_"\ MO^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I_R*W_5+/^%6?\7L_P"+ MV?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\ M2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X* M0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G_P"XG/[3_P *_:^U^M_] M1OM_KO\ S-/[4_XS@_A?].?8_P#S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0? M'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5 MO_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[) M\I\7]_G_ .XG/[3_ ,*_:^U^M_\ 4;[?Z[_S-/[4_P",X/X7_3GV/_[^V[_Q\?\+R_P""D'QR^T?\8U_LU_\ $Q_X5G_:&D_\2FT^R?*? M\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_PG'_-[O[;O_'Q_P +R_X*0?'+[1_Q MC7^S7_Q,?^%9_P!H:3_Q*;3[)\I_R*W_ %2S_A5G_%[/^+V?\5O_ ,,J_P#" MS_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8 MU_LU_P#$Q_X5G_:&D_\ $IM/LGRGQ?W^?_N)S^T_\*_:^U^M_P#4;[?Z[_S- M/[4_XS@_A?\ 3GV/_[^V[_P ?'_"\O^"D'QR^T?\ &-?[ M-?\ Q,?^%9_VAI/_ !*;3[)\OLG[/>B;/C;\,O#G_"$:Y#_PAGBW3?BC_P * MW^)GB7S+_P""W_"S7:P_X:F_;E\8>:?^%C?\%!?VG?[0_L'X(_!#S[K_ (4M MX;\0?VI_9]A_96]/&_\ D5O^J6?\*L_XO9_Q>S_BM_\ AE7_ (3C_F]W]MW_ M (^/^%Y?\%(/CE]H_P",:_V:_P#B8_\ "L_[0TG_ (E-I]D^7V3]GO1-GQM^ M&7AS_A"-933]E['X?8 MX_#Q]G]7_LU)O\ L3\+?^J+ M!A1117ZB?R2%%%% !1110 4444 %%%% !1110!_95_P1D_Y,2\$?]CM\2/\ MU*+JOU6K\J?^",G_ "8EX(_[';XD?^I1=5^JU?PCQS_R67$__8\S+_U*J'_0 MUX ?\F0\)O\ LW_"W_JHPH4445\J?KP4444 %%%% !1110 5_G2>,_\ D*?\ KWDW_I6: M'^9G[1S_ '/PB_[">.?_ $UPF7_ ":OC+_LX&(_]9SA\****_#S^_ H MHHH **** "BBB@ K^:W_ (.!?^0Q^RM_V#?C+_Z5?#"OZ4J_FM_X.!?^0Q^R MM_V#?C+_ .E7PPK](\)/^3@9%_AS3_U3X\_ESZ9W_*.'B!_U]X1_];;AT_G1 MHHHK^T#_ J"BBB@ HHHH **** "BBB@ HHHH *_M@_X)'?\H]?V??\ NJ__ M *N[XDU_$_7]L'_!([_E'K^S[_W5?_U=WQ)K\6\=?^21R[_LH\)_ZK,W/[M_ M9[?\GGXF_P"S89U_ZU?!1^D%%%%?R@?[%A1110 4444 %%%% !1110 5S/A+ M_D%77_8S>-?_ %,M>KIJYGPE_P @JZ_[&;QK_P"IEKU/H_5?DR7\"O^0/>?\ 8V^/O_4[\1UUM#W?J_S"'P1_ MPQ_)!1112*"BBB@ HHK\C/\ @K+^W=\5/V3?"7P>^#'[.7@FZ\3?M0_M@>(= M;^&?P-UZZE\(1>&_!>OV^J^ _"O]HO'XSU&UT#4O'NJ>(/BAX1TKX;Z;XMAA M^&MMJD^I>*OB/JLGA_PM_P (5XZVH4*F)K0HTDN>;=G)J,8QC%SG.4GI&,(1 ME.3Z1BW9[&=6K&C3E4G?EC;9-R;DU&,8I;RE)J,5U;6Q^N=%?S2Z/^U+_P % M9?V$/VG_ -D?X.?MQ_$?]G']IWPO^VA\6](^&FB6_@B*31?$WP^TK3/$W@CP M+XC\4Z-XA\.? KX'Z5:7<.K_ !L\%^)]0T7Q)X4^)$'BC3?!5UX7T74OAC=: MW<>*CS_QO_X*%_\ !0CXT?%W]OKQ)^QIXF\#^!/@M_P3 \36H\7?#CQ!\._! MU_XZ_: /A[X@0^#OBEI_C[5?&7B+7=,M?AEX5M?@C^TKX^LM?^%/B_X2?%/4 M_AXWA'P;I?A76/B9XLM-:^'/8LKKRE%1JX>5*=-5(8A3G["2=>.&4;NFJBG[ M><:=I4U9OG;5-.:YOKU)1ES4ZT:D9\DJ+C'VJM2=9RLIN#C[).=U-MVY4G.T M3^GJBOQ#_:]_X*:?$RQ_9G_96T+]D?P3H_B/]O']N[X;?#'QI\+_ (&6&KP^ M-O$_PE\&_$WX?77BS6/B=-%?^']+\):KI_A#4K>?PMX<\1?%1_AY\/YY['Q7 M\5/$-KK/@+X._$_PDO['?#_1_%?A[P'X)T#QYXQ7XB>.-#\(^&]'\9_$!/#M MAX/3QUXKTS1K*R\1>,5\):3<7>E^%U\3ZO!>:VOAW3;JYT_1!?#3+.XFM[:. M1N2KAZE&G"I4Y8NI*I&%-M^T:IODE4LDX^SYU*G&7-[TX344U%M=$*T*DI1A M>2C&$I32]Q.:YHPO>_/R6FXV]V,HMVYDGUU%%%8&I^/?_.=O_O&?_P"_"5^P ME?CW_P YV_\ O&?_ ._"5^PE=^/WP?\ V 8;\I')A-\5_P!A=7\H!1117 =8 M5Y+\>=;_ .$:^"_Q0\1_\)OIOPR_X1_P3X@UO_A9&J^&O^$SM?A]_95A-?\ M_";Q>#_*G_X2O4O"GD?V]HWAKR)O[=UBPL=+\J3[5L/K5>2_'G6_^$:^"_Q0 M\1_\)OIOPR_X1_P3X@UO_A9&J^&O^$SM?A]_95A-?_\ ";Q>#_*G_P"$KU+P MIY']O:-X:\B;^W=8L+'2_*D^U;#UX!7GYL7AH\O)[3FO6@N7V?U?%\ M_-MR?5,5S7Y?J]:_LY>/Q%4]EP_GM7VGL?9Y/F=3VOMOJWLN3!5Y>T^L?VED MWL.2W-[;^U\J]E;G_M+ \OUJE^#/_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG M'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5 M+/\ A5G_ !>S_B]G_%;_ /#*O_"P^K?\ AF^J?5/[&_ZD/]G_ -@_\TE_JE_QS^?\ MBM_U2S_A5G_%[/\ B]G_ !6__#*O_"[^V[_Q\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4 ML_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_ M\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK_P )Q_S> M[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\I\7]_G_[ MB<_M/_"OVOM?K?\ U&^W^N_\S3^U/^,X/X7_ $Y]C_W+>P^K?^&;ZI]4_L;_ M *D/]G_V#_S27^J7_'/Y_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGRGQ?W^?_N)S^T_\*_:^U^M_]1OM_KO_ #-/[4_XS@_A?].? M8_\ S_B]G_%;_\ #*O_ G'_-[O[;O_ !\? M\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ $IM/LGRG_(K?]4L_X59_Q>S_ M (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H: M3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_ /#*O_"S_ (O9_P 5 MO_PRK_PG'_-[O[;O_'Q_PO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[) M\I_R*W_5+/\ A5G_ !>S_B]G_%;_ /#*O_"S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8 MU_LU_P#$Q_X5G_:&D_\ $IM/LGR_I5_P3]3^QK/XJ>$O(_X0O[)=>#?&7_"H MO%1_PA?V2Z\&^,O\ A47BN7_A(_VA=)_X6#%XGU?_ (7/^USX^S+]O_:0 M_:%^R?\ "7>)?AU]I;_A4W@C2/A]H'V6R^W^4WS?%WO M?/S7Q-[_ %GVGM?:SO\ 6_:_7I_VA]?XO_4?!C]WXDV?M+?\G&_'_\ M[+9\5?\ U.M>KQ.O]"\M_P"1=@/^P+"_^F*9_P TG%'_ "4W$7_8]S?_ -6& M("BBBNT\(**** "BBB@ HHHH **** "OU%_X(X_\G[?#'_L6OB9_Z@.O5^75 M?J+_ ,$KYCC7_DC^*/^Q!FW_J#7/UCP'_Y/9X2 M_P#9QN#?_5_@#^SNBBBOX./^B **** "BBB@ HHHH **** /Y+_^"\7_ "=Y M\.?^S;_"'_JSOC!7XGU^V'_!>+_D[SX<_P#9M_A#_P!6=\8*_$^O[D\.O^2( MX;_[%M/_ -+J'_/]])W_ )/[XI?]E/7_ /47"A1117VA^$!1110 4444 %%% M% !1110 4444 ?Z0%%%%?YSG_3P%%%% !1110 4444 %%%% 'XZ?\%Q?^3+] M,_[+7X&_],/C2OY"J_KU_P""XO\ R9?IG_9:_ W_ *8?&E?R%5_7G@I_R12_ M[&V/_P#2<.?XK?3Q_P"3[S_[([AW_P!.9B%%%%?KA_& 4444 %%%% !1110 M4444 %%%% ']GG_!'+_DPCX7_P#8R?$W_P!3_7Z_42OR[_X(Y?\ )A'PO_[& M3XF_^I_K]?J)7\'\;?\ )8<4?]C[-?\ U,K'_0_X#?\ )DO"7_LW7!__ *H< M"%%%%?+GZR%%%% !1110 4444 %%%% '%Z'_ ,CAXX_[EG_TURUVE<7H?_(X M>./^Y9_]-_0G[?\ V[^IM4445)04444 %%%% !17\_OQ6_X+HWES M\:?'7PP_8?\ V+_BC^WUX0^&]IX?M?%?Q:^#6K>.[[PRGB77KSQ!;VZZ5!\. MO@5\8XKGX?WHT"_M?"GQ,U;5M"TGQ]J6A^+KCP5IVM>#-$TOQKXE]-_B)\6_%OP!^&_[-\&CZ#H_P 9=>^+_A[PM:>) M=/L;G0;+7O$UUK?@34SXJ^$FG:CXS^#%C\:=0\/ZE\:OAUX?G\(WOCB^U3P; MI?<\MQJ5-O#R_>.,4N:FY1V5.\4WLG;E6-PSK2W:/VFHK\_?V"OV^-"_;4L/C/X7UGX>7WP8^ M/_[-GQ'UGX8_'SX/2^)8/B)I'@[7;+Q5XT\+Z3<^'/BIH^B:'X:\<:?J-]X" M\5:5J0L;#3]1T+Q/X:U^QET^]\+R>#?&OC1W["O[?/AS]OF[_: \5?"GX=ZQ MI7P$^$_Q#T;X:?#KXP:[KUE!J7QBU\>&K?Q+XSED^%L^GV/B_P"&5GX?TW6_ M!&M:$GBYGU+Q-X:\=Z)=7^G>%?%.F>+/!GAS&>%KT_;<]-Q]A[-U7S1Y5[6W MLN62ERU/:)\T/9N7/33J1O3C*2UC7I3]GRSO[7GY$E*[]G?GNK7AR-O^"I?_)8?^"67_:0/X5?^CHJ_86OQZ_X*E_\ )8?^ M"67_ &D#^%7_ *.BK]A:[\3_ +EEW^#%?^I,CDH?[SC?\=#_ -,0"BBBN ZP MHHHH _GC\9?\4MXO\5?\BW\+/^%6>)-<^-G_ !77_%;^$/V5?^$XU.Z_XS=_ M:S_X^/\ A>7[?GQR^T?\8G_LU_\ $Q_X5GIFH:!_Q*;3[)\O-_\ (K?]4L_X M59_Q>S_B]G_%;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$ MQ_X5G_:&D_\ $IM/LGR])XR_XI;Q?XJ_Y%OX6?\ "K/$FN?&S_BNO^*W\(?L MJ_\ "<:G=?\ &;O[6?\ Q\?\+R_;\^.7VC_C$_\ 9K_XF/\ PK/3-0T#_B4V MGV3Y>;_Y%;_JEG_"K/\ B]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@ M^.7VC_C&O]FO_B8_\*S_ +0TG_B4VGV3Y?Z(H^]1I?;YZ=/_ *><_M(KSQGM M?:_6^^.]O]=_YFG]J?\ &P^K59_]B7ZI]4_L M;MD']G_V#_S27^J7_'/Y_P BM_U2S_A5G_%[/^+V?\5O_P ,J_\ "[^V[_Q M\?\ "\O^"D'QR^T?\8U_LU_\3'_A6?\ :&D_\2FT^R?*?\BM_P!4L_X59_Q> MS_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T?\8U_LU_\3'_ (5G M_:&D_P#$IM/LGRZ?%_?Y_P#N)S^T_P#"OVOM?K?_ %&^W^N_\S3^U/\ C..7 M^%_TY]C_ -RWL/JW_AF^J?5/[&_ZD/\ 9_\ 8/\ S27^J7_'/Y_R*W_5+/\ MA5G_ !>S_B]G_%;_ /#*O_"S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_ MPO+_ (*0?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S M_B]G_%;_ /#*O_"S_B]G_% M;_\ #*O_ G'_-[O[;O_ !\?\+R_X*0?'+[1_P 8U_LU_P#$Q_X5G_:&D_\ M$IM/LGRG_(K?]4L_X59_Q>S_ (O9_P 5O_PRK_PG'_-[O[;O_'Q_PO+_ (*0 M?'+[1_QC7^S7_P 3'_A6?]H:3_Q*;3[)\I_R*W_5+/\ A5G_ !>S_B]G_%;_ M /#*O_"P^K?^&;ZI]4_L;_J0_V?_8/_ #27^J7_ !S^ M?\BM_P!4L_X59_Q>S_B]G_%;_P##*O\ PG'_ #>[^V[_ ,?'_"\O^"D'QR^T M?\8U_LU_\3'_ (5G_:&D_P#$IM/LGRG_ "*W_5+/^%6?\7L_XO9_Q6__ RK M_P )Q_S>[^V[_P ?'_"\O^"D'QR^T?\ &-?[-?\ Q,?^%9_VAI/_ !*;3[)\ MI_R*W_5+/^%6?\7L_P"+V?\ %;_\,J_\)Q_S>[^V[_Q\?\+R_P""D'QR^T?\ M8U_LU_\ $Q_X5G_:&D_\2FT^R?*?\BM_U2S_ (59_P 7L_XO9_Q6_P#PRK_P MG'_-[O[;O_'Q_P +R_X*0?'+[1_QC7^S7_Q,?^%9_P!H:3_Q*;3[)\I\7]_G M_P"XG/[3_P *_:^U^M_]1OM_KO\ S-/[4_XS@_A?].?8_P# MB;/C;\,O#G_"$:Y#_P (9XMTWXH_\*W^)GB7S+_X+?\ "S7:P_X:F_;E\8>: M?^%C?\%!?VG?[0_L'X(_!#S[K_A2WAOQ!_:G]GV']E;T\;_Y%;_JEG_"K/\ MB]G_ !>S_BM_^&5?^$X_YO=_;=_X^/\ A>7_ 4@^.7VC_C&O]FO_B8_\*S_ M +0TG_B4VGV3Y?9/V>]$V?&WX9>'/^$(UR'_ (0SQ;IOQ1_X5O\ $SQ+YE_\ M%O\ A9KM8?\ #4W[?=?\*6\-^(/[4_L^ MP_LK>G)F$O\ 8,=+FWPF)ES<^_/1F^;VGUC7G^MWY_K53VOUV_UC'?VG[3C; MW.&8?\9)P_2]G\.>933]E['X?8X_#Q]G]7_LU '_ "9#PF_[-_PM_P"JC"A1117R MI^O!1110 4444 %%%% !7^=)XS_Y'#Q9_P!C+KO_ *=+JO\ 1;K_ #I/&?\ MR.'BS_L9==_].EU7]$> /\7BG_KWDW_I6:'^9G[1S_<_"+_L)XY_]-<)G-44 M45_2!_ET%%%% !1110 4444 %%%% !1110!]U?\ !,W_ )/M_9N_[':\_P#4 M7U^O[EJ_AI_X)F_\GV_LW?\ 8[7G_J+Z_7]RU?ROX[_\E+E'_8CA_P"I^./] M?/V>7_)J^,O^S@8C_P!9SA\****_#S^_ HHHH **** "BBB@ K^:W_@X%_Y# M'[*W_8-^,O\ Z5?#"OZ4J_FM_P"#@7_D,?LK?]@WXR_^E7PPK](\)/\ DX&1 M?X('_ %]X1_\ 6VX=/YT:***_M _PJ"BBB@ HHHH M**** "BBB@ HHHH *_M@_P""1W_*/7]GW_NJ_P#ZN[XDU_$_7]L'_!([_E'K M^S[_ -U7_P#5W?$FOQ;QU_Y)'+O^RCPG_JLS<_NW]GM_R>?B;_LV&=?^M7P4 M?I!1117\H'^Q84444 %%%% !1110 4444 %"O^0/>?\ 8V^/O_4[\1UU MMR_:#_8YFNY?3;!$0[\YQT!K^B6OC#]M MG]@K]GG]OKX>:3X!^.VA:FEUX8U*34_!7Q$\'3:1I7Q'\$-J$VG?\)1IGA[7 M-9T3Q%IK>'O&^G:79Z3XQ\,ZWHFL^']9CL]&UIM-@\6^%/!OB+P[VY?7IX?% M0J5>94W"O2FX+FE&.(P]6@YJ+:YN3VO/RW5TK+5G/BZC:-\9/VEOVJ_ M#6B?#2V\2P>(K?PTUNOA?Q%\+-6U_7_$.CZ#K=MI.DZ!XM^.'PW@U"V$5UXC MOK+6[B\\.:!KJ:/K"V/*_P#!2[_@F'^S!X2D^/W[:'Q _:(_:%^!_P"SIXVO M[#QY^UK^SW\!]%T+^S?C9X[AG\*Z%\$CX*T72K71O!>G^+KGX^ZC_P +'\0: M_P#'7PA\8](U;XF>/]=\;77BGX.6[:]XVM?I+]E+_@C;X;^%'QA\._M(_M:? MM&_$O]N[X_\ @*5;?X9^*OBU!K">$_!&F:7=VFN>"KRW\->./'?Q@\5ZIXM^ M'WBN]\<>(_!6HWWQ'_X0OPUJOC%?$F@_#O2OB'X(O$7AG3=(^'FI>)X MK;QMH6@02?#'6+*^U&*W\2>#O'UAXJ\-^)O&/P_O[+3_ QXQ\4P:QW0QE+# MRP="CBJGL^[&"9R2P]2JL3 M4J4(>TJRI*E2E._(H0]GSU)1:3_B593A!OGI?N]7)H_EJ_92\0_MG:=^T;^R M1\./ _CCPK\(/VH?VUOV:_"*?##XG:H;WXJ?#S]F'_@F[H]O8>./@IX)^ '@ MOQ!XF\<^&_\ A*M:\*_LU?=:\+_&;2OB[KFO^&-5^!NH:A\:?AU\=OB'^ MTSXS@_I3_P""5G[3GQY_:7_9V\61?M/^%=.\,_M _L\_&GQE^S+\6[G3;_P_ M=#Q7XV^&>@>#;_6_$VI6/A"-_!>C>(6N_%3Z#XFM? NHZIX%U3Q#H.I^*O!7 M]@^%_$.E>#_#=;]OS_@FMHO[:&N^ ?BUX!^-_C_]E;]IOX4Z#K7A;P#\>/A7 M9PV^MGP[XDU;3)=4T;QI>>&M4\ ?%/7M-T;P_+\0='\":=X:^,?@73O#%[\5 MO'FIZC9^)K#7M7T#4O>?V)?V)/@I^P+\%W^!WP+'BVX\-7GB[6?'.N:UXWUN MWUOQ)K_B35['1]#2[N_[*TOP_P"&M+MM)\*>&?"OA/2],\+^&O#^F_V7XU9N\J'U=T*=.G>34J M!KGXPW'Q#@D^'L/B*#P_P#\(+X[U;P8C)XH?1)-3_M-=,!& MHL&T"P^R--S:@W(C_P"/AZ^R:*\NE6JT*D:M&?\ AQW^Q/\ ]!#]H+_P^7BK_P")I#_P0Y_8 ME88:^_:!895L'XX^*2,J0RGE.JL RGJ" 1R*_8>BC^U?D@^ MH8+_ *!:/_@"\O\ )'XS_P##B+]@_P#YX_'#_D)?VS_R63Q!_P AC_H*_P"H M_P"0E_T_?\?7_36C_AQ%^P?_ ,\?CA_R$O[9_P"2R>(/^0Q_T%?]1_R$O^G[ M_CZ_Z:U^S%%7_;.:_P#0QQG_ (/G_G_7S9E_9.6?] &$_P#!%/R_N^2/QG_X M<1?L'_\ /'XX?\A+^V?^2R>(/^0Q_P!!7_4?\A+_ *?O^/K_ *:T?\.(OV#_ M /GC\(/ M^0Q_T%?]1_R$O^G[_CZ_Z:U^S%%']LYK_P!#'&?^#Y_Y_P!?-A_9.6?] &$_ M\$4_+^[Y(_&?_AQ%^P?_ ,\?CA_R$O[9_P"2R>(/^0Q_T%?]1_R$O^G[_CZ_ MZ:T?\.(OV#_^>/QP_P"0E_;/_)9/$'_(8_Z"O^H_Y"7_ $_?\?7_ $UK]F** M/[9S7_H8XS_P?/\ S_KYL/[)RS_H PG_ ((I^7]WR1^,_P#PXB_8/_YX_'#_ M )"7]L_\ED\0?\AC_H*_ZC_D)?\ 3]_Q]?\ 36C_ (<1?L'_ //'XX?\A+^V M?^2R>(/^0Q_T%?\ 4?\ (2_Z?O\ CZ_Z:U^S%%']LYK_ -#'&?\ @^?^?]?- MA_9.6?\ 0!A/_!%/R_N^2/QG_P"'$7[!_P#SQ^.'_(2_MG_DLGB#_D,?]!7_ M %'_ "$O^G[_ (^O^FM'_#B+]@__ )X_'#_D)?VS_P ED\0?\AC_ *"O^H_Y M"7_3]_Q]?]-:_9BBC^V*O_B:/^''?[$__00_:"_\/EXJ_P#B:_8:BI_M7,O^ M@[$_^#9>7GY(T^H8/_H&H_\ @"\O\D?CS_PX[_8G_P"@A^T%_P"'R\5?_$T? M\.._V)_^@A^T%_X?+Q5_\37[#44?VKF7_0=B?_!LO+S\D'U#!_\ 0-1_\ 7E M_DC\>?\ AQW^Q/\ ]!#]H+_P^7BK_P")H_X<=_L3_P#00_:"_P##Y>*O_B:_ M8:BC^U7GY(/J&#_ .@:C_X O+_)'X\_\.._V)_^@A^T%_X? M+Q5_\31_PX[_ &)_^@A^T%_X?+Q5_P#$U^PU%']JYE_T'8G_ ,&R\O/R0?4, M'_T#4?\ P!>7^2/QY_X<=_L3_P#00_:"_P##Y>*O_B:/^''?[$__ $$/V@O_ M ^7BK_XFOV&HH_M7,O^@[$_^#9>7GY(/J&#_P"@:C_X O+_ "1^+$O_ 0. M_P""?DTDDTVD?&&::9WEEEE^+&L222R2,7>21WM"SN[$L[L2S,222233/^'! M/_!/C_H"?%[_ ,.MJW_R'7[545I_;><+;,\;I_U$5?+^]Y?U=G,\CR9N[RK M-MW;>$HMMZ:M\FKT1^*O_#@G_@GQ_P! 3XO?^'6U;_Y#H_X<$_\ !/C_ * G MQ>_\.MJW_P AU^U5%/\ MS./^AGCO_"FK_\ )?U\V+^PLF_Z%67_ /A)0\O[ MGDC\5?\ AP3_ ,$^/^@)\7O_ ZVK?\ R'1_PX)_X)\?] 3XO?\ AUM6_P#D M.OVJHH_MS./^AGCO_"FK_P#)?U\V']A9-_T*LO\ _"2AY?W/)'XJ_P##@G_@ MGQ_T!/B]_P"'6U;_ .0Z/^'!/_!/C_H"?%[_ ,.MJW_R'7[544?VYG'_ $,\ M=_X4U?\ Y+^OFP_L+)O^A5E__A)0\O[GDC\5?^'!/_!/C_H"?%[_ ,.MJW_R M'1_PX)_X)\?] 3XO?^'6U;_Y#K]JJ*/[._\ "FK_ /)?U\V']A9- M_P!"K+__ DH>7]SR1^*O_#@G_@GQ_T!/B]_X=;5O_D.C_AP3_P3X_Z GQ>_ M\.MJW_R'7[544?VYG'_0SQW_ (4U?_DOZ^;#^PLF_P"A5E__ (24/+^YY(_% M7_AP3_P3X_Z GQ>_\.MJW_R'5JS_ .""_P"P+IUPMWI]A\:+"Z0,J7-G\7=< MM;A ZE'"S06R2*'0E6 8!E)4Y!(K]H**3SO-VK/,L:T]&GB*C3]4Y:_UW94< MDR>$HRAEF!C*+3C*.%HQE%JUFFH)IJRLUKH?CS_PX[_8G_Z"'[07_A\O%7_Q M-'_#CO\ 8G_Z"'[07_A\O%7_ ,37[#45G_:N9?\ 0=B?_!LO+S\D='U#!_\ M0-1_\ 7E_DC\>?\ AQW^Q/\ ]!#]H+_P^7BK_P")H_X<=_L3_P#00_:"_P## MY>*O_B:_8:BC^U7GY(/J&#_ .@:C_X O+_)'X\_\.._V)_^ M@A^T%_X?+Q5_\31_PX[_ &)_^@A^T%_X?+Q5_P#$U^PU%']JYE_T'8G_ ,&R M\O/R0?4,'_T#4?\ P!>7^2/QY_X<=_L3_P#00_:"_P##Y>*O_B:/^''?[$__ M $$/V@O_ ^7BK_XFOV&HH_M7,O^@[$_^#9>7GY(/J&#_P"@:C_X O+_ "1^ M//\ PX[_ &)_^@A^T%_X?+Q5_P#$T?\ #CO]B?\ Z"'[07_A\O%7_P 37[#4 M4?VKF7_0=B?_ ;+R\_)!]0P?_0-1_\ %Y?Y(_&._\ ^"#G[!.JS+<:I:?& MS4KA(Q"D]_\ KR9(59W6)9;BWD=8U>21Q&&"AI'8#+,31_P"'!/\ P3X_ MZ GQ>_\ #K:M_P#(=?M516BSO-XI*.98U):)+$5$EZ)2M_7FSGEDN43DYSRS M SG)WE*6%HRDWIJY.#;>BU;Z'XJ_\."?^"?'_0$^+W_AUM6_^0Z/^'!/_!/C M_H"?%[_PZVK?_(=?M513_MS./^AGCO\ PIJ__)?U\V3_ &%DW_0JR_\ \)*' ME_<\D?BK_P ."?\ @GQ_T!/B]_X=;5O_ )#H_P"'!/\ P3X_Z GQ>_\ #K:M M_P#(=?M511_;F2/Q5_P"' M!/\ P3X_Z GQ>_\ #K:M_P#(='_#@G_@GQ_T!/B]_P"'6U;_ .0Z_:JBC^W, MX_Z&>._\*:O_ ,E_7S8?V%DW_0JR_P#\)*'E_<\D?BK_ ,."?^"?'_0$^+W_ M (=;5O\ Y#H_X<$_\$^/^@)\7O\ PZVK?_(=?M511_;F2/Q5_X<$_\$^/^@)\7O\ PZVK?_(='_#@G_@G MQ_T!/B]_X=;5O_D.OVJHH_MS./\ H9X[_P *:O\ \E_7S8?V%DW_ $*LO_\ M"2AY?W/)'XJ_\."?^"?'_0$^+W_AUM6_^0Z/^'!/_!/C_H"?%[_PZVK?_(=? MM511_;F?^''?[$__ M $$/V@O_ ^7BK_XFC_AQW^Q/_T$/V@O_#Y>*O\ XFOV&HK+^U7GY(ZOJ&#_P"@:C_X O+_ "1^//\ PX[_ &)_^@A^T%_X?+Q5_P#$T?\ M#CO]B?\ Z"'[07_A\O%7_P 37[#44?VKF7_0=B?_ ;+R\_)!]0P?_0-1_\ M %Y?Y(_'G_AQW^Q/_P!!#]H+_P /EXJ_^)H_X<=_L3_]!#]H+_P^7BK_ .)K M]AJ*/[5S+_H.Q/\ X-EY>?D@^H8/_H&H_P#@"\O\D?CS_P .._V)_P#H(?M! M?^'R\5?_ !-'_#CO]B?_ *"'[07_ (?+Q5_\37[#44?VKF7_ $'8G_P;+R\_ M)!]0P?\ T#4?_ %Y?Y(_'G_AQW^Q/_T$/V@O_#Y>*O\ XFC_ (<=_L3_ /00 M_:"_\/EXJ_\ B:_8:BC^U7GY(/J&#_Z!J/_ ( O+_)'XVWW M_!"K]A;5(1;:F?CMJ-N'646]]\:/$=W")%#!9!%<0R1[U#,%?;N 9@#@FL?_ M (<$_P#!/C_H"?%[_P .MJW_ ,AU^U5%7'.LV@K1S'&17:->HETZ*5NB,*F3 MY55ESU._\ "FK_ /)?U\V']A9-_P!"K+__ DH>7]S MR1^*O_#@G_@GQ_T!/B]_X=;5O_D.C_AP3_P3X_Z GQ>_\.MJW_R'7[544?VY MG'_0SQW_ (4U?_DOZ^;#^PLF_P"A5E__ (24/+^YY(_%7_AP3_P3X_Z GQ>_ M\.MJW_R'1_PX)_X)\?\ 0$^+W_AUM6_^0Z_:JBC^W,X_Z&>._P#"FK_\E_7S M8?V%DW_0JR__ ,)*'E_<\D?BK_PX)_X)\?\ 0$^+W_AUM6_^0Z/^'!/_ 3X M_P"@)\7O_#K:M_\ (=?M511_;F7]SR1^-]G_P $ M+?V&=.MUM-/D^/%A:H69+:S^-7B2UMT+L7,/$/C?X M17/Q-GUKQ/X;/A74U\" RP_ M=E:ON>BHJ9CCJT)4JN+KSIS5I0E4DXR6CLU?7X5]Q4,'A:CPW_R+N@?]@72_P#TA@H\2?\ (NZ__P!@75/_ $AGH\-_\B[H'_8%TO\ M](8*K['_ &]^A/V_^W?U-JBBBI*"BBB@ HHHH _G8_X-H?E_8I^/-NN1#:?M MC^+K>WCYVPP+^SU^S2ZQIGHH>1VQZL3WK\G?@]^P'^T5\0/C9^U->_L>>'[" M'0O^"9'[>VL>,_V4?A;\2KS4+'X3>+]1TSQ;XSU#X@?#W3O'NIZ.WBCXB?%- M&_9:_8I\,P:)XT^.O@?PSX?\'Z_J^N>,/%WAO5/'-CXKF_1?P-^Q1_P5J_X) MQ77CK]GK_@G_ *C\(OC%^S=\>?']]J'A_P"*/Q,7P;:_$O\ 9HN=2\.>%O!< MGQ5\<66L:IX&T[6_$]GI^+[WX:>*? MT7_8B_8F^)O_ 3?_8 ^(_PO^%&IZ-\8/VE=0T+XB?M$U#RK?X77?Q_O/ MAAHOA_P;\./"YU#4/ &IO\-+?4/ _@_0+C6?%?B?POJWB6[F\0^+;F_^'.GZ MY9>&/!WTU?%TZ-7,,50Q&'JO,*]"6'IWORPQE%MU'*4?:IQNDX14KR=C^$?'GA?2+[XV?$RU\3>$?V<-*^&/Q&\?$'X6_M]_P $ZO\ @H]\&=8^(?PM_8?T7]DKQ%^QSX'\&_#'AS2?VC/#/C*;X^> OAW=Z5\/-*\??#[0_ MA_X7^,^IZKIWQ3\4?#SP_KNN>.[;Q%XZU?PKJ6F:*WPR\,^ .6_8F_8F_P"" MCUQ^T9^R?\0/VO\ 5?@K\.?@I_P3F\#?$#]G_P" OP]^'T*:_KWQ8T=/A1'\ M%].^+;ZM;ZUKUW::7\2?#5]H^M7NN>,/$/A7Q!8S?"?2-#M_V8_AQ<^./$?B MMYKU\%B,/6IRG3O04XQE&4Z7M*E+"1IX>K0I+2I!U*=/"PC44G2PL?:ODJU: MLQTZ6)HU:(YZL*L[>Y-0G4KR<&E/$2Y%S4Z<(K^AJOG_ M /:5^&7QA^+7PU;PG\#OC_??LU^.#KVE:D/B3IW@#1OB3<+I%DMV-0T'_A&] M=U?1+$IJK3V[-?\ VWSK7[(!'#()6V_0%%?/0G*G.,X\O-"2DN>$*D;K545.,HOFM)-/EE*$K/M*#C*+\XM-=&?A3\1/^"4_P"V?\7- M2^'NM?$O_@JAXC\6:Q\(_&FE_$CX87UQ^REX(L6\(>/=&N()-.\20PZ=\4K: M+49;:&.:)++41/9&26.:6&583#+ZA_PPI_P4H_Z3">+/_$0?AI_\\>OV&HKO M>:XQJ,7]5<8WY8O+\O:C=W?*GA;1N]7:UWJ]3E6 PZ;:^L)RMS-8S&)RLK+F M:KW=EHKWLM-C\>?^&%/^"E'_ $F$\6?^(@_#3_YX]'_#"G_!2C_I,)XL_P#$ M0?AI_P#/'K]AJ*G^T\5VP?\ X;+/_$0?AI_\\>C_ (84_P""E'_283Q9_P"(@_#3_P">/7[#44?VGBNV M#_\ #;EW_P R!]2H?S8G_P +<;_\T'X!6G_!'G]K"RN?#UU#_P %/-3>7PQ\ M3_$/QLTU;O\ 9)\%7]M<_&+Q/)-)J7Q3\0V=]\6+BS\7?$&V:=QX>\7^*X-: MU[PE&L,7A2_T6*WMTBATO_@CC^U;H_\ PBWV3_@I]K4W_"'_ !(UOXR:3_:G M[*?A/7/M?Q>\0>9]O^*OBG^VOB[J'_"<_$BW\UO[$\<^-O\ A(/$_AG$?_"- MZII/DQ;/Z Z*[_\ 6C/FFGF$VGS)KV.&LU+VW,FO8Z\WUC$7X+EM]5H>S_G\T MO_@CC^U;H_\ PBWV3_@I]K4W_"'_ !(UOXR:3_:G[*?A/7/M?Q>\0>9]O^*O MBG^VOB[J'_"<_$BW\UO[$\<^-O\ A(/$_AG$?_"-ZII/DQ;#2_\ @CC^U;H_ M_"+?9/\ @I]K4W_"'_$C6_C)I/\ :G[*?A/7/M?Q>\0>9]O^*OBG^VOB[J'_ M G/Q(M_-;^Q/'/C;_A(/$_AG$?_ C>J:3Y,6S^@.BF^*<_E?FS&H^;FYKT M<,^;G]MSWO1UYOK&(YK_ !>WK7O[6?,H< \%T^3V?"^2P]G[+V?)@:,?9^P^ MH^QY+17+['^S,M]ERV]G_9^!Y+?5*'L_Y_-+_P""./[5NC_\(M]D_P""GVM3 M?\(?\2-;^,FD_P!J?LI^$]<^U_%[Q!YGV_XJ^*?[:^+NH?\ "<_$BW\UO[$\ M<^-O^$@\3^&<1_\ "-ZII/DQ;#2_^"./[5NC_P#"+?9/^"GVM3?\(?\ $C6_ MC)I/]J?LI^$]<^U_%[Q!YGV_XJ^*?[:^+NH?\)S\2+?S6_L3QSXV_P"$@\3^ M&<1_\(WJFD^3%L_H#HH?%.?ROS9C4?-SCAGS<_MN>]Z.O-]8Q'-?XO;UKW]K/F(< \%T^3V?"^2P]G[+V?)@: M,?9^P^H^QY+17+['^S,M]ERV]G_9^!Y+?5*'L_Y_-+_X(X_M6Z/_ ,(M]D_X M*?:U-_PA_P 2-;^,FD_VI^RGX3US[7\7O$'F?;_BKXI_MKXNZA_PG/Q(M_-; M^Q/'/C;_ (2#Q/X9Q'_PC>J:3Y,6PTO_ ((X_M6Z/_PBWV3_ (*?:U-_PA_Q M(UOXR:3_ &I^RGX3US[7\7O$'F?;_BKXI_MKXNZA_P )S\2+?S6_L3QSXV_X M2#Q/X9Q'_P (WJFD^3%L_H#HH?%.?ROS9C4?-SS_ )_-+_X(X_M6Z/\ \(M]D_X*?:U-_P (?\2-;^,FD_VI^RGX M3US[7\7O$'F?;_BKXI_MKXNZA_PG/Q(M_-;^Q/'/C;_A(/$_AG$?_"-ZII/D MQ;#2_P#@CC^U;H__ BWV3_@I]K4W_"'_$C6_C)I/]J?LI^$]<^U_%[Q!YGV M_P"*OBG^VOB[J'_"<_$BW\UO[$\<^-O^$@\3^&<1_P#"-ZII/DQ;/Z Z*'Q3 MG\K\V8U'SCAGS<_MN>]Z.O-]8Q'-?XO;UKW]K/F(< \%T^3V?"^2P]G[ M+V?)@:,?9^P^H^QY+17+['^S,M]ERV]G_9^!Y+?5*'L_Y_-+_P""./[5NC_\ M(M]D_P""GVM3?\(?\2-;^,FD_P!J?LI^$]<^U_%[Q!YGV_XJ^*?[:^+NH?\ M"<_$BW\UO[$\<^-O^$@\3^&<1_\ "-ZII/DQ;)M#_P""/7[6WAR3PQ+I7_!4 M;Q!'+X1^(/B7XM:7)>?LL>%]6DOOBKXNMKFSUOXF^*WU;XOWS>._B#)9WES: M:;XS\;GQ#XCT"VE,&@:EID055_?VBE+BC/ICK MS_6,1S7^+V]:]_:SYG3X"X,HNG*EPSDU*5%T71E3P-&#I/#O N@Z;C%.#H/+ M,M=%QLZ;R_ \G+]4P_L_QY_X84_X*4?])A/%G_B(/PT_^>/1_P ,*?\ !2C_ M *3">+/_ !$'X:?_ #QZ_8:BN#^T\5VP?_AMR[_YD/HOJ5#^;$_^%N-_^:#\ M>?\ AA3_ (*4?])A/%G_ (B#\-/_ )X]'_#"G_!2C_I,)XL_\1!^&G_SQZ_8 M:BC^T\5VP?\ X;/1_P ,*?\ !2C_ *3">+/_ !$'X:?_ #QZ_8:BC^T\5VP?_AMR[_YD M#ZE0_FQ/_A;C?_F@_'G_ (84_P""E'_283Q9_P"(@_#3_P">/1_PPI_P4H_Z M3">+/_$0?AI_\\>OV&HH_M/%=L'_ .&W+O\ YD#ZE0_FQ/\ X6XW_P":#\>? M^&%/^"E'_283Q9_XB#\-/_GCT?\ #"G_ 4H_P"DPGBS_P 1!^&G_P \>OV& MHH_M/%=L'_X;,O^C^)__$9++_Y^=?U T5ZV$XQXGP%&.&P.<8K!8>#E*.'P MBI8>C&4Y-HU\1.%*G&,*<95&J<(QC%**2/Y?O^(<[QE_T?Q/ M_P"(R67_ ,_.C_B'.\9?]'\3_P#B,EE_\_.OZ@:*Z?\ 7[C+_HHLS_\ !R_^ M1\E]QY?_ !!'P=_Z-?P'_P"(KDW_ ,Q^2^X_E^_XASO&7_1_$_\ XC)9?_/S MH_XASO&7_1_$_P#XC)9?_/SK^H&BC_7[C+_HHLS_ /!R_P#D?)?<'_$$?!W_ M *-?P'_XBN3?_,?DON/Y?O\ B'.\9?\ 1_$__B,EE_\ /SH_XASO&7_1_$__ M (C)9?\ S\Z_J!HH_P!?N,O^BBS/_P '+_Y'R7W!_P 01\'?^C7\!_\ B*Y- M_P#,?DON/Y?O^(<[QE_T?Q/_ .(R67_S\Z/^(<[QE_T?Q/\ ^(R67_S\Z_J! MHH_U^XR_Z*+,_P#PO6G*I5K5L#@ M*M6K4F[RJ5*D\-*5Y9@\+EV6X19=E^!H4L+@L#@: MM?"8/!X:C!4Z.'PN%P]6G0P]"E"*A2HTH0ITX)1C%))'X\_\,*?\%*/^DPGB MS_Q$'X:?_/'H_P"&%/\ @I1_TF$\6?\ B(/PT_\ GCU^PU%9?VGBNV#_ /#; MEW_S(=7U*A_-B?\ PMQO_P T'X\_\,*?\%*/^DPGBS_Q$'X:?_/'H_X84_X* M4?\ 283Q9_XB#\-/_GCU^PU%']IXKM@__#;EW_S('U*A_-B?_"W&_P#S0?CS M_P ,*?\ !2C_ *3">+/_ !$'X:?_ #QZ/^&%/^"E'_283Q9_XB#\-/\ YX]? ML-11_:>*[8/_ ,-N7?\ S('U*A_-B?\ PMQO_P T'X\_\,*?\%*/^DPGBS_Q M$'X:?_/'H_X84_X*4?\ 283Q9_XB#\-/_GCU^PU%']IXKM@__#;EW_S('U*A M_-B?_"W&_P#S0?CS_P ,*?\ !2C_ *3">+/_ !$'X:?_ #QZ^#+O_@W8\=7U MUZW(JSP-'#81U?9\SI^U]A1I^TY'.;AS7Y>:7+;F=_G<_X M#X,XK6%CQ3PSDW$L<"ZTL%'/\%1SA8-XCV2Q#PJS&.)6'=?V%'VSH\CJ^QI< M_-[.%OY?O^(<[QE_T?Q/_P"(R67_ ,_.C_B'.\9?]'\3_P#B,EE_\_.OZ@:* M]#_7[C+_ **+,_\ P/?Z!KMK^R[HMS<:;>/;3VCSQ0:A\:KR MRD8V]S/%MN+:9,2$A=P5A]D?\,*?\%*/^DPGBS_Q$'X:?_/'K]AJ*\S&\29U MF52-;,<;]?JP@J<*N-P^$Q52%--R5.,Z]"I*,%*4I**:C>3=KMGU.0\%\*<+ M8:M@N&,@RSAS!XBN\57PF0X:.48:MB73IT7B*U#+_J]*I7=*E2I.M.$JCITZ M<.;EA%+\>?\ AA3_ (*4?])A/%G_ (B#\-/_ )X]'_#"G_!2C_I,)XL_\1!^ M&G_SQZ_8:BN/^T\5VP?_ (;/1_PPI_P4H_ MZ3">+/\ Q$'X:?\ SQZ_8:BC^T\5VP?_ (;/1_PPI_P4H_Z3">+/_$0?AI_\\>OV&HH_ MM/%=L'_X;?^&%/^"E'_ $F$\6?^(@_#3_YX M]?/WQQ_X(V?M4_M)2^&I_C=_P4\UGQ_+X/CU:+PV^H_LI^%-/.E1ZZVG/JRQ M#0_B]I8E%XVDZ<7^TB&*P6(IX/$T^;V>(PN M#P6'KT^>,H3Y*M+#PJ1YH2E"7+))RS-U/,LOQ#H5J>(H.O@\9.MAZSHXBE2KTO:4Y>SK4J=6%IPC)?R_?\0YWC M+_H_B?\ \1DLO_GYT?\ $.=XR_Z/XG_\1DLO_GYU_4#17K_Z_<9?]%%F?_@Y M?_(^2^X^,_X@CX._]&OX#_\ $5R;_P"8_)?,O^C^)_\ Q&2R_P#GYT?\0YWC+_H_B?\ \1DLO_GYU_4# M11_K]QE_T469_P#@Y?\ R/DON#_B"/@[_P!&OX#_ /$5R;_YC\E]Q_+]_P 0 MYWC+_H_B?_Q&2R_^?G1_Q#G>,O\ H_B?_P 1DLO_ )^=?U T4?Z_<9?]%%F? M_@Y?_(^2^X/^((^#O_1K^ __ !%,O^C^)_P#Q&2R_^?G7]0-%'^OW&7_119G_ .#E_P#(^2^X/^(( M^#O_ $:_@/\ \17)O_F/R7W'\OW_ !#G>,O^C^)__$9++_Y^=?7GPO\ ^"87 M[=7P7\"Z'\-/AA_P5A\1^$O WAK^T_[#\/V?[)7@2[MM/_MC6-0U_4O+N-4^ M*5]?2?:M8U74+U_/NI=DERR1;(5CC3]Q:*X\;Q=Q'F5*-#,&OA_POBZF8<,\&\.\.X^ MMAIX.KC+/_$0?AI_\\>C_AA3_@I1_P!)A/%G_B(/PT_^>/7[#45Y MG]IXKM@__#;EW_S(?5_4J'\V)_\ "W&__-!^//\ PPI_P4H_Z3">+/\ Q$'X M:?\ SQZ/^&%/^"E'_283Q9_XB#\-/_GCU^PU%']IXKM@_P#PVY=_\R!]2H?S M8G_PMQO_ ,T'PQ^RQ^SG^UA\&O&'B'7?C]^W-K7[4WAO5/#9TG1O!^I_ [PE M\+HO#VN'5+"\'B2/6/#_ (JUZYU"1;"VO-+_ +-FMH8"NH-=&?S+=(W^YZ** MY*U:=>;J5.3F:2_=TJ5&&BLK4Z,*=-/NU%-[N[.BG3C2CR0YVKM^_4J59:_W MZDIS?DG*RZ!1116184444 %"O^0/>?\ 8V^/O_4[\1UUMWVF0:YXP\0_8;MK.WNM1TS1M(TRRU;Q5XMUOPYX+\/^(_$ MFD?D7X!_X.2?^">GC3Q7I_AS6-'_ &A/AUIL\6IS:QXR\5^!/ _B+0?"T>G: M7?7\7]M:+\(_BA\3OB)=/JMY:0:%IT7AGP-XBE&KZG8MJ*:?I*ZAJMAU4<%C M,1!U:&&K5:<6TY0@Y)R2NXQM\4DFFXQN]5IJC"IB#]?T7Q7X2\5Z+I7B3POXH\-ZI8Z[X M=\2>'==L8-4T37] UO2Y[K3-8T76-,NK;4=*U73KFYL=0L;F"[M)YK>:.1OE MW]M?]LOP)^PK\'K/XX?$SX??%_Q[X'?QKHO@S7)?A!X8T'Q)=>"QK^G:WM[2>YUZ)XL(4YU*D:4 M(N52E)NRBEW;T-93C",IR:C"*RBE=M^26I]>45Q?PV\9GXC_# MKP#\0SX3\:^ CX\\%^%O&9\"_$G0QX8^(O@L^*-#L=ZA_PD'_"1_#JQ_L'QOXSV^/\ MX9_V)9_\+0\):O\ V3K/@[_A+?!OVRVD_MV/R?O"KJ4YTING4BX3C:\7NKI2 M6W=-,F$XU(J<&I1=[-;.S:?XIH****@H**^3_P!E/]IZ3]IK_AI+S/ R>!_^ M&?/VL/C%^S$FSQ0WB?\ X3"/X4?\([M\)O$&H:9X>\/:9J>MZG86%SK.C M5A5]C*#]K>*Y%[TFYI.*7+>[?,K)7=W;?0B-2$X>TC))8?#7A/QQXE^.!T?Q@=.M+?PW:R?!^/Q+!/KNE?\ "5^'_#$, M6M3:/^\M77PN)PO)]8H5:/.FX>T@X\W+;F2;ZQNN:/Q1NN9*ZO-+$4:_-[&K M"KRVYN22E:_PWMLI6=GL[.VS"BBBN+M T/Q7X4US1_$_A;Q/H^F>(?#7B M7P]J=EK6@>(= UJR@U+1MS::OMHS8 MHHHI#"BOD_\ :L_:>D_9E_X9M\OP,GCC_AH/]K#X._LQ/O\ %#>&/^$/C^*_ M_"1;O'*X\.>(O^$A?P__ & -OA<_V$-6^UG/B/3/L_[_ .L*N5.<84ZDHVA5 MY^1W7O =4ATI/AVW@ ME-9_X2)_'/Q'^'_V7[:?'FE?V2=-&K+*+34_MS:>8K(7W'_L4_\ !7[]C;]N MCQ0OP\^&VO>+_ 'Q4O9?$+^'/AC\7M&T70?$GC+2?#&E:5K&JZQX0UCPCXF\ M<^ =;>.TO]3G3PE#XS3XBG3/"'C/Q/+X,B\'^'[GQ"W2L%BW0^M+#U7A[2?M ME!N%HR<9-M;1C)-.3T35FS!XG#JK[!UJ:K72]FY)2NTI)6>[<6FENT[I'ZB4 M45YQ\7OB]\-O@+\-/&/QA^+_ (NTOP)\-_ 6D2:WXI\3ZO\ :9+>QM!-#:6M MK:6-A;WFJZWKFLZE=66B>&_#6A6&I>(_%/B+4=+\.>'-*U37=4T_3[GG2B2U;-FTDVVDDKMO1)+=MO9(]'HKP_XL_'#0O '[-O MQ+_:2\(_V-\3_#'@KX'^,OCAX8_L#Q/9KX>^(>@^&_ 6I>/=%_L3QGIEIXAT M\:-XMT^RMO[-\3Z?8ZY9BQU"'5;2TU.#RX9]CX"_$]OC;\#/@Q\9VT(>%V^+ MOPG^'7Q/;PTNJ'7%\.MX^\'Z/XK.A+K1TW1SK TDZM]@&J'2-*.H"W^UG3;' MSOLT5^RJ*G[7E_=^T]ES77Q\O-RVOS?#K>UNE[D^TAS^SO[_ ">TM9_!?EO> MUM^E[];6/6****S+"BOD_P#X:>D_X;F_X8Q_X09/*_X9/_X:=_X67_PE#>9Y MG_"W_P#A57_"#?\ "%_\(YMV;?\ B?\ _"4?\)=G/_$I_P"$CLUU2)C.,^;E=^2;A+1JTH[K5*]K[JZ\PHH MHJ"@HKX/_P"&_O O_#=7_# 7_"DOVD_^%G?V#_PF/_"RO^%>:!_PH_\ X0+_ M (5__P )I_PL7_A+/^$W_P"$G_X0#_A(O^++?\);_P (1_8W_"\O^+=_:?M? M^F5]X5>$:D+_:A+X9+R=F3&<9\W*U+EDX2MTE'>+\U<**\@UGX M_P#P6\._&KP7^SGKGQ+\)Z9\//!?PSN]3CB\3Z_X5\+3QP:KJ5I M:$&-)) NK7FBZ9^&O7ZEQE&W-%KF7-&Z M:YHW:YE?=735UI=-=!J2=[-/E=G9WL[)V=MG9IV>MFGU"BO@3]M;_@I7^RO^ MP9!I=A\:/$NO:O\ $3Q%H@\2>%O@_P##G0T\3?$7Q!X>3Q#IWARXUMDO[_0? M!OA/2TN+O4KO3+WXA>,?!\'BV#PIXRL? [^)]>\,:IHT/U;\$_BOX>^/'P9^ M$?QQ\(V.MZ7X4^,WPQ\!?%?PQIGB6WL+3Q'IWA[XB>%=)\7Z+8^(+72=3UK2 M[;6[33=8MK?5;?3=8U;3X;^.>.SU._MUCNI=)4:T*=.M.E.-*JY*G4E%J-1P MMS'/ MGX!&L7VNZ/H5EHNKZ MY\-_B3\2KGPBLG]K3ZQ?^+/&NF>'/AWX=T'0];U+Q3XST-8+..^Z:6#Q=>G* MM1P]6K3@W&4Z<'))Q2E):7;:C)2=D[)IO0QJ8FA2G&G4K4Z+/BWX%^&'Q+\)^-_%_P "/%]O MX#^+GA_P_J<=[J'@CQ5=:AS:GI[WNDVWC+POXY\"7-] M%XU\ >-M T#R[X1?M/2?%3]J+]K_ /9N;P,F@I^RI_PS_P"7XU'BAM5?Q]_P MO+X>:GX\??X:/AS3!X3_ .$6.G?V2NWQ!XF_MT3?;S_8QC^Q2:JC5:JOD:5& MG&K4O[KC3G.E3C*TK-J4ZU)+E3;4U*W+=J'4@G!3=.%M5*<8SFXW5TFH MTYMWLKQ:WLCZPHHHK(L**^3_ -JS]IZ3]F7_ (9M\OP,GCC_ (:#_:P^#O[, M3[_%#>&/^$/C^*__ D6[QRN/#GB+_A(7\/_ -@#;X7/]A#5OM9SXCTS[/\ MO_K"KE3G&%.I*-H5>?D=U[W(TI:)W5F[:I7Z7)4XRE."=Y0Y>=6>G,KQUM9W M79NW4****@H**^0_VU_VR_ G["OP>L_CA\3/A]\7_'O@=_&NB^#-#-&\.^"YM8TG3_!JZY=:P6E\:^+_!GAZWM) M[G7HGB^B/AMXS/Q'^'7@'XAGPGXU\!'QYX+\+>,SX%^).ACPQ\1?!9\4:'8Z MX?"?C[PTMWJ"^'O&OAS[=_8_BG0UO[U=)URSOK 7=R+?SGMTYJG&JXM4YRE" M,^CE!1JC)R47Z-QDEZ,[2BO./B]\7OAM\!? MAIXQ^,/Q?\7:7X$^&_@+2)-;\4^)]7^TR6]C:":&TM;6TL;"WO-5UO7-9U*Z MLM$\-^&M"L-2\1^*?$6HZ7X<\.:5JFNZII^GW/7^'O$.@>+M T/Q7X4US1_$ M_A;Q/H^F>(?#7B7P]J=EK6@>(= UJR@U+1M*-_JF*]A]:]A5^K_ //[DER6YN2][?#S^[S?#S>[>^AE]8H> MU]A[6'MO^??,N;:]K=^7WK;\NMK:GZ*4445SFP4444 %%%% !117X,_&+_@X M;_8V^"7Q7^)WP>\5_"7]J*^\4?"KXC>._ACK5WH?AKX'/HVKZ[\/_%6J^$-6 MO?#LVM?'_1-1NM'OM2TBXGTF?4M+TF_ELIK9[[3M/NFEM(>C#X7$XIRCAZ-2 MLX)2DJ<>9Q3=DWZO1>9E5KT:"BZU2%-2=HN;M=[V7>RU?8_>:BO#/V>?VE?@ M;^U=\.H_BM^S[\0]*^)'@9MLZ!XITR*\\.>(=$U34///!?PSN]3CB\3Z_P"%?"T\<&JZE:6A M!C220+JUYHNF7,T&K>)]*\(?$/6/#5CJ^D_#7X@7OAKR[XN_M/2?"O\ :B_9 M _9N7P,FO)^U7_PT!YGC4^*&TI_ /_"C?AYIGCQ-GAH>'-3'BS_A*3J/]DMN M\0>&?["$/V\?VR9/L4=PHU9M1C"5W2J5E?W;TJ-.I5J33E9-1A2J/1N[BXQO M+0F56$%>4E95(4G:\K5*DX0A%J-VFY3@M=E)-VCJ?6%%%%9%A117R?\ L/?M M/2?ME?LN_##]I&7P,GPV?XC_ /":[O!4?BAO&::+_P (A\0_%O@,8\2MX<\) M'4O[1'A<:L<^']/^QF_-A_I8M?MMS:IS=.=91_=PG3IRE=:3JQJRIQM?F?-& MC4=TFERZM-QO+G%3C3;]^<9SBK/6--PC-WM96=2"LW=\VB:3M]84445!045Q M?Q)\9GX6-@;NV%QYR?._P"Q1^V7X$_;J^#UY\"9?#7BSQGHWB+P7# MK&K:AX-;7+76 T7C7PAXS\/7%I!445Y!\$_C_P#!;]H_PGJ7CKX$ M_$OPG\4_"&C^+_%'@/4O$'A#4X]3T^T\5>#]1;3M9TV21 K&.1#9ZYH&IHCZ M3XN\&ZWX9\=^$[[6_!7BKPWK^JRHR<7)1;C%I2DD^6+E?E3>R(M M2TKPYX=TS5-_\ M'?Q6TCX0Z=\/_ =UCA,5B(SG0H5:L*?QRA!R2TO;3=VU<5=VUM8RJ8BA M1E&-6K"G*?PJ4DF[OE3UV3;LF[*^FY^]-%%%&_^1=T#_L"Z7_Z0P57V/^WOT)^W_P!N_J;5%%%24%%% M% !1110 4444 %%%% !1110 4444 %%%? ?[07_!47]A+]EKXG7GP:^.'QZM M/"OQ*TS1=(U[6/#.D?#_ .*WQ DT*SUZ*:ZTBU\0:I\./ OBW1- UZ]TZ*#6 MH_"^LZE8^)D\/:KX>\1S:3'H7B;P]J&IZ4J-:O+DHTJE:=F^2E"525EN^6"; MLKJ[MU(G4ITH\U2<*<;I37M+TZ2_T?QGX3BO\ 5O$6BZ1+XU^'GB>RT3Q]X(B\0WOA M+Q&_A>7Q;X:T6/Q3INE7&M>'6U/1C#?R?1M3.$ZC07.HP_85$X3IM1J0E"3C&24XN+<9I2C))I/EE%J M47LTTU=,491FKQE&23<;Q::O%M25UUBTTUNFFF%%?'O[5W[?'[)W[$'_ A7 M_#4'Q4E^&G_"Q-/\;:KX.\OP!\3_ !S_ &O8?#K_ (1;_A,9S_PKCP7XO_L[ M^R/^$T\,XBU;[#-J/]I'^R8[[[%J/V3["IN$XQA.4)QA4YO9S<6HSY':7))J MTN5Z2LW9Z.S!3BY2BI19+576JO:ZU04445!045\]_M!?M)^ M"/V;_P#A2/\ PFVC>+M8_P"%]?M"_#7]FSPC_P (E9:)>_V5XW^*7]M?V!K/ MB;^V_$&@?9/"-C_85W_;5[I/]MZW!YMM]@\/ZEOE\GZ$JW"<8PFXM1J'2;?]HKXW>&? M.LZV=.ETWPC;6/B/QQX_GTW5AXB73O$+/'5IX.N;KPGX@TQ?&MY MX>M_"2:WI_\ 8,NM)K-U96%QUG[./[6_[-_[7'A:Y\7_ +.OQ<\+?$S3-.6% M]QT3Q[X*CUZ]\*>(9/#,GBSPWHR>*- M-TR?6O#S:GHSPW\M.A75)5W1JJBW95G3FJ3;V2J6Y;^5R55I.;IJI3=1:NFI MQYUUUA?FV\CZ+HHHK(T"BBL6#Q)X>NO$.J>$;;7M%N/%FAZ+H/B36O#$&J6, MWB'1_#WBJ^\2:9X8U[5-%CG;4M/T7Q'J7@[Q=I^@ZI=VT-CK%]X5\26FGSW% MQH>IQVH!M4444 %%%?/?[/O[2?@C]I#_ (7=_P (3HWB[1_^%"_M"_$K]FSQ M=_PEMEHEE_:OC?X6_P!B_P!OZSX9_L3Q!K_VOPC??V[:?V+>ZM_8FMS^5<_; M_#^F[(O.M0G*,YJ+<:?+SR6T>9VC?U>B)\&_##Q#X;U'[9X<\1:/J!.EZQ>BU>[:PO#;ZC:WEI M;Z4J-:O)PHTJE::3DXTJJ)1E%N,HN,HNSC)---;IIZIKLRDU))Q:::NFG=-/9IK1H**Q=4\2>' MM#OO#>F:UKVBZ/J7C'6I_#?A'3]4U2QT^^\5>(;7P]KWBZYT'PW:7<\-QKFM M6_A/PKXG\3SZ7ID=U?0^'O#FO:U) NFZ/J%S;^*_M!?M)^"/V;_^%(_\)MHW MB[6/^%]?M"_#7]FSPC_PB5EHE[_97C?XI?VU_8&L^)O[;\0:!]D\(V/]A7?] MM7ND_P!MZW!YMM]@\/ZEOE\FH4YU)*$(N4I7Y8I:NR;=O1)__V5?VD_!'[7GP%\!_M$?#C1O%WA_P &?$+_ M (2C^QM(\=V6B:=XJM/^$3\9^(O ^H_VK9^'/$'BG1H?/U7PU?75C]CUZ^\S M39K.6X^RW3SV=O:A-PE446X0G"$I=%.HIRA%^4&2YQ4E!M<\HRE&/5 MQ@X*3](N<$_\2/H2BBBH*"BBOCW]E']OC]D[]M__ (37_AE_XJ2_$O\ X5WI M_@G5?&/F> /B?X&_LBP^(O\ PE/_ ATX_X6/X+\(?VC_:__ A?B;,6D_;I MM._LT?VM'8_;=.^UVH3E&RU9]A445BZ7XD\/:Y?>)-,T77M%UC4O!VM0>& M_%VGZ7JECJ%]X5\0W7A[0?%UMH/B2TM)YKC0]:N/"?BKPQXG@TO4X[6^F\/> M(]!UJ.!M-UC3[FX@HVJ**^/OBG^WY^Q[\%_C)X#_ &>_B#\=?"MA\;/B-XX\ M+_#?P_\ #70+/Q'X[\3Z=XU\;WG@RR\&:)X\LO >B>)E^%C^+&^(/A&[\-WW MQ.E\(:9K>DZJVN:;>W.C:;JU_8W"$ZC:IPG-J,I-0BY-1BKRDTD[1BM9/9+5 MDRG&"3G*,4VHIR:BG*3M%)NVK;LENWHC[!HHHJ"@HHHH **** "BBO(?CQ\> M/A5^S-\*?%'QM^-OB:7P=\,?!CZ GB7Q'!X=\4^*Y=.;Q1XGT;P=H870/!>B M>(O$M]]M\1^(-(T]CIVCW:V:W37U\;;3K:[NX'&,IRC&,7*4FHQC%.4I2;LH MQ2NVVW9)*[>B$Y**B26K;T2/7J*_.KX*_\ !6;_ ()Y M_M!>/=/^&7PQ_:4\/7/C76!9QZ%I/C;P?\3/A+!XBU/4]>T7PSI'AKPUK7Q: M\%>!]!\2>,]S_ $5JZM&M0ER5 MJ52C*U^6K"5.5N]I).WG8F%2G57-3G"I&]N:$HS5^UXMJX445BZ#XD\/>*K& M?4_#&O:+XCTVUUKQ)X;N=0T'5+'6+&W\0^#O$.J>$?%V@SW>GSW%O#K7A7Q9 MH>M>&/$FER2+?:'XAT?5-%U."UU+3[NVAS+-JBOGO]GW]I/P1^TA_P +N_X0 MG1O%VC_\*%_:%^)7[-GB[_A+;+1++^U?&_PM_L7^W]9\,_V)X@U_[7X1OO[= MM/[%O=6_L36Y_*N?M_A_3=D7G?0E7.$ZS6SL[/\58***^>_P!H+]I/P1^S?_PI'_A-M&\7:Q_POK]H7X:_LV>$?^$2 MLM$O?[*\;_%+^VO[ UGQ-_;?B#0/LGA&Q_L*[_MJ]TG^V];@\VV^P>']2WR^ M20A.I)0A%RE*]HK=V3;^Y)L)2C"+E-J,5:[>RN[+\78^A****@H***^/?VKO MV^/V3OV(/^$*_P"&H/BI+\-/^%B:?XVU7P=Y?@#XG^.?[7L/AU_PBW_"8SG_ M (5QX+\7_P!G?V1_PFGAG$6K?89M1_M(_P!DQWWV+4?LEPA.I)0IPG4G*]H0 MBYR=DV[1BFW9)MV6B3?0F4XPBY3E&$5:\I-1BKNRNW9*[:2\W8^PJ**Q=>\2 M>'O"MC!J?B?7M%\.:;=:UX;\-VVH:]JECH]C<>(?&/B'2_"/A'08+O4)[>WF MUKQ5XLUS1?#'AO2XY&OM<\0ZQI>BZ9!=:EJ%I;304;5%%?+G[4/[:?[,?[&. MB>$=?_:4^*=C\.;/QYK5[H/A"T3P[XR\:>(->O=,L#J.KW5EX5^'WAWQ7XH_ ML'1('L8==\43:/%X9T34=;\-:1JVK6>J^*?#EEJEPA.K-0IPG4G)VC"$7.!=9L]"\76AT#Q?X.U_0;S4[+^T-)N;WPKX^\/>%O$XT+6H([ MZ+0O$\>D2>&]*?#D/P;^/'BF/36\2>&-%\8Z,$U[P M;\,/$/AO4?MGASQ%H^H$Z7K%Z+5[MK"\-OJ-K>6EO];_ 0^/OP8_:2\!V'Q M,^!7Q)\*?$_P5?BQB?5O"^I)=3Z+J=_H6C>)E\-^+=&F$&N^"O&=EH?B'1+[ M6_!'B_3-#\7^'EU.T@U[1--NI/(&T\/B*<(5:E"M"E-)PJ3I3C"::NG";BHR M36JLW=:HSC6I3E*$*M.4X-J4(SC*46G9J44VTT]'=*ST/7J**Q=4\2>'M#OO M#>F:UKVBZ/J7C'6I_#?A'3]4U2QT^^\5>(;7P]KWBZYT'PW:7<\-QKFM6_A/ MPKXG\3SZ7ID=U?0^'O#FO:U) NFZ/J%S;XFAM45\]_M!?M)^"/V;_P#A2/\ MPFVC>+M8_P"%]?M"_#7]FSPC_P (E9:)>_V5XW^*7]M?V!K/B;^V_$&@?9/" M-C_85W_;5[I/]MZW!YMM]@\/ZEOE\GZ$JW"<8PFXM1JZM_8F MMS^5<_;_ _INR+SOH2KG"=.3A.+C*-KQ>ZNDU]Z:9,91G%2@U*+O9K9V=G^ M*L%%%%04%%?'O[*/[?'[)W[;_P#PFO\ PR_\5)?B7_PKO3_!.J^,?,\ ?$_P M-_9%A\1?^$I_X0Z)-,T77M%UC4O!VM0>&_%VGZ7JECJ%]X5\0W7A[0 M?%UMH/B2TM)YKC0]:N/"?BKPQXG@TO4X[6^F\/>(]!UJ.!M-UC3[FXVJ@H** M_+Q?^"T7_!,EO&I\ C]J?0AK*^,SX#.JM\/OC"G@#^V1KA\/'4Q\5'^'B_#% MO OVY3=CXGKXO/PV/A_'BP>+#X69=8/ZAUK5H5Z/+[:C5I M9+F6JU5]T9PJTJO-[.I3JC[!11161H%%%% !1110 44 M44 %)_%MEKOZF?\ M!3[P7X8\>?\ !._]M#2O%VDRZUINA_LZ?%#XCZ=8PZCJNENOC#X1>&;[XK?# M_4?M&C:AI=W.FC>._!GAS6)=+GNFTC6X[%]&U^RU/0K_ %+3;OXY_P""I?[# M?Q_^)/Q9_9T_;H_8HMM/U#]JC]G#5_#VDWW@N^\6ZQX0?XL?#O3_ !A_;VB> M'1KMQ\1/ _A2ST#P]=>(_B'I_P 2?!\^I>$;CXM_"KXD^-_#VH^-[BX\.^%? M!'B?YX^./[2__!5S]NCX=_&']E#X3?\ !.+7_P!F&XUKQ!;?!OXR?&#XR?$2 MQO?!UM\-O&5QXD\'^.CX"OO''PU^'NB^/_#U]96-XOB3XC_!*/X[7&E_#^>] MNO OAVY\6>,?AKXIM/=C'ZQ#*ZM'$4*4,)3C"LJF(I4)8:I#%5*LJRISG&<_ M:*<)QE1A4E*4>5KG2B>4Y>QECX5*-:I+$3)X] M6TWP]H/A3PWH?PB\"Z!X>T+41X>^&/A:#Q[XIT2OJWXE?L">*?AM^SA_P3+_ M &=O@'H0\<:;^RM^VS^S5\7/BGKJZI9^&DN?#_AB^\?^)?C9\68]+\=>-]5O M;:+7O'?C#5/%<7P_T#Q#XFO]%C\0+X>\)6%SHVCVT%M]%?\ !4WX(?%#]H[] M@_XZ_!GX,^&/^$R^)7C+_A6/_"-^&_[:\/>'O[1_X1[XQ_#WQ5K'_$X\5:MH M>@6?V/0-#U2__P!/U2U^T?9?LMKY][/;V\VWUO#3Q6$<8X6-#$9I4K8F52E1 M]HL.\?&I3C5G-.5&G&FY-J\%*#DIN4%99JA7A0Q'-+$.M1P$*=%0G5Y'66$< M9RIQBTJE1S2L[2:E9Q2EJ_@#_@IC\6_VCOC+^WG^S%_P3$^ _P ??&W[*>D_ M&KX1>*OB=X_^,GP]1=1\27LELOQ*\8>#M.A_L*[^'WQ*\(P>&KW]FG6-+N=1 M\!_&KPG'XUT_XK:CH?BO3-0T70?[-U_S_P#X)P^*/VPM%_;[^*7[&&N_MW_$ MC]IGX#_L=Z/?:GXO\7:K\&?"WCWP_P#%'Q#XKT2:#6_AOX^_:-\0?$/QW\5O MAC\1?A]\7/'=P/"G@W5?&'Q'U'Q!8? [XH>!Y9O 6B^ I/#8^8O^"KNG?%#] MKW_@IY<_ ']GKX'>&?VR=8_9V_94\-2^,?@;\2?B!\0?AUX*^'?C7Q1XWA\7 M^+/&&C"T^//[,.DZKXBOOAW\1/V?[?5-1T/Q]XBTG7M+UZPTC6=&U/7?AW&/ M!WLW_!*[XN>(_P!B[]IW0O\ @G_\?/V ? ?[*OQC_:MB\0?%+P_XP^$7Q&NO M'\>I:#X+\#>+=2\'Z)X_'B[XY?M%Z[#X:M+/X4?&^70YM#^-+6'A_P 3ZQ8V MVG_ _11XY\:_$F_MTJ<,K2IPH3JSP'M)472P3JTY.NZD\;[2K)XMR^K?NXPA M348QDJE.=HII*Z%IGA&_=[WPY:Z M9=.TI_-WXIZA_P %7=&_8ZL/^"N'Q2_;@\2?";Q+X<\$?!W3/AG^SG\/=#L- M5^'?C'X=?$O6_ _PE\+_ !:^(O@Z+Q5<_ 9?B'\1+CXI:[\7K[3=?^$?Q+OM M$2]\(Q6FI?#:[T;P_P#"WX,?KG\-/V6?CQX?_95_X*X?#?5_ OV3QI^T[^T% M^WMXW^!VC?\ "3^#9_\ A-_"_P :?AS8:#\,]3_M&U\0S:3X:_X275H9;3[% MXOOM U'1MOGZ_::5;%9CC_M:_LG_ !_^)O\ P19\*_LE^!_ /]M_M!:;\%?V M*O"5[X _X2GP5IOD^(?A)X\^ VM?$+3_ /A*M7\1V'@F3_A'],\%^);G[7%X MDDL=5_LWR=$N=2N+RPBNHC7PM*LN18*4*F88:%1U*>'JQ6$=&DJR7.I1A2E) M-3J12<6G:<7S7;I5ZE/WGBDX82M**C.M!NNJLW3;Y6G*I%6<(NZ::O%Z6G^. MOBS]KO\ :,_8M_9$^*7AS]K7X!_L'?##XO? #P]X]_;,^/6I1WVB>(O">J?& M#X2^#;;P-X<^!LWBS7K;2_"7A_6_B%XYUO3+O7;[XP^ ?BQX2U%/AKJ?P\^) M5_K=CK6A^*?A#]A3X_\ Q6_9M_X*.?";]A__ (;^O_\ @I-\$_C_ /"[QQXP ME^(MQXQTSQ?:_#7XJ0:#XV\4)!%XRU?QO^T!X\U*;0?"/[/HTL_#>#XM^$_" M%FGQHD\%1K5LEQXEV/V[_ -A;]IG6/V;O^"1_CGP]^SUI/QTU;]@/X7^$ M$_:+_9Y.M>&=4\4>*-.\-^"OV?/$/C7P#I>FMI_BS0?B%X?\0/\ ?Q)\-O$ MFD^#(?'OBC7;[Q5X8C\%?#[XBV-[J;:5Q?[)W[)7[6?C3_@J!^S/^VK=?\$Y M_AW^PI^S3X>\#ZO#%X)^'FJ?![PX^BZ7XG_9_P#C'86&O_$3P3HFH^#/'M_\ M4-<\ _$'A7P\OA'P;XF\-B]\":_P")K]T886.#Q*E5PLH2 MHX]P@_J49TZU.53ZM%3DWC:M2?+"=-TW&DX.,+2?,I*49J:<^:+EHK-?J/\ \$K/^)==T7X2_M!_M(ZII'CVW\+VOAJ/Q-;ZM+XJ^"7P MHT+QCX;\0:[H&NRZ/K_A'PC\;OB9%I436]YX_P#$Z\/:U_PD'PO\ M??\ "&?\(GXG_P"*>U;5O[)_M;^R=0_XDNN?V;XAL?L__$RTFS\V'S/$?^"O M?[!GCS]LSX-^!?&7P#U1] _:C_9K\2:IX^^#6IVGBC7/!VM:S9:C;:=<^*? MWA'Q99>)M!T3P)X\UC6_"G@'Q9X#^(.N02?V)XM\!:1X?'B3X>Z#XO\ $WCC M1>>G7HPSJ-:52"I7Y5634H4YSPKI4ZMU?2E5E&;DM8\K:U1M.E5EEKIQA)ST MDZ;5I3C'$* M&-"L_A+KO@3POJ_PRM-$\$W.DWO@S1K;P'J&E7'A6#2O"5YH.AW?AC3XM*2T MT&YT;29]*AM)=.LWA_F-_P""I/\ P4-^+.J_MM^//V'I_P!JZ[_X)\?LZ?#7 MPWX=7QK\<_ /@;XN?%+XJ_$+Q-XB\#?#GXO:%)HZ_!+P];_$OP?+8ZOKVB^# M['P[X9\=_#'1KKPGI_Q1\0^._B5XT'B7P;\';;ZIT[]M?_@LW\2K7Q-^RM;_ M /!/>T^$7[3TVBI#J'[6$NK75A^S'\-],\4^)- CA\<>&H?%&D_$7X:>/O$? M@#P-XRTR2X\*^%?CI\9=(?$.[/0+#2=-^- M/B)X'#T\/B)+%U,-.4J%:6%A'%82K'V]Z/+4,?%$!U[QS>-#X_\?ZS<_$.^U_PKXHUWQ#X@\?:;X^\/ M2>"?A;X0V7_!4W]H?]A5/VZ/&?[(_&' M[4T'P)A\6>+/%'B/]H0:5\0]$TKQ>(=4\ Z#\(=/U#XVZ9\3[GQG:>%/%VN^ M*/A=')XE\2^/OC[^R?\ P3H\)>/;WXB^)/BOKW_!*3]FC_@GEX&UWX+>#X?! M'B#P"?$&C>#+W1=-\!7WB+P-\1=$ M^&7BWX?^.?"5C;W^C?$B[\27D'P1Y_X$?LG_ !_\&?\ !$;X@?LA^)? /]F_ MM$:W^S+^V/\ #W2_A[_PE/@J\^U>+_BKJ'QMG\!:1_PEEAXCNO \/]O1>+O# MS?;[CQ+%I>E_VAMUF]TYK2^%MI4Q%"C+$3IT<)"J\1ED+3^I8KW/88KZU4@J M<7AXJTES2C&_O)2O\ FU^US\4OVHOVN?\ @A#\-_VGO'GQOT/1[6TCFT3]H/X< M:)\)/#1MOVB;W2/VS/ GPF^$WBJY\52:E%??"GQ!X,N?!D7Q \56WP_TJV\+ M^._$VMZMI=MX=\(>$HM)T+3ON/\ 9P\)_M*?"W_@CS\2?B#XU_:GU?X@:'X@ M_P"":.A>,?V=O#?A;X;Z)\&/$G[,>FZ9^R[XFUO3='T+XH>!-=_X3#QQK>EV MFI>#+#2?'>J2Z)XDTN_\"0^(;&6#5-SO)= _;%O/CS9Z!:^,/#NH^(?!ZZYXL\#Z=#;>&6 MO-A?LNWO[5_QE_P"";O[2'[(GC_\ 8Z\9 M_ CQ?\"/V5-2_8T^%NH>,O&M@[?M"_$#PU\!?$'PSU'6/#%MKOAKP3I.E>$) M-4L?"$VB_$#3?$?C'X3^*3XONH_"_P 1]7@\(>(+R&ZE2E[&I1I2P?U>CG=9 MM6PG,L)*K1]C.G*2]K.#:E%U*3D_8QY)R]@DE$(5/:4ZM2.)]M4RRFK_ .T< MOUB-.?M(SC%^SA-734*BC^\?-%>U;9Q'[&/PS_X*P_&?0/"7[>GQ$_:S\(:- MXO\ %W[.FM:'\)/V3=?\,:A=?L^_$32=3^$\]Q\$/BE\91X!\5P:1\/O%/CG MXMW6@_&3Q_K/PX\#Z_\ $RT\!R-\/=)\2>!?#VNW7P3^'?YW?M37'[4_[,GA MSQY^U3-_P7(?!VI>%K'XC7]YX9^"7Q$\-Z5 M\$I_BM+\)[P?#"WU7Q!XDU.;5?V0="U&?5?"=]X_U_P?X2\&M"^(>J_L\)\-;J MP\0ZWX7M_%,,^AZ9XDGDM]6U3P[:^(XI+""XN])M]75K>.X_E]@_8L_;;\3? MLG7O[#OA[_@D/X"L/CI\,_%'AR^^(_[:7BR[^!^G_$/Q!X7\9>/_ !)\9/#^ M@_"GXF:U%X)\/:_>^']/D\-?#7QEK_P^^.'QI@\.^!-#UKX>^*?"OAS7O&6D MCPO>"J4*V*K5*DL#"C#%4J+H^QR^G#ZG[2=Y\^(5Y4E&T)NES5ZCG!RJ>[ 6 M)A5IT:4(1Q4JDJ%2I[3VF,G+ZSRPM%QHMI3;O*/M.6C#EDE#WI'[@_MF_%<_ M'GX _P#!&[XY'0!X4/QG_;Y_X)Y_%<^%AJIUX>&C\1?!?BGQ>= &N'3=&_MD M:.=8_LX:K_8^D_VC]F^V?V;8^=]EB_;NOQL\;_LI_'S5_P!D/_@C]\+].\!? M:/'7[+7QT_X)_>,?COH?_"4>#(O^$%\-_!'X8W?A[XGZC_:<_B*+1_$__",: MQ*EG]C\':AXAO]:W?:/#UKJUJ#./V3KQ\7*G[#"PIRBU3GBURQDI.,76O"^K M=I1UBW\2U5ST,.I^UKSG&2YXX=W<6DVJ7O6T2T>C2V>C"BBBN ZPHHHH _FT M_P""ZOC3PS\-OVK/^"0'Q(\:ZFNB>"_AW^T/XD\?>,M::UOK]=&\)>"_B]^R M/XF\2ZL;#2[:]U2__LW1-+OKW[#IEE>ZE>>1]FT^SNKN6&WD^>+;XN6W_!6' M_@L9^S[\5_V.=/\ B'X+^&O[(VG^$A\9?VAUT[6=&U75_"'@7XH?%+Q78^&- M0L+?XOP:'8_"W]HC1Y)_AQX"TB;POX-^-NN>'_B?\8=4^*GP_P#&7@+X<7'A M?P3^F_\ P4U_90^/_P"T)^U5_P $N/B3\(/ /_"7^"_V<_VBH_'7QEUG_A*? M!6@?\(=X5'Q=_9I\3G5?[.\4>(]$U;Q#C0OA_P"+K\V/A6QUS4O^)1]F%F;R M_P!+M[W]FZ]SZ[2P^"P7LXJIB?J>-P[E[:/)0CB,3B(R52@H.4JDJ4W*'/4C M%*49^SE9,\M8:I5Q6*YY+ MM)T'7]1\'Z)^?_Q7_:8_:I_;K_X(E>/_ (U?$/XUS:9;_ KXU#X5_M >$;WX M:?#B[N_VHI?$_P 8/V7O'?P>U]];\.>'O R_ MO@:WQ(MM%70_!NBZ\?B-'X M8CO/%VKB?5[F*U].U[]DS]J3]F[]L;]M9'_X):_!_P#;R'[:/Q;^*GQ'_9I^ M(?Q"M/ /C/X.?"*\AU?XJ?%BXUSQJ_B[P?-;^$+G7V^+'AK1/%GA;X@^._V> MO^%B^+/AK?\ A3X8>.O&?GZ3XJMO3/V>O^"97[9.B?\ !&+]L']D3Q3\---\ M&?'OXD_'WPW\5/ '@SQ+\0_ 6HIXG\->"(?V6?$GA)RK8.;I8O+9TJB MA@%*-.2?UM^SI*5>T.9*I/%7FJM-58*%2/,N62K5IXB*IXF*G0QD:D'+%M>T M3C[!<\VJ5YV;A&A:/LY.G+F@[/ZL^ _P[^/7@[_@C'\7/$7Q8_:,C^,O@+QY M_P $P=/UGX*?#A/@]X1^')^ ?A,?LJ^*KYO!C>,/#VIWVL?%3.C:SX3T(>(O M%5O8:D/^$,.J>4;KQ'J*0?F;K7AG_@II\&OV!/A__P %*=8_;+\2? C3O@Y\ M'OV??AM\ OV5OA[8OXI^'>K_ 1\02_#OX$?#;XB?$70=3\:ZQ\';_XA^,[# MXAZE\4[Z/QI\,OBQK^GI/X1=]=^'VJ:5HGPS^#?ZM_LNWO[5_P 9?^";O[2' M[(GC_P#8Z\9_ CQ?\"/V5-2_8T^%NH>,O&M@[?M"_$#PU\!?$'PSU'6/#%MK MOAKP3I.E>$)-4L?"$VB_$#3?$?C'X3^*3XONH_"_Q'U>#PAX@O(>I_:U_9/^ M/_Q-_P""+/A7]DOP/X!_MO\ :"TWX*_L5>$KWP!_PE/@K3?)\0_"3QY\!M:^ M(6G_ /"5:OXCL/!,G_"/Z9X+\2W/VN+Q))8ZK_9ODZ)?M$_\%(_#WPEN]2^+-U8O/X-^&GB_Q-:?L_B;P]X7\&>*=#^)L=MX M>\9>,OC7::?=^)/$<'Q U/P7\/\ 0];T_3?#?B7QGXAT3QAX/^=OC-H_[%O 'QV^&GQ5T3Q?XL\7GPU!X=\8^( M%3X8+\6/C-\2I=,UV3PAI_Q$U6#4O#WQ0^#]E-\0- ^%L'CK3_B/X-;4],T' MWO\ :V_X)^?M=^,/V8/^"4OCWX(^'O!^L_M)?\$\/!GP7N-5^ /C+4-#6Q\4 M^-=%TK]GRZO##XWB\=^'/"%W#\.?&OP:MCX@T!/%VBV7C;PCJ/B&_P#"GQ!L M=?T'P]H7C;QKXS>#_P!O3_@M[:_!GP%X\_9/\;?L)?LM_#;XJ7VO_&8_%WQE M-ETK0-7\ W>F^, M_&FO^-)-6\8ZY\2[KPEX&^"_A273O#.L?MU_PI#XH?\ #U/_ (:1_P"$8_XL MO_P[\_X4A_PF?]M>'O\ DJ'_ T9_P )Y_PC'_"._P!K?\)7_P BI_Q-?[:_ ML+_A'O\ EQ_M;^TO]#K\9/V5-/\ ^"AW_!'+4/%?[)NA?L.ZQ^VW\-OC%\<4 M\2?"?XV_"?6]<\&Z7?:I?>&/A[X%UG7OB==:9X7^,&E?"#0[W2;#X>6_V+XN M)\,]!\'Z_H/Q1O-/^)OQ4\"6$7B[0UCB%AI8C%2J>Q5=2 MA>#_ SX4N[KXU?%?5/@3X"\;:;%/X5E\.^*_$'PD^(^D>.O$$.D:G\$?!'A MOQ?X$\/_ QT+7+2]\3:[XZ\16WQ_P#$+4OV^/V2_A-^RU^VI8_\%.OC[\3O MB;^WV_PWNK+]F2W^&:?%WQ1H&@?&_P ,:1\6_'5W\%_V?/B+\:?$/PU\;:_X M!\2WG@WX>^%=!^&GPR^#ME:ZAX\\+^ =$U[X<^'_ !A'H>H;?QF_9Z^-/_!/ MG_@F/^W#\5/VI_BD]A^U[_P48^+_ ,#O#MY:^!_$$SV&IM-X@O?C%\1O#'B> M?X=_#[P[X8\)>//$7AOQ#^U=#\5]*T/Q#K7P'\2^$]#\->"?!FKD>(Y-'\0> M%^'?@A^U%_P3\\5>'_VQ_CC_ ,$-]MYJG@SX;^/_ (PZ M7^T?8^%_$OQK7X(:/KEU\./"GC3Q4L%[B\TK3KG5-"T&_P#^$1L=@?!7XB?%CX?\ PZ^(WC31?B!XJ\;?"BT\%_$#P#\8?CQX7U/P M3X%N/&_BV7Q#>_#Z\C_E_LV?&;_@E;X" MT?PQX@\2ZEX.M/$>G>+_ (B?&+2?C7HO@KQ!X3TGQ3K6KVVMVG@+6+:]U74M M-BU;P=#?QSZ;9^*;^Z6-9?Q6_:O^'G[:/_!0S69/V==?_P"".GPW^!O[45SJ M?PI\4?'/]M?5KDZ?X.UBUTWP?X;\'ZQ>Z-\7?#_ARQ\+>+](@T_Q-X>AN_A_ M%\;OVL?$'A;X>^&O$'A+2?AOXJ^)/@+3/%OP]X<-["4E!_5:?/A<+&KB9/ M MX:?-5]LWA\3[M9-65>-)*M'EII?$H2Z:_M4N9?6)VQ%>5.C%8I*O&U/V:5:C MK3:U=*51ND[S;^'FCT'[4OPD_:CNO^"]/[//@[3?VNX=+^*WC[X8?$#QC\$O MC(?V?O 5\/@!\*-1M?VS=7T'X-/\/)M:3P[\5F\-^%]&\5^$/^%B^*[O3_$6 ML?\ "9GQ!>V2:AX=TV*3^JWX?Z/XK\/> _!.@>._&(^(OCC0_"/AO1_&7Q!7 MP[I_A!?'7BO3-&LK+Q%XQ7PGI$]SI7A<>)]7@O-;'AW3+FXT_1!??V;93RVU MM'(WX,?\%)/A-^U3\(/^"B?[//\ P4U^#'[.>M?M2?#SX%? JX^'7B'X9?#? M7[Y/B8?$VI77QQ\&+*WA/1_!WC3QEJ^BW5G^T5I6LZ9=_#SP=\0KZVC\%^,I MO&VF^!_#UGIWB35/WH\ :QXJ\0^!/!6O^.O!W_"N_&VN>$O#>L>,?A__ ,)# MIWBW_A!?%6IZ/9WOB'P=_P )7H\<.D>)_P#A&-7GO-$_X2'2H8M-UK[#_:5C M'':W,2CBS"JZN&RZ2>'<(X54I>SCAHU8UH5:W-"<::C7C%0E3DE-*FW/GC>< MY-]6$@J=?&IJLI2K\ZYW7=.5.5*E:493;I-\ZG'W7SI1Y7:,4E^'7_!;#]D/ M]FK1OV/?VQ_VK+;X/>$KO]HCQK>_LTS:I\5]=@O?$WB?29O#'Q6^%7PRT^?P M(_B.\U6Q^&,][X O+CPGXFF^&]GX4E\::.T=OXP?7?(MVB_27_@G'_RCS_8. M_P"S,OV7O_5(>!J^$/\ @JAI?[?'[2GPR^._[('P:_87B\7?"_Q?/\*G\,?M M'_\ #3WP=T"35D\,>(OAM\5=9;_A3OBE="UVQ^R>(]!U?X?XU#Q7:F<6?_"5 MVOGV5Q:Z9-]1?\$T&_:H\)_L^^ ?@)^TM^R['^S]'^SG\%O@-\(_!'B^/XW_ M ^^+/\ PN9O!?@F?P9XFUYM \"PR'X=?V:/"?A[4QI>JZSKPO?^$P-E8:G< MGP_>W5T5E.65X?GK49SAB:M3D^MX>I6C0GA\'2HKV2K2JI1]G*/L^3FI1@^> M$(H5-Q6/J\M*K&,J$8CNEM='UC1-"\+^.?AY\!_&7@+QYX0 M\+7]WX\\#RZEXY\+21RS>+O%'C3P3XN_9QT+X/ZWXP\=2^,;#Q#X8L?%?@3^ MF/\ X*J? WXI?M(_L&?'/X+_ 6\+_\ "9_$OQC/\*'\.>&_[;\.^'?[17PU M\;/AQXNUL_VQXKU?0M L_L7A[0-6U#%_JMJ;G[)]DM!/?3VUM-[U^QOX"\6_ M"K]D+]E7X7^/M)_L#QU\-_V;_@=X"\::$;[3-4_L7Q;X/^&/A?P]XCTG^T]% MO=2T;4?[.UC3KRS^WZ3J-_IEWY/VBPO;JUDBG?V\)C*.$P.'J.'M<31S&M7H MTU75-0DL/A>2K5IJ$JE2DYQ:24Z2DXRBYO5+S,1AZN(Q56"E[.C4P=.E4FZ3 MGS+VU9RA3FY1A"?*[MN,VE)-16C/S&_; ^!W[76E?#/X%?!KQ/\ \%3OAS^Q M_P#LV^$/V??AA\*O''[3/BC5M4\*_M)?M"_M5>%[FPN;_4-3\5>(_B1X+U/P MMHOBGPI\/I/&UO-X%_:)M_B#JVJW_P 3_#?Q"TOXF>#M5AU70/F__@G#\??V M@[S]HS]L#_@FWI?[<5Y^U%IGA']FZ\\;?LX_MLWL7A/XG1>!_&5U;^$+C6_$ M-O9:MK?Q$UOXUQZ;XY_:+TJVET[XB?'KQ-I'A_\ X47'X#TFPT?1M?O=.\.: MW_!6']F;XW:?^W/\#/V^_#?['>D_MR_ WX7? I?AC\2_@)9V^G^*/$/B751K M?QBT?0[;7?AU<^ ?B-K_ (FT"TU;X]>'O''AVY\#^ /B1=:5J/P]\3ZEXOT[ MP'HUAIGBJ_7_ ()B_L:_M:?#+_@I'^T!^U'\8OV.OAY^R#\(?B-\$_''@OP5 M\/?A1XH^#%WX \(W4OC7]G]O"/AC1?#GPR\9ZQ='4-0\)_#O5];\8^+/^$6\ M*Z/XG\=1>)_$H\/^$!XFTGPS!M35!9;4E4J86KP?%'PPO@K]GN MQN?A+\/OAU'X5\;>"?&3R_$3Q/JFLWWBV70-=\(0)X5\$:C;:U\0K33[T_"S MXQ=K^S%\/OVT_P!A#_@I'^T]ITG[(.M_&KX6_P#!0_\ :CNO%NC_ !T\$?$" M.V\ _"/X7Z1\0OBG\3]:\6^.95\%:RNA:UH7A+XZSVDGA/XCW_PMD\;>-_ F MM>#_ (0:M\2Y+_2M5N/T_P#V=?@A\4/ G[>'_!1KXS>*O#']E?#7X\?\,A_\ M*H\2?VUX>OO^$J_X5?\ !S6_"OCK_B3Z;JUYK^A_V'K]Y;V'_%2:7H_]I^9] MJT?^T+))+A=,3B^6KC*ZE@Y*IE>$6'M#"24YJOEOM(SI05Y5:4J=64:=>#E! M47RP]E3LHHX>]/#47'$Q<,=7=:\L0G&/LL;RN-23]VG44J:,_B+I5S MX7\1^(;W7?C1XW_9>N]=^)>I:+J-]JWC?0=!O? &B_% V&M:Q=_%/QAJE_XU MT'Q-\;KQ_$.@>)/!V+;_ +/7_!4VX_94B_X*G+_P5,\<_P#"R)_V"OVJOCC\=-(76].\!^)];\3>#-*\4Z3JO@K2;_4M;T5=?\*VWB^368/! MOBC4_#6H^$I^2T'Q[_P5:^(?[+$?_!)VR_8"\1?"#QOX?^!OP\^ _B+]JC4_ M%]A8_!'2O@M;S>!/!VK(=2UKP)X]^%GC?5=2^!>L1^"OB';?![XT^-OB19ZK M<^/?&?P[\%Z#XF\)-X.\*ZIX=R<\+_9JG/$82>,]LL)[-866#PLZOLXU[P4/ MK,L0J\,,O:QFHPY5:*)M645&O]=<8T:\:'L_K/.ZT<164.>5/WG+V*HNE*N^ M1QYI7=Y,^BOC#^TR_P"V'^R)_P $!O$?Q>^'?Q%F\-::?$GB^ZM?!E[XZ\)^(;[P.FJ^(M1UUO"%SHDGB#[ M+K;ZA96V)^U1\7?VS?VW?^"C_P 4/^"9/P!^/?\ PQK\+_@U\*=/^(/Q%^*? M@MM9U#XK?$"WGT7X)>.[?6=#UCP[<>"O%WA:31O%WQ-\"> [3P=X.^)/P]CO M_"C?$[Q/XU\<>.K#7?#OPFTKVZX_X)[?%;X4?L@_\$M?V=? &G#XA:_^S-^V MY^SY\>OCMJ5OXN\/?V3H=DGB3XG?$7XYZ_X7U3Q'I_PXN_$7@CPUX[^(>I:? MX$TF+PW_ ,+ O?!JZ%'?Z/JVN6^KWLOBO[5/PB_;)_8C_P""C?Q/_P""FWP M^ A_;(^&7QD^%-A\/?B/\*_!::U8?%;P#;P:+\%/ MKI.@Z1X=@\:^+?%$FL M^+OAEX$\<6_B_P '?#7X@1Z=X33XE^&_&?@CP38Z)H'Q7U+"E+"2:C1EAW*% M/,?J$<0Z7)&K+%4WA_:1K?NE-T/:.G[=*#GROXK&DHXA*]6-9*4L']:E153F M<%0E[7D=+]XXJMR*?LKR4.;I/\ X$?$CQ!H%U+]8\:C1-3@^'O MQAT"33]=\:_'6]MX](^"$7@^_P#AWX:G\9>'-*_.3P=\2OVS_P!MGX$?M(?\ M%6+C_@HY\4/V6?"?[-_Q%^(,?PU_9RL;B6#X:ZG:>$M,\+_&KX-?"[4-3\,_ M$#X,?"WXBWVO^(_BQH/P*M]0^)_P/^('B;XIO9:%H?BN/QA!J&G>#[?[[^$? MPG_:,^(W[9.H?\%F/V\_"D_[*GP+_9^_9X\6^)?AK\&;_P 30^,OBA\._!>C M?!+=K%UXS\-^$O@S:>)=:\#2:+\3?VB_'VJ>&_$X\+?M&>%_BFVB>![KP;<> M$-#L-'N_PG^ /[&?[<7[2GP>\,_&CPU_P3>^#O[4-I\3[GQ?K.I?M#_$W]HK MXH6'C_QYXH/CCQ+I7C75O$ILO^"B?P)O3JFG^*;'6=&N=7M?AQX+E1@YXF-54E["-*I/D4\3:G4G-TXU$ MDXN*DXRY4_VZ^(/QI_:UUW_@@Q\4OVDOB=^T-\9+GXQ?$G4/AGXW\&>,['X? M6G[(_P 2_AGX.O?C?\'? I\,>&;WX->([&_U_P &^)Y]'\6^-?!/Q7M[OPWJ M'Q2^$_Q.T.YOO#FCZ)?QZ*ES_@L'^T;^T7I?[7O[.?['NE_M0ZS^PO\ LO?' M7X;0ZAXG_:"?#OQKUCQ3\<-=UKX:ZGI=AIO3W/QEU'_@K=_P $=?CKX0_95_9S M'PT\9>&/&WP_^ ^@? C3O$W@33_!VE1?"OQK\"/B;IUE\/?$U^GPY\,VW@[3 M/@]K&@2V^GZKH'@4Z+K6F:WX-T32=5T[2O#^N^)?HO\ X*;_ !H^-?PVU_P] MI.H?\$L])_X*._LVSV/@'6O#0AT.#QYK_@'X]^=\:;#Q/=7OP\T_X9_'[Q1+ MIMO\.D\,0:)X]@^%W@_0_"]UXE\0^'+[X@^(=0\=Z;X;T3BARPJPC/#X98B. M.S13P\IX.E*C&5'!1H.+JKZL_8S]K*A&<73J3A4]FN:[73+GG3;A6K.D\+@) M0K*.)J*I)5<3*K?V;]LO:Q]FJKC)3C&4.=\MD_ST_;_^%W[0UI_P2(UOQ3_P M\YT+]LWX*>$_$?A.QUO6M!^$7PRU.Q^-OA./XQ?LW_"OX>>%W^-.A?$#QWXB M;6O@?\5?!'CSQIXF\=S^)_%WC7XF>)?$VK>#_B-J;2>&A=S?JW_P27^'?QZ\ M'?LB_!#Q%\6/VC(_C+X"\>?LW?LSZS\%/APGP>\(_#D_ /PF/AE#?-X,;QAX M>U.^UCXJ9T;6?">A#Q%XJM[#4A_PAAU3RC=>(]12#\VOAC_P3._:RL_^".'[ M6?[,>J?#3X;?#WX^_''X\Q?'+PC\'=&\>O>:%HNB^#_&7P&U>#P&GB_4_$?Q M%LK;6]=TCX*:Q9?#M?$GQ3\:VXT_6O 4/Q.^*6BZK/XRO_#/Z1_\$J?B)^T/ MK'P'M_@9\=_V3O&?[-L7[(_A7X5_LV>'/%7C+Q0=5;XW:Q\+O!3X0M!H7AO4-%\9^&M4\??#CQH?%-U:>"O'GB!O"FN3).+J+ZA7H4 MJV$K1I9A5E*4:6"I5)4JD,/R5*48+F=ZJG"4\,Y+DBXN7L$D5AXOZU1JSIXB MG*I@X12<\54A&<)5.:-1R?*OU;9][^)/#OP:\%^(/$/[1GB_ M0OAEX3\5>%_AEJ/AWQ7\=O$FF>%="\0>'?@UX>O;OQUJ^A>(?B?J<%KJ.D_# M+0]1BO\ QCJ.F:EKEOX5TR]CN_$-S!!.DUX/P7_X)J>([+]K;_@K#^WW^WM\ M((M:G_9MO_A[X1^"/A[Q-XN\.>)/#.H^*_&!\/\ P+LHY?"=I>:5)IITN#2/ M@C?^,/$&AZYK&@_$+PMH7Q*^$EUXF\"Z1>>+[RRT3UC_ (+-_!C]N?\ :LMO MAA^SK\!?V>M4^('[-MMK7@SXK?&GQ7X:^/OPY^%/B?X@ZQHGB#Q#:0_!J#3_ M !SKT.F:?I7AO3K;3OB);^(?%?@#XI>&I_B->_#/Q)IWA^VU3X37UGXB^C/V M-?&?[6?@2\^$O[.]Y_P2NT/]DS]FOPWIFL:*?&6A_MA_"3XI6_@&RL- \0:_ M87=QX,T+0(?&'C?6?&OC6.TL/$7B"ZUB[\0ZCK_BS4_'GBK4]6O?[9NKS"C# MV&7UZT:M"=?%T947!XO"QEA\+&I"I.]&=95IUZTJ2C3I0IMQIW>LYQBM:LO: MXNE3E3JPI4*D:BFL/7DJU=P<(VJ1ING&E34VYSE-7E9:0C)O]4:***\<]$** M** "BBB@ K^/K]E+_@H3^SM_P3Y_; _X+*>+OCO>^++O4?'7[5,D/P_\">!= M AUGQ9XV_P"$6_:'_::L?&B>(-4;QEXU\+G4=)2 M_@\+KX@UZWCT2?\ L%K\9/\ @FC^RA\?_P!G[]KG_@J7\3OB[X!_X1+P-^T; M\>M/\:?!G7/^$I\%:]_PF7AJ'XK_ +3?B674O[,\,>(]:UCP]LT3XA>#[W[' MXKT_0[]O[8%LEJUWI^J6]CZF JT*>&S%8A.<9TL.HTHUHT:E5QQ5*34)2A5O MRII*E*K""=&2]Y1G3MS;1;FES-:2V?P- M_P $?OV<_P!NGPI^P#^T[\5O@!JO@KX*^/\ ]J;5OA[J?[)_PX^*[_$*?X$_ M#GPIILS1>*OC[X(77_$'QI\;3KX]\$>,+O1?A9>?$?PEXIU3Q:OP/^$/C/Q] MK'QA^&?BK2=2D^:_CO\ ''XO?\$^=9\-?M<_#C_@L[!_P4,OO%OQLTFP^)O[ M-OAGQSX5U3PQJGPWU6\USXL^/#I7AB[^,O[1/@7X0>']9G\!67PQTWQ+\,O@ M[X4N?AQI_CV'2? FI^'M.EC\.:I_17_P5&_9W^(?[5G["'Q[^!?PHTS1=;^( M?BFS\ :YX7T/7]4M]$LM=OOAQ\5O OQ.ET.UU6^B?2[+7M9LO!UUIGA:;6[C M2O#_ /PDUUI">(/$'AO16O\ Q!IO\NGQ>_8D_;?_ &GOV;/A3\!/A+_P2)\ M? WQ;^SO=K\,?C#^T+/>?!#P#\8OV@OB#\,/AA:>!)?$\7B3Q9#\%[_7?ACX MVU+6-;\8ZSXA\-W?QN\#?$;QA+X7U+PU\4 O@'7+CQ'ZF"K4<75JXG%3PD(5 M\2X5Z%18.+A05&$82E6Q3^L2@[%.A0CB)2I45 M*G5A]9:E4=1N453H+V*DOB?MKQY)*$4TI7^K?VI?A)^U'=?\%Z?V>?!VF_M= MPZ7\5O'WPP^('C'X)?&0_L_> KX? #X4:C:_MFZOH/P:?X>3:TGAWXK-X;\+ MZ-XK\(?\+%\5W>G^(M8_X3,^(+VR34/#NFQ2?8O_ 4NTK]K[P[^T!_P21\* M?L^^*O"?Q'_;!3PC^U;X!TWXI^-="T#P5X3OO%VK_!?X5>#OB7\\-6_AW0;[QA\68/"VG:;XXM-.NM)M]$TCP)\3&CM/ _B1?^"DGPF_:I^$' M_!1/]GG_ (*:_!C]G/6OVI/AY\"O@5OBY^UK_P $L/VAK_X3_P#"'Z9\(_"7[3.L?M$:'_PG?@SQ!_PIOQ5\ M8_@'X7T+1O!W]IP:EIMQ\0_LOC6+5/"O_"0^!M%U/39_[-_MRZCTS2;RWF.: MQ*_X3ZSE@W3IY7CZ33CA8R^L+"X^*HU804:W+/GHJ-.:5.I*K[EZE1N5NB_] MLIJ.(4YX_"5$T\0U[%UL&W4IS=Z=X'_%6M^*O!'B3X.^,M5TWQ[:>"?B%XB\2>'9/B7I?@;P8FG_"SP[:?#CQ M[XITS6_BROVE\9?V3/V@?%?_ 6\_95_:^T#P!]O_9V^&W[-ESX \:?$/_A* MO!5K_8OBV31OVPK1-)_X1*]\26WCG4OAI^R9K'[=/P*_;3^(D7CF.Z^$,7BRU^(O@WQ M;JWCCXM?$;0/"VM>%_!/AWXQ>,-,TOP)9>-OB%H'B/Q%)\--3\#^,O[1^%VO M6OQ%\ ^)]2UGX4NH3HU;5:7U+Z_/+:3AS1PL*7UE8V<*MZ:G;>(M<\6:AH?Q.^$OB2WEUS3/'OBH^,+[XR+XR^-? MCFUMO!%Y=_"GA7]MKXE_L)_\$ /V8_B3\(=/T?\ X3[X@_$3XK_"#1O&.M?9 M[V#X7+KGQ+_:9\9WWQ%L?#-]I]]I7C#7])L? =QI?AO0]=:'PY:Z_K>G>)_$ M=EXKT+P]J'@3Q7^@'_!/']B[]I_0_P!L;]I__@H=^V):Z;X)^)OQ\T35/!?P M^^$6B>.?"7C'4/A_\/K_ ,=6;#PM\1[OP5X#TGP;K%]X+\"_"#X$^'OAAXN\ M'>,K^\\2>&Y/%NJ_%30X/'U^6L?EGX@_\$M_VF/B]_P11^!?[)]YI&C^#/VA M_@;\0O'OQ>N?A;K6M>%]5M_'OF^*_P!H*"T^'EEX\T'Q/>^#?#FN^(_"7Q8L M_$'AW7+W4]1\.G7;#3_"/BN[\(6.LZOXP\(6IX#VSA5EAO9RQN32Q,8."H2J M0P>-CBYPC3M%X>-><55E37LES^Z^24;RXXOV:E"-;GCALQC1E-2=6,)8C"NA M&;G=JLZ46X*;YWR^][T96\__ &A?@+_P5*_X)S_"?Q1^WY/_ ,%*=;^-?C#2 M-6\#:C\:?@-X_P!)\=>)/@ /A=^S5XCTOX2ZCXH/@'Q!\+IEM_!>I>H_ME_M6_'#]M?]I+]@S]B[]E MWXW_ !0_9 \ _ME?LL:?^U!K?Q2T&TTZ?XC)HOC?PKXU^+GPVT#6+7P;KOA? MQOX(U/P>GP O]$UVY^&/[0.D:7XO7XI:QX?U\:]X<\/QV_B3A?CUXT_X*M_\ M%1_@]K_[%C_L1O\ LGZGX<\8^$H/V@OC=\4?%NJ^&_@?\1+OP)IOB[5UT+P7 MIWB3X1:]XJU'P%XB^,W@KPOXGT+Q;^SSXS^.DN@V^E>#M,\1>,-8^'OC>]\2 MZQ\M_MZ_!SQE\2_VVOAA^PK^RA\';3]M[3_V%?V"O@_\,;WX0_&WXC^,O FF M^#-6T:^T1M4\?SW/A[XS_LD>%=>\>ZS\*O%O[.__ E.L^$?$U[X9\21>(H- M,O?"PG+"04:TL3&I4J^UFZT*;J*6(C&5)1525.+ M5[N*=JA]S_\ !.'Q1^V%HO[??Q2_8PUW]N_XD?M,_ ?]CO1[[4_%_B[5?@SX M6\>^'_BCXA\5Z)-!K?PW\??M&^(/B'X[^*WPQ^(OP^^+GCNX'A3P;JOC#XCZ MCX@L/@=\4/ \LW@+1? 4GAL>,:M^VA^V/\!?^""_[,_Q]^$/CGQKXP^+WB'X MP>*?"?Q#^,WQ%36OCCXR\-^!Y/C!\?38:SJ_BOXF2^,].L?[4\2^&/AU\'[' MQ%\2;3Q%HNGZ/XNM/"'ARVTSQ5J'@C4M%[#_ ()7?%SQ'^Q=^T[H7_!/_P"/ MG[ /@/\ 95^,?[5L7B#XI>'_ !A\(OB-=>/X]2T'P7X&\6ZEX/T3Q^/%WQR_ M:+UV'PU:6?PH^-\NAS:'\:6L/#_B?6+&VT_X'Z*/'/C7XDW_ -0?"?P9^UW^ MQ=_P2<^"'PSG_8QT?]IGQ?X8U#XY:/\ M/?LP:IXD\%ZYUCXF>%OVB(O!W[//AW]H+QKI'CS]F3_A4 M/A/Q"_Q&\47/[/7PL73_ !#Z&_X)7? #XS:_P#MH_%G]NG7OV&_!_[ 'P2\=?L^'X2^ O@K:KJG MASQ==:__ ,)IX 36=:O/AOJFB>$[WPENG^$6J7FLR3?"SX$Z+JVDZW\.-7\- M^#OB-JNI^._BOK6%_P $^#O%?C/Q_\ 'GQ' M^UMX>^($=_\ !W1- LO WA;X6>'[/P](G@HZ7XDU/QAXG^%NBSZ1X)U?QCX/ M^-&G^%O'$'C+Q)\(M#\/:!JMS4UIJ.'S.A3K82I*4<'6<94\NC-15.LL13C. MG%4JM:A>"3H-U%)N5*,:DICI1;JX&K.GB(QC]8IIQEC91;(OA/\!(M:M_ GP_\ $?Q5\&#X?U6W\1?UO\ [6_B?]I7P=^SYX]\1?L@_#SPI\5?VB+"7P>G MP^\">-[FPL_"^LI?^._#&F^,)M5N-3^('PMLE71/ =YXHU^U23QWH7)N6%:%>HL/[.%5)U:N+IT:N$5DIXBG0G47MG: M<7"]*K&4Z:A:[-\RYITI4H.MS2@VJ=/#SJPQ#O>-*=6,7[)7BU)^TIM1FY7L MC^DOPUXE\.>-/#GA_P 8^#M?T3Q9X1\6:)I7B7PMXI\-:K8Z[X<\2^'-=L(- M4T/Q!X?US2Y[K3-9T36=,NK74=*U73KJYL-1L+F"[M)YK>:.1MNO'/V=OA/) M\!?V?O@7\#)?$*>+I?@Q\'/AC\)Y/%<>CMX>C\3R?#KP3HG@]_$*: VJZ\VA MIK3:.=271VUS66TQ;D61U743!]LF]CKQI64FHOFBFTG:UU?1VZ76MNAZ2;:3 M:L[*ZWL[:J_6SZA1112&%%%% !1110 4444 <7H?_(X>./\ N6?_ $URUVE< M7H?_ ".'CC_N6?\ TURUVE5+=?X8?^D1)CL_\4__ $N04445)04444 8OB3_ M )%W7_\ L"ZI_P"D,]'AO_D7= _[ NE_^D,%'B3_ )%W7_\ L"ZI_P"D,]'A MO_D7= _[ NE_^D,%5]C_ +>_0G[?_;OZFU1114E!1110 4444 %%%% !1110 M 4444 %%%% 'A7[4?Q,\1_!;]F;]HKXQ^#[71;[Q;\)O@5\7/B9X6LO$MM?7 MGAV\\1> _A_X@\4Z):Z_::7J.D:G=:+<:GI5K%JMMIVK:7?3V+SQ6FHV5PT= MS%^)O_!&W]@_]D[XP?L9:!^TQ\>/@YX._:3^,?[1?C+XF^)OB!XN_:0\.^'O MC;=6^I>#/BY\1_ L7_",Q^/]'UF/2)]>GTC4?%WC/Q'(+[QKXX\5^(;ZZ\6> M*=9TC1_!>C>%OW?^,GPPT+XW?"'XJ_!?Q1?ZUI?AGXO?#?QQ\+_$6I^&KBQL M_$6G:%X^\,:IX4U>_P! N]3T[6--M=:L]/U:XN-*N=0TG5+&"^C@EN].O8%D MMI?YF_V3OVX?B3_P1F^#?C?]F/\ X*$? 'X_2^!?AQ\9+_1?@A\:_AAX0\)Z MG\%-9L?B!IM_X]U#P5X4^(/B^;X1:)XFMM0UFW\5?%+P[J%WXH\5_$.X7QKX MM\%^+O"_PVG^%)\+6WKX-5*N Q5#"RMBI8G#3E",U"I6PT85HN,+M?B7&&+P]6NKT(T:T8R<7*%.NY4G&4K)\KE34XQD]K2BKD?#3P+^T-^R_JFL_$+X?^&?!_@+0O!6FZ"? W MQCLCX+\ Z-H7@[2HO!WAV_\ &/[+GPQ^)NKMIER?$>H^-AXDDN]>/AC7Y/#* M]?X6_:;_ ."O?[4OQG_:!^"_[+2_!OP;X6_92_;(^.UEK/[0_P 9]#>R\%_% M'P1X<^*.H6GPX_91U>UT/P'XFENKS1?#EQJ(\:^)OAGHVC>/I/A[IOPYG\0_ M$CX;^.KY/$_QW[#]EKX=_M!?MN?\%/M2_P""AWQI_9^^(G[+GPE_9M\!ZU\% M/V?/"?Q*TG6/ 7Q4^(=W>V7C*RLM8\<^#_%>@74^KZ'%X6^,GQ&\1:]JWA>X M\*>&]"\6ZK\._ 7A#Q/\6)/ GQ6UVX^V_P#@FMX#\<^!/^&_/^$W\&>*_!O_ M F7_!2_]JCQYX0_X2KP[K'A[_A*O WB'_A!/[ \9^&_[7L[/^W/"FN?8[O^ MQ_$6F?:M(U/[+"OAM\*=&^(. MH:#X<_9?\:^.?%5G=^,],T'P?XP^*&L7,&BS0>$H/B_\0O$%CX5$B:%X6U'P M?X7]E^'P3?6MG-J-M M\1)?V8+B"/3)/AM=_%*WL3\2XF^)<4[?M>74PF(+$^%Q_P *Z/WE\9'\1? _ MQE_P$-%D^&'Q1\86?[*OCCP+IOA'P M\/B=I-S\-/BE(M*\":QHU_#!!=>*OB1\3 M_ '@K_AB71_!GAGPKXA\*>)?'NM6>I:#^T#X0UQO#GBS5XD_:#T.\U6\\?Q] M6%PV'F_:NG0J14*-2^&%WX*OKSQII^D^!?BSX.\43^(;;PIXA\-VEQ+#/+^W M1^UC^WOX4_;BL?V,/V,O#.@^+=8^/7[*'@O7?#/B3Q'HMDVC_LP^+Y/B_P#% M'P]XR_:/UW6GT+5+"X\*:;X#LK33[_0_']MXFT*3QUH_PO3P5X3\5^)-4UCX M0?&_I/VC?BEIO[>7P*_X)A?M#?LU>%/B+XX\!:I_P4?_ &:OB)KL$'@;79?$ M/P]\.?#OQ!\4O"'Q-O?B#IVEV^J6V@:7\./&&EZGX9\5>+8M0O\ P']LLTU/ M0O%FM^&]2T77-2]X_P"$#\<_\/C/^%G?\(9XK_X5K_P[0_X0/_A87_".ZQ_P M@W_"<_\ #4G_ D'_"&?\)9]C_L#_A*_[ _XGG_"._VA_:_]D?\ $R^Q_8OW MU>?35&%.,ZM&BZE.CF$W1JJRC6A6A[.,H)Q:<'HH::IJ6IWWPO\2Q^&]>TBT\%^ _"OB.&;PE\ M?/"-CI.K^'?A[\+7\,KX!O+36=,^(>H>+#XKTGQCXU>+O^"^5MX3\2?ME:MX MH_9<_92^$WP?\%>-_BQXP_8]N;W0?B?XEG\#?"75?&7CB\\.^//&6F?"7XFI MXO\ %OC'P+I=EX=U'6OA5\>?A3HVL:0FDZEH^C_![QC=Z\NG^F_LZ?![XN:) M_P %]_V\_C)K7PM^(VD?"'QA^SYX7T7PE\5-4\$>)M/^&_BG6+?X>_L0V5QI M/ASQQ=Z9%X8UO4X+SPGXIM)K#3-4NKJ*Y\->(('B671M12V_GQTWX=16_@#] MI;X(?M>?L+_MQ?M+_P#!6+6;/Q'XE^&_CF?6OC;XNU;P]\*--T'P%\#/#?Q6 M\6W_ (6^)7B3Q!\9/#WPS^(.@^,K_P )^+[3X9?$KX8?$C['X*^'T/Q,M_#& MK#5O#?70H4*M?VL885)X;+ZE6DJ%.M[U:#]O*G2JXBC2HTXM7KSYFZ+E#DC% M.1A4JU84O9N5=M5\5"G4=6I3]VG*+IJ=2%&K.I4=[4XV2J*,^9MI'[R?&']I MB3]L+]D3_@C?^T3>:6NC:YX]_P""F7[)=KXQT^WTO^Q=*B^(7@?Q%\7?AY\1 MIO#.EOXE\87=GX,O/'?A/Q%>^"(M5\2:GKA\(7&B/K\D&M/?VEO_ $*5_,C\ M$/@)\=-)_P"";W_!(#P-JOP6^+.F>-OAG_P4_P#!/C_XD>#]0^'/C"S\4_#_ M ,!VG[17[2NMW7C;QOX?N=&CU;PIX1MM%U[0]7N/$FO6EAHT.EZSI5_)>K:: MC9RS?TW5YN9*G"-*E2:<*6(S"$$I;H)STLK-2>JZ;'\LG_!%W]G?X;_ +>]S^US^WM^V+X'^&?Q_P#'OQ2^ M,MU\/[7P+\2?!%W\0?!/P\GL_#WA/XD^))_#&G_$WQ+XXTN]T*;3/''P\^'O MPWTS6-$O/$'PB\!_"R+PQX:\9W&A>,=,Q'IVL?C/\"OB=\(?$?BZ3X?\ M@KP?X@^*GQ$NM/\ @U\-/B1X#\<_$7X26?@G7_"MWXJ^'/A_Q'HGC7PS=?$3 MZU^-7Q%_:W_X*X?L@_M;>%_@;^S#)\-?V?/%WP\^ &O?LS>)_CUKES\-_BY\ M /CAXPN/#_AU+3Q%X!OOAQXV^'\%EHGPL\;CQKI7@?_ (2_3M$N M;CX@^)]&^(GC9?V:^[%4ZE;&JM*LEE-6>$AS1Q$8TE@^>@E14%--3HJSG2Y. M>$H2JN-ESG+AYQIX;V:I_P#"A"%>5G1DY_6.6HW4YG&W+4;]V?-RRC-03UY3 MX,\,_P#!73]O/PGX>/[9?Q _:K_X)I>//A]KVD>"'G_X)Y^&?B]X+C^..E6& MK>-O!?A>]N_!'A+P9IGC+XH>%?'VKZ!;W_C6_M/B1\!O@;XR^#7BGQ#J/A_5W_X1F\^$DWBW4-0^)$*_$33?A@_@ M&[^(C>+?%WA^WTWPY\6_A[^&'P3@_P"";/?^"2/[CKHWCOQIX>T?XQZ-\3OA1X4^)LWB#P-XH\0 M36O[.EUIWP[/Q$M-)\+Z-XYTVU\/7OB;^B'QQ\&-:T/]K7_@B\/AO\%?B3X. M^$?P+^&G[4/A36M&U*WO?&X^ ^@W7[,7@KPC\/O!'Q2^(6B>(?B+X;AUZ&73 M5\'6^M7OQ&\46GBWQ#I=Z=&\6^+'D_M2[UQ%/!TZ]/FPD5R4\RFE4A1I4*T* M6!J3P\$J&)JRJ)58IPKMQG4YTE.4DFHI3Q,Z4[8B3YIX&'N2J5*M.4\33C6D MW5H4U!RA*2E2M*,.7X8IM/YA_9<_:Q_X*+_L^?M^_!S_ ()W_MV^-_@I^TAJ MWQV\!>+?BOIWQ4\!VR>&_$_@#2(/"_Q)U#PS8R2>'?A3\'_"'B/1FO\ X >- M;"[\-2_#&R\0I?>/[7Q(/BI>:7X8A\!W7P=\#F_X*/\ _#ZG]K@^%8?V(S^V M9_PSQHW_ ME?$%Q\=Q^S&/!O_")_L@_9S\.WTVU/Q4/B8V7_"KO.'B6,:4+ MK_A/MA,7_".BOT?^.OP>^+FK_P#!P-^QQ\9])^%OQ&U3X/>&/V5+OP[XE^*^ MG>"/$U[\-?#WB!M"_;BA70M<\=6VF2^%])UEI?%OA6)=,O\ 5+>],GB;P^@@ MW:SIPN?F'XL_$[Q)_P $^?\ @M?^T+^UC\9/@#^T#XN^#G[37PV^&OP&^!>N M?![P1HOC7_A8GQ-\9^%/V;M+T3PAHEQ?^+?#FD2^,KO7?@!\1=%M/ANVJCXH M:F]GI6M:3X)O_"^NZ1KUY-"4&YNC1POML5DW/*DH14)8B&-<7",.91BY4:<: MDZ:LGRJ=D.K&2LJM6O[/#YDHQJ.4G)4I86,N:4TFWRU)N,9O:[BV?8G[(?#GB/Q/I%E_9'[,OBY_C!\4/# M?C#]HO6M9.AZG:7OA:P\#6ECIU_X?\=6_B71)/&^C_#+_A#/"_B3Q!J.N?"? MXU:_Q&LO^"YNM?#_ .%WP#^'=]^RKX/^)-C\&SKGQF_;BN-:M[WPWK_Q(TWX MLW&E^'_ WPY^'.I_#GQ#)/$X M^'=A\7=/OOCEX1\-Z_>V6E?$OX>^'/AM\0(O$7QA^#=E8^//$_B#P/?>.?#D MU_X*\+:[XNDT76_"UGST84JE7!X>G2PL7]46(G.5)5JM:LJ=3]VH2K4X3J-) M>SH.4(2J6E.[9M4E4A#$U9SQ$O\ :/8PC&;IPITG.'ON4:*? 7Q3^.OP(^&_AKXE:7\7OA?X8AT MK2?$NEZO+X4\2^*K+QIJT-C\-]&O=2TS1_CK\'="\#6W@_X$^";1+'PUXVD\ M6:MK>M#3=7UWV#_@E9_SD@_[2M?M@?\ O.Z_*G_@C[\#O%7@W_@J'^T1\3/" MO[%_[1O[(W[-&K_L]_$+PK\*O#OQO\(_%Z/^S$@^(7[-L>GV5_X]^)]E.VH^ M+?'4?AGQ'\1;SPO:^*O%5KX9GO\ 7O"OAWQ'XHT#P?'X@NOV!_X)K> _'/@3 M_AOS_A-_!GBOP;_PF7_!2_\ :H\>>$/^$J\.ZQX>_P"$J\#>(?\ A!/[ \9^ M&_[7L[/^W/"FN?8[O^Q_$6F?:M(U/[+[E3A4G&$FTG:PL+.K4>&E4YIG?! M75/@QX7_ &7M%\0V]G\<_"?AKQUH4WC+1_A=^QSJ%C#X,\&^(=(\07?BKXF3 M>%+;QE%X7\-^"]#UCQ]KUFVN:5X9TK49;JYLYOZPZ_G=\)_LB-\4?^"['[8W MC;X]?LP-\1?V=]<_9W\/-X,\7_%WX*'Q=\%M8\>Z;X/_ &/M%@;PQX@\9>&= M0\#:AXPL+33O'VDPG2KN76K:VL/&%C'LBM=:BC]7*YTX?V@ZLIQB\OFKTY1C M4;^M85VIN6G,[/OI=V.#'1G+ZHH*+E]<@_?BY07[FOK)+6WZV/B#_@F[K_[0 MNF_&C_@JM^T9_P $UO@II7Q"^!FIZE?^%_@W\&_%-YH'@+P[\0?BAKWQLCO_ M (1^(_"_B37OAU\%- \/_#KX&_!SQ1\6OB;K'[/3^+OASXP\*>!/B-\)?A-K MFH^(_%>J:'\5]/\ HOX\_M+_ /!7S_@FMX@\-?M,_MH?&[]F_P",O[-7Q"^- M^D?#K6O@M\*?!XU?5O!/AWQ->ZW\3=??X5F?X6_ 'Q,-=\+_ R^'GC'P=\/ M+WXH_&_Q_IPOM6TJ;QYI_C#4-WB?3OU&_P""@GP<\=^!?^"<7QF^&/[!7@C6 M?A9XQ\+VOA+Q)\-O!?[+<2?"/7M(LM,^-GA/XC_$]/AYIGPYG\*7*:GKOAV+ MQWJ6K^&?"2MX@^(EQJNL^'M/TCQ-K_BI='U;^/7XN_!?X ?V,/ M^";G[8G_ TG\+K@?#;]LGXRV?A+XV^,/"8^-7P[^%]KHWQ.^%NC?#O0?%'Q M3\+^&-2USXA:_)XRUFV\2:+\(?&/@�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end GRAPHIC 9 gb2k1ptlkg5v000008.jpg GRAPHIC begin 644 gb2k1ptlkg5v000008.jpg M_]C_X 02D9)1@ ! 0$!+ $L #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" .Y!YX# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH ^*O^"B?BKQ1X(_8T^-7BCP9XDU_PCXFT MJQ\'/I?B+PQK&HZ!KNFO=?$7PA8W+6&KZ5<6FH6;7%E0 MM%+(C?RC?\-:?M5?]',_M!?^'F^(W_S25_4U_P %.O\ DQ?X\_\ 8/\ _\ MZL_P37\<=?WM]%C*,JQ_ 6=5L?EF7XVK#B_&TXU<7@L-B:D::R;(IJG&=:E. M2@IRE)1345*4I6NVS_.7Z8.=9SEOB-D%'+LVS/ 49\%8&K.E@L?BL+2E5>>\ M0Q=25.A5IQE4<80BYM.3C"";M%6^@O\ AK3]JK_HYG]H+_P\WQ&_^:2C_AK3 M]JK_ *.9_:"_\/-\1O\ YI*^?:*_IC_5KAW_ *$&2_\ AJP/_P H\E]Q_*'^ MM7%'_129_P#^'C,/_FCR7W'T%_PUI^U5_P!',_M!?^'F^(W_ ,TE'_#6G[57 M_1S/[07_ (>;XC?_ #25\^T4?ZM<._\ 0@R7_P -6!_^4>2^X/\ 6KBC_HI, M_P#_ \9A_\ -'DON/H+_AK3]JK_ *.9_:"_\/-\1O\ YI*/^&M/VJO^CF?V M@O\ P\WQ&_\ FDKY]HH_U:X=_P"A!DO_ (:L#_\ */)?<'^M7%'_ $4F?_\ MAXS#_P":/)?;XC?_-)1_PUI^U5_P!',_M!?^'F M^(W_ ,TE?/M%'^K7#O\ T(,E_P##5@?_ )1Y+[@_UJXH_P"BDS__ ,/&8?\ MS1Y+[CZ"_P"&M/VJO^CF?V@O_#S?$;_YI*/^&M/VJO\ HYG]H+_P\WQ&_P#F MDKY]HH_U:X=_Z$&2_P#AJP/_ ,H\E]P?ZU<4?]%)G_\ X>,P_P#FCR7W'T%_ MPUI^U5_T;XC?_-)1_P -:?M5?]',_M!?^'F^(W_S25\^T4?ZM<._ M]"#)?_#5@?\ Y1Y+[@_UJXH_Z*3/_P#P\9A_\T>2^X^@O^&M/VJO^CF?V@O_ M \WQ&_^:2C_ (:T_:J_Z.9_:"_\/-\1O_FDKY]HH_U:X=_Z$&2_^&K _P#R MCR7W!_K5Q1_T4F?_ /AXS#_YH\E]Q]!?\-:?M5?]',_M!?\ AYOB-_\ -)1_ MPUI^U5_T;XC?_-)7S[11_JUP[_T(,E_\-6!_^4>2^X/]:N*/^BDS M_P#\/&8?_-'DON/H+_AK3]JK_HYG]H+_ ,/-\1O_ )I*/^&M/VJO^CF?V@O_ M \WQ&_^:2OGVBC_ %:X=_Z$&2_^&K __*/)?<'^M7%'_129_P#^'C,/_FCR M7W'T%_PUI^U5_P!',_M!?^'F^(W_ ,TE'_#6G[57_1S/[07_ (>;XC?_ #25 M\^T4?ZM<._\ 0@R7_P -6!_^4>2^X/\ 6KBC_HI,_P#_ \9A_\ -'DON/H+ M_AK3]JK_ *.9_:"_\/-\1O\ YI*/^&M/VJO^CF?V@O\ P\WQ&_\ FDKY]HH_ MU:X=_P"A!DO_ (:L#_\ */)?<'^M7%'_ $4F?_\ AXS#_P":/)?;XC?_-)1_PUI^U5_P!',_M!?^'F^(W_ ,TE?/M%'^K7#O\ MT(,E_P##5@?_ )1Y+[@_UJXH_P"BDS__ ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF M?V@O_#S?$;_YI*/^&M/VJO\ HYG]H+_P\WQ&_P#FDKY]HH_U:X=_Z$&2_P#A MJP/_ ,H\E]P?ZU<4?]%)G_\ X>,P_P#FCR7W'T%_PUI^U5_T;XC? M_-)1_P -:?M5?]',_M!?^'F^(W_S25\^T4?ZM<._]"#)?_#5@?\ Y1Y+[@_U MJXH_Z*3/_P#P\9A_\T>2^X^@O^&M/VJO^CF?V@O_ \WQ&_^:2C_ (:T_:J_ MZ.9_:"_\/-\1O_FDKY]HH_U:X=_Z$&2_^&K _P#RCR7W!_K5Q1_T4F?_ /AX MS#_YH\E]Q]!?\-:?M5?]',_M!?\ AYOB-_\ -)1_PUI^U5_T;XC? M_-)7S[11_JUP[_T(,E_\-6!_^4>2^X/]:N*/^BDS_P#\/&8?_-'DON/H+_AK M3]JK_HYG]H+_ ,/-\1O_ )I*/^&M/VJO^CF?V@O_ \WQ&_^:2OGVBC_ %:X M=_Z$&2_^&K __*/)?<'^M7%'_129_P#^'C,/_FCR7W'T%_PUI^U5_P!',_M! M?^'F^(W_ ,TE?7/A7]I#]HBX_8C^+_BRX^/7QHG\4Z9^T#\)-&TWQ+-\4?'$ MNOZ?H^I>#_B#=:CI-CK+ZZVHVFFW]S96=Q>V,%S':W4]I;2SQ2201,GYB5]I M^$/^3!/C9_V4NGD>3TW+BCA>G)PRS!1$X-QG%^[*+Y6FM#Z[@SB;B2KC2^X^1_UJXH_Z M*3/_ /P\9A_\T>2^X^@O^&M/VJO^CF?V@O\ P\WQ&_\ FDH_X:T_:J_Z.9_: M"_\ #S?$;_YI*^?:*/\ 5KAW_H09+_X:L#_\H\E]P?ZU<4?]%)G_ /X>,P_^ M:/)?;XC?\ S24?\-:?M5?]',_M!?\ AYOB-_\ M-)7S[11_JUP[_P!"#)?_ U8'_Y1Y+[@_P!:N*/^BDS_ /\ #QF'_P T>2^X M^@O^&M/VJO\ HYG]H+_P\WQ&_P#FDH_X:T_:J_Z.9_:"_P##S?$;_P":2OGV MBC_5KAW_ *$&2_\ AJP/_P H\E]P?ZU<4?\ 129__P"'C,/_ )H\E]Q]!?\ M#6G[57_1S/[07_AYOB-_\TE'_#6G[57_ $;XC?\ S25\^T4?ZM<. M_P#0@R7_ ,-6!_\ E'DON#_6KBC_ **3/_\ P\9A_P#-'DON/H+_ (:T_:J_ MZ.9_:"_\/-\1O_FDH_X:T_:J_P"CF?V@O_#S?$;_ .:2OGVBC_5KAW_H09+_ M .&K _\ RCR7W!_K5Q1_T4F?_P#AXS#_ .:/)?;XC?_-)7S[11_JUP[_T(,E_\-6!_P#E'DON M#_6KBC_HI,__ /#QF'_S1Y+[CZ"_X:T_:J_Z.9_:"_\ #S?$;_YI*/\ AK3] MJK_HYG]H+_P\WQ&_^:2OGVBC_5KAW_H09+_X:L#_ /*/)?<'^M7%'_129_\ M^'C,/_FCR7W'T%_PUI^U5_T2^X^@O M^&M/VJO^CF?V@O\ P\WQ&_\ FDH_X:T_:J_Z.9_:"_\ #S?$;_YI*^?:*/\ M5KAW_H09+_X:L#_\H\E]P?ZU<4?]%)G_ /X>,P_^:/)?;XC?\ S24?\-:?M5?]',_M!?\ AYOB-_\ -)7S[11_JUP[_P!"#)?_ M U8'_Y1Y+[@_P!:N*/^BDS_ /\ #QF'_P T>2^X^@O^&M/VJO\ HYG]H+_P M\WQ&_P#FDH_X:T_:J_Z.9_:"_P##S?$;_P":2OGVBC_5KAW_ *$&2_\ AJP/ M_P H\E]P?ZU<4?\ 129__P"'C,/_ )H\E]Q]!?\ #6G[57_1S/[07_AYOB-_ M\TE'_#6G[57_ $;XC?\ S25\^T4?ZM<._P#0@R7_ ,-6!_\ E'DO MN#_6KBC_ **3/_\ P\9A_P#-'DON/H+_ (:T_:J_Z.9_:"_\/-\1O_FDH_X: MT_:J_P"CF?V@O_#S?$;_ .:2OGVBC_5KAW_H09+_ .&K _\ RCR7W!_K5Q1_ MT4F?_P#AXS#_ .:/)?;XC?_-)7S[11_JUP[_T(,E_\-6!_P#E'DON#_6KBC_HI,__ /#QF'_S M1Y+[CZ"_X:T_:J_Z.9_:"_\ #S?$;_YI*/\ AK3]JK_HYG]H+_P\WQ&_^:2O MGVBC_5KAW_H09+_X:L#_ /*/)?<'^M7%'_129_\ ^'C,/_FCR7W'T%_PUI^U M5_T2^X^@O^&M/VJO^CF?V@O\ P\WQ M&_\ FDH_X:T_:J_Z.9_:"_\ #S?$;_YI*^?:*/\ 5KAW_H09+_X:L#_\H\E] MP?ZU<4?]%)G_ /X>,P_^:/)?NKJ%]8Z9)?7KZ?:75Q+;V3WETU MM'&UQ*7^1O\ AK3]JK_HYG]H+_P\WQ&_^:2O4?B%_P F(_LW?]EQ_:!_],_P MQKXLKY;A+A[(*F S)U,CR>;CQ1Q;3BYY9@I.,*?$F9PIP3E0;4(0C&,(K2,8 MQC%))(^NXSXFXDI9EE<:7$&>4XRX1X*J-0S7'P3J5>%,GJ5*C4<0DYU*DI3G M)^].;;X MC?\ S25\^T5]3_JUP[_T(,E_\-6!_P#E'DON/D?]:N*/^BDS_P#\/&8?_-'D MON/H+_AK3]JK_HYG]H+_ ,/-\1O_ )I*/^&M/VJO^CF?V@O_ \WQ&_^:2OG MVBC_ %:X=_Z$&2_^&K __*/)?<'^M7%'_129_P#^'C,/_FCR7W'T%_PUI^U5 M_P!',_M!?^'F^(W_ ,TE'_#6G[57_1S/[07_ (>;XC?_ #25\^T4?ZM<._\ M0@R7_P -6!_^4>2^X/\ 6KBC_HI,_P#_ \9A_\ -'DON/H+_AK3]JK_ *.9 M_:"_\/-\1O\ YI*/^&M/VJO^CF?V@O\ P\WQ&_\ FDKY]HH_U:X=_P"A!DO_ M (:L#_\ */)?<'^M7%'_ $4F?_\ AXS#_P":/)?;XC?_-)1_PUI^U5_P!',_M!?^'F^(W_ ,TE?/M%'^K7#O\ T(,E_P##5@?_ M )1Y+[@_UJXH_P"BDS__ ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF?V@O_#S?$;_Y MI*/^&M/VJO\ HYG]H+_P\WQ&_P#FDKY]HH_U:X=_Z$&2_P#AJP/_ ,H\E]P? MZU<4?]%)G_\ X>,P_P#FCR7W'T%_PUI^U5_T;XC?_-)1_P -:?M5 M?]',_M!?^'F^(W_S25\^T4?ZM<._]"#)?_#5@?\ Y1Y+[@_UJXH_Z*3/_P#P M\9A_\T>2^X^@O^&M/VJO^CF?V@O_ \WQ&_^:2C_ (:T_:J_Z.9_:"_\/-\1 MO_FDKY]HH_U:X=_Z$&2_^&K _P#RCR7W!_K5Q1_T4F?_ /AXS#_YH\E]Q]!? M\-:?M5?]',_M!?\ AYOB-_\ -)1_PUI^U5_T;XC?_-)7S[11_JUP M[_T(,E_\-6!_^4>2^X/]:N*/^BDS_P#\/&8?_-'DON/H+_AK3]JK_HYG]H+_ M ,/-\1O_ )I*/^&M/VJO^CF?V@O_ \WQ&_^:2OGVBC_ %:X=_Z$&2_^&K _ M_*/)?<'^M7%'_129_P#^'C,/_FCR7W'T%_PUI^U5_P!',_M!?^'F^(W_ ,TE M'_#6G[57_1S/[07_ (>;XC?_ #25\^T4?ZM<._\ 0@R7_P -6!_^4>2^X/\ M6KBC_HI,_P#_ \9A_\ -'DON/H+_AK3]JK_ *.9_:"_\/-\1O\ YI*/^&M/ MVJO^CF?V@O\ P\WQ&_\ FDKY]HH_U:X=_P"A!DO_ (:L#_\ */)?<'^M7%'_ M $4F?_\ AXS#_P":/)?;XC?_-)1_PUI^U5_P!' M,_M!?^'F^(W_ ,TE?/M%'^K7#O\ T(,E_P##5@?_ )1Y+[@_UJXH_P"BDS__ M ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF?V@O_#S?$;_YI*/^&M/VJO\ HYG]H+_P M\WQ&_P#FDKY]HH_U:X=_Z$&2_P#AJP/_ ,H\E]P?ZU<4?]%)G_\ X>,P_P#F MCR7W'T%_PUI^U5_T;XC?_-)1_P -:?M5?]',_M!?^'F^(W_S25\^ MT4?ZM<._]"#)?_#5@?\ Y1Y+[@_UJXH_Z*3/_P#P\9A_\T>2^X^@O^&M/VJO M^CF?V@O_ \WQ&_^:2C_ (:T_:J_Z.9_:"_\/-\1O_FDKY]HH_U:X=_Z$&2_ M^&K _P#RCR7W!_K5Q1_T4F?_ /AXS#_YH\E]Q]!?\-:?M5?]',_M!?\ AYOB M-_\ -)1_PUI^U5_T;XC?_-)7S[11_JUP[_T(,E_\-6!_^4>2^X/] M:N*/^BDS_P#\/&8?_-'DON/H+_AK3]JK_HYG]H+_ ,/-\1O_ )I*^N?VE/VD M/VB-"^&G[']_H?QZ^-&C7WB;]GZ76?$E[I7Q1\<:==^(-8'Q-\>V U;6[BTU MV&;5M2%C9VED+Z_>XNA:6MM;>;Y,$2+^8E?:?[5/_)*?V)/^S;)O_5L_$:OE ML[X>R"&>\&PCD>3QC4S;,XU(QRS!*-2,>',WG&,TJ"4E&<(32DFE*,9+6*:^ MNR#B;B2?#W',Y\09Y*=+)LIE2E+-7?\-:?M5?]',_M!?^'F^(W_S24?\ #6G[57_1S/[07_AYOB-_\TE?/M%? M4_ZM<._]"#)?_#5@?_E'DON/D?\ 6KBC_HI,_P#_ \9A_\ -'DON/H+_AK3 M]JK_ *.9_:"_\/-\1O\ YI*/^&M/VJO^CF?V@O\ P\WQ&_\ FDKY]HH_U:X= M_P"A!DO_ (:L#_\ */)?<'^M7%'_ $4F?_\ AXS#_P":/)?;XC?_-)1_PUI^U5_P!',_M!?^'F^(W_ ,TE?/M%'^K7#O\ T(,E M_P##5@?_ )1Y+[@_UJXH_P"BDS__ ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF?V@O M_#S?$;_YI*/^&M/VJO\ HYG]H+_P\WQ&_P#FDKY]HH_U:X=_Z$&2_P#AJP/_ M ,H\E]P?ZU<4?]%)G_\ X>,P_P#FCR7W'T%_PUI^U5_T;XC?_-)1 M_P -:?M5?]',_M!?^'F^(W_S25\^T4?ZM<._]"#)?_#5@?\ Y1Y+[@_UJXH_ MZ*3/_P#P\9A_\T>2^X^@O^&M/VJO^CF?V@O_ \WQ&_^:2C_ (:T_:J_Z.9_ M:"_\/-\1O_FDKY]HH_U:X=_Z$&2_^&K _P#RCR7W!_K5Q1_T4F?_ /AXS#_Y MH\E]Q]!?\-:?M5?]',_M!?\ AYOB-_\ -)1_PUI^U5_T;XC?_-)7 MS[11_JUP[_T(,E_\-6!_^4>2^X/]:N*/^BDS_P#\/&8?_-'DON/H+_AK3]JK M_HYG]H+_ ,/-\1O_ )I*/^&M/VJO^CF?V@O_ \WQ&_^:2OGVBC_ %:X=_Z$ M&2_^&K __*/)?<'^M7%'_129_P#^'C,/_FCR7W'T%_PUI^U5_P!',_M!?^'F M^(W_ ,TE'_#6G[57_1S/[07_ (>;XC?_ #25\^T4?ZM<._\ 0@R7_P -6!_^ M4>2^X/\ 6KBC_HI,_P#_ \9A_\ -'DON/H+_AK3]JK_ *.9_:"_\/-\1O\ MYI*/^&M/VJO^CF?V@O\ P\WQ&_\ FDKY]HH_U:X=_P"A!DO_ (:L#_\ */)? M<'^M7%'_ $4F?_\ AXS#_P":/)?;XC?_-)1_PU MI^U5_P!',_M!?^'F^(W_ ,TE?/M%'^K7#O\ T(,E_P##5@?_ )1Y+[@_UJXH M_P"BDS__ ,/&8?\ S1Y+[CZ"_P"&M/VJO^CF?V@O_#S?$;_YI*/^&M/VJO\ MHYG]H+_P\WQ&_P#FDKY]HH_U:X=_Z$&2_P#AJP/_ ,H\E]P?ZU<4?]%)G_\ MX>,P_P#FCR7W'T%_PUI^U5_T;XC?_-)1_P -:?M5?]',_M!?^'F^ M(W_S25\^T4?ZM<._]"#)?_#5@?\ Y1Y+[@_UJXH_Z*3/_P#P\9A_\T>2^X^@ MO^&M/VJO^CF?V@O_ \WQ&_^:2C_ (:T_:J_Z.9_:"_\/-\1O_FDKY]HH_U: MX=_Z$&2_^&K _P#RCR7W!_K5Q1_T4F?_ /AXS#_YH\E]Q]!?\-:?M5?]',_M M!?\ AYOB-_\ -)1_PUI^U5_T;XC?_-)7S[11_JUP[_T(,E_\-6!_ M^4>2^X/]:N*/^BDS_P#\/&8?_-'DON/H+_AK3]JK_HYG]H+_ ,/-\1O_ )I* M/^&M/VJO^CF?V@O_ \WQ&_^:2OGVBC_ %:X=_Z$&2_^&K __*/)?<'^M7%' M_129_P#^'C,/_FCR7W'T%_PUI^U5_P!',_M!?^'F^(W_ ,TE'_#6G[57_1S/ M[07_ (>;XC?_ #25\^T4?ZM<._\ 0@R7_P -6!_^4>2^X/\ 6KBC_HI,_P#_ M \9A_\ -'DON/H+_AK3]JK_ *.9_:"_\/-\1O\ YI*/^&M/VJO^CF?V@O\ MP\WQ&_\ FDKY]HH_U:X=_P"A!DO_ (:L#_\ */)?<'^M7%'_ $4F?_\ AXS# M_P":/)?%/C-I>E^%_CU\:/#>F2?!SX%ZI)IV@?%'QQH]@ M^I:O\)O"6I:MJ+VFG:[;V[7VJ:C5Y&^1O\ AK3] MJK_HYG]H+_P\WQ&_^:2O4?V]O^2ZZ1_V0[]GK_U3/@ROBROEN".'L@J\'\,5 M*N1Y/4J5,BRRKDVVWJV?7-^+*5'B M#.Z5*GQ!FL*=.GFN/ITZ<(XRJHQA"-=1C&*22C%)))66A]!?\-:?M5?]',_M M!?\ AYOB-_\ -)1_PUI^U5_T;XC?_-)7S[17U/\ JUP[_P!"#)?_ M U8'_Y1Y+[CY'_6KBC_ **3/_\ P\9A_P#-'DON/H+_ (:T_:J_Z.9_:"_\ M/-\1O_FDH_X:T_:J_P"CF?V@O_#S?$;_ .:2OGVBC_5KAW_H09+_ .&K _\ MRCR7W!_K5Q1_T4F?_P#AXS#_ .:/)?;XC?_-)7S[11_JUP[_T(,E_\-6!_P#E'DON#_6KBC_H MI,__ /#QF'_S1Y+[CZ"_X:T_:J_Z.9_:"_\ #S?$;_YI*/\ AK3]JK_HYG]H M+_P\WQ&_^:2OGVBC_5KAW_H09+_X:L#_ /*/)?<'^M7%'_129_\ ^'C,/_FC MR7W'T%_PUI^U5_T2^X^@O^&M/VJO^ MCF?V@O\ P\WQ&_\ FDH_X:T_:J_Z.9_:"_\ #S?$;_YI*^?:*/\ 5KAW_H09 M+_X:L#_\H\E]P?ZU<4?]%)G_ /X>,P_^:/)?;X MC?\ S24?\-:?M5?]',_M!?\ AYOB-_\ -)7S[11_JUP[_P!"#)?_ U8'_Y1 MY+[@_P!:N*/^BDS_ /\ #QF'_P T>2^X^@O^&M/VJO\ HYG]H+_P\WQ&_P#F MDH_X:T_:J_Z.9_:"_P##S?$;_P":2OGVBC_5KAW_ *$&2_\ AJP/_P H\E]P M?ZU<4?\ 129__P"'C,/_ )H\E]Q]!?\ #6G[57_1S/[07_AYOB-_\TE'_#6G M[57_ $;XC?\ S25\^T4?ZM<._P#0@R7_ ,-6!_\ E'DON#_6KBC_ M **3/_\ P\9A_P#-'DON/H+_ (:T_:J_Z.9_:"_\/-\1O_FDH_X:T_:J_P"C MF?V@O_#S?$;_ .:2OGVBC_5KAW_H09+_ .&K _\ RCR7W!_K5Q1_T4F?_P#A MXS#_ .:/)?;XC M?_-)7S[11_JUP[_T(,E_\-6!_P#E'DON#_6KBC_HI,__ /#QF'_S1Y+[CZ"_ MX:T_:J_Z.9_:"_\ #S?$;_YI*/\ AK3]JK_HYG]H+_P\WQ&_^:2OGVBC_5KA MW_H09+_X:L#_ /*/)?<'^M7%'_129_\ ^'C,/_FCR7W'T%_PUI^U5_T2^X^@O^&M/VJO^CF?V@O\ P\WQ&_\ FDH_ MX:T_:J_Z.9_:"_\ #S?$;_YI*^?:*/\ 5KAW_H09+_X:L#_\H\E]P?ZU<4?] M%)G_ /X>,P_^:/)?;XC?\ S24?\-:?M5?]',_M M!?\ AYOB-_\ -)7S[11_JUP[_P!"#)?_ U8'_Y1Y+[@_P!:N*/^BDS_ /\ M#QF'_P T>2^X^@O^&M/VJO\ HYG]H+_P\WQ&_P#FDH_X:T_:J_Z.9_:"_P## MS?$;_P":2OGVBC_5KAW_ *$&2_\ AJP/_P H\E]P?ZU<4?\ 129__P"'C,/_ M )H\E]Q]!?\ #6G[57_1S/[07_AYOB-_\TE'_#6G[57_ $;XC?\ MS25\^T4?ZM<._P#0@R7_ ,-6!_\ E'DON#_6KBC_ **3/_\ P\9A_P#-'DON M/JWP)^U9^U%>>./!MI=_M)?'RZM;KQ7X=M[FVN/C#\0Y[>XMY]7LXIH)X9?$ M31S0S1LT!?^QQ\,_P#I[L:_O?K^+OI8 MY=E^7XS@=9?@,%@55PV?NJL'A:&&51PJY0H.HJ-."FX*4E'FORJ3M:[/[O\ MH9YIF>9X#Q >99CCLP='%\-JB\=B\1BW24Z.=R" MBBBOY"/[:"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X+_X*=?\ )B_QY_[!_@?_ M -6?X)K^..O['/\ @IU_R8O\>?\ L'^!_P#U9_@FOXXZ_P!!OHF_\F^SS_LL ML=_ZI,@/\TOIF_\ )RN'O^R&P'_J_P"(PHHHK^HC^1 HHHH **** "BBB@ H MHHH **^ZO^"?W[)WAG]KWXO^(_ ?B_Q/KOA;0?#?@#4O&,USX;BT]]7OKJ#7 M?#VAVEA%+JEM>6=I;YUN2\N)WM+J1A:):Q1(;EKJV_3C4_\ @D?^R+/XCG^' MNA_M4:U8_$J)_+;PEJ?B+X9:SXC@DDLA=Q1S^#K.#1-?WF*>TOMI>)I+)@5" MK<17,?X[Q9XZ>'_!F?8SAS.L7F4+IX7+*]>E2>+PM#&T(JM>$)R>& MQ-&I+V?-&//R.7M(SC']QX-^CSXD\=\.X#BG(<'E4LHS*6+C@ZF+S:AAJU58 M+&5\!B)NA:_#OQ-='3?#_ (_TC3;G15;68;/[7<:)XA\/W%YJA\/:M-'#>WFEV\.M M:W9ZEIEI-QT,PRS%^TC3K1A4I3A4 MI3=.M0KT*T*=:A7I334Z=6G&5G&I'FI3ISE^8<5<*9_P3GF+X=XER^IEN:X+ MVW_)==(_[(=^ MSU_ZIGP97Q97VG^WM_R772/^R'?L]?\ JF?!E?%E?*<"_P#)%\*_]B#*O_4. MD?9>(G_)=\7_ /919M_ZF50HHHKZL^-"BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#L?A MW_R4#P+_ -CCX9_]/=C7][]?P0?#O_DH'@7_ +''PS_Z>[&O[WZ_B'Z7O^^\ M!_\ 8+Q#_P"G?]EECO_5)D!_FE],W_DY7#W_9 M#8#_ -7_ !&%%%%?U$?R(%%%% !1110 4444 %%%% '[-?\ !$;_ ).0^)__ M &1'4_\ U// E>3?MS_!SXW>//V^?BROPP^'/Q"\0:OJOB[P1)>7^H64%K-<1>L_\$1O^ M3D/B?_V1'4__ %// E?4'[7G_!5SXK? +XX_$OX->#/AE\/=1'@K4-)LM/\ M$?B>X\27QNEU#PYH^MR/>:1I6I:)EHY=3:!!!J<(\N)6;+,#75S"4L7B,/3Q'L,3#"4WA8R MJ3JPKS:I3C"5O[TRK <#8_Z+OA>O$#B3'\,9-A.+LTQN&QF6X#&8_%8S,Z&= M<=>QRV,<%AL35PWUC"3QM6.+E&E3HU,/33K0E.*E]#?\%5M/?Q-^SA\-?A'& M;+5OB7\4_C5\,O!G@:TE-K&U[XJN!?6MSJ*23^6UA8XNFL+O4HHL6W]M6UK. ML<-\U?-OCWX0?\$_?^"%/#D%_>"QT-(H+WQ)>!A!7[.'CSXX^+%U8VGQ*T71?#VF0VD.G^&?#(UV]>RTW3=!T:V4P6GVC6+ MO389=2N#=:O>O!8RZKJEX]G!+%^P/_!1K]H;X:_L^>+?AY?_ !,_8P^&O[0] MCXK\.W]GI'C[QJWAA;S1[K1=3EFO?"$3:[\+O&\L=M##JEMK5JJ:M:QW$NI: MB8M.5K:XN9_CZ?#'%O ^<<$^$F(JYKF6%XAI8[C+/,FX8SO#9!6S'-L1A\=@ MZ&54\]QT\)AYX?*\/PY@,95I5:T*>(Q5?$QPZJ5UEE:/V]3BW@SQ!R3C[QIP MU+)LKQ?#-;+N!>'\\XMR#%\24,KR;#8G+\=B,YJ\/9?#&XJGBLWQ7%&8X*A6 MHT)U,-@\/A98ETJ#S:C/X^_:7_9 _9E^/?[)T_[97[)'AZ]^'<^BZ/K'BO7_ M :(Y;32M9T/P]=OIOC'3M2\.27^J67A3Q)X/CTF^U*SN/"MY'X>U6TMM2$] MEJYUG2?$&E^._P#!._\ 8^^ _CWX/_%3]JG]I47FN?#WX87VNVUKX0MK[5=/ ML?*\%>'=-\8>(?$.LC0;JSUC6V,.HV.GZ'XVU.VU6PUF#4;"WCV M?%?_ 5@\(ZG\#OB7\$/AU^Q]X7^%7AWQWX&\;>$R/"'CS3++0O#\GCG1;SP M]?:^/#&A?"7P]8W5Q&^I+.Z?:[!KVY6&.:[4N#7U+_P3#TN7P1^P9\;O%OQ; ML?\ A+?@CXNUGQIK$7@?0M!U/7O%-[H-OX>MO!?Q%,ZV^J;;S3=;BT>WL[#0 M[&PTN72#I.O:Y=ZM>)K\:Z/]+Q!6\1^!?"W/LNSK$9SE&$Q_B#@)JY+@LURS$X^G0Q[AA,*YPJ+#T94)YA*E1=+$QI3^6X9H>%O MB%XO<.9ID6&R+.L=EOAKF&;9U7P7#689'PF^,LMQN"PM'/L=E&;83+:F(RY5 M,;C%"=-XFM#$4\LC6KJMA)5H=!^S)X=_X)I_MQ:CXMT;PC^RY+X2U7X?66D7 ML]IJ\,_A,:II&IM/I\%Y;W'@'QO*EY<6LVGHFIQ:N5F$E[;75M<:C+/J$EK^ M>EM^S+\%OVL/VY[CX-?L]>%/%'P8^%?@S1;N7XKVNLW"WVO:5<^"-;DT/QE< M: NH>)_&$7VC5=5O_#_AK3))-1N[2SOKBXUZ72+JRMYK6[^K_"_[97_!/7]B MSP_XWO/V6/!'CSQ/\2/'5C;L;'7[7Q996EJMF^I2:#9:SJOCBZMKS3O#=E=W M-X)!X:T_5=2U>6&.+4+RX>TM[^PX/_@BSXLEU[]H#X^W?B35SJ7C+Q;X%3Q3 M>75U'&E[K$__ FEM/XDU5_LUO!:1O)J>NV,US%"ENADO$-O;B*)A%Y.6_ZR M\-95XE^)G#=/CC*>'\%E&!RW@VEQ;C95<9*OFN9Y5EN;8S$8"=3$T\3_ &7/ MZUB<%5J>TPM&2H*K/%5:%65+V,U_U5XKSCPH\*.*:GA]G/$N/SK,,UXYK<%X M"%'!1P^3Y3FV:Y)@<-F5.GA*F%_M>FL'A,?2I>RQE>#KNC#!T,11A6]V^*>L M?\$I/V.O&$/P+\4? E_&_B6&TTP^+-6C\-6WQ%NO##:I;07%M-XDUWQCXHL] M1M+ZZTV^BUN6P\&VEW]EM)X&AT^UF-E9UX)_P4&_8"^"WA?X+6'[6'[+LPTK MP*UKX=UCQ)X4@U'5=9\-ZMX:\U\,OH%[9^(/@G_@H;X5\4>$_P!LGX[P>*8KWS]<\9W7BK1;N[MW MABO_ OXBBBU'P_)82DM%=V5AI\D>B?:()'5+O2KNSF$-Y:W-M!^W?CJWU#X M5_\ !'1='^(*WFEZV_P3\.Z/_9VH6OV35;:_\:>)-.7P_HMQI[K#/!=Z?;ZU M86U];S1+>V4%E=RWT2S6MT%[:N"S3@6EX*\;9+Q9Q7G.=\-I<]3@HX_*/$.MX\\ M9_P;P=D60>'V$SK_ %=S;*LCH99C,G61ULRP6 QE3%SD\/1_V?+X8RG+#PP- M/ZK+&X9NI@*OLZ7RS^S^_P#P2<^*!^$GPSM?@;XV\0?%SQ7IGA/0+^PCB^)] MU)/XMETJT7Q!=WM_IOC&UTN.PL;J/4=2UG6H;6RT:PTVUO=6D2RTRW7;V.L0Z9FBT"?5O"=W<>#WO9)_.T/X87/_VP?VA+[QCK#Q0>(OB3XHT?PUX3T2^U M6]FT/PGI=Y>6^B>%?#5K=-!,;/2M.6>&34KFPTR%;_5+G6/$,FF'4=4O%E]/ M@?AZEB?%W-\QR#B;BW&<">'LL1B,\S7.\XQ&9QS7.J%/%^WPF"='!X>G6P=& MM=SC*ECJN(PV7U<33QR?( M,CPV4RRC(L15P/U?&8]5\?B:E#&UZ"BJZ!HC^*/$$GAB\\4)#?7&EIJ+BXTSXBZ[X* M\%:?<(=3>&X@\(Z5/<6<\<>EZWG?M&_LG_LC?'W]C36/VO?V9O! M;_#+5M-\+WWC6WLX#=Z%97>G>$]4O++QCX3\2^#8M0UCPWI>LZ2MIKL=K?>% MEABU#5;'3BFMZOX;FL[@]+\>_AG^PK_P3<^'OP]L?$W[/T7[07Q!\?G6;:RO M/&UQ:W4VM+X6.@OXHUJ]N-5M]7T/PO;6;>(=(@TS3O#_ (9DFN!(_D8HHHK_1,_S""BBB@ HHHH **** "BBB@ MK[3\(?\ )@GQL_[.3^"__J$?$NOBROM/PA_R8)\;/^SD_@O_ .H1\2Z^4XO_ M -SRC_LJ^%/_ %?8$^RX)_W[._\ LC>,?_6=S ^+****^K/C0HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** /M/XA?\F(_LW?]EQ_:!_],_PQKXLK[3^(7_)B/[-W M_9[&O[WZ_B'Z7O\ OO ?_8+Q#_Z=R<_T ^A+_P B_P 1/^PSAG_TSG84445_ M&I_= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 ?!?_!3K_DQ?X\_]@_P/_ZL_P $ MU_''7]CG_!3K_DQ?X\_]@_P/_P"K/\$U_''7^@WT3?\ DWV>?]EECO\ U29 M?YI?3-_Y.5P]_P!D-@/_ %?\1A1117]1'\B!1110 4444 %%%% !1110!]E_ ML1_M(_ UYX-;1CXI/A%[1[G7_#^MIJ:ZE_PCOB< M3K$-$DM6L3IT1E-XEP+V(6I@N?)/VDOC1)^T-\;_ !_\99?#J>$F\GZ)IFB0P'5FT_23?.\6F)/)/\ V;9J9)658$51GP^BOE\+P9PU M@N*LRXVPN6^RXGSC!4\NS',_KF/G]8P=*&7TX4?J53%3R^CRPRO KVE#"4JK M]A=S;JUG4^NQG'?%6/X/RK@'%YK[7A/),?4S3*\I^HY=3^JXZK/,JE2O]>I8 M.&95N:>;YC+V6(QE6BOK%HTTJ5!4K%G>7>GW=K?V%U<6-]8W$%Y97MG-+;7= MG=VTJS6UU:W,+)-;W%O,B2P3Q.DL4J+)&RLH(_;'X?\ _!8EM4\$Z3X!_:;_ M &?_ W\9;:UMHXM7\317NCHNN3Z? D>G7^J?#_7_#.J>'KG5[F023:GJ-CK M.C6,4\CRZ;H5M&PM8_Q&HKS^-_#KA+Q"PN&PO$^6_6IX*HZF"QN'K5,)C\(Y MN/MH4<31:DZ%>,5&MAZRJT)M0J^S5>E1JT_3X \4.-/#/&8K%\)YI]4ACZ<: M>/P&)H4L9EV-5-2]A4KX6LG&.(P\IN5#$T)4<1!.='VKP]:O1J_JW^T=_P % M)O"GQ1^"WC3X"?"#]FKP=\&?!WC2ZTP:IJVG7VE+>7%AI'B'3O$4#6_ASPWX M4\.:3INH7MUI=O%>33W^NI';3W<<'^D-#>Q?I3^PS:^-/V:_^";NJ_%WPQ:: M]\8O%/B*S\1?$OP[\--+FDU+3-(FFU=O#EIIVCQ6=G_:QBALM.A\4^-K&V+O M%>PZS8Z5"+N&74M2_E[K[0_9S_;[_:3_ &8M%'A/X?>*=-U3P,EQ?7MOX'\: M:/'K_A^POM1DCFNKG2IHYM/\0:.DLZRW4FG:5KEGH\]]>7VHW.G3:A=S73?C M_'7@11CP5A.'/#K"X6A1I\0X/.\YRS-<=BI2XA="A+"1<\TJSJU<#/#TJD[4 M<)]4H5*=2O.')B8P5;]O\//I$XB?'N,XI\4,9C,16J<,X[(,BS;)\OPD8\-+ M$XB&,GR911A1HX^GB:U*'-7QGUW$TZM+#TY<^%E4=#]P_P!B3]N/]H#]JSXC M:U\.OBO^SQHECX#30M8?6_%VCZ#XGT[0="O[ Q1QZ)XCM_%][K6G:I-JT[M8 M1:1;7$&J1R>9>-8W&GV.I36OY1_M8^(;']BW_@H%XK\2?LOW.G>$Y/"T^@:Q M<^%[.SD?PGINH>*/#EAJ7BOP1-I9>*WG\+:M#?BZDTC39K:V\/\ ]J+I_AZ7 M0KO0--&E;'CO_@L-^V%XQT:?2-(G^&GPVFN!&CZWX$\'WKZRD(*"7QSXA M\;6-L;N)C;R7-O81WMNF)M.NK*\5;I?R^U/4]2UO4]3UO6=0OM7UG6M1O]8U MC5]3NY[_ %/5M6U2[FO]3U34[^ZDENK_ %'4;ZXGO+^]NI9;F[NYYKBXEDFD M=VY?#+P:S7)>*,ZS?..F39]PCD.2Y%GV?\ %'%F5<14\_P_'&9Y M+EG#&.R58:,_94,NI9-3PL5B*DI0C.I"C3@Z-/FK3KUE1]C^^%G_ ,%IO >N M6=KJ'Q"_96M=3\7:)';R:)>6?BS1M5L_MRLLT]Q:W>M^#EU/PQ&+F&">W2T. MN3*RJSW!D@1Y/SN_;+_;Z^*'[8EQI>CZSI&F>!?AKX=U,ZQH/@/1[RXU5VU< MVDUDFL^)=?N8;)M>U>TM;S4+/3YK72=#L+*QOKB*+3/M,]W>W7PE17Z+PUX& M>&O"FWP^">#PN(A7K4*]"IAY0HP_>K2_\ @MS;6?AS1_#U_P#LJ6&I M0Z9I6F:=(O\ PMZ.#3YWTZU@MQ+!IDWPGO4M(2\(DM[5KBZ-JNR,7$IC\UOE M']L3_@HU9?M3?#3P_P" -"^!&G_"'4-"^(&C>.8_%VF>.DUW5%.C:+XDTR&R MTT:?X&\&W6DWC76NV]_'K$6ISO;+I[V\=D9KN.]LOS#HI9?X#>$^5X["9E@> M$XTL9@<11Q6&J3SKB/$0C6H352'M,/BFY4J]*I2G M.$JS+Z1?C+F^7XW*\?QE*M@LPPU;!XJG#(.%\-4E0KTY4ZGLL3A"_C1X@\.107 MUC>ZE-X9OO#&M>)[>UN].&NOX9\4^#=>M_!VH3:?=SP7-_HTFL9-]J,=E8:? M87 L%Y'Q5_P5_P#%7C3X2?&KX4:W\#_#UO8?$OP_XS\%>"[C0/%QT;3OAKX( M\3>"H?!VFZ)_8H\'W;>*;S16.H:S+J1U7P]!?W.H&PL]+T72[*SM(OQNHK#! M> 7A=@<6\73R'$5.3&0Q^"PU7.LY>$RW%1J4:LJN!HT\=24)5IX;"JLZTJ[G M3P]*A=4%.G+HQWTD?%[,,''!U.(\-2Y\%4R_'8JCD.1K&9KA)TJ]&-+,:]7+ MZOM(T88K%NBJ$<.H5<56Q#4L1R58%%%%?LI^%!1110 4444 %%%% !1110 5 M]I^$/^3!/C9_V M4?\ 95\*?^K[ GV7!/\ OV=_]D;QC_ZSN8'Q91117U9\:%%%% !1110 4444 M %%%% !7]"%G_P $G/V4_#'PL\"^/_C!^T?XG\"1^(] \+3:AKNO^(?AQX&\ M*S^(]SKPQP67<48WA3+,\S3-<+G M^88-TU[' 0Q?#5*>-J*I3J1E_9^'QF,KP5K>]-233L?UA]&O@[(.)\A\6L?F MG". XQS;A[*,FQG#F68Z-1^WS&I@^*JT,!2E3J4Y0_M+$X'!8>;O?W8--6U_ M%3]LO]EK]C[X(_"[1?%GP%_:;T[XP>,[_P O/"EEX^^&WC.6#0+O0_$ MFHWFM/9>!X8]1T^&SO-)TZU;4[[.F"6_AL'(OK^P#:O[=/PU_P""?_@CX5_# M?4/V4O'-OXD^(.J>(K:/6;2Q\7ZSXJDNO!A\.7L]]J_B:UOE>V\,:Y#K?_"/ MQV^F-#H%U.=2UF-=&>/2YDTOPO\ ::_8*^.'[)_A/0/&?Q/O/ EUHWB/Q$/# M%A_PBFO:EJMVFIMIM]JJ_:8+[0=(6.W:UTZYQ+'),1*J(R*'#5^D_P#P5<^! MOP9^&?[-GP.U_P"'7PK^'W@77+SQMHNCW^L^$O"6A^'M4U33IO 6N7LMOJ]_ MI5E:W6K>9>6-M=/-J4MU.UQ&9C*9))6?DH9Y0PV>^$N'PWB5Q7QEALZXDXGA M0Q^$Q.'P>7XY8;#\/PGE>>T,/]76887!5I5:^$]K3K5:4\;BH75/V:75B.'\ M1BN'O&?$XOPIX.X&Q60\*\(SQ&6XS"XG'9GE\\7BN)*E/-^'L3B?K3RS%YA0 MC2H8U4JM"G5IX#!U&I5?:R?(_'']EGX!>&?^"6?P\^,^@_#C3-,^*,GA7X1^ M)+GQI!J&NMK%]JWC+5]*@\12:A)-JLL-_9WL6NZ@L&EW<,NF:8/L2Z59V2Z9 MIJVGX85_6CIVI_ W0O\ @F/\'/$/[1FE7NO_ I\/?"?X-ZUJ_AS3H;VYO/$ M>KV3^'G\*Z%#:6-Q927?]I>)6TJ"6"[OK'1C"9)/$-[:^'X]3F3S7X(:?^PA M_P %%_A=\3?!?A#]GSPQ\(];\)K9V(6:U,YXGIUW4P>18+'_V?@,#AJ2Q$:GUJNL3AY.>#^L8*E0CB\*U6=7%4 MZ?=Z.D7 MVV&ULKN:&WA+I$1Y:\W^UU\0_P!@#X3_ 5\?_L@?"?X7/XB^+7@U=%T.V^, M[>!_!FI7,?CC1?$^E7?C&ZU/XDWVIVGC3^W)(+37=&U3^P=&.@VXO)O"^DI; M>&T-C:_LV/\ &IKC.MP9P]P7GG$V+PTL@Q&(QV!J1I82CDV=X/+<;/-:L98: MKB*,<)2S3#+V&(I485IJHJF)PJBF_P +RWP&3X%P_'?$W'G#W">"Q<>),+AL MOS"G*MC:^>9!CLTP$,HI3CBJ.&KRQM;*,4W7PM;$3H4_9RI87&.;C'\5J*_6 MSX7_ +6/[!_P ^$OP_TOP[^R38?'/XMWOAW1[_XH^(/B7%HHT^V\6RV"VNNP M>'M9\5Z/X^NK.UCN(&^RZ9X=\,:'H;6$\%Q+=7>KW&K2/]8_M"_"7]F7]J+] M@"^_:S^%WP8\,_!/QIXMK;PQI.E:!MET#Q@?#_ (N\/^((?#%CI.B^ M*K;4(+.ZO-"UR[TQ-5M7.F2"32XYM;T>:!> M69_DV:U.&_$_AG/^+%,G066TL+&I7I4N(9U8X*KCZ6-E'+Y MX98=4J,ZV&K8S$X2&(A%?ES\ OV#?C'^T;\'/'/QM\!Z[\.['PQX!U3Q+H^I MZ5XFUGQ#I_B34+[POX6T?Q;?)I%MI_A35](D2YT_6[*VL9-1UK35>_$T=S]E MMD6[?XHK^OW]A7XO? _QY^R7KWB7X:?"6V\!>#_ HU3PUX^\+Q>'O"^GKXP\ M3>&/AIX0O_%6NW$&DR/9^()O$&EWEAI\NK>(675M6%F$U8")(R?QAUG3?@+_ M ,%#/VM?@O\ #[]G[X1#]G_P2^@:@GQ)NM%\.>#_ O)_=1C* M56*/K>-_ 3AK!<(^'F(X-XGP&;<4\3\^%PV&C5QRM;OQ+X+\4:AXWOM-T75[6\FN M->\5V"7.K7.H:'(^G>7-J0\!_P""EW[%/PS^&_B[X+?$'X*6=MX(\#_&_P 1 M)X4UNP@2XN?#/AGQ%JDNGWVC:[I%C/=Q&ST[5]+O]4N9O#]O>6&FV*Z $TM; M*WNWCM/;X>\?,!FF9Y9A)OHWYCE&59KB\CXLP'$N9\,XS*< M!Q3E<,GS;*:67XG-L3'"4WEF:XV$L'GN'PU>:6,K8?V#PT:>)C7IT\1AWAY_ MC!17],_[4-A^S_\ \$^O!7P\T'PO^P3X/^.7@?5]-UA/&?Q&\8:7I>J#3[JT MN=(L;>Q\6>+]:\ >/IGU+Q3<:U=SV=KK-UH>C6Z1/IOA72KZT^VV>@_@9^TA MXZ^%OQ*^+_B3QM\&_A]_PJWP)KMKX>N+/P*EO86MMH6KP^'=+M?$D5A!IUGB8XR,?:4FJ5YQ^:\4/!W!>&.$ MIT,7QSEV9\4T98268\-QR3.,N4<-CHSEA\7DF<8NF\%GU&FH+Z_[*&$E@92] ME53K6IR\+HHHK]B/P\**** "BBB@ HHHH **** /M/XA?\F(_LW?]EQ_:!_] M,_PQKXLK[3^(7_)B/[-W_9'[6!_$2^++C4[RZDT:YL[R[ MGVZ)8P6B/&?BA9:G MK/AF32]*\;>+M,US_A(-+O);"^L-&D^)6C:MX:UO5M/NK&[2"STZ'5%N5$TP MMKV!8I(\+_@A;_R!?VEO^PI\*/\ TD^(5?.WA#]@[]J?Q#^W6WCUOAIJGA?P M%IW[3%[\2KKQSK]_I^EZ9'X2TOXG3^*AJ&EB.ZN-4U+4M2TVV2/0K*QL9'FU M&[L?[1GTG3/MNJV/\*<29OF>9>(GBOALT\6^(>",%P[0Q&+R+!X?B/%8+#8O M$8?"Q]GEV"RV.887ZQ.7(I?5(J3?+&5:KS2_T/X6R3*LJ\,O!K%91X M+<,\?8[BBOA,'Q#CL3PM@\PQ6!PV)Q;]KF>/S6668SZM37M9Q^N9I5C@L+3I MKFE&A1Y8_*_[=G[$VM_L;>.M#LH=??Q?\.O'D6KWO@;Q%<6L5EJT7]CSV@U/ MP[XAM()'M_[7T>'5-+;^U+1;?3] M(OC1^Q9\#;^'2?$6H7?QD\/>)O&'A^^2TU*RA\+:OXD\-^&K+3M>TBYAGM[N MR\5)-KL1M;M3#-9Z51FOG3_@M=\/? /@:3]F:;P5X'\'^#Y=2M/B MS8:C+X6\,Z+X?DO[#05^%J:'97KZ396C75IHR:AJ":5;3F2'3EOKQ;-(1*DJTY2]I^1^,?@EPWE-7Q5XKX5S:GEV5\$XSA6E+A>E@ MYXNDL9Q)+*J6*P]/,ZF8J>"IX6>8K&PPSPF+4(S6#A*A",?9?A/17]$O_!-/ MX7_#/Q;^P9\;=;\5?#OP+XFUH>*/BG:C5_$'A'0-9U06VE_#SPKJ&F6PO]1T M^YN_(TZ_EEO;&'S?+M+N22YMUCF=G/SS_P $8? O@CQQ\3OC7!XT\&^%?%\- ME\/M(2SA\4>'M(U^*T34M:FL]12VCU:SNT@6_M/]%O5B""ZM_P!Q.)(OEKW, M3X[T'<'Q'/# MNG_:D/[4E5P^-AAXU%4R]1K0FW!PLW^,%%?T7?M$?M#_ +"_[*?@WXR_LA^! M?A;$_!U_I5E\1?%>CZK+I%GXGU_5-1TN_NKO0=3U M&RN+A-#TV_T[P-9K9:'H5LM[HUQH.D^?_L)?LW_ GX._LH^(_P!N7]H3PCIO MC^Z73->UWPCX;\0Z;9ZGINBZ'H&L7'A[2$T_0M;A_LBY\8^,_%5HL>CZQJ2W M4%A9W'AZ;1Y=,EN=5N+K&EX^PAP]BN(\TX(SS*L-C,9E>#X)PV(KTWBN,YYH M\>H3PR>&ITL#2PL<%&KBZOM<;1A1QF"E1JUIXS!T\3O6^C?4GQ/@^%LHX_X? MSG%X'!9OC>/L5A<-46#X%AE$*DL75K9C6QDLPE1P5'V. KSKX+'0KT: M$,%C:F%_!&BOZ7_V:_VLO@+_ ,%$?$_B;]GSXN?LO>"_#T4GA'5M>\,3?VE9 M:^S6MHUOI>IV>E:O;>&_"OB#PCXGLM.U7[9I6O\ AJ[MKL6\&HO!/H\]M;?; M?P@_:G^"J_L[_M!?%#X.07]QJEAX-UZ%-%O[PPM?7/AW7-*T[Q+X;DU%K>*" MW?4AH.LZ)6/XAXGS?@OB7A+$<'\3Y5EM' M.5@7F^#S["XG*ZL\+2=>.8X&A0P\:L*N,PT?8155.,Y?O54I5J4/BN/?"K+N M&>$LDX\X4XTPW''"6<9K7R)YBLDQO#F+PF;T:>+K1P\\LS#$8C$SHU*.!Q4E MB).BXRIQ_=.G6H5JF)^SMX&T/XG?'KX-_#OQ.+P^'/&_Q,\%^%]=73[@6EZ^ MDZWK]A87Z6MT8Y?L\[VT\B1S"-FB9@ZC< 1_09\:_P!C[_@E-^SK<>'K3XS6 M>I>"+CQ7#J5QX?BN?%GQDUHR*?#TVKK +9]1LU(NS 9#-^Y$@24 MI^$G[&?_ "=K^S9_V6[X:_\ J6:77]+'[>G[!>J?MG:I\--1T[XEV'P_'P_L M/%%E+%>^%[CQ$=4/B*XT.=)(W@US1Q:"T&CLK*RS^=YX(,?ED/\ B7CCQ)B\ M!XL\,9+CN/N)N!^%,1PE#%YGC,@QF;0]CB7C.)51KO Y4Y5,35Q-?!X#!2G[ M"JZ5)J;Y(0E)?OWT?>%L%F/@SQ;GV7^&_"?B#QEA>-*F"RK \28'):CKX2." MX4E7PTO7VI_$R7QWI\.L6HG^*-W;+X).@>))-3N;EO'EI:Z7#Y>MQ^'8H38S2ZK M(]P5CM)+$:A=67VM^R-^PK^QOXD_8P\)_M#_ !YT76KJYGT3QOXM\:>)#XJ\ M8:?8Z3HOASQ3XCTP"UT;PK=1.UM8Z1HL,LBQ6E]J-W=OR56N]3U2_\ %_CVWL[*V61T0S7$SI'&&=5+,,L!S7C<=9MC,G\/N :W#'BK MQEF^5\2\8YA*KQ;C-#&3]DZ\JN M(3='V#A[GAYDV!SSQ,\1L/Q;X/<#9)F_"O V6QI<&8#*,HS;*_K]64LWP^+C M0PL<=EU7,\RPN,P="5? P]M'#QHX5VKK$*IXCX=_X)__ /!.']JO1]?_ .&9 M/BWXCT?Q#HL$DC)H>OWNLC2II[9K.PO/$/@GXAZ7!XJO_#WVX"X9]/U30#?7 M2O9V^OV\9\E/Q,^(_P"SA\0_AK^T-<_LTZI%87GC]O&WASP1HLEM<^7I6O7? MC2YTJ+P=?V=S.JM#9Z]#KFDW$:W"+<69NS:7<4=W;S0I^RO_ 2E_8V_:'^# M?QK\5_%7XK^"+OX>^&%^'.K^#["UUK4+(:YK^LZUK_AK442WT:PGO)8]'TZT MT&YN+^^U22P#7TVCQ:5;ZH&U*?2/3/ OAWP_^TC_ ,%;/B#\2]&8:KX)_9G\ M(:7I]SK%I)8W^CZM\0X]%E\+V&F3>9&TL1TO5-5\77MG-9$LFL_#Y)S>+;W" M6T\Y5XBYOP!Q)Q[@,!QYC_$KA?*.#YYM1S;,<:LYI83/Z\,NPN54Z>:/%8F% M3#3S3'X?!8FEA,7[#_::D94)8[!U+WG'A?DOB1PKX=9CF/AUEWA3Q=G7&]/) MJ^397@'D5;&\.8>>9XO.:M7*%A,)4I8JGE&6XK'X6MCL&\0OJE.<<1'+\?2/ M6=3_ ."0_P"R)+X'U+POHVD^((?'\?A$V5CXUO/&GB&:]@\0S:=<6>F^+-2\ M/0Z@-$,5QJ]K+>SZ?#I46FS"&[L[2&)(L1?RL:QI&I>']7U30=9LYM.UC1-1 MOM(U;3[@!;BQU+3;F6SOK.<*6436UU#+!* S .C $CFOZ2_@Y^V*?$__ 59 M^+O@635#)X%\4^'I?@EX7B)46Z>(O@U_:FMP71N2WES6MWKTWQ632GB 2[/B M;3DA:4LLEQ^8O_!57X,-\)?VNO&&L6%E]F\-?%^QL?BCH[065W%9IJNKM/IW MC6U?4)B]K?:O/XPTO5_$M_!:NCV-EXGTA9[:-+BVGNOI? _B/B_).,Y<&\=9 MUG.:U.+>$LFXJX>GGN.Q^+Q%&4L'/&U\'AEF&)JU*4G1J8^GC*=-2;K9*Y2C M0E"M37ROT@.%^"<_X%7'/AYD.1Y/2X*XSSW@_B:GP]EV78+#5XQQU/ 8?'8I MY9A*-.M%5Z>6U<%5JRBE0SY1C/$1J4*C_-VBBBOZ[/XG"BBB@ HHHH **** M"OM/]JG_ ))3^Q)_V;9-_P"K9^(U?%E?:?[5/_)*?V)/^S;)O_5L_$:OE,]_ MY'_!/_8WS7_UF'O^2)OV,?"'[0_P =M!UJ>XET#QIXK\;>)'\6^,+*STS2?#GBCQ'I MK/;:/X6N8&-M9Z5HT4IB@L;W4+B=IB'F+Q1)_/37]9G['?PXF^,'_!+CPC\+ M+?5H]"G^(/PV^*?A*+69K-]0BTN37/''CFQ6^DL4N+1[M+8S>8UNMS TH78) M4SN'\S?26S_-\CRK@U99Q#F_#E#&\0U*.98[)L;C,%B5@XX://*<\#.GB*T* M,*E2LL.G*-2I&#]G*<:=OZO^BGPWDO$.=<+?LXPAF%.IAZ%2O.G3HO$VA.G3E->TA"=3F^+IO"/\ P0Y$4I_X3"]3 M$;G?#J/[0\LJ84_-%'_9,OF2+U1/*EWL OEOG:?B/_@F3^S9\*_VG?CEXN\* M_%?3M7U?PKX<^&FJ^*K+2;35;K09[K55\2^%]%LVU&\T>Z%TL5K9ZQ>RM:V- M^B27HMV:ZFM89(;KWWXU?\$>?$7P=^$OQ#^*DOQXT/7X?A_X3UCQ7-HJ^ K[ M2WU2'1K1[R6RBU!O%5^MK//'&R0.UI,IF*(RJK%U;_P1&_Y.0^)__9$=3_\ M4\\"5\/C,SHY?X4>(_$?!OC!QQQC7P_^K6 CB\TQ.>8.KDM:MQ!ET:T\!4S* MG0QE*OB\)BJE&I6P=2G#V+E"KSS]FZ7Z#@,GA;POQUX(^'W V'Q7^M M>8RP6483A_'4<^H4.&K>*+OP+\4K2_L]+N--G\=?$'3I+;4=4T^WN].LA MKWBJWO\ P4US=0ZG87%I$;R5YKIH+0"20SVC_GG_ ,% /^"=\W[(-OH'CSP3 MXJU7QG\)?$NKQ>&HYO$D6GIXN\+^(FTVXOK:PUNYTFVT[2];M-9M],U6\LM8 MT[1]%CM9+>32KS38Y%L;_5?8OVS?V%_VI?CC^VE\4]<\ ?"W4;GPGXP\1>&A MI7C?6+_3M'\(0V<7A+PSIE[JM_J4UQ)=II^FW%M=&[2QTW4-5E2UFCTS2]1O M#!:S?<__ 6.\?>'_"?[+OA/X6W>I1WWB[QKXT\.MIUF]RJZB^B^#K.ZO-9\ M1SP'S9)+9;YM)TU]SH7N]81TEE^S3H?'X5XEX@R7BOPACDGB?G/'M;C6EESX MPX;QV;SSRED$,72RZ>-I5>?&8QX3$8*&*S*NX2CA<=AO[(;Q7-1K2IGN\8<* M<-Y_P=XV3S_PER+PYH!O"FHV M'@[PY9V?B2[\/VC>(H]/B\1^*[_5KK2KBRU&$Z%HM_X7^Q*]['830Z_?S7,, MLEI:R0XO_!47]BCX?_LOZC\,/%_P=TC5-)\ ^,[;6/#^LZ=>ZKJ6N1Z3XMT5 MH-0M)QJ6KW-U? >(](OKC[/9F:6*%_#5_,OE"X5#]O\ QJ@?]BG_ ().^'/A MB3/IWQ!^+&CZ?X3UF*YCM!J$7B'XJM?>+_B1INH+8!([B#0O" UWP+;WP:0) M%;:(MSE^.5L=+T]C=S:MXMT;3O&&G:':HD\K?\)3I\T=O=[HXIIH>)7%M/CK!>*% M?.LWCX:YGQ_F'",,JK8W'4\CHY91R[#87"9A]2EC/[.C4GA*M;,Y5*<8P69Y M;C:BJ5W[>,*K^%7!=7P]QWA%ALBR67BKE7AOEG&D\XH8#+ZG$%?-J^9XK%XW M+/[0A@O[4E3IXVE0RF%.K*51Y3FF I>SPZ^KRE_+E1117]UG^>!_1?\ /\ M9 _9-_9J_9 TO]K#]I7P9-\5-4U3P-X5\>ZI:7^G2:W::)I_Q ET6'POX4\/ M>"[F^T_0;S5IYM?T*QOM5\3/(UOJLUW,FHZ'HZSJOI_P6^%G_!/'_@H7\-O& MX\ ? "3X5ZAX0U"/1;N_T[1=&\"^+-$U'6]'EFTGQ%I5UX-UG5-%U_3E9;U+ M6P\40WEL=1TFY:_\.?9C875YZ]^QKX)\8?'_ /8*TKX-_M1?#.[T#P_=>&K; MP)X9>^GTW^T_%/PTTS3=%OOAYXYM-+DAN9_"FN>&[B.UMO#_ /;%DUX;WPAH M_C&&)X-4MD7P3]J#XY>#?^"7GPHT+X ?LW?"S6K#Q7XZTJ\UBP^)WB:W%WX? M-ZT;:5K?BR]UF:.1?'/Q'TZ2WTMCX7-II?AWP[::GH=]<6Z:"FF>%-7_ ,U< M1GN?<3\19ODV!SKBO-?$ZOQW7I#J8:3P?U-4I4ZE*-"<,;_JOA>'>'.$N&,DSS,![VYAO;SP9XK\0^%+N\MU=+>[NO#NKWFD3W,".2Z0SRV;RQ*Y+ M*CJ&)(-ZF@O]0DCNF"73*[EJ^1*_P!!^%N(,JXCRBEB M\JSS <0QPLHY?C\QRZI3GAZF9X:A0EBU:DHPIRFZL,1&G&,8^QKTITU[.<&_ M\T.+^&LYX6SJM@LYX?S'AJ>+C+,\NRO,Z=6&)IY5BL17C@G>K*4ZL8*C4PTJ MDIRG[?#UJ=5^UIU$OW6_X)K?L.?LV?M!?L^^*/B?\9?#>LZ]K>G_ !&\0>'X MYX/%6OZ'8:=H>A^'/#.J+Y5IH%W8-+,\VL7DMS-=/=NRQP) L(1Q+Z%H/[-_ M_!';XT:C;^$?AY\5[SPYXDU6>VTO2EMO'OBGPWJ=]J=[<1I9VNCI\6M$NM,U M/4[R7;8VEC!:WCW,MPEO!:O>RVY'M/\ P2$_Y,D^(W_94?B/_P"H'X(K^7ZO MY5X8R;C+Q(X[\7L+#Q0XUX;I\*\5XK"Y3A\OS7'ULPPU M'ZK@X950A'#4G1C5IRG"4XM\Q_8O%N>\#>%GAWX)XN?A'P%Q35XPX-P>,SG$ MYGD^6T+QT\XQ,Y8JM&M*C5C3J1A-)P/TE_;G_X M)T^,?V1H['QOX>UV?XA_!_6-1.F#Q!)IPL-?\':K/)*^G:3XML[>2>SFM=0M ME$6F>)[!K>ROM2@NK&_TK0;B?1(=9]<_X)8?LA? W]J&P^-MY\9/#VJ>()/! MMUX!M/#R6/B/6M BLEUZ'QA+J4KC1;NRDNII3I-B$^U2310K$WEQ*9)&;]*O M"^OW'[0W_!(/7=?^);+K>HC]GOXG37>H:W="[EO-:^"5]XJA\*^)-5U&^(:7 M4UU7X?:)XAO-3O)6G_M))+VXN9)P]PWSA_P0M_Y O[2W_84^%'_I)\0J\7-/ M$[CC$>$O&66YGG.*P7&/!/%V4\/X[-\JQ=; 9C6PT\3BJ"56MA(86K"H\3EF M+HU,1"<*F,A"2Q%.,O:NM[V3^$OA]AO&?@;-LIR+"8_@CC[@G.>)$?B'XU\,:3]LE$]W_9F@>)-3TJP^U3JD2S7'V6TB\^58XQ M)+N<(@.T?L5\%?V&OV=_&_\ P36UW]HO7_#>MS?%FU^%7QZ\9VWB"W\4ZW;6 ML&K_ [UCXA6_AU5T..Z_L5[,6_A;38;Z&:QDDNEDNW\Z.:6.6'V[XC?\$5O M^$_^(7COQY_PTK_9/_";>,_%'B[^RO\ A3?V_P#LS_A)-;OM9_L_[=_PM6R^ MV_8OMOV;[7]CM/M'E^=]F@W^4GVC?? G_AFC_@F[\7O@E_PE/_":_P#"%?L^ M_M&_\5-_8?\ PCG]I_\ "1Z5\1?%O_(%_M?7OL?V/^WO[/\ ^0M=_:/LGVO] MQY_V:'Z#C?QHR+.^'?#_ "K@[C+-'Q'#BCA19Y'!1XBRO$U\!' XO#9G2Q>/ MK87!TL;0J8^KA57H?6:ZQ-3DK02Q\^&,XPM#,99C@L5E57!9=0Q>/K8#$4LNHXMX?$+"X=X6GST/:4I553 MG_'BSJBL[LJ(BEG=B%55499F8X"JH!))( R>*_J=^#_ /P25_9=M?A9X!L/ MBSX4UW5?BO?>#[#4?&EXGCS7]/EA\275K:W.O6NF:?I&H6>E-IWAO4=231[. MX73Y!+;P6,VHM<75W))-^'/_ 3V^"S_ !R_:S^%/ARYMII_#GA;6$^)/B]X MX[2:%-"\"2P:S!::A!>+(DVF>(?$2:#X4OTBB>X%MK[O"8&3[3!^P_QR_;%/ MA/\ X*H_!?P+%JAC\#^#M!B^#OBZ(%?LY\0?&T:7JMW?4 MFP?LDOAK48IY%=72V]GQUS[B_-.)L)P;P/FV%OC9X&^-6F67EZ3\5O"QT+Q M!/;V5VRCQKX!^S62WFJ:EE[&&;5_!^H^&]/T>P86]Q/#X0U>YB^U)#8\T.>"PN8U,5E+:?+/)LQ2QV6'HHKCQ!XS\2Z#X1T"WFF6WBN=<\2ZM::)I%L\[_ "1"YU&^MH-[ M9"F0'!Z'^I;4_P#@D/\ LB2^!]2\+Z-I/B"'Q_'X1-E8^-;SQIXAFO8/$,VG M7%GIOBS4O#T.H#1#%<:O:RWL^GPZ5%ILPAN[.TAB2+$7Y/?\$@O@L_Q(_:DC M^(%_;32>'?@EX=OO%4DGEVDUC<>+=?AN?#7A/3+U)U>='6&[\0>*-.N+-8WA MU'PE;&2X2-O(N?T%^#G[8I\3_P#!5GXN^!9-4,G@7Q3X>E^"7A>(E1;IXB^# M7]J:W!=&Y+>7-:W>O3?%9-*>(!+L^)M.2%I2RR7'\=^./$O&F9\69MDW!.\?Y%D.=XCQ0XUCPIPY'.L#E^8/!X? X/-*-'$8 M*./PU2KAZF-SRCB&-4REMH-Y927-S- M)](6>VC2XMI[K]9 M?^"/D$UU^Q9X_MK>-I9[GXK_ !"@@B7[TDTW@;P-''&N<#<[LJC)')KT_&7Q M"S3,/!;@WC#AG-\?DN)S[/,IABZ^38[$8"M"7]D9\\RR]8C"8A5E2H9I@G2J M4_;MN>%C&K>49(\KP+\,LIRSQYXZX'XLR3+L_P +P[P]G-3!X?/IW&BZ,L&B_:;Z;3]:EUJTNM'N=&-Y>-%?P VMW>V5S9WES]]?\ !.W]A7]J M'P/^U-\//BAX_P#AQJ?P\\%^ /\ A)=2UG5?$=_I]G>7\FI^$==\/V&CZ'IE MG=7FH:C=7M[K,#7CRPV>E6VCP:I)<:E]O&G:5JGWK\3M6\'?%G_@J]^S[X.M M9;#6)?@3\,/%_B7Q,HG6>*U\5:AIVLW6BZ0\4<;>5JF@&\\-^)LM.H1[FV1@ MDUK)#-\?A./Y-P]EF'RS*HY#BLRRG&8[+*698B66U<)@)5:D.%Q$XR\"\"?\$R/V4_V-M8U/]H3X<^ GNY_\ A'/"7PJL]=L]/8X@ M7Q!XL\2^(8=8U! '*L;C2_#OAVU!=%=#92@$I("?S*_9R\5:QX(^/WP7\5:# M=3V>IZ-\3_!%S$]O<3VQG@?Q#I]O?Z=<26[I(]AJNGS76F:E;%C%>:=>75I. MDD$\D;?09%P?XA\7>'^*\1,=XK\89?G^98/'Y_EN5Y=FF*P?#V'P^$IXN6'P M=? X2M"E".,EAZ,W/"4J5'!T:DZ<\%CJO-)_.<0\;^&7!?B5@_##+_!O@C,N M&\KQN6\.9IF^:91@\=Q-B<3C:F"CB<=A\PQE"=6I+!0Q->FH8VM6KXZO3IU: M>/R^BHP/1/VP?V4O%_[(OQ7E^'OB"];Q%H.J:;%K_@KQK#ID^FV'B;1)II;: M96A::\M[+7-(O()+36M'CU"\FLA)I]^6.GZQID]S]^?L-?\ !+O1_BUX!L?C MS^T=KNK^%/AUJ-I)KGA?PEIUU:Z#>ZYX;L\7+^+/%/B"_CF.A>%+ZV@N7LK> MTAM-1U'2FCU^+6]+T]K*34?LG_@LSX"L?&/@;]G*1?*M]>N_C0O@+3=2E0LM MG8^.M'=K_P S8#(T7VWP]H]PZ)R1;' +$5W_ /P5O\47_P *_P!BW2_!_@=8 M] T/Q;X\\$_"N[M-.,MH+/P79>'/$WB)-'L&A=&AM)6\%:7I-S!N,5SH\U[8 M3K)!$\JS2>5<3\99IC\ISWB3"PCA\53P.78^C@Z6,PK MIU*/L:U;"UIXS,)X.KA<3*O@)T\%[&&-5*/OKP9\/N!.,_%GC/.,HIYQPCP- ME.79QP]PMC)RQ.$JYAFF75L=5P.,52E6]O0H8NC3P66PQM'&82.'S*%3,/;S MP$JTO 6^!?\ P1?^(FHW/PN\)>-]'\+^,KUCI=CXGT7XF?$JUE&H%TLXFT/Q M#\0[K7/A?JU_'=%U&[T#2[?1+JUL#JNNFY\.:)K5O!XAMQJM M_=Z?J=I!<:3J,:Z1B15MOS@KL_AGX%OOB5\0_A_\,]&N;'3-1\?^,_"G@72K MR^$RZ;I][XJURPT"QN;P6L4TZV-K/?Q2W MH)9A!&XAB=]J']LR_PWXIX9PO M$=2?B]Q;C'R7!9]@ZM# M$8>>19M3H8"C2K4<1F4\KQ,:V+E7I0I8;$85TZ='&8J57^A#X3? [_@C5\7/ M%MK\'?A[*?&'Q$N+?6+>RDO/$W[0&AWFLSZ$C_VE<:5J^I3^'O NL7JQ13ZC M9P:.D\&J:?;W.IZ79WFEVT\\?YD?\%$OV+]/_8_^)'AF+PAK.HZU\-?B3IVK M:EX2_MQH9-=T74/#\^GP>(O#U_=VT-O;:I;V0UC1[[3=46VLYY+35!I]Y;2W M.FR:IJGZK_LD_P#!)2_^ _QJ\+?%_P ?_%;2_%8\#37.I^'O#?AG0K_38[S7 M)K*YLK2]U?5+^],J66F"Y>[CT^TM"U_>);?:;R*RAN;._P#SY_X*X_''Q7\3 M_CQX>\#ZMX"\6?#_ ,,?"O0=2@\,6WC;2/[*UCQ3=^)=21=>\:::8+^^L+KP MGJR^'-'T_P /R6LCS[M&U&74I8+^>;1=%_'_ VXEQ-?QDR7)>$O$?BWCSA& MMP_B\3GM7BC'9@_9XRC@<>IK!X3.%A:SC#,%E=6D\-A98B%+%5:52IB*&%KX MH_;O%3A3"X?P,S_/N,_"[@SPZXUH<28+"\/4>$+AAJE;!T:U.GAL1B\/@S\HJ***_M(_@T**** "BBB@ HHHH * M*** .Q^'?_)0/ O_ &./AG_T]V-?WOU_!!\._P#DH'@7_L[&O[WZ M_B'Z7O\ OO ?_8+Q#_Z=R<_T ^A+_P B_P 1/^PSAG_TSG84445_&I_= 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 ?!?_!3K_DQ?X\_]@_P/_ZL_P $U_''7]CG M_!3K_DQ?X\_]@_P/_P"K/\$U_''7^@WT3?\ DWV>?]EECO\ U29 ?YI?3-_Y M.5P]_P!D-@/_ %?\1A1117]1'\B!1110 4444 %%%?T)_LC?L*_L;^)/V,/" M?[0_QYT76KJYGT3QOXM\:>)#XJ\8:?8Z3HOASQ3XCTP"UT;PK=1.UM8Z1HL, MLBQ6E]J-W=O&N"RW&YYA,WQJS7&RP.$P^38;#8G$N MK"DZLI3CB\;@::A;E@E&K.K*I4@HTI1YY0_3/#+PJXA\5+PF%5"=:-&,83P> S"JZEW*HW.C"C&G3FYU8RY(S_GLHK^C'P[ M_P $_P#_ ()P_M5Z/K__ S)\6_$>C^(=%@DD9-#U^]UD:5-/;-9V%YXA\$_ M$/2X/%5_X>^W 7#/I^J: ;ZZ5[.WU^WC/DI^%7QW^#/BS]GSXL^,_A!XU^RR M:_X.U&*UDO=/=Y-/U73[^RM=5T;6;!I%606NK:1?65_'#,J7-J9VM+N.*[MY MXD\[@7Q>X6X^S+'9+E^'SO)\ZP%!8JIE'$. IX#&U<)^YYL31C0Q6-HRA!XB MAS4ZE:GB.6K&K&C*A>JO3\0_!+C#PXRK+L^S+$Y!G>0YEB'@Z6=<,YC5S+ 4 ML9^_<<+7EB,'@*T:E18;$.%6E0JX;FI3HSKQKVI/R.BBBOU,_( HK](OV,/^ M"=>M_MB^ /%GCO3/BEI7@2/PQXLD\)C3+_PK=Z\]_<1Z+IFL?:S=V^MZ8MK" M5U2*WV"WN7S'))TVH?S=KY[*>*LASS-<_P DRO'_ %K,^&*^%P^>8;ZKC:/U M&MC8XB6&A[;$8>CA\3[586N^;!U<1&'L_P!Y*#E#F^FSG@[B/A_)^',_S?+O MJF4\6X?%XKA[%_6\#B/[0H8"6&CBY^PPN*K8G">R>,PRY<=1PTY^T_=QFH5. M4HHHKZ$^9"BBB@ HHK](OVN?^"=>M_LG_![P=\7-0^*6E>-;;Q9XLT'PF=#L M_"MWHD^GW&N^%_$7B:.[%]/K>I1W<-O'X=GLW3[+:N[W$4R[0KQU\]FW%>09 M'FN09)FF/^JYGQ/7Q6&R/#?5<;7^O5L$L/+$P]MA\/6P^&]FL50?-C*N'A/V MG[N4W&?+]-DW!W$?$&3\1Y_E&7?6\IX2H8/%<0XOZW@@:3KX&M7B)XR++>Z1IUVEK=V&EW%I:76G:9/#)IUKYN!XNKXSC;.^#I\- MYYA:649;A5YDDXRPLXK MU:XS*JO"M#%PEQ#E<\)/')XK%X-3E)89TL)AJ] M2#[;Q!_P MKGP3J_\ ;MOX9T6'6/[6O_BKH0OM3_M..R6]_M&]%W="[O?/^TW(N;CSI7\Z M3=^;_P"R5^SK^S)^T7\-_$W@GQ%\;G^&O[5&K^*T7X8:;X@M;JW\&7FBZ=96 M*V^F27#6JZ;J]WXMU+5;VSDM[?7;;Q5IMQHVFWVCZ%J.GVVJV?B+\(R7QURW M'9)Q/GN:98JEFF9U5BJ;H\9"R(Z,51P MKJRDI*BRQ. P!*R1NDB-T=&5U)5@2ROZE_VYOV>_@MXX^(_A;XU?MB_%S3_A MO\)_#/PBM?!&A>&/#]]>-XI\1_$V]OO%.K>(]2TZ.'2=2O;G3= L[W0Y]*TW M1='U>_UK4+;S-973M(L18Z__ "\ZO;Z?::MJEII&HMK&E6NHWMOIFKO92::^ MJ:?#&(JXK&4?J6#SBKA,)3Q>,HX?#X;&8R@J,(T(9A0I4*V- M=#%5:/R_B]X0X[PHS982MG.79K@<7BJU++6L1@\/GD\+2PF!K_7\=D='&8VK M@\%7Q.)Q>!P6)=>)YYK*2^TFZM+E[26:VMII;9I3#)+;P2,A>*,K_+Y7TE\4OVN_VB?C3\//#G MPJ^)GQ&F\3> O"=WHU]H6A'PUX-T@VMUX?T>\T'2)I]5T'P[I>M:D;32]0N[ M?;JFHWJ7$DHO+I9KV*&XC_&O$WPXS3CCBCPRS?"5\JAEO!V>5\RSK#9C+$.K MC<)4QV08KZO@Z%/!XFAB)5:>58BE5ABZV&IKVM/6I%S4?W3PG\4\I\/N$?%C M)<9A\YJ9KQQP_A\JR'%97'#*C@,;2R_B/!_6L=B*N.PN)PT:57.,-6HSP=#% M57[&KI2E&FY^4>*_BE\3?'EI;6'CGXB^._&=C97!O+.R\5^+O$'B*TM+LQ/" M;JVMM7U"\A@N#"[Q&>)$E,3O'NVL0?Z%?^"R?_)JOP'_ .RD:!_ZKGQ-7\U] M?2'QD_:Y_:'_ &@/"_AWP9\7?B))XN\,^%+Z+4M!TL^&/!F@I97T&GRZ5# M99UCI\LZC64U,WE5698G&X^EBJ5%QQ]%8?ZM1 MQC]VJI0II1Y_Z&?$?P8\:_'[_@E!\-/AK\.X+&\\9:A\'/@_K&BZ7J%['IT> MLR^&3H'B"XT>VO9\6D&I:C9Z=<6^EM?2VNGO?M;QW]]I]F\U];^;?\$E_P!F M'XL_L^6WQL^(OQL\/77PXM=>L_#^B:/I7B&\M[.Z:P\-2ZYJ7B+Q#JUL+AK; M3]+MC>&[[0=#U;PSIV=:TW0+76]9L_^$>UW6-%O],\0:CJN MF:QIFI7=GJ]I?0RE*[7XK_\ !1+]KGXS>"KGX>^,_BDZ>%=4TT:7XCL?#?AW MPWX6N/%%NQD%RNN:EH>E66HO;:A#*UIJ>D:?=:?H&HVF;:\TF:)Y%?\ &JW@ MYXL0R3/N \/C^"O]4N,^)Z_$&;9CSYK6S;*N7'8#%0C2C.AA*5?VU++,"X4( M4*O-B85J-3%X/#S6*E^Z4/'+P:GGW#?B)B,)+)+>203%9GD54"^-Z_K MNK>*-=UKQ+KUX^HZYXBU;4==UG4)$BCDOM6U>\FU#4;R2.WCA@C>ZO+B:=D@ MBBA1G*QQH@51^Q\)>'F8\-^(W%_%,L5@JN1YUDG#>49515:O4S6G_8>4Y9EU M2>84W@J&$A[26!G*$L/B*O.I1E*E1;<(?AO&?B9E?%/A?P1PA'"8^CG^09]Q M5G.;UI8?#T\GJ?ZP9SFN:4J>6U5C\1C9^RCCZ<)PQ6&H\DHSC&K6454G_43\ M0M/U7]A;]E+X4:G^QE\!-)^)OB_Q&WAFQ\0>.;7P1K'C76KFWU;PQ>ZS>>./ M$8\*,GB.]76[S=:Z7/<:I!X6\/\ ]HV>B6T4=M<:+I$_4_%3Q;\:O'?_ 2_ M^*7B_P#:"\*VW@KXG^(/AOXAU'5O#%OI5WH,FEZ9/XA!\.)?Z'?WVHZCHNJ3 MZ"-/NM1TG4IX]4TZZGDM-3LM.OX;FPMOP3^$?_!1/]K?X*>#;/P!X,^)WG^$ MM(L'T[P_I?B;P[X=\3OXCZEJ^FW&K1VM@BK#IFDW=]>:'I]NJV]II M<4"B,)QF=OB'B'"^TI26!E25'%T,%2I4U6K8FA.BE+'+"4\- MB*E&GB<9B?Z+K_26\.J>#J5\'_KWAZ&8\&8CAFEP)A,#D$>&N&L7[*K%YA"L MZ^"Q./K5JKH4,)B(5Y2A@'C:N*PM*O5PN!PW[2_\$BK.;Q!^Q#\>_#&E&&YU MS4OB;\1[.UT_[1#%*9M;^$?P^T_2S*TTB);PWEY#/#%<3M'#N@G)D AD*_%/ M_!/#P=\0/V5/VV_AWX?^.W@O5/AS=?%SP;XR\(>&7\3BSM([B^GGCGT\P3"] M:/S=4UOPS'X>TZ)#+<7UYK.EK:P26^IVMTWY\? K]IKXX?LUZIK6J_!?QW=^ M#IO$EO8VOB&U_LS0] M/J -A:^&]/TFWCNWOG-U)J#QR:@[I ANO(M+2*#[W&^%7&^)XL\3<-3Q/#U+ M@SQ,POM,?F4YXVKG>7XC X#'PRBAA,)%4L/SQS;%TZN91K>VH8G*:$V*JX7B:KQWX48OV67973A@*.09EAL?F.63SNOC<;)U ML3[.IDV"JT^$_CKX@WT,2Z9IT6NZ;XGNO">KM!I6J6OB%M1%C;WM MI9&_TQ MT.Q\):OXL\6(-&\/A-6L_$/B74-:T&YT_P#X2VQL;6'7V\,61.O3SWBW/V03 MZ=Y_X0_X*C_MK^#]!B\/1?%E/$5M::>-.T^_\7^%?#'B+7K-455CNY=?O-+_ M +7UO4(]I)O/$UWK#V M:3PE=P1:9X'LTR=9CPAX8X7^P\/BH/BS!5,ZQ.=XW%PRZK1RG'8.A.='# MQQ,,?[&IFL\;A:,,5AI5WAZ-"NHJIZ/B1XS<%\391GDLLXU\6L9_K!BL'-<& M8^ED.$R# X*IFE"OG67XW$4Z=;$RPM3+O;TLGA@,97J83%PPZQ5;$8>4W3_< M?]DG]H?_ (*'^"OB=X)_9Q_: _9^\:^._"1U"T\(ZI\0-:\+:O%JGAW1?)L; M=O$-]\4+1KSX>^.?#GA[3C)-J=Y-+J&M:_<&2R_X2J]UW9I]U^?W_!6KX5_# M/X5?M1V=M\--(TKPY#XO^'.A^,O%/AW1(8;72M/\3WNO^*-*GNK33[4)9Z3_ M &MINCZ;?W&FV\,*F[EN-69/^)L&/)V7_!5;]N"RT,Z,/BS8W4H6..'7;WP# MX"N=<@BCCECV"=_#GV*Y9Q(C27-_87EX\EO$YN,M<>?\)>,O&?BSXA^*-9\: M^.?$.K>*O%?B&[^VZSK^MWDM]J5_<"..",S3S,2L-M;0P6=E:Q".UL;&WMK* MSA@M+>&&/U?#WPOXKR?Q#K\9YI@>%^$L*LNQF!S#*N#<5F57+N)L;B*L^7&3 MP.8.I3RO+X)T<51PV'>'JK%X2A.6'BJ^)/&\3/%W@W._#.AP+E&8<7<:XN69 MX#'Y;G''6#RJCFG"> PM&GS8&&898J=7-\SJ-8C!U\7B8XBC+!XW$0CB9_5\ M(.O"^F7>C^"/#, M^K_V/HWB/4](LH9;W7+#65%PMG:QAKVV@MKL3;IXYHY-A3Y:_90_;A^+/['D M'CJV^&>@_#[78?B!-XD>(M3-I)X937([)M+;P_P"*_##0_:5UZY%Z M+PWP?[/:&V%J5N/M/RSXP\4:EXW\6^*?&FLK;+K'B_Q'K?BC55LHG@LUU+7] M3NM6OEM(9)9Y(;875W*((GFF>.+8C2R$%S_.63>#4,7XG\<\4\99%DV;Y'FN M(H8K((8N5/&N->%6E*^.E3!^$GA[ MPCP-Q#GN2<09-A:^#XDG@H5, IX>=&I&G##8^$O:.4*E3FA5P\J-:E+WX3C* M*:]-^&?Q U35/VBOAC\2/B/XIU/6K]?BW\/O$7BOQ9XHU:XU'4)K?3/%.BSW MFH:IJVIW$DTB6EA:8,MS<".WM;=(PT<,2A?WI_X+/?!;XI?$WP[\ O$WP[\# M^)O'%EX-U;XB:/XBM?"6BZEXBU;3IO&5OX(GT2[FTK2+6\OETR5O">IVEQJ1 M@%G:WTVFV(V\1-]F#QV,WBZ72?$&G1>*S9VPMK1KA!HNM:BEN;K6-;U'5+FYU& M7J\3^#N-J?%7 '&OASE66YC7X0P^-RV60U*V"RRE' 8FE]55/#/%5\)A(X>> M KXO"$G'/ -7@[Q(X!\48X;!8WGJ4J]+,%/$TL54P_*IXC]6/V$O@A\ M1?@1^P7\0M ^)^AR>&/$GBR#XH>/(O#EXP&L:-H^L>!].TO3+;7K9=PT[5[B M+0WU&?2I'-[IL%[;6>JQ6.KPW^G6?P;_ ,$.?^2I?'3_ +$#PW_ZD4U?+NE_ M\%5_VJ[2#XJP:Y=>!_&B?%87EO=+XIT776@\%:32-2LM:OKV[A34M;OM5U*XU"[O? OV5?VOOB7^R#XA\5>)/AKHO@?6 M[WQAHUGHFIP>.-,UW4K.&UL;TW\$UBF@^)?#5Q%<^:61VGN;F%HF($ <+(/S MW#>#WB/B>%O&;#YMALCAGWB+F7"^;X.C@,P?]GQQ6&XDQF>YO2YZZG4PU+#Q MQCIX>-6I7E-PY(UJUE5G^F8OQO\ "["\7^!6)R;%<05.'/##*N+LDQU;,'HW]C#+_ &S/^3M?VD_^ MRW?$K_U+-4K^D/\ 9/\ B#XXD_X)G^"?%/P%TS1/%7Q-\%?#S6K#1/"^OV=] MJMGJ/B/P9XBU*#5/#]UIFBZQHVIR:AJ^G6=PV@6T6J6ZU\4OB%XW^)7B.+3X-?\>^*M>\7ZQ;Z3!/;:7;ZCXAU.YU2[M]-M[F MYO;F&P@FNGAM([F\O+E;=(Q<75S-OF?WS]F/]M3X[?LEW.LCX6ZQI%YX?\02 M+=ZOX(\9Z?>:YX.O-6BM_LUOK0L;'5-%U33M42 107-WHFLZ5+JEM;65MJK7 ML.G:I14L/B/:TZ-2$*E&HZ2Q$<5AO@/#CQFX?X3\7O$7B#'?7Z?"O'V9\29PPLE64_9TJSCB<,J56M2G4IUZ2K/#3PF+_ $.TS_@K M+^WIK6OOX4T;]GWX;:MXHCFEMY/#>F?"CXRW^OI/ XCGA?1[7XCRZBLT,A$< ML;6X>-R$=0QQ7Y:?M+_$[XC?&+XY_$+X@?%OP[8^$OB/JNIV.E^+/#.G:1JN M@VVA:EX2T32_!XTS^R-HZE?6_B_6XI9VBC47&EV"^)M*73]DPFE2&_ MN-;38\43F3RGDG_(CQOXQU_XA^,O%7CWQ7=K?^)O&GB+6?%/B"]C@AM8[K6- M>U"XU/49H;2V2.VM87NKF4PVMO'';VT6R&&-(D51Z/A-PKGF49UC72C0K3K.I56)>)H8;DA&ESR MJ>9XS<8.K?2M'^(4>M2?#SPEXK\3PZ;->7OA%K%-4?PWI]\E MG+=);7+6BW9C:=()S"&$4FW^?CX<>/-;^%WQ \$_$GPVEC+K_@+Q5H/B_1H= M4@ENM,GU+P]J=MJEI;ZC;P3VD\UC/-:K#=QV]W:7#6[R"WNK:;9,GZI?\/L_ MVJO^A _9]_\ "5^(W_SUZX/$?@'C/,O%+AKC[AS)\@S[!Y-P[+*JV69YC8X> MC6Q4ZG$$).M2G0J1E2ITLXHUZ$XN3^L8=J4(*O#CBG. M^).',=GO%$,XH9MP_@)8FO0PE.GPU."H5H8BE*%:I6R.OA\1"48Q^K8A.$ZC ME.$/S/\ B!\'?CC\/=/L]?\ BI\*_BMX'TJ^OXM$T_6OB!X'\7^&M/O-3DMK MW48=(L]2\1Z796UQ?O9V.HWT5A!,]PUM9WMRL1BMYW3^EW]ESQWK_P ,/^"3 M6D?$7PK):Q>)/!/PF^+OB70Y+ZV6\LTU32/&?CR\LVN;1F1;B$31(9(691(N M5)&:_$/]J'_@HK\!]#\4:?JEUJ&F M:3KND6]E=7'B'QGXGMO[-,>O7%U*EK9VMZUW:66V^2U%W:W=/P[_ ,%"/C9X M8_9AN/V3]/\ #_PTD^'MSX7\4^$)-=N]#\2R>-QI/B[5M7U;4]NH1>+X?#XN MHGUJ[L[.8^&2(K-(/.CN+Q'NY/-XYX!\0/$+(N$L)F?#G#>45%IQBE3ITY)WJ'J^'GB/X:^&7$7&6-RGBCB MK.Z&?\&T\/A,WS3*90S*/$RQ>.?LZD8U:C^KTJ$C>$KJYCZ.G_"0Z?:?\)5;QSK MNCNK>TUVWM;J&1X+B"6%C'7[(?\ !-?P]X._95_8;\0_M#_$<'1HO'-QJ'Q$ M\2ZD++?JR>#=$N)/#?@G28HE*/?B\D&H:WH%LK[[B;QGY47SW 4?R]5]V?%O M_@H5\;?C!\ =%_9NU70/AGX6^'.BZ?X+TA1X+T+Q'IVL:AHW@*VM(M TB_GU M;Q=K>F"P2YT[2M2GCT_2+"1K[2[+[/+;68GM)_9\1_"".;9+P_P?P-DF3C3J4J4O9R M\/PM\;99-GW$G&_B%G^>\2\1X'A?&Y=P3@,?/%8W+_[2QT:=2LGR25+*:5:6 M68#"XBKAH4U5IXS$UZM.M7@JD?U#T+]J_P#X)&>&?%>F>.= ^&5[I?B_1M;M M_$>F>(;7X>>(%U.TURVNQ?PZDEPVK,6N1=KYSF0.LQ++,LB.ZMZ+_P %;OAW MHGQN_91^'_[1/@B>#6[7P#=:+XKTS6;269X-3^%_Q7M='M9KVSAB#)="XU-O M VJQ33+BSTN/4YTDB22<2_S%U^@&A?\ !2'X\Z/^S;/^R]>:%\,O$W@.;P'X M@^'*:[XDT+Q+=>-+;PUK<.HVEG';7]AXQTW05N_"MC?P6/A>XD\.2BS@TC26 MOX]2N8)[BZ^6S+P#S/A;B7@OBG@#-\[SK%Y)FE*>:T.*,VP%:;RFC.E_LN75 MX8' JE"KAYYAA:N'GSQE'%1G1J865.3J_7Y3](_*>+^%>.^$/$G)<@R'!9_E M%6&48GA')%M,U?6O$>J M_!3XT6&B:1H%E>ZCK>I:E=>+?'T-I9:58:=%-?WE]<2LL5O;6D4EQ-(RI$C, M0*_EGK]*/@/_ ,%3/VA?V>OA3X4^#_@_PI\']9\->#DU:+2;_P 5^'?&-WKK MPZOKFIZ_/%>7.B>/M T^98+O5;B&V:/2X)!:I"D[W$RO/)^%^./ 7$G' M?#=#+L7B,BS[^TL3A"PW$/#O]E87&99A'BZM"NZ[YI3PO%=?L\_M(36[ &2.X^$OQ.DA(0AP7230"A",H< M%A\I4-P0#7Z$?\$1'5_VC?B:Z,KH_P #]19'4AE96\=^!"K*PR&5@0002"#D M<5F_\/L_VJO^A _9]_\ "5^(W_SUZ^%/V7_VK_B5^R=X]\0?$7X?:;X0\0Z[ MXF\+WGA35(?'.F:K?Z:]I?:SH^N37T-OX'*F8PR:ME<,ES2/L<3C,-GN58O&?6DJ%. ME1Y<#@I.%5J4JDH4Z.W*U[_"O%?A3P3XD\%<9X/C;C7BBEEE3/,/G$\^RB7M M\)@<7PYF^!P7U-_6*M6O?,#P9H&KZW;0WOA30M7N ]SKUKJMC<,UYJ-PR MM/ILFV/RXUP%.?AS]EO0O'?[:_[9WPTA^+OB#6_B,UQKB^*?'6H>)IY-6@;P M9X-^T>)+O0);>3_1=-\.ZM&;;2]/@M=-LGU](K2UMTDX^8?C9\7O%'QZ M^*?C#XN^,[71;+Q-XUOK6_U2T\.VMY9:+;/9Z98Z1;0Z?:W^H:K>Q01V>GVZ M_P"E:C=S/('D>9BW'I?[+'[6'C_]D7Q?XB\;_#CPYX!U[7?$GAL^%;J7QUI. MN:G'9:2^IV&KW$>FG0?$GAJY@>[O-,L&NA-0X7Q"QO!V$R3&YFE1A7EF6,R_"X'.:ZS6:=6,(U7B,=&-.4F\;^(? M"=C#XAL=,'A?4?$-CH7_ DT$9&^6QO;:.#4;NQLK2X>"9&ECLIK65"L=U\_ M9_L5?M$?L9_$%O$OP?\ V6].;PLFDVEUX]U/P=<>'[[08;RUNY])T#5M:L+; M4+J[^TQ03OH5EJ@A*10R7^GL\9>[9F_E ^,OQ:\7?';XG^,?BUXZDL7\4^-M M4&IZE'I<$]KI=DD%I;:=IVEZ7;W-U?74.FZ3I=E9:7IZ7=[>W8L[2'[5>75Q MYD\G3_LZ?M#?$+]F#XGZ;\5OALVD3:W9:;J^C7FD>(K2\OO#NO:1K-HT$^FZ MU:Z;J.D:E+;6]ZEAK5I]AU:PECU;2=.EEEFM$N;.Y_+,7]%Z+X"I4,+GN?5. M+X8+"8W^R<1F6!?"M/.Y^R>.HT\,L#&K&$*4\5A:.-6-YW/EQ,HSIREA9?K^ M"^EU+_B(U7$8OAWAVEP1/'XW ?VSA\JS#_7">00]K' 5ZF+>82HRJ3K4\'C, M1@'E_LU!2PD)0JQAC8Z_[6GP9;]G_P#:+^*_PJB@:#2/#WBFYN?"P,EQ<;O! MNO1Q>(/"(-UGVE_,7EQJ-O>1-+(\3M4/[)=GX/U']IWX!V'CV M.";PG>?%CP/;:M!>103:?<^=K]E'8VNJQW0-LVC76I-9V^LBY'V<:7+=F;]V M&J?]I[]IOQQ^U?\ $.P^)?Q!T#P3X?\ $%AX5T[PD8? NF:SI>FWMCI>I:QJ M5M?7\6N>(/$EY/JN=9ELWN5OHH386>GP);(T#R2_.=?T?E63YWF/AYA^'>)* M]3 9[BN%ZN0YICL%6IU:U'%SP%3+)YGAJU)QINO/3'TW'V:A5FH\M-Q<8_RW MG&>9!E?B=B.)^%L-3S+A[!\74>(\HR_'T*M"C6P=/,:6;4\IQ="LIU%0IOFR MZKS>TF_ GQ)\ Q\0H_"_AOQ-X@UKQ=??#BU MO[^[T[Q78)H5QX'N_%-CI<=S>R^'Q;Q^)H[9KNSG\+/?O)8>)#]MU#PS;7?K M'P3U_3/^"C/[-VJ>"/VGO@9XN\):OI4FFPZGJFI^&]6\,Z1J7B*".^@L_'?P MG\0:C;)<6&L6#0W,>KZ?&+B/3%U&;0-1.N>']7O;2Z_&WX-_\%=_VHOA;X>T MCPIXA@\&_%G2-'M[6RMM2\<6>LKXR_L^T58H;:;Q-H^L6*ZC,+=1&^IZ[I6L MZM<2*D]Y?7,OG&:?XM_\%@/VJ/B-HVH^'O"T7@OX2:?J,=Q;2:KX)T_5)_&* M6=RK120P>(]=U;4H=.N!"VV'5-#TC1]6M9BUU8WUK.L#0?R+5\$_%%Y7E'"% M'A3A?#8CA_-\1C,I\2<#G-++L8J%?&/$\N,CAZKS;%>SK.-?#5ZF62Q6"I4< M/1PJA.G4]O\ VM1\?/"*.;YUQM7XQXNQ6&XER3#8'.O"O,,CK9G@98C#X&.% M4L!+%4HY+@_:4%/#XNA3S6.#S"M7Q-?&.<*M-X?[V_X+-Z7X]D^#WP@\$^"_ MAMKNH_"[PIKEUXN\2>*](TY]3TGPG<>&O#EYX:\,:=>&T:ZOM)M(M$USQ%+= MZKJD-IIGEBQMX;^YN6NHK?\ FSK]%[/_ (*A?M.GX$^*_@-XIN?"7Q#TGQ5X M+UWP!/XV\<6&OZG\0+?PUXCT.X\.:@DNNV'B72XM#3+J=]/U[Q'8ZMJSZ MF_V_7KG7UW6S?G17]%>!_"?$W W#..X6XCRS+<(\OS;$5L#F>68QXNEGU/&) M5:N.J1G-5Z$J%J6!IPKX/+YRH8>DY89SYZU7^8/I \9\)^(7%>7<7\+YOFN- M_M+)L-0S#*,UP'U*KPY4P+]C1R^G*G3>'Q$<1>MCZL\/C&=-_9\^*NAW&H2A6U;QQX*\0^!?#=A"&'G M7>H^(/%>G:5ID$5O&6E,$<\VH7*H8K"RO+IH[=_2/V7_ /@HK\'_&?AF#["8=$M M9DCN;2YN$N);@_:C"T4,/O.M?\%HOVMM4L9;2Q\/?!/PW<2 A-4T7P?XJGOH M"01F*/Q#X]U[3"0?F'G:=,,@9!&0?S[*N#O&/@GBCQ-S;A3*.%,PI<;\0ULS MPF+S7-*R6#PT/ MN$?"?)N,L[XRRVMP!PS0RC&X/)\HH-XW%2RG(\#BDL=56,A##PQ&2PJ4ITZ# MJ5L-5G%K#5G&5/\ 2W]JC4?"/["7_!-^#X#VFIZ?J'BGQ1X'O?@_X?M4BEM/ M^$FUWQQ]LN_BSXI@LX8[J>PTVWM-=\6^(%GNPUK'JM_H&A7NHI?:U9S3?/W_ M 0M_P"0+^TM_P!A3X4?^DGQ"K\+_BQ\9?BA\<_%DWCCXL^--8\;^)IK>*S2 M_P!5>"."QL8"S1:?H^E6$%GH^AZ:LLDUS_9VCV%C9->7-U>M ;N[N9I??/V4 M/VX/BU^QY#XYM_AGH7P^UV'Q_+X=FUB/QWI'B'4_LLOAI-:2R?2V\/\ BKPP M\/GIKMTMXMVU\K^3:FW6V*S&?DQW@1Q-A?"O.N&\-C\!G/%W$?$V"XAS6M&I M]2RRG*B[5*&%J5:5)U(P;JUO;2PN%=659TXX:E"E#F[\O^D5PIB_&#(N*<5E MV8Y%P5POPGC^&)IKB:6XF?\ 9]_:SWRS2/+*^W6_C*B[I'+,VU555R3A0%' M K^9/QAXHU+QOXM\4^--96V76/%_B/6_%&JK91/!9KJ6OZG=:M?+:0R2SR0V MPNKN401/-,\<6Q&ED(+G[-\$?\%#?C9X!_9DOOV4]%\.?#&;X>W_ (2^('@N M;6M1T3Q//XT32/B1>^([[7WBU"#QE:Z$+V&3Q1J46F3/X(D\ M35H35-O]ZXJIO!'Y[X;>+F"R'B_Q!S/B7.<]Q.39_P +\5Y7DU"<\9CXQQ^: MYI@,1ESEA:E=PPT5A*->$JJ7[E/V:TG8_3O_ ((S?"[2/ WPJ^,G[3?BV*"P MCU*6Z\*Z3K%]"L3:;X(\$V:>(O&.I6UVV/\ B5ZKJ\MG!? L$%UX)4MM\K<9 M/$G[5_\ P2,\7^*=5\;>)?AE>ZQXMUS5IM# MY]=TW0O$<7C:;1_$&JWFJ>(_,OY?%TWAXW?B!M2U2SU6X'A@&:TU*\:%(+YT MO8_A.OEZ?@1C^+^+^..*^.%UC4I0P_P!=5^D3EW!/!/A_P;X>Y-D>?4LES:W N/ ,^L:5XSTZYLHM\QU2 MU\/KXVT-])E655\0001,OGVT4L?\F-??_P"SG_P4A^/7[-/PNF^#_A70_AEX MQ\&-JVLZG9VWQ$T'Q+JUSI=MK\4']J:#8OH/C#PS:G0[B^6^U9K:]L[RZ.HZ MSJK->M:2VUI:_ ).23C'/09P/89)/'N2?4U]EX*<"\3>'5+BSAW-72K\/SSR M>8<,8N&(H5<16P\_:86O/&48)3PM7$87"Y975"/M*4*TL6E[.6M;X;Q[\0^$ M_$^MP9Q/D\:V'XEAP_3RWBW!3PV(HX:AB::I8S#T\#7J.5/&4<-C,9F^&>(D MJ=>=&.#;56%E02BBBOW(_GL**** "BBB@#[3_;V_Y+KI'_9#OV>O_5,^#*^+ M*^T_V]O^2ZZ1_P!D._9Z_P#5,^#*^+*^4X%_Y(OA7_L095_ZATC[+Q$_Y+OB M_P#[*+-O_4RJ%%%%?5GQH4444 %%%% !1110 4444 ?U"_\ !-?P]X._95_8 M;\0_M#_$<'1HO'-QJ'Q$\2ZD++?JR>#=$N)/#?@G28HE*/?B\D&H:WH%LK[[ MB;QGY47SW 4>4Z%^U?\ \$C/#/BO3/'.@?#*]TOQ?HVMV_B/3/$-K\//$"ZG M::Y;78OX=22X;5F+7(NU\YS('68EEF61'=6_+SXM_P#!0KXV_&#X Z+^S=JN M@?#/PM\.=%T_P7I"CP7H7B/3M8U#1O 5M:1:!I%_/JWB[6],%@ESIVE:E/'I M^D6$C7VEV7V>6VLQ/:3_ G7\HY1]'W%\38_BWB/Q!S?/,FS;B+/,PK1R_A; M-\%#!RR?$J%6E0QE2O@,>\1&,JM3!PPTFH4Z&%@YRKNM>/\ 9&=_26P?">6\ M%\+^&F281RI5:^!I8?,+BG.K MB<7.-..'6'2G_3I_P5N^'>B?&[]E'X?_ +1/@B>#6[7P#=:+XKTS6;269X-3 M^%_Q7M='M9KVSAB#)="XU-O VJQ33+BSTN/4YTDB22<2ZW_!'>[FL/V,/'=] M;E1/9?%KQ_=P%UW*)K?P1X%FC++_ !*'1:%\,O$W@.;P'X@^'*:[XDT+Q+=>-+;PUK<.HVEG';7]AXQTW05N_"MC?P6 M/A>XD\.2BS@TC26OX]2N8)[BZROV<_\ @H1\;/V8OA5XA^$/@#P_\--3\.^( MM=USQ#<:CXMT/Q+J&O65]K^B:3H5VEA<:3XOT/3!;00:/;W5I'>Z3>R+>2W! MGEN+5H;6'YC%^"OB56\+'X?RIY;B:N5\?4\]R?$3S"A1HU,EJY3FV%Q$&ESR MHU8X_$0Q?L*G/+_;ZJC6J1H\L/KL%X]>%5#Q?7B5&KFN$HYOX-?^"J7[:GC3 M2[C1U^)EAX0M+RVEM+R7P5X3\/Z+JDL4P*L]OKDUE?ZWI%R@/[J]T/4-,O(2 MH:.=6R3QG[ 'QEM/AC^V9\+/'WCG7;M-+\0:]KOAWQ=KVI:A.S33>/\ 2-5T M2'5]?U&YG_?6L/B;4]+UG6;[4I)8XX[:?49W$T*W$?P_17]*U?#'@RGPWQ!P MUD^19;D6&XBRW$Y=C<5E^"HQQ;]M2JQP]>I7DG6Q,L#6J?6<+2KU9TJ=5/EC M%3E?^4Z7BUQU5XJX:XJSSB'->(L5POFN$S3 X3,\?7G@U["M1GB/8]*\ M(6WP^\:>&?"VE2:SKFF0:?XAU35O#_B2RT/2[6XUW6;>[D\4ZE8:]/:Q7::) M9:3I=]/#;Z=_:5[;_GQ^Q/\ L+_'KXF?'GX?ZGXF^&WC#P'\/? WB_PYXN\9 M>(_'7A76/#MC=:=X>U2UUJ3PWH\6M1:5/J^L:^+)-(7^S1>#0TU&/6=4@-I% M';W=_P"!_P#P5>_:G^#/A_2_"%]=^%/BMX;THP6]G_PL?3]6O?$UAI$$1C32 MM/\ %.BZWHUY,J$*8+OQ+;^)[BVA'V2$I:);0V_I_P 0O^"T/[3'B?3+S2_! M7A7X:_#8WEOY2:[9:9JOB;Q+I\IQNGTZ?7]3E\.*S#*RM_ -O+/!.IM-0&GG7]6NK&5$NU MT_4] U"-HX+Z%YONW]KGXD6&L:-K'@V_OIKBTTVVUJ*PUKQ3X8:WUF:TT_3?%]M!#K,^E+9W%[8_R7 M:]K^N^*=9U+Q'XGUK5O$7B#6;N6_U?7-=U"[U;6-4OIVW37FHZE?S7%Y>W4S M7G@#QI976N^#WU M%AM;4K.TMM0TO5-%OI5PMY-H.KZ6-3"6_P#:J7WV.R^S[9MX YWEG"O $N#< MTP4>->!\;7S2KBL7*I3P>9XO&XJAF-94I5*-6*A@,7AJ5# T*]"CA\7@I5WC M5&O5DI\^2_21R#-N,?$F/'64X^7 7B#@,/E-+"8.-.KCLIP> P=?*Z+K0I5Z M,G4S+!8JMB,PQ&'Q%?%8/'PPRP$I4*,7#F='_8R_:RUWQ/#X0L/V=/C"FLS7 MOV$MJ?@37]#T2VE*W+QS:CXIUNRT_P +Z7I\XM)_LVK:EK%KI=T51;>\E::$ M2.O_ -D#]H&#XK?$KX,:!X&G\;_$#X2:*GB/QII'@N_L=6GM=%:WT2<7NCVT MT]CJ7B6??XATBV32O#UAJ6MRW%T?(TV6"WN9X?OGQ#_P6Q_:0U'24LO#_P / M?A%X;U.2UDAN]:;3_%6LR1W#A@MYI%C=^)H;*S>+*LD.J)KT!93YJ2*VU?@_ MX5_MC_'KX2?'#Q%^T)HGBJ#7?B+XSAU2T\;7'BS3H=5TGQ;8:O?:?J5SI^I: M;;-IPL;6"^TC2I=+'AV?1)M&MM/ATK2IK/1I+K3KC[O 8_Q_S7!YOB,?P[P+ MD%:CE4893E&.QE?,/[2S5YEEL\2\?6R_'8ZA# 3RBCF]##TH8K"U(XW&X-8B MI5HQJXC"_GN8Y;]&W)\=DF&R[BCQ#XDH5\YG4SK.LOP.'RW^RLF65YK#"K+J M.99?E^(GF-/.Z^2XG$UIX/&4Y8# 8YX:E2KSHX;&>^_L4^$?VTO"G[2WPRL/ M!?A?XX>&K>+Q[X=3XBVFJZ'XOT?PE#X--[%)XK7Q]%K=K;Z#!IS^'(-1%M_; M 2^EU);"+PUN\4-HB-^G'_!<$>"O^%+?!IKX:/\ \+&/Q0OAX7,P@_M\^"AX M4U0^/!IQ;_2CHXUUOAP=:$7^CB].@?:/WAMJ^1YO^"W7[0[Z#!;0_"SX-0^) M00+O63:^-9=&D7;('-IX>/BY;RUDW&)HVN/$E_&FQU>*82 Q_F'\1;6&C^'M):YFN8-$T#2+&*"ST_3K4S% VR6_ MOF7[9J]]J.I27%[-\-DO /B'Q/XD\+\8\3<'\,\ Y=PLI25#*L1@,7BLS-?^"0<7A'PKI5UKGB7Q)\&?C+HVA:/9*K7>IZI? M^+_'MO9V5LLCHAFN)G2.,,ZJ6898#FOY8*_JS_9<\=Z_\,/^"36D?$7PK):Q M>)/!/PF^+OB70Y+ZV6\LTU32/&?CR\LVN;1F1;B$31(9(691(N5)&:_ECZ3\ ML5'"^'4L#"E/&QXMOA(5^94)XI4Z#P\:SC*$E2E5Y%4<9Q?(W:47JO[ ^B.L M)+'>)T\ECT?3K30;FXO[[5)+ -?3:/%I5OJ@;4I](YWQS\(O!'[>O_!4?QUX>DO) MK[X4?"3PMHR^/=0T>]F2/Q-+X-BTK2[[PO8ZM9Q?\2Z2]\6ZY+H5^\%S%?/I M/A_Q'>:-?VUXMK<6WP'\3?\ @IA^V3\4M'O?#NI_%63POH6I0"WO['P%H>C> M$KJYCZ.G_"0Z?:?\)5;QSKNCNK>TUVWM;J&1X+B"6%C'7UK_ ,$1O$VD:=\= M?BMX7O+@0:MXE^&4%]HT"HU#RY8BC@ MZ>!IX;&2Q];&3^LOCK^WE^S+^QC\2KO]GGX/AK MP?8:?=7UE:WKV-I:?\(IK)3K,EMH=WH7P%^W_ /LT_&C0 M_P!KKXL76G_#OQ[XJTCXC>,+GQCX.UK0_#FM>(K/7+;Q4\-\VFZ? M:-JEY/H#Z2ZK?6QM+7;%+:75A=WGZW?&^RF_9N_X)(VWP_\ B._]G^,;SX:> M&? B:%>ZC!)?GQCXSUN'5;OPY;2^9+#=W7A?3I]9O+JULI9XDTOPSJ'V*66V MMXY3\5_9.2<'KP1XLX'SFOB.,^*,;DT.(J"SJ&83S*OFT,NK9IA,=A(5%6IP MEC,94RZO1YZ3BI1CB'+'1CB5]ZLZS[CB7C]P7X@9%0PO ?"6 SV?#.(>0U,M MIY5ALEJ9G0RC&9?C:E)T*E2& P5+-%5BD9,[E21H9EC8@*[1 M2!22C8_'[]E[P1\0/@#^UO\ L]:]\8?A]XW^'FCK\8-*\,G5?%WAG5_#VE-J M=Q=+H=RL&JZM:VFFW46ES:K:W>HRVMU-';Z>?MA8PM&[^CPMPEPWPYQGXQXW M+Z]>'$/AW0J8_@+#5\Q=3%XS'_V-GU:M&KA).-?.N:O2P5.M1C&3DL0J4T_K M$4_,XOXSXIXHX%\#,OS+#4*G#/B=7HY=XC8K#Y7[+!X++O[MCJE"M.45%X=U:?^[-Q_7CXZ?$S]FW_@E=X>^&OPV^&GP'\.?$?XC^)] M$GU#6O$.OW.EZ?XHN=$L9ELI/$/BGQ3)X?UO5[V;Q#K2ZBFD>'].@L/#VG"S MUF6]K:Z?>&?%]QI5EIEGXPMYM"T1M4\*Z]J&G6^OV 32%MY-,LK_ %_0 MK[ZG_P""A'[4W[4G[+4W@OQ+\'OAQX'\:_#76].O;3Q-K/B+PGXV\07?AGQ1 M:7@:WCU"\\,>,?#]GIVE:SIMU;C2S>V+-)?:?JB&^??;V\?Y;?$#_@I1^W'\ M5_@G\3[/5?@1X'M?A9XB\(:[X,\9^/=#^%_Q6ATW0M)\86TGA*\9/$VH>.]2 M\.Z?J,KZP+.R:_BN0M[-'_HLI4K7A\%9+F^?X'A'C#+'E6"XO_UJCF&<\:YE MXCWSC.,-3S;$X:IE6+X7QD%2P\JL?J5*E"5>M+,,/2A&=&K0S*%*G]!QYGV2 M\-YCQKP1F\383$T\XP7%V"J.MBHT9/'5JT MX4*$CB,KE5K?77_ 3Z^!7P$^)W_!/K69?B]X0\(C1[CQ3XYU7Q M;XTN-$T6#Q%I^C>%;N&^EU!?%4NG3ZOIIT[2+>]M4U*UN([_ $W3;B\73KBT MD82+ZM^RY^UE^Q'\=/'&H?LI?#CX#Z9X>\)3:1K?_"*Q:_X%\)?\(IX^M-$@ M:?64O-&87NH1W^H:='>:Y!-XC@N;S5K*TOKC6Y]/UIH]/N?/_P!AG_E%#\9/ M^Q0_:3_]175Z_+C_ ()1?\GR_";_ +!?Q)_]5MXKK/'<.X7B&M](W-LQQF:R MJ\&<58[-,CPM',*U+ 4Y]A:N-JX57A4Q$,-EF%P]&I%TY0HQ]F^:,:7 ML],OXHQG#-#Z+F397@,FC1X[X0R[*.(,97RRA6S*ME>7\/\ #F+I8"CC'RSI MX:IBLVQF)KTI*I&=>?M4H2E5=7U'XMZ1\$_V"_\ @H+XH;7/A-IGQ/\ @Y/X M<;7-"^'FJ6VDZQ%HB>-=#21([:#Q5IM_I]PFA>(+?4[72A*6N+;0I[8-J,][ M;SQW'[B_MK_'KX1_ [X'^"_'OQ9^#VG?%WPEKOC?PYH6E>#]1TGPSJMOI.KZ MGX1\5ZS8ZPEKXEL[S3(I;#3-)U+2UFMH4ND34GCA=;>2=&_#K_@L[_R=UI'_ M &1KP;_ZD'C2OTP_X*J^ _&OQ*_8W^%MI\//"?B'QS>:7\3/A[XBOK+PEI-[ MXAOH-#/PZ\=:1_:OV+2H;JZEL1J.MZ5:M/#%(B-?0.Q$99U[\^X?R;B.?T?, MUXJQV*JSXPRNOE'$./QF9>QY\'DJRS#Y:HXBJU&A7E+'556Q$I2JXNO5]K6E M.O.4Y^=P]Q+GO"T/I+Y/P;EV$I0X(S?"YWPSEN!RMXAT\=G[S3$YKS8:C>6( MP\8Y?2EA\-"$:."P])TJ$:>&IPA3^5O^"9"?"7X]?M5_M2^.E^#O@C2?"NI: M7#K7@OP;J?AWP]K-IX/T[5_$%S9/!ID,FDI8:5-J.G_\A.VTBV@M$^TSZ=') M=6<22R_GCXSM_@;X _X*!?$&T^*7A(O\"?#7[0/Q!M==\'^%+%;.UM?#]KX@ MUR'3-.T[2M-N=*6#0]-OO[/:XTG3);8+HEM<6&GV[_N;1_OS_@BKH6N>&/C5 M^T)X?\2Z-JOA[7M(\%>'[+5M$US3KS2=7TR]A\1S"6TU#3;^&WO;*ZB/$EO< MPQ2H>&05XS\.?@3X*_:%_P""J_QE\#_$18[WP9IWQ7^-OBW6O#[S7-J_BE-# MUS518Z$EY9WEG=6L3ZI>66IZ@T#2R7.DZ9J%@BP&\%]:?24<3E/#/BQXMT98 M[-_]7,I\',#@,/B1.>/S'$87.%HQPD+2A3Y?6T5U)#>>!?!VLII=Y>,^M7C^!-!\&ZYX?O=52"ZO;Q;&;QN(-8U&22*\UJR M6[FU%:O_ 5__9B^$?@+PK\,_CO\*_"&@^")?$WBJX\(^*['PGHL.B:!X@EU MK1M0\4Z)KTFFZ>EKI5AK*_V/KGVZYAL8K[7_ .T1>*-(L[^SO/ 6C^$9?#$ M(T?3W^W^'[[5DEU2.?6]"UZVEN+$Z)>1UVO_ 6F>ZD_9(^&DE]"EO>R?'CP M:]Y;QL'2"Z;X9_%1KB%'5Y%=(I2Z*RR.&"@AV!W'Y;@QX;+/$;PFS+AWAG%\ M'X7B26-C5Q4^.<-Q1BN+,KJR5.6)S/!8:-*IE,O;TZU/$8?$4*.'Q&,HN-## MTL7E6(F?7\=_6\U\+O&?*^)N+,%QOC.%EE\J6#I^'V*X1P?!N;44ZD<)E./Q M4JU+.8_5JE&KAL5AL17Q.&P->,L1BJV#SC#0.>\;_P#*$ZR_[)1\/O\ U:OA MJOR1_9P_;LUO]EGX*_$GP=\/?AMX0;XL^*]7^U:!\9YM&T2?Q-X>\.SZ9%;W MFAS0_P!CB[\3G2;ZUFU7P?:Z[JEYI5AJOB#5I+ZPOM/@M](N?UN\;_\ *$ZR M_P"R4?#[_P!6KX:K^:"OO_!;A'(^-,J\2LIS_!QQF$H^(/\ :%"G.=:-.&-P MJQBH5:E.C5I+$TDJM2%7"UW.A6ISE&I!OEE'\W\=^->(. \V\)\ZX'4,10J4X3ISMS1E_1Q^U5 M_P %(O#GPI^)VDZ!X4O?A?\ M:_ KQ=\%[/1_%_@>76=*O[2+Q]IFJ>);:?4 M[W6TTGQ19):>)M,N="BUS0-4T[6X9K:P:[M(+"YFFGU+^=G6=2;6=7U76'LM M-TUM5U*^U)M.T:RCTW2+!KZZENC9:5IT/[FPTVU,I@L;*+]U:VL<4$?RQBLV MBOWOP[\+N'_#C#55E;JXG,<7@\+@LQS*I&&'>.IX'$XZM@ZM3!X>V%I8BG1Q MD<+6KTX*IBHX6C7Q#GBJF(K5OYR\3_%[B7Q1Q5&6;QHX7+,%C<7CLKRNE*IB M5E]7,,)E]#'4J>.Q-\75PM3$8&>,H8>K-T\'+&5\-AU#"4\+0H%%%%?I1^4A M1110 4444 %?:?A#_DP3XV?]G)_!?_U"/B77Q97VGX0_Y,$^-G_9R?P7_P#4 M(^)=?*<7_P"YY1_V5?"G_J^P)]EP3_OV=_\ 9&\8_P#K.Y@?%E%%%?5GQH44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% 'VG\0O\ DQ']F[_LN/[0/_IG^&-?%E?: M?Q"_Y,1_9N_[+C^T#_Z9_AC7Q97RG!__ "+\T_[*OC#_ -:;-#['C?\ Y&>5 M?]D=P/\ ^LCDP4445]6?'!1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]I_M4_\ )*?V M)/\ LVR;_P!6S\1J^+*^T_VJ?^24_L2?]FV3?^K9^(U?*9[_ ,C_ ()_[&^: M_P#K,YR?8\/?\DYQ[_V),H_]:S(CXLHHHKZL^."BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH ^T_V]O^2ZZ1_P!D._9Z_P#5,^#*^+*^T_V]O^2ZZ1_V0[]GK_U3 M/@ROBROE.!?^2+X5_P"Q!E7_ *ATC[+Q$_Y+OB__ +*+-O\ U,JA1117U9\: M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% '8_#O\ Y*!X%_[''PS_ .GNQK^]^OX(/AW_ M ,E \"_]CCX9_P#3W8U_>_7\0_2]_P!]X#_[!>(?_3N3G^@'T)?^1?XB?]AG M#/\ Z9SL****_C4_N@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@O\ X*=?\F+_ M !Y_[!_@?_U9_@FOXXZ_L<_X*=?\F+_'G_L'^!__ %9_@FOXXZ_T&^B;_P F M^SS_ +++'?\ JDR _P TOIF_\G*X>_[(; ?^K_B,****_J(_D0**** "BBB@ M K[K\._\%"/C9X8_9AN/V3]/\/\ PTD^'MSX7\4^$)-=N]#\2R>-QI/B[5M7 MU;4]NH1>+X?#XNHGUJ[L[.8^&2(K-(/.CN+Q'NY/A2BO!SSAC(.)/J']NY5A M6U>ERRC::Y8ZNZT6A]%P_Q;Q)PK_:/^KN<8O*?[ M6PCP&8_5)0C]KU"NL\#>.O%_PS\7:!X]\!:_J'A? MQ?X7U"+5-"UW2Y%CN[&[C5HV!619+>ZM+JWDFLM1TZ]AN-/U33[BZT[4;6ZL M;JXMY>3HKV:]"CBJ%;#8FC2Q&&Q%*I0Q&'KTX5:%>A5@Z=6C6I5%*G5I5:O\ PW^$?B#5T@@B ML=:BL_%>C RQJRS7.KZ;!XDNK>^EN&V.4TR308(F$@2+:Z+%\!?M*_M=_&[] MJW7;+5OBMK]HVEZ,\[^'/!GARR;1_!_AQKI(TNI-.T][B]OKN[N/+_>:IKVI MZSJWEL;1+]+&."UB^9**_/N'_"3PZX6S5YWD7"V"P6:<\ZE/%RKX_&2PLZBJ MQG+ T\=B\31P'-"M4IVP5/#I4Y*FDH1A&/Z5Q+XT>*'%^3K(.(>+\?C\H]G" ME5P<:&7X&.+ITY49PCF%7+\'A*^9U32?%D%C#XD\)^+]/O-1T#4IM,:X.FZG'_9FI:/JMAJNG MQ7E]#;W%GJ<5O-'=NFI6>H)!:+;]/^UK^W=\6_VPK'P7I/C[1?!/AG1O!-UJ M^HV6F^#-/U>W74M3U>&RMC?:KG7\/."\3Q10XSJ\/X-\38>49T\UA/$TJCJPIJE"O6P]*O#!XG$0I*- M.&)Q&'JUX0C&,:BC%)>5A_$WCS"\(XC@2CQ)C5PGB8RA5R>I#"UJ2I3JNM/# MT,36P]3&X7#3K.56>%PV)HX>=24IRI.4FW^J_P &?^"OG[3OPO\ #^A^$O$U MAX*^+.BZ'9?8(=5\86NMV_CJ>VM[>.WTR&Z\5:7K,%IJ LTC'VB^UGP]JFN: MIDR7VLR7+/4?7/[(I6J0C-0IX&-/FYGR7 ME*_T-3QX\7*N0_ZM5.-\SGE/U26 <70R[^T)X6=.=*5*KG2P7]M5>:G.4'4J MYA.KR\JY_RO+_0;Z'7O#^J>';R'4;;3=1T?4F2.U MU66[MFL=5L)4OK:U:62:T%S:7/C=%?10X$X0A#B.$,@P$8<75?;\214)VSBK M[;$8CGQGO^]+V^+Q-7W.3WJTWUT^7GXB<;5)\+U)\1YC*?!=)4.%9.=.^1T5 MA\+A53P7[OW8_5\#A*5I\_NT(=;M_0?[2_[2GCW]JKXD)\3_ (BZ?X6TO78O M#NE^&(+'P?I^IZ;HT&F:3/?W-OL@U?6=>U![B6XU*[FGEFU*4,9%2)(8HTC7 M['^#G_!7#]I?X1?#WPW\.?[$^&OCO3?"6F6FB:%K/B_2/$9\11:+I\0M=-TV M^O-"\4:-9:A%IEE%;V-G=2Z:NHO;P*VHWNH7#-/7Y:T5R9OX;<#9]D>7\-YK MPY@L3DV4Z97A8RQ.%GEZNG*.#QF$KT,=AX5>6*KPI8F,*ZC"-:-2,(I=N2>* MOB%P[Q!F?%.3\48_"Y[G/_(VQDX87&0S)I-0GCL%CO>,?C5'[/0_%.@WUK;:9&8]+LO[1U/5;E].MX3?W%]J)FU"7P5/VA/ MB99_'Z__ &EM!U.T\,?%&]\=^(/B#%?:)9[=,T[5_$]QJ3ZQ86>GZE+J1?0[ MNQU?4=$GT_4+B_:[T6[N+&_N+L3SR2^(T5MA_#W@K"5\7B*'#65QK8_):/#F M-E*@ZBQ61X?"X'!4,LK0JRG3GA:>%RW T(P<;\F&IW;:;?/BO$SC[&8?!87$ M<59O.CEV?U^*,!&.(5)X3B'%8O'X_$9M0J4HTZE/%U<9FF88B4XSM[3%UFHI M227[%:Q_P6L_:8U#PI)I&G>!_A'H/BBXAN[:7Q=9:1XEO/LBSPR16U[I&@:K MXEOM/@U6R=H[E)=7EUW29IH]L^BO;N8!\E_'[]O3XW_M)_!_P-\&?B9;>#+G M1O VJ>'M:C::WJ-]JTE MAHVEB[U6;[2BP1+]F/Q317E9%X1>''#6+I8_)>%,!A,=A\8L=A\9.KC<9BL/ MB5"5-2P]?'8K$U:%)1D[8:C*&&4GSJCSI2/9XA\:_%+BK!5LMS[C',<;E^)P M3R_$X&%'+\%A,5A74C4<<3A\OP>%I8BLYPC?%5HSQ3BN3VW(W%_<&K?M]_&7 M6/V6X?V2;C0/AO#\.8-#T;P\-7#T M>6$;4UR1T=WHM0HHHKWCYT**** "BBB@ HHHH *^T_"'_)@GQL_[.3^"_P#Z MA'Q+KXLK[3\(?\F"?&S_ +.3^"__ *A'Q+KY3B__ '/*/^RKX4_]7V!/LN"? M]^SO_LC>,?\ UG

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

'G\5:3=RZEX:75;+3]2GM-*5*K6FJ= M&E4JU'M"E"52;](Q3;^XB=2%.+G4G"G!;RG)0BO64FDOO/N"BOS@^&7_ 5R M_P"">'Q@^)7@KX1^ ?VC+'4O'GQ$UE/#O@_3=7^''QA\'Z7JVOW$$\NG:(WB MSQG\/?#_ (0TW5M;G@72?#>GZMKUA=^)O$=[I/A?P_%J7B/6M(TN^_1^G6H5 M\/)0KT:M";5U&M3G3DUW49J+MYVL*G5I5ES4JE.K%.SE3G&:3[7BVK^04445 MD:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2)]R7_=7_T- M:CJ1/N2_[J_^AK4= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %2C_ %+_ .^G M\FJ*I1_J7_WT_DU $5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2G_ %*? M[[_R6HJE/^I3_??^2U%0 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4LGW8O\ MI0>+O&:7,]))JS:M9LQP>%P^)QN;*O2A5Y:\5'F6L>9U>;E:LU> MRU33T1_!-_P2X_:@_: _8H_;D\&? /5-/UF^T/QS\<(_V8_C#\#-5^(FJ+X0 M\&_$'QI\3_!'PN\6?$32;'PKK.O?#C4?B?\ #77?"&FV+^*H]+\30>*/!>C> M(O NB^(M(LO%-AXQT/S/_@M/_P I0/VT/^PO\%__ %D[X"U/^U3')^T%_P % M;_B;X1^&H3]E;7/''[;5I\$/#OC#P 6EU'P1\0;'XJZ7\&I/C_I(\-_\*YO& M\:>+_'6FW'QVOXK'5=&UW_A,?$MY%-XVU#6A-XROH/\ @M/_ ,I0/VT/^PO\ M%_\ UD[X"U[E",99M@\5R1IU\7DTJN(A%6]_FH.[U:O[SA?=J"NWN>74E)9? MBJ',YTL/F4:=&3=_<_>*R\O=4K=Y,_T):**_CO\ VDO^#@K]L/X/_M&_M"?" M'PQX8_9'N?#?PG^.WQA^&'AZX\0^"?BA=^(9M#^'WQ%\2>$-)EU^[T_]H#1[ M"YUQ[#1K=M8GLM(TFTEU$W,EMIFGPLEI#\!@LOQ.83G3PT8.5.*G+GJ1IJS= MM')J[OT1]9B<71PD8RK.24Y'-)U&3XC^/+R/0M.UOPOIOBC1?$FE^--?^ M&^AS>(/B^W@67P]JT'B70OAWKEIJB:?H*ZMK6F?R(?\ !+?_ ()[I_P4M^,/ MQAU3XK_%OQ3HG@WX;V^E^*_BSK.E:I_;/QL\?>,_C#<^.Y?#=_8^)?&FC^*] M&2?4/$'A/Q5XJ\>^-O%MMXHUK4[NS@T>#0;^^\87_C+P;]+?M?\ [8?QQ_X* M*?\ !)/3?C?\1_"'@B;5/A1_P4@TKPAK5S\$O"7C"V\(^%? MC^R]KTNG>)/ M&9UWQC\0[C19+OQM\7+#PJ==O-:TK1KB_P#$7@WP_!91ZOJD#ZM^A7_!MC\4 M=#U;X _M&_!6WT[7(O$OP_\ C#H'Q1U;5KBVL%\-7NA_%_P7:>$_#VG:3=QZ ME+JD^N:7?_ _Q/<^(;:\T>QL+6PU?PQ+INI:K<7FJVNC?28>%;*]44EK&)XM:5/,,TP=.=Y87ZLZ].G).*J2:F M[M:/:*NGT@ULW?E?C+_P;4?"&Z\%6UC^S_\ M#_%FP\:W/BSPU!K=[\>CX"\ M9>%?^%>7U^FF^.3I6F?#3X;?#+5$\7:/HMY-XH\+0W^I76C>)M3T)? >KW'A M.S\6GXB^"?Z<:**^9Q..Q>,C2CB:TZ_L>?V;J6TY>=0NHODYN7W;\J?O.]DK];A1117(= 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% $B?!_@]X'\0_$?XC^(;'POX.\+V+W^KZO?N0D: A(+6UA0-<7VHWUPT=GINFV M<)K'RH+:#P[XNF>9[+2_&NJW<<^H:.EG(-(O5O8O"\4DFM6%E>^*.'$ MYG@<)B,/A<1B:=*OBG:C3D]7T3D]H*=#(\OQ-1J=9I3C3J8FHDZ6 H8K$1^HX&MC9T*>.Q\EA,*Z MU:-2,/V$HHHKN/T **** "BBB@ HHHH **** "BBB@ HHHH *E'^I?\ WT_D MU15*/]2_^^G\FH BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HK^:GX+_ /!8N'QY_P %<_&/PBN/$LI/H7Q!MY-S1/'\3/%FI>(O"=K<6T<69KC,JQ#]W6KA9I1KTK-\^&Q-*4*V'JZ*<6U\4))?MGC=X > M(WT?LSX-RKQ%RIY;BN.. N'./\G257]W@,_PSG6RK&^TIP6'SO(L;3KY;G. MO.>%KTZ=1MT<30G,HHHKZ0_$PHHHH **** "BBB@ HHHH **** "BBB@ HHH MH E/^I3_ 'W_ )+452G_ %*?[[_R6HJ "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH *ED^[%_N'_P!"-15+)]V+_F7(N M)?#/BP:#HGB9M"U+:-J7T>B>(]'O)4C:1(6NVM)72]M+RVM_$OVS/VF/#?[( M7[-7Q4^/OB/[-#/#B!'6=HM3\07=BFH MRVP>:PT=-2U0H8;&8K_(/_P14_;Y\2?#3]N+Q%X?^+OBJYU+PW^V9XBELO&6 MM:K< 1Q_&O5M7O\ 5?!GBRX+$1Q2Z_KFLZKX0O%A2*)Y/%6G7=TZVVBPB/\ M.N*/$7*^&.*.%N&L5R.IGU::Q==SM_9M"KS8;+JU1:+EQF8VI.-F1+$T\)X39?AI\.Y73P_M)<:9M@'0SKC'+\+-*= M1U>'N#G+'T\/0IRKYAFN8Y3@:#?-B(K^Y>BBBOT4_C,**** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@"6;[P_W$_\ 01452S?>'^XG_H(J*@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK\M/V\/^"G'@?]D7 M5]$^'_A/2=/^)GQ7FU'1[_Q5X;_M%[73/!_A%[BWN;Y-9U"T$LEMXKU[2S)' MX;TSRY3IZW$'B/6K:33ET[3/$'W!^S_^T!\-/VE_AIHOQ2^%NM+JFA:HOD7] MA/Y<.M^&=;ACC?4/#GB/3TDE;3]8T]I4\R/?);7=M);:EIMS>:9>6=Y/PTLR MP-?&5\!2Q-.>*P\5*K23U2>Z3VFX.RJJ+;IN24[-V/@,G\4N <^XTS[P]RCB M;+L=Q=PW0I8C-LHHU&ZM&,Y2C6IT:KBJ&,KY?+V<,TH82I6J995KT:.-C1K3 M=./M=%%%=Q]^%%%% !1110 4444 %%%% !1110 4444 *.H^H_G6O60.H^H_ MG6O0!E2?ZR3_ 'V_]"-,I\G^LD_WV_\ 0C3* "BBB@#^ []IG]C[]OWX>?MY M?M!?%3X;_LU_M"OK>F_MA?%;X[_"GXA> O@YKOQ/\.[-;^-FN_%_X6>+]'U; M2O#'C3P'KCII^J>&]7N]"U-=532]26[\*^,M$M=8T[7-!M?KGX7?M9_\'"_ M_9BTNR^&&B>+;)9_#^K?$2[U33+?P3I^H7'B6;4K!-,:[A_LXHKZ">>QJT*- M&OEF#KRH8>.'A5J<[DHQ@HW76-VN:RDM=F>1#*I4ZM2I2QN)I1J5G5E3ARJ+ M;ES6??32[6W3='\/G_!8#]BC]KCQK_P41_:.^(G@G]FSXV?$'P!\3Q\)_$'@ M[Q=\-OAUXF^(>B:GI6C_ (^&7PXU=;F_P#!6FZ_#H6KV'BWP/XET^?P_P"( M?[,U]+2UL->_LMO#^O:!JFJ>P?'K]O#_ (+O_%[0X=%TG]FOX^? ?2'T;Q5H M?B-/@+^R!\9;/7/%-GXHL;.P2XF\3^-M!^)GCCPCK/AF""^D\*^(/A7KW@'7 MM,OM8O-1FU&]U"Q\/7.B?V1T40SU>PPE&MEV$Q+P5-4Z,ZW/*R2BFW!^ZVU" M-[Z75U8#] /PREF\0_#7X#6-QX7^(.I'XAVEUXAT31?%'Q-U&/3M?\ M"Z39^!(H-'^)7PO@^'GB/Q!XC/CBY\&>*K[Q/\/M3^'%]X2\7_"/_!7_ /8H M_:X\:_\ !1']H[XB>"?V:_C9\0? 'Q/'PG\0>#O%OPW^'7B?XAZ)J>E:/\"/ MAE\.-76YO_!6G:]#H6KV'BWP-XET^?P_X@.EZ^EI:V&O?V6?#^O:!JFJ?W!T M5%+/\9#,)9A5C3K5)494%3:E"E3IN2DHTTFVDFK^\Y-W?,VW4X=X-8.G* M=."J*JYZ2G*:5N:3:2;:TT44K*R25C^(QOVKO^#BHJP _;,4D$!E_8*^%Q92 M1]Y0W[*3*6'4!E8$]5(XK^T'X(_B#X(_X5GX]U_P &^%]; M\;_#?_A)=,\9_P#"O_%^JZ)8WWB7P1_PF&B10:-XK_X1369[W0?^$ETB"'3- M=^P?VI811VMU$@[*BN+'8VCB_9>RP.&P?L^?F>'37M.;EMS;+W>5VT;]YZK6 M_1A<-4P_/SXJOB>?ELJS3Y.6]W'=^]=7UZ:W>WSM^UK^SIX;_:T_9O\ B[^S MOXIO%TJP^)GA2;3-,U][?5;Z/PIXQTJ\L_$GP_\ &DNDZ-XB\)WGB"+P5X[T M;PYXKE\+R>(M*TWQ3'H[>'=:N&T;4[^&3^&RX^"/_!1'_@DE\;[7X]W/PZ\7 M>!6^%K[=7^*V@VFI>-OV;_'?P]\0^-AX,_X1?QYXTT$0>''\"_%/6-)T=K'P M+\0;CP-\4=*NK[X>>+X/#?P^^)%OX#UC2?\ 0+]:OM<^&'CB^T6Y\.Z;J.D3?'_P7H.O:,WAOP[!X:EO M/&M];^+/[=Z**RQV-IXOV4:.#P^"I4N?EA1356HTG4:4(J+<597WOI MIA<-/#\[J8FMB9U.6\JKTBH_X*H:[XTUZ?X._LO^+=3\/>#/#>K02^)/BEX;OKC3=7\7ZWI%VE MQ!9^%M3M'BNK'PMI][;QR-J%O)'/X@N(E:-ET=%&H_HK_P $WO\ @I#HO[4V MBV?PL^*=YI^A?M!Z%IY(($%AIGQ4TRP@+W'B#P_;H([>U\2VMO&USXF\,VRI M'Y:3:_H$(T<:EIOAOP,/Q+E>)S*IEM.K^\C:-*L[>PQ%5-\]*E.^LHZLL31R^I5<,'+'_K/7"?$SXF>!_@]X'\0_$?XC^(;'PO MX.\+V+W^KZO?N0D: A(+6UA0-<7VHWUPT=GINFV<(/B3\2?$%GX:\(^&K-KO4=1NV^9V^[;V%A;KF:_P!4OYMMMI^G MVJR7-W?[>?CC]LKQQY,/V[PO\ !GPO?3GP)X$,X#SN!) / M%?BP02-;WWB>^MV=8HE>:R\/64SZ9ICRR2ZGJ>JK/\_H9+A_LU<;5B_J^'O\ MO:U;:QI1?I*I)#P;CRXK%8,_;S_;S\./)A^W>%_@SX7OISX$\ M"&'K*9],TQY9)=3U/5?D+X4_"_P ? M_&3Q]X;^'7PRT#4/$?C/Q'J$=KI&GZ<-KHZYFFO[J[9HX--T_38(Y;[4-4NY MK>STVSMY[V[N(+>"256_"SX6>//C3X\\/?#;X;>'K[Q/XO\ $]\EEI>EV2#T M:2XO+RXD9+:PTVPMDEO=2U*]E@L=/L8)[R\GAMX9)%_LK_83_83\"?L:> ]B M?8O$_P 7_$]E /'_ (_$!^;F.X_X1;PM]HC2YT_PI87*(Y+I!?>(KZ"/5]7C MA6'2=)T3\XRK*L?Q/CZF*Q52I[#VBEBL7+JU9JA05N53Y&E&*7)1A9M?!"?^ M8'A)X2^(?TK_ !#S/BSBO,\P61+,(5^+N+Z\$FVE"=+A_A^E*/U98WZM[.CA M<-1I_4DXO!X/&_1_[/G@CXA?#?X,_#[P1\5/'\WQ/\?^'?#]M8>) M/&DT'DMJ=VC.T=NDSQQ7FIQ:5:M!I,>N:HBZQKZV0UK5HX;^^G@B]DHHK]DI MP5*G3I1YG&G"-.+G*4Y.,(J*78?*,LR[*<)+$ MSPN68'"9?AIXS%8C'8N5#!T*>'HRQ6-Q=2MBL7B'3IQ=;$XFK4KUZG-5JU)S ME*3****L[@HHHH **** "BBB@ HHHH **** "I1_J7_WT_DU15*/]2_^^G\F MH BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR4_X+-_MD_P## M)'['?B:T\,ZK]@^+?QS^W_"SX<_9YO*U'2[74;$_\)UXSMMK+-%_PC'AFX>V ML;^W82:?XIU_PO-@H6Q^M=?YZG_!8?\ ;)_X; _;$\6W?AO5?M_PD^#OVKX6 M?"[[/-YFG:E:Z-?2_P#"5^,[;8QAF_X3#Q,MW%K#PO#."]F,?E' MC'QC_JEP?BEAJOL\VSOGRO+>5VJ4E5A_MN,C;WE]5PTFH5%_#Q5;"MZ,_P! MOV;7T;_^)AOI'9%4SO ?6_#[PO\ JO'G&GMJ7/@\?4P.*C_JQPU7YDZ53^W< M[I4ZF*PE5@C\M+&^O=+OK/4]-N[FPU'3KJWOK"_LYI+:\LKVT MF2XM;NUN8626WN;:>..:">)UDBE19$964$?Z0O\ P39_:ZLOVT_V2/AO\79[ MJV?QY8VI\#?%JQ@\M#8?$KPM;VEOKEP;>+]W:6WB:TGTWQEIEJA9;72_$5G: M,YFMY@O^;A7[L_\ !!+]LG_AGS]JD_ _Q;JOV7X9?M,?V;X4C^U3;++1?BOI M[S_\*^U-?,8K#_PD4EY?^![E($1KV_USP[/>2BWT=-G\Q^"/&/\ JQQ=2P.* MJ\F5<1^RRW%R7)7J2PLY2:C"CBZM27\-'^YO[4;Z-W_$= M/H[9AQ5D. ^M8\-K#P_P!=LAI\JE4G[?*L)1SS#4*4 M)U\3F7#V"P5!)XRIS?W3T445_>9_R8!1110 4444 %%%% !1110 4444 %%% M% !1110!*?\ 4I_OO_):BJ4_ZE/]]_Y+45 !1110 4444 %%%% !1110 444 M4 %%%% !117RU^VS\;_%?[-W[*7QR^.G@;3_ ]JOBWX9^"+KQ+H.G>*[34K M[PY=WT%Y96Z1:O::1JVA:G/:%+ERT=GJ]A,6"$3@ JW+CL91R_!8S'XER6'P M.%Q&,KN$7.:HX:E.M5<8K64E"$N6/5V74][A7AS,^,>)^'.$[P]7FM\-EW1_,OTCOH>^,_T5J'"&(\6L#P]@Z?&]7/ M*.1?V'GU#.W4GP]#*9YE]95"E3^K*,&_P!D+]FKXJ?' MWQ']FN'\%^'IO^$7T6YD,?\ PDWCG5G72O!GAQ CK.T6I^(+NQ349;8/-8:. MFI:H4,-C,5Y<;C,-EV#Q6/QE6-#"8+#UL7B:T](TJ&'IRJU:DO*$(R=EJ[66 MI[O#'#6=\9<29!PCPU@*V:\0\3YSEG#^1Y;AU>MC\VS?&4+O$&FWD2W.E)L_F_M;JYLKF MWO+.XGM+RTGBNK2[M99(+FUN8)%E@N+>>)DEAGAE19(I8V62.15=&# $;_C3 MQCXD^(?C#Q3X]\8ZK%-3E&RG6]I5MS39_VU?1R\$LC^CWX*<">$63*AB(<,Y+3IYYF%.ERQSWB7 M,'+'<39S44X^TE#,M(S&LL'Q$\+6MI%J&J/!'A8(/%VF7&E>,K.&,& M&VAU[^SU=I;&8+^@E?PA?\$(/VR?^&+-5^R?"[]I?\ LOP/>?:9 MMECHWQ-M9Y_^%;:Y\[%8O[4OKZ^\$W7EB-97\3Z;>WLOD:-'L_N]K^Z/"CC# M_7+A# XNO5Y\URZV69NF[SGBL-"/L\7+9OZ[AW2Q$I)*'MY5Z4+^R9_RJ?M M?HX2^C9](SBGA_*<"\+P#QBY\<^'LJ=-QPN'R/.<37>,R"BTG"#X8SBGCLGH MT'4GB%E5'*<;7L\?"Y1117Z4?Q&%%%% !1110 4444 %%%% !1110 4444 % M%%% $LWWA_N)_P"@BHJEF^\/]Q/_ $$5%0 4444 %%%% !1110 4444 %%%% M !1110 445\C_MB?MB?#7]COX:S>,?&,R:MXKU=+JT\ > +2ZCAUGQ=K,4:Y MY*RMIV@:GZ?=XXC$4<+1J8C$5(TJ-*+G4J3= ME%+\6V[*,4G*4FHQ3;2/%XCXCR3A+(\RXDXDS+#91DF48:>+S#,,7/DHT*,+ M):).=6M5FX4G4K5(0E]<45_(5\ /^"MWQ[\"_M!^(/B5 M\6]7O_'OPX^(VIVR^-/A_:N8K#PIIL!^SZ;>_#.QN9S;Z+>^'K(B'[ \ZP>* MK9)(_$%W)K$MKX@L/ZOOAQ\1_!/Q;\$^'OB+\.O$-AXI\'>*;"/4=&UG3I"T M,\+$I+!/$X2XLK^RN$EL]1TZ\B@OM.OH+BRO;>"Y@EB7R\GS[ YS&K]6S;A-\LMXN7Y+X+?2#X"\<V]E.<\OQ_";X37MAK?Q_UNP N+@"&^TWX5Z;?0!H=9UF%A);W7BFZM MY%N/#OAVX5XX8WAUW783IIT[3M>C_P""D/\ P4IT7]F32=1^$GPDO;'7/C]J M]B$NKM1!?:5\*["^AW1:MK$3>9!=^+)[>1+C0/#LZ/#;I)#K6NQFP^P:9KO\ ME.MZWK'B76-4\0^(=4O];UW6[^[U76-8U6[GOM2U34KZ=[F]O[^]N7DN+J[N MKB22:>>:1Y)9'9W8DDU\]Q1Q2L&JF79=43Q;O'$8B#NL*NM.FT]<1NI/_ES_ M -??X?\ -?TL?I9T^#*>8>&OAGF$*O&%2-3"<1\282:G3X5A)MZQXEUC5/$/B'5+_ %O7=;O[O5=8UC5;N>^U M+5-2OIWN;V_O[VY>2XNKNZN)))IYYI'DED=G=B237[X?\$4O@!^T':^+M3^/ M47B#4_ OP&U&PO=$O="O+8S0_&74;9;FWLVTW3[K$5KIGA'4GDN'\:1)]I-_ M'=^%]'>YBO/$[:9\[_\ !-?_ ()L:K^TSJMA\8/C!87^C? #1K\M86#&>PU+ MXLZE83E)M*TJ9#%.:\FCF\/^'YEU!=4U3P]_6GI&D:5 MX?TK3="T+3;#1M$T:PM-+TC2-+M(+#3=+TVP@2UL=/T^QM8XK:SL[.VBC@MK M:WCCA@AC2.-%10!Y?"7#M>I6I9QC'5I4X2]IA8*4H5<1)_\ +VHTU)4'=VBW M^_N^;]R[5?R?Z&_T:L^S;.LG\:^,Z^:9-EF Q*S3A+ T\3B<%FG$>+ES?\+& M/K0G3Q-/()J<^2A*2EQ#&<_;J63SE'--&BBBOT\_U@"BBB@ HHHH **** "B MBB@ HHHH **** %'4?4?SK7K('4?4?SK7H RI/\ 62?[[?\ H1IE/D_UDG^^ MW_H1IE !1110 45_/]J?_!=S2'_;DC_8[\*_LR:EJNDC]JG2?V6+GXH>(/BY M;>'-1BUV/XK67P<\9>*X/A]IWPX\56UQI.C>*UUV\\,V$GCZVO/%7AZPTF]U M63P;J6L7FCZ%_0#73B,)B,*J+KTW36(I1K4?>A+GIRU4O84445S&P4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !17Q%^S5_P4;_ &-?VO\ QOJ7 MPY_9W^+\WQ \9:1X0O?'>HZ1)\-OBWX.6W\*Z=J^@:%>:I_:?CWP'X7TB5HM M5\3Z':C3X+^35)1>M<0V4EM:7LUM]NUI5I5:,N2M2J4IV3Y*L)4Y6>SY9).S MZ.VI$*E.K'FISA4C=KFA)3C=;J\6U==0HHHK,L**** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH D3[DO^ZO\ Z&M1U(GW M)?\ =7_T-:CH **** "BBB@ HHHH **** "BBB@ HHHH *S-:T72/$FCZKX> M\0:98ZUH6NZ;?:/K6CZI:PWVFZKI.IVTMEJ.FZA97"26]W97UI--;75M/&\, M\$KQ2(R,0=.BDTFFFDTU9IJZ:>Z:>Z9%2G"K3G2JPA4I5(2IU*=2*G3J4YIQ MG"<))QG"<6XRC).,DVFFF?R(_P#!23_@FWK'[,&L7OQ9^$UE?ZW\ -;OP;BW M!GOM2^%>I7TX6'1M9F8R7%UX6NKB1;?P[XBN&>2&1X="UV8ZD=.U'7ORCT'7 MM;\+ZUI/B3PWJVH:%X@T+4+35M%UK2;N>PU/2M3L)TN;*_L+VV>.XM;NUN(T MF@GA=)(Y$5E8$5_H;:WHFC^)='U3P]XATNPUO0M;L+O2M8T?5;2&^TW5--OH M'MKVPO[*Y22WNK2ZMY)(9X)HWCEC=E=2"17\DO\ P4D_X)MZQ^S!K%[\6?A- M97^M_ #6[\&XMP9[[4OA7J5].%AT;69F,EQ=>%KJXD6W\.^(KAGDAD>'0M=F M.I'3M1U[\LXGX8E@I3S++8/ZK?GKT*=^;"2NG[2DEK["^K2UH/5?NOX?^1?T MKOHHXC@/$8SQ0\+\'6_U3]L\?GV0X!3^L<(8CG]K+-,KC2_>?ZO^T_>5*=/W M\BG[\/\ A+L\N^1_VG/VW/CU^UG;>#-/^*WB"UDTCP7I-G:6VBZ#:'2-'U;7 M8;86U_XRUC3X96MKCQ)JP!:>2%(-.L%DFM]%T_3+6:6!_!_A9\+/'GQI\>>' MOAM\-O#U]XG\7^)[Y++2]+LD'HTEQ>7EQ(R6UAIMA;)+>ZEJ5[+!8Z?8P3WE MY/#;PR2+-\)?A+X^^.'C[P]\,_AIX>O/$OBWQ+>+:6%A:*!'%& 9+K4-0NI" MMOI^EZ?;K+>:CJ-Y+#:6-I#-"W@ MOX@?2@XUQ7$'%&<9Q5X>PF(PT.*^->.)S6>$C3 MA&ZGA)_B_XGLH!X_\?B _-S'< M?\(MX6^T1I%LLP^49'E&'CA M\%@\/%V2UE4KUZLFZN)Q>)J.5?%8NO.I7Q->=2M6J3J3*_P!F/XJ>"OV7 MK+2IOC)XZT*3P9H&J:SX@M_#-GX8TWQ&?[.\2^)8M3G5W35=-\/2ZBF@?91] MH@UZXTV^!\FSFK^*#XN?\$2/VZO@E\,/'OQ>\=:!\-;?P;\-_"VL>,?$T^F_ M$73M1U"+1="LY+Z_>SL([-)+NX6")S%;HRM*V%!!-?Z!M?$?_!2C_DP']L/_ M +-[^)O_ *C-]7Y1XE^'>1\5X7%YWFN)S7ZSDV2X]X##X;%4:6#IRHT:^*U3G3I4H+E4$?Z!_0B^F3XI?1_SWA_PMX!R7@!9+XE>)_" M<.*\WSG(,QQ_$N,H9EF&5Y L+2S*CGF#H4L+EN"JXJIE=!X&=/"XO'X[$R56 M>*J)_P":W7[3^"O^"$O_ 41UG2?"7CWPKI'PULX=5T[0?%_AO48OBG8Z?J= MK'?6UKK.CWL;1VBSV-] LMO.ACD$MM<*"KAT#5^+%?ZE'P%_Y(9\&/\ LD_P MZ_\ 4/T>OYH\&N $S;*_9.SBHPY6Y0_ *X^+MQ\&/AJ?CWI6D MZ/\ &:#PGI=C\2;70M2M=6T:X\5Z;$=/U/6-+O;)([;[#XAEM1KUO:1J#IL> MI+ILA:6T=CZ]117]T8>D\/AZ%!U:U=T:-*C[?$24Z];V<(P]K6G&,(SK5.7G MJ2C"$93<%%%% !1110 444 M4 %%%% !1110 4444 2G_4I_OO\ R6HJE/\ J4_WW_DM14 %%%% !1110 44 M44 %%%% !1110 4444 %?-?[8GP,U;]IC]F/XS_ ;0]=T_PSJ_Q0\'7/AFPU M_5K:YN].TN>>[L[D75W;69%S-$JVS*4A(!Q47/# M8W#5\)B(*4H.=#$TI4:L5.+4H.5.ZBK?SK](#Z6OCA])VCPK0\8>),OS^GP95SFMP^L# MPYD>0O"SS^.5PS-U7DV!P;Q7MHY/@%!8AU%1]E)TN7VM3F****^R/YK"BBB@ M HHHH **** "BBB@ HHHH **** "I9/NQ?[A_P#0C452R?=B_P!P_P#H1H B MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^,_P!M#]AKX2?MV^#_ CX M"^-'B'XEZ;X2\'^(KGQ7:Z+X \2Z9X>M=6UZ73GTJRU#71J/A[7FOI=&L;K5 M(-($)M$MQK.IM,MPTL!M_LRBN/,,OP6;8.OE^8X:EC,%BHJ&(PU:/-2K0C., MU&I&ZYH\T(MIZ.UG=71]+P?QCQ1X?\2Y3QCP9G>.XMA9U\)5E&?LJWL,16A&JEST^?GIN,U&2_CZ_P""JO\ P2"_91_8R_9) MUCXV_"'4?BW<^,K'QUX)\.01>,?&&BZUHIT_Q!>W-O?L]C8^$M'G:X$<2_9Y M!>JL;9+1R X'\]/[.?@/0_BI^T)\"/AAXG:^C\-_$?XR_##P%XA?2YX[34TT M/QAXWT/P]JSZ==30745M?+8:C<&TN);:XCAN!'(\$RJ8V_MC_P"#@C_E'3XD M_P"RL?"W_P!.E]7\:/[%/_)Y/[)7_9S7P&_]6GX5K^)?%K(,ER;Q(RC*\JRW M"8#+ZV$R6=7!X:DJ="I*OF&)IUI2@M&ZE.,83[I)'_4+^SS\7?$SQ*^A9XB< M=<>\;9_Q7QAEG$/B;AL!Q%G.-EB\TPF'RKA#)<;EM*CB)).$,%BZ];$4%;W* ME24EN?V$VO\ P;O?L%65S;WEGXA_:+M+RTGBNK2[M?B7X=@N;6Y@D66"XMYX MOA^DL,\,J+)%+&RR1R*KHP8 C]S]+LI--TS3M.EO[_5I+"QM+*35-4>WDU/4 MGM;>.!]0U&2TMK.T>_O&C-Q=O:V=I;M<22-#;01E8EO45_9&2\+\/<./$/(L MHP65?6_9+$_4Z7LE7]C[3V/M$G:3I^UJ9_S7>)WCMXP>-$(?$O'O^KSQSR-\28[Z_/*_[36%68+!U)P52C'&?4<&\1",N2J\+0E*+E3B MT4445[Q^3!1110 4444 %%%% !1110 4444 %%%% !1110!+-]X?[B?^@BHJ MEF^\/]Q/_0145 !1110 4444 %%%% !1110 4444 %%%% !7Y\_M]?L%>#/V MS/!"7=JUEX8^-7A+3IX? 7CB2-A!=6RR3WG_ AWBSR$>>Z\,7UW//+;7$<< MU[X;U&ZFU338YXKG5]+U?]!J*Y\7A,/CL/4PN*IQJT:L>6<)?>I1>\9Q:4H2 M5G&233N?,\8<'\.\>\.9IPIQ7EE#-LCS>@Z&+PE9----3HXG#U8VJX;&86K& M%?"8JA*%;#UZ<*M*<911_GK?$?X<>-OA)XV\0_#KXB^'K_PMXQ\+7\FG:SHV MHQA9H)E >*>"5"]O>V%[;O%>:=J-G+/8ZC8SV][97$]M/%*WT3^S1^W'\?\ M]E+1/'7ASX5^([:+0O'.EW4#Z3KEJVK:?X<\1311V]OXW\-6DLR06'B:TMD^ MSEY8[C2]2C6U&LZ;J7]G:=]E_J=_;R_8'\"?ME>"C=0?8?"GQJ\,Z?-'X$\? M&%EBN8U:2X7PGXP6VC>?4/"][]LKB>VGBE;\=S?*,?PWC(UL/5JJA-R6%QE)N$TI1:E1JN-N M2JHMW7PU(^_#:48?XE^,G@YXA_1>XVH9UPYG&;T,AQM7&4N$^-\JJU<'BXTL M30JTZ^2YK5PO)'"9O#"3J0J07+ALRP\98S!17)B<-@N6UC6-6\0ZMJ6O:]J5 M]K.MZS?76IZMJVIW4U]J.IZC?3/G?&;XS: M=?:1\"-)OO,TC2)//L=1^*VHV,Y66QL9%,5S9^#K.YB:WUW7;=HYK^:.;0=" MF6^75-4\/_UAZ3I.E:!I>G:'H>FV&C:+H]C:Z9I.D:59V^GZ9IFFV,"6UEI^ MGV-I'%:V=E:6\<<%M:V\4<$$,:11(J*JCV.&.%WBW#,LR@_JUU/#X>:UQ+T: MJU4]?8-ZQB]:SU?[K^)^T_12^B;7XUK8'Q0\4L'5_P!5G5CC^'^',=&?M^*Z MO,JM/-LWC4]]9 Y_O*.'J?O,]E:K5_X2FEF::1I&E>']*TW0M"TVPT;1-&L+ M32](TC2[2"PTW2]-L($M;'3]/L;6.*VL[.SMHHX+:VMXXX8(8TCC144 :-%% M?J25DDE9+1)*R26R2/\ 6^$(4H0I4H1ITZ<8PITX14(0A!*,(0A%*,8QBE&, M8I**2222"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH 4=1]1_.M>L@=1] M1_.M>@#*D_UDG^^W_H1IE/D_UDG^^W_H1IE !1110!_GM:)_RFFF_P"TOOB# M_P!;NU*OZ)_^"Z_[=?[37['FG?LQ^&_V;?'=C\,[WXL7?QBUKQ9XNB\'>#O& M'B,VWPTMOAGI^C^'M-M_B%H?BWPG9Z-J<_Q,O]6UN8^%YO$$NH>'O#<>F:[I M6ECQ#IGB'^=C1/\ E---_P!I??$'_K=VI5^M7_!S;_R&?V&/^P9^U/\ ^E7[ M-5?=U:5*OF/#=*M3C5ISRZ/-":YHRMAYR5T]':23UZH^4IU*E+ YQ4ISE"<< M9[LXMJ2O6A%V:VNFU\SY,^*W_!:W_@J3\5_ ]K\7_ACX73X$?!_P$^E>$_'_ M ,1/A9\$7^(/P[E^(.KZ/\.]+O['QU\3OBUX5^(GA+PMD_$WP_X0\1ZE\3=7AT+Q9J'H_A+_@O%^W/\0_@QX=^"7PV^&6C_$?] MKG7]6\4Z%#X]\%_"?6O$VNW?P^T3X4:4-.\4>&/A5X:U?7+'Q7\>YO%UMX\^ M)7BC5(/!>E?!SPMX=\,Z3IEK\&?$6EZUK+^$?OG]BV61O^#;_P")DC2.77]F M'_@I&JN68NJQ?$/]J)(@K$Y B1$2, X1555P% 'Y??\ !N=+(/\ @H)X\A$C MB)_V./BS(\09A&\D7QL_9F6*1DSM9XUFF6-B"R++(%(#MG-?V;+!YE5_LK#K M^R<0H4DI2YJUYNE%UZFDZBYO?E!MQ:M'HV[?UU5\##Z_6?\ :%)2J-J-J7NQ MFU2C\,'ROE4DDT[RW/1?V8/^"SO[?/PA_::\'?"3]MJ_TC4?"7BOXA?#/PI\ M4+3]H#X?>'/V%? M$6GZUX0\*6NF:%J?P]B\1WWC2'Z\_P""S_\ P4R_:\_8^_:S^#_PQ_9\\8^& M/"O@[3?@YX3^,7B30M6\#^'/$T/Q.UCQ#\3?'V@3^$O'&IZ_8ZCK>F>"XM)^ M&%KI\ ^&FH_#_P 7I%XM\6W$GBR>_7PE=>%/Q!_X+<2/)_P4P_;81SN6*Y^$ M$4:D#"QM^R;\#)2HXY!DED8YSRQ[8%?8_P#P<:?\G[_#O_LT+X8_^KF_:,K: MG@<#B,=D]?ZG0IPQ^ KU:V'C!>Q4X4H24HP^%-.H[-)/W8R^+4F>)Q5'"9C3 M^L59RPF*I0IUI2;JB:[XV MAU>^TWX:ZWJ.D:OX-\+ZQXFT&T@TKX=>%]=U#4=.N?W<_P""-_\ P43\9?MU M_"'QEX9^+6ASCXT_L_P> ]*\=?$2QL]'T[PM\5]-\:P^+(O"_BZ'1]+-G'X; M\=R?\(-K:?$7P]I>B6/@M=0DTKQ)X);2M+\3S?#WX?1S^(=-\+?\$!-%U#Q- MKVF>&3=?\$G_ ?X:M=0\2:I::-%-XO\8_LJ:/X0\(Z"MWJLUO')X@\4>,]; MT7PQX?TO>VH:WXEU?3-%T^WNM3O[6VE_#_\ X-QO#NN7/[;WQ3\66^@:S<>& M]%_95\;^'=6\40:5?S>']'USQ1\7/@=J7A[0=3UN.!M,T_6?$EAX0\3:AH6E M7=S#?:S9>%?$5WIT%Q;Z%JDEKYU2&#QV49A6A@*."J9?6A&C4II\TXN<8N%6 M;M*K-IM-R;]Z46DGOU4Y8G"X_!TY8JKBHXRG*52$]HR47+FIQ5XPC=72C;12 M3;W7C7A/_@X"_;]TO1?C/J'BKQ3\/O$#?%#PM=3_ [U"[\$^$?#^G_LRZ]? M:Q_:"ZMX"M+'0@WCC0M)\+:IK&C:;I'QJU7Q]=0:SHGP_P#$NM:_K]CI'CWP MQ\3?TM_9+_X*W_M3_ WX%?M>>.?^"C/A3XC>)==^%'CKX,^ ?@KI7B#X+/\ M!KQKXN^,OQ4\!?$#QQJ?P6\1:AH_@CPMX+\,:3X8\!^$/ WQ9U+5]<\(+XL\ M,^$?B-_:\[^.'\:_!_P3>_B+_P $9=!T/Q+_ ,%(OV(](\2:+I'B#2AXB\=Z M\NF:YIEEJ^GIKG@S]G'XN^-_!^M)9ZA!<6Z:OX4\9^'/#WBWPUJ:1B]T+Q-H M6CZ[I<]KJ>FV=U#^PO\ P_LR&8)_%L+K! MYF/EW"+=SMKOQ>&RYYEAY&I"@X3Y6KNHY M_$KODPU?&+!5\PEBJLW0=2C3HRU@W-P7M)W?O.#JJ4;IV4.7X79?)NA_\%,_ M^"W'[34WQ"^)_P ;?Q]<^!?#D>FIK&A? ']E?PMX[^'WA75+/\ X0+PS?>' M?"FI>+?AU\5O&WB'QA>7GC/P_P".-;\#2>./&OC#2O#^NZSXXBT?2/A=X>U" MZ\/?H-_P1S_X*_?&W]I+XR6'[+O[4FL^$/&FL>*/!OB76OA1\7-,\,OX:\;^ M+/%_A^\UCQGK'A#QCH_@71(OAA=6$OPWEU.\\+^)=+T/X66>@Z=\+AH^N?\ M"Q_&7Q"L]4T[]!/^"&HNA_P2[_9K^V9\[^T_V@"F0V?LI_:;^,IL?O ''V(V M^.Q&-I*X-?RN:5X<\2>)_P#@MK+IFCZ#K'B/5+;_ (*Q:SXCFT_1=)O]9O;? MPWX2_;*OO%NN:]-9V,%U<0Z/X5\(:+J'B?7]6>-;#0O#^CZCKFH3V>EZ=,J48U:-27-3:K*,G[*/V.5.R:3ULU9-Q?Z6?LB_\%6?VU=-_X*;P M_LZ_M=?&WP%X@^'6M?'+XH_L[>*O"7A/X8Z0? WA+XG'Q3XA\'> ['X0>(?# M/@;0_BW-I4?Q?TOPU\-_#^L_%?5?%-O'\/O$&J:Q\18H_$$"^.?#GZ4?\%MO MV^_BI^Q;\(OA1X6^ VKW7@[XO_&[Q1KT^G?$-_"?A7Q9I_A/P+\,%\-WOC*W MLK7Q<^J:+#XO\2ZKXP\&:/I1U?P/XOT=_![_ !!D5O#GBFV\):S'^*7_ 7Z M^#/BKX*_MS^&OVB/"&J^-/#:?'?P;X7\8Z!X\L/%FEZ;JGASXP?!BWT7P+J] MO\.CX)9#I\VC>&/CK]MS]I+ M5_\ @J3^VO\ "W6? EEX&\':A\1_"W[,_P"SA\-K;4YO&5GI7AGQIXU.EW'B M'PK\1/$^I^'(=8\0IX _:0^+WQ+\#2>.O"WP\TG2O$7@OP_H>N^&?"FL?:8] M5\0:4+KY5F$:-*&"E@JE7&4XP2HJMA4HS4DM/>J3M*_QQHNZ3;(J8W$8 M>EC\&ZM26*6*A3PTY-^T=.N[QLWJK0C=/[,JBLVK'[^P_P#!6CXD?LR?\$M_ MV;_C/\?[;Q'\3?VR/VB].^,]9TS5?B9IVH^'/A3^RW=)X4^'NHZY.+/4O M#_@+Q;X/\4_&VY^'>A:;-'JFD^+O%&C^)?.^&MK!\2=<\6:SX4:Y\9W/AO\ MP7O^'_@WX4?M>_ 7X7^ -*_L/P9\-OV#/@+\/_!^BOJ6JZQ/I'@WP9\3OVA? M#WA72I=7UV^U/7=5_L[2K".T&I:SJ6H:K?/%+=:A?7=Y+//)][?!C]D__@M+ M\:?V)?A1X'\*?M:?LYZ3^S1\6?V6/ OA3PW\-O$VCV5KXGTSX&>//A+I>D:/ MX'\0:]IW[,6L^(;;7K+P#JMOH.K:O8^.-5UF'4([B\M?%=]?*FKRS1H8*C@\ M-C72RN+Q^(KU:BS"-1PIT/:NV'PD*<*D82IPLN9VL_YE91=2KBJF)K8;VF.: MPE&E"'U.4%*=7V<;U<1*(='M/AUXR\>_!WQ+>Z7JVIRWV MFV.LZGX0\3^"/$_A32?BCXAUV63P'?\ C!]2\&V/CSPUH&D?BQ\&?^"WO_!3 M?7O"?B7X)>'+/3OVAOC9X^U*[G^'7CZR^$&GZ[\6/"VDP>!/$X\4Z1X-^$_P M@\*>'?"/C#5=!FTW1OB5X6UO7O!_B2'P\-%\>6?C;PU\0/"^N:)!\/?T;^ G M_!.+XX?\$_?V"O\ @K-_PN7Q1\*?$H^+?[(/CG_A&S\,M<\7:R;,^ O@S^T% M_;(UP>*O O@O[,+C_A,]*.F&P;4_/,.H_:A8^3;&\_/;_@W.=Q_P4%\=QAF$ M;?L;_%IV0,=C/'\;/V951V7.TLBR2!&(RHD< @,V8A1RJE2SO$T<-1QF'PU7 M"3PW,Y5T*E:KAJM>%>%?E2YFH2L MI./P\\J<4U+[+DY12V+'[//_ 7A_;;^#'Q-\2:5^U5=K\;/#.F2>+=#\4^ M_$GPS\'_ P^)O@_QUX+\.^/-)TWP=I>H>#-%^'EOX(NK_XLGPOHOQL_#_A;XA>/_"6L>.M?T'XFZ)HFK^); MF30/C;>^(Y=+U/7+_P $^(_#^FV6DMHWRA_P7.FFB_X*/?MJ2Q2R1RP6GPJ> M"2-V22%T_96^#G14E3_@T MK>SC/FJZU$HRY8+JVS!?772S!/'XBV73G[-IVG4:GAO]HC]A"P_;!^*MQX,\%W/@;PO\1;_]H/3/ 6H:KXST[P!J/PC. ML7GBB^D\.Z9!K7C/0YO$'@;3='^+&C_#B[@\1>+M(\+>-?#FEVNI^-Q-IOB? MQ#^%NH_\%._^"J7_ 4$^,7C30_^";G@6Y\!_#CX;+?ZM'9VWAOX-7WB>_\ M">LSZ+H_AJ[^,/CKXZ3ZW\,]*\8ZC?Z3K^M^%/!'P_O= ODTS4/%NEM<_%.S M^']UXVM/F3X#+"?^#>3_ (* ><$V?\-J_"EAOQCSE\6?L&FW//\ &)UB\OOO M"8YQ7#_\$>OAY_P4&\>:G^TE_P ,%?&_X8_!*XTJQ^"G_"VKGXGZ3IVK6WBN M&^N/C!_PK^#P\NI?"#XN+;3^'GL_',FMM!!X;:>/7]&$TNN""%-&YJ&6X3#+ M-\3RX23PV-EAL,LP]I+"48.4)7J1A&BG=7;-JN,Q%9Y=0YL0 ME7PRKUGA.18BI)1EI"4G%15X.4K-:-K6R/T'_8=_X*Q_ML?#_P#;1T']B[_@ MH3'I>J3^+OB7>_#/4_$?B;P'8>#_ (H_#KXC^*;'0M-^%&C:9%\'O#EMX"\: M_#3Q;XG@T_2M'U$^#P-2@^+=A\6%^-4OPP\,V.C:GD_\%!?^"P'[7_[*O_!2 M[QM\//!FJ>%M8^ ?P2O?A7I>J_!"[\-^';"R^)^D^+?A1X1\?^*]0\0?$:Y\ M/^(/B%X=\9"?XBWMMX6U7PGJVG>$]'D\)>"9M:\!>*8$\:V7C?K/"_\ P1U_ MX*'^)?VV_A;^V)^T1\;?V:OB!XFT/XW_ /^)GQ(U;1-:\9Z3K>O:-\)=6\# MVRV^B>'M'^ WA+PC#JL7@WP58:7IMK&FA6-_?6T-QJE]#'],LM);1OU#^(W_!3;]KW]HG_@E_\.OC MO^QAX#\0/^U#JGQ]T[X#_'G3?@G\&?&/QMU#X5W?ASPAXG\?:]XJ\%^%]?\ M!7B[2H=&\::78_"N\-[XAT7XF^&O ^B_%VY^'3>+-6^)>D6GB[3]S_@Y2)'[ M&7P! ) ;]LGP@& )&1_PSU^TLV#ZC(!P>X!Z@5J?\&WJ*O[$_P 8F48,G[6O MC1W//S,/@I\ 8P3_ , 15X]/7-<566#K931S2&786C4PV/C1=&"?LZU)1OR5 MMG4OS1YI2O)N+UM)Q.BDL33S"I@98S$5(5L*ZGM)-<].HW\5+=0M9VBO=2EL MVDS^5_\ 8X^)/[9'PK^(NK:]^PNOQ3E^*EUX!O\ 1==/PC^#6E?'+Q*?AQ/K MGA>]U-K[PGJ_PY^)MMI^B'Q'IWA'[3XB30+.>TOSINFKJ]O'J\ME?_WK?\$[ M_B7^T#\7?V-_@MX[_:F\+:]X/^/5_8^,-&\?Z1XI^'VK?"SQ+=3^#?B)XN\% M^'_$_B#P%K-AI,^@:SXW\*>']"\::DFGZ+H/AO4+S7YM6\(^']!\*W^C:/9? MR[_\&W/_ ">E\2/^S3/&'_JU_@77]K=+BJO%XM8?ZO1C.$*-1XA)^VE%PDO9 M2=[."NFE:Z:7G=Y!2DL-[;VM1QE*I#V+:]E%J47SQ5KJ3LT];6;T"BBBOE#W MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@"1/N2_[J_P#H:U'4B?\0Z78:WH6MV%WI6L:/JMI#?:;JFFWT#V MU[87]E-M7O+W4-:UN[&KZOIVB37?VNP\&:-J$L$=Q9^%=)<(8+65 M[G4=0FBM[G7=3U6>SL'M/JZBBLJ%"CA:4:&'I4Z-&%^6G3BH0C=MNT59:MMO MNW<\G(.'#H.M5G7K.G0HQC!2JUJDZ MM25N:R%%%% !1110 4444 %%%% !1110 4444 %%%% !4H M_P!2_P#OI_)JBJ4?ZE_]]/Y-0!%1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %?$?_!2C_DP']L/_LWOXF_^HS?5]N5\1_\ !2C_ ),!_;#_ .S> M_B;_ .HS?5XG$O\ R3G$'_8DS7_U KGZAX(?\GI\(?\ LZ' '_K5Y2?YK=?Z ME'P%_P"2&?!C_LD_PZ_]0_1Z_P M>O\ 4H^ O_)#/@Q_V2?X=?\ J'Z/7\Q_ M1F_W[B[_ +!,G_\ 3V8'^YG[,* M*** "BBB@ HHHH **** "BBB@ HHHH **** )3_J4_WW_DM15*?]2G^^_P#) M:BH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ J63[L7^X?_0C452R?=B_W#_Z$ M: (J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\1_P#@X(_Y1T^) M/^RL?"W_ -.E]7\:/[%/_)Y/[)7_ & M.)_Y*\7^&^(LS\3,FQ^6Y!G688&EA,CC5QN!RO'8O"4Y M4%P%;"Y-FV:X3,<12QV)HU>\UOP%JEM);R&%[C4?"EY=R?:FMXI+75-.G:Z?0M5TEM3U0WOU MK165>A1Q--T<12IUJ4G%RIU8*<&XM2BW&2:NI)->:/%X@XY1B9T*E?+G"I3E:\915NMZ.EZ7INAZ9 MI^BZ+I]EI.CZ196NF:5I6F6L%CIVFZ=8P):V5A865JD5M9V=G;11V]K;6\<< M,$,:11(J*JB]116J5DDE9+1)*R26R2/8A"%.$:=.$84X1C"$(1480A%*,8QC M%*,8QBDHQ222225@HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!1 MU'U'\ZUZR!U'U'\ZUZ ,J3_62?[[?^A&F4^3_62?[[?^A&F4 %%%% '\LVG? M\$0_VL+3_@H/)^UC)X__ &>6^';_ +>&J?M/C14\6_$D^-/^%?7O[2UW\8XM M).GM\)%T,>,5\+7"V4FFCQ$=$&OAK-?$3:=C5C]R?\%A/^";?QS_ ."@FH?L MW77P9\5?"?PS%\'K/XTV_B8?$[7?&&C27TGQ&G^$,FAG0E\*^!/&BW26J^ = M9_M4Z@^EM ;G3!9K?B>Z-E^VM%>I_:^,]O@\1S4_:8&E[&A^[5E#D=.TE?WG MRMZOKJ, MOV#?$?B'X;WOQA\0_!W]KKX>V/B+1=9\3W/PUCUKX]^+/C/KO@VYN]9OO!VF M^*(]+TZS^(FAQ^)IX?!MQ=V-S:ZJFE6.M106DU_\;_\ !*'_ ()'?M(_L*?M M3>)/C=\6_&OP0\1>$]8^ 'COX5VUA\.?$OCS5_$4?B+Q/\1?@YXNT^\GL_$W MPU\(Z:NBQ:;\/=;AO+F/5Y+Z*^N=*B@TVYMY[NZL?Z***Q68XE4L913AR8ZH MJF(7(KN2G[1.#^RN9[+IH:/!T'/#5&I=E'E4?>7VG9?>?RP?\%$O M^"'_ .UC^UO^U_\ M&?M _#;X@?L[Z+X.^+=QX$F\,:7XX\7?$G3/$MF/"_P M,^&GPSOQKUIH/PC\3:79F;Q!X-U2ZM/[/UC50^CSV%S-Y%[+<:=:_'/_ <: M?\G[_#O_ +-"^&/_ *N;]HRO[9:_$G_@HY_P1TE_X* ?'SP_\<$_:-C^$8T' MX.^&?A0OA=O@\WC\W4GASQI\1O%X\0MK8^*G@GRDO!X__LXZ.-'D: Z3]L_M M:;[?]ELO6RK..3&8%XZI&&&P.'K4:4HTI-I3IQBE)4U*4F^2*O;36YP8_+N; M#8M86$IUL55I5)Q'-&\4_L^_M Z-\)_VGK.YT7XW:/8_"#X=^)_BSX3M]'L_&OQ ^'GC+4_" M7BAOBGX/^%U_IT7C3Q%X ^&7Q U&/P?>IX2\&>)_&]S;W.A1?U??\$Q?^"=' MAG_@GS\(]7TVZUT^,?C=\58_#.I_&KQ=87NJ?\(DU]X9AUH^'/!O@31[U;-( M?"O@QO$_B*&W\3:AI-EXL\;ZAJNHZ]KL6C:4_ACP-X*^R_V&G*E&CS\\E2IJFZ\D[QG6L_>>BE9**< MDFU=*W1A/)?$VF>"/%OQ)U+Q/>+XH^!GQ+^&>G MC0K+7OA)X;TJ[:'7_&6EW5X-0UK2Q'H\%_<0&XO8K?3[K]V_VY_V,/AY^W;\ M!-5^"7C_ %35_#5S;:Q:^-/A[XUT5YYKKP1\1=(TK6M(T3Q'=:"+ZPT[Q=HP MT[Q#K6C:_P"%=7GAAU31-7OVTC4_#/BJW\/>+= ^Q**Y\1F6+Q&*IXR? ?\ X6Q%X*M]6M/$3ZU^S?\ MA>'_AE\ M,?&GB'5O#V@KJ6LV7AWQ'\7/@QXIO-5T^&QL/"6K:GXR^'FA7EW)X;2#3I-4 M\.6^CZE=_KQ_P2T_X(JZQ^Q_\69OVA_VC/&'A#Q?\5?!B^(/$/A#1O!T^B3^#/"ND2W M_B>YNO%OBO6O#$GPM_H1HKKQ.?8[$T:E%^PI*LN7$3H453J5UVJSNV[ZIJ/* MFFXOW6T84BM?FLTGNDS\N/^"KW[ &N_ MM_? OP?X2^'FK_#KPI\6_AO\0K3Q;X4\3^/]$NI(+SPUJ>DZCH'C;P&GC+1= M-UGQ/X+TG7S=>'/&.H-I6A^(++Q%KGPW\*:-J^CP+)9^)_#/YT?\$U/^")WQ MT_9-_:V\'?M#?''XA?"S5M$^&WAGQU<>#]*^$?BWQ9J&HZCX\\6>'KCP!#;^ M+M.\9?"/P_;77@N'P5XM\(-*UV#QC8>#)E-[H@URQN/Z7J*YZ6;8V MC@JF7TYQ6'J\ZDG!.:C4LIQC+=1E9W7]Z7K6GW+L?F=_P4[_ ."=7AO_ (*"_"#2M+L]='@_XW?"R/Q+JOP4\6:A?:H/ M" U'Q)!H_P#PD/@WQYI5C'?"7PIXS;PUX?@N?$VFZ1?^+/!&H:7IVOZ%!K6E M1^)O OC7^9BP_P""_#KX40?M*:+X \%:]XDTWPM8_!C]N7PM M\._AIK%K)XDU/4;KQ3X,\'C]HSX?OI6C^,M3O;[Q:D?B/P=X3\3WOW.H64?]S%%7A,XQ6$H?5E##XC#J3G"EBJ*K0IR=VW3NXN-VV[7:3 ?!::E\0?BOX\\(>'?$B_!;QC\+[ M+XD>,O'/CG0[?Q-+X@\76GB#P5X.\5+IG@/5-1TGP#\&/ :1^(/%T::3X7\' M><_\$H?^"1W[2/["G[4WB3XW?%OQK\$/$7A+6/@!X[^%=M8?#GQ+X\U?Q%'X MB\3_ !%^#GB[3[R>S\3?#3PAIJZ+%IOP]UJ&\N8]8DOH[ZYTN*#3;BWGN[JQ M_HHHK.6:8J5/&4FZ2ACG3=>,:48+]U;D5-1LH)**5DM;:ZMLM8&@I8:=IN6% M4E2;G)_'?F'_A)XGTRT$NO>%=1N;7^S M]7U4OI$UEK^)=&T:?P[I?PK^+_@>>STZX\+^$?&5]-K3ZOX_P!%N(;:YTZS ML6TVVU29]2CN8+2SOOU3HHEFF+E+ 2;A?+E&.&]Q:*/);GU]_P""._Z@L#AT ML5&TK8QMU_>>K=[\O\OQ,_(;_@FA_P $Z/%_[+?[('Q[_9;_ &F;SX?>/=+^ M./Q*^(6JZY:?#+Q/XX?2-1^&WQ"^#GPU^%^L:%>Z[>^'OAYXGT;6[L>%O$<< MD^@>7-8V%YIE_INO0ZF\L6G?AC\;/^"*_P#P41_9>^,6K:Y^PCXC\=^./!/B M<>)-$\/>.OA1\>=%^ GQG\,> 7E\)ZW'X2^+=_J/C3X-P:@=6UN**UMW^'.M M^)M \4S_ _A\8>)/#GPYN;WP_X6M/[1Z*UHYSC:-?$UDZ518N7/B*-6FIT* MDKW3=.ZLULK-::.]E:*F6X:K3H4VJD/J\>6C4IS<:L(VM;GZWMU3UVM=G\G_ M .QM_P $U_\ @KMXE^,?P%^*G[47[1GQ1^'?@;X(?M">&_B/?>"?BS^U'X\^ M.GQ!UC3?!E@+F_G\&Z-X7\>?$'X?0Z+\6/#^O^*_@9XBN];^)WAOQ#IO@?Q9 M\1'U3P;XC\.7=MX8\<=#_P %)/\ @A_^UC^V%^UA^T3\=_AE\0/V>-#\)?%N MW\&1>&M-\=^+?B3I?B.S;P[\$_ 'PWO3KEIX?^$GBC3+59==\*ZC=6IL-7U0 MOI,UE<3""\EGL+;^I^BFLZQD<1]9IQPU&?L)890I4(0I1I3DIR2@OM.2OS-M M]-A?V;AW1]A)UJD?;1KN52K*4W4C'E5Y/I;HDD?E7_P5U_8=^+?[?'P ^%WP MI^#GB#X=>'/$/@K]H#0OBIJ][\3-8\3:+HTWAS3/A5\8/ ]Q::;<>%O"'C.^ MGUM]8\?Z+/#:W6GV5BVFV^J3OJ<=U;VEE?7O^"2W[$WQ7_8._9X\>_"3XOZ_ M\/?$7B/Q/\)-9T6/0-6^'OPP\*6]K?7'B?PEX.OH=834_! MFK2S6T&G75DMA-ITR:C)<3W-I9_J-17(L=76"> O'ZO*M[=KE7/[2R7Q;VLE MH='U6E]96+M+VRI^ROS/EY+W^'OYG\4?QR_X(>_M[_LQ?&+3_%7[$%UXF^+7 MAJRU7Q$_PT^('@3XO>#/@[\=/AQHDBW\>:KXH\6?"&PB\0:QIGB7Q)X M0.N?"O6]6L?%FCZ3KFJ>(- ^'EKXILO!:_U2?L*_"?X\_ []EKX;?"_]IKXD MK\7?C9X;O?B++XO^(2>-O&GQ%&OVOB#XI>-O$WA!3XP^(6E:+XNU1]'\#ZSX M;T%X=4TV"+2'TMM%TJ2ZT?3M/NY_KBBML;FN*Q]*E2Q/LI.DTU5C2C&M/EBX MI3FMTN9OE2BG)W:;L98; 4,)4J5*/M%[2_[MS;IQNTWR0Z-M+5MM)632T"BB MBO-.T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH D3[DO\ NK_Z&M1U(GW)?]U?_0UJ.@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "I1_J7_ -]/Y-452C_4O_OI_)J (J*** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ K*US0]$\3:/J7A[Q)H^E>(= UFSGT[6-#US3[35M M'U73[J,Q7-AJ6F7\-Q97UGA4J4:U&I"K1K4IRIU:56G)3IU*=2#4X5( M32E"<6I1DE*+329\]_\ #)'[*?\ T;)^SW_X9?X$PKD\-A'^XG_ M *"*BH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!1U'U'\ZUZR!U'U'\ZUZ ,J M3_62?[[?^A&F4^3_ %DG^^W_ *$:90 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M2)]R7_=7_P!#6HZD3[DO^ZO_ *&M1T %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 5*/]2_^^G\FJ*I1_J7_P!]/Y-0!%1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% $I_U*?[[_R6HJE/^I3_ 'W_ )+45 !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %2R?=B_W#_Z$:BJ63[L7^X?_0C0!%1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% $LWWA_N)_Z"*BJ6;[P_W$_]!%14 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 HZCZC^=:]9 ZCZC^=:] 'FM_KVK0WUY#'=!8XKNXCC7[/:MM1)G5 M1EH"QPH RQ)/4DGFJG_"1ZS_ ,_8_P# :T_^,52U/_D):A_U_7?_ *4251K9 M)66BV70PYGW?WFW_ ,)'K/\ S]C_ ,!K3_XQ1_PD>L_\_8_\!K3_ .,5B44[ M+LON#F?=_>;?_"1ZS_S]C_P&M/\ XQ1_PD>L_P#/V/\ P&M/_C%8E%%EV7W! MS/N_O-O_ (2/6?\ G['_ (#6G_QBC_A(]9_Y^Q_X#6G_ ,8K$HHLNR^X.9]W M]YM_\)'K/_/V/_ :T_\ C%'_ D>L_\ /V/_ &M/_C%8E%%EV7W!S/N_O-O M_A(]9_Y^Q_X#6G_QBC_A(]9_Y^Q_X#6G_P 8K$HHLNR^X.9]W]YM_P#"1ZS_ M ,_8_P# :T_^,4?\)'K/_/V/_ :T_P#C%8E%%EV7W!S/N_O-O_A(]9_Y^Q_X M#6G_ ,8H_P"$CUG_ )^Q_P" UI_\8K$HHLNR^X.9]W]YM_\ "1ZS_P _8_\ M :T_^,4?\)'K/_/V/_ :T_\ C%8E%%EV7W!S/N_O-O\ X2/6?^?L?^ UI_\ M&*/^$CUG_G['_@-:?_&*Q**++LON#F?=_>;?_"1ZS_S]C_P&M/\ XQ1_PD>L M_P#/V/\ P&M/_C%8E%%EV7W!S/N_O-O_ (2/6?\ G['_ (#6G_QBC_A(]9_Y M^Q_X#6G_ ,8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_\ C%'_ D>L_\ /V/_ M &M/_C%8E%%EV7W!S/N_O-O_A(]9_Y^Q_X#6G_QBC_A(]9_Y^Q_X#6G_P 8 MK$HHLNR^X.9]W]YM_P#"1ZS_ ,_8_P# :T_^,4?\)'K/_/V/_ :T_P#C%8E% M%EV7W!S/N_O-O_A(]9_Y^Q_X#6G_ ,8H_P"$CUG_ )^Q_P" UI_\8K$HHLNR M^X.9]W]YM_\ "1ZS_P _8_\ :T_^,4?\)'K/_/V/_ :T_\ C%8E%%EV7W!S M/N_O-O\ X2/6?^?L?^ UI_\ &*/^$CUG_G['_@-:?_&*Q**++LON#F?=_>;? M_"1ZS_S]C_P&M/\ XQ1_PD>L_P#/V/\ P&M/_C%8E%%EV7W!S/N_O-O_ (2/ M6?\ G['_ (#6G_QBC_A(]9_Y^Q_X#6G_ ,8K$HHLNR^X.9]W]YM_\)'K/_/V M/_ :T_\ C%'_ D>L_\ /V/_ &M/_C%8E%%EV7W!S/N_O-O_A(]9_Y^Q_X# M6G_QBC_A(]9_Y^Q_X#6G_P 8K$HHLNR^X.9]W]YM_P#"1ZS_ ,_8_P# :T_^ M,4?\)'K/_/V/_ :T_P#C%8E%%EV7W!S/N_O-O_A(]9_Y^Q_X#6G_ ,8H_P"$ MCUG_ )^Q_P" UI_\8K$HHLNR^X.9]W]YM_\ "1ZS_P _8_\ :T_^,4?\)'K M/_/V/_ :T_\ C%8E%%EV7W!S/N_O-O\ X2/6?^?L?^ UI_\ &*/^$CUG_G[' M_@-:?_&*Q**++LON#F?=_>;?_"1ZS_S]C_P&M/\ XQ1_PD>L_P#/V/\ P&M/ M_C%8E%%EV7W!S/N_O-O_ (2/6?\ G['_ (#6G_QBC_A(]9_Y^Q_X#6G_ ,8K M$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_\ C%'_ D>L_\ /V/_ &M/_C%8E%% MEV7W!S/N_O.KM-6L?]>D'_ *6V]95)):Z+?MY(;;TU>WZL MV_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ QBL2BG9=E]PN9]W]YM_\ M)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# :T_^,5B44679?<',^[^\V_\ A(]9 M_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ QBL2BBR[+[@YGW?WFW_PD>L_\_8_ M\!K3_P",4?\ "1ZS_P _8_\ :T_^,5B44679?<',^[^\V_^$CUG_G['_@-: M?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[@YGW?WFW_ ,)'K/\ S]C_ ,!K3_XQ M1_PD>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CUG_G['_@-:?\ QBC_ (2/ M6?\ G['_ (#6G_QBL2BBR[+[@YGW?WFW_P )'K/_ #]C_P !K3_XQ1_PD>L_ M\_8_\!K3_P",5B44679?<',^[^\V_P#A(]9_Y^Q_X#6G_P 8H_X2/6?^?L?^ M UI_\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# :T_^ M,5B44679?<',^[^\V_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ QBL2 MBBR[+[@YGW?WFW_PD>L_\_8_\!K3_P",4?\ "1ZS_P _8_\ :T_^,5B4467 M9?<',^[^\V_^$CUG_G['_@-:?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[@YGW? MWFW_ ,)'K/\ S]C_ ,!K3_XQ1_PD>L_\_8_\!K3_ .,5B44679?<',^[^\V_ M^$CUG_G['_@-:?\ QBC_ (2/6?\ G['_ (#6G_QBL2BBR[+[@YGW?WFW_P ) M'K/_ #]C_P !K3_XQ1_PD>L_\_8_\!K3_P",5B44679?<',^[^\V_P#A(]9_ MY^Q_X#6G_P 8H_X2/6?^?L?^ UI_\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T M_P#C%:,>MZFVEW5P;D&:.[MHD?R+;A)(YF9=HAV')5>2I88X(!.>3K7A_P"0 M)>_]?]G_ .BKBDTNRW73S0TWKJ]OU1)_PD>L_P#/V/\ P&M/_C%'_"1ZS_S] MC_P&M/\ XQ6)13LNR^X7,^[^\V_^$CUG_G['_@-:?_&*/^$CUG_G['_@-:?_ M !BL2BBR[+[@YGW?WFW_ ,)'K/\ S]C_ ,!K3_XQ1_PD>L_\_8_\!K3_ .,5 MB44679?<',^[^\V_^$CUG_G['_@-:?\ QBC_ (2/6?\ G['_ (#6G_QBL2BB MR[+[@YGW?WFW_P )'K/_ #]C_P !K3_XQ1_PD>L_\_8_\!K3_P",5B44679? M<',^[^\V_P#A(]9_Y^Q_X#6G_P 8H_X2/6?^?L?^ UI_\8K$HHLNR^X.9]W] MYM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# :T_^,5B44679?<',^[^\V_\ MA(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ QBL2BBR[+[@YGW?WFW_PD>L_ M\_8_\!K3_P",4?\ "1ZS_P _8_\ :T_^,5B44679?<',^[^\V_^$CUG_G[' M_@-:?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[@YGW?WFW_ ,)'K/\ S]C_ ,!K M3_XQ1_PD>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CUG_G['_@-:?\ QBC_ M (2/6?\ G['_ (#6G_QBL2BBR[+[@YGW?WFW_P )'K/_ #]C_P !K3_XQ1_P MD>L_\_8_\!K3_P",5B44679?<',^[^\V_P#A(]9_Y^Q_X#6G_P 8H_X2/6?^ M?L?^ UI_\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# M:T_^,5B44679?<',^[^\V_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ MQBL2BBR[+[@YGW?WFW_PD>L_\_8_\!K3_P",4?\ "1ZS_P _8_\ :T_^,5B M44679?<',^[^\V_^$CUG_G['_@-:?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[@ MYGW?WG62ZWJ:Z7:7"W($TMU=1N_D6QW)&L)0;3#L&"SL_\_8_\!K3 M_P",4?\ "1ZS_P _8_\ :T_^,5B44679?<',^[^\V_^$CUG_G['_@-:?_&* M/^$CUG_G['_@-:?_ !BL2BBR[+[@YGW?WFW_ ,)'K/\ S]C_ ,!K3_XQ1_PD M>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CUG_G['_@-:?\ QBC_ (2/6?\ MG['_ (#6G_QBL2BBR[+[@YGW?WFW_P )'K/_ #]C_P !K3_XQ1_PD>L_\_8_ M\!K3_P",5B44679?<',^[^\V_P#A(]9_Y^Q_X#6G_P 8H_X2/6?^?L?^ UI_ M\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# :T_^,5B4 M4679?<',^[^\V_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ QBL2BBR[ M+[@YGW?WFW_PD>L_\_8_\!K3_P",4?\ "1ZS_P _8_\ :T_^,5B44679?<' M,^[^\V_^$CUG_G['_@-:?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[@YGW?WFW_ M ,)'K/\ S]C_ ,!K3_XQ1_PD>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CU MG_G['_@-:?\ QBC_ (2/6?\ G['_ (#6G_QBL2BBR[+[@YGW?WFW_P )'K/_ M #]C_P !K3_XQ1_PD>L_\_8_\!K3_P",5B44679?<',^[^\V_P#A(]9_Y^Q_ MX#6G_P 8H_X2/6?^?L?^ UI_\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_P#C M%'_"1ZS_ ,_8_P# :T_^,5B44679?<',^[^\V_\ A(]9_P"?L?\ @-:?_&*/ M^$CUG_G['_@-:?\ QBL2BBR[+[@YGW?WFW_PD>L_\_8_\!K3_P",5HWVMZG# M;Z:\=R%:>T,LI\BV.]_/E3=AH2%^50,*%7C.,DFN3K7U+_CUT?\ Z\&_]*IZ M++LON&F]=7M^J)/^$CUG_G['_@-:?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[A ML_\_8_\!K3_ .,4?\)'K/\ S]C_ ,!K3_XQ6)119=E]P;?_"1ZS_S M]C_P&M/_ (Q1_P )'K/_ #]C_P !K3_XQ6)119=E]P;?\ PD>L_P#/V/\ P&M/ M_C%'_"1ZS_S]C_P&M/\ XQ6)119=E]P;?_ D>L_\ /V/_ &M/_C%'_"1 MZS_S]C_P&M/_ (Q6)119=E]PL_\_8_\!K3_ .,4?\)'K/\ S]C_ ,!K M3_XQ6)119=E]P;?_"1ZS_S]C_P&M/_ (Q1_P )'K/_ #]C_P !K3_XQ6)1 M19=E]P;?\ PD>L_P#/V/\ P&M/_C%'_"1ZS_S]C_P&M/\ XQ6)119=E]P;?_ M D>L_\ /V/_ &M/_C%'_"1ZS_S]C_P&M/_ (Q6)119=E]PIV]RD<- MR$0VMI(1Y%LWSR6\;NL_P#/V/\ P&M/_C%'_"1Z MS_S]C_P&M/\ XQ6)13LNR^X7,^[^\V_^$CUG_G['_@-:?_&*/^$CUG_G['_@ M-:?_ !BL2BBR[+[@YGW?WFW_ ,)'K/\ S]C_ ,!K3_XQ1_PD>L_\_8_\!K3_ M .,5B44679?<',^[^\V_^$CUG_G['_@-:?\ QBC_ (2/6?\ G['_ (#6G_QB ML2BBR[+[@YGW?WFW_P )'K/_ #]C_P !K3_XQ1_PD>L_\_8_\!K3_P",5B44 M679?<',^[^\V_P#A(]9_Y^Q_X#6G_P 8H_X2/6?^?L?^ UI_\8K$HHLNR^X. M9]W]YM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8_P# :T_^,5B44679?<',^[^\ MV_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@-:?\ QBL2BBR[+[@YGW?WFW_P MD>L_\_8_\!K3_P",4?\ "1ZS_P _8_\ :T_^,5B44679?<',^[^\V_^$CUG M_G['_@-:?_&*/^$CUG_G['_@-:?_ !BL2BBR[+[@YGW?WFW_ ,)'K/\ S]C_ M ,!K3_XQ1_PD>L_\_8_\!K3_ .,5B44679?<',^[^\V_^$CUG_G['_@-:?\ MQBC_ (2/6?\ G['_ (#6G_QBL2BBR[+[@YGW?WFW_P )'K/_ #]C_P !K3_X MQ1_PD>L_\_8_\!K3_P",5B44679?<',^[^\V_P#A(]9_Y^Q_X#6G_P 8H_X2 M/6?^?L?^ UI_\8K$HHLNR^X.9]W]YM_\)'K/_/V/_ :T_P#C%'_"1ZS_ ,_8 M_P# :T_^,5B44679?<',^[^\V_\ A(]9_P"?L?\ @-:?_&*/^$CUG_G['_@- M:?\ QBL2BBR[+[@YGW?WFW_PD>L_\_8_\!K3_P",4?\ "1ZS_P _8_\ :T_ M^,5B44679?<',^[^\WXO$.KM+&K78*M(BD?9K09!8 C(@ST]*]1KQ2#_ %\/ M_76/_P!#%>UU$U:UE;?IZ&D&VM>_^1X[J?\ R$M0_P"OZ[_]*)*HU>U/_D): MA_U_7?\ Z4251JULO1?D9!1113 **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH U;#_CRUC_ M *](/_2VWK*K5L/^/+6/^O2#_P!+;>LJDMWZ_HAO9>GZL****8@HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH *UX?^0)>_P#7_9_^BKBLBM>'_D"7O_7_ &?_ **N*3V^ M:_-#6S]/U1D4444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 :\_\ R!;#_K]O M?_0+>LBM>?\ Y MA_P!?M[_Z!;UD4#>_R7Y(****!!1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 5KZE_QZZ/_P!>#?\ I5/616OJ7_'KH_\ UX-_Z53T#6S]/U1D4444 M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH U];_ ./R/_KRL?\ TEBK(K7UO_C\ MC_Z\K'_TEBK(I+9>B_(;W?J_S"BBBF(**** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )8/] M?#_UUC_]#%>UUXI!_KX?^NL?_H8KVNLZG3Y_H:PV^?Z(\=U/_D):A_U_7?\ MZ4251J]J?_(2U#_K^N__ $HDJC5K9>B_(R"BBBF 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110!JV'_ !Y:Q_UZ0?\ I;;UE5JV'_'EK'_7I!_Z6V]95);OU_1#>R]/U844 M44Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>/_ W^/OP? M^+VO^-_#'PX\>:'XKUSX=ZK_ &/XJL=,F=GL[C8A^T6CR1QQZKI8G9[+^U]+ M>\TPWT$ULMT75=^%%%% !1110 4444 %%%% !1110 4444 %:\ M/_($O?\ K_L__15Q616O#_R!+W_K_L__ $5<4GM\U^:&MGZ?JC(HHHIB"BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH UY_\ D"V'_7[>_P#H%O616O/_ ,@6P_Z_ M;W_T"WK(H&]_DOR04444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K7U+_ (]='_Z\ M&_\ 2J>LBM?4O^/71_\ KP;_ -*IZ!K9^GZHR****!!1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 :^M_P#'Y'_UY6/_ *2Q5D5KZW_Q^1_]>5C_ .DL59%);+T7 MY#>[]7^84444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110!+!_KX?^NL?_H8KVNO%(/] M?#_UUC_]#%>UUG4Z?/\ 0UAM\_T1X[J?_(2U#_K^N_\ THDJC5[4_P#D):A_ MU_7?_I1)5&K6R]%^1D%%%%, HK\KO^"RG[0H^ 7["OQ&T^#0?[=U;]H2>7]F MK3%N],74_#^F6?Q-\)^+;CQQJGB-$\1>'KZSA7X8^'?'-CX9U#3QKIMOB#?^ M#?[6\.ZEX;?6S;_QF_!_Q1XU_96^+/[.O[1%EH5]#+INK:)\9_!=EH/C&V\* M7WQ!\#>&/B1XJ\!>*?#DWB'P_P#VSJ7AC1/&^J?#[XB_"WQ+::WHTDE_H#ZT MM_XK^YEV25,PPU7$*O&DXSG3HTY0YG7J0I^T<8OGAR]%=1G]IV] MUGF8S,X82O"BZ;FG&,ZLU*WLH2FH)M'_$&@^+-!T3 MQ5X5UO2/$WACQ-I&F^(/#GB/P_J5GK.@^(-!UFSAU'1];T36-.FN=/U72-5T M^YM[_3=2L+B>SOK.>&ZM9I8)4=OX0Y-7U7Q5_P %FO[7\4:GJ'B35;;_ (*I M1:%;:GK][G17XM_\ !7?_ ()V?'#]O:[_ M &=I_@WK'P>TA?A+;_&&+Q(WQ6\1>+] EG;X@2?"E]&7P\/"OPY\?"[CC'@? M5CK'V]](-NS:3]E74?/N38?RE?M?_L8_$O\ 8C^*&C?"3XPWGPTUKQ/KO@+2 M/B-8WGPUU77]?T%-!UKQ#XL\,VMM=7GBCP7X(U"+5X]0\':I+<6T.E7%FEG/ MI\L>H2SS7%M:=>793A\PC32S&%+$S51O#?5Y3E%0DU=S]I"+O%*?2W-;5HY\ M9CZV$E-O!RG1BXI5O;1BI.27V>24E9MQ\[7V>G^BS17\=)3X,-X?_X3 M*'P\X@735\5C1CKJ"U'B-+'_ (FH_L9KAQV&P^&G"&'QD<8FGSRC2E2]G).W M*U*4KM[W3TV.O#5JU:,I5L.\.TURIU%4YDU?FNHQMKI^(45_&M_P<+ZSJ]_^ MVY\-?"]_JNI7OAG0?V5O NOZ'X=N[ZZN="T;7?%?Q;^.6G>*-:TK2)I7T_3M M6\2:?X-\(6.OZC9V\-YK%GX4\-VVHS7,.AZ6EK\J:]_P1]_:JL?V4U_:]F@_ M9_\ $WPID^#.A_'J3PSHGCCQ'-\2;;X;:UX:TWQEJ.H7FA>*_A=X7\%?VCX2 M\%ZA>>(O%&D6GQ O;F:UT75=,\(?\)?KLVC:5K'HT,FH3PF%Q-?,889XMRC2 MISP\IIRC-PY7451);)WE&*5]^IQUA2P>*/C#X1^*OC+ MQ+JFM_$32$LO&_@O0=6\!Z_J>K+J.H>-M%U&]\?G7/#6L:OJT.L^"X]*O_"Z MS:]X7U'PKIGP_P#VG_:+_;:_97_9.;2K?X_?&7PWX%U?6VT]]-\+06FO^,?& M\VGZJ/$ L/$$O@3P)H_B?QE9^$KBX\+:]IJ^,KW0K?PHFLV/]ARZRFL7-G8W M'G8K+\3A<7/!N#K58V<51C*ISQDE*,HQ2YM4]5:Z=UKN^NABZ-?#QQ*DJ=-W M3]HU'DDG9IMNVZT=]59];'U/17Q1\ O^"B_[%?[3OBZ7P!\&/CWX:\0^. T" M:=X0\0:-XP^&_B3Q/)+I7B'79XO VC?$WPYX.U#X@3:1H?A77=9\2P^"(/$$ MOA72;./4O$J:59WVGS7?T#\9?CG\(/V>?!-Y\1?C9\1/"_PV\'VAO(8]4\3: ME':S:SJ5EHFL>(V\.^%=(C$VM>,?%]YHN@:U?:/X-\*:=K/BO7DTV[BT31M0 MN(C#7-*C6A4]E.E5A5;2]G*G*-2[V7(TI7?334WC5IRA[2-2$J>KYXRBX66[ MYD^73KKH:?Q8^+'PY^!GPZ\6?%KXM>+=+\#?#SP/IAU;Q+XEU=IS;V<#W$%E M96EI9V<-UJ>LZWK6J7=CH?AOPWHEEJ/B'Q/XAU'2_#OA[3-3US4]/T^Y\M_9 MK_;!_9P_:]T7Q/KO[._Q.L?B#:>"]5LM'\56;:%XL\(>(-"N=3LVO=)N;_PK MX[T'PQXGBT;68H;^+1/$0TAM UF^T;Q#IFEZG=ZEX;UZTT[\3?\ @J-_P4K_ M &)/VE_V$/CQ\(_@S\<+3Q-\1-5G^!.N:/XA?M/_!"YU:U MT/4?B#X)\*Z1K>NV>GO/K+^&-*U"[\2R>']+U_Q%#I,FA^'-?U#3?-_^#;G_ M )#/[;/_ &#/V8?_ $J_:-KTUE;CEF+QE>->CB,/6I4XT:D/9IPJ.DN:49P4 M_MOE::6G4XGC;XRAAZ3I5*56G4FZD9CO-'JOB;1+=-+COWU>XCNWO+:PFLK.^N+;6_:6_;]_9&_9!U_PY MX3_:#^,%KX)\4^*]%N_$FC^&M,\'_$+XA:__ ,(_:WC:,-1\ M.:3J>HPW]AX>U#Q%;Z5:^)[W1/$EIX(8],\WZOB/:*C["M[5KF5+ MV4_:-6O=0Y>9JVM[6MKL=GMJ7)[3VE/V:=G/GCR)WM;FORWOIOOH?8M%9.@: M_H7BO0M%\4>%]:TGQ)X9\2:3IVO^'?$6@:C9ZQH6OZ%K%G#J.D:UHNKZ=-?M)1W M5UX=U?5-$OKG0?A)\=O%&C7=WI%]/IUU<^'O$7AKX8:MH'BW1)Y[>272/$GA M74]9\.Z]I[V^K:'JFHZ5=VMY,J5"O6(/#/B[1/",U]XN\):G;:5\O\ _!.'_@LI\-K[X;7WAG]O/]IE M(OC?K_QBN--\'ZAKGPFU+P_X8L/AWJF@>!M/\/S^(/&OPP^%ND_"3PGHUMXN M;QC<:MKWCK7-(ET&P\[5O$VIZ?X8@TZ[BZX99C*F#GC8TVZ<*OL?9\M3VTFD MKSC!4VG"+?+*7-I*,DUH82QV'CB(X:4TIRA[3FYH>S5WI%R<[JHW>M27OB]-$\ ?#WQIX?^''AWQ[?^&O&']G?%JSE MT#6[72?W[_9\T[P+\$OV2?@AI/\ PM7P;XM^&?PB_9T^&NG?\+OM[[1]"^'W MB?P+X!^&FBVW_"U8=2_X2'7- T?P;K6@:3_PET=]_P )7K&CZ?HERMQ_PD.H M64/]I337PU&GA<)6IU:LZN(53VE.5"I"$'!I)4ZLDH5=79\CE9VO;9U2K59U M\13G"$84G'DDJD92ES*[YX)N4.C7,HW6U^GT717YCZY_P61_X)N>'M8US0[_ M /:1AN+WP]K&IZ'?SZ%\*/CEXHT:XO=(O9K"ZGT+Q%X9^&>K^'_%&CS3P/)I M?B'PSJ>KZ!K=DT.I:+J=_IUQ;W4OV[\%/CS\&_VC? UG\1_@=\1_"WQ+\'79 MLH)]3\-:BEQ)E\,^+]$F6WU[P1XSLM#\1:'?ZUX(\8:9H?B_P\ MFJ6<.NZ)IUS*(:YZF&Q%&,95L/6I1E\,JE*<(RTO[KE%)Z:Z=#6%:C4;C3JT MZDH_$H3C-KU46VOF>MT5\=VG_!0+]C2[^-7CW]GO_AH+P-9?%/X9:5XMUCQO MIFLOJV@^%]%M? &DIKWCZV7XEZWI>G_#+5-9\":,NIZEXV\/:-XPU#7_ E: M>&/'$OB'3=.7P#XU_L#S32O^"L/_ 3PUCQ]/\-[?]J'P39Z];:KXBT>?6-> MTCQMX8^'"7/A>'5+C5+H?&#Q)X6TKX2OHD\6D7?]@^)(_&S>'O%;RZ;#X6U3 M69M:T9+]K"XJ5^7#5W:"J.U&H[4Y*\:CM'2$EJI/W6M4Q.O15KUJ2O)P5ZD% M>:T<5KK)-I.*U5]C]#Z**Q_$7B+P_P"$/#^N^+/%FNZ/X7\*^%]'U/Q%XF\3 M>(M3LM$\/^'?#^B64^I:SKNNZSJ4]MIVD:/I&G6USJ&IZGJ%S;V5A96\]U=3 MQ0122+@:GR3\7_\ @H1^R#\"_BI#\#_B)\6VA^+UPOA]8OASX,^'WQ1^*GBQ MM0\5F/\ X1CP\VD_"SP3XSN(_%_B&*XT^[T;P7(J>+=2T_6O#VHVFBRV'B/0 MKG4?LZOXBO\ @F9X?\9_MX_\%/=!^,GQHN-%U_6O#^L^)OVKOB/IUSXD\>:? M%:ZCX0U#2XOAUH_PV?\ M37==.A?#3XL>)?A1%X4\%>)?%8\/V/PM\(OX5U& M_P!%="M)_&E@D,_@#0+7PYJ/A#2/'<^N:KXQF@UK M2/"&D>&YM?U7V<=E;P]:CA,-&MB,4L)&OBH+EGRS>LH4H1BI-06MFYR:DFNJ M/.PN.56E5KUG3I4?K$J5&3O&\591E4E*3C>3=OLI6=^Y^C]%#=8:_32/%O@GQ#I'BKPSJKZ5J5YHVJ+INO:%>7^E7S:;K M&G:AI5^MM=RFSU*QO+&X$=U;31)\U_MZZ1^T=XA_9)^,6@?LEMK2?'W7--\, MZ/X+?PWK_ACPIXACT_4_''ABQ\>2:'XI\8:KH6C>&]63X=3^+'T_7X];TC7M M'NQ%J/A/4[#Q7;Z+=1>53I\]6%*4HTN:I&G*=3W8T^:2BY5&_AC"]Y/HDSNE M/EA*:3G:#FHPU<[*Z4>[EM'NVCZ^HK^++XG?\$(/VA?@5^SC\2?C'KOQ-^ B MW_PDLO&?CC7_ )X5N/'4F@S?!CP)\/=2\7ZMK^A^*KGP#I%S/\ $F;5M*N- M"T[X;W7@K3O"\NEM#K\_Q7M;MG\.)]#_ /!O3\;?B3_PN;XI?L\7?B34=5^% M"_!6\^(/A_PMK&M^)M1T_P !Z]X5^)FC6TJ?#O0)]=/A+PAIOC&Y^,/BC6?B M&-+\-IJ/BK7K#PKJ-UJ4+:9=1ZE[-7**/U.OC,'F$,6L,TJT%0G1M=I>[*RO[RC%)O&&J?#3PIXHT7]G+3?A1I?BB7PIX2^,/ MQ\7X@:;9>(+GQ5I/B/3O NF7E_I/Q:L?#_PW\+/\0-8\2^!_#][\.D^)7@3Q M#H>F^/=B_!+XNZIXYT#Q3INL7OA:.;QW\/M0U M'PQK/PE_:(TVWOO&%KH/A:YN[G3O%NHV%@GAR[\0?#7XO:#;>']:FOO"^K7/ MB'PG\,M5MO"*^*KH9%&I#"K$8^GAL3C8>TPV&=&=1R@US1YZBG&--R3T33[+ MFDG%35S24)5W2PLZU##2Y*U95(QY97M+E@XMS47NTUW=HV;_ +OZ*_EH^-__ M 4B^-_Q-_X(Y?#SXFZ+\2_[.^/>J_M%Z1^SI\&;2P\7^-/ ?ASX1ZC\0=0\)/??#G4[+QW\0?"6F>&O#: MW!\-^$?RP^./[,^K?\$__"/_ 3K_:H^"WQ9U?2_BA\=OA#??&?2-6TCPMI. M@7GPQ\5VFG>"?$)L]"N?MVKVFN^%]2\#?&G0_ /B3POXBTJ\TCQ8GASQM<>( MX=2\'?$UOASX1C#Y'4J^Y5Q$*%>>(Q&%H4G3E-5:N&@YU.:<6E3AI:,G&3>Z MC9J]5)O'_ (1_X1;7+7PQXG_X M2?P;HNMWOB+0/^$<\2WUEX>U[^U=.M/[(UR\M=)U#[/?W$5N_P"4?_!0;_@K M+HGP9_9.^#/C?]GO4='M?C9^U7\./ OQ-^'GAWQPEI<>,?A+\&_B+X1N/$$--3Q-X6GU[3[@V?@[PKH?B/Q#%X8U;QE/KFO6#?$CP[\,/&GA34Z/_ M 1=_P""<\/[+WPULOVBOB=X?\7>%_V@OBKX-O\ PQ%X#\0H/#]O\)OA-<^) M+#5-+\-S^%M/U.ZCE\5^-X_"WA#QKXAG\76]EXF\$VJZ+\/4\+>!]?TCXB?\ M)?PK!I[+"4N2\\1.+_>RU:Y*5):.=I7G[MD[7Z7BN;$QPU**J M>O.]HT8M?NUL^:<]U'3W?>VO;[]\;?\%"?V0?AU\>K/\ 9B\8_%M]*^.5 M_P",/A]X"M? \7P]^*6JM)XK^*8\--X%TQO$>C>"-0\)0IK2>,/#LDNI3:]' MI6C17[2Z[?:9'9:@UI]GU_(7_P %^_AUKOPQ_:W^"?[0'A"YT3P3)\2OAK!# MI?B#P+OA+QW!XB\+7FAZGK>IZUX>U'1[O0 MM6,;0DU)P4N:24=9.Z M)P^)G4Q.+PU514J$HRIN*:YJ,TG%RO*7OQ3CS-63;TBK,^@J***\L[0HHHH M**** "BBB@ HHHH U;#_ (\M8_Z](/\ TMMZRJU;#_CRUC_KT@_]+;>LJDMW MZ_HAO9>GZL****8@HHHH **** "BBB@ HHHH **** "BBB@ HK\YOVW_ /@H M9X)_9+_LOPEH=A8^/OBSJ,^FWMWX3^W-;V/AKPT\T,]S>^(KNVWRVFIZO8>9 M'X>TM1]H GCUW4$738[&UUOZI_9]_:"^'/[2GPYTOXC_ XU075C=!;?6-'N M&C76O"^M)&KW>AZY:(S&WN[TI0T]I&+BL5"E*4HP]PHHK^>O\ MX*/_ /!2I[Y]<^ '[.NO@::OVK2?B/\ $S2)U;^U25>WO?"G@Z^B) TI-&C%KVM>I:ZA!/HMYS?NPCJ M]6D_*\7/%WA+P:X4Q'$_%.);E)SH9-DV'G3_ +3S[,5'FC@\#3F](0O&>,QD MU]7P5!^TJN52="C6O_\ !23_ (*2!QKW[/?[/>O!HF%QI'Q(^)&D7 (G!#07 MWA+PE?0-@VQ&^WUS7+=\7@\S3M.D^P_:;G4/Q0^#?QC^(7P+^(6A_$CX;:W< MZ1XGTBY# J7FM-6M)G47>CZO9YV:CINHIF&ZM)@V_<)(RDZ1R)Y;\\C_ ,4D MDC>[.[L?Q9F9C[DD^M?T*_\ !-O_ ()MKIRZ%^T'^T'H0:_86^K?#CX<:M;@ MK9*0LUEXK\5V4RD&Y(*7&B:)<)B$>7J&H1[_ +/;C\DI3SGBO.85:,H---23U5G[2M4U[N/^0N68[QG^ECXSX3-88.KBL/DOASDV'Q*J4*^&JTY1J4Z].I%3I.$UF&<9@N9R24I8?]E_@3\0 M?$?Q5^$?@3XA>+? ^J?#GQ#XIT.#4M2\(ZNT;7>FS.\D:31[9'F2PU.*./5- M,BO5@U&+3[RVCO[>&Z65*]:HHK]LI1G"G3A.HZLX0A&=648Q=248I2J.,4HQ MY9AL5@LMR_!X['UOF6*H4*=*OCZ MV'PL*>%H5<75C/$3HX>G"A2E4<*4(PC%(HHHJSN"BBB@ HHHH **** "BBB@ M HHHH *UX?\ D"7O_7_9_P#HJXK(K7A_Y E[_P!?]G_Z*N*3V^:_-#6S]/U1 MD4444Q!1110 4444 %%%% !1110 4444 %%%% !117Q'^V9^WY\#/V%K;X>7 M?QKM/'EU%\3)_%%OX<'@?P_IVNNDGA&/0)=5_M(:AKVABU5E\1Z?]D,1N3,5 MN XB\M3)P9GFF7Y-@:^99KBZ& P&&]G]8Q>)G[.C2]M5IT*7/-Z+GK5:=./> M4XKJ?5\$<#<7^)/%&5\%&R_!8O&5;/W:&'JSVB?;E%?AS_P 1!'["/_0'^/G_ (;[PW_\WU'_ !$$ M?L(_] ?X^?\ AOO#?_S?5\E_Q%'P]_Z*_)/_ LC_EY_U9G]"_\ $BOTP?\ MI';Q0_\ $=K_ /R1^XU%?AS_ ,1!'["/_0'^/G_AOO#?_P WU'_$01^PC_T! M_CY_X;[PW_\ -]1_Q%'P]_Z*_)/_ LC_EY_U9A_Q(K],'_I';Q0_P#$=K__ M "1^XU%?ES^S%_P5V_94_:S^,.@?!#X6Z=\6;?QGXDL=>U#3I?%?A#1M)T40 M>'-&O-+-5N(I#96,XMU6RD$D^R-FC5BX_4:OILFSW)^(<++'9)F. M%S/"0KSPT\1A*BJTHUX0IU)TG);3C"K3DX[I3B^I^'>)'A7XC>$&?4.%_$[@ M[/>!^(<3EF'SK#Y/Q#@Y8''5(Q>$PV/A1FVWAJV)P&-HTZFTJF&JQ^R% M%%%>L? !1110 4444 %%%% !1110 4444 %%%% &O/\ \@6P_P"OV]_] MZR M*UY_^0+8?]?M[_Z!;UD4#>_R7Y(****!!1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5K MZE_QZZ/_ ->#?^E4]9%:^I?\>NC_ /7@W_I5/0-;/T_5&11110(**** "BBB M@ HHHH **** "BBB@ HHHH **Y+QUX]\%_##PGK/COXB>*-$\%^#/#T,%SKO MB?Q'J%OI6B:3!>*,?,X!^7O^'BO["/ M_1V_P#_\.3X;_P#DVO.QF;Y3E]2-''YIEV!JS@JD*6,QN&PU25-R<%4C"M5A M*4'*,HJ23BY1:O=,^QX=\//$#B_"5LPX3X&XQXHP&'Q,L'B,;P[PSG6=X2AB MXTJ5>6%K8G+<#B:-+$QHUZ-:5":^\]__B"'C3_T:'Q0_P#$ XK_ /G2?9U%?&/_ \5_81_Z.W^ ?\ X:^\/\ MB"'C3_T:'Q0_\0#BO_YTGV=1117MGY>%%%% !1110 4444 %%%% !1110 44 M44 %%%% &OK?_'Y'_P!>5C_Z2Q5D5KZW_P ?D?\ UY6/_I+%6126R]%^0WN_ M5_F%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 2P?Z^'_KK'_P"ABO:Z\4@_U\/_ M %UC_P#0Q7M=9U.GS_0UAM\_T1X[J?\ R$M0_P"OZ[_]*)*HU>U/_D):A_U_ M7?\ Z4251JULO1?D9!1161X@\0:#X3T'6_%7BK6](\,^&/#.D:EX@\1^(_$& MI6>C:#X?T'1K.;4=8UO6]8U&:VT_2M(TK3[:XO\ 4M2O[B"SL;.":ZNIHH(G M=6!_'E_P<%?'K3?'/[4_@KX0:?+I%]IW[-'PTO)-=FM]!\16?B?2/B#\95T# MQGXJ\/WFIZE)%HOB'0S\./#'P3\0:%)X7T^6&RU37/$>FZKKVI:I!)HGA>#_ M (*I>#?V./#_ .S)^Q+IG[/7[1'[,/Q2\?\ P-T:/X >,['X'S_"N[\6_$K3 M]7\+77C:^^*_B2#P)XTU[6?#VAZ?\0O"?CSQ'=Z1JJ>);&?QU^T!KVJS>*;? M7]3U*X\7_(OP7^$/Q,_X*P?MT>/$37=2\ S_ !3UCXG?&?QKXC\0:C'\7+CX M.?#^&>9_#/A^O$WPXU3QUH7A;5]:^'/P6\-VF@3Z7)HF@WVC:G9^&]/\ M"OAR[L+#]*/B!_P;J?$+PUX#\;>(_ W[4=A\2_&N@>$?$FM>#_AQ#\!;3P=- M\0/%.E:->WWA_P $Q>+M>_:)FT/PK)XJU:"TT)/$FLPRZ3H;7XU/48WL[693 M]YSX'+?[*P]?&RPU;!0]M5HQHRJ*I4Q,;5%4G%-1WJQ751FI/3E/EN7$XWZ_ M6I895J>)E[.%252,'"-%IPY(RLY7M!RZ-Q<=[W_1G_@A1^T!_P +9_8M@^&6 MM:R-0\9?LZ^,];\ S0ZMX^;Q?XOO?A[XBF?QO\-]?OM$OH8M8\%>#=.@UOQ# M\'OAWHTDVJ:$-%^#5S;>&]3M[33KCPQX8_G T3_E,3-_VEG\0?\ K<6I5]1? M\$#_ (\7/P__ &QKOX2M=ZQ<>%?VD?A[K&D1:=I&D^'KO3I/'GPSTW5/B3X/ M\4>(]:OWMO$&E:+HW@>S^+6@V<'AVXO(-4U_QOHPUK0KN"UM-<\-_!OQ5^(L M_P 'O^"CWQJ^+MMH<7B>?X4?\%$/C/\ $V'PU/JSZ##XBD\ ?M8>+/%J:%)K MD>EZX^C)JYT@:>VK+HNKMIPN/M@TR_,/V658;!O#YQF]*G'W<1@*E:BEU5>4 M=%TLJO/%:VLD%;$*KE^7SD]:.*ITZC?1THO5^;ARR?J?Z&=?QM_\'"7_ ">Y M\.?^S5_ /_JV_CM7U7X/_P"#CZ'4/%WA6P^(?[)NA?#OX?WWB70;/QU\08_V MBO$7C"7P)X,NM5M(/%/C.+PCI'[,UMJOBN7PMH4E_KD7AK3+FUO]>DL%TJSN M;>XNXYD^5/\ @X2_Y/<^'/\ V:OX!_\ 5M_':O.R/!8K!9M1CBJ,J+J4*[AS M.+YE&*O9QE):75UOJ=F9XFAB"J^OZ^0/^">W_)@O[#W_ &:!^S3_ .J8\%5]?U\Q4_B5 M/\W#X(_P"&/Y(_C$_X.#/^3^O!?_9H'PF_]7/^TM7B7Q+_ ."G'[;V MF_LS?#K]D#7O#WA#X/\ P]O?@!X,\,:3=P_"[6--\=?%S]F_5/AWK/PLTB[O M;SXG:MXLT?4_!?Q"T:WN;M/'_P .O#/A:YU#7= >3PGXETW3XM6TJY]M_P"# M@S_D_KP7_P!F@?";_P!7/^TM7[ ?&C]FBT_:?_X(G_!'PY;Z=KFI>./AE^R+ M\!OC?\*[3PUHOB/Q5X@U#QY\./@1IEVOAC0_!WAK5]+N?%>M?$/PC?\ BSX9 M:-IMU;^((M/U7QI9^)=.\,ZUXBT'1+6OLJ.)PV'RW(GBL/3KTYU:L>>I_P N M/WS_ 'J6L9>"_BRL!_)S]E'QU^SG\;_VM?%?Q1_X*?\ Q%\7^)/"/B#P?XK\5ZWX MDN&\;-)XY^*37GA3P[X8\-:Y!\(M"G\6:)X:T_PMJ'B'5_#FE^"1X,\.>&3X M%\+>%[2YL/"4%OX-UCZ0_P""/WC[5?'6M?M-?L#ZM\0T\(^!_P!M3]G/XM>$ M/!\]YHOB[QDOAWXSIX%U72X?$7AKP_IVO:;X0TR*]^%.H^.]=\>SZT-"NO') M^&'PR\,P>-](N-,TG2]8^:_V6?%W@3]A+]K3Q9IO[$/%GPT M\;_"7Q)X9\ >,-9\%^)M2O/"GBOP_P"./#WACQW,? /B^]DC\.VND:'KEIXM MT32K_P !?$'4_&?A/Q=KFDRV6C^*^R%*I'%9XIRKU<7.G0G1EAY0I8J6#::2 MP\G%PBXN/)-QCK.*VG*#.>52$J&6."I0H1G4C556,IT%B%9MUDFG+F3!?#&D_#?XE>'=1U;3/%>JVGP\^ M.'@SQ5J=Y:Q>'].^-OAO_A(]8L=)D\*^!_'A7QBGC'2[GQ%K^JV4&H2:)!#X M7T+ZH_X+R_M$^(/B!^V1KOPGU6R33?!?[*WA32M%\/Q"?3+Z35M9^)W@;P/\ M6?&_C!;A- TW6-).J:=J/@GP=+X:O-;\1Z7"/AQ;>)=-FTR[\4:OIT/U;XA_ MX*L?\$@+#0;S5-,_X)EQ33Z?=Z1-J%EXF_9M_9(T2U/AD:Q8#QCJ-G>Z%XS\ M9O,M1EU;4?#O[2/P[\&>.-+O)_"U]I&@V%YX3\*Z5\%_$_@C2?$LUU>Z9 MXPUG0[3P+X;\9^(S9#3KWPY8_%#PIIVJZ+%!6\HQBW*G#VVKBFU-M:ME5J?)A,7*G6HU*=2OAI5:>$4E M2I1]_FLFY)*4O9Z)NSBKV5DOH_\ ;\_X(T_![]CW]C/Q)^T#X7^,GQ5\8_$+ MX>:A\(K3Q=8^*-/\$KX$\52>-O&WA3X8:TWA+0-&T/2_$G@2,>)_&-AXNTH: M]XX^)%-2^(]EX!U3XD^)O&'BSPY9:+\/\ Q-X# M^(OPR^)&GZ3X'CTBUUN\^*&B:QJ_AG6_#T^M^(8?A%J-E:)HNJV_AO4;G6+W M1M"]M_X-N?\ D,_ML_\ 8,_9A_\ 2K]HVN/$?VBN'\"_^S0/A-_ZN?\ :6KXE_8E M_:0\>_\ !.G]KG3_ !1XN\/WY'@;6?%_P0_:1^&NB:AX-U+6+S1K'4YO#GCO MPQI7B'9XAT&;7OA]\0_#FD>+]._X1WQ#I%EXPUCP%;^#I?'FB>$_%.L:VD__ M 4<_;1\/?MT_M+Q?%W0/ ]]\/+'P_\ #32_A;HFB:QXELM?US6_"?A3XB?$ M[Q-X=\9ZU:6&E6%KX7U?7+'X@)#J_A:SU#Q7IVB:C83VFG^,/$=NHOW])82O M+/Z..C#FPCPBM64H\K+YMKVX57I1RFKA92M76(_AV?- M:,X2;VLDDFKNVJMO8_4'_@I%\>?$7@W_ ()3?\$ROV=-)T^(:#^T'^SC\&?% M'C?6)9=,N5ET+X#_ R^!.O:/X0_LC4/#^H3K_:WCKQCX0\:1^)='U[0-4T: MY^&]OHK0ZQI/BS58K.#_ ()U_P#!&KX"?M=?LJ^ OVBOBA\8/CAI&L^//$7Q M$BLO#7PRN/AQX$/!D?AO1M!\0:KK M-S\1K?66ET?2?"NJS7>1^P7_ ,%EO@]^R!^QCX?^ /B/X+_$_P 5?$;X[\&S>&]2\(1> O&5UXS\7>*/B;HO_"7>)-6U6Q\2> (I_%7B^_\,:P^A^!? MB9)I6B:;;>++*'6[[4I?"&F>726+>3Q_LKG^L?VC6^M>P:56W-4Y>9NSY>7V M-[/:U_=YCNFZ"S%_7N7V/U.G[#VJ;I[0YK+:_-[2WG?K8L_MK_\ !&WX<_LH M?L3>-?COJ_[0WQQ^+7Q8^$^G^ ?#VAV.HS>%?#_P7L=#\6?'72])GT7PM\.; MW1?&'C#P?HT47Q+\1^)+C2M/^+5U97_Q#U/6_&+Q0)K^HZ*WGG_!,7_@E!\ M?V\?V=O'/Q.^*_Q#^.?A'7-(^+/B;X96]C\,->^'&E:-)H=AX&\ ^((;^>'Q MA\+?'&H-K3WGC#4899XM2AL#:VVGHFFQSQW5Q=_&K?Q-XEL/%?PH\"_&OX-^.+CXAZ7$-=FN#JOA'P_X=UW0M;T/Q;X MH\"II TJ/P1I%[H^J6&M:_\ V])K^I6E_I_AI/#UK>>(]*,\UJ93CX1J5IXZ MCF,H35.4>>$6J6NU]7K%_P<'_\GT^ /^S3?AK_ .K@_:$KC/\ @H-^TW\0[7]D M3_@FE^R/H5_JOA_X+=,U/4_#-MK7PY\*ZU79_\ !P?_ ,GT M^ /^S3?AK_ZN#]H2N/\ ^"@W[,GQ!N_V0?\ @FG^USH5CJFO_#RT_P""?'[* M?P6\?OI^CPO9_#?4-"\'V7B+P9K^OZHFLS:@^F?$2]^)NI^&K2X/AJRT+P[K MGA72],U+Q+^G-S?!?[?+;WK&6) M]ISYU[.]_P#9N;EW]G?W_ER_%_=O?2Y]V_LU?\$,/V?/C7^QK\+_ (F:Q\8/ MBS9?%OXX?"OX=_&'1/%NEP^%(_!O@6X\9>!]=\1Z!X4B\ W.D7-[XC\)K'XW M\)GX@_;_ !O9^*_%FJ_#G3[WP'XJ^$&D^)/$?AV[^$_^"#7[0NO?#W]LO1_A M1I=A'J'@_P#:H\)ZIH7B%/-TNRETO6OA=X(\<_%?P/XM>[;0-2UC5QI.G6'C MGPA#X;L]<\/:5,/B-=>)-1FU*[\,Z1IT_P!P?LW_ /!=KX _!+]E+X.?!_5O M@;\:=2^)?P>^"7ACX9V%MHT_P_?X;Z_JOPV\*0^$?"5Q=>-;[Q5I_BS0]-\5 MVNA:-J/B":W^%NNW'@V?5M0T_3;+QM%HUOJ.M?(W_! _]FC7?'/[55M\>;GP M[XO@^&O[.OA+Q9;Z+XXL9=)LO"=W\7?%7AFW\!Z?\/M6.I6LU_XBF'PO\=^, M_%^H6/A+[/<>%;VR\#7WBS5=*T[Q5X=T?QC@_KTT]G*RPRK-8Y%AH5)1H5<#3E4IJW+-NE-7EI=VY(\MW[ MK5U9MG/["E/!YG6E!.K#%2C";O>*]I!^[VOS._=:/0_77_@D#XO\3^-O^"<7 M[,FJ^+=275-1TK0/&_@739TL-*TU+3P=\,OBKX[^''P^T6.UT:QT^S,?A[P' MX4\-Z#'=R6[ZGJ*::NH:U>ZEK-U?ZC=?0'[=%NEW^Q+^V):2 &.Z_98_:#MY M 02"D_PE\71L" 02"K'."#CH17R__P $7?\ E&I^SE_U\_&S_P!:%^+%?5O[ M:NEZ]KG[&W[6NB>%="UOQ1XGUC]F7X\Z7X<\->&M+O\ 6_$?B+7M0^%GBJTT M?0O#^BZ7;W6IZOK>K:A-;V&E:7IUK\TZXTG]W?VQ?\ @G?^S/\ MOVVEW?Q@\/: MYI/CSP_I::%X:^*_P_UF/P[X_P!#T$^(-/\ $%WH;27]AKGA/Q-I5Q)::A8V M=GXY\)^*HO#%MXH\6WW@H>&=?\07VM/_ #P?\&\?C/QC9?M8?%_X?V&KF+X? M>*/V=]7\9^)M"%AIRU"[TK0Y]-^S?^"OWQ^_;CU+]IKX9_L7?L?:Q\1[3_ (3+X,>% M?B;X@T;X%V-]IOQ/U&ZU[XU7O@ZS\0^)/B7I#Q^(?A?\-/"NL^$_"FG:EXNT M_7_AQX-L[;QIXFL/BYXHUGPCJ]E8:/[69T<14X@K>QQ$<+)4Z555YU72C3IP MP]-3;FM=U+W=5*]GI>WFX*=&.4T_:495XNE[..NZM=: MI'YA?'S]GS]J+_@CCXUC\4_"G]M#X>/JGBS5O">FZ?X7\ ZQ/HGQ2\7Z#J7@ MGX@Q6OQ%^*W[+_BRT\;>!YOASX7\26GQ$\(^$-?U_P 2?$[2].\37NC:UI3: M%XIU*ZL?#G]+?_!+[]LWQQ^W'^SCJWQ3^(_A3PIX5\9>%OBEXI^&^KIX).KP M>&=:33-&\*^+=+U?3M(UV_UO5=!>/1_&FGZ'?V%SXC\0"\U+1;O7[>\T^UUJ M'P]HOX\_L;_\&^-^]OX;\8?MC^,(/#.E0IHVJ0?L\_""\M6OEA4>#==7P]\2 MOBE% ^F:8@7_ (3?X?\ CGP=\(K"^?;_ &3XL^'?[1%LX\@?I1^V9\:/AY_P M1Z_98^%]U^S+^SW\.;70_%OQZ^'GPVN_"T5U=^&H-3@3P#KOB#Q7XN\4>(;6 MSU3Q/X[^)OB3X X?B%XRU+7O$D6NZEH7CWQA/\ $"V\)77@OQ3EF-?# M8V-'!T6L?F4JL(?7XT8893^RJ?Q+VNNBG.T%\47J:8.C6PTJF(J7PF#4)2^J MNI*NXZ)N;T?)U;C&\M.5H_GE^+/[37_!:3XB_"GX@^$/C-I?[84/PEU3PGJ3 M_$FZUK]CJ?X0Z3%X*TV'^UO$;^(?'?AWX!> =0T7PQ)I=A M&)-7T;Q)%=^'=0U2PN?I'_@@'\0_V;O!GQ_\0^%/&-I\04_:K^+NF>-/!GPJ MUZ"VEN?A%!\*/#^B^%OB3KG@MXM+U.2_L_B=XHU#P5XD\5ZGX@\7^'Y?!]KX M6^&OA[P_X4\4>&O%?B35= ^(?VKJ_P#P<7?!"'X?6E]H'[-_QAU+XMOI/AJ> M_P#"&L^(? NA_"^WUNZN-*7QCIMG\4['4O$?C&]TW0K2;6Y_#&L3_!+3[GQ9 M<:?I5KJVB^"H]8O+O0OR;_X(B_#OQ]XI_;_^%/B_PMX2UC7_ =\)-*\>ZQ\ M4?%<"V\>C>!M*\6?";XC>#/"5QK>H7D]M#)J?BKQ7?VNDZ#X?T\WGB+5X8?$ M.O6.E3>'/!_C#5M"]24*M3*T^=*.L3A4H0S#!2P^*GCI3DX3]K>HZ,&XIRC*R47RRG+17CROFTD>7Z^J1_ M\%C(!$V5/_!6/PVQ((^_+^VYI3S+\H XD>12.O4,2,?"GB#XR7?Q7L]"=K&^\<7OAN'1O'/ MA[Q;\*CKVL:8FHZK-X-N/&UMX1M=)UG2M-?V_P#X*N?\%3_AG^W%\-?A7\,_ MA)X,\<^$O"7@_P >:U\2?'-]\6?#_AG2-=DU[1_#5UX6\#-X3U'P?\3O&.E) MH']C>,?B+)XOMM>TJ#4)+Q/"$^E7]G;VNM6U_4\-6Q>-R'&4(N>&AAJ#G5C; MDI^R;G)2_E>O)9J_,G'=.TQK4\/ALTPU67+6E6JJ$&G>?.E&+C;==;[_P#'&A?L M\?"WP[8:!XZCAL;_ %:#PKK.C^*=2M+G4= 0:QX?U)](\3Q:?XEM-)O/"'B/ MP3XF?LL_MD/\,_A=XC_X*G^-O^%!?LM_LMZ?H_PY^%GAK[=^SQXB^-?BK1== M\,6UJOP=_9PT;X*/XBL?%_C_ %6P^$?A/2[O6/C=XJAL/!>BB\^*=[/XB\*^ M#OB'%#_0W_P2(_97UO\ 93_8S\+:/XO&MV?Q ^,FOW?QY\=^&]:2^M)/!>K> M-/#?A70M \'IHFL^%O"GB+PSJFB?#_PAX,C\=^&?$-KJ6H:+\3I?'%I:ZS=Z M*NDPVOX>?%WXL_$7_@M/^WUX=_9]^%OB_4H_V/\ X?ZG9^-;+3)6B^%^I1_" MGPQ/X5\.?%OXYZCI&OQ^*=7\2?$?6]3\67'A3X,V^L>#_-\+:+XM\%:=XC\ M?#I]:^-_B*[XZ.-K5L?CG3G2C@,/B*V)GBITXRGAX2_=2EAINZC5Q*CRTTU* M[;DH_$GTU,-2IX7"J<:DL56HTJ$:"G*,:LHVJ)5HK>%%N\WI:R3>J9\?_!OQ MG9^$OB9I/_!2C]J[X107G@]O$UI;?LS?"[X/77A+X$Z#XY^-/P/\+:%I?PHL M?"/@>!XM=LOV1/V;-&^'W@SX9^+O&WAL>*;WP]XOE^#G@S5M/^-1_P"%Q:%; M_N/^S+_P77T/XQ_M!_#[X%?&#]FK6?@1#\4&\(Z+X1\6VOQ$U/XDS?\ "8_$ MVS\+ZM\([+7/"9^$O@35-/\ !GQ+T;Q5I%YH'CW3[O6K6*/Q%X,UN]TB'P!K MFL>.O"WR'_P7L^!?A+X+?!_]AOP%\&_AR/!7P@^'4'QY\':4F@Z3J3^&/#VJ M^)4^%FN6%CK?B287CW'C+QQ<:/XP\67>H>(M4O/%OCW5-+\:>+=2O-;U6W\0 MZG7R_P#\%&?BII/_ 4/_P""@OP*;]@WXBZWK_BG6_A=\-?A7X)\=Z=X>^+O MP\O_ '\4]%^*7Q>\32^+Y)+KP7IOQ T+1?AWI/B'1/B!K?Q \,^']1A\-Z! MI6I^(K2YD?P_>"VU=#"YG1H5YT)QIU:..C2J1J3C3RZE@WRX>FXQO2YJJ]^; MJ:SDWRZ))9JK6P56K2C6BYTZN%N#4=4B73?"7Q)^'WBOQ/XUTL MZ5%>IHM\=9UCX1^ ;I;^_P!.NM4TS^PS;Z1?6%IJVN6^I_:'_!&*)(?^":_[ M.*1C"F3XS2D8 ^>?X_\ Q4GE/ ^:21V)ZG.22Q_L<>%#9_V=JO\ ;OVG1_T$_P"".FE:[HW_ 3?_9MM/$6AZQX>U":U^*.J MV]AKFEWVD7MQH6N_&SXDZYX7UR"TU&"WN)='\3^&=1TCQ)X>U2.-K'6] U;3 M-:TN>ZTW4+2YE\NM=<-X3FWEF-25._\ (J=>,K>7/OY^NO;3USK$6Z8.*E_B M_V?=.EM>^1]FG98I&(UJ*35TT[V::T;3U[---/LTTUNGKZA=Z_'XUNKBZU"R\=V6H74SIXGTW5;H"2^AOI!)Y MZ2[+RPO$N-/OX+6]M;BWC7]ES]J3XC?LJ?$:T\<>![MKK2[IH+3QAX/NYY$T M7Q;HJR;I+.\C7<+>^MPTDNDZM%&USIURQ91+;2W5K#=6R2Q.L=W87<=QI^H6]M?6UQ;Q_C&?9'C>'<;',,'5K2PTJWM* M&*4FZM"JVY>RKRZMZJ,Y>[6C=27-S1/\4O'_ ,"^-?HZ\:X7Q!X-S3.*_#-; M-_K^0\54ZU2KFN0YK4J2K?V9GN(L_:5ZEZD:&,KQ>&SG#.K3Q$'6^M88_4;] MN+_@JJOQ5\"6'PR_9Y_MSPQI'BSP_:S?$GQ1?I]@U\+J=JK7W@'1S#(QMK.W M$CV?B/689%?62)-,L/*T;[9+K?XA@/(X50SR.P !9W=C@ 9+,S' R23ZT M*K.RHBLSLP554%F9F.%55&26)( &2>!7]$W_!-O_@FVOAU="_:"_:"T(-K[ M"WU;X<_#G5K<,NAJP6:R\5>*K*92#K!!2?1=%G0C2P8[^_C_ +1\B"QY*4,W MXOS./M)\S48JI4Y7'#8.@FDW&*NDY.[C!/GJSO=V3E'Y#+,'XO\ TPO$VA'' M8OZU7HT,/#'YC[">'X;X/R.$E&=2EA82=.BZ]15*E'!TYO%YICI3A M2_X)P?\ !-9M';1/C]^T1H _M,"VU7X=_#75H%<6&Y4N++Q3XNLI P%Z 4FT MC0+E-UJX6\U2%9UAM5_>VBBOV'*LJPF3X6.%PD++XJM65G4KU+6=2I)=>D8J MT81]V*2W_P!D_"CPHX3\'N%,+PKPIA.6"Y:^:YKB(P>9YYF+@HU_]?]G_ .BKBLBM>'_D"7O_ %_V?_HJXI/;YK\T-;/T_5&11113 M$%%%% !1110 4444 %%%% !1110 4444 %?SR?\ !?3]GGXY_'S2/V7(?@I\ M)O'GQ2E\+:E\8I/$(KX3#YBL*JF(PRIRK4_JN-PV-CR*K&4/ M>GAHPES1?NRDUK8_:?H\^-><_1V\8N#?&3A[)\LS_..#)YY/!Y1G,\72RW%O M/.&LYX9KK$SP52CBHJCALYK8FE[*I&]>C24[TW*+_P Z7_AW5^W=_P!&D?'S M_P -MXD_^0J/^'=7[=W_ $:1\?/_ VWB3_Y"K_1:HK\/_XEGX;_ .BBSS_P M5@/_ )3Z_P!+7_4?_BMUXT_]&;\+_P#POXK_ /GF?YTO_#NK]N[_ *-(^/G_ M (;;Q)_\A4?\.ZOV[O\ HTCX^?\ AMO$G_R%7^BU11_Q+/PW_P!%%GG_ (*P M'_RGU_I:G_%;KQI_Z,WX7_\ A?Q7_P#/,_C>_P""/_[''[5?P@_;N^&7COXI M?L^?%GP!X,TOPY\2K?4?$_BOP7K6C:+93ZGX"U[3]/AN+^\MHK>*2\O;B"UM MU9P99Y4C4%F K^R&BBOU_@/@C!< Y-6R7 8S%8ZC6S"OF,JV+C2C552O0PM" M5-*C&$.11PL9*ZUZ52,9JDJ=&DXQ4G-LHHHK[4_F0 M**** "BBB@ HHHH **** "BBB@ HHHH UY_^0+8?]?M[_P"@6]9%:\__ "!; M#_K]O?\ T"WK(H&]_DOR04444""BBB@ HHHH **** "BBB@ HHHH **** /X M+/\ @L'XL\4Z=_P4=_:5LM/\2Z_86<&J?#H0VEEK&HVMM"'^#WP]E<1007*1 M1[Y'>1MB#<[LYRS$G\T_^$Y\;?\ 0X>*?_"@U;_Y+K_0#^,G_!+O]A;]H#XE M>)_B]\7/@;_PEOQ$\8RZ;-XD\0_\+,^,.@_VC+I&C:=X?T]O[)\,_$#1M#L_ ML^D:3I]IML-,M5E^S_:)Q+=2SS2>8_\ #EC_ ()G?]&U?^9C^/W_ ,]2OY"X MC\!..^#_A3P#G_AOXQXW/>!_#;@;@_.L9EO M!_AUB;<-<+Y7DN8XK 8C&^(^"QE?!5\9@JU7"UL7@\)B:M"=.=?#4*LI MTH?PE?\ "<^-O^AP\4_^%!JW_P ET?\ "<^-O^AP\4_^%!JW_P EU_=K_P . M6/\ @F=_T;5_YF/X_?\ SU*/^'+'_!,[_HVK_P S'\?O_GJ5XW_$N?B#_P!# MSAG_ ,.6=_\ SC\E]Q^D_P#%9?Z(?_1KO'#_ ,0GPQ_^FB?PE?\ "<^-O^AP M\4_^%!JW_P EU_5Y_P &YFM:QK/PP_:?#Y('U*^NKYH5?P]X M@+K$UU+*8U--0T[5/$MM_PEOCGQ9_:5]I-O<6FGS^=XW\ M3>);BS^SV]W<1^582VL,OF;YHY'5&7[KPV\&N+^$.+\NS[-LTR/$X'"4L?"K M1P6-S2MB)/%8'$8:GR4\3E>&HR4:E6$I\U:+4$W%2DE%_P J?33_ &D_T=OI M%?1WXR\)O#_@3Q1R3BGB#'\*8K 9EQ-POP-EN3T:>1\4Y1G6-CB<9DO'>=YC M3G6P> KTL.J.6UHU*\Z=.K*C2E.K#Z5HHHK^G#_#H**** "BBB@ HHHH *** M* "BBB@ HHHH *U]2_X]='_Z\&_]*IZR*U]2_P"/71_^O!O_ $JGH&MGZ?JC M(HHHH$%%%% !1110 4444 %%%% !1110 4444 ?F]_P5W_Y1R?M0?]BMX5_] M63X+K_/XK_46UC1M'\0Z;=:-K^E:;KFD7R)'>Z5K%C:ZEIMXD7.A5P%3%.;AB\7B?:JI#%4%%-8E0Y.5M.#?-[UE_J9]!G] MHKDOT/\ PQXH\/LR\*\TXZK<0\>8SC*&:8'BO"9#2PM+%G^9517^FK_P *,^"?_1'?A9_X;[PE_P#*BC_A1GP3 M_P"B._"S_P -]X2_^5%'_$L>/_Z*_"?^&:M_\\ _XKC\*_\ 2.W$/_BQ\M_^ MA#U_IZ>IT445_79_SO!1110 4444 %%%% !1110 4444 %%%% !1110!KZW_ M ,?D?_7E8_\ I+%616OK?_'Y'_UY6/\ Z2Q5D4ELO1?D-[OU?YA1113$%%%% M !1110 4444 %%%% !1110 4444 ?GU_P4+_ &^-)_8"\ > O'FK_#34?B;# MXY\87/A&+3=-\3VWA>33I+?1;O63?27-UHNMK:0NP_DS_ M ,1)?@K_ *--\4_^'7$49@@DDF"L9"@121_ M.U_PXX_X*-_]$C\+?^'8^&W_ ,TE?S7XD\1^,>7<68S"\'8+-ZV10P^"EAZF M#X:H9E0=:>&IRQ*CBZF78B4VJSDI1=5\CO%*-K+_ &P^A5X,?LX.,_H_\.9] M]([B;P[RSQ5Q&<<3T%?VG/C_ /#' MX#6/[./B'PA=_$K79M#@\27?Q)TW6+?26ATK4=4-Q+ID/@W3Y;Q673S#Y:7M MN090^\A2K?AO_P ../\ @HW_ -$C\+?^'8^&W_S25]@_L!_\$E/VX?@-^V'\ M"/B]\2_AMX>T?P+X&\6W.J^(]3M/B-X%U>XL[*7P_K.GI)%INF:[KD/%OCY7SS)J&:9?GT,LK9KEU+,9U>$,-0IQP-3&4(8N M52NLI@Z,%AY5'.JIP=./--2BXWC\%XJ_1]_9*97X7^)&9\#\8>%-?C7+N N, M,?P?0P/TB,ZS7&UN*<)P]F.(X?I8/*ZG'V*IYEBJF;4\)##X">&Q$,95<,/* MA6C4=.7]>E%%%?UX?\[@4444 %%%% !1110 4444 %%%% !1110!+!_KX?\ MKK'_ .ABO:Z\4@_U\/\ UUC_ /0Q7M=9U.GS_0UAM\_T1X[J?_(2U#_K^N__ M $HDJC5[4_\ D):A_P!?UW_Z4251JULO1?D9!61K^@:%XLT'6_"WBG1-(\2^ M&/$ND:EH'B/PYK^FV>LZ#K^@ZS9S:=J^B:WI&HPW.GZKI&JZ?/A)K\_BOX4_ 7X,?#+Q3>%M0T#5_#'[)_P"S5X&1-WQE^RS^S'\1O$NI M^,_B%^SE\!_'?C#6C9G6?%GC+X0_#[Q1XEU8Z=I]II.GG4]=UOP]?:I?FQTJ MPL=,L_M5U+]ET^RM+*#9;6T,:>\45?MZW,I>UJ\R7*I>TGS*.CY4[W2ND[;: M(GV=.UO9PLWS-W7<^=-$_8^_9)\,ZUI'B3PW^RW^SIX?\ $7A[ M5-/US0->T3X(_#32M:T/6M)NX;_2M8TC5+#PS;WVFZIIE];P7NGZA93PW=E= MP0W-M-'-&CKTWQ#_ &<_V>_BYK=OXF^*_P "/@U\3O$EGI5OH-IX@^(?PO\ M!'C36[70[2[O]0M=&M]6\2:'J5_!I5M?ZKJE[;Z=%<+9PW>I7]S'"LUYZ7D'LJ:3BJ<.5M-QY(V;6S:M:ZZ=C&\.>'/# MW@_P]H/A'PCH.C>%O"GA;1M+\.>&/#'AS2[+1/#WASP]HEC!IFBZ#H.BZ9!: MZ;I&C:1IMK;:?I>EZ?;6]CI]C;P6EI!%!%'&NS11619XO\0?V;_V=_BWX@A\ M6?%7X"_!?XF^*K?1[/P[;^)OB#\+? _C/Q!!X?TZ]U34M/T*'6?$>A:EJ,6C MV.HZWK6H6>F)DZ M=H/AWP[H.G6>CZ%H.A:/9PZ?I.BZ+I.GPV]AI>DZ786]O8Z=IUC;P6=C9P0V MUM#%#$B+K453G-QC%RDXQORQ[^9X)X' M_95_9>^&7B#2?%OPV_9N^ GP^\5: ES%H7B;P/\ ![X>>$_$&BQWNG7.CWD> MDZSH/AVPU+34N](O;S2[E+.YA6?3KNYL90]M/+$_&?M(_L._LI?M<-I%S^T# M\&M \<:QH4FFC3/%EEJ7B;P-X[BT_2!XA.G^')_'_P /-<\)^-K_ ,&V]SXJ MU[4_^$(U#7[KP?+K5\-=GT236;2ROK;ZNHJ_;UE-5%5JJI%6C/GGSQ792OS) M:O1,GV=/E$M:A,&N^"O&5GH?B'6[#1O&WA'4]$\7: M FJ7(-3^'W[-?@F74/$VDW.@ZG>?$.]\ M5?&>X@T34O#WB?PEKVDZ%)\9/$/CUO"NG^+/"GC+Q+X8\;VGA@Z/!XY\/:F= M%\8)K>FVMC;6WT_\-O@;\%/@U)K$_ TGB M"/0SJ3:*FMOX8TC2VU9-';6=8;2UOS<#3SJNI&T$)OKKS?4J*)UZU1R=2K5J M.=N9SJ3DY6$5RWWM9*U^MM^I\3?M!?\$Y M?V*OVH_%<7COXU? ;P_X@\;!KA]0\7^&]?\ &WPQ\3>)I)]*\/Z%!+XWUSX6 M>)O!>I^/IM(T3PMH6C^&IO&MSK\OA72K.33_ T^E6E]J$-UUGAW]A3]C#PO MX*\+_#S3?V5_@)=^$_!RSOH5AXD^%OA#QC>QZC?:'X3\-ZQXCU/7O%VE:YX@ M\0^,?$NB>!/!=EXN\:^(=4U3Q=XP'A;09_%&M:O=:9:3Q?5M%/ZQB.6$/;5N M2F[TX^TGRP;T;A'FM%V;^%+<7LJ5Y2]E3YI_'+DC>6J?O.UY:I/6^J78R- T M#0O">@Z)X6\+:)I'AKPQX:TC3= \.>'- TVST;0= T'1K.'3M(T31-(TZ&VT M_2M(TK3[:WL=-TVQMX+.QLX(;6UAB@B1%^ -:_X)+?\ !.W7OB)!\4+S]F+P ME:>([?6/#>N1:1H/B/X@^%OAJ+SPK#ID&EVS_!KPSXOTCX03:'SAT[2-%T72-.AMM/TK2=*T^VM['3M.L;>"SL;."&VMH8H(D M1?@^7_@E1_P3RG^)\GQ;G_96^'$WB2:!K:7PY*WB.3X.RVS^%SX/>WD_9]?7 M3\!W@?1R9FB;X;F-O$)/C J?%Q_MROT&HI0K5:?-[.I4ASJT^2/-%2Y7WC=.ST6W8\9^(7[./[//Q--=M]!LKS4=1L]$@U?Q)H>I:A#I%IJ&L:M?6NFQW" MV<%YJFHW44*3WMR\O;I\/O 4?@)/A5'X(\(1_"^/P@OP^3X;IX:T9? 2> ET M8>'%\$)X/6R'AY?""^'@-!7PT-.&C#1@-+%E]A_<5U]%2YS:C%RDU#X4Y-J- M]^57LOE8I1BFVHI.7Q-)7ETU>[^9^:B_\$??^"<:>.3\0E_9JTL:\?&7_"=_ MV"?"/PZ\$Z*^HR:/X.\">&]&\(^%=)DUC5+W7-6? M3/#WA^RT_2;!]4UO4M1UC46M;2)KW5-0O=0N3+=W4\TG745=2O7K)*K6JU5' MX54J3FH^BDW;Y$PI4Z=W"G"#>[A",;^O*E?YG@#?LG_LLOXP'Q#?]FKX /X_ M'B]/B$/'+?!OX=-XP'CZ/7QXK3QP/$Q\.'6AXO3Q0J^)$\2_;?[:77P-8%Z- M1 N*ZKXE? GX(?&:?0;KXP?!OX5?%>Y\+1:O!X8N/B5\//"/CJ?PY!X@?2GU MZ'09O%&D:I)I$6MOH.AOJ\>GM;IJ3Z-I37HF.G69A]5HI>UJWC+VE3F@DH2Y MY7BELHN]XI=$K#Y(6:Y(VD[R7*K2?=JUF]%N"?#VD>%?#.EOJNI7FLZH^G:#H5G8:58MJ6L:CJ&K7[6UK$; MS4KZ\OK@R75S-*_5445#;;;;;;=VWJVWNV^K925DDE9+1)*R26R2/X?O#OA2 M+_@FM_P6*\&Z5K7PZU"7P5X0^.6IK\*O#?AB/XF>)[NY^!O[0&D^*_AOX"UK MP,+KP=XF^(_Q;U[P#X(^(MQHFIZ%X5T7Q?J_C3XK^ ?%OPNT+Q)K6NQR:^?[ M@:**[L?CGCWAYSI\M6CAX4*E3GSYDDX)W?,E96T5NU[ME9.O:#H?BK0M:\+^*-%TGQ)X:\2:3J M.@^(O#NO:=9ZQH6O:%K%G-I^K:+K6DZA#<6&J:3JEA<7%CJ.G7UO/9WUG/-; M7,,L,KHVM17 FUJM&M4UT.L_+O7O^",'_!-7Q'K&OZYJ'[.,MK>>)-9U37M0 MM_#_ ,9_V@?">BVM[J]]-J-U;^'_ YX6^*NC>'O"6BPW$[QZ5X;\*Z7HWAW M0[!8-*T32]/TRVM[.+] ?AK\(OA/\&=&U'PY\'OA?\//A1X>U?6Y_$NK:%\- M?!7AOP+HVJ>([JPTW2KK7]1TOPOIFEV-[K=SI>C:/IL^JW,$M]-8:5IMG).U MO8VL<7H=%;5,17JJ,:M:M5C'X8U*DYJ/^%2;2^1G"E2IMNG2IP'F\0 M>%]8A:#6_!WBZRT?7=7M-&\9>%-2T;Q7H']H7-QH>LZ?=/YX^:/@Q_P3+_80 M^ 6M/XD^&_[-O@E?$*ZQX4\1:9KGCV\\4?&'5_#'B'P1J%WJWA?7_ ^H_%_7 M_'5WX"US2]4N_P"T1J_@N70=1O+ZQT6[U"YNY] T.33_ +LHI1KUX0E3A6JQ MIRUE3C4G&$O\4$U%_-#=*G*2G*G"4X_#-PBY+TDU=?)G)^/? _A?XF^!O&?P MV\;Z8VM>"_B%X3\1>!_%^CK?ZEI3:MX7\6:/>:#K^FKJ>C7FG:QIS7VE7]W: MB_TK4+'4K,R_:+&\MKJ.*9/%OV;?V/OV;_V1-)\4Z-^SQ\,-.^'MMXWU2QU? MQ9>_VWXJ\6:_KMQI5F]CH]I?^*?'&N^)?$KZ)HD4^H3:'X;75D\/:+J&M^)- M5TO2[34_$WB"[U+Z5HJ54J*$J2G-4YM2E34I*$I1^%RA?E;71M-KH-PBY*;C M%SBFHS<4Y13W2E:Z3ZI/7J>>_%?X4_#SXX_#GQ?\)?BOX6T_QI\//'>CS:'X MG\.:B]W!%>V\2:%?Z;XA\,Z]8:;X@\/: MIIFMZ;87]OXI^S;^P_\ LJ?LBIJC?L^_!S0O ^J:RVH+J/BJ^U3Q/X[\=SV& MJCP^;_P^GQ"^(NN>+?'%KX2N+CPOH6HGP;:>((/"D>LV/]MPZ-'J]U>7MQ]6 MT4*K4C"5.-2:IR=Y4U*2A)Z:RBGRMZ+5KH@<(.2FX1^(. MAZ?\5O%/Q:U/POH'A[4[OP%I>G:+XYTVQ^*.LZ1HWB6]A^'_ ,'K3QIK%_-I M>F6NB^'_ .MWX/\ PST7X+?"7X7?!SPUJ&MZMX<^$WPZ\$_#/0-5\2W%A=^( M]3T7P'X:TSPMI6H:_=:5INCZ9V.E07.JW&G:1I5A-?23R6>FV-NT=K%Z M+17;B\>\3A\%AHTU2I8.DX)*7-[2K.SJ5G[L>7G:NH>]RWE[SN<]#"JC6Q-= MS=2IB)J3;C;DA'2%-:N_*M'+3FLM%8****\\Z@HHHH **** "BBB@ HHHH U M;#_CRUC_ *](/_2VWK*K5L/^/+6/^O2#_P!+;>LJDMWZ_HAO9>GZL****8@H MHHH **** "BBB@ HHHH **** "BBB@ KYT_:<_9C^''[5'PXO/ /CZS$%Y ) M[SPCXNLX(I-<\&ZY)$$34=.=S']HLKCRX8M9T:6:.TU>TC1'>VOK;3M1L/HN MBLJ]"CB:-2A7IQJT:L7"I3FKQE%[I_FFK.+2:::3/*SS(\HXFRC,<@S_ "[" MYMDV;86I@\QR[&4U5P^*P]5>]"<79QE%J-2E5@X5:%:%.M1G3JTX3C^*7[$' M_!*R/X/>.=1^)GQ_?0?%NN^%]>NX/AOX=T^0:CX>5+"Y9;+QUJHGB3[1>701 M+K0='NH4;2@4O=2A74UAMK#]K:**Y,MRS!Y3A_JV"I>SAS.&OA=P9X2\.QX:X*RSZA@98BIB\7B*T_K.8YEBZC=\3F.-E M&-3$U*=/EH44U&G0H0A2HTX13N4445Z!^A!1110 4444 %%%% !1110 4444 M %%%% !1110 5KP_\@2]_P"O^S_]%7%9%:\/_($O?^O^S_\ 15Q2>WS7YH:V M?I^J,BBBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#7G_P"0+8?]?M[_ .@6 M]9%:\_\ R!;#_K]O?_0+>LB@;W^2_)!1110(**** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "M?4O\ CUT?_KP;_P!*IZR*U]2_X]='_P"O!O\ TJGH&MGZ?JC(HHHH$%%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110!KZW_ ,?D?_7E8_\ I+%616OK?_'Y'_UY M6/\ Z2Q5D4ELO1?D-[OU?YA1113$%%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $L'^OA_ MZZQ_^ABO:Z\4@_U\/_76/_T,5[76=3I\_P!#6&WS_1'CNI_\A+4/^OZ[_P#2 MB2J-7M3_ .0EJ'_7]=_^E$E4:M;+T7Y&04444P"BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* -6P_X\M8_Z](/_ $MMZRJU;#_CRUC_ *](/_2VWK*I+=^OZ(;V7I^K"BBB MF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "M>'_ ) E[_U_V?\ Z*N*R*UX?^0)>_\ M7_9_^BKBD]OFOS0UL_3]49%%%%,04444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &O M/_R!;#_K]O?_ $"WK(K7G_Y MA_U^WO_ *!;UD4#>_R7Y(****!!1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 5KZE_QZZ/\ ]>#?^E4]9%:^I?\ 'KH__7@W_I5/0-;/ MT_5&11110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#7UO_C\C_P"O*Q_])8JR M*U];_P"/R/\ Z\K'_P!)8JR*2V7HOR&]WZO\PHHHIB"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@"6#_7P_\ 76/_ -#%>UUXI!_KX?\ KK'_ .ABO:ZSJ=/G^AK#;Y_H MCQW4_P#D):A_U_7?_I1)5&KVI_\ (2U#_K^N_P#THDJC5K9>B_(R"BBBF 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110!JV'_'EK'_7I!_Z6V]95:MA_P >6L?]>D'_ *6V M]95);OU_1#>R]/U84444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5KP_\@2]_Z_[/ M_P!%7%9%:\/_ "!+W_K_ +/_ -%7%)[?-?FAK9^GZHR****8@HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** ->?\ Y MA_P!?M[_Z!;UD5KS_ /(%L/\ K]O?_0+> MLB@;W^2_)!1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M?4O^/71_\ KP;_ -*I MZR*U]2_X]='_ .O!O_2J>@:V?I^J,BBBB@04444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% &OK?_'Y'_UY6/\ Z2Q5D5KZW_Q^1_\ 7E8_^DL59%);+T7Y#>[]7^84 M444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110!+!_KX?^NL?_H8KVNO%(/\ 7P_]=8__ M $,5[76=3I\_T-8;?/\ 1')7/A_39KBXFDDO@\L\LKA)+<('DD9F"AK=B%R3 MM!).,9)/-0?\(UI7_/74/^_MM_\ (U;\G^LD_P!]O_0C3*CF??\ K^OZW*Y5 MV7]?\-_5V8?_ C6E?\ /74/^_MM_P#(U'_"-:5_SUU#_O[;?_(U;E%/FEW? M]?U_6HNH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW* M*.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ MD:MRBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P"> MNH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ A&M*_P">NH?]_;;_ .1J M/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ M?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GK MJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1 MK2O^>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7] M+^KLP_\ A&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_ M6HNH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7 M=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MR MBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P">NH?] M_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ A&M*_P">NH?]_;;_ .1J/^$: MTK_GKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_ M^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_? MVV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^ M>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KL MP_\ A&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_ M7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFE MW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ M .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ A&M*_P">NH?]_;;_ .1J/^$:TK_G MKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/ M^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^ M1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH? M]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ MA&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:A MRKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\ M7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1J MW**.:7=_U_7]:ARKM_7]+^KLS8-"TZ*&[C22]*7$21R%I("P59HY!LQ &W* M,E@PVY &<$5?^$:TK_GKJ'_?VV_^1JZ!/N2_[J_^AK4=+F??^M/\OZU#E7;; M^OZ_X)A_\(UI7_/74/\ O[;?_(U'_"-:5_SUU#_O[;?_ "-6Y13YI=W_ %_7 M]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_\ D:C_ (1K2O\ GKJ'_?VV_P#D:MRB MCFEW?]?U_6HNH?]_;;_ .1J/^$:TK_G MKJ'_ ']MO_D:MRBGS2[O^OZ_K4.5=OZ_I?U=F'_PC6E?\]=0_P"_MM_\C4?\ M(UI7_/74/^_MM_\ (U;E%'-+N_Z_K^M0Y5V_K^E_5V8?_"-:5_SUU#_O[;?_ M "-1_P (UI7_ #UU#_O[;?\ R-6Y11S2[O\ K^OZU#E7;^OZ7]79A_\ "-:5 M_P ]=0_[^VW_ ,C4?\(UI7_/74/^_MM_\C5N44NH?]_;;_Y&H_X1K2O^>NH?]_;;_P"1JW**.:7=_P!?U_6H MNH?\ ?VV_ M^1JW**.:7=_U_7]:ARKM_7]+^KLP_P#A&M*_YZZA_P!_;;_Y&H_X1K2O^>NH M?]_;;_Y&KNH?]_;;_Y&H_X1K2O^ M>NH?]_;;_P"1JW**.:7=_P!?U_6HNH?\ ?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_P#A M&M*_YZZA_P!_;;_Y&H_X1K2O^>NH?]_;;_Y&KNH?]_;;_Y&H_X1K2O^>NH?]_;;_P"1JW**.:7=_P!?U_6HNH?\ ?VV_^1JW M**.:7=_U_7]:ARKM_7]+^KLP_P#A&M*_YZZA_P!_;;_Y&H_X1K2O^>NH?]_; M;_Y&KNH?]_;;_Y&H_X1K2O^>NH? M]_;;_P"1JW**.:7=_P!?U_6HNH?\ ?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_P#A&M*_ MYZZA_P!_;;_Y&H_X1K2O^>NH?]_;;_Y&KNH?]_;;_Y&H_X1K2O^>NH?]_;;_P"1JW**.:7=_P!?U_6HNH? M]_;;_P"1JZ&;[P_W$_\ 0145+F??^OZ_K<.5=OZ_I?U=F'_PC6E?\]=0_P"_ MMM_\C4?\(UI7_/74/^_MM_\ (U;E%/FEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^ M>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KL MP_\ A&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_ M7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFE MW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ M .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ A&M*_P">NH?]_;;_ .1J/^$:TK_G MKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/ M^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^ M1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\ 7]?UJ'*NW]?TOZNS#_X1K2O^>NH? M]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1JW**.:7=_U_7]:ARKM_7]+^KLP_\ MA&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/^$:TK_GKJ'_?VV_^1JW**.:7=_U_7]:A MRKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^$:TK_GKJ'_?VV_\ D:MRBCFEW?\ M7]?UJ'*NW]?TOZNS#_X1K2O^>NH?]_;;_P"1J/\ A&M*_P">NH?]_;;_ .1J MW**.:7=_U_7]:ARKM_7]+^KLP_\ A&M*_P">NH?]_;;_ .1J/^$:TK_GKJ'_ M ']MO_D:MRBCFEW?]?U_6HNH?\ ?VV_^1J/^$:T MK_GKJ'_?VV_^1JW**.:7=_U_7]:ARKM_7]+^KLP_^$:TK_GKJ'_?VV_^1J/^ M$:TK_GKJ'_?VV_\ D:MRBCFEW?\ 7]?UJ'*NW]?TOZNS%3PYI:NC"2_RK*PS M+;XR"",XM\XSUKLJR!U'U'\ZUZ3;>^H)6V1E2?ZR3_?;_P!"-,I\G^LD_P!] MO_0C3*0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH D3[DO\ NK_Z&M1U(GW)?]U? M_0UJ.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "I1_J7_ -]/Y-452C_4O_OI M_)J (J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH E/^I3_??^2U%4I_U*?[ M[_R6HJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *ED^[%_N'_ -"-15+)]V+_ M '#_ .A&@"*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )9OO#_ '$_]!%1 M5+-]X?[B?^@BHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 4=1]1_.M>L@=1] M1_.M>@#*D_UDG^^W_H1IE/D_UDG^^W_H1IE !1110!_/]J?_ 7L-)O=5D\&ZEK%YH^A?T U_GM:)_RFFF_[2^^( M/_6[M2K^B?\ X+K_ +=?[37['FG?LQ^&_P!FWQW8_#.]^+%W\8M:\6>+HO!W M@[QAXC-M\-+;X9Z?H_A[3;?XA:'XM\)V>C:G/\3+_5M;F/A>;Q!+J'A[PW'I MFNZ5I8\0Z9XA^DQN4TY5LHPV!A&G5QN"A5FZE2HXRJ^S]I.3&Q,J<5"$$XPYE",4ER\VK6LFWW9^_U%?Q5>.?\ @L7_ M ,%:?C_X43XF_ OX<:M\+/AA\.-)O[?XD^-/@=^S[J7Q9\#QZ_HG@7P?KGC[ M4?B%\1/B1X.^)OAGP?IF@3PZMXWT#1K=O"-UX.\#>-;32_&^M_$*32=-\;7? MZX_\$;/^"I_CW]MB\\>? S]H"+PG_P +G^'?@OP_XT\*>*O"NBZUHT_Q1\": M9_8W@[QYK_B_1[:QNO!&@^+] \8:GX5U75+K0=6\+:1XJ7XF16'@SX7^'M+^ M'^MW]_R8G(L=A<-/%5/82C2<57ITZRG5HO&A#VJE43=*$-!^&WB;XAV/QBUWX1:1HML/&S:I\$[ M'PO\-/#/Q=^#MOI'[//BO0?^$8\4>,_$5QI.F6/B/QZ/$EOKUC>^+8K7P;JG MAG1XKY/B<-0]M6K82$U2C6EA777UN-.;24G1<5UDKI2;6JM=6+I9C1KU?9TZ M>(E%SE35=47]7N6"6$NI/H\L>HO<7.FSWUM875I<_X+.?B)\4/"+VVKW?Q/\ "GCK3;32 M/#6F_"_3Y_#EMX;TG0+M[[Q'XFD\27WB.W/AVU\.-Y+C%F$RY>1SUER_,H:1YK6NU]I:?O\ MP6__ &H_C_\ LE_LN_"OX@_LY_$>X^&/C/Q#^TCX8\"ZUKEMX5\!>+GO_"5_ M\)OC1XDO-%;3OB'X4\8:/;)/KGA7P_?F_LM.MM6C.FK;0ZA%97=_;7?C_P#P M3M_X*#_M)?&+_@E[^V#^TI\5]=\'>-_C%^S%>?M#6OA'Q7KGA*RT/2_%2_#W MX >#?C?X7G^(_A[P)<^#=%NXK#7/&MSX:OAX+MO AOO!>BZ1%-(OBG^U_%FK M?-O_ 6D^)^O_&[_ ()(_L#_ !G\5V>CZ?XH^+OQ'_9P^)_B2P\/6][::!8Z M_P"/OV2OC/XKUBST.UU+4-6U&VT>VU'5KF'3+>_U74[V&R2".ZU"\G62YDI? M\$4/B?K_ ,$?^"3'_!0KXS^%+/1]0\4?"+XJ?M%_$_PW8>(;>]N] OM?\ _L M<_ GQ7H]GKEKINH:3J-SH]SJ.DVT.IV]AJNF7LUD\\=KJ%G.T=S'W1PM&.14 MZLJ%*6(6;*C*=DIR@KITG52YE!O3JENE='-[>I+-*D%5FJ+P'M8QO>,9-QM- M0>G,D_TV/H/_ ()*?\%=OCE^W1^T#X]^!/QK\ ?"'19=+^#FK?%KPQXB^%UI MXO\ #4UJGA+QKX&\':[HNMZ#XL\7^/FUR+66^)&BWVG:MI^J^'1X=;P_>V=Y M8>(SXFM+GPW_ $(U_*!_P05_;;_:#^+_ .U1\;O@G\2=7\ :]X3\>_#'Q]^T MUX@O] ^"WP=^%'B&\^,^F?$+X1^#_$/C74[WX*^!OAOI_BW7?B/I?Q!:7X@: M_P"/-*\6>)M4O?!_@Q](US0;:TUZT\0_&OP3_P""^?\ P43/B7Q7%>:5\//C MMKOQCO/#UK\)/A[>_#IK6Q^&'C'7/&VGSZ=X2^'V@?"^+P[X_P#B5I'B'0=9 MU/X?Z1X:\:>,_$GCA]=A^'OB"U\9ZE>:5XP\/_$LQ>38C$X_&4\)AL/AEAH8 M9SH1Q#E!*M!6E&I.$$]%*=2Z@HI.W,]YP^94:&%PTJ]>M7=:591JNBHR;IRU MC*$92=_>48M.3;:O9;?W$T5_$#X>_P""R?\ P5:_9?\ B7HR?M.Z?KOB^VO= M%T_4KOX-?M"_ C1?@+K6L^%;GQ-;I=>)O#&H>%OAM\-?%VAZSJ5OX:\3>$O# M?BS5--\:>!=-O+W6-0O_ #XMOM%M+2S_M-^'?C_ ,)_%?X?^!OBEX!U5M=\ M"_$GP=X9\?>"];;3M4TAM8\)>,=%LO$7AS56TK7++3=:TQM0T?4;.[.GZQIV MGZI9&;[-J%E:W<4T$?EX_*\3EWL95G2J4ZZDZ56A4]I3ERVYESSM>2L[/K=6U2NK]C1117G'8%%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% $B?_M+7?QCBTDZ>WPD70QXQ7PM<+92::/ M$1T0:^&LU\1-IV-6/W)_P6$_X)M_'/\ X*":A^S==?!GQ5\)_#,7P>L_C3;^ M)A\3M=\8:-)?2?$:?X0R:&="7PKX$\:+=):KX!UG^U3J#Z6T!N=,%FM^)[HV M7V?U_!_VCD-7ZQ3]GAL#[.O.[M2G]7G'EEIOS-+2^I\U]3Q/U+-:?L9\];%< M]*.EYQ]M"7-'7:R;/GG]C^61O^#:[XN.TCLZ_LJ?\%+E5RS%E6+QY^U,D2JQ M.0(T1$C .$555(](UKQ M1/\ #*+7?C_XG^-.M>"[J]UN]\&6'BF+2=.M?B-H) M?'>KZ_#K^M^/?A?XHL[JXM/$WPU\(:"> MYN;+CI8S#+!\0PE6@IXJOS8>+O>JO:U)7CIKHT];;G34PU=U\FDJ4K8>FHUG MI^[?LZ:M+7NFOO/SJ_:Q_P""(W[6/[+/C3Q#\>/V%_$FL^+/!^@ZGXW\1^$/ M#WP;\0>-?A]^T1\%O".IVWQ$F/A;P?-+XRU?Q?\ $NS\+_#4:-\.H_$'@_Q_ M>_&3XIZUXFN=+M/A1+;7.H7=S]C_ /!'_P#X+&?%W]I+XS:/^R[^U'JG@[Q/ MK_C3PKXEU/X0?%71_#EQX>\6^,?&/ATZ[X\UGP;XKT?P9I!^',UI)\,8-;U3 MPUXDL=*^&=AHNF_"]M'UD^/_ !AX^L+^S^/8O^"='_!;O]BVZUCX.?LG_$+Q M]\3/@K/\/_&'@OPYJGPQ^.W@KP7X'TGPKXR\5ZO>*;AOT:_P""/W_!('Q/^R#X MD;]H[]I#_A$)?C'/X0BT+X:_#30H]%\56?P9L?%&BZ1-XIU?6?%4VCRPVWQ? MMH9=8^&$A^&&LW?@_2/"-SXUM;7QO\1=)^(D4?A7JQE?"UJ37PMQY4HW1^0/_ ;P?$'PAX._;M;P[XCU8Z?K'Q:_9^\?> /A]:+I M^J7RZ_XMT[5? WQ4O-*-UIUE=V>D+%X#^&GC;71J.N7&F:5*VC+I,-])K>J: M/INH=!_P<912C_@H'X"G,;B&3]CGX3Q1RE2(WEA^-?[3#RQJ^,,\:3PLZ@Y5 M98R0 ZYN?M/_ /!"K]M+X/?'&]\2_L<^$-,^)/PO'Q$U;QI\%9_A_P#%/1_ M/Q$^!VD^']5T+Q/\/-)\17WQG\?^&]8'BCP9J5X="\#^//!_Q"\?:]KC?#U? MB%XHN?A_K^NZ=X?AMV?_ ;U_M]^/=(T_P"(_C+XI? C2OB-X_U'7?%WQ \* M^/\ QOX_UWQ=I6K>)[7PUXGDU/QC\0_#W@OQMI7BWXDZGXMUSX@V'Q&M]*N= M;T"TU+0M+\3Z'\4/B4OCB^3PEZ"Q.5RS3#YN\RHQC+#*E]7:;JQJ.$HOVEOX M<8Q>KDM9JT6U)')[#'QP-;+E@ZDG&MS^V37)*"G&2Y+_ !R;6R>D7=I.+/HG M_@J%_P H-/\ @EI_W9Q_ZQ)\4ZI?\$L_^4'?_!5W_K]_;#_]83^#E?HU^V3_ M ,$T_CM^T/\ \$X/V+_V/_!?BOX2Z7\2_P!G3_A0?_";ZYXHU[QC9>!=3_X5 M9^SKXT^$?B'_ (174])\!:WK]_\ ;/$OB.QO=&_M?PQH7VC0XKNZOO[.OXX= M,GK?L7_\$S?CS^SI_P $Y/VW/V0O&_BOX1:I\2OVDKGX]2^!-;\*Z_XROO V MEI\4OV:_ /P<\/\ _"6ZGJ_@#0]?T]K/Q/X6U&^UD:/X9U\6^@S65U9-J.H2 MSZ5;>(\9AO[(5#VT/;?VQ[?V>O-[&[?M+6^&QZ<.O^S-?B[_ZNW]F&OD3_@B0[K_P4Q_8F5695DN_C D@ M5B!(@_9,^.D@1P#AE$D:.%;(WHC8W*"/Z!?^"4/_ 2._:1_84_:F\2?&[XM M^-?@AXB\):Q\ /'?PKMK#X<^)?'FK^(H_$7B?XB_!SQ=I]Y/9^)OAIX0TU=% MBTWX>ZU#>7,>L27T=]/)?$VF>"/%OQ)U+Q/>+XH^!GQ+^&>GC0K+7OA)X;TJ[:'7 M_&6EW5X-0UK2Q'H\%_<0&XO8K?3[KT<5F."G5X@E#$TVL5@\-3P[3?[V<*%2 M,XQTW3:3O;#^ M!5R<#]C;X1D#)P"?C;^TX"0.@)"J">^!GH*_J\_8$18_V$OV*HT&U$_9*_9Q M15&>%7X.^#54<\\ _X)'?M)?MU_M3^'/C=\)/&GP/\.^$='_9 M_P# GPKN+#XC>)O'ND>(Y/$?ACXB_&3Q=J-W#9>&?AGXNTPZ)+IGQ"T.&RNG MUF.^EOK;58I],MK>WM+J_P#VX_9B^&NO_!C]FO\ 9Z^#WBNZT>^\4?"?X'?" M;X:>)+WP]WHTSW&BBBO /6"BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@"1/N2_P"ZO_H:U'4B?I:A.%\V\N4L;2X:STVUO=2NA%8V5S/%Z/IVHZ?J^ MGV.K:3?6>J:7JEG;:CINI:=6SRVUW9W=O+'<6US;R2 M03PR)+$[QNK&%4IN9 MY;6S#%931S#!5LJ4I.E/EN445^>W[?'[?'@G]C;P3]CLOL'BGXU^*;"9O W@9IBT-C M"QDMQXO\7BWD2XLO#5E<(ZVULKP7WB2^@DTW39(((-5U72,L7B\/@4Y.T8Q5Y2DTDCQ^,.,>'. N',SXKXKS.AE.1Y30=?%XNNV MW)OW:.&PU&-ZN*QF*JN-#"82A&=?$5YPITH2E(F_;R_;W\!_L:^"FMH#8>*O MC5XFT^5_ G@ S.8[>-S+;KXM\8&V=)]/\+6-Q&XBMUE@U'Q+>POI>DO!#%JV MLZ+_ #^?LC_\%3OC1\'/C1X@\5?&3Q'K_P 4?A[\4O$ U3XCZ1>7"S7VCW\Z MPVD?B?P+;2/!I^C76CV,-M8KX;LQ8:#J>A6-IHC1V#6&B:GHWYN?$?XC^-OB MWXV\0_$7XB^(;_Q3XQ\4W\FHZSK.HR!IIYF 2*"") EO96%E;I%9Z=IUG%!8 MZ=8P6]E96\%M!%$OVE^P/^P/XV_;)\;?;;W[?X6^"GA:_A7QSXY6$+-?3*([ M@^$/"!N(WM[WQ+>V[HUS>?2M*U;\HQ'$&<9SF^&>6>TI M>RJ_[%AH/2STG4Q6O)+FA=57)^SITVXK[4Y_X_<1?2+\:O''QHX8GX6+-,I> M59K-<#\,8*HG2]DU*GB\TXK]YX'%_6L"ZJS:6, M _'G@_XG>#_#_C[P#X@T_P 4^#_%.GQ:IH6NZ7*9;2]M)2R,"KJD]M=VTZ2V MFH:?=Q07^FW\%S87]M;7MM/!'UM<1\./AQX)^$G@GP]\.OAUX>L/"W@[PM81 MZ=HVC:=&5A@A4EY9YY7+W%[?WMP\MYJ.HWDL]]J-]/<7M[<3W,\LK=O7ZY3] MI[.G[7D]KR1]K[/F]G[3E7/R6U]3_ &9RMYF\LRYYTL%'./J. M$_M598Z\LN69>PI_75@)8E+$O!+$^U^JO$)5W0Y/:KGY@HHHJSN"BBB@ HHH MH **** "BBB@ HHHH *E'^I?_?3^35%4H_U+_P"^G\FH BHHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@"4_ZE/]]_Y+452G_4I_OO\ R6HJ "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH *ED^[%_N'_T(U%4LGW8O]P_^A&@"*BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** )9OO#_<3_P!!%15+-]X?[B?^@BHJ "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH 4=1]1_.M>L@=1]1_.M>@#*D_UDG^^W_H1IE/ MD_UDG^^W_H1IE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!(GW)?]U?_0UJ.I$^ MY+_NK_Z&M1T %%%% !1110 4444 %%%% !1110 4444 %9'B#5+G1-!UO6;/ M1M3\1W>DZ3J.IVOA_119G6-=N+&SFNH='TD:C=Z?IYU+4I(EL[$7U]9VAN9H MOM%U;P[Y4UZ*3NTTG9M;KIYZW6GFK$58SG3J0A4E1G.$XPK0C"4J4I1:C4C& MI&=.4H-J2C4A*#:2E&4;I_PP?MJ?M5?%[]J7XO:OKGQ/M[[PM9>%K[4M"\*? M"Z0W4-G\/;.&Z,-WIT]K,^)=9N[6"\O[R!(%ALM,LM-TRQ^V M_P#@FC_P4NU#]GW4-,^"7QMU.\U3X(:I>"#0-?G,U[J'PKU"]F+/-"JB6XN_ M!=W<2M-J^D0K)-IEZI(5CU2-8],U.08L[RT_DY MU72M3T+4]0T76M/O-*U?2KRYT_4],U"VEL[_ $^_LY7@NK.\M9T2:WN;>9'B MFAE19(Y%964$$5^.9C'.>',Y>-G7G6J5IRG#%R3=+&4FUS4JL59)I-];C?'9_CLXS+.,=B+\3&I4ROC;*JE6F\ M5E6;8:,E1I>SHQP^&QN1QG3_ +*]G@Z^4SI4*65XQ?V>?MS_ /!0GX<_LF_# MFQN?#M]HGCSXK^/-$34_AIX8L;^*_P!*?2;^$FQ\>^(;O3IV"^#E#";3/LMP MEQXLN$^Q:1/':QZGJ^D_QU_$?XC^-OBWXV\0_$7XB^(;_P 4^,?%-_)J.LZS MJ,@::>9@$B@@B0);V5A96Z16>G:=9Q06.G6,%O965O!;011+R%Q=W5VR/=W- MQ=/%#%;Q/<323-';P((X($:1F*0PH D42D)&@"HH Q7Z$_L!?L!>-/VR?&G] MIZG_ &AX5^!WA74(H_&_C>.$1W.JW,8CN&\&^#6N(Y+>[\1WEO)&U]?-'<6' MA>PN(]2U*.YNKG1]'UC',,SS+BG&T,-1I-0NE0P=.3E"$K>_6JS:BI-:MU)* M,:=/1)7DY>1XD^*WBC]+7CO(N&LGRBM1PDJT*7#G!>78F=? X3$.DHX[/,VQ MLZ>'IUJL(.M4KYGBZ5##97ERE1I1IJ6+K8M/V!/V ?&O[9/C(ZGJ1U'PG\#_ M M?Q1^-O'$<*I>([N"2)[Z]>.XT_PQ83QZCJ4=S= M7.CZ/K']C/PX^''@GX2>"?#WPZ^'7AZP\+>#O"UA'IVC:-IT96&"%27EGGE< MO<7M_>W#RWFHZC>2SWVHWT]Q>WMQ/T_PK MX.\*Z?%IFAZ'ID1CMK2VC+.[N[M)<7E[>7$DUYJ.HWDUQ?ZG?W%S?W]S6,/]3_H]?1YX M;\"^'?9TO89MQKFV'I?ZR\3.DU*J_=J?V3E*J)5,+DN%JI.$6H5\PK0CC,:E M*.&PV#****]X_HD**** "BBB@ HHHH **** "BBB@ HHHH *E'^I?_?3^35% M4H_U+_[Z?R:@"*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX8\7?\%, M/V#/ ?BOQ/X&\8?M0?#+P_XM\&>(=:\*>*=!O[[44OM$\1^'=2N=(UO2+U$T MV1%N]-U.SNK.Y5'=5FA<*[ G[GK_,O_ &]/^3YOVS_^SL/VBO\ U;_C&OR; MQ9\0,O$+AOC;B;BKAG"\'\,Y7G>!K\*RRB.(Q.(QV:RP%2CB_[7RW M,J;HPIKGA[&%*?/\4I1]T_O(_P"'K?\ P3J_Z.W^$_\ X,-4_P#E51_P];_X M)U?]';_"?_P8:I_\JJ_SAZ*_#/\ B9/BK_H0\/\ W9C_ /-I_JI_Q1-\ O\ MHZ_C!_X,X+_^A;U_I:_Z/'_#UO\ X)U?]';_ G_ /!AJG_RJH_X>M_\$ZO^ MCM_A/_X,-4_^55?YP]%'_$R?%7_0AX?^[,?_ )M#_BB;X!?]'7\8/_!G!?\ M]"WK_2U_U)?@O\>/A!^T3X/E\?\ P2\?Z#\2/!L.LWOAZ7Q#XX@MY/M%M!J%E+(OE[0MS'AB20/6Z_!O\ X-U/^3 =9_[.$^(O_J,_ M#ZOWDK^J>$,YK\0\,Y)GF*I4J&(S3+Z&,K4:'/[&G.JKN-/VDISY5TYIR?=G M^!?TBO#3*O!SQR\4?"W(\?F&:91P+Q?FG#N79AFSPSS+&87 U(PIU\:\'0PV M%=>:=Y^PP]*G?X8(****^C/Q<**** "BBB@ HHHH **** "BBB@ HHHH E/^ MI3_??^2U%4I_U*?[[_R6HJ "BBB@ HHHH **** "BBB@ HHHH **** "BBOC MG_@H+\5?'OP0_8O_ &B?BS\+]>_X1CX@>!?A[>:YX5U_^R]&UK^RM4BO["&. MZ_LKQ#IVK:)?;8IY5\C4=-O+<[LM"652./,<=2RS+\=F->-2=#+\'B<;6A14 M9594L)1G7J1I1G.G"524*;4%.<(N32E.*NU])P;POF'''%_"O!64UL'A\TXO MXDR/A?+<1F-2O2R^AF'$&9X7*<'6QU7#8?%XBE@Z6(Q=.>)J8?"XFM"C&_\ ,*_L\?\ SI:/^'X?_!47_HY[_P P MK^SQ_P#.EK\*_P")D.!_^A5Q7_X0Y1_\_3_5G_BBM]*;_HOO #_Q*?$7_P"E M4?Z$%%?Y[_\ P_#_ ."HO_1SW_F%?V>/_G2T?\/P_P#@J+_T<]_YA7]GC_YT MM'_$R' __0JXK_\ "'*/_GZ'_%%;Z4W_ $7W@!_XE/B+_P#2J/\ 0@HK_/?_ M .'X?_!47_HY[_S"O[/'_P Z6O[_ /PC?76J>%/#&I7TOGWNH^'M%OKR;9'% MYUU=Z;;7%Q+Y<*1PQ^9+([[(HTC3.U$50%'WW OB7D7B#/,X9-A,VPSRJ.$E MB/[3H8.BIK&/$JE['ZIC\:Y.+PM3VG.J=KPY>:\N7^1_I5_0D\5OH@8?@?$^ M)7$'A]GD./JW$-#)UP-FO$F9SPT^&H9+4Q[S-9_PGPRJ,:JSW"+"/"RQCJ.G MB?;*@H4G6Z&BBBOT,_CH**** "BBB@ HHHH **** "BBB@ HHHH *ED^[%_N M'_T(U%4LGW8O]P_^A&@"*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK M^*7_ (.4_P#D\GX,?]FRZ!_ZM/XKU_.S7\Z\6^/O^J_$>;7VU3:_-K9?[,_1]_9&?\1V\&?#[Q=_X MF"_U6_U[R-9S_J]_Q"C^W/[*OC,5A/JW]K?\1*RCZ]_NWM/;?V;@_CY/9>[S M2_U@**_R?Z*^=_XF<_ZHC_S9/_P ?L?_ !0S_P"LHO\ SB?_ .5P_P!8"BO\ MG^OZ)O\ @VL_Y/)^,_\ V;+K_P#ZM/X45]%PGX_?ZT<1Y3D'^J?U'^U,5]6^ MM_V[]9]A^[G4Y_8?V-A_:_!;E]M3WOS:6?XY](+]D;_Q GP9\0?%W_B8+_6G M_43)/[9_U>_XA1_8?]J_[;A,)]6_M;_B)6O:>V_LW&?!R>R][FC_: MU1117]%'^,P4444 %%%% !1110 4444 %%%% !1110 4444 2S?>'^XG_H(J M*I9OO#_<3_T$5%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%?DU\; M?^"T_P"P]^S_ /%?QS\&?B+KWQ(MO&_P\UR7P]XD@TGX>ZAJFG1:C###.ZVF MH17:1W<7EW$9$J(H))&.*\L_XB"/^"=7_0R?%C_PUVJ?_)U?'U_$'@?#5ZV& MQ'%>14<1AZM2A7HU,QPT*E*M2FZ=2G4BYWC.G-.,XO6,DT]F?TAE7T/?I39Y MEF79UD_@!XK9EE.;X#!YIE>8X/@W.*^#Q^79AAZ>+P6-PM>&&<*V&Q6&K4J] M"K!N-2E4C.+::9^W%%?B/_Q$$?\ !.K_ *&3XL?^&NU3_P"3J/\ B((_X)U? M]#)\6/\ PUVJ?_)U9?\ $2. ?^BPX?\ _#GA?_EG]?)G?_Q)3]+?_I'+Q?\ M_$(SO_YE/VXHK\1_^(@C_@G5_P!#)\6/_#7:I_\ )U?H+^R'^VG\#OVWO!/B M;X@? B_\2:AX=\)^*6\':Q)XF\/7'AR[36ETG3=:*6]K<33-/;_8=5M&^T*P M7S#)'C*$GORSC/A3.L7# 93Q#E&8XV<)U(87!XVA7KRA3CSU)1IPFY-0C[TG M;1)M[,^0XY^C3]('PSX>Q'%GB#X.>(?!O#.%KX7"XG/>(N&,SRO*Z&(QM94, M)1JXO%4*=&%3$UI1I48.5YS:C&[9]9T445],?AX4444 %%%% !1110 4444 M%%%% !1110 HZCZC^=:]9 ZCZC^=:] &5)_K)/\ ?;_T(TRGR?ZR3_?;_P!" M-,H **** "BO\\:?XH:A_P %5OVNQJW[4W[5N@?LX_#7Q9J7Q(\:^ ]6^.'B M&\\7_#7X$^&]0T.#4=&^&/P]MS'\/?AIHEU']9\3ZYJ/P:TSXA/X M9N/%?B+6O$WQ M62E))QIXG6E.<;NZ26SZ:GF8;,9XJHU2PLGAU4E3=?VM.\7%-IRH_'&,K:.[ M^_0_=NBOXD/CS^UE\9/^"SO[;G@_]DCX9?%:#X8_LO\ CWQ?XE\(?#S2()_& MD/A#Q]X \"0ZE\5KWXQ_$KPE=:;X8UCQWXVU[PY\+X_'7P[^'GC32/#^F?#_ M %6U\->#H;SPMKDGCKXG^(/$_P!M/]BWXW_\$:_BO\%?'?P:_:@U!_$/Q2T# MQ2_A[XA_#S0M1^%/BR"Y^&GBSP'X@\2>#O&7@]M?\;>&O&7PUO+_ %/X9:Q+ MX=\3Z[XD\*>.[VRU71/&WP^&CZ+8R^(]Z>0KCJ5#,,31]O1P;V52K3PM2I@Z-3V53$JI"-I7C%N%)^].-Y* MSND[J]NG][=%?Q\?\%]?C%J_QT_9_P#^"8'C:\L+SPSX7^.WPL^(OQSUWX6- MX@N/$7AK3_$VL^"/V==4\/C4"]CH^F>*-8\#Z9\2/&'AO0_%5UX=TZ^CT[Q% MXD%C::3;>(M4L9?B2Z_8\_X*"?MP_LA:E^WC\8/CIHWQ!^#/P5^'OQ7USP[_ M ,+O^*WC#7_&MQX)^ WA.W\.^/\ 6?A]X1T/P?XL\,:;JGB"Z^$=SX;\1WOB M'6/!/B[XC^._!M[XW\>/K%QK=MXZ\0QA\C53#4,5B<=1P=.M5JT&JD'*<:M. MI*E&$4II5')PFY:Q4(J]Y*]JJYJX5ZM"CA:N(G3A3JIPDHQ=.<(S^)]53\@Y_BAJ'_!5;]KL:M^U-^U;H'[./PU\6:E\2/&O@ M/5OCAXAO/%_PU^!/AO4-#@U'1OAC\/;%_"'A_6?$^N:C\& MM,^(3^&;CQ7XBUKQ-\7-6T/PMXW<>'ZJQ>-P];$0ITL#2A6JXB%*=9RA4CS4 M^2C"U23:4N97]UQ>LO=;'F]-X?#5J=*4YXJ";?QE:?$+Q3XLE\-KH,*FTLM=U71?#W\YO_!%'QAXMNO^"IO[,GB6Y\4^ M([CQ'\6KOXYI\5M?FUS5)=:^)T>M?L^?%_XCZQ'\0]4>Z-]XUCU7XB>'?#_C M[4D\2SZFM]XUT'1?%5T)==TJQOX-,)AHPP^=K#5\)BZ%/"4I^VJ8:HYM3C5= MJ*E.+P]6/O*3DJEIJ#M[K1&(KMULL=>EB,/5GB*D?90KQY$U*FOWO+%JK!OE M<;./NN2^T?TL_P#!2#_@L/'B+X2>'OBE_P )-+\8 MW^'ILVU[QC\0/"?]@_V*OPI\<_:%M/\ A!AJ']J_VM"9_P"U3:?V9#]@%S>_ MMI7^;-^VK^QY\+_&J^)[ MSQIXJ\8Z+JFN>+/$WCKP;X)\2:OXUU?Q)X1U[5=S^" MO$'CCQQXI\-?$?7+/XCZ%X'L?$7B/]G_ %+Q=XF\!WUS/X7\?:GXJ/=&^\:QZK\1/#OA_P ?:DGB6?4UOO&N@Z+XJNA+KNE6 M-_!J?MX_\$:/C[^R1X)^(G[2'QH^*_[-_P 6-#N/B-:Z?;^)-;\8>,(OCY\; MO$/CGQ>83XCN/#GC3P#>66L_$?4],GUKXI_$+0T^*WC#5;'1=#\50C4G^\4M')R7-%P2 MBN5M9X/&NC@95:-#$8B$:U;VDJV(A*5.,(P?,YRC'W6GHE'1J3;U/[^:_E(T MSX;_ /!8GPU_P5>9]%N_VK[KX!W7[46L_%B9-=^+=WXJ_9Y3]D?Q3^T7>^&/ M$%A$/%?CC5O@W:ZE:_"C6M0O_#/P0MC%\;_!_AV'2_$_@KX>:+J'A_1=2TWQ MK_@VM^ .NQ_M!?'7]HG2_#&F:-\/?#/P=NO@I<:V-#U'39-=\:>/?&G@'QW' MI/AS58-!'AW6!X6T+X<&]\=:*(+ZT^#K_QAXM' M_!<>+QJ/%/B-?&2_\%6M/\ #Q:NN:HOB<>!)/VL[7X.2>"1KZW0U4>$9/A"3 M\*I/#7VO^Q9/AL3X%>R;PN3I1G#9=/!XK-L)"KA,0Z&73G4G6P\JB3<%)PIQ M55>SJ).W.W)+2\'JE5;&1Q%'+Z\J>(H^UQD8PC3K*%[2MS3?(^>#:TC:+:O: M23/] VBOX,?^"N_QI^*'PL_X*\?&GXL^"_B/XG\)>./@7>?!4_"[Q=;ZB;RZ M^'NB1?L__#?Q3JGA[0;?6(]2TRV\%ZYJ?C+QS=>*O!./&UMXBT M;4[7Q;XAAU'BOVT/V /VWOV1/#7PX_;,_:9^*?A_4_B)XZ^(_P -=!TGQ!:? M%[X@^/\ ]HKPQ\3['X?ZSXT\+S>*/'&H^'$L4U[X%OBIXN73 M-3T+1$\*:O?Z3;V>J0X4>'HSA@IUE]*N;RA+$QIX.K56%J2C6FIJ,(PB[<]^5OF;3M"VROS6O;_ $ Z M*_G,_8V_X*??$3P[_P $;_C#^TS\5$USXA?$W]EWQ7J/P"T+Q=XGNXO&FH_$ MOQ;XBE^%UC\%/$OQ MDN? &I3Z+X>U;XY>!O!_Q$O9/%NL^/?$WAGP-KOQ O M/%6O^/?$\]@/R#_94_X)C_'#_@K3X5_:._;#\7_'[PI;_$^^\?:OX:M[GQ_X M3U'Q%J/Q0^)FD^!]#\0?V=XPUS2'TJT^%WPYTS3==^'?A3PM=^$/#?Q!@\,> M'8-1T;0/AMH^A^!/#.A>(>:EDS7UR>,Q5/!T,'B/JLZOLYU^>LW9*$(6DX\K M4G)ZI-7C\7+O/,K_ %:.&P\\15Q-+V\:?/"ERTTM>:<[KF3NK*]VGKM?^Z^B MO\]7_@BY^SEXA^-W[?OP6UCX8Z]HOPL;X,1)^T-XQ\3V4-]IWB;4? /@_P 1 M^$-#U[X>:##X?BLGOY/BDOC:V^'WBR#5=>TC1+?P!X@\87E_#XK%O'X'\3_Z M%5<^:9>LLQ$O&3[-)FV QCQM%UO8NE'G M<(WFI\W*E=Z)-6=U9K7=!1117F':%%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2)]R7_=7_P!# M6HZD3[DO^ZO_ *&M1T %%%% !1110 4444 %%%% !1110 4444 %%%% !7XZ M?\%*O^":NF?M&:9J7QE^#6FV>E?'32K,S:QH\(BL[#XI6%G%\MMJ2%8]4C6/3-3D&+.\M/V+HKCQ^ PV98:IA,73YZ4]4UI.G-7Y:E.5G MRU(WT>S5XR4HRE%_#>(OAWPKXI<*YAPAQ?E\<=EF.CS4JL>6&-RS&PC)8;,\ MLQ+C-X7'X64Y.E5490J0E4PV)IU\+7KT*G\8'["__!.WXC?M6?$;4(?%NGZY MX ^$O@#77TOXE>)+VQDL-7EUBPD4WG@'PS;W\&'\6.,)JEQ/!+9^$[.5+_5( M;B\GTC1M8_L-^'OP]\&?"GP7X>^'GP\\/:?X5\'>%=/BTS0]#TR(QVUI;1EG M=W=VDN+R]O+B2:\U'4;R:XO]3O[BYO[^YN;RYGGDZV&""W5UMX(H%DFFN)%A MC2)7GN)&FN)G"*H::>9WEFD;+RR,SNS,Q)EKS\DR'"Y)1E&D_;8BK_&Q4XJ, MY1O>-.*3?LZ<=&XIOGE[TF_=4?SGP&^CSPCX$9/BJ&55'G?$N:RDLXXJQF%I MX?&XG"QJ\^&RW!T(U*ZR_+:"C3G/#TZU26+Q<7BL34GR86CA2BBBO#;N>:ZNO"7A MFYN;F:2XN+BXT'2II[B>9VDFFFFDM&DEFED9GDDD9G=V9F8L2:Z:BIE"$[*< M(S2U7-%2MZ73-Z&*Q.%CVYM-(TVPTNU,C3&VTZSM[&W,KA5>4PVT<49D=40,^W

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end GRAPHIC 10 gb2k1ptlkg5v000005.jpg GRAPHIC begin 644 gb2k1ptlkg5v000005.jpg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ü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�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end GRAPHIC 11 gb2k1ptlkg5v000004.jpg GRAPHIC begin 644 gb2k1ptlkg5v000004.jpg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end GRAPHIC 12 gb2k1ptlkg5v000002.jpg GRAPHIC begin 644 gb2k1ptlkg5v000002.jpg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

  •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gb2k1ptlkg5v000001.jpg GRAPHIC begin 644 gb2k1ptlkg5v000001.jpg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

    *K+ M]):*XZ&=YKAH9K3H8VK3AG=)T,U24']=I2KK$N-5RBVKUHJ;E3<).\HWY)2B M^S$9!D^+GD]3$8"C5GP_6C7R=OVB^H58T'AHSHJ,TGRT'R*-13BK1E;GC&2* M_*O]AW_@DS\&/V%/C#XS^,7@#XD?%'QGJFN^#M3^&GAO2/&4GA(6.A^ -;;X M6:]JL.O3:'X:TN?Q-XR;QU\.[_5+#Q+IP\):':>$_$-IX5N/!=_J^A2^--<_ M52BIP><9G@,'F67X/&5'+[/&4\-4E5H1JWBW^ZG.;BXN+]Z2 M;<9-.\;DF4YECLJS/'8&CB& M\M+FVNK2:VU'2=9TC4K6RUGP]XAT:\T_7O#>O:?INOZ!J6FZUIMA?V_\\6J? M\&X'@M_B+#J&@?M9>+K+X0QZOX:EE\&>(/A-H>N_$^X\/VD&E)XOT]OBMI/C M7PIX0CUW7[F'7)_#VO1_!)=-\*Q:CI=OJ/A?Q>VC7<^N?TO45ZF0<8\3\+QQ M%/(1X3-*N#TPU:K[:E7IPW/@;Q#XR^)6@^/O&/PZ MU/Q3H'C:=/!>AVB?\(WX%\!2>"O@RGA6#PUX3^'NK^(-7^(/B;P5\3/$6L^, M8_%_Z5^+?V-/A%XY_8XT[]B#Q-=>,K_X2:3\)/ 'PBTW6XMK>$O#_ (F9+KPS/X.U?5[ V.N^$-4\+7NH>'+O MZQHK'%\5\28_ZF\9G688F67XZKF>"JU:\I5\-CZU2%6>*I5_XT:OM*=.<)>T MM2<5[)02-L%P=PMEOU[ZAD.6X6&99?1RK'T:.&A'#XK+J%.I1IX.MAOX$J/L MJM2%2/L[UE.7MG.Y_,1XZ_X-M]%U'Q3JUY\-OVOM2\+^"V%C_P (SHGQ ^!- MA\1O%^E-'I-C!JCZWXR\.?%?X5:+KK7NN1ZCJ-G_ &9X!\++I^E75EHLXU*[ MT^?7=2_63]@?_@FQ\%/V"=!U2[\+7VI_$7XO^+]'T;3/'7Q=\4V&F6.HSP6F MGZ0VK^&?A_H=C',/ /PXU7Q5IUQXL'AB?6?%7B6ZNY]*LO&/CWQK#X0\(2Z) M^B=%>EF_B%QGGN7O*\UX@QN+P$E!5,.UAZ*KJFXR@L3/#T:57%*,H1G;$3JI MSC&;O-)GEY+X:<"\.YDLWR?AK 8/,8N;I8E/$5Y8=U$XS>$AB:]:E@W*,I0O MA:=%J$I05HR:91117QI]R%%%% !1110 4444 %^T&?58+"R@U"?2Y[66 M\@M889W>) M=916E*M5HRYZ-2I2GR5*?/2G*G+V=:G.C6AS1:?)5I3G2J1OR MSISG"2<9-/.K1I5X>SK4J=:"G2J*%6$:D/:4:D*U&IRS37/2K4Z=6E*W-3J0 MA4@U**:****S- HHHH **** /Y)?VH=)FT3]H_XZV$\?E'_A:_CN^A3+'%GJ MWB/4-5L#ELL=UC>V[9)).!_VI]=U1HF2S^(7AGPSXPM M& Q%YD5DWA74(U8 RF^\-37DR$EU-ZCG"2QU^>O]NVW^3_]>O\ 4S@?-:&: M\'<+9A"I%_6C^W;;_)_^O7U/M*?\Z^_^NZ^\_(_J6*_Y\S^[T_S_K2^Y7COQ6B._19\ M?*5OHB<="#:NH)]P6Q]#7HW]NVW^3_\ 7KS[XDWUO=: MPH^>PO(9B<_\LIM MULXQ[R2PG/;;Z9KJP5>G#%46YQLY.._\\7%?C)?@?IG@[5K97XD\*XBK3E&G M6QE?+VVM'+-,#B MW_ ]#U_2[@#;\V<'D>W';'UKO+*=<#G[V,'U_P _D, ]*\-L/$$*E>V<=_KG MO_,Y!_3M;+Q+;@*"3^?X<\]L^OZ=/G<;"#;:DOEK=:/^M/F?4Y?4J)*\7K;] M+_UUOMT/6HY1CK]?TY_^MQ4^]?6N"@\1P8&22.?0\X]SZ>W^%:">(K<@9)Z] M<_SYQ_2O$G&"ZKY^?RN>[%MJZ37Y_@==N'J*-P]1^=:^\T7M'LG]W_ #J=P]1^=+7+C7X#T _S]#3O[?A_P [JBT. MZ_\ O3S_JXTJG;[UZ?Y^OSL=-17,_V_%_G=1_;\7^=U%H=U_P"!+R_KY^@[ M5.WX>G^?X^ATU%7]?/T"U3M^'I_G^/H=-17,_V_%_G=1_; M\7^=U%H=U_X$O+^OGZ!:IV_#T_S_ !]#IJ*YG^WXO\[J/[?B_P [J+0[K_P) M>7]?/T"U3M^'I_G^/H=-17,_V_%_G=1_;\7^=U%H=U_X$O+^OGZ!:IV_#T_S M_'T.FHKF?[?B_P [J/[?B_SNHM#NO_ EY?U\_0+5.WX>G^?X^ATU%G^?X^ATU%7]?/T"U3M^'I_G^/H=-1 M7,_V_%_G=1_;\7^=U%H=U_X$O+^OGZ!:IV_#T_S_ !]#IJ*YG^WXO\[J/[?B M_P [J+0[K_P)>7]?/T"U3M^'I_G^/H=-17,_V_%_G=1_;\7^=U%H=U_X$O+^ MOGZ!:IV_#T_S_'T.FHKF?[?B_P [J/[?B_SNHM#NO_ EY?U\_0+5.WX>G^?X M^A_7M^R1_P FR? G_LF/A/\ ]-<%?-_CW_@F-\ _B%XW\7^/-4\5?%S3=5\: M>)=:\5:K9:-K_@^/2X=4\0:C<:KJ7V"+4O >J7T5M)?74\L<,]_6 MJ*OT7^R%()?V7?@)*.DOPL\'R#Z/I%NP_G7\\/[2/[3OQXT/]H7XY:'IGQN^ M+>D:7HGQ<^(FCZ5I6C_$;QCI&EZ;I>E>+-6L--L+#3=-UBUL;2VM+&WMX(XX M((QB/>^Z1G=O\^N%.'^*N)..>),#PAG:R#,J7]L8JMC'F68Y6JN!AG&&HU,- M]8RRC7Q$^?$5\+5]C."HR]CSRDITZ:?^EW&/$O!_"WA[PKF'&_#_ /K'E5;^ MP\'A\"LJRO-_99C4R3$UJ6+^K9O7P^&AR8?#XNC[>$W7C[?V<8.%6HU]W?M. M_P#!.#X/?!_X%^/_ (E>"_&WQ'D\1^$K/2-1LH/&&J>%-1T&Z@D\1:/9ZG9W M%KH_A#P[?F[O-+NKRUTF:+5(TMM6ELKFXMM0MXI;"Y]._P""1FE6,/PP^+.N M1P(NI:CX]TO2KNX"1B26QT;P]!>:?"T@02LEO/KVINB/(T:&YD:)(VDF:3\. M/%/[0GQ;\<:+<>&_&GQ:^)_B_P .7<]CFRW MVD:IK%UIUZ^G:I9V>J6!NK:7['J=E9:C;>5>V=M/%^M/_!'KXH6-QJ/QC^%M MS>A;VZM/#WCS0; ^=^]AL)+K0?%5R"SF /&U_P"$4"(B3R(TCLTL< $'ZOQA MPIQMD?A-Q!1XKSU<28FGG>4XVE5IYCCLS>$R]5:>'J.6(S.AAL5+FQ6(@W2I MPJQI4VJO,H>T]G^-\#\8\ <0>,_#6(X-X>?"V$J69=E4<=F4J,\ M324,-E.(Q6$CRX/#S4:U2I2E6J7I?3H?"%_HUA?WLVO7&N1SRW#:WX<\0V\EI9II$:,L4=K,)KR$[Y4 M+JGWG_P5A^#VN^*OAOX/^+WAO3;G4W^&%UJ]EXOM[*+SKB#PAXA6RE&OS1B4 M2O8^'=5TN**\%I!-);VNOW&J78BTS3+RZM?P)\/?$KQ'X1NYK_PIXDU_PQ?7 M%NUG<7OA[6-3T6[GM&EBF:UFN=-N;::6W::&&5H'=HC+%%(5W1J1]-X;4,5Q M-X*4 ?_G:5\#?MV?L; M> ?V8=)^'&N?#_Q/XQU>V\4ZCXDTK6K'QG-HFI7 GLK;2+O2KO2[[0M&\-Q6 M4,,;ZI#J%I=Z?J;WSW-A-;WFFKI]Q#J?H7_!*GXJ^/\ QW^T#XTTOQ1X[\9> M)M,M?@YKU_'IWB#Q/KFLV$=^GC;X?V\%['::E?7-NEW#;W-W!%VS7,L1@<72QV64<>HO#8W$58^Y'$0@Y./,IP;@TF?J7$67 M\ \5>".;\;9+P)P_D-?$99C\1@70R;*L-C\'6P&;5LN7WB7 M3=*TWQ+8^*K*]\*WVG6&J0ZI8:=JVE1?O=5TG6[&2VDL=;OXIH9;!R2\ M&=<\">+_ !)X+U2^^+GAW1[W5?"NM:CH&J3:7/X3\WK8?ZKCL37A M1PF)^L8>,Z]#V%>=.K[:A"5:ER\]*,IQBGV>!N,P&7>!^9YAG&$^O97@?]:L M9F>!5"CBOKF78;#SKXS"_5L3*&&Q#Q&&A5I>PKSA0K<_LZLHTY2:YS_ATO\ MLZ_]#Q\;O_"B\ __ #M*_'S]K/X*:)^S]\=/%?PU\,ZUJ&M^'-.L_#>HZ//K M36'=,O+NSUJZTZUT^PN[L:H]_=6TUII>F(FDW6FVTEM+<037]YYC M_P -8_M"_P#1?_C;_P"'7\?_ /R_KRK7/'>K>)]:U/Q)XFUO6?$OB/6IX;G6 M/$'B+5=2US7=6GMK*TTRTEU+5]4N+O4;Y[/2["PTNS-U< MI5:=3VE^6'))2YH?A7B;X@>$_$W#?]G\&\"2R'.UCL-6AF'^K_#V3QAA8W[->K_&?XOZ3X]U:SDA M^&GPHUK3]>UFZO--N9+'Q-XEM$DO?#_A+3+V1X;":XM-133=?\31;=46VT&& M#2]1L;0^+-(U!/#OV1/V:O%O[5?CQ]&TQYM$\#>'6M;OQUXQ,+21Z79SNWD: M5I:R PW?B/5EBG73[:0^3;PPW&HW8:"V$%S_ $<^-/&GP._8I^!T6H:A%:^$ M/A_X0M4TGPYX=TE([C7?$^NW$=Q<6NA:';7-Q%/K_BO7YXKN^O+V^NU&%U3Q M)XDU2QTFQU?5[3S_ !G\2J65X2KP5PW4J8OB7-E#"8N6"YZE3+\4TJ6#X5R9U,;@EC^ M2G2S7%8.\_K515TJ<+]E'^U7^T)HW[.'PDU MOQG<2VLWBN_BGT3X?:)[35-1TR&X_E!NKJZOKJYO;ZYN+V]O)YKJ\O+N:6YN[NZN)&FN+FZN9F>:X MN)Y7>6:>5WEED=I)&9V)/I?[0_[4WC;]I+Q]=>-O&&.4[\]5KYOZ27+_J-E7*TW_K7@ M>M_^9/GG_ ^_T/J/HK7]?/T/C;5.WX>G^?X M^ATU%G^?X^ATU%7]?/T"U3 MM^'I_G^/H=-17,_V_%_G=1_;\7^=U%H=U_X$O+^OGZ!:IV_#T_S_ !]#IJ*Y MG^WXO\[J/[?B_P [J+0[K_P)>7]?/T"U3M^'I_G^/H=-17,_V_%_G=1_;\7^ M=U%H=U_X$O+^OGZ!:IV_#T_S_'T.FHKF?[?B_P [J/[?B_SNHM#NO_ EY?U\ M_0+5.WX>G^?X^ATU%G^?X^ATU%7]?/T"U3M^'I_G^/H=-17,_V_%_G=1_;\7^=U%H=U_X$O+^OGZ!:IV_# MT_S_ !]#IJ*YG^WXO\[J/[?B_P [J+0[K_P)>7]?/T"U3M^'I_G^/H=-17,_ MV_%_G=1_;\7^=U%H=U_X$O+^OGZ!:IV_#T_S_'T.FJO=WUMIEI=:C>WT>F6> MGV\U[=ZE->#3XM/MK2-IY[Z6_,L L8[2*-[A[PS0BV6,S&6/9O&#_;\7^=U= M[\.M&;QMXAMXY%/]B:)-;:MK)S(!=-#*9-)TDM#J-I/&M_?P+=78EM-2TS4- M'TS5M%U&W1=5ADK\B\>?$_A3P:\(>/?$?B^EA<=DO#O#^,J3RC%>RG3X@Q^- MBLORKASV=6-2G5>?9EBL+E'O$?BGXG\%\"\ M,U:^$S3.\[PL5F>&]I&KDN"P2-G/FGQMN=63PA;6%C ATK7->L-'\6WKS:>@L?#5Q;WT\T#VNJ65_: M:E;>)]6MM(\#ZA8>3'=2:9XIO9K"ZM+^WMKB.7XM>.KOP?I>GVVCSPV^NZM< M.]K/<6TEU;VMEIQBFNIIX/),%REQ<266G26+WNEW=Q8WFH76FW\%UI_F1]=H MFJZ1\0O!]KJ,:,=,\1:9-!>6BW<;7-C.WFV.K:5+>Z9<21Q:EI%_%=Z;=36- MVWV;4+.4V]QNB22O^2KAGA[B#P\Q7A/](SB/P]H8WPJS7Q3KULJRJ3Q%3)L[ M7 N<9/FN=<.Q^MXC%XJ&7UZ.(K93EM;,\3B99C4RO.*52>->5Y@W_P!*N?9W MDO&N'\1_!#(N-JV$\1,N\/:5',.HU:%/ M,L=2R_#T8X&..RRI&GA(YC@4_E/#O%MEXWN+&U\%WGAG7 MK7Q?=:EJK:'IUMX7N-+NHM?GO]:CN[!]'LH=)>[DNM42^LGT^!9+M;NW,(F3 M1URZ?P_KNL^'KY9?MFB7D=G/.]E":RM-1MKRP:W_/']O?XX?V#\/[/X5Z!?F#7?B$WG>(FM+OR[RP\":? M.K75O*;#6K'4K+_A+]4C@T5!>:7JN@^(?#-CX\T.\2.8Q$?]@>2<:<-<6<$9 M3QWPUC\+G/#G$F28+.LCQE*7/1Q^#S3#4ZV#4HIODG+VT:6*H3M5PU2-:E6A M&I2G%?\ ,U0\/^*L%XB3\/LTPF+R?B/*L^KY3FU.490K975RRO+Z]BHSM&\< M/2HU,3A:T&H8B/L9T)RC5IR?Y":Q:Z=8ZOJMEH^L?\)%I%GJ5_:Z5X@_LN[T M/^W=,M[J6&PUG^Q;]Y+_ $?^U+1(K[^RKV22[T[S_L=S(\T+L?4?V>O#?ACQ M?\=?A3X9\:R6/0^ /P3OOCEXRO/#@U"ZT'1-,T#5M3U MCQ-#937<>E7;V&-LZ+=R1Q MZCHVL64J0ZEI-^ZQW=JMS8W;!8IC\%&G.E]6Q52@WAI8B\8Z^SK+#3HSKT+R M=2:A.,XTG*;YI1E/DG*=.G.G]9G"C",:3EAW*G2IXBA&?]0EU. O7KG'M^/\ 7\>U<9JE MP,$;N@/Y_3M^ [UXG\%/C[I?QC^'FF^*(PT.N61CT'QE9+IUWIMI8^,+/3-- MO=6BTI+JZU 7&BW*ZE:ZEH\\.IZDR:??6UGJ-Q#K=IJEA9=CJ/B*%MW?D]\_ M0C^G_P"H5_0.5U,/BJ='$4:L9TJT8SA)-6L[:.U[2C+W91>L9IQ?O)I?YI<0 M8+'Y3C<;E>/P\\/C,#B*F&Q-&::<)TI!_GFLAM9A+'CV_S^ M-?64)4U%6G';I\K>E[_?U/A<13K2DWR.W_!6W3HM_-(UJ*Q_[8A]*/[8A]*Z M/:4_YU]_]=U]YS>QJ_R2_K^OZLS8HK'_ +8A]*/[8A]*/:4_YU]_]=U]X>QJ M_P DOZ_K^K,V*_1S_@E!HQA@K*8V!!'/YE_VQ#Z5^ZW_ 0V\!MKGQ,^,_Q8E@86GA+P9H_@ M:PE=3Y4FH^--7&LWK0,1AI[&Q\'0QSX.8H=7C!&)Q7YIXQYQ0RGPOXVQ,ZD5 M[?(<7E<-=95=592WM'DP#3ONWR[L_I2HHHK_ "E/]C@HHHH *Y77? O@KQ1K/A;Q M%XD\(>&?$&O^!]1N-7\&:WK6A:9J>K>$]5NK*?3;K4?#FHWMK-=Z+>W%AKZUX6O M=-UZT\=_#GQMH4MQ+<>"?B-I&CZ[H>CZ_?\ A\7UAIGC/09=(\2Z_H7B+PEK M,L4.I:)K5_-H>J>%?&-GX9\9^'/L.BNK!8W%9=C,-C\#7J8;&8.O3Q.&Q%)V MG1K49J=.<;IIN,DFU).,E>,DXMI\F/P&#S3!8O+KA<7AJJ;IU MJ%:#IU*#-5T;X,V>J M)XH\:W>N>&KCXG_LG>*Y+[4-;^%'A+Q?=_$/0FTUOA]?^)M6.A7VF:2/&'P? M^*^OQVOPKT_XG>%1IDFA>%9O0=+_ ."XW_!2S]H^V\1?#;X$>#/A9JOCV/0[ M;Q9)=_LQ_ 7X@_%'XK^&O#.B^(?#_P#:FNVGA+6_&_QOT230+^74--\)ZQJ> ML?#O5(+:#Q5#%I=YI/B.\T+5+7^T&BOU7$>*&59G-9AGOAYPUFN?6I^TS1SQ M&&I8J=)14*N-R^$9T\54:BE4]I7Y9P4:?+&E&,%^.X7PCSC*:;RWA[Q-XKR? MAU.I[+*(PPN*K82G6;E.C@,RJ2A4P=-.3E35+#WA-RJWE6G.I+\=_P#@D1^R M?^US^SOX7^-WC[]K_P")'C'7?'7QSU[P3<0?#3QG\1-0^*^N^$)/ACIWB'P9 M)X_\3^/6\9>+]#UGQE\3O#+>#-'GCTF]U6]T_P"'WPQ^&=IX@\57FI)_PA7P M\_8BBBOS/.9GB\UQ5+"T:^,J1G*A@J$<-A*$(4X4:5'#4(MJG1HTJ<* M<(N4I(H8&G*$<1C\1+%XW$3J5)UJU?%8 MB2BZM>M6J5*M22C""E-JG"$%&$2OX<_VP?#?[4G_ 3<_P""BOC7]L*\^'WA M=;>\^//QB^(_P0^)/B[1/%/BGX#>(%_:!TWXQ:=I'AO5M:T?5?A_.OQ&TKP) MXE\8PZU\/7\3Z!XCT[6O#MYK]A%XB^'LFA^)/$_]QE%>_P &\7SX3Q&9>TRS M"YSEN^'WP@TW4_"MW^SUXC\+^%/'EKI/B_ M0=8\3?%K1O%.CR_$KQ)K6H>$?BIKOP]E\&>'/#WB?6/ FD^%;:Q\13:E+JWA MK1/[7TO1=,_ 7XW_ +''[9O_ 2*_:4T[XT?LTS_ !-^('PK\*:'XC\9Z-\8 M]-\':QXL\-2?"3PZEGJ'Q#^&O[7ECX1TZT\.:+I%GI$-E=^)];U4^#/"GBNU MT_3OBY\*=5\!?$'P5>Z=\'O[::*]#*N/?[$S?.<1EF09;2X>SW#T<%C^%<14 MQ&+P%7"T**I4D\35E]9>*C)UJWUF3=ZN)KMTK2BH>;G'AU_;^2Y'A,W/^2E/ M^#CWXM>+_!_A?P)\.?V_M"^*CX"\*^'M>C\<^)O&_@_QA\0M6U/1-.U M.S\+? S0;#0O'%ZWC:ZEO]*\!>#['XS:SKFDZIK6B1W&L^-I-,FL]?\ U>_X M)6^/_P#@HW\4YOC_ /$/]NK0_%'A;P5XLO/!>J?L^>$_%'@+P#\,I_"9_P"$ MK^,UK\3O#.G>"[#2]*^-&EZ)H<5M\.=.\/7/QR75-8USPS!H>OZ!XD\4G4_$ M'B/5/UXHKESKB;AW&9=7R_(^!LKR&6*J4IUL?/,0\)\3X',\/F7$'B#F_$4,)3K4Z&70RS*\DRZHZM M*5%3Q]# 0E+'3I*6NJ537V2B_P"9C_@IAX7\3:C_ ,%H/^";T^G^ M'->OX->_X4/_ &%/9:/J-U#K7_"KOVAO&7CCXF_V3+!;2)J/_"N?!.I:=XQ\ M>?8VF_X0_P *ZA9>(?$/]G:1=P7DG],]%%>9GG$M;.\NX;RZIA:="/#F63RV MG5A4E.6*C/$3K^UG&44J;2E&')%R3<7+F]Y1CZW#_"U'(,TXIS.GBZN)GQ1F MU/-:M*=*-..$E3PM/#>QIRC*3JIN$JG/)0:4E#E?*YS_ E_X.&;.\;]ACPC MKJ6ETVB>$OVC? 6M^*]96WF;2O#&BWG@;XH^%;36/$.HA#9Z+I=UXG\2>'?# M=MJ&I36UI/K^OZ)HT4S:CJMA;7'ZF_L=Z)K7AG]D;]EGPWXDT?5?#WB+P_\ MLY?!#1-?T#7-/O-(UO0]:TGX9^&+#5-'UC2M0AM[_3-5TR^MY[+4-/O;>"[L MKN":VN88IHW1?HVBC%<25<3PME?"[PM.%+*\SQ^91Q:J2=2M+'4Z5N:PG"M'"<89QQ?'%U9ULWRG+\JG@G2BJ5&. J3FJT:JD MYSE5YHIP<(J'+)\TN9*'\=7_ < _#7XCZM^W%\+/%VE?#[QSJGA3Q?\ O@= M\&?"7B;3?"/B"_\ #_BKXPZO\7_VE=1TGX3>&M9M=.FT[7OB;J>GWME?Z?X" MTJYN_%=[9WMG=6VDRP75N\G]BM%%:YSQ36SGA_A7(*F$I4*?"]+-*5'$0J3G M/%K-,10Q$G4IN*C2=%T(QCRRES\S;MHC+(N$:&1\2<8<1T\;5Q%7BZKD]6OA M9TH0IX)Y1A<1AH*E4C)RJJO]8E.3G&/)RJ*YM6?QW_M>?#;XC0_\%\?ASK,W M@#QM%I'Q*_:K_9.U_P"'.JR>%->33?'^A?"/X>_LWZI\5];\$WS6 M?%>D?# M#3-)U74?B'J>@RW]EX*L=+U&[\2SZ9;V-U)%^[G_ 6-TO4]6_X)L_M.Q:5I MM_J\)_%_X?>*/%6O7B6T!CF6(G'Q!Q.D_\$V?V8HM M5TV_TR74-&^(/B.PBU&SN;*2^\/>+/B_\0?%'A77K-+F.)KG1?$WAG6-)\1> M'M5@#V.M:#JFFZQIL]SI]]:W$OYF?\(OXF_XB3/M7_".:]]E_P"$-_X6-]I_ ML?4?L_\ PKW_ (9"_P"%7_\ ">>?]F\K_A"_^%F?\6Z_X2G=_87_ G?_%(? M;_\ A(?^)=7],]%983C;$87..-BZTU# PXBQ4<55JT9J M#=:6&<>2G&:@JB=Y.+T-<9P#AL9D? >22S&O"GP)FO"^:X>NJ%-SS"?#&#EA M*-&M!S4:$<7&7/4E!S=-JT5):A7\A'[*WP2^-&E?\%XO$7BW5?A#\4=,\*Z/ M^TE^US\0M7\2ZC\/O%MCX?TOP!\4= _:PT+X9>.M2UFZTB+3K'P;\1M:TK4] M(\!>*+JYBT/QCJ>GWMCX=O\ 4KFVFB3^O>BN'ASBFOP[@^),'1PE+$QXCR6O MDU6=2I.#PU.O=.O344U4G&,I)0E:-[-NR:?H<4<'X?BC'<*XVOC*V%EPMGV' MSVC3I4X5(XNIA[..'JN;3IPE*,6YPYI)_$;2?B]HWA;6ECM;?XD_\(_X/\=>%[CP#9>([K4;'3?".N:E M#XT;5O#^MZW'=>'[K6M$L?#6OW'AC1_$%[XX\+?S4_LN_P#!4?\ ;5_8>\*- M^Q-H7PL\&ZAXQT[6[:Q^%OPM^,/PN\>:3\7/ _CGXO>,O"/CBU\+:AX!T+Q! M\/\ QCXMT[QQ9^)_%VI^$_"6K:78>/KOQE\5O#_B&Q\::IX*T#1OAIJ_]R-% M>SP]QW1RS(:O#.><.X#B?)?KW]IX/#XK$XC UL#CW#V)/ WA[1Y?AW\0=/U#X:6_A?QMX"\!?#?X?+\.[G0KJY^$W@WQYXX^ M)]SX2^!7AGQ1J%GXY^+?BO2_%WC)-*\5:CXVM?B%\0OZD-:7]JGX6?\ !'/X M4Q_L\>'O&VA?M0_#K]DC]E^+3O"MMX*T?5OB'H=_X3\._"Z/XHZ$GPZ\?:)J MD>J>+M*\&6'C2Q;P3/X;U+QA?:M;MH/AC0;[QK+H^G2_K#16V>^)&*S[#<.8 M3$9%DM'"\-9E/&X3 TJ$O[,JX7GH.CE=? R=I8.-*A[&OS593Q,*DW-Q QN85L1'^U:.+]GB(U\WP^817-#&SJXCV^ M'M2C3PDZ=-4U*,5;^1&P_P"#@/\ :B^!7@KQ-\'/VC/@/X.N_P!I3PCHD.F0 M>+?B!-K_ ,%=6T*\O/A_H-YX1\2_&CX$3Z%;WNLZ[J^H77_"PO$MKX0U_P"! MOA[Q+X<\06&E^#M \!V*6FMS]%_P3R_9)_:&_;Z_:]LO^"C7[6F@+HO@'3?& M7@SXP^%A?>%_$/@.U^+7BG0_#N@>(/@1<_"'3=/U+1=1D^$'PRM+3X<>*=)^ M(^J:IXOT7X@VOAC1/!U_>_%6]USXH^(?#?\ 6916U7Q"R["8#-:'#'!V6\-9 MAGF!JY;F>:4,PQ^.J/ XEP>*P^7X?%/V674\0X)25)S4$HN"56E2JT\*/AGF M>,S')\1Q;QQFO%>6\/9A1S7*,IQ&6Y=EU)9AA5)8/$YGB<&O;9I4PRG)Q=94 MW-N<9N5*K6I52BBBOS _6@HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _([_@L!\& M+KQE\!M&^+VA63W&M_!O6))]:-NF9V\!^)S;6.L3,J?O)UTC6;?0+\Y#)8Z: M^M7C>5$MPY_F!_X2IXE\.Z-XO\.Z_X3\1V$6J>'O$^BZI MX>UW39]XAU#1]9LI].U.RE,;(XCNK*YF@\TZ]\._$MS"4C\4^!M3FE.D7XE$<<,FHZ>T<^B:^D*K%#KF MFWZPJ;5K:67^L/ ;CE?V5B.$L764:^7U*N-RQ3;7M<#B*BGB:$+Z.6&Q4YUG M%-2E3Q3<8M49R7^.G[0[Z/T_]< MY_/_ .RKYY_X29_^>A_S^%'_ DS_P#/0_Y_"OZ#_MG^\NG7_#_G_5T?YL_Z MC_\ 3I=/L_X?[O\ 5_6_T-_PDX_Y[G\__LJJWVN0W]G=\BYUF2SN) MK69RLUO*\4@S_$C%20<$5#B7(-I0CIA\?2C!8FBT]5%3_>4> M:SG0G2J67/I]%VWBDJ5_?'KG.XG\,>OH>U=%:^,=H&)2<>K'W]25HVM2FMNCOL MO+OW[=[GUY!XVQC,QZ?WC_G].O-:TS#VW=OJ1Q7QZGBJ1+I?^>JGZ,/_ (DUQRQD&]_ZO'_/:RZJQW0RNO&W[J?3[+UV6KL_^&6M MMS[ 'C=>\I_[ZS_+%2KXV7'$IQ_O8_GFOCX>+W'\?/KN'_Q-2KXP?O(!]6'Y M]!_D5G];@^KZ?^V]?U^?4U675E:U&?3[+\O+^M?,^P5\;#_GJP_X$?SR,4[_ M (3__CP_PJ?K4._;_P!M_KYE M++JNEZ6OU[_PFW_38_P#?9_QH_P"$V_Z;'_OL_P"-?(7_ F3?\_'_CP_PH_X3)O^ M?C_QX?X4?6H_TO\ @^:^\/[/J?\ /J?3[+_N_P!?+RU^O?\ A-O^FQ_[[/\ MC1_PFW_38_\ ?9_QKY"_X3)O^?C_ ,>'^%'_ F3?\_'_CP_PH^M1_I?\'S7 MWA_9]3_GU/I]E_W?Z^7EK]>_\)M_TV/_ 'V?\:/^$V_Z;'_OL_XU\A?\)DW_ M #\?^/#_ H_X3)O^?C_ ,>'^%'UJ/\ 2_X/FOO#^SZG_/J?3[+_ +O]?+RU M^O?^$V_Z;'_OL_XT?\)M_P!-C_WV?\:^0O\ A,F_Y^/_ !X?X4?\)DW_ #\? M^/#_ H^M1_I?\'S7WA_9]3_ )]3Z?9?]W^OEY:_7O\ PFW_ $V/_?9_QH_X M3;_IL?\ OL_XU\A?\)DW_/Q_X\/\*/\ A,F_Y^/_ !X?X4?6H_TO^#YK[P_L M^I_SZGT^R_[O]?+RU^O?^$V_Z;'_ +[/^-'_ FW_38_]]G_ !KY"_X3)O\ MGX_\>'^%'_"9-_S\?^/#_"CZU'^E_P 'S7WA_9]3_GU/I]E_W?Z^7EK]>_\ M";?]-C_WV?\ &C_A-O\ IL?^^S_C7R%_PF3?\_'_ (\/\*/^$R;_ )^/_'A_ MA1]:C_2_X/FOO#^SZG_/J?3[+_N_U\O+7Z]_X3;_ *;'_OL_XT?\)M_TV/\ MWV?\:^0O^$R;_GX_\>'^%'_"9-_S\?\ CP_PH^M1_I?\'S7WA_9]3_GU/I]E M_P!W^OEY:_7O_";?]-C_ -]G_&C_ (3;_IL?^^S_ (U\A?\ "9-_S\?^/#_" MC_A,F_Y^/_'A_A1]:C_2_P"#YK[P_L^I_P ^I]/LO^[_ %\O+7Z]_P"$V_Z; M'_OL_P"-'_";?]-C_P!]G_&OD+_A,F_Y^/\ QX?X4?\ "9-_S\?^/#_"CZU' M^E_P?-?>']GU/^?4^GV7_=_KY>6OU[_PFW_38_\ ?9_QH_X3;_IL?^^S_C7R M%_PF3?\ /Q_X\/\ "C_A,F_Y^/\ QX?X4?6H_P!+_@^:^\/[/J?\^I]/LO\ MN_U\O+7Z]_X3;_IL?^^S_C1_PFW_ $V/_?9_QKY"_P"$R;_GX_\ 'A_A1_PF M3?\ /Q_X\/\ "CZU'^E_P?-?>']GU/\ GU/I]E_W?Z^7EK]>_P#";?\ 38_] M]G_&C_A-O^FQ_P"^S_C7R%_PF3?\_'_CP_PH_P"$R;_GX_\ 'A_A1]:C_2_X M/FOO#^SZG_/J?3[+_N_U\O+7Z]_X3;_IL?\ OL_XT?\ ";?]-C_WV?\ &OD+ M_A,F_P"?C_QX?X4?\)DW_/Q_X\/\*/K4?Z7_ ?-?>']GU/^?4^GV7_=_KY> M6O\ H9?L43_:?V1?V;;G.?M'P9\ SYZY\WP]929S[[J_DA_;-\4?V=^UM^TI M9^85\GXW?$KC<1CS/%FJ2],_[>:^+/!_[<7[3_P^\.0^$/!'[1?QE\*^%K6T M^P:?X?T/XD^*[#2-(M/WY\G0[UM]"7=;%$Z>&:I\1M5 MUS4]1UK6M9OM7UG5[Z[U35M6U2]GU#4]4U/4+B2[O]1U&_NWFNKV^O;J:6YN M[NYEEN+FXEDFFD>1V8_B?A]X;X_@_B_/^(\9F>!Q6'S+#8W"X3#X:GB/;'.%\%DV9X3$ MY7B\!B\9B<7*A[#FR_+L9EL*6&5&52I65>.,5>52K'#.A*FZ2IUD_:KZO_X3 M;_IL?^^S_C7J?P4_:4\6_ ?XG^$?BIX*OEBUSPIJ:71M)R'L=9TN='M-9T#4 MHV63=I^MZ7-=:;:ER5J%>#IU(-QE&4>:$K*4)1 MG%M2A*,DFOQ#+O[0RK'X/,\NE6PF/P&)H8O"8FG'WZ&(P]2%2E42G&4)WB\6>'9 MWMX?MJ2:=.(_^$@\.L;E8K7Q-I,-SHUZKFUN7LM6AU#2;'P_XH?\$I/V4/B3 MKIU_3[/QS\+)YKB>ZO\ 3OA?X@TK3-"OY9U(P-%\3^'/%NGZ/;PL0\%GX:AT M.SC90HMS$6C;^&33?B+J>C:A9:MH^L7VE:KIUS#>:?J>FWDUCJ%A>6[B2"[L MKVU:*YM;F"15DAG@D26-U#(RL :^Q?"/_!4C]N'P19QV.B?M.?$JYMXFE,?_ M E.IV7CN=1*$5D^U^.-/\179B14400M.8K4;OLR1;WW?S77\%^)\AS*KC. M.,7EU"O.+=/%XK,,NQ$*<*GM*>'Q%;+:&*HYG2A+E=J^&H4YJ3C.A*SE4_JC M#^.7"O$>54<%XD<"2S3$T(2BJN#P&79IAIU:E.-.KBL-0S2OA*^4UIQE)7PV M*Q%2#@IPQ$;J-/\ LX_9B_89^"7[*&HZUKWP]E\::]XIUW3I]%O/%'CC7K74 M]3CT*XU"UU231K6ST+2/#?A^&U^V6&GR?:#HCZFPLH4DU!PT_G?F[_P7$^(7 MA?3?"'P3\(Q>(M)?Q?%XK\0ZU=>&X+^"76K/0VT2WMH]4OK"*1KBQLKFZEC@ MLIKM(4OI$N!9^?\ 8[LP?SG^-/\ @I3^V=X_B>W\2?M-_%C[-*TS3VGA_P 5 M77@VTN%G\SS8;FT\'+H-O<6I\U@MG/%):QJ$6.%5BB"?)UUX]O+ZZN;Z^U"X MO+V\N)KJ\O+JX>XNKJZN)&FN+FYN)B\L]Q/*[RS32NTDLC,[LS,2?2X3\(^( M<%Q5@N+N*N**&8YA@\7'%U(T?KN8UL;*G0^KT(U$_P"B#_@C!XB_M;]KK5[;S"^SX,^,Y\;B M?N^(?!4><$G_ )Z?K7Z;_P#!:6^_L[]DGPY>9V^3\;O!_.<8\SPGX_BZ_P# M\5_&7X,^-WCGX<:[#XH^'GCKQ7X#\36\%Q;6_B+P9XCU;POKL%M=)Y=U;PZO MH=U8ZA%!OC/96.F?%CXT_$GXB:5IETE]I M^C^+O&6N:WHUEJ$<5U;IJ5MI%[>2Z;#J8MKV[M?[22U%\;6>2U-P8#Y=?0\2 M^&^/SWQ(R7C.EF>!H8#+L3D^*KX6I3Q$L9*63XBCB(4Z,8Q]C-8IP=.52=:D M\.G&:IUVW!?-\*^)N X>\+<]X$K9-F>(S',\+G>$PV*I2H1P,8YYAJN%G5KR MG+V]-X2-6-2-.G0K+$-2@ZF'24WZS_PFW_38_P#?9_QH_P"$V_Z;'_OL_P"- M?(7_ F3?\_'_CP_PH_X3)O^?C_QX?X5^V?6H_TO^#YK[S\$_L^I_P ^I]/L MO^[_ %\O+7_0R_8N\#^%O 7[+/P*T[PGIMI86VM_#'P3XRUBXM06DUOQ-XO\ M,Z5KNOZ[>W#R3375SJ-_>2-$TL\J6=A'9:79>3IMA96T./\ M ?L5_!S]IGQ M)I'B;XK77CW4I] TM])T'2M+\87FD^']'M[B87&H3V&CV\#6L.HZM-';'5M2 M(>^U&*PTNUN9WM-)TRWM/X7/#W[;'[3WA'1-,\,^%/VE/COX8\-Z):1:?HWA M_P /?%_X@:+HFD6$ Q#9:9I6FZ_;6%A:0CB*VM8(H8QPB"MG_AOK]K[_ *.Q M_:0_\/G\3?\ YIJ_E.'@5Q/0S&6:X7C6A0S%XBMB(YC1IYAA<=[:NY>UKJO0 MK*K3JUE5G[1PJN_M)1YI*3/[#G]('A7$97#)\7X?XNOE:PV'PLLKQ$LOQ>7J MAAU25'#O#XB@Z56C0=.G[)3I)+V49*,915O[#_\ ATM^R#_T"_B'_P"%Y?\ M_P BU^$'_!2?X*^ OV3OV@M+^'OPXO=8?PUKWPU\.>.$LM:U0:I>:3>ZAK?B MCP]=V(O/)@F>&8^&$U5$NO-FC;4G5)?LPMXHOS/_ .&^OVOO^CL?VD/_ ^? MQ-_^::O'?&WQR\??$O7&\3_$?Q]XN^('B1[6WL7\0^-O$VL>*]<>RM XM;-M M6UV[O[]K6V$D@M[.X@R_ZIB*$\NQ. M-S;%4Y5*OLW2K*&.Q%6C&=*4;J<8JHHR<8RY9RB_RSC[C/@3B;A^66&^" MX;S+ZYA<13S/"9;E&$J1I4G)5:#J9?AJ%>4*L)V=.4I4^:$92BY4X./]5/[' M?_!,7X$_'#]G#X9?%WQSXZ^)MWXE\?Z7J&NWL?@_Q%X8T_P[IL7]MZE86.DV M-M>>#]8OEN=.L;*WM]::\U2[E?7UU4Q"SM/LVG6?[1_ [X-^%OV?_A;X7^$? M@J[UV_\ #/A+^V_[,N_$MY9W^M2_V]XBU?Q->?;;NPT_2K279J&LW4=MY5A! MY=HD$4GFR(\TG^?AX0_;'_:.^'WAZP\)> OVAOC7X(\*:4;LZ7X8\(?%;QSX M:\/::;^]N-2OC8:+HVN66FV9O-1N[N_NS;VT?VB]NKBZFWSS2.W2_P##?7[7 MW_1V/[2'_A\_B;_\TU?&<1>$7&?$6(Q:Q_']7'9=4S&OCL+@PE3P<\35PU"I1H5YT8*A%1I4YRI4Y*G)I_<\,>,W _#&&P3R[PTAEV9TLLP MV7XS,,MP^4X;%8I0IX;ZQ&KC:>%HXO$4ZV(H4Z]1XB3E6J4X5:L74BFO[.?C MC_P34^ G[0'Q2\4?%SQKXB^*UAXF\6_V)_:=IX:\1^'+#18O[!\.Z1X9L_L5 MI?\ @[5;N+?I^C6LESYM_/YEV\\L?E1ND,?\MG[4'A?2_@+^T!\5O@_HFLZM MK.C> O%=UHFE:GKCVAUFZTX06]W9MJKZ=;6&GS:@EO=1Q7=S9:?I]K=3QO<0 M:?8Q2K:0_+/_ WU^U]_T=C^TA_X?/XF_P#S35X!K'Q*UCQ#JVJ:_K^N:CKF MNZYJ-[K&M:UK%_<:GJVL:MJ=S+>ZEJFJ:E>O/>:AJ.H7D\UW>WMW--'^%'_"9-_S\?^/#_"OU_P"M1_I? M\'S7WGXG_9]3_GU/I]E_W?Z^7EK]>_\ ";?]-C_WV?\ &C_A-O\ IL?^^S_C M7R%_PF3?\_'_ (\/\*/^$R;_ )^/_'A_A1]:C_2_X/FOO#^SZG_/J?3[+_N_ MU\O+7Z]_X3;_ *;'_OL_XT?\)M_TV/\ WV?\:^0O^$R;_GX_\>'^%'_"9-_S M\?\ CP_PH^M1_I?\'S7WA_9]3_GU/I]E_P!W^OEY:_7O_";?]-C_ -]G_&C_ M (3;_IL?^^S_ (U\A?\ "9-_S\?^/#_"C_A,F_Y^/_'A_A1]:C_2_P"#YK[P M_L^I_P ^I]/LO^[_ %\O+7Z]_P"$V_Z;'_OL_P"-'_";?]-C_P!]G_&OD+_A M,F_Y^/\ QX?X4?\ "9-_S\?^/#_"CZU'^E_P?-?>']GU/^?4^GV7_=_KY>6O MU[_PFW_38_\ ?9_QH_X3;_IL?^^S_C7R%_PF3?\ /Q_X\/\ "C_A,F_Y^/\ MQX?X4?6H_P!+_@^:^\/[/J?\^I]/LO\ N_U\O+7Z]_X3;_IL?^^S_C1_PFW_ M $V/_?9_QKY"_P"$R;_GX_\ 'A_A1_PF3?\ /Q_X\/\ "CZU'^E_P?-?>']G MU/\ GU/I]E_W?Z^7EK]>_P#";?\ 38_]]G_&C_A-O^FQ_P"^S_C7R%_PF3?\ M_'_CP_PH_P"$R;_GX_\ 'A_A1]:C_2_X/FOO#^SZG_/J?3[+_N_U\O+7Z]_X M3;_IL?\ OL_XT?\ ";?]-C_WV?\ &OD+_A,F_P"?C_QX?X4?\)DW_/Q_X\/\ M*/K4?Z7_ ?-?>']GU/^?4^GV7_=_KY>6OU[_P )M_TV/_?9_P :/^$V_P"F MQ_[[/^-?(7_"9-_S\?\ CP_PH_X3)O\ GX_\>'^%'UJ/]+_@^:^\/[/J?\^I M]/LO^[_7R\M?KW_A-O\ IL?^^S_C1_PFW_38_P#?9_QKY"_X3)O^?C_QX?X4 M?\)DW_/Q_P"/#_"CZU'^E_P?-?>']GU/^?4^GV7_ '?Z^7EK]>_\)M_TV/\ MWV?\:/\ A-O^FQ_[[/\ C7R%_P )DW_/Q_X\/\*/^$R;_GX_\>'^%'UJ/]+_ M (/FOO#^SZG_ #ZGT^R_[O\ 7R\M?KW_ (3;_IL?^^S_ (T?\)M_TV/_ 'V? M\:^0O^$R;_GX_P#'A_A1_P )DW_/Q_X\/\*/K4?Z7_!\U]X?V?4_Y]3Z?9?] MW^OEY:_7O_";?]-C_P!]G_&C_A-O^FQ_[[/^-?(7_"9-_P _'_CP_P */^$R M;_GX_P#'A_A1]:C_ $O^#YK[P_L^I_SZGT^R_P"[_7R\M?KW_A-O^FQ_[[/^ M-'_";?\ 38_]]G_&OD+_ (3)O^?C_P >'^%'_"9-_P _'_CP_P */K4?Z7_! M\U]X?V?4_P"?4^GV7_=_KY>6OU[_ ,)M_P!-C_WV?\:/^$V_Z;'_ +[/^-?( M7_"9-_S\?^/#_"C_ (3)O^?C_P >'^%'UJ/]+_@^:^\/[/J?\^I]/LO^[_7R M\M?L*'Q?+6.&""'S)9III7"1111IN>221V5$1%+.Q"J"2!7ZD M?"[P>_@#P/IVEZI=";5F2XU?Q%>R30/$FI7SM=7-K%XMYFAGMYX762&: M&:/;)%-%(JO')&RNCJK*P8 UU.H_'7XA:O8W^EZO\1/&VK:7JMI&>VFA>&6%WB=#&S*?X&^G)]&;Q6^E1 M@. >$N#_ ! X9X/X%R/,L;F_%>79Q1SF>+S?-:E.EALIQ]*GE]#$8;'QR;"2 MQ\,'@,35RV'M\SQ&(JXJM*&%6'_LOZ(OCIX=_1WQG&7$G$_ _$7$O%^;X'!Y M9PYC\K>5QPV6Y;"'I1>(E7^P M/B'\7U\9^,]<\013R?V=-<"QT*-U:-H/#]@7BTU=LEG97D+7NZXUNZL[U9I[ M#4M6O[1)WMXH0OMW[+OQ;1_%5_\ #S5+X&V\1P2ZOX6%Q, R:_I=LSZWH]NU MUJ,D\[:KH5NFM6&FZ9ID%G8+X9\4:E?7,EUJ\:G\HO\ A,F_Y^/_ !X?X58M M/B!J&FWEM?Z;J5U87]E/'*>VN;=HYX)HF 9)8G1T8!E8 M$9K]!\6/HG\">(/T7\/]&S*/89)E_#>29-1X$SNOA8XFIDG$W#U.^!S_ !-. MFZ&YN!:JG\K/Q ^('B/XE^*=6\8^*;VZFN]1N;F2SLKJ\CO M(/#FBFYN+C3/#6GS0V>FVQT_0[:?[(ES%I]E)J=PMSK>HQR:MJ>H74_Z4ZC\ M:_'VLZ/?>'];\?\ C77="U33YM)U31]>\8^(MQSK17MGJUSJ&MZ( M8[ZX2XN$M?#NLW=_X?T]"Z".!-/TVU6TM&DL;0064LMN_P O]$3P!\7/ ?PC MI^%OB%QKPIQ1@LIXBS3,N%89!4SN=#)LIS=4<5BLLGB,RR[ RQ-)9Q+'YIA: M4%K9OF498O%4ZF'I8;];\8OI#>$?'7B=F/B9PIP'QCE6<9QP_E>5YOB, MTI9'">88S+'.A3QBHX3,<6\)5K9:LOR_%XCZYBEB,/D^6QA@\+.GBJN)]]_9 MB\/0_#'X<0SWMO\ 9?%/C.6+Q%X@,UN(+^SM7BV^'_#UQ]HTG2]7MET?3'%S M?:-JAO#I'BG5O%*V=TUI=(*^8?VO_#4,'C?3OB+8D?8_&L<&C:V'FR8_%>BZ M<5TZ=3=ZK+/)_;?A73O)BL=*TBTTW3!X-O+Z^N9=1\0+O]R/BZ3M(,>[#C_Q MTUF:GK5EK-I+I^K6ECJEA,T+S6.H06][9RO;SQ7-NTMM%N>I*-[?OU4K0J-)\JKSG! M.2C;^2\BXQSK*>.*W&=>C6Q,\PJXF.:X2$G!8C XODOA: M ?AUX5OX]4T?06^W1*BP2ZKKGB#Q%';O%<6]U#(V.7Q4S#)^-.(:>=Y+EF98*57!4:&82Q M]+#TJF,KX;]W1K^RP]?%QC.&&]EA7.6(:E2P]!*G3Y)N?N4GB5F'^N;Z[\?J M>?;_ "*K?\)$#UE/_?5>&MXA+?\ +08_#_XFF_V__P!-1^G_ ,37TZSE+[6N MG5?W?Z?H_-GY:^'JDMZ,NGV?\/\ 7RUZV]T_X2$?\]#^='_"0C_GH?SKPO\ MM_\ Z:C]/_B:/[?_ .FH_3_XFG_;7]Y].J_N^?\ 5GW9/^KD_P#GS+I]G_#Y M?U;UM[I_PD(_YZ'\Z/\ A(1_ST/YUX7_ &__ --1^G_Q-']O_P#34?I_\31_ M;7]Y].J_N^?]6?=A_JY/_GS+I]G_ ^7]6];>Z?\)"/^>A_.O[AO^"7G[/MY M^SW^R%X TSQ!IS:=XY^(AG^*7C6WGCV7EI?^*H+4Z%I-TK#SK>XT?PC9^'[* M^L9#_HFL)J@"(\L@/\KG_!)+]CB]_;&_:,L-4\4Z7-[UB!3E?"VEZRADM[J[TYI?[L*_E#Z1W'\<; M3R_@K!5N;V56GFN=5L?3DDDN8HHHK^3C^ MRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "OA3]O\ _8D\*?MN?!BX\'W,]GX?^)?A M5KS7/A3XWGA9AHFOR0*EQHVKO!&]W+X3\31PV]GKMO LDEO+!INMV]M=7NC6 MMM-]UT5VY?F&,RK&X;,,EHTT])0G%N%2$DX5*+LBS3AKB' 4&_P!*U2SDFL-4TZYMK^QGGM;B*5O/O^$B_P!H?]]G M_"O[W/V_O^"<7P<_;S\%1P>(MO@CXO>'+&6#P%\7-(T^&YU;2T+23IH'B6RW MVQ\4>#YKF629])GN[:[TVXFGO=#U#3I[F_6^_AJ_:Z_8\_:,_8F\;2^$/CCX M)N],TVZO+BW\*?$'24N=2^'?CF"$-(MSX9\3"VAMY;DVP6YN="U&/3_$FF1. MAU32+/?&7_J;A3Q'P?$5"G2JSA@\VA%*O@ISLJLHI&.8U\5A*-;.N#J]9O+\\I4>:>%A.<53P6=4Z46L)BZ M=U3CB+0P>.LJF'E3JNIA,-YQ_P )%_M#_OL_X4?\)%_M#_OL_P"%>&?\)!_M MK^?_ -:C_A(/]M?S_P#K5]G_ &J_Y_Q]//T^_P S\,7"&W[KM]E_W/+S_K2W MN$NO1S1O%*$DCD5D=&8E65AAE(QT(->0:X\NE3Y1_,LY6/D2\97OY,AR/WBC M.#TD4;@ =RKG?\)!_MK^?_UJAGUB&YB>"?RY(I!M9&[^X(P58=592&4X(((S M71AL]E0G?GYH.W/'FW6FJU^+\[M/>Z^]X Q>+X*S/VSP\\7E.,=.&98!:2G& M/*H8G#.5HPQ=!2?)S-4ZT.:C4<4Z=2C!_;I_OC]/\:>-?8=7!_+^>:\^U:*X MLBTUJ[7-KR3@DS0CKAU'WU Y\Q1QSO5< MS?]N'^^/\ OO\ ^O7NT\YA5BI0 MJ*2T^T[KX79JUT]'OW;5]+_V]P_D.2<49?2S/(\10QV%FHJ7)[M;#U&HMT,5 M0DE5PU:/_/NK&+:Y9PYZ;C.7L_\ PD'^U_Z#_P#%4[_A(,=)?\_G7BW]N'^^ M/^^__KT?VX?[X_[[_P#KUHLTM]KMU?\ =\O)_CY7]Q>'O_3E=.C_ +O^:^]= MCVH>(>>9<_CC]C^W#_ 'Q_WW_] M>C^U'_/VW;_N_P"7Y^0UX??].5TZ?X?+S_'R=_;/^$A_Z:)^8_\ BJ/^$A_Z M:)^8_P#BJ\3_ +C^W#_?'_??_ ->C^T_[RZ=_[O\ E^?D'_$/O^G*Z=/\/E_5_6_MG_"0 M_P#31/S'_P 51_PD/_31/S'_ ,57B?\ ;A_OC_OO_P"O1_;A_OC_ +[_ /KT M?VG_ 'ET[_W?\OS\@_XA]_TY73I_A\OZOZW]L_X2'_IHGYC_ .*H_P"$A_Z: M)^8_^*KQ/^W#_?'_ 'W_ /7H_MP_WQ_WW_\ 7H_M/^\NG?\ N_Y?GY!_Q#[_ M *)_VX?[X_[[_^ MO1_;A_OC_OO_ .O1_:?]Y=._]W_+\_(/^(??].5TZ?X?+^K^M_;/^$A_Z:)^ M8_\ BJ/^$A_Z:)^8_P#BJ\3_ +)_VX?[X_P"^_P#Z]']N'^^/^^__ *]']I_WET[_ -W_ "_/R#_B'W_3E=.G M^'R_J_K?VS_A(?\ IHGYC_XJC_A(?^FB?F/_ (JO$_[C^T_[RZ=_[O^7Y^0?\0^_Z)_VX?[X_[[_P#KT?VX?[X_[[_^O1_:?]Y=._\ =_R_ M/R#_ (A]_P!.5TZ?X?+^K^M_;/\ A(?^FB?F/_BJ/^$A_P"FB?F/_BJ\3_MP M_P!\?]]__7H_MP_WQ_WW_P#7H_M/^\NG?^[_ )?GY!_Q#[_IRNG3_#Y?U?UO M[9_PD/\ TT3\Q_\ %4?\)#_TT3\Q_P#%5XG_ &X?[X_[[_\ KT?VX?[X_P"^ M_P#Z]']I_P!Y=._]W_+\_(/^(??].5TZ?X?+^K^M_;/^$A_Z:)^8_P#BJ/\ MA(?^FB?F/_BJ\3_MP_WQ_P!]_P#UZ/[73O_=_R_/R#_B'W_3E=.G^'R_J_K?VS_A( M?^FB?F/_ (JC_A(?^FB?F/\ XJO$_P"W#_?'_??_ ->C^W#_ 'Q_WW_]>C^T M_P"\NG?^[_E^?D'_ !#[_IRNG3_#Y?U?UO[9_P )#_TT3\Q_\51_PD/_ $T3 M\Q_\57B?]N'^^/\ OO\ ^O1_;A_OC_OO_P"O1_:?]Y=._P#=_P OS\@_XA]_ MTY73I_A\OZOZW]L_X2'_ *:)^8_^*H_X2'_IHGYC_P"*KQ/^W#_?'_??_P!> MC^W#_?'_ 'W_ /7H_M/^\NG?^[_E^?D'_$/O^G*Z=/\ #Y?U?UO[9_PD/_31 M/S'_ ,51_P )#_TT3\Q_\57B?]N'^^/^^_\ Z]']N'^^/^^__KT?VG_>73O_ M '?\OS\@_P"(??\ 3E=.G^'R_J_K?VS_ (2'_IHGYC_XJC_A(?\ IHGYC_XJ MO$_[)_P!N'^^/^^__ *]']N'^ M^/\ OO\ ^O1_:?\ >73O_=_R_/R#_B'W_3E=.G^'R_J_K?VS_A(?^FB?F/\ MXJC_ (2'_IHGYC_XJO$_[C^W#_?'_??_P!>C^T_[RZ=_P"[ M_E^?D'_$/O\ IRNG3_#Y?U?UO[9_PD/_ $T3\Q_\51_PD/\ TT3\Q_\ %5XG M_;A_OC_OO_Z]']N'^^/^^_\ Z]']I_WET[_W?\OS\@_XA]_TY73I_A\OZOZW M]L_X2'_IHGYC_P"*H_X2'_IHGYC_ .*KQ/\ MP_WQ_WW_P#7H_MP_P!\?]]_ M_7H_M/\ O+IW_N_Y?GY!_P 0^_Z73O\ W?\ +\_( M/^(??].5TZ?X?+^K^M_;/^$A_P"FB?F/_BJ/^$A_Z:)^8_\ BJ\3_MP_WQ_W MW_\ 7H_MP_WQ_P!]_P#UZ/[3_O+IW_N_Y?GY!_Q#[_IRNG3_ ^7]7];^V?\ M)#_TT3\Q_P#%4?\ "0_]-$_,?_%5XG_;A_OC_OO_ .O1_;A_OC_OO_Z]']I_ MWET[_P!W_+\_(/\ B'W_ $Y73I_A\OZOZW]L_P"$A_Z:)^8_^*H_X2'_ *:) M^8_^*KQ/^W#_ 'Q_WW_]>C^W#_?'_??_ ->C^T_[RZ=_[O\ E^?D'_$/O^G* MZ=/\/E_5_6_MG_"0_P#31/S'_P 51_PD/_31/S'_ ,57B?\ ;A_OC_OO_P"O M1_;A_OC_ +[_ /KT?VG_ 'ET[_W?\OS\@_XA]_TY73I_A\OZOZW]L_X2'_IH MGYC_ .*H_P"$A_Z:)^8_^*KQ/^W#_?'_ 'W_ /7H_MP_WQ_WW_\ 7H_M/^\N MG?\ N_Y?GY!_Q#[_ *)_VX?[X_[[_^O1_;A_OC_OO_ .O1_:?]Y=._]W_+\_(/^(??].5TZ?X? M+^K^M_;/^$A_Z:)^8_\ BJ/^$A_Z:)^8_P#BJ\3_ +)_VX?[X_P"^_P#Z]']N'^^/^^__ *]']I_WET[_ -W_ M "_/R#_B'W_3E=.G^'R_J_K?VS_A(?\ IHGYC_XJC_A(?^FB?F/_ (JO$_[< M/]\?]]__ %Z/[C^T_[RZ=_[O^7Y^0?\0^_Z)_VX?[X_[[_P#KT?VX?[X_[[_^ MO1_:?]Y=._\ =_R_/R#_ (A]_P!.5TZ?X?+^K^M_;/\ A(?^FB?F/_BJ/^$A M_P"FB?F/_BJ\3_MP_P!\?]]__7H_MP_WQ_WW_P#7H_M/^\NG?^[_ )?GY!_Q M#[_IRNG3_#Y?U?UO[9_PD/\ TT3\Q_\ %4?\)#_TT3\Q_P#%5XG_ &X?[X_[ M[_\ KT?VX?[X_P"^_P#Z]']I_P!Y=._]W_+\_(/^(??].5TZ?X?+^K^M_;/^ M$A_Z:)^8_P#BJ/\ A(?^FB?F/_BJ\3_MP_WQ_P!]_P#UZ/[73O_=_R_/R#_B'W_3E M=.G^'R_J_K?VS_A(?^FB?F/_ (JC_A(?^FB?F/\ XJO$_P"W#_?'_??_ ->C M^W#_ 'Q_WW_]>C^T_P"\NG?^[_E^?D'_ !#[_IRNG3_#Y?U?UO[9_P )#_TT M3\Q_\51_PD/_ $T3\Q_\57B?]N'^^/\ OO\ ^O1_;A_OC_OO_P"O1_:?]Y=. M_P#=_P OS\@_XA]_TY73I_A\OZOZW]L_X2'_ *:)^8_^*H_X2'_IHGYC_P"* MKQ/^W#_?'_??_P!>C^W#_?'_ 'W_ /7H_M/^\NG?^[_E^?D'_$/O^G*Z=/\ M#Y?U?UO[9_PD/_31/S'_ ,51_P )#_TT3\Q_\57B?]N'^^/^^_\ Z]']N'^^ M/^^__KT?VG_>73O_ '?\OS\@_P"(??\ 3E=.G^'R_J_K?VS_ (2'_IHGYC_X MJC_A(?\ IHGYC_XJO$_[)_P!N M'^^/^^__ *]']N'^^/\ OO\ ^O1_:?\ >73O_=_R_/R#_B'W_3E=.G^'R_J_ MK?VS_A(?^FB?F/\ XJC_ (2'_IHGYC_XJO$_[C^W#_?'_?? M_P!>C^T_[RZ=_P"[_E^?D'_$/O\ IRNG3_#Y?U?UO[9_PD/_ $T3\Q_\52'Q M"/\ GICWW9_K7BG]N'^^/^^__KT?VX?[X_[[_P#KT+-&OMKIU?\ =_R_/R#_ M (A]_P!.5T^S_A\O/\?)GM/_ D/_37_ #^=(?$ _OY_+^K"O%_[C^W#_?'_ 'W_ /7H_M3^_P!NK_N^7D_O?S/^(>K_ )\KIT_P_P# M_#L>Q?V[_MC]/\:/[=_VQ^G^->._VX?[X_[[_P#KT?VX?[X_[[_^O1_:G]_M MU?\ =\O)_>_F?\0]7_/E=.G^'_@?AV/8O[=_VQ^G^-?2_P"R9^S9\7OVS/C- MX=^"WP=TAK[6-5=;SQ!X@NHIQX<\"^%H)H8]5\7>*KZ%)!8Z1IRS1I&@#7FJ MZC/9:-I4%UJFH6=K+VW[ /\ P3(_:?\ ^"@'B2RG\#Z!<^!?@Q;WQ@\4_';Q M=IUY'X-T^.WEV7UCX5@+VEQX^\3PA7C70]!G%K9W30)XCUGP[:W$=X?[W?V+ M?V(/@;^PI\*+;X8_!K19&NKTVU]XY\?ZVMO<>-?B'KT,;H-5\1:C##$B6MH) M9H=$T&PCM]&T.UEF6SMC>7>I7U_^:\<^*V#X:P];!9?5IX[/IQ<*=",N>C@9 M-)>VQK6BE"SE#")^UJ-KVBITI*H_J^&_!R.9XFE7S"F\-E<)1E5DERUL2HM- MT<.GK%2MRRKMD:/::9HEK,]IIL#'Z8HHK^0 ML7B\3C\5B,;C*U3$XO%5JE?$5ZKYJE6M5DY3G)]Y2;T222TBDDD?TWA,)AL! MAA2CRTZ5&E%0A""[1BDM;M[MMML****YSH"BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "N+^(7PX\ ?%GPEJ_@+XG>#/#/C_P7KT'V?6/ M"_B[1;#7M$OXQS&TUAJ,%Q!Y]N^)K2Z1$N;.X2.YM9H9XTD7M**J,I0E&<)2 MA.+4HRBW&49)W4HR5FFGJFG=/5&=6E2KTJE"O2IUJ-:$J=6C5A&I2JTYIQG3 MJ4YIPG"<6XRC).,DVFFF?S.?M7?\&W/P7\>W>I^*?V3_ (EZE\$M8N6FN4^' M/C>+4/''PXDG?>4M-)U[[5_PF_A2T+L'DEOG\?; GDVMC;Q,@B_!?XT_\$4/ M^"CWP6DO)IO@+?\ Q1T.U>18O$'P6UG3?B)'?B)B"]GX6L);;XB!'7;)']K\ M%VC2*X15,R2Q1_Z)=%?;Y;XA<0Y?&-.K5I9C2C9)8V$I5E%=L12E3JRE_>K. ML_PM^#<4_1N\-N(JM7%8/"8SAG%U'*';_ 'P,%G3[ M)K&CV=QOA9E65?+S&S . 2*\H)8$@[@02"#D$$<$$'D$'J*_UIJ*^DAXK5$O MWF1PG+JX9C*FO_ 98*H^WVGZ]OR^O]$'#RFWAN/J]&G=VC7X9AB)I:63J4\] MPL6UK=JFD[JR5M?\EC?,AX#'U>/[K>Y&UB3DL:_UP M**VAXM3IOFAD;B^ZS7\'_P )UFO)Z'H9-]%W.>'<9''Y)XJXO+,7&R=7"\+N M"J13O[.O2?$SI8BDWJZ->%2E)_%!G^0S<>'-0B),+)*R)+.^ASYEMMA+OI[+!4HK7W7T_Q^ M3O7AMP/7!R/YTFX^I_.O]@>BM/\ B-/_ %37_F8__!1]*N&I67-CDY=6L*XI M^B>)DU_X$_4_Q^-Q]3^=&X^I_.O]@>BC_B-/_5-?^9G_ /!0_P#5O_J-_P#+ M;_[N?X_&X^I_.C5$K32M(56*%'ED*QJ MS#_63HK*KXT5G%^QX>I4Y6T=7,YUHW\XQP%!M>7,O4J/#<;^]C)-=5&@HO[W M5E;[GZ'^=!\!_P#@@)_P4H^-=QI]QK?PJT;X%^&;UHV?Q'\:/%FF:'<00$@S M[O!?AYO$_C^&ZCC.8H-2\+Z9#/,5B-W$!/+!_1=^QQ_P;?\ [*7P+O=.\8_M M'>(M2_:D\:V1AN;?P]JNF-X/^$.FW:$2CSO!]IJ>I:MXO,$G[G'B?7Y/#^HP M F]\(*T@CB_HQHKX_./$KBC-H2HQQ-/+,/--2IY;"5&I*/:6)G.KB4[:2]E5 MI1E=IQMHO0P^38'#M2<)5IK52K-22?E!*,/3FC)KN96AZ%HGAC1M,\.^&M&T MKP]X?T2RM],T;0M#TZTTG1M(TVSC6&TT_3-,L(;>RL+*UA18K>TM8(H((U5( MHU4 5JT45\"VVVVVVVVV[MMO5MM[MO=GK!1112 **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "OE+]L3XKM\,OA'J%GIMRL'B7QRT MWAC1]DH2YM[&: G7]4A7>DI%II[K8I/ PEL[_5=/N5^X:^K:_![]K;XL'XI? M%S5_[/O!<^%_")?PSX=\J3?:SK92-_:FJ1[)9()CJ6IFX>"[C5'FTR+3HI-W MD*:_FCZ5OBC_ ,0T\*LSA@,0Z/$?%[J\-9'[.?+7P\,51D\WS.%FIQ^HY:XT:ZG; D45]S1G2-3E#2+!&;'4UMTENY58V^G7.H!2BRN:_=NE]%#Q-_XB/X M2Y33QN(]MQ!P?R<,9USRYJU:G@Z,/['S"I=NQIU:\VW7Q^$QTKW32? MC;P?_JGQQC9X:E[/*\^YLXR_E5J=.=>H_K^%C:T5[#&>TG"G%)4L-7PT0HHK MXX_;]_:MT7]BS]DSXP?M ZE-IYUKPOX(/B5XASI/@G2/L@F M@GO[8:S,X+6Q^.7AV^N(ENHE% MGX3,?PS6*]T^:_\ #'B73/$U_ITJO?*5_L6^'GC[PK\5/ 7@OXF>!M4CUOP9 M\0?"V@^,_"NKQ(\2ZCX?\2Z7:ZQI-V8956:WDFL;N%Y;:=$GMI2\$\:31NB_ MY(/B+Q!K7BS7];\4^(]2N]8\0>(]6U#7-;U:_GENKW4M6U6[EOM0OKNXG>2: M>XNKJ>6:665W=WIB9I:MPQU6I5LM(PQ563]VFK?-Y3F M#?M)^+_ !)X0^$WB&3P=I&N:OXJUY1X:T5-!TV_U&YL)M4BG%WJLIT^-YK- M;#38;V6TNSM5=3^P1@YD%?B!:_#/Q99WUA<^-/#/B_PQX6_M+3XM?\17WAO5 MXK?2--NKV"VN;^62:RV$PK-N1#EII=D2*SNJG^CBOFW]KW_DW/XF?]>.A?\ MJ5Z#7\?_ $FO FCX@X?,_$7-.*\=2H< \'9QF.5\*QRZE4RO$3RG"8O.<5'% M8A8RCB5+-ZN&HX7%UJ"I5(86C0A3?/14W^\>#_B34X7K8+A/!Y+AIU>)\_P& M$QN=/%3AC*4<=7P^7T71H^PG2:P,*M2M0A4'/%WBSPDFKZI!X<\36/AK5Y;;6M+L=1N;2TU&-HK'8K3I;AI8L*T$WF M0R(DD;*/W1^ /B[Q!XS^%7A;4O%FE:SI'BFQM/[#\00:Y87MA>W6HZ0%M3JI M6]MK1YQJ]L+?4I9H8OLRW5S(O!F19KF?"CR^G2RO!8C-,+A,ZP:PF)>+K8J? M]CO&8O X2>(]I.IA<36]LW5DIJ?&/Q%J<3XG%<*XS)L/"MPIQ!F6"P>=_6IS MQF(I8.M6R[$>WHJA3HKZ_P#5Z&)KQI(_VGOC] M\4/AK^S'\'/@;\:?&7PJ^%&G6_Q \8Z_X4^&/CC6?#_B3XG^*K&6/2;6VU6S M\/7&DZK;^"O!MPJ6U_HVHS)#JWC+Q1HVIHMYI*QP_P!@E%?VUPYG2X?S6CFO MU*ECJF'A45"E6J2IPIU:D?9^VO&,G*4*+H2H>TE M24W'FE%7;BG?EU:T;2OY)K9G^6%HG[+D&C^!?BQI'QHA^*OPM_:?A_X5)_PS M3\ =7^&?BNUUWX[_ /"<>-]0\+>*OL-O=>'FNX/^$?MK'SM)VR6_]NZGYVE6 M'VJ\@DA7Z _8B\'_ +=?[%_[4/PD_:)\,_LK_M'W*^!/$D+>*=#MOA#X^0^* M/ FK1OI/C;PRP?P_)#YNK^&[S4+?3YYH9AI^J_8-4AB-U8P,O[K_ /!6W_E/ M;_P2V_[M/_\ 6M?B%7]>(6(PN5Y=.OEE#'4.)LNK8FOA:]>4:6%I2_ MV&IA*#IT8SG2FJ4J[E5I:??:1J,=KJ M-K%>6Z7^E:G!:ZEIEZD,R+=:?J%K;7UE.)+:[@AGCDC73HHK\%=KNR:5W9-W M:71-V5WYV5^R/J@HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !7S;^U[_P FY_$S_KQT+_U*]!KZ2KYM M_:]_Y-S^)G_7CH7_ *E>@U^>^+G_ ":GQ._[-[QI_P"LWF1]5P+_ ,EOP=_V M57#W_JWP97_8Y_Y-N^&O_7'Q1_ZFOB2OIJOF7]CG_DV[X:_]%G_ &;C@?\ ]9G*RN/?^2YXT_[*SB/_ -7&,"BBBOT<^3/Y&?\ M@K;_ ,I[?^"6W_=I_P#ZUK\0J_KFK^1G_@K;_P I[?\ @EM_W:?_ .M:_$*O MZYJ^WXJ_Y$O!/_8BJ_\ J=6/-P/^\9E_V%1_],P"BBBOB#T@HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "OFW]KW_DW/XF?]>.A?^I7H-?25>;_ !=^'H^*OPY\3> &U8Z$/$5O90?V ML+'^TS9FRU2QU-7^PF\L/M D:R$)3[9 0)"X(F58_/O#[CK(\JH?6 MLTSG@[B?*LMPWM:-#ZQC\QR3'8/!T/;8FI1P]'VV(K4Z?M:]6E1I\W/5J0@I M27O\)X[#99Q3PUF6-J>QP67Y_DV.Q=;DJ5/987"9CAJ^(J^SI0G5J>SI4YRY M*4)U)6Y80E)I/RW]CG_DV[X:_P#7'Q1_ZFOB2OIJO,_@[\.A\)?AOX:^'PU@ MZ^/#T>II_:YT_P#LO[8=2UK4=8+?8/MNH_9Q"=0-N%^V3[Q$)2RE]B^F5GX: MY1F'#_AUP#D.;X?ZIFN2<%<*Y1F>%]K1K_5LPRW(L!@\;A_;X:I6PU;V.)HU M*?M.BRY\*Z_]B2U%^GVEIC9Q_K?7U.?YE@L M;EG"V'PM;VM;+LIJ8;&P]G5A[&O+%5*JAS5*<(U+PDIA7?PUO=*T6WU2YTCQ-;>'_"GCOQ-\'O&/A[0?%WA'7M%\5>$_%6BZ7XD\,>)_#>J M6.N>'O$?A[7+]%U[0=:TR>ZTW6-%UC3;JVU#2]4T^YN+'4+&X@N[2>:WF MCD;HKX3%87D^L8>M0517@ZM.4%)*U^5R23:NKI:JZNE=&-+$4*_-[&K3J\C2 ME[.<9(M>\1:% MH&DPW&DZ(NI7/B_Q5X,\-^(\J=.I6G&E2A*I4F^6$(1^&M0EUO0-+TS4/#>HZ[]]TZM*K0J2I5JK_\ "4?#SPK\2;#_ (1Z]\1?&+PMJ4WDZ-XNT_3[S^V-(T7R M]9MK^&#[1IT=KJ=W^S5;U<-7H0HU*M*=.&(AST925E4A[KYH^5I1?S1E"M2J MRJ0ISC.5*7+4BG=PEKI+ST?W,****P-0HHHH **** "BBB@ HHHH **_/']N M[_@I9\#?^">M[\)+'XS^#_BYXH;XRVWQ#NO#4_POT/P5K,&F+\-9? <6M1^( M?^$M\?\ @F>VEOS\0M(;1O[+@U>.9;'5O[0DTUHK!=0^@OV3/VG/ O[8WP!\ M#_M&?#71/&/AWP5X_N?&EKHVD>/K'0M-\66S>!O'WBGX=:G)J=EX:\1^+-&A MBO=8\):A?:7]EUZ\DDTBYL);V.POY+K3K3>6&KQH0Q4J4UAZDW"G5:]R4X\U MXI]UR2_\!?8R5>E*K*@JD76A%2G33]Z,7:S:[>]'[UW/HRBBBL#4**** "BB MB@ HHHH **** "BBB@ HHHH **_&7_A^1^RG_P -/_\ #)G_ K3]H[_ (61 M_P -+_\ #+/]K_\ "*_"W_A"_P#A._\ A;__ I?_A(?[2_X7%_;7_"$?\)' M_P 3?[=_PCW_ D?_".?Z1_PB_\ ;'_$DK]FJWK8:OAO9^WI3I>UIJK3YU;G MIRVDO)^>IE2KTJW/[*<9^SFZ<^5WY9K>+\PHHKYS_:S_ &G/ O['/P!\ ;'0M2\67+>.?'WA;X=:9)IEEXE\1^$]&FBLM8 M\6Z??:I]JUZSDCTBVOY;*._OX[73KO*$)5)QIPBY3G*,(16\I2:C&*\VVDC2 M4E",I2:C&*/["/_!2SX&_\%"KWXMV/P8\'_%SPNWP M:MOAY=>)9_BAH?@K1H-37XE2^/(M%C\/?\(EX_\ &T]S+8'X>ZNVL_VI!I$< M*WVD_P!GR:DTM^NG_H=5UJ-7#U9T:U.5.K!I3A)6E&Z4E?UBTUY,FG4A6A&I M2DIPEK&4=4[-IV^::"BBBLBPHHHH **** "BBB@ HHHH **XWQ_\1?A]\)_" M>I^/?BGXZ\&_#7P+HDFF0ZSXT\?^)]$\&^$](EUO5[#P_HT6I^(_$5]IVCV$ MFKZ]JNF:)IB75Y$U_J^HV&FV@EO+RWAD_,3X'_\ !:+]D']I#]JCP=^RK\%] M*^,_C/5_'K:TOACXL/X'T7PO\*+T>'_ACK7Q0U=IX/&7C#P[\7=.^R6?A[5? M"QCU#X2VT\OBJW40Q2>&9HO$S[TL-B*T*M2E1J5*=&+G5G&$G"G&*NW.5K*R MULW>R;M9,RG7I4I0A4J0A.I)1IQE)*4Y-V2C%N[U:6BW:74_6VBBOPQ^._\ MP<"?L;? ?XR_$OX*WWPT_:;^(6L?"KQCK7@'Q)XI^'W@SX6IX0N?%OA:[?1_ M%VE:0_Q"^,WP_P#%5T/#'B>UU;PO?7]UX5L=,U+4]&O-0\-7NN^&;G1]?U0P M^%Q&*E*&&H5:\HKFE&E"4W&-TKNRT5VD%6O1H14JU6%*+?*G.2BF][*^[MKZ M'[G45_.Q_P 1+O[%W_1OW[9O_A(?L\?_ $3->O? +_@O]^QU\?\ XS_#7X): M9\,OVF_A_K7Q4\6:7X'\.>*/B#X-^%;>$+;Q1XAE_L_POIFKO\/_ (S^/_%- ML/$GB&;3?#5C?6OA6^TW3]2U>SOO$=YH?ANWU?7M,Z993F<8RE+ 8I1BG*3= M&>B2NV].B_7LS!9A@I-)8J@VVDE[2.K=DEOW?]69^Y-%>1?&WX^?!C]F_P " MWOQ*^.OQ*\)?"_P79F\@BU?Q5JD-E+K6J66A:SXE;PWX3TA/-UOQGXQO=#\/ M:Y?Z-X*\):=K7BW7TTN\BT/1=1N(C#7XMZW_ ,''_P"PSI6N>(-)L/AG^U1X MFT_1M9U73--\4:)X$^%5MH?BVQTZ^N;2S\1^'[;Q+\;/#WB>UT;7K>"+5-*M M_%?AWPQXB@L;VVBUW0=%U1+S3;3+#X'&8M-X;#5JT8NTI0A)Q3[.7PW\KW\C M2MBL-AVE6KTZ;>T932DUWY?BMYVL?T T5\ ?L2_\%+_V6/V]K?4]/^#7B+Q# MH7Q'\/:+)XE\4?!KXEZ+!X:^).@>'!XDU#PU;:^B:7J?B+P7XMTB::UTJ_U& M^^'GC/QC#X0MO&'@FP\>MX4\1>)],T.7[_K"K2JT*DJ5:G.E4@[2A4BXR757 M32>JU3V:::T9K"I"K%3ISC4@]I0DI1?HU=>O8****S+"BBB@ HHHH **** " MBBB@ HK^=_\ X) ?\%>OV@/V\?CKXZ^"7QU^'WP=TA],^#-]\6_#7BCX3:7X MU\*+9-X9\8^"/"6N:!KNA^,/&_Q'.MKKA^(VDZAI.IZ?K/AT^'AX;U&SO-/\ M2_\ "1VUUX;_ *(*Z<7A*^!K2P^(BHU(QC)I24U:<5*.L6UL_O,,/B*6*I*M M1DY0;:3<7%WB[/1I,***^=/VC/VN/V;?V2?#ECXG_:*^,'A'X866L"X;P]I> MJW%WJ?C'Q9'8ZMXRC%)MM]$E;/HNBOSL_8)_X*7_ 3_ ."A\WQ:A^#O@3XR>"S\'(OA_+XC M?XLZ-X TA-4'Q%;QNND)X>_X0?XD?$![A]//@/5#K']JIHZ1"]TK^SGU(RWP MT_[B^(GC_P )?"CX?^.?BCX^U4Z#X$^&W@[Q-X^\:ZX-/U/53HWA+P=HM[XB M\1ZJ-+T2RU+6=2.G:/IUY>"PTC3K_4[SR?L]A975U)%!)=6A6H570JTYTZT7 M%.G*+4TY)2BN7>\E)-=TT33JTZM-5:/_ *)FNW^Q M\T_Z ,7_ ."9_P"7]?)G-_:.!_Z"Z'_@R/\ GY_U9G]$]%?E_P#L)?\ !6?] MF[_@H%XZ\:_#7X6>$OC/\/\ QKX+\)P>.#HWQ=\,^#=-'B3PNNL6>@:SJ?A_ M4_A[\0?B3I$9\-ZMK'AJUU6Q\1W_ (=U*\_X2;3KCPY9Z]:V'B6;0?U KBK4 M*V'J.E7I3HU$DW"I%QDE)73L[.S1T4JM.M!3I3C4@VTI0DI*ZW5UU75;A17X MU?M#_P#!=S]@7X!^*;'PCH_B7QK^T7?RB4ZUJW[-^F^#O&W@WPVC:7X=UC29 M)_'GBCQUX%\&>+(MCZCH/B#1?%K>&]:LK?3[S$_9^_X+ MV_L2?M ?%SPI\'+?P_\ '[X7:[X\UCP_X4\$:Y\2?A_X:NO#7B;QYXN\6^'/ M!GA/P-;2?"KQ]\4->TK5]?U/Q''W-?2U[WTM<_;"BBBN$Z@HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\L? MX;_"3XB_%.Q\>ZKX!T]=8L_@O\'=3^,_Q!TBWM-=U#7)O &E>-_AE\/]7U;0 M-.T/1=7^T/X2O?B1IGC#Q9>:S/H6@^'OAMH/CCQ5J.M1G0H+#4/[=?\ @@U^ MV)_PT9^R./@QXGNC+\3?V2QX9^'%Z1:-"FJ?!_5[+4Q\#M<#:;X/\-^%M/;3 M-'\,^)?A2NA6.K>*O%,EM\*;;QWXUU*.^^(%A]H_!+_@W[^'WA'XM?M6_'?X M5?$#2GUWP'\3/V _CA\/O&VB1ZEJVBR:QX1\9_$C]GWPYXDTI-8T"^TO7=)? M4-&U*]M%U+1=3T[5K%IA=:=?6EY%#<1[7_!,GQQXT_X)X_\ !634_P!F3QIX MJUBP\$>+?B9XO_96^($GBKP9\0?# /%_B.#QKX;\/_"'XR^,+_3]*Y?'EI^@YTECX9C@K7Q& IT, M?AOYG2]E&.(@K:M)>];=SG#>RM\AEC^J/!8G:EBIU<)6[*?/S49OS;T;V48R MVN[_ -RU?P6_\%DOC1XU_;$_;Y^-OP]\$^-=!N?!_P"S#\-_C-X>^'.G:LWC M_P /Z!;WG[-_P6\;?'']I![G0]8CU:VN?B=?^*OAW\1_!%GXE\.>&_#GAWQY MHOP_^$^GWNIW'A[1[?Q]<_UU_P#!2/\ :BL?V1/V-/C7\6(O%;^$O']UX4U3 MP'\$[RQC\&7_ (@E^-7C?3;[1OA_>^'_ WX[NH=!\6OX,U"2;XE>*-!>Q\0 M3K\/O!'C'6_^$8\16FC7>DW7\O7_ 3*_9>&M$^#_C?Q%\8[RPT6YLK#P1XA\$:KXDT_ MX7>'=!\7Z=>>)-5L?&'PV^)/A,'PO_9NL0>)/ R5?5*&*S66DH*-$C:[UKP7XEL_[,EU)-7A_LT7-Q80VE M[I\]W^&7_!L9_P WN?\ =MG_ +WVOC+_ (..O^4AG@3_ +,R^$/_ *N_]J"N M[&8*EF/%.(PM:52%.<:\7IVW.3#8FIA,BI5Z<82G M!S24U)Q][%SB[J,HO9Z:[]]C^X&OAG]IS_@I/^Q;^QQXVLOAU^T=\8I_AYXR MU#P59?$2ST>+X9?%_P :";P?J.K>(]"L]6&H_#_P!XKTI7FU7PEX@M?[,DOD MU>/[ L\M@EM>6$UU]S5_$%_P49JS>^FVUCU,PQ-3"8=UJ<82DJE.-IJ3C:)/$4V MBVL%WKE[I?A'P-H7B;Q5<:%H"7NE0>(/$JZ,/#VA:AK_ (8TO5]4L]3\4>'K M34_XM?\ @B?^U[\)_P!F+]JWX@_'']KWXFZSH,GCW]G_ ,6Z!KWQ U_1/'_Q M,\4>*OBAXJ^)'PH\8:M/XAO/"6A>,_%.IZSKS>'_ !+K>L>)-8CEAOM1@EEU M'5'U&_MA=?VE_M.?L8?LQ_MD:/X4T7]I'X3Z1\2;?P-J6H:KX0OWU?Q1X4\2 M>'IM8M8+36[/2_%W@;7?#/BJVT/7H[/2YM?\-KK/_"/:[?Z#X:U35M,O-2\, M>'[O3?XH/^"%W[+WP,_;+_:(\0^ ?VD?!,GQ%\)Z=^S-JWQ"L]+3Q5XT\&O% MXOM/''PBT6WU=M2\ >(O"NJS;--\4:[;G3Y[Z32Y#?">2R>YM;*:W]7)5@/[ M-S7VRQ7,J$/K7LU1M[+VDO9_5N;7VF_/[3W=N4\_,WB_KN7JG["WM9>PY_:: MSY8<_MN73E_DY-=[G]I7[+O[<_[+7[9\GCN+]FOXFR_$9_AHGA:3QL)/ ?Q* M\%#1D\:MXD7PR5?XA>#O"::H=1/A'Q#N71VU!K#[ IU(68O=/-UY#\8/^"LG M_!/+X$_$+4OA9\1OVF?"]OXXT,7L7B#2_!WACXB?%.R\-ZKI>OZWX7UGPOXG M\1?"SP=XS\->&O'&@Z[X>U6P\0^ M=UC3_&GA\QVEQK6@V-IJFESWOKW[+O[ M#'[+7[&$GCN7]FOX92_#E_B6GA:/QL9/'GQ*\:C64\%-XD;PR%3XA>,?%B:6 M=./B[Q#N;1UT]K_[>HU(W@LM/%K^;'P1_P"#>/\ 8&^&VB:YI7Q.M/B5^T#+ MJ%]+%H,_BKQ]XF^'-MX/\-Z?KGB23PUIVCP?!?5OA_J%[K;>$M2\-Z)XXUO7 MM8U;3?$7B#PM_P )-X0\,_#;3M;O?"*J-K M]YSS_@04))M638JE24(81UY&=!O$^R>(;KQ3=?$]_#'AKPU?IJ7C+5_#;Z=KMMI M/Z=_%[XO_#/X"?#;Q=\7_C%XRT;X?_#?P-IJZIXF\5:[-(EG8PSW=MING65M M;6T5QJ.L:[KNL7NGZ!X8\-:+9ZCXA\4^)-4TGPWX#+KX8WWPJ\7Z"/BCI&N?%;XI>.+'QAX!\>:IIW@J MRFTJV^(VI_$741XS\-^/=5\&OI46G^)/!/A]O!VL?$*YUU?$FN67@NRLOTT_ MX)6_#3P;^T?_ ,$>_@5\*/C[I)^+_@+Q?X=^*7A'6]"\=W^IZYN\->&/CY\1 M;'P/I6F:E'YO#&A2:?T8 MK!9?]3H9C@YXKZO+&?5,11K^R=:$N3VMZT5*4>;V=IJ3"/$&A0> M--$T;2?B#9?%#Q"_AO2?"UM-K'B74-?\0Z1I>I7OB7[=J?\ 6]\$/^"K'[!/ M[1WQ4\)_!3X,_'2X\8_$SQP^N1^%_#;?";XW>&TU)_#GAG6O&.LAM<\6_#;0 M?#NGBS\.^'=8U -J>KV:W+6BV-H;C4+JSM+C^0W]H3]E[X&>!/\ @M&/V1_" MO@F33/V>W_::_9&^'K> 6\5>--0?_A$/BCX"_9]UGQUI"^+]4\17OCI?[!GUR3POXD;XL_&[Q(FFOXC\,ZUX.UDMH?BWXDZ]X=U 7GAWQ%K&GA=3 MTB\6V:[6^M!;ZA:V=W;^IG"RI8++KK'J;R^^"Y5AN6UDX?6^O-SVY_9=+VU. M'+GF'UG&?[IR_6U]:O[:]].?ZOTMRWY?::WM?0^>/VOOA[_P1[U3]M3X5Z)^ MUGX&\,:E^UW\5_\ A4P\%:3=>%_CO>:/\2?[1\;7O@+X:?\ "P;'X?V,OP8\ M7B_U_07\%ZE_PMR/4!=^#M&TGPWXS\SX>Z=HUE#^RE?RE_\ !5/_ )3B?\$W M_P#NS_\ ]:[^(E?L=_P5B_:]U_\ 8N_8Q\;_ !,\ >(M'\-_&'Q7X@\+?"_X M-WFN^%]0\5V3>,O$][+J6NW%O8P6\^B6VM^'?A9X>^(OC+PQ>^-=W@H^)?#. MD6&NZ;XG2_@\'^(?*Q.#J3ADU.G6KUIXVBE"G6J.5.C*57V:C25OW5+9R6MD MKMV1W4,3",LRG.G2IQPU5N4J4.6=2,:?.Y5'?WZFZ3TO=(ZWX_?\%0?V$_V7 M_BA>?!CXW?'NQ\*?$O3-%TC7]8\-:9X$^*7CIM"LM>BFN=(M?$&K?#WP/XJT M+0-?O=.C@UN/PMK.J6/B9/#NJ^'O$'RT'C.^/AF'\7O^".?_ 3!^$/[:_P]^+7[57[9FE?$ MWXG+XL^(WB?P?X1T/Q-KGQ'\$VOC/4(%\.>*?&WQWD^)V@>)M!\:_$W4M8\7 M:UK?@-=0LM=BT'3/%'AGXFP^)YO&'BNXME\ _2'_ 4I_P""&O[,/@C]F/QK M\:?V2=/N/@EXI^ ?A7QO\4_&N@^)_'GQ1^(WA;XH_#SPQX>E\0^*])GU'X@> M)O'?B+PGXT\.Z3H=YJW@#4M"GB\.ZQ>2ZKX/\9Z.8O$6A^/OAKU2P624<3_9 M];$8]XE3C1J8FG&@L+"N_=:5-Q=5PC-\LG>Z:T=KLQ6)S2I1^MTZ.%5%Q=2% M"3JNO*ENGSIJ'.XJ\5:UGJF[(_IYKY*;]N?]EI/VIH_V*V^)LP_:7EW-XM5=X&C9_M]ETL_D7_ ,&['[47 MQ*^,'P*^,'P%^(.H:QXGT_\ 9LU3X()XM$\;6/@?1[+PWX2\ ^&].E_(__ (*2 M_!WXS?M!?\%KOC)\%?@!*+?XI_$L_#SPAI%S/XLF\$:5;^'-9_9*\$6?Q(G\ M3^(;9GO8_!4?PSE\8'QUI6FV&OZMXD\'?VYX;TCPIXOU35K3POJ^6'R:+Q^8 M8'%UW2^I82MB%7C;D]QT7"I4BU)NG[*K[2<(N,NBFK7=ULRDL)@\5AZ2J?6< M13I.E*_-[WM%.$&FES\]/DC)IQZN/0_HR\4?\%P?^":7AGQ-;^&%^/USXED3 MQIKO@SQ!KWA+X:?$_7/"GAD:!IOB:YG\72>(X_",6F^-? ^I:UX>LO"WA_Q% M\*9?B%%X@U#Q;X8\0Z3!=_#V37/&NA?>G[._[2WP._:O^'$'Q9_9]^(.F_$; MP)+K6L>')M4L[#7-#U'2O$&@SI%J6B>(?#'BG2]#\5^&=52">QU:TL/$.B:9 M'?&OC[XLQ^#K M_1?$/[0%C\0OB#X*\07?B[5K>^,_C3PS\.-/\8:I\)]!3P[?WX;P/X;\0^$O M'-C9:5I.A6'CN[^)&HQ:YKGB#\+?^",OB/XP_LL_\%6X_P!EJ]U?P_=Q^,-; M^.W[/?QVTW1M5\6ZAX)U+6_@9X5^)?C&R\6>#()9_"D.I:OHOCGX8W.D>#_% M7C3PG&M(U+Q!XC\1^(-2L]&T'0 M-!T:SFU'5];UO5]1FMM/TK2-*T^VN+[4M2OKB"SL;.":ZNIHH(G=?R"U7_@O M7_P38L?%/@/0=,^*7CKQ+H7C!?$KZ[\0-*^#OQ)T[PM\,%T/2HM1TK_A/-)\ M6^'_ S\1[MO&EW(VA>&H_ASX"^($MIJL$LGC)/"6C&'5Y?C?_@Y2^*/Q8\- M?!C]G/X5^&[#6+;X._%+QMXZU;XJ^)].L_%,&GS>*/AS8^#[[X5_#KQ!KVFZ MG;>$WTWQ0/$7COQY:>"_%&F:IJ&OZY\)-)\6^&9-/;X(OB]H_F^)]9SP^! MP=/+H9CCOKE2%:M.C"&#]E%4E#W7.M.K&:4I._LX6C>RNVI/ENMBL3/&2P>% M^KPE3I*K*6(]H^=RLU&G&#BVDK<\KNUW9)QU_<3]G?\ :6^!W[6'PW@^+7[/ MOQ!TWXC> YM:UCPY-JEII^N:%J.E>(-"G2+4M$\0^%_%6EZ%XK\,ZJD$]CJU MI8>(M$TNZU/PYJ^@^*-,BO/#GB#1-4O_ '2ODW]C[]C/X0_L/^!?'?PU^"5Q MXP/@OQS\6O%7Q<71_&&MV?B!O"=]XGTKPUH2^$/#.I1:1INJR^$/#^D>%-(L M=$/BR^\4^+Y%6XN/$'B[7KRM07&N:+X4DMOK#]F;P[\#?"_[/GPA6HN.482O[>O)3Q6(IJA*I?#T^1) M\].G;W9RN^:5]>QR4ZM\QQ%+V5)"?#GP_\ #WPA\2V' MA'XDZ[K?Q!\:^%/#_P /3I'A/7=2M(=0U&R\4W=I)8&XUNRENM#LKW4;?Y/' M_!=K_@F2^L:/86_QV\17&D:IH.NZU<^+#\$OC=9:/H5WI%YX;MM.\-:QI.I_ M#ZQ\$-5T2VL_!WB2'Q1K7AO5+KPCIOBK^8>[_9-^-G[ M:_\ P5/_ &S?V?\ X,>)8?!EMXH_:&_:,O?C%XNU+5+B'P[X;^#>A_MM9 MUCQ%X4L]7TB^^)J6'C2T\!77A;X=VDNW6?B)#X+O]3U7P7H6DZK\0_!_]#'Q M=_X(!_L1ZA^SWXS\(?!7P+KN@?M!0_#=].^''Q@\7?&7XG2?VC\3="TJWE\/ MZW\0]%6?Q-\.;30_&NOZ;;V?Q,'@_P"#EN;'P[KOB.7XE1J*%!4;T(U(1*A M4EAZ.%BJ52I#FJ^UM5<).T:<8RNFE92E*7*Y.RM9L_97X1?%WX;?'GX:^#OC M!\(?%VF>.OAOX^T>+7/"WB?2?M,<%]9M++:W-M=V-_;V>K:)K>CZC;7FB^)/ M#6NV&F^(O"_B'3M3\.^(]*TO7-+U#3[;T>OXW/\ @VN^-7CRS_:)^-G[/<%^ MES\*_&7P3U#XWW.E7UUKL\FB?$#P#XV^&O@6RU3PQ8#6D\,:1_PEGAGXE75G M\0+T^';G7_$@\$?#*W_MNRTWPD+"^_LCKR5RNI1W2E%N+L^SM==4FD]3DO'WCGPM\,/ M OC3XE>.-3.B^"OAYX2\1^.?&&LK8:EJK:3X6\):/>:_X@U-=,T:SU'6-1-A MI.GW=T+#2=/OM2O#%]GL;.ZNI(H'^++'_@J3^P=J'[/_ (C_ &HH/C[91_!# MPM\3+/X-ZGXKOO /Q5TS5+KXG7VD>'O$,/@[PYX#U+P+:?$/QAJB>'/$VF^) M;QO"7A36[33O#5MXA\0ZA$O%=]HOJ?[>'_)CO[9?_9J7[1'_JH?&%?Q MZ?\ !(S_ ()C^)OV[= Y[O7S>^. MO@WU8#+\'7P.(QN+Q%6A'#5Z<))I8JCAL/2A5E6I3DN=RBHRC)+GG)/2G&-W)*+E)VC%IL_HZ\%?\%TO^" ]1>WTGQ[XD^.'AKX3>'-+DN#K.DZKKGA.RU/Q%8_K)X;\2^'?&?AW0/& M'@_7]%\5^$O%>BZ5XD\+^*/#>J6.N^'?$GAW7;-$U_0-;TN>ZTS6-%UC3 M+JVU'2M5TZYN;'4+&Y@N[2>:WFCD;^8C_@J9_P $2OV=?AU^R]XJ^._[&_@O MQ#\//&GP,L=1\=>.?!!\?>)_''A_XE?"^W;3Y/'=]?7_ ,9/B%J5YX1UOX4> M&;35OB/HMYX4U=CXDT?2/%G@6;P-XP\4^*/ NJ^#/3/^#;G]H+Q3XX^ 7QJ_ M9OUNP1_#O[.OBOPSXG\!:VDVE6XAT#X^:C\1?$.M^"AH^F^'=.N6&B^/?!OC M#QR_BC7/$/B/5M;N?B?"\K$X# U,OEF.6U,3R4*L*.)HXOV; MJ0Y[1A4BZ246I2E%6UU;LUR\HJ&+Q4,7'!XV%'FJTY5*-7#\_)+ENY0:FV[I M)N^FRT=[G[^_%_XO_#7X!_#/QG\8OC!XNTWP+\-O &C2Z[XJ\3ZHMW-#8V:2 MQ6UM:V6GZ=;7NL:[KNL:CB>&O#&@:?JGB3Q5XBU'2_#GAO2=5UW5-.TZY M_+;5O^"]'_!-FP\5^!/#^F_%3QOXDT/Q>OB5M=^(.D_"#XCV'A3X8C0M+BO] M+_X3O3/%6@>&_B'=MXSNY'T3PTOPZ\">/VM-4@EE\8CPGHK0:O-^%?\ P4S^ M.OQ7_P""B'_!2K0_V&_ _CG6+[X&^#?C]X4^"?A/1_ _P^\6:HOAWQO$^E^# MOCY\7_'W@^XN=)U3Q[JOP8UZ7XI6]QXA-UH/@KP]\)?!6K:OX8O]'T?Q!XZ^ M('B_]XM%_P""#O\ P3#TW2M!LM5^!'BGQ7JVC:1IFFWOBC6OCU\?--U7Q/>Z M?906ESX@U[2?!GQ*\*>"X]7UJ:%]2U.#P_X4T'P_'>W,Z:1H>E:>+>Q@IX#+ M\#A\-4S.>,E7Q=)5X4,'[&/LJ$_@E5E63O-ZM1C:TDXRV;<_6L9BJM>.!CAX MTL/4=*57$>T?M*L7[T8*F](K9MWNFFK7T^^_V=/VL_V>%M?D\-2>*O M#FCIXGTS39M:\/MJ6C/!?R^X^(/$&@^$]!UOQ3XIUO2/#7ACPUI&I>(/$?B/ MQ!J5GHV@Z!H.C6MZOJ,UMI^E:1I6GVUQ?:EJ5]<06=C9P375U-%!$ M[K_!;\?"SXE:I\0-$L-'\/_%'0+.VU&W\+^(OB;^S MSXH\::WI>L?!7XQEO"NK>$H];UN;X>Z[X9U'Q+HGAC6=&%_IWA3XS^$_#?@? MQE;:/X2\#?L;_P '*7Q1^+'AKX,?LY_"OPW8:Q;?!WXI>-O'6K?%7Q/IUGXI M@T^;Q1\.;'P???"OX=>(->TW4[;PF^F^*!XB\=^/+3P7XHTS5-0U_7/A)I/B MWPS)I[?#G6))JJ9+!XS+Z>&Q#E@\S3E0K5(I5(1@DZL)Q7*I5()JUN52E)1L MK7%#,IK#XR=:BHXC!/EJTH-N$G+2$HO5J$FG>_-RQ7-=GV1JO_!>O_@FQ8^* M? >@Z9\4O'7B70O&"^)7UWX@:5\'?B3IWA;X8+H>E1:CI7_">:3XM\/^&?B/ M=MXTNY&T+PU'\.? 7Q EM-5@ED\9)X2T8PZO+^D'[._[2WP._:P^&\'Q:_9] M^(.F_$;P'-K6L>')M4M-/US0M1TKQ!H4Z1:EHGB'POXJTO0O%?AG54@GL=6M M+#Q%HFEW6I^'-7T'Q1ID5YX<\0:)JE_^'?\ P3*_8#_X)1?M#?L8Z#8V?AWP M=\?/B?XT^'_PMU;]IJ]UCXA>)E^,'P[^(<&M>(= M,=-\7^#?#MYX"TSP*OQJ^&O@W2YO%GB+XO:/YOB?6?V&_8^_8S^$/[#_ (%\ M=_#7X)7'C ^"_'/Q:\5?%Q='\8:W9^(&\)WWB?2O#6A+X0\,ZE%I&FZK+X0\ M/Z1X4TBQT0^++[Q3XOD5;BX\0>+M>O)S2I M%-J4FH1A.G+9Q333A:]I,WPE3'5/9U*SPDZ%6GSIT/:$O"I\4_!)/$]UK_ ($\8^)M'U7Q/\./$EE'/-!CU[Y&_YV?_ M //_ $CVKZB_X+S_ +'/[-4O[)GQ\_;,3X5Z38_M+:-/^SSH,'Q/TG5O$VBW M>HV6I?'GX4_#>[N/$WAO2-;LO!GC#6V\ >(+WP;#XE\6>'-:\16GART\/Z3: M:K!9^%/"\6C^@J&'HYADBQ5;&UX5\#E^(@G.%1TZU6J^2C'VB2CA(N.L%>:3 M=FVSE]K6J83,O84L-2E2Q6*HR]R4%.E3@N:I+DNY5Y)NTG:+=KJQ\4?\$3/^ M"BW[%_['?[*WQ ^&?[07Q;;X=>-->_:"\5>.]-T6W^&?Q8\6I=^&=3^''PH\ M/66JMJ7@#P%XGT>%YM4\+ZS9FRNK^+4XEL%GFM([2YLIKC^ASQ'\5/V._P!K MW]BKQW\6?%=WIOQ3_8W\4^ ?B)KOC/5=<\&^/M.@N?"'PIU77XO&&MVWAF]\ M/Z/\2]-UKP7K_@75=5\-:KH&BV?C"PU_P]I7B;P'BWFO)+6ULX;?]W/CW\"OA7^S3 M_P $R?VI/@I\%/##^#?AGX-_95_:GD\-^&Y-?\3>*'TY_%'@?XD^,=<)USQC MK/B#Q%>B]\1>(-7U!5U#5[I;1;H6-B+;3[:TM(#.(X!YI.-!XV&,>.IJM*3H MQH13LG+#N'[U34N1P<]%[S>MA9:\6L#%U5AI8986;I)*JZK:V552_=N+7,I* M/]U+2YB_\$S_ ]_P3LM_A9\0?%O_!.?0M.M_A_K?Q"_X1WXA>)3I7Q?@\0Z MMXR\+^&M$U*TT+4-8^.MNGCZ^T/P[H?B^TU#0M,M;B7P9I.H>*/$MWHL%OKN MM^+9+K[;^+_Q?^&OP#^&?C/XQ?&#Q=IO@7X;> -&EUWQ5XGU1;N:&QLTEBMK M:ULM/TZVO=8UW7=8U&YL]$\->&- T_5/$GBKQ%J.E^'/#>DZKKNJ:=IUS^(' M_!MY_P F._%3_LZWQQ_ZJ'X&5^4/_!3/XZ_%?_@HA_P4JT/]AOP/XYUB^^!O M@WX_>%/@GX3T?P/\/O%FJ+X=\;Q/I?@[X^?%_P ?>#[BYTG5/'NJ_!C7I?BE M;W'B$W6@^"O#WPE\%:MJ_AB_T?1_$'CKX@>+\I96\3G&-PT\15=#"\];$XJO M)U:JH4E'F^ME>\KG[J:M_P %Z/\ @FS8>*_ GA_3?BIXW\2:'XO7Q*VN_$'2?A!\ M1[#PI\,1H6EQ7^E_\)WIGBK0/#?Q#NV\9W!/'[6FJ02R^,1X3T M5H-7F_0G]G3]K/\ 9Q_:U\+W7B[]G?XN>%?B;IFF^4= ?$EGHWCKP9'KMYX6U^3PU)XJ\.:.GB?3--FUKP^VI:,\%_+\":+ M_P $'?\ @F'INE:#9:K\"/%/BO5M&TC3--O?%&M?'KX^:;JOB>]T^R@M+GQ! MKVD^#/B5X4\%QZOK4T+ZEJ<'A_PIH/A^.]N9TTC0]*T\6]C!_,S\?\%#?#%Y\+/B5JGQ T2PT?P_\ %'0+.VU&W\+^(OB;^SSXH\::WI>L?!7X MQEO"NK>$H];UN;X>Z[X9U'Q+HGAC6=&%_IWA3XS^$_#?@?QE;:/X2\#.A@,J MS'VM#+JN.IXN%.52E'%JBZ>(4-917LHITY/I=V2L[-J1-7%X_!\E7&0PL\/. M<85'A_:J='FLE)^T;4HK6]E=OJDT?W>>/O'/A;X8>!?&GQ*\<:F=%\%?#SPE MXC\<^,-96PU+56TGPMX2T>\U_P 0:FNF:-9ZCK&HFPTG3[NZ%AI.GWVI7AB^ MSV-G=74D4#_%]E_P5&_80O\ ]G[Q#^U'!\>[.+X'^&?B79_!W4?%E]X ^*VE MZG=_$R^TO0-=A\(>'/ FI>!;3XA^,-2C\/\ B33_ !%>/X2\*:W9Z=XE3JRK4IR M7.Y1491DESRDG94XQNY)1A^#O#^N^+_ (;?$W0?"GB==>TSPU=0^+8O$<_A*33?!G@G3=9\07OA;7]? M^*LOP^70=2\)^)M?U6VM?A^FA>,]=_66OY-O^"P__!(G]F3]G7]E,?M$?LK> M"I?AA>?"OQIX>B^*6D:O\4/B9XQL/%_@+X@ZMIG@73Y])L_'][\0K\^,_#?Q M!U;P2VEP6/B3P/X>_P"$,UKXBWNN_P#"2:]8^"["U_0/_@WT^,_CWXL_L$W/ MA[QS?QZM;_ ;XT^+?@IX"U*:ZUW4-;D^'MAX*^&_Q&T+3->O]$K+18=#T#P[\-_#O@GPKINB0_V%-?7[QF!P3P$,QRZIB726(^K5J6 M+]G[6%3D4XRBZ247%IIM:_$M59Q1AL5BEBY8/&0H^T='V]*IA^?DE'FY7%JH MW*Z=[/3X7H[IO[]_:9_X*"?L?_L>>)/"O@_]HKXSZ=X \5>--&O_ !%H/AZV M\*^/?&^L-H&GWL>FMK6KV'P\\*^++CPSI>H:@;JQT"_\2QZ1;>)[S1_$EMX< MDU2;POXB32_G/]FW_@L[^P3^TQK/PT\%:%\1_$?PU^*WQ4UJ\\.>'/A3\6O! M.M^']>M]?COM4M-%T75_&WAV/Q;\%+;5?&4>G6TW@S3[7XJ7UWX@OM?\.>$K M:%?'NK1>$T_E)_9"N/@-^U]_P4'^(OBS_@K)XGNOAC#XSL_BKXJ\8^&/'7C/ MQY\%/#NG?&JPN++3K;X,^-_%GB#7$\=_"/P?\,/#2^+=.\(^&=8^)7@O4/#> ML_#3P!\+I_$]_"1X#\6?UH>)O^"/_P"PIJGQH^'_ .T!X*^%][\%?B;\/OBY M\,_B]:W?P=UV?POX/UJ_^%GV&31/"%[\+=1@U[X6^'?!VL7FDZ/J?BI?ASX- M\#>+-;U?3FU5O%EO?ZSXEN-;VQ> RS+U3H8J6/EB:F'C65>DJ/U7GG&\80C* M//4IQ;4:DU.^B<4KN*RP^+QN+S6&N?$K5]+N["\^)OBGXK M^,?A=XU@TSXI:AIWAB]N/#OA:P^%7AG\W?\ @FM\.-&^#G_!'?A/\ 'G]L?X9>']2\0S6%QK^H:%X ^&/[0OA/1[W7+C2M.T?2[C6+K3M( MMI]3GT[2-+L9KUYY+33K*!H[:+^[2OXC/V,/^5B+Q-_V=_\ M_\ _J,?M-5] M;EF.KXG!9K0DJ=.AA\HK*G1HP4(*7LW&526\IU)VO.R/[ M%+;6-^)/$5[JGB;7I]1\0:OJFIWGZ545\O2KUJ$G*A5JT M9- M_:H_X*5>"KSP]I[_ E^'_PL\5^)OVO;;X=1^/-1\4>(?"?@WX<_$CP]J_PZ M^%_A_P 9^(/"FK7?Q M?"OCSQC\+/!GB?6?$UIX9U;Q/\-[+Q5K$>N:/XRN= M+2;]Z?\ @X,_;4'P>^ V@?LG> _$ M/B7^T8DNH^/_[(U<6^M>%?@'H%\J:E M%??V'XTT7Q/H#?&+Q9!;^"=*;6/"_B7P'\0_AUX:_: \':EY%_9PUZ[_ ,$' M/V/O^&=/V1(OC)XEM/)^)?[60\-_$J^Q=-,FF_"+3++4C\$-% TWQ=XB\,7Y MU+1?$?B'XIKK5EI7A?Q/%!\5+?P-XSTV2^\!61@^EP^*Q6%R;%8S$8G$5*N. M;P>#A5K5*BC#7V]91G)I:^"?@=8 M_&FRU[0/ WAW19_&GC,?%6R^'G]E2Z#XX\1SZMH7@@^%]:^'>G7^HQZE\.?' MD?BC3KVXTN$>&KF&'6!V?A#_ ()-?\$YO!'@;Q;\/-&_9-^&5]H/C6379-8U M/Q@OB'XA>/;$^(M#LO#VHIX0^*GC[7/$OQ.^'T,-A86]QHEOX"\7^&H/#.NM M=^*/#<>D^)=0O]6N?K/]H#Q5X_\ OP&^-OC?X3^'XO%OQ3\'?"+XD^*OAKX M5GT#6_%%_#-_I7B3Q)%K/B*ST[3I- \/ZGIVMZP MER=.TJ_L[^XM[B/^+.__ .#D[]NOQ%I.M:#8I^QWH6HZSHVIZ7IOB+P5\.O' MC>*O#5_?V4UI:>(M A\7?'SQSX5N=8T2>:/4M,M_$OA'Q'H$U];01ZSH>K:< MUSI]QY^ H9MCZ,:.$KN-'#SLH?68T%"523GS!=0_8J_X+&?"?X5_# M+XGZ!XJA^''[;?@GX0Z)X\T75/#7Q FN_AY\2?B!8_"_Q%X2\5:BWA/1O#]O M\58_A=X\UWX6_&*WT/PSH[>!/BF/&VF>%)=.OO#VEZI#_H-5_#U_P0:\!?L] M?&K]LW7/'/[1?C;_ (2_X_>&AK_C_P"$GP]^+6B3^)A\2_B*VJ:'XOE^/>A_ M%35/B%?3>,?C'\.I[#QQKVL^!/'?@"^U\7>MZ'\?/!7B[6?$?P]\3WOP_P#[ MA:Z>):E\7AJ,E.5;#8.E1KUYTY0=>HKN4X\R3G!MMJ=N5R)7TK0X[C48?I"ORM_;#_ ."2?P"_;<_:;^'/[17Q MC\6_$)++P5\-=(^'.O?#3PS=Z1I&C^.;#PG\1+[QYX5BU'Q)_9L_B31=%N(/ M%_Q*\-^.;#0[FUU_7K+7_"NH>#_%WPXU/PCJ=QXR\3"QPTJT5BZE2E0M)SE2 M@IU':+<803:BG-VCS2]V-[O0]2O*M&FWAX0J5;I1523A!7:3E)I-VBKNRU=K M+4X$?\%Y_P#@FT?B#_PAO_"T_&W_ C/_"$CQ7_PMT_"+XB#X?'6_P"VSI7_ M K?^R#H7_"W/^$V&GC_ (2'Q-GPZ/T:_9T_:9^!G[6? MPW@^+?[/?Q!T[XC> Y=;UGPU/J=KIVO:!J6D^(= N$AU+1/$7A7Q9I6@^+?# M&JK!/8:Q9V/B+0]+N=5\-:QX?\5Z5'>^&O$6AZMJ'YVZ_P#\$&/^"8.K:3KM MCI7P+\7>$-7U?2=4T[3_ !5H'Q^_: O]6\+W]_936MKXBT+2/&7Q,\5^"+C5 M]$GECU/2[7Q-X1\1>');VVACUG0-7TU[K3[G\;/^"!/@KQY\%/\ @I#^U-\" M?%/B17O_ (??!CXJ>"OB%HWA'7M>G^'7B3QY\*?CQ\,O!UOXDM[#4+;1/[?7 MP_-?^-+7P-K^O^';+7M*T+QAXCAMK;1O^$EUVQN?6>#RO%8/%U\!/&TZV"A" MK.GB_8RC5IRERMQ=**<9+=W;6R2U+]<\.>%_ ^M>(? >F^(H=2$?AY?'^E^%[O7;W2O$^FZ3;7FH^$/ M%5KHWYY_\'(?_)COPK_[.M\#_P#JH?CG7R=_P2^_X(K>%?C1\+M-_:4_;]AU MCXD6OQ2\ >"(O@=\)HOB3XQLI_#WPIL/#_A^T^'WCKQIXZ\"^*]*\0R:I?>! M-'\-Z%\,OAII'B1/#GPX^%L=E9^++>_\6ZM:>"O@PJ& R]9=1S#&U\1!3K5: M3HT%3E4JN/+R*ESQ4867-*I.#'\8 MV_PJ\:^$/%GA#Q/8M8:;9ZIXB\)?VUJ6D?\ "N_$OC;PM;7-W/J_A_P#XX\8 M/'M5\0VWZ'U_"/_ ,%EOV%/!_\ P3\_:!^#?C;]FJZU MCX/9K:X\+>'](\%:;2-%AG\2^(Y;"VM[&.76=38/E=,TP>+K5*N)PV*C3A7PS@Y2I.7LIPG'FC)<[$%US36T&36TUJYL["X^ M=/V6O^"P?["O[5MUX5\-^&_B?<_"SXG^+MT6G?"7XY:;!X"\5_VI<>,++P5H M'AFT\2V^HZ]\(_%'C/QAJ6JZ)=^$O!/@7XF>*_%FM:?J\9BT:/4-+\1:?HO\ MMG_!/#]G/5?^"M'[?GQ,^(?[3-QXPO/"3?V[\?OC3>>$[/Q?/X7U[5[KQ3X> MTCP;\ +;X@:UKVL:O\-/"NHZ9?7.F>!M)?Q!JOBZU^#/PFU[P3\/[W0KC1+; MQOX+_<[]J3_@WH_9"^(/PZU./]E^TU_X!?%32M$UQO#,>J>/_'?Q"^&'C;7+ MN719[#3OB?:?$;4/B'XOTS2HK72]4T33=8^'6KZ')H,GBS4/$GB#PO\ $L:) MH_A8]=?+LHP4X8/&8G&1QLH4Y5:U*%*6%PTJD>91G!_OJBBFG)P=VN5KE?-% M<]+&9AB8RQ.&HX=X52DJ=.I*I'$5HP=FXR7[N#;345)63NG>RD?D-_P;:?\ M)]_CO_LS;XD?^KC_ &;Z_M]K^(?_ (-NV1OV]OB"T8VQM^QW\3&C4+M 0_&; M]G H HX7"X&!P.E?V\5GQ/\ \C:K_P!>UR MXN-=\+P0:/K7BF+2M-U.:?Q-X=ABLKF=Y-=TA%;4+?\ D(^(7_!(;]MOXG?" M?]H?]M;_ (*&?'G5++QM\-_@E\:OB5HWP]E\0V/Q3^)&I7?@OP]\:/'.E>#M M0\16%]<_";X-?#6S\=?\(]XQ\.^"/A4GCSP]/X%\7>*?!NC:+\$?$$5K>:=_ M:!7R3^WY_P F(_MK?]FD_M'_ /JG?&5<.78ZOA*BA05.$J]6C&5?D4J\8'?#_B_P_KOA/Q9H6C^*/"O MBC1]3\.^)?#7B+3++6_#_B+P_K=E/INLZ%KNC:E!F:A; M7%E?V5Q/:W4$L$LD;?RM?\&Q/_'Y^W'_ ->W[,/_ *-_:)K^KVNGB)_\+6-] M:'_J-1,]*OU^(GQ M U*W\.:?XB\-:;XH^)?B?2O&FO?#+1+O7_C#_P ('<>'M4MO%6B_#O6=.U7^ MR]";5M#/%/PQ^)=[ M\??#.O7JZ)?B==,HJ8_'8ZE3GCL6J%.]?$REBJRBJ%*TIJ3Y]%/2G?ISWV1& M80PN%PM2<<+A_:SM2HI4*;;JSTC9H:5XM^> M._\ B'!XA\._\BQJ9]G_ .#AS]N#6?AGX(\%?L9?#3Q1K/ASQ5\7=!N/B!\; M[S1KB^TF=_@9<3>(/"&@> +N\N/"TEGJ6A?%SQ3IGBJ3Q./"WC?2=L^(?%5YH$?C7QYK?B3Q9%X8B\0:EI?A:/65\ M.:'+'HFEZ?;P_P 5_P#P70^*/_"Q?^"F_P 5O"7Q)T=)O GP-\-_!GX2V\'@ MC5/^$.\7Z]\.=6^'7AKXX>(1<^+-?L?'FB:5XRDUWXT^-=+T3Q.G@J]T+1=) MM_#3W_@O7[O3-5GU_MP%2.;\0SQ52//3IJI7I4Y65X4$H8>+3LK\SA-IV7-= MMVN-"$N2?LU_#/XG_M._L_^%_B!^T3\4/"%UXF\7Z'\9-$U+Q;I'P^\.>-K[2_$'A+P M"_PE^(OAG1-"\)>.O"_A?2_#2>.I-=\%:CX^\*?$74?B3X3TSQU?>"9[2Q;[ MROO^"6O[ %U\6_ 'QPT[]F3P-X-^(OPOU3P?KG@F\^&-]XL^$WA?2M<\!^*Y M/&WA?7+KX<_#+Q%X2^'&O:W9>(G2XO-7\1>$]6U'6]/M-.T'7;G4M TS3M,M M?P3T;XX_\'*'[0>H^*/B'\.OAYXM^%'AS^W;;PZ?AU??!_\ 9V^#&B^']1TC MPUX=-_<>$=!_:YMG^,NN^'M9DNEUJ;Q-=^*/&OAV;Q)J/B+0_#^MVT&@2^&O M#U#]FK_@MW^U?^S#^T)XC_9__P""G%E/KNA>'O&.K^'_ (D^+)/AWH7A_P"+ MOP8U.[L/#;Z'J,6B?"G3-%\'_$3X2V6GQ2^*XU\.>#]8\9^+_#'CF'X@?#_Q MOX\T2R\'>!?%&5;!9OB)XBO#,G,VDKG]?%%%% M?,'N!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 ?Q!?\&VG_ "??X[_[,V^)'_JX M_P!F^O;_ /@Y'_9/N-'^)OPT_:TTG2- '@;XK^'+7X'_ !/BT_0?#NBWDGQ/ M\-6OB/6O"?B#Q1JL>MIXA\?:O\0?ABNH>$[6X;PM)#X+\-_ G2]+U7Q1/;:_ MX3T33/5?^"&/[ '[8/[+G[8'Q.\>_'WX(ZW\-?"&D_ #Q=\(I]=U;Q!X)U&R MOO'OB#Q1^SI\1]+TWPZWA_Q/J[^+='E\+6NHFX\9^%$UKP18>(M%U_P3?^([ M;QKH&L>'[+]T/^"DO[+>G_M>_L:_&GX41^$F\7?$"R\+:GX_^"-I9/X,L/$$ M'QL\$:9?ZO\ #^S\.^)?'=K-H7A"3QI?+/\ #/Q3KS7WA^>3X>>.?&>A-XG\ M/6>M7FJVWUV,S&E0XBIXNG5IU<.X4*5:5.<:D)4:E*,*MW%N+Y$^>U_BBKGS MN&P52KDT\/.G.G64JDZ<9QE"2J0GS0T:37-;EO;:3L?R1_\ !0W_ (*#>(?^ M"I%O^PO\'OA=H&OCXAVVBVFE_$CP':ZS?>!?!?BK]K?XG^(=(^&]IX:TGPAX MKUBY\')H^AOH"ZU\'?B9K7Q)\3S67@/]H+4?#7B2_P# WB33?B)I=Q_4)^T! M\#=&_9H_X(W?M%_ /0Y=%O;;X4_\$[OCUX/U#7- \*67@C3_ !?XFT[]GWQE M_P )AX]D\+6%YJ<&DZM\0?%DFM>-_$$3ZKK%[<:]K^I7FI:UK&HW%UJ=U^#7 M_!''_@EW\=-)_;+3XK_M3_LZ^-O!?P^_9VNO'Q\,W?C_ $WP=:Z!K?[17@O4 M_!^D>$6LO#7BF'4M<\?>#M'L/%7B/XF?#/XS_#*QF\ GXB?#GPSKOA3XHW5Y MHITK4_ZB_P!M?X?>,/BU^QI^UM\*OAYHQ\1>/_B9^S)\>OA]X'\/KJ&E:2VN M^,/&?PK\5^'/#.C#5=>O]+T/3#J>M:E960U#6=3T[2K,S_:=1O[2SCFN(^7. M*V%I5,%E^"J0GA,))UI3A.,XRJUZO.[SBVI>RA:*=_=3<7MITY93KSCB,9BH M2CB*Z5)1E%QE&G2@HJT6DU[2:;:ZV3ZG\\W_ ;&?\WN?]VV?^]]KY+_ .#D M'PYXAM?VZ_AAXMN=!UJW\*:W^R7\/O#FB^*)]*OX?#NL>(?"WQA^/NI^)]!T MK6Y+==,U'6O#>F^,/".H:_I5G=37^C6/BKPW=ZC;VUOKNER77Z6?\&^O[,'[ M0G[.?_#:/_"]?A%XU^%7]I^-/A;X"T3_ (332FT?_A)==^%W_"U/^$ROO"?G MO_Q5G@NV_P"$T\._V%\2?#?]J?#KQI]LNO\ A"O%7B'^Q]:_L_ZH_P""R?\ MP3D\8?MY?"7P3XF^$_B":'XT_L^P>/M2\"_#[4;K2-/\)_%73/',7A&7Q3X2 MN=8U)+4^&O'+GP)H)K;X@?#WLGCL-1XKG MBI5:> OBM\/M6;7O 7Q.\%^%OB M%X(UQ]-U;1GUKPAXTT.Q\2>&M6;2->L=+US2FU'1M2LKQM-UG3-.U:Q,QM=1 ML;2\BFMX_P")_P#X.2?$&@ZU^W!I&GZ/K>D:M?\ A+]D_P #>'/%5CIFI65_ M>>&?$,_CCXS^+8-"\0VMK/+/HNLS>%?%7ACQ-#IFI);7LOA_Q'H6LI VG:OI M]S<='\"/B'_P#O@+XPT'P M?J!\+^,/G3XU_P#!%/\ X*8V6H^"M0G^%^K?&/QE\>O"4GBOQQJ6G^-O!FL7 MO@CXX>+[CXO>,/%W@CXH^/\ Q#\0&75=>@\+^%M!\1>,OC%KDFF?#+6/BKX[ M/PW\,>/_ (@>(KKP[KGC6LKP6'RS'RK8C,L"XNG6AAXTZ\9NI&4)-5*LO=A2 MCRII7;YZGNQT2;,=B:V-PJIT<%BDU.E*LYTI1Y'&$?$^H:A86]IH&JS6G M]P=?Q5?MP?L&_P#!13]C_P#;C\>_ME?LO>'/'/Q)3QO\8_B1\2OAA\4O@A\+ M].^*_B_P#K7QZB^)LWB3P9XF^"]YHGQ-U2";PIX;UWQ1X4N/B!J/@O6OAQJF MFZMX4UF+7?#/COQ*G@;PQYF22I3I9G@YUJ5"IC,*HT95IJG3=2$FU!S>BYN; MULFTG:QV9G&I&I@<3"E4JQPU=NI&E'FDH323DHK5VY?3NU>Y_8=\8_B?H7P1 M^$7Q4^-'BFQUK5/#/PB^''CCXG^(],\-VUE>>(M1T+P#X8U3Q7J]CH%IJ6HZ M1IUUK5WI^DW%OI=MJ&K:993WTD$5UJ-E TES%_$K\&_!/[>'_!>KXR^)M"^+ MGQTM-#^#WPM6V\9>+KB32;>;X3?";5]>F^(X^%&B_#O]GW2O$?AY_&OC.]?5 M?&WA?2O'?BC7IO%VD?"S0]!OB_I/A3PAJ M'AF3XI^'W\+:?>>"(O ^H_M"Z!XFO=6TJV\/>)-/O_&]EJ6NZMJWXF>'OV"O%2^(_#5KJ7PZ^&'CSXP_!SXX>$-'L;"\T M+6/BE\,?A?J6J>,?A?XJ\)WWBRVNO#+^)=5\)>(=/\4V/C_PU\._''Q#^%][ MX]N/&?5EE*GA5F5"&(P']J15'ZI7J3IU*%M)5HT*M2/L_;)2<):.TXZ7C&"JRHXMX"3J_6*4(U(5;_#3=6G!J?LVUS*WV6W\4HIN_;1_X(,ZO^Q? M^S3\2?VEKK]K#0/B7!\-O^$.W^";+]F^Y\!7.M?\)CX^\+> 5\KQ9)\??&J: M3_9K^*5U9\^&=3^W1V#Z:/L1O!J%I_1-_P $1/\ E%_^S'_W6C_UH3XL5_/[ M^U'\&O\ @MG_ ,%'/@UXA^/7QB^%E[X8^%OPNFB\>^"/V75\/ZK\,?%^LRVE MO>^!?'.K?#'X#7=CX@^,'BOQMX;LO"^M>*+#2_CQK=KXPUC2/'NKVG[-:^*] M/\=0>"=0_H__ ."1_P +_B%\&_\ @G=^S9X ^*?A'6O ?CBPT;QUKVJ>$O$E MK_9_B+1;'QS\5O'?CKPY!KVDR,;W0=9G\,^)-'O-4\-ZS#8^(O#=]<3Z%XET MO2-?T_4M+M*S2O4EDT*.)Q^'QN,CF4)SC1G3E[*G]5JI0O!14^23O.I%.*G- MT^9N-W. I1CF,JE#"5L-AI8)QBZD9KVDU6I^][SDX.25HPDU)QASV29_,S^W M6Z_##_@X"A^(GQ+(^'?P_D_:9_8B^)$7CKQU_P 4CX.E^'?ACP#^SMHWB7Q] M%XG\0?V?HDG@KP]K'@SQCI.N>*DOFT+2=4\)^)M/O[^WN] U6&T_N#K^8[_@ MO)_P39_:*_:5\;^$_P!IWX&: ?BSI7A+X-O\,_B!\(]"M84^(&EZ/X0U3XD_ M$,>-O"UG<:FL_P 2X]>@\4WGA2;X?^%-/D^(<.O67AF/PCH'CX>+=63P//\ M\$UOC[_P6K^-W[3GPHM?VE/"OQ>\._LW> ],\3Z9\%QV,I5*&(DL5B(5*52G2NZM^PQ\-K_2- UK6-/\ #'[4O@37 M/%&H:7I5_J-CX5T*X^%GQI\-V^O>)+RTMYK?0M%N/$WB'P[X7@U75)+2QF\0 M^)-!T..X;4]9TZTNN"_X*-_LP?M"?$S_ (+"?\$[OBQX ^$7C7Q=\,=&_P"% M*?\ "1_$#0]*:]\'>#_^%*_'GQ;\4_B#_P )SXAC?^R_ WV/P3KFF:AX:_X2 M^YT3_A8>J32^%?AU_P )7XMLK[0[;]Q_VF/V=?AO^UE\#/B#^SY\6X-;E\!_ M$73M.M=4G\-:S<:!XATK4M UW2O%GA;Q#HFIP+- NJ>&?%F@Z'XAL;/5['6/ M#6JW&F1Z5XJT#Q%X:O=6T/4)J8VE0?#M=3C4^JT4ZT(2C*<$J[YHR2?NSY;\ MJE;4(8:I56<4G&4/;U6J4I1E&,G[)+/^":_P MH\-^'M5.HZS\*O&WQB\"^/;3^SM5LAH7BO5OB9XC^*UCI2W.H6-I::N)? GQ M,\%:TVH:'/J>E1/K#Z3+?)K6F:OIUA];?\%*=7T/1O\ @GK^VY)X@U[1_#=G MJW[*_P =O"5CJ.N:G9:393^)?''PW\1>#/!^AP76H7%K!-K/B?Q;KVB>&O#F MEQR_;M;\0ZOI>BZ9#<:E?VEO+_*KI_['_P#P5P_X),?&KQ=X^_9N\&>/_B9X M O\ QCX7\#R^)?A%X.M?B_X1_:#\&Z;\87F@>&]:^&NKZ]XV\)?#+XT#3O'NG>*_''7_$E/^"ZO_!467Q5\,O%O MPB^(OPR^#6I>,_A9<>(_AWXN^&\/[+?PC\*B56TNPUUM5^*VGZ7\:_BWX*T+ M5-&O_B7XZ\-:1K_QPOO#OB.+1]6TKP5!JD/POT&'6OEE"OCYXZ&98'ZC5Q#Q M4JDL1&-:$9U/:3I>QMS>U3DXPB[7TYK-V(I8VK2PD,++!8OZU3HJA&"HN5.3 MA#V<:GM+\OLW9.4M4M;7CJ_9?^#9CPM#J/Q._:Z\;+XO\96EQX0\!_"#PM+X M"L-=6#X>^((?B/X@^(&K6_B_Q5X8^RN^J^,O"#_"NZT;P!KWVVV7P_HGCCXE M:>+6^/B8RZ?WG_.S_P#Y_P"D>U?O3^PA^Q3\._V"O@%IOP1\ :MK/BB\O=;N MO'/Q'\<:Y)<07/CKXDZQH^A:)K?B.R\/&_U#3?!NAC2_#>A:)X>\):///#I> MAZ+I\FM:KXI\7W7B3QEXB_([_AF#]H3_ (B)/^%^?\*B\:_\*0_X0O\ X3W_ M (6W_93?\*Z_L+_AE3_A1/V'_A+]_P#8?_":?\+-_P")1_PK;[;_ ,+%_L/_ M (KO_A%?^$ _XJBJCF%#%9CGV)YXTZ=?*,91H>TDH.HXTZ%*G&*E9N=7V;G& MGK/6UM!/"5:&#RJARRG.EF&'J5>1.2@G.K.;;C=*--SY7/X=+WU/Z/*_B"_8 MX_Y6)]8_[/)_X*!?^H7^U+7]OM?RC?LQ?L ?M@^"/^"W_B;]HGQ7\$M;T;X) M:?\ '[]J3XO3?$>X\0>"9?#UQX"^.NC_ +4/A[X9:CI_P#&W@&PU[PUJ_Q"\.^%=)\2Z%>ZAP9/5I4\/G"J5*=-U,MJPIJ< MXQ=2;NE""DTY2;:M&-V[['3F-.I.MEKA"#XG>#OAWXG\*:W!\=--7X;>#KGQ:]_\-OB% M\';"\N/'GQLO?B'X>L7^%?ASPY\)OAC)#/K>FVD'BH^(/#=O?^*?UC_X*Z?! MS_@HI\1&_9B\:?\ !/KQ7XYTS6_AIXR\7W7Q"\+^!?C'IWPQEUN74'\#:]X" MU_Q5X<\8^(O"_P ,OB?X(\-ZAX(U[2/$'A/QI=^(!=?\)E9Z4/ OBCPIKOC> M72/QC\7?MV_\%[OCAX!\&_ S2/V;OCW\,=;\1R^'O VJ_%_P?^Q_\7_A=\1/ M&1UK0KOP1?7'C;XB^.]&_P"%:?!V#7M1UF'Q?K_Q(\#Z+\$C\.]C2E)R;496IU(.Z<92MRS]U23=M=?T=_X(7?\ M%*?&?[3_ (?\1?LM?'GQ WB?XQ_!_P $6/BOP%X[U.;Q!J?C'XH?";2]4T[P MMK]SX_U2?3+G2KWQ;\-]8U_P)I%UXQU?Q,GBOXF:?XTT[4-4T75O$OA3QWXZ M\3?T+U^+'_!';_@F)=_L,> -;^)_Q@32;W]I;XPZ#HUEXBTRVM/#>JQ?!;P9 M;SR:O_PK#0O&=C;7FHZGK.N:D^EZK\7;O0_$,W@'6M?\*>"]*\/6NMVGP_L? MB!XR_:>O-S:6$EF&)E@4EAG- M-?BIK7@G]H+P+XW\0>&/AYX=U/QEXP3PO_PAOQ)\%2:II'@WP_;ZAXJ\3_9/ M$/C3P[%J%EX8T?6-1TW2[J]\1W]I;>&]$UW5M-_3C]DOP1XH^&7[*O[,WPW\ M<:7_ &)XT^'W[/OP9\$>+]%^VZ=J7]D>*/"GPY\-Z#K^E_VCI%WJ&DW_ /9^ MK6%W:?;=+O[W3KKRO/LKNYMI(IGZ*]2F\CP-)3@ZD<;B92IJ47.,7&-G*%^9 M)W5FU9W1C2A-9IBIN$E"6&H*,W%\K:D[I2M9M=4G<_G-_P""5G_*<3_@I!_W M>!_ZUW\.Z_JTK^-?"/PQUG_A=?\ MPCGQ US2FLO!WC#_ (75\>?"7Q3^'W_"#>(9'_LOQS]L\$Z'J>H>)?\ A$+G M6_\ A7FJ0Q>%?B+_ ,(IXMO;'0[G^CRC/*E.KC*4J'FIPE!O$XAI3BXNSJ.SLTG9]'LS^(+_ (-M/^3[_'?_ &9M M\2/_ %;PM:ZBT_C/PI'K7@FP\1 M:+K_ ()U#Q%:^-= UGP_8_UU_5_#D.I6'O$FL>)->T M;P=I=K\.OBUI7B[7++P-U990IXG)L?1J5Z>&Y\9A^2K5NJ7M%%N,:DE\$9ZK MG>D7:]]C'&U9T?[96M>,]6?1-)UO]GKXE?#>PODTS5M6,GC#XP>'KOX3?#W3#:Z+8ZA M>1)KGCWQKX:T634IH(M)T:/4&UC7[_2M"L=1U.S_ I_X-B+N)]1_;FL5:,S MV]E^R[=R(,>:L-Y/^T?# S\Y\MGL+@19 &Y)<$\A?B+QSX:_X+7_ /!4#5/! MWP)^,OPJ^+EOX,T'5? 7CNUE^,?[.NF?LW_#;P=XB\+>&+7X/ZQ\5K_Q_P") M/AAX,\0:KX@U>T\<^*/&WC/P#X2U?Q5JUVWB+QI=?"WX1VOACPYI/A3PU_5W M_P $[_V,O#G["_[,'@WX-Z<%N/&^J?9/'_QMUJV\2:MXGT?Q!\:M=\->'-*\ M;7WA:\U71_#)M?!>G#P]IGAGP7:0>$_#%Q+X6T#2-4\1Z9<^,]2\3:UJRK1I M99E&)P,L10Q&+QU>C*4,-456%&C1E&HG.:22G*46N7JI)JZ38Z;J8W,:.)C1 MJTJ&%I5(J5:#IRJ5*L7!J,7JXQ3W[I]T?RJ?L]Z]8_!C_@X/UG5?BK;:WX"M MM3_;;_:CT'3(==\,^(X;^_OOC]/\8O!WP9N;?2X-)FU(Z+\1]6^)?@2^\/>) MFM%\.3^&O$^F^,;C5H/"4DFMQ_W'5_-K_P %D/\ @C?XG_:7\3ZO^U/^RQI, MOBGXW>*I?#&B_&/X.ZSXGTG3M.^)FFZ?I&A^ ]'\;>"=9\>:YI/A;PIXC\*> M%=*T;3O%WA'4-9T7PCXN\(Z*=?\ #XTWXDZ;JFE_&#X!L/VU_P#@OO\ "'X7 M^)_V?9_@=^TKXF\2>$M=MO#6F?'6_P#V0/B#\7_BAX'M#ET3PQ\0 MM/\ !'BGX4_&+0M8C\+:BMS\4/%WAOXO>)_&\/C#Q#XILOB9JUS=>%]>T33% MT:>=4L#BI/+: MF*HUL/B)TJN(G7HUJ--U5-5%%&_&-EIVJ6%[=^$M>M/B)\=/'!T?Q);VUS)+H>L3^ M#_&OA7Q/%IFJ1V=Y)X>\0:%K21/INKZ?,_&OBZSBT?4+OXF7NHZ19^ M,+GQ[HJZ'KMCXZCC\7>'Y]%UFUL+FT_GN_8 _P""2G[37C[]JG7/VVO^"F4^ MO6GQ"\(_$S1/'W@?P;+X[\*:_P"(OB%\2?#4FC:]X7^(GB?7?A9XBUCP[X9^ M%WP\O++1M-\!?"[0M2TM]2O_ S;>']7\.^%OA!X3L/"7Q4^\/\ @KI\'/\ M@HI\1&_9B\:?\$^O%?CG3-;^&GC+Q?=?$+POX%^,>G?#&76Y=0?P-KW@+7_% M7ASQCXB\+_#+XG^"/#>H>"->TCQ!X3\:7?B 77_"96>E#P+XH\*:[XWETC/& MSH57E65X?&T8_4:=7GQSFXX=8FHE5]RJE=0C.FHPJK2\T].5VO#1JP6/QU;# M57]:G3Y<+R)UG1A^[O*GMS.,VY4WK:+WOK^3G[5'_!O7X\^"6C>)_CI^R%\> M_$WC2Z^$[P?$[P=\._$_A36X/CIIJ_#;P=<^+7O_ (;?$+X.V%Y<>//C9>_$ M/P]8O\*_#GASX3?#&2&?6]-M(/%1\0>&[>_\4_J:=X6U^Y\?ZI/IESI5[X MM^&^L:_X$TBZ\8ZOXF3Q7\3-/\::=J&J:+JWB7PIX[\=>)OSB\7?MV_\%[OC MAX!\&_ S2/V;OCW\,=;\1R^'O VJ_%_P?^Q_\7_A=\1/&1UK0KOP1?7'C;XB M^.]&_P"%:?!V#7M1UF'Q?K_Q(\#Z+\$C\.]"]*\/6NMVGP_L?B!XRWQ MU27]EUH9KB<'BL8IT5E\Z%2E5Q$4I?O75G22_=.&SJ7 M HXC#X9QJ/%QJPG3HR;BO9J$)O\ B*6_+I%;>[S)_GE_SL__ .?^D>U?JG_P M7$\.>(?%/_!+S]IK3/#&@ZUXDU*UG^!OB.YT_0-*O]9OK?P]X/\ VCOA#XM\ M7:]/::=;W-Q#HOA7PIHFM>*/$FJR1K8:%X=T?5=;U2XM=,TZ\NH?B3_AF#]H M3_B(D_X7Y_PJ+QK_ ,*0_P"$+_X3W_A;?]E-_P *Z_L+_AE3_A1/V'_A+]_] MA_\ ":?\+-_XE'_"MOMO_"Q?[#_XKO\ X17_ (0#_BJ*_>#]H#X73?'#X#_& MSX*V_B%?"5Q\7_A'\2/A=!XK?2#X@3PS-\0/!NL^$XO$+Z"-4T0ZVNBOJRZD MVD#6M(.I"V-F-4L/.^UQ<>/Q%*.)R*K&<)QP^6Y9[7DDI\DZ-2)? M#EU^R!\:?!UKK^B7/B[0OVDM9\2ZYX6@U6QF\1Z-X<\6?##X8Z7X6\0:KH<< M[:GIVB>)=3\%^,=.\/ZK=VL-AK-_X3\2VFG3W-QH6J1VOZZ_MX?\F._ME_\ M9J7[1'_JH?&%?QR_#WX3_P#!8G_@EE\3/B;X7^"_P5^+ES-\1?#TEGXE\0_! MWX"R?M-?#CQSIN@1_%/P7\-?&VE^*_#WP]\:77A[5_!^K^*-?^)7@OP=KTG@ MKQ-+--X4G^,WPPU7PCJ;>#M3_J.\$^"/VS_B9_P2N^)?PV_:>TR;7?VS?'_P M#_:D\#:QH\][\(]-EUKQ'XIE^*WA_P"%&GG4?AM=Z=\)=/&I^$+[P/;QWEI> MZ?96D*+BSU>/6GBUS6A3CF4/V>]>L?@Q_P<'ZSJOQ5MM;\!6VI_MM_M M1Z#ID.N^&?$<-_?WWQ^G^,7@[X,W-OI<&DS:D=%^(^K?$OP)?>'O$S6B^')_ M#7B?3?&-QJT'A*236X_W4_X($_!?XN?!7]B7Q1I_QA^&WC7X5ZUXV_:"\=>- M_#_ACXA^'=3\&^,'\+_\(;\-O!4>J:OX-\06^G^*O#'VOQ#X+\11:?9>)]'T M?4=2TNULO$=A:7/AO6]"U;4OF_\ X+(?\$;_ !/^TOXGU?\ :G_98TF7Q3\; MO%4OAC1?C'\'=9\3Z3IVG?$S3=/TC0_ >C^-O!.L^/-$=%.O^'QIOQ)TW5-+^,'3'&859QG%*K7A##YC2K898F+ M4J<)3C%1FY)N/)\2;V4K7:5VL)8:N\MRZI3I2E6P=2E7=!IQG*,9-RCRM7YO MA:6]KV3;2?\ 257\-/\ P<:^(?#MW_P4 T:XL/$6BZF_@W]D_P"%WAOQC9:= MJEA>W?A+7K3XB?'3QP='\26]M2>'O$&A:TD3 MZ;J^GW,WIUA^VO\ \%]_A#\+_$_[/L_P._:5\3>)/"6NVWAK3/CK?_L@?$'X MO_%#PYI_@>;P]H&/B%I_@CQ3\*?C%H6L1^%M16Y^*'B[PW\7O$_C>'QA MXA\4V7Q,U:YNO"^O:)]@?L ?\$E/VFO'W[5.N?MM?\%,I]>M/B%X1^)FB>/O M _@V7QWX4U_Q%\0OB3X:DT;7O"_Q$\3Z[\+/$6L>'?#/PN^'EY9:-IO@+X7: M%J6EOJ5_X9MO#^K^'?"WP@\)V'A+XJ9X##T\EKSS#%8S!U52I58X>CAJZK5, M14G'EC:,5[M.S=YR^%M75M2\76GF5*.$H8;$P]I4INM4K473A1A%\TKN3UJ+ M2T5NKV;V/VG_ &J/!G_"N?\ @FS^T=\/?^$K\:>//^$#_8>^+_@S_A.?B1K@ M\3_$3QG_ ,(O\!?$.B?\)7X]\2BTL!XA\:>(OL/]L>*=<%C9#5M*/B;^RK^TS\-_ ^E_ MVWXT^(/[/OQF\$>$-%^VZ=IO]K^*/%?PY\2:#H&E_P!HZO=Z?I-A_:&K7]I: M?;=4O[+3K7S?/O;NVMHY9D_,?_@@3\%_BY\%?V)?%&G_ !A^&WC7X5ZUXV_: M"\=>-_#_ (8^(?AW4_!OC!_"_P#PAOPV\%1ZIJ_@WQ!;Z?XJ\,?:_$/@OQ%% MI]EXGT?1]1U+2[6R\1V%I<^&];T+5M2\ZC5A_8F.IRJ056>-PTXTW**G)*,K MRC"_,TM;M*R.RI"?]J86:A)TXX:M%S46XIMJR&AK?ASP[_:*>&_C;\-_%NN-_;/BW M6-!\/V@L/#N@ZMJ1%]JMLUR+,VEDMS?SVMI/\N_\$'?V#?&=EH'C3P_?:;<6NO^'M,F,:273JTEP[7HNI359YI":I<\?:.' ML*:YU"_,XW37-:UTU?1BE"I_:].IR3]FL#*#J-K'3]1T*. MUN/BEX"FO/#E[XMUW0?"6G:MX5\)>(]#\;^#-:L;;4](B\5WGC;PUX)\)^$] M-_G5U"7]LW_@@5^U+X;T.V\6CXF?!CQNOB'QS_PANG7?Q!T+X%_&OPOJ?B,> M$=8_M:QUC0SX4\%?M*:?X:\"^ M9US6_!I^('B'X5V>L> -)U;Q)X]^'7B*] M\->,/HWPM\0?^#@#_@G?XAU30?$'P[^+G[5_A?Q9J_CNWT1/$^C^/?VUO"EW MJ6A7G@W2W^(.C^+OAMK]Y\=?AQH6JZ/IEA)\/_!7Q)\0?#OP_JECXA\7ZTWP MFC\>P^)[O0N9^'W[&7_!3#_@KQ\?=&\??MSP?%OX+? CP=KGB_3[B?QKX$B^ M#=UX(T*;5=,\4WGPU^ 7P6\6:/I/B6\U+7K;Q)I/A_2OCCXW\*^+]/N/#_@X M+X\^)?Q3\5?#'1_A_K'L8)3PU-TL?F.7XS)HTJGN.M"M4?N-4XX>#7UB%2,K M)032@K\EI)6\W$\M>:J83!XS#9DZD??]G*G!>]%S=:2?LI0<;WDU[VG-=.S_ M +#/AQ\0O"'Q;^'G@/XK?#W5_P#A(/ /Q-\&>%_B%X'U[^S]4TK^V_"'C30[ M'Q)X:U?^R];LM-UK3?[2T74K*\^P:OIUAJEGYWV>_LK6[CE@C[.L7PWX;\.^ M#/#N@>#_ ?H&B^%/"7A31=*\-^%_"_AO2K'0O#OAOP[H5C!I>B:!H&B:7!: MZ9H^BZ/IEK;:=I6E:=;6UCI]C;06EI!#;PQQKM5\8[7=KVOI?>W2]NI]*KV5 M]^MMK];!7\1G[&'_ "L1>)O^SO\ ]O\ _P#48_::K]$OVB[G_@XUUSX^?&6_ M^!>GV_@WX)I\2_&6E_"#1?#[?L.W.G3?#'0M=O=#\">(Y)?BG?\ BSQ^-6\: M>&-.TOQEXAA\1ZO#<6WB#7M3MK30/".FQ67A/1/S'\'?\$WO^"W'P_\ V@;C M]JGP=\)[C1/V@KOQ?X]\>7/Q(3X@?L@:A/-XM^*%MXFL_'FKGPIJ_B[4/ *' MQ!;>,?$D36$7A./2]+&I%]$L=,DL]/>T^LRK"TL/AL?[7,?\ !9*S^,'C?1?^"B.E6.K?!O4OAM=ZIX4\6W\G M[-$>O:!\3=&\4>&;32O#FE6W[/VIZ;]\&^' M8](U[PS)=:CI_BSZ3_X*R:;\=_$G[ _[0'@7]G7P)XT\??$#XA^%I/!NJZ=X M'TOP/K^HVGPNOBU_\9([KPUXQU*#4_$L/B_X6:9XM^&>E:)\,= \:?%J\\5^ M.O#A\#>&X+^*7Q1X:^>GA/9XN&%>(PL^>=*/UBC6C4PR53E]YU?=24+^_>UK M/U/9CB.?#RK^QKQY8SE[&I3<*SY+^ZJ>KO*WNVO>Z/Y7/B3J'B+_ (+8_P#! M5JVT3PC<:TGP6O=6M?!6@^*-&LK_ $^\\%?LE?"R^U'4M<\>+K%S\)AJGA?7 MOB)+J7B?Q;X$M_B[X-OH_#/Q8^+_ (-^$?B767TFWTV6/^Z+PUX:\.>"_#GA M_P '>#O#^B>$_"/A/1-*\->%O"WAK2K'0O#GAKPYH5A!I>A^'_#^AZ7!:Z9H MVB:-IEK:Z=I6E:=:VUAIUA;06EI!#;PQQK_/3_P0:_X)T_$7]FVP^(_[37[0 M?@37?A]\5/B/X=T/P#\+_!_B0OI^O^'O@_J]EX6^(GB77M?T;3?&=[#IVK^/ M?$Z>$M#O?!'Q&\">&?B;\+M1^$.IV\OV.V\>:OIB_P!&->AGF)I5,11P>%DI M8/+Z,5T:D*53$5XM8G%U'5J*2:E M&-VJ=-IZI15VH]%*W0**_ ?_ (*Y_L,_M^_'#XI^$/VC?V*/C?XTTB\\(_!C M_A4-_P#!WP-\9?%GP,\RN_"]W\2M. MUWQ'\.[A=-^ _@>:SU'XBZR_AKP]X6_,G4/V\_\ @X&\$^$?B)\(]<^!/QZ\ M1>.+;QO>VZ_&_3_V'=<\5>+O"RZ!JFC6FH>'OAWJ?P\^&E^+=9U7PSXVGMO^$.U/0,O^ M(M;70? R^');37?A&+70].\"?%?PCX3:_@NO!4'CC2[WP$GASX=S> ?#^A_W MD_#C6_%_B;X>> _$GQ"\#_\ "LO'WB#P9X7UOQQ\-O\ A)=,\:?\*^\7ZKH= MC?\ B7P/_P )CHD5OHOBS_A$]:GO=!_X272((=+UW[!_:EA%':742#^3O]G? M_@B%^UI^U)^T'KOQX_X*VEGX<.B: M+:ZU\+;[5/!_PV^$>I65S=>%I)O#7B[1?&OA'PSX)'@'X=>"? >E:GX/^(7A M+^O>NO/,30G1RW"4\1'&5L'0G"OBH-RA.4_9VA"H_P")&'(_>UT<;-2)JQE2H37+**CS7G*%O<^'_C[XI?&_P"*]WX+\=># M--\-?&*Y\36^J>%?"-OI?B#X<^&;&ZL-9^$T*?CMK_[>'[)=SX[\?>)M>.@>*?B/X%\'ZM%HOQ6^&/B M'X0?#O1=*\,?$/X&W.AW&A>)_$BR:-\.M#6T\(>$I=7^-&F?%1]/U+X>P>,; M/Q8ND_##GR*6$CCT\6Z*7LJBH2Q"O0CB?=]E*K?W>5>]9RLE+E=T[&^:+$/" MM8=5&_:0]JJ+:JNAKSJG;7F?NW2U<>;=71Y?X=_X->/%S>'M DUG]LGX?>$M M?FT329O$7AKP[^S%J?C#P]H7B&6P@?6M)T#Q7=?';X>WOB71-.U$W%EI.O7W M@;PA?:O800:A=^&M"GN7TNTQ/^"%OPND^!__ 5,_:T^"LNNQ>*9?A!\(_CQ M\+I/$T&CMX>@\1R?#_\ :*^$7A-]=AT!M5UUM#BU=M).H1Z.VMZPVF)<"R.J MZ@8/M^*/$/BCXB_%.*#P?H6M37/BRV^(FJV?[-W@?PS\9=/O?#USK M/P=\.66EZ%JGA]NV_P""'W[#'[57[*'[=7[1D'QS^$>L>$_#W@'X*:U\,C\1 M;.WOI/A3XWUOQ9\0OAKXJ\'W7PE\8:KI^AK\1M#U;PCX/U;6-0N_#^FM>^ I MUM/"_P 4=)\!>-[R#PH?7*K:^5&C1>+P,\'@<32A&M^]K5(55?W-%:I*4FE9\TW:*:LF[Z? M5W_!R'_R8[\*_P#LZWP/_P"JA^.=?JU^P?\ \F._L:?]FI?L[_\ JH?!]?GE M_P %]O@O\7/C5^Q+X7T_X/?#;QK\5-:\$_M!>!?&_B#PQ\//#NI^,O&">%_^ M$-^)/@J35-(\&^'[?4/%7B?[)XA\:>'8M0LO#&CZQJ.FZ7=7OB._M+;PWHFN MZMIOZZ==>5Y]E=W-M)%,_AUZE-Y' M@:2G!U(XW$RE34HN<8N,;.4+\R3NK-JSNCU*4)K-,5-PDH2PU!1FXOE;4G=* M5K-KJD[G\XG_ <[?\?G[#G_ %[?M/?^C?V=J_5+0M!U_P 4_P#!"31_#'A3 M0-;\5>*/$?\ P24T_0?#?A?PSI-_KWB3Q)K^K_L=0Z?H^@^']#TN"ZU/6=;U MC4;BWT_2=)TZVN+[4;^XM[.T@FN)HXV^0O\ @OO^Q[^TK^U-'^R;J?[/WPHU MOXGVGP_U+XJ>'_&(T'4?#D-[H>H?%OQ-\ _#/@>6XTO5=:T[59]&N=1TS5;K MQ'XDLK*Z\.> O#ND:KXN\?ZMX8\*:=>:S#^S'[&_@+Q;\*OV0OV5?A?X^TG^ MP/'7PW_9O^!W@+QIH1OM,U3^Q?%O@_X8^%_#WB/2?[3T6]U+1M1_L[6-.O+/ M[?I.HW^F7?D_:+"]NK62*=]<1B*:R;)HPJ4Y5:&(Q>"?-%2 M5FKI7336YG0I5/[3S*4H3C3JTL/&%1Q:C*U*,9/] \::N=7ALY- M$LVTG6/BWX!LUT[4-0M-4U,:TUSH]GJ-II.N3Z7_ %I>(/$.@^$M UOQ5XJU MO2/#/A?PSI&I>(/$GB3Q!J5GHV@>'] T:RFU+6-;UO6-2FMM.TG2-)TZVN+_ M %+4K^XM[*QLK>:ZNIHH(G=?XU_VJ?\ @E7^V3_P3_\ VB[[]J;_ ()X^#]= MU_X9>#M7U2_^#G_"OUM?CS\;/@]9>,?!VC?#K7-'U?X8>./ VL:SXTMKB]^) M'CWPUX-NO#>C?&S6=&^&>B/XO^*GB32M9MKS7[J[:?"O_@N5_P %0].\-_"C MX^?\+$^%/[-6K>-? VA?$K4OBA\,? GP)T[0[SX9>"M#OM0^(.L?"^;1_AQ\ M<_BZ/%>L1Q>-[#P[IMGJ'P8U'X]:E96^AR_";PYX%M;OX5]N8X3"YEBO[3IY MAA*.%KPI3KJK5_VBA.%.$)TUATG.=3E@G"*?O2YK6CRRESX/$5\%0^I3PF(J M5Z4JD:3ITVZ-6,IN49NK?EC&\FI2:]V-K^]=+S7_ (-ME9/V\?'BL"K+^QO\ M2592,$,/C)^S>"".Q!&"*_M\K^4'_@A5^P+^V9^S'^US\1_B)^T9\#]8^&7A M[3_V>_%7PGU/6M1\0>"=1TV[^)'B/Q+^SE\2K/2_#+>'O%.MOXMT-_#EMJGF M^,_"?]N^"+#Q!HNO>";_ ,2V_C30-8T"R_J^K@XAK4J^9SJ4:D*M-T:%ITY1 MG%VI1NKQ;5UU5[IZ,Z*H=*TS4IKGQ5X9MXK.ZF>;Q M!HT:MJ-M_*OX\^&__!R_\3_ OC/X:>/)-2\0^!_B'X3\1>!O&>A/<_\ !/'2 MUUSPIXLT>\T#Q%I+:EH=MI>LZ<-2TC4+RS:^T?4=.U.T$QN-/O;2ZCAGCY2>-I/V:?A]=?"UOB.GAE/&WV?QE^Q9XR&NKX-;Q"WAK>/B/XA\9? MV:=+/BOQ!C^QO[.^V?VB?[1^V?9+'[+_ $Y?\$X=0_;ON_@'JUC_ ,%#-#TW M3/C9H7Q*\0Z7X>UFSE^&#ZCXS^&4^A^%M;T/Q'XBB^#NL:AX M=7L_$VL>,? M!]O!I&E>$YV\/^%="N=4T&ZU.XN_%/B7T>(:-.IC,1CZ.,P->E5G1C&E1Q4* MM=6H0@Y2IQO[JE3=VI.UXWW=N/**LX8>CA:F&Q5*=.-1RG5H2A2=ZDI)* M\U-67*MGVU]P_:V_:.\,?LD?LW_%W]HKQ;:?VIIOPR\*R:EIV@^9JUJOBKQA MJ]]9>&OA_P"#)-4T7P]XKO= B\:>.]:\.>%9O%$OA[4]+\*Q:P_B/78H]$TO M4+B'^3W_ ((>?LN^)OVO/VQ?'O[;7QSLQXLT'X2^+M7^)%SK>L>&-)M-%^(W M[5'Q%U+4?$=GJT&DGP!/X!O'^'4FHZU\6=2M/"&J^#?$_P ,_B5?? ;Q-H-F MFC7I@7]%O^"_GP=_:Y_:,MOV5_A-\!O@M\3OB-\-;;XAW>J>*[WPKH/@?7O# M4_Q?\7V5UX-^%5WJE[;:I>?$KP!IGP]\*_\ "UE\<^/_ !9I7@CX":3I?Q4\ M,/XE\<:MKUO;VW@_](_^"67['4G[$O['7@'X9:_926?Q3\8W%Q\7/C?&]TUQ M]E^*7C73='@O?#0CM?&/C?PPK?#GPIHGA'X6SZGX'U6V\)^,;KP//X_M-+L] M1\6ZH9HHU:6!R2M*G5IRQN9U/8N,)QE4H82FVI\\4[TW4:DFG;FC.#2?+=.K M3J8K,Z2G3FL-@H^U4I1:A5Q$[./*VK2Y-'I?EE"2TOK^BE?P;?\ !Q%\)O#G M@[]OGQIJOAZ_UFYU[X__ $^'7Q2\76VJ7%A<66E^((K'Q1\!--M?#D-I86% MQ::++X8^"7A[4)[;5+K5KU_$5YK]U%J<6FW5AI.E?WDU^0/_ 62_P""??B? M]NK]G[P_>_"6WTJY^/OP,U77O%7P[TG6-2NM+@\>^'-?TJ"#QU\*M/U&ZU_2 MO!_AWQ'XONM"\':SX8\5>,+"]TNWU[P=8>$[[7/ GAGQIXI\:Z+SY'C*6"S" MG4KOEHU(5*%6?\D:JLI/^ZIJ+EVC>6MK/;-,/4Q.#G&DKU82A5IQ_F<'=I>; MBY675V76Y^LGAOQ)X>\8^'M!\7>$=>T7Q5X3\5:+I?B3PQXG\-ZI8ZYX>\1^ M'M:.1OXG_\ M@X_\^/\ ;_\ A_+*66P'['/PL\IW.(1/'\:?VE&O",G 986LS*3_ >5SQQT M?PS_ &AO^"[?[$G@7Q3^R[8_L\?'7QOI7ACP;IG@_P :Q>?LX>+_P!H-?@G M97>AZIJNEW/P@^+'PKTWQ+X#\=RZ);>*M)M]/T'QMKOQH\%>!7\&>'_ASIOA M?P_H_AW7?!ESZK^Q=_P1Z_:U_:D_:#\._MC_ /!1"YET?POX@\7:5\7O%_@? MXF0Z+XA^,?QMO[.S\&>(_!WA3QQ\-M0T#5?!GPV^$&K6-P?!7C+X=^+K;1?& MG@_PGX'OO@CIGP:^'^C:GX>\6^#O4R_#4(/&%OJNO6_BO6Y?%EOJSZKXE@US68==OVGU2+5=12 MZ6\F^@:**^4;NV^[;TVU=]#WTK)+71):ZO3N^X4444AA1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S/\ MI:#KGBG]CG]K+PQ MX8T75O$?B7Q'^S/\=]!\/>'M!TZ\UC7=>US5_A;XJT_2=&T72-.AN=0U35M4 MO[BWL=.TZQMY[R^O)X;:VAEFE1&_-'_@@)\)?BK\&_V.?B5X8^+WPS^(/PJ\ M2WW[3'C'7K'P]\2?!GB3P-KEYH=U\+?@UI]MK-II/B?3=+O[G2;B_P!+U.Q@ MU&&W>SEO-.O[6.9I[.X2/]QJ*[(8R<,#7P*A%PKUJ59SN^:+III12VL[ZW.: M6&C+%4L5S-2I4YTU&RY6IM-MO>Z"BBBN,Z0HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBO#OVEO',_P .?@)\5?%5AXIN/!&O MP^$-2T3P;XMM=#3Q)/H'Q!\7"/PC\.]1CT6XTC7M/O3#XYUWP]N&MZ1>^'+= M6:Z\2I'H$&I31\&:9EA,FRS,A^'O'OC73-7U6XL?$VH?!W4-/\ &G@;P9JU]-\# M/"?C?P]X?UKQ#XU35_UEK\G_ /@FW\*]/MK_ ,<_%-;+28[70-(L/@_X+&GZ MMKD-]HT,HTGQ7X]TS4?#4:6_A=]-O+2S^$DOAO596U37+)],\0V-HN@:=>W9 M\2?J9KFNZ)X8T36/$OB76-+\/>'/#VEZAKFOZ_KFH6FDZ)H>B:3:37^JZQK& MJW\UO8:9I>F6-O/>ZAJ%[/!:65I!-)N)/#VIQWQ9F6,Q M.*XZS_/>)\OP&,Q4Z^&X$RC)L IJ-.A@J.$P7UR"@K26,]I4:J.48 M_H?BK@LHRGBF'#61X/#TJ/#>69;D^*Q-"@J=;-LTAAXU\=C\2XMRJXFI7Q'L M).6SHE32PO)IVN:-=7^BZO9M#J&E:A>V%Q;W,NA'@<@CW!(/:OM9^+WA-3JU*-3Q0\.Z=:C-TZU*?&O#4:M*I%N,H M5*'#8Q^(["_P!3T=TU/Q7H M>CWRW=EIFKZ%>RL=/U"[^RM#JEN(+S[/<3)=0126> M+H]#B\0:\_B0WT?AS3[_ $O1DCTSQ9KNCV"VMEJ>L:_>Q.-.T^T%X\VJW"W% M[]IN88[.":*RM_,OVJO$&E>+/V2O%7BK09Y;K0_$VC?#OQ!HUU/8W^F3W.E: MSXO\'ZCIUQ-INJ6UEJ>GRS6=S#))9:C9VE_:.Q@O+:"XCDB1W[*6NZ7X6_9- M\)>)M&TMYI%M; M&UN;RX91#;6\TSI&WPG^N69KZ2'^KG]N+_4K_B '^N7U/VV&_LK^T_\ 7SZA M_;GUFVW]D_NO;>W^K?5OWEOMGTG]@8/_ (A+_:W]F_\ &0_\1/\ [ ]O[.K] M=^I_ZM?6?[-]C?\ Z#O?]G[+VOM?=O\ 9/K>BO%OA3^T+\)/C;J?BG1_AIXD MU#7[_P &6/AO4?$<=WX.\;^&8+*T\6S^([;07M[WQ7XE/>^TU^WY7FV5YY@,/FN29EE^<97C(SEA,RRO&8?,, M!BHTZDZ-26'QF$J5L/7C"M3J4INE4DHU*%.K3GWW@;X@^%V_X1W3[W0=.O+U[CQ9X5T.TBF@O/ M$VB0MIDLZ:J3=NZ631V=\]MK_$W]HGX+?![4;'1?B%X]TS1]?U!=,GA\,V%I MJ_BCQ5!INL_\) FE^(-2\+^%-.USQ!I'A2^N?"OB#3K?Q=JVFV7AA]8TV71? M[6&K26]E+YE/C'A&KDE7B6EQ5PY5X249TJGL:L*N:QQ3P% M.=.K^ZJ1G73A4]R24M#LGD&>T\QAE$\ES:&;5(PE3RN>6XR.8U(U(>TA*&"= M%8F49P]^#C2:E#WE=:GM5%?*L_[;7[,=M<:9;3_$J2,ZKJFGZ1!<-X(^(O\ M9]K<:G>06,%UK6J#PD=-\.Z+;RW"3:KXCU^[TSP_H>GI)N'^):&$G"GBJW#^./VK?@)\.?'=Y\-?%_CB;3O&&G:5IVL:E8V?@_P = M:]IVF6^JK/+866I^)?#_ (9U3PQIVOS6D,>IMX7O=8@\20:+J.AZY<:3%I'B M'0KW4>%\!?MS_L_>,]-T"YUO7=5^%>KZX-9:?P[\3M.@TI_#4>BKJEQ)-XK\ M9>';_P 4?"S1+>_TW2SJ>F7,WQ >"Y6_TW2'DA\2W+:'%X^+\3?#C 9S_J[C M>/N#<'GRK2PTLGQ/$V34,RABHU*=+ZI4P=3&QKTL7*I5C&GA:D(XBJU/V5.: MI5>3OH<'\68G ?VKA^&.(*^6N"JK'T><>>'-]@U\,?&G]O?X>?!?XD:Y\,9OA=\9_B'K'AFUT9O$6K> ].^&EMH M&E:KK>F0:];>'CW,$6I:1J%CJ=D\@N;"\MKJ.*9/SOZ0_B+Q7X M;\)<-X_@V.3_ -M<1<>9!PC"KGF&Q.+P.'HYQA/=&\!:OI-]^MVN/#]MI)MM-O(IM5 MAOY--LM0^S_ 7Q%\#_%#P_!XH\ >)M+\3Z-+]E2:?3YF%WI=Y=Z7IVM)I'B# M2KE(-6\-^((-+U;3+O4/#GB"QTW7M+2]MTU+3K2601U\I1_\$Z_V6;&TU.+1 M/#?Q!T?4;_3KRRM=;D^.'QH\5W>B7-S:SV\&KZ9I?Q \>>+_ M+J.G23"\L MX]9\/:MI4MU! -2TS4+57M7_ #W^%VN_$W]EW]I'0/!M\;JXFOOBMX1^$WC+ M1;>_TO0]%\>>&/&WBVT\&>%/'%S90O\ $"/2DM++Q;I/Q<\-:%%J?_"5V">9 M\.]5\4:''KWC R?%8OQ.\9_"SB+@S!^,&7\!YYPCQIQ#A>%:/$W T,\PF-R/ M.LP4OJ$;2='$X:OR5:D8X.E"JL+A<;7=6=:C1PF(^@H<'>'_ !IE7$%? M@/%<2Y=GO#^5ULZGD_$PTF\\1Z]K6H6]_ MJ?]EDTK_U77Q-KR/]FG]BC]G; MXQ_!CPM\1OB#X;\A^/?$_A[3$MO#O@WX ME:!X;TY;?2-)L+9QIND6@NI8GO;OS[ZYNKF;7C#C_P 9,T\;\S\*O#;%\"97 MA\IX&P/%M;%\69=FV*E7]KF&&P6(IQK9=B)-3Y\?AO8T_JL*:ITJTIU>>44X MR'AG@#!^'>#XTXNH<2XRKCN(\1D<*&28O T53]GA:N)I3=/%4HKEY<-6YY>V ME)SG!1@HIM=9;_\ !4CX4I<0/KWP0_:*\*:$LT3:UXHU?3?@IJ.D^&])5U.H MZ_J>G^$?CCXF\5W^GZ/9B;4;VS\,>&_$'B&ZMK>6#1=#U;4GMK"X_32OB'3O M^"='[(FFZA8ZBOP^\8:F;"\M;T:;XE^.W[0/BWP[J!M9TG%CK_A7Q1\4M8\, M^)M%NS'Y&J^'_$6DZIH6LV,D^G:OIU[I]S<6TOT/\V(U M63PWID*Z+HKR:M;0>(/%FN:A9^'?!?AR[U/1= \4WV@V'B+Q=J^B:)?^)VT# M4].\+65_/XCUF!='TN^FC_6N"JOB7D65\0YCXQ9WP+7P^!HQQ^$QG"F$S; X M; 9=@\-BJ^;U\UGFC]Z-.$*-6BZ%->SIT\0ZDI&VU02/HVCB*_UKQ5K\-MJ>AZ1J5SX=\&^'K/5O%OB*ST M.\\2Z&_B2]T31;^T\,Z?J,.K^()M-TE9;V/Y+N?^"D'PC@O]:M(?AM\:;VVT MO4-1L[#5;;2_AK'8>);:RN[BWM=7T6&^^*-GJUMI^L0PQ7^G0^)-,\/ZO#:7 M=O'K&EZ5?I=V5K\'_#_P7\4_VT/CCJEQK?BC3(Y[&V\.ZQ\7?%\"/ M=]>^((O"/@[X<>"[F[U*ZMYO$5YI/B[3? YU07WA;PU_9WC/Q]XWU/QIXR0^ M&?BC^M'@O]D3]G/P%J/B+5-#^&=A?7/B@:6-2B\::WXI^)&G6W]CG43:?\([ MH_Q#UWQ3I/A S?VI<_VH?"=CHAUP1:<-:.H#1](^P_CO#_B#XY^,T,1Q'X98 M3@[@7PZ^NXG"Y%G7&F"S/->(^)J>$JUL/5S##99@ZL,%@\OEB*,J4H5I1JTZ MBE"CBL8Z594_O*EU7 MXP^']3TN"+Q-+>W]EJ'BWQ1:?$.R\8:M?ZKX=@O-4UCX@>)?"$/ASPNVEZ?X M L];UR]\4Q?I)7[+X<8SQ9F\ZRWQ4RCA2C7R[^S?[&XCX/QN*GEG$5+$QQBQ MT:F59C)YEEF,RUX?!RQ$ZT:>$QD\PM@:<886I?X#BRAP/%9?B^"\=G=2GB_K M?]H93GV'HQQF53I/#O#N&-PL5A,90Q:JUU2C3*-$U?P[9^-I= N?%&E74NH^'(M4L[#49K3[S-\[R;A_ U,SS[-LL MR3+:+C&MF&;X_"Y;@:4INT(U,7C:M'#PBN?-8#+LPS3$PP>68'& M9CBZB;AA#[;PSXBUO1K.'4/ 'B+Q9J7C#1M)$36GC;PIH_PMMOB#JTOAWQ"CRMHF MF:[9:#X[!MY8M9\&:/-):1W/UK<^-/!UEX.N/B)>>+/#5I\/[3PU+XTNO'5S MKNEP>#K;P=!I;:Y/XLN/$TMTFB0^&H=$1M8EUV2]72X]+5M0>Z%H#,/*X=XW MX-XOIXFIPKQ7PYQ)#!J+QCR/.LNS1X-3(I4U6<>>*DJ;ERN24K-V M.EHK^?C]K_XF>'/CG\>EU_PKK&I>+/A;IGP<\!:/HMMK>D^(M*T?3?'4GC/X MLWOCM]-\,>+].TNYLM2U+P[<_#6/7=8MM)BCUJUT_0=/GOKV3PZ+;3?UBTC] MM']F_7=:T/P_I7CS5+K5_$FO:'X:T:U/PX^*-NMUK7B/5;/1-'M9+JZ\%PV= MG%#/A7\-O'3>(M3\+_'B: MW^,&C>'SK+^>#PQ\._BMI6J:#X@UN*VC\'^)G\+_%I_!=IK'A2+5-6U#P[ MX^T*)=1TNQUWP;J)T;TK]F3]J+X ?"OX'^"? ?BCQ5M[.C2S;#TZE3%U MZ=3,UC*2P]>E/+8QA*NII^%G$M?@K"<6X7 9SB\5CQJT^:I/ U9QAAZ4H8-X>;JTYQQ;&_ASKVD^%M;T[Q=XQO%\%:3_9_C>32H/"9OY/%HT671[S7;S7-(TVQTO6( MK'5'U;4;32<U.9;0_,-Y_P4&_9U.G^%=3\.7?CWQ=:^)?$FD:+?1V?P\\3 M>$-0\':/J:7+W7C;Q5H_Q5M/A[JZ^&]!\B)-7T[P]8^(?'+/>6PT?P;J^R\- MI^H9]QYP1PM1PM?B7C#AC(*..I*O@9YQGN69VI\=EG#/$>=5*U+*,ASC,YX:;I8F. RW&8KZM45[T\0Z-&:H3337+ M5<'?2U]#[=HKPWX9?M)?!?XQ>)=>\'_#WQB^L^)/#FE6>N:CIE[X9\7^&7GT MB\NYK ZCH5QXJT#1+/Q1:Z=>QV]MK\GAFXU<>&I=6\.KXA_LP^)_#O\ :GN5 M>SE&K^'-8\/ZKXB\*:)K7AW3?%>AZWH6IZ=KWA&^U6#Q/H:?X,?$/@&>=+AN'''!\N M(GB?J:R"/$N2RSIXMRY5A5E:QKQSQ/-[OL%0]KS:TY+:W,']K'XQ>-/@E\/-"\5^!H/"]Q MJE_XWT_P_>1>+-*U;5[ Z9=Z!XEU&4VT&D>(?#=Q#?B\TJQ*7,MY+/AO\/O%6N"P&M>)O!'A/Q!K TJUN++2QJFLZ#8:CJ MTVRN[[5+NTL/M=S-]CM;K4M1N+>W\N*>^NY$:XD^1O\ @H9_R1;PQ_V5#1?_ M %%/&M=CX<_:/^#/P?\ AW\!/"'Q"\8MHOB+Q%\&?!VNZ=IMIX;\6^(VATBP M\/:%8F_UNY\,:%K-EX9@U"\EFMM /B2YTEO$TNE>(4\.KJA\,^(?[,_)L-X@ M5LI\=?$?*>)N*,)E/!61<"<(YGAX9SCL#EN3Y;C\QQE6A7Q,L9BY4(4JF*?) M2_>XCEG+EC"/-8^WJ\+T\=X;<)X[)\FKX[B',N)<]P=667X;$XO'XO#86A3J M4Z*P]!5)3C12E-)- U;3-0L7M;2TO-7\-7&OPVU[X#U+Q=HL=S/)>:%X:\7Z_->V.D: M]KV@R:QX;T34M9M_I&OW#(N(L@XHR^.:\-9WE/$&63J3HQS#))P5:M25:FIP=6BYJI3YH\\8MH_.SDVH5/98B%.;IS<9KRW7AGXIV%GI M4WA5-'CU2ZED\7^,_#.I^+/A/HL%WINEMJ-A=M\1)[.X%]INDFXC\1W7]BIX MN/\ $?P^RK.8\.YGQSPAEV?RE"FLEQW$>3X3,U5J.DJ5&6!KXR&(C7K^VIO# MT)4U5Q$9.5&%2,)N/HX;A/BG&Y>\UP?#>>XK+%%S_M##Y3CZV#Y(\_/46(IT M)4I4Z?LYJK44G"DTE4E%RBG]B445YE\2_C+\,/@_96E[\1O&6E>&SJ*2RZ5I M;BZU/Q'K4%KJ6B:3J-UH/A71K;4?$VNV>C7GB30_[?O-(TF]M?#UIJ5OJ6MR MV&G%[M/I\PS'+\IP6)S+-<=@\LR[!TI5\9C\PQ-'!X+"T8VYJV)Q6)G3H4*4 M;KFJ5:D8*ZNSQ\+A<5CL11PF"PV(QF+Q$U3H8;"T:F(Q%>H]J=&C2C.I4F^D M81E)]$>FU^:WPR_; ^*VN?M57?P2\6Z3\/K[P;JWQ+^,7P_\.7GAS0_$?A_Q M-HL7@%?'VN:%JFMZCJ?C'Q3I7B.2;0_ DFC:M:6.A>%UNM6U=-?L[C3;/3F\ M.ZA[)X-_;J_9]\476LVFMZ[J?PR&F^)O%&B6&H_$JTL-$\/Z]H/AFQFU)?B' M#XITO5=<\,^%O!6OV-K=2Z%_PL?5_!'BTSP)INL>%-'U6^TRQO?SU^%?_*0G MP_\ ]G'_ +2__J'_ +0-?S'XG^+M*OGO@@_#;CC*7XJ5&-;+,;.B\9]6=6G4G**C*A7Y7&M2FK0FOV#@_@6=/+?$3_6WAS' M8/&Y7P1CLWR=9KA<;@*M'%4%.5/%X>-3V'M>248QE=5*=[TYQUE%_N?1117] M4'XN%%?,GB+]LC]FOPQXOO\ P-J7Q/L[OQ!I(NTU?_A&_#OC#QCH6D:CINN: MQX;U;PYJ_B[PCX>USPEI?C'0];T'4['Q!X*O];M_%WA]H[6;6=%L;;4M-FN^ M$\,?M_?LZZQX>\.:UXHU7Q7\,=1\0ZE#I4WA?QMX2U*_U/PO/=ZVVBV=WXP\ M0?#H^/OAYX?T*1&M];O_ !/<^-V\->&_#UR=5\6:OH,>G:TFF?"XOQ0\-+L3@O[2P_"W$-?+W%5%C:.39C4PTJ;C*7M85H8=TYTE&#>4>>'-]K45R/COQ[X.^&/A35O''C_Q%IOA7PIHBV8U#6-5F,4"W&IZ MA::/H^FVD2+)=:EK6O:WJ&G:#X=T+38+O6?$.OZEINA:)8W^KZC96<_X3^+/ MB5X=\7?MH^(?C!J.LZCKGPSTKXP?!_6/ VMZUI?B"X?1? ?A'P+\)I_$$7AW MP[JNG_\ "1Z+IMC\0;#X@ZLFB66C6DU]X@N]8U[3["[N-=%]J'RGC%XSY#X0 MX#):^/679CF.)S&EAGB\)A,ORW&XR6/IY9B,=AZN,PT*,52]*#K2J\D93A0J['] U%?./@O\ :T^ 7Q"\6Z#X%\(^--1U3Q1X MFGO[;1=/E\!?$;2H;J;2]$U3Q#?++JFL>$M/TBP6+2-&U&Y634+^UBGEACLK M=Y;ZZM+:?Z.K],R/B/A[B?!SS#AK/LFXAP%/$3PE3'9'FF!S;!T\53ITJM3# M3Q. KXBC'$0I5Z-2=&4U4C3K4IRBHU(-_(9EE.:Y-7CA%_AKX5U3QK MXSU";2O#6C&Q&I7\&EZOK,MO_:6I6>D6>W3="L-3U6X$NH7]K"QM;*80)(UQ M<>5;1331^,:C^U_^SQI/@SP/X_OO'MQ'X8^(^O\ B;PUX.GA\$_$&[U;5-1\ M&:GJ^B^*KF?PO9^%9_%&CZ!H.L:+<:7J7BO6]&TWPM;ZC?>';-M8^T>+/"\> ML99EQ3PQD]?%87-^(\ARK$X+*UG>-P^99OE^!KX3)98OZA'-\51Q6(I5,/E< ML=_L:S"K&&$>+_V=5?;>X7A,FSC'TZ-; Y3F>-HXC&/+L/5PF Q6)IU\P5#Z MR\#1G1I3C5QBPW^T/"P)O$FB6&M?$RSL="\+:]H'AO2#K3?$6/Q;INJ:WX9\(>"-9M(;Z'1G^*&K M> ?%(\CXDP=&K[&OB&&SK*TIT< MRP6(P52I3O;VE..(ITW4A?W7.'-%2O&]TT%%>;?%;XN_#WX)>$V\;?$O7I-! M\/\ ]JZ7HEN]IHOB#Q-J^HZMK%R+>ST_1_#/A32M<\3:WH)I&D7O] MD>']-UGQ+JQL?#^B:OJ=E\^_\-X_L^_\)9_PC_\ :/BS^P/^$4_X23_A8G_" M)ZC_ ,(G_:7]I?8O^$(_LC/_ LK_A+/L7_$\\S_ (5__P (G_9O^C?\)3_; M_P#Q)*\_B#Q"X"X3Q5' \4<:\*<.XW$1A4HX/.^(,JRO%5*51RC"M'#XW%T: MWL'*,H^W<%1333FF=65\+<39Y0J8G)N'L[S7#4I2C4Q&797C<91C.*3E3=7# MT*D/:I23]DI.I9W4;'V717%^ OB+X'^*'A^#Q1X \3:7XGT:7[*DT^GS,+O2 M[R[TO3M:32/$&E7*0:MX;\00:7JVF7>H>'/$%CINO:6E[;IJ6G6DL@CJUXW\ M;>%_AQX2U_QSXTU5-%\+^&=.FU/5]0:VO;^6."(JD=O8Z9IEM>ZMK.K7]S)# MI^C:%HUCJ&M:YJMU9Z1HVGW^J7MI:3?1PS/+JF7_ -KT\PP4\J^JRQW]IPQ5 M"67_ %*%-UIXSZ[&H\-]5C2C*K+$>T]E&FG-S44V>5+!XN&*^HRPN)CC?;+# M?4Y4*JQ7UB4U"-#ZNXJK[9S:@J7)SN;45&[L=517Q_[/B^*O["-]XQ/A MW_A$CXE/Q%7P;JK>%1J8U1=/'@?^PU!^*)\6M9L=>$B_#IO"0TM6MV\5KKVW M16^IO WCCPM\2?".@>.O!.KQ:YX6\36$>HZ1J*6]Y92O$S/%/:W^F:G;66K: M-J^FW<5QINMZ#K-CI^MZ#J]I>Z/K6GV&J6-W9P^!P]QYP1Q=7Q.%X5XPX8XD MQ."BYXO#Y%GN69K7P]-3C3]M6HX'%5ZD*#J3C"->452E.2C&;;L>EFO#7$>1 M4Z-;.LASC*:.(:C0JYEEN,P5.K-Q<_9PGB*-.,JBC%R=-/VD8IMQ2/D;X1_M M\_"OXR^)_A3X2\.>!OBOI6J_%K[5_99\1:9X$M[7PW]D\ >(_B')_P )3-I/ MQ"UEESIWAJZTA/\ A&XO$F='POXF/A.'Q+:)\/]#:VGU1O#FEGP6+9 MK?PQJ6J:-X:\OPE>:K;2?+O_ 4$^.?@CXA:%X,^%?PV\=-XBU/PO\>)K?XP M:-X?.LOX:?0/#'P[^*VE:IH/B#6XK:/P?XF?PO\ %I_!=IK'A2+5-6U#P[X^ MT*)=1TNQUWP;J)T;\DP_B=FO 7A9Q/QGXC\6>'O%N:Y7F7$$,F7"&&H8;%XG#P]U4,5/#5)3^YJ\'8/B;C3)^' M^$\DXJR/!8S"97+,'GV7U<5C,##%55'$YU4H4))+*>2MAW0K5:U"C5D[^UHQ MK04?UWKPWX\?'WPK^SYHGA#Q!XNT/Q7KEAXQ\;1>!;0>$[;0KJ?3-0F\)^+O M%ZZGJT>N^(?#RC2!9^#KW3V?3'U34QJFH:6HTLZ>VH:CIWR)^S)^U%\ /A7\ M#_!/@/Q1XJN= U[0SXF:_P!)L? /C[4K6U;5O&'B#6X&CO?#_A/4-(G-S:ZE M!=RFTO)BDT\D=QLNDGC3ZF^*VI? +XA_ [3O'WQ2MAKOP@O;/P=X\TC5IM#\ M9P:O91^(C8P>%]4UG6P^88K%X'#>S^JUZE3"1=.>'7EXS@S%\,<7T,KXBR3B/&Y)'B.K ME-*OA,JQ6"Q/$6'P^->&C+(U73I8C$8ZE[.MA:%#$UN?VU.$*[4XU7J_ ?X^ M^%?V@]$\7^(/".A^*]#L/!WC:7P+=CQ9;:%:SZGJ$/A/PCXO;4])CT+Q#XA4 MZ0;/QC9:>KZF^EZF=4T_5%.EC3UT_4=1]RKQ/]GW2O@UI_PUT^^^!&EQ6'@' MQ#JFMZQ%=-8>);/4M:U>+49M"U74]9E\9Q1>+=0O(9=%31K.[UTRR1:%I&CZ M;I,B^';#1H8>C^*WQ=^'OP2\)MXV^)>O2:#X?_M72]$MWM-%\0>)M7U'5M8N M1;V>GZ/X9\*:5KGB;6[E(UN=3U!-(TB]_LCP_INL^)=6-CX?T35]3LON>&69MAZ+S/$83+\IQU&=3.J/+6E2A@L M5AZ:G4^OPE%TZM"*G.%5.G>'X/%'@#Q-I?B?1I?LJ33Z?,PN]+O+O2] M.UI-(\0:5K:9=ZAX<\06.FZ]I:7MNFI:=:2R".EP_P"(/ G% MN)KX/A;C/A7B/&892E7PF1Y_E6:8FE3BTG5G0P6*K551N[*MR^RD](S;3#-. M%^)#0K6[MM"\1>('DU2YLM0U"&W:S\-:3K%]"C MVFEWTANIK:.S1HEA>X6>>WCE\V\1_M:?L_\ A-?A^VO>.Y[,_$[P7;?$/PA% M%X-\>:A<3>#K^&PFTS6?$%MIOAB[N/!*ZPNH!-#LO&T7A[4=<<4\.954RG#X7%YK3S+.\LP,\LPN.J.E@L3F$<5 MBJ4L%A\953IX6MB53IXBHG"E*(HX65&C-8BK0@U.M3I.%/# M^OZEIGCCQ-X9;Q)!X,\2:!JVF:A8O:VEI>:OX:N-?AMKWP'J7B[18[F>2\T+ MPUXOU^:]L=(U[7M!DUCPWHFI:S;_ $C75D7$60<49?'->&L[RGB#+)U)T8YA MDN8X3,\&ZU-1E4HO$X*M6I*M34X.K1>,6T89EE6:9-BG@LWR['97C M(QC-X7,,)7P>(]G)M0J>RQ$*OB*.%HT,+A^:"Y55KPJ8FO.2I83"0KXNL_94)FN2Y;#-\TP M>75,QR_*:6)G)5U^7P_?:=J7B30M"K/6_#7B+PO?>'_$_@__ (2F3QSX>U*YTUM6\,6NGW?VZ/Z/^'WC*T^( MO@'P1\0;#2]6T2P\=>$/#7C&RT;7UTQ==TBT\3Z+9:W;:9K2Z)JFMZ,NK6$- M\EIJ(TC6M7TP7D4PL-4O[7RKN7\'?C1^S;K_ .SG8_#*W\2^*M'UK6?&^E^) M9[KP]X5T=M.\(^"8/"NE?#6W3P_H^I7V-9\62V^N^(O%*_\ "6W&G>#+'5?# MJ>%K6W^'7AC4M,UB]U_]K?V=/^3?/@3_ -D;^&'_ *A.AU^!>$'BKXD\7^*/ MB)P5Q]D&2\,/A?)N'LSPF1Y;6>8XO+GG=&ECJ6'S'.88B>&S#%+!8O#_ %F6 M%P]##PQ"G"C%1BW+].X[X+X2R+@WA3B#AC,\QSA9SC\UP=?,L736%H8O^SJD M\/.KA,!*E&MA:+Q%&K[%5JM6K*DXRJ2;:4>-_:,_:D\%?LUVWA(>(_"_CSQO MKGC2?63HGA;X?6/AF75VTKPY'IG_ D&OW=]XW\5^!_"UMIVE7FO>'-.DM'\ M1GQ!>W.O6LVDZ)J.G:?K]]H_RW_P]&^'W_1N7[37_?G]G/\ ^B,K[>^+/P)^ M%7QQL]&L_B=X5_M[_A'KF[N=$O['6_$?A77-,_M"*&+4K.U\1>$-7T'7TTG5 M/LMA-JNB_P!I'2-3O-*T6^O[&XO=$TF>S\0_X8 _94_Z$/Q7_P"'L^.O_P \ MNOJ^-\%](JOQ%BZGA[G7A3@^%G2PBP.'XHP/$E7.H5EAZ2QKQ53+Z5;"3C+% M^VEAW2<+8=TH5(>TC*(JY-B,IAE\J;JR^K MJC#%3IUXR5#D57G4KU5.49*-.^VQZ;KMM!::UI%W!/-8ZKHNK0V=WJ.G-J. MBZK:7NE7MQI&IZMH=W<6L:OI$]EJ5U^%'[9'@?X._ [XKG3?A]:R^%/ M"/P_^&%YK_Q$U*[^+OB_QW;W&N:_=G6&T_Q-X>\9:KK\W@F]^'G@WPOIWB33 MKVVUN)_$^B_%J6;4M%M+;0=!U+5/UIT/]G2_MOV/]=_9KO?$EM:ZYXP^$WQ$ M\&:UXDO;7_A--%T3Q/\ %73O$DVOSV6G+!X"N/$W@_PWKWBN_M_#^EWA\.:M MJ?A;3M.L-6U.WU26[U0_!^#_ (B^,6?^)'B1P9QB^",^P' &3X>EBLPX1PN9 MX"A4XNQ\L/6P.3T\;FM5.<(X6EFU#,)3P"6&QN&IVJ>S35;Z;CSA3@++.$N$ MN(,@7$668KB?'U9T<+GM;!XFI'(\-&K3Q./GA\%!\LG6G@:N%4<2_;8>M.\. M=KV?'>/_ -OSX%>#=7TO2_#L?BKXOV]_$\]YXB^%$7A+6/"6D02V.A:GI5P? M$WB3QAX4TGQ/:ZY8ZXTME>?#ZX\8VEE/HNM:;K\^BZK!9V-]@^'_ /@HS\"] M3\21Z+XDT#XF?#C1);>!E^('C31O"DO@B'4+O5]&TFVTW5+GP9XT\8:_X>AV MZK<:QJ7BSQ)X>T?X?>&M!T'7=6\5^,-"MK>R-_T/PV_8+^"/@[^P-6\8VNI_ M%/Q?HTLU[)J'B6_U*Q\&S7FI>%8?#>LZ>OPPTS48_!VL^%GN'U37M!TGXC6G MQ$UKPYJ^J)>VWBBZO=%\/WFE_''[=7P4\(?#;QYX,\9^![SPMX8T_P >Z-KF MGZ]\,H]:L].O'U;P@?#,&F>,_AQX#MM%5H?#ZZ9J\NC?%>^MM)>'BL&VJM?"JNHTL#4[>&\B\'>)NER4Z[IMSQ,?V@K\F_ MW[0_Q8\"?MK^._AE\5?C'J/CSP+<_$?6/A[I_@NUTCP&=$^&MW\3)_#GCOX* M)'=^#/@KH?Q$U?6+#PKXI\"^"M0L?$OB6XT71[3QMJGBKQ-XF\10^&;?Q->? M67[#>JWNK?LM?"XWNH0ZBNCCQKX1TMK;3]-TNVTWPWX&^(?BWP9X4\.6]GI- MK9V:P>%?#.@Z3X9AG,!O;R/25O-3N+S4[B[NY_AW_@IA\/[2[^(7@;7[[3_% MNM:)\2_A=XI^'?BA+BR6Y^&^BV_@C68[_1],:[BT=1I_C#XA6/Q8\8F:QU?7 MK@>(/#_PZ\[P_HUJ/#?BB]O/K/&3C;B"AX0<)>,O!V)S++HY+B>#..LQR.-> M<89WPKG4<)#,L@S6E3M2K06'S:C7JU91OAG@ZM:@Z=11G'Q. >'LKJ<=YYP! MGU'"8MYA1X@X;PF9.E&4LNSK+Y5Y83-,#.?OTY.I@JE.$$[557A3J*4;Q?[* M45XI^SG\55^-7P2^'?Q'EO-,OM9UG1'TWQE+H>BZ]X>T.W^(OA+4+WP=\3-- MT/2O$TMSK,&B:1\0= \2Z5H\]QJ&KV]_IME:ZAINNZ_IEU9ZS?>UU_1F78_" MYKE^!S3 58XC YE@\-C\%7AK"OA,91AB,/6B^L:E&I"D_"+X;:7HNK?V=I/BWXU:1H/C2P.G:9?+XC\.6/PX^)_C M"PTAI]0L[JYTHVGC;PKX/\2QZCHTVGZF9O#\>G/>-I.H:I8WOZ%5^=W_ 4F MLM5N_A3\*I]/TG5]1M-,^.6G7VN7FFZ?=7MGH&ER?"CXNZ;#JWB"YMXWATG2 M)M;U#1]"AU"^:*UDU[6M$TI)#>ZG9Q2_D/C]/$T_!3Q1EA74C5_U*SZ,G2OS M?5ZF"J0Q:?+K[-X2595>GLG.^ES[KPQC2EXA\&JLH.'^L.627/;E]K'$0E0M M?3F594W#KS\MM;':_L ^"]'\,_ 63Q)I5_K%Y<_%#QYXI\::[!J=Q!-9Z7K& MBKIOPI^P>'X8K.UELM';2OAII>HRV]W-J$\FNW^MWT=XEG>6EA8^/_\ !23X MG3Z;I_PM^!9TFUNM*^*D?C#X@:WJ%V^G747V?X(>(OA7=:-H9T;4-%OI&>X\ M7>/?#?C"T\0Z;J^CZCH6I> ["T2+4;77KO[%[;^P5XI\,Z[^SYI^@:!J;:AJ M7P]\7^,?"WC*W:SOK8Z-XFUK5F^)D&F>==6MO;Z@K>$_B#X7U1;S2Y;ZQ1=3 M%A+=+JECJ5G:>4_\%(?%<-KX2^%7@--.,VH>(?&&L>,1JMQ%>O9:;I'@C0FT M74;:TDT_Q3HQC\1ZI??$'18K!=;\/>,?#3^'K?Q<\MCH_BN+P=KUA^0<28BC M@/H58:KE^;4\E@_!OA2DL=3=1JI6QN5Y/0Q>6\U!3G&OG>(Q%?)IZ)4\1F$O M;.G&-1Q^\RBE4Q7TA:L,5@99A+_7[.YO#R45R4\/C,?5H8NU5J+IY=2I4\?# M5N=+"KV?/)QOM?LZ_L=?!G4_A+X0\:^.O#TGB_QC\1_A;>P:UJCZYX\T/3[; MPS\2;F/Q5IUEIGA2'QO?>'O#OCCPCH5SHWA>T^*GABST+QT)]*U'6-"U+PNG MB&_TB/X+^('@OX=_#[]K:+X8W7AS6==^','QF^%G@-=!U3QIJ?AM[RU^,UIX M)TRT:/Q1I%L->NM/\$ZO\3H+S1=/:ZCU?Q+<^$=/T#7/$CRZEJ6MR^C>!?@; M_P %!?A9IDF@?"S4/'GP\\+S:BOC:Z\*:9K_ .SCXJT";Q#XLTO1];\2Z7IL M?Q(M?&E]X8:+6GOK3Q1I?A&[\->$=1\>R>,?&6DRZY<^*+OQOXA]=_9S_8L\ M=W'Q,L/C)\>=(\/>'[?3O%VN_$ZV^'#6_@WQ%JWB/XLZKXL\4ZQ+XN\H9'DV%='B+ /-<7&4.+Z>< MXAT\1+#8FE5>;2HQJXNC*K6JNG]KA\\J<*U^/^(91G&%R'*\D MXDQ>-S6IF6/K*>58I8*A*,LBEE])3I1JTIP6!C4<*$XTX04_J']J?P[I/A#] MDCQ1X3T"">UT+POHGPZ\.Z+;76H:CJUS;Z3HGB_P?INFP7&JZQ=W^K:G/#9V MT,%]#\TDU#PUXP\/_ !)\ M+>(;"&^U#2YKW0_$'BSQEI.K6D6IZ3=6.JZ=)H6C.+BRNK> MYCCF3H/VS?\ DVOXD?\ S]G[G+RZ'YK[:M_Q MWZQ[6K]8_P"(P^V]OSS]M[;_ %0Y_:^UOS^UY_?]IS%_BQ!?Z3J'B'44^ _CFQTB[\;CPI!XZ\0^(]'TKP7XMTKPY)X2M] M4\::+K'CFTTOP]\/O%NM^'?#,&F_#_XHZC\0[C4M#\+7&MPWOZ/?MV^-;7PM M^S=XS\/R?V/->_%IK?X0VFF:_HNMZUI6M:5XS@O!\0M,E_L:6UCTN_;X3:?X M_O- U;6[VVT*W\16>DP7L&M2W5MXC_#V^_X0BT^&EU\-%\)Z]8:M MJ6L^#?B#XFCT;3M2T6\U_6\O]I[XYW7[1E_\#=(\$1Z7J&H/X'T>]U7P9X0^ M+FC^(](@^-OQ,NM-TVY^$OB6!ET#P[9>./AO>:/9:'I7B+Q3+I.HQP_$76;> M;2?"-G9UV[WQN(JT8^WY/9+]-Q'#^'\1.)?##CUQ@L!F^7^UXRJ\U. M&'P^8<'T_:XZ6*N_W5+'JA'!T[;8>E"H_9I_L;Z%%\(?AA\>?VO/&6B? MVYH6@^ _$"^#M-T+P_X4U'QY)X1^%UKX@\3_ !2F\(^)[KQ/;O&GQ#\2:7H_ MA&;P-KY\%VR>)?@WI6O:MJ6H:5JVA7^B^#_LY_!K6_VG/C/XC\0^.[R\&D3: MIVM=1TGP]"?$6D?IWXB^&%U\,/V*?&GPKT:QB\7:_P"'/V=? M'.A7*^!_!;Z+/\0O',_@+69/$6N:-X&T>XUZ[CU_XC>,;K4_$$NCP7WB#5[_ M %_7YUGU+6]4N9;Z[^/O^"2)XB\4^$/"OB/1=/33M5EB MGT7P%K.MZ9XFO)]6BL7T2QDM+[XD>$H;33K[4K?5=66]O;G2K&\M-&UFXL/; MSGP]R[(^+OHH>!W$-&E7X.PV6<3YWGN75I1_LWB#C/+LGKYK5^N*5Z&-H?VW M4K.E@Y^T57"YI4P4_:PQ,;^=E_%.+S'(O&WQ&RJI.EG];&9-E^6XJG&7UO+, M@Q684L%#V#5JF'J/+HPY\1'D<*V"CB%R2I.WO/B?_@G5\!;G1+JU^'TOCCX= M>('N[O4K?7)/'GC?XDV5Q=OI6JVEEIFM:%\3O$OBE&\+0ZI?V.MWNF>$-0\$ M:]=2:+9:=8^*M)TVXU&WO)OBGJNI?L:_LH:%X0\+?$74]8\<2Z[;^"O GBKQ M[I=_XJN)]3\2:_K7C?Q!I6EVMHDFF^']-\&_#RR\:6GPET_Q-<7GA?PGIWA; MP5X6U4^+UM(M'\1?>%?GW_P4V&FWE]:^ M'[%OAU\3;2/5];NK:WFAT;3)M3NM.T&+4M0DM+.76=;TC2$N&O\ 5;&UN?WK MQ*X4X:\-. O$WC[P^X8RKAGBVGP%F^"CF/#V#65;\7\3<'\,\4YQCLXR.7$V!Q#PN:XCZ[S M59S5.5#ZQBU5Q'L,7'_9JF&5949JK)QIJJU-?/'[(?[-7@[X^:+\0_'OQ@M/ M'6L6!\4W_A33+&]O?&?@Y/$^H-8>'?%6O_$FP\?Z1K&D>)O&/VC5=N?$'B"-8O"O9_M&?L*?#KX?_ PO_'GP5U#4O!*_#73_ M !'XO\;:+XV\9^/_ (AZ5XR\&6&F'4]<$>O>.-?\7^)_#7BGPS::9-JOA2?3 M;Q_#>K+)K'A;Q+H@?7-"\;_#_P"C/V"_$&C:M^SMH^B:9>M=ZAX)\6>./#_B M:(V.HVB:?K6K^([SX@6EE%<7UI;6^J*?"_C;PY>R7VD2W^G1W%Y-ICW:ZIIV MI65GWO[8:V=Q^RC^TAI5[J^GZ&?$OP2^)G@W3;_4[RVL;=O$'C7PCJOA+PQI MT,UW<6L4NI:SXCUK2]&T>P2=;G5-7O['3;)9+R[@C?X7@GP=\*,Q^CID]7,> M&>'<;6SOPZH\19QQ1B<#@Z^>+.?\ @GG\1_%OB3PQX]^'OB"6_P!5T;X> M3>$KOP?K6HZE#_;AUSQ%J\SVVC^'/B[\!O$6L74=M=7LEKH^ M@^&_A%J^JW:6=C#.)O4?^"<>G6.H_$O MXJ:M'XI\20:GX/\ WA73KSP39ZO'%X/U6Q^(^OZW62P7K:TTEAY=^T!I%AXA_;AUSP[J\+W.C^(_B[\ M!O#NL6L=S=64EUH^O>&_A%I&JVB7EC-;7UHUUI]Y"P]1P*6&I4Y4-P_#>,S+ZNJG[GV]2M7Q%:*E:E&M4Y))1BT?;7Q&_X*#?!KPUX;DOOAU8^) M_BUXJN);FQTWPY9:+K'@33;2\;1M7OM-U7Q9XE\?:5H@TSPB^KV&G:%K%_X2 MT?Q[XPTU]+O#6NV?Q/\-?#WP1;>*!X]OY=%D\26OA313X&N]4D_X0 M[X%O+ID?C/1M8?P$^N_IA;_L/_LQ6NH:5J4?P\U%KC1]4T_6+2.X^(_Q3N]/ MFN],NXKVVAU72;OQM/I>NZ7)-"B:AH>MV>H:)JUHTMAJNGWMC//;R?2/A;PE MX5\#:':^&?!7AGP_X/\ #=C-J%Q9>'_"VBZ=X?T.SN-7U*\UG59[72=)MK2P MMYM3UC4+_5=0EBMT>]U*^O+ZY:6ZN9I7_I>?A-XJ^(G%7".<^-'$7!$>'N", MWH\197PCX>X/.U@\TS["E"K3JT)5L/%4/K5:L?C M\>.."N%,ESS >'V5<1/->(L#/*L;GO%-?+GB,'EM?3$X? 8;*_W/-65K59NG M.%14ZLO:>QIP/AO_ (*.?\DA^'G_ &632O\ U77Q-KY(^#/QH_;"\%?#G0_# M?PD^'7A[Q-\/["[\22Z'K5Y\&/BAXNN;J74O%.M:KK<4OB'PS\1=#T6_-AX@ MO=5T\"STJU:S6U6PNQ->VMS<2_6__!1S_DD/P\_[+)I7_JNOB;7J'[#7_)L' MP]_["GQ,_P#5K^.:_/,_X9SSBKZ7/%&7Y!QKG/ F+H>$.68RKFV287+\7BL3 MAJ>=911EE]2GF-*M1CAZM6O2Q,IPBJJJ86E%2Y)33^HRO.,MR7P-R?%9GP]@ M.)*%3CO&4(8+,:V*H4:-6678VHL5"6$G3J.K"%*=)1DW#DK3;7,HM>%_![X] M_MI^)/C#\-?"WQ+^%>A:/\._$FL>(K'Q?KFG_ WXN>&KC1K.P^'OC/Q!I%T/ M$NN?$37=!T)+KQ3HN@:2USK.E75M>_VD-%M/(U?5--N(M_\ X*0/J:_"/X;) M8:OJFFVDOQITM-((Q$^@^%_A_XN\6^,IK32[_ $S6KO4/#NFV M]A/J!>30-8_8>.>"N+,L\!O$_AVOQ?GG'N>XSASB/$X7,LTPN#PV8SPSRNGS MY-AZ&5T:5.K&I2PN*C0BX2JUJV-G2E)P<(KX3AOB'),9XE\'9K2R++N&'C-*_,V_P#8-\&6/A?X M"PZW::CK%]G>'H[>RM9K31Y=-\!Z?J M\]O?3ZE=-K^J:Y=)>QV-S9Z=897[17[8^H_ ?XF6_P /;3X9Z;XPBG\"^'O& M9U:?X@S^&[N*37/$'C/1#ISZ-'X$\1*+>!?":7-OJAU4&]EO;JT.GVHTP7-_ MX=_P3U^,&FZ;=>*_@GXEUN:'4-=UD>,_AFNN>)-4O4U4MH$5IXS\">$='O-. M&C^'H/#EOX6M_B#'HNG:]+J'BJX\7?$+Q-:>&K>#PIXLUR[_ %5KSO"BIC^- M_HZ^'N&\-.,\/P7FN"X=R#*,3G=/( S/(J%'!\08+$9-F%?#X95\=BJ M->MSUIPJQHXJEC*49PK4YRZ^-HX;AWQ6XIK<7\/U>(<%B,US+'4+R=8 MG"9E4GB,KQ%+,,)3JU73P]"I3I\M.,H.=&=";C*G.,?R@OO^"E?B>*RNI--^ M &AWE_';RO96EW\9[ZPM;FY5"88+B^B^#VH26D4L@5'N$L;MHE)<6\N-A_5^ MOQ$_X* ?\G0Q?]D$^&7_ *L/XXU^W=<_@/Q7XAYAQWXU<#<>\80XT?A]C^#L M)E6;1X=R?AN4UG.#S[$XZ2\+8 M7AKP]XCX9R&7#ZXHPV?5\;@GFN/S=1^H5\LHX>*Q&.G=N/MZ\G*G1H*7M$I1 M?)%A7PO8?L _!N7QA\1_$_BV^\4^*M-\>^+_ !QXMM_"T6K7/A"PT6[^(.OV MWC+7+A]9\&SZ+XHOM8M?%UWXMDT?4;36]%L(_#/B*VT?6-#US7]&_P"$QU'[ MHK\#=7\6_&K]O+Q_;> +.ZFU'X<>,];N?$Z>#/%-MH_AOP;\-/@_9:KX7U2Q MU[Q[X-LM3U2;XD^,/#=SH_@RYL='N]5\87S_ !DU^27POJ_PP^&MYK&N>!_H MO'3/^",KAP3E?$O 2\2^)<\X@K4> ^$)TL#.CC,YH83V6*Q>,J9I-99AL#A, M-C81KXG&8?&PH3Q%"LL+:G/$X;R?#;+.(\;+B+&Y1Q,^$,HRW*Z<^)<]C/$Q MJ4,!4K\]&AAX8*/UNKB:];#2=*E0JX:56-*I3=:\XT:WUG\=/V"OA'X(^$OB MKQ1\$],\0^'?%_A46WBNX?Q=\7_BOXTT?5_"^BL9O&6CW4'Q UOXCM;W'_"+ M-JNK^&UT&W\/7EYXTTGPU8:IXDT_PM>>(HKOK?V O"^DZW^S[\3?#'B:W'BS MPEXJ^)7B_3]2\(>*BWB+PHN@:_X$\$V?B+PM;>'-9:^T:V\+^(KJXUK6=>\/ M6UE#H^L:YXG\3ZSJ-CKZ)J%]I_ARPN-6;2;+7C^T'JEOI%[=6]F;.VU[2+[%)]D_\$\_^2+>)_P#LJ&M?^HIX*K\0X/P69X#Z3?"E3'>%64>$D\X\ M..)L-B\HR'/WM8;F[OIKG M]:-(_8N_9OT+6M#\0:5X#U2UU?PWKVA^)=&NC\1_BC<+:ZUX16VI6%K/+8WUOZKHEEXC\.WFL:=;7$ MMYI=IX@T.YOH8(-7TY[G]LM U_0O%>A:+XH\+ZUI/B3PSXDTG3M?\.^(M U& MSUC0M?T+6+.'4=(UK1=7TZ:XT_5-)U33[BWOM.U&QN)[.^LYX;FVFEAE1V]? MP@X!X&J>/'TC,#B>"N$ZF'X=S3PTK\.8.OPYD\J.1?6,FS?%UJV28>I@W#+/ M;UZ>%Q-2I@(4/:U88>M)RG&G) M/_ ?A>U\*^*/B=^T1>:5XZN-(NM2MM+UZVUGX/?&[QUK<\GAG[:WAFQU77?& M?AK2?%.NZYI>CV6M:UKXU+5-4O[N\US7)=1];_9L_94^!'Q)^"O@OQKXS\&W M^J^)=:_X2/\ M*_A\<_$+1XI_P"SO%FNZ39[=-T/Q5INEVWE6%A:PM]ELH?. M:,SS^9<2S2R)_P %.-&UG5/AK\"K[3-(U74K+PY^T1::SXBO-/TZ\O;3P_H\ M_P "_COX>@U?7+FVAE@TC2YO$&O:%H,.HZB]M9RZWK>CZ2DS:AJEC;S^Y?L0 MZ_H6L?L[^%M.TC6M)U34/"FK>*M \46.G:C9WUYX;UVX\07_ (HM]%U^VMII M9M'U:?PSXD\.^(H=.U%+>\ET+7]%U=(6T_5+&XGJ/ G!./\ I?9_EF9\&\+8 MW+,9X+/B">7X[AW*<1@<5GF(XTRZGB<[EA,1@YX>OFU=3Q4*^9.G+&55+$1J M5I*51.7Q+Q%AO G+,9@\_P ZP^,P_B"LKCBL-FN.I8FCEM+A_%3HY'_ (1>)/!V MK^#WM7;Q!=6NE>%_#.K^ +C1I[WQ'/?ZG=W5W\/_ !)X@TK3M?O-2N=0L?$$ MVE^(-97Q/96>J^'=?X"7_@GE^RY?0:0-:\,^/-6U+2]/L;*?6(OC3\8_"D^M M7%G;P0RZMJ^D> ?'/A'PHVH:C+";N^33O#NG:8+B:=++3K*T9+5*7[;_ ,?? M&?P@T7X?^&?AWJ5UX<\6>.M5U;5YO%(\/:+KUI8>$_ DF@OKFCVSZY<7-AIW MB#Q)JOB?PS96\]YX7\1VLOA&'QQ%:/X=\2_\(UX@L?A#X<_L"?%/X]>&8OC1 MXB\<>#?AYXD\>3V]]8ZCX]\"7WQY\=^./ MEHVDZ3X+\9>,/%MO\5/!5[9ZC MKVB:=9S:'H6I:SXPU72_!$'A0>(;_0O$T^L>!O!WTG'.;<'8OQ0Q_"W"O@7E M/BOX@Y-PYE'^L&(S6KP[E&3<.Y#*,JN3X"GF&?X?,:%+%3I8R-6.#R_+:+J8 M:O0OB*\:%2EA?)X#L-G6=>)..X)X7S#-L=_9E+!0S7'9AFN9*489AB MI87+*N$J5*,9X=P=?$XNHHUJ=2U*DZL9U[WBWX'2_!G]K[X;>%='UC4;#PS< M?%KX5^-?AS>Z;XGUA_%>G>$=1\6:5::OX7U_6(++1+S[+/J%KXV\!7.GMJ'B M)O%'PEO;'3_'.N^)=1\1^+K:?]!OVX_BWJ'PK^",MCH@UNU\1?%K7U^$FB>( M-$GO+";PD=<\,>*?$?B'Q&VMZ1XH\*^(_#>I6O@SPGXFL_!GB7PU=:CJNA?$ M2_\ !VHRZ3<:/!JMS:?G1I_P UO]G']HWX)^"->\9^'/'-YJOC3X;^*H]6\, M?#^[^'%A;VU]X[32$TZ;0[SQU\09;J\AET.:YDU5=9MHYX;NWLQID+6+75[] ML_\ !1JVU"?X0?#^6STG4]1MK/XQ:56&GW=Y:Z!I[?#SXE6<>K:U<6\$ ML.DZ9-JMWIFA1:A?R6UI)K.M:3I23M?:E96UQ^1&,NS&CFN%X3Q>.X?C+%_P!F8S!4)L+EN>\6^!\,;F7^L6$S# 8'#XG.,5A)X*MG=##9HU1^N8?$3JU MT\1.]*I"M5J5*LJU63DYU6?-_P"R#^QMX,^*?@S5O&'Q1TW5U\!7 N/!_P / M/!WASQ#>>#;.\L-(:PBU3QNOB3X>^*-.\7V3V6KVNI>!="\.&?PE_9+:%XHU M?4['Q3:>(/!E_P"&_H'QG_P3B^&.I2Z8?AIX^^)OPBMK==-L[Q=&\3:IXIUB MRM[-];N)_$W@GQGXNU#5/'7A7XG_ &R_T2;1_%U_XE\4>'?#W_"+Z?<:?X"_ MM:ZO]6G]"_8(\1Z+K'[.^E:'IEY)=:EX%\7^./#GBB)M.U6RBL-:UCQ#=?$2 MRL[>ZU&QL[76(SX5\=>&KR74=$FU'2H;R\NM'>^&KZ5JUC9?9]?MOA#X+>$V M:>#OAW/%\&E_9E;GP-2-3"PA4E.>'E[6I-XA/FFI'P?_P %#/\ DBWAC_LJ&B_^ MHIXUKP/]F/\ 8ND^(NC:A\2/VBTU"]T+Q1I6E6GPX\"Z?XPUVRUA?#-C#81Z M1X[\6>,O"6O66K07&J:+IVEZ;X!\!Z+K<>G>$O "0MXO:]\1:[!X(^$OOG_! M0S_DBWAC_LJ&B_\ J*>-:^H/@A_R1;X0_P#9+_ '_J*:37S3X$X5XU^E9QM4 MXKRC#9[A\@X X2Q^ RS,J<,7E,L=B)XG"+%XS+:T9X7'5L-0G6AA%BH5:5"6 M(JUHTW65*I2]9<2YUP]X*(-%_8I\-?M!^)[CPGI?Q!\1? SX>^)H?(\.^* M]1\!#XN_$OPWX=LO"VFCP]INIW_BN/P7?_$KQ1I&F213>(1FZ-J.NSQ M_"#]D>[FLM+TR_U:YM].L-?^#U]J^MS6NG0SW$.F^&]*M[WQ%K.J2HNGZ)H^ MEWVM:K-;:787EQ%\WPNEX=>*7TMLMX(P5'*\OR3@?).*\FR+ T(T\MPV??ZF M5:TOAK1O"LWBWQ+XW\*3:-XQM]$\+^.O!_B7ZW_ &H/V0?A M9;^ OB3\5/AYX?@\(^.=+MK#QEJFSQ3XET_P3<>'?!^F0VWB73K+P65U_P ) M^&R_A"TO]8LK;P5X:\)S>(?'6GZ5=>(]=AMM6\2W]Y\R_LE? 3X2_'S3O'5C MXH\2>-++QKX,U/1;NYTGPX(=/TV#P=XIL;J'PSJ$VI:SX2U33-0U2_U_PQXY MM[FRTK6);O3+'3-+FU72]/CU32[O5OKW_AWG\%_^AG^*'_@Z\*?_ #%5\9X7 M\&9_Q-X(X;!8;P)X)XOCQIEN:XS'<>9QXA9=#B3,\XS"OF%*6=UGB.#<=C\% MF.5XJI4AA:,,VE5P=3#R7UA5ZF(JS^AXRX@RS)_$2KB*WB3Q%D3X?Q>"P^'X M9P'"V+>4X3 86GA:D%_X)Q?% M'4-=T#XG?![6-8\5Z[=?"^\\&>)_#4VM0:0^@^&OAS\1+'7-%\.> ?#>J6\X M\0W\?A[Q/\,/'FL-9^(;26W\-Z%XI\,>&O"VKR>&M*T_PUX2^)[$/^V)^TZ- M1L-;\07/AKXM^(KY=+\>^%/#'BC48O"GP5\*:!KVL>!KW^RO&LEZ?AS;:YX= MTNRM/,U[3[+PIIWQK^)5YKESX'N-5\6WGA35OV&^"'[.'P\^ 4GBN[\&2>(K M_5?&8T*#7-6\1ZK%?74FG>&1J[:#I5M::?9:3H]K:Z==>(?$-Z+F+2QJU[/K M,T6I:E>6-AHMII?Y._\ !-W5+;PA\5_!.A^+X-;\+>)O$7PCU/P!I_A;7/#N MN66MVWC&RL_#/C'5_#_B*Q>R,OA35-$T7X?^*!J,/B1-,CMM3L'T.6>/7+FP MTV]]WC;AWB2AD/T3_"3Q-Q%'%87,>+*N"XRITL=6Q.#S1\//#PX:R;%8YN@\ M3#&8'&QP=:FWS5<3'FPTY5*-.J_-X=S;*:N9^-W'/!]&I1K83)(8C()SPU.E MB,'_ &JJLLWS"CAK5%1=#$X>6(A)+EIT7:M%1J2@?>/C#_@GI\"-7TZ0>"'\ M9?#?Q MU]0TS4].O MK626UO=/U&PN;>\L;RVEEM[JUGBG@D>*16/L^.7AYP)PIXF?1TSOACAK)>&\ MTS#Q6R#+<7#(\'ALIPV.P.&Q^ KTY5LMP4*&$J5<)5FH1Q<<.J\88CV-6K.# MHQAYWASQ5Q+G7!_BMEV<9OF&;8+"\%9GBZ$LRKU<;6PV)JX;$TI1IXO$2J5X MPKTTY.@ZKIN5+VD(1DJCE^[5%%-?B!JMEJFI:7X&\)>(_&. MI:=H<%M\UJ\LM'MKV\T^SN-4NK>RD@T^"[O[&VENY(8Y[RVB9Y MD_M^O7HX6A6Q.(J1HT,/2J5Z]6;M"E1I0=2I4F^D80C*4GT29_.M*G4K5*=& ME!SJU9PI4X15Y3J5)*,(Q75RDTEYL^)_ '_!-SX!^%O"TGA3Q3<>,O'>GPV] MMI.B*/%.N_#W_A'] T:[U:'0+?3KGX9ZGX4UIM6;PWZ1)X^OO'6K_\ "2Z-XLD\.P65E:^(O"V@-X8UKQC>:LFM MZQI_A2UMOGG0O!_Q[_;Q\;0^'/'7B31M<\/^&(9/%OB;Q'XATJQN/AQ\,M6N M#XNB\"6W@GX-VVK6%QKWB;49]=\4>&M#UN[U6/Q#IOPUT;71X^^+FL:[9^%- M!\>]%\2/V ?&OP3\%ZS\3M7^,WPY\6:?X9_L[[1X?T']G_5O!&K7_P#;.K6/ MA^+[)XGN?CIXR@TS[+/JT=[/O\-ZC]MMK:;3U^QO=K?VO^=/$M;AOC#P?XTS M3PX^C+DR\/UP_P 4XC+_ !#S/-N%\BSZE/):6.JXGB;"8"K@LPXCS!9;C<'5 MK057-H8G,8X6IEW-34JE*G_5V4T\VR'CSA_!<6>,&/?%#S3):6*X5P>!SG,L MLG',)X:%'**^)AB,+E.%>,PV(A!N&!E2PKK0Q=I-0J2^_/V6?ASX5\=?L;>" M?A[X_P!/;QUX3U,^+HY=,\57=]K M+/3_BIXDU?PI9:1=WEU+?:)!\/Y;+18 M?AR=&NK"3P!!X:\,IX.;0U\/:*MC^9FK_#_PIIW[:GQ ^#-II]RGPXTGXY_! M_P &Z=H$FLZY)2;[6?&'B*]2\?6'U"Q;4? M)T^ZM+:TL8;;];?V,O\ DVOX;_\ +_P#BFO"Y\%:!\&/@)I^N^,5\0:U]BTE_"FB:AX9\2Z?J M_B)+MM'TV_\ #NO65[>07.C:C%;>UXP93E>:_1W^CSGV9Y7E^8YO4K>"^"Q> M(^H8W$RC4Q>&G5^K8BLXRJPG-IGG,Q6%P,:?B!B*& P^)K4<*L9A_$;58;6;5-$U M3P[?-+I>L>+=0TB_672-9U&W6/4+"ZB@EFCO;=(KZUM+F#Z.HHK^Z,CXX M8P<\OX:R')N'L!4Q$\74P.1Y7@.?B@LUM\$[&TU[3?!GA>V\2:I_PD'CK5=4UG6M0UW4O[4TC5X]0^'WP_\ M#GB?6?$EU8:)I-YIGBCQ7\0;O5M:D3PIX0T9/^%P?H5^V;_R;7\2/^Y/_P#4 M]\+53_8IU&PO?V23^6.+N#>&>-OI!HYMEV6^!&' MSW#93C)*>6YAF>"\0,SPN%AF.!J7H9IAL/2Q^*Q<<#B(5*$J]"E6JTYTZ,H2 M_:,BS_..'? S'XO),34P.+QGB35RVMCL.G'%X7!XCA?!UJTL)B8VJ8.K5J8: MC0>)I2A45.K.G"495%)?!O[7_P"R#HWP)['P]_:[\03:3\-_$7@ZR?QA;:H_B3P7XCT M/2_ UEX3^(.J>,/L#_@G]XVU7Q1\ X_#&HZ;!8V7P@\32_"CPO=6TNFI#J/@ MW1/"WA/7_"L4.D:1H.A6/A^U\)Z/XGMOAYI^G@ZS>7VF^#;/Q'JFN76JZ[?6 M]H?\%!]?T33OVH36.J>/?'WPWT#PI'%IFJW\>I:WX;\6:?\5-0T^Y MNM/M+BTT6%O!_P .O%5TFIZ[<:;I4ES:6^D0W<^MZKH^EZCR'_!-S6;+4_A- M\3[*UEMI)_#OQMU+1M22#;YL%[/\+OA/X@CBO,,Q%R=.UVPF7<$;['-:G:5* MN^&3Y)DW WTO*>2\%8+!Y)E'%'A'/->)LBRBA0PF50S#!YSBJ&#QBR["PIX7 M!5G2P>$Y?94J^) M]=U/P#XH\2^+H?!.O>"_!6MQZ7X(^#EC9:]XJT37[[1M>BDE\'ZKXRT'0O#> MA:YXS\<6OE'XG>*/#.FW>A-IT?A/X'?'?AO7- M3TW4;&SUS2?C%\6+T>'[N^MIH8-:T?PGXH\8^(_AW+J6DS2I?:=!KG@W6M$- MS!#%J.CZA8&:RF^"O^">FKVGA7XW^&=)\4VNK>%=?\3_ O\0^!=+\,:QX?U MVQUFU\6VZ>&?&NH>'M;T]],67PM>Z1H/@'Q0=0C\2IHZ6NHZ$.$_$7@_BSCWCSAW(^+.,>*N-^(Z?$&*XCR["9SBLNAA)4*&%R+ M#QS*GBIY9A,'A9PE2PE+V,XT*V'IR,&?9YPIGV2<,\-9KF.1Y! MDO#N4SRNCE6+KX"CBY5U4J5LRK2PDJ,<97KUHRC.M-U(NI3JSBE5JXAU/PD^ M$-W\2?V9?VH='^&[^(++Q9J,7C[P7\-/B+:>%I[CP]X7\::+XYBT?^PO$-_I M.LZ?XFNM&U'POI7CG2/B-!HEI=WNI:5JEGJOP_L?B'=^&M>UWQ!K?I/_ 47 M\:^-KCXL^&_ATVGW=MX)T;X8Z9XZ\*W\UAK]GHOB3QWKWB+QOX?\3V(_VS_BS9 MK\0=4T'1OBC\>?A%X%L_'/PX\26.G>*/!^N:KX(^"GP,O7\)^)8CJ5MHOCOP MIX^TK4;&SFDM9KKP_P",; VEUIDE_I\UK)^X7Q7^%?A/XR^"=5\"^,+>X^PW MZ&;3]6TXVL.O>&-:CAGBT_Q+X;O+VTO[6SUO3#<2F W=C?Z9?VLUWH^N:9J^ M@:EJFDWWQ/!' &:\<^'/TD?!GA/.99;D>1^*.8X#@J6+KU\1EU"A@\TCF-?A MNIB%[7%T\KK5,OP]+$5:4ZW+6QM;'.AB95L52Q7T7$?$^"X(51I4Z6*J5:^"^JT\VA2?)0EC:<<55G2A*-/FAAZ>&56BH49T/D M_P"%'[*W[&OCOX8Z-8^$&N_BCI6E^(]&\1:QXRE^)7C.+QW=^-XO ^CVLUIX MWN/#>N>&+[PJVH:'J>F^(]?^"*Z/X1^'VE:]J\>O1_"_0]4EMI(OK'X2_#32 M_@]\/?#GPXT76->U_3?#<>HI;ZQXGDT>77;]M3U?4-:N9M1?P_HWA[1S(+K4 M9HXA8:-81+;I"K1/(KRR?D/\<_V)?&GP5TBY^*_ASQI=>+;+PGJ>NRV&K^$= M"\:>$?C%X!T;Q9K%CX)T2;PYK'@*ZU_5+BXL?!_BS7$^*_Q)TK5OA;IFB>&= M,USQ&VB:?X8U'5K+PY]\_L??M(3?'/PYXA\-^*;JQE^)WPWC\./XG-C:WMN- M9\->*8]8M_"/C*]C72;'0-.U/7M2\)^,M+U'1-!O[^*"[\-2ZY]B\.Z9XCT7 M0K/]D\*^*,FR[C["\#\7>#^2>%/B=_JMB89/C<@HY1B/_ ?A>U\*^*/B=^T1>:5XZN- M(NM2MM+UZVUGX/?&[QUK<\GAG[:WAFQU77?&?AK2?%.NZYI>CV6M:UKXU+5- M4O[N\US7)=1]"_9B_P"3T?VA?^ZL_P#JU] K8_X*<:-K.J?#7X%7VF:1JNI6 M7AS]HBTUGQ%>:?IUY>VGA_1Y_@7\=_#T&KZY?\ )98&5>E4E@\9AZ-2LH8S#NG7I4IU4JD8RG?[?,#DHB_LV?L MJ? CXD_!7P7XU\9^#;_5?$NM?\)'_:5_#XY^(6CQ3_V=XLUW2;/;INA^*M-T MNV\JPL+6%OLME#YS1F>?S+B6:63VG]J3PUHW@O\ 9$\2^#O#=K+8^'O">@_# MCPUH-E-?:AJ+?!VEZ7:RZEJUU?:IJ$MO8VL$4E]J5[>:A=NAN+RZN M+B225['[$.OZ%K'[._A;3M(UK2=4U#PIJWBK0/%%CIVHV=]>>&]=N/$%_P"* M+?1=?MK::6;1]6G\,^)/#OB*'3M12WO)="U_1=72%M/U2QN)];]LW_DVOXD? M]R?_ .I[X6K]/RSA?A?)_HFYGF^3<.Y#E>:9S]'&K6SG,\LRC+\#C\VQ$_#: MI7K5%]&O?$^NZGX!\4>)?%T/@G7O!? M@K6X]+\$?!RQLM>\5:)K]]HVO122^#]5\9:#H7AO0M<\9^.+7RC\3O%'AG3; MO0FTZ/PG\.;7]0?V,O\ DVOX;_\ ']=L=9M?%MNGAGQKJ'A[6]/?3%E\+7ND:#X!\4 M'4(_$J:.EKJ.G+HSA5JX%9AG6=4\?F.'A.$^6MA*.'IR]LERPI2JPJWI59 MQ?WKJW_!/3]F#4#K%YIWAWQWX;US4]-U&QL]X\/>%_&FB^.8M'_L+Q#?Z3K.G^)KK1M1\+ MZ5XYTCXC0:):7=[J6E:I9ZK\/['XAW?AK7M=\0:W^[=?S[?''3-$\1_MG_%F MS7X@ZIH.C?%'X\_"+P+9^.?AQXDL=.\4>#]OX3\2Q'4K;1?'? MA3Q]I6HV-G-):S77A_QC8&TNM,DO]/FM9/I_I'\'\*\ TO"GC7@3A[)>%>,, MN\4N&,HRVKPWEV"R2IF6 S*EF'UW*<30R^A0HXS#5XX:E2DL31K1AAZF(PJM M1QM>G5\?PES[.N)Y\:\/<2YIF&=9#B^#,XQ^+AFV*Q&8QPF*PD\+]7QU&KBJ ME2I0K4W5G-.C4IN56%*M_$P]*=/]&?\ @H9_R1;PQ_V5#1?_ %%/&M?/W[+O M[%'_ GN@7?Q!_:%AO[GP[XBT71M.^&?@'3O&.O6>KQ>%--M]/@T3QSXK\9^ M$]?L]7@GU/0]-TK3/ '@/1M<33_"?@".%O%[WOB/78/!'PE^@?\ @H9_R1;P MQ_V5#1?_ %%/&M?4'P0_Y(M\(?\ LE_@#_U%-)KU'P)PMQK]*OC:IQ5E.&SW M#9!P!PCF& RO,J<,7E$L?7GB<)'&8S+:T9X7'5L+AZE>*IU:6'EB*M6-/ MVRI5*?$N)\%.'HY+CJN6U? *P^!?Q#T./P-=:AHG@#QEX<@U/P:MOXS\ M27?C?PCXT\%W=I:>)IM*UVXM(M>TFQLTU#P%XJ\(>);CQQXD\8IXTU'QC+'< M>'=)T+PC;M^Q7P'\9^(?B-\#O@S\0O%L>C0^*O'?PI^'?C+Q-#X M(?%'A#1];UJ/0K+4]0U;4K31DU*^N5TNUU#5=3O;>R$$5WJ%Y.DES)\ _P#! M2?\ Y#7P)_[!?Q<_]*_A57VS^RI_R:]^S=_V03X/?^J\\.UOX-Y7E_"OTB_I M!\*]T445_79^%GY5_\%)_^0U\"?\ L%_%S_TK M^%5?>'[.G_)OGP)_[(W\,/\ U"=#KX/_ ."D_P#R&O@3_P!@OXN?^E?PJK[P M_9T_Y-\^!/\ V1OX8?\ J$Z'7\G>'O\ REE]('_LFO#O_P!9W)C]MXI_Y,CX M7_\ 8WXJ_P#5ICSV2O/?BQ\3?#/P;^'/B[XF^+Y670_".DR:@]E;WFBV6J:_ MJ\(^'&\1:MH6C7GB_QIXAN]+\)>#=(O=8TY==\5:UH^BPW4=Q?PFO M0J_,;_@H;\7A;6GAWX%:8V)=9MM.^(7CQYK27R1X=T_6+J+P+I,&KG2K MW^UO%_A_4_$ES>^'_%.G>)/"MU\/=&M]5TZ;0_'$#R_MWBOQ[@_#/P^XHXTQ M;IN>49;5>6X>IJL;G.*:PF3X+E34Y0Q&8UL/&NZ=Y4<+[?$.+A1E;\\X)X9Q M'&'%.3SI)\U2)\X_LK> M ?$G[1'Q_'C_ .(=VFJ#P;KNG_&#Q]=6-_KB64_CA]8FU3X=^&M"%[X[;QGH M'AG3O%6E/K?A2PN+KQAX)M M=TE;/XC_ !7?3_$_BJ6\TV.UUS2/#UM;S)X \!W?R6*]CB6US1JX+!?5<+B*7,X+'0QE:"B\1-'T'BOQ-0XCXOQ4 M"M#C\9> _A!I$UJ8[CQ9X=^%4GQ!T+4O%.ER^(A M:^(?B);:1XWOOB1X@T>W2QT>[\4?\(C\/_ =I_3#7YU_\%"OAY\+IO VC?%G M6;FTT'XK:/JFB^!?!-W%K5EH]Y\0K'6]4DU#5? %_IEUN'C:/P[H$'B[XEZ# M96<#>)/"2^'?%>KZ)J.F>%M7^)-AXB_(?I >$OB+C^&^,>*L1XK5^(^%79GBZ&"PU!T\%'$6EB:]##.=;# M8JV-I_>>%_''"F&S?(,EI<$T\ISK,:6%X>CQAEF/>+S6AC\=3A@/[4HX',\' MBL'0J8BM4Y\0Z=XT*=6MRTZM&^'E]M?#/PG\/O!'@3PWX<^%>EZ#I/@"WL7U M'P[#X:>&XTF^@\075QXAO/$":E%++]8^$GPVU'PWICW^C>%/C3IFO_$"Z6]T^U&B^ M$;GX9_%+PO9:G)!>ZA9W.I)+X]\2>"-'%EI-OJVH1R:LFHR:?'I5AJ>J:;0_ MX)SZQXJG\$?$70+W1+\>"]'\5Z=J/ACQ9=^+4U2UNM>UW2V/B_P-I'A"1Y+S MPA8>%HM,\,^,)[N(P:+XHUGXH:M=V5HNLZ?XDO+_ '/^"BWC?Q)X4^#O@?0= M#M-*N=,^)GQZS:)IL5[=6>L:5]]Q1Q7E?'GT4^).*_[,_L+ YSX5YUB:.4 MTH*-++L9A\KQ6'PF"PR="C&6!I9EAJ5+"588>C"K@O95:4:<9P->4Y)]<_M+$X#C7+Z-3'3E>>+H5<;1JU\16M5J-8F>$K3G7A*K4E#$<].HY M2C).;_@G7X\B\5_!'Q/X4@T)-'B^$/Q6\2^ _MB:B;[_ (227Q#H'A+XTW6N MM:_V?9?V,ZW?Q:GT-M.%QJWF_P!B?VP=0C.JG2]-^]J_/W_@G)X!U?P?\'O' MWB34;O2KJP^+/QBUCQ]X=CTZXNI[FQTC2O /PX^$]U9ZVD]G;0VVJ_\ "2?# M'Q!Z=8?H%7Z'X&SQ4_!KPLEC.;VW^H/"J7/&,9 M.A')L)'"-J*2=\*J+4G[TTU*;S^$-'T'3[NSOK M[5O&MMX:F\(Z:;1KJXM+W6X+Z'2M:>V&D7WT917DY_DV$XBR+.N'\P4I8#/< MIS')L;&+:E+"9G@ZV"Q*BTTU)T:\TFFFGU1W99F%?*(HMW3T52G&^C]#\N_P#@G#X]T>./XF_"IX]&L-6GO]/^*NER/XBM M#KWBVWO].TOP3XKDLO"C6L-[_9'@5/#OP_CU3Q%;7NHVK7?Q T73;ZVT>5=. MDUS'_P""C?C?X92ZMX+\#W-MKTWQ8\)Z'+XW35H[B_TOPEX7^&_C/4+W2KT: MY]KM9-$\57_BK5OAS<+I>GZ0T>N^$CX5GUS6=?T#1=5L_"WQ0\I\,?#/XJ_L MH?M9>$=(^'/PV^(GB?X=2^,M"\$6.J:7X/\ $^N>&+GX%?$_6=*T>2SUWXC' M2OBQ>Z*WP9N9-*UW7+_Q3X@\->,O'-]\';;4_$>H>%_!?Q".L3>L_M]?LY?$ MWQOXO7XM^%=$F^(?@P_"Z'P-XQ\#^'M,,OC7P_;>%+GXA^+KKQ5IME'J/]I_ M$'3O$NG^)9/#(\'>#]+N?'VG^(-.T%?#6@>-HO&&K2>!_P"&98/Q"E]$WB_P MUCPGC-^1<6O.\/@\CXBP5'B3"8F&8PH1PF9XC+*E M"IEN;UX5'+!>UQM.HL;0KNG3E#$_5*MJ4ZD%Y/\ #G]E+]L6/P!X1F^&GB[1 M_AGX(UG2(O%^B^!Y_BS\ M>+M*O ^IP^)KG5Y-58ZI->LU'Q3XC_:Y_8_\1V4>M_$F+Q+K'C_P_J&JZ5!X MQ\;^-/C3\/-0O?#$5]I-Q8C3?%^I>&/&NAIX:O\ QAX>US71X/D\ Q>)_MOA MBSN/$&MQ:3?Z7I'L?@K]I?\ ;9L?".O:?K_P3UKQ?KC>%=/TOX?^+-4^"OQ( M\+:E8^)K/1[ZSN?%?Q3\/64FGZ?XW&JZNVD:S?\ A[P18?!.SB6WUG3=,FTZ M'5=.F\.^-:]X?_:]_:^\9>$]%\:_#U_"%YX-MUT/5/&VH?"SQ1\,OA[X-L?% M[7FI:WXMT[2_B#X@N?%OQ$N[Y?!NFZ:_A+P-XJ\2PV^LVG@NT\27GPYT7Q+J M'CI/C,YP/!]'AW+,+X"8OQ^?BHJN44<@PE9<=8/ 9?4I8W"TL>N)5G>'H<,T M,L>61QCKPP]:ME\'*G3Q')@?;PC[^ Q.?5,UQE;Q-H^&*X+<,=4S.M3?#=?$ MXF,\/6GA7E#RZK4S>IC/K;PZI2JTZ>*DE.5+FQ/LI/\ 0KX^ZG>?%_\ 8^UW MQ9X*\-^)M0/C#P#X)^(NE>&(=+_M+QB=%:]\->.;G3X] T"?69M8\2VFA07( M7P]X9EUW4=7U.#^R?#<6MZA=6$%WU7[)&BZUX?\ V=?ACI_B#1M5\/ZI+I>J MZN^C:[I]WH^MV-GXB\2:UX@TN+6-%U"*WU30]4;2M3LI;_0M9M+#7-%NI)=+ MUO3M.U:TO+&W]N\*>&-$\$>%O#?@SPS9OI_AOPCH&C^&/#]A+>W^I26.B:!I MUMI6DV_"*RU+XR^'[NR@U?4)XK_P/ MX$["WU#=+OM=>6WT MCP?XV_X3#Q#IWQ+\$:I?1:GK&H/\*/$+Z#IRW.EW?B'PY]W?M^W'C+Q-X'\( M?!CPE\*_%WC^V^(&MQ^+_%.MZ3X%UGQ5X=\,:3\'_$7@[Q7H-E/JVC7Z/X<\ M=ZQ\0[KP3K7@Y-1T?6=-U?PSX-^)(']G:KIVE7@V/V!_AK>^"_A+K?BCQ#H. MH:%XL\?>--?:\L/$W@"^\#>-=%\/>"-1N_!&A^'=9?6DBU[7M#EU71_%/Q"\ M'ZC=VFFZ:VD?$=Y]$L9[.\?7]=_G7CC@;!(^)\YE MAZ]/+\PQV"S&MB>%\JC6G"&%Q&,P.-QN#QU1PG7JUL'5GAJD%3P,O9_JO#G$ MF(X8\$.):4LQHO$<3YW4RG)\OC5ISQ6&PV(PM.CG.-=.,I5J5#$X;#U\/%2C M3A3KPC5C+GQ*YON6OP__ &AOV0?&/P%U[PWX^^!VC_$G7/!O@C5-)\3>"]3\ M 1Z]XU^*'PJU^SO]/\,Z9HZZ/I9U[X@_$31M1L_$5WI5W=PZ#XTM-8^'&N)L@Q:R_/^ M'\RC[-O$9=C'3JQC"LZ-'ZQ1G3E"HZ-"K!TL5A\-B*'YAP=QMFW!>+Q=;+Z> M"QN"S/#/!9OE&:4/K669IA'S6I8JASP;E3YZGLJD9J4%4J0DIT:M:E4_$Z74 MOVX?VE-%O?AWJ6A_$B'P?/X4\$?#[XA:;XT^&^F_!O0_%EKJVI:A;:QX[\1Z MCXR\)>$->\1-K5G:7(^*_A7X6SW7A9O"T$6BP_"F&W\5QZ+XG^V?A!^R#8:% M^Q_I7[,7Q5U.'47O-5\5>,?$5_\ #J]U7P[:Z'XM\6?&;7?CM8P>%M3E6WNM M9M/ GB_6+&QM=1\0:+::3\0[?0#=^+_ %GH7B35_ L7VQ17D\&^#66<-8G-\ MSS_BGB_Q%SC/-LTCF6%CD&(JJKB&]2\1^)_# M7AS7/AUJNL^-?#_P[^)<&G^-[;Q7XUW=?UG]M_\ :;O/%&@?\(1\3H_"]QXE M^'[W?@KQ/X$C^!?P^\)QW\?]E0:Q:ZY\1= \+>-O'WA32+O3;[QUXWTS3=:^ M,&O:!J7V6ZT;PHM\W@/PZ?W%HK\_C]%G),/@J_#67^)/BGEOAYBJN(J5^ <' MQ)1CD_L,5*K/$972Q53 U,?3R;$2JS6)P$JM66)4ZDZV(GB)NNOJ)>,^8U<1 M2S?%<(\%XSBFA"E"GQ/B,IJ2Q_M*,81I8VI1CB8X:684E"/L<3&$%1<8*E2C M2C[-^(_ #X&^'_@!X$;PAHNI:EKE_JVKR^*/%WB#49KE1KGBJ[TO2='N[[3= M&DO+RR\,:-#INAZ3INE>']+D:*WL]/BO-7O=>\47^O\ B;6_@SXH? SXNZY^ MVQ:>,M+\!ZO=^$K_ .)7PH\=6OB6.?2O[%/A?X;P_!33_%U[=WYU$0:3J%G= MM=II7AK66T_Q3XK@T?7]1\(Z)KNF:'JE[:_K#17Z=Q=X.\(<6\,<(\(2CCLA MR+@C/\@S_(L)D-3"T%2K<.T<3AL%@JSQN$Q_M<'.ABZRQ#2ABZM7DK2Q7/[7 MVOQ^17DY"BBBOU4^)/C']M[X9_$3XJ_#[X?^'OAQX4G\5ZE9_%:QUG M68XM8\.:,FBZ!;_#_P"(MB^LW$OB36-'CO(/[9U'1=(%GI;WNJ&?5X;L6)TV MTU*\L_C_ ,)?"O\ X*(?#_0;3PGX$UKQ%X4\*Z=-J,^FZ!9R?LU:K;6$FKZG M>:UJ1BO_ !-H>NZW,+O5M1OKTB]U6Z\EKEH+;R+.*WMX?V.HK\)XQ\ \CXNX MWQ'B#0XW\2N#>(\5DN&R#$U^!^(L!D=.OEN%K*O&C5E5R3'8N4:E6%&I6I_6 M_J\YX>A/V,9PYG^DY#XFYCD?#M+A>IP[PCG^54UC&K5BZCC*R_(+6?#W_!4X:/JQTKQWXO.J#3;XZ:(; M/]D$S&_%K+]C$0O_ >E@9#<>6$%ZZ6F['VEEAWD?K[117V? /A]/@.&:0EQ MUXA\;?VI+!R4N/N(:.?SRWZFL2N7*Y4)-$DTG M5_A?=:M+I'AFWT;3GEN/%TEE?^+/"5_X!G\+X\ GQ&VK>'_"GA7YFNOBS^WI MHLC>&M-U_P#:[T>V\ 2R^%+BWM?V8F\>QZF?"[#1Y)5\>^*_V>O'FK?$:*X. MFR/%XXTOQCXD7Q@MP=>M?$FN+J-MJ<_[]T5^7YM]&?AY9UF>>\!<:%6(S MO$/%9OEW V>?V?D.-Q,W)U,0\IE1E3H5I.3<8T*T,)0O;#X2DKGV6!\7\U>7 MX/+>)N'N&.-:674E1P&*XCRWZUF6'I1LHTOKJJ*56"44G*I3E7J[UJ]1GX<: M5^S'^U/\>?&UIXX\?Z=K6ER>-/#7A/4K_P"(_P 3]1TK3C8>'K1=)MK+PW8_ M"S2+JW\2^$?$=CI.KZOXD'P]E\"?#?09?$L7BG_A+-7\,>,?$%_>ZC^X]%%? M>^&/A!PYX62XAQ>59EQ+G^=\6XC XKB3B+BO-Y9OF^;5\NCC%@Y5ZT:.&H1] MB\?C&I1H*O4591KUJRI4>3YGC'CS-N,UE5#&X/*,LR[(Z6(HY3E628!8' 8* MGBG0==4X.I6J/VGU6A=.K[.+@W2IT^>?,5^$'BG]GKX[_L<^-_!FN?"Z/XK^ M//#OA;5/#^C^#?'/@OPSJOCW6O%6D7&GZI]N\#?&KP%\/=)OKZYTV[TCP]+: M^-O$5QX3T;XSJTK M2YL^#^-LQX/J9E##X3+\TRW.L(L#G&3YK0E7P./P\7)T^=4ZE*K"M1]I55&I M&=H^UGS0G[O+^)_C.3]N_P#:R\*^)!:^ KK0M \/6R2KX#\8>'];^ GA?Q3X MO\'75KK-K;V.G>/K"^^)?B;6];L?%5I<>';G5KM?@1<>(? MC]H\3>"?&&A7 M6L'[2_8 T3Q%I'P*NKSQ#X7\5>$7\2>.M=US2M)\;>&->\$^)_[+72_#^A"Y MU3PAXKT_1_%7A]I=2T34DMK7Q!HVEWEW9Q6^K6MO-I&HZ;?7GV]17SG"O@3E M'#?&V7>(F.XOXUXLXNP>4YEE&(S+B3,\)C*>-PV8>P5.E'"TE[3%UJV(=>JY2GZV=>)6.S;AW%<*8;(N'LDR+$8W"8ZEA,HP=>A+ M#UL+[3FFZT\34GBJV*&O%OQE^SCXR_;,?6OA#\-/#6E_'#1?AOX*UGP@+_1_ M&'P%T?X9:)I_P5T_6_AEX/O/"!\3?$WX6^#OM%IX'\*Z9JM]HFDZ3KTOQAU: MS\0>,+]KCQA_8_AR+PI^VU%5GW@9E>:^(=?Q(RCC+CCA#-\VAE%+BC!\,YO1 MP67\2T,?A]X6UK3- U_6AH%UINH:U9W5YI4LOA[Q1HGB M:32+_P"Q2I=V-OXAM]'ET!];MX-3F\/?VG_;J:%XA;3AH6H_CAX*/[87P2UW MQ!\-/ /A3XW>"+SQCKOAQM6L]%^"6G>-/"-OXZ\1K\.UM_%O_"U'^'GC;P"T MZ^$O#6D_#_Q+J\OC_4/AOX3T&^\22ZQ#H7C+1K?Q1X;_ 'ZHK?Q$\$\LX\XG MRCC7"<6<8\$<5Y3E-7AYYSPAF5' XC&9!7Q%?%5,NQ"Q&%Q*@Z>(Q6(JX;$4 M'3=.I6E.M3Q$J6%>&SX5\1,9PSDV.X>KY'D/$628W'0S7^S\]PE3$TJ&9TZ5 M*C'%4O95J7,ITJ-*%6E44U*-.,82I1G657\Z_C[^SA\4OCE\&O@GXTU*^U8_ M'KX8?#":/Q'X!O[CP7:Z=XX\1>,-#\!WWC_2;O4-&,/AC2O'=GX@\%0IX1U3 M2=>M?ANT][KNB:BMOH^N:3XT\%_)'PX^+G[9?PQ\.ZA\#/"_P^^,ETG_ EF MO>!O#7B'Q7\!_BEXCO?A[J&JWH\.6EKX)^(VJ:*/AK+\.?"_B!KC7/"'BKQF M?&_PLT/1+B.&PU__ (4SH_AS1-%_68/-<'7Y,IQ6*G.K5A@GA<30DL'*I4J2EA9 MN7-[24'5]G[A^&_AOX,?M.Z/^U%\*=;^*O@76=8N_B'XN\(_$F;QEH3ZGXTM M=(E\/W.F:UXYT3XM>)])T:/P-\-=?\(Z;:V.D^&]"&OW/@SQ%IUMIWAOX/\ MB'Q3+I=QX8\._L/\4_AGX8^,/@/7?AUXQ74_[!U[^S)9I=&U.ZTC5++4-"UG M3_$6A:E97ELVTS:5KVDZ;J0L;^&^T351:G2_$&E:QH=YJ.EWGH-%>YP!X+\) M>'N"XRRW 5LWSO <=8QXO/J'$V,IYO+%.KERR_'PQ&(J8>GB,9_:CGB\3F$\ M;4KRKU<74BN2FN5^=Q/X@YYQ3B,@Q>)IX#+L3PW0]AEE7)\/+ *@J>+^M85T MJ4:LJ6'^I*-"CA8X>--4X48M\TW=?@EJ?PR_:1_9,^,JZ[X%\/\ Q4U"XU;R M]#7Q1\+_ (?>(/B3X(^*_@;PCJNA>*DTKX@>&/#.C^.HO" 6XUV\T/2[CQ=; M^%/'^CR:O\4-/^#/C6;2-2\3>)-6V/'_ , /VP?VZ?"5QX?^(WV[0/!'B23X M@7&@ZE\6_#.F^#=*^&L?B;5I_ .M1Z5\)K31M ^(VO\ B/PMX2U;Q*_PQ;XA M:39S>)/"UIJ>FW7QET2Q^(4_B7Q!^ZM%?G^7?1>X>RV/]C4?$#Q/_P!0*>-> M/H>'4>)_9<.PD\5'&/+ZM2GA8YC7R;V_-4^HO%0JSJ\F(K8NMB54K5?J,5XR M9IBW_:%3A?@[_6B6'^K5>*WD_/FLDJ+H?6H0E6>%IX]TK0^L^QE",.:E3H4Z M3C3A\0_M_:'XBUCX%V=WX=\,>*O%K^'O'OA_6=4TGP5X8U[QKXE&F3:;KWA\ M76G>$O"NGZQXHUT0ZGKNFK>0Z%H^I7-A8276LWT-OHNF:IJ%E]0_"O1M3\.? M##X<>'M:M38ZSH7@+P?HVK61FM[DV>IZ7X>TZQO[4W%G-<6DYM[J"6(S6MQ/ M;2[-\$TL3*[=[17['@. ;\19#E'#^+P=2>'>74<-E%:M M5I5L/".&CB57K>TA&I[3$U*:Y).,%SI0^!Q7$^-Q7"^5\*3H86.!RK,\=FE# M$0C66+J5L=3IPG3JR=9T73AR2<>2C"3YDG+W6Y?G7^WK\*OB+\1+SX0:EX'\ M(:KXHLM!;Q9HFLR:0+6YN-.U#QWXB^%NB>&O/T[[2NJ-ITUU!>W6L:[!92Z# MX2T73=2\1>+]3T'0;&XU)/I/X8?"L7/[*WP\^"/Q2T:Y@6X_9^\)?"OXB^'K M77;FQO(1+\.=/\)>+M&MO$W@_5H+NSN8PVH6,.N^%]=AN+>4+J&B:M'*EM># MZ!HKDRGPSR'*./N-O$.CB,QQ.:\>9?DF6YSE^,G@ZN44J&1X&GEU#ZGAXX*G MB(_6,-1I?6HXK%XJ$Y^T<(TX5%3AMC>+\SQW#/#O"TZ6%I8+AK%9CB\!BJ$: M\,=.IF6)EBJGMZKQ$J3]E5G/V,J-&C*,>12/ MOA5:_%'4M+\%Z++#X-^-'POTO0/&?CB70_B!=P>'M4\%>(/A!INE^)M:\9ZU MIM]:Z+K/B6RC^#_BSX6S?V9X.^*UK'X>UKPW&?%?C/X[>'O$'PU\-: M9J"QM=07U[J7@W5]3UNRT30=#UL76HOI&M_L?17Y?AOHVX/(ZN-PG!'BAXH< M!\+YCBZV-Q'"G#N>8.&78*KB:DJE>.15\9EV*QF30J)6+Q$*45&D\SI8?%T:&/E"VTX4 MH6;2@N:3E\??L6?"SXR_"?X:^)M+^-7B7Q#XBUKQ'XVM/%7AFV\6_%;QG\7_ M !1X4\*7/PR^&VBGPEXA\2>,K[6OL6LZ7XMT+Q9/J.E>&/$WBSPI/=7TOB.Q M\2ZG?^(-4=/D?]IK]DCQOX6\?ZM\8?@YX4?Q'X9M]?M/C%>Z7:ZG<>-O'6A_ M%33?$_B;XHZ]XGT'P-KVAW)-%\,:]X3\.Z#J_CCQ7=^-]?F\/>&/ M&G^%-'T6SMOUYHK[KBSP9X4XRX'R7@?-\5G\J/#D\!B42P48Y'C,'BY*57 SR^E.G&&&5DJ483C*FE;FE&=13_"JVN_V_OCKX>U M/P)-?$5_)XJ\1:UK7PT^&WB M#6]'T/0Y5\+^/O#_ ,+DUX2_#/PWI-AK'PS\4^*_%VHS?$#JOV;/V:OV@/ W M[3W@:]\;>"KHZ)\-/'OQ.U&_\:V\>DZ;X=U3X?:WH/Q]^'_PO\2ZE:QKGB[P2GB/1[KQII.@V6KZ=<7'[5T5\-A/HS\.U,[X6 MXJXEXW\0^,>*^$\]RG.\NSOB#/,-BI1IY-5J8C"Y+3P<\OGAL-E&(Q+HXO,( MT%',,7B:+J_VA2]K**^BK^+^:QR[./A M"E6S"=>.*56MCJ=%5*&%=1O"T*-10^K3Y$V5Q?Q(\#V'Q-^'?CWX;:KJ>LZ+ MI?Q"\%^*? ^I:SX=EL+?Q!I-AXLT.^T&\U/0I]5T[6-+@UFPM[^2ZTR;4M)U M2PCO8H'O-.O;=9+:7M**_H^M1I8BC5P]>G"K0KTYT:U*I%2A5I58N%2G.+TE M"<).,HO1IM,_)Z=2=*I"K2E*%2E.-2G.+:E"<)*4)1:VE&233Z-'X2-X+_:@ M_9!^+5KJ?A3PQ\0?%:7L7B31;6_\!_#[QQ\2?A=\4?#EE8:7 UU M_4/!.H:-J&NV-[X87Q3J7A/Q;8>(M-\9:#X#\5^+_A]>^.IO&%GXJ:5^VW^T M%X(O/BUX@\!Z[+X*\'W\/B>R^&NI^'-=\"^(H=,MHKWPGXVO?AE\%VT'4OBK MXK\6Z+#X;U#7[+2?B68?$VN:3XUU%/@AJ'BRR\2V?@F__=*BOYAA]%CAREE. M8\(TN/\ Q*H>'F-GCZV&X#H9]A:>38"OCIU*W+"O_9TL?BLOPF,J/'X;+,9B M*N&JXVG2Q&8_7Y^W>(_8I>-&;3QV$SRIPQPC5XIP\<-3J\2UA#ZM6QE"E"M##SG2PGU6/LE2^<_V2M#UOP[^SO\ #/3O$.CZ MIX?U5]-U;5I-'URPN=*UJQM/$'B36M?TN/5M'OHX-2T74WTO4[*6^T35[6RU MK1KF273-:T_3]5M+RR@^1_V^OV<_B'\1M7'Q'\.Z0WC_ ,'0?#>;PAXL\!:/ MIDESXJTZRT9O&OB/4M>TZQBO9;_QW:^(]/UA?#B^$/"^E3>,[?6;'28]"TGQ MW6'O7:I-8CVT.2FW5DU+F_*3]EWXB_MH^. M_BQX+@\=-\89?AKX=CU&T^)$WQ#^#?A7X3V^I0ZWHWQ1USPMK;2>(OAO\/?$ M&NWUGKK>%O!]S:?"T7$>BZ9H7@ZX\8Z);7>M>*/$_B?]6Z**^BX"X/Q?!.25 M,IQW%_%7&V*K8ZKCJN<\78^&/S"'/A\+A88/"RIT:,4'5]Q*A2P]",%&BF_E_]LW_ )-K^)'_ ')__J>^%J_(FQ^'O[3?P_\ M!OA;XY?!V]^)Y\->([/5+ZYUKX(V$OB3Q+X5UG2]?U?X76.@^-_@R\'C/_A< MEA=KXGU+Q/X3U2+X:>/M \'._B'7O$_AOP'/X$T'X@>)_P!B?VM-$UKQ'^S[ MX_T;P]H^JZ]K%Z?"@L])T33KS5=3N_(\;^&[J?[-86$-Q=3B"VAFN9S%$PAM MH9IY2L44CJ?LEZ)K7AS]GWP!HWB'1]5T'6+(^*Q>:3K>G7FE:G:>?XW\274' MVFPOX;>Z@$]M-#!% M#'9'Q;PUBL3E>-R7B7#>(.,HT9X/,X4YX66*>6YAC:5? 5U55; XJLW3@_9U MZ?ZQPOQ=/A;P>K2P]')\RGC/$JIALQR/-Z-+&8?,,HK<+8>I4C7PDIQK*DL7 MA#I[_X>^&?#US/HVB_%[QCH9LO M"E_X[NYFOUUN\_;+X8?#?PW\(_ N@_#WPD-2.A>'TOS!-K&HSZKJ=Y>ZOJE] MKNLZE>WSL(+'1M-^U#3M"TO2=%M+#3;3O:*_9?#?P;R3P\ MS3/.)JN=<0\9<:<24Z&&SCB[BS&4L=FU3 X;V?L,LP;I4*,,%ET/8X9RP\/: M.I+#8:,JCHX7"4)_AOXZU/6-0\?3?$?POXP\3>+?#NK6>AOXQC_M32K? MPYKS>,_AGXTN]#F^'UG_ ,(8+2V^%OGEE^TA^W-KVA>!O"6G^'/CW8Z[/XTM MPWCF]_96\2Z'KOB6/6]2U>TL/#7CF;Q/\(+7X=>$?!>GR:SIT=QXGC\-^!+K M2=-\-:1J?B/QM':-XHU'7/V[HKY3-/HZ95_;^>Y]P7Q]XA>&JXJQ4\;Q+E/! MV<8?"93F&-JM2KYAA<-B,'7GEF8UYNK.>+P]67LY57'#4L/2YJ<_;P7BOC?[ M,RW+>(>&.%N+O[$HQP^48[/\!5KXW"X>"<:>%K5:5>G'&82G%0C&A5@N=03K M3JSY9Q_-?]D3]E'Q;H7B2'XX_'2RUW0_B'INM>*9?"7@V\\56>M:E976I1:Y MX;U?Q[X^USPOK^N:1XHUKQ9I>JZOI?V3K^C1>*1JLNL_ M _69K[1?BCJ6N>&_$L$?@C2]/^'WQ3U:\\0Z"SC0=%\1Z)\/[S5/TCHKZ?#^ M"'">5^'M/P[X;S'B?A7!4\QI9TN(>'\ZG@N*ZV>0K0KU,XQ>;NC46*QF+E3A M3Q2JX=T)8:-/#4:-"C1P\*/C5?$7.\9Q3+BK-L)DV=8B>%GE_P#96:9?'$9) M#+90E3A@*& 52'L*%!2E.CR554564ZU2I5J5*KJ?AUX_^,O[:GQ[NM%\!6_P MV^,WA33M>M/$=O<^%?"?P,^('PN\/>-((;2Q\1Q6/CSXG_%;2X;'PDME;^'; MW3M,LW^)'PS\/^-?^$BU3P5XHLO&(UG2M#B_2[]F/]G?3?@!X2U"*ZETS6/' M_B^73K[QMXDLM-L(25TRUDBT;P?I>K+IMCKVI^$/"LU]K=YHB^()IYFUSQ-X MMUZSLO#\'B1] T[Z7HK+@KP7P'#'%,^.,^XMXL\0.+XY;/)LNSCBO&86I3R7 M*JLN>OALHR_ X7"87"SQE^+?#/_")^ M);RUAT+QIYFA6%U/KG_"(ZAK?_"'7R1Z%XR_L#7[BVTR;ZO_ &B?AKX@^+_P M<\8_#[PMK6F:!K^M#0+K3=0UJSNKS2I9?#WBC1/$TFD7_P!BE2[L;?Q#;Z/+ MH#ZW;P:G-X>_M/\ MU-"\0MIPT+4?:Z*]SACPIX;X9X,XAX$A4S'-,BXGQ?% M6(S:&8UZ2Q%6CQ=4Q/\ :6#IUL#0P?LZ,E.,?;K6I[7F:4?.SCC;-\ MXX@RKB64,+@LRR:ADM+!2PE.I[*%3(HTOJF(E#$5:_-4=6C&K.+?LWI#DLFY M?@+X*/[87P2UWQ!\-/ /A3XW>"+SQCKOAQM6L]%^"6G>-/"-OXZ\1K\.UM_% MO_"U'^'GC;P"TZ^$O#6D_#_Q+J\OC_4/AOX3T&^\22ZQ#H7C+1K?Q1X;_3+X MS:/\3?$?[%-S9>)M"U[6_BLGPQ^'FM>.-"TW3]+UGQ-=>)_#\GA7Q#X\M['1 MO JWNF:[KD4^F:V]OH?@.#4EUN_B32_!ECJ F X7X4XJ MX)GQ[Q_GW#7$?#&8\'X/+,ZS7!8C#\-9)F.&QN%J?V-0IY=2PT,PITL=.,,7 M5H3I*G2H45A(T:?LW[N=^)N)SG.\DXACPSPQEN;Y3G.%S[$8S+\%B*57-\PP MM7#UH?VA4EBIUI864\-%RH0JQGS3J3==U)G:=JUI>6-O\*?M1?L-^*Y/%Y\6_ [0_$/BS3O'_CG4_%7BC1+ M;QQ:Z%XG^&_CK4]8U#Q]-\1_"_C#Q-XM\.ZM9Z&_C&/^U-*M_#FO-XS^&?C2 M[T.;X?6?_"&"TMOA;^O%%>]Q!X*<&\4>'?#7AQG#S2IEW"& R'!\/9YA<73P M?$F58GAW 4!O"6G^'/CW8Z[/XTMPWCF]_96\2Z'KOB6/6]2U>TL M/#7CF;Q/\(+7X=>$?!>GR:SIT=QXGC\-^!+K2=-\-:1J?B/QM':-XHU'7/I/ M]D3]E'Q;H7B2'XX_'2RUW0_B'INM>*9?"7@V\\56>M:E976I1:YX;U?Q[X^U MSPOK^N:1XHUKQ9I>JZO'? M #+<#Q'DG%/&''/'7B7F?"\_;<,4>,RI MR688FI5FZM.CB)0>*P^'KTO5S7Q/Q>)RG,<5,@P52CC< MQH-RD\'5Q56M4E3P,N>2>%HPA%0G4I*2HU:M*?Q#^W]H?B+6/@79W?AWPQXJ M\6OX>\>^']9U32?!7AC7O&OB4:9-INO>'Q=:=X2\*Z?K'BC71#J>NZ:MY#H6 MCZEUJU-CK.A> O!^C:M9&:W MN39ZGI?A[3K&_M3<6M[2$:GM,34IKDD MXP7.E#Y3%<3XW%<+Y7PI.AA8X'*LSQV:4,1"-98NI6QU.G"=.K)UG1=.'))Q MY*,)/F2OPJ^(OQ$O/A!J7@?PAJOBBRT%O%FB:S)I M;FXT[4/' M?B+X6Z)X:\_3OM*ZHVG374%[=:QKL%E+H/A+1=-U+Q%XOU/0=!L;C4D^M_V? MO#&N^"?@+\$?!GBBP.E>)O"/PB^&WACQ%I9N;*].FZ[H/@W1=*U>P-YIMS>: M==FSU"TN+75E/Y?FVMS/ \NT5SY+X;Y)D?B%QGXD83%YI4SKCC!9 M%@_TYM-\10:SXOU34)=+\*ZA?17?A/2DD\1>'K:9],\5?7U%?1\ M3Y%+B;((I5W/+L=5PV,IX:I55)T*DW MAZC>'JU81Y)RC./E9/F2RC,L+F3R[+,V6%G.?]GYQAIXO+<3S4ITU'%8:%:A M*K"#G[6$55@E5A"3YHIQ?XI^-_@!^W+\4+C1[KXGP:OX\E\/0ZI!H)U/4_@/ MH:Z5'K;Z9)JXA7P5%X6^U&_;1=*WG4_MWV<62BR^S>?=_:.HTCPG_P %,?A] MX>TRQ\&7>J:KIO@C1K*T\*?#_5&_9KDT'4K'PU8Q0Z%X.U'4A::/XHDTB\M[ M*UT6\OAXTTK7WLY)+@>*+'43_:T7["45_/V ^BWDV6Y]CN)\'XN>.='/\T6" MAFV;1XTRE8[-J.70I4\'A\SQ2X75?&X>A2HTJ-.CB*DX1HPC3BE%)'ZAB?&; M'XO+QSPV"J8J4YXBK@Z+SET\/5JSG*I.I2C&4J MDG-MMMA7X5VO[-/Q8^/G[1/Q%A^)/P^^(GAWP[XR^)MMXC^+>N^*] TCPPUK M\-O$&C3WOA?P+9^+?AWXL\,^'?%^NZ=\*?"OA;X W_C7X%^.O'_B#X=:_P#V M)XH\5ZKJFLZ?J&H:C^ZE%?JOB/X79%XH1X6PW$F,S6.5\,<283B:63X*MA:> M7YYB<#3J1PV$SFG7PF(JUL'%U)QG3P]7#3G0KXFGSJ=2E6P_Q?"?&>9<&O.J MV4X?!/&YQE-?*%C\13K2Q66T<1*$JM?+Y4Z]*%/$/DBU*K"K%5*=&?*XPG3J ME>%_M+?"_P 3_&?X(^.?AKX/\36_A37O$L&AB"_OAJ TK5+#2?$VBZ[KG@S7 M7TN:.\@\.?$/0M+U+P#XDNDMM9AM-!\2ZC"S3 XO+L9&E5J4*LL+CL/4PV(C3KT90K4:CI59J%6E.%2G)J<) M1DDU\S@L76P&,PF.PSC'$8+$T,70 M,DXMH_$R'6/VZ?V;O%-G]N@^.7CO1=9\6>-M2?0)-%\0?M)^%/%&Q MJ=UX@T*P\>?$+X8^$;F$Z-XH\$>%$\5?">WO]3M[V\F\(OJ,_C[2KK/N/!_[ M:/[5G[[Q!H_B\:'IWC+QE+HEG\6= 7X(>$O!>JW.C-K%A;?\(]=>#]'^(7B' MPS9VEY:>"/"?CN/P7\4=8L!J6K6,_B*[ED\>7U?N'17\WXKZ,>#S'"RR'-O% MOQ@S;@B52$Y\(8_BJC6PF(HTY4IQRW&9A_9ZQV)RF,J4?9X)S@Z24)TZ\<3# MZQ+]:H^,.(PE99G@>!^ \%Q$H2C'/<-DU2%>E4DIQ>+H87ZU]7HXV49OGQ"3 M4VY1E3=*7LEX1^SQ\ _#G[/'@2Y\(Z)JFJ^(-4U_7I_&/C7Q)JD]T/[?\7WN MD:+H5U>:5HDE[>:?X3T&TT;P]HFC:+XGP_I]]9?\))^KU?B1KOPQ^*GQ\_;5U[ M^W/AG\1--\$77Q)_%?PHL_@Y\'6L=#GT30[CX@6?@GPMJ?A; MXY1^%4M[?P;X(F\2)HWB3XV>)_B%'H'CSP[HGC?7M0V^D!DV+P_A/E/A/P!D MM>C/C+->'. \MH9;@<37P>09##$T:^88_&U8*5/#9?AL!@OJV)Q&,K1E-8N5 M5SG452K#/POS"A5XWQW&W%&80G'(,%FO$N+JXO$4J>(S/,Y4ITL+AL/"34ZV M*K8G$>VHTJ%-J+H1@HQCR0E^E/[(OA!?!/[-GP@TLV7C#2KK5_"D?CS5M#\? M63:9XN\-Z_\ %"_O?B5XB\*ZSI4NDZ'>:/+X5UWQ9J/AVVT;4]-AUG1['3+7 M3-;EO=6M;V]N/HZBBOZ&R7*L+D63Y3D> CR8')LMP&58.&GN83+L+2PF'CII M[M&C!::::'Y7F&-KYEC\;F.)?-B,?B\3C<1+7WJV*K3KU7KWJ5),****](Y MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B 9BB@ HHHH **** "BBB@ HHHH **** /_V0$! end GRAPHIC 14 gb2k1ptlkg5v000003.jpg GRAPHIC begin 644 gb2k1ptlkg5v000003.jpg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end EX-101.SCH 15 etnb-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Organization and Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Consolidated Balance Sheet Components link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Term Loan link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Consolidated Balance Sheet Components (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Term Loan (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Organization and Basis of Presentation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Term Loan - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Term Loan - Schedule of Repayment of Principal Amount (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Expense) (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Income Taxes - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 16 etnb-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 17 etnb-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 18 etnb-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Available for sale securities debt maturities after one through two years fair value. Income tax reconciliation change in effective tax rate due to reorganization. Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Current Reporting Status Entity Current Reporting Status Entity Voluntary Filers Entity Voluntary Filers Entity Interactive Data Current Entity Interactive Data Current Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Well-known Seasoned Issuer Entity Well Known Seasoned Issuer Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding ICFR Auditor Attestation Flag Icfr Auditor Attestation Flag Entity Shell Company Entity Shell Company Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Annual Report Document Annual Report Document Transition Report Document Transition Report Documents Incorporated by Reference Documents Incorporated By Reference [Text Block] Auditor Firm ID Auditor Firm Id Auditor Name Auditor Name Auditor Location Auditor Location Short term available for sale securities current. Term loan current. Other non-current liability Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Restricted cash Restricted Cash Current Short-term available-for-sale securities Short Term Available For Sale Securities Current Prepaid and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Other assets Other Assets Noncurrent Total assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued expenses Accrued Liabilities Current Term loan, current Term Loan Current Total current liabilities Liabilities Current Term loan, non-current, net Long Term Debt Noncurrent Other non-current liability Other Non Current Liability Total liabilities Liabilities Commitments and contingencies (Note 5) Commitments And Contingencies Stockholders’ equity: Stockholders Equity [Abstract] Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2021 and 2020, respectively, no shares issued and outstanding as of December 31, 2021 and 2020, respectively Preferred Stock Value Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 20,317,204 and 19,931,660 shares issued and outstanding as of December 31, 2021 and 2020, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other expenses, net Other Nonoperating Income Expense Net loss before income tax Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit Income Tax Expense Benefit Net loss Net Income Loss Other comprehensive (loss) income: Other Comprehensive Income Loss Tax [Abstract] Unrealized (loss) gain on available-for-sale securities Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax Foreign currency translation adjustments Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Total other comprehensive loss Other Comprehensive Income Loss Net Of Tax Comprehensive loss Comprehensive Income Net Of Tax Net loss per share, basic and diluted Earnings Per Share Basic And Diluted Weighted-average shares used to compute net loss per share, basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Issuance of common stock warrant in connection with term loan facility. Issuance of common stock warrant in connection with debt financing. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income [Member] Retained Earnings Retained Earnings [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Public Offerings I P O [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] A T M Facility A T M Facility [Member] Statement [Line Items] Statement [Line Items] Beginning balance Beginning balance, shares Shares Outstanding Issuance of common stock Stock Issued During Period Value New Issues Issuance of common stock, shares Stock Issued During Period Shares New Issues Issuance of common stock upon exercise of stock options Stock Issued During Period Value Stock Options Exercised Issuance of common stock upon exercise of stock options, shares Stock Issued During Period Shares Stock Options Exercised Issuance of common stock upon ESPP purchase Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock upon ESPP purchase, Shares Stock Issued During Period Shares Employee Stock Purchase Plans Issuance of common stock warrant in connection with term loan facility Issuance Of Common Stock Warrant In Connection With Term Loan Facility Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Issuance Of Common Stock Warrants In Connection With Debt Financing Issuance Of Common Stock Warrants In Connection With Debt Financing Net loss Other comprehensive loss Ending balance Ending balance, shares Temporary equity, issuance costs. Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Convertible preferred shares. Convertible Preferred Shares Convertible Preferred Shares [Member] Temporary equity, issuance costs Temporary Equity Issuance Costs Amortization of debt issuance costs and accretion of final payment fee. Deferred tax assets. Payment for purchases of available for sale securities. Proceeds from issuance public offering. Statement Of Cash Flows [Abstract] ESPP Purchases Employee Stock [Member] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Stock-based compensation Share Based Compensation Amortization of premium on available-for-sale securities Accretion Amortization Of Discounts And Premiums Investments Amortization of debt issuance costs and accretion of final payment fee Amortization Of Debt Issuance Costs And Accretion Of Final Payment Fee Depreciation Depreciation Deferred tax assets Deferred Tax Assets Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable Increase Decrease In Accounts Payable Accrued expenses Increase Decrease In Accrued Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Proceeds from sales and maturities of available-for-sale securities Proceeds From Sale And Maturity Of Available For Sale Securities Purchases of available-for-sale securities Payment For Purchase Of Available For Sale Securities Purchases of property and equipment Payments To Acquire Property Plant And Equipment Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from term loan facility, net of issuance costs Proceeds From Issuance Of Other Long Term Debt Proceeds from issuance of common stock upon public offerings,net of issuance costs Proceeds From Issuance Public Offering Proceeds from issuance of common stock upon stock option exercises Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Proceeds from issuance of common stock upon ESPP purchases Proceeds From Issuance Of Common Stock Payment of debt issuance costs Payments Of Debt Issuance Costs Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net change in cash and cash equivalents, and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash and cash equivalents, and restricted cash at beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash and cash equivalents, and restricted cash at end of period Components of cash and cash equivalents, and restricted cash: Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract] Total cash and cash equivalents, and restricted cash Supplemental disclosures of cash information: Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid Net Cash paid for income taxes Income Taxes Paid Net Supplemental disclosures of noncash information: Noncash Investing And Financing Items [Abstract] Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization and Basis of Presentation Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Balance Sheet Related Disclosures [Abstract] Consolidated Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Term Loan Long Term Debt [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Principles of Consolidation Consolidation Policy [Text Block] Foreign Currencies Foreign Currency Transactions And Translations Policy [Text Block] Use of Estimates Use Of Estimates Fair Value Measurements Fair Value Measurement Policy Policy [Text Block] Concentrations of Credit Risk Concentration Risk Credit Risk Other risks and uncertainties. Other Risks and Uncertainties Other Risks And Uncertainties Policy [Text Block] Segment Reporting Segment Reporting Policy Policy [Text Block] Cash and Cash Equivalents and Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Investments Investment Policy [Text Block] Property and Equipment, Net Property Plant And Equipment Policy [Text Block] Impairment of Long-Lived Assets Impairment Or Disposal Of Long Lived Assets Policy [Text Block] Accrued research and development expenses. Accrued Research and Development Expenses Accrued Research And Development Expenses Policy [Text Block] Leases Lessee Leases Policy [Text Block] Research and Development Expenses Research And Development Expense Policy Stock-Based Compensation Share Based Compensation Option And Incentive Plans Policy Income Taxes Income Tax Policy [Text Block] Basic and Diluted Net Loss per Share Earnings Per Share Policy [Text Block] Comprehensive Loss Comprehensive Income Policy Policy [Text Block] Recent Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Summary of Financial Assets Measured at Fair Value on Recurring Basis Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block] Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities Investments Classified By Contractual Maturity Date Table [Text Block] Schedule of prepaid and other current assets. Schedule of Prepaid and Other Current Assets Schedule Of Prepaid And Other Current Assets Table [Text Block] Schedule of Accrued Expenses Schedule Of Accrued Liabilities Table [Text Block] Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block] Schedule of Repayment of Principal Amount Schedule Of Maturities Of Long Term Debt Table [Text Block] Summary of Stock-Based Compensation Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Stock Option Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of effective income tax rate of company and subsidiaries. Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries Schedule Of Effective Income Tax Rate Of Company And Subsidiaries Table [Text Block] Summary of Income Tax Benefit (Expense) Schedule Of Components Of Income Tax Expense Benefit Table [Text Block] Summary of Components of Deferred Tax Assets Schedule Of Deferred Tax Assets And Liabilities Table [Text Block] Summary of Loss from Operations Before Taxes on Income Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block] Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block] Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table] Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table] Underwritten Public Offering [Member] Underwritten public offering Underwritten Public Offering [Member] ATM facility. Svb leerink llc and cantor fitzgerald & co. SVB Leerink LLC S V B Leerink L L C And Cantor Fitzgerald Co [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Maximum Maximum [Member] Minimum [Member] Minimum [Member] Subsidiary Sale Of Stock [Line Items] Subsidiary Sale Of Stock [Line Items] Date of incorporation Entity Incorporation Date Of Incorporation Payments of stock issuance costs, other. Shares issued and sold Proceeds from issuance of common stock, net of underwriters discount and commissions IPO price per share Shares Issued Price Per Share Payment of underwriting discounts, commissions Payments Of Stock Issuance Costs Other offering expenses Payments Of Stock Issuance Costs Other Selling commission per shares sold percentage. Selling commission per shares sold percentage Selling Commission Per Shares Sold Percentage Issuance of common stock, weighted average price per share Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Cash and cash equivalents and short term available-for-sale securities Cash Cash Equivalents And Short Term Investments Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Information related to various accounting policies of the entity. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Leasehold Improvements Leasehold Improvements [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of operating segments Number Of Operating Segments Property and equipment, estimated useful lives Property Plant And Equipment Useful Life Leasehold improvements amortization, description Property Plant And Equipment Estimated Useful Lives Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Recurring Fair Value Measurements Recurring [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 Fair Value Inputs Level1 [Member] Level 2 Fair Value Inputs Level2 [Member] Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Money Market Funds Money Market Funds [Member] Commercial Paper Commercial Paper [Member] U.S. government bonds U S Government Agencies Shortterm Debt Securities [Member] Corporate Debt Corporate Debt Securities [Member] Agency bonds Agency Securities [Member] Municipal Bonds Municipal Bonds [Member] Non-US debt securities Foreign Government Debt Securities [Member] Cash equivalents Cash Equivalents [Member] Short-term available for sale securities Short Term Investments [Member] U.S. treasury bills U S Treasury Bill Securities [Member] Agency discount securities. Agency discount securities Agency Discount Securities [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Short-term investments, Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Short-term investments, Gross Unrealized Holding Gains Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Short-term investments, Gross Unrealized Holding Losses Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Short-term investments, Aggregated Fair Value Available For Sale Securities Debt Securities Within one year Available For Sale Securities Debt Maturities Within One Year Fair Value After one year through two years Available For Sale Securities Debt Maturities After One Through Two Years Fair Value Total cash equivalents and available-for-sale securities Research and development expense prepaid current. Prepaid Expense And Other Assets Current [Abstract] Prepaid research and development Prepaid Research And Development Current Prepaid taxes Prepaid Taxes Prepaid other Other Prepaid Expense Current Total prepaid and other current assets Accrued research and development expense current. Payables And Accruals [Abstract] Accrued research and development expenses Accrued Research And Development Expense Current Accrued employee and related expenses Employee Related Liabilities Current Accrued professional and legal fees Accrued Professional Fees Current Accrued other Other Accrued Liabilities Current Total accrued expenses Operating lease monthly rental payments. Loss Contingencies [Table] Loss Contingencies [Table] Geographical Statement Geographical [Axis] Geographical Segment Geographical [Domain] San Francisco office. San Francisco Office San Francisco Office [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Restricted cash and other assets member. Restricted Cash And Other Assets Member Restricted Cash And Other Assets [Member] Teva agreement. Teva Agreements Teva Agreement [Member] Research and Development Arrangement, Contract to Perform for Others, Type Research And Development Arrangement Contract To Perform For Others By Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Research And Development Arrangement Contract To Perform For Others Type [Domain] Tevas glycoPEGylated FGF21 program. Teva's GlycoPEGylated FGF21 Program Tevas Glyco P E Gylated F G F21 Program [Member] Tevas development program. Teva's Development Program Tevas Development Program [Member] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development Expenses Research And Development Expense [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Lessee, operating lease, description Description Of Lessee Leasing Arrangements Operating Leases Operating lease, payments Operating Lease Monthly Rental Payments Lessee, operating lease term of contract Lessee Operating Lease Term Of Contract Lessee,operating lease, renewal term Lessee Operating Lease Renewal Term 2022 Lessee Operating Lease Liability Payments Due Next Twelve Months 2023 Lessee Operating Lease Liability Payments Due Year Two Total future minimum annual payments Operating Leases Future Minimum Payments Due Operating leases, rent expense Lease And Rental Expense Security deposit Security Deposit Asset transfer and license agreements initial nonrefundable upfront payment. Obligation to payment upon maximum achievement of certain clinical and commercial milestones. Nonrefundable upfront payment Asset Transfer And License Agreement Initial Nonrefundable Upfront Payment Payment upon achievement of certain clinical and commercial milestones Obligation To Payment Upon Maximum Achievement Of Certain Clinical And Commercial Milestones Asset transfer and license agreement termination period after written notice. Asset transfer and license agreement termination period notice of failure. Asset transfer and license agreement termination notice period if bankruptcy petition filed. Asset transfer and license agreement, termination period after written notice Asset Transfer And License Agreement Termination Period After Written Notice Asset transfer and license agreement, termination period notice of breach Asset Transfer And License Agreement Termination Period Notice Of Failure Asset transfer and license agreement termination notice period if bankruptcy petition filed Asset Transfer And License Agreement Termination Notice Period If Bankruptcy Petition Filed Milestone payment. Milestone payments Milestone Payment Debt Instrument [Table] Debt Instrument [Table] Loan and security agreement. Loan Agreement Loan And Security Agreement [Member] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Term A loan facility. Term A Loan Facility Term A Loan Facility [Member] Term b loan facility. Term B Loan Facility Term B Loan Facility [Member] Other Assets Other Assets [Member] Variable Rate Variable Rate [Axis] Variable Rate Variable Rate [Domain] Prime Rate Prime Rate [Member] Valuation Approach and Technique Valuation Technique [Axis] Valuation Approach and Technique Valuation Technique [Domain] Valuation Technique, Option Pricing Model Valuation Technique Option Pricing Model [Member] Measurement Input Type Measurement Input Type [Axis] Measurement Input Type Measurement Input Type [Domain] Measurement Input, Risk Free Interest Rate Measurement Input Risk Free Interest Rate [Member] Measurement Input, Expected Dividend Payment Measurement Input Expected Dividend Payment [Member] Measurement Input, Price Volatility Measurement Input Price Volatility [Member] Measurement Input, Expected Term Measurement Input Expected Term [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Line of credit facility, maximum borrowing capacity Line Of Credit Facility Maximum Borrowing Capacity Line of Credit Facility, Description Line Of Credit Facility Description Warrants to purchase common stock Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Warrant exercise price Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Warrant expiration date Warrants And Rights Outstanding Maturity Date Debt issuance costs, gross Deferred Finance Costs Gross Risk free interest rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Expected volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Expected terms (years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Line of credit facility increase in borrowing capacity. Line of credit facility increase in borrowing capacity Line Of Credit Facility Increase In Borrowing Capacity Net cash proceeds from sale of equity securities. Percentage of fee on loan. Term loan amount drawn Line Of Credit Credit facility maturity date Line Of Credit Facility Expiration Date1 Proceeds from sale of available-for-sale securities, equity Net Cash Proceeds From Sale Of Equity Securities Debt instrument, interest rate Debt Instrument Interest Rate During Period Debt instrument, basis spread on variable rate Debt Instrument Basis Spread On Variable Rate1 Percentage of fee on loan Percentage Of Fee On Loan Fair value of warrant assumptions, dividends. Fair measurement input Debt Instrument Measurement Input Fair value of warrant assumptions, dividends Fair Value Of Warrants Assumptions Dividends Fair measurement input Debt Instrument Term Deferred tax assets Deferred Tax Assets Gross 2022 Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months 2023 Long Term Debt Maturities Repayments Of Principal In Rolling Year Two 2024 Long Term Debt Maturities Repayments Of Principal In Rolling Year Three Total principal repayments Debt Instrument Carrying Amount Less: unamortized debt discount Debt Instrument Unamortized Discount Total term loan, net Long Term Debt Less: term loan, current Long Term Debt Current Term loan, non-current, net Number of shares issuable under share-based payment arrangement. Period for increase in number of shares of common stock reserved for issuance. Percentage of increase in number of shares of capital stock reserved for issuance. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] 2019 equity incentive plan. 2019 Plan Two Thousand And Nineteen Equity Incentive Plan [Member] Two thousand and twenty equity incentive plan. 2020 Plan Two Thousand And Twenty Equity Incentive Plan [Member] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Service-based RSUs member. Service-based RSUs Service Based R S Us [Member] Restricted Stock Units (RSUs) Restricted Stock Units R S U [Member] Performance RSUs. Performance RSUs Performance R S Us [Member] Title of Individual Title Of Individual [Axis] Title of Individual Title Of Individual With Relationship To Entity [Domain] Employee Share Based Payment Arrangement Employee [Member] Executive Officer Executive Officer [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Number of common shares issuable under the plan (in shares) Number Of Shares Issuable Under Share Based Payment Arrangement Period for increase in number of shares of common stock reserved for issuance Period For Increase In Number Of Shares Of Common Stock Reserved For Issuance Percentage of increase in number of shares of capital stock issued and outstanding Percentage Of Increase In Number Of Shares Of Capital Stock Issued And Outstanding Common stock reserved and available for issuance as future option grants Common Stock Capital Shares Reserved For Future Issuance Share based compensation arrangement by share based payment award remaining options vesting period. Vesting period Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Percentage of option vesting Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage Terms of award Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award Remaining option vesting period Share Based Compensation Arrangement By Share Based Payment Award Remaining Options Vesting Period Expiration period Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Percent of purchase shares of common stock Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Share based compensation arrangement by share based payment first offering period. Share based compensation arrangement by share based payment first offering period commencement date. First offering period Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement date of first six month offering period Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement Date Number of shares of common stock available for issuance under ESPP Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Research and Development General and Administrative General And Administrative Expense [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Total stock-based compensation Allocated Share Based Compensation Expense Expected volatility, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected volatility, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Risk-free interest rate, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk-free interest rate, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Expected dividend Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Number of Options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward Outstanding, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercised Cancelled and forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Outstanding, Ending Balance Exercisable as of December 31, 2021 Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Weighted Average Exercise Price Outstanding, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, Cancelled and forfeited Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted Average Exercise Price Outstanding, Ending Balance Weighted Average Exercise Price, Exercisable as of December 31, 2021 Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Share based compensation arrangement by share based payment award options weighted average remaining contractual term. Weighted Average Remaining Contractual Term (In years) Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Weighted Average Remaining Contractual Term (In years), Outstanding Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2021 Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Share based compensation arrangement by share based payment award options aggregate intrinsic value. Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value Outstanding Aggregate Intrinsic Value, Exercisable as of December 31, 2021 Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Sharebased compensation arrangement by sharebased payment award options grant date fair value. Period of share based compensation arrangement by share based payment award anniversary. Estimated total grant date fair value of options vested Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value Weighted average fair value options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Unrecognized stock option granted under plan Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Unrecognized weighted average period Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Shares granted Total grant date fair value Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Fair Value Share base compensation expense Cancelled shares Outstanding Anniversary period Share Based Compensation Arrangement By Share Based Payment Award Anniversary Income Tax. Income Tax. Income Tax Disclosure [Table] Income Tax Disclosure [Table] Consolidated Entities Consolidated Entities [Axis] Consolidated Entities Consolidated Entities [Domain] 89Bio Ltd. 89Bio Ltd Eighty Nine Bio Ltd [Member] Eighty Nine Bio Management, Inc. 89bio Management, Inc. Eighty Nine Bio Management Incorporation [Member] UAB Eighty Nine Bio Lithuania. UAB 89bio Lithuania U A B Eighty Nine Bio Lithuania [Member] Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Effective income tax rate Effective Income Tax Rate Continuing Operations Current: Current Income Tax Expense Benefit Continuing Operations [Abstract] Federal Current Federal Tax Expense Benefit State Current State And Local Tax Expense Benefit Foreign Current Foreign Tax Expense Benefit Total Current Income Tax Expense Benefit Deferred: Deferred Income Tax Expense Benefit Continuing Operations [Abstract] Federal Deferred Federal Income Tax Expense Benefit Total Deferred Income Tax Expense Benefit Income tax benefit United States UNITED STATES Israel ISRAEL Net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards Research and development expenses Deferred Tax Assets In Process Research And Development Stock-based compensation Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Accrued expenses Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Other Deferred Tax Assets Other Total deferred tax assets Less: valuation allowance Deferred Tax Assets Valuation Allowance Net deferred tax assets Deferred Tax Assets Net Deferred tax assets, valuation allowance Deferred tax assets, change in valuation allowance Valuation Allowance Deferred Tax Asset Change In Amount Accumulated tax loss carry forward. Taxable income utilization percentage. Accumulated tax loss carryforward Accumulated Tax Loss Carry Forward Operating loss carryforwards limitations on use Operating Loss Carryforwards Limitations On Use Taxable income utilization percentage Taxable Income Utilization Percentage Deferred tax assets tax credit carryforwards research, federal. Federal research and development credit carryforwards Deferred Tax Assets Tax Credit Carryforwards Research Federal State research and development credit carryforwards Deferred Tax Assets Tax Credit Carryforwards Research LITHUANIA LITHUANIA Net loss before income tax Income tax benefit computed at statutory rates Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate Change in valuation allowance Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Foreign rate differential Income Tax Reconciliation Foreign Income Tax Rate Differential Change in Israel effective tax rate due to the 2019 reorganization Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization Research and development credits, net of uncertain tax position Income Tax Reconciliation Nondeductible Expense Research And Development Other Income Tax Reconciliation Other Adjustments Increase in unrecognized tax benefits Unrecognized Tax Benefits Period Increase Decrease Unrecognized Tax Benefits Unrecognized Tax Benefits Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Stock Options to Purchase Common Stock Employee Stock Option [Member] Unvested restricted stock units. Unvested Restricted Stock Units Unvested Restricted Stock Units [Member] Warrants to Purchase Common Stock Warrant [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive common stock equivalents excluded from calculation of diluted net loss per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount EX-101.PRE 19 etnb-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 20 R1.htm IDEA: XBRL DOCUMENT v3.22.1
    Document and Entity Information - USD ($)
    $ in Millions
    		 12 Months Ended
    Dec. 31, 2021
    Mar. 01, 2022
    Jun. 30, 2021
    Cover [Abstract]      
    Document Type 10-K    
    Amendment Flag false    
    Document Period End Date Dec. 31, 2021    
    Document Fiscal Year Focus 2021    
    Document Fiscal Period Focus FY    
    Entity Registrant Name 89bio, Inc.    
    Entity Central Index Key 0001785173    
    Entity Current Reporting Status Yes    
    Entity Voluntary Filers No    
    Entity Interactive Data Current Yes    
    Current Fiscal Year End Date --12-31    
    Entity Filer Category Non-accelerated Filer    
    Entity Well-known Seasoned Issuer No    
    Entity Public Float     $ 165.5
    Entity Common Stock, Shares Outstanding   20,351,384  
    ICFR Auditor Attestation Flag false    
    Entity Shell Company false    
    Entity Small Business true    
    Entity Emerging Growth Company true    
    Entity Ex Transition Period false    
    Title of 12(b) Security Common stock, par value $0.001 per share    
    Trading Symbol ETNB    
    Security Exchange Name NASDAQ    
    Entity File Number 001-39122    
    Entity Incorporation, State or Country Code DE    
    Entity Tax Identification Number 36-4946844    
    Entity Address, Address Line One 142 Sansome Street    
    Entity Address Address Line Two Second Floor    
    Entity Address, City or Town San Francisco    
    Entity Address, State or Province CA    
    Entity Address, Postal Zip Code 94104    
    City Area Code 415    
    Local Phone Number 432-9270    
    Document Annual Report true    
    Document Transition Report false    
    Documents Incorporated by Reference Portions of the registrant’s definitive proxy statement relating to its 2022 Annual Meeting of Stockholders, to be held on or about June 1, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.    
    Auditor Firm ID 185    
    Auditor Name KPMG LLP    
    Auditor Location San Francisco, California, USA    

    XML 21 R2.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Balance Sheets - USD ($)
    $ in Thousands
    Dec. 31, 2021
    Dec. 31, 2020
    Current assets:    
    Cash and cash equivalents $ 52,432 $ 98,183
    Restricted cash 25 25
    Short-term available-for-sale securities 98,288 106,446
    Prepaid and other current assets 11,237 5,548
    Total current assets 161,982 210,202
    Property and equipment, net 150 166
    Other assets 290 706
    Total assets 162,422 211,074
    Current liabilities:    
    Accounts payable 6,843 2,065
    Accrued expenses 10,194 6,048
    Term loan, current 2,500  
    Total current liabilities 19,537 8,113
    Term loan, non-current, net 16,898  
    Other non-current liability 30  
    Total liabilities 36,465 8,113
    Commitments and contingencies (Note 5)
    Stockholders’ equity:    
    Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2021 and 2020, respectively, no shares issued and outstanding as of December 31, 2021 and 2020, respectively
    Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 20,317,204 and 19,931,660 shares issued and outstanding as of December 31, 2021 and 2020, respectively 20 20
    Additional paid-in capital 339,218 326,046
    Accumulated other comprehensive loss (64) (10)
    Accumulated deficit (213,217) (123,095)
    Total stockholders’ equity 125,957 202,961
    Total liabilities and stockholders’ equity $ 162,422 $ 211,074
    XML 22 R3.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Balance Sheets (Parenthetical) - $ / shares
    Dec. 31, 2021
    Dec. 31, 2020
    Statement Of Financial Position [Abstract]    
    Preferred stock, par value $ 0.001 $ 0.001
    Preferred stock, shares authorized 10,000,000 10,000,000
    Preferred stock, shares issued 0 0
    Preferred stock, shares outstanding 0 0
    Common stock, par value $ 0.001 $ 0.001
    Common stock, shares authorized 100,000,000 100,000,000
    Common stock, shares issued 20,317,204 19,931,660
    Common stock, shares outstanding 20,317,204 19,931,660
    XML 23 R4.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Statements of Operations and Comprehensive Loss - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Operating expenses:    
    Research and development $ 70,330 $ 36,199
    General and administrative 19,413 13,156
    Total operating expenses 89,743 49,355
    Loss from operations (89,743) (49,355)
    Other expenses, net (526) (203)
    Net loss before income tax (90,269) (49,558)
    Income tax benefit 147 59
    Net loss (90,122) (49,499)
    Other comprehensive (loss) income:    
    Unrealized (loss) gain on available-for-sale securities (71) 8
    Foreign currency translation adjustments 17 (18)
    Total other comprehensive loss (54) (10)
    Comprehensive loss $ (90,176) $ (49,509)
    Net loss per share, basic and diluted $ (4.48) $ (3.08)
    Weighted-average shares used to compute net loss per share, basic and diluted 20,098,340 16,087,785
    XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
    $ in Thousands
    Total
    A T M Facility
    Public Offerings
    Common Stock
    Common Stock
    A T M Facility
    Common Stock
    Public Offerings
    Additional Paid-in Capital
    Additional Paid-in Capital
    A T M Facility
    Additional Paid-in Capital
    Public Offerings
    Accumulated Other Comprehensive Loss
    Accumulated Other Comprehensive Loss
    A T M Facility
    Accumulated Other Comprehensive Loss
    Public Offerings
    Retained Earnings
    Beginning balance at Dec. 31, 2019 $ 89,944     $ 14     $ 163,526     $ 0     $ (73,596)
    Beginning balance, shares at Dec. 31, 2019       13,788,982                  
    Issuance of common stock     $ 157,680     $ 6     $ 157,674     $ 0  
    Issuance of common stock, shares           6,072,040              
    Issuance of common stock upon exercise of stock options 271           271     0      
    Issuance of common stock upon exercise of stock options, shares       63,366                  
    Issuance of common stock upon ESPP purchase 134           134     0      
    Issuance of common stock upon ESPP purchase, Shares       7,272                  
    Issuance of common stock warrant in connection with term loan facility 634           634     0      
    Stock-based compensation 3,807           3,807     0      
    Issuance Of Common Stock Warrants In Connection With Debt Financing                   0      
    Net loss (49,499)                 0     (49,499)
    Other comprehensive loss (10)                 (10)      
    Ending balance at Dec. 31, 2020 202,961     $ 20     326,046     (10)     (123,095)
    Ending balance, shares at Dec. 31, 2020       19,931,660                  
    Issuance of common stock   $ 3,289           $ 3,289     $ 0    
    Issuance of common stock, shares         186,546                
    Issuance of common stock upon exercise of stock options 487           487     0      
    Issuance of common stock upon exercise of stock options, shares       188,286                  
    Issuance of common stock upon ESPP purchase 144           144     0      
    Issuance of common stock upon ESPP purchase, Shares       10,712                  
    Issuance of common stock warrant in connection with term loan facility 574           574     0      
    Stock-based compensation 8,678           8,678     0      
    Net loss (90,122)                 0     (90,122)
    Other comprehensive loss (54)                 (54)      
    Ending balance at Dec. 31, 2021 $ 125,957     $ 20     $ 339,218     $ (64)     $ (213,217)
    Ending balance, shares at Dec. 31, 2021       20,317,204                  
    XML 25 R6.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Statements of Stockholders' Equity (Parenthetical) - Convertible Preferred Shares - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    A T M Facility    
    Temporary equity, issuance costs $ 165  
    Public Offerings    
    Temporary equity, issuance costs   $ 1,208
    XML 26 R7.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Statements of Cash Flows
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    USD ($)
    Dec. 31, 2020
    USD ($)
    Cash flows from operating activities:    
    Net loss $ (90,122) $ (49,499)
    Adjustments to reconcile net loss to net cash used in operating activities:    
    Stock-based compensation 8,678 3,807
    Amortization of premium on available-for-sale securities 865 268
    Amortization of debt issuance costs and accretion of final payment fee 617 230
    Depreciation 79 60
    Deferred tax assets (150) (69)
    Changes in operating assets and liabilities:    
    Prepaid and other current assets (5,672) (3,600)
    Accounts payable 4,778 1,131
    Accrued expenses 4,146 1,428
    Net cash used in operating activities (76,781) (46,244)
    Cash flows from investing activities:    
    Proceeds from sales and maturities of available-for-sale securities 148,422 12,189
    Purchases of available-for-sale securities (141,200) (118,895)
    Purchases of property and equipment (63) (126)
    Net cash provided by (used in) investing activities 7,159 (106,832)
    Cash flows from financing activities:    
    Proceeds from term loan facility, net of issuance costs 19,951  
    Proceeds from issuance of common stock upon public offerings,net of issuance costs 3,289 157,680
    Proceeds from issuance of common stock upon stock option exercises 487 271
    Payment of debt issuance costs   (161)
    Net cash provided by financing activities 23,871 157,924
    Net change in cash and cash equivalents, and restricted cash (45,751) 4,848
    Cash and cash equivalents, and restricted cash at beginning of period 98,208 93,360
    Cash and cash equivalents, and restricted cash at end of period 52,457 98,208
    Components of cash and cash equivalents, and restricted cash:    
    Cash and cash equivalents 52,432 98,183
    Restricted cash 25 25
    Total cash and cash equivalents, and restricted cash 52,457 98,208
    Supplemental disclosures of cash information:    
    Cash paid for interest 16  
    Cash paid for income taxes   142
    Supplemental disclosures of noncash information:    
    Issuance of common stock warrant in connection with term loan facility 574 634
    ESPP Purchases    
    Cash flows from financing activities:    
    Proceeds from issuance of common stock upon ESPP purchases $ 144 $ 134
    XML 27 R8.htm IDEA: XBRL DOCUMENT v3.22.1
    Organization and Basis of Presentation
    		 12 Months Ended
    Dec. 31, 2021
    Organization Consolidation And Presentation Of Financial Statements [Abstract]  
    Organization and Basis of Presentation

    1. Organization and Basis of Presentation

    Description of Business

    89bio, Inc. (“89bio” or the “Company”) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia.

    89bio, Inc. was formed as a Delaware corporation in June 2019 to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018.

    Public Offerings

    In July 2020, the Company completed an underwritten public offering of 3,047,040 shares of its common stock at the public offering price of $27.50 per share. The Company raised a total of $78.2 million in net proceeds after deducting underwriting discounts and commissions of $5.0 million and offering costs of $0.6 million.

    In September 2020, the Company completed an underwritten public offering of 3,025,000 shares of its common stock, at a public offering price of $28.00 per share. The Company raised a total of $79.5 million in net proceeds after deducting underwriting discounts and commissions of $4.6 million and offering costs of $0.6 million.

     

    In March 2021, the Company entered into a sales agreement (the “Sales Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (the “Sales Agents”) pursuant to which it may offer and sell up to $75.0 million of shares of the Company’s common stock, from time to time, in “at-the-market” offerings (the “ATM Facility”). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. During the fourth quarter of 2021, the Company received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of its common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.

    Liquidity

    The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of $150.7 million as of December 31, 2021.

    The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with proceeds available from the Company’s term loan (see Note 6) and its ATM Facility, will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission (“SEC”).
    XML 28 R9.htm IDEA: XBRL DOCUMENT v3.22.1
    Summary of Significant Accounting Policies
    		 12 Months Ended
    Dec. 31, 2021
    Accounting Policies [Abstract]  
    Summary of Significant Accounting Policies

    2. Summary of Significant Accounting Policies

    Basis of Presentation

    The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”).

    Principles of Consolidation

    The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

    Foreign Currencies

    Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company’s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.

    Use of Estimates

    The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.

    Fair Value Measurements

    Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company’s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company’s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:

    Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

    Level 2—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

    Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

    Concentrations of Credit Risk

    Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.

    Other Risks and Uncertainties

    The Company’s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company’s early stages of clinical drug development; the Company’s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company’s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company’s ability to enroll patients in its ongoing and future clinical trials; the Company’s ability to successfully manufacture and supply its product candidates for clinical trials; the Company’s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company’s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company’s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.

    The Company’s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.

    The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company’s business and delay its preclinical and clinical programs and timelines. The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for pegozafermin. The extent to which the COVID-19 pandemic may impact the Company’s future operating results and financial condition is uncertain.

    Segment Reporting

    The Company has one operating segment. The Company’s chief operating decision maker, its Chief Executive Officer, manages the Company’s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.

    Cash and Cash Equivalents

    The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.

    Restricted Cash

    Restricted cash consists of a money market account that serves as collateral for the Company’s operating lease agreement for its facility in Israel.

    Investments

    Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management’s intent to use the investments to fund current operations or to make them available for current operations.

    Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method. The Company has not experienced material realized gains or losses or other-than-temporary losses in the periods presented. Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.

    Property and Equipment, Net

    Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from three to seven years. Leasehold improvements are amortized on a straight-line basis over the shorter of the assets’ estimated useful life or the remaining term of the lease. Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. Maintenance and repair costs are expensed as incurred.

    Impairment of Long-Lived Assets

    The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.

    Accrued Research and Development Expenses

    The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company’s research and development expenses.

    The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company’s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company’s accrued expenses could materially affect the Company’s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.

    Leases

    The Company leases its office facilities under non-cancelable operating lease agreements and recognizes related rent expense on a straight-line basis over the term of the lease.

    Research and Development Expenses

    Research and development expenses consist primarily of costs incurred for the development of the Company’s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies, and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.

    Stock-Based Compensation

    The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.

    The Company estimates the fair value of stock option awards on the date of grant using a Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.

    The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:

     

    •

    Expected volatility—Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company’s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group.

     

    •

    Expected term—The expected term of options granted to employees and directors is determined using the “simplified” method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.

     

    •

    Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.

     

    •

    Expected dividend—The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.

    The fair value of restricted stock units is based on the fair value of the Company’s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.

    Income Taxes

    Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to

    taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.

    Basic and Diluted Net Loss per Share

    Basic loss per share is computed by dividing the net loss by the weighted-average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss by the weighted-average number of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive.

    Comprehensive Loss

    The Company’s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.

    Recent Accounting Pronouncements

    In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2016-02—Leases (“ASU 2016-02”), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company’s consolidated financial statements.

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.

     

     
    XML 29 R10.htm IDEA: XBRL DOCUMENT v3.22.1
    Fair Value Measurements
    		 12 Months Ended
    Dec. 31, 2021
    Fair Value Disclosures [Abstract]  
    Fair Value Measurements

    3. Fair Value Measurements

    The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):

     

     

     

     

     

    As of December 31, 2021

     

     

     

    Valuation

     

    Amortized

     

     

    Unrealized

     

     

    Unrealized

     

     

     

     

     

     

     

    Hierarchy

     

    Cost

     

     

    Gains

     

     

    Losses

     

     

    Fair Value

     

    Money market funds

     

    Level 1

     

    $

    21,477

     

     

    $

    —

     

     

    $

    —

     

     

    $

    21,477

     

    Commercial paper

     

    Level 2

     

     

    59,647

     

     

     

    —

     

     

     

    (10

    )

     

     

    59,637

     

    U.S. government bonds

     

    Level 2

     

     

    21,662

     

     

     

    —

     

     

     

    (42

    )

     

     

    21,620

     

    Corporate debt securities

     

    Level 2

     

     

    8,776

     

     

     

    1

     

     

     

    (1

    )

     

     

    8,776

     

    Agency bonds

     

    Level 2

     

     

    7,747

     

     

     

    1

     

     

     

    (7

    )

     

     

    7,741

     

    Municipal bonds

     

    Level 2

     

     

    4,251

     

     

     

    —

     

     

     

    (4

    )

     

     

    4,247

     

    Non-U.S. debt securities

     

    Level 2

     

     

    2,506

     

     

     

    —

     

     

     

    (1

    )

     

     

    2,505

     

    Total cash equivalents and available-for-sale securities

     

     

     

    $

    126,066

     

     

    $

    2

     

     

    $

    (65

    )

     

    $

    126,003

     

    Classified as:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cash equivalents

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    27,715

     

    Short-term available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    98,288

     

    Total cash equivalents and available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    126,003

     

     

    The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):

     

     

     

    As of December 31, 2021

     

    Within one year

     

    $

    120,726

     

    After one year through two years

     

     

    5,277

     

    Total cash equivalents and available-for-sale securities

     

    $

    126,003

     

     

    The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):

     

     

     

     

     

    As of December 31, 2020

     

     

     

    Valuation

     

    Amortized

     

     

    Unrealized

     

     

    Unrealized

     

     

     

     

     

     

     

    Hierarchy

     

    Cost

     

     

    Gains

     

     

    Losses

     

     

    Fair Value

     

    Money market funds

     

    Level 1

     

    $

    46,134

     

     

    $

    —

     

     

    $

    —

     

     

    $

    46,134

     

    Commercial paper

     

    Level 2

     

     

    76,605

     

     

     

    —

     

     

     

    (2

    )

     

     

    76,603

     

    Agency bonds

     

    Level 2

     

     

    29,654

     

     

     

    15

     

     

     

    —

     

     

     

    29,669

     

    Corporate debt securities

     

    Level 2

     

     

    11,890

     

     

     

    —

     

     

     

    (6

    )

     

     

    11,884

     

    U.S. government bonds

     

    Level 2

     

     

    7,093

     

     

     

    —

     

     

     

    —

     

     

     

    7,093

     

    Municipal bonds

     

    Level 2

     

     

    5,592

     

     

     

    2

     

     

     

    (1

    )

     

     

    5,593

     

    U.S. treasury bills

     

    Level 2

     

     

    4,680

     

     

     

    —

     

     

     

    —

     

     

     

    4,680

     

    Agency discount securities

     

    Level 2

     

     

    200

     

     

     

    —

     

     

     

    —

     

     

     

    200

     

    Total cash equivalents and available-for-sale securities

     

     

     

    $

    181,848

     

     

    $

    17

     

     

    $

    (9

    )

     

    $

    181,856

     

    Classified as:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cash equivalents

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    75,410

     

    Short-term available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    106,446

     

    Total cash equivalents and available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    181,856

     

     

     

    The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):

     

     

     

    As of December 31, 2020

     

    Within one year

     

    $

    160,304

     

    After one year through two years

     

     

    21,552

     

    Total cash equivalents and available-for-sale securities

     

    $

    181,856

     
    XML 30 R11.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Balance Sheet Components
    		 12 Months Ended
    Dec. 31, 2021
    Balance Sheet Related Disclosures [Abstract]  
    Consolidated Balance Sheet Components

    4. Consolidated Balance Sheet Components

    Prepaid and Other Current Assets

    Prepaid and other current assets consist of the following as of the periods presented (in thousands):

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    Prepaid research and development

     

    $

    7,895

     

     

    $

    2,534

     

    Prepaid taxes

     

     

    836

     

     

     

    481

     

    Prepaid other

     

     

    2,506

     

     

     

    2,533

     

    Total prepaid and other current assets

     

    $

    11,237

     

     

    $

    5,548

     

     

    Accrued Expenses

    Accrued expenses consist of the following as of the periods presented (in thousands):

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    Accrued research and development expenses

     

    $

    6,195

     

     

    $

    2,884

     

    Accrued employee and related expenses

     

     

    3,168

     

     

     

    2,552

     

    Accrued professional and legal fees

     

     

    495

     

     

     

    453

     

    Accrued other

     

     

    336

     

     

     

    159

     

    Total accrued expenses

     

    $

    10,194

     

     

    $

    6,048

     
    XML 31 R12.htm IDEA: XBRL DOCUMENT v3.22.1
    Commitments and Contingencies
    		 12 Months Ended
    Dec. 31, 2021
    Commitments And Contingencies Disclosure [Abstract]  
    Commitments and Contingencies

    5. Commitments and Contingencies

    Leases

    In May 2018, the Company entered into an operating lease agreement for its facility in Israel. The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months. Under the lease agreement, monthly lease payments are approximately $4,200.

    In December 2019, the Company entered into an operating lease for its headquarters in San Francisco, with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year. Under the lease agreement, monthly lease payments are approximately $18,000.

    Future minimum lease payments under the Company’s non-cancellable operating lease obligations as of December 31, 2021, are as follows (in thousands):

     

    2022

     

    $

    212

     

    2023

     

     

    7

     

    Total future minimum annual payments

     

    $

    219

     

     

     

    Rent expense was $290,000 and $273,000 for the years ended December 31, 2021 and 2020, respectively. The Company has security deposit balances of $95,000, a portion of which is included in restricted cash and a portion in other assets in the consolidated balance sheets as of December 31, 2021 and 2020.

    Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd

    In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the “Teva Agreements”) with Teva Pharmaceutical Industries Ltd (“Teva”) under which it acquired certain patents and intellectual property relating to two programs: (1) Teva’s glycoPEGylated FGF21 program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2) Teva’s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $6.0 million and the Company could be obligated to pay Teva up to $67.5 million under each program, for a total of $135.0 million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds.

    The Teva Agreements can be terminated (i) by the Company without cause upon 120 days’ written notice to Teva, (ii) by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within 60 days after receiving notice thereof, or (iii) by either party, if a bankruptcy petition is filed against the other party and is not dismissed within 60 days. In addition, Teva can also terminate the agreement related to the Company’s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva.

    During the years ended December 31, 2021 and 2020, none of the development and commercial milestones were met and accordingly, there were no milestone payments related to the Teva Agreements.

    XML 32 R13.htm IDEA: XBRL DOCUMENT v3.22.1
    Term Loan
    		 12 Months Ended
    Dec. 31, 2021
    Debt Disclosure [Abstract]  
    Term Loan

    6. Term Loan

    Loan and Security Agreement

    In April 2020, the Company entered into a Loan and Security Agreement, (the “Loan Agreement”) with the lenders referred to therein (the “Lenders”), and Silicon Valley Bank (“SVB”), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the “Term A Loan Facility”) of up to $10.0 million and (ii) a secured term B loan facility (the “Term B Loan Facility”) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company’s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.

    In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase 25,000 shares of the Company’s common stock with a warrant exercise price of $22.06 per share that is immediately exercisable and expires on June 30, 2025, as amended. The fair value of the warrant at issuance date was determined by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 0.75%, no dividends, expected volatility of 92.3% and expected term of 10.0 years. Upon issuance, the fair value allocated to the warrant of $0.6 million met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. Additionally, the Company incurred $0.2 million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs classified within other assets in the consolidated balance sheets.

    In May 2021, the parties further amended the Loan Agreement (as amended, the “2021 Loan Agreement”). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022.

    Concurrent with the closing and as a condition of the 2021 Loan Agreement, the Company drew $1.5 million and in December 2021, drew the remaining $18.5 million under the Term Loan A Facility. The 2021 Loan Agreement provides for interest-only payments until October 1, 2022, followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through September 1, 2024, the maturity date of the term loan. The interest only period may be extended to April 1, 2023, if on or before September 20, 2022, the Company receives net cash proceeds of at least $75.0 million from the sale of its equity securities. The term loan bears interest at the greater of (i) 4.25% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) 1.00% (or for both amounts drawn 4.25% initially and as of December 31, 2021). In addition, a final payment fee of 5% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.

    In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase 33,923 shares of the Company’s common stock with a warrant exercise price of $19.12 per share that is immediately exercisable and expires on May 28, 2031. The Company determined the fair value of the warrant at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 1.6%, no dividends, expected volatility of 98.6% and expected term of 10.0 years. Upon issuance, the fair value of the warrant of $0.6 million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term Loan B Facility, if funded, the Company will issue additional warrant to purchase 11,305 shares of the Company’s common stock with the exercise price at the Company’s stock price at the time of issuance.

    The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $0.4 million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount. The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method. Interest expense is recorded within other expenses, net in the consolidated statements of operations and comprehensive loss.

     The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):

     

     

     

     

     

     

    2022

     

    $

    2,500

     

    2023

     

    $

    10,000

     

    2024

     

    $

    7,500

     

    Total principal repayments

     

    $

    20,000

     

    Less: unamortized debt discount

     

     

    (602

    )

    Total term loan, net

     

     

    19,398

     

    Less: term loan, current

     

     

    (2,500

    )

    Term loan, non-current, net

     

    $

    16,898

     

     

     

     
    XML 33 R14.htm IDEA: XBRL DOCUMENT v3.22.1
    Stock-Based Compensation
    		 12 Months Ended
    Dec. 31, 2021
    Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
    Stock-Based Compensation

    7. Stock-Based Compensation

    Equity Incentive Plans

    The Company’s board of directors approved the 2019 Equity Incentive Plan (the “2019 Plan”), which became effective in September 2019. The Company initially reserved 2,844,193 shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to ten years, commencing on January 1, 2020, in an amount equal to 4% of the total number of shares of the Company’s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company’s board of directors. As of December 31, 2021, there were 1,428,304 shares of common stock available for issuance as future option grants under the 2019 Plan.

    The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant.

    Employee Stock Purchase Plan

    In October 2019, the Company adopted the 2019 Employee Stock Purchase Plan (“ESPP”), which became effective in November 2019. The Company initially reserved 225,188 shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to ten years, in an amount equal to 1% of the total number of shares of the Company’s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company’s board of directors. Purchases will be accomplished through the participation of discrete offering periods and each offering is expected to be 6 months long. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to 85% of the lesser of the fair market value of the Company’s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period. The first six month offering period under the ESPP commenced on January 1, 2020.

    As of December 31, 2021, there were 544,410 shares of common stock available for issuance under the ESPP.

    The Company recorded stock-based compensation for the periods presented as follows (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Research and development

     

    $

    2,966

     

     

    $

    1,250

     

    General and administrative

     

     

    5,712

     

     

     

    2,557

     

    Total stock-based compensation

     

    $

    8,678

     

     

    $

    3,807

     

     

    The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Expected term (years)

     

    5.5-6.1

     

     

    4.0-6.1

     

    Expected volatility

     

    86.9-91.9%

     

     

    86.4-97.6%

     

    Risk-free interest rate

     

    0.7-1.3%

     

     

    0.2-1.5%

     

    Expected dividend

     

     

    —

     

     

     

    —

     

     

     

    The following table summarizes stock option activity for the year ended December 31, 2021:

     

     

     

     

     

     

     

     

     

     

     

    Weighted

     

     

     

     

     

     

     

     

     

     

     

    Weighted

     

     

    Average

     

     

     

     

     

     

     

     

     

     

     

    Average

     

     

    Remaining

     

     

    Aggregate

     

     

     

    Number of

     

     

    Exercise

     

     

    Contractual

     

     

    Intrinsic

     

     

     

    Options

     

     

    Price

     

     

    Term

     

     

    Value

     

     

     

     

     

     

     

     

     

     

     

    (In years)

     

     

    (In thousands)

     

    Balance outstanding as of December 31, 2020

     

     

    1,898,395

     

     

    $

    12.79

     

     

     

    8.6

     

     

    $

    25,918

     

    Granted

     

     

    830,013

     

     

     

    22.22

     

     

     

     

     

     

     

     

     

    Exercised

     

     

    (188,286

    )

     

     

    2.59

     

     

     

     

     

     

     

     

     

    Cancelled and forfeited

     

     

    (133,454

    )

     

     

    19.55

     

     

     

     

     

     

     

     

     

    Balance outstanding as of December 31, 2021

     

     

    2,406,668

     

     

    $

    16.46

     

     

     

    8.1

     

     

    $

    9,970

     

    Exercisable as of December 31, 2021

     

     

    922,104

     

     

    $

    10.76

     

     

     

    7.3

     

     

    $

    6,800

     

     

    The estimated grant date fair value of stock options that vested during the year ended December 31, 2021, was $7.0 million. The weighted-average grant date fair value of stock options that were granted during the years ended December 31, 2021 and 2020 was $16.18 and $21.88 per share, respectively. As of December 31, 2021, there was $17.9 million of unrecognized stock-based compensation cost related to stock options granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of 2.3 years.

    Restricted Stock Units (“RSUs”)

    In February 2021, the Company granted 56,545 service-based RSUs to its employees with a total grant date fair value of $1.3 million. The RSUs vest annually over a three-year period. During the year ended December 31, 2021, the Company recognized $0.3 million in expense related to the service-based RSUs. As of December 31, 2021, 11,651 RSUs were cancelled and 44,894 remain outstanding.

    In February 2021, the Company granted 61,500 performance-based RSUs to certain executives, one-third of which vest on each one-year anniversary of the grant date subject to achievement of a development milestone and continued service to the Company. The performance-based RSUs have a total grant date fair value of $1.4 million. During the year ended December 31, 2021, the Company recognized $0.8 million in expense, using the accelerated attribution method, related to the performance-based RSUs. As of December 31, 2021, all of the performance-based RSUs remain outstanding. Subsequently, one-third of the performance-based RSUs vested in February 2022, upon achievement of the development milestone and satisfaction of the continued service condition.

     
    XML 34 R15.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes
    		 12 Months Ended
    Dec. 31, 2021
    Income Tax Disclosure [Abstract]  
    Income Taxes

    8. Income Taxes

     

    Tax Rates Applicable to the Income of the Company and its Subsidiaries

    The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    89bio, Inc.

     

     

    21

    %

     

     

    21

    %

    89Bio Ltd.

     

     

    23

    %

     

     

    23

    %

    89bio Management, Inc.

     

     

    21

    %

     

     

    21

    %

    UAB 89bio Lithuania

     

     

    15

    %

     

     

    15

    %

     

     

    The income tax benefit is comprised of (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Current:

     

     

     

     

     

     

     

     

    Federal

     

    $

    —

     

     

    $

    (11

    )

    State

     

     

    (2

    )

     

     

    1

     

    Foreign

     

     

    (1

    )

     

     

    —

     

    Total

     

     

    (3

    )

     

     

    (10

    )

     

     

     

     

     

     

     

     

     

    Deferred:

     

     

     

     

     

     

     

     

    Federal

     

     

    150

     

     

     

    69

     

    Total

     

     

    150

     

     

     

    69

     

    Income tax benefit

     

    $

    147

     

     

    $

    59

     

     

    Deferred Income Taxes

    Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets for the periods presented are as follows (in thousands):

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    U.S. net operating loss carryforwards

     

    $

    29,094

     

     

    $

    11,342

     

    Research and development expenses

     

     

    6,529

     

     

     

    5,392

     

    Israel net operating loss carryforwards

     

     

    4,262

     

     

     

    3,978

     

    Stock-based compensation

     

     

    1,969

     

     

     

    610

     

    Accrued expenses

     

     

    220

     

     

     

    635

     

    Other

     

     

    191

     

     

     

    48

     

    Total deferred tax assets

     

     

    42,265

     

     

     

    22,005

     

    Less: valuation allowance

     

     

    (42,046

    )

     

     

    (21,936

    )

    Net deferred tax assets

     

    $

    219

     

     

    $

    69

     

     

    As of December 31, 2021 and 2020, the Company recorded a valuation allowance of $42.0 million and $21.9 million, respectively, in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by $20.1 million in 2021, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction. The valuation allowance increased by $11.9 million in 2020, which primarily relates to significant taxable losses. The change in valuation allowance during 2020 also includes a partial release of the valuation allowance against deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction, which decreased the valuation allowance by $69,000 in 2020.

    Available Carryforward Tax Losses and Credits

    As of December 31, 2021, the Company had an accumulated tax loss carryforward of approximately $138.5 million and $18.5 million for U.S. and Israeli tax purposes, respectively. As of December 31, 2020, the Company had an accumulated tax loss carryforward of approximately $54.1 million and $17.3 million for U.S. and Israeli tax purposes, respectively. Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. Carryforward tax losses in Israel have no expiration date.

     

    As of December 31, 2021 and 2020, the Company had federal research and development credit carryforwards of approximately $2.1 million and $0.6 million, respectively, which expire beginning in 2040. As of December 31, 2021 and December 31, 2020, the Company has state research and development credit carryforwards of approximately $1.1 million and $0.7 million, respectively, which will carry forward indefinitely.

    Loss from Operations, Before Income Tax

    The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    United States

     

    $

    (91,141

    )

     

    $

    (58,760

    )

    Lithuania

     

     

    10

     

     

     

    (73

    )

    Israel

     

     

    862

     

     

     

    9,275

     

    Net loss before income tax

     

    $

    (90,269

    )

     

    $

    (49,558

    )

    Reconciliation of Income Tax Benefit

    The reconciliation of income tax benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Income tax benefit computed at statutory rates

     

    $

    18,757

     

     

    $

    8,285

     

    Change in valuation allowance

     

     

    (20,111

    )

     

     

    (11,914

    )

    Foreign rate differential

     

     

    (19

    )

     

     

    1,671

     

    Change in Israel effective tax rate due to the 2019

       reorganization

     

     

    (2

    )

     

     

    647

     

    Research and development credits, net of

       uncertain tax position

     

     

    1,331

     

     

     

    815

     

    Other

     

     

    191

     

     

     

    555

     

    Income tax benefit

     

    $

    147

     

     

    $

    59

     

     

    Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.

    Unrecognized Tax Benefits

    During the years ended December 31, 2021 and 2020, the amount of gross unrecognized tax benefits increased by $0.5 million and $0.3 million, respectively. If the total amount of unrecognized tax benefits was recognized, it would not have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.

    The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2021 and 2020, such interest and penalties were not material.

    The Company is subject to taxation in the United States, California, and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli taxing authorities for 2018 and 2019. As of December 31, 2021 all tax years remain open to examination.

    XML 35 R16.htm IDEA: XBRL DOCUMENT v3.22.1
    Net Loss Per Share
    		 12 Months Ended
    Dec. 31, 2021
    Earnings Per Share [Abstract]  
    Net Loss Per Share

    9. Net Loss Per Share

    The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect:

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    Stock options to purchase common stock

     

     

    2,406,668

     

     

     

    1,898,395

     

    Unvested restricted stock units

     

     

    106,394

     

     

     

    —

     

    Warrants to purchase common stock

     

     

    58,923

     

     

     

    —

     

    Total

     

     

    2,571,985

     

     

     

    1,898,395

     
    XML 36 R17.htm IDEA: XBRL DOCUMENT v3.22.1
    Subsequent Events
    		 12 Months Ended
    Dec. 31, 2021
    Subsequent Events [Abstract]  
    Subsequent Events  
    XML 37 R18.htm IDEA: XBRL DOCUMENT v3.22.1
    Summary of Significant Accounting Policies (Policies)
    		 12 Months Ended
    Dec. 31, 2021
    Accounting Policies [Abstract]  
    Basis of Presentation

    Basis of Presentation

    The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”).
    Principles of Consolidation

    Principles of Consolidation

    The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
    Foreign Currencies

    Foreign Currencies

    Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company’s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.
    Use of Estimates

    Use of Estimates

    The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.
    Fair Value Measurements

    Fair Value Measurements

    Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company’s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company’s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:

    Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

    Level 2—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

    Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
    Concentrations of Credit Risk

    Concentrations of Credit Risk

    Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.
    Other Risks and Uncertainties

    Other Risks and Uncertainties

    The Company’s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company’s early stages of clinical drug development; the Company’s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company’s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company’s ability to enroll patients in its ongoing and future clinical trials; the Company’s ability to successfully manufacture and supply its product candidates for clinical trials; the Company’s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company’s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company’s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.

    The Company’s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.

    The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company’s business and delay its preclinical and clinical programs and timelines. The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for pegozafermin. The extent to which the COVID-19 pandemic may impact the Company’s future operating results and financial condition is uncertain.
    Segment Reporting

    Segment Reporting

    The Company has one operating segment. The Company’s chief operating decision maker, its Chief Executive Officer, manages the Company’s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.
    Cash and Cash Equivalents and Restricted Cash

    Cash and Cash Equivalents

    The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.

    Restricted Cash

    Restricted cash consists of a money market account that serves as collateral for the Company’s operating lease agreement for its facility in Israel.
    Investments

    Investments

    Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management’s intent to use the investments to fund current operations or to make them available for current operations.

    Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method. The Company has not experienced material realized gains or losses or other-than-temporary losses in the periods presented. Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.
    Property and Equipment, Net

    Property and Equipment, Net

    Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from three to seven years. Leasehold improvements are amortized on a straight-line basis over the shorter of the assets’ estimated useful life or the remaining term of the lease. Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. Maintenance and repair costs are expensed as incurred.
    Impairment of Long-Lived Assets

    Impairment of Long-Lived Assets

    The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.
    Accrued Research and Development Expenses

    Accrued Research and Development Expenses

    The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company’s research and development expenses.

    The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company’s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company’s accrued expenses could materially affect the Company’s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.
    Leases

    Leases

    The Company leases its office facilities under non-cancelable operating lease agreements and recognizes related rent expense on a straight-line basis over the term of the lease.
    Research and Development Expenses

    Research and Development Expenses

    Research and development expenses consist primarily of costs incurred for the development of the Company’s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies, and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.
    Stock-Based Compensation

    Stock-Based Compensation

    The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.

    The Company estimates the fair value of stock option awards on the date of grant using a Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.

    The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:

     

    •

    Expected volatility—Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company’s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group.

     

    •

    Expected term—The expected term of options granted to employees and directors is determined using the “simplified” method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.

     

    •

    Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.

     

    •

    Expected dividend—The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.

    The fair value of restricted stock units is based on the fair value of the Company’s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.
    Income Taxes

    Income Taxes

    Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to

    taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.

    Basic and Diluted Net Loss per Share

    Basic and Diluted Net Loss per Share

    Basic loss per share is computed by dividing the net loss by the weighted-average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss by the weighted-average number of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive.
    Comprehensive Loss

    Comprehensive Loss

    The Company’s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.
    Recent Accounting Pronouncements

    Recent Accounting Pronouncements

    In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2016-02—Leases (“ASU 2016-02”), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company’s consolidated financial statements.

    In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.

     

     
    XML 38 R19.htm IDEA: XBRL DOCUMENT v3.22.1
    Fair Value Measurements (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Fair Value Disclosures [Abstract]  
    Summary of Financial Assets Measured at Fair Value on Recurring Basis

    The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):

     

     

     

     

     

    As of December 31, 2021

     

     

     

    Valuation

     

    Amortized

     

     

    Unrealized

     

     

    Unrealized

     

     

     

     

     

     

     

    Hierarchy

     

    Cost

     

     

    Gains

     

     

    Losses

     

     

    Fair Value

     

    Money market funds

     

    Level 1

     

    $

    21,477

     

     

    $

    —

     

     

    $

    —

     

     

    $

    21,477

     

    Commercial paper

     

    Level 2

     

     

    59,647

     

     

     

    —

     

     

     

    (10

    )

     

     

    59,637

     

    U.S. government bonds

     

    Level 2

     

     

    21,662

     

     

     

    —

     

     

     

    (42

    )

     

     

    21,620

     

    Corporate debt securities

     

    Level 2

     

     

    8,776

     

     

     

    1

     

     

     

    (1

    )

     

     

    8,776

     

    Agency bonds

     

    Level 2

     

     

    7,747

     

     

     

    1

     

     

     

    (7

    )

     

     

    7,741

     

    Municipal bonds

     

    Level 2

     

     

    4,251

     

     

     

    —

     

     

     

    (4

    )

     

     

    4,247

     

    Non-U.S. debt securities

     

    Level 2

     

     

    2,506

     

     

     

    —

     

     

     

    (1

    )

     

     

    2,505

     

    Total cash equivalents and available-for-sale securities

     

     

     

    $

    126,066

     

     

    $

    2

     

     

    $

    (65

    )

     

    $

    126,003

     

    Classified as:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cash equivalents

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    27,715

     

    Short-term available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    98,288

     

    Total cash equivalents and available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    126,003

     

    The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):

     

     

     

     

     

    As of December 31, 2020

     

     

     

    Valuation

     

    Amortized

     

     

    Unrealized

     

     

    Unrealized

     

     

     

     

     

     

     

    Hierarchy

     

    Cost

     

     

    Gains

     

     

    Losses

     

     

    Fair Value

     

    Money market funds

     

    Level 1

     

    $

    46,134

     

     

    $

    —

     

     

    $

    —

     

     

    $

    46,134

     

    Commercial paper

     

    Level 2

     

     

    76,605

     

     

     

    —

     

     

     

    (2

    )

     

     

    76,603

     

    Agency bonds

     

    Level 2

     

     

    29,654

     

     

     

    15

     

     

     

    —

     

     

     

    29,669

     

    Corporate debt securities

     

    Level 2

     

     

    11,890

     

     

     

    —

     

     

     

    (6

    )

     

     

    11,884

     

    U.S. government bonds

     

    Level 2

     

     

    7,093

     

     

     

    —

     

     

     

    —

     

     

     

    7,093

     

    Municipal bonds

     

    Level 2

     

     

    5,592

     

     

     

    2

     

     

     

    (1

    )

     

     

    5,593

     

    U.S. treasury bills

     

    Level 2

     

     

    4,680

     

     

     

    —

     

     

     

    —

     

     

     

    4,680

     

    Agency discount securities

     

    Level 2

     

     

    200

     

     

     

    —

     

     

     

    —

     

     

     

    200

     

    Total cash equivalents and available-for-sale securities

     

     

     

    $

    181,848

     

     

    $

    17

     

     

    $

    (9

    )

     

    $

    181,856

     

    Classified as:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cash equivalents

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    75,410

     

    Short-term available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    106,446

     

    Total cash equivalents and available-for-sale securities

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    181,856

     
    Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities

    The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):

     

     

     

    As of December 31, 2021

     

    Within one year

     

    $

    120,726

     

    After one year through two years

     

     

    5,277

     

    Total cash equivalents and available-for-sale securities

     

    $

    126,003

     

    The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):

     

     

     

    As of December 31, 2020

     

    Within one year

     

    $

    160,304

     

    After one year through two years

     

     

    21,552

     

    Total cash equivalents and available-for-sale securities

     

    $

    181,856

     
    XML 39 R20.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Balance Sheet Components (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Balance Sheet Related Disclosures [Abstract]  
    Schedule of Prepaid and Other Current Assets

    Prepaid and other current assets consist of the following as of the periods presented (in thousands):

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    Prepaid research and development

     

    $

    7,895

     

     

    $

    2,534

     

    Prepaid taxes

     

     

    836

     

     

     

    481

     

    Prepaid other

     

     

    2,506

     

     

     

    2,533

     

    Total prepaid and other current assets

     

    $

    11,237

     

     

    $

    5,548

     
    Schedule of Accrued Expenses

    Accrued Expenses

    Accrued expenses consist of the following as of the periods presented (in thousands):

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    Accrued research and development expenses

     

    $

    6,195

     

     

    $

    2,884

     

    Accrued employee and related expenses

     

     

    3,168

     

     

     

    2,552

     

    Accrued professional and legal fees

     

     

    495

     

     

     

    453

     

    Accrued other

     

     

    336

     

     

     

    159

     

    Total accrued expenses

     

    $

    10,194

     

     

    $

    6,048

     
    XML 40 R21.htm IDEA: XBRL DOCUMENT v3.22.1
    Commitments and Contingencies (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Commitments And Contingencies Disclosure [Abstract]  
    Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations

    Future minimum lease payments under the Company’s non-cancellable operating lease obligations as of December 31, 2021, are as follows (in thousands):

     

    2022

     

    $

    212

     

    2023

     

     

    7

     

    Total future minimum annual payments

     

    $

    219

     
    XML 41 R22.htm IDEA: XBRL DOCUMENT v3.22.1
    Term Loan (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Debt Disclosure [Abstract]  
    Schedule of Repayment of Principal Amount

     The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):

     

     

     

     

     

    2022

     

    $

    2,500

     

    2023

     

    $

    10,000

     

    2024

     

    $

    7,500

     

    Total principal repayments

     

    $

    20,000

     

    Less: unamortized debt discount

     

     

    (602

    )

    Total term loan, net

     

     

    19,398

     

    Less: term loan, current

     

     

    (2,500

    )

    Term loan, non-current, net

     

    $

    16,898

     

     
    XML 42 R23.htm IDEA: XBRL DOCUMENT v3.22.1
    Stock-Based Compensation (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
    Summary of Stock-Based Compensation

    The Company recorded stock-based compensation for the periods presented as follows (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Research and development

     

    $

    2,966

     

     

    $

    1,250

     

    General and administrative

     

     

    5,712

     

     

     

    2,557

     

    Total stock-based compensation

     

    $

    8,678

     

     

    $

    3,807

     

     
    Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model

    The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Expected term (years)

     

    5.5-6.1

     

     

    4.0-6.1

     

    Expected volatility

     

    86.9-91.9%

     

     

    86.4-97.6%

     

    Risk-free interest rate

     

    0.7-1.3%

     

     

    0.2-1.5%

     

    Expected dividend

     

     

    —

     

     

     

    —

     

     

     
    Summary of Stock Option Activity

    The following table summarizes stock option activity for the year ended December 31, 2021:

     

     

     

     

     

     

     

     

     

     

     

    Weighted

     

     

     

     

     

     

     

     

     

     

     

    Weighted

     

     

    Average

     

     

     

     

     

     

     

     

     

     

     

    Average

     

     

    Remaining

     

     

    Aggregate

     

     

     

    Number of

     

     

    Exercise

     

     

    Contractual

     

     

    Intrinsic

     

     

     

    Options

     

     

    Price

     

     

    Term

     

     

    Value

     

     

     

     

     

     

     

     

     

     

     

    (In years)

     

     

    (In thousands)

     

    Balance outstanding as of December 31, 2020

     

     

    1,898,395

     

     

    $

    12.79

     

     

     

    8.6

     

     

    $

    25,918

     

    Granted

     

     

    830,013

     

     

     

    22.22

     

     

     

     

     

     

     

     

     

    Exercised

     

     

    (188,286

    )

     

     

    2.59

     

     

     

     

     

     

     

     

     

    Cancelled and forfeited

     

     

    (133,454

    )

     

     

    19.55

     

     

     

     

     

     

     

     

     

    Balance outstanding as of December 31, 2021

     

     

    2,406,668

     

     

    $

    16.46

     

     

     

    8.1

     

     

    $

    9,970

     

    Exercisable as of December 31, 2021

     

     

    922,104

     

     

    $

    10.76

     

     

     

    7.3

     

     

    $

    6,800

     

     
    XML 43 R24.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Income Tax Disclosure [Abstract]  
    Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries

    The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    89bio, Inc.

     

     

    21

    %

     

     

    21

    %

    89Bio Ltd.

     

     

    23

    %

     

     

    23

    %

    89bio Management, Inc.

     

     

    21

    %

     

     

    21

    %

    UAB 89bio Lithuania

     

     

    15

    %

     

     

    15

    %
    Summary of Income Tax Benefit (Expense)

    The income tax benefit is comprised of (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Current:

     

     

     

     

     

     

     

     

    Federal

     

    $

    —

     

     

    $

    (11

    )

    State

     

     

    (2

    )

     

     

    1

     

    Foreign

     

     

    (1

    )

     

     

    —

     

    Total

     

     

    (3

    )

     

     

    (10

    )

     

     

     

     

     

     

     

     

     

    Deferred:

     

     

     

     

     

     

     

     

    Federal

     

     

    150

     

     

     

    69

     

    Total

     

     

    150

     

     

     

    69

     

    Income tax benefit

     

    $

    147

     

     

    $

    59

     
    Summary of Components of Deferred Tax Assets Significant components of the Company’s deferred tax assets for the periods presented are as follows (in thousands):

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    U.S. net operating loss carryforwards

     

    $

    29,094

     

     

    $

    11,342

     

    Research and development expenses

     

     

    6,529

     

     

     

    5,392

     

    Israel net operating loss carryforwards

     

     

    4,262

     

     

     

    3,978

     

    Stock-based compensation

     

     

    1,969

     

     

     

    610

     

    Accrued expenses

     

     

    220

     

     

     

    635

     

    Other

     

     

    191

     

     

     

    48

     

    Total deferred tax assets

     

     

    42,265

     

     

     

    22,005

     

    Less: valuation allowance

     

     

    (42,046

    )

     

     

    (21,936

    )

    Net deferred tax assets

     

    $

    219

     

     

    $

    69

     

     
    Summary of Loss from Operations Before Taxes on Income

    The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    United States

     

    $

    (91,141

    )

     

    $

    (58,760

    )

    Lithuania

     

     

    10

     

     

     

    (73

    )

    Israel

     

     

    862

     

     

     

    9,275

     

    Net loss before income tax

     

    $

    (90,269

    )

     

    $

    (49,558

    )
    Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate

    The reconciliation of income tax benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):

     

     

     

    Year Ended December 31,

     

     

     

    2021

     

     

    2020

     

    Income tax benefit computed at statutory rates

     

    $

    18,757

     

     

    $

    8,285

     

    Change in valuation allowance

     

     

    (20,111

    )

     

     

    (11,914

    )

    Foreign rate differential

     

     

    (19

    )

     

     

    1,671

     

    Change in Israel effective tax rate due to the 2019

       reorganization

     

     

    (2

    )

     

     

    647

     

    Research and development credits, net of

       uncertain tax position

     

     

    1,331

     

     

     

    815

     

    Other

     

     

    191

     

     

     

    555

     

    Income tax benefit

     

    $

    147

     

     

    $

    59

     
    XML 44 R25.htm IDEA: XBRL DOCUMENT v3.22.1
    Net Loss Per Share (Tables)
    		 12 Months Ended
    Dec. 31, 2021
    Earnings Per Share [Abstract]  
    Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss

    The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect:

     

     

     

    As of December 31,

     

     

     

    2021

     

     

    2020

     

    Stock options to purchase common stock

     

     

    2,406,668

     

     

     

    1,898,395

     

    Unvested restricted stock units

     

     

    106,394

     

     

     

    —

     

    Warrants to purchase common stock

     

     

    58,923

     

     

     

    —

     

    Total

     

     

    2,571,985

     

     

     

    1,898,395

     
    XML 45 R26.htm IDEA: XBRL DOCUMENT v3.22.1
    Organization and Basis of Presentation - Additional Information (Details) - USD ($)
    $ / shares in Units, $ in Thousands
    		 1 Months Ended 3 Months Ended 12 Months Ended
    Mar. 31, 2021
    Sep. 30, 2020
    Jul. 31, 2020
    Dec. 31, 2021
    Dec. 31, 2021
    Subsidiary Sale Of Stock [Line Items]          
    Date of incorporation         Jun. 30, 2019
    Cash and cash equivalents and short term available-for-sale securities       $ 150,700 $ 150,700
    A T M Facility          
    Subsidiary Sale Of Stock [Line Items]          
    Issuance of common stock         $ 3,289
    A T M Facility | Maximum          
    Subsidiary Sale Of Stock [Line Items]          
    Issuance of common stock $ 75,000        
    SVB Leerink LLC          
    Subsidiary Sale Of Stock [Line Items]          
    Shares issued and sold       186,546  
    Proceeds from issuance of common stock, net of underwriters discount and commissions       $ 3,300  
    Selling commission per shares sold percentage 3.00%        
    Proceeds from issuance of common stock upon ESPP purchases       $ 3,300  
    Issuance of common stock, weighted average price per share       $ 17.97  
    Common Stock | A T M Facility          
    Subsidiary Sale Of Stock [Line Items]          
    Shares issued and sold         186,546
    Underwritten public offering | Common Stock          
    Subsidiary Sale Of Stock [Line Items]          
    Shares issued and sold   3,025,000 3,047,040    
    Proceeds from issuance of common stock, net of underwriters discount and commissions   $ 79,500 $ 78,200    
    IPO price per share   $ 28.00 $ 27.50    
    Payment of underwriting discounts, commissions   $ 4,600 $ 5,000    
    Other offering expenses   600 600    
    Proceeds from issuance of common stock upon ESPP purchases   $ 79,500 $ 78,200    
    XML 46 R27.htm IDEA: XBRL DOCUMENT v3.22.1
    Summary of Significant Accounting Policies - Additional Information (Details)
    		 12 Months Ended
    Dec. 31, 2021
    Segment
    Summary Of Significant Accounting Policies [Line Items]  
    Number of operating segments 1
    Leasehold Improvements  
    Summary Of Significant Accounting Policies [Line Items]  
    Leasehold improvements amortization, description Leasehold improvements are amortized on a straight-line basis over the shorter of the assets’ estimated useful life or the remaining term of the lease.
    Minimum [Member]  
    Summary Of Significant Accounting Policies [Line Items]  
    Property and equipment, estimated useful lives 3 years
    Maximum  
    Summary Of Significant Accounting Policies [Line Items]  
    Property and equipment, estimated useful lives 7 years
    XML 47 R28.htm IDEA: XBRL DOCUMENT v3.22.1
    Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2021
    Dec. 31, 2020
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Aggregated Fair Value $ 126,003 $ 181,856
    Recurring    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 126,066 181,848
    Short-term investments, Gross Unrealized Holding Gains 2 17
    Short-term investments, Gross Unrealized Holding Losses (65) (9)
    Short-term investments, Aggregated Fair Value 126,003 181,856
    Recurring | Cash equivalents    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Aggregated Fair Value 27,715 75,410
    Recurring | Short-term available for sale securities    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Aggregated Fair Value 98,288 106,446
    Recurring | Level 1 | Money Market Funds    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 21,477 46,134
    Short-term investments, Aggregated Fair Value 21,477 46,134
    Recurring | Level 2 | Commercial Paper    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 59,647 76,605
    Short-term investments, Gross Unrealized Holding Losses (10) (2)
    Short-term investments, Aggregated Fair Value 59,637 76,603
    Recurring | Level 2 | U.S. government bonds    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 21,662 7,093
    Short-term investments, Gross Unrealized Holding Losses (42)  
    Short-term investments, Aggregated Fair Value 21,620 7,093
    Recurring | Level 2 | Corporate Debt    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 8,776 11,890
    Short-term investments, Gross Unrealized Holding Gains 1  
    Short-term investments, Gross Unrealized Holding Losses (1) (6)
    Short-term investments, Aggregated Fair Value 8,776 11,884
    Recurring | Level 2 | Agency bonds    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 7,747 29,654
    Short-term investments, Gross Unrealized Holding Gains 1 15
    Short-term investments, Gross Unrealized Holding Losses (7)  
    Short-term investments, Aggregated Fair Value 7,741 29,669
    Recurring | Level 2 | Municipal Bonds    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 4,251 5,592
    Short-term investments, Gross Unrealized Holding Gains   2
    Short-term investments, Gross Unrealized Holding Losses (4) (1)
    Short-term investments, Aggregated Fair Value 4,247 5,593
    Recurring | Level 2 | Non-US debt securities    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost 2,506  
    Short-term investments, Gross Unrealized Holding Losses (1)  
    Short-term investments, Aggregated Fair Value $ 2,505  
    Recurring | Level 2 | U.S. treasury bills    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost   4,680
    Short-term investments, Aggregated Fair Value   4,680
    Recurring | Level 2 | Agency discount securities    
    Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
    Short-term investments, Amortized Cost   200
    Short-term investments, Aggregated Fair Value   $ 200
    XML 48 R29.htm IDEA: XBRL DOCUMENT v3.22.1
    Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2021
    Dec. 31, 2020
    Fair Value Disclosures [Abstract]    
    Within one year $ 120,726 $ 160,304
    After one year through two years 5,277 21,552
    Total cash equivalents and available-for-sale securities $ 126,003 $ 181,856
    XML 49 R30.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2021
    Dec. 31, 2020
    Prepaid Expense And Other Assets Current [Abstract]    
    Prepaid research and development $ 7,895 $ 2,534
    Prepaid taxes 836 481
    Prepaid other 2,506 2,533
    Total prepaid and other current assets $ 11,237 $ 5,548
    XML 50 R31.htm IDEA: XBRL DOCUMENT v3.22.1
    Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2021
    Dec. 31, 2020
    Payables And Accruals [Abstract]    
    Accrued research and development expenses $ 6,195 $ 2,884
    Accrued employee and related expenses 3,168 2,552
    Accrued professional and legal fees 495 453
    Accrued other 336 159
    Total accrued expenses $ 10,194 $ 6,048
    XML 51 R32.htm IDEA: XBRL DOCUMENT v3.22.1
    Commitments and Contingencies - Additional Information (Details) - USD ($)
    		 1 Months Ended 12 Months Ended
    Dec. 31, 2019
    May 31, 2018
    Apr. 30, 2018
    Dec. 31, 2021
    Dec. 31, 2020
    Loss Contingencies [Line Items]          
    Lessee, operating lease, description   The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months.      
    Operating lease, payments   $ 4,200      
    Lessee, operating lease term of contract   12 months      
    Operating leases, rent expense       $ 290,000 $ 273,000
    Teva Agreements          
    Loss Contingencies [Line Items]          
    Nonrefundable upfront payment     $ 6,000,000.0    
    Payment upon achievement of certain clinical and commercial milestones     135,000,000.0    
    Asset transfer and license agreement, termination period after written notice       120 days  
    Asset transfer and license agreement, termination period notice of breach       60 days  
    Asset transfer and license agreement termination notice period if bankruptcy petition filed       60 days  
    Teva Agreements | Research and Development Expenses          
    Loss Contingencies [Line Items]          
    Milestone payments       $ 0 0
    Teva Agreements | Teva's GlycoPEGylated FGF21 Program          
    Loss Contingencies [Line Items]          
    Payment upon achievement of certain clinical and commercial milestones     67,500,000    
    Teva Agreements | Teva's Development Program          
    Loss Contingencies [Line Items]          
    Payment upon achievement of certain clinical and commercial milestones     $ 67,500,000    
    Restricted Cash And Other Assets Member          
    Loss Contingencies [Line Items]          
    Security deposit       $ 95,000 95,000
    San Francisco Office          
    Loss Contingencies [Line Items]          
    Lessee, operating lease, description with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year.        
    Operating lease, payments         $ 18,000
    Lessee,operating lease, renewal term       1 year  
    XML 52 R33.htm IDEA: XBRL DOCUMENT v3.22.1
    Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)
    $ in Thousands
    Dec. 31, 2021
    USD ($)
    Commitments And Contingencies Disclosure [Abstract]  
    2022 $ 212
    2023 7
    Total future minimum annual payments $ 219
    XML 53 R34.htm IDEA: XBRL DOCUMENT v3.22.1
    Term Loan - Additional Information (Details)
    $ / shares in Units, $ in Thousands
    		 1 Months Ended 12 Months Ended
    May 31, 2021
    USD ($)
    $ / shares
    shares
    Apr. 30, 2020
    USD ($)
    $ / shares
    shares
    Dec. 31, 2021
    USD ($)
    Dec. 31, 2020
    USD ($)
    Debt Instrument [Line Items]        
    Risk free interest rate   0.75%    
    Expected volatility   92.30%    
    Expected terms (years)   10 years    
    Percentage of fee on loan     5.00%  
    Deferred tax assets     $ 42,265 $ 22,005
    Maximum        
    Debt Instrument [Line Items]        
    Expected terms (years)     6 years 1 month 6 days 6 years 1 month 6 days
    Minimum [Member]        
    Debt Instrument [Line Items]        
    Expected terms (years)     5 years 6 months 4 years
    Loan Agreement        
    Debt Instrument [Line Items]        
    Line of Credit Facility, Description In May 2021, the parties further amended the Loan Agreement (as amended, the “2021 Loan Agreement”). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022. In April 2020, the Company entered into a Loan and Security Agreement, (the “Loan Agreement”) with the lenders referred to therein (the “Lenders”), and Silicon Valley Bank (“SVB”), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the “Term A Loan Facility”) of up to $10.0 million and (ii) a secured term B loan facility (the “Term B Loan Facility”) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company’s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.    
    Warrants to purchase common stock | shares 33,923      
    Warrant exercise price | $ / shares $ 19.12      
    Warrant expiration date May 28, 2031 Jun. 30, 2025    
    Debt issuance costs, gross $ 600 $ 600    
    Line of credit facility increase in borrowing capacity 15,000      
    Proceeds from sale of available-for-sale securities, equity     $ 75,000  
    Deferred tax assets 400      
    Loan Agreement | Measurement Input, Expected Dividend Payment        
    Debt Instrument [Line Items]        
    Fair value of warrant assumptions, dividends $ 0      
    Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Risk Free Interest Rate        
    Debt Instrument [Line Items]        
    Fair measurement input 0.016      
    Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Price Volatility        
    Debt Instrument [Line Items]        
    Fair measurement input 0.986      
    Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Expected Term        
    Debt Instrument [Line Items]        
    Fair measurement input 10 years      
    Loan Agreement | Prime Rate        
    Debt Instrument [Line Items]        
    Debt instrument, basis spread on variable rate     1.00%  
    Loan Agreement | Maximum        
    Debt Instrument [Line Items]        
    Line of credit facility, maximum borrowing capacity $ 25,000      
    Loan Agreement | Minimum [Member]        
    Debt Instrument [Line Items]        
    Debt instrument, interest rate     4.25%  
    Loan Agreement | Other Assets        
    Debt Instrument [Line Items]        
    Debt issuance costs, gross   200    
    Loan Agreement | Term A Loan Facility        
    Debt Instrument [Line Items]        
    Line of credit facility, maximum borrowing capacity 20,000 $ 10,000    
    Warrants to purchase common stock | shares   25,000    
    Warrant exercise price | $ / shares   $ 22.06    
    Term loan amount drawn     $ 1,500  
    Credit facility maturity date     Sep. 01, 2024  
    Loan Agreement | Term B Loan Facility        
    Debt Instrument [Line Items]        
    Line of credit facility, maximum borrowing capacity $ 5,000 $ 5,000    
    Warrants to purchase common stock | shares 11,305      
    XML 54 R35.htm IDEA: XBRL DOCUMENT v3.22.1
    Term Loan - Schedule of Repayment of Principal Amount (Details)
    $ in Thousands
    Dec. 31, 2021
    USD ($)
    Debt Disclosure [Abstract]  
    2022 $ 2,500
    2023 10,000
    2024 7,500
    Total principal repayments 20,000
    Less: unamortized debt discount (602)
    Total term loan, net 19,398
    Less: term loan, current (2,500)
    Term loan, non-current, net $ 16,898
    XML 55 R36.htm IDEA: XBRL DOCUMENT v3.22.1
    Stock-Based Compensation - Additional Information (Details) - USD ($)
    		 1 Months Ended 12 Months Ended
    Feb. 28, 2021
    Oct. 31, 2019
    Dec. 31, 2021
    Dec. 31, 2020
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Share base compensation expense     $ 8,678,000 $ 3,807,000
    Service-based RSUs | Employee        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Vesting period 3 years      
    Shares granted 56,545      
    Total grant date fair value $ 1,300,000      
    Share base compensation expense     $ 300,000  
    Restricted Stock Units (RSUs)        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Cancelled shares     11,651  
    Outstanding     44,894  
    Performance RSUs | Executive Officer        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Shares granted 61,500      
    Total grant date fair value $ 1,400,000      
    Share base compensation expense     $ 800,000  
    Anniversary period 1 year      
    ESPP Purchases        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Number of common shares issuable under the plan (in shares)   225,188    
    Percentage of increase in number of shares of capital stock issued and outstanding   1.00%    
    Percent of purchase shares of common stock   85.00%    
    First offering period   6 months    
    Commencement date of first six month offering period   Jan. 01, 2020    
    Number of shares of common stock available for issuance under ESPP     544,410  
    2019 Plan        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Number of common shares issuable under the plan (in shares)     2,844,193  
    Percentage of increase in number of shares of capital stock issued and outstanding     4.00%  
    Common stock reserved and available for issuance as future option grants     1,428,304  
    Vesting period     4 years  
    Percentage of option vesting     25.00%  
    Terms of award     The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant.  
    Remaining option vesting period     36 months  
    Expiration period     10 years  
    Unrecognized stock option granted under plan     $ 17,900,000  
    Unrecognized weighted average period     2 years 3 months 18 days  
    Shares granted     830,013  
    Cancelled shares     133,454  
    Outstanding     2,406,668 1,898,395
    2020 Plan        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Estimated total grant date fair value of options vested     $ 7,000,000.0  
    Weighted average fair value options granted     $ 16.18 $ 21.88
    Maximum | ESPP Purchases        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Period for increase in number of shares of common stock reserved for issuance   10 years    
    Maximum | 2019 Plan        
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
    Period for increase in number of shares of common stock reserved for issuance     10 years  
    XML 56 R37.htm IDEA: XBRL DOCUMENT v3.22.1
    Stock-Based Compensation - Summary of Stock-Based Compensation (Details) - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
    Total stock-based compensation $ 8,678 $ 3,807
    Research and Development    
    Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
    Total stock-based compensation 2,966 1,250
    General and Administrative    
    Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
    Total stock-based compensation $ 5,712 $ 2,557
    XML 57 R38.htm IDEA: XBRL DOCUMENT v3.22.1
    Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)
    		 1 Months Ended 12 Months Ended
    Apr. 30, 2020
    Dec. 31, 2021
    Dec. 31, 2020
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
    Expected terms (years) 10 years    
    Expected volatility, minimum   86.90% 86.40%
    Expected volatility, maximum   91.90% 97.60%
    Risk-free interest rate, minimum   0.70% 0.20%
    Risk-free interest rate, maximum   1.30% 1.50%
    Minimum [Member]      
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
    Expected terms (years)   5 years 6 months 4 years
    Maximum      
    Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
    Expected terms (years)   6 years 1 month 6 days 6 years 1 month 6 days
    XML 58 R39.htm IDEA: XBRL DOCUMENT v3.22.1
    Stock-Based Compensation - Summary of Stock Option Activity (Details) - 2019 Plan
    $ / shares in Units, $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    USD ($)
    $ / shares
    shares
    Dec. 31, 2020
    USD ($)
    $ / shares
    shares
    Number of Options    
    Outstanding, Beginning Balance | shares 1,898,395  
    Granted | shares 830,013  
    Exercised | shares (188,286)  
    Cancelled and forfeited | shares (133,454)  
    Outstanding, Ending Balance | shares 2,406,668 1,898,395
    Exercisable as of December 31, 2021 | shares 922,104  
    Weighted Average Exercise Price    
    Weighted Average Exercise Price Outstanding, Beginning Balance | $ / shares $ 12.79  
    Issuance of common stock, weighted average price per share | $ / shares 22.22  
    Weighted Average Exercise Price, Exercised | $ / shares 2.59  
    Weighted Average Exercise Price, Cancelled and forfeited | $ / shares 19.55  
    Weighted Average Exercise Price Outstanding, Ending Balance | $ / shares 16.46 $ 12.79
    Weighted Average Exercise Price, Exercisable as of December 31, 2021 | $ / shares $ 10.76  
    Weighted Average Remaining Contractual Term (In years)    
    Weighted Average Remaining Contractual Term (In years), Outstanding 8 years 1 month 6 days 8 years 7 months 6 days
    Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2021 7 years 3 months 18 days  
    Aggregate Intrinsic Value    
    Aggregate Intrinsic Value Outstanding | $ $ 25,918  
    Aggregate Intrinsic Value Outstanding | $ 9,970 $ 25,918
    Aggregate Intrinsic Value, Exercisable as of December 31, 2021 | $ $ 6,800  
    XML 59 R40.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Income Tax Disclosure [Line Items]    
    Effective income tax rate 21.00% 21.00%
    89Bio Ltd    
    Income Tax Disclosure [Line Items]    
    Effective income tax rate 23.00% 23.00%
    89bio Management, Inc.    
    Income Tax Disclosure [Line Items]    
    Effective income tax rate 21.00% 21.00%
    UAB 89bio Lithuania    
    Income Tax Disclosure [Line Items]    
    Effective income tax rate 15.00% 15.00%
    XML 60 R41.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes - Summary of Income Tax Benefit (Expense) (Details) - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Current:    
    Federal   $ (11)
    State $ (2) 1
    Foreign (1)  
    Total (3) (10)
    Deferred:    
    Federal 150 69
    Total 150 69
    Income tax benefit $ 147 $ 59
    XML 61 R42.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes - Summary of Components of Deferred Tax Assets (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2021
    Dec. 31, 2020
    Income Tax Disclosure [Line Items]    
    Research and development expenses $ 6,529 $ 5,392
    Stock-based compensation 1,969 610
    Accrued expenses 220 635
    Other 191 48
    Total deferred tax assets 42,265 22,005
    Less: valuation allowance (42,046) (21,936)
    Net deferred tax assets 219 69
    United States    
    Income Tax Disclosure [Line Items]    
    Net operating loss carryforwards 29,094 11,342
    Israel    
    Income Tax Disclosure [Line Items]    
    Net operating loss carryforwards $ 4,262 $ 3,978
    XML 62 R43.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes - Additional Information (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Income Tax Disclosure [Line Items]    
    Deferred tax assets, valuation allowance $ 42,046,000 $ 21,936,000
    Deferred tax assets, change in valuation allowance 20,100,000 $ 11,900,000
    Operating loss carryforwards limitations on use   Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized.
    Taxable income utilization percentage   80.00%
    Federal research and development credit carryforwards 2,100,000 $ 600,000
    State research and development credit carryforwards 1,100,000 700,000
    Increase in unrecognized tax benefits 500,000 300,000
    Unrecognized Tax Benefits 0  
    Israel    
    Income Tax Disclosure [Line Items]    
    Deferred tax assets, change in valuation allowance   (69,000)
    Accumulated tax loss carryforward 18,500,000 17,300,000
    United States    
    Income Tax Disclosure [Line Items]    
    Accumulated tax loss carryforward $ 138,500,000 $ 54,100,000
    XML 63 R44.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details) - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Income Tax Disclosure [Line Items]    
    Net loss before income tax $ (90,269) $ (49,558)
    United States    
    Income Tax Disclosure [Line Items]    
    Net loss before income tax (91,141) (58,760)
    LITHUANIA    
    Income Tax Disclosure [Line Items]    
    Net loss before income tax 10 (73)
    Israel    
    Income Tax Disclosure [Line Items]    
    Net loss before income tax $ 862 $ 9,275
    XML 64 R45.htm IDEA: XBRL DOCUMENT v3.22.1
    Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details) - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Income Tax Disclosure [Abstract]    
    Income tax benefit computed at statutory rates $ 18,757 $ 8,285
    Change in valuation allowance (20,111) (11,914)
    Foreign rate differential (19) 1,671
    Change in Israel effective tax rate due to the 2019 reorganization (2) 647
    Research and development credits, net of uncertain tax position 1,331 815
    Other 191 555
    Income tax benefit $ 147 $ 59
    XML 65 R46.htm IDEA: XBRL DOCUMENT v3.22.1
    Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details) - shares
    		 12 Months Ended
    Dec. 31, 2021
    Dec. 31, 2020
    Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
    Antidilutive common stock equivalents excluded from calculation of diluted net loss per share 2,571,985 1,898,395
    Stock Options to Purchase Common Stock    
    Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
    Antidilutive common stock equivalents excluded from calculation of diluted net loss per share 2,406,668 1,898,395
    Unvested Restricted Stock Units    
    Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
    Antidilutive common stock equivalents excluded from calculation of diluted net loss per share 106,394  
    Warrants to Purchase Common Stock    
    Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
    Antidilutive common stock equivalents excluded from calculation of diluted net loss per share 58,923  
    XML 66 etnb-10k_20211231_htm.xml IDEA: XBRL DOCUMENT 0001785173 2021-01-01 2021-12-31 0001785173 2021-06-30 0001785173 2022-03-01 0001785173 2021-12-31 0001785173 2020-12-31 0001785173 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember 2019-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001785173 us-gaap:RetainedEarningsMember 2019-12-31 0001785173 2019-12-31 0001785173 us-gaap:CommonStockMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001785173 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember 2020-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001785173 us-gaap:RetainedEarningsMember 2020-12-31 0001785173 us-gaap:CommonStockMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001785173 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001785173 us-gaap:CommonStockMember 2021-12-31 0001785173 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001785173 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001785173 us-gaap:RetainedEarningsMember 2021-12-31 0001785173 etnb:ConvertiblePreferredSharesMember us-gaap:IPOMember 2020-01-01 2020-12-31 0001785173 etnb:ConvertiblePreferredSharesMember etnb:ATMFacilityMember 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001785173 us-gaap:CommonStockMember etnb:UnderwrittenPublicOfferingMember 2020-07-01 2020-07-31 0001785173 us-gaap:CommonStockMember etnb:UnderwrittenPublicOfferingMember 2020-07-31 0001785173 us-gaap:CommonStockMember etnb:UnderwrittenPublicOfferingMember 2020-09-01 2020-09-30 0001785173 us-gaap:CommonStockMember etnb:UnderwrittenPublicOfferingMember 2020-09-30 0001785173 srt:MaximumMember etnb:ATMFacilityMember 2021-03-01 2021-03-31 0001785173 etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember 2021-03-31 0001785173 etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember 2021-10-01 2021-12-31 0001785173 srt:MinimumMember 2021-01-01 2021-12-31 0001785173 srt:MaximumMember 2021-01-01 2021-12-31 0001785173 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001785173 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AgencySecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashEquivalentsMember 2021-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ShortTermInvestmentsMember 2021-12-31 0001785173 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AgencySecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember etnb:AgencyDiscountSecuritiesMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashEquivalentsMember 2020-12-31 0001785173 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ShortTermInvestmentsMember 2020-12-31 0001785173 2018-05-01 2018-05-31 0001785173 2018-05-31 0001785173 etnb:SanFranciscoOfficeMember 2019-12-01 2019-12-31 0001785173 etnb:SanFranciscoOfficeMember 2020-01-01 2020-12-31 0001785173 etnb:SanFranciscoOfficeMember 2021-12-31 0001785173 etnb:RestrictedCashAndOtherAssetsMember 2021-12-31 0001785173 etnb:RestrictedCashAndOtherAssetsMember 2020-12-31 0001785173 etnb:TevaAgreementMember 2018-04-01 2018-04-30 0001785173 etnb:TevasGlycoPEGylatedFGF21ProgramMember etnb:TevaAgreementMember 2018-04-01 2018-04-30 0001785173 etnb:TevasDevelopmentProgramMember etnb:TevaAgreementMember 2018-04-01 2018-04-30 0001785173 etnb:TevaAgreementMember 2021-01-01 2021-12-31 0001785173 us-gaap:ResearchAndDevelopmentExpenseMember etnb:TevaAgreementMember 2021-01-01 2021-12-31 0001785173 us-gaap:ResearchAndDevelopmentExpenseMember etnb:TevaAgreementMember 2020-01-01 2020-12-31 0001785173 etnb:TermALoanFacilityMember etnb:LoanAndSecurityAgreementMember 2020-04-30 0001785173 etnb:TermBLoanFacilityMember etnb:LoanAndSecurityAgreementMember 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember 2020-04-01 2020-04-30 0001785173 etnb:LoanAndSecurityAgreementMember 2020-04-30 0001785173 us-gaap:OtherAssetsMember etnb:LoanAndSecurityAgreementMember 2020-04-30 0001785173 2020-04-01 2020-04-30 0001785173 etnb:TermALoanFacilityMember etnb:LoanAndSecurityAgreementMember 2021-05-31 0001785173 etnb:LoanAndSecurityAgreementMember 2021-05-01 2021-05-31 0001785173 srt:MaximumMember etnb:LoanAndSecurityAgreementMember 2021-05-31 0001785173 etnb:TermBLoanFacilityMember etnb:LoanAndSecurityAgreementMember 2021-05-31 0001785173 etnb:TermALoanFacilityMember etnb:LoanAndSecurityAgreementMember 2021-12-31 0001785173 etnb:TermALoanFacilityMember etnb:LoanAndSecurityAgreementMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember 2021-01-01 2021-12-31 0001785173 srt:MinimumMember etnb:LoanAndSecurityAgreementMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember us-gaap:PrimeRateMember 2021-01-01 2021-12-31 0001785173 etnb:LoanAndSecurityAgreementMember 2021-05-31 0001785173 us-gaap:MeasurementInputRiskFreeInterestRateMember etnb:LoanAndSecurityAgreementMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-05-31 0001785173 us-gaap:MeasurementInputExpectedDividendPaymentMember etnb:LoanAndSecurityAgreementMember 2021-05-01 2021-05-31 0001785173 us-gaap:MeasurementInputPriceVolatilityMember etnb:LoanAndSecurityAgreementMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-05-31 0001785173 us-gaap:MeasurementInputExpectedTermMember etnb:LoanAndSecurityAgreementMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-05-01 2021-05-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2021-01-01 2021-12-31 0001785173 srt:MaximumMember etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2021-01-01 2021-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2021-12-31 0001785173 us-gaap:EmployeeStockMember 2019-10-01 2019-10-31 0001785173 srt:MaximumMember us-gaap:EmployeeStockMember 2019-10-01 2019-10-31 0001785173 us-gaap:EmployeeStockMember 2021-12-31 0001785173 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001785173 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001785173 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001785173 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001785173 srt:MinimumMember 2020-01-01 2020-12-31 0001785173 srt:MaximumMember 2020-01-01 2020-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2020-12-31 0001785173 etnb:TwoThousandAndNineteenEquityIncentivePlanMember 2020-01-01 2020-12-31 0001785173 etnb:TwoThousandAndTwentyEquityIncentivePlanMember 2021-01-01 2021-12-31 0001785173 etnb:TwoThousandAndTwentyEquityIncentivePlanMember 2020-01-01 2020-12-31 0001785173 us-gaap:ShareBasedPaymentArrangementEmployeeMember etnb:ServiceBasedRSUsMember 2021-02-01 2021-02-28 0001785173 us-gaap:ShareBasedPaymentArrangementEmployeeMember etnb:ServiceBasedRSUsMember 2021-01-01 2021-12-31 0001785173 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001785173 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001785173 srt:ExecutiveOfficerMember etnb:PerformanceRSUsMember 2021-02-01 2021-02-28 0001785173 srt:ExecutiveOfficerMember etnb:PerformanceRSUsMember 2021-01-01 2021-12-31 0001785173 etnb:EightyNineBioLtdMember 2021-01-01 2021-12-31 0001785173 etnb:EightyNineBioLtdMember 2020-01-01 2020-12-31 0001785173 etnb:EightyNineBioManagementIncorporationMember 2021-01-01 2021-12-31 0001785173 etnb:EightyNineBioManagementIncorporationMember 2020-01-01 2020-12-31 0001785173 etnb:UABEightyNineBioLithuaniaMember 2021-01-01 2021-12-31 0001785173 etnb:UABEightyNineBioLithuaniaMember 2020-01-01 2020-12-31 0001785173 country:US 2021-12-31 0001785173 country:US 2020-12-31 0001785173 country:IL 2021-12-31 0001785173 country:IL 2020-12-31 0001785173 country:IL 2020-01-01 2020-12-31 0001785173 country:US 2021-01-01 2021-12-31 0001785173 country:US 2020-01-01 2020-12-31 0001785173 country:LT 2021-01-01 2021-12-31 0001785173 country:LT 2020-01-01 2020-12-31 0001785173 country:IL 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001785173 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001785173 etnb:UnvestedRestrictedStockUnitsMember 2021-01-01 2021-12-31 0001785173 us-gaap:WarrantMember 2021-01-01 2021-12-31 iso4217:USD shares iso4217:USD shares pure etnb:Segment false FY 0001785173 --12-31 P3Y 2019-06-30 P4Y P3Y P1Y 0 0 0 P5Y6M P4Y 0.869 0.864 0.007 0.002 P6Y1M6D P6Y1M6D 0.919 0.976 0.013 0.015 P8Y7M6D P8Y1M6D P7Y3M18D 10-K true 2021-12-31 2021 false 001-39122 89bio, Inc. DE 36-4946844 142 Sansome Street Second Floor San Francisco CA 94104 415 432-9270 Common stock, par value $0.001 per share ETNB NASDAQ No No Yes Yes Non-accelerated Filer true true false false false 165500000 20351384 Portions of the registrant’s definitive proxy statement relating to its 2022 Annual Meeting of Stockholders, to be held on or about June 1, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates. 185 KPMG LLP San Francisco, California, USA 52432000 98183000 25000 25000 98288000 106446000 11237000 5548000 161982000 210202000 150000 166000 290000 706000 162422000 211074000 6843000 2065000 10194000 6048000 2500000 19537000 8113000 16898000 30000 36465000 8113000 0.001 0.001 10000000 10000000 0 0 0 0 0.001 0.001 100000000 100000000 20317204 20317204 19931660 19931660 20000 20000 339218000 326046000 -64000 -10000 -213217000 -123095000 125957000 202961000 162422000 211074000 70330000 36199000 19413000 13156000 89743000 49355000 -89743000 -49355000 -526000 -203000 -90269000 -49558000 -147000 -59000 -90122000 -49499000 -71000 8000 17000 -18000 -54000 -10000 -90176000 -49509000 -4.48 -3.08 20098340 16087785 13788982 14000 163526000 0 -73596000 89944000 1208000 6072040 6000 157674000 0 157680000 63366 271000 0 271000 7272 134000 0 134000 634000 0 634000 3807000 0 3807000 0 -49499000 -49499000 -10000 -10000 19931660 20000 326046000 -10000 -123095000 202961000 165000 186546 3289000 0 3289000 188286 487000 0 487000 10712 144000 0 144000 574000 0 574000 8678000 0 8678000 0 -90122000 -90122000 -54000 -54000 20317204 20000 339218000 -64000 -213217000 125957000 -90122000 -49499000 8678000 3807000 -865000 -268000 -617000 -230000 79000 60000 150000 69000 5672000 3600000 4778000 1131000 4146000 1428000 -76781000 -46244000 148422000 12189000 141200000 118895000 63000 126000 7159000 -106832000 19951000 3289000 157680000 487000 271000 144000 134000 161000 23871000 157924000 -45751000 4848000 98208000 93360000 52457000 98208000 52432000 98183000 25000 25000 52457000 98208000 16000 142000 574000 634000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Organization and Basis of Presentation </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Description of Business</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc. (“89bio” or the “Company”) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc. was formed as a Delaware corporation in <span style="-sec-ix-hidden:F_000299">June 2019</span> to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018. </p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Public Offerings</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2020, the Company completed an underwritten public offering of 3,047,040 shares of its common stock at the public offering price of $27.50 per share. The Company raised a total of $78.2 million in net proceeds after deducting underwriting discounts and commissions of $5.0 million and offering costs of $0.6 million. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2020, the Company completed an underwritten public offering of 3,025,000 shares of its common stock, at a public offering price of $28.00 per share. The Company raised a total of $79.5 million in net proceeds after deducting underwriting discounts and commissions of $4.6 million and offering costs of $0.6 million.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, the Company entered into a sales agreement (the “Sales Agreement”) with SVB Leerink LLC and Cantor Fitzgerald &amp; Co. (the “Sales Agents”) pursuant to which it may offer and sell up to $75.0 million of shares of the Company’s common stock, from time to time, in “at-the-market” offerings (the “ATM Facility”). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. <span style="color:#231F20;letter-spacing:0.1pt;">During the fourth quarter of 2021, the Company received proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of its common stock at a weighted-average price of $17.97 per share pursuant to the ATM Facility.</span> </p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of $150.7 million as of December 31, 2021. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2021, together with proceeds available from the Company’s term loan (see Note 6) and its ATM Facility, will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission (“SEC”).</p> 3047040 27.50 78200000 5000000.0 600000 3025000 28.00 79500000 4600000 600000 75000000.0 0.030 3300000 186546 17.97 150700000 <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”).</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currencies</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company’s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurements </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company’s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company’s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: </p> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1<span style="font-weight:normal;">—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; </span></p> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2<span style="font-weight:normal;">—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and </span></p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 3<span style="font-weight:normal;">—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<span style="letter-spacing:0.05pt;"> </span>instruments<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>the Company to a concentration<span style="letter-spacing:0.1pt;"> </span>of credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>consist primarily<span style="letter-spacing:0.1pt;"> </span>of cash and cash equivalents and short-term available-for-sale securities.<span style="letter-spacing:0.1pt;"> </span>Bank<span style="letter-spacing:-0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>are held by accredited<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>and these deposits<span style="letter-spacing:0.05pt;"> </span>may at times<span style="letter-spacing:0.05pt;"> </span>be in excess<span style="letter-spacing:0.05pt;"> </span>of insured<span style="letter-spacing:0.05pt;"> </span>limits. The Company limits<span style="letter-spacing:0.1pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with cash and cash equivalents<span style="letter-spacing:0.1pt;"> </span>by placing<span style="letter-spacing:0.05pt;"> </span>them<span style="letter-spacing:0.05pt;"> </span>with financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>it believes<span style="letter-spacing:0.05pt;"> </span>are of high quality.<span style="letter-spacing:0.05pt;"> </span>The Company has not experienced<span style="letter-spacing:0.05pt;"> </span>any losses<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>of cash or cash equivalents. The Company <span style="color:#000000;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other<span style="font-weight:normal;font-style:normal;"> </span>Risks and Uncertainties </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company’s early stages of clinical drug development; the Company’s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company’s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company’s ability to enroll patients in its ongoing and future clinical trials; the Company’s ability to successfully manufacture and supply its product candidates for clinical trials; the Company’s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company’s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company’s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company’s business and delay its preclinical and clinical programs and timelines. <span style="color:#000000;">The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for pegozafermin. </span>The extent to which the COVID-19 pandemic may impact the Company’s future operating results and financial condition is uncertain.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment Reporting</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has one operating<span style="letter-spacing:0.05pt;"> </span>segment.<span style="letter-spacing:0.05pt;"> </span>The Company’s chief<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>decision<span style="letter-spacing:0.05pt;"> </span>maker,<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>Chief Executive<span style="letter-spacing:0.05pt;"> </span>Officer,<span style="letter-spacing:0.05pt;"> </span>manages<span style="letter-spacing:0.05pt;"> </span>the Company’s operations<span style="letter-spacing:0.05pt;"> </span>on a consolidated<span style="letter-spacing:0.1pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>for the purposes<span style="letter-spacing:0.05pt;"> </span>of allocating resources<span style="letter-spacing:0.05pt;"> </span>and evaluating<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>performance.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Cash</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash consists of a money market account that serves as collateral for the Company’s operating lease agreement for its facility in Israel.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management’s intent to use the investments to fund current operations or to make them available for current operations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company has not experienced material realized gains or </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or other-than-temporary losses in the periods presented.</span><span style="font-size:12pt;color:#000000;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.</span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Equipment, Net</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and equipment<span style="letter-spacing:0.05pt;"> </span>are stated<span style="letter-spacing:0.05pt;"> </span>at cost, less<span style="letter-spacing:0.05pt;"> </span>accumulated<span style="letter-spacing:0.1pt;"> </span>depreciation.<span style="letter-spacing:0.1pt;"> </span>Depreciation<span style="letter-spacing:0.1pt;"> </span>is calculated<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the estimated<span style="letter-spacing:0.1pt;"> </span>useful<span style="letter-spacing:0.05pt;"> </span>lives<span style="letter-spacing:0.05pt;"> </span>of the related<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>generally<span style="letter-spacing:0.05pt;"> </span>ranging<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>three<span style="letter-spacing:0.05pt;"> </span>to seven years.<span style="letter-spacing:0.05pt;"> </span>Leasehold<span style="letter-spacing:0.05pt;"> </span>improvements<span style="letter-spacing:0.1pt;"> </span>are amortized<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the shorter<span style="letter-spacing:0.05pt;"> </span>of the assets’<span style="letter-spacing:0.05pt;"> </span>estimated useful<span style="letter-spacing:0.05pt;"> </span>life<span style="letter-spacing:0.05pt;"> </span>or the remaining<span style="letter-spacing:0.1pt;"> </span>term<span style="letter-spacing:0.05pt;"> </span>of the lease.<span style="letter-spacing:0.05pt;"> </span><span style="color:#000000;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span>Maintenance<span style="letter-spacing:0.1pt;"> </span>and repair<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>are expensed as incurred.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairment<span style="letter-spacing:0.1pt;"> </span>of Long-Lived Assets</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically<span style="letter-spacing:0.1pt;"> </span>evaluates<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>long-lived<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>and equipment,<span style="letter-spacing:0.05pt;"> </span>for impairment<span style="letter-spacing:0.1pt;"> </span>whenever events<span style="letter-spacing:0.05pt;"> </span>or changes in business<span style="letter-spacing:0.05pt;"> </span>circumstances<span style="letter-spacing:0.15pt;"> </span>indicate<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets or group of assets<span style="letter-spacing:0.05pt;"> </span>may not be fully<span style="letter-spacing:0.05pt;"> </span>recoverable.<span style="letter-spacing:0.1pt;"> </span>If indicators<span style="letter-spacing:0.1pt;"> </span>of impairment<span style="letter-spacing:0.1pt;"> </span>exist<span style="letter-spacing:0.05pt;"> </span>and the undiscounted<span style="letter-spacing:0.05pt;"> </span>future cash flows that<span style="letter-spacing:0.05pt;"> </span>the assets<span style="letter-spacing:0.05pt;"> </span>are expected<span style="letter-spacing:0.05pt;"> </span>to generate<span style="letter-spacing:0.05pt;"> </span>are less<span style="letter-spacing:0.05pt;"> </span>than the carrying<span style="letter-spacing:0.05pt;"> </span>value of the assets,<span style="letter-spacing:0.05pt;"> </span>the Company reduces<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets<span style="letter-spacing:0.05pt;"> </span>through an impairment<span style="letter-spacing:0.1pt;"> </span>charge,<span style="letter-spacing:0.05pt;"> </span>to their<span style="letter-spacing:0.05pt;"> </span>estimated<span style="letter-spacing:0.1pt;"> </span>fair<span style="letter-spacing:0.05pt;"> </span>values<span style="letter-spacing:0.05pt;"> </span>based on a discounted<span style="letter-spacing:0.05pt;"> </span>cash flow approach<span style="letter-spacing:0.05pt;"> </span>or, when<span style="letter-spacing:-0.05pt;"> </span>available<span style="letter-spacing:0.1pt;"> </span>and appropriate,<span style="letter-spacing:0.1pt;"> </span>to comparable<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>values.<span style="letter-spacing:0.05pt;"> </span>There were no such indicators<span style="letter-spacing:0.1pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued Research and Development Expenses</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>study and research<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>based on the services<span style="letter-spacing:0.05pt;"> </span>performed,<span style="letter-spacing:0.1pt;"> </span>pursuant<span style="letter-spacing:0.05pt;"> </span>to contracts<span style="letter-spacing:0.1pt;"> </span>with research<span style="letter-spacing:0.05pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>conduct and manage<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and research<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>behalf. The Company records<span style="letter-spacing:0.05pt;"> </span>the costs<span style="letter-spacing:0.05pt;"> </span>of research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>based upon the estimated<span style="letter-spacing:0.1pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>provided<span style="letter-spacing:0.05pt;"> </span>but not yet invoiced<span style="letter-spacing:0.05pt;"> </span>and includes<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>in accrued<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.15pt;"> </span>in the consolidated<span style="letter-spacing:0.1pt;"> </span>balance sheets.<span style="letter-spacing:0.05pt;"> </span>These costs<span style="letter-spacing:0.05pt;"> </span>are a component<span style="letter-spacing:0.05pt;"> </span>of the Company’s research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status<span style="letter-spacing:0.05pt;"> </span>and timing<span style="letter-spacing:0.05pt;"> </span>of actual<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>performed<span style="letter-spacing:0.1pt;"> </span>may vary from<span style="letter-spacing:0.05pt;"> </span>the Company’s estimates,<span style="letter-spacing:0.1pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>in adjustments<span style="letter-spacing:0.1pt;"> </span>to expense in future<span style="letter-spacing:0.05pt;"> </span>periods.<span style="letter-spacing:0.05pt;"> </span>Changes in these<span style="letter-spacing:0.05pt;"> </span>estimates that<span style="letter-spacing:0.05pt;"> </span>result<span style="letter-spacing:0.05pt;"> </span>in material<span style="letter-spacing:0.1pt;"> </span>changes to the Company’s accrued expenses<span style="letter-spacing:0.05pt;"> </span>could materially<span style="letter-spacing:0.15pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>the Company’s results<span style="letter-spacing:0.05pt;"> </span>of operations.<span style="letter-spacing:0.05pt;"> </span>Contingent<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments,<span style="letter-spacing:0.05pt;"> </span>if any, are expensed when<span style="letter-spacing:-0.05pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>are probable and estimable, which is generally<span style="letter-spacing:0.05pt;"> </span>upon achievement<span style="letter-spacing:0.1pt;"> </span>of the milestone.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>facilities<span style="letter-spacing:0.1pt;"> </span>under non-cancelable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>and recognizes related<span style="letter-spacing:0.05pt;"> </span>rent<span style="letter-spacing:0.05pt;"> </span>expense on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the term<span style="letter-spacing:0.05pt;"> </span>of the lease.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development<span style="letter-spacing:0.05pt;"> </span>Expenses<span style="font-weight:normal;"> </span></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>for the development<span style="letter-spacing:0.05pt;"> </span>of the Company’s lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of external<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to<span style="letter-spacing:0.1pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical development<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>supplies, and personnel<span style="letter-spacing:0.05pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>employee<span style="letter-spacing:0.05pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:1.05pt;"> </span>stock-based<span style="letter-spacing:0.1pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for individuals<span style="letter-spacing:0.1pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>efforts. Payments<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with agreements<span style="letter-spacing:0.1pt;"> </span>to acquire<span style="letter-spacing:0.05pt;"> </span>licenses<span style="letter-spacing:0.05pt;"> </span>to develop, use, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>products and purchases of pegozafermin from contract manufacturing organizations<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have not reached<span style="letter-spacing:0.05pt;"> </span>technological<span style="letter-spacing:0.1pt;"> </span>feasibility<span style="letter-spacing:0.15pt;"> </span>and do not have alternate<span style="letter-spacing:0.1pt;"> future </span>commercial<span style="letter-spacing:0.1pt;"> </span>use are expensed as incurred.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>equity<span style="letter-spacing:0.05pt;"> </span>awards made to employees,<span style="letter-spacing:0.05pt;"> </span>directors,<span style="letter-spacing:0.1pt;"> </span>and<span style="color:#000000;"> </span>non-employee<span style="letter-spacing:0.05pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>providers<span style="letter-spacing:0.05pt;"> </span>based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts<span style="letter-spacing:0.05pt;"> </span>for forfeitures<span style="letter-spacing:0.15pt;"> </span>as they occur.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates<span style="letter-spacing:0.1pt;"> </span>the fair<span style="letter-spacing:0.05pt;"> </span>value of stock option<span style="letter-spacing:0.05pt;"> </span>awards on the date of grant<span style="letter-spacing:0.05pt;"> </span>using a<span style="color:#000000;"> </span>Black-Scholes<span style="letter-spacing:0.05pt;"> </span>option pricing<span style="letter-spacing:0.05pt;"> </span>model.<span style="letter-spacing:0.05pt;"> </span>The Company recognizes<span style="letter-spacing:0.05pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for the value of stock options<span style="letter-spacing:0.05pt;"> </span>awards, which have graded vesting,<span style="letter-spacing:0.05pt;"> </span>using the straight-line<span style="letter-spacing:0.15pt;"> </span>method<span style="letter-spacing:0.05pt;"> </span>over the requisite<span style="letter-spacing:0.1pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of each award. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected volatility—Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company’s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected term—The expected term of options granted to employees and directors is determined using the “simplified” method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected dividend—The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of restricted stock units is based on the fair value of the Company’s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>are accounted<span style="letter-spacing:0.05pt;"> </span>for under the asset<span style="letter-spacing:0.05pt;"> </span>and liability<span style="letter-spacing:0.1pt;"> </span>method.<span style="letter-spacing:0.05pt;"> </span>Under this<span style="letter-spacing:0.05pt;"> </span>method,<span style="letter-spacing:0.05pt;"> </span>deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are recognized<span style="letter-spacing:0.05pt;"> </span>for the future<span style="letter-spacing:0.05pt;"> </span>tax consequences<span style="letter-spacing:0.05pt;"> </span>attributable<span style="letter-spacing:0.15pt;"> </span>to differences<span style="letter-spacing:0.1pt;"> </span>between the consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>carrying<span style="letter-spacing:0.05pt;"> </span>amounts<span style="letter-spacing:0.05pt;"> </span>of existing<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>and their<span style="letter-spacing:0.05pt;"> </span>respective<span style="letter-spacing:0.1pt;"> </span>tax bases and operating<span style="letter-spacing:0.05pt;"> </span>loss and tax credit<span style="letter-spacing:0.05pt;"> </span>carryforwards.<span style="letter-spacing:0.1pt;"> </span>Deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are measured<span style="letter-spacing:0.05pt;"> </span>using enacted<span style="letter-spacing:0.05pt;"> </span>tax rates<span style="letter-spacing:0.05pt;"> </span>applied<span style="letter-spacing:0.05pt;"> </span>to </p> <p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">taxable</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the years</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in which those temporary</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">differences</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effect</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and liabilities</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of a change in tax rates</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is recognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or loss in the period that</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">includes</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the enactment</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date. A</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuation</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is established</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to reduce</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the amount</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to unrecognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax benefits</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are included</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">within the provision</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax. </span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and<span style="letter-spacing:-0.05pt;"> </span>Diluted Net Loss per Share</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>during the period.<span style="letter-spacing:0.05pt;"> </span>Diluted<span style="letter-spacing:0.05pt;"> </span>loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>together<span style="letter-spacing:0.05pt;"> </span>with the number<span style="letter-spacing:0.05pt;"> </span>of additional<span style="letter-spacing:0.1pt;"> shares of </span>common stock<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would have been outstanding<span style="letter-spacing:0.05pt;"> </span>if all<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>common stock<span style="letter-spacing:0.05pt;"> </span>had been issued.<span style="letter-spacing:0.05pt;"> </span>Since the Company is in a loss position<span style="letter-spacing:0.05pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented,<span style="letter-spacing:0.05pt;"> </span>basic<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>is the same<span style="letter-spacing:0.05pt;"> </span>as diluted<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>since<span style="letter-spacing:0.05pt;"> </span>the effects of potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>securities<span style="letter-spacing:0.1pt;"> </span>are antidilutive.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Comprehensive<span style="letter-spacing:0.05pt;"> </span>Loss</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2016-02—<span style="font-style:italic;">Leases </span>(“ASU 2016-02”), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company’s consolidated financial statements.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued ASU 2016-13, </span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments—Credit Losses (Topic 326)</span><span style="Background-color:#FFFFFF;">: </span><span style="font-style:italic;Background-color:#FFFFFF;">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;">(“ASU 2016-13”)</span><span style="Background-color:#FFFFFF;">, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company </span><span style="color:#000000;">for the year ending December 31, 2023 and interim periods within that fiscal year</span><span style="Background-color:#FFFFFF;"> and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”).</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currencies</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain transactions during the years ended December 31, 2021 and 2020 were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of other expenses, net. The Company’s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurements </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company’s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company’s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows: </p> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1<span style="font-weight:normal;">—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; </span></p> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2<span style="font-weight:normal;">—Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and </span></p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 3<span style="font-weight:normal;">—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<span style="letter-spacing:0.05pt;"> </span>instruments<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>subject<span style="letter-spacing:0.05pt;"> </span>the Company to a concentration<span style="letter-spacing:0.1pt;"> </span>of credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>consist primarily<span style="letter-spacing:0.1pt;"> </span>of cash and cash equivalents and short-term available-for-sale securities.<span style="letter-spacing:0.1pt;"> </span>Bank<span style="letter-spacing:-0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>are held by accredited<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>and these deposits<span style="letter-spacing:0.05pt;"> </span>may at times<span style="letter-spacing:0.05pt;"> </span>be in excess<span style="letter-spacing:0.05pt;"> </span>of insured<span style="letter-spacing:0.05pt;"> </span>limits. The Company limits<span style="letter-spacing:0.1pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>credit<span style="letter-spacing:0.05pt;"> </span>risk<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with cash and cash equivalents<span style="letter-spacing:0.1pt;"> </span>by placing<span style="letter-spacing:0.05pt;"> </span>them<span style="letter-spacing:0.05pt;"> </span>with financial<span style="letter-spacing:0.1pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>it believes<span style="letter-spacing:0.05pt;"> </span>are of high quality.<span style="letter-spacing:0.05pt;"> </span>The Company has not experienced<span style="letter-spacing:0.05pt;"> </span>any losses<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>deposits<span style="letter-spacing:0.05pt;"> </span>of cash or cash equivalents. The Company <span style="color:#000000;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Other<span style="font-weight:normal;font-style:normal;"> </span>Risks and Uncertainties </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company’s early stages of clinical drug development; the Company’s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company’s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company’s ability to enroll patients in its ongoing and future clinical trials; the Company’s ability to successfully manufacture and supply its product candidates for clinical trials; the Company’s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company’s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company’s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company’s business and delay its preclinical and clinical programs and timelines. <span style="color:#000000;">The Company does not yet know the full extent of potential delays to clinical trials, which could prevent or delay the Company from obtaining approval for pegozafermin. </span>The extent to which the COVID-19 pandemic may impact the Company’s future operating results and financial condition is uncertain.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Segment Reporting</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has one operating<span style="letter-spacing:0.05pt;"> </span>segment.<span style="letter-spacing:0.05pt;"> </span>The Company’s chief<span style="letter-spacing:0.05pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>decision<span style="letter-spacing:0.05pt;"> </span>maker,<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>Chief Executive<span style="letter-spacing:0.05pt;"> </span>Officer,<span style="letter-spacing:0.05pt;"> </span>manages<span style="letter-spacing:0.05pt;"> </span>the Company’s operations<span style="letter-spacing:0.05pt;"> </span>on a consolidated<span style="letter-spacing:0.1pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>for the purposes<span style="letter-spacing:0.05pt;"> </span>of allocating resources<span style="letter-spacing:0.05pt;"> </span>and evaluating<span style="letter-spacing:0.05pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>performance.</p> 1 <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Cash</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash consists of a money market account that serves as collateral for the Company’s operating lease agreement for its facility in Israel.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management’s intent to use the investments to fund current operations or to make them available for current operations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in other expenses, net. The cost of investments sold is based on the specific-identification method.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company has not experienced material realized gains or </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or other-than-temporary losses in the periods presented.</span><span style="font-size:12pt;color:#000000;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on available-for-sale securities is included in other expenses, net and is not material for all periods presented.</span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>Equipment, Net</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="letter-spacing:0.05pt;"> </span>and equipment<span style="letter-spacing:0.05pt;"> </span>are stated<span style="letter-spacing:0.05pt;"> </span>at cost, less<span style="letter-spacing:0.05pt;"> </span>accumulated<span style="letter-spacing:0.1pt;"> </span>depreciation.<span style="letter-spacing:0.1pt;"> </span>Depreciation<span style="letter-spacing:0.1pt;"> </span>is calculated<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the estimated<span style="letter-spacing:0.1pt;"> </span>useful<span style="letter-spacing:0.05pt;"> </span>lives<span style="letter-spacing:0.05pt;"> </span>of the related<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>generally<span style="letter-spacing:0.05pt;"> </span>ranging<span style="letter-spacing:0.05pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>three<span style="letter-spacing:0.05pt;"> </span>to seven years.<span style="letter-spacing:0.05pt;"> </span>Leasehold<span style="letter-spacing:0.05pt;"> </span>improvements<span style="letter-spacing:0.1pt;"> </span>are amortized<span style="letter-spacing:0.1pt;"> </span>on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the shorter<span style="letter-spacing:0.05pt;"> </span>of the assets’<span style="letter-spacing:0.05pt;"> </span>estimated useful<span style="letter-spacing:0.05pt;"> </span>life<span style="letter-spacing:0.05pt;"> </span>or the remaining<span style="letter-spacing:0.1pt;"> </span>term<span style="letter-spacing:0.05pt;"> </span>of the lease.<span style="letter-spacing:0.05pt;"> </span><span style="color:#000000;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span>Maintenance<span style="letter-spacing:0.1pt;"> </span>and repair<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>are expensed as incurred.</p> P7Y Leasehold improvements are amortized on a straight-line basis over the shorter of the assets’ estimated useful life or the remaining term of the lease. <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Impairment<span style="letter-spacing:0.1pt;"> </span>of Long-Lived Assets</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically<span style="letter-spacing:0.1pt;"> </span>evaluates<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>long-lived<span style="letter-spacing:0.05pt;"> </span>assets,<span style="letter-spacing:0.05pt;"> </span>including<span style="letter-spacing:0.05pt;"> </span>property<span style="letter-spacing:0.05pt;"> </span>and equipment,<span style="letter-spacing:0.05pt;"> </span>for impairment<span style="letter-spacing:0.1pt;"> </span>whenever events<span style="letter-spacing:0.05pt;"> </span>or changes in business<span style="letter-spacing:0.05pt;"> </span>circumstances<span style="letter-spacing:0.15pt;"> </span>indicate<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets or group of assets<span style="letter-spacing:0.05pt;"> </span>may not be fully<span style="letter-spacing:0.05pt;"> </span>recoverable.<span style="letter-spacing:0.1pt;"> </span>If indicators<span style="letter-spacing:0.1pt;"> </span>of impairment<span style="letter-spacing:0.1pt;"> </span>exist<span style="letter-spacing:0.05pt;"> </span>and the undiscounted<span style="letter-spacing:0.05pt;"> </span>future cash flows that<span style="letter-spacing:0.05pt;"> </span>the assets<span style="letter-spacing:0.05pt;"> </span>are expected<span style="letter-spacing:0.05pt;"> </span>to generate<span style="letter-spacing:0.05pt;"> </span>are less<span style="letter-spacing:0.05pt;"> </span>than the carrying<span style="letter-spacing:0.05pt;"> </span>value of the assets,<span style="letter-spacing:0.05pt;"> </span>the Company reduces<span style="letter-spacing:0.05pt;"> </span>the carrying<span style="letter-spacing:0.05pt;"> </span>amount<span style="letter-spacing:0.05pt;"> </span>of the assets<span style="letter-spacing:0.05pt;"> </span>through an impairment<span style="letter-spacing:0.1pt;"> </span>charge,<span style="letter-spacing:0.05pt;"> </span>to their<span style="letter-spacing:0.05pt;"> </span>estimated<span style="letter-spacing:0.1pt;"> </span>fair<span style="letter-spacing:0.05pt;"> </span>values<span style="letter-spacing:0.05pt;"> </span>based on a discounted<span style="letter-spacing:0.05pt;"> </span>cash flow approach<span style="letter-spacing:0.05pt;"> </span>or, when<span style="letter-spacing:-0.05pt;"> </span>available<span style="letter-spacing:0.1pt;"> </span>and appropriate,<span style="letter-spacing:0.1pt;"> </span>to comparable<span style="letter-spacing:0.1pt;"> </span>market<span style="letter-spacing:0.05pt;"> </span>values.<span style="letter-spacing:0.05pt;"> </span>There were no such indicators<span style="letter-spacing:0.1pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;letter-spacing:0.05pt;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Accrued Research and Development Expenses</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>study and research<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>based on the services<span style="letter-spacing:0.05pt;"> </span>performed,<span style="letter-spacing:0.1pt;"> </span>pursuant<span style="letter-spacing:0.05pt;"> </span>to contracts<span style="letter-spacing:0.1pt;"> </span>with research<span style="letter-spacing:0.05pt;"> </span>institutions<span style="letter-spacing:0.1pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>conduct and manage<span style="letter-spacing:0.05pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical<span style="letter-spacing:0.1pt;"> </span>studies<span style="letter-spacing:0.05pt;"> </span>and research<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>on its<span style="letter-spacing:0.05pt;"> </span>behalf. The Company records<span style="letter-spacing:0.05pt;"> </span>the costs<span style="letter-spacing:0.05pt;"> </span>of research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>activities<span style="letter-spacing:0.1pt;"> </span>based upon the estimated<span style="letter-spacing:0.1pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>provided<span style="letter-spacing:0.05pt;"> </span>but not yet invoiced<span style="letter-spacing:0.05pt;"> </span>and includes<span style="letter-spacing:0.05pt;"> </span>these<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>in accrued<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.15pt;"> </span>in the consolidated<span style="letter-spacing:0.1pt;"> </span>balance sheets.<span style="letter-spacing:0.05pt;"> </span>These costs<span style="letter-spacing:0.05pt;"> </span>are a component<span style="letter-spacing:0.05pt;"> </span>of the Company’s research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status<span style="letter-spacing:0.05pt;"> </span>and timing<span style="letter-spacing:0.05pt;"> </span>of actual<span style="letter-spacing:0.05pt;"> </span>services<span style="letter-spacing:0.05pt;"> </span>performed<span style="letter-spacing:0.1pt;"> </span>may vary from<span style="letter-spacing:0.05pt;"> </span>the Company’s estimates,<span style="letter-spacing:0.1pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>in adjustments<span style="letter-spacing:0.1pt;"> </span>to expense in future<span style="letter-spacing:0.05pt;"> </span>periods.<span style="letter-spacing:0.05pt;"> </span>Changes in these<span style="letter-spacing:0.05pt;"> </span>estimates that<span style="letter-spacing:0.05pt;"> </span>result<span style="letter-spacing:0.05pt;"> </span>in material<span style="letter-spacing:0.1pt;"> </span>changes to the Company’s accrued expenses<span style="letter-spacing:0.05pt;"> </span>could materially<span style="letter-spacing:0.15pt;"> </span>affect<span style="letter-spacing:0.05pt;"> </span>the Company’s results<span style="letter-spacing:0.05pt;"> </span>of operations.<span style="letter-spacing:0.05pt;"> </span>Contingent<span style="letter-spacing:0.05pt;"> </span>milestone<span style="letter-spacing:0.1pt;"> </span>payments,<span style="letter-spacing:0.05pt;"> </span>if any, are expensed when<span style="letter-spacing:-0.05pt;"> </span>the milestone<span style="letter-spacing:0.1pt;"> </span>results<span style="letter-spacing:0.05pt;"> </span>are probable and estimable, which is generally<span style="letter-spacing:0.05pt;"> </span>upon achievement<span style="letter-spacing:0.1pt;"> </span>of the milestone.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>office<span style="letter-spacing:0.05pt;"> </span>facilities<span style="letter-spacing:0.1pt;"> </span>under non-cancelable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreements<span style="letter-spacing:0.1pt;"> </span>and recognizes related<span style="letter-spacing:0.05pt;"> </span>rent<span style="letter-spacing:0.05pt;"> </span>expense on a straight-line<span style="letter-spacing:0.15pt;"> </span>basis<span style="letter-spacing:0.05pt;"> </span>over the term<span style="letter-spacing:0.05pt;"> </span>of the lease.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Research and<span style="letter-spacing:-0.05pt;"> </span>Development<span style="letter-spacing:0.05pt;"> </span>Expenses<span style="font-weight:normal;"> </span></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of costs<span style="letter-spacing:0.05pt;"> </span>incurred<span style="letter-spacing:0.05pt;"> </span>for the development<span style="letter-spacing:0.05pt;"> </span>of the Company’s lead product<span style="letter-spacing:0.05pt;"> </span>candidate,<span style="letter-spacing:0.05pt;"> </span>pegozafermin. Research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>expenses<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>primarily<span style="letter-spacing:0.1pt;"> </span>of external<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>related<span style="letter-spacing:0.05pt;"> </span>to<span style="letter-spacing:0.1pt;"> </span>preclinical<span style="letter-spacing:0.1pt;"> </span>and clinical development<span style="letter-spacing:0.05pt;"> </span>and related<span style="letter-spacing:0.05pt;"> </span>supplies, and personnel<span style="letter-spacing:0.05pt;"> </span>costs.<span style="letter-spacing:0.05pt;"> </span>Personnel<span style="letter-spacing:0.05pt;"> </span>costs<span style="letter-spacing:0.05pt;"> </span>consist<span style="letter-spacing:0.05pt;"> </span>of salaries,<span style="letter-spacing:0.1pt;"> </span>employee<span style="letter-spacing:0.05pt;"> </span>benefits<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:1.05pt;"> </span>stock-based<span style="letter-spacing:0.1pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for individuals<span style="letter-spacing:0.1pt;"> </span>involved<span style="letter-spacing:0.05pt;"> </span>in research<span style="letter-spacing:0.05pt;"> </span>and development<span style="letter-spacing:0.05pt;"> </span>efforts. Payments<span style="letter-spacing:0.05pt;"> </span>associated<span style="letter-spacing:0.1pt;"> </span>with agreements<span style="letter-spacing:0.1pt;"> </span>to acquire<span style="letter-spacing:0.05pt;"> </span>licenses<span style="letter-spacing:0.05pt;"> </span>to develop, use, manufacture<span style="letter-spacing:0.1pt;"> </span>and commercialize<span style="letter-spacing:0.15pt;"> </span>products and purchases of pegozafermin from contract manufacturing organizations<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>have not reached<span style="letter-spacing:0.05pt;"> </span>technological<span style="letter-spacing:0.1pt;"> </span>feasibility<span style="letter-spacing:0.15pt;"> </span>and do not have alternate<span style="letter-spacing:0.1pt;"> future </span>commercial<span style="letter-spacing:0.1pt;"> </span>use are expensed as incurred.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures<span style="letter-spacing:0.05pt;"> </span>its<span style="letter-spacing:0.05pt;"> </span>equity<span style="letter-spacing:0.05pt;"> </span>awards made to employees,<span style="letter-spacing:0.05pt;"> </span>directors,<span style="letter-spacing:0.1pt;"> </span>and<span style="color:#000000;"> </span>non-employee<span style="letter-spacing:0.05pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>providers<span style="letter-spacing:0.05pt;"> </span>based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts<span style="letter-spacing:0.05pt;"> </span>for forfeitures<span style="letter-spacing:0.15pt;"> </span>as they occur.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates<span style="letter-spacing:0.1pt;"> </span>the fair<span style="letter-spacing:0.05pt;"> </span>value of stock option<span style="letter-spacing:0.05pt;"> </span>awards on the date of grant<span style="letter-spacing:0.05pt;"> </span>using a<span style="color:#000000;"> </span>Black-Scholes<span style="letter-spacing:0.05pt;"> </span>option pricing<span style="letter-spacing:0.05pt;"> </span>model.<span style="letter-spacing:0.05pt;"> </span>The Company recognizes<span style="letter-spacing:0.05pt;"> </span>compensation<span style="letter-spacing:0.1pt;"> </span>for the value of stock options<span style="letter-spacing:0.05pt;"> </span>awards, which have graded vesting,<span style="letter-spacing:0.05pt;"> </span>using the straight-line<span style="letter-spacing:0.15pt;"> </span>method<span style="letter-spacing:0.05pt;"> </span>over the requisite<span style="letter-spacing:0.1pt;"> </span>service<span style="letter-spacing:0.05pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of each award. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected divided rate. These assumptions include:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected volatility—Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company’s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected term—The expected term of options granted to employees and directors is determined using the “simplified” method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise share options evenly over the period when the share options are vested and ending on the date when the share options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Expected dividend—The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of restricted stock units is based on the fair value of the Company’s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>are accounted<span style="letter-spacing:0.05pt;"> </span>for under the asset<span style="letter-spacing:0.05pt;"> </span>and liability<span style="letter-spacing:0.1pt;"> </span>method.<span style="letter-spacing:0.05pt;"> </span>Under this<span style="letter-spacing:0.05pt;"> </span>method,<span style="letter-spacing:0.05pt;"> </span>deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are recognized<span style="letter-spacing:0.05pt;"> </span>for the future<span style="letter-spacing:0.05pt;"> </span>tax consequences<span style="letter-spacing:0.05pt;"> </span>attributable<span style="letter-spacing:0.15pt;"> </span>to differences<span style="letter-spacing:0.1pt;"> </span>between the consolidated<span style="letter-spacing:0.1pt;"> </span>financial<span style="letter-spacing:0.1pt;"> </span>statements<span style="letter-spacing:0.1pt;"> </span>carrying<span style="letter-spacing:0.05pt;"> </span>amounts<span style="letter-spacing:0.05pt;"> </span>of existing<span style="letter-spacing:0.05pt;"> </span>assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>and their<span style="letter-spacing:0.05pt;"> </span>respective<span style="letter-spacing:0.1pt;"> </span>tax bases and operating<span style="letter-spacing:0.05pt;"> </span>loss and tax credit<span style="letter-spacing:0.05pt;"> </span>carryforwards.<span style="letter-spacing:0.1pt;"> </span>Deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>are measured<span style="letter-spacing:0.05pt;"> </span>using enacted<span style="letter-spacing:0.05pt;"> </span>tax rates<span style="letter-spacing:0.05pt;"> </span>applied<span style="letter-spacing:0.05pt;"> </span>to </p> <p style="margin-bottom:0pt;margin-top:6pt;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">taxable</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the years</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in which those temporary</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">differences</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effect</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and liabilities</span><span style="letter-spacing:0.15pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of a change in tax rates</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is recognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or loss in the period that</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">includes</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the enactment</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date. A</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuation</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is established</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when</span><span style="letter-spacing:-0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">necessary</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to reduce</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deferred</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax assets</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the amount</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expected</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to be realized.</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and penalties</span><span style="letter-spacing:0.1pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to unrecognized</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax benefits</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are included</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">within the provision</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of income</span><span style="letter-spacing:0.05pt;"> </span><span style="color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tax. </span></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basic and<span style="letter-spacing:-0.05pt;"> </span>Diluted Net Loss per Share</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>during the period.<span style="letter-spacing:0.05pt;"> </span>Diluted<span style="letter-spacing:0.05pt;"> </span>loss per share<span style="letter-spacing:0.05pt;"> </span>is computed<span style="letter-spacing:0.05pt;"> </span>by dividing<span style="letter-spacing:0.05pt;"> </span>the net loss by the weighted-average<span style="letter-spacing:0.05pt;"> </span>number<span style="letter-spacing:0.05pt;"> </span>of common stock<span style="letter-spacing:0.05pt;"> </span>outstanding<span style="letter-spacing:0.05pt;"> </span>together<span style="letter-spacing:0.05pt;"> </span>with the number<span style="letter-spacing:0.05pt;"> </span>of additional<span style="letter-spacing:0.1pt;"> shares of </span>common stock<span style="letter-spacing:0.05pt;"> </span>that<span style="letter-spacing:0.05pt;"> </span>would have been outstanding<span style="letter-spacing:0.05pt;"> </span>if all<span style="letter-spacing:0.05pt;"> </span>potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>common stock<span style="letter-spacing:0.05pt;"> </span>had been issued.<span style="letter-spacing:0.05pt;"> </span>Since the Company is in a loss position<span style="letter-spacing:0.05pt;"> </span>for the periods<span style="letter-spacing:0.05pt;"> </span>presented,<span style="letter-spacing:0.05pt;"> </span>basic<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>is the same<span style="letter-spacing:0.05pt;"> </span>as diluted<span style="letter-spacing:0.05pt;"> </span>net loss per share<span style="letter-spacing:0.05pt;"> </span>since<span style="letter-spacing:0.05pt;"> </span>the effects of potentially<span style="letter-spacing:0.1pt;"> </span>dilutive<span style="letter-spacing:0.05pt;"> </span>securities<span style="letter-spacing:0.1pt;"> </span>are antidilutive.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#231F20;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Comprehensive<span style="letter-spacing:0.05pt;"> </span>Loss</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2016-02—<span style="font-style:italic;">Leases </span>(“ASU 2016-02”), requiring the recognition of lease assets and liabilities on the balance sheet. The standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. As an emerging growth company, ASU 2016-02 is effective for the Company for the year ending December 31, 2022 and interim periods within the year ending December 31, 2023. The Company expects to adopt ASC 842 using the modified retrospective method with a cumulative effect adjustment, if any, to equity at the beginning of the period of adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (i) whether a contract is or contains a lease, (ii) the classification of existing leases, and (iii) whether previously capitalized initial direct costs would qualify for capitalization. The Company also anticipates electing not to separate non-lease components from the associated lease components and to not to recognize lease assets and liabilities for leases with a term of 12 months or less. Based on its existing facility leases as of December 31, 2021, the Company does not expect the adoption of this new standard to have a material impact on the Company’s consolidated financial statements.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued ASU 2016-13, </span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments—Credit Losses (Topic 326)</span><span style="Background-color:#FFFFFF;">: </span><span style="font-style:italic;Background-color:#FFFFFF;">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;">(“ASU 2016-13”)</span><span style="Background-color:#FFFFFF;">, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company </span><span style="color:#000000;">for the year ending December 31, 2023 and interim periods within that fiscal year</span><span style="Background-color:#FFFFFF;"> and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard on its consolidated financial statements and related disclosures.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Fair Value Measurements </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,662</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,620</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,747</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,741</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,251</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,247</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S. debt securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,505</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,066</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,715</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,288</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,726</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,277</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,605</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,603</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,654</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,669</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,890</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,884</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,592</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,593</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury bills</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency discount securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,848</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,446</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,304</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,552</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2021 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,477</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,662</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,620</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,776</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,747</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,741</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,251</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,247</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S. debt securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,505</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,066</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(65</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,715</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,288</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the Company’s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of December 31, 2020 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Valuation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Hierarchy</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-top:solid 0.75pt #000000;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,605</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,603</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,654</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,669</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,890</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,884</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government bonds</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,093</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,592</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,593</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury bills</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,680</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency discount securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,848</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Classified as:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term available-for-sale securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,446</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.02%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 21477000 21477000 59647000 10000 59637000 21662000 42000 21620000 8776000 1000 1000 8776000 7747000 1000 7000 7741000 4251000 4000 4247000 2506000 1000 2505000 126066000 2000 65000 126003000 27715000 98288000 126003000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2021 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,726</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,277</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126,003</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the Company’s cash equivalents and available-for-sale securities by contractual maturity as of December 31, 2020 (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within one year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,304</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After one year through two years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,552</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and available-for-sale securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">181,856</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 120726000 5277000 126003000 46134000 46134000 76605000 2000 76603000 29654000 15000 29669000 11890000 6000 11884000 7093000 7093000 5592000 2000 1000 5593000 4680000 4680000 200000 200000 181848000 17000 9000 181856000 75410000 106446000 181856000 160304000 21552000 181856000 <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Consolidated Balance Sheet Components </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Prepaid and Other Current Assets</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,895</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,534</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">836</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">481</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,533</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid and other current assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,237</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,548</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consist of the following as of the periods presented (in thousands): </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,195</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,884</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued employee and related expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,168</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,552</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and legal fees</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">495</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">336</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,194</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid research and development</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,895</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,534</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">836</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">481</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,533</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total prepaid and other current assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,237</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,548</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 7895000 2534000 836000 481000 2506000 2533000 11237000 5548000 <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Accrued Expenses </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses consist of the following as of the periods presented (in thousands): </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,195</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,884</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued employee and related expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,168</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,552</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional and legal fees</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">495</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">336</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,194</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 6195000 2884000 3168000 2552000 495000 453000 336000 159000 10194000 6048000 <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Commitments and Contingencies </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2018, the Company entered<span style="letter-spacing:0.05pt;"> </span>into an operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>agreement<span style="letter-spacing:0.1pt;"> </span>for its<span style="letter-spacing:0.05pt;"> </span>facility<span style="letter-spacing:0.1pt;"> </span>in Israel.<span style="letter-spacing:0.05pt;"> </span>The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months. Under the lease agreement,<span style="letter-spacing:0.1pt;"> </span>monthly<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>are approximately<span style="letter-spacing:0.1pt;"> </span>$4,200. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the Company entered into an operating lease for its headquarters in San Francisco, with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year. Under the lease agreement, monthly lease payments are approximately $18,000. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum<span style="letter-spacing:0.1pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>under the Company’s non-cancellable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>as of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum annual payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent expense was $290,000 and $273,000 for the years ended December 31, 2021 and 2020, respectively. The Company has security deposit balances of $95,000, a portion of which is included in restricted cash and a portion in other assets in the consolidated balance sheets as of December 31, 2021 and 2020.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the “Teva Agreements”) with Teva Pharmaceutical Industries Ltd (“Teva”) under which it acquired certain patents and intellectual property relating to two programs: (1) Teva’s glycoPEGylated FGF21 program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2) Teva’s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $6.0 million and the Company could be obligated to pay Teva up to $67.5 million under each program, for a total of $135.0 million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Teva Agreements can be terminated (i) by the Company without cause upon 120 days’ written notice to Teva, (ii) by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within 60 days after receiving notice thereof, or (iii) by either party, if a bankruptcy petition is filed against the other party and is not dismissed within 60 days. In addition, Teva can also terminate the agreement related to the Company’s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, none of the development and commercial milestones were met and accordingly, there were no milestone payments related to the Teva Agreements. </p> The Company amended the lease term to expire in April 2022, with an option to renew for an additional 12 months. P12M 4200 with a lease term that was due to expire in January 2022. In July 2021, the Company amended the lease agreement to extend the term of the lease to January 2023, with an option to renew the term for one year. P1Y 18000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum<span style="letter-spacing:0.1pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>payments<span style="letter-spacing:0.05pt;"> </span>under the Company’s non-cancellable<span style="letter-spacing:0.1pt;"> </span>operating<span style="letter-spacing:0.05pt;"> </span>lease<span style="letter-spacing:0.05pt;"> </span>obligations<span style="letter-spacing:0.1pt;"> </span>as of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.1%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.1%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future minimum annual payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 212000 7000 219000 290000 273000 95000 95000 6000000.0 67500000 67500000 135000000.0 P120D P60D P60D 0 0 <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Term Loan</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Loan and Security Agreement</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company entered into a Loan and Security Agreement, (the “Loan Agreement”) with the lenders referred to therein (the “Lenders”), and Silicon Valley Bank (“SVB”), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the “Term A Loan Facility”) of up to $10.0 million and (ii) a secured term B loan facility (the “Term B Loan Facility”) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company’s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase 25,000 shares of the Company’s common stock with a warrant exercise price of $22.06 per share that is immediately exercisable and expires on<span style="font-size:12pt;"> </span>June 30, 2025, as amended. The fair value of the warrant at issuance date was determined by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 0.75%, no dividends, expected volatility of 92.3% and expected term of 10.0 years. Upon issuance, the fair value allocated to the warrant of $0.6 million met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. Additionally, the Company incurred $0.2 million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs classified within other assets in the consolidated balance sheets.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, the parties further amended the Loan Agreement (as amended, the “2021 Loan Agreement”). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrent with the closing and as a condition of the 2021 Loan Agreement, the Company drew $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.5</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and in </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 2021, drew the remaining $18.5 million </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">under</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Term Loan A Facility. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Loan Agreement provides for interest</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">only payments </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">until</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> October 1, 2022, followed by consecutive monthly payments of principal and interest starting on October 1, 2022 and continuing through</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 1, 2024</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the maturity date of the term loan. The interest only period may be extended to April 1, 2023, if on or before September 20, 2022, the Company receives net cash proceeds of at least $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.0</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from the sale of its equity securities. The term loan bears interest at the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.25</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.00</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% (or </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for both amounts drawn </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.25% initially and as of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 3</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021). In addition, a final payment fee of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5%</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between 1% and 3% of the principal amount of the term loan depending on the timing of prepayment.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase 33,923 shares of the Company’s common stock with a warrant exercise price of $19.12 per share that is immediately exercisable and expires on May 28, 2031. The Company determined the fair value of the warrant at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of 1.6%, no dividends, expected volatility of 98.6% and expected term of 10.0 years. Upon issuance, the fair value of the warrant of $0.6 million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term Loan B Facility, if funded, the Company will issue additional warrant to purchase 11,305 shares of the Company’s common stock with the exercise price at the Company’s stock price at the time of issuance.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $0.4 million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount. The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method. Interest expense is recorded within other expenses, net in the consolidated statements of operations and comprehensive loss. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="font-size:10pt;">The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal repayments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: unamortized debt discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total term loan, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,398</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: term loan, current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,898</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> In April 2020, the Company entered into a Loan and Security Agreement, (the “Loan Agreement”) with the lenders referred to therein (the “Lenders”), and Silicon Valley Bank (“SVB”), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the “Term A Loan Facility”) of up to $10.0 million and (ii) a secured term B loan facility (the “Term B Loan Facility”) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021 pursuant to an amendment executed in April 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company’s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants. 10000000.0 5000000.0 25000 22.06 2025-06-30 0.0075 0.923 P10Y 600000 200000 In May 2021, the parties further amended the Loan Agreement (as amended, the “2021 Loan Agreement”). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million thereby increasing the total term loan facility from $15.0 million to $25.0 million. The Term B Loan Facility of up to $5.0 million remains available to be drawn upon the achievement of certain additional milestones, and each loan facility is available to be drawn upon on or before September 30, 2022. 20000000.0 15000000.0 25000000.0 5000000.0 1500000 2024-09-01 75000000.0 0.0425 0.0100 0.05 33923 19.12 2031-05-28 0.016 0 0.986 P10Y 600000 11305 400000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="font-size:10pt;">The expected repayments of principal amount due on the term loan, excluding the final payment fee, as of December 31, 2021 are as follows (in thousands):</span></p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal repayments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: unamortized debt discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total term loan, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,398</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: term loan, current</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,898</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:12pt;"> </p> 2500000 10000000 7500000 20000000 602000 19398000 2500000 16898000 <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Stock-Based Compensation </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Equity Incentive Plans</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s board of directors approved the 2019 Equity Incentive Plan (the “2019 Plan”), which became effective in September 2019. The Company initially reserved 2,844,193 shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to ten years, commencing on January 1, 2020, in an amount equal to 4% of the total number of shares of the Company’s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company’s board of directors. As of December 31, 2021, there were 1,428,304 shares of common stock available for issuance as future option grants under the 2019 Plan. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The board of directors determines the period over which options become exercisable and options generally vest over a <span style="-sec-ix-hidden:F_000467">four-year</span> period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2019, the Company adopted the 2019 Employee Stock Purchase Plan (“ESPP”), which became effective in November 2019. The Company initially reserved 225,188 shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to ten years, in an amount equal to 1% <span style="color:#000000;">of the total number of shares of the Company’s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company’s board of directors. Purchases will be accomplished through the participation of discrete offering periods and each offering is expected to be 6 months long. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to</span> 85% <span style="color:#000000;">of the lesser of the fair market value of the Company’s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period</span>. The first six month offering period under the ESPP commenced on January 1, 2020.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, there were 544,410 shares of common stock available for issuance under the ESPP.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded stock-based compensation for the periods presented as follows (in thousands): </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,966</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,712</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,557</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,678</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,807</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000485">5.5-6.1</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000486">4.0-6.1</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000489">86.9-91.9%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000490">86.4-97.6%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000493">0.7-1.3%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000494">0.2-1.5%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity for the year ended December 31, 2021: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.79</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000509">8.6</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,918</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">830,013</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.22</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(188,286</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled and forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(133,454</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.55</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.46</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000510">8.1</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,970</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">922,104</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.76</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000511">7.3</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated grant date fair value of stock options that vested during the year ended December 31, 2021, was $7.0 million. The weighted-average<span style="letter-spacing:0.1pt;"> </span>grant<span style="letter-spacing:0.05pt;"> </span>date fair<span style="letter-spacing:0.05pt;"> </span>value of stock options<span style="letter-spacing:0.05pt;"> that were </span>granted<span style="letter-spacing:0.05pt;"> </span>during the years ended December 31, 2021 and 2020 was $16.18 and $21.88 per share, respectively.<span style="letter-spacing:0.05pt;"> </span>As<span style="letter-spacing:-0.05pt;"> </span>of December<span style="letter-spacing:0.05pt;"> </span>31, 2021, there<span style="letter-spacing:0.05pt;"> </span>was $17.9 million of unrecognized<span style="letter-spacing:0.05pt;"> </span>stock-based compensation<span style="letter-spacing:0.1pt;"> </span>cost related<span style="letter-spacing:0.05pt;"> </span>to stock options<span style="letter-spacing:0.05pt;"> </span>granted<span style="letter-spacing:0.05pt;"> </span>under the 2019 Plan, which is expected<span style="letter-spacing:0.05pt;"> </span>to be recognized<span style="letter-spacing:0.05pt;"> </span>over a weighted-average<span style="letter-spacing:0.1pt;"> </span>period<span style="letter-spacing:0.05pt;"> </span>of <span><span style="color:#000000;">2.3</span> years</span>. </p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Stock Units (“RSUs”) </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted 56,545 service-based RSUs to its employees with a total grant date fair value of $1.3 million. The RSUs vest annually over a <span style="-sec-ix-hidden:F_000523">three-year</span> period. During the year ended December 31, 2021, the Company recognized $0.3 million in expense related to the service-based RSUs. As of December 31, 2021, 11,651 RSUs were cancelled and 44,894 remain outstanding.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted 61,500 performance-based RSUs to certain executives, one-third of which vest on each <span style="-sec-ix-hidden:F_000529">one-year</span> anniversary of the grant date subject to achievement of a development milestone and continued service to the Company. The performance-based RSUs have a total grant date fair value of $1.4 million. During the year ended December 31, 2021, the Company recognized $0.8 million in expense, using the accelerated attribution method, related to the performance-based RSUs. As of December 31, 2021, all of the performance-based RSUs remain outstanding. Subsequently, one-third of the performance-based RSUs vested in February 2022, upon achievement of the development milestone and satisfaction of the continued service condition.</p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> 2844193 P10Y 0.04 1428304 The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options will expire within ten years from the date of grant. 0.25 P36M P10Y 225188 P10Y 0.01 0.85 P6M 2020-01-01 544410 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded stock-based compensation for the periods presented as follows (in thousands): </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,966</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,712</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,557</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,678</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,807</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> 2966000 1250000 5712000 2557000 8678000 3807000 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:59.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000485">5.5-6.1</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000486">4.0-6.1</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000489">86.9-91.9%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000490">86.4-97.6%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000493">0.7-1.3%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000494">0.2-1.5%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.74%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes stock option activity for the year ended December 31, 2021: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.79</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000509">8.6</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,918</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">830,013</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.22</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.32%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(188,286</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled and forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(133,454</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.55</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance outstanding as of December 31, 2021</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.46</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000510">8.1</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,970</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.32%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable as of December 31, 2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">922,104</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.76</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000511">7.3</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,800</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.92%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 1898395 12.79 25918000 830013 22.22 188286 2.59 133454 19.55 2406668 16.46 9970000 922104 10.76 6800000 7000000.0 16.18 21.88 17900000 P2Y3M18D 56545 1300000 300000 11651 44894 61500 1400000 800000 <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;;font-style:normal;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;text-transform:none;font-variant: normal;">8. Income Taxes</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Tax Rates Applicable to the Income of the Company and its Subsidiaries</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89Bio Ltd.</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio Management, Inc.</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UAB 89bio Lithuania</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income<span style="letter-spacing:0.05pt;"> </span>tax benefit<span style="letter-spacing:0.05pt;"> </span>is comprised<span style="letter-spacing:0.05pt;"> </span>of (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Deferred<span style="letter-spacing:0.05pt;"> </span>Income Taxes</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred<span style="letter-spacing:0.05pt;"> </span>income<span style="letter-spacing:0.05pt;"> </span>taxes<span style="letter-spacing:0.05pt;"> </span>reflect<span style="letter-spacing:0.1pt;"> </span>the net tax effects<span style="letter-spacing:0.1pt;"> </span>of temporary<span style="letter-spacing:0.1pt;"> </span>differences<span style="letter-spacing:0.1pt;"> </span>between the carrying<span style="letter-spacing:0.05pt;"> </span>amounts of assets<span style="letter-spacing:0.05pt;"> </span>and liabilities<span style="letter-spacing:0.15pt;"> </span>for financial<span style="letter-spacing:0.1pt;"> </span>reporting<span style="letter-spacing:0.05pt;"> </span>purposes<span style="letter-spacing:0.05pt;"> </span>and the amounts<span style="letter-spacing:0.05pt;"> </span>used for income<span style="letter-spacing:0.05pt;"> </span>tax purposes. Significant<span style="letter-spacing:0.1pt;"> </span>components<span style="letter-spacing:0.05pt;"> </span>of the Company’s deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> for the periods presented </span>are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. net operating loss carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,094</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,342</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,529</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,392</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel net operating loss carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,262</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,978</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,969</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,265</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,005</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,046</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,936</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As<span style="letter-spacing:-0.05pt;"> </span>of December<span style="letter-spacing:0.05pt;"> </span>31, 2021 and 2020, the Company recorded<span style="letter-spacing:0.05pt;"> </span>a valuation<span style="letter-spacing:0.05pt;"> </span>allowance<span style="letter-spacing:0.05pt;"> </span>of $42.0 million and $21.9 million, respectively,<span style="letter-spacing:0.1pt;"> </span>in respect<span style="letter-spacing:0.05pt;"> </span>of deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> </span>resulting<span style="letter-spacing:0.1pt;"> </span>from<span style="letter-spacing:0.05pt;"> </span>tax loss carryforwards<span style="letter-spacing:0.1pt;"> </span>and other<span style="letter-spacing:0.05pt;"> </span>temporary<span style="letter-spacing:0.1pt;"> </span>differences.<span style="letter-spacing:0.1pt;"> </span>Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by $20.1 million in 2021, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction. The valuation allowance increased by $11.9 million in 2020, which primarily relates to significant taxable losses. The change in valuation allowance during 2020 also includes a partial release of the valuation allowance against deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction, which decreased the valuation allowance by $69,000 in 2020. </p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Available<span style="letter-spacing:0.05pt;"> </span>Carryforward<span style="letter-spacing:0.05pt;"> </span>Tax <span style="letter-spacing:-0.05pt;">Losses and Credits</span></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company had an accumulated tax loss carryforward of approximately $138.5 million and $18.5 million for U.S. and Israeli tax purposes, respectively. As of December 31, 2020, the Company had an accumulated<span style="letter-spacing:0.1pt;"> </span>tax loss carryforward<span style="letter-spacing:0.1pt;"> </span>of approximately $54.1 million and $17.3 million for U.S. and Israeli tax purposes, respectively. Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. Carryforward tax losses in Israel have no expiration date.<span style="letter-spacing:0.1pt;"> </span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;letter-spacing:0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021 and 2020, the Company had federal research and development credit carryforwards of approximately $2.1 million and $0.6 million, respectively, which expire beginning in 2040. As of December 31, 2021 and December 31, 2020, the Company has state research and development credit carryforwards of approximately $1.1 million and $0.7 million, respectively, which will carry forward indefinitely. </p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Loss from Operations, Before Income Tax</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,141</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,760</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lithuania</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">862</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,275</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss before income tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,269</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,558</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reconciliation of Income Tax Benefit</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation<span style="letter-spacing:0.15pt;"> </span>of income tax benefit based on the statutory<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> </span>to the effective<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> for the periods presented </span>is as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit computed at statutory rates</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,757</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,285</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,111</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,914</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,671</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Israel effective tax rate due to the 2019</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   reorganization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits, net of</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   uncertain tax position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">555</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-weight:bold;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Unrecognized Tax Benefits </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the years ended December 31, 2021 and 2020, the amount of gross unrecognized tax benefits increased by $0.5 million and $0.3 million, respectively. If the total amount of unrecognized tax benefits was recognized, it would not have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2021 and 2020, such interest and penalties were not material.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to taxation in the United States, California, and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli taxing authorities for 2018 and 2019. As of December 31, 2021 all tax years remain open to examination. </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio, Inc.</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89Bio Ltd.</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89bio Management, Inc.</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UAB 89bio Lithuania</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> 0.21 0.21 0.23 0.23 0.21 0.21 0.15 0.15 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income<span style="letter-spacing:0.05pt;"> </span>tax benefit<span style="letter-spacing:0.05pt;"> </span>is comprised<span style="letter-spacing:0.05pt;"> </span>of (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> -11000 -2000 1000 -1000 -3000 -10000 150000 69000 150000 69000 -147000 -59000 Significant<span style="letter-spacing:0.1pt;"> </span>components<span style="letter-spacing:0.05pt;"> </span>of the Company’s deferred<span style="letter-spacing:0.05pt;"> </span>tax assets<span style="letter-spacing:0.05pt;"> for the periods presented </span>are as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands): <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. net operating loss carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,094</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,342</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,529</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,392</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel net operating loss carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,262</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,978</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,969</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,265</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,005</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,046</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,936</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">219</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> 29094000 11342000 6529000 5392000 4262000 3978000 1969000 610000 220000 635000 191000 48000 42265000 22005000 42046000 21936000 219000 69000 42000000.0 21900000 20100000 11900000 -69000 138500000 18500000 54100000 17300000 Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. 0.80 2100000 600000 1100000 700000 <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-weight:normal;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.77%;font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91,141</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,760</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lithuania</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">862</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,275</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss before income tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,269</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,558</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> -91141000 -58760000 10000 -73000 862000 9275000 -90269000 -49558000 <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation<span style="letter-spacing:0.15pt;"> </span>of income tax benefit based on the statutory<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> </span>to the effective<span style="letter-spacing:0.1pt;"> </span>tax rate<span style="letter-spacing:0.05pt;"> for the periods presented </span>is as follows<span style="letter-spacing:0.05pt;"> </span>(in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit computed at statutory rates</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,757</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,285</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,111</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,914</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,671</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Israel effective tax rate due to the 2019</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   reorganization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">647</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.84%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits, net of</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   uncertain tax position</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">191</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">555</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.84%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 18757000 8285000 -20111000 -11914000 -19000 1671000 -2000 647000 1331000 815000 191000 555000 -147000 -59000 500000 300000 0 <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Net Loss Per Share </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,923</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,571,985</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares, including all outstanding stock options, have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406,668</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,923</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,571,985</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,898,395</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 2406668 1898395 106394 58923 2571985 1898395   EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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Ð46L=4QR12'I$\.O !G0EMN@63/4S,8V-CSJ/V;OJV!3)<Z#2B1(W JF)VF"DO[)!2>#L3@[[^= M9MGH942SV8NKXY?/G@SU8,M.I]Q$5K>E"3A#?S1:<.;L DY\<"UTPP;8<;B" M$Y&$3N8"".#8I.G0!H:-N5.E?T$'XV>T=C8^>>EI;E:YO7G[;F5BY:[?7:,P MK7R_I46T%&M6[_44@7&N*9L&O'H+'5_%"N ;"1 MC OL@VP'1L'@M*UCG5OOPAE?*F/0RXBP,3*6%GJJ@W614#,5$*O*=4%^A6Y' MHP_HIG&^46GV".:="MVG0ZV@&R64$%L'C2Q6ML(E!6&J*5PV]3XXW3/LS8U'90TDC=&MJ:(CD.K\BW[;P*5)2P9)=+G#"&1L

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

    %1+#D75X@, !,? / M " 5H# 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " "LBWA4 M_2S5I:X! #!&P &@ @ %I!P$ >&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;'-02P$"% ,4 " "LBWA4)OJ'I[4! #<&P $P M @ %/"0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 -@ V +$. ( U"P$ ! end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 145 294 1 false 60 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Consolidated Statements of Cash Flows Sheet http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 100070 - Disclosure - Organization and Basis of Presentation Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 8 false false R9.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Fair Value Measurements Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100100 - Disclosure - Consolidated Balance Sheet Components Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents Consolidated Balance Sheet Components Notes 11 false false R12.htm 100110 - Disclosure - Commitments and Contingencies Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 100120 - Disclosure - Term Loan Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan Term Loan Notes 13 false false R14.htm 100130 - Disclosure - Stock-Based Compensation Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 14 false false R15.htm 100140 - Disclosure - Income Taxes Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 15 false false R16.htm 100150 - Disclosure - Net Loss Per Share Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 16 false false R17.htm 100160 - Disclosure - Subsequent Events Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 100180 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements 19 false false R20.htm 100190 - Disclosure - Consolidated Balance Sheet Components (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables Consolidated Balance Sheet Components (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents 20 false false R21.htm 100200 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies 21 false false R22.htm 100210 - Disclosure - Term Loan (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables Term Loan (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan 22 false false R23.htm 100220 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation 23 false false R24.htm 100230 - Disclosure - Income Taxes (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes 24 false false R25.htm 100240 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare 25 false false R26.htm 100250 - Disclosure - Organization and Basis of Presentation - Additional Information (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails Organization and Basis of Presentation - Additional Information (Details) Details 26 false false R27.htm 100260 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 27 false false R28.htm 100270 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) Details 28 false false R29.htm 100280 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details) Details 29 false false R30.htm 100290 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) Details 30 false false R31.htm 100300 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details) Details 31 false false R32.htm 100310 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 32 false false R33.htm 100320 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details) Details 33 false false R34.htm 100330 - Disclosure - Term Loan - Additional Information (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails Term Loan - Additional Information (Details) Details 34 false false R35.htm 100340 - Disclosure - Term Loan - Schedule of Repayment of Principal Amount (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails Term Loan - Schedule of Repayment of Principal Amount (Details) Details 35 false false R36.htm 100350 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 36 false false R37.htm 100360 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails Stock-Based Compensation - Summary of Stock-Based Compensation (Details) Details 37 false false R38.htm 100370 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details) Details 38 false false R39.htm 100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 39 false false R40.htm 100390 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details) Details 40 false false R41.htm 100400 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Expense) (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails Income Taxes - Summary of Income Tax Benefit (Expense) (Details) Details 41 false false R42.htm 100410 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails Income Taxes - Summary of Components of Deferred Tax Assets (Details) Details 42 false false R43.htm 100420 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details) Details 44 false false R45.htm 100440 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details) Details 45 false false R46.htm 100450 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details) Sheet http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details) Details 46 false false All Reports Book All Reports etnb-10k_20211231.htm etnb-20211231.xsd etnb-20211231_cal.xml etnb-20211231_def.xml etnb-20211231_lab.xml etnb-20211231_pre.xml etnb-ex231_7.htm etnb-ex311_9.htm etnb-ex312_6.htm etnb-ex321_10.htm etnb-ex43_8.htm gb2k1ptlkg5v000001.jpg gb2k1ptlkg5v000002.jpg gb2k1ptlkg5v000003.jpg gb2k1ptlkg5v000004.jpg gb2k1ptlkg5v000005.jpg gb2k1ptlkg5v000006.jpg gb2k1ptlkg5v000007.jpg gb2k1ptlkg5v000008.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "etnb-10k_20211231.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 145, "dts": { "calculationLink": { "local": [ "etnb-20211231_cal.xml" ] }, "definitionLink": { "local": [ "etnb-20211231_def.xml" ] }, "inline": { "local": [ "etnb-10k_20211231.htm" ] }, "labelLink": { "local": [ "etnb-20211231_lab.xml" ] }, "presentationLink": { "local": [ "etnb-20211231_pre.xml" ] }, "schema": { "local": [ "etnb-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 457, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 24, "http://www.89bio.com/20211231": 2, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 31 }, "keyCustom": 42, "keyStandard": 252, "memberCustom": 21, "memberStandard": 39, "nsprefix": "etnb", "nsuri": "http://www.89bio.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Fair Value Measurements", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Consolidated Balance Sheet Components", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents", "shortName": "Consolidated Balance Sheet Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Commitments and Contingencies", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Term Loan", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan", "shortName": "Term Loan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Stock-Based Compensation", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Income Taxes", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Net Loss Per Share", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare", "shortName": "Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Subsequent Events", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Consolidated Balance Sheets", "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "lang": null, "name": "etnb:ShortTermAvailableForSaleSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Consolidated Balance Sheet Components (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables", "shortName": "Consolidated Balance Sheet Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Term Loan (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables", "shortName": "Term Loan (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Income Taxes (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Net Loss Per Share (Tables)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables", "shortName": "Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "shortName": "Organization and Basis of Presentation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210301_20210331", "decimals": "-5", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "U_etnbSegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "U_etnbSegment", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails", "shortName": "Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails", "shortName": "Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "etnb:PrepaidResearchAndDevelopmentCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails", "shortName": "Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "etnb:PrepaidResearchAndDevelopmentCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "etnb:AccruedResearchAndDevelopmentExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails", "shortName": "Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "etnb:AccruedResearchAndDevelopmentExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20180501_20180531", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20180501_20180531", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails", "shortName": "Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20200401_20200430", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Term Loan - Additional Information (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails", "shortName": "Term Loan - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20200401_20200430", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Term Loan - Schedule of Repayment of Principal Amount (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails", "shortName": "Term Loan - Schedule of Repayment of Principal Amount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Stock-Based Compensation - Additional Information (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "shortName": "Stock-Based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_srtTitleOfIndividualAxis_us-gaapShareBasedPaymentArrangementEmployeeMember_us-gaapAwardTypeAxis_etnbServiceBasedRSUsMember_20210201_20210228", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails", "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20200401_20200430", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "shortName": "Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails", "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_us-gaapPlanNameAxis_etnbTwoThousandAndNineteenEquityIncentivePlanMember_20210101_20211231", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails", "shortName": "Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Expense) (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails", "shortName": "Income Taxes - Summary of Income Tax Benefit (Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "shortName": "Income Taxes - Summary of Components of Deferred Tax Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Income Taxes - Additional Information (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "shortName": "Income Taxes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-5", "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails", "shortName": "Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_srtStatementGeographicalAxis_countryUS_20210101_20211231", "decimals": "-3", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails", "shortName": "Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails", "shortName": "Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)", "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "etnb:TemporaryEquityIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)", "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical", "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_us-gaapStatementClassOfStockAxis_etnbConvertiblePreferredSharesMember_us-gaapTypeOfArrangementAxis_etnbATMFacilityMember_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "etnb:TemporaryEquityIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - Organization and Basis of Presentation", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation", "shortName": "Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "etnb-10k_20211231.htm", "contextRef": "C_0001785173_20210101_20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "country_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ISRAEL", "terseLabel": "Israel" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" ], "xbrltype": "domainItemType" }, "country_LT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LITHUANIA", "terseLabel": "LITHUANIA" } } }, "localname": "LT", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm Id", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Entity Incorporation Date Of Incorporation", "terseLabel": "Date of incorporation" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "etnb_ATMFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ATM facility.", "label": "A T M Facility [Member]", "terseLabel": "A T M Facility" } } }, "localname": "ATMFacilityMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "domainItemType" }, "etnb_AccruedResearchAndDevelopmentExpenseCurrent": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": { "order": 10010.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued research and development expense current.", "label": "Accrued Research And Development Expense Current", "terseLabel": "Accrued research and development expenses" } } }, "localname": "AccruedResearchAndDevelopmentExpenseCurrent", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued research and development expenses.", "label": "Accrued Research And Development Expenses Policy [Text Block]", "terseLabel": "Accrued Research and Development Expenses" } } }, "localname": "AccruedResearchAndDevelopmentExpensesPolicyTextBlock", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "etnb_AccumulatedTaxLossCarryForward": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accumulated tax loss carry forward.", "label": "Accumulated Tax Loss Carry Forward", "terseLabel": "Accumulated tax loss carryforward" } } }, "localname": "AccumulatedTaxLossCarryForward", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_AgencyDiscountSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency discount securities.", "label": "Agency Discount Securities [Member]", "terseLabel": "Agency discount securities" } } }, "localname": "AgencyDiscountSecuritiesMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of debt issuance costs and accretion of final payment fee.", "label": "Amortization Of Debt Issuance Costs And Accretion Of Final Payment Fee", "negatedLabel": "Amortization of debt issuance costs and accretion of final payment fee" } } }, "localname": "AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Asset transfer and license agreements initial nonrefundable upfront payment.", "label": "Asset Transfer And License Agreement Initial Nonrefundable Upfront Payment", "terseLabel": "Nonrefundable upfront payment" } } }, "localname": "AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset transfer and license agreement termination notice period if bankruptcy petition filed.", "label": "Asset Transfer And License Agreement Termination Notice Period If Bankruptcy Petition Filed", "terseLabel": "Asset transfer and license agreement termination notice period if bankruptcy petition filed" } } }, "localname": "AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset transfer and license agreement termination period after written notice.", "label": "Asset Transfer And License Agreement Termination Period After Written Notice", "terseLabel": "Asset transfer and license agreement, termination period after written notice" } } }, "localname": "AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset transfer and license agreement termination period notice of failure.", "label": "Asset Transfer And License Agreement Termination Period Notice Of Failure", "terseLabel": "Asset transfer and license agreement, termination period notice of breach" } } }, "localname": "AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": { "order": 10020.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Available for sale securities debt maturities after one through two years fair value.", "label": "Available For Sale Securities Debt Maturities After One Through Two Years Fair Value", "terseLabel": "After one year through two years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "etnb_ConvertiblePreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible preferred shares.", "label": "Convertible Preferred Shares [Member]", "terseLabel": "Convertible Preferred Shares" } } }, "localname": "ConvertiblePreferredSharesMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "domainItemType" }, "etnb_DeferredTaxAssets": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets.", "label": "Deferred Tax Assets", "negatedLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssets", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets tax credit carryforwards research, federal.", "label": "Deferred Tax Assets Tax Credit Carryforwards Research Federal", "terseLabel": "Federal research and development credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_EightyNineBioLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "89Bio Ltd.", "label": "Eighty Nine Bio Ltd [Member]", "terseLabel": "89Bio Ltd" } } }, "localname": "EightyNineBioLtdMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "etnb_EightyNineBioManagementIncorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighty Nine Bio Management, Inc.", "label": "Eighty Nine Bio Management Incorporation [Member]", "terseLabel": "89bio Management, Inc." } } }, "localname": "EightyNineBioManagementIncorporationMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "etnb_FairValueOfWarrantsAssumptionsDividends": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrant assumptions, dividends.", "label": "Fair Value Of Warrants Assumptions Dividends", "terseLabel": "Fair value of warrant assumptions, dividends" } } }, "localname": "FairValueOfWarrantsAssumptionsDividends", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_IncomeTaxDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax.", "label": "Income Tax Disclosure [Line Items]", "terseLabel": "Income Tax Disclosure [Line Items]" } } }, "localname": "IncomeTaxDisclosureLineItems", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "etnb_IncomeTaxDisclosureTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax.", "label": "Income Tax Disclosure [Table]", "terseLabel": "Income Tax Disclosure [Table]" } } }, "localname": "IncomeTaxDisclosureTable", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation change in effective tax rate due to reorganization.", "label": "Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization", "terseLabel": "Change in Israel effective tax rate due to the 2019 reorganization" } } }, "localname": "IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock warrant in connection with term loan facility.", "label": "Issuance Of Common Stock Warrant In Connection With Term Loan Facility", "terseLabel": "Issuance of common stock warrant in connection with term loan facility" } } }, "localname": "IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock warrant in connection with debt financing.", "label": "Issuance Of Common Stock Warrants In Connection With Debt Financing", "terseLabel": "Issuance Of Common Stock Warrants In Connection With Debt Financing" } } }, "localname": "IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit facility increase in borrowing capacity.", "label": "Line Of Credit Facility Increase In Borrowing Capacity", "terseLabel": "Line of credit facility increase in borrowing capacity" } } }, "localname": "LineOfCreditFacilityIncreaseInBorrowingCapacity", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_LoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan and security agreement.", "label": "Loan And Security Agreement [Member]", "terseLabel": "Loan Agreement" } } }, "localname": "LoanAndSecurityAgreementMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_MilestonePayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Milestone payment.", "label": "Milestone Payment", "terseLabel": "Milestone payments" } } }, "localname": "MilestonePayment", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_NetCashProceedsFromSaleOfEquitySecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net cash proceeds from sale of equity securities.", "label": "Net Cash Proceeds From Sale Of Equity Securities", "terseLabel": "Proceeds from sale of available-for-sale securities, equity" } } }, "localname": "NetCashProceedsFromSaleOfEquitySecurities", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issuable under share-based payment arrangement.", "label": "Number Of Shares Issuable Under Share Based Payment Arrangement", "verboseLabel": "Number of common shares issuable under the plan (in shares)" } } }, "localname": "NumberOfSharesIssuableUnderShareBasedPaymentArrangement", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligation to payment upon maximum achievement of certain clinical and commercial milestones.", "label": "Obligation To Payment Upon Maximum Achievement Of Certain Clinical And Commercial Milestones", "terseLabel": "Payment upon achievement of certain clinical and commercial milestones" } } }, "localname": "ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_OperatingLeaseMonthlyRentalPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease monthly rental payments.", "label": "Operating Lease Monthly Rental Payments", "terseLabel": "Operating lease, payments" } } }, "localname": "OperatingLeaseMonthlyRentalPayments", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_OtherNonCurrentLiability": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other non-current liability", "label": "Other Non Current Liability", "terseLabel": "Other non-current liability" } } }, "localname": "OtherNonCurrentLiability", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "etnb_OtherRisksAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other risks and uncertainties.", "label": "Other Risks And Uncertainties Policy [Text Block]", "terseLabel": "Other Risks and Uncertainties" } } }, "localname": "OtherRisksAndUncertaintiesPolicyTextBlock", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "etnb_PaymentForPurchaseOfAvailableForSaleSecurities": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment for purchases of available for sale securities.", "label": "Payment For Purchase Of Available For Sale Securities", "negatedLabel": "Purchases of available-for-sale securities" } } }, "localname": "PaymentForPurchaseOfAvailableForSaleSecurities", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "etnb_PaymentsOfStockIssuanceCostsOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of stock issuance costs, other.", "label": "Payments Of Stock Issuance Costs Other", "terseLabel": "Other offering expenses" } } }, "localname": "PaymentsOfStockIssuanceCostsOther", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_PercentageOfFeeOnLoan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fee on loan.", "label": "Percentage Of Fee On Loan", "terseLabel": "Percentage of fee on loan" } } }, "localname": "PercentageOfFeeOnLoan", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of increase in number of shares of capital stock reserved for issuance.", "label": "Percentage Of Increase In Number Of Shares Of Capital Stock Issued And Outstanding", "terseLabel": "Percentage of increase in number of shares of capital stock issued and outstanding" } } }, "localname": "PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "etnb_PerformanceRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance RSUs.", "label": "Performance R S Us [Member]", "terseLabel": "Performance RSUs" } } }, "localname": "PerformanceRSUsMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period for increase in number of shares of common stock reserved for issuance.", "label": "Period For Increase In Number Of Shares Of Common Stock Reserved For Issuance", "terseLabel": "Period for increase in number of shares of common stock reserved for issuance" } } }, "localname": "PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_PrepaidResearchAndDevelopmentCurrent": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": { "order": 10010.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expense prepaid current.", "label": "Prepaid Research And Development Current", "terseLabel": "Prepaid research and development" } } }, "localname": "PrepaidResearchAndDevelopmentCurrent", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "etnb_ProceedsFromIssuancePublicOffering": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance public offering.", "label": "Proceeds From Issuance Public Offering", "terseLabel": "Proceeds from issuance of common stock upon public offerings,net of issuance costs" } } }, "localname": "ProceedsFromIssuancePublicOffering", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "etnb_RestrictedCashAndOtherAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted cash and other assets member.", "label": "Restricted Cash And Other Assets [Member]", "terseLabel": "Restricted Cash And Other Assets Member" } } }, "localname": "RestrictedCashAndOtherAssetsMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Svb leerink llc and cantor fitzgerald & co.", "label": "S V B Leerink L L C And Cantor Fitzgerald Co [Member]", "terseLabel": "SVB Leerink LLC" } } }, "localname": "SVBLeerinkLLCAndCantorFitzgeraldCoMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_SanFranciscoOfficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Francisco office.", "label": "San Francisco Office [Member]", "terseLabel": "San Francisco Office" } } }, "localname": "SanFranciscoOfficeMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of effective income tax rate of company and subsidiaries.", "label": "Schedule Of Effective Income Tax Rate Of Company And Subsidiaries Table [Text Block]", "terseLabel": "Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of prepaid and other current assets.", "label": "Schedule Of Prepaid And Other Current Assets Table [Text Block]", "terseLabel": "Schedule of Prepaid and Other Current Assets" } } }, "localname": "ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "etnb_SellingCommissionPerSharesSoldPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Selling commission per shares sold percentage.", "label": "Selling Commission Per Shares Sold Percentage", "terseLabel": "Selling commission per shares sold percentage" } } }, "localname": "SellingCommissionPerSharesSoldPercentage", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "etnb_ServiceBasedRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service-based RSUs member.", "label": "Service Based R S Us [Member]", "terseLabel": "Service-based RSUs" } } }, "localname": "ServiceBasedRSUsMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of share based compensation arrangement by share based payment award anniversary.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Anniversary", "terseLabel": "Anniversary period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options aggregate intrinsic value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options weighted average remaining contractual term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted Average Remaining Contractual Term (In years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award remaining options vesting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Remaining Options Vesting Period", "terseLabel": "Remaining option vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment first offering period.", "label": "Share Based Compensation Arrangement By Share Based Payment First Offering Period", "terseLabel": "First offering period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriod", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment first offering period commencement date.", "label": "Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement Date", "terseLabel": "Commencement date of first six month offering period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by sharebased payment award options grant date fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Fair Value", "terseLabel": "Total grant date fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "etnb_ShortTermAvailableForSaleSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10200.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short term available for sale securities current.", "label": "Short Term Available For Sale Securities Current", "terseLabel": "Short-term available-for-sale securities" } } }, "localname": "ShortTermAvailableForSaleSecuritiesCurrent", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "etnb_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "etnb_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information related to various accounting policies of the entity.", "label": "Summary Of Significant Accounting Policies [Table]", "terseLabel": "Summary Of Significant Accounting Policies [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "etnb_TaxableIncomeUtilizationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Taxable income utilization percentage.", "label": "Taxable Income Utilization Percentage", "terseLabel": "Taxable income utilization percentage" } } }, "localname": "TaxableIncomeUtilizationPercentage", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "etnb_TemporaryEquityIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Temporary equity, issuance costs.", "label": "Temporary Equity Issuance Costs", "terseLabel": "Temporary equity, issuance costs" } } }, "localname": "TemporaryEquityIssuanceCosts", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "etnb_TermALoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term A loan facility.", "label": "Term A Loan Facility [Member]", "terseLabel": "Term A Loan Facility" } } }, "localname": "TermALoanFacilityMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_TermBLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term b loan facility.", "label": "Term B Loan Facility [Member]", "terseLabel": "Term B Loan Facility" } } }, "localname": "TermBLoanFacilityMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_TermLoanCurrent": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10140.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Term loan current.", "label": "Term Loan Current", "terseLabel": "Term loan, current" } } }, "localname": "TermLoanCurrent", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "etnb_TevaAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Teva agreement.", "label": "Teva Agreement [Member]", "terseLabel": "Teva Agreements" } } }, "localname": "TevaAgreementMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_TevasDevelopmentProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tevas development program.", "label": "Tevas Development Program [Member]", "terseLabel": "Teva's Development Program" } } }, "localname": "TevasDevelopmentProgramMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_TevasGlycoPEGylatedFGF21ProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tevas glycoPEGylated FGF21 program.", "label": "Tevas Glyco P E Gylated F G F21 Program [Member]", "terseLabel": "Teva's GlycoPEGylated FGF21 Program" } } }, "localname": "TevasGlycoPEGylatedFGF21ProgramMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_TwoThousandAndNineteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 equity incentive plan.", "label": "Two Thousand And Nineteen Equity Incentive Plan [Member]", "terseLabel": "2019 Plan" } } }, "localname": "TwoThousandAndNineteenEquityIncentivePlanMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "etnb_TwoThousandAndTwentyEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty equity incentive plan.", "label": "Two Thousand And Twenty Equity Incentive Plan [Member]", "terseLabel": "2020 Plan" } } }, "localname": "TwoThousandAndTwentyEquityIncentivePlanMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_UABEightyNineBioLithuaniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "UAB Eighty Nine Bio Lithuania.", "label": "U A B Eighty Nine Bio Lithuania [Member]", "terseLabel": "UAB 89bio Lithuania" } } }, "localname": "UABEightyNineBioLithuaniaMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "etnb_UnderwrittenPublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwritten Public Offering [Member]", "label": "Underwritten Public Offering [Member]", "terseLabel": "Underwritten public offering" } } }, "localname": "UnderwrittenPublicOfferingMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "etnb_UnvestedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unvested restricted stock units.", "label": "Unvested Restricted Stock Units [Member]", "terseLabel": "Unvested Restricted Stock Units" } } }, "localname": "UnvestedRestrictedStockUnitsMember", "nsuri": "http://www.89bio.com/20211231", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r99", "r194", "r198", "r203", "r331", "r332", "r337", "r338", "r380", "r468" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r99", "r194", "r198", "r203", "r331", "r332", "r337", "r338", "r380", "r468" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "label": "Executive Officer [Member]", "terseLabel": "Executive Officer" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r208", "r232", "r252", "r253", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r430", "r432", "r469", "r470" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r208", "r232", "r252", "r253", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r430", "r432", "r469", "r470" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r208", "r232", "r243", "r252", "r253", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r430", "r432", "r469", "r470" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r208", "r232", "r243", "r252", "r253", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r430", "r432", "r469", "r470" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r152", "r153", "r241", "r242", "r431", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r152", "r153", "r241", "r242", "r431", "r455", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467" ], "lang": { "en-us": { "role": { "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r154", "r379" ], "lang": { "en-us": { "role": { "label": "Title Of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title Of Individual With Relationship To Entity [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r33", "r383" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10120.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "auth_ref": [ "r86" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Accretion Amortization Of Discounts And Premiums Investments", "negatedLabel": "Amortization of premium on available-for-sale securities" } } }, "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10130.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued expenses", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r9", "r10", "r37" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": { "order": 10030.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees Current", "terseLabel": "Accrued professional and legal fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r23", "r51", "r52", "r53", "r419", "r437", "r438" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r50", "r53", "r61", "r62", "r63", "r101", "r102", "r103", "r336", "r433", "r434", "r484" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r21" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r101", "r102", "r103", "r285", "r286", "r287", "r345" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r254", "r257", "r291", "r292" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AgencySecuritiesMember": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Securities issued by government sponsored entities.", "label": "Agency Securities [Member]", "terseLabel": "Agency bonds" } } }, "localname": "AgencySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r257", "r281", "r290" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Total stock-based compensation", "verboseLabel": "Share base compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Antidilutive common stock equivalents excluded from calculation of diluted net loss per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r95", "r138", "r146", "r150", "r166", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r331", "r337", "r356", "r381", "r383", "r400", "r417" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r45", "r95", "r166", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r331", "r337", "r356", "r381", "r383" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10150.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r160" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10010.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax", "terseLabel": "Short-term investments, Gross Unrealized Holding Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r161" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10020.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax", "negatedLabel": "Short-term investments, Gross Unrealized Holding Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r158", "r168" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Amortized Cost Basis", "totalLabel": "Short-term investments, Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r162", "r163", "r412" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": { "order": 10010.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Available For Sale Securities Debt Maturities Within One Year Fair Value", "terseLabel": "Within one year" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r156", "r159", "r168", "r404" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": { "order": 10030.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Securities Debt Securities", "terseLabel": "Short-term investments, Aggregated Fair Value", "totalLabel": "Total cash equivalents and available-for-sale securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r258", "r283" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r342", "r343" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r29", "r87" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10180.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r12", "r88", "r399" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy", "terseLabel": "Cash and Cash Equivalents and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash Cash Equivalents And Short Term Investments", "terseLabel": "Cash and cash equivalents and short term available-for-sale securities" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r81", "r87", "r90" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash and cash equivalents, and restricted cash at beginning of period", "totalLabel": "Total cash and cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]", "terseLabel": "Components of cash and cash equivalents, and restricted cash:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r81", "r357" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsMember": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Equivalents [Member]", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r93", "r95", "r113", "r114", "r115", "r117", "r119", "r125", "r126", "r127", "r166", "r194", "r198", "r199", "r200", "r203", "r204", "r230", "r231", "r233", "r234", "r356", "r480" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1", "terseLabel": "Warrant exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights", "terseLabel": "Warrants to purchase common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial Paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r41", "r182", "r405", "r423" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 5)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r179", "r180", "r181", "r189", "r456" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "terseLabel": "Common stock reserved and available for issuance as future option grants" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r101", "r102", "r345" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r235" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20", "r383" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 20,317,204 and 19,931,660 shares issued and outstanding as of December 31, 2021 and 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r56", "r58", "r59", "r68", "r409", "r426" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income Policy Policy [Text Block]", "terseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r130", "r415" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk Credit Risk", "terseLabel": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r92", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy [Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r244", "r251", "r439" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate Debt" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r96", "r314", "r321" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": 10040.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense Benefit", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r96", "r314" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": 10060.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r96", "r314", "r321", "r323" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense Benefit", "totalLabel": "Total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r96", "r314", "r321" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": 10050.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State And Local Tax Expense Benefit", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r15", "r16", "r17", "r94", "r99", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r225", "r226", "r227", "r228", "r369", "r401", "r402", "r416" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r17", "r223", "r402", "r416" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10030.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "totalLabel": "Total principal repayments" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r39", "r218", "r367" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument Interest Rate During Period", "terseLabel": "Debt instrument, interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMeasurementInput": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.", "label": "Debt Instrument Measurement Input", "terseLabel": "Fair measurement input" } } }, "localname": "DebtInstrumentMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r40", "r94", "r99", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r225", "r226", "r227", "r228", "r369" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r40", "r94", "r99", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r225", "r226", "r227", "r228", "r236", "r237", "r238", "r239", "r366", "r367", "r369", "r370", "r414" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument Term", "terseLabel": "Fair measurement input" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r212", "r366", "r370" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10040.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "negatedLabel": "Less: unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r96", "r315", "r321" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": 10030.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense Benefit", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r368" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Gross", "verboseLabel": "Debt issuance costs, gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r85", "r96", "r315", "r321", "r322", "r323" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense Benefit", "totalLabel": "Total" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r306" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10010.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Gross", "terseLabel": "Deferred tax assets", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r312", "r313" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10040.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets In Process Research And Development", "terseLabel": "Research and development expenses" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r308" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r312", "r313" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10030.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r312", "r313" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10080.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "auth_ref": [ "r311", "r312", "r313" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.", "label": "Deferred Tax Assets Tax Credit Carryforwards Research", "terseLabel": "State research and development credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r312", "r313" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10060.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r312", "r313" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10070.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r307" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": { "order": 10020.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "negatedLabel": "Less: valuation allowance", "terseLabel": "Deferred tax assets, valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r85", "r173" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases": { "auth_ref": [ "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4) restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.", "label": "Description Of Lessee Leasing Arrangements Operating Leases", "terseLabel": "Lessee, operating lease, description" } } }, "localname": "DescriptionOfLesseeLeasingArrangementsOperatingLeases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Net loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share Policy [Text Block]", "terseLabel": "Basic and Diluted Net Loss per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r120", "r121", "r122", "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Continuing Operations", "terseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": { "order": 10020.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued employee and related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Unrecognized weighted average period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized stock option granted under plan" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP Purchases" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options to Purchase Common Stock" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r61", "r62", "r63", "r101", "r102", "r103", "r105", "r110", "r112", "r124", "r167", "r235", "r240", "r285", "r286", "r287", "r317", "r318", "r345", "r358", "r359", "r360", "r361", "r362", "r364", "r433", "r434", "r435", "r484" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r347", "r348", "r349", "r354" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r214", "r225", "r226", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r348", "r386", "r387", "r388" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r347", "r348", "r351", "r352", "r355" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r214", "r244", "r245", "r250", "r251", "r348", "r386" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r214", "r225", "r226", "r244", "r245", "r250", "r251", "r348", "r387" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement Policy Policy [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r214", "r225", "r226", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r386", "r387", "r388" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r353", "r355" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions And Translations Policy [Text Block]", "terseLabel": "Foreign Currencies" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "auth_ref": [ "r244", "r439" ], "lang": { "en-us": { "role": { "documentation": "Debt security issued by government not domiciled in United States of America (US).", "label": "Foreign Government Debt Securities [Member]", "terseLabel": "Non-US debt securities" } } }, "localname": "ForeignGovernmentDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r70" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10100.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General And Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General And Administrative Expense [Member]", "terseLabel": "General and Administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "I P O [Member]", "terseLabel": "Public Offerings" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r171", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r65", "r138", "r145", "r148", "r149", "r151", "r398", "r406", "r410", "r428" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10050.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "terseLabel": "Net loss before income tax", "totalLabel": "Net loss before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r176", "r178" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r97", "r302", "r304", "r310", "r319", "r324", "r326", "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r98", "r111", "r112", "r137", "r300", "r320", "r325", "r429" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10060.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "negatedLabel": "Income tax benefit", "negatedTotalLabel": "Income tax benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r60", "r298", "r299", "r304", "r305", "r309", "r316" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r301" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance", "terseLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r301" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Income Tax Reconciliation Foreign Income Tax Rate Differential", "terseLabel": "Foreign rate differential" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r301" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate", "terseLabel": "Income tax benefit computed at statutory rates" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": { "auth_ref": [ "r301" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": 10050.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.", "label": "Income Tax Reconciliation Nondeductible Expense Research And Development", "terseLabel": "Research and development credits, net of uncertain tax position" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r301" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails": { "order": 10060.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Income Tax Reconciliation Other Adjustments", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseStatutoryTaxRateToEffectiveTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r84" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase Decrease In Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r84" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase Decrease In Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r84" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets", "negatedLabel": "Prepaid and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r79", "r82", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid Net", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r165", "r427" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment Policy [Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investment Type Categorization [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified By Contractual Maturity Date Table [Text Block]", "terseLabel": "Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Lease And Rental Expense", "terseLabel": "Operating leases, rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases Policy [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r378" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": { "order": 10010.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r378" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": { "order": 10020.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Renewal Term", "terseLabel": "Lessee,operating lease, renewal term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract", "terseLabel": "Lessee, operating lease term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r36", "r95", "r147", "r166", "r194", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r332", "r337", "r338", "r356", "r381", "r382" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r95", "r166", "r356", "r383", "r403", "r421" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r38", "r95", "r166", "r194", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r332", "r337", "r338", "r356", "r381", "r382", "r383" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10090.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r17", "r402", "r416" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Term loan amount drawn" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityDescription": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.", "label": "Line Of Credit Facility Description", "terseLabel": "Line of Credit Facility, Description" } } }, "localname": "LineOfCreditFacilityDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line Of Credit Facility Expiration Date1", "terseLabel": "Credit facility maturity date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r17", "r213", "r224", "r225", "r226", "r402", "r418" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "totalLabel": "Total term loan, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt Current", "negatedLabel": "Less: term loan, current" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths": { "auth_ref": [ "r99" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10050.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree": { "auth_ref": [ "r99" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10070.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Rolling Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo": { "auth_ref": [ "r99" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": 10060.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Rolling Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10100.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt Noncurrent", "terseLabel": "Term loan, non-current, net", "totalLabel": "Term loan, non-current, net" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanScheduleOfRepaymentOfPrincipalAmountDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long Term Debt [Text Block]", "terseLabel": "Term Loan" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoan" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r190", "r191" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputExpectedDividendPaymentMember": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend to be paid to holder of equity or financial instrument.", "label": "Measurement Input Expected Dividend Payment [Member]", "terseLabel": "Measurement Input, Expected Dividend Payment" } } }, "localname": "MeasurementInputExpectedDividendPaymentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input Expected Term [Member]", "terseLabel": "Measurement Input, Expected Term" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input Price Volatility [Member]", "terseLabel": "Measurement Input, Price Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input Risk Free Interest Rate [Member]", "terseLabel": "Measurement Input, Risk Free Interest Rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MunicipalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.", "label": "Municipal Bonds [Member]", "terseLabel": "Municipal Bonds" } } }, "localname": "MunicipalBondsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r81" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10050.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r81" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r81", "r83", "r86" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r54", "r57", "r63", "r66", "r86", "r95", "r104", "r106", "r107", "r108", "r109", "r111", "r112", "r116", "r138", "r145", "r148", "r149", "r151", "r166", "r194", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r346", "r356", "r407", "r424" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing And Financing Items [Abstract]", "terseLabel": "Supplemental disclosures of noncash information:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number Of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r138", "r145", "r148", "r149", "r151" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10070.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "terseLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r373", "r374" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases Future Minimum Payments Due", "totalLabel": "Total future minimum annual payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards Limitations On Use", "terseLabel": "Operating loss carryforwards limitations on use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r341" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r9", "r10", "r11", "r37" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": { "order": 10040.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Accrued other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r342", "r344" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10170.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r48", "r49", "r51" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax", "terseLabel": "Unrealized (loss) gain on available-for-sale securities" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r47" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10040.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r55", "r58", "r61", "r62", "r64", "r67", "r235", "r358", "r363", "r364", "r408", "r425" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Net Of Tax", "totalLabel": "Total other comprehensive loss", "verboseLabel": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Tax [Abstract]", "terseLabel": "Other comprehensive (loss) income:" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r71" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10080.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "terseLabel": "Other expenses, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r4", "r7", "r170" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": { "order": 10030.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense Current", "terseLabel": "Prepaid other" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables And Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r77" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments Of Debt Issuance Costs", "negatedLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments Of Stock Issuance Costs", "terseLabel": "Payment of underwriting discounts, commissions" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r74" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r258", "r283" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19", "r230" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19", "r230" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19", "r383" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2021 and 2020, respectively, no shares issued and outstanding as of December 31, 2021 and 2020, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r27", "r28" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10210.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid and other current assets", "totalLabel": "Total prepaid and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expense And Other Assets Current [Abstract]" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r5", "r7", "r169", "r170" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": { "order": 10020.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Taxes", "terseLabel": "Prepaid taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r75" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds From Issuance Of Common Stock", "terseLabel": "Proceeds from issuance of common stock upon ESPP purchases", "verboseLabel": "Proceeds from issuance of common stock, net of underwriters discount and commissions" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "auth_ref": [ "r76" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.", "label": "Proceeds From Issuance Of Other Long Term Debt", "terseLabel": "Proceeds from term loan facility, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r75", "r284" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options", "terseLabel": "Proceeds from issuance of common stock upon stock option exercises" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "auth_ref": [ "r72", "r73", "r157" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds From Sale And Maturity Of Available For Sale Securities", "terseLabel": "Proceeds from sales and maturities of available-for-sale securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r54", "r57", "r63", "r80", "r95", "r104", "r111", "r112", "r138", "r145", "r148", "r149", "r151", "r166", "r194", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r330", "r334", "r335", "r339", "r340", "r346", "r356", "r410" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r31", "r175" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property Plant And Equipment Estimated Useful Lives", "terseLabel": "Leasehold improvements amortization, description" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r13", "r14", "r175", "r383", "r413", "r422" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10160.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r30", "r175", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Policy [Text Block]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r13", "r174" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property Plant And Equipment Useful Life", "terseLabel": "Property and equipment, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "auth_ref": [ "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Information by form of arrangement related to research and development.", "label": "Research And Development Arrangement Contract To Perform For Others By Type [Axis]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "auth_ref": [ "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.", "label": "Research And Development Arrangement Contract To Perform For Others Type [Domain]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r294", "r396", "r471" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10090.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and Development Expenses", "verboseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research And Development Expense Policy", "terseLabel": "Research and Development Expenses" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r3", "r12", "r90" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10190.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r240", "r288", "r383", "r420", "r436", "r438" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r101", "r102", "r103", "r105", "r110", "r112", "r167", "r285", "r286", "r287", "r317", "r318", "r345", "r433", "r435" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule Of Accrued Liabilities Table [Text Block]", "terseLabel": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]", "terseLabel": "Summary of Income Tax Benefit (Expense)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]", "terseLabel": "Summary of Components of Deferred Tax Assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r257", "r280", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r257", "r280", "r290" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]", "terseLabel": "Summary of Stock-Based Compensation" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]", "terseLabel": "Summary of Financial Assets Measured at Fair Value on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]", "terseLabel": "Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]", "terseLabel": "Summary of Loss from Operations Before Taxes on Income" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]", "terseLabel": "Schedule of Repayment of Principal Amount" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r258", "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r264", "r270", "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]", "terseLabel": "Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r139", "r140", "r141", "r142", "r143", "r144", "r152" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting Policy Policy [Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r84" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Expected dividend" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum", "terseLabel": "Expected volatility, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum", "terseLabel": "Expected volatility, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum", "terseLabel": "Risk-free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum", "terseLabel": "Risk-free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant", "terseLabel": "Number of shares of common stock available for issuance under ESPP" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Exercisable as of December 31, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Exercisable as of December 31, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period", "negatedLabel": "Cancelled and forfeited", "verboseLabel": "Cancelled shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Granted", "verboseLabel": "Shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value Outstanding", "periodStartLabel": "Aggregate Intrinsic Value Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r266", "r283" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Outstanding, Ending Balance", "periodStartLabel": "Outstanding, Beginning Balance", "terseLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of award under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award", "terseLabel": "Terms of award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r256", "r262" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Cancelled and forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Issuance of common stock, weighted average price per share" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r258", "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share Based Compensation Option And Incentive Plans Policy", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r255", "r279" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share Based Payment Arrangement Employee [Member]", "terseLabel": "Employee" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage", "terseLabel": "Percentage of option vesting" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r275", "r289" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected terms (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1", "terseLabel": "Aggregate Intrinsic Value, Exercisable as of December 31, 2021" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2021" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2", "verboseLabel": "Weighted Average Remaining Contractual Term (In years), Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value", "terseLabel": "Estimated total grant date fair value of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "Percent of purchase shares of common stock" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued Price Per Share", "terseLabel": "IPO price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestmentsMember": { "auth_ref": [ "r451", "r452", "r453", "r454" ], "lang": { "en-us": { "role": { "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.", "label": "Short Term Investments [Member]", "terseLabel": "Short-term available for sale securities" } } }, "localname": "ShortTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r91", "r100" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r18", "r19", "r20", "r93", "r95", "r113", "r114", "r115", "r117", "r119", "r125", "r126", "r127", "r166", "r194", "r198", "r199", "r200", "r203", "r204", "r230", "r231", "r233", "r234", "r235", "r356", "r480" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r43", "r61", "r62", "r63", "r101", "r102", "r103", "r105", "r110", "r112", "r124", "r167", "r235", "r240", "r285", "r286", "r287", "r317", "r318", "r345", "r358", "r359", "r360", "r361", "r362", "r364", "r433", "r434", "r435", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r101", "r102", "r103", "r124", "r397" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r19", "r20", "r235", "r240" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period Shares Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock upon ESPP purchase, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r19", "r20", "r235", "r240" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "terseLabel": "Issuance of common stock, shares", "verboseLabel": "Shares issued and sold" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r19", "r20", "r235", "r240", "r268" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r19", "r20", "r235", "r240" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period Value Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock upon ESPP purchase" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r19", "r20", "r235", "r240" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "terseLabel": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r43", "r235", "r240" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r24", "r25", "r95", "r155", "r166", "r356", "r383" ], "calculation": { "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r384", "r385" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]", "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary Sale Of Stock [Line Items]", "terseLabel": "Subsidiary Sale Of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Consolidated Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureConsolidatedBalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae).", "label": "U S Government Agencies Shortterm Debt Securities [Member]", "terseLabel": "U.S. government bonds" } } }, "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryBillSecuritiesMember": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.", "label": "U S Treasury Bill Securities [Member]", "terseLabel": "U.S. treasury bills" } } }, "localname": "USTreasuryBillSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r297", "r303" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits Period Increase Decrease", "terseLabel": "Increase in unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r128", "r129", "r131", "r132", "r133", "r134", "r135" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r308" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance Deferred Tax Asset Change In Amount", "terseLabel": "Deferred tax assets, change in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Technique [Axis]", "terseLabel": "Valuation Approach and Technique" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Technique [Domain]", "terseLabel": "Valuation Approach and Technique" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueOptionPricingModelMember": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating price of option.", "label": "Valuation Technique Option Pricing Model [Member]", "terseLabel": "Valuation Technique, Option Pricing Model" } } }, "localname": "ValuationTechniqueOptionPricingModelMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants to Purchase Common Stock" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants And Rights Outstanding Maturity Date", "terseLabel": "Warrant expiration date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number Of Share Outstanding Basic And Diluted", "terseLabel": "Weighted-average shares used to compute net loss per share, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.89bio.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r189": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r328": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r341": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r365": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 1)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r385": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8,17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r46": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r472": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r473": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r474": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r475": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r476": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r477": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r478": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r479": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r480": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r481": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r482": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r483": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" } }, "version": "2.1" } ZIP 74 0001564590-22-011706-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-011706-xbrl.zip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

    %X=!H<\@O);&FLG0BMP. VG!V T?,=5 M/Z+M3MF?\#?G E,5O?YPSH%+N)PJFETF(,WF127=C2J+R=HG>KJ.="N^.3:& M_8K1.")?8L!.Q5U#3Y23/LX?J)U4SXW-MGD&HSS'UR6H7CKB/ F>(:3#* M_:<2QN :C+^C*X8]*%029+([0T=I53Z0<8#7C-_%6";1ZT]/NB%(W&>G,0TS M2:A N9 Y-36,NU6VT+2JB71%J0->#\&I^%EM/@)V0+ZS/RFIGR&44#YD+)F#>T;(H*FQ*=4),?DP.26X=#=5(91< M"">@.ET\4HZP'&\]6K1"-U.2_F3>NTR&%J<3^SU.ME$#W_G3C9SZOM1F#^<4 MW*]%D=R9$ M?#&E2U,B.R>9(4I-+P)?*1.[J>D8MW?TN<$4)3ER%AP7@:K.5%J=49@VLZG- M);QGE3G:X[JS2!HUFZDN@WPT3YG1EMFR.4@"520,P6.X%+9M%H[V_IK MK,T+9T8O"2+4^Q3![;8#.QP 9'"7BCQXDRH_74&^AJTI#+!2A,R/Y!SL]$7< M@TR9S7+.BGQF'E]1YXM2FVH[0B&2QDPJ(P//)D(Q+C,S'B=CIA*-BI5L4=/2 M51LDW9TLJ9ML-:R]G#YSZHM$H$RHWT]:OV41@HN4DOYV$U8%ZCDZ$TEZ9,"2 M;E!PM6L&MX)H,4X_TK'HC@&M6,QB,%=KHRTFCFN'&^!$"+0+V@#"G!/]Y;?OF]FOB_1 (9A@ZFYV,>UCX M9-Q9'2R/GMZ:Y#'%9[%E+@'ECLR"74$SH2&28(\>EX)Q^;Q,6#:I$>N)/+*RD?5LI"D;6:^DD?63#:OBMK%> M[9;*%M3/VX)Z9I-P78!.WG0+K-BFZGJJ7\KI]J1RVA--5V?X,_OW++28QZ0Y M9D$NLG.PX;I@1\.ZIREL_WDZX2( C^CL4C M(M@T_HX=Z[OL,<$#.[C#P2+;NLG+[T][_6!7.YG>P3T&PHD5Z.;VA%*2ZE&X MS*Q+G78]&8S.]C(BD;E0FSN1^/*SD:\%.FM)54NVO$=AVG6\Q-(/A]@Y9MHQ M2@G?&*\3^2$0U: "8_/\:-Z]UJ\BZ245SCS *0W@22BXX&264H07C)V5(KP4 MX:4(7[\([P#?%]5X)#M"8[17;U,*^X@QF85H7$+5LM8<0VD-W,\Z3[E.._8C@Y9TO]$F4C MZ%+0;B;3*05M*6A+0;M^07NN$H_9#I/L%S-O C.,@IAD&)IT&"SM"[\/1#< M.W&1!9&M1WYAD$RN_8!)I $N!>/%LYI^DKGM<==/7]EY;%""V HG5R9'U+!\ MF0X<2UOTJ^>@;=S!05EAVCE?"B(W\LO,@)3A8#*4@<%W_2059_*-22J, MOBG9*M+I)1*K0JWBR A'F++5"8\+8VQ[&!KG<>"/V.UP.@"SN)1PFTGMI80K M)5PIX=8OX3[&5%-GV)@6%/)X!.H=6#5#3!(<.2-R'_(P'1 W:7[1PD(N%5AB M.')]G%B"(D54[8#*Q8;TP R/VX-W&$#-\06] 8T^N MRU,9 >QHE;G#HM=S+(<-;EB=3S:A- DUI^[/3+9>*"]PFD$L4!\P(W[[]+1 M3*&[4"=SF1SJ*1_JE^10S_A05U49L;:9NR8-KDJ2_[0BMDG4EU%ZH$-*'N39 MYYC^SJG3/ SA7F3G)FC=851]@S<1_5@T.3 4R6==&TPZ'&)HH:+-IE!)CWW7 M[Z+O".N *:50Q588_82X237V575[@$; %$ J4 M7(F#+_P(232B\(O6^A.]PZ5F:YCWIN.2/HA\1$N> MSFR8BX9YW)B6O9Y#ZSV5JY^.J4_3,Y';R1D4\A0,/XXP;L4K5863H*%W8] U M/>ZN0A!D*%B(,>$XC,1PYAC&I2I,UX__J<-10W]_]OB\3# *4X:6GHY'>4J5 MV9E6"4)G@G-3'C<:,$2X+9F?<^=36O;3\^9G6U5FQGJQ13V2 M'3>!9UZ$-7Y?5 ]B,:+I?4F&%]8-XFZ(1P&#^D[=42\NS_0A(_;DQ"1)@!5T M/2N.DXPFUUMOTI"\4(X:X>>FR5@!"V^G&T=RJS/>4S-:2.&<&5;1-0 GDLVK MU"!R7(0G'G26'"8\I:=Z8LTXHXFW9ZM ,\>F"K:TOH.;3O4S*LDG?>J/%I0G ME=_DN7A"^??43! E/^6T!F3=>BX!E5+3,!DUC6$A4Y.C\IG.$ J MC=.&:%K?WO1I"5IL5Y'-N\(7V2Q#7VL$Y+3IMYYUR-KUF0;I>E9%+1:UAH*9 M\OVDGVW!%IT?J5WC@NZ4\JLWXL!N#C@Z*U5ZDEI;UI^!,Q9L'S,<&.O$S]FS MA_(<]45#C$2D%6Q="+B"+4EV%2G:LC(]O;/]>C)M3=1LL*FF*8C 5-BOJ%^- M\BW81HN)I-.=C=(9SZP D%11L/7I-SA8XGJ5#V;@&&^S>@7=69?]UQS*'N14+T;SFCU,7). M3@TYF58%\>^=T.$.9L#A?$]YN ?FA$L5.[UBLW.: .MQA_&D U4FWS\928\Q MD\Q0W8HV(AUXS.?3T]J4^;RB9GSK.]"^[D&7U:3_P'V3R(L!]F*]/ M4A\OE8I2,\X<$V&NW'0T6%FV) @<.9T:/2YZ_6$R(-@.3!K02+@CW^;!GD"$ M6*8M5-,U3"U1."0140ZXE.U02)'XX6 3%WA0\^ 7U?4?\'5RL=E/81$"C(PR0J.DZ)_FJGC=P6-+9*N3>N1'FL95V*4 MLW4!G8#EX=M+7*?L.N6*, MU\ RZ($X=(.'<0+H[L8C+%>Q';,K(M4$(OL(.993M;H*)\M/D^/OQ0$I+/ 6 MXI_RT&*/XQ9CPXM!O2!NP:&9-,$'9X'$PY%22TR.Y@R 7*CU'F8V^>@$ANL# M-20]Q('=Y-;OF:IO9(@&:83J:5< CMD6YE1ALL90]\6 ;;/PS'G8^P4_;SM M.M=FLAL6@AO5.HHFC ;C4+KCT\*J4/=*YW4>F9C#34BK&AFJ*3E:3 *>BFW% M5/?_%+6G$;"2S"[WE>@8*Y8T,2.=[QL!EHCLU?(1M8F"Y&16_0]4D]&-:UI6 MK$:\TO0*,U(4P^]B.F5^J1B '!P.$/0##KB:W^%17?^>4; KQCYU0A-!?TS! MOQ![$BM\YP=CSKR)C3E=C@/ LH %]7 N>C>.DEE$-'%\*+!_-DD[VA"F#,C[ M.:1(MR,G@_N16#$(U>4SU[S'E*:/P0X..#);2(\1OE)Z =_C"2"K:B+/T1C! M;J*B(JD'WDF1.$QTM\P@H"Q[9-=#S>YA# MRA%9(B6V1/6X=Q*68(]YMF)2%E5(YI[((&JM+2>%F!4,%^ MO##"'MQ83V*2>(!C3ZF7CPG55W\XI+[S@0";+6")1$,)5=0D''LVD+'858V% M-4F5THDB$S7<9E9T<'MM'33@-]O6^?/G@H&?">DT!QBBI2IF@BN28J8IJPGT M1.&"RL2ZB)QZY)KAT,SM%OS/?QPVWS?K=6/8?VM?)ID&U#,,YX/R&'G1H?O#^0#VHECQE+5G(RF6&IS.&\[\BN0;E]0%/&-.:X M.ZGQ8I(-,0&/Q$.FLG4>T_T3F]D%SB?]^7P&88;3:)BZV)&L5%U=([FV\Z0B M9UDA&>_C6 ?7T;/5<@U8=@WDD\C<$Y+T(X&ID=&ULGGT1)FJ4??\;L&*RG_YYS\.CM^GWOALVX&T4[C6=9OO /%_V'C? MV-^5&ZUHTWQIJ1,FH#[Q]_! 7D.6V.79I50Y5>9::HC/- KM.)&M<$A:7I"5 M,4^GY76^>9K1JZ1O"M4Z(EGI51ZH2(7N*X+%D>\B-8#& M;1/08;=GYI!:.9+H]:@+A@YUE1*9'^1>C0MLS2:M/B2H#Z_WTIX>TBH-R7F M/@ X9X"$' /#U@;@7A7C*U35BX.-M .3Y!#8APL!0!QBUB: M3%V@DC!JIL*MZW%%:-_)/MC*(M4:KI"X#(5J\_U(VW!)OBI%=JC2[$"\>5%: M_#M;PZE(KB9OD&EX0RSM+ CM?AAH@E2 M2>=)T%,S8C@[F3PK<9/)X]N5VG14IC9M5VI3UO=P %(12*71E"-(]*1R,". MNX!51=2F$@IIS/, /26I#@C$ 'R_>IJ,F#[X!0=F ?$ C>"CDJ:(23/N:;&; M3F.E(6W$T"@5U]2X7N:=M&$ HC>EW&?2?YTPC(6:6$))Q6,?G8AC4(^0*1HZ M4^20-.V/G%3H8 VC9*0/>^^4VDW0FIUEX/=RW/\,GL)E1:$ *-B2)D\E03VL M\,)LZ45MI2(83^ MLJE47SUE6HTTR/J74I&6(&C1SB%UQJ:H#\18M&5.S^TEUQK^(]"YV<,*%SE; MMD+:@?*=@>P'"NYBS0,>5!(?HN.>M.HI&X6Q[(#-)36O=J(;&UI_L:=R]--B M&"?(M?'@&C!OZN^-Q'P#_LD*4ARFTS_0+0JL,4S"ES1[WJ82D4#T II],-:4 MFX(=$Q=?Y:RT8.LL&MQDKE07XTUD",ZHS$QKUK*<3AJ46C/<@FUPNC>O255) MP$*K'+:G/LPF%NND211SF_M2'T4CYI!=2IESI\05#"J%2Y1*"U[D6"MD38R+ MA(-JT!/;J*E)AH$(+HU+-4@>[2/^(3>EXM# M/CB54I#DAXE[W[UG,2'SP<;"Q+,_3]);5(H*SCYU?=.NS"HGK4P7^4_85LBB M0)P(#%1HX^#2-#496?L.!OL !S1/!K$H&8_BCNREC&CFJ3[N3^TX4H8'QN#Q M%>C#SH!G3.8$/S-)64C:0ULF=F7))![I)0KI%F6&#JF"TK<+8.CZ@[$=)&F0 M:8R1\P$1EF &N4-AR[B';X$X#MDV2OL!J#0C2BL*A- ?!)"AL1/I.%,V#%DR M.Q34@PO0PZIB.3(=B"M$V8!&Q_=D E,8!R.7QAU.O!'1)TP#$,$PN27R?P L M>.XL50,7?L('E M&9E4(I6YE4SJ,SUM%&!^TC!/]P14D)!'RU/119(<(S'5'U)N%G9M(^>5>@_> M0YG$'H\$QN*%Z0RDSZ>G%5HBMVIPQYM>7?V4Q+]EDO[>-'872/Q[T]Q])/GO MS=[NG 3 -_N[CZUJV1S!II:5R(K=BCSLV*4#6G-I\3!P9N1B([EA+ M"(C2C-H>'K'9Q=G6I=L%& M/[)B&U0-*TIBYYSKS*@ N\[13/&ELKJ0LRZI0&1J]T+?#&\"J<*M2QU2=5/2SC/KAD];]Q7G$:5P;XYK]=&Q=BSHJ3K> :]8!.L MWN@2$Z (OT5*$\5&&>D+$ M&3 B]B+M#<&,M@: A#2GI0O(7Y5*+:8>4PR")V2W[FXJ!DW%1E-BEZDL$%40 M!H!S/97407T%@V&&0'7%EW3K+A50\50ZZOA'".>B,86%--^I[VY"%+BC(K "GA?=%N%M)]'[[VI"SR8MFH[81CM*4N=IOH8IMMG[9S'":L1.@E M(FEU'-J;G(!Z[]BQZ;('4TMSX+"N"08849Q.!M=RL_HY]36VVR^]J<, MG:1QCPDC37D!)BPQZ=7*AC.R3 .K\@)?5=UHP9M*Y@6H3Y*%AN3,80\9"\GZ M.&1 0S:_R V#S(A_Z'U1*I0UGU2L$KN49I*D'Y&HPKJ[6PEIV0$]TVI%S5[W MM&ZT6.B65+DQW3HRU)84UJ0KQ#@8%_CJ;G**M_#O8!_JM?+H8E=.)-5%N#N6 MY2::;0!&K:9EC"9KRN$M_G=':>J4Z>N/V"Q]0ZH\K6!7Q:12 ''*7I!4$K$Y MRSPE4E/1,14UE*$*3%@"*3=1I:#M-7VS5NM-/"7M3H-^6=3.*M11W81]66E; M9@RN](1) W>2P^+!=)E01I -25*C7\K#Y>2:B; PO5TE!J:WL>NER;EYQ^6QL=D5%:+H>J,8Z-EX=E$+/ F:]$PF[S08H&W M6BPP%9\&R]3-%J(=I:GQQ0*T0],6XG;B32)2(D2^0 ISG_@)!>5L.S M9CG!4#/B6:9X$N(EW4*D.LHJ_ R@Z3=VA9&Z!#(ZNPI4)'#2P@Q CJ"C574]:/DS0$ MH%PEBD+#%Y;/!C@(.)JJQ%&?Q.I.N@T-N?28="P[#D3:BPNH % H,$,,^5:H MXY\%VH(L+64B1J\+V=H4"<8Z#U+GT/%[CU7R_;3"-:F7YA<+[]]CZIYPC;9? M&(>R>CDMF$_;$H&D'(5C-O;E2$/JW=,CY9:BW[;L5Y?I ><)LLBCQ)3\%S6J MU7L7)@&1RF0_0M?ORD0D37+R:G7ES\5B;*_G!&1@D%**-GKB,<'N@MTL:&XQOK".D#EB MHQMNIEXBU!=@F)2S)[XAN,M'UP#U:$H"0V_H$7N[E5P(:#_G='K40,C7-7=E M[;/@"(3*'3+YW=PS.&&KB=C&F5?TD(MZ]6(?PVLN57LQT_[=!19.S6I1%T\B M;G"Q03T.X$W)0]EQASX V#6HYB%PR'AR4^;X!I<*S&*P*V]O MRMOQN\EG4$+2]$/DG7OJ3C!.:4L3O^_+WQ->O+OI6O9G#9<561+E#JGY&:G MP/@-2H"PB[8GTN9S@-P$37(?\X=P^GJV?#\M M:"*O"7;GIJMDET1MHW20JN@7_7(\LVN[PFB->AE'VZXX&HIP5P8+E"5/7N^" ME6I4"[8>::[ Q05;6-$ A8P0>*[&'@NVP,(5.19L/1U9&@G7 '^^-\F4CWQ? M?>@!M@ M3\1SV&N$TN:>FA6 @5R5'6M<:L4(KR;S6[@FF-G]P!P-QI6B;;U@ZU%L^X_3 MN_.T'B2=^Y&Z(U7;G"F9KD+U!=L9"J*"+2DSD@"0UL/6'WW.'1D%V)"&_D3_ MCU!5M*9EB1$/+.803]ZUZ(1"YW(20$N:R!=0DF KVZ(AR\7>;C8^EJ^]8H:^ MLA="$6$X+IST\8E[AP=B8D;<4 3]9%HUMF#CGOT!M33#LY+I.@4#1]&.)].P M6ZMCP1[_9DC![N[84,V4B[9ZSL;6=M"ZO,M=XZS&SP7;3^.=\?7M91&A7+ E MI:&]HJV,R[+$L("S2'TO$]PIV.H*YW%K>SARK1<9_1@ST"S!2O3%63' M@=G'@A),@Y+-52@EP.F-$<#6 !L_8+3R3U3^3\KSQ*\^'31;"13;38['8B,WR[:LS3)$6<# MRT9,23>"3Q=A:KBE@3"& AXX_-4XKG .D0P=\V94U5=$ZKDV@'.0 LCDU)S M^FYL^:&H%01K.XI"2D:FE*CN$PMTJH#9.V6U0@QX%RAY*4L!$Q MIB=$'!-+$EHXI5+;3(B%RF@*3TV'E-PMIJ(D;K>LKE7S(P?8CW:BS$B=X9^M MN_0(P^_ #S&;9!B'EIL6XG\R0Q/-4%FB$C!HKY*^JI1!-?B&ET$FL6,*B==$N@_DK<;$FE M+:G*Q4[*XU8EW'(DUA+R[LG"C0@M(4QM7!+/$4B;?T\TL% TRK^&4_TM )+8 MUD,;[)/;?$*O$52M/.39<(E%IG7+9#N@R1X]DJ=GBEY57YWDN=3?)=/T8(J9 M)P,0)4,RJ&&3MBX.!J<#KF3#OC>BUJ]5L@5Q%1HKI'52V-7;UW"^S)3@Q!K9 M>;]K8%>UL#RH3#:ED&>6OTQJY8BYP@[-,ZL8$TB0G=XV@0"RL#,[+U/IKLDP MG&E385,9H,X.?C)=-NF@JL0#UJWWL?U5B+)9 M]3G!>DB1#F:MJCD22>9G4L>88-2]8QK1@Z^U*54J(Z9_)PHDIU:G"E:JV";Z MEY)4.(M IL[3S.":<>E[_2HF@AN:%X:J4M+':.IV.O\ E(Z^SV7S7 _*E<$T MXS6@PL>,"SL:Q A2%YW.6M&V;(")\XDY59S38;6=F:H/&%6VT3.CA!])+4?8 M!*L)32:ME$M*].-1IDB?8))P&&'K3R"U*34&YE3)T,/)H$GJ8V*L2DHKS)/B M-]D.TL$ "IJZ>24S$X:VEI0N3U#C2::G'UO:74EO0:D/*U3LR9S@2U-L:<.S M:QM;DUU;) DP[69JI\Q;,I.)EV0LUIKZ M(4AJX\GTM$7:[]"/(ZTS*';Y,*33@,,5)^(;[VM,HE M3[$F$65; G2?P)/D !]]KP*'_RAU]RI]@NJK1Q%T'.5)0Z%H +KLN,K#P\@' MC4"7-5ORN)1G([D'M4Y\H'(%\"H>H;DT35FNEDI*)EY%72KQM MEAE:INQ;P4")TG2*G,L$#T5B*-(\4^SW.(&LO=CC)CAS*SL?ER=KIU#IP902 M/E1-5"5:2JIZ,],;M:L\/UW2,X!&X65I])X'4K'EDC485%M#68([J4"D7AXV M$D.N2:0A."*FXLRT"9%">-D;8D&?5"RIS1W^'?G'\:NU)#-P&[$^JKY(] 2NH,:>SN_/7<3*\GI:]9 MJR+S-3(ES:4ENSW#XXPO9@8/U"X&0"E8J#HTEM?M5;''>,WH:$^G$>3)>S.O M.B&'%[G3T6Z3\0SZK+EHI"D9"'0-.4/?C1.C"AOX8]"2;L2=D5UM89:4+N)3:SOF/J0T MG1E'2(()\98F24YF63TD?:?9&%P6GZA*4G"F::+0F#VJ*N>!:!F5I(*VJ^E& MW'^,]0DOVX@JJ^S(9K\4 U>M<57Z'L[TL&B2F@IV;["/ZD8V->I$V%4ZEAFZ M-S*P/-9X=[@+1/N MU=<3."NX(1?Y73@^RSI\NA8:S0F:AQ^,_,#,=*YF;L8N%&P=B!8_,!-J8TYQ M99KLB_T.J7<)I4%ZZ%6.P_0N*J9&;AZ.7=ETH9/X9;ACOD@N8/]>H(8S8)JF M,)IUX_N9F8@$8^@[ @B:%DYM)\Q(LFI4RGTYP82MK^NJ]!AFEJ"O$V.X;Q*W M$8!TESV&7"(.]AGWS=<%$K5DP:HH.!\M2714:./ F^S!56[&IM M(B6?[#A(ZJ M.G;%./UR4^VTJG!#,KSA!\X13+HVIN>(V^$0K8KGF5"3@;2L9$IKX-A 9'-DV.U-[2!G/\) LJV[E7CV5O M'P[8A6?"3YSFW?4#6P2_[=1WV-N)XZV\?O)YA&.4Y6?Y'+ZC2J[-42A.U!_O MT5SK0Z_\&,R-[:J&XGKV]:L=,X%7R]+O@[?:T0^ XFVEWXR MT)MQPKG8D __26[; 4%[=V)T4(T4*)N$ C,6A4HPG6YS!UVM%GKZEC@ M/P'^!SDM_ O,N.3)A<2IDB>7/+GDR87ER;=@1[9.C!;"8Y(KMUPSAR^-4>1^[Q_7T!3F7N*PNGX^@3^E0V ;XM\3 K1S4EQS>.:_ODC0>=<+\N_^H+2C=-/-G9 M@$7JHC;M?YG4AE[&%]3P# Q;WF,_=7+&)RD6;U3I:>M&MI=.)J&D09#&NX:, M@315/V$9B]7O MS[O5-$+'TS3C71D;1Z5.J,;SKJ_:0ZLP["2,'XN(:F&"V?$(V7=?<%N*X<@, M3-E4&S1(6((,K]!\Z9XK?E 63*)<*BB9VF35B<$4)@)!ILZHEOPU(W\M26R, M>FV$L85I9-BWEA*UN>9P8 (J6I1GP^-S>+Y&6O>8?$5 2!O94!FS#*[P?FAZ M0*-NC'&$Z4HZ+V]@(".FT3H+1J\43.4Q 47<.WX<9KJ68YP>>\+&FTO?^SL6/X"+OMM_CV^Y$_?F;KHB3.ZC0;5) M"=T8\[@"_U[VZ<8^RW$04" 1<7TH IR'3"7L$G?/8P"# &A]]7A4RCS9O6DJ MNE2(FZ#>Q4-BI1B0GXL=.6D3K4A.#>*,DH\R,W9]DE1Z#9[JIN5EG=#1K,AE MVYURMNPUC]^=[;WGIS3A(7*A!(W0!](QZK5W!Z/(4&XB=8$$X-QKT%L&E#OYZ+Z_(;6D3SJ+8'7V4/%[^80FP)F OZWSS?8CXR/#6CE&=U MA0MXE1\YQ(/M/<1Z;;_(9W@FDAKGGS_&O>T]QKW]6O.@R =YDR3]22&B'^=; MR6$5GPW\!Y0_O^WL[_S#BH)4YB MA0KD5S8<,-_G#68X3>B$NXO'Y0I,84L=6[,^=6J'M<-F]MBJ#3K;G,C9NKHM M'A_N-]^SPC3_OW,5056N&28=.\CJISJ#L0TJ^M@SL63]WG?C8=+5A0W+_\/> MNRBWC279HK^"Z&E/RWU)6:3>53,G0I8?I2Z[2F.IN^Z-B8D3( E**(, !R D ML[_^YLK,_0)!69)=;5+FB3G5%@D"&_N1SY4K!6T\3M%.2J3VXR)BF\4P:'1R MN[BZU.MYQWUC\A&:_=GZ7X/^YMI=Z;CU^81H>'I763\^XO1^'[N#8T=>$4'+ MHC?5ZUK+[T>+C/[VX='W(C*X,*3BBOZK)$=%?3IC<2X=H@K;A5.D>UV.P=JW ME6XGV]Z/DFE*"Y,GOF0^JO]/)I,X+7G^O ][T.8 M7* *"A0ETSJK/ YK4ZZ@97@J0RJ;,*JB6VY:BPHQ+1YS16F5JR+[WJV4AEF[ M]YULJP^NO)G3,XMYHR^2/:L<=OWB^,'1]O&*!1 ND-8UQ:O1>Y/6W<0-Z!&' MV_V#[^-,FW5OPO,Y 3A1)JEL_OED_Y;+ZS\/,__?N;+X'G;1HUQ:&S'N?[6( M\2KOAO:H\G%OM;3"VP:TX-)" C:*@7V(_>]#+YP(*R$+300 M47[-]>=Q&?=(57]/TC,L V^97OKXZTWJ9]SB;RV#/,(#8=>N BX/RR9:&6/$ M .Z^5Q.CL9X[A]^'C/K Y#V6LL:2ZE@6.;12$290R^.RB8XM#;7W]KZ/;7/. M-(H,JA0(+0>Y+';6DI<,"J;H!7HQR:95JV0NDPGXH])\%@]GG6A<;CM"3'+1=T?MBI'T-0"38B5ZE\2 QJ.A?!TGU=;IS MK&%%@2,H1&]:QSL*\M98)F]B)T^)YLLD2[AA+8PJH4H5$ERIZTA&PF]X,4N8 M[LI;@HYM$W1Q>?+>-2D"I>$K4J)=L?%'PO=HKGUU]HOM4<^#L9TZP/4ZB_,$ M[:I&O*;TP&* L0SG>4&^P!4:617YQV0N/_7K<"RM[*B0*I^1V1:3 K4X[EET ME>GN,^+[PT'S+T(M-W:?H9ZFF_$CM1L?S9V;-,,O^S2:XITP.794& MJI/GW5]=F_T1U<5!T<%*(]4]]3_U]SC+!B[N_ K%UFLS'=,&B6N+O_FPK=WC MN/=F9__KEU(:3"6C[VG[:AN][^F5&QT#O_S [FWO;0[LMSRPT:7?YH^MW5/7 M .+K+/+N9I&_S2(+\O:[$LH_H7$;JE>2[^FMS[A-W=?&;DW[Y_NZSA[W9W__Z=7Q9C!9"V4_Y?7_C$7Q/ M;\P2K,FH8($+C7!6[VA[]Q[AK+6(6H5+V ^7L'__)?PV2*979[\$*8.S:*NW MPP'P:EF!?NLBK7?\Y6NOVD5R5231W\^BB_F$SN0? ?H[>SL["ZC-F]?H;5V MN+^+%5IK;_F[6*'U]I"^BR5:;R/_*2S1QNI;.ZL/9M_QQNQ;P\.V,?O6?H4V M9M^JK]#&[%OY)=J8?=]ZB9:9??VC[:.-U;<*5M_GL,B"1>M%6T=B"DH'1$7# M"NIU8QVNU9G<6(=KOT(;ZW#55VAC'?XKM=@OQ>;B/_U6U24T7_U?]M8B>MX+#=6XMJOT,9*7/45VEB)&RMQ_=;I&UJ) M3=X1^A\S"S(!>".U&1]9H'N/HMS[=&M3[B4N>K^]EF:D\1#3<5O&TZ4+R./_ M+*'#O68\)*JY]_QGR8RV4%=GZH?[ 41;BZ7OQ[NX,C/4>).O-6%_:*G'U M!)0\IZ8&_Y778EBI3[Z(:N>;ON$U6FGW8O=VEZ7R$5W0KLR2[JM">['Y?2/(JO)F$C*+^/:.-P^.'[FO4A_^DBNI[WIBO')_): X!,5#LDH MBB,[XY;38<8S/BNLT2F-R6FNT;YX5F1)&7L-*\Y_QG+<>7:G+9US:]T..PKSDW:OZ43H0-?G\?BT$*)KHN:DS0R2RJ M^# H%Q#]XGB[%TV$6_&:'IJ4G4!$*C'GA/ND,760$9:&2"E+IRFWJ(XGR0R, M2I,DKNH26V06O8KGT1'?'/_J[4?,[V;(@XIZJ>FHPJ+@>"* M [J"[C--=1/;@6!G)R#FP@MHNVLY(4*TM'WWACAOV1"C9$+O,),.WF0)TG1N MV8[WX[*8\"SUG]/*U!6X5#&WH+ZJ2S;Y@S6B.5U8$71JG]T6$JR,3-MV60K9 M#UWLAR@>T:C22OL+;C^\J?6MX8^2L\YR8E@6E;!R\C.$C2IFSDYL)]Y3>4&3 M$,^N*WI%6D!PAL4C; &FG>+7HDV35CBV:5Y+"PQZ?Z8Y"Z_4O514,^Y-7N1T M#NR6G=%JSS!/W3*1YCKACSM1,41O;Z#(^>!5>@PQ/8.L*$;<]@R''=?1>$LZE!#[>HJW%\ITU\AB$JTP>-$G M35<6-/WT?Z=@0IO.FC:&VD[1.6U,S.$?PU?X;6)(I%,OZ)63R8"$17^GO\-[ M\V\QG<)RC@_ZV,NF_QUM+6&8O\'1G++$++4?$4NR87%-&[>*>CBY!WPO^2@Z MQ(53'(<;Z"Z:4])9D;\,LV"RISK9>BS EI@R^WC"H@4G&YQ^;-QB]>AF5I>+ ML+WBI]QY@,4DYH/;$.R+?HK6FC(Q)NBM&N.&$&Z\/<3EA.8FE2A6YX&&"_]T M2@H@KN@&?"K92H"(394O. 6?[M[@&\?^&!C,(PC7Z3B&3HQ/+VB MNWM]473;T<\)-W.=0LJ!VY!,GHJF@D5AFU7:\D4:R -YM'[#V?=\U=OW@C/(M,2D](F"0Q^SHEP5(I*DUU$-@D)8K3] :]E M[K$C[BD[8K2$O')IT'0]6(/WUH\U>-T(*=LDX2I09-X1Y/FVPVN5"RLQLKV5 M'=D/JSMIOJTAAMTKEK:/;;3^]07+([@S&H-8&;OR/]+)5525P__\T]6@_[$W MG64?K_9O>%C][=^G5W^*9ND,[_PGXYJ2>+1LF^&"7BPK+_S^XO.]$-8SB(@BP/\S@S MBOZ/S;D=B8>S3PRKU?B$FX<'.LX6($@PN^?;0?:O69(?]ZA8S;?NAIN#> M[C/3+LHZ+#1P_,WAMFHFTT*.?IK ,]=8DGM-6/SJP_S[O]'.BO:?/7@4)\&$ MNB@B&[IF6'"_"MJ (^W75,93X>35:3HZ>L:3=MA[%OQ.ALX.AVG!<72TL__C M+DTK&>7AA_OTH5V><#T;"]0)_,'/4+*OFZEECLS:3_XLR(4:&\P*V3^ MGZN/0W_^)CO^ZRN&E=!.W]#!N$,?[=Y#'^T=]IT^VMTY,OKHCYDBGH:#[W I M]NYE&NRXI6 SX2M8!E]SX3:&PJ*A<""&0DN4K..B]J*-=(6FRQJIW/%@VB]5 MH0%)B8(OS759U<2O3O.7DUZJ.KY"C*.]O88V.WEWR3HRCG;WH[^_>$=6CXQ*VX]PBWQS&&28:L/((^7^^UE[WQ/3)H_:-G F^?BOFQL[VS_[Q# M:YYW?WKUSES5.S!7F8MZ+7FWQ:OVGV\W&)@UO2%,H#S)5Y@'M.OZ-%.@PI(9 M#,=/RM).Z=;EVT@-D/[.3C2Y>C%Z]URB??O.0/N2&;9#2C4'S7:N'@WN8^*/ M3M?8F#QD$YFDDFIZ_K4U\Y;V#/KL5E]J5)O,ITUGI<+FWJV$XOR?L.?H&$[0 M?R<>I609PA3+S5(>])I+22N^'9TMI(MY&'G12 6R85?6$TQ],]X9C>)9S':/ M']O%KQ!81IF%5"@OP1+NF@K MV'U/,UJZOXF6?J_1TM6-KQVL[,A6."AYZI+Z[UU2'Z:$=1A%$+]5-1GXD>>! MIOR)AHB?;@*:_]J YOY# YJ[_?XW"&ANG)3 27'-"&/ZSQRVDD,Y: SO=3XJ MAB5,S(MBB%;#Z(;8._P1")Z\1H?&))DIFNA]7 ZO@9CHA689]R[^$MO3^4?W ML_/%KP%P[L*+AL6DVE/>*@2"P-168TG,)?JQ,,AZC M(28 FE\PM4!F33,TX=3)V+KXQ_,6" I)UZ*>&&'Z--*H24<<]'X\(I_G2^X-Z$9+'TCO M_KR#>@?!VZ@5S^A3MR72&<^+@^;A%.AD#8O2X/-8;_D;MA/=T-PR M #PXB7 MCD?2C,;5K+@JX^GU/-KZQ^GEZ^=1-63 HW$$)K13T#,T^11MO7Q_IIY@GES% M"CYJ#F"*?V<)@O%U/MN.WJ0,M^&M+\7@0&CN[UBDZW&_Y8Q_Q3A&9IQCN M@,%#!!D/]T^]'WN@F?6/IO&LMA2"N[_363S757Q+]XQBFGQR'J+#[;UGS7OR ME,[-*R_[9:^W?=3\Z?-'-5G]@U362@$/XY06J3M(BVDU[T2_3I.\F\6#)"/S MC38V]TL\%)VN8J,0^BBK[T$Y.[] M0^#M&PBS[:AWC,]D+)J.8X@=H-X L7&0R@H0&:(VY[7*@Q\P*FEE:.S0H5"P M)GS&500 Y?UO+44:_2X#X_RPIVJV:(M'VM,+&+B9I Q.&Y#2*HJ<%7$)P*5M MS".R/Z>Y*$IZMJIJ.W7<()BQ\A-&&T_+= ($J<'G"5JO2E!AXG]N,,> QG." MDC'DZ 1=J!:FCTDSL,=C]'#K$#K--[7P;DRA+&TPXH6;86I8R#)V\(4/'=QV MKM9UC/@O5S.0VF'FM11R/G2[>P6Y[W!?V21L?8V#'7!U2<)B[&7?J_H:*>^:G: MI5DPB@4-'<-BYMW/Q@S-,&9E2R/[O4B&*I#;YQ&[8KT?_;%N'1X_(VO/'V^TM7?X M3"W RK0G&2=@[@ZSU':HO<0^2T7%O];2#QGHVX M>-Q,U)OWE)R&IMJPWJ9X.UK]H_Y;!Z&>C@I/E-S%:C.F:0L[0U MS!A9%'AO^ZASV&YH> >O_YF#]^"PT7I$YP_6+SK_[1[9N^/MXOTGW$00J#W>WCX^?<ZDFFENM]*[/# M9,KOMA*6VMG_4=5V^MP;'=&N@JG8-9C=/AUG0&ZNG_B;:: M'L+SSW-D;';3ZNVF@]UG+0NWD0GKM8J?E0E?Y]1OCO@Z;@YREC9'?.U7\4'! MM,U!7<HM_NLNW^X.;WKO[2_DI*5X&\0H[HSGDW?>@0' MF[.\5@O>/VB7MGTQ6=H.P3/($70.Y\):3(NDW*UW&I3^Y*]PDPJDS^MTZ9 ML6]9ON^SV?_O.4W["O4J#)*(HSRY=4A&K2NJXHF?_*LRKD\:S '?BO.$.9F MEG* T]EUF211\FE*RZH)O6E,UAL2'5HSN%* E3&B^(B?'# M$!.*^R21Q5E$>Q,-!M%F6;0X:42?MSC-C?O/ UMU@(>*9/1'T+2\-B4XW>2 ME#KZ@9]ZXFUAB[-RV:H+V<(OL87/S1:^Y$W[FC=M=:^U.[K?)*Y<%?+!0_'\ M_8.])07A3V-"#N\Q(;O'^]Z$].XU'T]485P6BE6_"\P!+ >TQRV)_424 /!< M>@*$H-+'"02D3*N/D5"[ AXLI*/0_@JU&=1I M-A,,".LLH)JWH]-62M$FT-B0]K9B=NANI(S %,P#IA>:W?>:: \<.-\"Q M?S5P[(^QRM7:/B9KN\B[9P:+>9G N]N"!GH>_;?2(13C_UEE/-C>WG;OZ&X\ MV%W?[NYL'QYNT&(VH.GMJ=[T0>VEGOJD/++TZHLD[GO7DT(B/(X^4+G8^CMK MO#2/*+]?X<7ZH 2&I4:J!G._)8)%OR.X5I%3-:JB398L7+5O8]98#O3_7F"] M_)^O!2O;'-$56>SNP=ZS+US4O_[UKVN_K.N]B&@)^N+PZ%GTWR85L$L?F'_O M[SS[GXUD785U DW0UDF&P!U9+),T+^1W24EFS',C;T?QA+S(+Q6U_;4_DT]. MU.X=;$3MNA]APYY]W_]&X.?^PE7?U1(<*]U[AR SW0CUE=@1;TXN+@47$_TW MYTQ0*+S //2EXGQO[<_]DQ/GAQMQOO:']UXB//CCR)K9>S_2S.SN;\3P2JPD M>$Z,!5W-TO$X3ZHOEKK[:W\\GYS4W?UBRK3L1F=+._]PVR70 MZ8UI.S$CL>U!R+.6YM%M09/A[ZX]^Q6^4 ;KWM[#J'17>+[V(@X42H57"B)< MYDPD*XGQSPH7%P;GK"A&IMLX?V+9VHL\VNGVZ"YQ!AYWO9T?C@"%Z2@%^> ; M4_=S(22D.R_>]/AN6MVW\^->]%1F=Y]Y3F5>Y;V'*.%B5#].72=BU=4/VEU> MTQYM/;OMY;U/8Z8.(K76>:YXJW4A^>TF\Z8+BOX;39=G_S1Q=RVW9;CP9]'" M2\M35KM$^Z1- MTF&DY/X=>L@T':&*Q74A6VCJM;2/UQ-!(:]@I6!OYX?H-"Y':=%];SNXO39% M-]^7,FB\SM\J, MX@'762:ZX%^)R'7#4[...^*AN*-5^&_4W=D^?L:QWHU 6N_M%S2%_EK(U'67 M0QN3Y UGY/O/_KHYY$]@);DY_/H?R^]QZ59!W=\/#NW_U>WM/ML(CO7??3]M M!,>Z+MTJ"(4'"Y'_I[^[,3F>Q/8[<4F$C?Q8QP5=^%_:L%3.Y+7X2_ND]ZYI._!JC* M#:OXX[,Z"V \22$9N.+!]OXSI AMNM [':>RUJX'X,T%+2=!8 ^^;"8I&@' M[-ID3P O8\+2^[$*;Y:L/?Y]!WYRYD?;6Y>MI\OFT%GH7M[M'SRS/*],A>HZ M=W_/C/ TTT=^BW5NQ#UJ@T59CMQH7-,9.+^FB8]Z@Q?].&(*7J"LADS 744] MH+$..^$= )-*W";APN4>]?7@.;HF3,C72Q1]_I M<9HES*Q+)]$!C/,B&I7U5== [RK:'D5=H=0\*4&P>Y,8=MTBI^?1O#D(F/W5 M**UTB-H)^[R@(8W"EW#(,?.SQD/HFB_I>/[ IN11;R=LO,XR*LVE H$&-YTF M,^!HMWJ[SZ*;*J++IUD\3 ;%\PX$5UE>)[']MM?SO\9\Y7%=\07]A0NVH_=% M-3.M ]Z>-6>"AT*;?203/P9[?DG2LBYU?D^B,>U_OB+-?T_DL#+JET;O-U5F0A.95"/6RQ3=7_G(Y)+W4+[#$IB7W?DNW*Y-API!: MZ=C2VX\FW*QE=P?_N$V2CR2J1T4%ZO,RVMO#IW2,RWDTNRVZ^)Z_9?'G'V:Z M6$44\XWT]_A>%?V19<6M%%T WHVE&T4TJ1 7=-2GO"T7.IQXOR_I=V(\.#4P MA:YA\;9W)!=ND]?-'5&&,TR>""_ZUY3-%*: %P9WFKV2!.AUG(WQ^_Y.?_=. MG;$=O62A3F/-2 B!XU[KDXJZY.D$PSVK8)+M-%59,9T8I23/2[*1R/5QDHP& MM#'<[ZM90J^27Z'X@@Q;^JM#[Q/%$+9%^9%[HF!HR905>#&=I1/:P'SC8 _I M%MI^F#UUM.R<+LBC1Q)V/D1 ^=O)-!:(7KD9Q81>_'3Y]NL*_G^UC=A0@:A* MFI#.G8D5YL/?G2W-)I SP6DCTJ14?D\#["72EX;/E'>;_0.68IK0$2&[$Q?Z M5B1OGKNQ^4T3\R#:0K,'YP1Y6H'T?U$),>1L2!9@/&. M7.(RF27R?"5=KN9<7KZU7G%_9X>F9+(P@=XEO7US"0FOW<-G1G?@![O]9YW@ M?1XWL=;"^NV:#/\%Q;_F'/E'3X4C_\#,S@KXNM]P',.Z+&G&R6HAMPO%1R-6 M$NRQQ%,2>[8TO$V&=G#=W/.*1P7=>J9N;EG$H(N>V/J5 5TW3EWYRHK,0535 MPVM4N 8J8X$MN=-4*71OL'[2W&@7H$;]5K/8:L5>>WO%Q@,3%$XKI.)(VP[- MV%3[)5:[]AV*U:(3;7*$A9@DR8S[,^6P17O242BP"6+NK;2XG&*^AF'4P,;M M[3GMI%]8+NVJ'JS8['57;#P27]- R^M?+C^#6!*]_(:O^!LV M#+E<$N1=>$UC<"_LHMEU6HZB_ZWCZ@QO[1Z8 MKXRS74 HQ.C 2IM"_/.FFRQ-T:9E2GMQ;ON>H=X::TG7P(Q#($'KN-"B,ZY8 M*+5Y'4&9UW;T,ZG/*J%Y&/EW-YWGR+7GA98B7>4.,-K49Q2((9&Z$L::1EJCH-$Y-R%LZO\&'X&=C M+!PH&232J/6?D, 5+6O) I1!+K7>STN7U 994 G$8_+2H9ET^NC,7N,)ZR)3PM1)AV%4U M@F=4&(.L)V*298$9J&RKQI&\2$5WS,Q8Z9/#?3C)O9T=)U:GR-_8+0"Q/C6Y MJUY? Y0VV?$RW 1NT\4(HWJA29%28$")B5-:VU1B@">NH>QOV&4/CB OJ-&5;;-\]-"^T[L[G^D[ M??\]\X7;Y%Z$.M]T(&L>]CQ^*F'//_21ZR8C3Z[(VYFX],,E*>PO2H]]RP2@ M]S(? /.1!MK1F[=O^CV0A%V5\>1KY?Z^S2D\RZ,3LG$R\NEZ1VPSLB1A[P_I MI1S:BHRU2^W"Q#;$NY3D#5D*=GJB+5BS: ??W_E19L=^QY_V?GSNM@-L/'K\ M,*D9^!>=Y:.Z(C."WOO=;!1MZ7UPJ?EQ)ZJY3>+M=3J\YG3T4+T%XRF0V8%U MZF#<"9FUPQF 5&35PT29>Z8/+"B.A;CU-$_B7O8P9HKSUV_G NN2MYG*6F^3 M1S=BM!:HX!T !CIDJN?UF QHF#V2 )Q,R/HE(R?]I_4C9MS@ M?C)E^SDTR_&!YUAAI3#GH=GOL;>U[,#HHAYD"QN.-Q/[5%-LIF #>A^[WR[= M29Q1;5TVNT;^[%=N-%^V '7E0BP/G_.'3_.:!VK,P4NBAGRQZ)2"%N;*3'S- MCHR9./9(XZK(.0J2C,><[J;+=.(7YCE9P!LD,6T7W>QA6(=A-#C)D_AW.E2O M:\@<<%#1>6"IQD @]MSYI&%*F*70[23@)?CSRIQN?0D$ EBXU,M>?]W7];PN MJYJ;W!9MKV>@GJ"&_<57.!YY+BX9<0Q^@- )+>CM<]X5TS@=J6R&1"V3,4TC M;X%Z2CXYG-1X;GSI/Q]L[P"$FG&8)I!)2R??[CT;O.+PQL?$4TMSL1]4S0AN M#(?SS_WM??,\%V<<7B-@8\9D[F(C-'XXAGZ;5#.:6LV4>E@U[ZGZ-$&9_/E@ MW[TD?89LQ)(GVL/@/8C$_ PHN\L?F;A"OM (**TXF9![)&R'\#NEPU"/Y9A^4?JA1:/'@(-N!MV:M^4YV-I]'O5VHCE9!!J\-^ M=LL$(5YS2I *\T^(I[FG#;G0JM377?@A_(9]:?9+4_CQQC7U$H_=M_0'V?<\ MAWHV^)%B00DTJVF!+NP*V< :,&Q=BG"LYJ'FS+&E$P^'13E"TS]Y.(X[KA"Y M,HGG[OH[54'[\QF6FQM%OQV]EGRNY X^?W/..J#(P.@=U/N0\WP1" M &< T8KA];8_IL5G+1^P$;>-^TDK^+IZ\%OHT-L?J"*'2R"PXP9Q_K&LI[.A MQ11XK[PMXOSSCTS'4(+#:^02$ O'-2SH(&X813U7X=:T;9;;-/1L>:0G2Q_T MJKP9T\F4S&@!18MQY9[8[B4N,;ZP\=QS0D!C)X([Q\^#B(NY9*3]F>IY6I'/ M#UEW$;880&#CH.'#?4C0]&A&2S2=9J)D+ITK9(,+GF'E>VF\"#S%E?R^UN"2 M.3ZEW+X*DXB8\Z8#1DN-W)EFQ*"7$OR-K M^@G7S;:Q[^5]B?AEW7?>.&9KG M%3:&IM+;).,@;LU[B)QUFL&/-G#"E,&^(TD43FK>Q.X"D;VOZ,4F QK/;J_# M&?LU!N*'QG^U";F9"(CG&RZ&QMARXRN^6G#,/QL:$[.9Y&A2T)WK#,+U.AVD M,]3CT9>\>$& ,%A-$YAQL;4%9^\/]_3*#GG;>D"?B: FNBS(UZF:GXZN?WYE90#+DO/D[<"-RW(&7> MU,\@BBW^,YU,F0N CAG_KR ^.\IO0F,@Q4L/RF+@A7&[:3S\R,T6\8)%25H5 M)#' : QJ,:?+!+'G5X:O M:%H[AE\*:P*3#M!Q2Z5=*(W5E!?2JB#<)S:#S@U=#4E"0\DPFUI3X8#D/"^, M"@9*6BLK?/,_CV_8[-!8II (>;7LG2BL:G#O@#?LQS'\XE_ # MALY^EQE_E612"F9GC38V=(XX/$S295XFJ72WIR[#IY7PT5N09UD"E7,(7UK4 MRB[I\.WIN8L#7OHG:19_Y--*!I_G$*3T""FXG%V717T%!J),M02OA[\S;- I M2S^2@KLNA*='RVBPMZ]),B&MD*MONL:A\O,&Y4H;;9& M^JA_&,@;5\73$&@LAR8U_< (G#SIW&!3!Z]OU@XE:<%ZK;M=DIR/S7SS^;^.&4;QMP,J9<6Q 7D;&44I:WJNDY\$-8T(25E&5<;#E*VC*=)A.8U-2"OD=;*0Y60]U"4=G4L!IX7T_2J8) M+Z51KX,B+ATB_.S#2WL \2S&9#)1)%)91:49*V,DLTT2R@,^\GIOQLP)08OL M>QP"$UQH_(Z92+B$?/&5)[[EUO@=;_-*(GKT'XQ552T&HIZ/+"H7F$JDQ1AM MHVWC<3=<4+$V:#H,"J*:TGCT]%5UA5E<.%P8!5X--BP"0<:QD<)'3@YB0[ ? M1M(T'XED5?/$[@&8(8,$W\&=U,06S5R=TVXCI=:=+-_"0R,*OMAW$\KIY > .X75U.A;UP;"P3=97;;7*V MX^=3?)3-S68V'DJ9H""?] I7&@I7H<9R60"3AYG%4R-'OT$7Z][.3K.'=5N# M ;E8UH?$T2SIXMF8XMLRGBYM(LCCOQ\'U>=646-K_=W>&Q(M]UY3.I>DIKLZ M4S_CD.I'Z[ MUWH8F]#"X[%Y2/L=_/CY/AY/]_Q\AD"05[AU-[3/?Y,;9>D:W1U=;]Y&^2SO M\T3VT_L_7MYA#*:5DB)),?Z,/S9X(5&U\Z:YZ+,<6%:9&:US@D8%%;//P;@W M9>F&F]=$HR2>ZI"*"#6+(:!!A%%1@0%!Z-K)PNPLM,WF!A_+VWNL.;BAM_K@ MAHWZ7SGQ]=74__DPBI% PE2;]OW MDYR;X[QRFW)CS6^L^8TU_WU8\_VO9\T'G)M<().E$TX\+[)GF1P&,G(2YFTS MWQG\9ZC1)(J?X)XY\XF-042/+!]W:P (F8UW23".)'!:#:^3$=#[G 6W5FV^*$:M&E41'MJ[:C]W4V2Z>9H7+K+P2X-/7N(EMH(S%@3*C$5TVI MSD*>)X/_(@41B!I[R7E#&]=XUD:SKJMDV&C6C6;=:-;O0[/N_H&:-8>2B+E6 MLD6WTA5CR4(Z[2FZL2,0&\EW,N-W-=.4C-_:Q?ET8Z=[C+XUJM0\8F;0 ":& MYIH\(']C].95 I3T]%H?1^J>F]F-FOD\1M^8N%U;%@G5?OSF, XJ:#*&$0*F M?,//997]0EM(2(GSYUQD?24S,\RZJI@D1HL+PX2YV% 3/S TN&99OM,B-T@G M2;,W06^.Q9?SOF,RR[@&,;8PIS$G;WVTF(^F#ZME_A?U=8(C:\OQRTB"L]04 M)ML[^RPD3,CV"I"HX/%W_[P7_'IJ\%P/^9&#?KVWT*\ -2O8EG!.S&SQ+,*$ MC*=LGN'P*6TS]UV1><,O#!9Z$,^85D%W]R+"D8,W;?!K?I8I(S7 /$8Z),KX MB]/"QC*.=#6CV;^:73L8-L/L!'&G3^?U-V/@P@+0[/BJP1/ M0P+<@P_AK3XP'&.],6DGE2""/6[N!AQ6 #4&]*I;I^7XQD*E#G 9=K:'%/4V#!4:;"O WN+NZ@KDUPF#86FT MJ%/*(!WBZ#9F8FQ A#XE$P&*\B_7'_K^*W:*S!9:]7'?8[MV%H7LV"P+P=MP M TJ&/6$J1T!5>5,I*4( 3.AN) -GUS2+2&%%@$8RK$< A/[T,_-_*@4C1UDO])9C_^E[L5,V%_(B@KGK JR.]: M.'KR* "YFPC,+OT"F0VQ#F_2"N++MA/US4._HIYWJY$TNF@E M](G=_TQQ]+A)]^6_4T1>S8 ,M_F>I^=TNL?VYFU3&=1]M-N("P9U8XIY&2UB ML8-%X]"":_*+AJD6:)EV.*'U4HPA,[61L>"]/=EA%'U1^F)D._JE MF.%E^2@:&[*A$/.YN6$R6B*.W + =43!:B85L.33"TQW<;K(O4VD[T4%GW8\ M5PEIS8PA'6T4OHH8= [<6FO-DT"]&%??2&LMLY'2?T<(I=L8!R(L[]%68;18 MM1$!VDV'?1[N2Q.=FLJK#PFCK*YV@V0TTP2C*I"P!Q M2Y4TN@1A\LEL:+=W[48TIU4V; J-IG+K\T?-]&$S/VBT"C(_DM*S\B:AMV=1 M!*-6T=F:W8 Q:>(Z/NO NA\-DK1^.6JP/IY"5(9L4WEK+C/ELX9 F^T\!O_3 M'4M_U]D*,]!TI)EDO/0K;8>D5]-MZDIM1K%S D*)1N4FJA!AY\?8T.$Y]='] MV&J:2?L 5/IK[>BF8OQ]:HO:+K@6\FINRPX^O'Y_84,4"*7EUE0RW5>;!Y24 M""\1P]HU+W82X492&J1[JC*/8A\J!YXN9L8XZ5YO&LI$52)0?<;3-X$H<3,V MEP@+EH7_ 23(31"M'1=+Y1MS5M',3A*:=U:PH)/#.%0GI;+[L1P=PQ'A]2/B MW\FD7=7H%4:6X?6\HGO%$K"J<_,]BBLJMD23++%T2FH"N&>XKK$ [7!R\(EQ M(O57'S:XX41ZR#@"?)G&!VW/38C65'M;>+P2.,;(4TQ<15R154YS".6]W**456:7>E53F&$8'4R;DGAP*])Q3Y%7TN E 15#*NKBQ(KDU(V Z'=>F% M#,R3#7>N.%NX-_J-V?,W);.XQQMMQ<:YO*WTMQF/1F_]"''3%C893*WS%P".*UYL1HS4O G8 M(G+^(9_9!4;=E=M)*S8>8SJSS6P78ZE[V&@T:Y,$0LG1$+VFJOM1=&BKE%IZ M_6E*]BA,1NW,)1[$A=K.K@'C>J>:G"X3]4BG+>%LOF%7JX*\OT:]#$M5HI.T MP'+M^$P,W8 <<\?#PCP%TM:RSLG04?,?_ 3)R#5B]WLA&[^%68G&21?UJZ ? M9-"\H!BK ,9HX0S>NXBO\08,AY=E//RH86N-@+V$X6Q(0"ZU>6MPQ;G)"7QP M==\GY "A;@F[Y<3OG^P_>HBS[[ >3-2%PBMY3U11IS/E)S&$AO7)AD%_5C\K6FSQ[_;/B+E36P) MLS3FX)&>82\YJBZ/=:#=K0D\ Y^77!CHNI:!+F"*,U!EB+L2\4N.3?!.38?N MTHX]#A7"1R82&%+=29K%DMJ9;FO":]=0O=N11)I=C?^D "N-\\TT',_.E(. MF+B'X(A9!/NA,^32>5:L0\?.]X"4Y=XLXEA^;"8,J_?ITWAYJXWHY(D*M.=SNC"KI&UJ?,XSPLP,8W\ M +S/[K;\UL)7TY(XVXY.PR5HSQGQH#CPY+$RCK2R2\A)>(-I)LCJAJ%I)*\K MW?$]36]1K&ML".J81R-%Y!)3R,%,7CMS4BH)!9@[A>Q;*\(?.73! 4\,Y)<+28J=EY?+(E'&=BL&&VH3_I\(%5>=YI;";&2]D^ M0,))G"AU'HY#GEC'@,9AZ8E)C7LX%O-Z#2I+B9.*W=.>(/5;&4RE$#J(;[L? MK7O<_K(M#G-7[&4)E$C\/8L)^(K!E^WHG9@@:<4\TW-98-J?9!,RW9J$NNVM MPW!V0$ACY/F-(=2$G%"*(:2O80*;U#ZG39G4#@D$W'-)YEV@=W&:<3A?R1+G M=\Z6.=F&W IO4_%A:\IV*ZK%;F:9KGZQEY_Z]W_;/_Y1CF9J>\LX!\TG^ER M/>_>G&R0NV+A@AL'H4H38@\53/"I4$[%DK=0LSC4TBY%P81(/.]/@+;' MG*UA1A+34P7^[F;SP5'FWFDA6"<*62 1LG-V+[C11)&#!XF);$6M!W9.&$O1 M.JY% $YD.QK9'=A0F2U@0SV_9@L7XY8M[$6EG6PU^C;6+EA1@BVMKE$6WU;J M4SH]1K?DIC >M-G-3S$>=_EAG/@C)=A^)B5^$0@O3*(]C>T6I)$=4V[/PB#= MVUAX>"7GS0!M4:,WR>)"NBV>WJ3*^%MR:1VYW$DN/0@6M_R:YZEV5SY/M9Z. M))G@%6V>+%:[^T,R3DJN(#%LZJ]=-X7U]BTA-\XU#T8O-TN<77<"XT_:^)Q" M9IU W-V-8G0PY@]7=VCAWQ\/GIV8GK(R[0A"%'M$8, QH,2C:^ M$^=S(1%X3<N(^32[5D27=OLLWGSM MU; [*R*U><(M1MR$H=B/0CS+&$@ P24Q!#Q@^*-TK%,$M/3L%H#I62MCLFLP M:B?5*\#A3J4MXZ:."8=,9_YIAL\2J[#]OX."!N%#1+@(\.Y MNN9+Z7J[\2GJ-)&S##;TSX"/]C%QQ+82!6','(/G7OFA T[RD:4U;U]8-%,4 MYF#;I\V938T68LXV,OBHN\<[B6V=/ P+SQR30??ZS1XWTN#'H+OO.^+MZ)4I M&2/OK=?OXJXF+LOM@JQ"P;R+=62L4&8,G2%:JQY'S%]);@B&DQ?D:CD7#J:K M(@G"EXY=QH K$Q9W=[2%5X7MX2T24/9"[G*(XADZ,FON.\31.?R#I\SB%_ Q MN-N[&B<(B-Z74=W?56*%-TZ%\%;#>C.9W=_K7+ML"/:>_LPPVP;.;^7Z"$UG M1D9K-62Y*A%_2R!@WN%>(3%T(7>DB$=(MG/Y2SKC*"S]@'O0QA)(DWT"[2&] M)>0*B8GI=<@#W#Z%6 ?+#4RYU%5]\L/+X@P/I.*UI%TC&GGDA]:6GVMD7,A$ MN7)];@1 @UW#P+D*8GPF 5"; #+G;/%0^.VPY!1N1[\V8U*>**R*"<T#EM'AL,<<]A?R11: M>-U8M7_2[R2HJY$)3Z6>HK1$R9J:&-!I86JUZ *I%0Y)J'O084NZJ&<>!/F' M8'@G)%2Z/Z?#CP.DF]$+AH2O=0-.?KYP3H#_LS=T$,FID! .>S0_G9V?2-S$ MF GZ)AW[(XV^TOW'95PCUS!@G+SI*(W.*+E(\;6O7;STY_CG"QL3JI8$;G*6 MGY4DGZ7 6A0_XL:T-LEB[6 UE_95!<=\% ,IN76)[""J-ZG! MOZ#6'=J>L'271F^D1.I2#%.M][ F4*GV'U/6T_U&-3)]!@M50]$+/1-RE.C0 M,XI=AH8,AV0BC9O*&WBA#N9NJEXMPIWL1XW!TG#-S'DG;FH:4F)FN2>?_TZN M0-17BX.RB$="O&ZP%71WGG,,$+!X14QBB5IO 0G ?=CQ#YH-LFHD&F?\JVDH M1\($$28B1__D7#)KMG[%I"+-#):V,(#WA;3=M&0#UM)&7!--#AE,PESR^-/D MX_QJIJD+0IC0=L6'6YM8:DN9L+DE@]/I?09%&00FFT]J=OR*_3H(K\+E04]T MU5H<*38@#<@Y.AFTA2+:^\D5S;%K#T'+!@.GFI']* **K_#X![PULP4EG0QTDN<%SA9/-#V M#0$CLK4*L;0HQT$G8_[*YE6(9$VGI=-Q39L>XP2-]K#G]\,D6X?^[O=G9V=A;$RYHGA?:>4%)H MY62Y. LVG^!<+'.N;-91E:"&P(V4;)>%R2<(!:G9!\7G))%(&!\5%JS><35, M8#;7[T2:D>T^*(BD(O=0%7CZ1RFRSRIUW18A>]Z3Z)S,!$GTI1:!=U-Y)V,B M^+$?D8@RPW>;#KZ1\7W8$"=9572DPZ*ZW!+T$H]55M=Q.W!QC4WFWY#T-CMI MI*ZKW9W.JA6 C(GSBN\Q ^*'O5_Q@[!5TLF@9J8[62^C%#TEJ+%-JTR9>":W M$'AY@8X^AIX>ER.FY# P3>S8=5\PZ"Z.2QG!<&Z+;L_%3JFBBSJOKD%C<<+0 M+$V9&=1DPR$;M^+]&;,EAITQ53IN2=3;/;U.LQ$9#S9L+[$R^!\UMP4QQ1B= M!FF!=7ZJCO TYC7O+X$GXJ-3%$M[E?PL2;1CK'E-BUN2F=.W81]6W&=<;&9' M48W J4$@71?5%"'%L%MW<4ON,TW=5#$S %RRD<<.,/,#,9<.1^+#&TM3O G* M(CB>PYN#_,3)@"7=2TMC3"O0W^GWU13T@,N#3 .UE?/+#'NEYZ_;UW?GHN7] ME6-GI(_K,9I&-\""14D7CQ.V[(0U>:T/R&ML/DRHB0*&40K7$%Q<]*0*4$:> MK^Y-4"NHB6OY83_#S9]I1J*:,1YJE,0W"!F<21/N8JI1&0FFCD'&:I,6H:$+ M26R8 A>BA,TA&:H.2%]P'6C_0DWR*2LE3.,:I]WS6KA)^3+I7$NG9@U$+8GS M6Q/8MQ,68ZL=L9@[SGY13@Z_(^9-XM].C>\.F!+Y[[2Z*DI9/\Y0E"F9#/*7 MID9,5]6%SI-A6N<^/AA>A_-\(IV,Y:/.LGJQ)H47&WQZ*4FBP=P+"L*9INU M#D5QFY0VLIW'$VN^N.%U+$V*D.I)[^^Z$DH')F-#OR?O?0Q4GP%L\L^:,Z4Z M>R19ZIDA<(5;V6G..:E;.K(\P_SYM10E,*4%!]YEUR2"EV,PG35+V^46BR3. M&V,VTC&VT0!AT#"! ,3=M.!,+ 3KE21@K\I$HE)6KKN/./M6<3O5F&->,X-9 M)%'0;8*=G?/;L; ..@U@'C$/8*AK;4#!1?.8=LPY5)P/,U\HEA"!9\[K\V_B M@="* ;;#/T_X8R=\,"5UZ5=BNL>L<8;L%1+QYS@=2G5\0:Y&N?:PM5_J25*B M:I$%;IBI,8DHV5AR%#4J*W@UB#N25E4"22=_"GF*85SAHSH6YB3'#UOIS#'\ MF_VA)M.7D["B ;K&' IXQ@X71P#@.,;G1^?;1[5DNGE^46.0%55=)B:G8&]& M4]J8,FI&%S:TMQJ^_BM MM>D4(L@!E33,[Q/LSSXWBV8=CRDF*YJ,<3"K+,Q("PA[?67I*3.RHW(,T%2S M(A^,1PR=M=Y2]:(=($+F6UIQ=S4#ZAOJ3.CY]R9 (@N5,9$7.+Q]QC U7K6M M3 O!6;NL-(421LX+)@XB+LZ2YI,;SS.%VVUL:EJ7:(C]<#?#M(?B.(YA0'YT M3,:3R6EYFQN(0S/LYCA4_0ES-/\6'!?.88:Z?QFYSZI6+=,=+0\V;NB=SHFS MM8W]+ 1G2!R5UCDMO>^M+*A<5:J(1#+]XURI0IB;U-(6+=TJ[ L$SL[#D)Q/\9+1%""A9Z:\+2T9 MOQP.LI17 1T(0S8YS.XN-KTE_))]5YG.//S\-G9HAAC9RL4FMM../;C2WC,U MKQUS<797+'%C>V@@RUS,-I^E.48Q>FVXYJ1%#FABV3.07]M*AGK* 5T#!4>& M8.E^Y5!'+$@H1DC16W-"5:/'N5)&"BT5)Z>#3=RN\DPH53H C,)6(;"[!UKI MK%M/T/6DA]I%]MT">N4,KS>%ATH/VB,YR! M$I(PKAF##6UW=':8<^(>DEV_#C]HWNQP6[*&IK3$TU2?R_#BPAF9 MD*. M1%TV4-#NTJI)[&MSWK(XU:RKA3:-^'>0UQ\Z M!.@Q8@OVM?R2<>ZE&<"JU6 M45G"+51F4F8FZ"7;17(/I:M 5(AIWOWUK'@#VE:&NE_G,#2IU2X_M;=I:<*!M ML$(3B.UB2(O" M'T-,.]/8JS;#:+5XQY/3E=G8AJYWE$STI/F:8(WC2E[IR@=P#DW6.XJT-&;# M-52M92(=K1&V2$GC3#B&H@&8QQ5!8J2N(3#SN8.40DKCRT*Q;#YT+EH#E%3- M*P#^U5K%/@0%CEH@TA[!D7'ZY:5M[IPYP1ZV1@D][2^9DB.=N:IB250Q[MLE MJB3)1\IY3F^>96VVN MNM8P/OH.:S22F&'>F#A* Z@;(;^)%2Q8MR:J$N^^8 M-4I#P+&!7'!T3/A"()%TQNG#A6GV2,A8B8ZX 9;!M!JK)4#25A#?'&Z^\1L& M:K!L,EYGS.0H0@>3SYC:<3J.SKB?N-&;L=".RJ<#3W?9)MT;;T4C5I&;/BO"XE&@,R M9FIS="X+545)KE7B:>[N&P2H@YASQ^2=DM'BO.9,LPCX&IH1*A8L_F16SRQ0 M*3 N?UBRCB*F79=B0S_K=V>;B104>I*;Q%6*%;2G,3RM);,[W'Q!(V T6%>J M=WP)6X<6,$HDXG)XO>XBY9+U"SDJ6 NIF))R_TQ#]J&':U:M M4;#=(@A8(9 QRRB_J+_3.T(]0ZCK7J6JM4\+,IC)/ %\F>Y^24*.IK@6?AKE MJ&@3-D(T .X"]:Q8O;#\@>0IX3F8V,K,<>5X0"2I;[#$ [?<8V5*@E+.Z"F) M*F9V9JQ@[U#DGK6S<3FI?KE<14GXBA?U%%Z@O*$)CD"TH(@2YVQF,EM23.;X MB#/D =/Q+:%<8F:9H,H;@QA9E:D=&QHIT:QBZH8,TA5/%>C@+Z'Y@@WO<,X*F[S6W1^A4[E1E+->)4-'6GZ MPB7I35QAD8I9G$/X:G\T9.QE@^M#$3^G@#6BE)?\<9)7EM+>@41N,HK'E M"@AN;S'?DM%2.U4\+)&4(7&'N#R59=H)XD,.;130-V#R93C&1:WU>4)4;&*Y M'-.3R#M=50-R-6-U:;Q*=C,[41&V^DC\K(]A9C!/E2F72I_<\;TJRC+W-MO( M/-9,Q6(621>;N8UL0^YL;MNXFQC//;$B6N 4@#YYF]$N50]#&%!'CDO.\[7- M4Q='NNY651#*ML% XY0&A>T.6,?IH:HR-H]9^,8)ZRR=V788K3+L^!ZQ"10$ M-;(2M;'A4=@;::Z4/JUZ-8:-%0^9G'O-E^M2 V&6TL%$W!>B7CYWBQ^%633\ ME"Q9NRP74N##)=QP;ECZ2II!:1OHV)O^8J9CA1^"]7NCP\8^\W!\8!M!:?6&W[')WYBJ=IP,-4C]\O6$-52<@2A MA]# $J++$^&A_7S_4H;CW89&]GY#*=8U"'-)*R-+!A.?$V@TGG]=3@KQ%/I M[[A^(=S*=L1='#FW/G(=96V25.ZTX/YZ#69FHH7(G+4J*""K=$&*H--$S)0D MHB3+]"K-M8FT^OZ<50)@CI6CB?$.@5?A)KUM_LAV=&YYQN4M+\MZ,@U0LE)2 M)H&,V+A,+\E7IE7)9QWC*B%/G,5"$,-E'&YG) :D++0QM6R+8@@:/0XLNM(Z M%77&ZG$$8U+6Q?$4N7&P#X:.H=3%7:2&)+DJ.-['D5<,"PI?W=8[^0<@[G+$ MB/^9+*ZFO"&3AM TJ?$D[E/J='?'?V]VF9:_NTO031%D&V[Y(Q(L<%L-H70X0A%H/%35:9I9F=LZJ,$XYD MF*R8-!J6JG\@;IGDZ+8H/VJ261M/^=U$ KL!Y011\Q*4\XGX.PUI%C/W7X;">FAJY"Y>$USIF]E]QW8>D(O.42:-S1%OC M7,& 'Q)M;F&R GP^BT_ID!P<\U3\BH\IXE!9"U^_-A@"<4LV)DJV+!33N':1- MIU'^TE;/ZGQ75G 69ZA1-V_=(LFHH3;$C\8SO8)9*D%8M"_=;>)\B$PJ2-BZ M,06/X19!W'"4.AI+R*P@X\-%,MO1;S ]LS2Y<6$" :1@OX(\+%OHI>)AF\)G MVLJEPM]7"FWG1+5L,;[.&@4"WO$>PE8Q/\DV4A/7V UIT44.]Q.]U1"ME*#$ M89#2OKLFY7X#;"XBDEX:U15+-KURQ]^$%W8BV/[A-O_'%(^[_\X=_B>E9\7L NZ(Y%]?+(:AYKMJVW MGD!90Z@["$>FETN_1H<"0Q!2@5M7G4#[?#_HRF8DE;\)QU: MX*>U1ZJ$#T#)*,>C)00% >+:M7C@KEF!OI,:'.)X6<:.(L29ALU((MPD.7>M M8R.ZJ+15'>E!0^A'K^6CZX:-3@:!/RC$B>82OX)GPG1;1DI-E["_=HQ33]N, MG3B[6G/_HCI/N8#0,L39CD*<061 M69EF/W#DDX3 LQA M>VQ&]+.?JS43H6BT<]\)L=&6(:_(LGA0J"F]2%>184 =5]ZEZH*?OQV]1;K6 M0JJQO##\9?O\B6?F8S'! MIM;=*1M.Q;8O-+7F&X>8GE)I;H'T&C2)W?^:I>+HE"]Y/*?BA^A-6E8%C*%X M]N+M17?G^/" VUV/D4U'BPN.#PSV^\,W_^R&*KPJX MUAT9QUM2$C$Y6$/3RO0L'VY+D[?3+*EB?=KYF^[.?K_?V]W96_9$7')PM+M_ MW#L&3N'GGW[VK^"'G8]IO4KO$;^2\$QOXN;8Y.HS[FR03&<-XLI@D.0\D1A( MA; 3T<^X.[N>EP49!=>TEJ #1KQWBG[RP=W?QZ,RO6**JZ4W_\?/_:.=XP?> M^!\I"[E+%F9\U^">)]E(]Y2\]=LWO>,(?5P*Y:;\Y>U[M!.:+A_6^Y^[NP?[ M^^;W'WK#%S^_>VE'@7S6H!C-3::P''Z,_OW?=H]H18MM_SZOQV7]*;6#P;WZ M/=K"E99RS9)4J6]./B9EL?257B99S-U4^2YO8^9/R+N[;OUUK^DWP8W\J2GC MR?"ZR'"7:I[3$9NQ 9+_7E\Q]0DIDVN6]_%0J=OB$I1;(_.1>0PH/!OK&KV; MC?0Y%PDY=1E]/F*&T+?OSKN])8OY2W%3T'](W50?HY,7%W*#\V0"!Q,W>''R M[K)[M-/#C1@.PW=[0;C))O%+Z[BR21NGK,; MCMK&71WM'1R=N2]^QH]^299K#JEO[K-F#ES/) L%^=7B$!3*6-.?4Z$"+2?\15[0!XVCK'!KM]?G)0O3GX^?7W2/3G_]?3L M[*S[[L,G45#T]X( .L-V4MEW0][)L)[$ [DZ_LW'ZGQ$UY?"1*@&.8./Z] M*FEYNP"3GQ7DI]EH*&H+:#\5-CMM7M[UH;?OQ3=+M1/!3-AS:7 60/5HRW6;$&V\$WD[C.G[KV9N7.A?6\TZ"V,V&)N:$8D M9^Y@0'YP.,@I5SZV:3!7[BR@D@1PGA"9RQ^6&=&U2= M/-9[;]@&5S'"9M[ --A&'^0&N&9JT]U]OGAA^0*RV1.>0C_<:ON):^#>M'J_ M1'>\VWN1)#;A@XN[B&?."$YM8DWPH$Z:7+ ML";B.'UH3?R2*5BT3,G0[P7P;'Q?:"&W954V[]EX_E+V%^G1Y%I^!D0R*('B M/(AWQ!JT:N%STD:MNII!+Q M6A59C2TK"15P#VRQ[RG4 6LY^>L/72;#VG7J%E<\1 LOSV^@05;UE-%E' 3 M86VGBL>D#<,U:CZI8V-Q0&EF(R/AT%O6TJ5*&_)5FLT^KG$Q)1?US#@[-802B M5GD>@VOIBIV/KV*R"'.4(YE;D#W#+8 0SYC-2-N[VB[S*B8[]3;.?CD18J<+ MV!7#Z 2!/+KA1X'Q\>E9J9F)9:NGRX:YF^>)ID-W^@O).5H M2\MGXBDE_B)?+7TZ"5HDODI+7')#KK[H?JYV;9%7MY CWC^\Z;H&.-;-.8-)1YIU?\8'-!^KC'IF S(.4/ M@=QII1S0.,#66UG[..!OXL0:'"?+&YYM3ON UKR@?Y"7-X)=[*@'04PT,1H5 M,&-E"6280[<: N[O6<=CU\!"8U^A/V?)UGY+3 ARL>J+8?X(F)&"+M,KA3AF M*;EH(U](JB_KBTT_Y._U;%=3(@B%UY7TC:I+'2H/BJE&[&4Z(#$1_(K&Q<&0 MLK#8SD"V2_@+5D.6P8TU3@"+:[8,M,V"[D:!+9JEP(2>ETGW3O:N&?)K(HQ/.ZI+YP_PW1"\ MY&E+#3&M_(91.=IBQ MM$GEL;"- _DKI78)07,G\\#F8V$7>"I]KGDS4% MF0" PP?,7&^#T"-'_\$1LUVH5Q;;9\G &B']8#KN>O>Q]G9URU.X7UK2B!J0 M9=^?DHX6'1,&45:N,3FA^4>X@D/+'.'=;O%RD^#P.J-R2SS=>-YO/<"S_367 MM VQMK\G3P@"?<%D@-AH[TVH9+TE;! 0,_DI&P:R'0+*1B:LF;"R#27#,'W0 M5L#F00*<0:-_@#3HJL%9*>TSQJ-W;A6N<&GR) H(J4I M@'"(,NX\)*]5Z*U#QA"I,+,Y>A/?][AKTS5G1/ORCKY5)3VF8\J.%=4P7JK;:263:F/--NI3+,=L6P;L2 % M6RC$ P(FK$QI!5Z0"Q'^\BYX1D=XB&1["L0#"?TR!OEP^9')E:=SA7)PO!=? M(992)C,MP6WVD',D#9JFFTRS8IXD7E\T'3VC2 OFV4^OI"C3VM&*YV@?/ (= M7G^;A0Z'MV"7+%.I?S%SD8N;6*27M[3;W8UJ3)-8>>8/E2^EIF6DQ M2PQV,,FO.:FX6+874-AS/9BXKEF<@CJ3+0@)7>1"P&*Q;4IZD+;UWESSO,?Q M$\I[K%*@4+#RYR*JUU\=RNN80T@R:EQDJ>TNSHF*4KJ7DPS\8;W?]]+V\]%V M[*E0ILX0A=)H]X>$V7*-9/3SP(;%*!V4Q0 L+=';LK@E0_$-5QU'6S27SS54 MKGD#G5=]G 9.JXA,%:&^VV*&+-F; MT2_BI1UW^CL[G9V]8S H3U-R/2&J?XC^5I/EV]_O@/SIR"':@SL4VU%OIW-T MN-WVO_.6MIV9JVF$B@&;YQ*0[&)L[DQ1]I !@L/IR.VID_V4@X*/WV,I$O2!MAVUE5E1UCKYY8 9R MU9YPX%@(45!+LJ36V:IQYH$HQ@'HR6AN8>.R"KWF20KNCM N\,_Z-B/RWKB" M<"ZX$4,R1G_DB3 4X6%D!.;:E,8S=SBJG>2.]@4I,M[CZ^Y48RTU4;E<1KRO MV9*CB>Q"%213U(.!U46KWO@7%&&PBWSKQ%\OV5;GIY?F,)YX MTR^NN9UTYB4$DGD$+^*"QB,$U'L=S@%%6W2;%V\7.SN]7O\Y2N[EI*/X M@?87BOE??W)T+:=B^\D?+2/8\O^XD @ZBXN#%WT2*@=[.\_#45E6;-2:\JA M(VUL3"M<_9'20(5P""$&":6UR#>2/WL[AYV]PV-^H%)C!?,@(JIW+'.*O(&) MU-]]/YK@QF3N'BF]JCQ%3SOWWUNRCIK\QG$#UQM9\W5C!] 91-RA6CRRFF%= MD *;9.4$LG_KKE?-*E-"\)XY@1:U#O/U)\2/C1$[K+S&AA)- OEW/26OV.C$G]HH5!8?EU MW>W*>0K%GY8RN2+II2%7UVUO86ZWDNVK;4!FA\#GW2+JQ0B)(6>&@ J_+?CC MZKEA4[>WQMX3.G\$$+R[VDP7^?NJ-;5$"3"9<3=+Q]I^_*9XL)2/?O%X0BK. M,)>Z*^@B2"U?/G@DH]R61+"*)Z"-(]+;_5S0QO _$%N";(MK$DW1 M5BQ0S.<=<21^PNO\7"#EHN:%^Z58(QX#F>,.8?<\_1;E1E%,5[\X. MT:;R/G.'/_$F)TC3$O0>VG9O;*MY(#(A[';[_>.]719@QI(()=@A&T8[M%5\ M&VQ!.I%@YQD,'M#;Z?;I_CN[A\T'O.?JQIY87;U[W%PFV;OWP=%^_WCW>,F- M]^]]XR=@-DC&[ ZK0<7?K^/HTE8(_YTE[6<,BLHZ%:JU=0'\LQHH6T9_')DM M\_<+JZ%5Q1V\.#K:[^SN[SX/_93&X6>^L%J#WT]BC>#- @7[V462Z@/394I& M0<*S\I<"8JY]"?X6DTE#^[U_; Z L6OZO1> M>SM"1B])48%$GNCF#T]-BO M*,N3:!!E[GH>XX7LFZP$$*99EC\>B5BMJ?U$79BOS0C(MJ6G!][@&R MJUJ.(V\4X_6;Y)MP7K,%/_?@^JU#,FE>&;K"48)!]LE*C<$H^=#4Z$J%YTXN M?GE"T3F\S4)PSD%/M'NU]B1"1,6/.*5A1D732T9,M)V#]G[K^$CLL-@Z@Z>% MR7*XN,_[Y%,Z+#J6\%5L-AO[>0JQ 0D?!F&]3N#[7;[^1W?O:!<&FT5_2.5G MHI[L97(3>TW/>(DM\-3/(_4Z>UW;01?1PA0P&UI*T\"+?VJY)K#6/OY8C5MS MV+$YC(7F&1&6>/1&QJ.5Q8@ZHHSICG"4%XU;^)UN,2^O9!T^#+HK7*S"%, @ MJ$I]SL:=Q-VB1>FZ[F]PWQ7#4B7V+21?I/%$$G<?< #KP3 MK>I&*0W$HSRV9:WE0ALH#E_G?M/H$&IW3%_%>V(PDW7 M9R?J::4!=W=6/@WX$'WP#6JVHH#6WDD]X<]OL@KJO/:V!&D5[H$?,LBZ70A@D M%'JACM4^ZQ^YCX6I.;_BSJ^,UU4",,;Z^;5/MJ\V>=H,(11(3'BG,@'R-LG5 M!F.L(IB1V:=TO7RY"PICK' @!C39!O7D8;%^DU:6*SH V)<;]!WZ+_A-E*7!EA 3 M, #8Q81Q,U)>F6'*8GJWV3RZIOW$<-ZQ_^+))]/HN[>S\ZSQD_!2#'#917;V MZ'V181!-B/B@WK_CWPG==2>S',R,>-RX9YK[O?^RE@_+0J@ M&4F&-4NJ I3V*NK0)68F((O>7C^ZH/NBE]$%61T)F0(7( DM0?E7(4!PBI+G MHLS3.#K>Z^WLB=.+*MDD2Z;7$*A:8T!+L+77VW\>[>WVN\?]PQU!I=XF R0^ M\?6B>1#(FS_]G]O;VVU>C6VR:FSMN"=#O%9<4D8>,ZHP90HM!:P6X4.YR[#@ MAN]SGW*\W?7I/\7B5 2/O0S^;KRO_\OVH3:9;;Y[1%-,B?M M2?..I+B40ZL0:J5>JYD6%*+3+I;*"F06%>![H4G%WNY6_!R7]?:W1L^-X*%O MZU+(GUZK>.%^0?1U[WAWCQ/T_'"ZZ];,=?#V+S85V5H)^I&VT$V<9AQ@5AR[ MW5NSQYT14V2K3P?G<,4>LX&SC!%28H9GZ4 )8F[V6B7 "O)PE>X,K M#)4Z6A$EIA6%;%]#F.:M^^NG+)F[.=OI^TO4$49/1]#J%;,4]"I7MO^8:3+G#!4F MCR1STR!LQ7^Z2JTXF;A^8,DP&W%.NT8%N_W4D], M)[A[X-('9\G-C=>-YS?3I8ZFBGD4\B6'RY2TLFNBA!" ^O6>\T>,-Q_%EH1@ M#O:VL>>L8.K'W%=.6B_%I;U6*$9GGMTI0*S,C+S +. VAO/E[/Q7)YNV^G<, M(/#3P*U&J M[5AN2?IFM0W\H"B)!0GML>@:I&^#.>>MXC%.!,/7R9=,$FB;/Q_N[&SO1!-Y M>8Q,WY;?WA;2>=-@(,DIV)! &07+EC%K %OR)*$ 84\F45A]FPNCF%7I;PVV M8BR!60'&?=-PF5>9-C%V_B@9 #)OM>%(B#L$9) 6BN'O\M.5LN.))4]Z*Y\\ M66,?+V!W86M*K2+7/HV+9<0P62XVVVTF%J,V9XP!"5.UDM[HW4<&\="P$94N M8)K-+9,92@>YE)PT. (=0R[2T4X<^0BH+3#2W3U,()B9J6"49/(WC;J8&M%L MR79:;F[5 _Q0]ZG*)]SY%HTY8F:^XZK;] 9R(-1%0@N6V>PH>XV.C<%&,ZSM M 94H=IA5YK8+Z2!I$@=Q$[W4$EJ+.A;"/-IB%3&( M^6='670[F6&Y$]Z@C^6*G)%K31':%"8"L'PX+%AA4 5O$BCN6:GT_AAW 1- M>#_8# Q-G'G3_VJJ46MF^C \UMI+;\EL2!H24(6?%Z:WQG(YX#BQEOI/1IF" M47#D.1"5%SP!8F#)R$P##H.D,]>W"I^J]3G,3B8O@XG;2I_S!KPI+(T]E+#^ M>1^; HPO;#NS0N_O^W:%]F ?F7!_JW7!EG&[=4$&1:H#5'/.&'+A4WN!->-9 M"9."'@B6;,6JL16:V >QX6 BOU]K"D+3ZLNFX&%GN*G6'WR$E\$BUMR(ZJ^\ M$;5^CWPDCO9+%C)*1__YI[/+U^__;^_D_WXXN_CY_[XY.;W\]<,%67(S\LE[ M)]O1!_38 >LH1/'RW[KN96/>#9+S,<\]J: '?CP7\;2;7B47&E6@"RLC]L/ MO\__5]2/>=UK-H.'9"PPS>_=S^TMWL!@*QX^8 [\T;L^9LY0:IFK=0+?X\'# M'C&QVR 9/?SA@R0K;I4X[>&_9IHWT#@^^)>WUPG;S\P0]S&19*8Y*$P?5UDV M+S*9#"-<=1V7XI]\^;EXW+:,=).Q2:L'R5;X.,] M_(=W9%L?,PK-(SS\IZ96RW9T,K6N#[_5*S+X:J9J?=SQ/[[H.0[CYJ$+_:#D ^30$;_8 M%\@+T\_N$2+&N!>/.!-?,%=#LR$>\=CR"[:/:R#UN#6:E@7+^$?\?*A$E);# M^7-Z?]D8;(^Z1_RA X#:?:SO. MN$HD>@MBPD=)\VF9#A_Q^E_%$GCLIAMQ7[+D$6<-^VU.QH1V(&$ZBHS;F1HT MV5P2=,8DDA1B+!2C^*6E]>4-T E7TRL?&XL?)J9*:?)E,/HXN9Q5B=!JW -S M9K*U:G3XZ,Q[#H('S>EFUP52,\:&,9Y_9*7)=O2>#%, 5(5XD9\CH3<. "9M MW/UG,UNV7BB S] ]>NT?.3B>@):!7X3O_%3 1)X''EW4$QKU,CS00_SPE>E$ M)R T)219R+L:[]5ORZS+&WD&O/42':+>[N3(>E21[R!9D)5#'W$+6:-6I1E M] M61/IM] NU".6T:VY[EOMI/0QX5XV(A8C(^5PXN\EXU[R9#.W3R7;EK/;P!#[ M@@9S2B+%%JB/TANSK25 FB5CB%SZ2HKM!US<])]_VOF3=/P3V6S_GB(#J7_K M?>077>:6GE;)#^8?/Z+%\.SZ!T#(]0DE_W<$) ]^S__1$?*WD8NEN-S>RTD M331PVMVW93S]T[( +X__LXB]>QTK7Q[=^X@U==C#:N[\&.=_O)B-UF9^VL26 MOO)?&N_\ER^:S+8ZPGO)1SI:2G0N#WP9#S]>,3EDUW^1;_52RTKU[OGX/XE/ M?V"LI#LVT%,].<'<+5G=UIW0/OO-+DHFGVM[Z-(K(ULY2(N62G'8]]HDS#:4 M$.T"^K"TDA86G*OS&B[),.JPON;"!=8)PT3;KGI=,0KY M5:#7A=M["$1YZAH9T[_TGAZB-@>+&O0?-WQGQ2!E)&HV0.L@>HT&%_3 6MI= M^/JIN2WI/R7^@UO1_Y(:VFBC%3Q3&VVTT48;;;2:VHA=>45YF9;AC$GVV@4, MXRD\8J'NRF.C)'Q'QX&[%)$60'EJ+NL")G@J$IC;Y[%[%+/WW\"I&X6A$'# M51:Z'[1V&^5F2#ZG9^%Z<"%\L=@K8:-3UO-D;'3*1J=L=,H*ZA00U13Y5<&E MD+_^X^Q5MW<5+I'PRTG9"P-M5,1:;O2-BMBHB(V* M6$$5\:O?I\XT %1HN.D+V##D)0D#3HU%&UY+!ZTZ"#J>B]B'VO&]"28-3F^X M1I*U1WNFZ(Y^L=Q+@%MV>\FDL']PTQ'15*QHN;:N;45IHFW2QC=4@"A5XA+? M$>O6J@@34[8>PLLN(:*8C#;Z:SU/X49_;?371G^MH/XZM9H&;<3\H)2%/L01 MP .SZ[E22$R5+H.;PE;*H&/1.HR;0\B7N\Z*>D4XQO4Z$W,("#:3Z>UHF M5O,5BTZ1*TW"F.C,#8*8P45AO@6GF'O MC'DGKP51U['8+DW;._R8+7A>P(R9'Z$%A034."&?V!H"ZR0HX<[&,5CGW;J1 M\QLYOY'SJROG<^9324I'0P(T/I@#\Y($72I-@%)#V=:2R^B$'[9SGCM ,:L3 M84+U*&@6H<4;>;^6NW8C[S?R?B/O5U#>&S M4[""W:9CPSV"E_7IEDJ(8B%9 M2\M1%S48H,+*:Q1GU27H,/'CFR0?<:F6@?2*%4^_9HN^F50 1'AI2@%,:.A- MF6;X'J6.P<.7/,+#:2W>DA,?=17P;#-SC^FEK7VO^7XV;>)XQ80\%*QK=)]T M,HU3*0R+!VFF[1-->^+(L+\!_M6N)"4_(SB"-%^6K-$V'WYNQH*D#6QZHQO7 M\X1O=.-&-VYTXPKJQG-?47%Y_UV:2L@)X[J2;'Z5"NLSRD(5E<5"G+6M$C^B M$6HYLPR4IB)<5VJ) MI\(9M[OZG'$;A;QB8F6CD#<*>:.0OU@A/V3)[U[7^ZGK!Q2O:C0289)JOB7DXN?.L)2-S+=2W&AX/N8T=MP%"_Z=M$EF%7 G.=%S8P+ MVNNFNEZD7)3HJ71[B;4%CB),Y#&#!#!RCY2! [)ET#B(>88U!5G:5)X@UD?< M-L6+L[HB75M$*\^O;#5O"LV#IV]4RWH>D(UJV:B6C6I90=5RR=TO+7 $+LP@ MI6NNTJ&C@4LK!4]\,AQL#7D_D79XYC;P1Y1%6 FQ?2_$8P;*/'RY@YWC&9). MJVKN?:>511M\Q7IOY8T2V"B!C1)8027PFU P!YQMW+Q\II34CI+-&>L,G:BX M%R(XW;G>R(M'-6!RJ?9<3&9"/JV:1;FXZ6)V- (&!.[^5V^D_9KNV8VTWTC[ MC;1?06G_][P2B:A=[QEF/BSR8L+-C[4/@60E&"17H<%V7=F,!GHL)/];H_JT M:A*<\=U:VAILI/AZ[L6-%-](\8T47T$I#N*S=T4L>.B+9%B7R-F>H%8BS5(2P=$_T(!F'KV,\X^FXU-E>ZC#?"=Y/0N"\JVI8L>!B:=VHI1AS0*. M+L9H&A_#.;@%@ JU/$,:%3,PV^I2FO.A]*TJDVFL_=+J&=?T2 ^@43*8)2-6 M)55!TU&*'S#-XCQ7GD_M!#5GPF=)6MQ>)SD>-"J8H4;45HUNW;MYUH-LV-5:Y"S]/ER6NX1>[Z6F2NS6)/3F!O[.M6^$ M*6+&N%39KJ1<]C,WRU*%\EF=/ZOS9W4^0W7^JW(H-,0HF:G26 +O=^H^Y:)0 M3"CW_HD^0^24U"X'!GEI=?5[.*.C)E1^;'C/=BM+-,!4T:F+VIF!_^(6S_\@7)[@ONMW?%"P+22&+D_$ M\X);MT,7NI0;C1&D>3317&A/@9S=)#]WFX)6SM^#7%CO# V.](LO[K[X$YU5 MU_WYILQ;TYPD>#^MAJ8P$,93'*W"9;I$L!X7<](^MBY?W+WLK7\D2GJ7\%2W3%#VPZ 4/2K9L MC*,F^L041[%DQ?ITQJ)/Q\EKQ#Z(Q56Z[J?(FB4+"3I5]M%'2: E7^[Q15^A MDMDM><2 ?>S2^ACP.R?TLDA6I#K\3XM5XFA=BAY *4=(B$0_^MS+P8P\>(1D M&4 M@8%=M&!Q""?EZRMENFC3"YE+52BQ:E$TIDI2U$_"KWM&$=%C]]K:MB)% M\ZL%[RHQ1]TENT5?!E_DU1#VVJ@3M=69\$Q-+ M*G$#J57?N*9(3M85-7PF5Q!67$QI9KM$_.C'5\ M$"/=2FRL_+36+)KIAPICL[>\0V7N/]9M(!BYV!Q5>SCFJ(Y$4ISFZC>QQ99[^AF R5#A1"$* EO/19 M16A[);.:R=G[:=A5%TYZ\%=-H+230!%;7*>=ZF(+PX[L$TEP$&4RKO#56!AK M2W'=5WRJUWVH+0O7]M>"\BOZY;C#35DXB/U_S1_$7B#_GU':+RWL^=3C.%,N MODK2 I[&HT-Y"_>[M&[@.)A5'[# $0R9,;N0K7TWD^P1E"@THW=U%$/Y7?+: M3")$?\:E.P=&_1F'-M:?JZ Y3'E*+;LK?:6I&S+6TZ1L]VM5HX8\@LUDJ-T- M,YFP&46SJ]KM#E^*J1^CU/M>OT+P.BKW7-L"*R8*<0HY*/LAZ>IANW+?'";9 MRZ8X>L\"A&07/ABT['%@#TNB^'6N FCES1M/S<[CLUA.78J6-#(6VU9T*@;? M"DMZ%GS1_JH\D7V7CZ:U.%79D$Q4*]PE7[DN>-B>E8-^Y][(==5R@95=<%?V M#+OO$U.\[/:2->CNMW2_IKBGZFBKN. ?]8:O>ZRG V6T53Z3!#MJLYM4-M;] M8=/7)0$JR[":"_^N'XD,D.Z=56L.=().T]'A#\ \Z17)*0,+@ !\.^;EBC< MV/5(!NX$#)??3:=HLM<']G25C+(F9^CJ?E7!:&TA1X!OTZ_.");4[CEBVI ! M58)HP=CN,?S-F@#W"'?7S6C5FTY?]]LZ]A 9+6!==>!G=\F;TH,LKQ(;,W55 M=J"(5(T #(2I9DTMF_VAUZ3&5)DF&Y!._O2.]O5A6+V8-B>*";V0IOE]BF>@ MV=6D^'K[![*7[33\#8T61.$ VH89#V /0=_1"1O=B:-VKPGZ!'SW'AEP\65N MM5@,T3^DBDHX($3>P!W 9+RZ\2"ND.LA<(>=T\() M^A G+@9#LH-#2&])6"_-(PL]:'41KORE: M;'IH5'BXX$C3U?);"R,"YZFI7MC_9)7-Q;$)^EM5CO_*_R4OUP!YJ\J88@%& MB9+7&<1ER$--FFRK*@^(/419[IXDP%CP+D&Q%Q41? /;RDI;6*&&;?3M^4CE M9&).&)F.B:19>?VTH<@3Y6+">,,J9OW!.G1JHZ M*+7"JA;9-EV$5&0-ITF40U)3IL7X M5/;IRO.?B*98J@?9=R;[:Y95MA BFH4>- #I;,U-AU91@' MJ>1]'# T$#_L&0]X'*=?(U4\>5W6@5,?M"$?EN9.OC[^!UXX\!;?:V=V50T; M!2_JE.L+^,(+3);"( A+BJ;05%M%#+DV/J68PD'E)N!_\+P31$V!*X]^7#.B M=7\,K>H/& *!_\H5ICG@.]2^^<67K[YX]9(?]+^E?WGYY1]/(US]P3[\]I]_ M#WZ,!2.M]<=@%O\BE(_ [[?W,H?5. +(?A/M#KAGL/^PS#!%# )T"9;<>H*$ M*?6:#9N?%5:NH:_X+4A\\O*+%_\/8Y)89Y%W:_GVFZ_N1AF2Y4730JMFBBD* MLU86)-A'2E:/8+OPX@\"52HF_A.B@;G\H6X:"B" ^.,@.4K%GCPB$C A-$&. MX1:U)55^. EL=H>#CSR>$F"> 2M "*I,&."94KN )6WQ;P?"- M_+.N*]3!'UC!3V'W=NH%X^/8(P!?V!!*,T(]VQA(+T3FK#>[I*0Y2CKJ+NA# MG#$9,V*#0@&QQTUO*/J(L&W^$X9_8_2\B4M8>:-D!P\XH==6V" MNKBR<2.RO0B*SMI3C"1D]QZ+U:>D_BH+Q@"^S;Z#8 MT0#\M***U;:TZO,28%0/052J+157(B<"7'M98]'N?(2>&DS_-@@$$4GY*C$9 MJNXUD=#5?-QL>+9_O=ES>$3J.1BIQ2A0'Z?8P1H@_9P:' !ZP<%?' M[W_WI[]^R3<;E]TALP3LDTX)/A8E]^0-;/GDC _N=9O X7'8/ H!XM:7";P$ M+D1,S:(Y06?XP?VR>Y(X^)05))*>A#+8F_2^8FX^>G)/_=S=8Z%L\IQHY* * MX R8W:I+[9!8M&7P/A91,C:H=YR.<0!.XKJ^)Q;7J8+AS%W*R2[7<,_(YC&J MN$=-^-&NF(E[0Y"(C[UB>J%QW3?7N\3J,)O:3Z"N?&AXK=Q=E3.&&*A7F((R M366)M>KJ".(+NY$>;8ZM(DR#%=_Y#SO\'_AI9M_B^C!".(-IP!JJ4**0>]6; M!><_>F^WHI1?#9( 2Q%B) RX7OHVY;:4CEX,Q7(JQ\-$C<..*@\\QBG+,:#6)FLF=@K>=HB_?2=E*@RGMD%$'\_B[7 4R+3?.H N]U,V 'IS@%9U%B6A=5&<"$S]@[1)9H>S2 MV^_G8,_BY%WE @(7FM#8]"J<^G%2VXR^;<&.H] !6K#]5U;DP;MZ#ZZPPH0" MKK15;40X&U03^7\'5Z=^_P)?"D;O7B4',!@S;9U&BG?"+ZNC8A:2M.2/@4UU M?,'_91.,5&'AN-:1H_V#REJ<)F\ B$61ULD6'>/2.L Y5W?N5(&!>3@$AR(E MXEQ:$1]=!-=67)?\E3 M1#D%[]]*Q3C>0-$!&_'T_T^:JHW!\M"BF M4.6VV=E0-G*"-<<.*0R\?U\@YYI"^$PZ\1U!@;IP>6]>3N[1&T'NXXP\7=ID MT]M1NU*JWJ4'2V1,HU*KGOK5Y3#:PX=O>@/=,%:]R#%5NYRDOEEZC/?'B=NI M0Z68.L*H, ,UB?LULO[8W50?4CSN=*$5BHN?$+N!% X\]M,.G"E*XAT&3 M:1\I5N6]KJNR(]= /6ICIWYRM<)Z,TK!D.RBDJ&H(FD<"Q7(<\%630O.Q[J) M9(V5U6BQ"$3=AP7MZRI>?%7655&X*>-D>3:#^&[-.0E'(=Y1AI-#C\ %1W>V M#-)!Y:ZZ ]_ZZHM7K^Z2[S36-C&03&WYN;.4JB4WW9B[3A\B*;]'[B@[T:YL M\1A$%%@56+FSA<_(5=[XBD",>81I-KM=*'9KY=?E+K818E:GK1?NPBW N@]2 MR@C"W7VM;0^$5\J;*:/&*D]+_3)E M.OB7ZY*D'@M;01]C\ @&X2R$+OX]81Z@,H8O&DS$%AC\);/G!=Y%0QIBF^S0 M'9G\+R59@6\;1LO\IL7H7' E99AHJ+7J5LW&??E:JIBE&*?O#&Y*[5*];NWS M8"=NK_#FGRS+M;X)V MH"PKK2Q9(\8]Z 3BA1,2WE@G9[KV$P!-]FU;XROP$N\,R5#13$E*]^^#3S^ MF6U MZ1Y;UT36)%6F5Z8=O+J6G$Z'PN-C:VZQ[NQ.-I4"EKL/FOB%MC.AM?U M/LTR7#)GQ_5)5IG\>AH7/:,DLX96VFSYQP3+[9 M@03;1!_9!$6%SX?)>?X-*5*JAV$CC7T+R\TU^"YGR>P'*2MIT>ZL,F:[A30A M?)F2'-86%[ZH6P18?C?=90[LYC0Y:LQO"@FIP[:J;3F5F]CV)DR=!=0@K;GVT^JKAZ5 M,U]5+>TH?X,>>K"SXI].Q::P;\..VFJ1+LS5EJQ**,EC&KY&NXRT\WE'KQQD MC%-X!D,N5HMR."%+J7W-M1:E#^FQ*\0)#)/3)X!U5>_-E:%\OD&>4SX/9F*$ M=FOIV:N\BLA[-4L\&-3OC&MD*LW/4W<+I!!8(!@BJFHH .&C$,@YBS^[8!0<7F MIZKF_%Q@8,+@;&2B#MQZVY._F/:MJML3T@2@46:EQOG5*S&U[$I\\?SK9^:5Y]$>*-(7L\_1# MOO8^L)$5BC[88?9?T(N#'L.&-]M89CM4%F7?W$IRQ M>^4J8[Q4ARJ)- =HI/'IY@O+7Q135[8]E6X^? 1=L#JLJ3E3KVJKK/"V[KP> M'E%XXO'FM<'$L$N3ZDP&I3)$V.DQ1R]5;BR4F]:@RF"A_/;KUX3_2N7U0>AA M*"Y8V>?B1EN%@I.I]2!<=H;3J<\GUH9P9^75T:P%"-_+N@%TP' MGMNA[JL"<0O2@\Y=S!#U'UJ7WE?8G+ J;39Q8KZV1K09>3M(U-C@;Q;<*C*Q_#KA3C/=TTCN,G=%P;(LXK1E9P&$)^]E/JG+(-U.8P-'-6LZ M@E_G@PGA(Y.#OJ_$[::H-Z2LP;ZSY#34THA-F-718WS"M;S5/PX++Q+SD6\4 M&0!S"9<61?NK$X3)';V89"C8WD?4RDLN/7KG4/BX'PZ,+O2XT$]R;M%$9H/WV^[OD*X<$-0#"T>81!9+TE4(X'K09M>DZC-(RZN+,X4I(Y?5 M=<=Y32+E4!' .D'89UN^GF)77MY]Y2YY&^;YV6+.1Q_TIO*4CKBHL W)P>X$:@?#H]3*A],\KLN:[ M$K&@5XUJ > T#"I3.J_?YBVF!&3<'<"ZUF;FIP"FKFSJ.]62Y:?<+]-AK\=# MFG5?['TD7.3AP0FL]1#MC5"61@!)>M,'S5M5*'?*XL)"%>BQ65R ML-#T1H[!IQC)"1=I6M9 S^"_#?M&^F^DL+R'C.L-=[(TQG=_59O-BR)=JR*Q ML%/=6[B)L.-X--WLJ9<77B,M<)H3A,=74083IEFC&15*RY@+R09DGXPB+F+#7\ZQ)'4,E6D M=7\)8O-P32P^8JE0!N#,R*P\AX4H(PKIHV_9%9;!<"_;KOSI=(/[)P?WZNPT M.0W'6KF;5(K04^MMA<"&8D1Y"IR)==KM\,[CQG=#/@VKWH7;'53N2T9H*X"_ M_?JU$.B(+;E#6DLQX-"/ )/X%JL?U,6LR7^170ID,&LA<#_;9&>?^@AR(N;H MD)-O7;WN(G1&]!FN,M](,3M[/<9*PNYIMN4BU)XUY<0F3A*U^]I8,$9K8L6P MHV$EU04(= -4+C%"%NYI4"G3]Y*<4TG^D.U/P/)[^0:X0GV)R 7U8?*;1\I? MZG#"N95+-,&/P=#!\%@Q9"3106#1Y>R@'Z26"NOI&][F8OX9&S7KPN GL,9$ M@Z$.##A%9U=L0%F%13PR':7*0ANAS1IQJ'K5G2+J3*YT$J)VNE)MR8DFEOF)7*BGYU,..P02U,'(2$VTASS2&03;*4*+5MWZWW#;; M%.F#C\7??C^[D+N87Q$6*ZVE%C311(GE_#9KH5U?#_,=Y)B+D1FBHWO8;BC; M[]BN)USB&\V<@,?EQ^5**R=Q:/FI2SG; V,]B62 MLU;,^SO*CTE=).SGCO&0& 1P:VG"A0#.A[;&QH7%]YB]([P0;8C(9[MS:6Z1 M=R,M&L*%)\^9 3TTX1%F,=%FV>UL482E/J(#(KV1._WM)3LP81Q1PPIC4A[) M]I0E%[G/]G9WG@UBR6S6=]=DP:+R7[9=0AZS2<_R4WP6SV18D-"C(KQ=PB?2 M5$RBDWQ7Y$^Q3[QFM'C1%7$K<:OJF""+K<&(7).;C1-%M,16IUZ-FO2[Q5F? M<3Q%7[['$=4*RV$H]B>,&5(*EZK#Q+$ Q%J0.9%["VY^H'H\Z3BIC+%' MO" Z7-9RZ'!GA=_/6T-P&Y*]85K"%N'&^P00HA.N&@3,%J]7<:G6?.%5R5F% M]5EN(&RA2*AG3':I$DN6.+Y?5WMMI$_%*,5^F^6M3 Q];A6'G[J=3(B,WNA@ M)'5U1NE*<9(Y+$4 M]0 +,P.VS6JV>:\WA&].R 5&KV4U(AWAJ"RPO%-RDJ@A:OT2;'V*H'/&/"JH M@_DD:0 )EF;7@C5CF'&=>&4(WS]2 I,XL?KQXH==,6'\P2, M0_/4Q6MDV@PL]QTVB*]F(9*^-B,RR,F\"W)7!!<>UB_;84NT_!JQ]O*%ZS]: M+Z2#$%XGTAXSA++ =+!L.3VF;P>;VDRCD;]UYYG>G&SP]=S8&&XU5 M]*0%(P^X;?^6;H+%Z*-H,,$X83&C44J: R]C;PL\4IM6%KM$1689M*EL0AR+ MC-$=Z@,C)9$%<;-::Q32 M7/W62NTB2L@U4K.^3H6K;Y$59-M\'Q.2VV#[8KF5WI_"Y"(N.G6IKI5=/Z&7 M6!%DXG4G3B;.!CQA,(TTJ%-A 1P22TE+P:-4$96/5(@KKS V;ADKQ4%D/.K" M_$\E,T>X8QH;?!C1^R4!L+D_K/_CU15U#K+INLY:;,*32:#9I\(*0+NGLF>J M@\-VE(K""FMXD#-"O/\(9B&>W1.#UOKO)P6M]0RD]7\-40LX815)]EQF %]= M\O@)KSK;<;9Q9F,S,QO/:LD;'2:P%SP-N@IG-B;LIUOPDGJK[I(YO)SE%!:C MO98B$]8!=^FQ!<^$JJ;7IDD9O)%^P)0-,QOH$ )=EUAN6C;AD)/4F"IC[B6* M0JYU=3 6,)]1:*R/>ME=-<_3[)A";'&0PVZZOTS+SG-.2&JG,7Z[Y+-D4T\+ MG@&%^_5^P8+T%&PXBFA>:'#,= Y/8!MF!W+KD(4YF;N/S > %[SJ9#40$ MM>19(-06[WV MRS48PK*=YR.Y*O(+XYXSW8H08W[) M\QA34"2>5X('NE@TAJ++9-^ M*F$)L+3X57JHO33:8(&CVY:< X>>7-P.F&_$K20:;T:CU>91]BG_%)+0N]KJ M&%#/R#;%J%90[Z.)CFO4ISJC42305;(E*6NOI1F3' MA$IYFX?*$@L);[,>.C%8VP\,#/V'W__N+Z]>??'EFQ^^IO]Z^>4?<5T*Q_ C M/O2NFIA(! [>1I]KR1U=4;[Y M7*9_8+,B]L4B=,@,)XV$Y>C-9K0^.AXLR(08F7 M6S-#H*Z$M*&G3AI23%AP=)>\%FI61Q OL[ECU-AZS"YY"U/#!1VDBWH%BG-W MWXL2G0'GH1!&KF-'1F9DH0JW<,)$72S6X[>!V+&&/.)K(RM! 5X'TOG17Y>* M>TC75#K=U+!ZK;#/S*$DK%4D^6H%O\QV*F\+(:=$54=!7?_828HP7!&GON7N M-:UGE'^MGT3P9B#Q'+N1;?+;.#RNVZ!=1JP=G/G*\IZ;754WCP/ 3-S-1]>7 MF5AP3P;GB;F+V.4!TTE]R(I63C&%,12I:QA_,1R61VF&BJTHJ@=/@*L:C601 M(JD$I4[[' 6.B\W#1/ D>BJ"?$HJ?WFU?/1K&4Q:&+^5W>Z16*0=.:]X@CYJ+[_O>7(F$"W^4281YIAPA"DIN%[?:WBB MJ63QIT-ZW$%E2#\ MV(R:P#G?Z*R]Y#8?6>5,>7E6>(?[%(-CAK[XQ4=TJ%DN >F,3B-^I$!T7#4' MJ[#X_!JE11ZTM%#LJAJXA=>&(98HN^#'ATDP(F@;_*U4&5N4'0 M7"OZ]N"@C"!_( 5O@A-) >@D/%^KA%A8@RPC_Q.:A1UMG(4X#=E7V'SCP #G MP39!+&0XY!63$"+K X$I\D&C4"RSR0?-O6*(.(AKC"N#6, M"OO@//Q$J)]P37*=;LL*>2((<<(%')%6RQ<)!3B2&ZJ,NZ=]X"?1IK4T82EW MHC*,Q9%GKU'*](;P]=]^_^X[/Y&[Y.U!992V* KX" 7 :$$RH3A&%_5[#B;-(@0@2C341@^7M=JI0*7D6 M\!;X]_ T!&.D#V/]24\$',IMP.GBH_!X$)DJ,*M;W3@9H6=Z>YD$V2XO^R#C MO4AATHO^C>6?A\WL..Z]#RKPFJS0#_5"U3$.XTII0Z?;)DN3T'<=IAA6B:GV M"M?E88>;1"0WW3K ^QS,)ZP@/)NA2PJN*0X+8_,I3(:(P<*J*\R<@B\2N*]N[7I?=W6I33?S_K\E MQ%7.L^J]H=N6I#7*2S==R!M6:K -\.7A3#IAV56T)>D]G*MT+! MW"48U?:AY6!7SNGB4^]_"$*S^+'P<-GKB'R58V)+:3%*BL&.-8A&Q;Q?^(-J M?*> 5#?5E@HQ.C+7!U;R@Y-T;O0#&W L.:O@[AQ?M7;\;HXNA9]SB;V;(%LI MM&5P1O&8T)HUV6GIZ>^]I409& >\?4$5M+>AW!>#L#$M+1,,6\IG;U,F0U; MOL,T5?>7/#$8UK\L#X;5NXR7+>S(91Q[E1_=B>R9\I]M%+\JOM5JN"^(9\*: MI*$RIQP$&Z!DZJ'9J.O\!=*K(*M"V2)!'AR&FD\:G,8 OO/4X>=]P MC6G"B7]=TA\F2(V,?5/0I>$+K+MRS#EMFQ>BTWKTSV?5:! B^#Q75%>T6CU0 ME)?K'E2@G-"P@/_"O=>J,[WMK@PC"KUM1%.X;/@Y:Y",Q97U)MA9Z!XZ^ECK M$C@7*DL/+'V:4U&%.Y0(9,2=L.WC#!LRW(3";H[I_4SE>T< M#O *.%KDZTJ-F[ YB.\.,",K^#[/%L?'1W.G#_R%O[_[Z?O>,6;KC3AY'AD, MN&8;&Z P.Q=VP\'EVM3M@?;,6JCV+6E=8UJ0S#;_Y1!G$Y^V=F#"U!S6&,1_ MM#]NK%EII^9Z!BSE&J]N8'2?,Q69Q*>KP\')PV+!-C]4-3EX+JY!/V>O"_\; M[7A58RF^FQXO\,!CQ1-0.C_Z1)<9^T%V]WN" M%>)W>CPE>'7O@%EV-?IX'0R19(I)('@IT!))!V<7A;G$:$GO:+[@C_1^NDIV MU0/L2LV':=!6:AU+#'.X5PY[._F=[2&Q95#>I0Q6E?:/?3A>]S,+)Z<+F%4, MME.P]E@45;E]@LR"7M3;O3:;.@Q=;-#5XQ951475\$:@[P!^]1 +\-,__\(CM??]VCGGFOC@.Q#+6= M\6%;-(1PP$CD S\YP)V@]L,S0X.QZH/>CG=7_^V]"T,'8:P]MBW471BK[Q&? M,7NL,3-AO_AXA5\C[A_V>,I%U^F>^&9YG@=;3_#@1N,\49@-K26( JER7M/' ME\2OX$"7D->,Y&U5)VCVRH"#N2_4?8HL1G7'G@XWIN,T3_ZGR7U#,?[4=Q2W ML(0L_#_SZ)*W5K/!-K[S7.K)._O9Y+43Q.[^0JGU;3\TVL$E5E=8,4VS33F4 M;8+5(.&=O*_<+1\!BVO=*L2FZ[>^PX#2[:/W@*L/XN=V!\ :C]5^Z/)(P MN!#&E/7K!+.W![348>"##'60D ;4^M<*%!=&2O_SY2IY]<6K5[3]SCX?;;G+ MJ?@/N'T72C8+8-IX._#Z?=<-J([@Q[ MD[A_YK \WU,^A%NG#QY8*#SB=CX?9=S]Z[.+%'/G;R\VS6W:MF_09YAJJ]:F M(@+#)5KXD?I5N3A@SW1S03]G0:3&4 "F\X[HZK7=:V@/, _1Q"M.P[)ZI4>= MRL;:\?0I0ZX;F@YGS!7V[3_]/B]\F]_%&S'>)QJ%'IRE=#(NP\RQL=^EMD P M.YTJAET/K#<.9F\T^"RL/\D#X5O@NW_\U-WB\/N&9:_D^'==H7^]10!J:X14 M&7O!F6)%->W"H/"12VM8,;KXJ$M6'[NONS5CP]:3_^)*5.>6H/?H4+2#9)?W M]S%FE-9XP@EA[,@I\I4-QNQ2 M1JDXJIZ?@-&!(#QG/\'&?1H&T]SS:T7E%NPG-EY&\![J<"_^-]KK83R'8W^. MHSQW6\S55"3J[0$O;ERA+H ZN%6G@Z."!Y-V7;3B?&'NFP\)XMP_#*"\'PTQXK]HH::9R^(T]:N'U1L&2)DS-L8^%44(L M0F$D+]2U]F#ZO-ZVA=L3Z]I&$3IV&+CNPSG(K@[,P*OA;J.:QU,7\R@HCFX% MWSGL"6C#B85J&%UV5]40RXL6M5.?W2)R/.!#Y].,8AS3,0)4F0&@:F"BIGLL M7$TL2[0S>QOLB\+IHT^GZ!*<#K*QC64+=X8$8_A^$@/K79(A/!*$U41-49#& M\*D+U+:\7BMKF'003"?*<+S1,=;QTP%0'#;\R[K-MZI9/N#L3X,$DA""Z3'3 M3-;G"")%S-445C":K"%9'R%(A,V:2;$9R0QG4PRF<5#U^3+]"4#0833<%HH) MWZ.$WZWSN82]H$0!B/4"9_J1AFV&5FGL4B%XPFU@S-C? MN0+?@6J'I1 D,,X+<%T'?6MTY*5]4HTS43A07$I!I4!'70?R)X/Z\4$$F5J, M@B'N@A.2>=DXQB>YRDX>51'J\&O?[1[5&!S3OVY;3*+@JC$K#7+2BMNN.V8K MHYRZ>ZDNT^*XDP[_4>XN"O6OW M- CN1: 6L@;]M4-E#'6\D.W'7QJ^R7J]U%L )SVEP!>N3,F-8!V>K_T@W@#\ M/=HR]]F[Y$WC&I1\1DUX,>7:9. E"?OH&6'3IBU%SW+!FU01F^/^ $:9\+FU M4?6]\$!9)+Y88 #Y'8HMGL-B[K$4>> M9"L9;DA8RRT[HBBU!YE/D.;P24V(1^W;VFNLFL;=)252T::?_BE*ID M!#:0GU$IKC@(%6\G8 Q<"R,9N[J"CPEQ.\(%%J*]<-V*+-R!Q2G:O+]LD&0G M.V62"N7-6M8WL$ QXXH)%VR0+[<7/HYZ' UL4#"8W/)RYHL&##Q)S0(/5 T\ M=18O^M*#+R-V]P!ON1("QR-X!98<1YFC%?=%6# "H?8A'&SIV<,TS.JR%;+Y MN9K+8]O2[UNHVY^]=2OIWD-+NT3V M!*X3QF(&[#%3-0/J;%RH? 5/X*92'P@Y,+ 9_&3APG/YQ @H!AE4]Y44/"3@ MJZ0@"!_3I%ONESR!TZ/KY% UBON$&,X)7I<>M#(]!!Q7^0%7^<["(TUW6O7? M06P+C-7FL!)Y>J2N5RSDP7LA!2F8&.W1[H"K(%I7;=-#Q$I $E(&?^.E500F M0/4UJ6$YU"6>:3YT&%1NUTB B26G]#K<"0^51L?=EJZ@& T_=9=\U?4]#3&, M*/2M/-U,'\5 ->LT>V^FI"3 @-KMBU]&PC5,-E3/6C3#AB=> :T?ZX[;^5% M%@&/W*>#+FC;\RR59P97Q\6U]FF_#V((1)> #=!PCY47#IX4+MU/.RSB?[5. MOOGA?][\\YL?K#R%O8*$)J&H!/A0:[@K>B_"B$-RT/<56%WV;?]I7V*'1S7 MKC;Y$Q3V?O[;",M]PQ+?4']S*R>[,Q90S_=.@)P\UN=^IB86M'G17A7YUFQ]5)#*+/,;K30%:? M8S0NL#FG,"T1MX$V5 MO<>D0J:>M=+C2^4X$.F*J$PMT[0TP-,FQ^J^PK^I\ZU>4])QM?O55UA_K1. M#P1D:U;)FS*[F\SRPL=>O3S%HC%9P16BUGJ4.\ZE4OW0B$6M=XH2*RL,NE9< ML]9A#+QQB91_1$#THSJ5ZCR#)N4 M"#''EP$QOCBARXT@(<>'/#S206VIZ4C-NZT,:ZE@F; R@V@+ HH"6$EL)1'HXU%["I?=!N) MK_8P\G9;' M1P;B)ME'%8='#H346I[FW_U9^ EQ,R^=7[6$L.UL-VR?ZI(FY M#UETZ*XJDNJECKY:BC0\711868]07^V>M ,L >+P@+ MKH21EX;K9+NU"%#[+9T802WFC*#":U4=#E7=M*55QPSHRY#GM>(_.4 % H;C M"LH>.0Y=9':/W=*[@ULK?#W3/NF.6-46^KA?VW4DWDE;738H(@OG3M"K%DR: M5P=?[SA:+*XWO7C%!+[!W4);9<'P5=FM",ZX/]O\+GD7"BYM6:T0;"]"7_1) M%_N: 8:"@A; RO6+YRPETD!G/M#?W>NJ-<6QJX@=[DTXA8ZP!Z77@)9(8]X90LHG/V&'#=T6D( 4[ M5Y&.(NK_!3\P',>I&X;+O!U!J#QL@YFKI&6R8RCSOFT.R[&$;3D M&'T<9Z%3,#NXOG>5;-78V>KY>H@C3K=X"$(N65ABQ$3,&"&"4P!@*_E<#ZM5 M\B!!X)Y9KH'(5(44N&+#6)RW ODB$S,:4$@$8?:.&241OU=ZAPQ @'O(PMRK M%;8_24$!!I##THL*)[0*+BJ9;M[!428R2ZKD1[KXR&O%(*N?L!.6R>/8/Z.& M -G.!%PV(OB:#P1:>^Y:F,!TM,D.R1AU>0_N'!IX(KGPX21QO_05W<6693T? MR'N#_%KZMS;B:,><-QON%/;^_R/$_!6U*R#S O M4Y6E$DI*BD2VR,%@ DHDR7?IY#$L, :TL' M Q>#?R)3\%??QT[R+1OLL6H3,8X8NL!QAS@&A9B )&3"S0VCY]32"-5EP#(D M5$]C=#6BB4?^+A\?I1!QR/\%;K/P_$48(;%65$@*++HF"3R7Z)LSN8>" 5'$ MI/C0(+.'S$ ]36I\[DC]:7BF>BS4E'@0.O?\O.\*%VURD1*).=%82J.$'=4S MB5R:Q>P@YB-B=Y_#,'8]!I,;S0,JLH M0S??#$WX6OK<.<7/?R4A56%@5&BY,M0)VO@BBT(>P>TR7D(SV7'9.:! L3T9 M]+T(#T0H*A;+!9=+^"*?0V"^'F>D,0;4T8WC7)?J M;AMCVG-!D^#!'P<03>Q(1^#PEJFMZI8(TA4RZ"' A%X4HU_!P9,E,W3E]T8N MO1'C;$M$UC)B]I^.T-4QW@KEV( @M'+?3\@"4[;()Q^1=([UQC[&H$T;3<,$Y= MAX;F6#VM>8LU/6@JW[GYO 73HI >Z#H!!876ME:6?OI.NW)S3*@Z;GFI+\[%_V<.Z/@:O>Q$(SR<:Y"TK$P1Q!9R M]8GPJ#&7Z&,_?_EQ[CVCU'OQE5SG(>8PSVY)K4NFWVE#P7Y>O+ZP H#1#E4C"5HW7@ M96'$V^\"-81_4+7,,8D@>Q<[/YGKM#(:3EMZ9O?&G#EA?80N;6OX/VP_A7QO M_#(S@0B>-"PQ>A'I*T=M5M7U+H@#HS1@I$LY>D(!T3N0479W-#H#)24,SV> V:.K?=C9&))D3FEW-X-4PZ*(I0^;R /(3M M6^-$\HC]Q<2&(2P 7J=&"Z-$[QS^/?7\QI)I<0U%0BS5MD%4GZVX&Q:KM)'' M$+LG/\=](*]3X'Y4CS(G&3/S"L@N9UC0-3)/2XNW+.W/D4K<5,=2)!OP3,CD MY4?6;C2UCQ\=!3R#A,AT>]I0%U=4-/U0J[UN]XRP$IG%CU$A[@3>HH3<70+7 MC%.F[=Z4YH)NC(DK,\;0O>*2[1K7J=FB3K?2/D!%-6UP2U^SN-*4%!4(;,Y] M[.6D$/C:)#AH!,V1M(UVA7%#:!SIKG?-_,+T6'F,S*SU6?Q$CY;J0980#5%[ MQ(:--/O:9UN3)7H=TQU6".9I+=.F2+3'UC8KY"$[X"(N&(+!DM['/M$9PWG; ME4+C&D%'TRX M3XA[ PZ?,/1VC3J\A9V6:W6N57@8R/J 0B<-!2$RH-XH^KDHV%;E'M]("DDW MN^BTI;D4[NO2G:VK^<0YU?*X)3/PR(6&#RDI]L1D2\I85K>/0?<3U8(';06; M;#.1?1D#PM$&QZ":6J2YP3USW7F_E-B,E[QMY/*(X=QU7:5Y5"5W1$&8,-+] MT>J_<:8Q?F&<*\1-OUT81%CFMT6-()3&$O'Z:I55\%%NK!)(TQ6":*E."?F1 M(1MKH>=>5 ^JYF"3N.RVC''FPM+5N-"DI800&2^MJ[26?8DR+-BL(4;BB$Q/ M1Q91%<)M+(C2WCEPW1 MP2+<(#[H=UHFR@NW;M^,B.UEZE6L,J+\43F6 IBR>VE')6?[]?TYHV'@+**- M+PW,9CN5'F(J-:)=>C+GTP8NX5381L7X#>*--A6(G<5:#4XLQF)E\W, M-?U(\\$C$![77IRN3(M,B]8,072DN4_CZT=V<:$IS MP-9B._@*5Z-:8U>;4%@)GZ@ZUX ^%8@00CJPP:WC=DMF[4FO7FI2E[<911U8 M:BJ-VJNK*IQ$\;,H1*>R444!'VNEC>LUXJH)P_HUFJ"?V(H3XQ]?E:/@CI@! MMD=TR51(/Y-5Y;TJM=SUEW[(EN^VQM:C%F!>$]RZ\((@[A+$&8LQS-"M$VH1$)6- M%@.$7^/4V8S";6)H_C2N(V2T0RD2^0XQ5SR>(5U*Z M.F='"!^.-JT\956HN()8O8$!0JKVHLS*B77V,AQ&]@A1W_H\::D\F; 0F?F,G&&%71BF;QT[:8"IS(Q(?E2'=FB MS$;XT-1*CC93MX<+#L- ?S8)KK'T%# 1D^R"=[4^16J:9 ,"DJLLS<_#DO;> M\F8#9T#N;E%M5[=$4GMT[M*&'\M50^&="[#@AH[0!KFJ-A$ )\C7=9WB9G!@ M:<%\TS7=H%-5*C174B$L8*[6#1&+_M9*75"[L4+_1&R'17438>;<$IY]8M.? MK7PI=50NMT=S7;3H,LDLKV]3>$SX)>(]R:1/QIZ+^4*P?Y:ZP@ZHCW1?19AGJF($@SV [=U]<"8_-3R M)3L*4;<#&!1H(DFI Y@D(15'GK3P0F ^4^;0E>-VVR9(5:3$JYJNX755>0T@ MX0@D^O$7O.I/'[FH^VR6TERL< $T<7QJ\_[3AFH#JDMI3H)XOU5]+Q4,3X M M[B&ZF 5HM/ER,Q$;SDIIA]L#R3OFL4T+"R/,8\,X@YJWO9(C4PK#&'@D=',) M;-_H:H3SB<3R-6/29+K.VCU#U)_MM!@L&17-L:+(04MDTM+>N**YR&Q#VHB3 M3_@UYK^1WNW;"NEK0>N9;*?R5GCCVNMZW>9;U2P8$!^1PE]]\>IE\C\53/[U MME;*<^K"7AA/%XQ0\G"--CW^=E^)F;"@),%V6-;M5:+1DTS@:BF);CM7FQ1I MG!]432>1_!)B+_:8'\RW@_]8JP/&5[$LI&VH 453_3:Z%"JG2$U848,726GC MXX?*&+W&H376B$L>=HIP34.Z#=.BZ4]DP9:ESJD'!* 5D7>AM!>S"[>,Y/ M"%-,".3<^3:QZ[0+M"K@U8!@#PADB1S:$:8;HX@?O*..KHA[ILNV)BZ#FG!6 ME!D?V>3$+^8][FA2Z\C:5-'+];:TCY&,8"J TLRFJWXY\3&LXP9AL0Q>VI*= M6^%[^\^_WR6O/9TY.%6GUF)\ D#$=;TG^%8:1*FV_(?)HX$]5O@:4.7,09XB M8&;WLHQ/2#C:8)PXX4+A%0!VT3N+!>R^@LM%26#ZV:90'S3K6PSP>V68C.*9 M@68F(2"OWHZ#2=9QP?$ /C&3J! 03[IB1Z;MY-LT5?9^!_>E M.SF39YL2=K9[!@YX"T_!*A_YDC+!+174GH/ZVF/SD--X\%>HTAPU/8P5,7(LK4K+PI18'DK?*&H*GM)3EMO^#;2O* M4H932!-PZ=YC$#:SL_JCJ_ Y]02J7IK::!%H[+8GOCJXP8,J_2,L#[A].8+H MP/6 HZ6;-SVBF0T.W?3-__B,S([TYX198#U=,@S"[YXW$F@H\"I,@K:E\P'X M.8Y8PT_Y*K!:-WEP7W6_1BJ:K*APM7CE.'Z5,[!W0VQ_ >TGUF1O M_X6QY@VX&"0@O1XH^&7>@OCB=!ZJFN\P:R<1@?/^D.IZ>+7P)<3@!VR2>03' MQ5K*O[*=XFEEXXE=.0V?;IV8<'#+=CC) UC YR]KO6X\ON9UR.^-O**(B:DLG5:*@;VA8RBZ^!BI"NZK5-AJF1375F^ M*N6O4NI]%40]R%.(R][C-X@,:1QH%9GF%E^F5O9M1HB1MW$HZ M)2BL^?NTNKFG8*/V+[;,.[I[UE#83HKD1LY,#HI<4S;Q/%CAH-Y(I3E9@#+] M^JM%!"//TRVSQU20C#^N'R^:8)=@6G)I4V9U1;L .C(WQ'<1GRR'GF!13^Z2 MMX1GA:Y65;3BJB=\721LJDV'R^1_4V5!O"17AZ(ZBK4?':*BJ+)+BJ"&ZCJR MI_S'OH])+I2:R#BX8@'? ("A"0+L,DGK(C,N%%/@VN,^[H/(*_&>YV"N@=,. MGG)54SS5'$VC]G;IW!?1Z??U!;;K$&R$]][Z0B T?6GWV88;&4NL&&>?C$ MG7^VNVG1? *5%]\G2 SZ^RF3TV46D/+(48\J,>T!%Y(C!?X*S!,$Y'F!]2N= M&VQ5Y? R8E\9\6#L2@\6KSTZL] MW@9*>(.&*L+VH=F J]"A1/X21"GP<HJ5 *?-GHBWEJZP>-, MV/Q>F[-]2E-%6IW^GJOT_@9W,JP'YI[]VL0A*WS:J?G,JK\M5OV,*]UA6%V@ MZN4'2B>,EXL$:-3 ?8U$W.8.QRP\7*FID&TUYV.%MB76)92FQZ8KNQ]MW1?B MZ][KO,4Z)1O0^6STV# 6N//J\_2NHRZ2:V^!"#G#N48(6EQE^1((ZKI:>*)GZ5@%9*K(R"> L;J9XZG/%3AH34K;-3XM^("KT*#L.0KZL^P8!JX(: 0,6]&(%RH M@RE-]0 KU&(E[PK^&18$\=3X0;0(OOGA?][\\YL?Z#?,5=F_?9)T='K"80TY MY9B_"33;"ZH_3(9GLN^&6F>$/DN=-_1/B),2.DQ<,7ZHU8L-Y0P2W_:FNK* M7'>08U+KKJ& P./\ JZFIT8P@;UQ4,&T2Z421RW]"+L%BE5BH8G#ADH.3PR# M!M,[D'@;;WB1*HYY5]64YNRW@,/RE5X< MK$@2#6/E! MVVP\;1O6Q]8ZI\KHB=3Z5[RJ_._NWO)'8!> M74-?V@G7$7["!\E7=8+ .^]K)G,)%=G,AD8ZZE^J.B#%X;_5L$7%783^RC!I MH6S]$-68-*AK[A6F2ZF!']BP$JB^S3;D/D\E5ZU9Q)9>F1F1+W^CIFG%0;+CN],$V M\%+NS&6Q>N#YO7),5Z?F$#\2@QV!:.QT#=ZC&9B[T<6ZN#2VLBSQ(8,GM>^M M$__7 <*)\\B4;O+)E ME5XL_)OZ)FUBX.]4\ANB"; 9ZE)G:();R #;\MJSRFTI( /OK;C=GWZ$17QZ MW3:,,N6HEBU:)-DN6#>4''\IR$U+FX)4+I.5+FUY4T1 M='=8"-S0FJ/;(V1>EB5/K/H/AT(Z4+R>0@]( MM.MTPT7$L/2]0,QU'9:1E(8B!>4\7!# M_Q 2)UU5>3$,KGXN\A#9&O.WQ)G+"W,9_:TI*F,BRB? OJ[AIA,.L253\E A MTI.PB,KZZ@ON*_B[JQP.$,9M0-6G]1-,U3/L$XFH#U'T2H@2#_NJ0/"=?8OJF/?7WBCP MCP^((1/^>E-450[_OVOK&JLGZ0W'PZ[B7)6FIRR"/9CBJ1NQ!?Q>(;87G:>' MM 9/5.7DRL%9R=5>9Q105P?-?UA9^])PN@>\3Q2B&I3%O:[;WIJ ^=EB!Q:W M5KS8I[E"B4U-@RYN%53 8QUT[229TQP!()+--GC\F;5(_ +\,GT! G++1;*H[7!4+O;7?#\M$K MJGX_@@6BC4M;RTK V#O5>S$P.G;CK0BI*:T[[,$*_,6:^C(E@[@*IOM!^?2Q M ENPE5;O?.YM=)$]A;2-,@>?0KG"7CU8IA]>O_W^C-\S43,N=E@+?1\!9I]A MWJ5ZL5?@RU?%V0:W86>K0;4M[!#'&\8&#*6^%F*]1M5LBAYR;>A\4+7LA%/O M^C4UK3FUT\G;AN PRFOIL(J SP*U&XE\UTBWR(:7W3QE#Y^\045RZPI1V,Q8 M:R80C@ Z<+:JK!N TP72$)\NM9PJ&PS5![0H]F>;#\:%BR[!(74/O6.8G%AG MT=N.JB'[27J.CEH]7GKXD6,#XFC:+1&U\'MI)&P36N9B&,%9&>&V,[:U#@:! M,LOZ5./:?L35HD0<+RV7C>*+KY(# HTCK0R%K;.V2,5$]7+59^&XDFHBL2FT M(M,&C7#$]=P3OJSHCBXOI?0<%Y 7XK:1N$\Q6#L9JU%X>%-++(=<Q'*(SX=N,H&B2O!<2^'&XN5J]N*ZET<=;B M&G<.ZTVY,"=&B<0>AUO<[W*V^%2::Z>Z+32D242W<$M+WQ#7!AT5]B=EQE0/ M3V_OF*J$[U-&M'+'47;XHX#:]QHF6N^UF#DO M4E1C:,E9V#9:7-L000M=43596S(8FN1C*&4&HQ0:TUWPR:F[(XJ M76XJ<2@"5-6T1FRAK*KKL[5-$S#;E$D+5?->&Y-0H%VZT_':Y>.X^B/'?NS[ M7Y:+EKOZ!,X=0O>&=;%=*3'G=FUETU3>S3&C6024$/"H>S78-7LN4>Y.L8V: M\(^QN&[5\Z12%76G,O'EB5YQG]7AW5.!K?9X&J1]=Y?&@Q)X.FBT'4%U1 MR<0JG*R(YMY#UZD6D*&%:55B>4%3IPTSRP[R%;54KK@^VTF'LMVA[(/W0+EH MO$^L@>V_EM? =EKT/^-"]A3M9QQ'#X3.XORZ?IB!UVZ9&"..WEWR55^;HIKD MEM(/?*AATB^H(&>/IFJ#L.K;JM'$.X1&896U3)LTC5_8_7J@MD=MP"OZ*U^6 M[-2N;PZ>9I<"S\U4(^4,YG1#-1N#=;*83..^(5Q4[JVU7\ ;R$XXT"@K3]3D MXB<:^-^C.UF[(1 Y5E8=?(T/M]91P9 M#DVZ M0GC\^UZ9#JE0T*Y8%D4[2:Q81)S56[$)TNGPM:F%IWXHG5)^$JUH@23W&^)I MZ3@!V,N"PK^]L*U,)+(9768KGX1;^>*AP8J>J1U:>-G@P)Z+6"YAK17I(?@C MF7H(JHTK),(Y!JNCI*L4L*6K7RSJ0K%5PE%^,ICI+["-T/)K L M$! 0,5J;=X+Z^^-J3(M+B@CGR0G(B5? MBXN$FEH(P6I-F1[WU,(O"W0QVZZB7'#UN\'DL4;VD35YHKV2G4>PQ B>/$J+%J83\3W?)$$"Q;?:L& MSVO6<:BN2!_(_4&$Y_,=:E.G6-[K?.5PJ6RY,F=KED]LBH'3R^(*AGIZ":/J M*"0/Q_=%YI=,%)3\NJ?SA,5L@280AMB],R4K,='E?56+G1LB19>/A<> MF F$+%=]E J1"01='=A3&3QR. M%-QJ4B#*'NF4>/H$AF' X*?.!9F.#7M-(JTX47VQ:Q%":+.*@5O$*\7.AQP] M^RQ[\@+\DY^L6PBZU@(JX1W08H0HW8+TFP:U^3CCI,L,L\N!-^C>H&VH!WY$ M-5'3D<(>.$A81.: 099M9?Z*_5S2V@[TY!$^49B(1,4NE=V8K+<7$*S'8Z)J*+*'I9/KV.!\EBG%]AN=X] MV$];*:P[ITS2',S3"TKZI[Z)>;ZH19&&>CXYT3=W?($A)L3SFU4B3!PA]^0C MLJ,; $#('H3[+V<\P1H66Q^$1ZJ/,RAT;BXC%;NVI<@"D#B\1'GZ@(#KB.L! M4VNEV(SR<-G$CGR0MBC[9)(,$Z[,BI9J8Q%L^XH079UKF)R4!0 M-HY)I,5/@[[68AKX.L6E6KY;ANE3CE/FCN0QQH':U&DK,V^BR)8BS].:(0X_ MN:9\>96B' 5#/[6>'+%?Q8"#624IL^#^$;V/\OA_#,2@94$@C2C[FD,]$MFE M%9=_R?0EZ=IOOWXM594^&R+C'J[06+^79DQ31$62-JKJDA ,I6T]5GW!DCPZ ML_&:7+'^&P4WA[S%&7Z*%7 [E1;-+DMEN(MR74N<%FN,5E)&BX.\T7)0*W&* M,BJ8'2D&6":8-J[.4:KJB=A#V!I--48LY])F#V*6QP(L9$J4.=&E94OYMS"N M$ ?4:U%H_U&9AH57:(-CDP=5BN+#[=G')]BUH[*XAGMPY&I$N!LQ>@#/HF.7 MV3,91D'0]KI1>^-AZZZ@MHYJYB/UI.I[+05(\'5 HJ[O-28^]+W\CC"$/"^S M.WY5,3BL'2AEE&D4$ZBT849IR#_-][K4!."D[\]5G@QSRJ 5(IB^:XV-9B+% M;N ND&=BL13B7E<12F" QR@^I,N&RAD$8"C0PM<$6ESO;EK,_C:+LTGM)@=8>45W)_ M:*4I-2LPXIS%QY.O+.N"/G(I2]$3<,&XR9T+=S=2=G,$XL4_S>U":,EVK0 ])LS 1%E.MX!9C;[P3WHH/UFQWT)2(&\88ZFJ)[1_TSCB-P$EFM MS&5@R8UJ;JO$G!B;.C5-W1+)XVIF(YSCBO7I9"P@VKR&.;=EZ_+D M\QK7W-8IC*O,:V1S6ZD3H:1Y#7)NBQ8$S^8UL+DM5!@NG-?(YK92 QZTF8UN M=JL%/O!]6Y2J)I3%>0UN;HN%51[I'LO[YS6NN:W3IJ[V,QO2W);(9\KF-:RY M+1.Q.ZIGZ^#,>,(R,D("-,_WWEG_#RLINV;)>0UO;LOUK-'/CF>/<>OG>-6Y M\5AZWIF-:FZKY F+G\7I7/ZAKN'>,_OGA7I\/*";.-DYY/B>V3CGMFX$ 8;I MW9K@SST?^LR&.;=ERU6IT^)%M7GQ' B]2,R:)LW>/XO5.;?YN%;U"[M8,QO; MW-8*Z]=HN739@!=-]?;S&N'L5NR>"=*3-U1]HYKGX_CX>'9P#,%Y7B6'G3:[ M9S?Z$F.",2$( ?G9"WI\/*K\1C:WE7HV'RY+-U.]Y?,U^/AX&$IE M9H.:VR(1!'"]34N+__DL5(^/YP^^8GIF YO;0GE\FYF-:V[KQ.TYKBCFC\]7 MW^/CX;XM=EZ-A4NBBHC?,YSPOFRVJ'G%H!GZ_,369\S&][=S,:3 M?%M7>\*2(GA$^/]5QSI'&"W,[5+K*M>9CV8EX%:#.=:8N\1V&%(Y?/);F]8- MUB TS7\J3V2:78]TDPWD",&M?O(7?(.FZX(G#Z_+ M"1.XXY##S\,KB#_N !,,20>0VM=80KUFA^C8;GH:H;"P.1S?C>":.;8R[E5J MB+X2AW5H"GA#5135 _X(IFA\#[UE*K6,CH56R!**Q :Z279I'K3^)K:?-^$> M7:0D'?=>,I/>%I8/]D>ICES0#U/E$Z,DF/=#C:#M34C_9UN>>V0F;>G_U@,! MS$X<9S:>-S,;SV9N"Q1TN,]K8-:FF-NH9C8>F[1_]GK.2'G&^G)FPYK;,B$@ MCD.WF=?(YK92C.<#5W--=E>%\)I,2TRD2X1QX&!^9C;TN2VEY1$)^,_F-;ZY MK1='NI[7Z^+UVB3/K;YQK;XS&]S<%NNY_D_6")T\M_I&MOH^G\0S-D23]- - MYS6ZV:U6#\]Q7F.;VUH%$);S&MC<%FH"M'-> YS;@GF8TGD-:V[+1'#_>EOJ MC<[@7P($R[1XOA;/1 <=5N?S0ITI(5';YT4Z-YZ.-^]YIP"P\9>Z9;CPM$JZ7RY2^ M5[E/CB0V_)]208 AP]>60"5_>(2_(9E&TDNF0R1)GQ#ACZNDP\-V91,.LYXI MOBC'!1=9TI9%^K!I:?@3""I)4ZT()*3:K+#40*7VOSVQ*XP(?XA5$_!V!^9< M'!/&C-YHQ-3J@3X3K1DB2"46>MW!Z"-ME&W(-MT')O^5ZANH4H-?T4'PTCY8 M3G8P W.=(\47#1AL'%\XHAQ7&?+C#E&N^14>NKH'>DWPV993$3X<4$AS:SDL M]::M>>2=A^.V>#PR^[8UTML4Z5'E=\GK\NAZK/M2Y?YR?80]H34ICQ]-:A)/ M'IA012,/E^D)AB0 *]X5+^68#F1^LJ1:%TCU2:P5;HC]'_N2E&Z/!\<%5H7. M5K_PYV.(;4]::7Q\\+F0R7,5G,(YOT"\5\2 UHV\5%NBL$H.+:Q,1HN'&MI) M;H"SGVRQ>*K6 M5'B;ZM(TL#HK*WJ?Q1QL]Q83$3'8QV0,YRHT HW88+ (/&D!*%B M[9,'C$#JAT1:9R'IOX336]5_^QU(DX(K[69OW)OF9 MZ\=0#G[N1.PUJL_[M#!7,25\3A:QG]2V^G<*QWT/TKM+C:TOM/HU.$VIG>I= M\F;CZ@A!T>!AQX.[;N 43?V>C@Y,_KUJ0%MT'^L98N<).&I;TLCT[>/K[+'7 M3=)Y^&I,JB.$V\8>!"%5+-LQ<$DMFRL#R>2XH%-].* >"+[B9-=T&Z3U2H4KQS]29![5> ,/7D3[/)\.BWW'8%);H& M85B:@$<4]6\HBGP;DAZW5^G6@'& MD8V'!+_7A5?@CF@VQPG";8?7*QI-!SA5A2X),,8TLMAIJG/?*W<9@ +9-:&T:?^7Z M\F62X&Z1X<]\(<*+09KM]H>ON$N^)CO<;1*"X5V\ -J$\@O'\>A(8VIX16-M M>AHDW]ID"J,M@XPT9(USW?/$\JSHB\XR'MBPP>]K]5NK:VL$L3.0PU^A0(.& M:3$Y-"2[5(8/EE/C?(L?7K_]GE<"C!^4J!W6F^$$MBT84@7J?M@&TW+= MO647]^\:>"IYW6X?^9#56O0&\)_J:HNKJ,K\4&ETB[T>Q/=TAXYKYIF)WB1O MOW_WW0I+Z#76JV=@HM?^&#>T>,%^;=C_X_?0@"QQXE7$&;.MTKJRZSFIP(_%I6&6O^\0&AY(PK MQ.SQ8M&K?!U> G@4M1Z6QPSL'1QA0O<5(/] M .G4-KGOHEKJ%O?QW7]\T^ O_=MIDSP/].1%TJDE*WYD:]'V^==HMM!RA?T0 M]";WRFEOF@;W,-C*4+IQ6_$T7+JK)Y>![B!_5*D/!#U=;;+6$,X0:R"W:: + MTIHW26R< III>6UXPZ:'(;L2&%B&X7 MO=,J?%1/ZQ1;@9 *C'U5@[[@$^/[^O,SW]='6#E#]2 M],6L]LK6UMQPRWPQ7:WNJ_<86;8E9@_:/"I]HS>YNBTL]0)K HL>9/L+4B$3 M=^GQR :Q?='H*!-F&FGYAW1.5.AILZIT6%R]Y)GO]D60$]L+KSD)*@A<"G\B MG2TN36!4,4JW438*_J;A(HH]%7F46)W".9^D;/=KKG0$ITM39C7GI#<>U$$^ MB+)Q^/>]PEL<'I<'4"ZK5F&6.D_V%8[1O7RMMIB5K+@4LTO8K2C[6E.E&7=M M=:H)JP21%P G$=2AVN0WYJ76(=#<7?+:4(H*:_)6IU+NG 9&C8 +H^M!*"UP=YN(EY'=K:M%A!@^E#Q?GF/WWQYS]D M?TP(- />H7(J>?JVJO)5\C6,BLL1OJK,'F0E2UYGC2]R.+=&R1]>O4R^NOOV M[N<[*BE-_O/E?ZU0S=$?OO_][_[TUR^3P4_^_,7+[B??_)%J2(TV5*A/6XBS MQ!5.RTQU9V;M*PWRL#H@ -@;IDGA?*64J$0I\/^X5J7::"HHQ1DBH2;6G(+T M-N"-*K>=@I\I \#:V:,)5 ^!?A-4 *_]F/ NFP;F[PH@4M D( M->P"2#T5U?*@#17U'#&D1:N*0(O) 6Z-%X$&L*777(B&-7&:AGN7O,5$?FI? MX?/0A#])5>=[>IS0"_ >XN*54_B(;KL,_ 6,@(NT;2'NJE?PVZ\9QT.?>9A( MDCU?HO/:[W%0EB66AY6MO;(%)_#=(L4R*^Z'Z"F]6N$E@4+>TX8)J=3@'<20 MPO8NZLFNT N%HK+P4=1)TJ)J5K7Y_>_^\NKE?W\YJ&2"_W*M":-;Y5SA(2O& M/=Y^]EZIZ!CE=?K 1= 9WB@]Y4PU80312>)Q*-),\6M@86'\%:7_:[@;,A2Z ML%W!P7415#K8 M84V7YGOLT6YBN AK16<[J*THT@?3ZJ97 0_6BS&N9)]KE%@6/?>N\=5'MAXE M*'G#3>JM@]<6@?C " PV<7 QZD19"S'XP2Q+PR_JBE?UO]TY[ YUL-QGS#VV MTY;OS[[;"8WO*[V:KLI05LF]<6K\HGV)-MLI@%I3UE7H,,-./1H8^&@+V5EW MLN= %Q2JW#8[T/EX&;WPEY'(*9:NJ"ZQ(K.4.EQM"7H@UQEEP.]$C_[8/NJU M3PTQPC7[:*&9T14U$;,+/:_+FR5$PR%#1;9N/>4K63NZ:\+FC(5[N%^YFD19 MH$0:]["%_]S9U166RN)$<=)!"1-9H.[>N_N/BE6T7GPY>9IDJ@*+UR<[?%<4_>4T/ZP /YB&2%[N.3N6LG4,)36-<%(GK3],M+P M:Q+S+?94A?8->"/@+^0@, =P@,H6_(6J%>X'-YH+\R*>(TVZB<%%+)DK!OMJ M1CT^D:?WC*;N/_>F])$(83+"^QT5-J%+.TB#V)QHC6P,ZWC@?HMT MC\V&4H\G1N*I7]SWMTFO,VR13Z(N*(PFV-8D&UEG[=+6PO03Q]JNL6QL3$BT M86'5FE0QX=2QM0]W&>;]+YB^P6N&HAYG!M%_VQOJ^SE4QFBI!RHVT-">9>"2 M4RD7T>MN:(M2/!03"3'6UY769;^/^3,M5T1B&-M$I):B+7WWQY=^M MGT^J^=67=@3?>=07A[6A*P[0_V1C&:\E@D'?>ODEAZQ!C[XNRQ8N_I_5H:HI M/_4M^.O)RR]>_#_[?0MQ(2U6J(.ZG+CRD/D*!24L.,[N0&4NC(E_+.V.8KE1 M#ZC=:\JJBYZFQGD21=> *9H^W**E6"(P=J!,(]M57&C"9OCTL0-$OH)_D)HV M-J%[4#5!/,$)%WH)$64V_1RKR'8:9">%UGI/[J\3=Z$M@Q2JG#G]M/9>7BEN M*;?-+>*KTV5W9:M"!4S"^K,8YP6;P)31,==TPBZT@RH1U6<%V<3TO"/]:L*1 MOIW9* NRSRI+&55U*RDF$][(9!C+Q/K*+!'A._@*%FDPR@&%)%?XN3=)$^=Z ML]$9%A&II2>%NK)'H<=AD89FZW?A4;KNBA3&19L1FHA_\;>6,#$9R;42>E$6FE:FC#IE*?N8,Y5D M3\'?OZ>:<=EC!C8\W0K/5*X13&_=7A!0'V1OX$(]5R@Q*A.H[Q5<6E1_*LK9 M[=%SETU,?:!G&.6QT>;\?OE3J<]UM&&J*F"(7T*"%L MKWPSJ()2?!("OTRT@1TZ\&VR/8%J.9=!?3E:30*1<#6=XD6E\GJI76:K5$4C M#7CKI=<@1P):X85?JWN-U;@P2:P6K7*="?.:YL"E\S>[<^42?O/0*Z$U:FE8 MA>(%V7?_^.G1;$4P'_WU_WO8=7S1MB=4%F3Y@YXK( M7, \W=G*RK$<;"BH"ELJ!'SN4$KE*_S$P/?^^QE\[TF![Q%D*9L,DQ3-9T[B M7*;Q0 "]E%FP(81+YC(XKW.9C#:A-YM/8C,M9%]Z-^^"I\&& $9*T7TTD^AY M2Q&O6C'D_2D*^W.NPESF0:G$:<2=I6R%-[X6/(=^\ WC#LFSH'YK@[W4 M)[C>%S.13?\>G"0-7<@M0G&V2\R2<3!J+E.89K18M(#5R1,TMD[@BB[%"W$@ M(D_@/GP:IX2:$A8\?L^YM>1)<'*!D<[6TV0#"]%2)SC/EAR4(Y+?KJYUN1/I M87 N=QK$&$QP92'.TJ*5,)83.$KGYPCV'*;A(]A_F]G(YK92A!6YY+-GZ[<6 M/(.T4/6E5^Q,I_ U#8ND,[FN"-9S;< MN2W?'HLQI^DEER(!^RHG]-O%ES4@X;5K%[@P4SA/98F W=PUO=PY$#0S17V6 M?#:8JOW =MR2)Y)5=8U%__=+CEH%_2L+G@4(U$[FWLQS'H<:H<1Q,PCX_=E6 M.&_&+UX?+KUL\.&2U9]O9MZQ0 QP619LLUGTT6?U\;]"?; Y1B@TB M)")7DMZO$36704H6?-5BO577^[WDK2$JH44K+<]OL. YY*U*EE_SAD74<"0P M KI@E9L*FM)FNA.,9U&FQ>5UK;.[9OI^V>7 ".I2Z[U>=B[H*:A$0HXN59->6 @X4X$BC^!9FU^@S:DK M+2#R7++L;E8=W^S3*&AU**,+/HJ(@U\_@=[FYW*;.,U"7 @61-;3,BWW2#YG M0021DTV[;,,:

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Ŕ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£R;<8> M:49'L$;!L;A.F[1"]VTQZ>%;L78W\O:I;GFC7_ D;J^]#O8H7JP+LD/E.?OR MS"9N)[;79J0'!0[(U^Y89=S5]AO_>5U6\GT?=T'5[=*%+U^.,-_\+GJJF+^[2="X.TI(YWQ'>3FQ MBFR[3:"M+5"P^\-XV]%?MPG@;(1.?#[74+?R!5?Y+)L[CP7%<14T#_+]67V_ M, $C!"(HLWZ!!$1E9R9)QQ>A=X,--[N&6L8,E=;J"1),H6)L+_2''.MH%?TB MNN4:[A]Y71%$+O0P$E9#S*6WP_8C@Q3>Y>1JT%9K?9Y ML2PN^O%C_8?J4-LFPP)$X-R:G"Q3#OO9]\ WN_54Y'_] M@X'_B7;N[%^&H'TI4-"^P920?<:P;UB&()%U%%S,T.A7(KBN/P_Y-:RK375Z M=0PCS+ M=#RMR)":9KH,FGA-FVB2^:3K1AC.15"!N<:GR:*+^%/U==6Q;IAV MK.[+U2>L6TED[8$HZV?)Z[)UFC5V/KFBO(>:*\]7X#M4!HP6!TLNF"<3KF*X MR 8QP89+O&]OII+J$M>BYY6C3#C&1:^!6,VT. W#". GN=P9'U][>T5 MNR4G(<"LN+5CY;'"KTV% *48P40!YNS7IP;3NQ6/SX6WV]5M5.AF2 UN.OSL M5NCH;?\ ]?754JGNTZY\D.Y1^ *7TB.?T">9]'5MQ396,G.[;T6)=GB1Q8]V M1K^'0"G8I:97$4^$#QT]KI2\V.0M_J\W()9.C6]5V=WO;F^:: L(E/?S$2VW/4N+D@-JPG>=+EL$5?B M5##; Q=GM<.@#'\S9@P> RQ@G5FM;-!]%(9D0!.B[^=$\Z,T2#6ZD0U*P2HM ML\0P)S[FPZ=T,1YLD-\>&Q1MD(QV42IB:5IC<5-C8/6IQ_!W(>\SP^L3"[=.S#_X#+U]:/[1C*FA_:YZ;RT2:CEWU49 M>UQGT>T'69=.J[O<CP/V08SJSZLC)5>W(*]7M[!>2R>? M&Z?=DBQ/Z5<02"%@MT/1GLZ(:MZ(/ /NB'OO?WCRDXRBP+Q'!O+TL_GO.1OE MJ)Z^<=+0[G*(S0<+MK]1=T;AA]-3WMC'-;H^ZBZ54SQ"MCXJ/N1Q>E#MT86N)J #,]V M>]95>;488;.+=B $3J%[>7PCMI@SB\-3/<.3&+076#GYN ;K+]U2 U:O*:=E M#^9A3K?/K(GA+=%-GNCIJRP<:;J?#=*.WF7(HLK )P>U#>R!KOLB\0QEQ>' MV:">Q=D=S"5.[E-AA3/8H$_%_ZZ503 EBG=W#H-A@^R2 ;W#C$THAS]6& SE M%?6P0=Z;K/*F2C9H>->#ONB_S )#H$V[:-;)HBWP/.N@ 4,"N@#I8QS%O^&T M> G=I\)I?6\0W7H:,I^)0C,]=2MX=&%T.&;[X:P?$YZ.P6>8$DB;6_2^#$Y> M%T%?9Z&G[Z'_JU=E2[S_KG_&N7!6<-$\I^O\I>_$63:HEN.NE9,UY(\K?USY MX\H?5_ZX\L>5/Z[\<>6/*W]<^?^J*]%M/I#HC0-LD#2VF#?\&AN4;H3"L$H] M*/ "(\@QCK(!6R;_RY,]9L\ M^22S;AUF6K<(5H(2&G1==,6&=?9NYY,,1:F-]TH.($ MS**E)"7\&&L!O#A%I"QI6I9?"3O%2J,'L1J4MCL]IYK"U-'3'&4S4JKKZC7Q%2.[K.$JK96B!\I9XJ.#F(PC!#H"L8^.\; MQTX->V<7[H:*&PR_T53C$C5@Z=C)-[!!#_V9D&^3#<)L4"6-#F84VD6[MP;%M1$2(R#Y)6!&2, XA@(*TV MT( 0 9F%B(A,(H(@ 4.B,H31=,ND($1$)ADBRJ (B20!6E#F05 )251FJ6(( M!23AI/=Y]][O^WWG]_ES]H_*53\JM9YGK7NM==]7U5./)5SJ0QW8I;J[7],D*).?T3?<&K:_%GQW:A*7#YXA\ZUG7J]5(HT]=]M8.KU\] M']0WO-A22WOQ*F]XL7-Q^'SAV(_^F>WW;H7D!_%L'A99=GSF7E\3_&V)RNNCJ0Z.)0C<;H M@H8-;BF)@>?Y=5ZIU*1'%,W 6RF5HXOG;47=3^S;?I3LM-V["7-[I@6V7S+Y[R%K$P8]=>QQ/O]/Z.234;(,^\+1*K8L7D:M-R@OC/5[UC9MS_K7 M>3U6X.#OI?NK+DPW?<7(^6C:G[075E)Y:DN:'0 _**WSF*Y/EV)\Q3L][X'* MG9JZ+E/O2GJL6DQ4LKY=7KNF1]^DGH(]G_IV,I!0CJY'6$IZ)?8 MN9,@FX=@2-F=[;/0@&Y@ [T+\>6B)9R_)I$@;BZM%[FJ>YA_ GT,U-&7(C'C2(A VM!\1G^/7%J4>\B MUOL0.T/6I/OH_D8@6B#;U8YN4+]S]> @08DPHC+"0*=)&O!N^O+GWVE@H:J M?62HRHXWOHG\0;\4Z),F*&DH+L='H-SX=S@+BMP59;E@NYF'I8H["_P.??^S MVE*K##D'Z707U]N>/[RB3W#-!@D!TWIQYH](2(P !+) -2DZL(&G@7TOEZT+"V"G>:F)*39Y(:B96< MHJF-&."500F&2<.8=UVNC_(@_B17]6%]N_#@)NSNKX01ZH:+Z*]QY5KP"FV] MIQU[AWX)<@./VSN[Q=FQ:+_4]<_EBN076-6>]E[MZH9@3BWR7K/FMA9ZLB"< MV]A_$,QM(^_&GZ=8]T_TUWW\5;!]$Q:?2?\ZU6RZ";MRXREQA@G-8H]Q%G;U MEW"E_9EXFUQ?,*+KA>!'P=7C6GF5EB-,QQ8U>V/C*G]%%2BXP9YQO4+5^]@L MRHZW:ZC9N!,J3EQ".4B;%OHS5P(O/<_V5IF%I[)*L)*NY\?OIV<]AYX9U#US MKK -&BW>L!6G#LCC\^Y!:>!6!GJG"(&;Y5+(*V%S\"T"(R Z14#DA4;/J116 M"M,XB.U3N>,'0*UJX<,GH\%FW<7"_.*@D4;*Q?[(#:'#TKL-\\3LH<$_Q7U- M[>]OMP..R'AT8X= ?Q,&G?>!0U0.!G+9VJK-TN;>S)CXH#T_V?&/I2'^4K(B M&80Z]/FS*@8Z$X6<1\]O*=U!&RH3IK-CNZ%]U]C41&R__>?%4A@ =O8T.61(Z:N/GSQ*-=TU0_T(OFJ(L^B[Z(,X[F]X((4[VE&"WJ74[=]&?%YSE29 8O67"8OWC MOL(*Y>//AW2=$H853CP3H@.)F.PB$?L49HTV8 MNXL^636EC:M+]&?*YQ O.QS!*#ID!V>-'\5Y1LF?N(4),G0OI;?LTEO:A(EV M=H"K_!+A$Y$DKJN=6-_82H><$#)&86F>/0D"- <+N;!E+62)03B%GE8T?*4% MS<)^1,BMM-SR&:0-<0V(;698/I\2+4U"\]'\RPJ5%4%F3P=$-T5LL4,\J7L$ M\M ',;T8VM# F_42#@H\@4;6%Y.W!).1YI"2S[C5UG'-X:@XQ&\-_2)5_'Y@ M@4%.;@I+$UB"*E@$[B%*DKNC?MK(VYFI;@)<>SFABMB"HSN!\@VO.6326^!* MW,/)5S3UKBE?$/=9HK[P:(N:C[K'395$:6Q(:N4#TRJCZ[W?[<:6-OJ#]SCE M.Q(??T=%,5]CX!=?Y1YE7;KNOKOCH_56$O4NJ^-8VZ4C)I&'(R.&[+G?TBCZ ME!?GA7^5.3TMMC>E3MFFBAP7Z!.E%, =/4H81ZH0^M$OCT)I''):/1F.#VD9 M0?D"V#8?I0&+?0)=B,PU/VG;1]OEB?\-BHGQY6 25;XE]-%)>!/.)FQLJRV8 MV]&S*Z3P0/\WJ* ,5[]@9*^[L!K/5Q(VB?80OM!WT3DG(&*X^AT>=7?'TX]X M;\BR?.8Z%BKCD)/KW0W'WP4\#%U>!27NXFW'KE2'3\"3%9K\D_*Y709(EQ>O MGXO91[K F(?=CG.[NGKGQF?2EMUCE5TO]9]$#@SS&K MH48^=D@=_C,4PK$F$:2@R?-0##?_ X8GYZ/26[V,( ^K*[> TM4;O\[FU0W3 M89%IPI-.KZ%P(N_D)^(+4?>(^K&:.I) M?7CIY6Z%,/([\-59:9>TMI'6H:Z0 087?)#LE,:/B0P9S-#%5>4!,$Q G71J\D,*G4^+>64,N:W\QP=;>V2K6^$?"%Q?2)6F*#V_Q6 M'C&5MD5\YZMX'3")"C 91R [.Q)/X@X!!G7QM-MO>:W5SY\6Y[OL#<[TWXP5 M_E9=$B('<3X$,$2RP"2+DAC+3OG1?+(T1*05BF&J'Z:IJT#A75FXT#;E86S. M=RCXA*ZI@_]N?]N80A/$F9UW&1W;,CSB7#*J7:B^3J6:KSCE)68?DQE/IYVS M@@;#Y[J;G3GZ:<<^'#WK?34./ZM;<:?$6>>MN)-?0RNB"%LW;#/?GBM6 .6F M?4T#4JN^F"D%.128#6F8U0W2G\7JK25!JILP"8F00F70) TENW$=__,KH+3H M<1)T"#7):BG"-C+S09X'LG2@W@-BQ/EY2^1&7Y@,>S^12=WV&QI>X MVS.>0GYM>=1X(ZP*SII!VU,/]K0AI'#D-CID !?(27#_YL\6VH0NQ+:HL)VB M]XB=!"TBP[H((Y9<\4>9'@ /:UFVLEU!@X] M'>-FI-8T8*&=*"TX0GSB/L66_U[[X@W8D;I1S$&JZ$==5=>6N/O6J7B7K$?I MR2.,WDZ]*GM1M9JA:?8KVF9,H7/NK'.[_\RC8%\=WS7>!Y_F(JLRDQ_:KOV-*SW8#'&A M=5U(_KM]8A)[\5M Q)Q. AW[+WVPT)[BJA415 5: %A[08>];=>X;>6XPV; MZ, X=8*B!KUQ&#"8JZ.F]!U_P]F01$I]&O?V#!HWH(D&AU#RH19$P=Z7HEU% M-80OL?1[%@IX5P =+Y !P]Z.R]2!'^X53=A1%=!)HOU01)C\3"PZF:HO,*D. M&AOT$0,Q07H?EG,O$Z72V(:0#_8Q&VQV?!:2I_6P:#K6L*C,_5:T0-Z-_PZJ MV("+>GRDH%J 9 D1:Z!,%EJYV1Q87._A6F5PS>/W25VW8F>>\L-TC%\OY#RBB@6 M;.\ADB$7-:#_+IBSSR/@X8%J4O?1R<2V?GYOF4,ORY%E56)"HF(^9]O*:^NZ M[#.KFT5?%=XV)HZYL= OD SX'L)(L1=V3 +;"!:^YAUJMA$7^UTX#&M/X#J= MA54,1DL;U%,E<<=L>NO"I&9NTG<;XI7#;CW^'-B$38E,X<:AVQL4QH\UCG"Q MM97MZ !$_-0< #&PEP<5#+6!:FX!' /_63%LEX,JFNQ=I#Q?IVLSTSGG-A$Y:Z MY/.+AX4;"?=HNVX]WL'K3I:.$U/HA]!'7?^XRPE?D[CK)?_ZA1FYY\#DH\'] M.L@SJNTHT]8U].[F)1-6E:%_0A&)<>5U0K!+=>IZ@]?NL[4Q&8'M(.O2(>;8 M8&9:P55[3, .VZ<\1:&^(_8OGS*QO!2KDKNU@85*O1;'Q3R8UW'6PWN M'UQ>4)C=B],[![!_A ED3XIVR3\FL!$[Z[V^6)]1WPNQ@1K$[B"*"@I9.KW^ M#&>ZT&PG_0)ESL/ 9G(79[8TZ_%,@([DTGA&4\[+!E+;.E7N:3%QD?_&W.7Z=S MS_<+RSRG$MV(1P&NC_P_,&G: '7O]]D#K>??7W]8<,&H]H'^\;"<2XOOKKB[ M6W9' 0B/A+AFOQW=97I?*W4C9X8239V+7<\)M9_0Y= 35 3@V"-VT',K^H9Q M$'$[RAC(9"FPE2+)]SQ)J5@ND83WHV("3)AV/7>'UW^"X@0ZX-:WX&A')$6F MOGUX>[%"S8A!R%-ARC(G#(?M71OA_^0#C*_"'GJ'YC\JSSTQ?O/\FF M,B[.6%7YN[H\C\C2J^CS$9ZH.'WA1<[]AGR*=0(77Z;*\J!*]E9X?%\[KK@S MH\,I>V=[^B&_HIV]V68+GRNT5?[\GAZ5,<-F'34<#;F)11^I ?C2!J\!1MJA>7& MVX;L6^/MCV=<_*5)D4X4* H?/QFA7Q+#?Q-6[]9^,D.#>2X$^U+B#CH0F9I+ M4.[#GSI^Y[%EN4"GGZ:!XTXR1>I)1'GHF;>&K4V]362!BAYE+^[.W./&6IN5 MC-]2#)$R3(\&5:UW+Z=[TP%EOH9B8E=@[M9$,,\PGEO(:F8MQ'L5))41.KPY:46.9UX.);%+?]@ M6]ET?N7[Z,OI=;TUJT'T1#41<&1_\N.B6=0$['/%UDIQ$IMX%C[C6(4*#\&3TE;!MP5C97P#%#(/(?+@JSM[H<6,T M&RZ0H>*8'2J&^3QSS (=TEH0R&'XKX1/T8%T-5$/O;YL;A-6C)<;KJ;MT&Y? MV.9IPB2G8;?C Z032Z$%6T!S.8]]U\(P1$542YTB: VB3C6>!O?=Q7E^.D,' MW)*-7EEI!R= ZO M3.GBN RFASK-GW;..Y?_[45:[H=O%CK7VZ,>^!YVW^4Q!ZS=T\7IOS&K^..[ MT0M]@FY^>8FUU$.'U#(=GSQ;YXP3)DYYW]_<)\^OR#EB?R+<^Y\[$6!3Q<(L:^IUFW-4B;U+A6U^MCN^424\R?$M MWOA!N$_<2DG6MQMOK97U]VU+83G?\WUX<;')Q<]RL'3F=#8^5#<[Z^",KDR% M[OF9P7,EZ+$9O44)OH6X*O83WK'KU@;P1[A"-Y'R*K?@8RH"LB0A2;'4'-BCN'A)OOUU5R^JGJ "J[3T&B68=A=(RLK M@3(\GO@E&Z\9/.C5YS!=[*/(DU;B76A0;MPUB=N]L,701?>5V>>APTOWFXK3 MF?9GY.]20WT0BE89E^NOUS^H<[3$3R_?L90[)]$CSC5D1P:"'PA)@$B>5:V: MHOW$ MS^>&()1CNG:2'-6%FC7Z#S9.\^S<5Z \(B0W+48/5#2)EJUU!&SE ; M$48P&T$Y@MKM/H>@.SQO)YX/&)9>_P7#*CPP]..OH(654)\?7EWO_I*X[/C0 MW__N^"]_>+ZM_?2I0TW&*DV()+9&6.A_F5%$[$0'5!^]J>!X*AST:_NC6-"H MN+>K H=M?6[SLFQ4([YMQ/E3Y^_$^NE&5;DVV<:E47%VB8_",W\_/@A97VJ] M)HVS4/;X%JPW^W#>YGR9CJ6I<]?SE7WZQL:1GUV"4VLT1\=*S+),LSFR O?U M*(@M?,U](U9P6]-R^4C2JUCW"Y:Z4>@;*=P+G4D(U8?<@YFV$:V^SR86RZV" MNN#)S._JW;8G4I,!RAR6;RU<1+>3_WG2\DDD\_(?[_1LPF[W_8]A\3%S%41M MSO2W::$Y,5E1R7F '6?1+YJDK!"]WO?EC, M]OEY2S_"4);=_3#AB,S;[H[K7[>NGB\>]R47^*&?ZPZ+IT04Y=]U=[3**AL]$:G29PLW3KL#SQ&,M@LLSW^ M>(/EX^0MV3%;A,O-X3GAM9@S*OL1N&$C,QF_530HGLB,(.Z83RV"M$3^8Z^- M]M_/:0I"1W'7C]U0N0-19FZI+5LDT>Z;HFL3+CX>])7+?1,B,*.;'O^TM(*F M1Z@Q"JUS_->LMMN>N"JM+J=#3QR\;^L28J_C,1$SJ M"A7V]G1])&@K:SRZ-9GW0Q^E\VKK-^G1"4)!>/JMD?(@=:6?D3\Z?KYI\7IU M M_8Y?I\EAU[Y+< 1+=YS(DGC)35B;H_!N\5.B.+U2 MR])-[S?H-&M.2^;FCR?NK)#!.HAQ)%!X @G$KW8A?XUBPZD404@^OX( MC>B[5? SN6(3QLU \G\2WTY+T ,-"FVQG>N1FS#XRBK?->1D1=F"(J8N=S%F M/4YD?8?(,*0OL41VUH(#LV(L8K[6+] _2HK/\I?08H#]\R9]*\I$O>D! 7KD M'=]5(=H9,VY("2+>Z!E86$1)BF2BQ-C37O1$*HAB3[\1VOVS*(X"1&W8;A00*\<\)[']-X>\L:!*; ME%TSN+7P;^/"V_2E=_1C(J,XJW].93$N.[%@<& UK6P,^WEI>4- %E^=X$V< M3!'DD"'+$1&.\BZ$3?R7\;EMXB':KU' XIFC(K>!,HA(S9RKTO]12FGV_D=F ME;&_XA3_Z82Z?[K%9^-?MHD7D8+%L/>;L R$8^XBK0#-%.(I_KX!449"[C0_ M=Q4E%!=UC;?T__)!\;^\LLK^M_&-+<3)3$* (' ]G9Z]/"U"S'[=T)/\KYC0 M7T].KZZI;_NW$Q#_"NTF[-_F_QV?07\!M0PCKD98[5%WCR_V:%Q37(FP!XVA M_P4@_\L+@?_R2\OJO\S_.SX6QC>R9HHVU@'OGC/^#X#SC^ M X[_@.,_X/@/./X#CO^ X_]I<$C7(M[I_?>X[C&S8H)H[J'_[E#$IRCTY'\+ MRN02)W%>29!%U!#)R^)<,(*7B+,!2[]LPLS6X1L[,>=[_L7T<9LP](*SNRGU MA2AH+69-M-ON9&79PH'A@E!!85C7@@7.0M8)/01_BQ#5.U,8OV[7V@^5KZ\+ M0Z8U'N^?55I?71?^J-]=N._T#IF 0:$S:;,+V-ZI)%BXD+";>=DDO+!BS:G6XYM[!T2YT1B&9@(6OS;UVM8*/ZI_W(J89-,LZA^L:V^HD?FW MB+KKR'- [S;ZS=<]F ?1ZCSJMX4+GVF(KZ*Y&^U6&.H(96"LI2GFPM/BP,9- MV+4W<90.[,SD';>42LM/8P2#39CN-#(?&^V%H_S_-3!3'*I-V(;DVC]682<0 MA8D"^OI*4Z=F6=-Z7*ZP!T+TCR!62JD"H2 .W3(K- Y3%[5MPBX3V1IB;/[S M+.0CD8/8A/D2D:(6!$#>A#VGYV["?!*S[#!1RQO(#0J +JD0U0UMPBATK_TR]A=^UNYIWEB4QY,HQ/>V?T]\ M=D,L(N_"!5>;0/K<:VY8O$I+UX5@^A;!Q>'U<_?M?Q1NAQ+6-HAQP9M':KU5G)>QNO%NI1]'G&"Z=GRKC:!K^=]Y M^NR2SH#;)NS!(YK\L\'8V=MEE[.>]GRV/?2$3H;/__&/]ZUHI__>2OU:SRB) M;]ZOV0*-@,BS ZA?AZ\LV$+1CQ\(3H&JWJY)7"]'7XZ7:>*'['JPOE#2/H1U M++!0+21K ]7T_NB>,C!L(E>@T,@MF_?;B!3LAHR!D=98-&/A3N$!L%Y44,6L M; OE8I/5C_5S>P6_]AK6/CM+&?51J<]SK_O@:F["O$D#4Z[Y8L#G0M>@Z>(.ITA8^6:IN^CWGNKE)W6"GXU;,ZX%B%A-OA MZA-.V68A$K;UAX;"[QVHWM%HO%8F"[UY>T&[P/^"R8/)R' UR_SO#PG.B>^. M=E^XZ6LM\X [Q3DTV,%X-*3?E*#M*:^+"@TV]K>Q=8\U_IJ%6&9:RKE-:D_[ M6LJ=V_*O0WXM>A.V+5#8L(+Y2.?[-=&@&UP##2OA8PO]X(H).!- MKY-68PNX"6,Q.5+1%P9*!I<7?L)Y?[B76R4%;Q]7[;/0Q;WAV%/O->^OP6&\ M!R,WJ-8ZG>#K$O8,E15%ZK("FAU#G;"Q7/%A9F$/\/506F7 MX.+/0(X9'ZGB-M3 MZR7B1#[-''3(G!"J\O/ZC5JY-RCHV0S9OV@Z-*9Z)O8:)5K %]_2G#Z1ZW-"G#'W MIO,6YI$;UH(;4'4I3@6C\&&BN";XR.RX 30$%@FT)\J739MMG@H\H&J%EB=E MI&9$)7D'9#O2=B,(K9CKW0P$L#!)(S=]=@PUZX14(6>LTX@37]BCR//U0V5 M=#MR#,F(_5H('UC&PJTK0M"[!Z&'HG9B#N=VN*>\,/\'5T/?1FUE1R[;Q_;80\K!U$1U\AZ M8';A%//S?N:)L_%RV?A&"W#NW&0\E--;BDH))?![Q.>"6]Q-F#(]*0K[$ZZQU4(BGBDZ"GEPR>J!9@9">EL(>V\(I<9X M+>E&/,-_K?"8Q.WW@=\A7?F8ZZ^S=T4=&FCKR_(SBS+/QA"R!B\7N69&\*/\ M3NATZ]B(ZO_D@:\+G>]T7/'PQNIRIT%M@[UR"_#\5FF M4T.IY+KB0_:,O==V/&G>X%JW41.QVY=/8F3Q/M!#8(/CEK0BY2GU$Y.%V(L* MX/1L#8QNFO^0+2H.?3(6/*X]6/=&LL"3A^FOMX.,IJZI+WH9'!?-G/"4/$DB MKQF+47A,Q*;(X,]LV$-L<4UO:)R/J_: 0EB;,)@ 4X-"[!/S088&0$.DC(DA MGMA4W,H)DX"*L7T$-9R71RHC3%XKD,16+\H23W-S[F\U+@\:D6CX\\AD_ MU3I*V>./.I7/P6JJD22M974CBI(KG!&Z0P&8CQ>_F$4DS Q\C2A_1)4_%+3@ MC5.S[O!PDPI &=_W4[302 ;KG_]1H6:E4H!J,@IRKEA)CZAT.I:H6]AGE>E8 M]RC@V0O,AN239@J'W$&]0U%%>),G>MJ)"9LPQ8- TS2&&RA2$E@")#*665%3 M8!]I/>+&:&JO&CL]:_!D5K+D^&.#]L>1!6<]E3,21[++P&,\. -S=^QX/A>= M3I2C[<-K ?R7-5Z0G_4(00OWB6FQM:\>N_?+]'IA=0AGWN0\Z%!6XLX.R35S M3:N:N;EN7[7(_E V;58P=W,^U#?J(/:(OJ&6L:A2WQS'O5"\+2E;)96.ZK]. MK@WG/^IW2DN/"3LX8/,%X:7FHX C5C-E23FR.<[K@R'..8C[4A4]GW3,+CP/ MOY_UNEHA+]2HQ_()[204(B[)VX0I-,,0%1()+[GA@-]/ [?ELMY0$X[G23=R MWZ"WA_CH@I]5$I.R0_R )5N0*M 8V83)UMD3G0?GQ%)" C? ^4)/1AZEJ1XXT.8[P_G.%?4G!IYVL AR3U?W MO?->I[-FJVI"AU/Z:TUGB93BE#+E:IY.WR/N4WKVF[5M\E]%!M J<.RMA0G M9J+WX0,AS 0]1?UHJ QJ/[#11I?!(S@]JE"%P+X:PZ%*49,$.E4A"K'\5^._ M@/NJN^\\,7SH&QD5&CP>I_OV O;,0P$5P MUN>4WT0\5\I2],[-VO!]^-&$P]#NT)C!8I3E"4?&2*4.9WH3MK=98U=$1#&\ MT45[A[#B@-[WAU<49"M2WE\_@7.F[C:P&6GC3#$*M9ZTH%#?G)Z>#QFT/^&8 MZ7*P/MUC)5%>3*?W6AC@]2"3HC%5U4/:A.UJ-B%6GGK\$2)QK=,%IA-Q MTJL7FE[2!T/KO.R]6.LYN;XW*B\$K?N4Q6TOD&*.VP6483]W2)X*N ZN-8KS M;FR2?Q$Z-N$MR<6P>LC$7Y&0+ R(KW[.W9EF(YC3D<@NW@;" M-X$UO,[Z9@>?*W>IF)\YY7-^:O'4AD=;R*$S>3;!_4;5]UI]A2]9?H?K%%0> M!7/-&PYD("O[\^MT72\R20NA?2W+#!_RPL7D9#OQ.V M"2X VJS9$Y$822C>M1:@T?VCN9A=TZ)C+][0@4&"&8!_<8K; PM>?V1&*%," M5C/JO+=BZVC]QAE'-\[6#]9EV/:/W!,6H4/AHWY\UQ>#AA;F^.L ^O:*_4G+ MOF9;T2Z31@LMJ(3(8>_!I6)W!7F*X@%RZW#A?JB(&ZK \VX8-- )1= MLQLM"SEF>B7FZG6[HSF^=^Y=X'77+K;UNFM+OEK2=ZZ8,XW)))O4U0^X-5D4 M4BG$P(4QRH3U7.:$6)M#&_R[(*MP"Y";BOTG3Q#&T(=JPC..9[7 M1BNH#');FLZ5[;@EE5-6]L7FI]:8T(,48Q$;_;)C;F#C=T+/JH^2\)D@V$)) M"VS MPG:S>N^AA?CDDR^:70([G#>@M6)F>P8SA$M\)3 M[IN9$VNDR$G*U[ME_8]*!UVSICI>3,<@/0#QMU/G0\5.W8/;X,>)G6H!Y"8V M^\=,2-UP(XJ=RC@PT):CK@Z,I%Y;?E75',7IV3UC K85X>C,$;%3HTK&_UC$ MFJ='+Y2[!Q]OH)QR:\,^1\Z!&T9_;Q;P4DA-0ONC58F,'LB?)^84Q1W11-D. M#9/]MV M'R*[#PI7:.:"W=C4G8 YS0BOC)'%6KD7!A3ND4:F!GHD=-D/7!LH>N7=>S0:0T..C4,=!ZKN+= M?#A0['"X^-#TO%>9[>%0G?9'%%T/JV-*B_@GM#AGO:(\O\.02XI'W,W%F0<" M2V.T7^YYJM.-ZIVS,9RJ\X62[\-DT'YW86'&$B52%KKLE=X[)!OSZ! MWP1F;^ X$JBIUB(_&Y_R;(X-2,:C;Y4'*2Z4S,9>*2F>T0N)T7.?:8K[08DX M(.9C2M#LQ?"/P4:U2NGJNHF[ILWD9WUGG8H]C,8BGSG()/[6'QIA\T5K_5A# MDM_M-M?J)*;? UL&;S*&D]['"(6S/;XZ=JW$+]R\8.41 M\,7S@_[>X@:G(A^C(I_SP>V)-K9&L[:/AG3O)V6FZQJ_,[6>/]0PXJ7:(7,Z MZIDOSS.K5JY8V:5(Y8^HBO98AHN.CBGCF&=;IXY=R8=@O4X+;7P,I K8UQV$ M/H 4CC7#!#P]0^8\A0I 68;Z3V$RADF1?=4-"33=8:/,RII[405JP22,XE:, M64V>X7NM]9$/"\VF7 P8XQH M_[7?]K(GLV/2]:68J-)9E>.UI5^\@E5\*LH^?W:?43#9XSV&,9*UUMA;Y"-7 M,5*@4EOL\L?Y[7AR.9_ILW[FHGH.FLF[<>OY%DB'.$V1T"QJ^LFQW95%[)#W#>.0EO26F45&AP#O.4F[&=Y )%(T"6V6M"#L4GJ9@/^PW@9$,$G0143 M2.6@/<&QM)3CE1RL$J$;O45@SMUW?%_(K_3^E?D#7O,:CLWUY/-]QN8GW9[' M6([G$P-BY$QDA&_^S\9*-F';Q?SGW2-!J+A$-H+1HG+ZZ S=]ZWM.>",T2/- M0P[J^SG?E"U?=1Z]YW@[/.MRU>"3_J#2O. I@?61]&"<,),1GLY![P;//=*6 M/]1]M/OEMD.=!L:'WAW/"RK-MW<7Q$!QT=5BP:M.G'CF-%VHG>F*V&7TY=)J MJ]E(\HJ]Q8_%V7;TB]RV-Q^0SOVHBTV=^$.ASJP\\AW#2.I.7&-[+_X 4)#@ MHP&]!,+:L#N-I&(B,ZN4;V[")KAB[A'=3JR38++_K0]%3)$LJ)TH<.2T.'5X M PLIJ),UT CO9L63D/7MC24]4:4A*H:UI=Y>P6:NE647/G\4X_JP&-?&S7U_ ML>O1P 7$QQXF195XA;A'U$=3 KK3%-O)HSV6%CI#*&?YZL2<-USL[28)/JT, ME&2HT%X3N5BIZ;+? ,W"RDK\Q3Z*:R/H4UWZCD-7P'EQ1&EA57CG$<0YT3&" M,?X\V,$B)XE4>IL#RJ5\1B9&6NW]."9WZE7SO]QR&MZ$<7ZN Q59B'U3ZU;U M1&J(9T<^(A&)NE4!V3$4S(P\$:1F$X!W&L F1%9+CR/AYM\V87,H23=X>W8$ M#55VJ /5N7BA*PE7DQGNS!JZMZW'\,-YE]>TVI\Y3C=72]"^\!O;M @:7"DU MS!:G;I19QJ*=&P#R%-08!7S?X):V\# I31(,RC;( B$[!FG;-('2E1RV M(FY\?8E%,\RU NU_)#YUQYF\5==_59__.Q"=NK""V&MXYXE]65">0T4%5,;< MA*70P;VYZ<2I-KQ8A*8$/2,NZ[LMSX,2G XF.\UGSQ -@7E,=\Y71^*LXGVT0]T,'X\HRIB::C@:D3=D!@GPF*T(<3"4H\ M_>VG*BI?+.Y^@:ZS9E#VO5NQAZ9GVSU;V?[B=A7Q]]O.>>P&;# M _[)2[1C= ,KB,WGS*\RA!A/8=8F[&J!A#MP=:10"]S^9YD/%,!I9(4:CA-W M0ZLL]2W0#7]0UGK0*'FY:Y:^!W(^_0K@9W ]!*< 49S39)OZ+M"@I>PM'0BE M"\;#A)\:1:NVPGDH@$1)_;) MV@+$VPCN*JG9N62&=J"?AL!=P^Z<&M$RN-&6EYM:;Z#;O73&3%1AOMQH5E ] M7FSQ&/T #9EL\', -(-ZCZX@DL9-N@)A"EH0B;*.D,9 M$W05)@>^':\!T$A5S&NT(R"1M0)]>#9C)G4ON]JR6@-2N"5UDCFV-ORTJ9Q$^F_7U5QNMWVWS3J<=>1A_E]!G#(GI<#N M$*F5*E>MW)=/*2_3*Y]=OYGF*"HG!BVD6&A QAO&A%ZV$@H15#RC;@ Y R;< M$19%TAV7-,S?^+4%1-QIWDJ%BG^K&]&O^V)G-1AF=*L 8U=/@$"@L=6 ?VI-;DMJ^SDZ+H<*C]$S-')2P>I5$#V?DDH^.;0T!GINB7 M%TWUPW.>R#EV>RY]%_H:?#231V1/@%&&GK MD8;06)#-G*U6_F'( R@IG($5<[M?!YJ]GT*I8;OIR7;.2U2AC?L'VLE " M.A,):6#GRSCDCXW\=+"'&48>7L(?!>#M4"3F)UR7-TA*,LY 8"$[,(WSHZ7R M(V31Q0W@UU0^[0)XK3D14#%7.X&@=2&$)CM8#Y> .GFM8Z34'\V2$V1I_.F1 MN5MXXZ1]US$I[K:O'9!&'5;*FA=\,(EM@UW'U%P][&1<78KM9-0,=:OV6]Z* M?94:"0SM"[Y99(P(<["62*T_;WG41(%7\7B@BBA?O?H)'C<056VP4%=P M^L=0U#X-Q^=#^GF.-\K&Q[ZTR8$">7$,9V8V8;*_",MI)H&>EV,?0-:5A!ZQ M,!>32?41YG/O0 TNED3;#UGT<'X*)AC&'?!J473>A"4$B/&IUD-J-LL;SY=( MO2HN[ <')_N-'^+WAT4_)KK%CK2'Q8M4(?]0D,K"RM-4 Q';J9%$*2BIASM> MSZ-*3A-WURS#E>U+/D%G+C2 \_P*B<2 /H%+>$W@7-CO0",YTO[*TEL?G4Q;$'';F"(+$<\-5%U=R;=W\$9X M]5+KT86;,*^C32C--F7#,ZW*A9+;'A$#K ^_/^+!US!A^*\\=W]UGCD866B7 M6&+5/&EL8WI)QS9*\[1 U"WW;9D]1QQ2N>\_FX M7?K[+;LBIYL^6$MY'BZM/.LUGKKHVAY9!MW$VT[.BGX&B5WV)=%E8^<1;@@>HRO4;H73CG,WV" M(YRPW8'K >+&RJ'#@W(\#>]PYK=:OHBW[ULVAUL/7&P8J"M V Q45U<9?3C* M&!OO9'2.2WJY'[A[B(?]CA'=%$<;O>QK+#SM6JASJ?8H PJ]FQU,WFG-]%%J M+I?M9(V^!S8&OD,8"T,^D>L@V%#W1V'Q/IA5_; M6Z-I>2OXP06#"\97S7=BHATR+ES1?:KQ(CNF9530(N9.[Q!+5["KX>@-QNSJ M M]3F$.3%G40)>J0=^G;C'9&4J6#,NTJ0YJ^5QJ(KTXG[,=UBL:Z/UWX^[&, MU,WQ_K8HMF)(BJ]?F!$P&K1^G/1D>DP[7H!X H6]%:D /4F186\QD*F&Z&J7 MZ(?V)@SG33R7C7))IL(E47I,J_K?.;.#/,^A/?N:.;F&XV"Z'?GW_H95Y-^?A%1N#J]RX,VZ#82MZ+PV^ M?6/U$]4H]1*"JOUH8:')G-XF[!F5[T*=UWV#=V!Q=:^/)&8%>%9-&\*9P_R( M1X_,J5HJN77?KG43NA_I+!E'*967^9$85PU5*')0BT^A>KJ>A0FK-\K/0;>L MUHGE>O[U_::R^6"'L@/XFHB(X$G0>D,2(C+__H#SW7G$;BCD5!_>F$.1( QN MPAI-D@2:'+KT]$TQ'Q00$=HFY2*W']F87QR->%.=]-F,X*B!06 M_KW><1-F3ZS[1J@EMC*)B_[TW<2YJ;\_H/RLF.<=1PO\W.P./(FXYD21O/Z^ M3+NJ1&O)J]-^YNMZ8R7:O-.)%.]S]+2.E1S4D5JTP]+S< *QMEJI+4BI)L5# M8T62_\LF+-- ^ =];H0&VX3-E ,%Q*/$%Z2Y>B":7R.>:0?AHX\2Q'MLQT-L MPQM#U1MG!=BTMR-.GR@[H1$LL# /]^6T:)R&$DOM@TY"N6]!&][.^A9G!C;H M1;_ .:9X.@^1EHD%#%93\?NYZ.F7_P>#!&EBZ^%-V#>R=7*:3^Z>&%JN$PEJW3Z:U;PF4)9AZ..CS0./LUK=B4M5X#PMSYR M4.4$7$V !+\_U*J?(*:HPT&3V_B XC,5,V/Z38V)*-\GX] MEN=ES^X[Q)+9 MIK.YZU;%,<%YA6D5TV/U\;:&=9\V[/XJ>D6&IC9A\;AL;>$;E-^M _M?(VHG M65\]PI/.-T%M&\>[KJ=-W;<)VWIX)<5<;\.:RIT527T63YT+DH4/5UEA0B_V MR^R(ZP>?"E!@<'[HP+VM)-U#QS_+C9OLBREOD6,?1!ZL6=.@-E6SN0@A&:$;HDA?^3& AQ'AYH2C,6WV+$+JHRU+;$-")#4X&K0@8X+M";'1*\0OB MSW@KB 0$#S P)2D(E@E66:!9@A/,.H8$G"?-(3EIZ-'AQ:&ZJ+[Z[<-^X#'V M)BPH2(_SO6&8\$(,$&]BZZ\T&)3&5X)\RP27H25 D4-EP6_3I,)@@M^ U>1F M_U*!D;H3 M=*QNA?(I'71T8;5N]&2%4O,BW@&QA4=5=6IW+4DJ]&>\5M?^J7(PT3BE)*$L MJ20Y\M'7K!+;<^7?MBTL.E4Z?<[ZI@E$"]2R-V$(>JV;,%;43U\WX<=1>Z?1 M5S!["!\I@"7F-OUE1X+ L1AWDB4Z+OP3[1?GQAR;3%Z>K;;^566$6:TXP68) MCUD/N[9FB I*<7E+K7] 5U99K@IY;:N)H2O1H#&%A+*_\;2-,X\!R"))OXWK M>&UAM<51P4E HK4A3 :RYD=BDL>,.]KTXDZ/ATD+?@.1]Z[AI8TA 3QDM^&( M2 K(A!2Z,,_!+JPJ4BTX-H<:Q6DQ%JB6XOS:"6:B+.(5=@9Q]R8L( S2^EMG MD'F*R6P&5AJU;T-#U#G)(NPGGP81*5B,B U% SS&NL,768:G50M7E1==,QOK M?\](J#7WUI P%+'_Q5TN%^&6?#UFW(XSF3#H%]_FN]2I/!R:UGIQ7-WE"-&# M^E 8;9#*.-0=4>WAPNQ6"I!P=7@:U)F7?QU%4.JX;+J:0COFEG-R9\I?1Y05 M[.YV\(I3,O05AZZO80:/>:#\LG08B1+6\KL>E ^>?U+1617<%'16%$F_B(4. ME:5LPB9R5-AM8:/'^)F0!-5 M]'2+H[E\//0-\&.,[P+_&"1HXZ@BF2DD;<>4NC;@$,^E)(?/6!P>3OJ31QFE MMZU'QWLQU?>#=29Y)"8]6?UG44]OO7<<"OUL*D?VXR9,'_MBJ!4ZN0G;E@K0 M$^F^"*4IK )-=9:(6*%L#W(.\DRB/X;TW(4%^#/AX35X'V#.+7:2M4,+RB\5 M2$+A(=P,;*N/'@U$IQB%I8X?@4Y.+*19*/7B'865G.J??H2[H])836K.^9NP MR]]1!NVFAB[)W4LQ39G53&C]@5+;I2+/$^7M-(\,EI7>Q]Y)1Y*!;28NU[;N M&PX5)H-S3N'LSMP(T.?^D.AY^*T/\V)MZB,K 3-U86X+^7@*,$E>.^Q":*R89.W%HT;&:YP*E170S/N)^YPN.98O!-C&)$5U-Z;EAD1I*WU*5H4 M2N?,LH'SY'5+ZS:TP&@35F>]"3M21V2.T",ZJI+6X?C->"@!CI57(M@-1(;X%_<=^:=#^^76;/6O!^R5LHY M^^S?WL_^/<]SLO<^)*ZN>?81LGW['8(# K/L%S@@6PATU76> SK5WP[?,\Y% MM9+"SPZU'D3"2@;\7[LP+NQ1_M MZ_WN7KWMZV2&%'J%) MHE?; C:Q,GJ:B>^P;6SY/LTJH:T6G9Z+-I\*$ZCHU0N?[SG?"2IER")PA1;B M"9]*%K*:+UA7.1#4P(?Q%/MT%Q&J$J'/_AQ\X:I0T>]SC_^^],/L\O%MH^,L MY9W#3%ENCV2Q)XFU=\A4/&[V!"DP8![Q& I=J\O3Y&:7NSM8*9=O,:^#\@F&.4:V ME@.P2[?W7?=J_KEQ=9,\@6?J#)RM!M3IS+[9]AKG1$L?&C(>33R%OLH ^5)3 MOL^BG@?X8FL#@S']1S*C%.)4ML$G>V#7[FF%O_NFC&',ZZ:TB-R\S_(1N%6S M1FY'MVZU1=I#O9"*K;>$0NS5]?M5G3P9(H5AY!K"N=.7R]T45,Y76&,.S^'_ MPJC-;\F 13PU85T4V/O[=G&!KE-?^]3'[\SK(OB?;PT2S@FX**ER0 $QR$-/ M"^7TS,3YAS!C=.6N&5T@GU[0VF(()-,SVR&'F[QI1IKKDV,4L/"JE-6'VX3IJMAULC%%C62RA5E M88\XL8QCL?X[_@.M-PAG*T[(*:7+&:#\M=7#JR5*TWY<*KU!D&_VWTSB^J42 M747X]@;/E7H(;RR%QCU@YX?GC\&*E'9;RF!54IE5KJ>MJ$N&4 J$WZHBLLCA M]<7Q**TSBGJ#A5;92=:F(H[Z@U@Y"-W:T@4+P8S#Q3>^I_4'O%QQ03RN^V[3 M>[J"'+NMJGN]Z>'Q_IG1@I&@PB-Y#>*:%SX>,FLGTI/!OQ9G4\?&9NM45HM9 M:& 6L\+O@78'GH5N*?]V9$9]U-TQ(,/[^&NE_%O6?[@Q/. +9@<=K+(#"ZI; M#O@A->5T:YNB&?^S!3O15^G?8"=E-5+9VX62YH@(A8B*_E]BC.B4+1D.J ,K MK-GTYX+!^P8( ^,I_WW!.X%V(L;WLNHZW[TTOZ&$FF2]R^K7SF?^_<\&\?"E M' S"C'7.A!W9\'UG=<8..XW\C%>"_X0N<+//L"+68JBG^^ 3:^/ J^/7 9LX MUHUNPK$%\SD@V-1FU!8R/@J:_F:965IN/(3:?$M!]P2*J???'#N.>.>R5_ 9 MOY_XRS&)96^W;Y64 ^(_.H^!RKV#83\>#9_3V-/HL&ETL+*9*O<,'RI /H+; MTEVUJEX Z90P_[*A0EM(HA^9].0S(_T':4F*7B@WE0Y'9+[ZJO''INO?^E-C MV[O_[/UH5H2*7N3I/O>2_1X6T8LZQ[H[WGM;;EWO+1)W$P)>08\^[7- 2EH;[[X M#IC]$[@Z]6=(,I,[#XH4NMU?/)Z7$U"\1 MBS>X%T \V4O^8O%[PT?/9VG&,],[YZJHML[F];5F&J^>OX;TL+8\/G@R3NK] MGB(?>\W^<-+A+K>%JZM#S>@6S[@.V^][>7K]ORJ;#+F?%)P[:]Y%K3)6X'M[C@ 3LI(FL3LMOC6(-MZ\:Q4>!>.) MI][F:BH8SR*191I)Z-+C@%ZB,++([^SOT1"G;OB/LU4SK";6[ R>:WIC+Y5P M0/U<$D&3(/1B;?BO[_"-C*K;W!]2P2PZ)!O+$/E7R48I(1S0'W06C,S%C7'U M<^Q74V3SK\A?Y&99KMWE>VS[S])D]B]_./6&/W;K$W96U:.; ^*7A_R:@VO] M\YB??Y<;+3//?D@%(K&I^W_'>)WGUC*!'+VYM86-@@6S18\5_;-B^F!S^-\! M-Z>RQ:[#MSYBN.S;;OV?2F;J=QTYS4.Z)(H9G=A:9&]C9IE M*0D@V)'@_87B_Q1QM )+Y05VZ2_6$)>?"_Y=]%HH?H\'1UU@(WY>VDE*93]2 M.MCHZ>\]^,$@_T>;6_\[8B8"<.;:W?Y#O[CU%C3[=[GC2Y!M,)C2PR)./UZ5 M5#@X8K\_FTG,V1^8Q_Y'BQ?\GP&/K!'I-9[<8@]O(=AG\?^IV.H^^ ]9""[S M%_P]SZ@&8N]XV2X9"M?=+>CDBHC_H\G-_B/:LHE_0P'R[V*]OKBN:J* S3NQK[C* M ?UF+ '@NK "MQG!B2P3:HY[A,>8-E@,&+/*CEYWN5:5/6H( 0.)9H,5Y=OO M%O$6U4XJY[+65:C9[(#>RQ9E/?@PKK8.8+=S0-M_JF+IC0"1 ^JMB/99>W\? MBO4)?JS[UTUW%IR^\TGV4?3YM)/J0Q&%6'VR+,NDP(RQ-/_:I1)?M!+QEN4' M5///(%U;+K+^8(@XA&CM7K103!CM_;VN/NF]D^K+A../3*7.IEY;G_KC?XOVXI)]9 M:)#;VXP8Y8!2N-8) 9V0IL"/8"X"F6U$'MH@RY8Z&R<+&VO2+*;,@Y^.;4X M.#-Z2TGQCP9>STC:?J+KO&QAX%U,1\B1KS,GIJY)E[^&+)'_A:%E"/T9RC:, MZRV.M\2V\"<&O)/>5[;\)C"2R_CFXM8^>_M+A%C##4IHH(;@>>$.F0&-3PF4 M;5TV[Z\Y7XPVVA,KM'+O"TR=_EP:*NPQ]7O-\S%'AEHAPNVJ: MN-A>9D)!*B)CTFRX2;G(::;;.#6FV,F#O?!\0<:$"A<(D0]IE\QSV^"W]%37 M*C8G^?!II[%+CML0E$+#5KRJ)9)4I5(3_*XD2]ZWLOZ.[7__,X)BK,%PY/N. MUDVS^:0>+JO)[RHHI77.8%C&*SG/_&UK9W89 MIE?OFRI:[#CU6^E&>K, M =6:L80\ECJC'L3.D_$N3!+U-/^-AOH1%;:T;SW_&Z!O<_):>=5=+%5I)/Q% M$)PJ'/=ST##'W;6-\4,#R%.X^MJE M^PU4;C=9=K^CX8K?F^Q;QRKFW1'.'V(]KKT6=&D-%:BS/EY1,9^ M"YUT&6+Z 3XGWP<$BQ7,0T7]H50.B,=O2TM^1OHUZ?F&]=B.Q&V"XIO!;8OP M^-LI(VKG<^R'PP+TY^/Z?BXRQW[]8)AU(4ZAQIP_,,")I!C']JC>M=H>G?QR M?V'D]42CD8ZE"578 6/<+V/+_;K6@7R':EVOVK>,?JLZ4EW"!>$M-.X\ ]+1 M30ME6<4\_7P?=_TAE8G3[U@?LJ+NZN&!+$,94$5NXOAZL\I(\5SI8M9S7?5 MSI8'.*;KC^0_I%!CGIQ]/R)S6FH\PI4K!#T.GG! 7E#(^-W@1S/'4H[\K_-DG&.XS^47=A2C\6H-!%2[<]:IG4YS(2'G@VJWANM7]2+78 M5[U%K=&W&B,MRGHM?QH/0/H-L!W1S9 ;>*=71:='\#4 M:?SKB4='44#VG_4N]7G,Q\%W-XV2%YH(@:2Z_/9Z>F,4&<\!W87$PT6:E*EX M/A0'Y")['M?6F%);[+PR)O9 +*KS9;AC\MWUG7BMGH#3!CLPHUNXZP,;QW). M5AB5CPD#CVW&PJ]]'W;=T NE] L!"../]FT, ;?Y,WD1!X6Q'6-5_$-YHI+# M3C*6;NX2([8WOE?@VDO7;8KZ]S\,(?-"S.)G1!B9)^^(A.2J(\[3#,+.':0G MMMZ@V(64\*W<*#PHB"U\5*5D)923=\)*E#I4H0N>N3]\]@"']88<83D!&U[4 MC80]^[Y:*C_X!(!S)YH\8G- YCBG%E+*9&?G*'O?@M!OG] W8WF-]$=CX$'2 MD/LR\^]I2S6BW'K>V#J<98AD*G! K\X$<%GQGPG4[," K2DV;S-M?&=C4MY5 MZ^D9/!?$\96AZ3"YGS@Q/2[C&>$P(TPH2U2);02?TWTH]SXY2*40&,HWB?:Y MX%C?](0%!S)5K-TO_>Y;E&#XJ2)H4-]Z)"CP9=X?&1+?L$:,*VZ74AC00Y3M M6I6@8Y&//M$E_.T8J!>>Q?9?2BDG2TNU2CO5K0JO]A6=M2&J3@5U+6-.=<75 M<(DV5%:N(FTN]+AW%?Q+M;W_W-OT$%2VLX>L4Y8-P>V?%R( [FIL$%T?)I['!LQ-(ZE(;.7D2$M=R$KB!4H!X[Q[-,(FEXZ>6Q3%XL3<#1H=%F+^A9 :XF(2SNMU??KTAMIVXA M6>.F7LK&MQ+$0QI.+(W?G1)OMP\!7.RJ MM-MV9;N>.+/L,:RRZGN@;^PIU'-'V'.E!?E.4?; MMFO6W/T!\SIU=M7: MD0[ =AX+ D)I79V!)DX,#2 Y6"ULX]"R8RB -:NKK1W1%M!E*V1WYAFL-J;M MEMW.M.XJ]/CQ6ZNWK_SS/00!,J0*99X_>%Z7R!^H,\3$ #ZJS:\M3MCX$V0? MNY+#_@#I&E363<:51"L>7B1L;D;F+A"NW++$"$&FX+1VY,DF77J#.<-H*0ZF M3,UHWI1NTW0#(CQ&A5:=I;X+KL[\_O:]NY6OUGZ6VMJYZD'Y :T*1]/& +#P M\B2K-&@VC@Y9%Z"1XUK49'7H*D,N0*GK"X4/FTL$+<;UO[L73?])%'_WA):- M>UQ%Q^<3E+LO?[Y=CU]7%H3H$H 06F4$;$R_%Q4[1\65O'#\N+!ZL?URK(J< MKOY0TIG8>ZUS5)MT)8NLT)%[23X)F$%5: EU5J3I]"?%[Q-B" J_-,P25@M^ M<<>FYQY)730DW5XIW-L&1;(]G9*G-%)* G\;M$TKF1NKR77>Z]K_$]NJQ#X& M;/TYJEWU6,H5K08\^GMZUMG)><4@=O8AZQ(Z@[E\+ ];X)^I6T9]MVBA55_? M2*_+=B!Z&WT;+2KV;>QHQQ,_OL<(!#AL=A_M36-F7KQ*GW:9<9EV<9]"2(MD MS*R,+NI5JE:>>>:BO[Z4H)^?[J+O9>9@??!Z;)/"J*7QN:"#@?F L_WJ]< W MQJ/I:_=K.A?U,.=1!+U'_"\RKM1?31?J,^UM&DT\4I_"Q//7&Q\+<12Z@_K2 M@U,>J\KR? OP9%%+;RT8[-Q+(2CPQY7@XLZ^+M2^4M-^N=! Z'Z2W)7[K_-[ M'7,*EGE;6:II<_>+D[[#I]N$ JJ!E< MVI?+.)7D8Z.]?/E#2;=9:AH@N'^4Y0+LER=BP7Z,'\:B=>]JI693FDP#BEV M!WTS ?$V/T^?O4W" M=(JP'1 3@IV;2UP,KS0\+MXFS9MR,5VIK[Z?0&-F_^ MOB(:1F^N3ZQ$"<'C]QC?U"IH')#TM+LEMMAJ:]JJ>F(Y*K W([' CWEK;F)\ MRFDBAK06N'Z,5+(:E63C'\K2G)L%%$_FT#_,01\;RP"'6S5[YYNE!&RF[$:; MKJJ*M]5;1M+X>UW7LRU3,HNQOJN9X@\RM\J)DPI_X!$CZH:4RLDRT]"]S/W3 MJ/UVK C5(56H1*16(GNDI6Q$.=+1M_KC8T85IG"I):< *^BJ?(' MHQG3Z_6WJAN)(ES<_WUXY)-7'S MFWUN2+H?K5JP4#N^O<3Z8W=GY9E!KNH^B5(Q2'8AR6W+"GG/"-ET4.0_E7F^ M*XA?^6ZW53YTL8,ZGUSP^!7AMV0W62G[E_1W9E*_GH@4>]K?M6PNA%%$%:T+ MS.']9NNI^WJ ST=B';&=S(_6H;.,9>@>1'CL3ZUD,?X*\SU^16WL$2#8><2! M=\?PPRKI4:#/C>$@SWK=8Y.?]3,^=RH'2$<'^&*\_I.?PN QW]BZB5FGS(NJT^(.%5HG_JQ6 M[25UO ^WUA(V:]39SCO'C 1,2WR9O5 484C[1)A<%-49LRY< MZ$]4#>=-]S8+<+]:;N/Q\>;PS?N9@E>_@?]5M^(ZR.E)A:3 P!/&IL3$+1]E MD^ 7-(9V;$YOT8Q[<\:S_<)1K0#%[>AF5_=1FZ-- RQIZL'9D:KP6UR!G@>O MRZ00A;?ZCUU I7--@V!(,'B1+>+8>6=BE"=VBS6O6)1-C_.1.2VS)?JT;>'% M%YBZ1.ZC-^##.2:"#JK4FFS]G@^+CY#3D$MJ1O0M189YPZ&0!PC*^TXDS4A& MS3W]UA:+J/+%YR_:7?*JZ/U<;9DK<+!'F*_/Q0XOC:7+N<^KLNP^/T] ]_[B M]O"QJO6@C;NW_(+FW[X/\-U0B'^2>2\RI#<@]'R\MY>?UI:+Y>$9Z>-'T\0[ M5_J$6T=X%5MZN'SZ6'"KPD_AZ?.K;\AXI MI3;?8S6[L=LHKOIH.>/:&R"@0ZP^,RKH;6/,#GG 6*>^92@HK%_*[YK*D.^R M<6;5,B/KFS;TA/_SR][O]O5'MGM5@UG:I9>\*BCE_@_V>CLSJ?GSELHF0QT< M4,+Y%W=1'J,_^ZT:1T@U@3M&=VB6R!MQD=Y.=8F7^$S>+)_5)ZG:C'Y:=K%O MKO'O?N->B8^DB8UI3UE$8]=R5_Q"OF92Z2+'H8A1R,!Y]SY MBR]*!OHOUM6XD0\Y&C%XP!Z)!4@P$M8=XARCY/1%D]+#TYXUJA$9BAQ?[]JS MC6UYDA7DO%WUI5KBRRL],J^&OSJ#7[GMUCU&69I#1?9\2%I-"G_9E2I2@4<* M(MNSFE046UG:)?AL 77!*Y4]6-?B"^33S[4*^M43I.@"LT]9RO,;I^H:I*Q( M@?.J/NU1<;B7/W8-L"PY Y:L!&/L:3@1[-]]NJ7 DUJL!FW2IUD$"GLP/!Z6 MN_T8NS&I,[OHT[5+/LV6 /H[("=9G@SXO!SN*>MVNL5<%#Q"NFW5R?X%'K&Z\#>%;6$,&@IHUV8 M;_';>7'W;D'*(I,#6GOKV_CG9%JVQJ6"&=>)CL*9/FW77A,'Z$UMGZ9F]I=A M;?Y5 7'3A"Y&%9LOF=XV9#/"4M__ PBX=BIGFT0W:R>_=7HSVO1(-_@(0+8U M0.*&-[)'U)J$*X#4#MFSYW2XLDHU?X+G&04;'0-&0QA@"@*$PC3$9\T*A_!( M,-PC&971%O&U36/Z%92TT"^R2 L5*@NFZ6;J=W/IKYZ++Y2R.J3"J'I+>N6= MZ>;C23K"O!>P1D#5/!@'"Y[_&9YZ+\.L[5<$W\T+MG,LO&#Z]TBKWPBA+[Z_ M* ^_:Q5H4PD6 )=;?ZD>__) 6CFT1 ]QV$2YS#P#(IC8<05KP_[LPLUVLNSC M/SQTU()A9@4(^..F>Y8?E'43MI4#%(.@$Z\&PBS5<]H-C-AX6HEJG;)S6-Z9 MG: M.+$[3\"7(&=)Y+^:(OE0XEW,,?'G)H6N$RN.%V9.,\*_.+JP8ZG[KG@>U%]3 MB$B:98BVXU<8;RGK4L.@BA0'Y/K-PX2Q2V,7,GIH8TEL>7_YGY-=SL,>D!/+ MCA4P'PK[Y)"F'[7WPH1%^6I]E/ORT+R[8WM&XY57>ZI=B3L(P54I](VN4@W' MG2=;"4,]WI>#1A:T329+M'4OY_I]#G=%^E>,*(8'CCPGO<)H/Z*7"> 80JC, M2W;4:6U]'ZT?=D62GGEH2Y>W;0OHYTW>"%X7T8 +UZR@ B9@OH;P;"-EIA<9 MZ&+PS$<\#G,WI!';71/=E2SPHL KU>@N;NT3M3KI04^9;P,>C&&D&(CXR2[K M1 ^BW1#LC.AZ12&[D%K& 0F- Y6=PQ;YB3G8<2/'/SZAVT/[K8=%X46;/TPC MB6LA=/G9.2YK[\=$.-202A.9PF$Z9Y<,ER)5J#VKQE=Z;H6 M"+XQ4-<;%,$0K>C+DR\E* QKY_#GN5H/UGWCDP:_)EW,02H9LCT(BRV[3S8= M8ULOA_\LN_6]^F3V_7L%EL6=:?H0%7NS(T7.Q5?0FTR-O*O6A7* >"++_6$? M4"!\@@B.*\CPUIIQQ%7@\B\G58]3 MKUNBX#DD!/@^D/@A#()_R0&!]!??2VZ?=-U5'7LSBX["[G#Y?K?"5#B,>&$^ MA(VDNCWY@5/P72*RHLC7V^84[\L/+J\VA;N@^S^&..^,AY]*Y4MR $QI3?_^<^ZZ)??P8!9!O&;Z,0.'S*3/<5&9F:U'A0Z M]G- OW% X%]PRL+B_[[=U.P_VTWA 3,.:#RXYY^')1(7BG9-95VP8=;_<>H+ MK)_]UC*33%GXSCV9^[$-SJ9@D =1!UDT#G>^/,#[U@YX,F:LOA>LWK\PI5O4@5>&-RML\;-[ L+O8 M(/+#"@G#("3M=%KI:P'&-$N)T7;AUJ5?7B],=8[Q2SSZ?J>%IP.6"4ZBSZ8H M6BJL 5YZG9>TP]=KUD2V^*1W[-_^[;?M9[ST@PU> G+!"1X0A\=I[AXJG^C" M_@X'?7XI^1DTJ'=IF+J]K?NM]>6#>&M34;8-9 WEN/F8 SIZB1M"&68&*<#R MK&!)T&=;-P39GV:DWZ7:U [!@LM- JJ K:ZH/P7DRAN[GK!"O)BS1Y:SP[YZ M+&\VS1Q[/QJ>QV-W; 1]NT%1M1'K.++$ 0FWB+"T@0&J@-E'N!@,3"4^-3XY M8K9WYR$M3W[,H7HK_7R*]*IUJ+1%T4K&(\=H 5?$\S';H<6ST=(?(D=N0UZA M?#IRM5M9IA9:M!2!CXR40_]_\R;@:BWC3S) M/;,60)7KMT'F 5M,HC.7&U71:J5]A<]Y8N9=??;YY9MTU7:A!Y9\"2V#R5I M7A>5'\DXI])ADVMO3I@%)^'DN"+R!9-,$XCN<.DKHD&%5PVJGC9=*I^97G%I M::B8_>:?75]2[/%E5S>B,2X_6F4W(B)"5Z@;MBO<<[ZFY]RGM2_MQ :R5YXE M!HR:YX[+]:-T?+L.5@+KNR& _O-= YW+/\\*6 8 J13H:I>*]HNJJ!X+9%E0 M9T]XH&ZQQUW?OV=W#I)S.)HU]#R" ](@TT08'!"N MY0Q]E"=!(^&=WYTFB]0YC3Z55PS]."2NZ]86^KROC_,=G61_B:@)@A!V7>NB M_HA^IV/PZ?3A1#QT#<. KA;_,Z,QCLA\R@$MZN#_R^ETV&M:CG0P MZ\\4$ =4(->&!;"T*NC>BU]8E]D#,%?O^M @!Q K*%>)1S]I(J^X+@![L[_J M_\M9C0/_]8S JF7Y!#CM_#V> TDU;N;Y9Z9L)':XJV=O=(EE C_% ?W8"\&R MSTW++7! -K/0KE$.J+?AOQD"UX (GOL+_J/['I$- $;FG#@%'T\4-Q9?(1XS/H67YWEAY#^LD=".7&>*/O,P.+8;#>O6,Q.V$)GR@PLI) M?_!+=?B/*VDK=D7NPT]$[0U.)3Q/*E6,01Z_AQ>AL^&"B?TPLWY4%[\KCXJ1 MR@>MSYLP@1-&D0[Y-GKC]CT7PY0_ERL.EERRS3,SI0CJFY\,>?(,^0G"DK%F MG/,8(?OU/\0>#RJO,Z7W_V5\F-R>S'\C;G0';:;S@1%- R9880Y>2B.3!>JM 7U/HFET*[;LSJU*\_&?XZ'RAF.JTSJQ$2HTSA3+52]?N9 M[R6)7V=9PCCSK]M5XX>9*K*0KV'!)YU7D5RWU0J60/I-BF5Y%3KUTY"GT8;< M=)(,\ZQ$!!9-34[UEP,%'8WL!EJPH#\>/!7>?\I_CT JL0@I7A%W%#HH1!*0 M='-\(OLW@+Q_B/UE?/%I[ M[@#31<,^9H66HZ*[(MAR@RVG6?;TQ5AOFH#._$>,X3 :6H1*V1R[-K@3$V$* M%+V2)A]!S2.(77 !M)SOGLZSB!"?>2PO5A?)$)A=YXX^([(G@J6'%>6 ]D3+ M?KR+P.D%Z'SL%\YAM/#C0JS;[5Z_E4@J@B27**G'*IH(KK_=3%9S>9X[][+J M0F-@]_XH4K-]VKHC4L?SA+S%1PFV0FN/@%5=K8Q.:,:<8EO=BOT3>E^7U 7A(78^@6HXEN+:VJ '! MM-.:5\;N;N-E3%[B)5!!*T/M+1 &-K:JCGC* V76VEC8T=L5-]4N)DX0&Z(- MA/="+8=A9D6KQ*X&EI 9\Q(0NH]FW1HQEF$A&>)X-+3 CP,Z!,4H=L30>ZSI M,\_*>FC\"!&6SM?G?7Y-SE2$E--IR76T=TFO7)-+F&/GRDQKJO756^\?K>YQ MN'GSD0^[!RG([8B)PUQ7_Q&>('N6/MI JSJQBH&/R VA>2,"BED&]%A:FKQ8)5([U8!"-; P=DV?4X\M0CV:[/!09#XA%JUN 1D];E$O?+&-"E__8)-8MD+KW,PC%"R]_K%#4F)R^4E?3_5'"(B4ED%[==Q MBGTH.M?(:R-.S7@L,^NEO/,&+0I- M HHM(EE?T2KTABXRH 9>_U"^PH:/LA#T_KF?L1^ZV,J#*N'$TZC=5O)AUB$F M]@A@A)% G_TPMAX./N0+$</7@M]TZ%=O$,?FXI:<;F-NS*$<_XT#;\ M"[KR/[=&'EW'],X*8?V(PNA@>F8;<0K;.5L#2=A6Y?^(.4>DD,'!.ZTT.#=2 M_ V&0U;QJNT/@C1001^R:QXP%EMQ2<%Y191V!]/X!>0Y(%I&EI_*I&HGZ6YV M-Y6I5JDLQSB<4GM]4\_J3,&) M6"]O=QPL)9=I^7O11.R-V]?A$PETC8K')Y M<@\P%_7[FIJ_1OL^?VGL T/YJ 4O 0BD_K2F;'7>ZXW*&O5#QMZ?#A)6*LP9 M^=CI-"EQC:;^+DE'5B]*="&^KJ(0CX9@ B@Q<(?%V3KPN#)M*;%%$\&@V '5-/<(*FFC;5W8J@&(\:+O M7QJ P2N!'(JL$D-UM""(K<3H*ZCPS]1E'Z,G2DU_9*<0:9([ M@4KS%'16U:GO+RJ/]6_>74V9[XPLJ/JKDSZ\XJW/"AF7L5,NGI\_R,^>\RN\ MW"):O&G59/=[6;%'N&)'Q.UIS78)^"E4L-$GM&'F;PO\X"QOEJ-51B@EM8A]MCHHT?STC:Z_*%WX>4W_AT5W(X(?./1]1)XW(J4;H$".::CMVM'RW<$9'^J:MH, MK@??)HWH+LL<,\(^S:J,^F';W;:+=XXH"T H8U6A MH7-$7M2CGSVF)""?QA6FK0CX/PLA$?#]NOX#_PW(V ZO.\RT,W+C!!V)T[N. M$ZKY/#X=2PO)BN4+(^@TP]34RN^-PP-LA!;:AO)<=HH0]@[A0NAJVV0/#ZDY M*UE:'XP!EVY'.>;<^!@BU';S_K2I>=EA7%GBQZ\$J$R);VSSB: MF7.MC]8"KPT[C#Q73^2'P>F:;-XLKE@3IJ]W0VDO? M]5? &).K81_9H!T/FM%R!:SP Q(:R_#Z2.3;)L>V' :L]W5_3(H0I 8P<@'$ MDVS9Y5$#W2?:4_Q0$<"DG2!#-VL--+Q,:FJ@A\?3XQG0SM.A[5(<4">OVG:% MV/YU!KZS?P !Z 6SKS=0\0=YX$<+=90BA&EEYPKMU;.S_VBZ;L^?X+"$T[JLH#V42[ ,>XDW5#J,A;15+^S5?5 M(B_SJ8AF?X5AVJ6"_L;MG;L*7DN"UO_,SF?=1S(HS4+[;?-2 !8 MQH [)#^@$--MV8DX!Q/P58Z%$2O;N M([0CG6@WQ(+/'R=]0 JA&B@7V>68'C+=!"G,_NH!SIS'K6\PAN:]T)>!+*Z; M8RC$UE6!43FV'P!2(? >\BW+Q#KBQ3"#, %FBQHBT#Z&U.=G+D<\F\=A5?8 MH,16@=.SR4WV\F39V#GD<_@<%?+K*N0Q>:WOGR=(KJP>%*WNFU=Y);Z;?7H/ M)DAEACSN,!$@,,206=0M-V8ZGWIOM81;JF1?4:O2EA^TC';26 M@G6C=//A_"=Q$+X5126MVX-X+;_/$,K26HD70YP+1P[H: B=W&K8:TLA"FG[ ML<\"FDQO1DL5M0S%,O2D<:_!]1GN_90*5XI4%\LN&Q)/PO/._+@/X*BX#N@I MP.3/X4KO8"% 8Y7:4=0>Z$-QS#16'B&_A@ J&ZP"5R;7##4:<4!E&]1 +)Q( MZF*5'RW"3LRQ6XE[L>R>G8-#W!'J@UV0FJW#'PQL'""Q_+XT)?SI3@]>GQ=/ MVYP)X4_FOCCXQ#\Y9TEC*&NUDH-M1(8]UR&D-+9EF)A2O8WWQ;TUU=MK)=9/VYJ,;CLX9U6MZ*0;K[RDB9 M/I%^!?KK2L,:-U>'<[V6XVR'$CL2/O>J!HU! BK8CI[@B?NSG0UPV? &.L^3 MID-@2ET=0D*R*71?"=!M-3Z;>FVD:I(?>OPI[ P-<@J!91S;L*7O-% "-0S[ M(=.HJK8;0"#+LA!K@OV_7^B?G0[RTCB@_@,)2V^*!+D8%3]O;#CNR4 * MIT%/W+/IN+G2*-&D%8(VBJ=\;A&KL1QLM[$_;:YM$R1Z3M)Y_">,EP,ZMLBZ M .<)<\4^G95MD?D;%*+=^+>W0"RM MGP>PHLU;#E41D+( V(%Q4(\/+YN<8JG'8%3Y*61^;K>)&NNA@P[R.*"@ZGUI MH*7+N88+R0Y+'UK#PQ8Y-+21X?$X\A5+ YB@9[:VR#.,\^>CG;5RX"++44M/ MZP",2 "2-[R0[A._'0CNR,9\*$#A'<9@M@'T^58=_H-L1T;X_CD.Z/-'%_P! M ;R^Q $5(]9'U1UU4.8<*J1?: M5J>@&D+1*MX6:EG$"?$--!F:<' MXWNJ$Y*EMAF5KY=4+*_9A@M7V%B]_N;\N:!$SI*RW _H6[#-P...[(ZJR2$. MR(I8TX&]!*GF864%K\5R0'>:Z3PQ8=JN#S*@M(LE:Z)[5]FB.%+ M?V2_%FLD$","P?U+W1Q0N^RO/Q^:+T?Q[)EN%*0QS%"J(A.7K$JKG40 M698J;^$=18=ZTP"T89EOI@$R06Y F)+]9"^<4*93Y$.'_J<'78\]W0CJ6"W=!/-97PTP9[,]&&J_J+]>_CG+S#@J9'FT] XV1%;H4X M^?:I,NYB*?MMQHS#/(>^N5J&/[UB1I$UJ;4WJ0*Z^]HDKT ZRY,5W MU^W>.C4AP/=&(0+)CQ8)8$'7,_E6*4KJC4UO=^2DJAT=[YG_8 >1YY[!Z8BJ MA_"&2T %8Y>9 >!I5?$>Y^G$]OT\N"N@"4YL:2U!Y34Y4ET/@C9H^$ZXJ.N* M+EPT/ !)+:*HEB4/AFZ[JP#2A3[&S0L!\%M$X'P7 MA3CNR(P=Q6BPH !Y?D,2%>H*R)6BE3_0,]L/I-NRB8G'R.6HC3:V*IEQU\.( M[HU[&'9UV[8(!;\R0*7?9VF+^Z&#PTN:D"$GZAM5,Q?-UKGV]X@BL$KOHF'* M& 5LWGW&_=D_24/B71AY.N[A!BN MA%'E&B1O19"1=V]VW2(7D:;R3+.!R<& MP3P:JY*;E+W+@=5V(J\TI47J YW]P2@QZHR@+*%5-E\L(^82Q'MP!P'\G"+=*OV8<^ ' &3^=%?[%1K(@W M YX DX/C8)KSD22B!,N&(=YIY!X6:.L(Q ?.]VI:T\6_,NXH&]"^B)]:RI7L M?-Y;P[LP4)%-#PRZ*ZLKWZ-X6792I*9T@"!4(2/].,\M"#QAYW=AJ"3>7U0) MW7^,JB%[HHO>#V:,'>J2IQE$OBZ^S0K%67?=U)R>J5M:4[+O_6$N,:F7Y)\= MJW),W_YU3EKI8%NGO>(0FW#A50([#%[4EG#AY6__EQ?XT#_;]<"/8D:QA]$! M7)TF7T%K!K?.&&:VW5_9*WH$#8LQ;&);XSTJ/:LY(! M+II(=QE[*98D5RBI+GGO;:V;#+L$$)'WL+FKV7%@4L)BB'#*H;'K;,_,] M[)N?N3_C?F+:K]MIK[.03PEGN7KS-S;%0XFQ])3E5>%/ENK#T8@R 02U8;;H MCY;S0"05''?#MY$#>OJ3-$6.,Q#+G)N-;8$P(''&,I/+N_=1<+,:^E*"5I7P MCQG1E,G3FAT/&D?J#&B8;P.NWC*7\KY#13;O]HMG- 5"RFCL,NLAYK;]Y)/1 MDLTMB^?F0SBM][??%Z(U*Z4^Z27?'(U.F]LRS1S;ZP.OAJ4CRD;1#7FZ88.9 MY_7G-G@W30@:"\D)%UXUA4[SL=%PORI =VJNOP,NZXX:8T8!#;IK0V]6)S.J M__%R7X@G[K:<9QD,+C4W#&1:U0#.K_P(VH!K#'WCCWIR/>-D20SU0[-KI]1Y MUI[0T(%\&[R&H$+&#>?RQMH@?*BI M#L@I-9@IK9H![L2<9ZA6XM^XSJ!^<@G9^#@=^[20GA'[>I(7K3VW.D:WK"\K MX.:0,71 Y8_>XF\32-00,L4PLN#7/G.!VYE7V/V0^K%$M1;EF=465> 2H[!) MNA0(;_*>T)!Y_<,!Z2 )?A,RL<$4_MID7806K6,DXF4 M:#6)H7U!L6U[8);%%= MUKG&B D.B.J);>,JSE@X!\0+9\G/3LH&L\Y@Z>5<0PSI*GR'2NBNNP MYX#XS[$%-X"7J]L9")7NFB_$?9-]31X$ST%9%FTKES+QGEQQ![7AL]/D M;15I/A*PKX1>D7GK5I:A;+L5P.:3YE+3/+V?)0)FBY@Q=SL$HJE$EN*&9(!X M8P,3C@O;$.2 VMSINYU(>@KW700UV7"],2Z36^F&9"B6*LAM+=998]A[KN0J MNTSO8EEAZUND@:']RUW[$&X %]H7)U*@AS(64+GVYN,G"E:)$^^<+T3#%)BQ MOC1U0F]Q";S<(Z$FF7&S5J5,=VVN>6!+[7D8@[(GT9;6E7ZQ"=G\90=^CJV";3W'ED%;'#3#)/?#7='NC'[< M3AD\OH4/*&.Y"$ M>'HO8 _9/L4!2;FL2!$RJ15FU/8W0_:D@WNO$LHQ(5F+:1IK.G!)1U$3Q3:5 MD^Y617)OWUWM[K;&J=R:MGU@%61K;8W3/7].5/^!6;JW7E*_:.;-$D]UR3[M M1W**]C<:'^A>["TC?Y/ J*FUM]-MCG\!/DN>?(DQ@1S.PNL4$! MAU%#33*5#USG(>V&^-CLT<27TY^,U=%W1V#W88B*CODRR-H((BXJ.,[X]]5L MCX?T=9:D0D+%SFJ@0KL!OB/9%E'?3&\IV-9EB6@R%6H/FHU!K70_]CEWM-+H M-D(6"*4IQ,)NMX@E=N[99Y!>C:\2(!](#/ 3:0]Z^F)SX2R [/ X6U^/LV3@ MXM2V#V*V+?U=U\VL!C=8^A4' Z8/^A-0C]YX9]S9^K+:K]']%K@K[YR8YF?P MXKHQ>!*F+:& F/@LTEQAH?0V)Q.6-IVJ=Z9-1ANAW%OC$GE%2M(C,J'#*_2N MC+LW0CJAX5A\4%67M+(OY1A6=%3VZN:%\;D649;A .84ZR(00B=2(EPJ M=G$8<8"_E0,ZNME8')80C3@ID-\2^'U68[9R>-=0;JEF$\3".>5@@]#N6XW@A^ MBJ5ZKNQ>1)7V<$$]GY^W^,[W3MT/+_^AN(AK7WMM;F#="Y56A>;M/ZN6C2;D MI.OR&G[6_9[V:E]=\A@BD8"P%?RKP $-=]'>?'#P:B_6Z2O*MR\A:1!=!SF; M;*I7=L5A*>EV JOL (>=2X4?@WLBDHPU@8XY<#Q$!.U3&M!R2(O6&-S^0DGKDB3A,$^6-P#S=C/FURVZG.&-PT%K.VTI=NDN@F6HAOV2 MOB U->C,\\!.2\/.[UE6WBF?:V$/CJ4H0)[;MSM\KM;6;W[#]T8IU^^6G%G& M-0PS]XRD8@GTOJKO \RYC=('H^1C5.KP0$.!T MK:4G^JY"W.;@XN3*8$"@V;71L&3ST1YG^N[3L(!>N =]IKEHN9']L,2O<33' M$QO,8O@3Z4$\CV9I*@9Q#_>=48T]U!-1Y+C"S%;"[X!E_BI9^"<,[GFL/C^0T) MEL$PR_8E:C*,[H'S)=*3 ?&/-BCEN<\H![ "D']64430-+ \4VB#,UVE_XD M+P9V&9F(]4(\\= _2-':&'_JZ)KK5#;%_=QEGJ0VQ M](/G$.("/HC!P#!%EGO^RHP0-TW'9ZDU:<(?DV(\/HZOMIP:@:E&%Z/N;ZQ* M*KYFX(2>8MN2*X23]=* 4,%:Z7#L MU7W#4=O,^M#WK';4*EN@82 <(K(R1A0@!ZQ;M+'Y/;VX/-(7SS@\9XEK#Q9? MMI1-]3I6O#>;U*3/0%(=$BM)/]_+%A1S^?,.BJ>MIVC9T<%%9=[FP]#26#AT M%#$.8?-6TVV9O%_#+#PZ /P$=D8M?D_!-,J9_-3- MA["PH=R+>BR=^/':)3L*"?>JK#1(XU%[/_A*NIM-4K[DE*!!29]Z3M.@3^9S MP.]CDV&6RJP"M?P86#TQIS >(>CA%&&MUTL]$U_EDB'P62,-&EMD6FQ^PR$I MVUO$&BD5\^G?^[,[*E0 _!_9<@QP+,R=!C\&N"(9C@_/CWC3S9[N5!RV&-'N MY^FM-/4Y1H+'[KBN.F_42>XXJ:B\'%887")E;/([>>;-G.=W]Q8M5!KQ[2$D MFZ<5==L0C10_YS;G^8<6N,@,^&W:%^H/EDAO]N4N\2I(:FV574E'11L,EXP^ MRE-*$/64^IN9YG^9))5;:QDZ6&&5YV+3H&WP=^Q5[0MON *^5HOOPJN__GG! MGR,G<==R_CPH8!N,(R!I6&H \'-/I$?&>67FW+"VZ^&,GM.CNO7KSZ_I]R%< MZ-G[']A\H=1G<]A)HON(E+P%_*F')+T_257BA.FBZ>T9T>%S#J##BBWTX;'4 M,W+#,P6YYZO'EJJ8_XN]]PQK*FW[O3-C800!Z4V(BHATE2HMMPT$A$CO9%"1 M$@$1D "!C$JO(PHH+8.(D1KI+1 A0 :0(BU2!!*DA9900DA],[/W\]SW^[[/ M_O!\V/O#/NX/ZTBRCG6>:UW7.LOOGUS'RF;3(8@=Q078&P!UB_,H$0(/3Y5) M[1+#Q4P_.9%9W+WRWUTE498'X%_7#&#PE^,0#U;DLV!S7*5H)J,3=) M9.F(BS/3"ZJ^;[Z8N29;*&W=VR'3/>[H>"VYK-:;+4DDLML".>"_5J!MS@3O M(!C[^Z:CR%TTEK'5L;L#*KN'7?G"V0;O*7_APM>^;/>;Y_\K8G?-%K@SX?*H)W^P,FAR]OG/Q709M;RR)W. MJ)..DBMR5PVV6=002%KN0NS;A4VW*4BRL5I2A8TMRET&HA58=;KNCI"RUCLT M%^ M7:ZW%M9J H\4!D%VU +Z*#]\90 9A6VQ1A<*H4S'4 M/GF$S?Z>KK)U[^SZ@%>3$XL!7%V2=71XW2+_:G-NGF(B#!G= LSL^O*]W,0_ MBH%B:@L?7V5^Z]SG D"_?S91PSTROL:?O5D0P5C![E[EV]M\A+$*^ODY>(4> M.OR(P2DTC9#[16\ZZQ :7L*I/T3:YXY_S,)X-;*UV.$=WX7=,FPSL) Q)*=) MPG1_OYI?6*3S6=;ME9'=S-"U38[$'T7GFLX\*&H/91WB]]"B(<_)';$(M:(- M]X UW4,.GV=S5(J^L.TA08.-Y4-S7IC36, 5X*+KSHU6YA+'"[JMX_5U _F= M"P"0(WB'C1(T=>G"_P -CXQAFXA<@%&YAM!?#S[8V^54ZY0_91)0APS61MBX MLS8;*W7XG><-LA(NF<@C[&=:6NLKJT8.F_0H!')Q]7]]B&39#&6/-S/XD;6/ MU;[,6*W=ULQ-.G:(_#_.Y 4A#(]HV#<1USB(S.(Q6X_AOQT 9ZB(PG$W>0+G M* :+1O[AA@K&C;&X ."-#^]:D'_;@YI(O O^6&^$9IV(1$! _VBPF4]$'7), M$ZUOA8+^MD<$]W B;/TB('31'4Y'[+. 0JPP>)<5(Y27LHSX'^:<^536UKN1 M+2Q%:8D-9_\\812K@%RA,^1U);YP 7_;_SVN6\7?$0M6 XQ#QK'RIRP3T#!U MSS! [>W?YB5_CRKU1BL7\#DW=W]W3^#_VFD!$IHV7G(!%_HHRIR^S#@N8(]P M##Z_.$^_H/^95XGTJ8A,7; $W&,L'"(+RW6C.E7XE$ YPIE6B0[4XR4AY63( MKZEV%(6R&(GZ7(+]P&GM^=DW+P[]E7,^5NQ!-N+/Y-(\Z2/I2\1I2KD-C3=8KF1I*NI!9ZN\&Z@Z6YGW.+UWS M4I^HU)D1$-2WGM1X%*A1I1ZXN9!A<";MGLEVJUE$\.YZO $BI?E5!NS5D2Z9 MZ3^U52$STN7?\&\?7G6K>)80DE!B+[B?5IL.OWE(E: TQ*0M?!SXMMMO&;:& MXN2&9(I2$ *PZ*Z61#E>ZV?@LYTXN$XB14VU?Q?A\V:\[[)NV3U.53X!1RSN M2\215IDP:T)F$RWD1;Q;>LQWI@T7T&E@*@P'TJ46>>3@)4!MZHXT-B>JF2C: MUK[HE47%Z\H?)Y\POE4R17X:(=D*BC,VB@W:UFFK&/"\X-=P>W3&*:=_F31S MMRG%70!I\]>W'/Y.EWAD7U=M_K-FZ4?Z@=5H]=;/9N=S\&:4/:D\N,:9:VI* M& ;MPVJFHEG"LEFRHO\%?Y"0L3WS.MR=VIL:0L3*PMWH2-[M%O("2U]0, M6&H=S!)9)\6G]Y90,XF!@ZON,Q5@8=CNM4^F$=O>G[+6KU$=_U1?!E ;>%+V M[KESX',Z&8/JCW_B([.\NPH"7]*MN\5A:!,/BV14X9+!M*/_LL'&(/'*OE.1 M0DF.HG9Q0H]5OD32B["RKDI_^P#TE<1Z&B*= I*F\)V"#>-<,@2)*UW?+ M MA;^JV1:YYOK8XA_:E1A;*YW4LT_J\58<>($;-&NP?%WJ5KKVI*75ICJ")3%C MB\DE"7=N*BT_'=O R)$$S::_L?]$ZUH'S4TSPH'SS8FWQTI"9]V52V'"&TI, M%=@1VKMQSOD9V$&WJ?I7#9;4?6+DWBK\+*+$!3(WB/: OAS6P$%C3U,%,3DY M_N_-TFK,H9?R=L0Z'#3+#I LB<0%6AL)G< 1IK<3V_56[!$)4F[MN:F;&^]V MJ\]0$I.<^FW1@]*O+6FF\A-AS>\PDK];*[578T/*/9/J!Z_LD D49=R\*,:< M*->"9JF0K!$X*8+DIF](-''SOOW7H)5Z_WMOJQZVC 4%?LCY_B%!QHWO:=* MN)W$=]F7>W-R=WM"])^_?J)P>E@I:^7-(S/M8_:72IW:9:=B?+NO#'XH,=8A M)F5./OERQ]^L5,7NB"S\>5@B5.$%'[=^8%56M+G:XXX7J:F7O;;$$N %?*!?A"& JF^@CB MK04@YVDV17]SBBD'XZ-YC\:>AB*%6>!%>:^9'L/,9)VJ 'QOJ%]>]N>B_IG; M;:/5>VV; F:46:>[.#GR[V3)W*C8#P?#H=ZZ[KPMC&K%"4 )U;>X,U;2E\IMY;)$>'1%\;.-I7O;^8*LG+C@T MXJBSFG2>05#U.><3QBES,US L22,NU8B[W4I*'T1*&8^7_;U47X3,_NP]U;& MHIOB/VAV9>EQF?201LD2DJZ$8!5\7V&_ DIP 6MC.$=F#/,Z9SCV%W8I M7.3^ D@! LNU'JV?%_U&+^\_Z&J:#D\H$RKS1@5,.T#:)\(*@WJM_-7#V^@? M$MSYSF.>F)^WNUD%B0=1+ 6MM1 !:JNYY2QUZ@-DST@ 1\J+"]@FK$%8$E(D MK?0.&'19Y%WB; MMF!ZBHNCKW. M6P$11[F .C1;&"B'I;RC"//:E"4+SJ[D\/LAZP[P8 F6+F6HX2,O&\;Y+??_=O''6W"CE* M."CBZ2;!^\SK7,!7!)T7(8D0/!? PJ)5"<81%3"DVSA/<@8&NU*UDO;+B"V3 MQM=(&LYV!-WO;M%0->LKHYY6SA.:FOMR*W6C&^HZ;=KAH5I3.@,"\H8S_;5U MC<^UIC#&"PA1>C2(<2!!+="N+%Y8'\WA8T88#?H8WV$C/^65YOVZ:ELJ&U%0 MZE0(]H]U>6)AE0>,A^63^.)8UCC$%$ON<]:?H0T9.*<$;PZ:0@-+>WM_H8I_ M?U0BGX1VSUQN_]RNK7J7^L/GD?'#D9A>Q&I#'!F./3J6;H_ MI<1M;'_S(7G7NB4+WSVG5&^A!0<1-:[0S!.ZH*G6MW2^([J_!DY(SEQ+$-2R MK:DW51_5/4K9GA*C!5"#-YT7\5_K\?DW*?J);I/;>*_+E^I?KCT-;8N4=U!IS:39 W_N/QE,>7("YJ0X5]7G[&VHAS"VA6 (=9PJD M7Y_000K!(BQN;^G.BZTWB M<%]9ATM[X^6C)6Z.[\O&BT0<]C!\E ^-P6DE>(R]98YP_!-?>[GG+AS+L#H/ M)Z%=QL0M3]60_BMKU\-KI/.J=:#W+I:+T%Z7D=BO$0V0S1,EL4/ $[I8F5DK MJ'[*-@EYDQ[SSJ-'J9_,T6AMR*[TVIJ4V?0)%#/G#P^,@C1,'?%^]$AC:\QA M/.S/(-!KN8J*BO6*_)GU_-29F;[E5@RF+<\]OZVM(ED6FII?\?;M8,S/J?'?H^)"5\,ENF33R\ ^M52D'&501>0MRD)SP\$ M=3O>0K5['DWGO%M?ZF@BG:C2T-1M^[$[.7!G[-U86*!V)Q?P-\-5K,&!%/)I MX9<#8F^85T.$PD^:P+L&]7\KEE89Z2\QC;QN7VR8K9Q689XC42/F,%XQVD6L M &53L=V']/CN2UU+02'$@@18FJEK#*B^1NQC:^+4$;RF-, I\?&HTNQ/Z@=EQ"? ?Q=KLOI- _=/# ^WEF M '6:,S4O\VM0&1? OPN*IG>(TV68(5\K>&#S-QFS[_\V#AH/.MGFS 4X&CQE M< 'C)<=X<"OU$^1G&.N'UR M)-4G[8M/YD/JB[\'Z+F-JY+!!)+D8#_LVF*PB\,U'O:?9=RC'!DI6*1XK1[3O1O_ H-5:K-![_ &.$ MH_>_ZK_LU1]&?P%,3QG8J3Y-"[]O5^B,?.A2J>E\<1QE]]J?M.*$B8DW3(_- M7R D8LQ)R&26U&>,ME.'F,[0+D;=R3>!]K(B:^'3$Y>- 1-'%4LQ%#OS-QQ) M6[I?+-["H9@_[$&%0RFB0DN9V:#D\^A#56*1 DE8^+*7&%O1(!,W+3W/7P<1 M7Y_LKRTSOG4GW\A#H.#!874XKH8QIRB5D@#QRCC7:)\S^85J\/:A[A4,*=MB MTO:.I5Q5'%-"FT[-/XRRDE)PG*<._LY;=/;8L& MR/67OODO?IPH!E_!VPU0]NX_RS!2+Y.%W5XV$.?8SYJ8KW@,IP>R-&(6MB6G M8'.D7D)G1)$,H0H."2\+J"I>FYR3:A[=>D=8P4Z6M'V*4>B75]KZT3HARNC; MHTM:-;0U74I^9>[1BA!>;QU.1.= &OUR7TX-&TUY3,W,G:BLTI6##APOP.@[ MY>HY3X[*J&\%>S>TZKMY]GP>KV\O#@I1%=]TF[.? M_2CPQWFX=LJ Y2F3(($"RHKH@S?JZXJ]=KDFIV.%=7#V52_L4H*SGM"^EJ84 M&SGB'-(#'(ME7Z-XO*SM8 PB54HEO:(P=;KN[<0J]M>1#VT";6Q?J_F$/^G? M8=!4M>N#3YNHZEXVN9&=: MJW,2J'9K#[3Y_61+G+#_2"+1R^<\?K;:&PM^D'6MLTN!Q^J."A0LP^< M6L?%2E,1>$B\J0RU,B>$;N](?7#?Q=K,4UZ';69M=&=\/UT ETMC[!?2WI:[ MP :ZIY\F+\QLBEJ%AE:YTI_':-GD")IMC<+V3'F]L8.^M*@V+"1X??W:5YW! M(T[C^YEB-WQT9Z,<9Z8&_8EO)/7J7]ETM&"H)R?U]64%EU%_>$(5I$99#M-F M=?<_NIB'2/UN)=E"3'^R/.F,H7 !*<9:5=]=9AL+R]X%&/(EPXW*+/R?-D8- MI4:<#R$;ZM7XJ-XH\]??JOD^7368/G,LY3[%%F4(<>IQ^&-.UB6UUY!I."!H MJ(V^OA-^H=A@2*?@PV&I##CK2>'5?N"L"\9+2B4 M3@Q!, 6W0*65\NN4>A6LL1\^+OFE]U6.?#\/%5)$D/LGP@T$"-4AFSSM!L$W MA.25?NZ4:SURR#:*/=(.0W:",ULAO:#$O. 414&AE@?W1^ ^#UK#Y_+][R\* MF&A;MT^\&\TBK]^5DM7H)SNUYF0:&Q:][T/-N[N2]4^M/\TKC<^]_Y&>(OE] M_M4\Z#H(Q05\=-X3PT(4:^6U&6UXY\)&J?%@ P>1! MEG-/_5IS:*,OE[U(V<4M7C)(>?/(6N9#@;*E1VW#YN )5YN"T:4R&]LROOZQ ML^-*0%-A^TPOV,J(L[[*#S8BEPOP<-"/VE#_UGL)'/)B-?1E$=_A,4]Q^FZHP1K5_5B)V$R*NN,.CVUO5#.B6O%@Q6<69! L&+JET1DZT]*^5'_2.B@PO0VC=IMG,*B[@J!Y%#HH4,]5FN>0\ 1G M7RA9M/: ZE<=$4DHZL5WCN!-A>XE.J>))/?$^B\JA-Q0H6#3:[3+)#9W3GLY M"X9G>RR9JWQXUQ2,E)?Z,# WI;T/.5)K;!9*F@=X^X^^8F!%%D*C,J;-,FXI M%SJ^;JJ/O"1HM#6ON<%Y_?%="A>@ J897'R7 E#+)L %%M#B4%-)JE2R\5DB M\A24PS<>I(LX#HV:C/\0$-44M^]>H;(W4V6.RTO?K"1$:6SVQ _V%!P8ADWN M6@6K=6_UAW@Z2I0:-OS/GVL&#$+'"HHU+3]EJWY:3@7GE%X=*EB,MA%]?;[@ MP=A0E:IC29];MN&G%91]5J6BG?%>N5F5RLZ@[K!-Y5F[@BJ80YRO9*GXUUOB M3@^?W1*_^]-_;!"%V%ED329N>P:UX+G2B98G,PCQZ+#O46-XA! \L-@J1 /_ M/%;17]:TK7B5P>8IR9[]A+>+)L<]%;M;.?$DK1/0*SU"I>^@SKM^4:AX^'U? M(E*&'KIAJ%9Q++W'Y]L7/= 1KP]R,B_08+&$;KNGA;+C#U$V(:W^S7T7QE^E M92^>)TW#W["."^MTWMN9Q0F#I9[AO9Q&$@$5?AZH&X'$$+/=S*4H+U]GRD-!]+1:#R4@@;3"XFV'RR*84[! MUWAJ?*%YGF(W/&TZTPT1[#@*TR8^K%C\MF<4+&D1P;S,.D9_034G81,PVN_H MB3@N8#IO$Q77@)5C!7\]/Z*U-*XS?V)=MJB&LNWP?%I8XH9D;N1[>L;N]0D- M1+VLVKZ'>8J,DZ_N&]\.A<>34*0;LG[P-%4ZP*5LU/9N1?H 46:LQR% Q8&6 M?>A[3!9>4RK=&6L43\DTZ/?'-"5BK$D89*)]V49M$DX@I2H.Y=IBDW'D2ME% MA\XQ&QN'"743HKYJ4[;_T'NL/&\8+X&UB,U0IA$=LAB1B85R ]'CG)>%Z)*@[-+.I:CM&J_H=?N^+=+2[;'K^HI.*Y/I M3^"/>_S-\E2\@6VIN>!UC?(POU$4_^/4UZ4#XBM7!_O!^_!49=QCCOWS/DIV M""Q%6O9)7(@TZV8-;/8FV:$P8(+JDGRQM6'=JQ>6R\NX#@53@>+O(V^4R=0L-0RY&FO/GAEUM'RM6)2UWA6[A95_#7*[-U! MR9=BW8&KT>4!!<3=@M!.'?JP8+:A:[66XN 3]:&$JO!K^9SYNN%':ISG8ZL.X.%R 6 M>P:N1OF02 +)K,Y+[\WS0174*>/($\:&.5&)W: $;,-29ES8.EC(K_56T4O! M[/GD_78'NG97D5K#V-YV*I(_'/(3_!K%<:N0$LWT?]=^LB(34:,-7Q')>2 3 MJ*DP_'COL0M'HMNA^QY%XG']Q7*'5]T3N9->JE?"*V(>6L]57V@+J[KX,;(% MGPB9.=0TCQ^$9>I6=&-,DJLR!F X0;#@BR]E]R]+?'<;]/;K\984#7&X:'S> MCCTD)0R$P@:'#U7 =(,#$B&5!20B?H9?91=T2,YQ1CI437^FH!,;5EFAI& Y M.J@7>*HA$'QSK,$() _.?)(1^NT5U-Z=2EV%'-L@0E,FQYJ>4_.FTR6[ZU; M]-?IJ]SG">YMNE(P3\,OE"#$EWGMG"I,(X^P;(G!QV"UNYU1J(U#(D@<)O 9 M=!)%>ZATV6]DHM[ BDK-I3]8;S2A&YZ*.Z27Q3G M&0DL7@CN5E"< 'E=K/983VZ.D,EU'M@Q/=Z_(W.OW*[P$7SW--X /^9 -JM( MX&_4"\D0DCBM:/,N_FJH;;C**OFJ?*3P":HIGS9NV>,:22BX^VZ7?95-@N?) M.K6^*^2,*A5;>_S(Y^MV>)NL@G*[<%7SG-92>\B#=US VTRZ2F(\R_HC%]#I M!UK('UOCG":@%PA8X@TNP!OL4T+6O[L.H51@_8)E8(ND8-J=3^ZW\S)9:LBC M9+>(-'@D32^?IWES<;3EQ''?B#'3,2=WQ:%:#S:UB1B6C](%OY" M678U;BQT<7B]E))&%4-O^LK<4@U4,3O]\HEUST#^G&UF%8ZE87YFT "EC4JM M2$:*/QS?=:M'6>HLQF4;:QCKUZ N]MN4!XF6#2L=?_WZ*D2M@ LX@5@@YAOU MLA.,%:M+2\?\BD39)?!C572TJWMDOB6E-S5R(3C%5*)^TOC&QSB]*,W<SJ=4*K;\)[!P;[S^WIG.J/".S"$D<^47\TC)" >!$_YXF+/?]V'",-2 M>56[+K=34 PRHCMHNGM[ MDTJ.@;/ A38V\+XG^.R62F7^KUTA"2$]U)Z)PD?S*@,[90N%O,2X_UO9U?*O MY>]7KCHNISQ^G)*HCM1IR4JD3G !? "6+CVS(G86(F#L60HWI0Z5$<%2K)_I M\A3?+J\+8W!%D@ 7($RO6!1"4Q&T[/$P9-R<[&1@V%K]9C0I"(6:FX*L<7X> MK0YB.4?[1ON&![X?.#;1UL=.^7H+6D"U?K222'<^4Q97>ATI,#JH8MM]_?V* ML=O@9?'+HN$JS1]'PSQ_Z36NS05I!TTKJJ?&^3V 6_2>-@?+.8LXIY;_V(<2 M?2U/H9Y'FDF))#POM;ORI+R"?<_^5<']OOYW+0V^U'FF%UR/GB[,DL(3A^KT M?S,.E'Q)5:-5L%\U\)J(8661..&5-97#ZVG$[8WYH M;3$1#DR**GJAP60].WN\5LX0*.I8_NF[AS3M0Q;7I*_9L8 M!:VQZ11F=P35?S)"O]:%'MV%D.( 824];OLD=W,U=[\.& MYLEG-=Z0;AD=:-I+)FF-6:J-]80L*TND+=QY4,LXE7O$>Z? 5(&_P?QTIX]! MN4'>D\I9K6N3#F=M A3&LEMLM!Q_.70!"U&:[P@GP:2779+QW:=M0I.[QV%1 M :[0H4OAG[+/7E.9.?6Q=;>,SWYJ5TG:PF]%ZPN6KIB36[8&HE@CIU(TG*VQ M8TKC.L%)IHJ?4FWK6FJSF+@Y=3J6RM>C($&H'%TVR%NY1=5/"$]7[O92F/A5 M^'Z5G^&'_$K_NMFU@\DF4K+T)H61 YWUXM4B?(ZD_C>#)MSHN MX*^EPPG7N8!X""^-5I"T8#7.*2S=%4D-PA)5OK/C>7OG67; 8)Y9(D=I@JW] MU=7;8$8D?LB 8)#Q<]I*;V2PR%+#:NO8W<^XI!K;'L<*LP#!R1P9?%;!PS_* ME2,-V@5#"HXD]#Z \V5974;SPT_D43J@B=4?[4._*..DKWI?_%K%IRLKTM/K ML:_$IV]=<]0JC.9%K$$T*D&A"@9 M)(QQOT]D:WT&BH<)3^.NTWT6JZQ<6T?/C57"Y:AR;J,-)HJ?O2ZVMJ3>H&;P M(OP;_2D78-?2F'>>T[Y:K7":E,D&Z(W]:2?T.+%,)_"^BM()-_VZH#[4:H@Y'Y%>(M_5/$WO_^;ZN#$F<=AOK-1&0C&U++$N M0Z$BWZ9 Z6)/"R[/(E1)KN$BYQZBTPUQ?SX9VYBX@0Y> ,49?LCDRXQ5X %% MK);?G.1DCI$[(AE$R:2#\%Y2S13!W*2M!CEY_2[#Y5+A=#DG"J>I"A].9%9! M;]90)K$AQ'1@MU2' :5IUYZIR:O.MEQ (.1;=%_+PX:U)0;M]-?%UNF582&Z!RW8Z6?8_<&NYS!$<*%EI?GC4W M3S5 ).\JB UW_%%;$*O,%X][**Y]LL6!]K+4^41J2*GLR-,?U=]O]XR5Z)I/ MVZ8-+QC1VN@\4#LF2Y\G@80XD]CZB$Y0:NTL_ E5/]E8D+BI $E$G ICWR"6 M8N-9@0M:/\'UZ7"LT%:86@6OE@E25S),E6?I5@O."7#;CZZ\P<^G[&&E8'TZ M:(D 4[T&>CQ5@/'[9"ZMC.[* YQ0NCUP@TKM4R5&KAI>]82? M+"Q]D:ZJT(O5=06+\;\*#7D2@4N$:W0]WE)+N?PF]NQPC72':G_9PN66^$ GXA&'8A.[%'O=#D4] M_%3]SN%I[070BVHNP!_\R^KO:[_#FDA'IWG!XNE^'8.A(_Z8@YEW8V5-CX*+ MW>?6#;?0'ST175U4#72<+A?PK$.!JI5H?,V[E&[T#XI\BALT= _RUQ^;*-,2 MV!U8Z(P6_2)AT_\/S=0%>?U>KY-T'-$[AH@X11]!(24) +<'WM M- &_/O#IS6GL0!,SY2#'+Y4G!+=+@]S37<^,9S M.X>"<='4YX[^=A5@?E.99=@7O')W2/#IAQCG' K-VURW_TJ!F7NNSWB.=[R= MB[&-;W(G.C#/ :?2US/I,#M3\'#)LBK T?+B.^PED-M_K#G\/[6!%+$+GX#' M-3$^%#DS>GNQJTEO$R78)2O&;^:#;_!/]((9EW6Q*ZAM94]%UZ81K:$;2AEY MC(G%2%L-''*9CR,:P@68#*]P 5/.!V4DB-#JG!9E"TL$B7R[50Z+[F9HEA$W M(ZR1L,2[7_?S5?8V;?KMY123MBJK'S[K-VQV5I)Q^1D4CYBQI\50G3=>4+=[ M$/SAZ"9/>O2@X0$.*SK;90<2I\O9Y]F_AR3?#,%=*$'5AZ[F,:Y7B!LNY\=^ M*FN ^OMP/E'D,IQI3HIQ->&OH4O[JHM/>O0(#9])JBHDO^N,J]XU]H6^XN.E M8/'9>Q,R?8@,9+W1*ANTC]>@YBMWABZQK!,['\!=51W&&(V('.*DG"J>=-4[ MW$JGC[)W220?HT*ZDBW[RO%RO;1\[,D]Y ME7FXA0!Q^LOGH;_/3\U.#5Z^_/W:>8T_#415[N)6F'_>]MD[(TL!_5?>H8;^ M'SZ\LM89FV*V MK6ZNP%,+'UH9)5<]?%+GWD^]K0*"&D].=CF099J^F)4G[8]-V,-_"8 MBYWW_.KW;>W92PK0JR.%JCD>C!BI0%)6*0(>M6*4S+J\OAKM? NZ*/_'/;L0 M,GZ> $R4'H37=IPS*05>-]_I<0&+&>Z_7IEJ882M;=K;ZZ0Q.'H)76"ODD(Q:Y<%TLBY>_8'E MV)V?]KT/]X _G!#N+\@,Q&8[ H*T=\QUMW\0NX+E&(.Z4.MWMV=X/9;3 MX:/>6IV+XE7((!Z(#C":^F*B>8'!J[Q%> XSF%K"$0MF/$)LUW%T=Z18%ZRY M !"0SNNS_"#BE>##O];G)-)M]WF"RHHCG,?L=XVQ!H6;(GD$%L$XC(3N;[,N MS.]]XP+F?5E^O-//4%.$1+([;]7^V!E'S$V'TN( 9)1?^._9=+^5>W5>8, M" 5.F -.[8-6QADQN>SY]:4E- '[3^/_WO!P3%,4BX$$UW(!;6PXIH%Q\)_F M.HBN0"[ .I--0_1V\%@SK@^[LL@%* ")YO_JUK0!N(;HW(7 $+[C7 #2?HT& M.4"@. _ MG3+&$:4\?3480V0C[3DQ8-04XCNGP\N-'?VOUB"B'A?P@1<2H$7(6437@_E= M*A>0*4PI^5>G;IE[V(5#- 941T8,E_&"DXDE# Q T(A_&IO_,R"@/[3^>>/_ MU>6Z+2>7!=0]2*3%@ _W_QU-_S=$$Q=0G+MA"YI&/(!,-:Y<99IW(@'#12V[ M6'Z2F*^:84-;>K0[*AGGD<260+D\ I&SKIY\8.5OI&-GX=GYR_[DFX MTE;;,C?A+A.;%?O6[L[36CYCNN:V-N/ M:YYOPXZ'RS&;\L@T!HWL'Q2TM>630UHFN5[(,W\YE4F*!<*",QHJL6@OU]&^Z8E81$=#T\P$XCV#;6-_Z8A?[7]XQ-=KI M<&-)W^<]/G3RI>Z%FF]1S1Y."@$>V1^=7Z#L!'MM7T<6JZEFOH1L/:V8_N@#Z*;DXM>N>/WZ^. DW'F_I*%K@<^+)D$JSC3;J?(&O MS'5J+N,D9P#4&/P9.W.D2^ CC ]2F]AS:NHH-;.+'14-P[@2I^;F@(WO\\)( M(/IM8\/>I7L-5+U7@D/I4=6!05X#3HEW1Q_!0:1$EN@KVEWZJ^I"!+B..MS5 MM]Q<1.8A$!U"$E2[,X)>*KS]^2L<3!R67&.88-1O=/H2/X89&4Q=3PT5\9NA M/QB+/4>.TBOVJ?!C]-"RR]<(E^;\&47YD;H9Q=Z10:3;FAOH0#>U?/*J6/7[GRZ7A'#R63):%((U)N%3PU5-Z\2E5=GKOP&L_+!!N4SV++N*6( MJREA,1W4[?SPO(/M48VK*>-!S"NWV@\0N@0*)'GG='^U]F\&/4OC:D,:8SVD MNI-M(OR/RS95B%2)VFGI\JN%%ZVRISMDXZ^6&0S%52[9,TJ$%W/YJ0J.YL=( MYC];Z72/Q+TK7Z#(//5/*'1[O6A3K29X0P<=AWX]6>"C!-=3$[$3XG_<;4;6 MX0+J,J=2:3)T)>;% ,/)=@H-(@N=4R&$K>VY#XO#%KT:QO<-]M32KQ,<7IDU MU(W49PK28^4@C2[^.S%_K&:6?:J-/S]^6H<3L;S-DA(C2<7OS?\"%Z.D>9T; MA?108>ANPPE"P@+VN6? \(U T;EI$SM&EXHLJ;=_F>RR4)NW>=9J373!]9 + MN-]V"7&5P[N>YZ\Y4W.@Y$V6!=.:Y<+4J=(&^Q.Y E/F-XHT7?7^%M0H/'I M5L'VGK)=%XT"J@54-LZ%Z)AR!JGL":/M,,C+#.;=9DP[ICF/O+-#)FYI5E=7 MG_>OU@P*NJ"E?B#6OZT^9KEYOE;;J$Y;-$93C)*9]-C#\3EI2Y64(I/A_:(' M+V6G$]OV9K*WOU"X8B3= P?H>IBI"0G.>ZJ'* ^<^ MD=J0R=B&>3PZC>9DZ-N3F0X2C3WG[^8S"O%G@%(Q/M70*-V-?33UCA$7IP9G#\-M]L*$\G!:3-JG2.99M,?F>LM8;4/AT5FJ0@DYN%E*@-)DL M6$[I^29]"376C(C#W2NSC'M\.2,RH2*^T&VGH+U=/R[=93S=,$Q-_8;=B[)$ M"VO&\'^OD4LP??^C/X&._G];.6)D@*9) <5CCC'56?QC&.4/TR[N4,1)N-BB MQCW2N.0K=ZI^*DN[%-K*:8M^O&.M.S%4@HA4O#DZK.KZS=RG="K2,# ^NYXG MP.KY-IPIH;2WU LO2<$I!"^3<=2(3M-HF+R:%35^^161K3!'\@[Y"/8NF?D\ M^8EL6/]U1M[=[NQV@W2E3IO[V[DQBS&-35#\L'#L#+#^("[,6AMG*LXN-36B MW\=%*;UWBTWGQ;\P'$)_]FXU[U;@9%Q>WZP8ITY._%*<]3E+S MY=C7Q 5GL9$O/GE$V&3\R1Z2VCW%-U]1;[Q# MYJ;;5%/Q5M)E"B-L*$MT^C_NHL4#2^A)4,+%K M0*W;2JMGB9P@;^?P>%LXZ8\UQY)K8ZB-UVOGVU\_*)&YYLGB,0^5CBR 7T;]@'V],"5O1H"NG !2$(G1>$7UV,JYULN%;N MY:_?FM!$RA3V_)8Z?.%$D4QF@ICCS=;=A^D-R@ZY&UUS%[$\M4GLP$*W&4; MZ1N\F4!VSW/\*_#P0.H ?EYTOY<*ZD8 86TDOF2%R;D>UHW%8#&H@AI!H7_$ MH*$NT-VS#8N%NGN??SXW.RM=+,1QTUQ$CL(47S03$D/_7);9EE]L?J'%^' N M;F?#1E^OQS[;LF-PM+(XH]NQ1&;T=1!*NCSE2DA:B^]%[( !,XTNEMP;M.K1E[^]/W+D^-+8Q'8[?A$KR49R).D0 M(O!Y]3Y/DIVD6S&#F5>VNYMR(ACCV)FY1R=GI!: LUQ"WR+&0_:VMX:;*]'^+6W-K?FPW=O;_)0&1<32YC? M>PJJ3^0 0JFLQ(H9?YR#OWU!F7T6Z@)REH)/FQ7&23\2&\#H)'B^'1VX-!6K M?6G@\:&-G$3*750"HSM@T9_H1Z**K]^[:(^V)9U?4-W^B6O4 I8RA)*V4284+U&":,JT0E8 Q)PX(2FIM (76%&3JF!(\Y'S1 MX-[32P.B%J?E'Z[;G'+_/M58S@AO2$#J_9%S8-L3$>J#6J,UV?<>G/*G7;9L M_)U5QP4([C,AB*_?.*- .IS# ZE=:Z^?*N&6D\8W*@+R.-CJ ,/EMNH _=;> MABJHU(%L455EP'3AEZ;6G++R &>TR7+Q1[+4J\&(Z.@('8)^A+:5\4Z?>L;* M)LMP84B5>!*^4A 2#]^]F&'/+GS1[P.Y7);0Z8!R/TIIN#1^V1%U/=[85#;^ MD:[!W;BK_A-IYUHD_N]AO=H^%_ ?^B=6^=\Z M\=\Z\=_?.OP[FOZW1=/&13A$X\M7]YFWOLU%+L3GO\#['N;Y>YRWO24;%'G^ MY92MB'A=#?\?6<=BW\,U*='T(Y\93W/+/4\T/+1*AW0[UUH?Z<[+WFV8&*QT MONSV[99F_KOK][[6SY1I_-KWP*BO,I(FPC;,5T!N3^GY=K4!DUW.%"C?*LWGL2B:3\O&>^( MY)'>+RBZW%K?WD.J^YKM;PL*H@M!;&!?:>5423/EJ<6 M^'07@#^S;G5C(/D+CR-]A>[O-&7C!7.6/A54++NHC..=BR%'=^]8=@Y+I!6# M@M>]C%^I^KADI"?>;%A;^)I5J[5GK M.N5UG=!6K=M68321%RUHY82MMYB;NWB=&;'11@T$]CCS"$[7:B$08WZT%1L? MW_WY"I3A66?:5#+3,%ER?K>QHMC]0X/WA[6\!Y)/!8A(\0!GPA7/ &H9Z]V_ MAH"3ANF9 -G I09.?IFG"V0*+#]8N)\]GI/[-%?D$@S5V-+DM_+<[\UQBWMA M8;_*N(CDL?EZ,M\A?H:]V(/@V')7,KVS?%CZ60_&86)&Z/B,"Q\LNF=-;.BG MN0 QFWR4:G/:=.FCWL133N\G%27BA^N2[0/:87UPYT3@[0R=!>Q[>82"MBJL M@:628*DA =+TS_0R-!VL^5E*R.U MBC^WSU"64X*"-'6&!?UW;_A^F)$'W6A$;B2'2B)]+J >-QG.E9S.:T1]] 0S M[#^RH%1:730I?S_!/ M+$44,3C) ]I58/N\'Y:J\Z792>;8G:VP*X]0^@XA+I6UL+0!S<\#8A:^HOCE M-VZVG^_"W*8Z?&3N41W(WFO>6'=JZIH@$2@/*WQ#?]M5P-=[U2FDX#''.7N9 MGC::8WYB6?I+S5"\\;V2N"\AP2><&MUJ65BI),:RRKU+AZ;NTK]2ZE I%FET0&D[..G=0JUG!L]@7=" M0F-* A(H:PHJ$QB[Q@AK_[#G'=YL-$OWI(+^6,>Y;R]I(%G\\?2JQ/P+((G5 MUA!/PW#]J,JZ/G83T=.H+P5O.:JA\_T23&^'P5CV-.\6P,YFIK[?/(-O$P)1 MQUSSBAI\*J>M4.3)',/2N$&!P?L?KP5'^ZK-#$L,MED%AI[^_<\1CT[!;O6O MK\2IYE?NW70"3DE7'I<3>3TZH#)X;8066NQFV^9(#(K*2M]D[MO5J^H@5=%7 M.Z]>G#G4.K=X>EUE,676URO]T9U=_N8WR\VW+3KO73+HL"+Z]]O"/W4RC37N MG'\P'DDQ@#G "U8/ZVB/Z"^U+!HL92"TUR!2 M?@H_T<.)[O1]:^"UX*:;'S]9E:\7G:&*/]V6Z&D?U]<;@24Z3&ALHA>*IE4T M]J7/97!.WJ[Q>&=]I6^UBJ1W]'OKJ7O8ORPE!3A\VA-%@;."8I>4DUT3&7U+/,U+J";,%:YI-50 M7>A\@$"MLJ8.H41RUEQ::PR2U_8@&E$SWT'$L\#=$4X8HNLZ:*68M=[%!31Q M 6L?V2!Z'N@_WR%F(',QANBM0R[ *68*1/[!!:Q\^>'.JP1SX &KJK[]QVP]V MCT:QSBMRHH!#V.9@NM+*!C.2:<+YTPLP9GP-I5>XB$Q*0*1XZ385F>3FY')4 MGX^ONEF/?MJMVM)!_#)%C^UG]-[@)%=>^/BSXL 94/\*2]2*9M#.KL'Z#0C: M]QAZ$(!'387!*%@3R61\Y/(8YMK']\L0 ;B)F,2)\QWG.QJCV^\=NPH1\(_J ME]'8JMY;SF5^0B\)OX\ XN7 6@N5$D'!/DY%T,(G_61MA]DG&Z?SH@9RJCQ\ M IZX(6HB[1"4,P%:?/P5P3DM%]/Y?VIE=@1-IG.\2H.H]GIM8;*>I9[@/'\ZMF9CR] M5B<;QV((MYXN'29HJ_82ZTX?\R=2898U%=<&#:!)C\5#U?,-NH;Y,CLGP3FE*M.VO(-19NW\+^/A>N=> M%[L+)J$LVV6ZJ@PL$'GH'C ?C+F [!86AVO2D<3!&UVF!I2G*,WLZM6HO/K0 M:U>.90GD^YO]VL&C'^<$+L!R0OU''LYAK#H0O>%;-$E2<1_&$L]Q 7X('CVK M,6?96.Q" 80/% PZ9LZ7U$A7)!TDJON\^ R1TDDWE2MTM[H^:I/'E_RH:08H M#C.%OGWP=N_MUF;UWDPRJGUD7] P.G^_@R.+A:*_[=+2V,F80*TX4P/ZA>T[ M8T%H30V6"I7/PJK0BCB?\6N<3FHH$2DFX!>XU*+7&104IF%F NK.>V"3Z#"J M?M +8>3'&YMW4B7XP\J'I(VG12P[^$-K*RZ6#CH?_['M]+KRQ]KWB9)(LP#; MI0K0CG(OL.1X##'C/D0BKL3=<(&\GS^PV^\0B8J/6Y$ 'RNT+Y7\]*8UPF$Q MJ?X2;%WU3:1].=G[TEP(C^2EF#=X"H1'T./'Y MC%L/PAXJN;IXOTX+.T/X'9JIF6UJRQJXZG(H2LW>_O'G$Q"LQ,#DO&TS($)U M!=%UC3/-0; #$F+NR;TI.L%J.?=[X(,@SD*:A/>$ZVT?@S//M3VE']$)0.\C4S.3_XJO<;ET@7:V24G M/8\I]WV9,!Q9+K'M,0R_V,EN172 P%14>DRB,]\.)Q)M.O&NN59#MZ)A$'U^ MX96.8K6\^?S=J[OB(4/['C_/SM.(')XLZ> "&/M;8T/>3JIW/[ZO9]JL$Y\& M$,#FV*<3>UC:@?"/J\KB/GMUQIDB-^3C\U)RE=O8U#X+S@ GKLL<0S> O$\(J7!KN9=UW;6$X[<":1N:0GF=PH4 -PE_;]+VV7N_)#EWC MONIIB$@<&*;N1-"&Z;<1:^]B>0HMA7>3@0P_Y!LN@/2_\@291LQY&OT_[+T) M4%-IVS:8=J,5(6Z @! 5E4U,*R"*0%II0$"(K)$@1$6%$#$J(!%"TK+OO(J M@I!FC9$E(IMLB1"65D2$L @((4%%-LE1"4>R_!DI*P43OEL(1(.)%.8QI]Z^Y^4;%RV&W0A:EO"\2 M2;1LU_\^OA5VA;3Z7V-Z])?T -0"1PJ942C_I4^R=R@>8IGWSY?$H18/Y/W M&$?[![4=(CC=D(Z&RB%FB5U';;.&ZN_6KPB)!^(O"?KJ_IO9ZY/2I1^X[&5J M]]!TW=C R!G)75_U\$'%4CAS4WALD6OU,HQZ%63"Q[6)F'XGR0XH9D MT$I<#Y>:H%]1 ?>_)$>B_16:OP!&6\YVEL/&(4?<^R=*@*!R,[ETD,PN6^&- M_66ZTO^5'W/K7Z'Y"V!,S(1Z50ZK M@]I3IM;_A$(#,@A_IICEBUZD&LMV01>D_4!'#GLN.:;=(6V2O96B.M/_XVJF M4^Q_2Q\:[W]K*J6+'ZGMEKBO_UQE("+>[RV[GCJ&H(/#_7+84__Y$2!"] KL MX?.B> HA<:PA4XQW[R92U*Q^5[R%(C]@7YPEIF/"@!6[1]7<]F&U[9T_E&X] MGC4>"1AU5\.6%O@3D$%BF!S6>@@%<0/44TC<3Q=:W0Z>Q$6K+G?"MTEN C?S M;B&B0\"%#R.1?OPSBJ-G2>)V82QIV/J-OVI=F-,J4KJ7<*&B/2Q>/"Y-IEZ MWV8_H;%(TUTKHV/O2,,"[9:-5Z,] -6BC0=W8T?77X[_ M[E[V/^=T*8^!P,D*7E>$YD #W7IL]2$_KI:MM"-$Y$'Y$W22[ MKK.V\-[^#QMW4X:*"*,&(<6/465\MH+. P$>\TJ_^3!FO:W'Q6RC*P[)3GT< M>KE[1;?!P@TN#FXQ]3(4]=1LGBF<$AT!-?GH*(32.7QYR)E1.:P]?U]371S/ M"^A*04[%$%@'AMJ-=JKEW'MBHU1"S[,(MTW'EP9D55N6YJY&E.H5LO]116IV M1JDD=$X9NK<+ (_'F';,X^^//2H\G=T>TF[9MVRQ-]I]UQ[!)9W:I_E3+&?R M28@^_\E]K,FG\Y]8-&W^/^ZI]?_I>,9. MP"E;_ 3XMV'9O[-T2<8<*Y30MT5A9"E=$6RR>3)#.EH^O^3H-M3GJ4_9J-86/#]W;J][F&B,8*-*K5[>U'WZ;VC.)+J<:TVC") M9K 0UU4?3DNB7I3#$L.S6XTN?"AM0,=;F26?!KHXB;J1'XQ,\GYL#90+NKYI M4KCK/0V(GN<[5:0VGXI"ME)344(;.*BWW(I'[LN=-()T54MY\/V9YN-";R\N M9;<=9?<%Q1$0V^9-3+BM=?,%8E2B%M!O&.-AO*?*3I88@AG[P-IU71FWG5OF MF>7G<-C>[[R^IXM/U;82Y_(2Z>SK:HD1:+9-JME\6&!0>_V,Q3[CN.NA.^CZ M%TUG^EL=BD:ZC3I1TT'Z2F9.4Y3 QL@NUCK(? M-':#[_=W!OPY[.TDZ SR1M40\;ZJHI%WQ-@'GAY?OFK^HOS3[N8_LM9$/]MT M5#I6RA^KG'5CS\BDC"8OTZLH$ S,L (N7D4V]E 5("D?(KSX%*YN MUA=VE/_NXO7ONDG/FJO5-'4QBFV?-Q2[L:N9]H!Q24+Q1&4JR;U$%SA.>V]\ MG=]S8O>I_=F&8X3O1+ X!CE9V2XEE2?N7RSH?1!TX_?0??J'I=9^>.W).[@Y MLJ9^[TL!LT!%)BJ*/5"LX;_MZ]9>7P;%K,IC*FRNR M!(_#0O?:)U/KV+1$_CYN$V"$"#.ILCA[WJE<.BHJ7>X*AKELX_'=&Z;;G6Z/\^9.]_(@2%10:OSFOB?74<_GPC_+ 5Z@A MYZ27S%25A[@J_JS[AR"MLZ]#BZA'NGXZ7OOA58M#NE*G3'3(*=3ECT+9LJ>G MF%8@"_FQE]WD[S2A:WIJF$9D9[VPS!94X^<.I=+:J1H67J4!89M^/6G\68B+ MSVV7H>)FC[R^$.TJ9#W8^%4E8;Q]S9=6J1JE"R$,DL/F2X0'EIV!] 4M@9&C MJ!BHN!/WD<<9K;P_ 0>M2\<+MJ0?:Q7EY)>4D9I;=3]?%T12T/#97U81R3LK M=J8A/W4F@9*I]DJ]G@*#@^W<[E^^.CGD>Z]W8>B)LO8%ER4ZCSJ.>)2H^] U M UHV6CG=YM3JKO?,&72H=K7_?ER/P\TY1&C(+/B$U8TS"3+FL#3Z:IAP$O6W MI_5Z5J3-!)E+C4T_B)EZVO1S:=J9BP>A+/&"> M%=LPS^O&@G[\?!XC>HY%U"W[EV]SL=GY7_[DQ-_QW\=W1U$[6,G;R-H\JQH> M]+)5@-M1,[&]3^2PY>-$9\#ZX:63F' 'F]+\N0L9S]N\CTDQZ ;<,\+LJ$1; M6L':CTC"J9E2Y\6MP7SJS]G"WG@RPVST=9VKF:B4H?WB8I0?(_ R?[(IU>4C M=S>W,"/L'Z7L'*M,EA[4A9L(RXSC5F_Z!"#4&IM-[XB/?AGF<%1LT6:O^)?I MB$8>S!J#8Y(+J^R+WLGC6AU5I+#O)\-*^QW0N+OO3_[@.77HSKCD:F1 M/'ODJ#1[Z:%K"MT9Z][VIN,WJ9XTA6) ;>L ;2X5!ZKM)FZ6H A4I4"'?F)^ MD-Z)'G[+"9M.EWU5<4&_J%V^56E"8(RMLE%9ZJ%LH?R)4T'QO M/E-]K9#5\/'/%X0UV=6V(:G.I_OW;\[5<@KJ]V[P2&7E!3]:J_>T@3G>B+.! M;Z4*=$#'>]Q.@67]IFM4W8W^9[]\K,#F*Z>@JKYNR+YZ8^6CUSQ^D'EXG$S9 MJF4X;D)+;4;(&$#G85*@;Z]A;T-U"CL3FW=T^)&,'9M:H3)_,+__&GU;YGY3 MLLF)),.I]+%E444?]4+OB/&4PL)JAA,]C] FVY'K#%)+ M=8^.X$,P4[9JS6 M]UO]N2\J0GR^_!V',>RA%1RNX+8Y MJ<(1;JMXRZ/,]&>DX4N'Q8NUX3K :$;J$>=BWOY=ZL[HF@N5O'?I'^0PV09( MKM<& A@.#C0(:STN3/?0H-U&G4_?Y%A*8CIP37^.S4ZW\)DZ8G2%H, M2=0!A;91>(K$L*P]?X7'^7H/G,UQO?IUMWKWEK9X;M M)_;[: %R$\%W__ 2>QN8[MKT8X<-2^_3PZ8M6-FMJ\Q0(V^/IBSQ:5;3L[SW M.1')98P/.5Z7PL+"]K^RW\>NAX.'BT10*8G-$]IU\*KHJ;5$5"=U5;,5%F+BZ'H#,:+.C.578JS99MPZK/G:NJW9FG@4D-\#K]<4]V'\%\@1[:: MW)!M?WG=*])D]J+)KI@NYX,U5=O#OTXS$G.P]1M#L9E7:E(.>ER4C@;RS.Y] MO%&1RMQ0V:VBZWJ7>-)YPTO%H7ONQ$%NTCB-*]WF@HM#.$,*"?L[_M<-DMF" M[C]WP+'FFR5<%-Z\4QDH,QB^1R+8."DXL0>N7MDWN/NAS^S3/"NSG)XK)F^) MEVJ:CGF$HI[8*E]4 6\3A+T=66%#:E8FPMYDR4$^<<'(RHC:CIG0'!34]YN, ME;TUJB1^N$LPBFFKOOK;47S)R!;#8X]IGP2L("F3^OZ=;!]U."U6#F/X1O_8 M;L:>N2H C(Y_);'I.<+4O_^!;+BC,?,4<[,%?7WRZ^LN'1=4#Z7M M=30KBRN*[1CZ@^$>IYKZLQOYFSMO41L.9KC%SIU[AE:XRZ=C$K]*UFW5S+-P MYZ>4[ @E6^%L^HKF=>W+-QH,5)Q0V3%EL&3@0)E_A^YHZHW+UVL>J#6DK28% M=TSL%]X-7"G6W@&8IL?5W@JJK3C0Y=)04S/@%U!^T] YBU^2O.&-TT?KW7ON M/$T?1_QN=0!02)&ID+Q=@>:%7!!?&C\[+O1SE=!M!V8^6 Y;-^X<%CV#"R2P]QP6S!<#ZHM?(V> M<-WJ \#6_8*4H+-F"OF[94AUXLI7>B-@=>M])5:7OV*A>^X9U^NWJ6HD*>-#"X\X+^ MN3G/[BKMB:0"YZ05.6SPTP5"9_8>/VRJU6\%:JH88%D.4] DI8OR02E@S6?. M=PF#)XF=-'6R >A"]Y;\"J2Q^>@XJR-#9)0 G2@SJ,JRW##P& M&K;6;\@:7CE<=,BZC-3=H7&X-/E6S](Z*, BD/2S;<>%187J&O3R?I?)?#U.-(C5L*%O;:.W7EN&"N MZO.R/6N"#+_OJ_/_?CZ ]O2]!NHV93\>H;$++!/6BVCQ,A5=B3'ZN1:.3TM: M".6ER6'"AR3>:6%]$HM##.5_;(J6;183$,?LQ_:R19_ITWA/1&!SU$G,)_C; MY!\[QN#F<>+3DCW20K*QV%#6MVPXB=YR8D+_S0)K$_@=GF2QOLQV!9W:?*A5 M@MIC=97);^HYP4/G!US6H)2)E%RWIPZF;&0W0C?UY'U'$R5;QF0+*#D,.RQ0 MH9X=7!'=$JCJ*&9^X#*S3G>=%EQIK-O'4FVY99NE>H_]-O"\GGF(W]'^G!*# MSQYG'QO4/K[QXKA;C!55\9YMZ.RCX4S]>TC?*QYTQ60X.#XXKE>B M?<9V=J'^06'@4*,LM7BN[N!$QZ4*?)9&[#!T=G#5;[>);),1BN! M@<]F;/RS'DLI( 1%7CIR=_3SS_YI)X>=DPR%&$+3OLSQC#!\B-.(S_<1W%.K M1WJ%2;_^5RO3W_$_#Y6OQ(4(2#>F 6-9? MCR$5J._[2%YRV.6IVW+8TH.7+Z=XWP^0N+*7KW4@%>G\!:*,=,=WX^_J4 L, MM;XO(ZB36;QEZ*8K0^Q-92L?F>_]91L@@Z*_ )W@31VGRV%S6,D)YEP.BY?$ M?N_8BA+M+H.R'DPW6RT#'E#?NE._O5J5I,=,L-Q9F*0'^SO^UPUF+I7 ^VZ& M2J0M31509S%_#/=[?)3#U"C:Z4EL9;+3Y+K!M!@+&^(E!=&3*AGW\.5N]ZJ! M05D;<;_5FSV$7>O1=;_^^H]G-S $YMR[]BVR;G>M.66H!>N._QH\R/A9WSY"HIO&N?30 MC>.5=9A>U7KIN\PIK6/H/<-MY/RU!VD:K-W,ZI+U@XSY&;>'#?HG0O=>/7/" M%8\RDJ91WX^Q-.2P8<0VZBQ!X+ 2V-P[N<@I$&;SV7$LA-*YN2E.WRQ>6ADB MA\VSZ[0X>K0S;_MW5\B0I9Z4C0^J,?#P=#G1Y6) M\2NEA+O7,!L^J.>KC?8QEZYPC/Y\LMWB*F*,_]B3XRDZDF.J+SYK&5AC<.-K M/\/\ZJ'0CK?S!_ =9/2#R4 Q6=6O_>C0,07ONR7(H-B.CV<>VFHSJRLVA.+% M#AZ[K!R>Q)[$95U+R3A9F&2X@,Y'W:&!AD0)O5ZV/D@.NTF3PRH(P 9V9:#D M'](*:"ENI@RPZYGSM6)B?==1BXV\:HS$X)7D$"XN6> RA0,]42J2XX#M#M(K M4/RKE:;L;;:O^?X&825;M*=6;4:4=7^D:X6'!]X&7@ M^:HGHM#S\X1N%=?'\:8.UU(=VQS.#I0<(5PEC.\X@S75'^IROEY#N+!MIJGC MJXU;"O'B&+:T8@\M,PI:V%G'3OQ7?\[[_]N0: JG)3M^O/$6XC5E=_?DW+B. M*$Y8'S7L!F@5(W:8\N+"57@<[W%#F_K! R'I6[U)U+;\8X!9U\%B<.",5P<_ M5Y$6?5-F4)OKVY_1::4IS.%46J6*,_GL+:2(3BOM-V0?OE:$#8")D7@4SE#V M"+L2)6:/S\SE:P.(^-KN[::6:KYO0BL.1528G>D+33T\.W:Z?\G)ZJ.@ZW35 MLZC/_;? M9O;,!W++_NS/KGYXJ3N2>7DA\HKHYLV17'<7G!IEC%9/?XY\J\GOS 963_F( M6AX'6ND.9ML)D1PX;.R3.;-=#D.\\SX[PQ MM%-1HXAM.?DG7SV MVN*%O>^!'E\C^S GR_N,@=@SMB7ZG<5[*5ZM#)N1FOFA'!/N/!?M#KF$RV=< M;+;!_KO I;!KB1(U'9&;-%UV1.(.K@9T^?0%+2;8RT=(=*ACC?&W+0R%]:[" M":8@QQ,P093@_Z\(Q=V]=JZ>GKL^LP*^(YUH9I+K*!:BTB@\HT R%3XUV5))"?Z-6UEW=&8M$M5@^R: M/5RLX=H!JRAI!@K?NTKVE@,P[ECPSNA!:HZ'/1$RD^Y:,+ MBW:+/KU%D$=Z/O!CLY]_&\Q.'$BQFX>,D1+4.&Q\((=MX(J@+B;V#G0$"1VI MED*3\C.SC0>>D,/XQZ"_L*%S<+(MB 4D>!8WAA/&4-OLY+"MU'IJFR4T?]"4 MTF80PF0Y[ JU_2[[Y1F;?>XN)4 M+;?R2\Q>U^OTGQN<;Z3L4FDNV5>TG7EX]&2_Z^F4'[_3])F&"ON^IC%2W MH9!D;2BA:^]MMO!T&2_Y)FJ=!0((;EL0!H[Q/PPG^H,%!:"A;;0;+M$5_&*D MBH)3V_9.R6&:Z&"CVV!$65VUE+'NS@[#R&(YS/\%PZ1^CBZ+]Q@JPL ]0PAN MF>9/\,Y;/.]=O9'@<"VKZEZHS^3LNY^-N6,J8SYZBZ^+\N[N)EV4M(,(.6QMH?0?5#Q\M*B5 M]Y39&FDXA4I9HFK7U;"V@T]D"GUDI+#P&XG*3ZL%K#'X22 [Q>(8$.8LWDN+ MK\4I;E^"Q]1QNP5EH9LZ=.,N)[?WMNP_O+O&8*#$ML0AY,*TY_68A_J=!@NO M/9\^'>J9>-'D9:P_7.)P.M;A'S&S]K8/+^TI.6IVL4CU\Q(^H!X?BO(.*&1O MI$#L:GU.JZI_3DUA;Y%MX)%-I*6R703$AF:_"I)">[X^&#G9&\O@*])40>S" M-ZH:'FLM.0'V"'\\N6G-T=:M'6Q&1E)#^=Y:QJX#WPB0GF$:%^.NAD12W7\! MS]H:N,9IQ&*_)'V\AS_A=CVUO^EIGT^Q"J&O0,5@\+R#T1?Z4;W2Y:>LSZ,K MB(8!S-$"%_=)8?]UA.^_!P)(I?G0Z'E/X7BX**P_ASD M*)$OJP7<.G)PMR5'!>D)5DJ@Y\2F.L NX9*L5\AZ4,;FR&$I,A3@] 303;C, M)9OZ11+XW@MFZ(':B&.+FR<"*)KU@TL+QJ5>SO[;7[H^OW#OPL/B.FT=ZK(HU3DC"I.@YORP]KE6!;S(,6 MU)WT37G9@OJ\ 0O3(&8A/IR6T*PF&-^-KP@ID]J*^=,I$C]XC%'S^#ECGX"O5R@Q/E M[C.O37>*[NTI4?LT.,P\!]6+0VW_R>O(PN2PR7\@A!CFZ&H1 ,Y-,:-P6A0$ M6:L?<0HTC@2('%\]T*D$'&Y+OCBA#J1'6>RM#-#X'#\%UY38F8_.Q0L.9SS" MF^?3RL$0D$0BNE0W'LG['77 MM*J@*[*O&ZUV9QGHR;T27DV6E*RUD M_4*RX\=F/3F@R1GU+;L>Q@"[.NZ\G9W8T1=ZJUD-6C*(9X(V:H7 M%AZH6(NCY=9\)V//^B')R17?I.K S>=_=BXNVG#MWC0DE"<.N&9$Z'7L&XO< M@CE\KPC24X>#23_D=%NVY_A=WRLK!Y(D\](HZF3)/QW@9,%7,C9^M1O0?FS2LJ7;=2A4AQZP$OIA\DF_R9S4^>L+L65LYN# G>-[!PNPL9@3 M%4>Y%6K;9EX:.1W=JU?IL[AWSW!(G\DLM\S)@W[D]<.,P.MAR?8U2U_P]!%Z M<%4A.R\=3 P3'9##BBC2:JKP'])\U,J^ #DL(9MZ87'%;'',[,>#UB-0FH67 MFZA57]$KL YH[% =S5[ZXF\F2E.017VB3OXIA]%H2Y>IOWW#?( :NKV0_/I+ M<]F3?_B: TP.+C9_"]C[8\L,EJ+PH?81<[,.WD;0S$E[C[!Q3C5\734#I+J! M$8""P/F.NG"BHIP4..Q1!6C)8?&AAKV@?D"G(:L+^Q+HG-M&:5GA1C='#3)4RK"4[2&3![H M-) M%J&3N'6DIT8WNMLWUCV5& ^3P[33'WVRVME'QDYH#I57?!._0H^(98ICXBV4 M-P@U"WWA#1ZD?PB6&H%E,62!XJ/7$&A;* @P<([CNP^83F[VYO>N(Z&?#_63 M#8#E#J4(A\$E*;K]^KO6"C";LX*X'=)RS''P@(6U0*KA4CHVZX,:>9!>)9+# M7-O%!WPIU$O';BSV$()OC/D2L*,3H_>E$0H+EME# 6+'+U_$)WFY5WT6>B*- M(GB.9Z50=36,F?TO_[SXORA0W0@^NPV=P-XV3XYX#"J@?2[T3K);Q]%3J':M MW1-R/;T@+>*25Q.K)S7JVH1O,7XT;A M:18>C^9<\C8H*EF+0R$GK$1Y2Q/VT9X> 0\*(HJ0[;R1_21_?L>,:NJ&0)K" M4H31*;+R\&H\"R[DQ=:(N";4C6 VW^&3IWE]4K/;WOJV7*(6..R:)A:LC1]% MK6%/\MCQ$YO!6K&G) ST %8[1(8]IVY%G4.E(>#-085VC,#1_3E=,61_0$<4 M*9Q.-"D>,E%<0/KTXT[WU1J.V0S4^*"=!\NQYT/I.*ROC5)[!$YXBK:#Q)6M MAQ;KVHL#!*PH%IL/"??,+LKB_;'M+T? M__YD!=EV5=Y&BN;W/.2E[8*=%67V$4/CKZ]-O.3MRD(]ME#5#3S#&&SSG*?W M]M@2>UHT1VP/C7Z6P][54M>RA5[(5&U3:16*2$MEP\E;IWS63;?*8=5P#C5E M0AL,I@?V0.G#/ZDNTZJIK41-\G5IL?:T]9#.8$4E11<'EO%Y[=0U7M"JR8>Z M\7CRK4()"D33)V;#M+7[%B21P5)HKEI/RF&!AHB1K2(3)^/^$E2-_V@H-3D8?%MB U FHEE<#/LUH*'K#]SO('&S-_SW=,XQP74K=[VF3N3+$AO"MT K_V&$\(J_9&):.N8O M6QZ5]DA+4).02Z_RGX\'MG3Q[1;@0!H51A*["IWO %NZCR?SLR$A5U\OT6(2 M\O6%$YEEU$!0\;FV7I\.H8702ME;+7N5[>KDBYCO"[Y^7JGD,\T26C02374Y MS*Q!#KLY(H>UB%B'Y+#H-/:'7?E00:P^!$)"6\86_5$Y?WE#EE_'D10CO'OL MTP,/(^?/"CX7 MZ;7DYRSR_,2WF7%4?"^HCYKW%N\@C7;SAQ>T@"1J?/ZA 0N52\"67KO_2%]C M?3/BT>R$SIORI?./)"BA0M*WDENUN/6DJ&'Q(8']3(S M5FZ0W\"K@Z:_W _#/CRO;W!O"L\X,GK#7G(HN:5NF)(BJT?A>6/6H@O2U)KT M]7.HFNR./!U^C;;Y0*T6LG4E8D9;#_!/M+ YG$Q8.]$040+:/1]52VSVN%X0 ML#ZBY+@ OJ4RQ<*R(%!##HLS:<&Y5P](7/AS3FBP%B*6KFR8O1Y:PLC1>@&\ M"S&Z++A:_<>+*1X$>T?CNA9@-:[/@@H8=V@;@ 4"9B)B@\7Y,K1 LW=]@*\Q MX$POG^N!6+UE+KPKT33A0YS8)R4ZHPNR:'Z%FR<7:8K<2*(L.LGT4).QO*?+SWO'D*($ /X[=.$U+P"U MMO"P^9XR\HGJ?FZ'KXF0T"$0HW>0=_<%+=T<:/Y)@-PP6WT%,MZ58WE6$3,F M#4K"?$?=AMJG.;S!%YZKQ6:FHFZ55X^LYWQ[7.J?BNZ*J)X?AT>)O0N6XPUH ME#&)7?EAEO:DOC;[R;0HIS=KAVPLVQGW_OUP!&T4,]\D#I9UX^K(^<>2100P M%]GN#P;DJV9TMJ%_DC@(3_=E=%8(;(0O,&#LY.+ZTD>A6_F(39]]M&K7/1&O MRCOIE3QN,7X+W@D'#74E6[LGT>U&CGS_=N*H?YM(=N1-Q[SOSGZ)%C\]@;9M MOMGL\4RXK)X?Z=\FTX7&W*M ZN7X:@"=T95@A,<3"(W:<3\T0(]_=3-;8RC: M#_\8'SRQL@QEN)'2C:N*R3^6#65X"GGIQ0-++ RJZ0-T.+D"2'G2/&C>YK*"$[ MUX"9XE^['^$<5:-120_7IGH[ 6H)%D:0VS.+L3 6CCD/+9)UX1D_?U"NO>7.2$]3-: -SG2: M:!L4$98??I6MV;8GU]/II9'WA+,L)?\"P_5TW.;A;+.ZW$R/$ZJ4Q3W49#.] M[\7%>=\"EFBQ.*%/.JBKT%Z!:,W&3GOYET* M"@I2Z2PJ)S1^KHJ@?]+>+AQ*]G\$QG=8[1DTH2F!P8Z#IN,89^YG:C8/-%R6 M;%DM.B_-0UW2$9^0O?3=V CZ10K+.E9^!HN*"305ECY)T-6I_1/PD4$G&;P, M,A@3'*8#:B[:QD)>>BAN'2M3E29 KP$CF[7*R2<:AC'M.1^RH^;+V4ZHR4RV MDH6FV ZJ4=JRM9#Q%Q?3DF6K &H\19]DY_VF.8S*F,MM-N6GI],V7R'#2_ Y MF3TS@Q(KFM*\"7SC*/E@DU!64(J3'$:O!YW1J\9)%.+& %>\='NY*F[)7#U- MF<0LZU9?.F6C(7LQ%--@63'S[(:*#3BXA%SXK"F]Z('LR"F=A7H@O60S;BOK!WP3_&R#V!M%\*L=);7*B&E@%WTC2:=?8IFW29Q*D*U#*[H!O M8L=]HREZ.Y63LD\/2ZR+\>&9BXF4<88U4EA]^0C]&34/M'%8KJ2Q]!M+'69YR2YO-$.=([+.WZ MW[TAZ1E R#;#DZQ626FA-"V\HD#JUHYAF>,6>AP[97H-&E'@_< +;0KL5-- !B"BE#E'7"SA*QCP0CA\6>LE I'B?AIEH^ MI@.Z8KO.8=8J$"^'*:[KXDM3V.LL?)%+TK42-0:U[5WZ:36*5V $ M/6#HM.PEYDLV--5NIN7WXZBUWH:$E1_?HI:Y073U$E M10B0*^G/WH8E ME,Y8(D/2ZJ>6)2H*HJW2;)F>+WD[. Y\[FJC;?G6HW9R>"E="9^_!BR9*GU3 M7ONIM*'?B'R\C&PI1"75&*W&M7"+HKW3VT9?,_P$%X6?R_B+F[N+[0I(4"^6 M1A<@5J,FZU%"9UYJG6Q+73/8%2RTZV 9RF$QO[.C*9:D\.7G]+8R/E!QMAKL M%OC$Y.N \ *[K>1_ 57K'1S.[4-G]7A8%*(I6OU(>)KR%Y9 M_2R]+R$ =)$]][/5>A)]$A%+)@+HSD9XHN068",=?Z6#&IY'@B'ZD\IW9WE@4'\M,N *KQ4XMQ+:ZM%^]= M1XTL56U?3G1+U;B?<_V/)T\JI4.99FH>;<;DIV&-!#M"M4IBCX'+RKCY$0^; MCH'8]>:5S8RK-// '9\- ,_:?$:3SLHMYMU^\GI<8O M>BIZY-3P@4[B>%;GN^["2./B76IM 61SWZ9#22;38A: MM79F"F(5ZQ?R6C#Z$4%;EPOYI!XW_I\@4= 2[!5_NHDKTY;86X.LT9!4"M +U*HEX4DA/7G+"1C/.& M%U1(8QGO0LX:N">[7J4]+5O0_?E9=V%.[?C0J^(G]RT\M>\REA[:F#O?8_8L M1M@<.5Z:C;*T.OF"KEUI"?_4W8$0GD6 ^[+CR$Y$?BPH#19X;>W,68RV.,XD M.?+I[=+@MGQUC76Y L(#B8]NPI0P!4M,)<,9!%_MI\+Z>(F-L!27X$**/@T0 MXRRLBUO#A"*GX,Y&M0E:-7O!2'A,Q 2O*W301I8%RKF YO.[<]BN^'V#^^=- M>^ N_Q$C13L MQP8!O(T'ZB 39+_(NE%"CV=RV*6R<1QG^3K(\087Q):2F]R0($Q'8WQ4J!%Q MTC^6LA?L[.[(WQCE)=%7+BG[Q#H*^@47DU _#&E>SU(\AZ<)RF'.-6],M-PZ MELW,(U;BO)+:_ PN+57E\U:CQYPN9*HXM^C5]QH$YGR,MO?1;QK+.F#TXAFS M8NK1A5_>=' Y$?O=I0^U%%Q>9]IU=ZLWL+P"%SZ76?KTVSN*J8!"@@EB_2=S M7A+9K6)&6P,R,C6ICNW:.@ BP=304O,X=%N-UT%VF*&E%IQ+SABZOR;5$%WW MC#50:SB7L'_^RF3.[&S 'XGCU)VU.!")DVR]T-5AM1I2@B1?<^! [-1:P'". MO$K*H2/[%!^Z0[-+/YEOTD[VA+F"CQ*Z)J.'SYZA:7!$8/(E,V#(: M^,11-R6C#7LP'I,]106/.@K2.]*5R-NE#V4JX%7.F3KP&.#8.6$^R#( :<[5 MP"D-\H0>&.PW*5Z,I2HW'V?B&_/J8WA.P*^ 6IKD%GZ2O0V?4UK G*.M-Z&I M@I>=+%D[YK8X]5-;#['/H<"]:@M*XNV?#A^F: G#NGH392:03ZOWE)8R0],3 M?/?A4A#*LEVM%:3XLU3EM]A/&KTQS=Y"!8YHXB"7C)OD*4^0%$\)#22!(&%R M_ !1E90L$*5_!&E>O?#;K=SN@OM3K 97E3+GE%W1(A?W>Y;#YMPR]1+]8^(C M6+.G38'HK+D+5<:=C@JQ*\U[G>^6Z5^P+)J^4>U"WWZD[FZ]1>5"V,6'H=)V M:9XYM7&]J807L+$ZESLD,71PPP\?2Y'M:B$%'TB;_= #7H3 MB.O ^L8*V!MG&6M$YK4E\0DU3@?FW(0?F7^ 1:>2OG+R=_:9.LIA(73J#)BI%L0)Y=I&#[VF-72V\,#]:GQ M@]4?K,\ MA@'55H.RKM\ Y42^9I,T[%3#L^361JA!C;,P"ZLX?KTR@+7M[M@?':/$L#:@92D79<4WS=H].M;*0W +@'9X?G$3\.BC6H(PS*ZQ]'R0C?V, #1VVWL.N9>RT\=^<4&&1SN._M MOW+IQ)LWFCYF+LW?<"LC=VUV''$]6Z./'GV$K6G(:_ _-J=RZ5*0R?PYDJYL MPV:QEN0XY.C2)]/C9"8S10+DO+A0GGB=$I*U1Y]1N41+<)+L4D$BNC<*TW(%S(_:BR(G<$1,@.HA9-NN M_/BOP&17XGGAI?HD5 !Q]-#RE%IRK9&K *$,$B0Q8V?$=+W$D6 MF).E;5(C5!F.96F-.M9[@8GPJ,4E2TQKN&K&8XFUD/KM(! F^UE!O'D64P28IXW?KXM/FXM'/^V&(_8;N$#9 M":*.HK2%&!A,X^!QUTSTW'=?--QC8X-B<&S>NQ>Q\7Z#YHON!;I>=^@-!@>N9\"-G'GL86.

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�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˰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�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

      -A7ZM7'(JDR_LLMQ8KCU5/*YC"U8> TH_'P=6#>".@P&AD]$7JHP*!YH*!O M?O5\\*QMZ[4ZO+90I:OBO8(F8 QZ%T6"ZPB2&(F4.+(T*LZ($K6D&59Y_A4Z MFU];B>;+#MMJKJ%WKRBEF@]5ZLH]3>0LVUE!QH;\V/Y.6W\&6D8JYK+[.[2W MXX2-=,#+8^Y:O2:1#V&/ PU)9.-AW8CQ1PAQ*\;[NDHM3L>&47T.BJWUZ%MG M\Z=F"4Y[B,3JO F,+?\Y&1^(:6B4I/_$_6Z-'^/&$8?J(N@'%O 2UP!R3.G/ MFBM+V!WY9PZQO,KXUPY)HN9+C6A>TMZ\&RG4/PN'2A B\,3OGI6R-:%/W3K M/)RT<3L[AGK(ZH+F:HXCU>3$-9<#9]EI\:=>7-B6Z S][=9%@B;3[^K"X)OG M3:W=FF]J#WH!FUZ=5X'56&V%N=%.I S\@J2!FHM+)%(DV#>::_H8 M#&>@]C!T6JGW9VGON0*(<2^&C%'3"TGR@6KTZB21-)+WG"):UN^S"3PL*2)N M@X&_N*K"F&?X,ZL?=8]V(1>U4RB-64L]'&FN90LO#W<8U\.79A_(8CY>:]&& M30F3%;I]0S9R9#VC#%[,*T^6]20\B- MGI+6;_P]4(X*=QN8RSGM@ANGU])CUE9$4.WY8%"743&!:2PV9CH(1S/ZI19N M%V^M>@#DS&K_9E0R_"R>1*XN7]RH[HX,00>2_*>4C-YF3LA/Q0!2RT(_JLOU M>R> H$F)4JYX*D4!+/\53)[>2Y &S[J^XQI68A+ZW1O8]E3LQ U"2)&+N[JG MWT31IZUM\UKED=<#-6]W:A:-Q'R<70SOXJA2?%; X\F-0K)\L,(C3,OUQPKU M[3$_Y^8D,900L-\MSK$%F*DC7WO^\2,&94.XW-I<7Y.)2;,"^O(W5+T;&E/L MV:AQ0V41TG9,[;W5;#!%AY5TP_K L3]K2WS$WY9_?M=3[O/XXFTQ"8F FYDZ M,O9:)/.\M(1TKP>WNB\89'PK-^IO8GDB;J(>R$CLT_X)R-QF3-C'4C"UUR1F M7*EQ?9*[KT F:SK +E3-(7;;#BL]ZNBGBD*F*O-9S7RKXI8(?W<[F\ D=@7= M"_'DZH&VQ=@34>U;56E,J/A\LW7L/:] %O20_Q04^-0<]Z#V3_^M $^]">3^ MIM9AS2S;[+/7=*)_4D12H1-[IQ'MA$G?3@'D)S(4UX^O)<7A=H&);F",9!2> M964MWM'L]H&4J%7G(=9QM@>UTV^T9FI>ULMXJK;,W1.9:[)7 NURW.UI:>#W M:5G&@UM=>%\!)/%D_,$W!.FBAZQ]Q;^DH'9@'*\^3#N;<=S/Q^7][U4#OQYZ ME)S:O3(>T0X[: +ACPH-Z&@;.X[Y+9FOX+?(CK($7H]@/9BY*.J$?4"XE%7^ MAPK9JDJT?_%'LZ+>LHF/"ZE ^VVU=>.)7VB*9FCUP41;YE M\758>2H,U+;3W)[]YXG[P%S/% _6&75H!D=#8:\6_P.S65?92FX[L G54F@P M*MHSE.[@*3]"Y"]]P'N:&&$O\I[B&1E3"D+S,,DDOL0?P)J#J:Q(L4A35_8! M2DC1/%_EQ8"&CYLJW)1%./2:R0MR;GM*,QI<4"W$X&WN4ZD3-VM'>M/O>K=5 M5A'N='-QH".@O/&9%[>.G^"\A.W738U!27!A3 %$$J0X\&G6)E,1M8S+)Y"' M,;Z=WV0=,Y_X3N^]4ZK]]4'+*^O0; 03UCD0F?G?DN&%Z MO?)2O?Y]KA40P>R^QT4#8VY#I$"X=068V($[P]Y!C\7:^F-DIXS/KU(53@&\ MO-PBM%'@2--@[W*B;M8$KB1V\]OD9/=F('L;?X\M)YCK#"JS3?H=05%&!"HF M[Q@0V\+HEP&_F8(HMJN\_OE![)5 Y6B2#-RZ!+-B!WPAE+S9>EE;@P:KSD_U MPK8TBBS'XMHO:P41&!CSI-/=&;\U47@!*5=RV%7>+./5I.G]R#,T9IFW"UFJ MZYP=]4T%KL@R7!?\.?(1,.75U2KZM-OPK8$R#YGI M]A"0=&:&7#YA$9]G'4T;ZCOI[G&_9/%JP06DO&L=\WSTK;?6_F]R[QHD53FB M(\.$_+T%2@#BK'"N^.+E+-:W:/@QW8C40^"L(SLH64O76A(JZK^E'W.#2NJ$M9=-4]S Z<8%>,[OLS1'EAK*[\CFJ M6 ,06HR)Z+#WEZ5SCU6C^3N +.ZQ/).Z@2/^Z^FM X\]%T3I"[*AX=F?Q#$I M>Y_VNKX9W)IV(R!'LXU-9OL%D"N$33-H%Y)S".&/X)F%W>4V"7O2%O_Z*_>$ MT$ZC: 2>TY1Z!?O#V1B6+/W7#Y.GNGQJRMMS'%-Z3\,U#W?4:^PXW W+FWWO MVC31Y(AQH)GNS[QR553NDS4KRW?=N2^O:N.>V$\D*9YG[ M6E18^[RQ-3'7WS0X9P$"R(&K\[^I3,,TYIEE5VNO^YQH4U5[F'N'XY"OZA@6 M:@@@-X22[OY],+^^/WK"5^CTH]+ X/K>O^X__NOPG MV^DIGOCA1 QK;Z3-F*589E/#.V+#_I+^B"!X.*R)TD#I)D7CMY%%0.UNBB0. MZD^7PBI5@71JMF0&@V=N ?25!Q4N;!&BL5W*@JJI9-:2QRK0,Z MCRFB?E[ZQ3LW8O4+['53"M[\[5A"]?NRVNE]561;F@'7QWOI#G!'K>?D9D#* ML7+;?$^[;D?':K'T,M;BR$9]D=%J^NSLS6]BLZV:T$(RLOW%;;%T T7]CEFL M3B;C5N.#4/8XI_>4(>F,;/+, VJ78:3J%>!=M!_C^5JNFB@QEKC+?M.-O_L/ MPFZ<,6X$7Z^=DL58N:]+V+/@ZFXT=I\K5PJ&4R=ZB5%KRRB:U!GDSB?[LBU= M_.T#C/#P=XYQ,J*3N3N!L:6 MM[%WCGD ^!@-I[[1,>H&^+F%0O215S^T ]5(*Y)C&-.(#;#JIOQ C'3CG7&T#0S%*^M6>' M=^*3R9JCK2:K[A.4!'O3,3U;KWREF=R9W)$*9)GGY8"[43\/O@XIG,^.N:^Q M$T"Y1BH=MK&GFFA@&B^X+-%Y[F^PAU\R3H(Y1'G9)S4]\Y_<1>ZU7SW](PU6!G@W5P3I43/^=0(GA/Z8P4NT3;_S#LY*V1J9!\7/ C1=,SD?'(\UM MK6XRK3>.C.K)'$]8=:UQ>U$O42Z [,#S'I-%P;T=E'W\LUQU(#:*$8^U9I6G M[@*KNCON:AB=N,?:'58I=XEM$T^R*)Z?1Q>YH-5YJ561S9_EI$GU LBR:$B) ME<:$S\8&9<)Y8Y!-6>KE_#(O@-2,+;WFJ&//2AD%9L6Z40%K1J3-;JS7'5;R ML3Y^W^I+5T2T-T!3-!^B+_-AY)%''G:&ZVU[/1LR6;2YK(=CPH;O*(XH15Q+ MC7V$.I_YK0:+ =!3;EWM@WN+05^V;=51<^>''L?2F]4U4J15CKZ7[YYI.L6L MZ1=M/?&V*3PV& N+85EX>3E+F!A2@R^H)YYNKG&8B7\+N/@-EJ;W3 Y5(D7C M:)<*XFA>*DWOJ(.=,R[Q!%0WWJT7J\4FJ+-N:+0'DW5B,E%J+D8XV-4FH-PO!-J4 M K"T=>]'GTQ 2'I >?(E\U7\?+@V ,#Z!F 8,1\ M>_VYP9LIV=9:<;M#":L;Q-I>R\P[,:05JE+?N\UAJ+[)I^$YNN57#2V?[$BKS?'1L!.C89'. M+A&:^M:!SG;DX:._J MDA :_+!CE&2SIUC-P%6/?0!3]CAAA)+3BF1'Q&-M.VTS@V0-W&MW)'=.U[16 MI9===4(YG^SP7CLU7#I=K=\YTC%,^\TW*3^N7!\IHN&-/2-ONANY][S013O/ MF\\<_7_M2)!_H_QO_RKQWRD2?[F+&*PA#_'*\)_2^33"1F :?F$<3$:IY@D@ MK[[?E+X4E"T,CDX.P8M*_VH3O,*+/YW*0Y]69+U1>4:N !G_<>OROUFV_4\6 M*_]J77/&0(K_*UE" *G>*7P;2D)3:]CB?"NRMO %33PC[.8W^?\,E>S?#=5M MQ%_-6>TRD1= 7O\,:/-23&0$D*&/R?B(=:[I6IL $LE <':P8+RS:80YD7=9 M?#/^,?Q[W^]_FK.D\BR!KX=H_L>_W.+ZO[M [PL@#"+JZU4!1 &_!&/@>9?Y MNTG3*93J?E!UC/N8TDW@B(#"L>>$OX\&ITEKV/$,\_.^_0UX$5KB'%*=]8Q$^;1J:>FSBY M+'RI*%B&C=N&Y\ V.S1M>MRL@C M7:JJ?3EEQ,93$5)^"L: )*4$@^KD2PT?&]'5#+=ZZ-52W9+L>F;'M\$*1VG#9!3U51Z)*7\ZTS 5+"YT-KY^% M+]TX?^"V++Q!^"90\=&X(R.#NXY5CSZK97LF[:LNUQ@S(C\5B=>J7"EJ"DRQ MOYAV[OX)L>V)Z&>=@-2R.L>#>X-7'C:IZ<9JH/A->":M4N+@,LR>$P-"=]G5 M_.O@@O599$3BY&)+2ZKVM^SBMM)%H\;,K@'MP2X#S:N;CQ*XG#CN<6 QIM8Y M]Y.[YOUVGYS54J24&LB]]KRVI*SKULNA[JMLW9N'WU7:Y3YW .;M'Q4_BKXB MS<^@D74Q^9V;1J\,XA+9(+=@O"/#_;"?-RC-FA_*D.DPC'&GB$23GMSJAUH6 ML=>#3V]4A[F%*1M:+4+'W39Z0"KGZ"+NR#!9%A%7;ZW<^8<+E87<#5*0K<.A M^RT#3U4=>%K:S7M2ZK=5&5M.[+P3N;^M,X\HT3KPL3G Z>[],]K\!*%8(<,P 9&QJT_6/ 5G+F4T8OPKG1P\I^A%G3H#]1V==2B6[4"EVT M,CPR].?S1QT0/?GS5FN4/]Z?(;#-).;'@-7[;+BM:=("P-_//J-@FPL?%:<- MEBQT9!?M67^^5DX5B:>=?Y1L<#58^FX]A5A?N11K'$9.KOX8M;$VRR-;]HT_B ><("FTNL(O\/- -+E=V0% MC/Y+G-*+ZDB[_HXMFVJMEDBOHH4-URD"D8[.GFHI[:[1-+6ISF9%*EL-%+5\ ME=U]RA>^48,+LO641^S@:A?E"B 5NB!".]9WO63:2\D-MJYR]8K!<++E'?,Q M1(VJ:Z&BWAZ,]-#GS]BL=-*:'AS#OE5ERJ]TF,;VW4&.*/T>''IZ97DWT]\%[=XK4#M1L(V[C#1BZ-,9.W,=O& M[G'=B!BZ%7DTK%**EN6I5=?(WL@U>5)A0HCT92TC?K&HS&_*]- CP1%W_^@[ MUYSR]<@QTC9P&[N["U$;UYFZEWL%4*J*PK.0>ZH:Y8L)K CU'M[.+?D(ZA8Q M+NCH<&#=1W/SX2>*]2/>+0UH>:<.!W)#O?^U['?N$^[@1XFU2PR;@]$&*0=? MG12-DW+%27WCO>:AMT47^JYRZHZ/+/!&.%7\PSYA71CZN M+'31#YKQ,75MM[4/S..D[W>W;^&(Q7/O_+,O?OMVAG-D9#TWXE)$_ T]]1?$ MS$#+2UUFOSZ2+OAU; D?10"!Z.DV_0Y7[^+X?+2)]B#\ M M9,,I%(TPS]>&9K]3S[0K)WB5GQ9;,@+]\PK>SFQ,F7E253"U+[AL9F*B5> M/P4#7XYOF&;.(KV>Z;*3=K^F<2+N4=W9',I5U MBVMM:=&SL*Y^Q=?^P*SAI0Q#FT#> %# WP-E=S.ENH(2!1!Y70]%YE3;-"S9 M6<<=4SQ&VU)H.Q-%[)HH7\C,S(/5ON/:_TEWG?1_^'UV>ED>Z?@BTFA*'!\< M6?*D?C=6 N&'C,_$PT@"B'^@B'T=T-TI1Y<'HUC[G">4\C[JV(QPD<&E)M57 M?(D+=@MF:V=;Y%&V \I#ZWL3-UH&;GS1"/JB15M]K?U@P.T*UYA1H83U/!:W MWSNX,O6U'_#YC-V?"QI.YG$=C)L.I]^\*U<=RI/,D])\^2[I<-#K6.+MBNGG.R^XL9[DMF^QW>CUQ-CW+.[,YEJ6C/PS='M3(12LR+.\7EX[HT M;L-DC)H^^*A#XR]EZ&D88V^KBSO%*,FW="%Q@)-BG0 M3RQ^!]\,TCA:_R(#?OIIA>LO\5>:O5N0<7//R$1%H6B()5-X,1E7;O4OP^V[ MIOF5,N:++J6>ZPNKELY//V>6]3CGL[GG.ELM.E'C],4#P4F]E)J;#U]Z4]S2 MO=?AA^_%TW^GF R!0@=X0I&CCQ\/YOV)7^L'NL@:I#K^ M4?SK!_Q>^H8[W@_&T^&>^J=N1O#--HF\#.P5 :3RC%]DJM \O^I7$TJ]L_<$ MD/6'K^\GJ)#*30S^K\-8__TB#,H$D6^!7++XOFM8GU])>##"]HXDF M_W-'8OM_Q:KN!+ZQD9OEH3JOG(!Y-(\S)NES,W"H@00;\E :0TX_P_0Z7[=T.UA/LK M-W'P^\G&C^XQ4)S#6!T!A-@BR_^V",;-1_ Y+_$;>VF(K7!EQ#MHOC8WD?N+ M /*\[_N?&KZW=6_K3JC4_*+^V^'[5_U/Y1^T?M_^-J]Z?@_W+&I"DU M%0%MU>16ARS96LE5;KQH>GN$CX)5 MF]:43"O'7V2\\*G/^&TC_F6AE<\10'RUMU0%$#G$RLH]_.83TF(J!.O&($.8 MAX>46>Z>.M"4SF %]=,%^TQ0#SK;F0$S3VQDQ<)4.KM.A]W,2(O"OE;2+$QE M40KC[K?>82%EKVW2]S">2U?L%(\!GGCXLVKA6GN>=0[VUB:YLTJ=T[U5U PF M]CM8932JK.R&]G, MV[>*Y)Z>IFQNVUSE*R&[$%N'9F @KD< V?1=_^J[&F>&-R< LXCQ'GX"7JB- M. P4W\=/ (DSY/>AUNSY9_!T^C\$D%4=<^Y%4@QJ3:<7 ?2D"""?MOU ^X'V M ^T'VO_'T?YB96D1R37LW[@E@#PCL&OY?%!((4^RUWGJ_-UQ ,(:E)^&10$8 M 815ER?/1M*T=V%8 HA])G*7 !+HMI G/=!J5N0R<3G]G1/-Q?U+VR?J M'TWWQM)?9^JN2K0J'-TRQ7@_OE*SA;G>?3K]^2;_7&I94;K7D4RYGYY>"79Y MHJR"5ADHTI?6]!E,&"F8 WWG7K/Z+B>\76!];2T[V7ES5G2F+D>G=?MDI\]E M$VV1F*1'I5^Z'!?MDXK7[M^P&]#9O/:,4M /AA"6A#G>#"%L&0\0&E8=W;^@ M!E($_X1S!VE+YC,!].[&?Q7IP]-*P6X!Y'Q.@0 "'<<+(!I\\D7^S3G2W.I? MT CL+SHB/@,HY\?>(?)E@NG?\#C9O[EM-Y"T/=3**]P MH:.X/5@3T"ID6@!)&,!$O.3KL,<2UGHM=\,5>;7A)9BN(6KF1'+]9MHYM*)O M0/;^\LM[(_R*H7K=A.,%/;L__:>G0KK?X1T!Y/^/'?D# M[P?>#[P?>/_[\!;_8K%E:T@ .1#"RZ',$;G7!1#*]ZMC/_NTX5F^7'$H T^# M[L,>!OBD[^PQZH3?:Z) N;G3VX10EIVR3D@HLR5:/&?Y- M9AVK0:+Q19(%98FW[IH1S-(C9>"7.ZY]<(XB9&>+*,.45J;*!/8G+.S\'-7BXS-]T1XD>B?YH MH3T^G2#_D/3'7WD*D1CR'U,RWEB]/V::WG:?CE7_*9UQ\O$#JDJ70Q+Z$M6> M:'LA.$YC,-VCL [M$ F3_DYSTIS?61#^H!#LVK221<7 M[&\1U1(NI26E!6=6AR-]\ :ASFMW_HIX4_^SY]%;P=/>@(X"B"ELN1X6&;WL;:"XL45Y+&0( M1:#Q@4N>1#G5(,?IA(SC/E;>*=;-,"!%K,NAI\CTH9/51(B&L:D=/[W&_'-UQQ3?GZBW+Q["RZ>?@C &CU">8%M(LEE4;C"F#ESE] M;FGLZ)61:@^A:]YRB*6S=5 MGB7\]G>_8?E?*0'O\=V9U0*(YQ_X^< V;Z?*..X=-&Q]7H2?.3GJJ-2RSCLX MU3.T?L7LD/U!6[-#D+]3G%H17[>W"2 D#H(G$7Q9@@3EWM/&+_+[A2SI;A>! M'?LNJ /)*DLJG!.'7]MY] M]6<0_A'W#^&#[?K;>Q]1=@)(J@>,WRHG@%@2*Q+&ABG38^;"ENX40 9+YV3' MMW EKYXEJ/SM$ K+3Z1* :3[$WY]QDL *:QV,D,OXMF;,-X=%P%D7L/QH<7U M-JE/^BWK^,?"RK2_.SZL1+9 _&(%?DN:A"8=BN)A$>NC"-X^Y_K1,".L4,FX M!*[R1*>;"=SH>N@6OT78W'BU9,]_&>VC/0.X"^?,)%BPNC%:&YI!6?K(.<>] M"GRX>WSJ&(@$3%D46MM.F%A[>!CS=1CI'Q@HBGTA2X$2>*74;VQ,5I'N?TFK M?$=F=9%'[U7?E$F[ZB>/%M23W(ND*V>4)"(E)FM:[FK;GGF6D_?Z#$^LQ9B< MP-+OG6#ENZHTSHF9+G26 @,JD9;EIV,30QL^@ M.>=G<&NL?=13D[V*/2=;3_K]^KH5=#=5 -E%Z(3)88YUAK98HVD*JL//O(K! M&[WUL+K%1K)/69!W3*#FE+I<4)UZ9[F-0\!PP=F0P5*CD-KFS]$YWCYU ?/C ME0JSQ-UE?\3\2L\,3IH.\^TY7EC5?-;8^>=GE"S-LQN?!)#[3^=0@$,L+^]& M,1C#ZH\)1]3U555SM<80OH%[% ,YQX3RNTYIMD,]*/'Y DX2#&:N/(ACXN_K M&CM-K0H?4::JU1H1K32R9JQLRTYI8R4?"T0C1Q$E$W2)Z#S1 ?O2"\2& MF! M#3W#32_- F/%'KV1@!:+!6]3TTS'$*#]FB M>KNYA_>SLZ:U.SQ0&\;(:(HT7PNKG$HS"E^6Y1]-90;1!!!YK&$J3;O@ _&-!=?24YI;JC0S1R17)J/A 2^[##0YUX"3?+>EIBP8,>H)QM*S,6O24TH@>_F" 46;IG:VS+B/%\XZE MEM;ZEH7S#20?IK+DR-+2Q.#<8,Z(YCR\<426S.))U?^ M^SYE">X+?WJC,O<0_;RPZPJ%-!:F3].6Q*J_X!6'A:4R;[_@G/6SE0L:ET+Q M\K5-1-VP'G'V0",U%8K]!;&7*YJ_T/ M#P;VAK'\N4>U2/GS1JE)82N'_,71 MKKCJL9@.I&1YDT,!\KUMAG]$0$[.0.IX;&IVT+/;'I^2U*\JGANTB[&(<$W( MB\^+/[4NN6#O'^17_)$T9KIV-X$?BF#\#JN#=2.2G"CU^!B<-M8=C&>[60+& M_>W0@Z -*AZG,=H:435W-S6%!=878YZ=14A@RE:"G1?B6!-PU>4)<\#S"EI@JYTF-OO^@ ;AD-[D^2IJUZ#0\SR5EBV;7#T98 M*(>U??O0#_4TR-9=;+<\5?+4TJFY+L=C:>)CY/>O;= M/2> %#6L9[@VP-@S%?BQ0MB66]!EA\R5L373"&WD2,PAVXOG_NYF>%=A!%Z) M?>-3EH2:P['SVO](QQ;+JZCL_YNH5!_\74K\7L8(_)\;8.N<" 'D3[=1,[20 MYX^X0;=XPM]\I[EX[%X;W^KK]U8=^;O?$E=&6O&-0_%;0!!/+:_F7]CX3[3O M_%;!L025/_]V!(5E)[E1 ($]%$#&,E+YCSJ%(N9?V%BI9@WUQ]3*"/^_0C+] MI %;9 H@54*!-G>UK:K5#KHN[,0Q(=.OG?(_%K.W]\@@#PL_TX=U?@-802'4I<1J#(*X*J]>8&X+ PE"K%= M %G/QXF/S3ASY0(%$$7GY=<"R%4!9*E( "'")G#D5*@ WN085^L=7!70;B<<"JV$MN.. MM+Q;DS?O=AWK1,9G2DT04G3/BC0.F9SP%[O,-0 R"-RC HAH(->6 2YIUC_= M%:I2"?=@S=7W'^6EFZC@V]T$$'\!9 +%R%KV_7-! #F\KGTO#\$KXVHS$=*N M8 1M[*[STB(1L^V7MA3Z])FT JP2&Q%?!3\E0B7MX:H/P/V9:.0#G3FCPG"8 ME&[)FKQ^]\3LLI7FLZD0 G 3SR4@?T%D!9 %!B]??>NF,%5'/*(_1RR9 MO+50WCC'RXX__L@"L1,N:7'\JP7\T=W1]46[]D_CV/RHCKX&K=AC28L.A3D% M>\F^]K*_C; _Z= M2A%?*DE?)R,X_OS1 6$"]E0W1[_"ZA9/5#0)>3]KPWYL<,CF"%#\%/E2H((BQ6>QU[>5)C@]?R'X- MOLMM!?P.1#62%AC!+,Y@!,7?7;E7R':^ASL*#C$E7TRCXCUW#^H],-%8R#O+ MCDS"2;#-XH32(,K7@KWQ""[*K&/OCTNZ 5C&,YE99P-0=:U3: HQ7!,?CF97X+H0H M5QSHZS<'L_Z4FP&G2>@I$["%+:D=Y\07%>9X>QNPJ&*>K\".BU\30/9AB.WD MTX-DZ=>,DJ.CQT L/^GFX_!XZNM+U%+[5UZN8N4V".<4Q2<7)()%+4(FOBR7 MZJ9ELJV#X69!7DY:E3[$[&:[)&7M0#6GUM+!0$Z+5K5SS7A=_^0V9^$#IN"Z M4)(K?%&L/Z^*XN_/M8!&AZ+DYYI)OR/0E)0M8@SW,M,X="&SH9E\?Q4S1+W; M61)%,Q*);U4/\V*1#H"^#AXH:M8WIP9G3^E6X;OZ((Q4AF=4D"5X?[:*YF4?6 _C;V@H&ARC.WYL )]&M/3]16%2%Q_0181 IH((&@"J!;>F>P\ M[;NL+!2= \!6.OMDV&Q2>731KO;AK;9?.TZ52W?-$Y7MU&V\ M1;ROI>6J5;?[2!2M/[;-JDY1R#MVZ]:EC;H/12IGEKYDJ4_U67GT/\&:5O$' M<-N$H3_*I\'$342X*+ %&*/B9,!%COD<0;R.'BT&$CN^?7L.UDX+<^TKKOPT M0AJ+!"Y4%B[R#P%!,?61)[ZUTX&4!1U\QU'A_W$=@)"%6]KQ7'U&DQ;%!\%( MI334=W?#WO?0G"GR?,6Y0;!GPVMX'7\ ^PM[-H5_S"\+I]@&VGO]V2E4\+NP M;F"N,:\J.9P9>8QN:J($'">?9L?P7R"2JDR@8'DW[BB[H9REWB]A5K@9SA6G M;&" _F4/H9K\&0A?XK!Z"HKGZ:(%O *-NH\WSA MK ?6!9"]'Q>K09WNN\IQ<$?M6)^Q.IYZI^C<,O/C;8M0:^2EQJ>;&: VQPQK MPWL*W\9!8>5B4=*8/0+(]+>.IXAH!0T@LX"!VJ=57@36G@!%'[4/6QFP3=P<_9]S<>A=]XHSL:?^&C&$E#XJ+2'6S[&$SC *MIT,I6.LNI;]]))UNG":P.S]>N0_N-IL M?(H)#,1?Y$"C RM:=;;?]4T,Y!HS>\6I8Q.Q<;.P0Y0;2% %SSV4N)&0VH&H M*2YGQU'/R(IP-1(IL;#]N.V8%G=0*E*9>HV]HZ^T&&R9[J,$L3W@ROI)3(#F MN1\@5Y:#1-:.1FHB5%HN$LK,>_ILD7+PQC+<8PW*%5O=^&UT'0HJ"W^@?+J> MU7)1[#[HI#-K6RI!W5@*&D/9H5[<)OC8!UI,,G(SZ/'8"T)2,]F#>>XON[_R+=NZ8J%A2A+ )W#/ MG2$0S4/"#\0]0QO5TAIDO==IQHZ28A(ZUQWW:2D4UC0;8#7WW"+*V-NY3TU4 M_JH>TG?Z5N)3[(VRZKURE(]2_-=2&9B,D%M M*+OX(W]5^,J%@FG\/:D?E&(]2)LW&@&O=CB+!*-%(^0QZF# M_P 5_8OF;WZ/XXJ:$]@$YX2F ,/J7\-/+(1LW0-\"?Z.XU%;C0K-I#B$F M^TL&$[FCLBM..06GP3T'AF83:/+.#FRGZNG]"7H1VS;H"U M9IM?'LT'9>Y4N6%LH")SA*"1M*X) 22NU:T S.I0V/&B,:Z3?P9X/HI%,N7% MW809.Q9K53(/>[7"%8B.=< J,V+-DIE0"A*RM;B@83H2\X MD=79A2'1]QG(8?:1*I)19@W#_&,!1I$I+W!'A\A2[@'?C/:/ M-#S1*G]VBV&<0XG\>8#)08,'N%6;3@YB:H%@3[3$3V.+65#[#ST3<'R>=LMB9 M)]HVP'5HMB&@V2*=2/TXQFC^NS"KQ;:SCB-KD\OV5/+AUL$[J$0!!#C__=3+ M47Y/-TH!SRCR/,KVJ8+&X&#SN-,@!9BT'UL9X9JRZ@?@4,93[8.8GHV$%R_Z M7DP3I(O3F*C];E.E(T*OGC&TEFA8GWS3+$28>MI?T;_*\.(I2S(<)'[>>6G& MT>8R3EWGC3RL?*QL])@TW3/,-;A>B%MSH5)[LZLCF3@\0=";+(<]_3M(4H# M- ;Z0)SV%G?&3!I_.>=5DHQ_!*R'IJ*1$0 MR+;GD ,[\)K?!)"OCW\50):UC(+XC9&5CGOJ3CFNNB+L.NR(]U].J[Z[5*" M/F]Y*OW3RMUXZA,+E;I/W^[6V^GYV;UT<,GY93:!QB0ZOBFHGY%KZE1W/; Q M$U@I90V=6 $U4=Q#:2QD.UX2$[Z!XCTU41):;PG6;:"ALA*+99O'9%$;\]3? M+6&]"UX7@^I,_D.6WWJDN0?HSRKX\9D+'A<:>L'PJDN. I\*Y/S> P<681[ $ 40:QKK] MJ"$+=QK T^C;&Q/)DVM;\A:MD(Z MPI<>FW?(Z%M\12'& A=B<=#M?7P25X,?"+NX/P?F$GJ:137":#$XOV@]W G MV2(/<'*N6L6^[-'D HS3%I7FFDED8M;=SAI+77H^3'RBL1+HDS&8 =^_+R'W ML()";7>339MK^HN%U1<#^)9L_RZ'MH)@>M8CS>/#50YVM-&WL_;BKEDCXLEJ M-PD:AQQ\*YZM/2(H90]R^Y8YQ-E4KEPC2QL*GH=.3G;F:8R%XO>"SAW\0[Q< MK!DK2!R3:%\S $(YE@&M?2]6B4?K&Q.V'!?.R8?5]^:4+=V-ZVS)B M,EJ_.=MW;K?[E>Q+PHW3&U.Y$FD;6110AP,#.>Z\IV29N0F;_.D5J+\HAC_+ M]&DIPMBWHX/S7T\3$A$',DO( H\7A55A2%N6 BYZPW&BVJD4,W"BV%2-VR C2BANMJ/B;!J M&],30 XNWJ50D1.SR,%08ZC9T&_-PV')7DZ4IL;G0Z%M)A.L;Y?:FF('1W<3 MLPTFIRG@"40[09H;R2/Z@F@A!6SDLT66,J;EW9B(9&U=[0W8:UI ]1D/N#\"=':'X&>]E:;>7EY/$_+([NSLV^>H!V= D^#96 MKY$_/,B_H*BX /@331?%2C!;"/(38 \S-R5-LIZ7Z[QJP<;S=Z%8=%GZ.&9Q MNE\HAF@F&B/M (G*T^Y"2?'E N[RMB@/L$[-RO>XXMXLJ QNP%G?< P>,GUH M$*O.+(\8,2(F<.V:<0]]SU17[:K"%S5O+K&J]M1T.%!MDBVY&4<3,_89NQNK M6IKTC[\^7V2@Y9.STA-QV;,G??TK>+6T]1?UKD+5D/,NF)'R/4,) >[L6]$S MSP+.M#7>)G\_W>W!W7]W F?G_[BJ]2]K7G9N%-3 _J4VA-,A6[-3_]/#_20V MOQ^7N>?[56M^]-HSR>% /S/W8VPC>];MN6;;N/O&!+ MO!73[(Z#&]ZL>"HK'^(>/:^,'.*>VQ0ZF.T<(4;VXM2.L6G0F6,.%CBP8??A M5N5(DV2V%*KMQ? Z0631M7[R@[M6"_[6JL=_8^V]@YIE*BU20NBA!) N$& ) M*"!BD) M(3:B2% MFW7V[+FSS[[GGIES[TS^2";E>]^G_G[YGN=YER(\'W47&U7DVV:^Y(MT(R__CCT$4'.8-PEGBA[>[B00*@0,CM.R45*>CA$\Q*G,.&,3A!GOD%<%) M)SQ)K 82R*K/0@X;8;7BV6"=UMP\R%AX'&RY"HY6>TO16XSVP1YIJJ*8MBSN MEV^!F 97,<)74OJ^.AF)U[\O^41_X>VP]BX+'.A*L([WNP?^K0"THD\U]L[4 M*D)A:H2'G9*HA &"N_1LG13%<,K8C$T?LG_:U#W577?Q16:&2AE?I@4]FA2P M(8OO??U^CX.XQ_6D4:-K6F/P$?WK@/NC>!D4NSOO3'9P+2XS#YW&;]XWU6>> M2B*G*J.22NZ5>T_%BYY.EW8AEU%#J(1>(%WX5R\7_>J6^9;P=:SH=SFS)GG+ M^[,W#1E8]*^Y;1LC1U,L>BV';^U[L6%%,CB*PIHRIKP_5YC M'%AE7&ZU,?/:(A8O'C&B[*""K2H[>=:F/'J0VGLQ?]7NAYI;KH>&C\:7/T&7 M' 12)6XS)\;Z?,6X;DUE5\TB; K+-$RYO"L8)FZ/^R^S(?_+75@;/=^!,\ - M\-+I&:#Y##!IRU.\I/J[I Z.W$Q-EBI]%_._'#LH2Q*BL^C].ZC4+(&Y/AI M/EKY'A]4*$>*:-_OU[K',H[PR< CC>7KO74[I08UC2HKYM:ADN22_F*N MY\7J*1%M0MNWLA4-+KPJQWX$=1]IVOC&CA'?#KJZAY;[3.5T(UAR.Y'F M"MUNXKOCNH?.K>O$LL%T;E)"++'+NO]=O1B\,-O[C9!!>$G(GC^).YCC6)S+B;($C(T2W M4'QCB9*ON%;\AA#/.TOIW['1%=QV$3[]KO2LX'VSRO$TI/<7<7Y;FVOD6NO+ MO"SO"DT,)TN,=:8+BS(=Q7+WLXO*!,I7I54%*G &KP:OF;\ANMQ_3P)QK]E% MEXF-W-K'K#1^>Z_*\MPF57HZUK(*PNU2%G=-03!6YHF21G+VKT=(K>94R/<0 MV_VW%%58GSG]=K0F>;J>W+;"WEY#O4^.(@G9I:\/]5R/O ^*?]_JZ.BK>PZ= M:[A]&!D2I9K\[=31]LN@0G9O\%G^'=5CWS[EG M.F \B.N;7I57![9 .A.[C[TW\JE&QL0OU$\9[/O2+92'O^/E-C^?.O;X).S@ M/O!]EB?YVFZ107P0TB8[ORJA9J2Z.GKL7K6YGS&W36=*=%9T)D4!DDN69X38 M"Q'X5U^VGH\YZ5]0'5%2+4G'4^>^38]Y+]_IJEH.]K(LLT!HD>7)+N#GQ-QP6%WKQD@=BQ*4,!KC7 M9/#I"A/N7[!S,*^]*T9BRI_YWB\K)NV^:[_],X?@ M6&5V'*QB\Z(S30Y!SSK((A16%_LTM=NUJ6;6TF< =FZT MN+B"/V1M.WP*V?^L=] !ROOD=KJ39_?KP<";.8I' 1 M[R:$M%5V!IA[#=NP.F1[1@-9/?U_+L21XO,Z3_ M(6*%$)XAIZ-*T8XH<" :#"B>VSK&%>4EH;\KJ'0'$R1ZRYV2_$)3#F]J[G2) M^.E$'0:P+7R@3PN%!G#."^4V3*$5@9KCQ$@)8=5&^7&$P:@!A^DBML8D6 /I M+G!7>R3(1]:P9L35J+[=U3>J7VRR+ Q+X'SU6+@$%QEPQ M&&P92W.VBV+"0^^30[]+A=J)#10=W$N M_@Q0^JCO;W>1G+]E/OV\HG_WC^=WK\5HW&P:N1TM$1QG5RC78I/FH]S64F)> MLV\B/SW;[[N0;U*C*C7\#S%AB)V3!(^K"E1D?>+D,Q5"_+UHE)0-:E&^UO]H M/>*AGX:V:]9&H&O:L6=I@K\T]YJTO*OM#":>^7_UXVA>(GGY#V\!/;>.*Z M+3F')&OK##)JL RHV&A=8P G;E\+ ]'O7H(7LSY?[9[9>_@L\FEK70_6)6,%6$J6+>?^>[V,\IZ*0>3/P,0#P" MXH!TP?MT?M@\C)!V!G@#I$IGM)F= 9A@U!MG )^#WJ:32-B^RAE@=(\J 7.G M?Z7/_(9.T%Z= 7AHL(? YKV=B\3UXVQR,()J0 ZL9JT1^M!Z.I3Q?+*^!?_2 M6]2V\^O1Z ,/M9.PU38]F=W6WE8OE-QJ[J*U#TDY772T.;_E%QXA95TF'619 MF^WIDMQDO5&SQ4>7 BW>-]! B$%%\)>FP /PJPDFO-9H.H MN,+G'VOW),JD^HNC(,\*AQJE8QU,3B>-ID6F4>7$ S,.]MCQ_O[^\?Y__8V=W=^3%B9\=/WF\E M,ZK@_<]T 9&TU9Q9WG=L\[:E#JVGW-)#G-GK4OU74K+7)()X?%VND(.7=_QQ=#-!KS;;%[K= M*PLP@TYPBLD]:8*78L@9@,7.N3]K0\OQ=[!/9OF+UF:N$3F5!=$C5CHSC9&8 MSGT%^9B<7_I4K/VQX2M4VXM/"%5K.](\3;_A?1SH >,D!YUKDFK1*+T/2HR^ M<_[5LS\Z6K/XCPUP.RJ@HOY ?>O4+]6KZ&H*">V%#;-24N6E(;24>^JU@M3= M'1>/_1#\H'4%SE/+".NA8O$UJ*"[9LWIKN"C@9_MJ][F\0:#5]/45=-']Y^9 MW=FT_C C&E-E<0M1\'&./I%C-\ J%["1QF,.>0 SB/N_"9DD8\U<#%=/\EYJ MWBVJC+Y)UJMT\($+'H'OL]?5W'O2V4CV= OG'PT.ZM51%Y;[&(?)]WA_X^FT M>9;%S)NUJ:FM%3.RI">59\*<.(YP)9H=9Y/T%I'X(@?RX/)$,E2D)W>7,J"5 M1ET=2EB1M]A9](5?7O@Q FL^FF]W@;"-W6B9$0]@5[$D1ZW[DO2M$\9$.NO@- MUT5^.)KHJJ68T/1PWUIZ@/GMFMV<>92.GN-L_&UN7CD)VZ33'J'K%H7KJ;D7 M3M5+\].;;GX6DBVK[M"Z\L^O3\I-39E7[:Y8O[H1PZ2!M)T$3FXL65>_J.CX M3QEQ]=%[@*=;0'J\+&YKD.%A$ Y:*"/WWN?="2TRA8.^8H6BSP /(G;_IW)4 MVQ;0;V8?X!$MG)&CN:P%6YH.(6__+97\]#O@>)*6?P; HWH]4(E+S<-4"3@1 M!<(_!B^_!^%OG0%B@^E<2]MP\OT>$;+9<"<,#Z0O$B?FSP!H&)Z?_GGB>"'O M&WWAF.K\,F\['"@#ZU/K7*W;DKMZKAWNQQZS^ND) @'I\ MQ@ K/%F=30E.Y]X33//R[24V\?*)L&>&]&Y;#)F *0\5X*=PO9!A_L1TP0B- MF59!A)Y-R&^1/2NGUCSM##3DCQ +\VD_9U*(M#$ZD)V_CDDK$*Z"?MT])_\; M@CD*#' ^!EUEP*D2(-%PA1).#?FJ^V_Q\5V..-@W&'.T*O%CA"^=UX J"?36 MO4Y*P(#X8/Y%GG0^V]?4MY%G .;E!OHH?21O^PSP76*+H@]KH^6/'JX,4L^\@-*H+W@+>YK&H2<'8E-WGL$"J7E-7;TR0XY?4-G4Y M?(*41?=H&B_(72DQ+C)N*6&UJAO=$1^3'!LMG6SC#=A%K$$O_(#UL>%@\\PP MWW.41[&R%&='Z.RE3Q!B^:B['UU'C]1,OP(B&\/P_@JLB;UX 8;JD'3.*9ZV MXR6J:%K&]FLJ'I74)?]O6*"A43JNI N#0*8SP),E9OHD5)IDD!*ZQ&_F6[X0 MK4#6;X6QM_1RVSF3D]<=2*!^FC:&P6O30U&7-T[#4[K<(NO)=Z@!),MA!U3J M\B3Z>^A''5'@J:#MS_ =$8;F'6AO>KTAJ2XBY+G:31@?]&I$QA S[U+*H6)L M_M+?AT"FB*Q!B;7]%6O2PG$6(2!!^%8GFA20I(>Y@#D15$,B-@07CMZ2Q-?2 MZ8K8:$O"=1ANM!GNJ842LJF&SZS$]A.D+M?VV M+EJ !/P$FB_ V^XXU_HZP)-U#!C:AWVR)>Z^@A&#,1!V%)45MKQ@;&+0!Q?L MD=WDJRM VD6L"'4N!$T0W-?35TD5R3B7A)=(QQ\T;N(2G4F1PD/5 M(:%1=1+ U+9NXGJ!SAX&B.;QT.8GI MK\LB'/N+^2;1O>P1;@/"UZ:VT68<$<$#./%408^4#[^T%-Y?K"\H]\+I%_CZ M(3=>N,#] MR0W^;[O+W_>*1WS==N>\-8 U0]6^7(&U=DU/72A\=[K&KHT7$@ MTGMP.-?&'QPQ6-/9Z!J$+1:=GX[3XEUAHED4.60E/P_,TT%&]/A[;8P<^]U1 MT?6B)9P!/"Y0!.E?8!P@3]&55Z0;9-9'Y P80TUOB)^)SV=A^,?1%J0V3 D_ M512)T96AJR+[]N5GD?D) AJYJ^H YN6RY]Z+3!E21M-B^8N*Q1^BI MJ^^K\O(8Z'> Q^F*^;B(DT'E$2P#8*)"VLLZV$O5WWH(!H&[#G('<^!R>GVU MEZY0/>>Z0J!JOG#T>;*9)2D@KI8.E,28V Z>T$'3_C83 \5_?(UVPIG%=;F' M^Z*\.IR*E3-E?X<47-<>G""D\:W83ZOZ/RM31L8,/FF,2)H)KM)'R8GP^LQ6 MF]X^V?$:4C?9\(6 Q3U;75\72\1=OB,P>(_7-=*H2MJOF;V M90M%!CJA*T#+AGG"XR#-)['UIF455$TBOFDFM#N_[B,)E'+4K7\&&!0&D6*\ M<>.]A)0Q%M#5B#TG$C#Y"7'&X;@$07:YXQQ]I^0S7U*%]S&1?ADZQ\!\ 3M+ M*5VV=1'KQP;DC.6%/X'\Y#9K;$MO+)R_=JX?RD1,0R4>P?E]3^-Z!S(XHV6) MPDCV'#R0#;$72Q59AL7S][*5^ZG_U3BC*L0PW[;FNVYE9C15-9P-78^LL MNEG&565:-UO+5"WSG2:*E4WE6^>[LVS#?+8WZV('YI LUMY(EC"K[55^5K$\ MN2P3K\R6[>WZ]V00(_!,,[##;4?H/_0[Q).=#N'QRZ5>Q4-'-%WL#16%WE*=&[8EFL8? 2PN^ MB_*Q&RZW9Y:)&:DAP#]I'V'+KUX3#-)5S8#T89>;9,@RF^(@KBYV\2;Y*DF8 M+6H SMZE["^"72M0 M!S"^MDN>2#&EYWK5E16L<6)&^1HY<.,LA;01Z+C5"K%O:O4XNA&+39OV0T:J M'41"V2;3.)YT%SY=![[P\0F(C#+UC^J4W?)\6O>TCIH:+7@&>.VO*^&CWM$- M']Y+[66&"D>8@GLY/F$A '1WU#!4E!0>O[O6G3'L$+P%524B^\=NXQ<[A?.N MYZ!B0X^)>X-^=U!'LD5@>^+$=[04&LX)G6 8M2$CC>8/TUDXHXC&>W1^ ZJ, M"#%HCO"R+8\!/-<9Z9O,^ 3>;91(>$1A/-$AVAX;'*M39?<[PWS@.!!N>;>! M/C&XMZG'4^WQ[33G%\'Y:37^]RR_H)65]\%P;EB"I.B:XX&T+K;IVBT!.XNJ MNY;^1;;\YEHY0@4IINIYZLK-8$-T+_?/,\ WV/%C4"-J>YAXC8"\_%&N2/SU(B4%4_J M#1@Q^PS0_\.)G_%[2HQX8T85+9<.V.DE&P@!OU\Z(23WYZKSZD,REGY MW.O\64$K]VE=JY-2%?8XB4EQ%E0M%HPSG$S%1WS-%C<*-@G2D-7;$!][VIHS MO16\S\\(1PQKK9D$^8_672(@8W2"X.RZNF39OK8>]H9.TF4&D"=2"/QQZ%62 M;6*TZ#**V][!I67XE0(#R0A')*^M@9**^2>I=ROMR%$0DEY>H@XSB3T*=@'U M&B;5P\G07 =$L"4*Q0WKIY IQ&'\4V3*;\C_X@$GXQM"E)O*;%'C_7(][^MM_*W%C:-.]FQ7:F465%BW?%?*@<.U^(:T*.XH*%W[33]-IK MO[917?^7CG.+S5,469@H\,_>Y?F,I/RT790GB;*BV ])*.;.W!L@JN9]DE=T M(2TE4IWQG>TH-Q*V\'0I+5J:V/R0'%X_C!AV]\5??]FE37(T\Z49KUM@HV\? M^['(2V(@^4B!Z3B-/N,?V$>IX=YJ"TOO(Z+EK\ED MEO$+AQ7.9U?\G&KJS(J2EZOMBDF6JK_]X?^TV'N6X4(9\F[T;@;+F)I_,5+G MR$'>QX*VICAH\FVUU>#PK5.1[CSD9G^R5,7_5/"]#TN'<2OJLD>+D=8Q6QR7 M?'MT.XG^KX-K[^,A[#?5RJI4'K[="_<;\T-\8P:A54?)C[O@)I-^ 4=,M0&" M\]O[>L9O$*8(AXS<(BGC\I_9"*]["A;1C:86:,NPY* HL<4$/O=W>.743F"! M!Z^XP;G22231XP3RVQJJ"3FG]C,,!?E' MI*&Y37E^0_?JE-]J)IB#@QPV6)Y%T09/=PTK29RTM[='I1D\^M@YL[N[)TEC MX+P8/X:3&O%CP"70B5XT7P<_Q#R@G*I)3JMQNN@<:"6GYL)+LM[^ L "F/], MJ3,ESU[* 7"Z#TZ6^'-(]=S =[/]-L@C!U6)LEEPM+]A 9^MBC)T_YB8:_>2OO@[; M)A6JZ46H?^\?,;A@3/P&J-D_*Y+8AO=;36\FS=DWGH_\%']B2G9#NO0+7G>S MBXM]XT3.7V/F6QF@ S_:I@LLR@T[8G R)FKJ 'O]VBY^AZNW.J M8YX8W'@5 7AE,^]TL;-N:<$G?ZBQVMGD997/BYS#_[HJN6GC[7UMOB=&J!D@ M63*/RCUJ0RL_\@4E0WAJ]] !KQQ42;?^>HAUR,#LZ(\\:?8ZU1EQ*YX?4)L> M^AKQ&G-%V4@E22&IU%B5L])'D!'A_]AG2#729PE=7.=) A-RBH[3B++Z/1), MS/FCYN2BRN\/;?R !N\?!L]'>. B1T9;SYAD@ ME&J&@2;#]'0,KC^Y!96**'E=2S;'VE$31(:K:&XIC=?H6,UZKVJ0-^W5CJ)% MD4PQ/0H$A1'SPM_5ORWW=@%.A8Q=NC==BW[)K3>]?5@D:C3M5]H\C1Z[;=J6 M/C5@UH!N,UQN:6YNB9>-\HTPOQDO,*4Q:_V7H(HYI%8LTT@LT\9(5BSWLWB3 MP>F"Z14$DP6"R1)IRHDT+=*HO%=X(]N5Z9ZT_JU4BU0WGFP+([&W7\BC0RY\ MY"B\7_!0C]J;)_N?:#9UF,Q74]9:B(G2P"V31 M),#=/2 P//"RLC ;*2^N1R3"\3X)%1,ZRL$588O)Y?1Y(=%6 5ZW7[(?>]MN MQ"QW>T#&R"_2,_B:>B[_FQ_V+O/S"_-CEV$C2U2>FN-N<@T)22CN).993^K< M)<[AEQA8E# R^DFPJ> .Q';6+QQ3+$ORN2N6.Y>7%[9_-43;-W+WL$@6W''! MI+T[=Y]B,_,;\DWQ^)!DM@TGY!#7$^]JM=#98(J<]!/ZE*] ;2^=_FGCC,RX[F AN016P6'F2]PLGLX_EA@Z:JG=,#7%S MX!97N5+[532Z8PUZB_YMZ0_=*]%7&LD[X81N$&91@*0&/X8GM+Y@^Q'D(WQG M1BSU7KF*"^H4]!T'D8&.XU0;>$ M=(G _L%1?$='$S]JD!-BQN*5(MO=^K;<4;OAP5^#N_7PT%G:-#@\7*YY9#LJ M(B/IE[L*KYQYBB1-6G5?6(VD=P? K3ES5,M87*D*Q_ M6%SG[G\A\D8,EUZFG*JSJVZ ])YLP[4(U37TESQH&H)^@34#,0&X H)JWM_4 M2T^?H!,'PPDH7N=!D4D=R=*KYTTJ-V]+#8ROA+P(*Q)Z66/>,7]9A@^AUS9ZV7NN>Y=*W>3\L75*^Q)8%##XXGNJ^%!S[8\;H_^L!SDX MB+[,,VV9]WOV@5DL;WG_\FM>C$;5"FFZY@CDL^K2-7_\KJ/-U*K*:,L_1T8Q M+/]$9,_>@"SYBW8()?26V_*N:)QD!+:7+9\!=K3>=5%T!V>J:(C!]YF52(CL MR-:8\UUMR^&5#91;WF0K-U-/\^@U[5[/@.\K^/7M4>+\0[(?K:G[/+;YBRCERRK33)G:OG83W[?E1>.Q"V%E.L4[>KP4<4&5AL.J MKR6F*I53R7%:SVU217F?9M(+7G2VPIK?ZYKE$.G6>3_?2UQ@RUF]ZL*7SJHX M2@PI,V"+[?^:'">C4C7\H#3G1]&ZIJ9I4/:JM'*R5!V'X7]I+WI >N?)7!9.PK3>LN:Y^+6;+ MEL^A;..12T5650OR#?0[!'TI$>0!_YLN22[!PR[XN&ABMU=;IM!DO^7($#,. M9Y\8K[HNDY5+,79[(L3Q(BV#:PQ"!5$^L>B85LD*1BJ4ALJ:K;P>7.*%BI"W M",(E),B@L#PV5#'1(;=9N%<]V>1'+JZH!^DG%F0WB@3[N HZ:=G%,ZD4F-SQ MJPOI=/3U=11XW!8C-?V3G)(L_3/'RW7C:T2JB0%+BZB"EV6\4/Z43]A)]8QY MMO?^@3Z;IE5WMB0U[3#MU&IU\9)')#^[^^]KY)0DI?V^M??%0EPD ;D_+\6O M)N5H[9>E/FH551T>BK\9?U[%^IDN"T+S23/3V+U<5G[:RB0D$T8T72)+Y191 M[GKC8/V**1UQ%7DD%!A]94,+/20+!B;EJKV-GE,;W;\?0!B->/2Y:N-MG(D1 M[Y&\ZI\*._+1!706 P:D$34[+]%. 4$G<(3>].O^*JA$.*=*S=^?E]&/ORY& M0/I/WC2R$8XO+L\>15S+8#U_;&/&8!V*1>H)44C,>R=E1$$4U(?KQ,W(<7Z4 MTY?F^'W)^#/5]D04N'@0I6U"6U/?D,7;#DC^]W#UD0AQ-N M'X&+B!/'496K8'6$1+&(*<2Z).X,$"?]1-@!GURX1#1?(DL_@'%DN9 O4$"^ M8,6,(H^IKI7;4SS;2X[1E:=TNY*GS+\LKL]OLMX MIU'NRQS22#9+FU1[;],O?,RKVY/^A*BR@&6-(Y2R[KWJ0VU3G-I=ZV&Y(UB91> MA-A\PN]F(S4=IXO#UNMT[89 ?XC2+3SLX2G AP&\E:X-AQ"94+X+YZYBSP"V M&D()SEY1SVQDFN)19#.A]!P0RE-@]CY; L+]5=\C,[+$.I7;KRL"!]PY1_GK MU\/B/_5?6Y,CB7O6;3*+*NZR\O DJKFG3EY+EI;/SI?_??Y2@ <(%G MDQ8L^9G8KL:E\4PE$B$+YG0QBC(^LFC.SL0DF%.LUZ.QY6.^-CBJ<\-"6U:["K\=ZK@^K=(-ML@PZYTMG]Y6 M5"R;0E_M\AIL*0Q7#VNX@WE;.W=+W\&:KM+K M%X#K)>3M:)/ %O"AX_R$6$;69+MO/DF5)@X%!UZ&7DD7>AT0IFHGD;ZPVV4= M=KQ!ZZQRFK^OD_4@-XQHOX$-4^/KBM:#6_[3T)A?L?6DIMV S:1*QC:M?=W& M!QNK6;:K;QSL)[5?[SV\ GV["%K68<)'*R@7.\NM) ?_?O+\AVJ>#2(IW683 M;RV9,NSQ<<0I6<")QW 4._0 +'@>:<^L3<3EY/D3/\9 M&5J *4"(IG"R5,L9X%,437UY:,^"K%3E_%M+N%V]*!)&'*+O/QE3D2D% MIZ N+3@93OMT6,F*X9Y.@6N]2"H[E1NXX9W>G4B*'U65EDL7=(@HA&Q E4CP MU)#&2.)$?X=_"=N,L$C\YI7C8HFNSJ8X9L%JZ8_^^*]VM>L M!?OOQ=YFLNV;;*.XT[]#+]#>=OV)*Z[ XDXP?E <7H=Y^<''^< J)X5?O:VA M<.E8K+!@PSM8^0]JUN;M,F]<,+/>[&S"/C\I@+"4H:M./G F9Y" SNUS5!/4 M#_0M#\MZ>[7I LF>>$I!.&DBW>4'6NU-(Q<;OQ[7.=XS0"**\(?C M?,R3IL2"^:DW-VM[WWO\[@$E*QT2WQF'ZJ)V-)^_,]R3Q/;G1 M0<>K)>BXQ#=>'5)OF%!4/=B5FXL_N'FS'RPN9K_B=:=WZ?)'*Q+-^E#G(V#X MX8$Q+K9+_<6":+Y6OD?4_5'1QMR]1[WM-XRBJGSX%<47:#_;,Z.2G!L2N50" M^B?BBO\D*R[[L>+G!NI8Y@?H?$1:4Y^W]_GX_#4/P(*/0\[D>4>:!?V19T]/ MX7O/[.5G2:)I=UAZC?&[PB5O\;N_?59J]%ZZ? MEC#!*D &D++6N\L!'!1CN.W8QRWU@6DG/8Q,02"2;\66(B1Y_-;ZUF]3X5HW MZ;$AW@,=/0T"*3#6-;;_\;]GB:?2W_[_/+BGQX]62]?86FIN^S0A$&U!G'L5 M:@;- MP+_K((Z=;5W-D[GTS9%=@9<*O:^7$D%\4)'H1^2X:JH%"96L>@<]>3Y#_.M-TE2ZCYSL4*2SPFWC"L1;D'-0ZN&+[]ZX\W M/:+FW4JU?SJ#5_:AROUK=IL?C0^QG%95S_Y85R0,/ZBR"0],BQS93U!LEZTV M:A]2KJ&&+D],&\1U/5PIG'Y]\*7UFNCE8:7CZ(MI@P2>LGS\;U?C8OO"F>!< MX"7XD\VAB-1K7F:;UK2NH.K@8G6.>SV^E*N0Y%ZB^1F +$4%L;IB>RY$_XDM M@Q.<2!,5Y*UAAV>C8A".E;<.LG67[G8D)?>F%8'U*GTXE82Y+M;MS-.Y8,IF M;/#_C]\_ ZA,FZE^F?KA!!8[F! =59EJ-I)K,APL-KJ>Y!G^Q/[]OZW^*% R M&?4MZF&S7!5EQS5Y\.X9X%)YY63F8LVL525\MR45@NY$_IZ;FMCP:-)['P'! M0Y\6A\PZOQ9AWU8M$%0?IC%:?)];2S8XDNPH,49(!85Q1J7=PQOJJM^7*W^\3OC3S)**"M#VI$:%:Y+'X M%PKX>B64P^\9'H+Q__!&Y;GI!UB?!FBYD#O:K$"?3"*MZ.20/S6UI?V/D,NX#7DH5QW_M[$Q?NWO!:+KI_:A/#Y%<2C\,)U.WL M$-*9;L2H)@N()/T1>/^R>9QA:1*OA<:D-2>/S-\ WH'^0JDMBLZT"I)2)./Z MO(6?5)RNNC6(6CY"FIP!^ EYN]O5T0:3ZK\*Y/;MPY-UI58G*,*'C53I_G>; M9@6:.;-.NN%%7RM1M!RH0SL48J,^!E20Y05N+[F#E4("AR\'#O)X\YC?'.8Q MKS1<2>.1,1"48DE,/E]=R5(- )PS*TVF/3P#6$\U&&:(B0%\YY"1[^8=/B4Q:3Y$4;[>RTHMI=_V=B'2WH6?D]=%05?C:$ MLB4+^\(P51G4SDL2:)D_3@44#[]\>"=J8.X,P*U2,]=#[KFY7ZM2I*;YM+F' MN!>K6!+F%>TN%R4QH[C&=R(,G$(]\T(2N2.@F2GT")^2#, M4H+6SU-(XF'[YX_V@D9H6K!9OIXO3<@9K5!3N9&?7#__SOWQ)EZA;C5FGTE! ME/QE/941RW+D+GL9H[T_OX0B$%*Y2//=Z:EG09 M4L'&VS=D:X*-[:>/T0G<1:Y-VR; (XKPBB,K1'Y@Y=9D3?S 3YX:&:N#RWY, MMB7OGOA:^UZPB;&'"J*P2KQ*D; 39RM59]N'7]%C!H[8(R%Y48,IN?H6>5OK MF=V2QFGT@M;0I?:NGI[N]HB='7EY^97,J)2DGX8E2<)&U\V-@.+T45!K0C\* MYX:W7L>P.MN:$.,;\6PJ"]%F1&Q;U;P#_**0H[>"HJKWGG\Q$X)8WG@W,-2] M_O.J8UV7Q4"T7_U.O8A9'P.X95!Y#*QH9:':>[$,SH5"H3->O= C.FZM1H3UITW%J.PX6MA6T<5OS2M"TCNDI."(4?Y)@#Q-^ M?. DR0U.:LBJZ;,W=4Y*1L'GS-$(&U)H$)7=V;K24R/51&#VDW5*GQ;W%Z3! MI4=G@!@&_.E[$&J&4[?L(9L1\T\IAF3^H%P'M;2:B!2;Z9#KEQ[V8$.[/4[G M'DZ%%"EC?1<,+&8"/,!1VD)"VB&9404U[W\:/H[AB11[.VMM=,.\S O7EMCB MIW[W:\CHCJHWLF5%[_^&E;_&#>"81@TRC MZ]96F1=A5B"BF2)9,C>+HN:M!N/ID;;_M@6Z'EK ]?CO=P$A>_%:H=OB'I.' MD=F?+TXDU3]^^X%T*5'^^TJ\>MZ#27&MP!E5MO"#R\(<*H3MJ= :D_U%1>[$ M0-HX7QH-9^4:%>RPF2.V)SEF4=Z;Q)"0?,3MU]'FIX\C$.GCMU-#K>.LO68( MNJ)5^K!O5,4LBE&7@ED67ASDN?.RH,9,9L1[]KAE,RH:JMMI!LSP9P@X M:G M_ 53=5QP)(A\8=9KQOW.3T6?E?K]F MER,PRG@ASC32'2DUI)2F:(/Q*'CN))VZ2\2 M"N.]*]_%C]^Y]VOP9;V)?VV80:R7W\692JR#VZ8R3@)5[68TE7]@Z8[6\=RY M0\JS(U\DF@TM\1P"+_@"KX2"V+QW5'N2R@?7[GL]O8QTFJ.V6QR#V+RHSEN6 MWI-.SL//VET]O8_K+ ;( ^0J4@*!?R@@T6$8 9/;<(-3B[)Z- M5'#P'Q4*V\?B?SU9D'/V3$_3MOFBE)PNROPW(N&8V(>U&%J[DB-C]=SN#+"[ MF4RU9JCS.:S/ $]&L*<0A5;&6ZX!N9;3V=0_]6C-5-@1R*^N^30Z_-(ZFJGE MU7F6S"I3S-\F+->#Y$C'K=U!$5A2=1?4_,)*\=TTT%UFRYFXDR7^?6:[+ MFE CS14%2^ [*#%Z5HNX-SFZ8F2>*,;5<\VR^Z"6UUF])5#"9A^U$Q#@P[H0 M@C[MQSB< 6R.&28DM/[Y,V4QP',/[@G>D,=;F[' 4V#S;^,-F&@.%58+BD:N-18G7*JF\$L/%#&&77OR-9:DOH ZYN#AO MJH&]JNY]E>+%KXU*XEEFD#[_FU$Z5TN MG(,+HE1ZTR""AYT%'+%A_++!_W9YR;6VP;D4Y=T)1I=VUUN)<>A?%OL[+.": MD0SDQFYU6UXN+(>@=!7)[_$&:BVR M<..EYRT,Y;(P>UQO\_ZI)Y6[@,X\%DFJ/P"39TDH<'L#6<\UJ$U7D#@[->H; M2;JYCW41>Q.=Y4B^M_A4.C(L3GQVU6#Z\,3:<704M('%XG CN,7Q\456L+;A MS18TNB5>0[[.[T/:DYC%1::AI]!;8 METVW'\E&*QK=^HI+Z-_;3R(Q3.8WX\4,5_3T /8H;)-3 M'FLFWIJ%M;CVMWL21M5[KC*7%ND]M&-9451:X-<^8I%WNKX,CRF47J_5>NSKHH.IKCD@9TB_\M7PKI&JJ*A$S5TTKKYPJTI&7(2?= MRZ)G]PA3'Q!M!P,N_2K6)8<3[H &H5=(O)5=4ZIUJHA]_YL_)D=YOCH-7MQ) MVZG]+-YR7%3IZ+ I^'+& N>"F_\Q* ;^/D?Z3.&@_Q!6H;V-]OXY=KS$114A MR6]+#M&9N,\3VYG/D0SB,+L-]A&9(Q?-Y?1*FN=J\2;:YA'%\MKFTR#DDA#T M&^A<-#>1;^DXI9U4%U]#/+!NL.^Z=?HP20U%*')YFO=MQ4/B#UB_P7&B M1\N,RM9@ZTO.'90'-BVN)>[G5]+30I.8L>>ALC9%.@JBK&;PJ\9!J[$WVE F MGQ>^!G0&(25*M!>YJTC02S1)#<5!_\O#Z_8]VO)X%Q'\LPZ[Q=LCC>\JO_8_ M;D#?[*Z/RK/!S 37O<7FV8]7B"JB-)8;@ZJD\4H:B_,K2\.]":#FA($B",$6 M4^<<0I/H,^DIJ)A_]Q/;95)G="W#_8,7GYF8QXEEMU+C:B9N'*=YQ'8ORI'5 ML>!=;\8$#G5<0TZCV$7K?R2ATA0$!^XW^*: _B!+C!.,0B!,7DV& H[S\9PI M"PZ'!I<[%MODE'XP#*ZTVF'CN ,*?PJ=A;5 , &X 8+J<%JT]W.LX/773O9D MR3ZU<"YP*?F^7N9?_8L_;J6Z;,Z5:KACC]I=T];,6J8/*0JRRT & M2#X#H!,P+T7Q\ &3&TN;IZ\HIH@JI]^-7L4"DS=S-?:Z] BR/]/-W1!V28^X MN!QKYJO\T MJN /++C0:?K K0KAF"DM*OW!.L-?BN)K'JP_DFUH34F91SM>Z MALV1)%*#3[9+Z.&TF]"W.N##5P0G1<#S/_EOGP$83 _]"Z\<#6?6;SM&75TK M_F[9OT(B._CB:! <+M+&6O69UNK0BMO1N.%CL[]A +HH?0K(>9@1#V-3>0VK MV;RTHY6+"%X;+(UP>Y!LM])#XD]$96KJI><\$?_+T,@?Y8]HG0Z9]QTSW9^: M@FWS'UO3_'>?B$I1A42CF.F)]:SJCRT')@[) '8%#Z0 F-HZ(>/(/:#/$HG M8"5JWHN I;K7#7(KXNI;T17#AHW*$^RO/PSHM':8U#8U@R.K%GWR*TH.5U_. M72:.Z13G8PA6/FO6;GM@H_NLS/)>DU&:+0B'&@+V"G1\%WD2,/GZUT N635W MBN O@8S[0C7^0NSZF/H@4A8? 6%.3-A33BVM:"Q6>)Z%S%]#GP$R]AX3@^QX M;>HU2I.I9?^.3H7. ;D9D09VSJN'G>R.IP4;SO2(X19Q/Z@N=C$;T*LM^IFL M=1P#;>:&^_-DW"[ _R)M)FSI&\ZI<>%777C-N&+TG<.K\;KQCJ_KTC#!%!DE MDTJ]$8OL_-2;F9.:1I4'1I5#)]F9G:!2G0%OHMZCWR;1*K 1F^S,'I\HNN,+EG@EMB%K2:$.@V*UB8'Y]/;04]!\P%XU(X1<6H/LW8& !/# M4ZG7$0432<6\,RU,?H^)AVH->9TDU:*%[4IQ8G2)&)QB' DBF 9[UAC7MI[D M+=T9H-K>U\AYJ'OS2K\;#U++ZO<\TB'9K]YH9*[&%(1)+_RLU6"L,XFD[AQ& MG-H3SP"I'PL'$IJI"ARQ'_O3GODKRHU"VV3>75X1C]VT01S)N4AF6HX%_1 $ MJPP869YBI*W&;EF5Q$<4*C@?.]-+&-[GLIF/V*DHJ/!NS5,_32^#!;,5Q<7% M%2H&_IMWGI/F<3B'^6&Q$_7;GZ_=NB\T*ELM>XL.@2V7+A'-?1E&PG^:U]?[ M^D7.8@'1S:1S/W0L"*@U?@8@A-(*^W*]4RAJW(U6S3+4NRP M-^WG3*?1P726?QL@^'K))%A5M!!9O2:L9D/! MG5%LZB8-;;F[I_337>L8W-04[F)DO8*"1$BRP!/]R.LY#,YE.TJRY=5Q++;/ MF8'9=B*3,-,O""[C:7PMQ_Q3P9 ALANEIJ-WY Q@O(=XZ:)0DT[L[-\.-1A( M+V^X9H1YQSR*(ZFZ!'A:2GZNGHH^ WR+/D$D#UJ<-+>[Q%VBY8S)??D_6M/1 MO\T:6PPG"_\&G7" PDDPPFQ::QFIV:I)$>$=%!FNQ@A/E*VP=$=PV$7"1Y+S M AKU9TWED,,=W:OB4X5"SA3H+S MFJJ0"F\/V'7X/,)7?I:>'+NM==L$G"B67\S/JH(UKK,II<^NVGO_CPGEX8-U MMLL!?;#K5(O):.Y:ZE\ST>)EGROOXA?X0,KW#^0"JGVBA':4O 2UVF=:Y@LT M_!7\0CJC"EYQW>>9N_5RU:>AQ!CADU8=XCU>]W_1]AY03:WKNG#L(B(B5>J2 MW@*B%*5%5$! 0#H$(0L1(41 >H!(EDB1ON@* DJ5&BD!J5D0RA*DAAI*2%"0 MGJC %)+PA[7//O_9^^QSQ[WGW#L&$Q@#,@GO_-[R?-_SO*]!H9S::?T^4P.Y M/ENC%GWU/8G]-8V!)PY\-J_<'7*-1OIK$TXJ7^F=*+W9+AWP'BG(W47QO,49 M76K'!;U7:.9G_6ZTS#;H2Z24=,H(LG]1HW,HIEV>JA&AC5C,/84/5P#2WO47 M(V5NCU5G*[3Y[E9'N-1[QLFE@%76O7R8- M$L\>!_6M?V]-Q6VA#X]KSQCD:9ER[H0SW@1VFPN+SZS SC'%/1N/6/6\>.M2 M1\7%*4O_RM^]>E2OR//[!U&Y(XH8&/,"3-J'"^5MU?/R/OYR123&U$5N[%WA M;Q77T=P>Y-8;KOX7:U3-M-7N!U_RX? M3O( M% HUJ M7:>$K"C% M[JSS']+N$B3/9GM>\82F"A.A3F)4"^6_3OQU5X@QG M6J%%+#I(PQ?5J*'P'>]+Z7]QWZ@$GGK25.VB&MCHG!=8"9FYNE[MD4"L4]Y%&VG7O*]*N7J:9^ M+'>O%"_+_()5C@N.EN$^%1AM'AI0E+_?L^IW ,K2^HMY^"4\$V(B\"3]*N=9 M^M5/$KKRKSU=KN7$OL_@>8N_E_JD*N-+X)M9M_P^,)XW[CE"RI10<@#">G\C M6(VK@1$6N FU^+4V*YMQI4WE;; QD^+8LK:_U@0-RVEI*9M>^O#APZMYAY*, MZ<]!CQY)IL&J<(<'FS*F!Z#>>(;&HDR/J?J6*:!2,O>3*!JCD>N.IFDR!Q]4 MG54LT8J'G2+.&@RO-E>"A8FO1_H+OWZK7'NWJGF=%2Y6#KL,DNA('"'\"NHA MP?L'Z;F@%RGW[5?_D(G@ Q W9GU)?KBSS_4#EOJTJLOK7$5YY\A V8!PLVZR M_&!S4B$KI]^SY>/3M(G*S"J>AL*;'^7 O5Q*X1-\P]-3]O8.G9D[F;:VF2LB M;57%5:V^'5Y>QWWQQU6*+,0+RI-EHI VE-FK=T=S]MK&[ZH+%DQ>V+6ID,&\ M;W__G*G1K3SG8$//^EKXXUY%]_@375F@\-D[P&LL&A(-^(BQA3E+EW\N'QV\ M&A>H8&MR.^L6PRW!]73/ M^;@$\717@6*!'A7;!%?>AX=TQ%KH(4%:X/]-_^>C<=^K-!8Y.TW=*68X*N(. M4$Q=LP%P9%-QY?/(4K)9SJ(/!PQE1)UXKJK)T:4YCUM .)G!N+_NW7Z/+,5S M=Y=Y:CIA7_\.).NE/)*K6-GP?47%+4[^,92(AT).,*_298!6;?5LZW9Q"#M3 M'+C5NZB7[,0<87:E00] D5;VX[A:@@.SE_4E;_]/IUO[RA;[EW+6[71M_ 8' MOO5]U&_L6T]OYYNKM]P';PW?[UMQT%E)\>I.?D4Z( MW4Q>5.[QB1)CDZ3=&!?"R]$T*#*1VL>9XDZ<^UK[7O52--N:8O5J5?1&HLS^ MO17*PF%KZ.Q@(CV_82:D&>9 HB M)_'.6B.JI//$J15B\<1S=#G@:#7^^/%VA==5^]' BS]:8A?;HWNM"=6?GWEM M516E?\Y7AD@V"=7F*WSQ:52K0K_T-\S)>N7OTQ\XX+TS^\/X,RIP\0!T%*5$ MK2Y;Q,3FJ5.3\9CC'M$=@1@!8*TK6R,2I5 D8F=9-Q)0_$ VE#R:WL5'PG,3])5PH@=,(XM7D+K$*H_RC[:K,_\\ +%Y,<_2X8 IS6^Q$XU=QD]K6YW"B[V8YZ2MSPLF M=XF!()XJ;W OQ*G5=16Z"=G3(VHI1>H%#?UE(A)6^UPYZ_SA=@:<'(JVXE%B MH9KH&Z!/3,\YF* MFW-S1J$OH"[23@-!D/,<=[Y>011V:DY4!T1.]"16Y%[";_>LCH_/S43;="=[N6_S^Q7U M#=[S,1@+9WW*%I%]0?DW[3 R)BI<&YBCQG= N.EP1C1*A+K83;J $B+C1($Z MYH6GWLMX9R&6AR$Z]@:Q;A218.8%,:YI9R3Z%K.?4(W#8EM,:H%SP>K-P75F1(BR M"Y7!1THH)B&N;4^MQL1-7TF#D!9>!3C"OMOL"0P'_!-D<](':-S^$ M+M3L+Q]X/)$STCF)@6:%+T_*5QE#*R A>(F+P7L:=ON*+?A\,,RJ^0TU-U;.38AM2,NY: M6<-MWQI1>!VLC.6-SUTN$W6[[J3E.&>F-/C-#NZ4/VG#8_>Q]I!'\;[>MF0' M-F.X8YKTYZ7?YS[N&Z#$3"P$(TQ>S?2(__*;PH69G=_89$"39UVNDU(O9"G5 M?HG/R I^N/%=\WZAD+^Q2GOS']-7A:C287UB$7F7U [ DC[E%TW:DTX\(L#5,S<'^S;[&-4_MN4/0$GS[@4CSE)4TDX6 MXW7XE;4TP)U\:N,(U82"B04'A"5S.2'19%PW["AR^7X#E5&UE%\ZAZA;T168 MQ)H 6$(AJ-QS8>QSXV.LCYJ.KI$HPG$S,.T&7C?E>=?7KOQMQ6]=F[Q6-^^ MD)K:"DW=S$9LZ>GS6"?\3^==_ \D4++'?BZS_"25A8[4H]/5MHC\.Z'#-T9O M-(TSI5!JH^#WJD\TS)]2MDY/_='J@5]NFJP7>G@ BI794M.Y EF'8*%?81&_ MM'I?-)%\\4<$FYVAU>]Z O)]^%\2SAM6H=^HH;4/0%1+&" ]/!K=MG^3.00] M+7B'7Q/7A8ENUF\XF71R9:O5B2PDP)\H@-K5W'G^.)\FR5@J+3%DQ.Q4.+%_ M5U(@F\'@V6X!/R9*E-E,43INSI%V9EBX] MW%:YN',KNEAL 653=[&EV( MKH Y'8+[B>(RV*Q)\%/T4^U&NZPLJZ941'S.J^FE/+A3_$?%I,%UHP>FX66' MX!&WD$LLW1 JFZ([ '6N3XM0[*/*\?93-7F]%D#QNZE!2Z>K=U^=#>;+NU#_ M(;%JFQ$^E^K89.G%?O.53Y;5V _>0_QZ>!^L.?&J=2U00WO4N6\(\!>2^&K? MHW5[+8'",OM!2R]ETXR[=NIYW/4?8C>V&:$GDQ!-J7_=9-)JK%YLU=UXM'Z M_2ZAWI3;K'94]:EXW^3=T?JJ*Q-"(EJFA,I?31"'AZD/D^9'1T?GKRTT-D:H MQ@FD2"3R\ASYV-DJ3TNZF.=^:MNQC$S];@:4!HQ#RS"[X37Q$RWCS#4@7^J' MQ9[LQ")T2HR[U?R/L?NRY89"^%:MI,@,;X7*X@VYI5=5FGE[Y&W(_+VW5O-# M;OM]^=0TMU>-=T95,9PKT*"8M_!,0?7X(@='>+-M6C%1SZ5DI?GI:SD?N*N+ M&T+8=B(S\U"CXW,]%7=.3[3P?:9G@>\'/+W5N+C07OX7JR#4H#CJ[,U M;(^_-&-S?LK3>I_1':@SW=G+S^B^;TF 3[>S$"[+;$+UJ0$W[T#5)\-WJVF. MGZ)DL,W//C>T-*0JY,#=(JR#F+N([Z2=348D2F;? 3#%MG$]UM:@5>"#+BA' MM5J.O*C"SG@\[\OCHYET12T1'OGAS<>,/_H7S/[I]L+$'3Q>2>+LU@8+]UWM M7;@DX$K!V*;6NR;$.84JWK:LEUPO5[CI3:^%=;+J:5Q!B5C7:UWE9. 8FR%[ M+P!5JH9GC-XKC%D\JR.@M*GZE79"T-<"_\"M_VPG5Q(_KY3%/8SYSW/YUF/5 ME8_K^W/V/_[84*L6,Z_)ICB %?,V4C:S)^9>=A^[K^I;WZ-F=4D?_/K,[M9T M\HXKD+AOA3*HI8K]MIY@FR)03;>A5'PHTI2)_''K%R.LB(&;0,BL=[(9H= ' MZZGAZ!)U,]8MN0+0V.>E^P$MM#X6]+4.YQO3!F, QWO?PB]Y0K\4U<#;3Q,> MI"L2,]]>.2;R9U-"S,BE^M1;U1=_"3N52KSU)'^B][^KS%A$^D>K7&P+MN,7 M3+]\+>2;K9]EE#&A9!3IZ6F;'N+5;QO$(-Y/V66*4;8*T2-A+[1A0Z4YON%B M5SY>X_RE5YO/RY'[S-3]_NN];M^M$4\VH14]:AX,!\)>@WN"KXE2@O.%N+WE MEAN,7+0[+ 92IXS/U3@D+ZKJ'[^IE8N&-25=K0(PCBJ1'R8"9Z4#>CG!)M5DSVMUQ[=PU&5>L4@-?M:QO>C\6L+;OX:.HO*Y\*2RL16'&)#)U?G5T M==[HEZ:&O.N7\BZ*REFDO#+_MG^X-?DW?'T*-]9^!25$\-Y6?BZ80^*/Y=1_FG4M,14$JI;HV!&#"JL1%M@+9F= MO3;OVT:W311,3>Z.52D]5A/19!*%^MGWV?]TGM_LVQDE2S8VUS;1AG_?"1U:*[@Q*_5F?K4V<@WIJ:;7!E72 MT?RTE@Y17AHNRCUE.7TQ8O"R195C-) :)3 DDKI8ROMTUED!W'W-*MHURZP( M3H'W\,H-1E^)YN>]!9PC;+,SI/<(5J-;2O4;AN9-T=]ZF'TA7CZ*FQN?'7YM M:FB*2K67B=:W2[*?LJ):6 MS0AA62H>W:'IPSQ&6H5=U.58:0S-ZD@TWAJ<5+V&6NL_ $5K[*:=L'_TZ,I] M)Z3N*D4_QGC\$5R:()T*%K//*/72LIC046:R-1V CL^B1=IC]F\PAS6%9)Z- M5&W#8M#GMAW],(N&EG4.0&$WG[^L IGWDLRH:NRP&,_O68VLS'5Z.%J,*QPB M*C3@EHU^J FVB5_.L!O81@Y[&:[=WV'RI!JI-GV1+//;U_\3UWM69@33G0"+ M\Z-&.*@97^\1+9U4N?B:T?HAF#/%NDS0/,XUR7I,)L,V4D+0,DHM 1,7Z8>K MJ.Q[_3Y]Z"\%@R\]:$]LX]C^C:^/\TX9-(Z'B]"UQKWZ<(DBQ@/NE&0>AT]O M,)'6D?EW1F5NH"QO.L^7TB5N"J#T&;^(_R]4"_^KGZTRDO]_14.I@G%;B-2& MPEA#;9JCGF<9P;3G-A]L??=YWKDG^1&S,K>B >^8AF[;'?N$?=TNRTA_ MQ?TK"=?=8KOZM.=[.4RRG_1_ \RL+ZM*+O+;<=GQQAU.L@SM7;MTJ,FQ4 9D MO/_2Y,1TDR*A3_^FR;GJ2;PK_G=-3L,D^-\T.88EGGZ\ID:\JG-&/6"E#;2C M;+4B7KESZ27TY5TGW5"K<34W37\8A[$E_)MULF&=74)ZH9P^'?(B3X25OK3! M+Y\D\[O1>MU>?OUN62%J[^HW^UA"*OK3MT\F"5^B>LGW/Z_8&-\K8[/&4^0F M6+#D9BF5O6PE.S/V'>GK7G?4?%;Y2G PGV!F#MH'7+P=M5U4=6*@>*Z>E<]F M'3\E\PSWQ=&::VLC3A>WCZN!31]/6N!:VYTT!W5T.[PWI3[P!:E<;;4-ZK1U M.5'O(YGP>V^#FOL#?LG);:%_ZWP6M$*JY\M]AW("]$N)<+3@CY9;ZE5%G>+U M-< K5SA_OYDEZ[$4*].QUP]&-R=I,CLW&-'A4DP"Z<(6 MZGI8Z6H[.]4P8AM60S>FZ9:6#GCIQNO4=RNAU%P002DYR;SW!3Y'*=X_4OK; M9.AO2;+C4G1'%7)K_[&7>.528V1RE?&4<3WA7I>^Y\_V@>N6T FKH)(LR-62 M10VF-#+^ASOMZC-MPPYD<-:7EX,2]RWBTJ\9JO5_'110W#]EYNF?)VUF%@V+ M[5O!VETOC"\O^S(@+CO:4?!&AXK#;=.-E3MF+^ MVUQYJT.N?*K+YD^$:WGWOW/E[1)EV^93*Z2&M*1.WV) ]S09(DCT'_-B.QFZ MF!S:A$],R8>8%S;JBV;@GM(===,-\7*7;Z]U]/FO?R!@7DV6"CLK74ZX_/+N M17T>NY'\T7]N3?L_;D^KY^_E%>;EZQ[BGQ$RU#14L%0\O&?J]:_NQ<\4RUZ_3"]4'*L8)Q@ZE"2EZA6:&Z0O&3' M/'.XX;O8!!CY5[#J$:$B\V!J\V:(,@I&9I?]G+=,WOCTS3OK'H'B]&U@X6J=H^*'+V:ZIEX^2:>6#W[;,6QK::YKR!G<&D=5>2AO%2"5P]25?2:L.5;>' ML?M=FG_AV\9_6H(D&4%Q:1ELM0@AM:_X)VB0^I<:_K<1D-' M*A:FAN7'-%[]V.QTRSPVN%_C^5+& 8B8II<2>97[@4LVI ^HB'*^.#9PI=EG MRFFLVP5>Y:$SYRF'[L]9NZ:\0+=@C(\K?\M:SYIK'@>@1V'&(3Z+JH0!?]5& M_@L?M;__^6U M7+41#%5Q3W5\('#W%3F(2C5I1?K:8O0U2IQJG&R*:YSLF*1O3QRO1"+/B=OZ1VRL3]BPHG\YV8QG M9WY(=4".N6S\\KZ4/MV[!N.LS'0*_(OE;300IB#?!KE-*GA<%Y.%+*9DWC\ MU6Z9B'6B9)*+MK+[5JO%=(:>;-L<@.I\^NV4^LM[?J9]Z:8L,O+7RQYQ_&^3 MS<$\=JN&>P6I1O\FZ@=?,/)(=?S[7OJ_'DG=7GP $FV&,) :S QSAW]J3CRL M5O>#89'R+T94'NMGJM"% 31MF0J;T5:+=CPSM@#([Y>IV%, M]G68Z43]9,;\Z ;72,IR;5O$EFE+6VT34P_]6'EJEW)J/9EVY ?'4ZD).F=5 MO[_O D34$=H*#7X1\#77!#HG"[7.$V1G-!P MFR\'( 'F.10$^$X] #D"<)KRK7A'ZD0C'W*:K[#(4T4RWK7ZJ]V ,*9D#8KH MVX('O?CZY_=IYX[@DKGYZ?OT2:XG&V\;UY[M5I0[$O O#>2T/%IP3MFRW\WM7>W2#$ MESF"JRP^#G?)CG6YV<>E=I$++3/N.G/STQ4<5IOS\L\5>KF\X2LET+'"(@2."/CEI;;ST]8K&R3!WQE"!N.M^A7PYG// M2V (S?FZIX@2N*;9*X3:9F&9IT:=5%MN8F)NLY'.P/BG;Y*7]SJICS(_4QBZBZ"M_WP,0V\L/37'L3J): M0BZ^X,9X<-&'!NQ8P'F"6=K \1V?D%)G>YA3..T U*&-6\B#FJ]/%TW3+8%B M=]=*>N#$8Z.(HRYMA':!EJS+&VXW"K/(/'_+_Q_3J;=LXA9W7N"-1_9?KJ2^-/7/E M$I9:M#4?1L9Q,>-^@>%IWL4& V'*C4F/[4_JG;S/%FX^6*X55;GM[1Z M6DCT%=^XKJ603"F#*]U+ DUZQFWP0\ZR)H_<2.?(VYLLY[&#[SR73+I>F"KG M:O0@0_#Z@Y1;O9+>Q<[7N9[9&5K:9#RSM=0[+LCTPBT4P:BFT[HB'ZOHX<"Q M NUV4,;R&!V]P''E9(@VAT1-YEI7N##V!1_Z5 M?EB7A@>4\_X-)]3Z4YL/D MF\PTN51#X9&//#5%-<:)PC5WWBZF:EABA%_\45%8)M_W1X7<+Q$<(=<'S:,& MWV,X7]RO2_P2TZ4O8QEET"Z[,<#F()\^8_':SU MKH"GT5=BL%T/+S)%TZ5>?KZ>\*:@1B!81LPKJJK_]*.+J&5! 2)7G%]Q;'%4 MM\L!:(AY<:DA6R$^Y&$$4M+()5O:XTOF/4%':@-O_<*XGA]^B%UVBJF59^?+"F8:]R$O3V3CY[E4S2;J?H^;:D.TKA ME^YW2'_%V9=3/Y.?OWF^?G(7TA.8;H/G@P+O62PXZ1H_JRK:G'O7/* GEW2P/ M$]LN7FS+%^^7X",KX-=JNG'KN(K6[DK%9$!&[# 54^8&4VC]BYDI.J6=:T:+ M;=282&775/;\%W:7C9K!M^[%-IAP/B=G0*;3G%/N7DYY()UMOA(W.$HPK\>^ M?X]MK*FI:8P8[.L;/+U1I;@!+K#WJO+R>FL=/3\_SW/G380D*S/P'39Y8??R M\G+S\G%W]SE1G%O$Y0@ESN@+\TU,#!O4Z/GX'#=.N75+$-8LVTM/H[)4;A"VGA4QS_ZD M- *E8/(+><^$]]4#&WGZK2Z;E9L7H\->&H U,Z#^2-0YD3X6C/EJG2$L)6?4 M9-MMV_V@AE5T.3?MG_Y7PW[_>90P8@U-^RG&"+$_ *THVJ08/6[C_ZS1LHU^ MR?KEKK]ZZ;.\C=%XMF*@#>@[X+,!$!SOY/:0>@SJL4'W&- M#^W4MFU\R]$RM:5G(:K9)5G"_>IEQ6MB3RSN ZU*8B(Q95'=EHE07M?^:T:H ML;3YJ_'UA;)8V8_2V1X_YQ7)NF*+26*? ,J]9K M%F5\Y2XU2,^:*)22?.3*)/Z!'*'*H$C^YA581VD7*=I9 ]!9?(HFD[I,CW[' MARM0YQ8=5J%>%$X]2?Z@+*ZLQG8"IFI>80!RKRX3H;5__4U+?1XBI#"EB4U- MQ_B0]YO)W#&5[]O<9 [=#7N5USFQPU2XXX,!;US\='YV_I:+&^\G6D^MN4AQ M[9U/[WOX]P49#>@'/L?#)\-/3QV 7*FD;C3']* V^V+AD9\AJ6C &7ZV6"7 M?YZ__4/PKS;2K# M-@7*JT!K9+TY^U??C_PYE"HKZV=*8!(>XZ/-K^G]]N$DHAH\GJ IN*JA&97 M+Q;OCE)+[*OYO? FKZ\]RDG?G,V2R^_U9R*"TT;?P=:VF:@F(087\AN\? "Z M0/?94Z'AHK3=GW_T$Q:%=PMK=$]'^FV>__3^6LA$MZLO[ZI\^HAZ>\4R(8"3#<(#&V\Z>IX.RYU+B;KMM\<4BY9_9SG-O0=#"Y=[V42IG\H_T$EC\T=ZJQE9:5@ %3XAUI M28T\=Z-W?A0:>ZG.W%*D>80*6_4CBJ#],EM*VPIMYE9CNFF8D6ONT?"'8YD2 MYPOMKE2(A8<:7_/XB#"(7Y/!0BLH@,2FTQ!#>$_EJ4 M[J1?,\JH*X#:5!I[ M/8\_BS?^?@:U]6H4YL3&E82\0E,3+EF<>_:C].VN]L?2?"9'2[5=6/EG(G]2 MSSF,9DYV?]:NBA1R @)I_#<;:*>B6O4>#SL1S=X^:GBEI]ZOV*:[\0<03%G01_C# M^CG.JQV4VO5>MIC>7U6F0J?N>K/S&^1)L,=W4N3Z,E"ZXE'V?;F>:F5]]\K, M?--EV*Y]5!U:A.P0&/':_OL2R"]52A/+76)GZ7K^3Y@G:7V.&=&;O-*W"M9N M7G[PGL8;>9L]WN^V7)A]2:-'P&984 ^,*4/ YCW3L MXALX,5>TRH> IW,CRN"--RX^5C-ANY/7LW=4*L+B>;M,J@;3\ "$. !-N5-@ MZWB:4C\^$QI>L6A^'$FPV1?#P[A7LE&35]>L9C]=F,';[33$7FJDV32E7G/N M/B+XFT)P::QX2JIR+S(_:M7-1O3JL8MC_:OFY,0O5FS76^3]0ONLBTA@^:0- M];(QU&QM&5.-(:L;?STKZGJBL^J"MJZ&")GI&F>1)QC3T.4*&%Z,+UM?6?"] MD*P6^M- NEC_%KCW8U_Q]<&+0;KF7(KJ,F(TW5_21_H+EU*;F.;5_KE\Y. MV//.7M8(#C9DO93)-E,:/M0TM& F^O;,>,@VD=;?%?MR:68$O$M)]?N/ MTSU5^I-<]/?HCCGF+H >A?U%8S2^B/Z+QEC6;96H#3M+'53*3K_F><$XP/_N M: (AH>ZG?AGY29WIP[+R#/Z=JDRHA3[OWA%F](E+1Y[9'LEX=K;HX7F#T[]0 M]83/(\4SXT!,/_1"43[5M&YA$1,^G%\W'^'8>=9;#1TKQO$CWL\\,A:LLQN/ MDG(]^AFPSMT57(KQ?D5M^JXFH@D!#,()7F1Z#FKJKUA>>QHY3&%HQ?O_/E+PGF]A8AKOU#UT==A5$MS0'J: MZCN)\S"?WM(#DT]J".*ZDJ/W])MD.F]GYNUWMU^H>>:'DC?;3_2_U7@7N/\S M.RE7C"X!@3=024O"=IUY0\1'KYP@_M"7K5)J=-U:S$V%]< *(S2G0X>?OT'^ M3_B/NCUI[;8E9SG (1/W;KX:$O_!\(C)_6,3U3*Z?SX9R]I/[G:\VB_;RX@A M]2R\W1;S,CP&^+_SY-_#;L^7ECL[>6HFO?57^[+-6/\VY^SL-'MG=,C?W_^J M=MV0:L*09*V65LMA1[Z) Q @8T[G+CD +78S$MX!#K9\B5YF7E\897CMH%C@2+"A_OVA[O1[=HD M..YB^!7X9*A/QU/U=?.W'H?4.!(WIO+_'3,NX9I=E+, 1[JE/$78SMS0C H MU\7K;XQM.1^XFQO<.^5OC&U6(39L*'SYEJ#^!7GY=XVL95M+N%V9&:L4L_=1 MH(5W-":& MV=Q[ 'H;M],\6&J>_Q7!T8XNT [^9TH<,9\>B>7<8[8<@$9CY1.ATZ'*?_XI M6Q#W*SJ7M"%2@IQT9K3CX#!VN@9S*JN7JN>)P3HA(N=)0')#D = MK8YRJO,K78 XL%11 +3E1&T=ZD\E;1-77S))D*Y'S8I%(=YU+^!BLHG&I_/\TTA7M1*):8Y[G70>^[Q]G#A^ .)A"4TI5BPJ)G)VZ5T9_6&,GMCEN MP9Z385WHDW3K"6TM\H8ROEFWI7)-5YEV+F9AP$2?^BC&O>0CHY'2OR%D]*&) M4.4C,U:EVW^U>U!L^IJ<\>7.!T\^R,3ONH;@B7JZ\/HOO*<[ZBF$^Z-M/QH' M%YY0LR9KY*]DBB>BC-]N&8]D259Y2*?Y^=4MF;LAQ/JVUEVH=0OF&QNTF)TH M(/\ =.(8 R,#N%4;GGJ^_6&[*K@7Q]XNQ$+(P7%T5W\,U"BP$'A. 1?O1E.H M6_AD3D"4<"/MCWD^JDOMB"J&&Q#%WVFE!L>T0DJ^:FX,_;;VEMD+H]JAH^?Y M&*]TP7 Q_G8Q(UHC>;F3 ]*[ _T$S8JA!U.3%ZE4I])8;96J5=@YNA&"? 2 M=@(N:KL<[0Y0@I OY"\JXY4YD?.['8)/>Y[YD'6N?CHDL)/HW/EF-,[N"A@@ MZQU+86>+?(6="[RF> !Z7"4_TPGC3*S:%J]'<+CTB%?K$9]%3FX@N$7DA;7\HJQ9M!N,0U&A]*R.HI3, ML](3QN?4Y,82]27+IIN,BOMFZW-R=A*O MF9T#:VA5*.SW9SD:V]$/.Z>_1#VB^6RPOCLA 'L>+OB!B1^E<](>].]H D8E MR-$MN]$ #D@/@6X20YY,H+M4$U="<4GKJ@#=A>;PQ229%X#=J)U4PT6%"P!N MG"]:Y61>M%Y6Y%9FGI$Y !U_/0'Y%1V#X]!5(*&\J5L]IF+=N O5ND*G>_$F M!Z 8S=T8;;URI%97N^)P"<$KIP?']7@[]\J^'M4GP6M[_RMW9/A\ MO_&DRP1F4QNRC*XOKD?7G:+S9E'X8W4E3/AP;M2AG67J\H849AIYTGS#U-C\ M-)!,:8S&>>HAG_7OZ,V M@VE'+]1!J!;YT\$[38 IM7\!]X"3$RA]JU$V4&._DP;&4MOW<\9/PE+\?X^!N,Q:M%EPH,E\O ' MB] BCS+3'KC!*E]08_Q55'!X.Y\;2+X_@?/T$L,S MA:A+6>CJ0_'G?.F^&$JN=K1>YY3^Z,;FMHZKPSAF.0)O,OICS3&'<7./PFYB M$E(MG:0.:#!/;^R'((_M7 %Z:<=N P-!S?P=/HFBW(2T^S1L3+3:%L\JDYM& MPJ\$FM[Z(Y@_J%VDK6G\5 2V2N:0&X@M'M$66N1X2G=\A])INCV,DG-?%'DD M:OQCU0Y/ PM>SC#&7+QI_)H[G9@(]0^*:PE?EUS/F,M-BO-/E)\&&Z?>BQDO MUQ\TE2U9Z9/?^(I-#]Y$NM/YW)F6.OMP].16)XSA)O9L?)^-99L#$ .C[4KV M,B1GK<>38=0H4CX:B[\>LQ ML2B)NVZ2(V=(L:[ M0_HHD9_,S**TL7>B>=Y0;8N+OSI?8T6M Q#OBDPGR_;M8G3-,?!V&.P<,J8; M*M^:W1BQS5[AH*BV!A37YLV]6LP9B(9,DH!KP0M;B>OANG1!QAO!;N]P(60A M^60.U5O$;' &FEL/$P;X>]#GZ3Z^I4#J]WT1;:UB3AX/,2[P)HH;P<#Y5@$Q MS/.L8'&50W00CS^YLU^B*EXCK&'(>^*B5:<=8TX?ZV%1L,B7]WHDM3E^W\)X M1C%L)=S&D\>Z@WC M)"+^@/*UT1S)NJ]HD$X(ASO@2.&PNZ$"].OI2@,A1:SH78Y<-L>-9MF.8#G/ M-2;XU+/<0?077:XQY< <,!^A-Y.HGUE<#6#H/!),MFH M@3\ \:,<*/D74%* 4/ "CH,NF=P1"HGX@6.CL[\\>H M61UMW'\0'U6AJ3.=FLOQZZFD;N=?XO!.3XTG]K<;#S7Y$1^9^/RC!Z 'YM-K M'&^",E;Y"%Q7!$"4KX;:Q6[# ]#/ M"? KCO!@4>TZ#1;$"F! T:>\GM6_;/4C4:,X3[/N7!E.:#ZU\8SU7(L8&1"/ M1'8\M#3"*UR<.::NGB7*/>'CI:90)=3%PMQV&VH+YOPK#:'85#Q?8^$MBL^I MM5&DOV,F7A\WT7I-=<[1BKH5O2W4TG;,C/(V81!7_WZ-K]RJ4/'Q.QE-GH7L MO-IB,[,SEB6+I]L]&MJFVA%MH?+D;UME$\A@MG%[CS%/-2F932+AM75V0EK: M2'$+P53[.9.M@O7.8L=T+P-V.[:,#]P[\;74N>H46C">Q#/4V:1[=J!JZ$G^ M,5VM^Y+9IVD+ +;(D!UX1]=]%&_'>E[B%N3OE=(! X]7BC$'(.T#T$+#'V* MK/+&F]/'A<2B?XNX+$- MT7$ $@*W7T*@.0*4.3QUC]-*JEP6P?X43'>;N0/5=.D9!<;FD2=!W*')6\_I*A2QXTY?!3DV ML\@8&8I-8RRV#6%&8T$9' =VCDOW.BLTG*2[4*UV;&CY/3/Y1 6\X')7,X*BE:6XX\Q(5PYJ$&)R2U!%*X*P%C$3%*X%(.90[1 M<<\!91EV #KJ$:Q[#E!7W3J/3+/ZB6.REU(->_+.,YK:99$S79F>[>R,@E:Y MA2%N)*=C+7:"V.EHSHZZ0D5WFO-\Y2=F;*:4PCDI&YQ0:A@"6AWS9C6;/$J7 MHVP=\206SR5.QA82O-!N$$\2H*BQ+D+SWU$%]A=@I^EZM.(#4)=//*EN.0EU MJHBNFD^V2Z[?.@\7%0?*%N*'3B=J.=&D"PN(**53'5G.4@@2OY-'_OGMBHL! M#&Y[78X6VM.5D74LRE7;6^Q$JF(Y=\":$LJJT,C:JG).2@UZ/_6+47.*%]9- MR'ELO*R7PY'WU=-0([/\%CWK?!FPEE'WZ/V^K84@NY;4(-3F 4B39=)67/W\ MFV5*_CJ\TK!\'IYMD%&)"@?< @0WMTRH@SDR+[2ODI/CG'GA@9S<_3YOX=FE ML71'LI@@TA'?SD-]6I+K3W'R63P5AS*M5,=BI@S#Z QF#^P8W6+?E.X-&.YK M %8]_0L*F"3U(;)(L$-+#C3M=E:G*,\(FAR C!/QT1N5CH#PHQ]U4PMFNG7Y MJ3T8M;RT=\ ^/H\+D8C 7]'CC*U'SZ !#?>%S:IRE!OP ,?!65F0R7 '+P\]H3T;F+[BTQ)D[^Y)U75#S>!P.8$7NMQ@QR:8:= MQ,%"_[?0CT6]%/,!$B"A02\*VSG,\J1XV%X?1!A1;A4MQ-L5^*3OC/4[%\_B M_HLWU<8UTWPRJNVDM$RKO"QWQU6;-C3'_#QLE^I7)TK#L#)&8Z4\U5@C_)RY M2>?$2(D_J3%X/;X"W:&#]O Y25<8#;_BZ:Q%LT:?T^:B]1H \>0A=A)=:KP5 M7$$"#D"]>V(Q,WC2K[3)!#4G#1AUJ90ZHJU7@BPTHW%$,3+?^KNK1:K;00." M636&_P&H3KDK^3S](2,'YSX4/Z]4/ZJH;4>S6XCI3(X5E:FA,JHV,I^[4<2$ MD9PW6!4RO,#!$YI4\XX(YR-FEOF?RT&@*SRS&G;@9^V@B>LK4I]P'_/IPAOZXF @ MWV+59;[&E6MFW_U1SD&Z()60\;@JK&U&1[&=ZVUR[W#1:[B^I6_4YU%4X\C' MQIU\I\IFB=4XV8+VASO_]1SL_[V+XQ^IX?_,'"]J#,<5"$V'AE?^YZ&>?[OD MIQT<5AJ"FL-SX0@6X/;A+B_>?0);5<\FK+Y#[:D0OM<5*^Q1 M_N+M#5[/.%FH1T;JB-2P18*+0">71>1A1_O#T9(C"0\J_SHR-[G-8Z%_[.]_ M0PY?.N4X-^]YWGZZ _VNJM:3__W,+9&Y;].2*=-57_K$!_P:4OKE'=GFNM@D MX\_?6.?HDRWTRFA$AV.V0FM=!3J@7 E6Z45C#PI>E\I<[^OKS_9/+Y5I+9:1 M"9KYCP#^'ZY_XD[^685$?V9C/3?8#GI/GI(VLX13_?NAO-7Y?W6( MT9'+*L M:R%@A4P0#%TF,4QA36A*O+FNK:XY=J&IOJ4A5U0H'O'"B9S'ED+)ED%^-C#X M9?!%34&O8+FX?(&XK/7M>[PV-C?.E(/.O &!0&>MWA40YXD;80CO29E,[4%4 MS;*OA?^7^X,J7CU*CA]*Y50Q#S\3Q]\7Q,G*_ET'()];DN_RJ_= 8F)N"JXU MZUZ[>N;PC-#,SPG5[+WUSA?>RM)W'AAY/R*IQO-X;MZ4Y96P@JD0/IX3?^R\X#$P>_#Q MADG;1A5#'>Q /:W>:F963[[52D_5;*2?)V[DH] 5S0S)BU_?F,K)7)22_:@F MBPT@V,)+"TT]""-O4WJ%57IY+(HL;L<+6QB\E4A2O5U0?AGQ>K0+,DN4D3F+,5J$# MD''I&X3[REZA^'_QCYTPJ6 7FE8L;JVM;\DR;=D/SP6/UU_]6$IB9"_U;S28 MRVM!YQA).]\(&Y<%EO;5YCX)T+3"P5*U8O5 M"])>IUMSIT$_ONM1,9U[UPU.U?N/S^.C1)+'YSC[4?MB@R3[HGNTCT)E=DFW M?[49&]DX4-#0VU#8UU=8T1HX.CIZNJO+P*DM@1" \)^S>-C1%2 M=]Y&"!QR:\9=D]2L]<^ N$<,<[%$RI=D#8C\LE&W<7].1OUL2&,=7!V#*-H[ MI&UU_E=QY1^;^2C '%DV^_, M-;7>P R>E 99^+V%7>IC51!_P<12GF9F[O( MY[TX*+3D;: 7PMT?E4D#?^DN3L_R=X .!9PW5\,63>Z.$CLDZFV_.<^U&B?Z MJH19WY,1^-C=)_?!))NC:-:M7_:[/B[Z?FVZ=^5/-ZDZ%Y:)+O_[_8-#GT;] MK->84 \NZ?P&OMDU-W/+[S%FP>&"T-JM*]<;6Z.D,\2;8AZ.5-;*7SOWQVQ! MXJZ=M$4"9?%:CV]0JQNO;(OJ.*%YI&CR4=HLR\/._'LDO/DOMIK!K" P.$@P MJS_L\^*($&(7\E!I]R],*\W'R1;4ET&QWC"$;;'SG7>WB&96GR.(7$L^F0I%-JE?7T1I!OQL MR[UV*]O,\G-MRQYN[35^4IZ#J,4MY" KNG=@-#X=BG5;W2E4:*TTA>L M%>%,V]CJ\.%"NAL2PB^M-7\2U 97(>/Q\UI46!?XF/$X>&ET<]LDGG04WLZ1 M?SC\,U;;A (1AL1A-PQT#"8-=Q L3*01WD6J@[V@:RU6*',@AQ9/=9F?1(X! MRQW.UX 12OQ3OZW.YM=\?+9$<%M,)(J_$,E)3BK(XQW;>$B#16*3+R"YG6@^ M,=JNOIRQJD,7]-Y]=>9)8T'"\@ [PYWHZZ,[8HY=8:+.YNX;[OT?$7X^5$9([9#=4?IL\Q!C:6VGPT !J.^.[&KR\.HA2R\/JQ&-KK/Y;]# M.5&9+6_IMX;K[>D:9%P\Z1SVA;86C?,6]2N--^;%\O#<-EBC2Y239I;^?<8S M$QJ8G]PJ1IEJE?&BD"[. R(H%0PRQVKBT<\Z,HQ^?H;)QJ!^QS/%1[3M%I*% M4(%M-(Y!NVX(?ZLO4OL6>>.*CF&GYD!U"EF%6CU$#GI.7JZ;T+[$.^:L4#.< M1A'>Z]K+BI)DA!>4"*R[:1HG:MN*\Z0M69-M?>."VV.- M'.=W*^N7=JN>&F<*<5[?=[A7+)_H,&A-^4RP':_?*LF:)WJ]74#7-:YW4*_N MF%.#L N8@$Y]DY=<9K7BE M7B!81F]4T[FI5EU,MEJJ9&@;L[$289<]D?B&?@?PI\G1Y8L\WW\E!D>BI,+> MHJY1EYX5>#3#HNB\!?HG9N:9XQ;&>5?YC8O6K+HFHZ!9.QD2EIZ!2EM;?;MI M[8UIWGN;W/CALM.$7$'+4LZ(:#L8]J@=R:=5XB[''U=M#YY$11BB]"GO4G89QE&FY?@C%R:!GR(G& MNU16M<(4.B0Y/5]78_=A \P[FZ43=PU[S)_EL^SD 3LQ2]$[]-Z_!V,H?&"[I"^3/1FH4#$#_4(_S2Q ^&1(\N[Y@JFM?# MUS,+4XC@X[X[.EEA8:%M)E[X/#>4$)"3H:%9EU8J9Y)MQO'QVW4C.0TA#:G@ M,HM"8WECU;)N4RDU05]CN(*49%9KZHA,&)@OAF*;PC+X:4;4CZT7:4C"O7%= M;61:)P$A*CD6TS$ HXC&NE,WA3B"."Q%-/!/UG0%J.8QX2K5R0N[8V!OE$80 MB9?4UEX;KMSB)'KCI 7(0M8GPHQ]S&@9X.LE84J,+B^&" MF&@?U5P38T+U1IM97/.'3T[!9C8U:JM]:68YN0X?.RIT/1H8TTXRG]J61KV^ MQI;&O#4RLBHT/A-J:L!E;/0C([/"KI!@]_;G,6HR\W3\/B_]%V .06LQS5KD MCZNF0Q8Y(+TX3ETQH*YWQVA!.3I<@;J;% 312I;4[ORSE.'(MM_0< 7*C;. M3!J.JF[%BNK2EC(J/:R<\(L(,3Y//\-R_ _^GJV_(NN^ 0NZ8KHA";ACR0FH M$!J7ZI]T%PQG+$Z@53,P8(0.+@04S([=I99VB; ;$MH'R+G'C C^Q? =:5?$ MSO2GYJCN\5E2N(69_?KC\C"'!S2E4HGB#1VL&?K1W)RN-^*;1D7B^GS5?1.. MF(00WC/RPK/TO$'AUC5]!>CL1X^\%8]D 6![7YM^D5$:+C9$;5G$/%,EO1!E MR[$;Q0(_^F<&8'?:"($#?(^RS"=4E;F0_A8C=!/RG.FE[.]WF]J'L4\UE^\- M!YHB\,V16=!S314KD[BT\!.LA1L.>6#.ALRZ,ZFMOP@A:E'RTDHY]'WHW(L8 M$8#;A#KY(FKG59B+#P/SE-I(]L'["$$;,OR#3]:50F*T7=YH>89ZI8>F>6J: MK HZ'8 VG7@L>A8O4S,T!;)_N(#ORXV_E@AN,5*#:TE^KB0:W0^\/!4Z:E5A MD&%D"#?C2FM$8,N_A8J&4//)$#SF6?XYE 0UC:P1I4HZ3M>F*J5F:T2C-(H9 M)?:/-VX3G)RS)%W2C:MBJ\R4:Y(4:AWF7KOBXFHZ/ M%6Y,*=P N,I:\ZV,*!9,C!5E YJH,0N^U.0NY1CSBH\+6^% MK!/\![',2Z;K '0^L(K3OSK3X%V4D, MKXT!UKZ<:&M1IEI>Y51>M&'E (G;;U]O-'[]6KBLX_]C[[WCFLZV?N',C(J( M$&F"H$0%I!.59L%D+(" $.F=B(@T(2(@04+B*+UEI(X@1*4) 2*])T(HBB+2 M.R&)TI%$*9&T&\]SGWN>,_?.*>\Y[^>]][WGC_4/?/+;>Z^]]EK?[]YK[]4$ M)P>*!^91?O*?&D?IC]^%@+E/^8#9/%PE'[!JQ?RQCY;5C8NRH),.+?+$^CD_ M>)?S >VO6/G4Z-AV9[%Z&D;C@#Z5(PT=2>UF-X-%=:='];>]5RK M@N!=4S4X6[.=]0J]F]%-!O^$U*&2'NB2G[/ U*UHP[.SV-T+JY$E?LD%+,_V M;*.\AT]]8VU&$'JB<"M].;OHPA+B,&*M5J-:9@),T XLR/1>6BA4'RZVE"JV M+RBQ(547J_78+G[U^W9X,BEPZY,9][Q-\8&> M\VR[LVV0DV&36N V9?JOK= MF@4(QBGS>Q[9/R-^8YCN3(%:W'_%+ :T>MF7QW+"_4$;BT*\S,D1.^7F#>Z^ MF;>#&QY_P-?^(;%O@7[9(8@Z!#:4*QWD)$T D^1^5?[(.P=\OO^,V A(W1**/F@A&NHL/&"A9D!O?1K]X+4#2_[0* M_Q_E&?XS8BZTS<(LEV&V90G^!*F'7!1T8P3*W>M0.Q)Z1H"-+SH&?.6*TYO^ M\BP^U&!&85BEM27[5/Z)WM @=4G#G]-3'4*5]K]6OCS[Y8PC[@+SYA MPE$\4\]A)O(!/Q[A V@+;LCN4#$O-YXKDN M/&0G'_#+/CZ &1*LO;PF NG[?%Q5T,&_;.[WO3Z=%;H5C?/>DI6RYP-^UZ MNGD+_IIW C-["5\U.VJ.!^5V#F/\ZP!2OZ4CJWZ4DDY.?B8SJ M%1[]QP3*[QH#_>4 _ZW-?VOSW]K\8VVJ_V5\='#S?;IDY>)WHL4JMJ$^X=3] MO*,B6D,G]UV^!7Z==.>V3K>U>NQ?MKEXK'88L7VD9KU_=;+WM[^M<(A D;3_ M8]3S;V/[OU.;O]OGK_S][_JQYX>RKC36G3"9>Q,6H X\HRF5O*H\X!_ MQ$6II[W[R-^^$'_0BI%WO'/R;.@N@09%52JP@3,^](6_J\U_!Y)_&_G_'[39 M^;O#XI=#ZX?,YJA*":H]B?Z7W^A<*D;9,_.3]@O%V#S\D&(BG?O[OIGBM>Q? M!YQM55A[]C>T./A=-QK_GX_XW_;S;VW^L39/_.5-HCDK),+.R?-FS.']EZZC M^X$_O\+1UPD6+W):RROX@&<%VIEXPK<#UIBR-.XF'_ A^21.9?L-E(+@[A[4 M./E'"1K_;XFPY&=SWI* 2_E;#<5O*?,!H9AUO1<+?S6_YN^5$I/M+#X@$IIF M:Z?ZI]HU:\5?_ )_ZJ>P[;3!5_G U*'[-0$G\>MD;XX)_S3>_=_DDQ8LPQ; M,.47]*3-5:83N63!O,G]ZWI^DTWF=@BFWLC(NG\C\?J/77:'5]M]'"D^8%/R M _$IDJYUD0HA1#8.??J[];PN+S%$?6*7O'D6>;)*=9S#+L)M=?I:)_NYII2KIP]? M+AD,/:(:W+9Z*EBY5V; JBGR=;19Z,%T%>$&TRX_B:0G2O5)913-+-N5]@26 M!GV+(_5UBD]KJM]G=84Z=AI-G%-/,+40ZLG<]*PF'"-;W M3CP?\.#&\C8OFMH,F@CSZV9T-PZ&M,-C JC;AR,2I@[=F2R\*)>2> MUO892E$H>TKG]/B):847>YZ^_K(_+:I22E%WA:H^-)0V:"*C45PZ,#H,*JEQ M ,V"X] _L/!4"W W3H03-,L'Q"L(C5"LL$9,W/T6\^FWE1<;&5L5-3ZA![2'NVP0>DQ8(DK-:)W MV)?]+>X"1?UE[-V/0@X-UP#WY:J%P,1]'+93;!=&\ :6&7*U?AKUEKFGW_N: MT )/6)IG562'ZN8ZA]"*K0N.[!JP>4*7K==*3<^V(&8O?V#3$E3+$O>H$@1K MQP?&4@.M7&1K(=N!L21YD@]8!.G='3A8R <\7-=2[ *)<\RIL8GFC,^-"%!* M#3P&9YB>D>7<;R@QYLH\XS[=/"M NIA<.W:KAF$19JUGAGOUPY M._6AB OIRM:(@1,6I(;XH>A3C4-/U-H0:F\N:(Q8^X);V \2.+,L+\&CIO^ ( M[B^.XXY&OL%,P[FB?F<>03Z2/A-X,;6'_JDCM_\4Z3][ZX1"T!*+9V[UO\XO_4?%^LV6 $W<%L0RX^]^T6I$U%@(D'0=?%_3<=_3,E?@N;ZC_R\!,G_-M(*\#+E5<&V)@71 M1[<'A5M6$@0YTKKBE3^%#N#7B7[H)]U!S 0<=9X/*)\N<=B6&/VVZH/[DNU+ M6@43#_,!(Y^'\%QA_T5D+"LR+V*M!]??:+5@ M\H^EX:?'_ VN+ML[AW;]4HH64.PV7S[@DRJH+I8;S1/A Y954#L)Z\H5+6\/ M);9YC>]X6;MT]4Z[Z9OS[.K;,?)9>=K,;-<^TV-E$[4Y)]JHMUE/ F_A!Z+= MG9E6<\[=CX?G/OGUNK^U'>P'M1EP).B;3[E/H=>QDVEM.,"&!=2)^($3S&R' MCF/IP%>]#K1C+XC[&(@.D!P*QC!I7]N/NC1P"Z51MDP1TP,) K!H*&6W;QV8 M]F*=)'F>AMVY,'.4H9U(TSKZME-?X<0'3A]/!,8'J/W,K8&N@!EP02P].ZL% M8]MVJZSN%'@9!"N'"HIY!O4*".X&U0T7MP'%6.17.PN'4.+,7=VTBBR&'PR[ M?9E!X6CD=#&+$SFA15.HNZ2$;KO^6@KK"LH\7&I&?TCOF4$2X:G 80WR 3U7 MH0% M@A'1C"AEBP1]T^[NYSJ@-)OY$*9X;JEM"/2"$SVP^9A//N]S/0+C?K& M3T/IF?"$9^_FS8&/C7,/&&""MQ+>OIVVK@_7X0K[/">E\ $3YCRQ/=R7/""O MGU2CT@[:B_3<-&ED4-HQ*119M"SR'KT#(LQZ%D8[4 .-I8BC3*FBQ]S0:S#N M4]T(D=R@%5W_NR,J50.Z.::ADL'*=8^+V]_X E]=J^)8>IP>)!N+V=**M>\] M*BJ;KKGC]YDKOO';$[>#2I[J[TTM74NZ)/*:EWMRL0N>O#T!;!LXNIL/J,0( MH'2BN^R(;H *+6 NUU.PK*A"FYF-U%X5JS0:% M6_%"S*@CZB 1=N(0O6G>4 M)[\0C'Q(8R/WPX%^'Y!9%UAA%#]@XABCE0]'=AU MR(9&ZB1)+>2)LA"(0A:!]KZZT \W"94WC*1#DPP@9[/(89L09681EM9Z0&7( M\#P5*HW$=Q/UF0'U"7KEEI_?BRJ([N*QNV1X)QF( 4HM'[ :R^SF[1'XL!UI M@V@#C@DC]L&Q88@4INVR+F&WOP-T1XLR702QF^7PJ@Y:M=FJG4N#'<@-ZX+N M^ZSKI,T)8-XAMQ>[M8S4E,O1^( .=U$&9[_5TG8!$(^.QK350:5"SKG, E?E M&?84R]&C3+ >":=$>H\Y&+?4/<2+NJ^@)'AR/A2H4#?"8NI>^E-!=MS61@& MM&,+\Z(EY_+..;Q_?N0Q!>FJ)]CCY98?NB.#/$I''B;E MRJJ8.I]T@ >,XR.&I3(KXVDC&89DW;;!W$_1V]4$RR=I"27'BCZ/8'WPQ0.B MMZ:_P9-(C "3=GG"3A?'[QDS-=#.'*#<%*N:?-4_C*2 O=_B186S'+)&%XM8 M'Q>=OVDO,N]CG,Q8TK,A%3(F;S\RQH75EA@(AB'H6NA\71Q3F/?%Y M3O263.FD*YJ=RAXDK(1S@+3)$!Q@2'J!EG MU7R:O]J4^''NTQ:B!]>R=H,P0C62SS;^(#QGE"RW(9"VHT?Y"ZB(_A6=IBGG?5 ,>_=+H;\BR_\,G# MRZTN8RU@J51_^_T.1%5JQQSRX#%%8'3'==\!0L+=?$N80__IV%E.RH7)'BT66E^OYSN'YBXIOF7IRN3?3Z99%QYY;9OX8 MHR$.>C'K[^E](>\L2#FJO6DXW_HX-^IY@D8#]P\3D]2M> *<1X%]')8V@PZ1 MV(N<[/M'_R[>2,K&/1#P;L<&5+C KP8SL>T:6(ENE142_<4*R9L4_54^XXPA M1IP#*EF"/4.=KT\+OL3D7&'>+*2!A2>F7$P.9N<]*D6=C3S?@0;MQ!3Z?2/* MT5IP"0MS>E\2>!-Y3MGTDV47MT+QT=E6!+/>K]1*W<(]8_>:U#IKF1=,T>/T ML/L*BI&@:HAH3XM13YY+ CWE1^I[Z)L!.TS8_3[&^]"J,D1-\<[8]U\T \Y\ M"PR^WS(?3;#,-9X^:"'\3J"316#'7Z/P_QN2U@:*".H" Y9<"Y5?X$DP]=-H MHC J*0%#%68.YSV^HZW,Z$O<]? Y\G&-EKG/1%;_0IYB_YKRY8E+T143 P[F MD^9O_3$2W&JH+U:4]QI>[= )PQ(5V7ID%I@\B&D'/Y]Z_?WE@ISN,]45&;-] M8H=-G":T8!TR=]5>O+VEX"]Z2$_KZK.8KNNDUU".N,WF-Z8*&3:9V.$.8C73 M\+GF9$R==UQA%3.SMG3JAX,8N8T =S[ CN&=J"TB?M!Z>7NNNI1U@>EQ^7FX MH5VQV_2929^7<7S &1I6_ Y1EI:RGUKFH%B"L\_N' VNWPS8TS)VJZG6Z/FG MKIOZ!?/Z^6;1!XV< B39.J^PSXH/L19G3; *^C?,)6'"5'UX#$[L4PB#-^#J MFW/MT-[EI#L N;)//V!,UBQF4<^B$@%LQT MD'<,Y9!CU;_&L:.25F5J!PU!5)F&^D:BA??5&HDW ;36"/.3)M16G;?IB\M! M0G$;>%_=3X,U??LBV]A0W@>0*-07$Y,-[@1'-PTL9>]_033B1O% 8D@LS%0Y .HX.&'[59&B7#M=DSF1F1,<7N3N- ,CFY]\-=KE\,JZ8S!/ M RBM7I,VK-($\VTXJUZJU11H:MD[QMJ+Z]3^H:]A$,+84J7=:C[4.65P(5-1 MOT=U*+!<]KUULE^(7T.I;,\W5.L3'3-9LXQ2KPS__OSD9+G!$/IJB)51& C] M1WY:]3_0\@VQ/X'G#[ML_XR4B]_\&4#_276\GTB^N#'V)I<5S@Y'?X!+0^1Y MO9@:C>5[B-5HI@N=U(Z+<_^1=;J" V-\[D70;S8S,53OQ/5(%S-&=[*A4,49 MW^WBF(V(5A$;-SO=5M- C@9=2V+4<;"V=]?H,BZ:4HOC'%0!=E!B)?UYN[EE M1&6?JZRMMD%_C!CJ(OL81^E/3P+$G;GD?G3PQE +D(!R('%_JVD&Q\BI)-[* MQ "7*.+:&Q8G*6UGT,^":$ZU&CL&Y3Z#5F@)V\+SE?@+R7+?;HJUO/"@QT8[ M/_EL=N)!\JCC=(6_FM9=[T=[2VV7ADK,Y>,+Y3)RG6QBU1,#74=GUV10^JQ0&B+NWK'B M0A\^X$?( =2IX9$Y 5AW#B2)1>/'D/6O>,J#\P)L%H>IUENOJ7TY2JJ:)&]O M_E+JE]?&7-X4_.?!&L?] [4_!#=.H,^_BCRRCI#V02O"[I.JA+IWP.@!0C3O%$/%,M;-W> "!B$.(KT\\\-HS=O5ZU^M\3T/I>A5$[MZ):X PL1YH/V%3E5ACZ"T*4.#>?>!2ILNG/&F<* MO0))=K=C]B'/=I)$>8>0.)I"?,FB,_05-@8NIA?:2&+8YQ(N/O/;5-!B&,2' M?.- :3\5+B_Z^GL0,%XXX/+$KI)2S.T06^L^YJ_OE'^S2SXSK&QL*ZU?N,=V ML5%-=="T+M6/]S4M#-5;?ZFVQ)V2V5+WBGMF=;/NY--]C$X-&4F5E MJ?;0N"XNGC1+>UX&X%9+_?JS%_8ZC$\0ZS%'G2.&PH'["+!7=ADL@8EFE(WP$^H)W$1..?.U*066T@ MQF\^C\[G(PD\<8N;$=-"/ FWH[M#>L-60!.9XB;^H1)B/0FT;D\?&C>KZA7U M);H/]Y@ZZ#Z8DSDU"0[+F#3FSI>.<&5=]:Y H1!UH@HNLZ<:EI:Y%33-'G48 M+:J/0*VRG7GO\^2YY="; GI JB8E(&3,7K(>4TUK>G7@$9'VV] ]R&ZSEFI! MJ. #Y,P+OG.UW/FXHPR'E'6$&+("+O*&IJ5AP;QR[RPRS+DA0-Z&% .C5M%G ML8)%P!-69A)'Z=-]9((,4IJXGS@-I]4]]"U!3FXBF!0R91]K#*G#$\!D+N5#'"'//8GE-5 !8&H@"0"13D0UB/$[#E/4X$S[]%P;=;' MWX_V$TO6M)<11P3$EN$T[IKV:*%.^BI-)F4^NMMB8Y7TZJ*,>JB=Z8<.*]XA M/XR$RY5<_#SQNG ($/B@TQV5*V=Q)PVE]LL\W'?*] MH*[5Z02/6"R2$36$GBV)+X_/M73IP0^H'QRYFD!2#[1H=5M?+1& [;S0Z+\' M!?\#(J$RE<4=Y@,^C.27_/D@XL,?[Y9(2VWM[MD*B3W M[>9EJ=7WWDJ:@$OLR$*:F.5SMW&2D&-(T.S6+YR+3! -&G<+!9Y=$QEKY1'P ME$9AN1\E1%P!+LOB13?='7=V]U3YP'JY@)>X7;R1&F M >.A$JCSWE3";I9?;\7&(>-5HC>B&>'A$=B8S0?8DG("ZG#%$V59!F$GE:R. M*#WBW.;-8.IQ*=!;A(/AQ[G-[0+/@@)'GF:H_+)WUO#SCE^!TJR7YQ5=*,B\ M[>G:-=7+*$A_8MW&C 5#O(VX.76!&AA6\,76J6CSN97;@LGB.V%I+^)79V18>E0(Q;[?C'<[?W#_&VE^TA" MYP-AN1EVQ];(RK*4V5[T'=[DS3T',PNV\B5)A@!"#.#>96#.\0ZN0' M/: XJZ_C7M3=)F-F=B01R'[D5SH,:WB.,4FMCR6TP 3N5Y*B_/TQQL/KOMI@L+;2C;J7@[>T M4EVFS:U;,T4.0;J$U\ J,3,'E. KA$U);A1'F"V'!%Z/3.S@ V0X,"\ DP_ M=@C-S9W%LHQ:M#;C!N9AC,+H'L74Q9U;<82G6(=A>K3'0$BNY-!8YMI4>_/%5?M/-A]]C=7N6$7GP'>H\*XA3:G@.(P9'[#O*T23 MUM)WW$GBW1%X8@.Q12*@4'B R@,5JG*=/-'E*PO4VT.^7!.E5VSUC<53+0I M^77,RK=9;!Q7 V&8=,) O4QH-^\0@UL;&V_HJZM@[A?F\[Y_LJ#OH$/V M$V<[_/F"[@J_N*8N8MU%Y^'\&-XV\NBFF2IA7*W-NM@R/?R);[LN;5[-TO)X M0L*=)SGIG[S*"J8*/D\&X%8W';(\OB15:_?<3NWH$\F\=OLQ6@[YSE[Q4&+& MWD-[D/=.=GH&A6I.3Q)H*36=&_RMKII*-4?*$(^!;YYXIM)$LJ35W(;K>91RC:>F3[G@%R8; % M5E[*G)>+\'-E&49>$5.'+G6+.LQ99L!6ISYGG/FM3-GN;<+KJG>;&C,/H%J: M"$)(\_(YF$7SGVJ0X2.61=BG"^I:JEIK'FMK!:X&>MS(G)F;0-*SA6FAJ6I6 M-XSMKYIL7_A>LQ+CCP=/PC8OLQ#,NQ%X;^:GY!*&02=>UK!&'R31HH7P152X MRB-)8;X!-'_3=WO MK?V.YR?BK>%D$W8.VXJ83&$>@J2,QTK?. 4L#^(#'D+A]"N)8P/SG7.&^B\% ML-BM2@Y5:J>R^J5,^>!7T0OI*G#)Q[5TDJZ>4.]AM)<^O$O-7P T(^HQ?*>321(+)P)2UC5TU@3$*J\4[_^-*FY/[=EV9_+'^;TF7UEN'X#JW\QH-QRM7X9'.4 MZ]P+:HEEK8-LN9?R;O/,<&=3ILP\N,K)Z3M M04##/L-WQ[_=_%%O^&?3TMMW"$#0112<#YA?AF,Q'1C&&N]!,(*C)X * M'P73= _./'MS*7E'V&1'HC0DQ>J3#43)=YH[![^]*A]IZABG2,7)\2*)C\)UFP_ M(.KJ9NI523:7WBC39(PXUKM9?9Q+;_S,V @O9XR'F7P%#YQ=B*!#^YUC=U\W M='[%V!3#R0_WJ7Z$CX5O[%T=P@$OJN5Y;61HBB2K3'WCCA, K6=!SG4;-&-ZQ^Q3+5O<7TT2:I8:\ MZH!Z,2G9F2^NDCU/N+L&ZHAF76,Z[E1B

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end

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